FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Moriguchi, H
   Zhang, Y
   Mihara, M
   Sato, C
AF Moriguchi, Hisashi
   Zhang, Yue
   Mihara, Makoto
   Sato, Chifumi
TI RETRACTED: A therapeutic method for the direct reprogramming of human
   liver cancer cells with only chemicals (Retracted article. See vol. 2,
   839, 2012)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID HEPATOCELLULAR-CARCINOMA CELLS; AKR1B10; RETINOIDS; SMOKERS; MARKER
AB Various methods for the direct reprogramming of human somatic cells have been developed. However, a therapeutic method to reprogram and eliminate human solid tumor cells has not been developed. Here we show a novel therapeutic method to reprogram and eliminate human solid tumor cells with chemicals. This therapeutic method may be applicable to various human solid tumor cells that express aldo-keto reductase family 1 member B10 (AKR1B10) and retinoid X receptors (RXRs).
C1 [Moriguchi, Hisashi; Mihara, Makoto] Univ Tokyo, Sch Med, Dept Plast & Reconstruct Surg, Div iPS Cell Res & Applicat, Tokyo 113, Japan.
   [Moriguchi, Hisashi] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Moriguchi, Hisashi; Zhang, Yue] Harvard Univ, Sch Med, Boston, MA USA.
   [Zhang, Yue] Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA USA.
   [Sato, Chifumi] Tokyo Med & Dent Univ, Grad Sch Hlth Sci, Dept Analyt Hlth Sci, Tokyo, Japan.
RP Moriguchi, H (reprint author), Univ Tokyo, Sch Med, Dept Plast & Reconstruct Surg, Div iPS Cell Res & Applicat, Tokyo 113, Japan.
EM moriguchi-tky@umin.ac.jp
CR Balendiran GK, 2009, CHEM-BIOL INTERACT, V178, P134, DOI 10.1016/j.cbi.2008.10.044
   Crosas B, 2001, J BIOL CHEM, V276, P19132, DOI 10.1074/jbc.M010478200
   Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238
   Gallego O, 2007, P NATL ACAD SCI USA, V104, P20764, DOI 10.1073/pnas.0705659105
   Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988
   Matsushima-Nishiwaki R, 2003, CARCINOGENESIS, V24, P1353, DOI 10.1093/carcin/bgg090
   Moriguchi H., 2010, ACSC, V2, P5
   Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402
   Okita K, 2010, J CLIN ONCOL S, V28, P15
   Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]
   Penning TM, 2005, CLIN CANCER RES, V11, P1687, DOI 10.1158/1078-0432.CCR-05-0071
   Ruiz FX, 2009, CHEM-BIOL INTERACT, V178, P171, DOI 10.1016/j.cbi.2008.10.027
   Tatsukawa H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-4
   WARBURG O, 1956, SCIENCE, V124, P269, DOI 10.1126/science.124.3215.267
   Yoshitake H, 2007, INT J GYNECOL CANCER, V17, P1300, DOI 10.1111/j.1525-1438.2007.00932.x
NR 15
TC 5
Z9 5
U1 2
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 21
PY 2012
VL 2
AR 280
DI 10.1038/srep00280
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 896RB
UT WOS:000300586700001
PM 22355790
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Kaspar, JW
   Niture, SK
   Jaiswal, AK
AF Kaspar, James W.
   Niture, Suryakant K.
   Jaiswal, Anil K.
TI RETRACTED: Antioxidant-induced INrf2 (Keap1) tyrosine 85 phosphorylation
   controls the nuclear export and degradation of the INrf2-Cul3-Rbx1
   complex to allow normal Nrf2 activation and repression(Retracted
   article. See vol. 130, pg. 814, 2017)
SO JOURNAL OF CELL SCIENCE
LA English
DT Article; Retracted Publication
DE INrf2 (Keap1); Cul3-Rbx1; Antioxidant; Tyrosine phosphorylation; Nuclear
   export and degradation; Nrf2; NQO1
ID UBIQUITIN-PROTEASOME PATHWAY; TRANSCRIPTION FACTOR NRF2; RESPONSE
   ELEMENT; ADAPTER PROTEIN; EXPRESSION; STABILITY; MECHANISM; RADICALS;
   INDUCTION; FACTOR-2
AB INrf2 (Keap1) serves as a negative regulator of the cytoprotective transcription factor Nrf2. At basal levels, INrf2 functions as a substrate adaptor to sequester Nrf2 into the Cul3-Rbx1 E3 ligase complex for ubiquitylation and proteasomal degradation. In response to antioxidants, Nrf2 is released from the INrf2-Cul3-Rbx1 complex and translocates into the nucleus, where it activates ARE-mediated cytoprotective gene expression. The present studies demonstrate that INrf2, Cul3 and Rbx1 export out of the nucleus and are degraded during the early or pre-induction response to antioxidants. Mutation of Tyr85 in INrf2 stymied the nuclear export of INrf2, suggesting that tyrosine phosphorylation controls the pre-induction nuclear export and degradation in response to antioxidants. The nuclear export of Cul3-Rbx1 were also blocked when INrf2Tyr85 was mutated, suggesting that INrf2-Cul3-Rbx1 undergo nuclear export as a complex. INrf2 siRNA also inhibited the nuclear export of Cul3-Rbx1, confirming that Cul3-Rbx1 requires INrf2 for nuclear export. Newly synthesized INrf2-Cul3-Rbx1 is imported back into the nucleus during the post-induction period to ubiquitylate and degrade Nrf2. Mutation of INrf2Tyr85 had no effect on activation of Nrf2 but led to nuclear accumulation of Nrf2 during the post-induction period owing to reduced export and degradation of Nrf2. Our results also showed that nuclear export and degradation followed by the new synthesis of INrf2-Cul3-Rbx1 controls the cellular abundance of the proteins during different phases of antioxidant responses. In conclusion, the early or pre-induction nuclear export of INrf2 in response to antioxidants is controlled by tyrosine phosphorylation, whereas the nuclear export of Cul3 and Rbx1 is controlled by INrf2, allowing normal activation or repression of Nrf2.
C1 [Kaspar, James W.; Niture, Suryakant K.; Jaiswal, Anil K.] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA.
RP Jaiswal, AK (reprint author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA.
EM ajaiswal@som.umaryland.edu
FU National Institutes of Health [RO1 ES012265]
FX This work was supported by the National Institutes of Health [grant
   number RO1 ES012265 to A.K.J.]. Deposited in PMC for release after 12
   months.
CR AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258
   AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251
   Brazilai A., 2004, SCIENCE, V3, P1109
   BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3
   Chakravarti B, 2007, GERONTOLOGY, V53, P128, DOI 10.1159/000097865
   Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545
   Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004
   Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506
   Fukuda M, 1997, NATURE, V390, P308
   Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005
   Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1
   GRISHAM MB, 1986, PHYSL OXYGEN RADICAL, P1
   Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76
   Jain AK, 2008, J BIOL CHEM, V283, P17712, DOI 10.1074/jbc.M709854200
   Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200
   Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200
   Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100
   Kaspar JW, 2010, J BIOL CHEM, V285, P21349, DOI 10.1074/jbc.M110.121863
   Kaspar JW, 2010, J BIOL CHEM, V285, P153, DOI 10.1074/jbc.M109.040022
   Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035
   Kim SH, 2010, DEV BIOL, V346, P247, DOI 10.1016/j.ydbio.2010.07.031
   Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007
   Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021
   Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692
   Maher JM, 2007, HEPATOLOGY, V46, P1597, DOI 10.1002/hep.21831
   Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200
   Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200
   Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013
   ROSEN GM, 1995, FASEB J, V9, P200
   Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420
   Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200
   Strachan GD, 2005, BIOCHEM BIOPH RES CO, V336, P490, DOI 10.1016/j.bbrc.2005.08.127
   Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07
   Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006
   Velichkova M, 2005, MOL CELL BIOL, V25, P4501, DOI 10.1128/MCB.25.11.4501-4513.2005
   Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248
   Wang W, 2006, FREE RADICAL BIO MED, V40, P1119, DOI 10.1016/j.freeradbiomed.2005.10.063
   WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401
   Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200
NR 39
TC 29
Z9 31
U1 2
U2 6
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD FEB 15
PY 2012
VL 125
IS 4
BP 1027
EP 1038
DI 10.1242/jcs.097295
PG 12
WC Cell Biology
SC Cell Biology
GA 925NF
UT WOS:000302767200022
PM 22448038
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Liu, XW
   Chen, ZL
   Wang, LL
   Wu, YX
   Garoma, T
AF Liu, Xiaowei
   Chen, Zhonglin
   Wang, Lili
   Wu, Youxian
   Garoma, Temesgen
TI RETRACTED: Degradation of polycyclic musk HHCB in water by O-3, UV, and
   UV/O-3 (Retracted article. See vol. 239, pg. 65, 2012)
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY
LA English
DT Article; Retracted Publication
DE Polycyclic musk HHCB; Ozonation; UV radiation; Kinetics; Quantum yield
ID ADVANCED OXIDATION PROCESSES; PERSONAL CARE PRODUCTS; NATURAL
   ORGANIC-MATTER; WASTE-WATER; ESTROGENIC ACTIVITY; AQUEOUS-SOLUTIONS;
   BISPHENOL-A; COSMETIC INGREDIENTS; FRAGRANCE MATERIALS; OZONATION
   PROCESSES
AB An investigation on the degradation of polycyclic musk HHCB by three processes (ozone alone (O-3), UV radiation alone (UV), and UV plus ozone (UV/O-3)) was conducted and the kinetic parameters (second-order reaction rate constants and quantum yield) were determined as well. HHCB underwent rapid degradation during ozonation process, but unsatisfied performance was shown for UV and UV/O-3 processes. Degradation efficiencies of HHCB follow the trend of O-3 > UV/O-3 > UV. Removal of HHCB by O-3 was appreciably affected by pH, ozone dosage, and bicarbonate alkalinity, while only the bicarbonate alkalinity and UV intensity exerted influence on HHCB degradation for UV process. Scavenger experiments indicated that the synergistic effect between direct ozonation and indirect free radical oxidation contributed to the HHCB destruction for ozonation process, while direct photolysis was responsible for UV degradation of HHCB. According to the yeast estrogen screen (YES) bioassay results, intermediates with similar estrogenic activity to the parent compound HHCB were assumed to be generated during the three degradation processes. The second-order reaction rate constants of HHCB with O-3 and hydroxyl radical (OH center dot) and quantum yield of HHCB under 254 nm UV light were determined to be k(O3-HHCB) = 153.8 +/- 6 M-1 S-1, k(OH center dot-HHCB) = 6.3 +/- 0.7 x 10(9) M-1 S-1, and phi(HHCB) = 0.012 +/- 0.002 mol Einstein(-1), respectively, which suggested HHCB had moderate reactivity towards ozone and was resistant to UV radiation. Published by Elsevier B.V.
C1 [Wu, Youxian; Garoma, Temesgen] San Diego State Univ, Dept Civil Construct & Environm Engn, San Diego, CA 92182 USA.
   [Liu, Xiaowei; Chen, Zhonglin; Wang, Lili] Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Sch Municipal & Environm Engn, Harbin 150090, Peoples R China.
RP Garoma, T (reprint author), San Diego State Univ, Dept Civil Construct & Environm Engn, San Diego, CA 92182 USA.
EM temesgen.garoma.sdsu@gmail.com
FU National Natural Science Foundation of China [50821002, 51078105]; Funds
   for Creative Research Groups of China [51121062]; State Key Laboratory
   of Urban Water Resource and Environment (Harbin Institute of Technology)
   [2010DX12]; National Important Items of Science and Technology for the
   Control and Treatment of Water Pollution [2009ZX07424-004-06]; China
   Scholarship Council; San Diego State University Division of Research
   Affairs
FX This work was financially supported by the National Natural Science
   Foundation of China (Grant Nos. 50821002 and 51078105), the Funds for
   Creative Research Groups of China (Grant No. 51121062), State Key
   Laboratory of Urban Water Resource and Environment (Harbin Institute of
   Technology) (No 2010DX12), and the National Important Items of Science
   and Technology for the Control and Treatment of Water Pollution (Grant
   No. 2009ZX07424-004-06). The authors also greatly appreciate the
   supports from China Scholarship Council and San Diego State University
   Division of Research Affairs.
CR Acero JL, 2000, OZONE-SCI ENG, V22, P305, DOI 10.1080/01919510008547213
   Acero JL, 2001, J AM WATER WORKS ASS, V93, P90
   Alborzfar M, 2000, WATER RES, V34, P2963, DOI 10.1016/S0043-1354(99)00410-8
   Artola-Garicano E, 2003, WATER RES, V37, P4377, DOI 10.1016/S0034-1354(03)00434-2
   BADER H, 1988, WATER RES, V22, P1109, DOI 10.1016/0043-1354(88)90005-X
   BADER H, 1981, WATER RES, V15, P449, DOI 10.1016/0043-1354(81)90054-3
   Balk F, 1999, TOXICOL LETT, V111, P57, DOI 10.1016/S0378-4274(99)00169-1
   BELTRAN FJ, 1993, WATER RES, V27, P1013, DOI 10.1016/0043-1354(93)90065-P
   Beltran FJ, 1999, IND ENG CHEM RES, V38, P4189, DOI 10.1021/ie990189r
   Bitsch N, 2002, ARCH ENVIRON CON TOX, V43, P257, DOI 10.1007/s00244-002-1192-5
   Buchanan W, 2006, CHEMOSPHERE, V63, P1130, DOI 10.1016/j.chemosphere.2005.09.040
   Buerge IJ, 2003, ENVIRON SCI TECHNOL, V37, P5636, DOI 10.1021/es0300721
   Calza P, 2010, APPL CATAL B-ENVIRON, V99, P314, DOI 10.1016/j.apcatb.2010.06.038
   CANONICA S, 1995, CHEMOSPHERE, V30, P2365, DOI 10.1016/0045-6535(95)00108-K
   Carballa M, 2005, WATER RES, V39, P4790, DOI 10.1016/j.watres.2005.09.018
   Chen PJ, 2006, CHEMOSPHERE, V65, P1094, DOI 10.1016/j.chemosphere.2006.04.048
   DULIN D, 1986, ENVIRON SCI TECHNOL, V20, P72, DOI 10.1021/es00143a009
   Eschke H., 1994, ENVIRON SCI POLLUT R, V6, P183
   Esplugas S, 2007, J HAZARD MATER, V149, P631, DOI 10.1016/j.jhazmat.2007.07.073
   Felis E, 2008, ARCH ENVIRON PROT, V34, P13
   GONZALEZ MC, 1995, RES CHEM INTERMEDIAT, V21, P837, DOI 10.1163/156856795X00512
   Guo R, 2010, SCI TOTAL ENVIRON, V408, P1634, DOI 10.1016/j.scitotenv.2009.12.009
   HATCHARD CG, 1956, PROC R SOC LON SER-A, V235, P518, DOI 10.1098/rspa.1956.0102
   HOIGNE J, 1976, WATER RES, V10, P377, DOI 10.1016/0043-1354(76)90055-5
   HOIGNE J, 1994, OZONE-SCI ENG, V16, P121, DOI 10.1080/01919519408552417
   Horii Y, 2007, CHEMOSPHERE, V68, P2011, DOI 10.1016/j.chemosphere.2007.04.054
   Hu JY, 2002, ENVIRON TOXICOL CHEM, V21, P2034, DOI 10.1002/etc.5620211005
   Hu JY, 2002, ENVIRON SCI TECHNOL, V36, P1980, DOI 10.1021/es011177b
   Kim I, 2009, ENVIRON INT, V35, P793, DOI 10.1016/j.envint.2009.01.003
   Lau TK, 2007, WATER RES, V41, P765, DOI 10.1016/j.watres.2006.11.021
   Lau TK, 2005, CHEMOSPHERE, V60, P1045, DOI 10.1016/j.chemosphere.2005.01.022
   Lenz K, 2004, WATER SCI TECHNOL, V50, P141
   Lopez A, 2003, J PHOTOCH PHOTOBIO A, V156, P121, DOI 10.1016/S1010-6030(02)00435-5
   Nothe T, 2007, WATER SCI TECHNOL, V55, P287, DOI 10.2166/wst.2007.422
   Pera-Titus M, 2004, APPL CATAL B-ENVIRON, V47, P219, DOI 10.1016/j.apcatb.2003.09.010
   Radjenovic J, 2009, ENVIRON SCI TECHNOL, V43, P6808, DOI 10.1021/es900965a
   Reif R, 2008, DESALINATION, V221, P511, DOI 10.1016/j.desal.2007.01.111
   Rimkus GG, 1999, TOXICOL LETT, V111, P37, DOI 10.1016/S0378-4274(99)00191-5
   Rosenfeldt EJ, 2007, SCI TOTAL ENVIRON, V377, P105, DOI 10.1016/j.scitotenv.2007.01.096
   Rosenfeldt EJ, 2006, WATER RES, V40, P3695, DOI 10.1016/j.watres.2006.09.008
   Schreurs RHMM, 2002, TOXICOL APPL PHARM, V183, P1, DOI 10.1006/taap.2002.9458
   Seinen W, 1999, TOXICOL LETT, V111, P161, DOI 10.1016/S0378-4274(99)00177-0
   Simonich SL, 2000, ENVIRON SCI TECHNOL, V34, P959, DOI 10.1021/es991018g
   Simonich SL, 2002, ENVIRON SCI TECHNOL, V36, P2839, DOI 10.1021/es025503e
   Snyder SA, 2003, ENVIRON ENG SCI, V20, P449, DOI 10.1089/109287503768335931
   STAEHELIN J, 1984, J PHYS CHEM-US, V88, P5999, DOI 10.1021/j150668a051
   Suarez Sonia, 2008, Reviews in Environmental Science and Bio/Technology, V7, P125, DOI 10.1007/s11157-008-9130-2
   Ternes TA, 2003, WATER RES, V37, P1976, DOI 10.1016/S0043-1354(02)00570-5
   Thomson J, 2004, J WATER SUPPLY RES T, V53, P193
   Trovo AG, 2009, CHEMOSPHERE, V77, P1292, DOI 10.1016/j.chemosphere.2009.09.065
   Verbruggen EMJ, 1999, ENVIRON SCI TECHNOL, V33, P801, DOI 10.1021/es980747d
   von Gunten U, 2003, WATER RES, V37, P1443, DOI 10.1016/S0043-1354(02)00457-8
   von Sonntag C, 2008, WATER SCI TECHNOL, V58, P1015, DOI 10.2166/wst.2008.467
   Zhao L, 2010, J MOL CATAL A-CHEM, V322, P26, DOI 10.1016/j.molcata.2010.02.007
NR 54
TC 7
Z9 7
U1 3
U2 56
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1010-6030
J9 J PHOTOCH PHOTOBIO A
JI J. Photochem. Photobiol. A-Chem.
PD FEB 15
PY 2012
VL 230
IS 1
BP 1
EP 9
DI 10.1016/j.jphotochem.2011.12.017
PG 9
WC Chemistry, Physical
SC Chemistry
GA 906AH
UT WOS:000301316800001
DA 2018-12-27
ER

PT J
AU Lin, YY
   Kiihl, S
   Suhail, Y
   Liu, SY
   Chou, YH
   Kuang, Z
   Lu, JY
   Khor, CN
   Lin, CL
   Bader, JS
   Irizarry, R
   Boeke, JD
AF Lin, Yu-yi
   Kiihl, Samara
   Suhail, Yasir
   Liu, Shang-Yun
   Chou, Yi-hsuan
   Kuang, Zheng
   Lu, Jin-ying
   Khor, Chin Ni
   Lin, Chi-Long
   Bader, Joel S.
   Irizarry, Rafael
   Boeke, Jef D.
TI RETRACTED: Functional dissection of lysine deacetylases reveals that
   HDAC1 and p300 regulate AMPK (Retracted article. See vol. 503, 2013)
SO NATURE
LA English
DT Article; Retracted Publication
ID ACTIVATED PROTEIN-KINASE; HISTONE ACETYLATION; CELLULAR-METABOLISM;
   ESSENTIAL GENES; CANCER-CELLS; INHIBITORS; COMPLEXES; IDENTIFICATION;
   PANTHER; YEAST
AB First identified as histone-modifying proteins, lysine acetyltransferases (KATs) and deacetylases (KDACs) antagonize each other through modification of the side chains of lysine residues in histone proteins(1). Acetylation of many non-histone proteins involved in chromatin, metabolism or cytoskeleton regulation were further identified in eukaryotic organisms(2-6), but the corresponding enzymes and substrate-specific functions of the modifications are unclear. Moreover, mechanisms underlying functional specificity of individual KDACs(7) remain enigmatic, and the substrate spectra of each KDAC lack comprehensive definition. Here we dissect the functional specificity of 12 critical human KDACs using a genome-wide synthetic lethality screen(8-13) in cultured human cells. The genetic interaction profiles revealed enzyme-substrate relationships between individual KDACs and many important substrates governing a wide array of biological processes including metabolism, development and cell cycle progression. We further confirmed that acetylation and deacetylation of the catalytic subunit of the adenosine monophosphate-activated protein kinase (AMPK), a critical cellular energy-sensing protein kinase complex, is controlled by the opposing catalytic activities of HDAC1 and p300. Deacetylation of AMPK enhances physical interaction with the upstream kinase LKB1, leading to AMPK phosphorylation and activation, and resulting in lipid breakdown in human liver cells. These findings provide new insights into previously underappreciated metabolic regulatory roles of HDAC1 in coordinating nutrient availability and cellular responses upstream of AMPK, and demonstrate the importance of high-throughput genetic interaction profiling to elucidate functional specificity and critical substrates of individual human KDACs potentially valuable for therapeutic applications.
C1 [Lin, Yu-yi; Liu, Shang-Yun; Chou, Yi-hsuan] Natl Taiwan Univ, Inst Biochem & Mol Biol, Coll Med, Taipei 100, Taiwan.
   [Lin, Yu-yi; Lu, Jin-ying] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.
   [Lin, Yu-yi] Natl Taiwan Univ Hosp, Dept Oncol, Taipei 100, Taiwan.
   [Kiihl, Samara; Irizarry, Rafael] Sch Publ Hlth, Dept Biostat, Baltimore, MD 21231 USA.
   [Suhail, Yasir; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
   [Kuang, Zheng; Boeke, Jef D.] Johns Hopkins Univ, Dept Mol Biol & Genet, Sch Med, Baltimore, MD 21205 USA.
   [Kuang, Zheng; Boeke, Jef D.] Johns Hopkins Univ, High Throughput Biol Ctr, Sch Med, Baltimore, MD 21205 USA.
   [Lu, Jin-ying] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan.
   [Khor, Chin Ni; Lin, Chi-Long] Acad Sinica, Inst Mol Biol, Natl RNAi Core Facil, Taipei 115, Taiwan.
RP Lin, YY (reprint author), Natl Taiwan Univ, Inst Biochem & Mol Biol, Coll Med, Taipei 100, Taiwan.
EM yuyilin@ntu.edu.tw; jboeke1@jhmi.edu
RI Bader, Joel/A-1818-2009
OI Bader, Joel/0000-0002-6020-4625; Boeke, Jef/0000-0001-5322-4946
FU National Science Council [NSC 98-2320-B-002-057-, NSC
   99-2320-B-002-057-, NSC 100-2325-002-044]; National Taiwan University
   Frontier and Innovative Research [99R71424]; National Taiwan University
   College of Medicine; National Taiwan University Hospital Excellent
   Translational Medicine Research [99C101-603]; National Health Research
   Institutes [NHRI-EX100-10017BC]; Liver Disease Prevention and Treatment
   Research Foundation; NIH [U54 RR 020839]
FX We thank H. Zhu, S.-L. Yu and L.-P. Chow for gifts of reagents, J. Lu
   for IMR-90 cells, Department of Medical Science, National Taiwan
   University for technical help with sequencing, and the National RNAi
   Core Facility, Academia Sinica for reagents and technical support with
   RNAi screen. We are grateful to P. Meluh and members of the Lin and
   Boeke laboratories for discussions. We thank D. Root for discussions.
   This study was supported by National Science Council grants NSC
   98-2320-B-002-057-, NSC 99-2320-B-002-057- and NSC 100-2325-002-044
   (Y.-y.L.), National Taiwan University Frontier and Innovative Research
   99R71424 (Y.-y.L.), National Taiwan University College of Medicine and
   National Taiwan University Hospital Excellent Translational Medicine
   Research Project 99C101-603 (Y.-y.L. and J.-y.L.), National Health
   Research Institutes Career Development grant NHRI-EX100-10017BC
   (Y.-y.L.), Liver Disease Prevention and Treatment Research Foundation
   (Y.-y.L. and J.-y.L.) and NIH Common Fund grant U54 RR 020839 (J.D.B.).
CR Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759
   Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460
   Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498
   Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133
   Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241
   Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371
   Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3
   Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106
   Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485
   Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249
   Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519
   Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879
   Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28
   Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418
   Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195
   Jayapandian M, 2007, NUCLEIC ACIDS RES, V35, pD566, DOI 10.1093/nar/gkl859
   Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681
   Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026
   Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508
   Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033
   Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105
   Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006
   Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019
   Nakatani Y, 2003, METHOD ENZYMOL, V370, P430
   Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094
   Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349
   Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200
   Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017
   Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185
   Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116
   Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097
   Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932
   Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346
   Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689
NR 38
TC 69
Z9 74
U1 3
U2 65
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD FEB 9
PY 2012
VL 482
IS 7384
BP 251
EP U149
DI 10.1038/nature10804
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 888HI
UT WOS:000299994100045
PM 22318606
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Feng, EY
   Shao, X
   Yu, CH
   Sun, CY
   Huang, WY
AF Feng, Eryin
   Shao, Xi
   Yu, Chunhua
   Sun, Chunyan
   Huang, Wuying
TI RETRACTED: Low energy collisions of CN(X-2 Sigma(+)) with He in magnetic
   fields (Retracted article. See vol. 136, 199901, 2012)
SO JOURNAL OF CHEMICAL PHYSICS
LA English
DT Article; Retracted Publication
ID MILLIKELVIN TEMPERATURES; COLD MOLECULES; ATOMS
AB A theoretical investigation of the He-CN((2)Sigma(+)) complex is presented. We perform ab initio calculations of the interaction potential energy surface and carry out accurate calculations of bound energy levels of the complex including the molecular fine structure. We find the potential has a shallow minimum and supports seven and nine bound levels in complex with He-3 and He-4, respectively. Based on the potential the quantum scattering calculation is then implemented for elastic and inelastic cross sections of the magnetically trappable low-field-seeking state of CN((2)Sigma(+)) in collision with He-3 atom. The cold collision properties and the influence of the external magnetic field as well as the effect of the uncertainty of interaction potential on the collisionally induced Zeeman relaxation are explored and discussed in detail. The ratios of elastic to inelastic cross sections are large over a wide range of collision energy, magnetic field, and scaling factor of the potential, suggesting helium buffer gas loading and cooling of CN in a magnetic trap is a good prospect. (C) 2012 American Institute of Physics. [doi:10.1063/1.3679869]
C1 [Feng, Eryin; Shao, Xi; Yu, Chunhua; Sun, Chunyan; Huang, Wuying] Anhui Normal Univ, Dept Phys, Wuhu 241000, Peoples R China.
RP Feng, EY (reprint author), Anhui Normal Univ, Dept Phys, Wuhu 241000, Peoples R China.
EM fengbf@mail.ahnu.edu.cn
FU National Natural Science Foundation of China (NNSFC) [10874001]
FX This work is supported by the National Natural Science Foundation of
   China (NNSFC) (Grant No. 10874001).
CR Bakker JM, 2006, J PHYS B-AT MOL OPT, V39, pS1111, DOI 10.1088/0953-4075/39/19/S21
   Balakrishnan N, 2003, J CHEM PHYS, V118, P7386, DOI 10.1063/1.1562947
   Bohn JL, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.032701
   BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561
   Campbell WC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.213001
   Campbell WC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.013003
   Cybulski H, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1857473
   Doyle J, 2004, EUR PHYS J D, V31, P149, DOI 10.1140/epjd/e2004-00151-x
   Dulieu O, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/8/086401
   Egorov D, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.030501
   Feng EY, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2794034
   Feng EY, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.062711
   Feng EY, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3640415
   Gonzalez-Martinez ML, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.022702
   Gonzalez-Sanchez L, 2007, EUR PHYS J D, V44, P65, DOI 10.1140/epjd/e2007-00156-y
   Gonzalez-Sanchez L, 2006, J PHYS B-AT MOL OPT, V39, pS1203, DOI 10.1088/0953-4075/39/19/S27
   Guillon G, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.052722
   Guillon G, 2008, EUR PHYS J D, V46, P83, DOI 10.1140/epjd/e2007-00313-4
   Guillon G, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.042718
   Han JD, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2834932
   Hancox CI, 2004, NATURE, V431, P281, DOI 10.1038/nature02938
   Hudson ER, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.063404
   Hudson JJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.023003
   Jochim S, 2003, SCIENCE, V302, P2101, DOI 10.1126/science.1093280
   JOHNSON BR, 1973, J COMPUT PHYS, V13, P445, DOI 10.1016/0021-9991(73)90049-1
   Kohler T, 2006, REV MOD PHYS, V78, P1311, DOI 10.1103/RevModPhys.78.1311
   Krems RV, 2005, INT REV PHYS CHEM, V24, P99, DOI 10.1080/01442350500167161
   Krems RV, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.060703
   Krems RV, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.051401
   Krems RV, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.050704
   Krems RV, 2004, J CHEM PHYS, V120, P2296, DOI 10.1063/1.1636691
   LEE TJ, 1989, INT J QUANTUM CHEM, P199, DOI 10.1002/qua.560360824
   Lique F, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3285811
   Lopez-Duran D, 2009, EUR PHYS J D, V55, P601, DOI 10.1140/epjd/e2009-00281-7
   Maussang K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123002
   Nemitz N, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.061403
   Rama R. S., 2010, J MOL SPECTROSC, V263, P82
   Stoll M, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.032707
   TIESINGA E, 1993, PHYS REV A, V47, P4114, DOI 10.1103/PhysRevA.47.4114
   Tscherbul TV, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.060703
   Tsikata E, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065028
   Turpin F, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.032717
   van de Meerakker SYT, 2006, ANNU REV PHYS CHEM, V57, P159, DOI 10.1146/annurev.physchem.55.091602.094337
   Volpi A, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052712
   Wang ZQ, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2823029
   Weinstein JD, 1998, J CHEM PHYS, V109, P2656, DOI 10.1063/1.476864
   Weinstein JD, 1998, NATURE, V395, P148
   Werner H.-J., 2006, MOLPRO VERSION 2006
   WERNER HJ, 1988, J CHEM PHYS, V89, P3139, DOI 10.1063/1.454971
   WIGNER EP, 1948, PHYS REV, V73, P1002, DOI 10.1103/PhysRev.73.1002
   WOON DE, 1994, J CHEM PHYS, V100, P2975, DOI 10.1063/1.466439
NR 51
TC 5
Z9 5
U1 4
U2 22
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-9606
J9 J CHEM PHYS
JI J. Chem. Phys.
PD FEB 7
PY 2012
VL 136
IS 5
AR 054302
DI 10.1063/1.3679869
PG 7
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 896EC
UT WOS:000300547200019
PM 22320737
DA 2018-12-27
ER

PT J
AU Panagiotopoulou, O
   Wilshin, SD
   Rayfield, EJ
   Shefelbine, SJ
   Hutchinson, JR
AF Panagiotopoulou, O.
   Wilshin, S. D.
   Rayfield, E. J.
   Shefelbine, S. J.
   Hutchinson, J. R.
TI RETRACTED: What makes an accurate and reliable subject-specific finite
   element model? A case study of an elephant femur (Retracted article. See
   vol. 11, 20140854, 2014)
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article; Retracted Publication
DE finite-element analysis; elephant; bone mechanics; validation;
   simulation
ID FUNCTIONAL-MORPHOLOGY; PROXIMAL FEMUR; STRAIN; BONE; SENSITIVITY;
   STRENGTH; VALIDATION; LIGAMENT
AB Finite element modelling is well entrenched in comparative vertebrate biomechanics as a tool to assess the mechanical design of skeletal structures and to better comprehend the complex interaction of their form-function relationships. But what makes a reliable subject-specific finite element model? To approach this question, we here present a set of convergence and sensitivity analyses and a validation study as an example, for finite element analysis (FEA) in general, of ways to ensure a reliable model. We detail how choices of element size, type and material properties in FEA influence the results of simulations. We also present an empirical model for estimating heterogeneous material properties throughout an elephant femur (but of broad applicability to FEA). We then use an ex vivo experimental validation test of a cadaveric femur to check our FEA results and find that the heterogeneous model matches the experimental results extremely well, and far better than the homogeneous model. We emphasize how considering heterogeneous material properties in FEA may be critical, so this should become standard practice in comparative FEA studies along with convergence analyses, consideration of element size, type and experimental validation. These steps may be required to obtain accurate models and derive reliable conclusions from them.
C1 [Panagiotopoulou, O.; Wilshin, S. D.; Hutchinson, J. R.] Univ London, Struct & Mot Lab, Dept Vet Basic Sci, Royal Vet Coll, London, England.
   [Rayfield, E. J.] Univ Bristol, Dept Earth Sci, Bristol, Avon, England.
   [Shefelbine, S. J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.
RP Panagiotopoulou, O (reprint author), Univ London, Struct & Mot Lab, Dept Vet Basic Sci, Royal Vet Coll, London, England.
EM opanagiotopoulou@rvc.ac.uk
RI Rayfield, Emily/F-5038-2010
OI Rayfield, Emily/0000-0002-2618-750X
FU BBSRC
FX Thanks to Michael Fagan University of Hull for allowing access to the
   mechanical testing machine and the laser speckle interferometer. We
   thank Peter Njuguna, Michael Doube, Sue Taft and Andy Greenhalgh for
   technical support and Peter Zioupos and Callum Ross for useful
   discussions. Thanks also to Michael Doube and Stephanie Pierce for their
   help in the use of BONE J. We thank Whipsnade Zoo and Paignton Zoo for
   supplying cadaveric material. This study was funded by a grant from the
   BBSRC to J.R.H.
CR ALEXANDER RM, 1979, J ZOOL, V189, P305
   BENZLEY SE, 1995, P 4 INT MESH ROUNDT, P179
   Bessho M, 2007, J BIOMECH, V40, P1745, DOI 10.1016/j.jbiomech.2006.08.003
   CHANG CL, 1998, J ACHIEVEMENTS MAT M, V28, P167, DOI DOI 10.1016/J.ENGFAILANAL.2008.12.010
   CHO YH, 1996, TRANSPORT RES REC, V1539, P96, DOI [DOI 10.3141/1539-13, DOI 10.3141/1539-13)]
   Cifuentes AO, 1992, FINITE ELEM ANAL DES, V12, P313, DOI DOI 10.1016/0168-874X(92)90040-J
   Currey JD, 1996, J BIOMECH, V29, P257, DOI 10.1016/0021-9290(95)00048-8
   Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023
   Ellis BJ, 2007, J BIOMECH, V40, P603, DOI 10.1016/j.jbiomech.2006.01.024
   Helgason B, 2008, MED ENG PHYS, V30, P444, DOI 10.1016/j.medengphy.2007.05.006
   Hutchinson JR, 2012, BIOL LETTERS, V8, P115, DOI 10.1098/rsbl.2011.0399
   Kessler O, 2006, CLIN BIOMECH, V21, P603, DOI 10.1016/j.clinbiomech.2006.01.011
   Keyak JH, 2005, CLIN ORTHOP RELAT R, P161, DOI 10.1097/01.blo.0000174736.50964.3b
   Keyak JH, 2005, CLIN ORTHOP RELAT R, P219, DOI 10.1097/01.blo.0000164400.37905.22
   Kokshenev VB, 2010, BIOL J LINN SOC, V100, P16, DOI 10.1111/j.1095-8312.2010.01415.x
   Oden ZM, 1999, J ORTHOPAED RES, V17, P661, DOI 10.1002/jor.1100170507
   Panagiotopoulou O, 2010, J BIOMECH, V43, P1603, DOI 10.1016/j.jbiomech.2009.12.027
   Panagiotopoulou O, 2009, ANN HUM BIOL, V36, P609, DOI 10.1080/03014460903019879
   Panagiotopoulou O, 2011, J ANAT, V218, P75, DOI 10.1111/j.1469-7580.2010.01257.x
   Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104
   Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169
   Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172
   TYRER JR, 1995, OPT LASER ENG, V23, P291, DOI 10.1016/0143-8166(95)00035-M
   Yanga L, 2007, OPT LASER ENG, V45, P843, DOI 10.1016/j.optlaseng.2007.02.004
   Zioupos P, 2008, J BIOMECH, V41, P1961, DOI 10.1016/j.jbiomech.2008.03.025
NR 25
TC 15
Z9 15
U1 2
U2 17
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD FEB 7
PY 2012
VL 9
IS 67
BP 351
EP 361
DI 10.1098/rsif.2011.0323
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 866KR
UT WOS:000298380100014
PM 21752810
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Ma, YG
   Sahebdivan, S
   Ong, CK
   Tyc, T
   Leonhardt, U
AF Ma, Y. G.
   Sahebdivan, S.
   Ong, C. K.
   Tyc, T.
   Leonhardt, U.
TI RETRACTED: Subwavelength imaging with materials of in-principle
   arbitrarily low index contrast (Retracted article. See vol. 18, 059701,
   2016)
SO NEW JOURNAL OF PHYSICS
LA English
DT Article; Retracted Publication
ID FISH EYE LENS
AB Perfect imaging with Maxwell's fish eye opens the exciting prospect of passive imaging systems with a resolution no longer limited by the wave nature of light. But it also challenges some of the accepted wisdom of super-resolution imaging and therefore has been subject to controversy and discussion. Here we describe an idea for even simpler perfect-imaging systems based on geometrical optics and prove by experiment that it works.
C1 [Sahebdivan, S.; Tyc, T.; Leonhardt, U.] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.
   [Ma, Y. G.] Zhejiang Univ, State Key Lab Modern Opt Instrumentat, Ctr Opt & Electromagnet Res, Hangzhou 310058, Zhejiang, Peoples R China.
   [Ong, C. K.] Natl Univ Singapore, Dept Phys, Ctr Superconducting & Magnet Mat, Singapore 117542, Singapore.
   [Tyc, T.] Masaryk Univ, Fac Sci, CS-61137 Brno, Czech Republic.
   [Tyc, T.] Masaryk Univ, Fac Informat, Brno, Czech Republic.
RP Leonhardt, U (reprint author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.
EM ulf@st-andrews.ac.uk
RI Zhejiang University, Dep. Optical Eng./G-9022-2011; Ong, CK/G-1646-2012
FU Key National Science Fund of China [60990322, 91130004]; Fundamental
   Research Funds for the Central Universities of China; SORSAS; University
   of St Andrews; MOE of Singapore; Engineering and Physical Sciences
   Research Council; Royal Society;  [MSM0021622409];  [MSM0021622419]
FX We thank Aaron Danner, Andrea Di Falco, Lucas Gabrielli, Yang Hao, Simon
   Horsley, Susanne Kehr, Michal Lipson, Thomas Philbin and Gunther Uhlmann
   for discussions. MYG acknowledges support from the Key National Science
   Fund of China (no. 60990322 and no. 91130004) and the Fundamental
   Research Funds for the Central Universities of China. SS is funded by
   SORSAS and the University of St Andrews. CKO is supported by the MOE
   academic research fund of Singapore. TT and UL are both funded by the
   QUEST programme grant of the Engineering and Physical Sciences Research
   Council; TT is also funded by the grants MSM0021622409 and MSM0021622419
   and UL is supported by the Royal Society.
CR Abbe E., 1873, ARCH MIKROSK ANAT, V9, P413, DOI DOI 10.1007/BF02956173
   Blaikie RJ, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/058001
   Born M., 1999, PRINCIPLES OPTICS
   DEMKOV YN, 1971, SOV PHYS JETP-USSR, V33, P867
   DEROSNY L, 2002, PHYS REV LETT, V89
   Di Falco A, 2011, OPT EXPRESS, V19, P5156, DOI 10.1364/OE.19.005156
   Erdelyi A., 1981, HIGHER TRANSCENDENTA, VII
   Feynman R P, 2006, FEYMAN LECT PHYS, VII
   FIRSOV OB, 1953, ZH EKSP TEOR FIZ+, V24, P279
   Guenneau S, 2010, J MOD OPTIC, V57, P511, DOI 10.1080/09500341003640061
   Hendi A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.073902
   Kinsler P, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/028001
   Kinsler P, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.055804
   Landau L. D., 1982, MECHANICS
   Landau L D, 1977, QUANTUM MECH
   Leonhardt U, 2011, PCT Patent, Patent No. [WO/036-469 A1, 036469]
   Leonhardt U., 2010, GEOMETRY LIGHT SCI I
   Leonhardt U, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/028002
   Leonhardt U, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/2/024016
   Leonhardt U, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.057802
   Leonhardt U, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/058002
   Leonhardt U, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.011804
   Leonhardt U, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093040
   Luneburg R. K., 1964, MATH THEORY OPTICS
   Ma YG, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/033016
   Ma YG, 2009, NAT MATER, V8, P639, DOI [10.1038/NMAT2489, 10.1038/nmat2489]
   Maxwell J. C., 1854, CAMBRIDGE DUBLIN MAT, V8, P188
   Merlin R, 2011, J OPT-UK, V13, DOI 10.1088/2040-8978/13/2/024017
   Merlin R, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.057801
   Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966
   Quabis S, 2000, OPT COMMUN, V179, P1, DOI 10.1016/S0030-4018(99)00729-4
   Schultheiss VH, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143901
   Smolyaninova VN, 2010, OPT LETT, V35, P3396, DOI 10.1364/OL.35.003396
   Sun F, 2010, PROG ELECTROMAGN RES, V110, P313, DOI 10.2528/PIER10110313
   Sun F, 2010, PROG ELECTROMAGN RES, V108, P307, DOI 10.2528/PIER1009100
   Zhao L, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3043414
NR 36
TC 14
Z9 14
U1 3
U2 29
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1367-2630
J9 NEW J PHYS
JI New J. Phys.
PD FEB 1
PY 2012
VL 14
AR 025001
DI 10.1088/1367-2630/14/2/025001
PG 14
WC Physics, Multidisciplinary
SC Physics
GA 919DX
UT WOS:000302303100001
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Dilnawaz, F
   Singh, A
   Sahoo, SK
AF Dilnawaz, Fahima
   Singh, Abhalaxmi
   Sahoo, Sanjeeb Kumar
TI RETRACTED: Transferrin-conjugated curcumin-loaded nanoparticles induce
   augmented cellular superparamagnetic iron oxide uptake and apoptosis in
   K562 cells (Retracted article. See vol. 9, pg. 7077, 2013)
SO ACTA BIOMATERIALIA
LA English
DT Article; Retracted Publication
DE Magnetic nanoparticles; Magnetic field; Apoptosis; Chronic myeloid
   leukemia; Transferrin
ID CANCER-THERAPY; MAGNETIC NANOPARTICLES; MULTIDRUG-RESISTANCE; FELINE
   FIBROSARCOMAS; LEUKEMIA-CELLS; GENE DELIVERY; IN-VITRO; KAPPA-B;
   PHASE-I; P73
AB Superparamagnetic iron oxide nanoparticles are currently used for precise drug delivery and as an image contrast agent. In the present study, the potentiality of curcumin-loaded magnetic nanoparticles (Cur-MNPs) for the treatment of chronic myeloid leukemia (CML) was investigated. For active therapy, transferrin (Tf) ligand was further conjugated to Cur-MNPs, which demonstrated enhanced uptake compared to Cur-MNPs in p210bcr/abl-positive cell line (K562). Cur-MNPs demonstrated greater and sustained anti-proliferative activity in a dose- and time-dependent manner; however, with the advent of a magnetic field the anti-proliferative activity of Cur-MNPs as well as Tf-Cur-MNPs was enhanced due to higher cellular uptake with enhanced cytotoxicity activity. Down-regulation of Bcr-Abl protein activates intrinsic apoptotic pathways for promoting anti-leukemic responses. Our in vitro results advocate potential clinical applications of Cur-MNPs by activating multiple signaling pathways for provoking the anti-leukemic activity. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Dilnawaz, Fahima; Singh, Abhalaxmi; Sahoo, Sanjeeb Kumar] Inst Life Sci, Lab Nanomed, Bhubaneswar 751023, Orissa, India.
RP Sahoo, SK (reprint author), Inst Life Sci, Lab Nanomed, Bhubaneswar 751023, Orissa, India.
EM sanjeebsahoo2005@gmail.com
FU DBT, Government of India; DST, Government of India; CSIR, Government of
   India
FX We would like to acknowledge Dr N. R. Jagannathan, Professor and Head,
   NMR and MRI Department, All India Institute of Medical Sciences, New
   Delhi, India for providing the MRI facility. S.K.S. is highly thankful
   to DBT, Government of India, for providing a TATA innovative fellowship.
   F.D. gratefully thanks DST, Government of India, for providing a Women
   Scientist (WOS-A) fellowship. A.S. is extremely thankful to CSIR,
   Government of India, for providing a Junior Research Fellowship.
CR Acharya S, 2009, BIOMATERIALS, V30, P5737, DOI 10.1016/j.biomaterials.2009.07.008
   Aggarwal BB, 2003, ANTICANCER RES, V23, P363
   Alexiou C., 2007, MAGNETISM MED HDB, P596
   Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968
   Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113
   Benard J, 2003, HUM MUTAT, V21, P182, DOI 10.1002/humu.10172
   Bortner CD, 1999, J BIOL CHEM, V274, P21953, DOI 10.1074/jbc.274.31.21953
   Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141
   Chen BA, 2009, INT J NANOMED, V4, P251
   Cossarizza A, 1993, BIOCHEM BIOPH RES CO, P197
   Das M, 2009, EXPERT OPIN DRUG DEL, V6, P285, DOI 10.1517/17425240902780166
   Dilnawaz F, 2010, BIOMATERIALS, V31, P3694, DOI 10.1016/j.biomaterials.2010.01.057
   Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj/leu/2402482
   Gaurisankar Sa, 2010, Al Ameen Journal of Medical Sciences, V3, P21
   Goodwin S, 1999, J MAGN MAGN MATER, V194, P132, DOI 10.1016/S0304-8853(98)00584-8
   Huttinger C, 2008, J GENE MED, V10, P655, DOI 10.1002/jgm.1185
   Jacquel A, 2003, FASEB J, V17, P2160, DOI 10.1096/fj.03-0322fje
   Jaetao JE, 2009, CANCER RES, V69, P8310, DOI 10.1158/0008-5472.CAN-09-1083
   Jahnke A, 2007, J VET MED A, V54, P599, DOI 10.1111/j.1439-0442.2007.01002.x
   Jain TK, 2005, MOL PHARMACEUT, V2, P194, DOI 10.1021/mp0500014
   KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J
   Konwarh R, 2010, COLLOID SURFACE B, V81, P578, DOI 10.1016/j.colsurfb.2010.07.062
   Laurent E, 2001, CANCER RES, V61, P2343
   Leszczynski D, 2005, PROG BIOPHYS MOL BIO, V87, P247, DOI 10.1016/j.pbiomolbio.2004.08.014
   Li XM, 2009, INT J PHARMACEUT, V373, P116, DOI 10.1016/j.ijpharm.2009.01.023
   Limtrakul P, 2007, MOL CELL BIOCHEM, V296, P85, DOI 10.1007/s11010-006-9302-8
   Lunghi P, 2004, BLOOD, V104, P519, DOI 10.1182/blood-2003-08-2743
   Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523
   Lv G, 2008, LANGMUIR, V24, P2151, DOI 10.1021/la702845s
   Ma YJ, 2007, J MATER SCI-MATER M, V18, P2145, DOI 10.1007/s10856-007-3015-8
   Misra R, 2011, MOL PHARMACEUT, V8, P852, DOI 10.1021/mp100455h
   Misra R, 2010, EUR J PHARM SCI, V39, P152, DOI 10.1016/j.ejps.2009.11.010
   Misra R, 2009, NANOMEDICINE-UK, V4, P519, DOI 10.2217/NNM.09.28
   Mohanty C, 2010, NANOMEDICINE-UK, V5, P433, DOI [10.2217/nnm.10.9, 10.2217/NNM.10.9]
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mulik RS, 2010, INT J PHARMACEUT, V398, P190, DOI 10.1016/j.ijpharm.2010.07.021
   Novak U, 2001, ANN ONCOL, V12, P981, DOI 10.1023/A:1011153206003
   Peters UR, 1999, CANCER RES, V59, P4233
   Pluta A, 2006, LEUKEMIA, V20, P757, DOI 10.1038/sj.leu.2404166
   Prijic S, 2010, J MEMBRANE BIOL, V236, P167, DOI 10.1007/s00232-010-9271-4
   Pulfer SK, 1999, J NEURO-ONCOL, V41, P99, DOI 10.1023/A:1006137523591
   Qian Z, 2002, PHARMACOL REV, P54
   Ralhan Ranju, 2009, Front Biosci (Schol Ed), V1, P45
   Sahoo SK, 2004, INT J CANCER, V112, P335, DOI 10.1002/ijc.20405
   Salvioli S, 2007, EVID-BASED COMPL ALT, V4, P181, DOI 10.1093/ecam/nem043
   Shaikh J, 2009, EUR J PHARM SCI, V37, P223, DOI 10.1016/j.ejps.2009.02.019
   Sincai M, 2002, J MAGN MAGN MATER, V252, P406, DOI 10.1016/S0304-8853(02)00714-X
   Singh A, 2011, ACS APPL MATER INTER, V3, P842, DOI 10.1021/am101196v
   Stiewe T, 2002, CELL DEATH DIFFER, V9, P237, DOI 10.1038/sj/cdd/4400995
   Terme M, 2005, CANCER RES, V65, P6409, DOI 10.1158/0008-5472.CAN-04-2675
   Toh WH, 2010, CELL DEATH DIFFER, V17, P787, DOI 10.1038/cdd.2009.181
   Vandana M, 2009, NANOMEDICINE-UK, V4, P773, DOI 10.2217/NNM.09.54
   Wang J, 2010, J AM CHEM SOC, V132, P11306, DOI 10.1021/ja1043177
   Widder K J, 1979, Adv Pharmacol Chemother, V16, P213, DOI 10.1016/S1054-3589(08)60246-X
   Widera A, 2003, PHARMACEUT RES, V20, P1231, DOI 10.1023/A:1025005232421
   Wolanin K, 2006, MOL CANCER RES, V4, P457, DOI 10.1158/1541-7786.MCR-05-0172
   Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753
   Wu LX, 2003, ACTA PHARMACOL SIN, V24, P1155
   Yallapu MM, 2011, BIOMATERIALS, V32, P1890, DOI 10.1016/j.biomaterials.2010.11.028
   Yu CJ, 2008, J BIOMED MATER RES A, V87A, P364, DOI 10.1002/jbm.a.31786
   Zandi E, 1999, MOL CELL BIOL, V19, P4547
   Zebib B, 2010, BIOINORG CHEM APPL, DOI 10.1155/2010/292760
   Zhang GM, 2012, NONDESTRUCT TEST EVA, V27, P1, DOI 10.1080/10589759.2011.577428
NR 63
TC 20
Z9 20
U1 5
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2012
VL 8
IS 2
BP 704
EP 719
DI 10.1016/j.actbio.2011.10.022
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 902YZ
UT WOS:000301081400026
PM 22051236
DA 2018-12-27
ER

PT J
AU Cho, CH
   Jeon, TW
   Kim, MK
AF Cho, Choa Hyoung
   Jeon, Tae Woog
   Kim, Myung Kon
TI RETRACTED: Effect of Gamma Irradiation on Color Characteristics and
   Biological Activities of Ethanol Extract of Lonicera japonica (Retracted
   article. See vol. 55, pg. 577, 2012)
SO JOURNAL OF THE KOREAN SOCIETY FOR APPLIED BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
DE biological activity; color; irradiation; Lonicera japonica
ID CONSTITUENTS
AB Effects of gamma irradiation on color characteristic and biological activities of ethanol extract of Lonicera japonica irradiated at 0, 10, 20, and 30 kGy were investigated. Hunter color L*- and a*-value increased by irradiation in a dose-dependent manner, resulting in lighter color than the nonirradiated, whereas Hunter color b*-value decreased with increasing irradiation dosage (p <0.05). The L. japonica extract showed inhibition effects against tyrosinase, xanthine oxidase, and nitrite-scavenging ability. Tyrosinase inhibition effect of L. japonica was higher in the gamma-irradiated sample than in the nonirradiated sample, and the effect was increased by increasing irradiation dosages. The L. japonica extracts had a higher inhibitory effect against xanthine oxidase, and the effect was not greatly changed by irradiation. Nitrite-scavenging activity was the highest in L. japonica extract at pH 1.2. Overall, the gamma irradiation may not greatly influence the xanthine oxidase inhibition effect and nitrite-scavenging ability of the L. japonica extract, except for the tyrosinase inhibition effect when irradiated up to 30 kGy.
C1 [Cho, Choa Hyoung; Jeon, Tae Woog; Kim, Myung Kon] Chonbuk Natl Univ, Dept Food Sci & Biotechnol, Iksan 570752, South Korea.
RP Kim, MK (reprint author), Chonbuk Natl Univ, Dept Food Sci & Biotechnol, Iksan 570752, South Korea.
EM kmyuko@jbnu.ac.kr
FU Chonbuk National University
FX This paper was supported by research funds of Chonbuk National
   University in 2010.
CR Byun MW, 1999, RADIAT PHYS CHEM, V54, P291, DOI 10.1016/S0969-806X(98)00233-3
   CheorunJo, 2002, Preventive Nutrition and Food Science, V7, P273
   Dasgupta A, 2002, CLIN CHIM ACTA, V324, P51, DOI 10.1016/S0009-8981(02)00212-7
   GRAY JI, 1975, J FOOD SCI, V40, P981, DOI 10.1111/j.1365-2621.1975.tb02248.x
   Jo C, 2003, RADIAT PHYS CHEM, V66, P179, DOI 10.1016/S0969-806X(02)00273-6
   JUNG SW, 1995, KOREAN J FOOD SCI TE, V27, P891
   Kakuda R, 2000, PHYTOCHEMISTRY, V55, P879, DOI 10.1016/S0031-9422(00)00279-X
   KAWAI H, 1988, CHEM PHARM BULL, V36, P3664
   Lee SJ, 1994, KOR J PHARMACOGN, V25, P363
   Loaharanu P, 1989, RADIAT PHYS CHEM, V34, P1013
   MARCOCCI L, 1994, METHOD ENZYMOL, V234, P462
   No JK, 1999, LIFE SCI, V65, pPL241, DOI 10.1016/S0024-3205(99)00492-0
   Park YB, 1995, KOREAN J FOOD SCI TE, V27, P124
   Peng LY, 2000, FITOTERAPIA, V71, P713, DOI 10.1016/S0367-326X(00)00212-4
   *SAS I, 1989, SAS US GUID
   SON KH, 1994, PHYTOCHEMISTRY, V35, P1005
   Son KH, 1994, KOR J PHARMACOGN, V25, P24
   STORCH J, 1988, ANAL BIOCHEM, V169, P262, DOI 10.1016/0003-2697(88)90283-7
   Wang CY, 1998, J CHROMATOGR A, V802, P225, DOI 10.1016/S0021-9673(97)01070-4
NR 19
TC 3
Z9 3
U1 2
U2 11
PU KOREAN SOC  APPLIED BIOLOGICAL CHEMISTRY
PI KANGNAM-GU
PA RM 803,  KOREA SCIENCE & TECHNOLOGY CENTER, 635-4 YEOGSAM-DONG,
   KANGNAM-GU, SEOUL 135-703, SOUTH KOREA
SN 1738-2203
EI 2234-344X
J9 J KOREAN SOC APPL BI
JI J. Korean Soc. Appl. Biol. Chem.
PD FEB
PY 2012
VL 55
IS 1
BP 111
EP 114
DI 10.1007/s13765-012-0019-y
PG 4
WC Food Science & Technology
SC Food Science & Technology
GA 904TF
UT WOS:000301220100019
DA 2018-12-27
ER

PT J
AU Friman, H
   Schechter, A
   Nitzan, Y
   Cahan, R
AF Friman, Hen
   Schechter, Alex
   Nitzan, Yeshayahu
   Cahan, Rivka
TI RETRACTED: Effect of external voltage on Pseudomonas putida F1 in a bio
   electrochemical cell using toluene as sole carbon and energy source
   (Retracted article. See vol. 160, pg. 828, 2014)
SO MICROBIOLOGY-SGM
LA English
DT Article; Retracted Publication
ID MICROBIAL FUEL-CELLS; EXTRACELLULAR ELECTRON-TRANSFER;
   SHEWANELLA-PUTREFACIENS MR-1; ION-EXCHANGE MEMBRANES; OUTER-MEMBRANE;
   GEOBACTER-SULFURREDUCENS; ELECTROKINETIC EXTRACTION;
   ELECTRICITY-GENERATION; ANAEROBIC DEGRADATION; NUCLEOTIDE-SEQUENCE
AB A bio electrochemical cell (BEC) was constructed as a typical two-chamber microbial fuel cell (MFC), except that it was operated under external voltage instead of constant resistance as in an MFC. The anode chamber contained a pure culture of Pseudomonas putida F1 grown in a minimal medium containing toluene as the sole carbon and energy source. Operating the BEC under external voltages of 75, 125, 1 75, 250 and 500 mV (versus an Ag/AgCl reference electrode) led to increased bacterial cell growth to an OD600 of 0.62-0.75, while the control BEC, which was not connected to external voltage, reached an OD600 of only 0.3. Examination of the current generated under external voltages of 75, 125, 175, 250 and 500 mV showed that the maximal currents were 11, 23, 28, 54 and 94 mA m(-2), respectively. Cyclic voltammetry experiments demonstrated an anodic peak at 270 mV, which may imply oxidation of a vital molecule. The average residual toluene concentration after 147 h in the BEC operated under external voltage was 22 %, whereas in the control BEC it was 81 %. Proteome analysis of bacterial cells grown in the BEC (125 mV) revealed two groups of proteins, which are ascribed to charge transfer in the bacterial cells and from the cell to the electrode. In conclusion, operating the BEC at 75-500 mV enabled growth of a pure culture of P. putida F1 and toluene degradation even in an oxygen-limited environment.
C1 [Friman, Hen; Cahan, Rivka] Ariel Univ Ctr, Dept Chem Engn & Biotechnol, IL-44837 Ariel, Israel.
   [Friman, Hen; Nitzan, Yeshayahu] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.
   [Schechter, Alex] Ariel Univ Ctr, Dept Biol Chem, IL-44837 Ariel, Israel.
RP Cahan, R (reprint author), Ariel Univ Ctr, Dept Chem Engn & Biotechnol, IL-44837 Ariel, Israel.
EM rivkac@ariel.ac.il
FU Samaria and Jordan Rift Valley Regional RD Center; Research Authority of
   the Ariel University Center; Rappaport Foundation for Medical
   Microbiology, Bar-Ilan University
FX This research was supported in part by the Samaria and Jordan Rift
   Valley Regional R&D Center, the Research Authority of the Ariel
   University Center and the Rappaport Foundation for Medical Microbiology,
   Bar-Ilan University (to Y. N.).
CR Afkar E, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-41
   Aislabie J, 2000, POLAR BIOL, V23, P183, DOI 10.1007/s003000050025
   ALLEN RM, 1993, APPL BIOCHEM BIOTECH, V39, P27, DOI 10.1007/BF02918975
   Aronsson K, 2005, INT J FOOD MICROBIOL, V99, P19, DOI 10.1016/j.ijfoodmicro.2004.07.012
   Beliaev AS, 2001, MOL MICROBIOL, V39, P722, DOI 10.1046/j.1365-2958.2001.02257.x
   BELL A, 1989, J BACTERIOL, V171, P3211, DOI 10.1128/jb.171.6.3211-3217.1989
   Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771
   Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07
   Chakraborty R, 2005, APPL ENVIRON MICROB, V71, P8649, DOI 10.1128/AEM.71.12.8649-8655.2005
   Chaudhuri SK, 2003, NAT BIOTECHNOL, V21, P1229, DOI 10.1038/nbt867
   Chen CI, 1997, APPL MICROBIOL BIOT, V48, P121, DOI 10.1007/s002530051026
   D'Elia LF, 2005, PORT ELECTROCHIM ACT, V23, P481, DOI 10.4152/pea.200504481
   Desharnais BM, 2002, SOIL SCI SOC AM J, V66, P1518, DOI 10.2136/sssaj2002.1518
   Dupont M, 2007, ANTIMICROB AGENTS CH, V51, P3190, DOI 10.1128/AAC.01481-06
   FROUD RJ, 1984, BIOCHEM J, V217, P551, DOI 10.1042/bj2170551
   Gaspard S, 1998, APPL ENVIRON MICROB, V64, P3188
   Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103
   HAIGLER BE, 1991, APPL ENVIRON MICROB, V57, P3156
   HAMED J, 1991, J GEOTECH ENG-ASCE, V117, P241, DOI 10.1061/(ASCE)0733-9410(1991)117:2(241)
   Hernandez ME, 2001, CELL MOL LIFE SCI, V58, P1562, DOI 10.1007/PL00000796
   Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200
   Husken LE, 2001, APPL MICROBIOL BIOT, V55, P571, DOI 10.1007/s002530000566
   Kim BC, 2008, BIOELECTROCHEMISTRY, V73, P70, DOI 10.1016/j.bioelechem.2008.04.023
   Kim WS, 2005, J HAZARD MATER, V118, P93, DOI 10.1016/j.jhazmat.2004.10.001
   Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x
   LeDuc DL, 2005, J IND MICROBIOL BIOT, V32, P514, DOI 10.1007/s10295-005-0227-0
   Lloyd JR, 2003, BIOCHEM J, V369, P153, DOI 10.1042/BJ20020597
   Myers CR, 2002, APPL ENVIRON MICROB, V68, P5585, DOI 10.1128/AEM.68.11.5585-5594.2002
   Owsianiak M, 2009, APPL MICROBIOL BIOT, V84, P545, DOI 10.1007/s00253-009-2040-6
   Pandey J, 2009, FEMS MICROBIOL REV, V33, P324, DOI 10.1111/j.1574-6976.2008.00133.x
   Pazos M, 2006, CHEMOSPHERE, V62, P817, DOI 10.1016/j.chemosphere.2005.04.071
   Pham TH, 2008, APPL MICROBIOL BIOT, V77, P1119, DOI 10.1007/s00253-007-1248-6
   Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017
   Reddy K, 2009, ELECTROCHEMICAL REME
   Schoenbach KH, 2000, IEEE T DIELECT EL IN, V7, P637, DOI 10.1109/94.879359
   Schroder U, 2007, PHYS CHEM CHEM PHYS, V9, P2619, DOI [10.1039/b703627m, 10.1039/003627m]
   Schwartz DT, 1997, J HAZARD MATER, V55, P23, DOI 10.1016/S0304-3894(97)00015-0
   Strycharz SM, 2010, ENV MICROBIOL REP, V2, P289, DOI 10.1111/j.1758-2229.2009.00118.x
   Vidali M, 2001, PURE APPL CHEM, V73, P1163, DOI 10.1351/pac200173071163
   Wick LY, 2007, ELECTROCHIM ACTA, V52, P3441, DOI 10.1016/j.electacta.2006.03.117
   WINGARD LB, 1982, ENZYME MICROB TECH, V4, P137, DOI 10.1016/0141-0229(82)90104-1
   Yeung AT, 1997, J HAZARD MATER, V55, P221, DOI 10.1016/S0304-3894(97)00017-4
   Zeng CC, 2009, J ELECTROANAL CHEM, V625, P131, DOI 10.1016/j.jelechem.2008.10.019
   Zhang T, 2010, ENVIRON MICROBIOL, V12, P1011, DOI 10.1111/j.1462-2920.2009.02145.x
   ZYLSTRA GJ, 1989, J BIOL CHEM, V264, P14940
NR 48
TC 15
Z9 15
U1 2
U2 22
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 1350-0872
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD FEB
PY 2012
VL 158
BP 414
EP 423
DI 10.1099/mic.0.053298-0
PN 2
PG 10
WC Microbiology
SC Microbiology
GA 900CP
UT WOS:000300864500012
PM 22096152
OA Bronze
DA 2018-12-27
ER

PT J
AU Shreaz, S
   Wani, MY
   Ahmad, SR
   Ahmad, SI
   Bhatia, R
   Athar, F
   Nikhat, M
   Khan, LA
AF Shreaz, Sheikh
   Wani, Mohmmad Younus
   Ahmad, Sheikh Rayees
   Ahmad, Sheikh Imran
   Bhatia, Rimple
   Athar, Fareeda
   Nikhat, Manzoor
   Khan, Luqman A.
TI RETRACTED: Proton-pumping-ATPase-targeted antifungal activity of
   cinnamaldehyde based sulfonyl tetrazoles (Retracted article. See vol.
   57, pg. 483, 2012)
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article; Retracted Publication
DE Antifungal activity; Candida; Cinnamaldehyde; Tetrazole; Plasma membrane
   H+-ATPase
ID MEDIATED FUNGICIDAL ACTIVITY; ELECTRON-MICROSCOPY; CANDIDA-ALBICANS;
   RESISTANCE; SUSCEPTIBILITY; ECHINOCANDIN; AZOLES; AGENTS
AB Azoles are generally fungistatic, and resistance to fluconazole is emerging in several fungal pathogens. We designed a series of cinnamaldehyde based sulfonyl tetrazole derivatives. To further explore the antifungal activity, in vitro studies were conducted against 60 clinical isolates and 6 standard laboratory strains of Candida. The rapid irreversible action of these compounds on fungal cells suggested a membrane-located target for their action. Results obtained indicate plasma membrane H+-ATPase as site of action of the synthesized compounds. Inhibition of H+-ATPase leads to intracellular acidification and cell death. Presence of chloro and nitro groups on the sulfonyl pendant has been demonstrated to be a key structural element of antifungal potency. SEM micrographs of treated Candida cells showed severe cell breakage and alterations in morphology. (C) 2011 Elsevier Masson SAS. All rights reserved.
C1 [Shreaz, Sheikh; Bhatia, Rimple; Nikhat, Manzoor; Khan, Luqman A.] Jamia Millia Islamia, Enzyme Kinet Lab, Dept Biosci, New Delhi 110025, India.
   [Wani, Mohmmad Younus; Athar, Fareeda] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
   [Ahmad, Sheikh Imran] Jamia Millia Islamia, Dept Appl Sci & Humanities, New Delhi 110025, India.
   [Ahmad, Sheikh Rayees] Indian Inst Technol, Dept Chem, New Delhi 110016, India.
RP Khan, LA (reprint author), Jamia Millia Islamia, Enzyme Kinet Lab, Dept Biosci, New Delhi 110025, India.
EM profkhanluqman@gmail.com
FU ICMR (India) [45/93/09-Pha/BMS]
FX Sheikh Shreaz greatly acknowledges the financial support by ICMR (India)
   grant 45/93/09-Pha/BMS, (S.R.F). Authors are thankful to Dr. Sumathi
   Muralidhar from Sexually Transmitted Disease Lab, Safdarjung Hospital,
   New Delhi, India for providing the Candida strains. Authors are also
   thankful to AIRF, JNU for SEM analysis.
CR Ahmad A, 2010, FITOTERAPIA, V81, P1157, DOI 10.1016/j.fitote.2010.07.020
   Ben-Josef AM, 2000, INT J ANTIMICROB AG, V13, P287, DOI 10.1016/S0924-8579(99)00140-5
   BORIACK PA, 1995, J MED CHEM, V38, P2286, DOI 10.1021/jm00013a004
   BRADLEY PP, 1980, ANN INTERN MED, V93, P560, DOI 10.7326/0003-4819-93-4-560
   Christie M.S., 2007, TOXICOL SCI, V97, P163
   HAMOR GH, 1967, J PHARM SCI, V56, P134, DOI 10.1002/jps.2600560127
   Jesus FPK, 2011, VET MICROBIOL, V152, P161, DOI 10.1016/j.vetmic.2011.04.027
   Joanna M., 2003, IL FARMACO, V58, P455
   KANESHIMA S, 1977, J ELECTRON MICROSC, V26, P355
   Khan A, 2010, NAT PROD COMMUN, V5, P345
   Kohli A, 2002, ANTIMICROB AGENTS CH, V46, P1046, DOI 10.1128/AAC.46.4.1046-1052.2002
   Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f
   Manzoor Nikhat, 2002, Indian Journal of Experimental Biology, V40, P785
   MARES D, 1989, MYCOPATHOLOGIA, V108, P37, DOI 10.1007/BF00436782
   Nabaweya S., 2000, CHEM HET COMP, V36, P449
   Perlin DS, 1997, ANN NY ACAD SCI, V834, P609, DOI 10.1111/j.1749-6632.1997.tb52330.x
   Pfaller MA, 2011, INT J ANTIMICROB AG, V38, P65, DOI 10.1016/j.ijantimicag.2011.02.016
   Pfaller MA, 2011, DIAGN MICR INFEC DIS, V69, P45, DOI 10.1016/j.diagmicrobio.2010.08.013
   Pfaller MA, 2011, J CLIN MICROBIOL, V49, P396, DOI 10.1128/JCM.01398-10
   Ram S.U., 2004, EUR J MED CHEM, V39, P579
   Rashid Bushra, 2004, Korean Journal of Biological Sciences, V8, P307
   Sanglard D, 2003, ANTIMICROB AGENTS CH, V47, P2404, DOI 10.1128/AAC.47.8.2404-2412.2003
   SETYOUNG D, 1997, BIOCHIM BIOPHYS ACTA, V1326, P249
   Shie JJ, 2003, J ORG CHEM, V68, P1158, DOI 10.1021/jo026407z
   Shreaz S, 2010, MICROB PATHOGENESIS, V49, P75, DOI 10.1016/j.micpath.2010.03.013
   Situ H, 2000, ANTIMICROB AGENTS CH, V44, P1485, DOI 10.1128/AAC.44.6.1485-1493.2000
   TAN GT, 1992, J MED CHEM, V35, P4846, DOI 10.1021/jm00104a010
   TANIMUKAI H, 1965, BIOCHEM PHARMACOL, V14, P961
NR 28
TC 4
Z9 4
U1 2
U2 32
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD FEB
PY 2012
VL 48
BP 363
EP 370
DI 10.1016/j.ejmech.2011.12.007
PG 8
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 895GT
UT WOS:000300484900038
PM 22209273
DA 2018-12-27
ER

PT J
AU Turkyilmazoglu, M
AF Turkyilmazoglu, Mustafa
TI RETRACTED: Effects of uniform radial electric field on the MHD heat and
   fluid flow due to a rotating disk (Retracted article. See vol. 140, pg.
   830, 2018)
SO INTERNATIONAL JOURNAL OF ENGINEERING SCIENCE
LA English
DT Article; Retracted Publication
DE Electric potential; Radial electric; MHD flow; Rotating disk; Heat
   transfer
ID BOUNDARY-LAYER; MAGNETIC-FIELD; ABSOLUTE INSTABILITY; HALL CURRENT;
   INJECTION; LAMINAR; SUCTION
AB The flow and heat transfer of an incompressible electrically conducting fluid over a rotating infinite disk are studied in the present paper. The disk finds itself subjected to a uniform normal magnetic field. The particular interest lies in searching for the effects of an imposed radial electric field on the behavior of the physical flow. The gradient of an electric potential generated on the disk penetrates through the fluid and greatly influences the boundary layer formation. The presented model representing the fluid motion is a general case since it reduces to the traditional Karman's viscous pump when the electric potential is ignored. The governing Navier-Stokes and Maxwell equations of the constructed model together with the energy equation are converted into self-similar forms using suitable similarity transformations. The flow and thermal boundary layers are shown to be much affected by the presence of a uniform radial electric parameter. Some parameters of fundamental physical significance such as the surface shear stresses in the radial and tangential directions and the heat transfer rate are numerically evaluated. The effects of electric conductivity of the disk on the flow and forced convection heat transfer are further discussed. (C) 2011 Elsevier Ltd. All rights reserved.
C1 Hacettepe Univ, Dept Math, TR-06532 Ankara, Turkey.
RP Turkyilmazoglu, M (reprint author), Hacettepe Univ, Dept Math, TR-06532 Ankara, Turkey.
EM turkyilm@hacettepe.edu.tr
CR Ariel PD, 2002, Z ANGEW MATH MECH, V82, P235, DOI 10.1002/1521-4001(200204)82:4<235::AID-ZAMM235>3.0.CO;2-L
   Attia HA, 2001, APPL MATH MODEL, V25, P1089, DOI 10.1016/S0307-904X(01)00033-6
   Awad MM, 2008, J HEAT TRANS-T ASME, V130, DOI 10.1115/1.2780185
   BANKS WHH, 1976, ACTA MECH, V24, P273, DOI 10.1007/BF01190376
   BENTON ER, 1966, J FLUID MECH, V24, P781, DOI 10.1017/S0022112066001009
   Cochran WG, 1934, P CAMB PHILOS SOC, V30, P365
   Evans HL, 1968, LAMINAR BOUNDARY LAY
   Hossain MA, 2001, INT J THERM SCI, V40, P11, DOI 10.1016/S1290-0729(00)01183-2
   Jasmine HA, 2005, J ENG MATH, V52, P337, DOI 10.1007/s10665-005-2732-6
   KUMAR SK, 1988, COMPUT FLUIDS, V16, P183, DOI 10.1016/0045-7930(88)90005-9
   LAI CY, 1985, J FLUID MECH, V157, P471, DOI 10.1017/S0022112085002452
   LINGWOOD RJ, 1995, J FLUID MECH, V299, P17, DOI 10.1017/S0022112095003405
   MILLSAPS K, 1952, J AERONAUT SCI, V19, P120
   PAO HP, 1968, AIAA J, V6, P1285, DOI 10.2514/3.4735
   PARTER SV, 1984, ARCH RATION MECH AN, V86, P305, DOI 10.1007/BF00280030
   RILEY N, 1964, Q J MECH APPL MATH, V17, P331, DOI 10.1093/qjmam/17.3.331
   Shevchuk IV, 2009, HEAT MASS TRANSFER, V45, P1313, DOI 10.1007/s00231-009-0505-x
   Shevchuk IV, 2009, LECT NOTES APPL COMP, V45, P1, DOI 10.1007/978-3-642-00718-7
   Sparrow E.M., 1962, J APPL MECH, V29, P181
   SPARROW EM, 1959, ASME, V81, P249
   Turkyilmazoglu M, 2007, J ENG MATH, V59, P337, DOI 10.1007/s10665-007-9137-7
   Turkyilmazoglu M, 2011, INT J NONLIN MECH, V46, P1042, DOI 10.1016/j.ijnonlinmec.2011.04.023
   TURKYILMAZOGLU M, 1998, THESIS U MANCHESTER
   Turkyilmazoglu M, 2009, J HEAT TRANS-T ASME, V131, DOI 10.1115/1.3139187
   von Karman T, 1921, Z ANGEW MATH MECH, V1, P233
NR 25
TC 4
Z9 4
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7225
EI 1879-2197
J9 INT J ENG SCI
JI Int. J. Eng. Sci.
PD FEB
PY 2012
VL 51
BP 233
EP 240
DI 10.1016/j.ijengsci.2011.09.011
PG 8
WC Engineering, Multidisciplinary
SC Engineering
GA 894ZT
UT WOS:000300466700017
DA 2018-12-27
ER

PT J
AU Saitoh, Y
   Sashiyama, H
   Oshima, T
   Nakata, Y
   Sato, J
AF Saitoh, Yuhji
   Sashiyama, Hiroshi
   Oshima, Tsutomu
   Nakata, Yoshinori
   Sato, Jiro
TI RETRACTED: Assessment of neuromuscular block at the orbicularis oris,
   corrugator supercilii, and adductor pollicis muscles (Retracted article.
   See vol. 30, pg. 1097, 2016)
SO JOURNAL OF ANESTHESIA
LA English
DT Article; Retracted Publication
DE Orbicularis oris muscle; Corrugator supercilii muscle; Adductor pollicis
   muscle; Rocuronium
ID OCULI; ACCELEROMYOGRAPHY; VECURONIUM; DIAPHRAGM; LARYNX; MAC
AB We studied neuromuscular block at the orbicularis oris, corrugator supercilii, and adductor pollicis muscles in anesthetized patients.
   Fifty-four adult patients undergoing air-oxygen-sevoflurane-fentanyl and epidural anesthesia were randomly divided into orbicularis oris, corrugator supercilii, and adductor pollicis groups of 18 patients each. In the three groups, the degree of neuromuscular block caused by rocuronium 0.6 mg/kg was monitored at the orbicularis oris, corrugator supercilii, and adductor pollicis muscles acceleromyographically.
   Onset of neuromuscular block did not significantly differ among the three groups [157 +/- A 60, 186 +/- A 73, and 148 +/- A 45 s; mean +/- A standard deviation (SD)]. Minimum value of 1st stimulation in train-of-four (T1)/control at the corrugator supercilii group was significantly higher than in the orbicularis oris and adductor pollicis groups (0.108 +/- A 0.066 vs. 0.021 +/- A 0.024 and 0.002 +/- A 0.007; P < 0.001). T1/control at the orbicularis oris group was significantly higher than at the adductor pollicis group 30 min after rocuronium (P < 0.05). T1/control at the corrugator supercilii group was significantly higher than at the orbicularis oris and adductor pollicis groups 10-30 and 10-40 min, respectively, after rocuronium (P < 0.05). Train-of-four ratios at the orbicularis oris and corrugator supercilii groups were significantly higher than at the adductor pollicis group 40-120 min after rocuronium (P < 0.05).
   The corrugator supercilii muscle is more resistant to rocuronium than the orbicularis oris and adductor pollicis muscles. Recovery of neuromuscular block at the orbicularis oris muscle is slower than that at the corrugator supercilii muscle but was faster than that at the adductor pollicis muscle.
C1 [Saitoh, Yuhji] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Anesthesiol, Chiba 2768524, Japan.
   [Sashiyama, Hiroshi] Tsujinaka Hosp Kashiwanoha, Endoscopy Unit, Dept Coloproctol Surg, Chiba, Japan.
   [Oshima, Tsutomu] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Vice Director, Tokyo, Japan.
   [Nakata, Yoshinori] Teikyo Univ, Sch Med, Dept Anesthesia & Crit Care, Tokyo 173, Japan.
   [Sato, Jiro] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Anesthesiol, Chiba, Japan.
RP Saitoh, Y (reprint author), Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Anesthesiol, 477-96 Owada Shinden, Chiba 2768524, Japan.
EM ysr311@auone.jp
FU The Japan Society for Clinical Anesthesia
FX This study was funded by The Japan Society for Clinical Anesthesia.
CR Browner WS, DESIGNING CLIN RES, P65
   Fragen RJ, 1996, J CLIN ANESTH, V8, P352, DOI 10.1016/0952-8180(96)00082-7
   Gatke MR, 2002, ACTA ANAESTH SCAND, V46, P1124, DOI 10.1034/j.1399-6576.2002.460911.x
   Hemmerling TM, 2000, BRIT J ANAESTH, V85, P856, DOI 10.1093/bja/85.6.856
   Hemmerling TM, 2003, CAN J ANAESTH, V50, P779, DOI 10.1007/BF03019373
   Hemmerling TM, 2002, BRIT J ANAESTH, V88, P389, DOI 10.1093/bja/88.3.389
   KOPMAN AF, 1984, ANESTHESIOLOGY, V61, P83, DOI 10.1097/00000542-198461010-00015
   Larsen PB, 2002, ACTA ANAESTH SCAND, V46, P1131, DOI 10.1034/j.1399-6576.2002.460912.x
   Mapleson WW, 1996, BRIT J ANAESTH, V76, P179
   Plaud B, 2001, ANESTHESIOLOGY, V95, P96, DOI 10.1097/00000542-200107000-00019
   SAITOH Y, 1993, BRIT J ANAESTH, V70, P402, DOI 10.1093/bja/70.4.402
   Saitoh Y, 2010, J CLIN ANESTH, V22, P318, DOI 10.1016/j.jclinane.2009.09.004
   VibyMogensen J, 1996, ACTA ANAESTH SCAND, V40, P59, DOI 10.1111/j.1399-6576.1996.tb04389.x
NR 13
TC 2
Z9 2
U1 3
U2 3
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 0913-8668
EI 1438-8359
J9 J ANESTH
JI J. Anesth.
PD FEB
PY 2012
VL 26
IS 1
BP 28
EP 33
DI 10.1007/s00540-011-1262-9
PG 6
WC Anesthesiology
SC Anesthesiology
GA 893HC
UT WOS:000300345900004
PM 22045128
DA 2018-12-27
ER

PT J
AU Yang, XC
   Zhang, SY
   Pang, X
   Fan, MW
AF Yang, Xuechao
   Zhang, Siyuan
   Pang, Xin
   Fan, Mingwen
TI RETRACTED: Mineralized Tissue Formation by Bone Morphogenetic
   Protein-7-transfected Pulp Stem Cells (Retracted article. See vol. 38,
   pg. 868, 2012)
SO JOURNAL OF ENDODONTICS
LA English
DT Article; Retracted Publication
DE Adenovirus; bone morphogenetic protein-7; dental pulp stem cell; gene
   therapy; regenerative endodontics
ID DENTIN MATRIX PROTEIN-1; IN-VIVO; GENE-EXPRESSION; OSTEOGENIC PROTEIN-1;
   IMMUNE-RESPONSES; REGENERATION; ADENOVIRUS; SCAFFOLD; DIFFERENTIATION;
   DELIVERY
AB Introduction: Recombinant human bone morphogenetic protein-7 (BMP-7) is a well-established agent to induce bone and dentin formation. Little is understood until now whether BMP-7 could be used to genetically modify human dental pulp stem cells for tissue engineering applications. Methods: This study was to determine the feasibility of mineralized tissue formation from human dental pulp-derived stem cells (DPSCs) transfected with adenoviral-mediated human BMP-7 gene through in vitro and in vivo evaluations. Results: In vitro results of alkaline phosphatase, calcium content, and real-time polymerase chain reaction showed that BMP-7 transfected cells had the ability to differentiate towards the odontoblast phenotype and produce a calcified extracellular matrix. Transfected cell were seeded onto a porous ceramic scaffold and implanted subcutaneously in mice. Samples were retrieved after 4 and 8 weeks for histology evaluation. The results indicated that only the cultures with BMP-7 gene transfection showed obvious hard-tissue generation. Conclusions: Our data suggest that adenovirus-mediated BMP-7 expression can induce odontogenic differentiation of human DPSCs and show effectively mineralized tissue formation in vivo, which may provide support for gene therapy candidate of BMP-7 in dental tissue engineering. (J Endod 2012;38:170-176)
C1 Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Wuhan 430072, Hubei Province, Peoples R China.
   Wuhan Univ, Dept Endodont, Sch & Hosp Stomatol, Wuhan 430072, Hubei Province, Peoples R China.
RP Fan, MW (reprint author), 237 Luoyu Rd, Wuhan 430079, Peoples R China.
EM fanmingwen@hotmail.com
FU Natural Science Foundation of China [81000679]; Fundamental Research
   Funds for the Central Universities of China [3082026]; Youth Chenguang
   Project of Science and Technology of Wuhan City, China [201150431106]
FX Supported by grant 81000679 from the Natural Science Foundation of
   China, grant 3082026 from the Fundamental Research Funds for the Central
   Universities of China, and grant 201150431106 from the Youth Chenguang
   Project of Science and Technology of Wuhan City, China.
CR Aguiar MC, 2010, ARCH ORAL BIOL, V55, P210, DOI 10.1016/j.archoralbio.2010.01.005
   Alsanea R, 2011, J ENDODONT, V37, P1092, DOI 10.1016/j.joen.2011.05.019
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082
   Chen XQ, 2002, J ORTHOPAED RES, V20, P142, DOI 10.1016/S0736-0266(01)00060-2
   Chirmule N, 1999, GENE THER, V6, P1574, DOI 10.1038/sj.gt.3300994
   Demarco FF, 2010, J ENDODONT, V36, P1805, DOI 10.1016/j.joen.2010.08.031
   DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040
   Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457
   Fischer J, 2011, J CRANIO MAXILL SURG, V39, P54, DOI 10.1016/j.jcms.2010.03.016
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   Harvey BG, 1999, HUM GENE THER, V10, P2823, DOI 10.1089/10430349950016555
   Kofron MD, 2006, ADV DRUG DELIVER REV, V58, P555, DOI 10.1016/j.addr.2006.03.008
   Lin ZM, 2007, J ENDODONT, V33, P930, DOI 10.1016/j.joen.2007.03.010
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Nakashima M, 2005, CYTOKINE GROWTH F R, V16, P369, DOI 10.1016/j.cytogfr.2005.02.011
   Rutherford RB, 2000, EUR J ORAL SCI, V108, P202, DOI 10.1034/j.1600-0722.2000.108003202.x
   Shiba H, 2003, CELL BIOL INT, V27, P815, DOI 10.1016/S1065-6995(03)00159-8
   Six N, 2002, ARCH ORAL BIOL, V47, P177, DOI 10.1016/S0003-9969(01)00100-5
   Sloan AJ, 2000, ARCH ORAL BIOL, V45, P173, DOI 10.1016/S0003-9969(99)00131-4
   Thaci B, 2011, ONCOTARGET, V2, P113
   van den Dolder J, 2003, TISSUE ENG, V9, P315, DOI 10.1089/107632703764664783
   Viereck V, 2002, J CELL BIOCHEM, V86, P348, DOI 10.1002/jcb.10220
   Walther W, 2000, DRUGS, V60, P249, DOI 10.2165/00003495-200060020-00002
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   Yang XC, 2009, TISSUE ENG PT A, V15, P367, DOI 10.1089/ten.tea.2008.0133
   Zhang W, 2005, TISSUE ENG, V11, P357, DOI 10.1089/ten.2005.11.357
   Zhang W, 2008, TISSUE ENG PT A, V14, P285, DOI 10.1089/tea.2007.0146
   Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013
   Zhang YF, 2007, BIOMATERIALS, V28, P4635, DOI 10.1016/j.biomaterials.2007.07.009
NR 34
TC 10
Z9 13
U1 2
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0099-2399
EI 1878-3554
J9 J ENDODONT
JI J. Endod.
PD FEB
PY 2012
VL 38
IS 2
BP 170
EP 176
DI 10.1016/j.joen.2011.10.010
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 891DE
UT WOS:000300195900008
PM 22244631
DA 2018-12-27
ER

PT J
AU Schietroma, M
   Carlei, F
   Cecilia, EM
   Piccione, F
   Bianchi, Z
   Amicucci, G
AF Schietroma, Mario
   Carlei, Francesco
   Cecilia, Emanuela Marina
   Piccione, Federica
   Bianchi, Zuleyka
   Amicucci, Gianfranco
TI RETRACTED: Colorectal Infraperitoneal Anastomosis: The Effects of
   Perioperative Supplemental Oxygen Administration on the Anastomotic
   Dehiscence (Retracted article. See vol. 18, pg. 219, 2014)
SO JOURNAL OF GASTROINTESTINAL SURGERY
LA English
DT Review; Retracted Publication
DE Rectal cancer; Colorectal anastomosis; Oxygen
ID SURGICAL SITE INFECTION; RANDOMIZED CONTROLLED-TRIAL; RISK-FACTORS;
   CLINICAL-TRIAL; RECTAL-CANCER; BREATHING OXYGEN; WOUND INFECTION; TUMOR
   HYPOXIA; LEAKAGE; RESECTION
AB Background The role of supplemental oxygen therapy in the healing of colorectal anastomosis is still very much at an experimental stage. The aim of the present study, prospective randomized, was to assess the effect of administration of perioperative supplemental oxygen therapy on infraperitoneal anastomosis, where the risk of leakage is higher.
   Methods We enrolled 72 patients between February, 2008 and February, 2011, who underwent elective open infraperitoneal anastomosis for rectal cancer (middle and low). Patients were assigned randomly to an oxygen/air mixture with a fraction of inspired oxygen (FiO(2)) of 30% (n=37) or 80% (n=35). Administration was commenced after induction of anesthesia and maintained for 6 h after surgery.
   Results The overall anastomotic leak rate was 16.6% (12 out of 72); 8 patients (21.6%) had an anastomotic dehiscence in the 30% FiO(2) group and 4 (11.4%) in the 80% FiO(2) group (p<0.05). The risk of anastomotic leak was 46% lower in the 80% FiO(2) group (RR, 0.63; 95% confidence interval, 0.42-0.98) vs. the 30% FiO(2).
   Conclusion Therefore, supplemental 80% FiO(2) during and for 6 h after major rectal cancer surgery, reducing postoperative anastomotic dehiscence, should be considered part of ongoing quality improvement activities related to surgical care, with few risks to the patient and little associated cost.
C1 [Schietroma, Mario] Univ Aquila, Fac Med & Chirurg, Dipartimento Sci Chirurg, I-67100 Coppito, AQ, Italy.
   [Schietroma, Mario; Carlei, Francesco; Cecilia, Emanuela Marina; Piccione, Federica; Bianchi, Zuleyka; Amicucci, Gianfranco] Univ Aquila, Dept Surg, I-67100 Laquila, Italy.
RP Schietroma, M (reprint author), Univ Aquila, Fac Med & Chirurg, Dipartimento Sci Chirurg, Presso Osped S Salvatore Edificio Delta 6, I-67100 Coppito, AQ, Italy.
EM schietroma2001@yahoo.it
OI SCHIETROMA, Mario/0000-0002-2698-5501; Carlei,
   Francesco/0000-0003-4556-7548
CR Abele D, 2002, NATURE, V420, P27, DOI 10.1038/420027a
   Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991
   Alves A, 2002, WORLD J SURG, V26, P499, DOI 10.1007/s00268-001-0256-4
   *AM SOC AN, 1963, ANESTHESIOLOGY, V24
   Belda FJ, 2005, JAMA-J AM MED ASSOC, V294, P2035, DOI 10.1001/jama.294.16.2035
   Brasel K, 2007, CAN J SURG, V50, P214
   CALDWELL PR, 1966, J APPL PHYSIOL, V21, P1477
   Clarkson AN, 2005, ARCH IMMUNOL THER EX, V53, P213
   COMROE JH, 1945, JAMA-J AM MED ASSOC, V128, P710, DOI 10.1001/jama.1945.02860270012004
   DUBOIS AB, 1966, J APPL PHYSIOL, V21, P828
   Dworkin MJ, 1996, J AM COLL SURGEONS, V183, P357
   Eriksen MT, 2005, COLORECTAL DIS, V7, P51, DOI 10.1111/j.1463-1318.2004.00700.x
   Franchi M, 1997, OBSTET GYNECOL, V90, P622, DOI 10.1016/S0029-7844(97)00359-1
   Garcia-Botello SA, 2006, BRIT J SURG, V93, P698, DOI 10.1002/bjs.5370
   Garcia-Botello SA, 2006, BRIT J SURG, V93, P1148
   Garcia-Granero E, 1998, DIS COLON RECTUM, V41, P598, DOI 10.1007/BF02235266
   Gardella C, 2008, OBSTET GYNECOL, V112, P545, DOI 10.1097/AOG.0b013e318182340c
   Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303
   Hamzaoglu I, 1998, AM J SURG, V176, P458, DOI 10.1016/S0002-9610(98)00234-7
   Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266
   HUNT TK, 1972, SURG GYNECOL OBSTETR, V135, P561
   Kabon B, 2006, CURR OPIN ANESTHESIO, V19, P11, DOI 10.1097/01.aco.0000192775.24774.15
   Kirchhoff P, 2010, PATIENT SAF SURG, V4, DOI 10.1186/1754-9493-4-5
   KNIGHTON DR, 1984, ARCH SURG-CHICAGO, V119, P199
   Kockerling F, 1999, SURG ENDOSC-ULTRAS, V13, P639, DOI 10.1007/s004649901064
   Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5
   Law WL, 2007, J GASTROINTEST SURG, V11, P8, DOI 10.1007/s11605-006-0049-z
   Makela JT, 2003, DIS COLON RECTUM, V46, P653, DOI 10.1097/01.DCR.0000059328.10563.8C
   Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023
   Mayzler O, 2005, Minerva Anestesiol, V71, P21
   Meyhoff CS, 2009, JAMA-J AM MED ASSOC, V302, P1543, DOI 10.1001/jama.2009.1452
   MONTGOMERY AB, 1989, AM REV RESPIR DIS, V139, P1548, DOI 10.1164/ajrccm/139.6.1548
   Platell C, 2007, COLORECTAL DIS, V9, P71, DOI 10.1111/j.1463-1318.2006.01002.x
   Pryor KO, 2004, JAMA-J AM MED ASSOC, V291, P79, DOI 10.1001/jama.291.1.79
   Qadan M, 2009, ARCH SURG-CHICAGO, V144, P359, DOI 10.1001/archsurg.2009.1
   Rullier E, 1998, BRIT J SURG, V85, P355
   Sala C, 1994, BRIT J SURG, V81, P35
   Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9
   SHANDALL A, 1985, BRIT J SURG, V72, P606, DOI 10.1002/bjs.1800720808
   Shannon AM, 2003, CANCER TREAT REV, V29, P297, DOI 10.1016/S0305-7372(03)00003-3
   SHERIDAN WG, 1987, DIS COLON RECTUM, V30, P867, DOI 10.1007/BF02555426
   Sohn Vance Y, 2009, Clin Colon Rectal Surg, V22, P21, DOI 10.1055/s-0029-1202882
   Sorensen LT, 1999, BRIT J SURG, V86, P927, DOI 10.1046/j.1365-2168.1999.01165.x
   Tornero-Campello G, 2006, BRIT J SURG, V93, P1148, DOI 10.1002/bjs.5591
   Turan A, 2006, ANAESTHESIA, V61, P628, DOI 10.1111/j.1365-2044.2006.04703.x
   Vignali A, 1997, J AM COLL SURGEONS, V185, P105, DOI 10.1016/S1072-7515(97)00018-5
   Walker KG, 2004, ANN SURG, V240, P255, DOI 10.1097/01.sla.0000133186.81222.08
   WEST JB, 1999, RESP PHYSL ESSENTIAL
   Yeh CY, 2005, ANN SURG, V241, P9, DOI 10.1097/01.sla.0000150067.99651.6a
NR 49
TC 32
Z9 32
U1 2
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1091-255X
EI 1873-4626
J9 J GASTROINTEST SURG
JI J. Gastrointest. Surg.
PD FEB
PY 2012
VL 16
IS 2
BP 427
EP 434
DI 10.1007/s11605-011-1717-1
PG 8
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 892NR
UT WOS:000300293400034
PM 21975687
DA 2018-12-27
ER

PT J
AU Akpinar, A
   Kaygusuz, K
AF Akpinar, A.
   Kaygusuz, K.
TI RETRACTED: Regional sustainable water and energy development projects: A
   case of Southeastern Anatolia Project (GAP) in Turkey (Retracted
   article. See vol. 83, pg. 173, 2018)
SO RENEWABLE & SUSTAINABLE ENERGY REVIEWS
LA English
DT Review; Retracted Publication
DE Southeastern Anatolia Project (GAP); Hydroelectric; Water resources;
   Turkey
ID RENEWABLE ENERGY; HYDROPOWER
AB Southeastern Anatolia Project (GAP) region in Turkey is rich in water for irrigation and hydroelectric power. The Euphrates and Tigris Rivers represent over 28% of the nation's water supply by rivers, and the economically irrigable areas in the region make up 20% of those for the entry country. Turkey has a total gross hydropower potential of 433 GWh/yr, but only 125 GWh/yr of the total hydroelectric potential of Turkey can be economically used. By the construction of new hydropower plants, 36% of the economically usable potential of the country would be tapped. The GAP region has a 22% share of the country's total hydroelectric potential, with plans for 22 dams and 19 hydroelectric power plants. Once completed, 27 billion kWh of electricity will be generated annually. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Akpinar, A.] Gumushane Univ, Dept Civil Engn, TR-29000 Gumushane, Turkey.
   [Akpinar, A.] Karadeniz Tech Univ, Dept Civil Engn, TR-61080 Trabzon, Turkey.
   [Kaygusuz, K.] Karadeniz Tech Univ, Dept Chem, TR-61080 Trabzon, Turkey.
RP Akpinar, A (reprint author), Gumushane Univ, Dept Civil Engn, TR-29000 Gumushane, Turkey.
EM aakpinar@ktu.edu.tr
CR Akpinar A, 2011, RENEW SUST ENERG REV, V15, P2013
   Akpinar A, 2008, RENEW SUST ENERG REV, V12, P2013, DOI 10.1016/j.rser.2007.04.011
   Alboyaci B, 2008, RENEW ENERG, V33, P2499, DOI 10.1016/j.renene.2008.02.008
   Altinbilek D, 2004, INT J WATER RESOUR D, V20, P15, DOI 10.1080/07900620310001635584
   Altinbilek D, 2002, WATER SCI TECHNOL, V45, P169
   Bagis A.I., 1997, WATER RESOURCES DEV, V13, P567
   DPT, 2010, 9 DEV PLAN 2007 2013
   DSI, 2010, HYDR POW TURK
   DSI (General Directorate of State Hydraulic Works), 2009, TURK WAT REP
   EIE, 2010, REN EN TURK
   GAP, 2009, EN WAT GAP REG
   Gleick PH, 2000, WATER INT, V25, P127, DOI 10.1080/02508060008686804
   International Energy Agency, 2010, EN POL IEA COUNTR TU
   Kaygusuz K, 2002, ENERG CONVERS MANAGE, V43, P1099, DOI 10.1016/S0196-8904(01)00086-3
   Kaygusuz K, 2002, RENEW SUST ENERG REV, V6, P339, DOI 10.1016/S1364-0321(01)00007-7
   Kaygusuz K, 2010, ENERG SOURCE PART B, V5, P199, DOI 10.1080/15567240802458757
   Kaygusuz K, 2009, ENERG SOURCE PART B, V4, P34, DOI 10.1080/15567240701423928
   Kaygusuz K, 1999, ENERG SOURCE, V21, P913, DOI 10.1080/00908319950014281
   MENR Ministry of Energy and Natural Resources, 2009, EN REP TURK
   Ozturk M, 2009, RENEW SUST ENERG REV, V13, P605, DOI 10.1016/j.rser.2007.11.008
   Parlak ZG, 2006, DAMS SUSTAINABLE DEV
   POLATOGLU A, 1995, METU STUDIES DEV, V22, P191
   TEIAS Turkish Electricity Transmission Company, 2010, PERC EL GEN PRIM EN
   WECTNC World Energy Council Turkish National Committee, 2008, TURK EN REP 2008
   World Commission on Dams (WCD), 2000, DAMS DEV NEW FRAM DE
   Yuksek O, 2008, ENERG POLICY, V36, P3374, DOI 10.1016/j.enpol.2008.05.004
   Yuksek O, 2006, ENERG SOURCE PART B, V1, P279, DOI 10.1080/15567240500397976
   Yuksek O, 2006, ENERG POLICY, V34, P3093, DOI 10.1016/j.enpol.2005.06.005
   Yuksel I, 2010, RENEW ENERG, V35, P1469, DOI 10.1016/j.renene.2010.01.013
   Yuksel I, 2010, RENEW SUST ENERG REV, V14, P462, DOI 10.1016/j.rser.2009.07.025
NR 30
TC 8
Z9 8
U1 2
U2 30
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1364-0321
J9 RENEW SUST ENERG REV
JI Renew. Sust. Energ. Rev.
PD FEB
PY 2012
VL 16
IS 2
BP 1146
EP 1156
DI 10.1016/j.rser.2011.11.015
PG 11
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA 891GM
UT WOS:000300205200007
DA 2018-12-27
ER

PT J
AU Markovic, D
   Cvetkovic, D
   Zivkovic, D
   Popovic, R
AF Markovic, Dragan
   Cvetkovic, Dragan
   Zivkovic, Dejan
   Popovic, Ranko
TI RETRACTED: Challenges of information and communication technology in
   energy efficient smart homes (Retracted article. See vol. 18, pg. 646,
   2013)
SO RENEWABLE & SUSTAINABLE ENERGY REVIEWS
LA English
DT Review; Retracted Publication
DE Smart home; Information and communication technology; Smart grid; Energy
   efficiency; Internet of things; Smart objects
AB Energy saving is an important issue in the times of increasing energy prices. Products and services provided by the information and communication technology (ICT) can support energy efficiency and emissions reductions. The synergy of ICT and a residential area gives rise to the smart home environment. Ecological and smart home network applications should not only improve the peoples life satisfaction in the domain of health care, security protection, and efficient management of energy and resource consumption, but they should also enable personal happy life through easy communication with community people, high level entertainment, continuous education and so on. A smart home in the smart grid is the latest addition to a family of ideas emerging in relation to the ICT usage in the home. This paper presents an overview of the smart home concept and some challenges that ICT faces in that environment. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Markovic, Dragan; Cvetkovic, Dragan] Singidunum Univ, Fac Management, Belgrade, Serbia.
   [Zivkovic, Dejan; Popovic, Ranko] Singidunum Univ, Fac Informat & Comp, Belgrade, Serbia.
RP Markovic, D (reprint author), Singidunum Univ, Fac Management, Belgrade, Serbia.
EM dsamarkovic@singidunum.ac.rs
FU Serbian Ministry of Education and Science [III44006]
FX This work has been supported by the Serbian Ministry of Education and
   Science (project III44006).
CR Allameh E, 2011, 18 ANN EUR REAL EST
   [Anonymous], 2008, SMART 2020 REP ENA L
   [Anonymous], 2010, BDI PUBL
   Bierhoff I., 2007, INCLUSIVE FUTURE IMP, P110
   Black R.T., 2003, J REAL ESTATE PRACTI, V6, P85
   Dong B, 2009, P BUILD SIM 09 IBPSA
   Junestrand S, 2004, THESIS ROYAL I TECHN
   Karnouskos S., 2010, P 14 IEEE INT S CONS
   Khalili AH, 2009, BEHAV MONITORING INT
   Kofler M J, 2010, 2010 IEEE International Energy Conference (ENERGYCON 2010), P85, DOI 10.1109/ENERGYCON.2010.5771803
   Kuo-Ming Chao, 2010, Proceedings 2010 IEEE 7th International Conference on e-Business Engineering (ICEBE 2010), P415, DOI 10.1109/ICEBE.2010.23
   Markovic D, 2011, RENEW SUSTAIN ENERGY
   Mattern F, 2010, P E EN 2010
   Nyborg S, 2011, ENERGY EFFICIENCY 1, P1849
   Reinisch C, 2010, 2010 4th IEEE International Conference on Digital Ecosystems and Technologies (DEST 2010), P256, DOI 10.1109/DEST.2010.5610636
   RICH E, 1991, ARTIFICIAL INTELLIGE
   Vasilakos A., 2006, AMBIENT INTELLIGENCE
   Vermesan O., 2011, INTERNET THINGS GLOB
   Wolsink M, 2012, RENEW SUST ENERG REV, V16, P822, DOI 10.1016/j.rser.2011.09.006
NR 19
TC 11
Z9 11
U1 2
U2 53
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1364-0321
J9 RENEW SUST ENERG REV
JI Renew. Sust. Energ. Rev.
PD FEB
PY 2012
VL 16
IS 2
BP 1210
EP 1216
DI 10.1016/j.rser.2011.11.004
PG 7
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA 891GM
UT WOS:000300205200013
DA 2018-12-27
ER

PT J
AU Haspot, B
AF Haspot, Boris
TI RETRACTED: Existence of strong solutions in critical spaces for
   barotropic viscous fluids in larger spaces (Retracted article. See vol.
   56, pg. 442, 2013)
SO SCIENCE CHINA-MATHEMATICS
LA English
DT Article; Retracted Publication
DE partial differential equation; harmonic analysis; fluid mechanics
ID NAVIER-STOKES EQUATIONS; DISCONTINUOUS INITIAL DATA; HEAT-CONDUCTIVE
   GASES/; GLOBAL WEAK SOLUTIONS; COMPRESSIBLE FLOW; MULTIDIMENSIONAL
   FLOWS; CONVERGENCE; UNIQUENESS; MODEL
AB This paper is dedicated to the study of viscous compressible barotropic fluids in dimension N >= 2. We address the question of well-posedness for large data having critical Besov regularity. Our result improves the analysis of Danchin and of the author inasmuch as we may take initial density in B-p,1(N/p), with 1 <= p < +infinity. Our result relies on a new a priori estimate for the velocity, where we introduce a new unknown called effective velocity to weaken one of the couplings between the density and the velocity. In particular, our result is the first in which we obtain uniqueness without imposing hypothesis on the gradient of the density.
C1 [Haspot, Boris] Heidelberg Univ, Inst Appl Math, D-69120 Heidelberg, Germany.
   [Haspot, Boris] Basque Ctr Appl Math, E-48160 Derio, Spain.
RP Haspot, B (reprint author), Heidelberg Univ, Inst Appl Math, Neuenheimer Feld 294, D-69120 Heidelberg, Germany.
EM haspot@u-pec.fr
CR Abidi H, 2007, ANN I FOURIER, V57, P883, DOI 10.5802/aif.2280
   Bahouri H, 1999, AM J MATH, V121, P1337, DOI 10.1353/ajm.1999.0038
   Bahouri H, 2011, FOURIER ANAL NONLINE
   BONY JM, 1981, ANN SCI ECOLE NORM S, V14, P209
   Bresch D, 2003, COMMUN MATH PHYS, V238, P211, DOI 10.1007/s00220-003-0859-8
   Chemin J. - Y, 1996, PREPUBLICATION LAB A, VVI
   CHEMIN JY, 1995, J DIFFER EQUATIONS, V121, P314, DOI 10.1006/jdeq.1995.1131
   Chemin JY, 1999, J ANAL MATH, V77, P27, DOI 10.1007/BF02791256
   Danchin R, 2007, COMMUN PART DIFF EQ, V32, P1373, DOI 10.1080/03605300600910399
   Danchin R, 2005, NODEA-NONLINEAR DIFF, V12, P111, DOI 10.1007/s00030-004-2032-2
   Danchin R, 2001, ARCH RATION MECH AN, V160, P1, DOI 10.1007/s002050100155
   Danchin R, 2001, COMMUN PART DIFF EQ, V26, P1183, DOI 10.1081/PDE-100106132
   Danchin R., 2005, FOURIER ANAL METHOD
   Germain P, J MATH FLUI IN PRESS
   Haspot B, ANN I FOURI IN PRESS
   Haspot B, 2010, REGULARITY WEAK SOLU
   Haspot B, 2010, MATH MOD METH APPL S, V20, P1
   Haspot B, 2011, ARCH RATION MECH AN, V202, P427, DOI 10.1007/s00205-011-0430-2
   Haspot B, 2009, PROC SYM AP, V67, P625
   HOFF D, 1995, ARCH RATION MECH AN, V132, P1, DOI 10.1007/BF00390346
   HOFF D, 1987, T AM MATH SOC, V303, P169, DOI 10.2307/2000785
   Hoff D, 1997, ARCH RATION MECH AN, V139, P303, DOI 10.1007/s002050050055
   Hoff D, 2006, SIAM J MATH ANAL, V37, P1742, DOI 10.1137/S040618059
   Hoff D, 2005, J MATH FLUID MECH, V7, P315, DOI 10.1007/s00021-004-0123-9
   Hoff D, 2002, COMMUN PUR APPL MATH, V55, P1365, DOI 10.1002/cpa.10046
   HOFF D, 1995, INDIANA U MATH J, V44, P603, DOI 10.1512/iumj.1995.44.2003
   HOFF D, 1995, J DIFFER EQUATIONS, V120, P215, DOI 10.1006/jdeq.1995.1111
   Kazhikhov A. V., 1977, PRIKL MAT MEKH, V41, P282
   Kazhikov AV, 1993, SIB MAT ZH, V34, P70
   Lions P. L, 1998, MATH TOPICS FLUID ME, V2
   MATSUMURA A, 1979, P JPN ACAD A-MATH, V55, P337, DOI 10.3792/pjaa.55.337
   Matsumura A, 1980, J MATH KYOTO U, V20, P67
   Meyer Y., 1997, CURRENT DEV MATH, P105
   NASH J, 1962, B SOC MATH FRANCE, V90
   RUNST T, 1996, DE GRU NONL, V3, P1
   SERRE D, 1986, CR ACAD SCI I-MATH, V303, P639
   Solonnikov VA, 1977, J SOVIET MATH, V8, P467, DOI 10.1007/BF01084616
   Vaigant VA, 1995, SIBERIAN MATH J+, V36, P1108, DOI 10.1007/BF02106835
   VALLI A, 1986, COMMUN MATH PHYS, V103, P259, DOI 10.1007/BF01206939
NR 39
TC 2
Z9 2
U1 3
U2 8
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7283
EI 1869-1862
J9 SCI CHINA MATH
JI Sci. China-Math.
PD FEB
PY 2012
VL 55
IS 2
SI SI
BP 309
EP 336
DI 10.1007/s11425-012-4360-8
PG 28
WC Mathematics, Applied; Mathematics
SC Mathematics
GA 891DZ
UT WOS:000300198700006
DA 2018-12-27
ER

PT J
AU Natarajan, S
   Mathews, R
AF Natarajan, Sampath
   Mathews, Rita
TI RETRACTED: Cloning, expression, crystallization and preliminary X-ray
   crystallographic analysis of aspartyl aminopeptidase from the apeB gene
   of Pseudomonas aeruginosa (Retracted article. See vol. 68, pg. 1419,
   2012)
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article; Retracted Publication
DE Pseudomonas aeruginosa; aspartyl aminopeptidase
ID CRYSTAL-STRUCTURE; PROTEASOMES
AB Aminopeptidases (APs) are a group of exopeptidases that catalyze the removal of amino acids from the N-termini of proteins and peptides. The APs are ubiquitous in nature and are of critical biological and medical importance because of their key role in protein degradation. Pseudomonas aeruginosa aspartyl aminopeptidase (PaAAP), which is encoded by the apeB gene, was expressed in Escherichia coli, purified and crystallized using the microbatch method. A preliminary structural study has been performed using the X-ray crystallographic method. The PaAAP crystal diffracted to 2.0 angstrom resolution and belonged to the rhombohedral space group H3, with unit-cell parameters a similar to=similar to b similar to=similar to 133.6, c = 321.2. The unit-cell volume of the crystal is compatible with the similar to presence of four monomers in the asymmetric unit, with a corresponding Matthews coefficient VM of 2.95 angstrom 3 Da-1 and a solvent content of 58.3%.
C1 [Natarajan, Sampath; Mathews, Rita] Konkuk Univ, Dept Adv Technol Fus, Seoul 143701, South Korea.
RP Natarajan, S (reprint author), Konkuk Univ, Dept Adv Technol Fus, 1 Hwayang Dong, Seoul 143701, South Korea.
EM sampath@konkuk.ac.kr
CR Auld D. S., 2004, HDB PROTEOLYTIC ENZY, P268
   Borissenko L, 2005, J MOL BIOL, V346, P1207, DOI 10.1016/j.jmb.2004.12.056
   Groll M, 2003, CURR OPIN STRUC BIOL, V13, P665, DOI 10.1016/j.sbi.2003.10.006
   LAZDUNSKI AM, 1989, FEMS MICROBIOL LETT, V63, P265, DOI 10.1111/j.1574-6968.1989.tb03400.x
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pulido-Cejudo G, 1997, ANTIVIR RES, V36, P167, DOI 10.1016/S0166-3542(97)00052-1
   Rawlings N. D., 2000, NUCLEIC ACIDS RES, V34, pD270
   Russo S, 2004, J BIOL CHEM, V279, P51275, DOI 10.1074/jbc.M409455200
   STOUT GH, 1968, XRAY STRUCTURE DETER
   Stover CK, 2000, NATURE, V406, P959
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008
NR 15
TC 1
Z9 1
U1 2
U2 15
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD FEB
PY 2012
VL 68
BP 207
EP 210
DI 10.1107/S1744309111054388
PN 2
PG 4
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 887RW
UT WOS:000299948000022
PM 22298001
OA Green Published
DA 2018-12-27
ER

PT J
AU Tulugan, K
   Park, C
   Qing, W
   Park, W
AF Tulugan, Kelimu
   Park, CheolHong
   Qing, Wang
   Park, Wonjo
TI RETRACTED: Composition design and mechanical properties of BCC Ti solid
   solution alloys with low Young's modulus (Retracted article. See vol.
   26, pg. 3741, 2012)
SO JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY
LA English
DT Article; Retracted Publication
DE Cluster-plus-glue-atom model; Composition design; Low Young's modulus;
   (Ti-Zr)-Mo-Nb alloys
ID TITANIUM-ALLOYS
AB (Ti-Zr)-Mo-Nb alloys were studied to find some stabilized BCC solid solution with low Young's Modulus. We propose a cluster-plus-glue-atom model to solve the composition design of multi-component complex alloys from the structure viewpoint. The alloy composition is expressed with [cluster](glue atom)x according to the model, x denoting the number of glue atoms matching one cluster. Alloy structures were identified with XRD and optical microscopy (OM), and mechanical tests were finally carried on to the BCC alloys. The experimental results indicated that a series of beta-Ti solid solution alloys with low Young's modulus and good synthesized mechanical properties can be obtained with the cluster model, where the [CN14 clusted(glue)] alloys given by of 1:1 cluster model have the optimum properties.
C1 [Park, Wonjo] Gyeongsang Natl Univ, Dept Mech & Aerosp Engn, Inst Marine Ind, Tongyoung 650160, Gyeongnam, South Korea.
   [Tulugan, Kelimu; Park, CheolHong] Gyeongsang Natl Univ, Dept Mech & Precis Engn, Grad Sch, Tongyoung 650160, Gyeongnam, South Korea.
   [Qing, Wang] Dalian Univ Technol, Sch Mat Sci & Engn, Dalian 116024, Liaoning Provin, Peoples R China.
RP Park, W (reprint author), Gyeongsang Natl Univ, Dept Mech & Aerosp Engn, Inst Marine Ind, Tongyoung 650160, Gyeongnam, South Korea.
EM wjpark@gun.ac.kr
FU Ministry of Education, Science and Technology (MEST); Korea Institute
   for Advancement of Technology (KIAT)
FX This research was financially supported by the Ministry of Education,
   Science and Technology (MEST) and Korea Institute for Advancement of
   Technology (KIAT) through the Human Resource Training Project for
   Regional Innovation and Second-Phase of BK (Brain Korea) 21 Project.
CR Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Ezugwu EO, 1997, J MATER PROCESS TECH, V68, P262, DOI 10.1016/S0924-0136(96)00030-1
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   Ivasishin OM, 2008, J ALLOY COMPD, V457, P296, DOI 10.1016/j.jallcom.2007.03.070
   M. D. Biomedical alloys, 1998, ADV MAT PROCESSES, V154, P63
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
NR 6
TC 1
Z9 2
U1 4
U2 14
PU KOREAN SOC MECHANICAL ENGINEERS
PI SEOUL
PA KSTC NEW BLD. 7TH FLOOR, 635-4 YEOKSAM-DONG KANGNAM-KU, SEOUL 135-703,
   SOUTH KOREA
SN 1738-494X
EI 1976-3824
J9 J MECH SCI TECHNOL
JI J. Mech. Sci. Technol.
PD FEB
PY 2012
VL 26
IS 2
BP 373
EP 377
DI 10.1007/s12206-011-1207-0
PG 5
WC Engineering, Mechanical
SC Engineering
GA 888VW
UT WOS:000300033700010
DA 2018-12-27
ER

PT J
AU Jadhav, A
   Ingole, A
   Chockalingam, A
AF Jadhav, Amar
   Ingole, Apeksha
   Chockalingam, Anand
TI RETRACTED: Ventricular Ectopic Beats: An Overview of Management
   Considerations (Retracted article. See vol. 344, pg. 256, 2012)
SO AMERICAN JOURNAL OF THE MEDICAL SCIENCES
LA English
DT Review; Retracted Publication
DE Ventricular ectopic beats; Ventricular tachycardia; Ventricular
   fibrillation
ID CONGESTIVE-HEART-FAILURE; SUDDEN CARDIAC DEATH; MYOCARDIAL-INFARCTION;
   MEN; ARRHYTHMIAS; TACHYCARDIA; CAFFEINE; ABLATION; FREQUENT; TRIAL
AB Ventricular ectopic beats are commonly seen in daily clinical practice. Majority of them being asymptomatic, some can cause symptoms. In a normal heart, their occurrence is of no clinical significance. However, in the presence of an underlying heart disease, they signify a susceptibility toward more sinister arrhythmias. In some patients, they are triggered by the same mechanism as ventricular tachycardia and these can be cured by catheter ablation. Recent reports on the use of catheter ablation in cases where focal ventricular ectopics are found to trigger ventricular fibrillation. Clinical evaluation and investigations are important in assessing patients with ventricular ectopic beats so that appropriate treatment can be targeted when necessary. This article discusses the current knowledge and practice in this commonly encountered clinical problem.
C1 [Jadhav, Amar; Chockalingam, Anand] Univ Missouri, Sch Med, Dept Internal Med, Div Cardiovasc Med, Columbia, MO 65212 USA.
   [Ingole, Apeksha] MGMs Med Coll & Hosp, Aurangabad, Maharashtra, India.
   [Chockalingam, Anand] Harry S Truman VA Med Ctr, Cardiol Sect, Columbia, MO USA.
RP Jadhav, A (reprint author), Univ Missouri, Sch Med, Dept Internal Med, Div Cardiovasc Med, Columbia, MO 65212 USA.
EM physician79@gmail.com
OI Chockalingam, Anand/0000-0002-4502-1759
CR ABDALLA ISH, 1987, AM J CARDIOL, V60, P1036, DOI 10.1016/0002-9149(87)90348-1
   ALMENDRAL J, 1995, AM J CARDIOL, V76, pD60, DOI 10.1016/S0002-9149(99)80494-9
   [Anonymous], 1989, NEW ENGL J MED, V321, P406
   BIKKINA M, 1992, ANN INTERN MED, V117, P990, DOI 10.7326/0003-4819-117-12-990
   Cairns JA, 1997, LANCET, V349, P675, DOI 10.1016/S0140-6736(96)08171-8
   DEBACKER G, 1979, CIRCULATION, V59, P762, DOI 10.1161/01.CIR.59.4.762
   DOBMEYER DJ, 1983, NEW ENGL J MED, V308, P814, DOI 10.1056/NEJM198304073081405
   Domanski MJ, 1999, J AM COLL CARDIOL, V33, P598, DOI 10.1016/S0735-1097(98)00609-3
   ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201
   Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742
   Fontaine G, 1999, ANNU REV MED, V50, P17, DOI 10.1146/annurev.med.50.1.17
   Frolkis JP, 2003, NEW ENGL J MED, V348, P781, DOI 10.1056/NEJMoa022353
   GONZALEZFERNANDEZ RA, 1993, AM J HYPERTENS, V6, P308, DOI 10.1093/ajh/6.4.308
   GRABOYS TB, 1989, ARCH INTERN MED, V149, P637, DOI 10.1001/archinte.149.3.637
   Haissaguerre M, 2002, CIRCULATION, V106, P962, DOI 10.1161/01.CIR.0000027564.55739.B1
   Haissaguerre M, 2002, LANCET, V359, P677, DOI 10.1016/S0140-6736(02)07807-8
   Joshi S, 2005, J CARDIOVASC ELECTR, V16, pS52, DOI 10.1111/j.1540-8167.2005.50163.x
   Jouven X, 2000, NEW ENGL J MED, V343, P826, DOI 10.1056/NEJM200009213431201
   KENNEDY HL, 1985, NEW ENGL J MED, V312, P193, DOI 10.1056/NEJM198501243120401
   KOSTIS JB, 1981, CIRCULATION, V63, P1351, DOI 10.1161/01.CIR.63.6.1351
   Morshedi-Meibodi A, 2004, CIRCULATION, V109, P2417, DOI 10.1161/01.CIR.0000129762.41889.41
   MYERS MG, 1988, CHEST, V94, P4, DOI 10.1378/chest.94.1.4
   Ng E, 2004, J ROY SOC MED, V97, P23, DOI 10.1258/jrsm.97.1.23
   PRINEAS RJ, 1980, J CHRON DIS, V33, P67, DOI 10.1016/0021-9681(80)90029-6
   Ramires FJA, 2000, AM J CARDIOL, V85, P1207, DOI 10.1016/S0002-9149(00)00729-3
   Reiter MJ, 1998, AM J CARDIOL, V82, p9I, DOI 10.1016/S0002-9149(98)00468-8
   Simpson RJ, 2002, AM HEART J, V143, P535, DOI 10.1067/mhj.2002.120298
   SINGH SN, 1995, NEW ENGL J MED, V333, P77, DOI 10.1056/NEJM199507133330201
   Stevenson WG, 2005, CURR OPIN CARDIOL, V20, P42
   Takemoto M, 2005, J AM COLL CARDIOL, V45, P1259, DOI 10.1016/j.jacc.2004.12.073
NR 30
TC 1
Z9 1
U1 2
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9629
EI 1538-2990
J9 AM J MED SCI
JI Am. J. Med. Sci.
PD FEB
PY 2012
VL 343
IS 2
BP 150
EP 154
DI 10.1097/MAJ.0b013e31821d677b
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 886RY
UT WOS:000299872800010
PM 21681072
DA 2018-12-27
ER

PT J
AU Negri, B
   Calvo-Guirado, JL
   Pardo-Zamora, G
   Ramirez-Fernandez, MP
   Delgado-Ruiz, RA
   Munoz-Guzon, F
AF Negri, Bruno
   Luis Calvo-Guirado, Jose
   Pardo-Zamora, Guillermo
   Piedad Ramirez-Fernandez, Ma
   Arcesio Delgado-Ruiz, Rafael
   Munoz-Guzon, Fernando
TI RETRACTED: Peri-implant bone reactions to immediate implants placed at
   different levels in relation to crestal bone. Part I: a pilot study in
   dogs (Retracted article. See vol. 29, pg. 668, 2018)
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article; Retracted Publication
DE crestal bone resorption; crestal placement; immediate implant;
   subcrestal placement
ID FRESH EXTRACTION SOCKETS; ACID-ETCHED SURFACE; TOOTH EXTRACTION;
   TITANIUM IMPLANTS; HISTOMETRIC EVALUATION; SUBMERGED IMPLANTS;
   CLINICAL-TRIAL; SOFT-TISSUES; SLA IMPLANTS; FOLLOW-UP
AB Purpose: The aim of the present study was to evaluate bone remodeling and bone-to-implant contact (BIC) after immediate placement at different levels in relation to the crestal bone of Beagle dogs.
   Materials and methods: The mandibular bilateral second, third and fourth premolars of six Beagle dogs were extracted and six implants were immediately placed in the hemi-arches of each dog. Randomly, three cylindrical and three tapered implants were inserted crestally (control group) and 2mm subcrestally (experimental group). Both groups were treated with a minimal mucoperiosteal flap elevation approach. A gap from the buccal cortical wall to the implant was always left. Three dogs were allowed a 4-week submerged healing period and the other three an 8-week submerged healing period. The animals were sacrificed and biopsies were obtained. Biopsies were processed for ground sectioning. Histomorphometric analysis was carried out in order to compare buccal and lingual bone height loss, and BIC between the two groups.
   Results: All implants osseointegrated clinically and histologically. Healing patterns examined microscopically at 4 and 8 weeks for both groups (crestal and subcrestal) yielded similar qualitative bone findings. The distance from the top of the implant collar to the first BIC in the lingual crest (A-Lc) showed a significant difference (P = 0.0313): 1.91 +/- 0.2mm in the control group and 1.08 +/- 0.2mm in the experimental group. There was less bone resorption in subcrestal implants than crestal implants. The mean percentage of newly formed BIC was greater with the cylindrical implant design (46.06 +/- 4.09%) than with the tapered design (32.64 +/- 3.72%).
   Conclusion: These findings suggest that apical positioning of the top of the implant does not jeopardize bone crest and peri-implant tissue remodeling. However, less resorption of the Lc may be expected when implants are placed 2mm subcrestally.
C1 [Negri, Bruno; Luis Calvo-Guirado, Jose; Pardo-Zamora, Guillermo; Piedad Ramirez-Fernandez, Ma; Arcesio Delgado-Ruiz, Rafael] Univ Murcia, Dept Gen & Implant Dent, Fac Med & Dent, Murcia, Spain.
   [Munoz-Guzon, Fernando] Univ Santiago Compostela, Sch Vet, Dept Pathol, Lugo, Spain.
RP Negri, B (reprint author), C Carretillas 25 1 8, Alicante 03190, Spain.
EM brunonegri2000@yahoo.com
RI Munoz, Fernando/I-1858-2015
OI Munoz, Fernando/0000-0002-4130-1526; Delgado-Ruiz,
   Rafael/0000-0003-1721-0509; calvo guirado, jose
   luis/0000-0002-4067-2253; RAMIREZ FERNANDEZ, MARIA
   PIEDAD/0000-0003-1913-9902
FU Department of General Dentistry; Master of Implant Dentistry, Faculty of
   Medicine and Dentistry, University of Murcia, Spain
FX The authors B. Negri, J. L. Calvo-Guirado, Z. G. Pardo Z, M. P. Ramirez
   Fernandez, R. Delgado Ruiz and F. M. Guzon, declare that they have no
   conflict of interests. The study was initiated and self-funded by the
   Department of General Dentistry (C.O.I.A) and Master of Implant
   Dentistry, Faculty of Medicine and Dentistry, University of Murcia,
   Spain. The study materials CIH (R) Tapered implant internal conection
   and Evolution 2 (R) Cylindrical external connection implant were kindly
   provided by B y W S. R. L., Buenos Aires, Argentina. The authors
   gratefully acknowledge the assistance of Manuel Canteras and Maria
   Garcia Garcia (University of Murcia, Spain) in the statistical analysis
   and Nuria Garcia Carrillo (Veterinary).
CR Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P615, DOI 10.1111/j.1600-0501.2006.01317.x
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P606, DOI 10.1111/j.1600-0501.2006.01315.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Barros R. R. M., 2009, TITANIUM, V1, P45
   Barros RRM, 2010, CLIN ORAL IMPLAN RES, V21, P371, DOI 10.1111/j.1600-0501.2009.01860.x
   Becker BE, 1998, J PERIODONTOL, V69, P920, DOI 10.1902/jop.1998.69.8.920
   Bornstein MM, 2003, INT J ORAL MAX IMPL, V18, P659
   Bornstein MM, 2005, CLIN ORAL IMPLAN RES, V16, P631, DOI 10.1111/j.1600-0501.2005.01209.x
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Botticelli D, 2004, CLIN ORAL IMPLAN RES, V15, P285, DOI 10.1046/j.1600-0501.2003.01008.x
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P309, DOI 10.1111/j.1600-051X.2004.00502.x
   Botticelli D, 2006, CLIN ORAL IMPLAN RES, V17, P351, DOI 10.1111/j.1600-0501.2006.01270.x
   Bragger U, 1996, CLIN ORAL IMPLAN RES, V7, P268, DOI 10.1034/j.1600-0501.1996.070309.x
   Calvo-Guirado JL, 2010, CLIN ORAL IMPLAN RES, V21, P308, DOI 10.1111/j.1600-0501.2009.01841.x
   Chung SH, 2008, J ORAL REHABIL, V35, P229, DOI 10.1111/j.1365-2842.2006.01653.x
   Cochran DL, 2002, CLIN ORAL IMPLAN RES, V13, P144, DOI 10.1034/j.1600-0501.2002.130204.x
   Degidi M, 2006, INT J ORAL MAX IMPL, V21, P763
   Degidi Marco, 2003, Clin Implant Dent Relat Res, V5, P89, DOI 10.1111/j.1708-8208.2003.tb00189.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Pontes AEF, 2008, CLIN ORAL IMPLAN RES, V19, P483, DOI 10.1111/j.1600-0501.2007.01506.x
   Fick S, 2010, INT J ORAL MAX IMPL, V25, P577
   Frost B, 1992, J Can Dent Assoc, V58, P521
   Grunder U, 1999, INT J ORAL MAX IMPL, V14, P210
   Hermann JS, 2001, J PERIODONTOL, V72, P1372, DOI 10.1902/jop.2001.72.10.1372
   Jung RE, 2008, J PERIODONTOL, V79, P260, DOI [10.1902/jop.2008.070132, 10.1902/jop.2008.070132 ]
   Lazzara R J, 1989, Int J Periodontics Restorative Dent, V9, P332
   Nemcovsky CE, 2002, CLIN ORAL IMPLAN RES, V13, P410, DOI 10.1034/j.1600-0501.2002.130410.x
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   Roccuzzo M, 2001, CLIN ORAL IMPLAN RES, V12, P572, DOI 10.1034/j.1600-0501.2001.120604.x
   Sanz M, 2010, CLIN ORAL IMPLAN RES, V21, P13, DOI 10.1111/j.1600-0501.2009.01824.x
   SCHENK EA, 1983, STAIN TECHNOL, V58, P377, DOI 10.3109/10520298309066818
   SCHROEDER A, 1986, DEUT MED WOCHENSCHR, V111, P1427, DOI 10.1055/s-2008-1068645
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   SchwartzArad D, 1997, J PERIODONTOL, V68, P915, DOI 10.1902/jop.1997.68.10.915
   SchwartzArad D, 1997, J PERIODONTOL, V68, P1110, DOI 10.1902/jop.1997.68.11.1110
   Todescan FF, 2002, INT J ORAL MAX IMPL, V17, P467
   Weng D, 2008, CLIN ORAL IMPLAN RES, V19, P1141, DOI 10.1111/j.1600-0501.2008.01564.x
NR 39
TC 20
Z9 21
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD FEB
PY 2012
VL 23
IS 2
BP 228
EP 235
DI 10.1111/j.1600-0501.2011.02158.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 876HP
UT WOS:000299098700013
PM 21435017
DA 2018-12-27
ER

PT J
AU Negri, B
   Calvo-Guirado, JL
   Ramirez-Fernandez, MP
   Val, JMSD
   Guardia, J
   Munoz-Guzon, F
AF Negri, Bruno
   Luis Calvo-Guirado, Jose
   Piedad Ramirez-Fernandez, Ma
   Sanchez-de Val, Jose Mate
   Guardia, Javier
   Munoz-Guzon, Fernando
TI RETRACTED: Peri-implant bone reactions to immediate implants placed at
   different levels in relation to crestal bone. Part II: a pilot study in
   dogs (Retracted article. See vol. 29, pg. 667, 2018)
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article; Retracted Publication
DE bone-to-implant contact; crestal; cylindrical; immediate implant;
   subcrestal; tapered
ID FRESH EXTRACTION SOCKETS; TISSUE FORMATION ADJACENT; SCREW-SHAPED
   IMPLANTS; RIDGE ALTERATIONS; HISTOMORPHOMETRIC EVALUATION; TOOTH
   EXTRACTION; LOADED IMPLANTS; SURFACE; SITES; SOFT
AB Purpose: The aim of the present study was to evaluate bone-to-implant contact (BIC) and bone remodeling dynamics after immediate implant placement at different levels in relation to the crestal bone with two different implant designs in beagle dogs.
   Materials and methods: The mandibular second, third and fourth premolars of six beagle dogs were extracted bilaterally and three implants were immediately placed in the hemi-arches of each dog. Randomly, three cylindrical and three tapered implants were inserted crestally (control group) or 2 mm subcrestally (test group). Both groups were treated with a minimal mucoperiosteal flap elevation approach. A gap from the buccal cortical wall to the implant was always left. Three dogs were allowed a 4-week submerged healing period and the other three an 8-week submerged healing period. The animals were sacrificed and samples were obtained. Biopsies were processed for ground sectioning. Histomorphometric analysis was carried out in order to compare BIC, de novo bone formation and bone remodeling.
   Results: All implants osseointegrated clinically and histologically. Healing patterns examined microscopically at 4 and 8 weeks for both groups (crestal and subcrestal) yielded similar qualitative bone findings. The total BIC mean value for the crestal group was 36.48 +/- 3.4% and for the subcrestal group was 41.46 +/- 4.2%. The mean percentage of newly formed BIC was greater with the cylindrical implant design (46.06 +/- 1.09%) than with the tapered design (33.89 +/- 1.72%). There was less bone resorption in the subcrestal group (test) than crestal group (control).
   Conclusion: These findings suggest that apical positioning of the top of the implant does not jeopardize bone crest and peri-implant tissue remodeling. However, less resorption of the lingual crest may be expected when implants are placed 2 mm subcrestally. Moreover, higher BIC values were found in cylindrical implants placed subcrestally.
C1 [Negri, Bruno; Luis Calvo-Guirado, Jose; Piedad Ramirez-Fernandez, Ma; Sanchez-de Val, Jose Mate] Univ Murcia, Fac Med & Dent, Dept Gen & Implant Dent, Murcia, Spain.
   [Guardia, Javier] Univ Granada, Sch Dent, Dept Pharmacol Interact Dent, Granada, Spain.
   [Munoz-Guzon, Fernando] Univ Lugo, Sch Vet, Dept Pathol, Santiago De Compostela, Spain.
RP Negri, B (reprint author), C Carretillas 25,1 8, Alicante 03190, Spain.
EM brunonegri2000@yahoo.com
RI Munoz, Fernando/I-1858-2015; Mate Sanchez de Va, Jose
   Eduardo/R-9750-2018
OI Munoz, Fernando/0000-0002-4130-1526; Mate Sanchez de Va, Jose
   Eduardo/0000-0002-4216-421X; calvo guirado, jose
   luis/0000-0002-4067-2253; RAMIREZ FERNANDEZ, MARIA
   PIEDAD/0000-0003-1913-9902
FU Department of General Dentistry (C.O.I.A); Master of Implant Dentistry,
   Faculty of Medicine and Dentistry, University of Murcia, Spain
FX The authors B. Negri, J. L. Calvo-Guirado, M. P. Ramirez Fernandez, J.
   Mate Sanchez de Val, J. Guardia and F. Munoz Guzon, declare that they
   have no conflict of interests. The study was initiated and self-funded
   by the Department of General Dentistry (C.O.I.A) and Master of Implant
   Dentistry, Faculty of Medicine and Dentistry, University of Murcia,
   Spain. The study materials CIH (R) Tapered implant internal conection
   and Evolution 2 (R) Cylindrical external connection implant were kindly
   provided by B y W S. R. L., Buenos Aires, Argentina. The authors
   gratefully acknowledge the assistance of Lucas Yacovino and Marta Lopez
   Mari (University of Murcia, Spain) in the statistical analysis and Nuria
   Garcia Carrillo (Veterinary).
CR Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x
   Abrahamsson I, 2008, CLIN ORAL IMPLAN RES, V19, P153, DOI 10.1111/j.1600-0501.2007.01454.x
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P615, DOI 10.1111/j.1600-0501.2006.01317.x
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P606, DOI 10.1111/j.1600-0501.2006.01315.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Botticelli D, 2005, J CLIN PERIODONTOL, V32, P448, DOI 10.1111/j.1600-051X.2005.00693.x
   Botticelli D, 2006, CLIN ORAL IMPLAN RES, V17, P351, DOI 10.1111/j.1600-0501.2006.01270.x
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   BUSER D, 1992, J PERIODONTOL, V63, P225, DOI 10.1902/jop.1992.63.3.225
   Buser D., 2007, ITI TREATMENT GUIDE, V1, P26
   Calvo-Guirado JL, 2010, CLIN ORAL IMPLAN RES, V21, P308, DOI 10.1111/j.1600-0501.2009.01841.x
   Caneva M, 2010, CLIN ORAL IMPLAN RES, V21, P885, DOI 10.1111/j.1600-0501.2010.01931.x
   Caneva M, 2010, CLIN ORAL IMPLAN RES, V21, P43, DOI 10.1111/j.1600-0501.2009.01842.x
   Cardaropoli G, 2006, CLIN ORAL IMPLAN RES, V17, P165, DOI 10.1111/j.1600-0501.2005.01210.x
   Cho George C, 2004, J Calif Dent Assoc, V32, P983
   De Pauw GAM, 2002, INT J ORAL MAX IMPL, V17, P405
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Pontes AEF, 2008, CLIN ORAL IMPLAN RES, V19, P483, DOI 10.1111/j.1600-0501.2007.01506.x
   Hammerle CHF, 1996, CLIN ORAL IMPLAN RES, V7, P111, DOI 10.1034/j.1600-0501.1996.070204.x
   Ivanoff CJ, 1997, INT J ORAL MAX SURG, V26, P141, DOI 10.1016/S0901-5027(05)80837-9
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137
   Negri B, 2012, CLIN ORAL IMPLAN RES, V23, P228, DOI 10.1111/j.1600-0501.2011.02158.x
   Orsini E, 2009, Minerva Stomatol, V58, P263
   Palacci P., 2001, ESTHETIC IMPLANT DEN, P101
   Palacci P., 2001, ESTHETIC IMPLANT DEN, P69
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   Persson LG, 2001, CLIN ORAL IMPLAN RES, V12, P595, DOI 10.1034/j.1600-0501.2001.120607.x
   Sanz M, 2010, CLIN ORAL IMPLAN RES, V21, P13, DOI 10.1111/j.1600-0501.2009.01824.x
   SCHENK EA, 1983, STAIN TECHNOL, V58, P377, DOI 10.3109/10520298309066818
   SCHROEDER A, 1986, DEUT MED WOCHENSCHR, V111, P1427, DOI 10.1055/s-2008-1068645
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Spray J R, 2000, Ann Periodontol, V5, P119, DOI 10.1902/annals.2000.5.1.119
   Tomasi C, 2010, CLIN ORAL IMPLAN RES, V21, P30, DOI 10.1111/j.1600-0501.2009.01848.x
   Tran BLT, 2010, CLIN ORAL IMPLAN RES, V21, P794, DOI 10.1111/j.1600-0501.2010.01911.x
   Trisi P, 2003, J PERIODONTOL, V74, P945, DOI 10.1902/jop.2003.74.7.945
   Trisi P, 2002, INT J PERIODONT REST, V22, P535
   Vignoletti F, 2009, J CLIN PERIODONTOL, V36, P688, DOI 10.1111/j.1600-051X.2009.01439.x
   Vignoletti F, 2009, J CLIN PERIODONTOL, V36, P265, DOI 10.1111/j.1600-051X.2008.01363.x
   Welander M, 2009, J PERIODONTOL, V80, P324, DOI [10.1902/jop.2009.080375, 10.1902/jop.2009.080375 ]
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
NR 44
TC 22
Z9 22
U1 1
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD FEB
PY 2012
VL 23
IS 2
BP 236
EP 244
DI 10.1111/j.1600-0501.2011.02290.x
PG 9
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 876HP
UT WOS:000299098700014
PM 22092544
DA 2018-12-27
ER

PT J
AU Biebuyck, W
   Rumford, C
AF Biebuyck, William
   Rumford, Chris
TI RETRACTED: Many Europes: Rethinking multiplicity (Retracted article. See
   vol. 20, pg. 576, 2017)
SO EUROPEAN JOURNAL OF SOCIAL THEORY
LA English
DT Article; Retracted Publication
DE Europe; imaginary; multiplicity; ontology; postwesternization
ID INTEGRATION; GOVERNANCE; ONTOLOGY; POLITICS
AB This article advances a non-reductionist theorization of Europe as 'multiplicity'. As an object and category of political reality, Europe is made (and re-made) within specific spatio-temporal configurations. For this reason, the first section argues that Europe should be approached as an instance of 'historical ontology'. This counters a reductionist tendency to 'fix' Europe with definitive political and cultural characteristics or historical trajectories. The second and third sections of the article interrogate a few of the ontological 'lines of flight' taken by contemporary Europe. The article discusses Europe's multiplicity through its fields, imaginaries and ways of being in the world. Such a preliminary sketch of European multiplicity is not meant to be exhaustive. Rather, it suggests a new ethos in the study of European politics that privileges historicism, practice, and Europe's recursive relationship to the world/globe.
C1 [Biebuyck, William] Carleton Univ, Dept Polit Sci, B640 Loeb, Ottawa, ON K1S 5B6, Canada.
   [Rumford, Chris] Univ London, London WC1E 7HU, England.
RP Biebuyck, W (reprint author), Carleton Univ, Dept Polit Sci, B640 Loeb, Ottawa, ON K1S 5B6, Canada.
EM wbiebuyc@connect.carleton.ca
CR Agnew J, 2001, EUR URBAN REG STUD, V8, P29, DOI 10.1177/096977640100800103
   Appadurai Arjun, 1996, MODERNITY LARGE CULT
   Archibugi D, 1998, REIMAGINING POLITICA
   Barry A, 2003, ALTERNATIVES, V28, P305, DOI 10.1177/030437540302800301
   Beck U and, 2007, COSMOPOLITAN EUROPE
   Bevir M, 2010, EUR J SOC THEORY, V13, P423, DOI 10.1177/1368431010382758
   Bhambra G., 2009, SAGE HDB EUROPEAN ST
   Biebuyck W, 2010, J CONTEMP EUR STUD, V18, P161, DOI 10.1080/14782804.2010.486967
   Biebuyck W, 2009, EUR J SOC THEORY, V12, P291, DOI 10.1177/1368431009103712
   Boon V, 2007, REFLECTIONS EUROPE D
   Borocz Jozsef, 2010, EUROPEAN UNION GLOBA
   Bourdieu P., 1992, INVITATION REFLEXIVE
   Carter E, 2005, EXTREME RIGHT WESTER
   Castells M., 2000, END MILLENNIUM
   Castle S, 2011, NY TIMES        0509
   Delanty G., 1995, INVENTING EUROPE IDE
   Delanty G, 2009, COSMOPOLITAN IMAGINA
   Delanty Gerard, 2006, EUROPE ASIA E W
   Delanty Gerard, 2003, THESIS 11, V72, P8
   Deleuze G., 1987, 1000 PLATEAUS CAPITA
   Diez Thomas, 2001, COOP CONFL, V36, P5, DOI DOI 10.1177/00108360121962245
   Elbe S., 2003, EUROPE NIETZSCHEAN P
   Foucault M., 1991, FOUCAULT EFFECT STUD
   Gotz N, 2008, ALTERNATIVES, V33, P359, DOI 10.1177/030437540803300305
   Habermas J, 2003, OLD EUROPE NEW EUROP
   Hacking I., 2002, HIST ONTOLOGY
   Hall S., 1979, MARXISM TODAY, P14
   Heritier A, 2011, PALGRAVE STUD EUR UN, P1
   Hix S, 2007, HDB EUROPEAN UNION P
   Holmes D., 2000, INTEGRAL EUROPE FAST
   Jachtenfuchs M, 2001, J COMMON MARK STUD, V39, P245, DOI 10.1111/1468-5965.00287
   Judt T., 2007, POSTWAR HIST EUROPE
   Kauppi N, 2003, THEOR SOC, V32, P775, DOI 10.1023/B:RYSO.0000004919.28417.7c
   Kauppi N, 2010, COMP EUR POLIT, V8, P19, DOI 10.1057/cep.2010.2
   Kohler-Koch B., 2006, J COMMON MARKET STUD, V44, P27, DOI DOI 10.1111/JCMS.2006.44.ISSUE-S1
   Ladrech R, 2006, CONT EUROPE
   Leonard M., 2006, WHY EUROPE WILL RUN
   Magone J, 2009, SAGE HDB EUROPEAN ST
   Manners I, 2000, NORMATIVE POWER EURO
   Manners I, 2006, HDB EUROPEAN UNION P
   Manners I., 2003, J CONTEMP EUR STUD, V11, P67
   McCormick J, 2004, EUROPEAN SUPERPOWER
   McCormick J., 2010, EUROPEANISM
   Meyer JW, 2001, I APPROACHES EUROPEA
   Milward A. S., 1992, EUROPEAN RESCUE NATI
   MORAVCSIK A, 1993, J COMMON MARK STUD, V31, P473, DOI 10.1111/j.1468-5965.1993.tb00477.x
   Moravcsik A, 2001, SOCIAL CONSTRUCTION
   Moravcsik A., 1998, CHOICE EUROPE SOCIAL
   Neocleous M, 2003, POLITICS, V23, P145
   Outhwaite W, 2011, 18 INT C EUR BARC SP
   Outhwaite W, 2008, EUROPEAN SOC
   Parker N, 2009, ALTERNATIVES, V34, P17, DOI 10.1177/030437540903400102
   Pirages D, 2007, ENCY GLOBALIZATION, V3
   Pollack M. A., 2005, POLICY MAKING EUROPE
   Reid T. R., 2004, US EUROPE
   Rifkin J, 2004, EUROPEAN DREAM AM VI
   Robertson R, 2011, EUROPEAN COSMOPOLITA
   Rosamond B, 2007, INT AFF, V83, P231, DOI 10.1111/j.1468-2346.2007.00616.x
   Ross George, 1995, J DELORS EUROPEAN IN
   Rumford C, 2008, ROUTL ADV SOCIOL, V42, P1
   Rumford C, 2011, GLOBAL TRENDS REGION
   Rumford C., 2005, RETHINKING EUROPE SO
   Rumford C, 2009, SAGE HDB EUROPEAN ST
   Schimmelfennig F., 2004, EUROPEAN INTEGRATION
   Sheridan GJ, 2005, ENGAGING EUROPE RETH
   Taggart P., 2004, J POLITICAL IDEOLOGI, V9, P269, DOI DOI 10.1080/1356931042000263528
   Taras Ray, 2009, EUROPE OLD NEW TRANS
   Taylor Charles, 2004, MODERN SOCIAL IMAGIN
   The Independent, 2010, MIGHT HER PER
   Therborn Goran, 2003, EUR J SOC THEORY, V6, P293
   Therborn Goran, 1995, EUROPEAN MODERNITY T
   Walker RBJ, 2000, INT RELATIONS THEORY
   Walters W, 2005, GOVERNING EUROPE DIS
   Walters William P., 2004, GLOBAL GOVT GOVERNIN
   Weiler J, 2010, EUROPE 2030
   Zito A., 2010, LEARNING GOVERNANCE
NR 76
TC 24
Z9 24
U1 1
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1368-4310
EI 1461-7137
J9 EUR J SOC THEORY
JI Eur. J. Soc. Theory
PD FEB
PY 2012
VL 15
IS 1
BP 3
EP 20
DI 10.1177/1368431011423567
PG 18
WC Sociology
SC Sociology
GA 882QB
UT WOS:000299577900001
DA 2018-12-27
ER

PT J
AU Obaid, H
   Clarke, A
   Rosenfeld, P
   Leach, C
   Connell, D
AF Obaid, Haron
   Clarke, Andrew
   Rosenfeld, Peter
   Leach, Christopher
   Connell, David
TI RETRACTED: Skin-Derived Fibroblasts for the Treatment of Refractory
   Achilles Tendinosis: Preliminary Short-Term Results (Retracted article.
   See vol. 97, 2015)
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Article; Retracted Publication
ID MESENCHYMAL STEM-CELLS; VIVO GENE-TRANSFER; TENDON INJURIES;
   EXTRACELLULAR-MATRIX; TENDINOPATHY; REPAIR; TENDINITIS; BIOMECHANICS;
   RELIABILITY; ULTRASOUND
AB Background: Chronic Achilles tendinosis is, a common musculoskeletal disorder often refractory to conservative management. Our study aimed to assess the safety and efficacy of the use of autologous skin-derived collagen-producing cells in the treatment of refractory Achilles tendinosis.
   Methods: We conducted a randomized, double-blind study on forty Achilles tendons in thirty-two patients (eight with bilateral involvement) who had a clinical and radiographic diagnosis of Achilles tendinosis. The patients ranged from twenty-two to sixty-seven years old and had a mean age of 45.2 years. The patients with unilateral involvement were randomized into the treatment group (twelve patients) and control group (twelve patients). The eight patients with bilateral involvement were individually randomized into treatment and control groups, with eight Achilles tendons in each group. Achilles tendons in the treatment group were injected under ultrasound guidance with laboratory-expanded, skin-derived fibroblasts suspended in autologous plasma. The control group received ultrasound-guided injection of a local anesthetic and physiotherapy. The Victorian Institute Of Sport Assessment (VISA) questionnaire and visual analog scale (VAS) scores were used as the main outcome measures for both groups.
   Results: Significant differences in the mean VISA and VAS scores were detected between the treatment and the control groups for the patients with unilateral involvement at six months (p < 0.001 for both). With use of the Mann-Whitney U Test, significant differences in the VISA score were observed at the second visit and at the three-month and six-month visits (p = 0.02, p = 0.007, and p < 0.001 respectively). The VAS scores also showed significant differences at the second visit and at the six-month evaluation (p = 0.014 and p < 0.001, respectively). The eight patients with bilateral involvement were analyzed separately; with the number of patients studied, no significant differences in the VISA or VAS scores were observed between the treatment group and the control group.
   Conclusions: These preliminary short-term results demonstrate that the injection of skin-derived fibroblasts for the treatment of Achilles tendinosis is safe. However, larger studies with a longer duration of follow-up are required to determine the long-term effectiveness before wider clinical application is considered.
C1 [Obaid, Haron; Clarke, Andrew; Rosenfeld, Peter; Leach, Christopher; Connell, David] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England.
RP Obaid, H (reprint author), Royal Univ Hosp, 103 Hosp Dr, Saskatoon, SK S7N 0WB, Canada.
EM haron@doctors.org.uk
CR Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630
   Calder JDF, 2003, FOOT ANKLE INT, V24, P119, DOI 10.1177/107110070302400203
   Chan K B, 2009, Foot Ankle Surg, V15, P183, DOI 10.1016/j.fas.2009.02.006
   Chen JM, 2007, TISSUE ENG, V13, P1479, DOI 10.1089/ten.2006.0266
   Chen YJ, 2004, J ORTHOPAED RES, V22, P854, DOI 10.1016/j.orthres.2003.10.013
   Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0
   Chong AKS, 2007, J BONE JOINT SURG AM, V89A, P74, DOI 10.2106/JBJS.E.01396
   CLEMENT DB, 1984, AM J SPORT MED, V12, P179, DOI 10.1177/036354658401200301
   Connell D, 2009, BRIT J SPORT MED, V43, P293, DOI 10.1136/bjsm.2008.056457
   de Vos RJ, 2010, JAMA-J AM MED ASSOC, V303, P144, DOI 10.1001/jama.2009.1986
   Deng Dan, 2008, Zhonghua Yi Xue Za Zhi, V88, P914
   Devereaux M D, 1983, Br J Sports Med, V17, P137
   Dong Qian, 2009, AJR Am J Roentgenol, V193, pW173, DOI 10.2214/AJR.09.3111
   Doral MN, 2009, ARCH ORTHOP TRAUM SU, V129, P1093, DOI 10.1007/s00402-009-0880-2
   Fahlstrom M, 2003, KNEE SURG SPORT TR A, V11, P327, DOI 10.1007/s00167-003-0418-z
   James S L, 1978, Am J Sports Med, V6, P40, DOI 10.1177/036354657800600202
   JONGKIND JF, 1984, CYTOMETRY, V5, P182, DOI 10.1002/cyto.990050212
   JONGKIND JF, 1982, EXP CELL RES, V138, P409, DOI 10.1016/0014-4827(82)90189-6
   JORGENSEN U, 1985, AM J SPORT MED, V13, P128, DOI 10.1177/036354658501300209
   Juncosa-Melvin N, 2006, TISSUE ENG, V12, P369, DOI 10.1089/ten.2006.12.369
   Kryger GS, 2007, J HAND SURG-AM, V32A, P597, DOI 10.1016/j.jhsa.2007.02.018
   Kujala UM, 2005, CLIN J SPORT MED, V15, P133, DOI 10.1097/01.jsm.0000165347.55638.23
   KVIST M, 1991, ANN CHIR GYNAECOL FE, V80, P188
   KVIST M, 1994, SPORTS MED, V18, P173, DOI 10.2165/00007256-199418030-00004
   Liu W, 2006, TISSUE ENG, V12, P775, DOI 10.1089/ten.2006.12.775
   Lou J, 1997, J ORTHOPAED RES, V15, P911, DOI 10.1002/jor.1100150618
   MacLellan G E, 1981, Br J Sports Med, V15, P117
   Maganaris CN, 2004, SPORTS MED, V34, P1005, DOI 10.2165/00007256-200434140-00005
   Magnussen RA, 2009, CLIN J SPORT MED, V19, P54, DOI 10.1097/JSM.0b013e31818ef090
   McCrory JL, 1999, MED SCI SPORT EXER, V31, P1374, DOI 10.1097/00005768-199910000-00003
   Mitchell AWM, 2009, J BONE JOINT SURG BR, V91B, P1405, DOI 10.1302/0301-620X.91B11.23060
   Mohr RN, 1997, FOOT ANKLE CLIN, V2, P439
   Nakamura N, 1998, GENE THER, V5, P1165, DOI 10.1038/sj.gt.3300712
   Ohberg L, 2002, BRIT J SPORT MED, V36, P173, DOI 10.1136/bjsm.36.3.173
   Ozkan N, 2004, J CLIN LASER MED SUR, V22, P105, DOI 10.1089/104454704774076154
   Paavola M, 2000, AM J SPORT MED, V28, P634, DOI 10.1177/03635465000280050301
   Paavola Mika, 2002, Foot Ankle Clin, V7, P501, DOI 10.1016/S1083-7515(02)00056-6
   Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335
   Rosenzweig S, 2009, FOOT ANKLE CLIN, V14, P699, DOI 10.1016/j.fcl.2009.07.002
   Sengkerij PM, 2009, AM J SPORT MED, V37, P1627, DOI 10.1177/0363546509332255
   Silbernagel KG, 2001, SCAND J MED SCI SPOR, V11, P197
   SOMA CA, 1994, CLIN SPORT MED, V13, P811
   SUBOTNICK SI, 1986, J AM PODIAT MED ASSN, V76, P552, DOI 10.7547/87507315-76-10-552
   Tasto JP, 2003, ARTHROSCOPY, V19, P213, DOI 10.1016/j.arthro.2003.10.004
   Thermann H, 2009, KNEE SURG SPORT TR A, V17, P1264, DOI 10.1007/s00167-009-0751-y
   van Schie HTM, 2010, BRIT J SPORT MED, V44, P1153, DOI 10.1136/bjsm.2009.061010
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
NR 47
TC 23
Z9 23
U1 1
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0021-9355
EI 1535-1386
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PD FEB 1
PY 2012
VL 94A
IS 3
BP 193
EP 200
DI 10.2106/JBJS.J.100781
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 888AX
UT WOS:000299977300001
PM 22241604
DA 2018-12-27
ER

PT J
AU Grenz, A
   Bauerle, JD
   Dalton, JH
   Ridyard, D
   Badulak, A
   Tak, E
   McNamee, EN
   Clambey, E
   Moldovan, R
   Reyes, G
   Klawitter, J
   Ambler, K
   Magee, K
   Christians, U
   Brodsky, KS
   Ravid, K
   Choi, DS
   Wen, JM
   Lukashev, D
   Blackburn, MR
   Osswald, H
   Coe, IR
   Nurnberg, B
   Haase, VH
   Xia, Y
   Sitkovsky, M
   Eltzschig, HK
AF Grenz, Almut
   Bauerle, Jessica D.
   Dalton, Julee H.
   Ridyard, Douglas
   Badulak, Alexander
   Tak, Eunyoung
   McNamee, Eoin N.
   Clambey, Eric
   Moldovan, Radu
   Reyes, German
   Klawitter, Jost
   Ambler, Kelly
   Magee, Kristann
   Christians, Uwe
   Brodsky, Kelley S.
   Ravid, Katya
   Choi, Doo-Sup
   Wen, Jiaming
   Lukashev, Dmitriy
   Blackburn, Michael R.
   Osswald, Hartmut
   Coe, Imogen R.
   Nuernberg, Bernd
   Haase, Volker H.
   Xia, Yang
   Sitkovsky, Michail
   Eltzschig, Holger K.
TI RETRACTED: Equilibrative nucleoside transporter 1 (ENT1) regulates
   postischemic blood flow during acute kidney injury in mice(Retracted
   article. See vol.127, pg.2438, 2017)
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article; Retracted Publication
ID ISCHEMIA-REPERFUSION INJURY; ACUTE-RENAL-FAILURE; A(2B) ADENOSINE
   RECEPTORS; INDUCED VASCULAR LEAK; SICKLE-CELL-DISEASE; INDUCIBLE
   FACTOR-I; ECTO-5'-NUCLEOTIDASE CD73; NUCLEOTIDE PHOSPHOHYDROLYSIS;
   ISCHEMIA/REPERFUSION INJURY; HIF-1-DEPENDENT REPRESSION
AB A complex biologic network regulates kidney perfusion under physiologic conditions. This system is profoundly perturbed following renal ischemia, a leading cause of acute kidney injury (AKI) - a life-threatening condition that frequently complicates the care of hospitalized patients. Therapeutic approaches to prevent and treat AKI are extremely limited. Better understanding of the molecular pathways promoting postischemic reflow could provide new candidate targets for AM therapeutics. Due to its role in adapting tissues to hypoxia, we hypothesized that extracellular adenosine has a regulatory function in the postischemic control of renal perfusion. Consistent with the notion that equilibrative nucleoside transporters (ENTs) terminate adenosine signaling, we observed that pharmacologic ENT inhibition in mice elevated renal adenosine levels and dampened AKI. Deletion of the ENTs resulted in selective protection in Ent1(-/-) mice. Comprehensive examination of adenosine receptor-knockout mice exposed to AM demonstrated that renal protection by ENT inhibitors involves the A2B adenosine receptor. Indeed, crosstalk between renal Ent1 and Adora2b expressed on vascular endothelia effectively prevented a postischemic no-reflow phenomenon. These studies identify ENT1 and adenosine receptors as key to the process of reestablishing renal perfusion following ischemic AM. If translatable from mice to humans, these data have important therapeutic implications.
C1 [Grenz, Almut; Bauerle, Jessica D.; Dalton, Julee H.; Ridyard, Douglas; Badulak, Alexander; Tak, Eunyoung; McNamee, Eoin N.; Clambey, Eric; Klawitter, Jost; Magee, Kristann; Christians, Uwe; Brodsky, Kelley S.; Eltzschig, Holger K.] Univ Colorado, Dept Anesthesiol, Mucosal Inflammat Program, 12700 E 19th Ave,Mailstop B112,Res Complex 2,Room, Aurora, CO 80045 USA.
   [Moldovan, Radu] Univ Colorado, Sch Med, Adv Light Microscopy Core Facil, Aurora, CO 80045 USA.
   [Reyes, German; Coe, Imogen R.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.
   [Ambler, Kelly] Univ Colorado, Dept Cardiol, Aurora, CO 80045 USA.
   [Ravid, Katya] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.
   [Choi, Doo-Sup] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA.
   [Wen, Jiaming; Blackburn, Michael R.; Xia, Yang] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX USA.
   [Lukashev, Dmitriy; Sitkovsky, Michail] Northeastern Univ, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA.
   [Osswald, Hartmut] Univ Tubingen, Dept Pharmacol & Expt Therapy, Tubingen, Germany.
   [Haase, Volker H.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.
   [Haase, Volker H.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.
   [Haase, Volker H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.
RP Eltzschig, HK (reprint author), Univ Colorado, Dept Anesthesiol, Mucosal Inflammat Program, 12700 E 19th Ave,Mailstop B112,Res Complex 2,Room, Aurora, CO 80045 USA.
EM holger.eltzschig@ucdenver.edu
RI Choi, Doo-Sup/G-9474-2012
OI Klawitter, Jost/0000-0002-6413-4820; Blackburn,
   Michael/0000-0002-1394-9966; Ravid, Katya/0000-0002-9918-3024
FU NIH/NCRR Colorado CTSI [UL1 RR025780]; NIH [DK081646]; DFG (Deutsche
   Forschungsgemeinschaft) [GR2121/1-1]; American Heart Association;
   National Heart Institute [R01-HL0921, R01-DK083385, R01-HL098294];
   Crohn's and Colitis Foundation of America (CCFA)
FX We thank Thomas Finger (Rocky Mountain Taste and Smell Center,
   Department of Cell and Developmental Biology, School of Medicine,
   University of Colorado Denver, Aurora, Colorado, USA) for support on the
   different immunostaining methods. We also thank the Advanced Light
   Microscopy Core facility, supported in part by NIH/NCRR Colorado CTSI
   grant UL1 RR025780. The present research work was supported by NIH grant
   DK081646 to V.H. Haase; a DFG (Deutsche Forschungsgemeinschaft) Research
   Fellowship grant (GR2121/1-1) and American Heart Association grant to A.
   Grenz; National Heart Institute grants R01-HL0921, R01-DK083385,
   R01-HL098294; and a grant from the Crohn's and Colitis Foundation of
   America (CCFA) to H.K. Eltzschig.
CR Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398
   Aherne CM, 2011, BBA-BIOMEMBRANES, V1808, P1329, DOI 10.1016/j.bbamem.2010.05.016
   Al-Mashhadi RH, 2009, KIDNEY INT, V75, P793, DOI 10.1038/ki.2008.684
   Awad AS, 2008, J AM SOC NEPHROL, V19, P59, DOI 10.1681/ASN.2007030276
   Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2
   Bauerle JD, 2011, J AM SOC NEPHROL, V22, P14, DOI 10.1681/ASN.2009121217
   Belikoff BG, 2011, J IMMUNOL, V186, P2444, DOI 10.4049/jimmunol.1001567
   Bernhardt WM, 2010, J AM SOC NEPHROL, V21, P2151, DOI 10.1681/ASN.2010010116
   Bove T, 2005, CIRCULATION, V111, P3230, DOI 10.1161/CIRCULATIONAHA.104.509141
   Brezniceanu ML, 2006, KIDNEY INT, V69, P1977, DOI 10.1038/sj.ki.5000396
   Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851
   Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740
   Choi DS, 2004, NAT NEUROSCI, V7, P855, DOI 10.1038/nn1288
   CONGER JD, 1989, KIDNEY INT, V35, P1126, DOI 10.1038/ki.1989.100
   Corset V, 2000, NATURE, V407, P747
   Day YJ, 2006, J IMMUNOL, V176, P3108, DOI 10.4049/jimmunol.176.5.3108
   Day YJ, 2003, J CLIN INVEST, V112, P883, DOI 10.1172/JCI200315483
   Dunn KW, 2002, AM J PHYSIOL-CELL PH, V283, pC905, DOI 10.1152/ajpcell.00159.2002
   Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516
   Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044
   Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697
   Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177
   Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891
   Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507
   Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283
   Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2
   Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746
   Faigle M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002801
   FLORES J, 1972, J CLIN INVEST, V51, P118, DOI 10.1172/JCI106781
   Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132
   Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285
   Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324
   Gallos G, 2005, AM J PHYSIOL-RENAL, V289, pF369, DOI 10.1152/ajprenal.00470.2004
   GELMAN S, 1995, ANESTHESIOLOGY, V82, P1026, DOI 10.1097/00000542-199504000-00027
   Gladwin MT, 2011, NAT MED, V17, P38, DOI 10.1038/nm0111-38
   Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137
   Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141
   Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com
   Grenz A, 2007, AM J PHYSIOL-RENAL, V292, pF475, DOI 10.1152/ajprenal.00275.2006
   Grenz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014812
   Grenz A, 2011, ANTIOXID REDOX SIGN, V15, P2221, DOI 10.1089/ars.2010.3665
   Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89
   Hansen PB, 2005, J PHARMACOL EXP THER, V315, P1150, DOI 10.1124/jpet.105.091017
   HARPER PA, 1984, KIDNEY INT, V26, P875, DOI 10.1038/ki.1984.231
   Hart ML, 2008, GASTROENTEROLOGY, V135, P1739, DOI 10.1053/j.gastro.2008.07.064
   Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911
   Hart ML, 2009, J IMMUNOL, V182, P3965, DOI 10.4049/jimmunol.0802193
   Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998
   JABLONSKI P, 1983, TRANSPLANTATION, V35, P198, DOI 10.1097/00007890-198303000-00002
   Kim M, 2009, KIDNEY INT, V75, P809, DOI 10.1038/ki.2008.699
   Kloor D, 2002, BIOCHEM PHARMACOL, V63, P809, DOI 10.1016/S0006-2952(01)00892-9
   Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180
   Koeppen M, 2011, ADV PHARMACOL, V61, P145, DOI 10.1016/B978-0-12-385526-8.00006-0
   Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364
   Kumar AB, 2011, ANESTHESIOLOGY, V114, P964, DOI 10.1097/ALN.0b013e318210f86a
   Lee HT, 2000, AM J PHYSIOL-RENAL, V278, pF380
   Lee HT, 2004, J AM SOC NEPHROL, V15, P102, DOI 10.1097/01.ASN.0000102474.68613.AE
   Lee HT, 2002, J AM SOC NEPHROL, V13, P2753, DOI 10.1097/01.ASN.0000032421.79225.6E
   Leonard MO, 2003, J BIOL CHEM, V278, P40296, DOI 10.1074/jbc.M302560200
   LIN JJ, 1987, CAN J PHYSIOL PHARM, V65, P1491, DOI 10.1139/y87-233
   LLACH J, 1993, HEPATOLOGY, V17, P59, DOI 10.1016/0270-9139(93)90192-P
   Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714
   Lorenz JN, 1999, AM J PHYSIOL-RENAL, V276, pF172
   Luippold G, 1999, J CHROMATOGR B, V724, P231, DOI 10.1016/S0378-4347(98)00580-5
   Marzilli M, 2000, CIRCULATION, V101, P2154, DOI 10.1161/01.CIR.101.18.2154
   Mehta RL, 2005, J AM SOC NEPHROL, V16, P12, DOI 10.1681/ASN.2004110954
   Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763
   Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037
   Nakamoto H, 2008, HYPERTENS RES, V31, P315, DOI 10.1291/hypres.31.315
   Okusa MD, 1999, AM J PHYSIOL-RENAL, V277, pF404
   Okusa MD, 2000, AM J PHYSIOL-RENAL, V279, pF809
   Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241
   Reyes G, 2010, PROTEIN EXPRES PURIF, V73, P1, DOI 10.1016/j.pep.2010.04.008
   Rose JB, 2010, AM J PHYSIOL-HEART C, V298, pH771, DOI 10.1152/ajpheart.00711.2009
   Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683
   Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002
   Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429
   Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401
   Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731
   Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998
   Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337
   Tanzilli G, 2010, CATHETER CARDIO INTE, V76, P787, DOI 10.1002/ccd.22724
   Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915
   VINAY P, 1981, AM J PHYSIOL, V241, pF403
   Yan L, 2004, J MED CHEM, V47, P1031, DOI 10.1021/jm0310030
   Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933
   Yang ZQ, 2005, CIRCULATION, V111, P2190, DOI 10.1161/01.CIR.0000163586.62253.A5
   Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022
   Young HWJ, 2004, J IMMUNOL, V173, P1380, DOI 10.4049/jimmunol.173.2.1380
   Zeiser R, 2011, J MOL MED, V89, P833, DOI 10.1007/s00109-011-0767-x
   Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280
NR 91
TC 84
Z9 86
U1 3
U2 17
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD FEB
PY 2012
VL 122
IS 2
BP 693
EP 710
DI 10.1172/JCI60214
PG 18
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 885GF
UT WOS:000299765800033
PM 22269324
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Braet, W
   Wagemans, J
   Op de Beeck, HP
AF Braet, Wouter
   Wagemans, Johan
   Op de Beeck, Hans P.
TI RETRACTED: The visual word form area is organized according to
   orthography (Retracted article. See vol. 86, pg. 599, 2014)
SO NEUROIMAGE
LA English
DT Article; Retracted Publication
DE Multi-variate pattern analysis; Visual word form area; VWFA; LOC; fMRI;
   Reading; Orthography
ID HUMAN EXTRASTRIATE CORTEX; VOXEL PATTERN-ANALYSIS; SHAPE SIMILARITY;
   FMRI ADAPTATION; VENTRAL STREAM; HUMAN BRAIN; FACES; SELECTIVITY;
   PERCEPTION; OBJECTS
AB Efficient word reading depends on a left fusiform brain region, the Visual Word Form Area (VWFA). The internal organization of this brain area is currently unknown, as are the potential factors that might underlie this organization. Here we combine functional magnetic resonance imaging (fMRI) with multi-voxel pattern analyses (MVPA) to probe the internal organization of the VWFA. Our findings reveal distinct activation patterns in the VWFA associated with individual letter strings, as well as for pictures. This result demonstrates that the VWFA is organized in such a way that similar words (as well as pictures) activate neurons consistently, irrespective of their exact visual appearance or location. The activation patterns for letter strings were driven primarily by orthographic similarity, and we observed no effects of semantics or lexical status (words versus pseudowords). This effect of orthographic similarity was significant only in the VWFA and not in retinotopic areas and object-selective control regions. Given the relationships between the internal organization and how visual input is processed in a brain region, our findings provide important constraints for computational models of how visual word forms are represented in the brain. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Braet, Wouter; Wagemans, Johan] Univ Leuven, Expt Psychol Lab, B-3000 Louvain, Belgium.
   [Op de Beeck, Hans P.] Univ Leuven, Lab Biol Psychol, B-3000 Louvain, Belgium.
RP Braet, W (reprint author), Univ Leuven, Expt Psychol Lab, Tiensestr 102,Bus 3711, B-3000 Louvain, Belgium.
EM wouter.braet@gmail.com
RI Braet, Wouter/A-5061-2009
FU Research Foundation - Flanders (FWO-Vlaanderen); Human Frontier Science
   Program Organization [CDA-0040/2008]; Fund for Scientific Research
   Flanders [G.0562.10];  [METH/08/02]
FX WB is funded by the Research Foundation - Flanders (FWO-Vlaanderen); JW
   is funded by METH/08/02; HODB is funded by the Human Frontier Science
   Program Organization (CDA-0040/2008) and the Fund for Scientific
   Research Flanders (G.0562.10). We wish to thank Maximilian Riesenhuber,
   Laurie Glezer, and Elfi Goesaert for their comments on an earlier
   version of this manuscript, and Bram Van Rensbergen for help with
   stimulus creation.
CR Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104
   Barton JJS, 2010, J COGNITIVE NEUROSCI, V22, P1649, DOI 10.1162/jocn.2009.21286
   Ben-Shachar M, 2007, CEREB CORTEX, V17, P1604, DOI 10.1093/cercor/bhl071
   BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037//0033-295X.94.2.115
   Brem S, 2006, NEUROIMAGE, V29, P822, DOI 10.1016/j.neuroimage.2005.09.023
   Chan AWY, 2010, NAT NEUROSCI, V13, P417, DOI 10.1038/nn.2502
   Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226
   Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094
   Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049
   Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004
   Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004
   Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003
   Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140
   Downing PE, 2006, SOC NEUROSCI, V1, P52, DOI 10.1080/17470910600668854
   Drucker DM, 2009, CEREB CORTEX, V19, P2269, DOI 10.1093/cercor/bhn244
   Duyck W, 2004, BEHAV RES METH INS C, V36, P488, DOI 10.3758/BF03195595
   Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031
   Glezer LS, 2009, NEURON, V62, P199, DOI 10.1016/j.neuron.2009.03.017
   Hata Y., 1991, J PHYSIOL-LONDON, V441, P614
   Haushofer J, 2008, PLOS BIOL, V6, P1459, DOI 10.1371/journal.pbio.0060187
   He S., 2009, J VIS, V9, p[853, 853a], DOI [DOI 10.1167/9.8.853, 10.1167/9.8.853]
   Huberty C. J., 2005, HIGHER ED HDB THEORY, VXX, P437, DOI DOI 10.1007/1-4020-3279-X_8
   Ino T, 2008, CORTEX, V44, P773, DOI 10.1016/j.cortex.2007.03.002
   Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687
   Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444
   Kanwisher N, 1997, J COGNITIVE NEUROSCI, V9, P133, DOI 10.1162/jocn.1997.9.1.133
   Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934
   Kravitz DJ, 2010, CEREB CORTEX, V20, P2916, DOI 10.1093/cercor/bhq042
   Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104
   MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135
   Mei LL, 2010, NEUROIMAGE, V52, P371, DOI 10.1016/j.neuroimage.2010.03.067
   Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005
   Op de Beeck HP, 2010, NEUROIMAGE, V49, P3414, DOI 10.1016/j.neuroimage.2009.11.022
   Op de Beeck HP, 2008, J NEUROSCI, V28, P10111, DOI 10.1523/JNEUROSCI.2511-08.2008
   Peelen MV, 2007, TRENDS COGN SCI, V11, P4, DOI 10.1016/j.tics.2006.10.009
   Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001
   Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3
   Reddy L, 2010, NEUROIMAGE, V50, P818, DOI 10.1016/j.neuroimage.2009.11.084
   Sawamura H, 2006, NEURON, V49, P307, DOI 10.1016/j.neuron.2005.11.028
   Schurz M, 2010, NEUROIMAGE, V49, P2649, DOI 10.1016/j.neuroimage.2009.10.082
   Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90
   Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031
   Wagemans J, 2008, PERCEPTION, V37, P207, DOI 10.1068/p5825
   Walther DB, 2009, J NEUROSCI, V29, P10573, DOI 10.1523/JNEUROSCI.0559-09.2009
   Williams MA, 2007, NAT NEUROSCI, V10, P685, DOI 10.1038/nn1900
   Zhang J., 2009, J VIS, P9, DOI [10.1167/9.8.459, DOI 10.1167/9.8.459]
NR 46
TC 22
Z9 22
U1 3
U2 26
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1053-8119
EI 1095-9572
J9 NEUROIMAGE
JI Neuroimage
PD FEB 1
PY 2012
VL 59
IS 3
BP 2751
EP 2759
DI 10.1016/j.neuroimage.2011.10.032
PG 9
WC Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 881NS
UT WOS:000299494000074
PM 22032948
DA 2018-12-27
ER

PT J
AU Yang, XC
   Zhang, SY
   Pang, X
   Fan, MW
AF Yang, Xuechao
   Zhang, Siyuan
   Pang, Xin
   Fan, Mingwen
TI RETRACTED: Pro-inflammatory cytokines induce odontogenic differentiation
   of dental pulp-derived stem cells (Retracted article. See vol. 113, pg.
   2796, 2012)
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article; Retracted Publication
DE DENTAL PULP STEM CELLS; CYTOKINE; DIFFERENTIATION; INFLAMMATION
ID IN-VITRO; TISSUE FORMATION; STROMAL CELLS; GENE; VIVO; EXPRESSION;
   CHEMOKINE
AB Postnatal dental pulp stem cells (DPSCs) represent a unique precursor population in the dental pulp, which have multipotential and harbor great potential for tissue engineering purposes. However, for therapy applications, transplanted cells are often exposed to unfavorable conditions such as cytokines released from necrotic or inflammatory cells in injured tissues. It is not clear how stem cells exposed to these conditions changes in their characteristics. In this study, the effects of pro-inflammatory cytokines, such as IL-1 and TNF, on DPSCs were investigated. Cells were treated with IL-1, TNF, or both for 3, 7, and 12 days. The cultures were evaluated for cell proliferation, ALP activity, and real-time PCR. We found that a short treatment (3 days) of pro-inflammatory cytokines induced the odontogenic differentiation of DPSCs. Furthermore, post 3 days treatment with pro-inflammatory cytokines, the cellscaffold complexes were implanted subcutaneously in mice for 8 weeks. Histological analysis demonstrated that the cultures gave obviously mineralized tissue formation, especially for both IL-1 and TNF applied. These data suggest that IL-1 and TNF produced in the early inflammatory reaction may induce the mineralization of DPSCs. J. Cell. Biochem. 113: 669677, 2012. (C) 2011 Wiley Periodicals, Inc.
C1 Wuhan Univ, Minist Educ, Key Lab Oral Biomed, Wuhan, Hubei Province, Peoples R China.
   Wuhan Univ, Sch & Hosp Stomatol, Dept Endodont, Wuhan, Hubei Province, Peoples R China.
RP Fan, MW (reprint author), 237 Luoyu Rd, Wuhan 430079, Peoples R China.
EM fanmingwen@hotmail.com
FU Natural Science Foundation of China [81000679]; Fundamental Research
   Funds for the Central Universities of China [3082026]
FX Grant sponsor: Natural Science Foundation of China; Grant number:
   81000679; Grant sponsor: Fundamental Research Funds for the Central
   Universities of China; Grant number: 3082026.
CR Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082
   Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189
   Coil J, 2004, J ENDODONT, V30, P88, DOI 10.1097/00004770-200402000-00006
   Cotran RS, 2002, ROBBINS PATHOLOGIC B, P50
   Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457
   Fink T, 2004, STEM CELLS, V22, P1346, DOI 10.1634/stemcells.2004-0038
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hartman EHM, 2005, BIOMATERIALS, V26, P1829, DOI 10.1016/j.biomaterials.2004.06.016
   Keller JF, 2010, IMMUNOBIOLOGY, V215, P53, DOI 10.1016/j.imbio.2009.01.009
   Kim CH, 1998, J IMMUNOL, V161, P2580
   KJELDSEN M, 1993, J PERIODONTOL, V64, P1013, DOI 10.1902/jop.1993.64.11.1013
   Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061
   Lisignoli G, 2004, EXP GERONTOL, V39, P659, DOI 10.1016/j.exger.2003.09.030
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MacDougall M, 1996, CONNECT TISSUE RES, V35, P267, DOI 10.3109/03008209609029200
   Min KS, 2006, J ENDODONT, V32, P39, DOI 10.1016/j.joen.2005.10.012
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Spoto G, 2001, J ENDODONT, V27, P180, DOI 10.1097/00004770-200103000-00010
   Stashenko P, 1998, CRIT REV ORAL BIOL M, V9, P498, DOI 10.1177/10454411980090040701
   TANIISHII N, 1995, ORAL MICROBIOL IMMUN, V10, P213, DOI 10.1111/j.1399-302X.1995.tb00145.x
   Tincani A, 2007, AUTOIMMUN REV, V7, P1, DOI 10.1016/j.autrev.2007.03.001
   van den Beucken JJJP, 2006, J BIOMED MATER RES A, V77A, P202, DOI 10.1002/jbm.a.30583
   Yang X, 2009, J DENT RES, V88, P1020, DOI 10.1177/0022034509346258
   Yang XC, 2007, J TISSUE ENG REGEN M, V1, P66, DOI 10.1002/term.16
   Yang XC, 2007, J TISSUE ENG REGEN M, V1, P128, DOI 10.1002/term.13
   Yang X, 2007, TISSUE ENG, V13, P2803, DOI 10.1089/ten.2006.0439
   Yang XC, 2009, TISSUE ENG PT A, V15, P367, DOI 10.1089/ten.tea.2008.0133
   Zhang W, 2005, TISSUE ENG, V11, P357, DOI 10.1089/ten.2005.11.357
NR 30
TC 28
Z9 28
U1 6
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD FEB
PY 2012
VL 113
IS 2
BP 669
EP 677
DI 10.1002/jcb.23396
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 872XB
UT WOS:000298843200033
PM 21976040
DA 2018-12-27
ER

PT J
AU Zhao, X
   Li, B
   Wang, L
   Kaufman, A
AF Zhao, Xin
   Li, Bo
   Wang, Lei
   Kaufman, Arie
TI RETRACTED: Texture-guided volumetric deformation and visualization using
   3D moving least squares (Retracted article. See vol. 30, pg. 1073, 2014)
SO VISUAL COMPUTER
LA English
DT Article; Retracted Publication
DE 3D MLS; Volumetric visualization; Texture-guided deformation
AB Examining and manipulating the large volumetric data attract great interest for various applications. For such purpose, we first extend the 2D moving least squares (MLS) technique into 3D, and propose a texture-guided deformation technique for creating visualization styles through interactive manipulations of volumetric models using 3D MLS. Our framework includes focus+context (F+C) visualization for simultaneously showing the entire model after magnification, and the cut-away or illustrative visualization for providing a better understanding of anatomical and biological structures. Both visualization styles are widely applied in the graphics areas. We present a mechanism for defining features using high-dimensional texture information, and design an interface for visualizing, selecting and extracting features/objects of interest. Methods of the interactive or automatic generation of 3D control points are proposed for the flexible and plausible deformation. We describe a GPU-based implementation to achieve real-time performance of the deformation techniques and the manipulation operators. Different from physical deformation models, our framework is goal-oriented and user-guided. We demonstrate the robustness and efficiency of our framework using various volumetric datasets.
C1 [Zhao, Xin; Li, Bo; Wang, Lei; Kaufman, Arie] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA.
RP Zhao, X (reprint author), SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA.
EM xinzhao@cs.sunysb.edu; bli@cs.stonybrook.edu;
   leiwang1@cs.stonybrook.edu; ari@cs.stonybrook.edu
FU NSF [IIS0916235, CCF0702699, CNS0959979]; NIH [R01EB-7530]
FX This paper has been supported by NSF grants IIS0916235, CCF0702699 and
   CNS0959979 and NIH grant R01EB-7530.
CR Alexa M, 2000, COMP GRAPH, P157
   Bier E. A., 1993, Computer Graphics Proceedings, P73
   BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792
   Bruckner S., 2005, P 7 JOINT EUR IEEE V, P69, DOI DOI 10.2312/VISSYM/EUROVIS05/069-076
   Bruckner S, 2006, IEEE T VIS COMPUT GR, V12, P1077, DOI 10.1109/TVCG.2006.140
   Brunet T., 2006, P EUROVIS C EUR ASS, P219
   Caban JJ, 2008, IEEE T VIS COMPUT GR, V14, P1364, DOI 10.1109/TVCG.2008.169
   Carlos C, 2006, EUR IEEE VGTC WORKSH, P9, DOI DOI 10.2312/VG/VG06/009-016
   Chen M, 2007, COMPUT GRAPH FORUM, V26, P824, DOI 10.1111/j.1467-8659.2007.01102.x
   Chen M, 2003, P VOL GRAPH, P35
   Cohen M, 2004, THEORY AND PRACTICE OF COMPUTER GRAPHICS 2004, PROCEEDINGS, P32, DOI 10.1109/TPCG.2004.1314450
   Correa C.D., 2007, EUR IEEE VGTC WORKSH, P91
   Correa CD, 2007, IEEE T VIS COMPUT GR, V13, P1320, DOI 10.1109/TVCG.2007.70565
   Correa CD, 2010, COMPUT GRAPH-UK, V34, P370, DOI 10.1016/j.cag.2010.01.007
   Cuno A., 2007, COMP GRAPH INT C, P1
   HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314
   Ikits M., 2004, FOCUS CONTEXT INTERF
   Keahey TA, 1996, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION '96, PROCEEDINGS, P38, DOI 10.1109/INFVIS.1996.559214
   Keahey TA, 1997, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION, PROCEEDINGS, P51, DOI 10.1109/INFVIS.1997.636786
   Kruger J, 2006, IEEE T VIS COMPUT GR, V12, P941, DOI 10.1109/TVCG.2006.124
   Kurzion Y, 1995, SPRING COMP SCI, P21
   LaMar E, 2001, NINTH PACIFIC CONFERENCE ON COMPUTER GRAPHICS AND APPLICATIONS, PROCEEDINGS, P223, DOI 10.1109/PCCGA.2001.962877
   Lamping J., 1995, Human Factors in Computing Systems. CHI'95 Conference Proceedings, P401
   LANCASTER P, 1981, MATH COMPUT, V37, P141, DOI 10.2307/2007507
   McGuffin MJ, 2003, IEEE VISUALIZATION 2003, PROCEEDINGS, P401, DOI 10.1109/VISUAL.2003.1250400
   Schaefer S, 2006, ACM T GRAPHIC, V25, P533, DOI 10.1145/1141911.1141920
   Tory M, 2005, IEEE T VIS COMPUT GR, V11, P71, DOI 10.1109/TVCG.2005.2
   Viola I, 2004, IEEE VISUALIZATION 2004, PROCEEEDINGS, P139, DOI 10.1109/VISUAL.2004.48
   Wang LJ, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P367
   Wang YS, 2011, IEEE T VIS COMPUT GR, V17, P171, DOI 10.1109/TVCG.2010.34
   Zhou J., 2002, 3D DATA PROCESSING V, P87
   Zhu Y., 2007, 3D DEFORMATION USING
NR 32
TC 6
Z9 6
U1 2
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0178-2789
EI 1432-2315
J9 VISUAL COMPUT
JI Visual Comput.
PD FEB
PY 2012
VL 28
IS 2
BP 193
EP 204
DI 10.1007/s00371-011-0635-2
PG 12
WC Computer Science, Software Engineering
SC Computer Science
GA 881SW
UT WOS:000299510100006
DA 2018-12-27
ER

PT J
AU Murdoch, BE
   Ng, ML
   Barwood, CHS
AF Murdoch, B. E.
   Ng, M. L.
   Barwood, C. H. S.
TI RETRACTED: Treatment of articulatory dysfunction in Parkinson's disease
   using repetitive transcranial magnetic stimulation (Retracted article.
   See vol. 20, pg. 1497, 2012)
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article; Retracted Publication
DE dysarthria; Parkinson's disease; transcranial magnetic stimulation
ID MOTOR CORTEX; PREFRONTAL CORTEX; DOPAMINE RELEASE; SPEECH; VOICE;
   REPRESENTATION; EXCITABILITY; MODULATION; DISORDERS; LEVODOPA
AB Background and purpose: Neuroimaging has demonstrated that improved speech outcomes in Parkinsons Disease (PD) subsequent to behavioural treatment approaches are associated with increased activity in the motor and pre-motor cortex. High-frequency repetitive transcranial magnetic stimulation (rTMS) is capable of modulating cortical activity and has been reported to have significant benefit to general motor function in PD. It is possible that high-frequency rTMS may also have beneficial outcomes on speech production in PD. Methods: High-frequency (5 Hz) rTMS was applied to 10 active stimulation and 10 sham placebo patients for 10 min/ day (3000 pulses), for 10 days and speech outcome measures and lingual kinematic parameters recorded at baseline and 1 week, 2 and 12 months post-stimulation. Results: The findings demonstrated positive treatment-related changes observed in the active rTMS group when compared to the sham placebo control group at 2 and 12 months post-stimulation in speech intelligibility, communication efficiency ratio, maximum velocity of tongue movements and distance of tongue movements. Conclusion: The results support the use of high-frequency rTMS as a therapeutic tool for the treatment of articulatory dysfunction in PD.
C1 [Murdoch, B. E.; Barwood, C. H. S.] Univ Queensland, Sch Hlth & Rehabil Sci, Ctr Neurogen Commun Disorders Res, St Lucia, Qld 4072, Australia.
   [Ng, M. L.] Univ Hong Kong, Div Speech & Hearing Sci, Speech Sci Lab, Hong Kong, Hong Kong, Peoples R China.
RP Murdoch, BE (reprint author), Univ Queensland, Sch Hlth & Rehabil Sci, Ctr Neurogen Commun Disorders Res, St Lucia, Qld 4072, Australia.
EM b.murdoch@uq.edu.au
RI Barwood, Caroline/E-6627-2012; Murdoch, Bruce/C-1397-2012
OI /0000-0002-3174-8412
CR Chen Y-T, 2008, J MED SPEECH-LANG PA, V16, P21
   Darley F. L, 1975, MOTOR SPEECH DISORDE
   del Olmo MF, 2007, CLIN NEUROPHYSIOL, V118, P131, DOI 10.1016/j.clinph.2006.09.002
   Dias AE, 2006, ACTA NEUROL SCAND, V113, P92, DOI 10.1111/j.1600-0404.2005.00558.x
   Edwards MJ, 2008, LANCET NEUROL, V7, P827, DOI 10.1016/S1474-4422(08)70190-X
   Elahi B, 2009, MOVEMENT DISORD, V24, P357, DOI 10.1002/mds.22364
   ELLAWAY PH, 1995, ELECTROMYOGR MOTOR C, V97, P169, DOI 10.1016/0924-980X(94)00336-6
   Filipovic SR, 2009, MOVEMENT DISORD, V24, P246, DOI 10.1002/mds.22348
   Gangitano M, 2002, CLIN NEUROPHYSIOL, V113, P1249, DOI 10.1016/S1388-2457(02)00109-8
   Hamada M, 2008, MOVEMENT DISORD, V23, P1524, DOI 10.1002/mds.22168
   Hartelius L, 2010, FOLIA PHONIATR LOGO, V62, P104, DOI 10.1159/000287208
   Ho AK, 2008, MOVEMENT DISORD, V23, P574, DOI 10.1002/mds.21899
   HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181
   JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913
   Khedr E.M., 2006, MOVEMENT DISORD, V21, P1311
   Khedr EM, 2003, EUR J NEUROL, V10, P567, DOI 10.1046/j.1468-1331.2003.00649.x
   Khedr EM, 2007, MOVEMENT DISORD, V22, P1046, DOI 10.1002/mds.21460
   Krack R, 2002, REV NEUROL-FRANCE, V158, pS135
   Liotti M, 2003, NEUROLOGY, V60, P432, DOI 10.1212/WNL.60.3.432
   Lomarev MP, 2006, MOVEMENT DISORD, V21, P325, DOI 10.1002/mds.20713
   Maeda F, 2000, CLIN NEUROPHYSIOL, V111, P800, DOI 10.1016/S1388-2457(99)00323-5
   Muller J, 2001, ARCH NEUROL-CHICAGO, V58, P259, DOI 10.1001/archneur.58.2.259
   Murdoch BE, 2010, INT J SPEECH-LANG PA, V12, P375, DOI 10.3109/17549507.2010.495785
   PASCUALLEONE A, 1994, ELECTROEN CLIN NEURO, V93, P42, DOI 10.1016/0168-5597(94)90090-6
   Rodel RMW, 2003, ANN OTO RHINOL LARYN, V112, P71
   ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9
   Rothkegel H, 2010, CLIN NEUROPHYSIOL, V121, P426, DOI 10.1016/j.clinph.2009.11.016
   Siebner HR, 2000, J NEUROL SCI, V178, P91, DOI 10.1016/S0022-510X(00)00370-1
   Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001
   Strafella AP, 2003, BRAIN, V126, P2609, DOI 10.1093/brain/awg268
   Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8
   YORKSTON K, 1984, ASSESSMENT INTELLIGI
NR 32
TC 17
Z9 21
U1 3
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD FEB
PY 2012
VL 19
IS 2
BP 340
EP 347
DI 10.1111/j.1468-1331.2011.03524.x
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 878KH
UT WOS:000299255300028
PM 21967191
DA 2018-12-27
ER

PT J
AU Hellstrom, WJG
   Paduch, D
   Donatucci, CF
AF Hellstrom, Wayne J. G.
   Paduch, Darius
   Donatucci, Craig F.
TI RETRACTED: Importance of hypogonadism and testosterone replacement
   therapy in current urologic practice: a review (Retracted article. See
   vol. 47, pg. 1919, 2015)
SO INTERNATIONAL UROLOGY AND NEPHROLOGY
LA English
DT Article; Proceedings Paper; Retracted Publication
CT 103rd Annual Meeting of the American-Urological-Association (AUA)
CY MAY 17-22, 2008
CL Orlando, FL
SP Amer Urol Assoc (AUA)
DE Testosterone; Hypogonadism; Replacement therapy
ID TANDEM MASS-SPECTROMETRY; LATE-ONSET HYPOGONADISM; BONE-MINERAL DENSITY;
   SERUM TESTOSTERONE; INTERLABORATORY CONCORDANCE; ERECTILE DYSFUNCTION;
   ANDROGEN ASSAYS; ELDERLY-MEN; HORMONE; PLASMA
AB Evaluation of potential candidates for testosterone replacement therapy (TRT) includes a complete medical history, physical examination, and hormonal screening. The choice of testosterone assay is important in clinical decision making. TRT should, in theory, approximate natural endogenous production of the hormone. There is no apparent association between TRT and the development of prostate cancer. The administration of exogenous testosterone is not a means of reversing the aging process in men with normal testosterone levels, but it may offer considerable benefit for those with hypogonadism.
C1 [Hellstrom, Wayne J. G.] Tulane Univ, Dept Urol, Hlth Sci Ctr, New Orleans, LA 70112 USA.
   [Paduch, Darius] Weill Cornell Med Coll, Dept Urol & Reprod Med, New York, NY USA.
   [Donatucci, Craig F.] Duke Univ, Med Ctr, Dept Surg, Div Urol, Durham, NC 27710 USA.
RP Hellstrom, WJG (reprint author), Tulane Univ, Dept Urol, Hlth Sci Ctr, 1430 Tulane Ave,SL-42, New Orleans, LA 70112 USA.
EM whellst@tulane.edu; darius.paduch@mac.com; donat001@mc.duke.edu
CR Albrecht Lindsey, 2007, Pediatr Endocrinol Rev, V5 Suppl 1, P599
   Bhasin S, 2008, STEROIDS, V73, P1311, DOI 10.1016/j.steroids.2008.07.003
   Boyce MJ, 2004, BJU INT, V94, P881, DOI 10.1111/j.1464-410X.2004.05051.x
   Bui HN, 2010, ANN CLIN BIOCHEM, V47, P248, DOI 10.1258/acb.2010.009171
   Chen Y, 2010, CLIN BIOCHEM, V43, P490, DOI 10.1016/j.clinbiochem.2009.12.005
   Corona G, 2009, INT J ANDROL, V32, P720, DOI 10.1111/j.1365-2605.2009.00952.x
   D'Amico AV, 2007, J CLIN ONCOL, V25, P2420, DOI 10.1200/JCO.2006.09.3369
   English KM, 2000, CIRCULATION, V102, P1906, DOI 10.1161/01.CIR.102.16.1906
   Fears TR, 2000, CANCER EPIDEM BIOMAR, V9, P403
   Fears TR, 2002, CANCER EPIDEM BIOMAR, V11, P785
   Ferrer JE, 2009, J SEX MED, DOI [10.1111/j.1743-6109.2009.01508.x, DOI 10.1111/J.1743-6109.2009.01508.X]
   Hak AE, 2002, J CLIN ENDOCR METAB, V87, P3632, DOI 10.1210/jc.87.8.3632
   HERZOG AG, 1992, ARCH NEUROL-CHICAGO, V49, P133, DOI 10.1001/archneur.1992.00530260033014
   Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166
   KLEY HK, 1977, ACTA ENDOCRINOL-COP, V85, P209
   Kohler TS, 2008, UROLOGY, V71, P693, DOI 10.1016/j.urology.2007.11.073
   Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792
   Leifke E, 1998, EUR J ENDOCRINOL, V138, P51, DOI 10.1530/eje.0.1380051
   Marks LS, 2006, JAMA-J AM MED ASSOC, V296, P2351, DOI 10.1001/jama.296.19.2351
   McMahon CG, 2009, J SEX MED, V6, P567, DOI 10.1111/j.1743-6109.2008.01092.x
   Mellstrom D, 2006, J BONE MINER RES, V21, P529, DOI 10.1359/JBMR.060110
   Moisey R, 2008, CLIN ENDOCRINOL, V69, P642, DOI 10.1111/j.1365-2265.2008.03251.x
   Moreley JE, 2006, MATURITAS, V53, P424
   Newman JD, 2008, AUST FAM PHYSICIAN, V37, P670
   NIESCHLAG E, 1972, Z KLIN CHEM KLIN BIO, V10, P164
   Rayanaud JP, 2006, J STEROID BIOCHEM, V102, P261
   Sartorius G, 2009, ANN CLIN BIOCHEM, V46, P137, DOI 10.1258/acb.2008.008171
   Sikaris K, 2005, J CLIN ENDOCR METAB, V90, P5928, DOI 10.1210/jc.2005-0962
   Somani B, 2010, BJU INT, V106, P688, DOI 10.1111/j.1464-410X.2009.09145.x
   Thienpont LM, 2008, CLIN CHEM, V54, P1290, DOI 10.1373/clinchem.2008.105841
   Vermeulen A, 2005, J Endocrinol Invest, V28, P28
   Vesper HW, 2009, STEROIDS, V74, P498, DOI 10.1016/j.steroids.2009.01.004
   Vesper HW, 2010, J STEROID BIOCH MOL
   Vicente FB, 2006, CLIN CHEM LAB MED, V44, P70, DOI 10.1515/CCLM.2006.014
   VLAHOS I, 1982, CLIN CHEM, V28, P2286
   Wang C, 2008, EUR J ENDOCRINOL, V159, P507, DOI 10.1530/EJE-08-0601
   Wang C, 2004, J CLIN ENDOCR METAB, V89, P534, DOI 10.1210/jc.2003-031287
   Wierman ME, 2006, J CLIN ENDOCR METAB, V91, P3697, DOI 10.1210/jc.2006-1121
   Yildiz G, 2007, ANN NY ACAD SCI, V1100, P353, DOI 10.1196/annals.1395.038
   Zacharin MR, 2003, CLIN ENDOCRINOL, V58, P691, DOI 10.1046/j.1365-2265.2003.01746.x
NR 40
TC 11
Z9 11
U1 2
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-1623
EI 1573-2584
J9 INT UROL NEPHROL
JI Int. Urol. Nephrol.
PD FEB
PY 2012
VL 44
IS 1
BP 61
EP 70
DI 10.1007/s11255-010-9879-4
PG 10
WC Urology & Nephrology
SC Urology & Nephrology
GA 876AZ
UT WOS:000299080500012
PM 21152980
DA 2018-12-27
ER

PT J
AU Raval, JP
   Gandhi, AN
   Akhaja, TN
   Myangar, KN
   Patel, NH
AF Raval, Jignesh Priyakant
   Gandhi, Ankur Navinchandra
   Akhaja, Tarunkumar Nanjibhai
   Myangar, Kruti Navinbhai
   Patel, Nilesh Hasmukhbhai
TI RETRACTED: Synthesis and evaluation of anti-inflammatory, analgesic,
   ulcerogenic and lipid peroxidation properties of new
   2-(4-isobutylphenyl)propanoic acid derivatives (Retracted article. See
   vol. 27, pg. 898, 2012)
SO JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
LA English
DT Article; Retracted Publication
DE 2-(4-isobutylphenyl)propanoic acid;
   thiadiazolo[3;2-a][1;3;5]triazine-5-thione; anti-inflammatory;
   analgesic; ulcerogenic; lipid peroxidation activities
ID INFLAMMATION; INHIBITORS; ULCERS; DRUGS; ASSAY
AB Synthesis and pharmacological evaluation of various 2-(4-isobutylphenyl) propanoic acid derivatives containing 1,3,4-thiadiazole and thiadiazolo[3,2-a][1,3,5] triazine-5-thione nucleus is reported here. The structures of new compounds are supported by IR, H-1 & C-13 NMR data. These compounds were tested in vivo for their anti-inflammatory activity. The compounds which showed activity comparable to the standard drug ibuprofen were screened for their analgesic, ulcerogenic and lipid peroxidation activities. The compounds, which showed less ulcerogenic action, also showed reduced malondialdehyde production (MDA). Compound 4i and 5f showed 89.50 and 88.88% of inhibition in paw edema, 69.80 and 66.25% protection against acetic acid-induced writhings and 0.7 and 0.65 of severity index, respectively, compared to 90.12, 72.50 and 1.95 values of ibuprofen.
C1 [Raval, Jignesh Priyakant; Gandhi, Ankur Navinchandra; Akhaja, Tarunkumar Nanjibhai; Myangar, Kruti Navinbhai] Ashok & Rita Patel Inst Integrated Studies & Res, Dept Pharmaceut Chem, New Vallabh Vidyanagar 388121, Gujarat, India.
   [Patel, Nilesh Hasmukhbhai] EMCURE Pharmaceut USA INC, E Brunswick, NJ USA.
RP Raval, JP (reprint author), Ashok & Rita Patel Inst Integrated Studies & Res, Dept Pharmaceut Chem, ADIT Campus, New Vallabh Vidyanagar 388121, Gujarat, India.
EM drjpraval@yahoo.co.in
FU Charutar Vidya Mandal; ARIBAS SICART
FX The author (J.P. Raval) wishes to express his thanks to Dr. Kishor R.
   Desai, Director, C.G. Bhakta Institute of Biotechnology, Surat (Gujarat,
   India) and Mr. Priyakant R. Raval, Cynamid India Ltd. (Atul) for
   extending help for assessment of pharmacological activity. We are also
   thankful to Charutar Vidya Mandal, Director-ARIBAS & Director-SICART for
   providing necessary support for research and analytical facilities.
CR Brown DE, 1982, Patent No. [EP19790300756, 19790300756]
   Brown DE, 1982, EP0005911 B1, Patent No. 0005911
   CIOLI V, 1979, TOXICOL APPL PHARM, V50, P283, DOI 10.1016/0041-008X(79)90153-4
   Desai KG, 2006, J IRAN CHEM SOC, V3, P233, DOI 10.1007/BF03247213
   Duflos M, 2001, EUR J MED CHEM, V36, P545, DOI 10.1016/S0223-5234(01)01242-9
   Geronikaki Athina, 2003, Farmaco (Lausanne), V58, P489, DOI 10.1016/S0014-827X(03)00065-X
   Hawkey C, 2000, ARTHRITIS RHEUM, V43, P370, DOI 10.1002/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D
   Kalgutkar AS, 2000, J MED CHEM, V43, P2860, DOI 10.1021/jm000004e
   Kim SH, 1987, Anti-inflammatory 7-phenyl pyrazolo-[1,5a]-1,3,5-triazine derivatives, Patent No. [EP19860304353, 19860304353]
   Kim SH, 1987, EP0207651 A2, Patent No. 0207651
   KIMMEY MB, 1992, J RHEUMATOL, V19, P68
   Lanza FL, 1998, AM J GASTROENTEROL, V93, P2037
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Omar FA, 1996, EUR J MED CHEM, V31, P819, DOI 10.1016/0223-5234(96)83976-6
   Palaska E, 2002, FARMACO, V57, P101, DOI 10.1016/S0014-827X(01)01176-4
   Raval JP, 2008, ARKIVOC, P233
   Raval JP, 2005, ARKIVOC, P21
   Sainy J, 2009, PHARM CHEM J, V43, P19, DOI 10.1007/s11094-009-0236-9
   SIEGMUND E, 1957, P SOC EXP BIOL MED, V95, P729
   Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313
   Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563
   WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544
NR 22
TC 4
Z9 4
U1 2
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1475-6366
EI 1475-6374
J9 J ENZYM INHIB MED CH
JI J. Enzym. Inhib. Med. Chem.
PD FEB
PY 2012
VL 27
IS 1
BP 110
EP 116
DI 10.3109/14756366.2011.578743
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 871OZ
UT WOS:000298748800017
PM 21612370
DA 2018-12-27
ER

PT J
AU Wang, YS
   Yang, CH
   Zahng, CY
   Zhang, FQ
   He, MR
   Cui, XY
   Ma, J
   Li, HF
AF Wang Yan-Song
   Yang Chun-Hui
   Zahng Chun-Ye
   Zhang Feng-Qing
   He Ming-Rui
   Cui Xiang-Yong
   Ma Ji
   Li Hua-Feng
TI RETRACTED: Determination of Flumorph Residues in Vegetables and Fruits
   by High Performance Liquid Chromatography-Tandem Mass Spectrometry
   (Retracted Article)
SO CHINESE JOURNAL OF ANALYTICAL CHEMISTRY
LA Chinese
DT Article; Retracted Publication
DE Liquid chromatography-tandem mass spectrometry; Conversion; Flumorph;
   Vegetables; Fruits
ID PESTICIDES; JUICES; SAMPLES
AB A method was developed for the determination of flumorph residues in vegetables and fruits using dimoxystrobin as internal standard (IS) by high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS). The conversion rule between flumorph (Z) and flumorph (E) has been studied by sunlight test of flumorph. Flumorph and IS were extracted with ethyl acetate, then purified and concentrated by Oasis HLB cartridge. Qualitative and quantitative detection for the analytes were carried out under the multiple reaction monitoring (MRM) in positive ion mode after the chromatographic separation on Symmetry C-18 (150 mmx2.1 mm i.d., 3.5 mu m) column. Studies at fortification level of 0.05-25 mu g/kg gave mean recoveries from 77.6%-92.8% for flumorph, with relative standard deviation (R.S.D.) <= 8.6%. The limit of quantification (LOQ, S/N=10) was 0.05 mu g/kg. The proposed method was successfully applied to real samples from different kinds of vegetables and fruits. Flumorph residues were detected in 70% of the samples analyzed and the highest concentration level was 1.83 mu g/kg in tomato sample.
C1 [Wang Yan-Song] Northeastern Univ, Coll Sci, Shenyang 110004, Peoples R China.
   [Wang Yan-Song; Yang Chun-Hui; Zahng Chun-Ye; Zhang Feng-Qing; He Ming-Rui; Cui Xiang-Yong; Ma Ji; Li Hua-Feng] Shenyang Supervis & Inspect Inst Prod Qual, Shenyang 110022, Peoples R China.
RP Wang, YS (reprint author), Northeastern Univ, Coll Sci, Shenyang 110004, Peoples R China.
EM wys5715@126.com
CR Deak E, 2010, FOOD RES INT, V43, P2452, DOI 10.1016/j.foodres.2010.09.014
   Hu JY, 2008, J AOAC INT, V91, P1459
   Kotake Y, 2004, J CHROMATOGR B, V806, P75, DOI 10.1016/j.jchromb.2004.03.017
   Leandro CC, 2006, J CHROMATOGR A, V1103, P94, DOI 10.1016/j.chroma.2005.10.077
   LIU Chang-Ling, 2006, WORLD PESTICIDE ENCY, P80
   Luo S, 2008, CHINESE J ANAL CHEM, V36, P7
   Mayer-Helm B, 2008, TALANTA, V74, P1184, DOI 10.1016/j.talanta.2007.08.033
   Mol HGJ, 2003, J CHROMATOGR A, V1015, P119, DOI 10.1016/S0021-9673(03)01209-3
   Monaci L, 2008, J CHROMATOGR A, V1192, P113, DOI 10.1016/j.chroma.2008.03.041
   Pozo OJ, 2003, J CHROMATOGR A, V992, P133, DOI 10.1016/S0021-9673(03)00325-X
   Romero-Gonzalez R, 2008, TALANTA, V76, P211, DOI 10.1016/j.talanta.2008.02.041
   Sagratini G, 2007, J CHROMATOGR A, V1147, P135, DOI 10.1016/j.chroma.2007.02.066
   Sannino A, 2004, J CHROMATOGR A, V1036, P161, DOI 10.1016/j.chroma.2004.02.078
   Tian HZ, 2011, CHEMOSPHERE, V83, P349, DOI 10.1016/j.chemosphere.2010.12.016
   Tian QG, 2005, J CHROMATOGR A, V1091, P72, DOI 10.1016/j.chroma.2005.07.036
   Zamora T, 2004, J CHROMATOGR A, V1045, P137, DOI 10.1016/j.chroma.2004.06.041
NR 16
TC 4
Z9 5
U1 7
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0253-3820
EI 1872-2040
J9 CHINESE J ANAL CHEM
JI Chin. J. Anal. Chem.
PD FEB
PY 2012
VL 40
IS 2
BP 286
EP 291
DI 10.3724/SP.J.1096.2012.10463
PG 6
WC Chemistry, Analytical
SC Chemistry
GA 074ER
UT WOS:000313796200012
DA 2018-12-27
ER

PT J
AU Chirica, I
   Boazu, D
   Beznea, EF
AF Chirica, Ionel
   Boazu, Doina
   Beznea, Elena-Felicia
TI RETRACTED: Response of ship hull laminated plates to close proximity
   blast loads (Retracted article. See vol. 109, pg. 401, 2015)
SO COMPUTATIONAL MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper; Retracted Publication
CT 20th International Workshop on Computational Mechanics of Materials
   (IWCMM 20)
CY SEP 08-10, 2010
CL Loughborough Univ, Loughborough, ENGLAND
SP Inst Phys, Appl Mechan Grp (IOP), European Network MaMiNa, Adidas
HO Loughborough Univ
DE Composite plates; Ship hull; Blast loads
ID STRUCTURAL RESPONSE
AB This paper presents selected results of a study concerning the protective capacity of ship hull structures made of composite materials subjected to an explosion of a spherical charge. The analysis of the effects of explosion on ship structure made of composite materials is presented. The main application of these structures lies in design of ship structures of great importance, which should also be protected against exceptional loads of this kind. In this study, a non-linear analysis with the finite-element computer code COSMOS/M was done. The methodology for the blast pressure charging and the mechanism of the blast wave in free air are given. The space pressure variation is determined by using Friedlander exponential decay equation. Various scenarios (parametric calculus) to evaluate the behavior of the ship structure laminated plate to blast loading are presented: explosive magnitude, distance from source of explosion, plate thickness. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Chirica, Ionel; Boazu, Doina; Beznea, Elena-Felicia] Univ Dunarea de Jos Galati, Galati 800008, Romania.
RP Chirica, I (reprint author), Univ Dunarea de Jos Galati, 47 Domneasca Str, Galati 800008, Romania.
EM ionel.chirica@ugal.ro
CR Altunc AB, 2011, COMPOS STRUCT, V93, P2042, DOI 10.1016/j.compstruct.2011.02.017
   Baker W. E., 1973, EXPLOSIONS AIR
   Batra RC, 2007, COMPOS PART B-ENG, V38, P448, DOI 10.1016/j.compositesb.2006.09.001
   BRODE HL, 1955, J APPL PHYS
   COOPER PW, 1996, EXPLOSIVE ENG
   CROCKER MJ, 1969, J SOUND VIB, V9, P454, DOI 10.1016/0022-460X(69)90184-9
   FORGHANI A, 2007, 16 INT C COMP MAT KY, P1
   GUPTA AD, 1985, P 13 SOUTH C THEOR A, V1, P385
   HOULSTON R, 1985, COMPUT STRUCT, V21, P273, DOI 10.1016/0045-7949(85)90250-0
   Kadid A, 2008, J CIV ENG MANAG, V14, P155, DOI 10.3846/1392-3730.2008.14.11
   Kinney GF, 1985, EXPLOSIVE SHOCKS AIR
   LIBRESCU L, 1990, AIAA J, V28, P345, DOI 10.2514/3.10395
   Turkmen HS, 2002, J SOUND VIB, V249, P663, DOI 10.1006/jsvi.2001.3861
   2003, RISK MANAGEMENT SERI, P426
NR 14
TC 7
Z9 7
U1 3
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-0256
EI 1879-0801
J9 COMP MATER SCI
JI Comput. Mater. Sci.
PD FEB
PY 2012
VL 52
IS 1
BP 197
EP 203
DI 10.1016/j.commatsci.2011.07.036
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 858EW
UT WOS:000297779700034
DA 2018-12-27
ER

PT J
AU Rottlaender, D
   Boengler, K
   Wolny, M
   Schwaiger, A
   Motloch, LJ
   Ovize, M
   Schulz, R
   Heusch, G
   Hoppe, UC
AF Rottlaender, Dennis
   Boengler, Kerstin
   Wolny, Martin
   Schwaiger, Astrid
   Motloch, Lukas J.
   Ovize, Michel
   Schulz, Rainer
   Heusch, Gerd
   Hoppe, Uta C.
TI RETRACTED: Glycogen synthase kinase 3 beta transfers cytoprotective
   signaling through connexin 43 onto mitochondrial ATP-sensitive K+
   channels (Retracted article. See vol. 109, pg. 21552, 2012)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Retracted Publication
ID GAP-JUNCTION CHANNELS; PERMEABILITY TRANSITION PORE; PHARMACOLOGICAL
   MODULATION; ISCHEMIC-MYOCARDIUM; IN-VIVO; PROTEIN; HEMICHANNELS;
   INHIBITION; CARDIOPROTECTION; PHOSPHORYLATION
AB Despite compelling evidence supporting key roles for glycogen synthase kinase 3 beta (GSK3 beta), mitochondrial adenosine triphosphate-sensitive K+ (mitoK(ATP)) channels, and mitochondrial connexin 43 (Cx43) in cytoprotection, it is not clear how these signaling modules are linked mechanistically. By patch-clamping the inner membrane of murine cardiac mitochondria, we found that inhibition of GSK3 beta activated mitoK(ATP). PKC activation and protein phosphatase 2a inhibition increased the open probability of mitoK(ATP) channels through GSK3 beta, and this GSK3 beta signal was mediated via mitochondrial Cx43. Moreover, (i) PKC-induced phosphorylation of mitochondrial Cx43 was reduced in GSK3 beta-S9A mice; (ii) Cx43 and GSK3 beta proteins associated in mitochondria; and (iii) SB216763-mediated reduction of infarct size was abolished in Cx43 KO mice in vivo, consistent with the notion that GSK3 beta inhibition results in mitoK(ATP) opening via mitochondrial Cx43. We therefore directly targeted mitochondrial Cx43 by the Cx43 C-terminal binding peptide RRNYRRNY for cardioprotection, circumventing further upstream pathways. RRNYRRNY activated mitoK(ATP) channels via Cx43. We directly recorded mitochondrial Cx43 channels that were activated by RRNYRRNY and blocked by the Cx43 mimetic peptide (43)GAP27. RRNYRRNY rendered isolated cardiomyocytes in vitro and the heart in vivo resistant to ischemia/reperfusion injury, indicating that mitochondrial Cx43- and/or mitoK(ATP)-mediated reduction of infarct size was not undermined by RRNYRRNY-related opening of sarcolemmal Cx43 channels. Our results demonstrate that GSK3 beta transfers cytoprotective signaling through mitochondrial Cx43 onto mitoK(ATP) channels and that Cx43 functions as a channel in mitochondria, being an attractive target for drug treatment against cardiomyocyte injury.
C1 [Rottlaender, Dennis; Motloch, Lukas J.; Hoppe, Uta C.] Paracelsus Med Univ Salzburg, Dept Internal Med 2, A-5020 Salzburg, Austria.
   [Rottlaender, Dennis; Wolny, Martin; Schwaiger, Astrid; Motloch, Lukas J.; Hoppe, Uta C.] Univ Cologne, Dept Internal Med 3, D-50937 Cologne, Germany.
   [Hoppe, Uta C.] Univ Cologne, Ctr Mol Med, D-50937 Cologne, Germany.
   [Boengler, Kerstin; Heusch, Gerd] Univ Essen Gesamthsch, Inst Pathophysiol, D-45122 Essen, Germany.
   [Ovize, Michel] Univ Lyon 1, INSERM, U886, F-69373 Lyon, France.
   [Schulz, Rainer] Univ Giessen, Inst Physiol, D-35392 Giessen, Germany.
RP Hoppe, UC (reprint author), Paracelsus Med Univ Salzburg, Dept Internal Med 2, A-5020 Salzburg, Austria.
EM uta.hoppe@uni-koeln.de
OI Schulz, Rainer/0000-0003-3017-0476
FU Deutsche Forschungsgemeinschaft [Ho 2146/3-3, Schu 843/7-1, 7-2]; Koln
   Fortune; Marga and Walter Boll-Stiftung
FX This work was supported by Grants Ho 2146/3-3 and Schu 843/7-1, 7-2 from
   the Deutsche Forschungsgemeinschaft and by grants from Koln Fortune and
   the Marga and Walter Boll-Stiftung (to U.C.H.).
CR Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298
   ARMSTRONG S, 1994, CARDIOVASC RES, V28, P72, DOI 10.1093/cvr/28.1.72
   Beardslee MA, 2000, CIRC RES, V87, P656, DOI 10.1161/01.RES.87.8.656
   Begley R, 2004, BIOCHEM BIOPH RES CO, V318, P949, DOI 10.1016/j.bbrc.2004.04.121
   Boengler K, 2005, CARDIOVASC RES, V67, P234, DOI 10.1016/j.cardiores.2005.04.014
   Boengler K, 2009, BASIC RES CARDIOL, V104, P141, DOI 10.1007/s00395-009-0007-5
   Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1
   Costa ADT, 2008, AM J PHYSIOL-HEART C, V295, pH874, DOI 10.1152/ajpheart.01189.2007
   De Vuyst E, 2011, BRIT J PHARMACOL, V163, P469, DOI 10.1111/j.1476-5381.2011.01244.x
   Dhein S, 2001, CELL COMMUN ADHES, V8, P257, DOI 10.3109/15419060109080734
   Eloff BC, 2003, CIRCULATION, V108, P3157, DOI 10.1161/01.CIR.0000101926.43759.10
   Er F, 2004, CIRCULATION, V110, P3100, DOI 10.1161/01.CIR.0000146900.84943.E0
   Gomez L, 2008, CIRCULATION, V117, P2761, DOI 10.1161/CIRCULATIONAHA.107.755066
   Hawat G, 2010, PFLUG ARCH EUR J PHY, V460, P583, DOI 10.1007/s00424-010-0849-6
   Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242
   John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236
   Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906
   Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5
   KWAK BR, 1995, EXP CELL RES, V220, P456, DOI 10.1006/excr.1995.1337
   Lewandowski R, 2008, CIRC RES, V103, P519, DOI 10.1161/CIRCRESAHA.108.179069
   Liu TF, 1997, METHOD FIND EXP CLIN, V19, P573
   Michels G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001511
   Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389
   Miura T, 2010, AM J PHYSIOL-HEART C, V298, pH1115, DOI 10.1152/ajpheart.00879.2009
   MORENO AP, 1994, CIRC RES, V74, P1050, DOI 10.1161/01.RES.74.6.1050
   Murphy E, 2005, EXPERT OPIN THER TAR, V9, P447, DOI 10.1517/14728222.9.3.447
   Murphy E, 2004, CIRC RES, V94, P7, DOI 10.1161/01.RES.0000108082.76667.F4
   MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124
   *NIH, 1996, NIH PUBL, V8523
   Obame FN, 2008, J PHARMACOL EXP THER, V326, P252, DOI 10.1124/jpet.108.138008
   Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007
   Rottlaender D, 2010, J CLIN INVEST, V120, P1441, DOI 10.1172/JCI40927
   Schwanke U, 2002, AM J PHYSIOL-HEART C, V283, pH1740, DOI 10.1152/ajpheart.00442.2002
   Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569
   Shintani-Ishida K, 2007, AM J PHYSIOL-HEART C, V293, pH1714, DOI 10.1152/ajpheart.00022.2007
   Sokoya EM, 2006, AM J PHYSIOL-HEART C, V291, pH385, DOI 10.1152/ajpheart.01047.2005
   Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200
   SUTHERLAND C, 1994, FEBS LETT, V338, P37, DOI 10.1016/0014-5793(94)80112-6
   Terashima Y, 2010, J MOL CELL CARDIOL, V49, P762, DOI 10.1016/j.yjmcc.2010.08.001
   Tong HY, 2002, CIRC RES, V90, P377, DOI 10.1161/01.RES.0000012567.95445.55
   Verma V, 2009, CIRC RES, V105, P176, DOI 10.1161/CIRCRESAHA.109.200576
   Vetterlein F, 2006, AM J PHYSIOL-HEART C, V291, pH813, DOI 10.1152/ajpheart.01177.2005
NR 42
TC 22
Z9 22
U1 2
U2 22
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 31
PY 2012
VL 109
IS 5
BP E242
EP E251
DI 10.1073/pnas.1107479109
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 884TJ
UT WOS:000299731400009
PM 22238425
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Alarfaj, NA
   Ammar, RA
   El-Tohamy, MF
AF Alarfaj, Nawal A.
   Ammar, Reda A.
   El-Tohamy, Maha F.
TI RETRACTED: Disposable screen-printed sensors for determination of
   duloxetine hydrochloride (Retracted article. See vol. 6, 6, 2012)
SO CHEMISTRY CENTRAL JOURNAL
LA English
DT Article; Retracted Publication
DE Disposable screen printed carbon electrode; Potentiometry; Duloxetine
   hydrochloride; Pharmaceutical preparations
ID ION-SELECTIVE ELECTRODES; HUMAN PLASMA; LIQUID-CHROMATOGRAPHY; BULK;
   VALIDATION; DRUG
AB A screen-printed disposable electrode system for the determination of duloxetine hydrochloride (DL) was developed using screen-printing technology. Homemade printing has been characterized and optimized on the basis of effects of the modifier and plasticizers. The fabricated bi-electrode potentiometric strip containing both working and reference electrodes was used as duloxetine hydrochloride sensor. The proposed sensors worked satisfactorily in the concentration range from 1.0 x 10(-6)-1.0 x 10(-2) mol L-1 with detection limit reaching 5.0 x 10(-7) mol L-1 and adequate shelf life of 6 months. The method is accurate, precise and economical. The proposed method has been applied successfully for the analysis of the drug in pure and in its dosage forms. In this method, there is no interference from any common pharmaceutical additives and diluents. Results of the analysis were validated statistically by recovery studies.
C1 [Alarfaj, Nawal A.; Ammar, Reda A.; El-Tohamy, Maha F.] King Saud Univ, Coll Sci, Dept Chem, Riyadh 11495, Saudi Arabia.
   [Ammar, Reda A.] Al Azhar Univ, Coll Sci, Dept Chem, Cairo, Egypt.
RP El-Tohamy, MF (reprint author), King Saud Univ, Coll Sci, Dept Chem, POB 22452, Riyadh 11495, Saudi Arabia.
EM star2000star@gmail.com
FU King Saud University [RGP-VPP-062]
FX The Authors extend their appreciation to the Deanship of Scientific
   Research at King Saud University for funding the work through the
   research group project No. RGP-VPP-062.
CR Abbas MN, 2008, TALANTA, V74, P1113, DOI 10.1016/j.talanta.2007.08.008
   Aboul-Enein HY, 1999, INSTRUM SCI TECHNOL, V27, P89, DOI 10.1080/10739149908085836
   Brunton LL, 2005, GOODMAN GILLMANS PHA, P436
   BUCK RP, 1994, PURE APPL CHEM, V66, P2527, DOI 10.1351/pac199466122527
   COSOFRET VV, 1992, PHARM APPL MEMBRANE
   Dhaneshwar SS, 2008, INDIAN J PHARM SCI, V70, P233, DOI 10.4103/0250-474X.41463
   Elmorsy K, 2010, TALANTA, V81, P510
   Kamila MM, 2007, PHARMAZIE, V62, P414, DOI 10.1691/ph.2007.6.6205
   Khaled E, 2010, DRUG TEST ANAL, V2, P424, DOI 10.1002/dta.159
   Khaled E, 2008, TALANTA, V77, P737, DOI 10.1016/j.talanta.2008.07.018
   Ma N, 2007, CLIN CHIM ACTA, V380, P100, DOI 10.1016/j.cca.2007.01.018
   MA TS, 1982, ORGANIC ANAL USING I, V1
   MESARIC S, 1973, ANAL CHIM ACTA, V64, P431, DOI 10.1016/S0003-2670(01)82475-2
   Musenga A, 2009, J CHROMATOGR B, V877, P1126, DOI 10.1016/j.jchromb.2009.02.059
   Prabu SL, 2008, INDIAN J PHARM SCI, V70, P502, DOI 10.4103/0250-474X.44603
   Raman NVVSS, 2010, J PHARMACEUT BIOMED, V51, P994, DOI 10.1016/j.jpba.2009.10.025
   Satonin DK, 2007, J CHROMATOGR B, V852, P582, DOI 10.1016/j.jchromb.2007.02.025
   Selvan PS, 2007, J CHROMATOGR B, V858, P269, DOI 10.1016/j.jchromb.2007.09.002
   Singh AK, 2009, ANAL CHIM ACTA, V643, P74, DOI 10.1016/j.aca.2009.03.047
   Sinha VR, 2009, J CHROMATOGR SCI, V47, P589, DOI 10.1093/chromsci/47.7.589
   Sweetman SC, 2005, MARTINDALE COMPLETE, P292
   Umezawa Y, 2000, PURE APPL CHEM, V72, P1851, DOI 10.1351/pac200072101851
   Yunoos M, 2010, E-J CHEM, V7, P785, DOI 10.1155/2010/709176
NR 23
TC 2
Z9 2
U1 2
U2 19
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1752-153X
J9 CHEM CENT J
JI Chem. Cent. J.
PD JAN 21
PY 2012
VL 6
AR 6
DI 10.1186/1752-153X-6-6
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 892RO
UT WOS:000300303500001
PM 22264225
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Martinez, JA
   Kasamatsu, M
   Rosales-Hernandez, A
   Hanson, LR
   Frey, WH
   Toth, CC
AF Martinez, Jose A.
   Kasamatsu, Manami
   Rosales-Hernandez, Alma
   Hanson, Leah R.
   Frey, William H.
   Toth, Cory C.
TI RETRACTED: Comparison of central versus peripheral delivery of
   pregabalin in neuropathic pain states (Retracted article. See vol. 8, 3,
   2014)
SO MOLECULAR PAIN
LA English
DT Article; Retracted Publication
DE neuropathic pain; pregabalin; diabetic peripheral neuropathy; spinal
   nerve ligation
ID INDUCED TACTILE ALLODYNIA; SPINAL-CORD-INJURY; DEPENDENT
   CALCIUM-CHANNELS; CENTRAL-NERVOUS-SYSTEM; SUBUNIT UP-REGULATION; GATED
   CA2+ CHANNELS; DORSAL-HORN; INTRANASAL INSULIN; PROTEIN-KINASE;
   ALPHA(2)DELTA SUBUNITS
AB Background: Although pregabalin therapy is beneficial for neuropathic pain (NeP) by targeting the CaV alpha(2)delta-1 subunit, its site of action is uncertain. Direct targeting of the central nervous system may be beneficial for the avoidance of systemic side effects.
   Results: We used intranasal, intrathecal, and near-nerve chamber forms of delivery of varying concentrations of pregabalin or saline delivered over 14 days in rat models of experimental diabetic peripheral neuropathy and spinal nerve ligation. As well, radiolabelled pregabalin was administered to determine localization with different deliveries. We evaluated tactile allodynia and thermal hyperalgesia at multiple time points, and then analyzed harvested nervous system tissues for molecular and immunohistochemical changes in CaV alpha(2)delta-1 protein expression. Both intrathecal and intranasal pregabalin administration at high concentrations relieved NeP behaviors, while near-nerve pregabalin delivery had no effect. NeP was associated with upregulation of CACNA2D1 mRNA and CaV alpha(2)delta-1 protein within peripheral nerve, dorsal root ganglia (DRG), and dorsal spinal cord, but not brain. Pregabalin's effect was limited to suppression of CaV alpha(2)delta-1 protein (but not CACNA2D1 mRNA) expression at the spinal dorsal horn in neuropathic pain states. Dorsal root ligation prevented CaV alpha(2)delta-1 protein trafficking anterograde from the dorsal root ganglia to the dorsal horn after neuropathic pain initiation.
   Conclusions: Either intranasal or intrathecal pregabalin relieves neuropathic pain behaviours, perhaps due to pregabalin's effect upon anterograde CaV alpha(2)delta-1 protein trafficking from the DRG to the dorsal horn. Intranasal delivery of agents such as pregabalin may be an attractive alternative to systemic therapy for management of neuropathic pain states.
C1 [Martinez, Jose A.; Kasamatsu, Manami; Rosales-Hernandez, Alma; Toth, Cory C.] Dept Clin Neurosci, Calgary, AB, Canada.
   [Martinez, Jose A.; Kasamatsu, Manami; Rosales-Hernandez, Alma; Toth, Cory C.] Univ Calgary, Calgary, AB, Canada.
   [Hanson, Leah R.; Frey, William H.] Reg Hosp, Alzheimers Res Ctr, St Paul, MN USA.
   [Hanson, Leah R.; Frey, William H.] HealthPartners Res Fdn, St Paul, MN USA.
   [Frey, William H.] Univ Minnesota, Dept Pharmaceut, Minneapolis, MN 55455 USA.
RP Toth, CC (reprint author), Dept Clin Neurosci, Calgary, AB, Canada.
EM corytoth@shaw.ca
OI Frey II, William/0000-0002-6373-0794
FU Pfizer Global; Alberta Heritage Foundation for Medical Research;
   Juvenile Diabetes Research Foundation; University of Calgary; University
   of Calgary Department of Clinical Neurosciences; Valeant Canada;
   Talecris Canada
FX CT receives salary support from the Alberta Heritage Foundation for
   Medical Research, and also receives research operating funds from the
   Juvenile Diabetes Research Foundation, The University of Calgary, The
   University of Calgary Department of Clinical Neurosciences, Pfizer
   Global, Valeant Canada, and Talecris Canada. CT has received honoraria
   for medical education seminars and consultancy from Pfizer Global,
   Valeant Canada, and Talecris Canada.
CR Bauer CS, 2009, J NEUROSCI, V29, P4076, DOI 10.1523/JNEUROSCI.0356-09.2009
   Bayer K, 2004, NEUROPHARMACOLOGY, V46, P743, DOI 10.1016/j.neuropharm.2003.11.010
   Bennett MI, 2007, PAIN, V132, P12, DOI 10.1016/j.pain.2007.09.003
   Boroujerdi A, 2008, PAIN, V139, P358, DOI 10.1016/j.pain.2008.05.004
   Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124
   Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013
   Brown JP, 1998, ANAL BIOCHEM, V255, P236, DOI 10.1006/abio.1997.2447
   Calvo M, 2010, J NEUROSCI, V30, P5437, DOI 10.1523/JNEUROSCI.5169-09.2010
   Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102
   Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521
   Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104
   Coderre TJ, 2005, J NEUROCHEM, V94, P1131, DOI 10.1111/j.1471-4159.2005.03263.x
   Cole RL, 2005, J COMP NEUROL, V491, P246, DOI 10.1002/cne.20693
   Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005
   Davies A, 2006, J NEUROSCI, V26, P8748, DOI 10.1523/JNEUROSCI.2764-06.2006
   Dhuria S.V., 2009, J PHARM SCI
   Dickenson AH, 2002, EUR J PAIN, V6, P51, DOI 10.1053/eujp.2001.0323
   Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006
   Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103
   Field MJ, 2001, BRIT J PHARMACOL, V132, P1, DOI 10.1038/sj.bjp.0703794
   Francis G, 2009, DIABETES, V58, P934, DOI 10.2337/db08-1287
   Francis GJ, 2008, BRAIN, V131, P3311, DOI 10.1093/brain/awn288
   Frey W, NEUROLOGIC AGENTS NA
   Gajraj NM, 2007, ANESTH ANALG, V105, P1805, DOI 10.1213/01.ane.0000287643.13410.5e
   Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768
   Gustafsson H, 2009, EUR J PHARMACOL, V605, P103, DOI 10.1016/j.ejphar.2009.01.014
   Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006
   Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5
   Heblich Fay, 2008, Channels (Austin), V2, P4
   Hendrich J, 2008, P NATL ACAD SCI USA, V105, P3628, DOI 10.1073/pnas.0708930105
   Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648
   Huge V, 2009, EUR J PAIN
   JAY SD, 1991, J BIOL CHEM, V266, P3287
   Khosravani H, 2004, J BIOL CHEM, V279, P9681, DOI 10.1074/jbc.C400006200
   KIM SH, 1992, PAIN, V50, P355
   Klugbauer N, 2003, J BIOENERG BIOMEMBR, V35, P639, DOI 10.1023/B:JOBB.0000008028.41056.58
   Lee MS, 2009, J DRUG TARGET
   Li CY, 2006, PAIN, V125, P20, DOI 10.1016/j.pain.2006.04.022
   Li CY, 2004, J NEUROSCI, V24, P8494, DOI 10.1523/JNEUROSCI.2982-04.2004
   Ling B, 2008, NEUROPHARMACOLOGY, V55, P724, DOI 10.1016/j.neuropharm.2008.06.007
   Maneuf YP, 2001, BRIT J PHARMACOL, V134, P237, DOI 10.1038/sj.bjp.0704227
   Marcol W, 2007, NEUROSURG REV, V30, P235, DOI 10.1007/s10143-007-0085-5
   Messinger RB, 2009, PAIN, V145, P184, DOI 10.1016/j.pain.2009.06.012
   Moore KA, 2002, NEUROPHARMACOLOGY, V43, P1077, DOI 10.1016/S0028-3908(02)00226-5
   Newton RA, 2001, MOL BRAIN RES, V95, P1, DOI 10.1016/S0169-328X(01)00188-7
   Patel MK, 2000, BRIT J PHARMACOL, V130, P1731, DOI 10.1038/sj.bjp.0703530
   Pitcher GM, 2004, EXP NEUROL, V186, P173, DOI 10.1016/j.expneurol.2003.10.019
   Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S
   Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36
   Reger MA, 2006, DRUGS TODAY, V42, P729, DOI 10.1358/dot.2006.42.11.1007675
   Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992
   Scranton RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018711
   Snutch Terrance P, 2005, NeuroRx, V2, P662, DOI 10.1602/neurorx.2.4.662
   Sun H, 2001, PAIN, V90, P105, DOI 10.1016/S0304-3959(00)00392-4
   Suzuki R, 2005, PAIN, V117, P292, DOI 10.1016/j.pain.2005.06.015
   Svensson CI, 2003, J NEUROCHEM, V86, P1534, DOI 10.1046/j.1471-4159.2003.01969.x
   Takasu K, 2009, J PHARMACOL SCI, V110, P223, DOI 10.1254/jphs.09091SC
   Tanabe M, 2008, J NEUROSCI RES, V86, P3258, DOI 10.1002/jnr.21786
   Tawfik VL, 2007, BRAIN BEHAV IMMUN, V21, P238, DOI 10.1016/j.bbi.2006.07.001
   Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029
   Toth C, 2008, NEUROSCIENCE, V154, P767, DOI 10.1016/j.neuroscience.2008.03.052
   Toth C, 2006, NEUROSCIENCE, V139, P429, DOI 10.1016/j.neuroscience.2005.11.065
   Toth C, 2006, DIABETOLOGIA, V49, P1081, DOI 10.1007/s00125-006-0169-8
   Toth C, 2009, PAIN MED, V10, P918, DOI 10.1111/j.1526-4637.2009.00655.x
   Toth CC, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-16
   Tran-Van-Minh A, 2010, J NEUROSCI, V30, P12856, DOI 10.1523/JNEUROSCI.2700-10.2010
   Tsuda M, 2008, GLIA, V56, P378, DOI 10.1002/glia.20623
   Valiveti S, 2007, EUR J PHARM BIOPHARM, V65, P247, DOI 10.1016/j.ejpb.2006.08.009
   Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X
   Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251
   Wen XJ, 2006, ACTA PHARMACOL SIN, V27, P1547, DOI 10.1111/j.1745-7254.2006.00461.x
   Wilson-Gerwing TD, 2006, NEUROSCIENCE, V141, P2075, DOI 10.1016/j.neuroscience.2006.05.056
   Wodarski R, 2009, EUR J PAIN, V13, P807, DOI 10.1016/j.ejpain.2008.09.010
   Woolf CJ, 1991, HYPERALGESIA ALLODYN, P221
   Wu G, 2001, J Neurosci, V21, pRC140
   You HJ, 2009, NEUROSCIENCE, V164, P1845, DOI 10.1016/j.neuroscience.2009.09.047
   Zhang YL, 2008, J NEUROSCI, V28, P2601, DOI 10.1523/JNEUROSCI.4314-07
   Zhao P, 2007, J NEUROSCI, V27, P2357, DOI 10.1523/JNEUROSCI.0138-07.2007
   Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006
NR 79
TC 11
Z9 14
U1 4
U2 15
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1744-8069
J9 MOL PAIN
JI Mol. Pain
PD JAN 11
PY 2012
VL 8
AR 3
DI 10.1186/1744-8069-8-3
PG 20
WC Neurosciences
SC Neurosciences & Neurology
GA 910OQ
UT WOS:000301649500002
PM 22236461
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Liu, L
   Xia, N
AF Liu, Lin
   Xia, Ning
TI RETRACTED: Zinc-mediated modulation of the configuration and activity of
   complexes between copper and amyloid-beta peptides (Retracted article.
   See vol. 425, pg. 120, 2012)
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article; Retracted Publication
DE Alzheimer's disease; Amyloid-beta; Metal ions; Ternary complex;
   Configuration and activity
ID ALZHEIMERS-DISEASE; COORDINATION GEOMETRY; BINDING-SITE; AGGREGATION;
   AFFINITY; STOICHIOMETRY; FLUORESCENCE; MECHANISM; CU(II); CU2+
AB A growing body of Alzheimer's disease (AD) research is concerned with understanding the interaction between amyloid-beta (A beta) peptides and metal ions (e.g., Cu, Zn, and Fe) and determining the biological relevance of the metal-A beta complexes to essential metal homeostasis and neuronal cell loss. Previously, many studies have dealt with the interaction between A beta and "single" but not "multiple" metal ions in terms of binding affinity and coordination chemistry. In the present work, we found that Zn(II) ions modified the configuration of A beta-Cu(II) by forming Zn(II)-A beta-Cu(II) ternary complexes. As a result, the catalytic activity of A beta-Cu(II) against a biological ascorbic acid species was repressed by Zn(II) binding. The formation of the ternary complex can therefore explain the protective role of Zn(II) in AD. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Liu, Lin] Anyang Normal Univ, Coll Chem & Chem Engn, Anyang 455002, Henan, Peoples R China.
   [Liu, Lin; Xia, Ning] Cent S Univ, Coll Chem & Chem Engn, Changsha 410083, Hunan, Peoples R China.
RP Liu, L (reprint author), Anyang Normal Univ, Coll Chem & Chem Engn, Anyang 455002, Henan, Peoples R China.
EM liulin82414@yahoo.com.cn
CR Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x
   Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5
   Clements A, 1996, J NEUROCHEM, V66, P740
   Damante CA, 2011, INORG CHEM, V50, P5342, DOI 10.1021/ic101537m
   Dong J., 2006, J AM CHEM SOC
   Drew SC, 2009, J AM CHEM SOC, V131, P1195, DOI 10.1021/ja808073b
   Faller P, 2009, CHEMBIOCHEM, V10, P2837, DOI 10.1002/cbic.200900321
   Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k
   Garzon-Rodriguez W, 1999, BIOORG MED CHEM LETT, V9, P2243, DOI 10.1016/S0960-894X(99)00357-1
   Guilloreau L, 2006, J BIOL INORG CHEM, V11, P1024, DOI 10.1007/s00775-006-0154-1
   Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Hatcher LQ, 2008, J PHYS CHEM B, V112, P8160, DOI 10.1021/jp710806s
   Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808
   Jiang DL, 2010, J PHYS CHEM B, V114, P4896, DOI 10.1021/jp9095375
   Karr JW, 2004, J AM CHEM SOC, V126, P13534, DOI 10.1021/ja0488028
   Liu GJ, 2006, J STRUCT BIOL, V155, P45, DOI 10.1016/jjsb.2005.12.011
   Liu L, 2011, J AM CHEM SOC, V133, P12229, DOI 10.1021/ja2045259
   Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6
   Ma QF, 2006, BIOPOLYMERS, V83, P20, DOI 10.1002/bip.20523
   Maiti NC, 2008, J PHYS CHEM B, V112, P8406, DOI 10.1021/jp802038p
   Que EL, 2008, CHEM REV, V108, P1517, DOI 10.1021/cr078203u
   Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n
   Shearer J, 2008, J AM CHEM SOC, V130, P17826, DOI 10.1021/ja805940m
   Sigel A., 2006, METAL IONS LIFE SCI
   Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200
   Tougu V, 2008, J NEUROCHEM, V104, P1249, DOI 10.1111/j.1471-4159.2007.05061.x
   Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274
NR 28
TC 6
Z9 6
U1 2
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JAN 6
PY 2012
VL 417
IS 1
BP 153
EP 156
DI 10.1016/j.bbrc.2011.11.074
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 881MU
UT WOS:000299491600027
PM 22138653
DA 2018-12-27
ER

PT J
AU de Oliveira, MF
   Pinto, FCG
   Nishikuni, K
   Botelho, RV
   Lima, AM
   Rotta, JM
AF de Oliveira, Matheus Fernandes
   Gomes Pinto, Fernando Campos
   Nishikuni, Koshiro
   Botelho, Ricardo Vieira
   Lima, Alessandra Moura
   Rotta, Jose Marcus
TI RETRACTED: Revisiting hydrocephalus as a model to study brain resilience
   (Retracted article. See vol. 10, 375, 2016)
SO FRONTIERS IN HUMAN NEUROSCIENCE
LA English
DT Review; Retracted Publication
DE hydrocephalus; resilience; brain; neural networks; plasticity
ID NORMAL-PRESSURE HYDROCEPHALUS; SURGICAL-MANAGEMENT; ADULT HYDROCEPHALUS;
   COGNITIVE ANATOMY; SMALL-WORLD; ORGANIZATION; DEGENERACY; PLASTICITY;
   CHILDREN
AB Hydrocephalus is an entity which embraces a variety of diseases whose final result is the enlarged size of cerebral ventricular system, partially or completely. The physiopathology of hydrocephalus lies in the dynamics of circulation of cerebrospinal fluid (CSF). The consequent CSF stasis in hydrocephalus interferes with cerebral and ventricular system development. Children and adults who sustain congenital or acquired brain injury typically experience a diffuse insult that impacts many areas of the brain. Development and recovery after such injuries reflects both restoration and reorganization of cognitive functions. Classic examples were already reported in literature. This suggests the presence of biological mechanisms associated with resilient adaptation of brain networks. We will settle a link between the notable modifications to neurophysiology secondary to hydrocephalus and the ability of neuronal tissue to reassume and reorganize its functions.
C1 [de Oliveira, Matheus Fernandes; Gomes Pinto, Fernando Campos; Nishikuni, Koshiro; Botelho, Ricardo Vieira; Lima, Alessandra Moura; Rotta, Jose Marcus] Hosp Serv Publ Estadual Sao Paulo, Dept Neurosurg, BR-1800 Sao Paulo, Brazil.
RP de Oliveira, MF (reprint author), Hosp Serv Publ Estadual Sao Paulo, Dept Neurosurg, Ave Pedro Toledo,VilaClementino, BR-1800 Sao Paulo, Brazil.
EM mafernoliv@yahoo.com.br
RI Pinto, Fernando/F-6094-2012
CR Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006
   Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017
   Bergsneider M, 2008, NEUROSURGERY, V62, P643, DOI [10.1227/01.NEU.0000296954.22901.C6, 10.1227/01.neu.0000316269.82467.f7]
   BERKER E, 1992, DEV MED CHILD NEUROL, V34, P623
   Castejon OJ, 2010, FOLIA NEUROPATHOL, V48, P159
   DENNIS M, 1987, J CLIN EXP NEUROPSYC, V9, P593, DOI 10.1080/01688638708410771
   Drake J.M., 2008, NEUROSURGERY S2, V62, P640
   Drake JM, 2008, NEUROSURGERY, V62, P633, DOI [10.1227/01.NEU.0000296952.38148.49, 10.1227/01.neu.0000316268.05338.5b]
   Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08
   Feuillet L, 2007, LANCET, V370, P262, DOI 10.1016/S0140-6736(07)61127-1
   Friston KJ, 2003, TRENDS COGN SCI, V7, P151, DOI 10.1016/S1364-6613(03)00054-8
   Ishikawa M, 2008, NEUROL MED-CHIR, V48, pS1, DOI 10.2176/nmc.48.S1
   Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64
   KAYE JA, 1990, ARCH NEUROL-CHICAGO, V47, P1336, DOI 10.1001/archneur.1990.00530120082014
   Kondziella D, 2008, J NEUROCHEM, V106, P1515, DOI 10.1111/j.1471-4159.2008.05422.x
   Ladika DJ, 2011, JAAPA-J AM ACAD PHYS, V24, P57
   Ladika Douglas J, 2011, JAAPA, V24, P28
   LEWIN R, 1980, SCIENCE, V210, P1232, DOI 10.1126/science.7434023
   McGirt MJ, 2008, NEUROSURGERY, V62, P670, DOI [10.1227/01.neu.0000316271.90090.b9, 10.1227/01.NEU.0000175724.00147.10]
   Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062
   Miller Janet M, 2007, Cerebrospinal Fluid Res, V4, P5, DOI 10.1186/1743-8454-4-5
   Missori P, 2010, BRAIN, V133, P1836, DOI 10.1093/brain/awq014
   Nakayama T, 2007, J NUCL MED, V48, P1981, DOI 10.2967/jnumed.107.045310
   Noppeney U, 2004, J ANAT, V205, P433, DOI 10.1111/j.0021-8782.2004.00343.x
   Oliveira J. R. M., 2011, ISR SOC NEUR 19 ANN
   Penn RD, 2009, PEDIATR NEUROSURG, V45, P161, DOI 10.1159/000218198
   Price CJ, 2002, TRENDS COGN SCI, V6, P416, DOI 10.1016/S1364-6613(02)01976-9
   Rekate HL, 2009, SEMIN PEDIATR NEUROL, V16, P9, DOI 10.1016/j.spen.2009.01.002
   Simon TD, 2009, PEDIATRICS, V124, P1431, DOI 10.1542/peds.2008-3834
   Stopczynski RE, 2008, BRAIN STRUCT FUNCT, V213, P119, DOI 10.1007/s00429-008-0185-1
   Tsubokawa T, 1988, Brain Inj, V2, P19, DOI 10.3109/02699058809150929
   van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010
   Wojtowicz JM, 2012, BEHAV BRAIN RES, V227, P490, DOI 10.1016/j.bbr.2011.08.013
NR 33
TC 4
Z9 5
U1 2
U2 15
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1662-5161
J9 FRONT HUM NEUROSCI
JI Front. Hum. Neurosci.
PD JAN 6
PY 2012
VL 5
AR 181
DI 10.3389/fnhum.2011.00181
PG 4
WC Neurosciences; Psychology
SC Neurosciences & Neurology; Psychology
GA 882KT
UT WOS:000299563200001
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Yadav, VR
   Prasad, S
   Gupta, SC
   Sung, B
   Phatak, SS
   Zhang, SX
   Aggarwal, BB
AF Yadav, Vivek R.
   Prasad, Sahdeo
   Gupta, Subash C.
   Sung, Bokyung
   Phatak, Sharangdhar S.
   Zhang, Shuxing
   Aggarwal, Bharat B.
TI RETRACTED: 3-Formylchromone Interacts with Cysteine 38 in p65 Protein
   and with Cysteine 179 in I kappa B alpha Kinase, Leading to
   Down-regulation of Nuclear Factor-kappa B (NF-kappa B)-regulated Gene
   Products and Sensitization of Tumor Cells (Retracted article. See vol.
   291, pg. 16926, 2016)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID CHEMOTHERAPEUTIC-AGENTS; ACCURATE DOCKING; TYROSINE KINASE;
   BETA-DIKETONES; ACTIVATION; INHIBITION; EXPRESSION; PROLIFERATION;
   DERIVATIVES; PHOSPHORYLATION
AB 3-Formylchromone (3-FC) has been associated with anticancer potential through a mechanism yet to be elucidated. Because of the critical role of NF-kappa B in tumorigenesis, we investigated the effect of this agent on the NF-kappa B activation pathway. Whether activated by inflammatory agents (such as TNF-alpha and endotoxin) or tumor promoters (such as phorbol ester and okadaic acid), 3-FC suppressed NF-kappa B activation. It also inhibited constitutive NF-kappa B expressed by most tumor cells. This activity correlated with sequential inhibition of I kappa B alpha kinase (IKK) activation, I kappa B alpha phosphorylation, I kappa B alpha degradation, p65 phosphorylation, p65 nuclear translocation, and reporter gene expression. We found that 3-FC inhibited the direct binding of p65 to DNA, and this binding was reversed by a reducing agent, thus suggesting a role for the cysteine residue. Furthermore, mutation of Cys(38) to Ser in p65 abolished this effect of the chromone. This result was confirmed by a docking study. 3-FC also inhibited IKK activation directly, and the reducing agent reversed this inhibition. Furthermore, mutation of Cys(179) to Ala in IKK abolished the effect of the chromone. Suppression of NF-kappa B activation led to inhibition of anti-apoptotic (Bcl-2, Bcl-x(L), survivin, and cIAP-1), proliferative (cyclinD(1) and COX-2), invasive (MMP-9 and ICAM-1), and angiogenic (VEGF) gene products and sensitization of tumor cells to cytokines. Thus, this study shows that modification of cysteine residues in IKK and p65 by 3-FC leads to inhibition of the NF-kappa B activation pathway, suppression of anti-apoptotic gene products, and potentiation of apoptosis in tumor cells.
C1 [Yadav, Vivek R.; Prasad, Sahdeo; Gupta, Subash C.; Sung, Bokyung; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA.
   [Phatak, Sharangdhar S.; Zhang, Shuxing] Univ Texas MD Anderson Canc Ctr, Integrated Mol Discovery Lab, Dept Expt Therapeut, Houston, TX 77030 USA.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Zhang, Shuxing/F-9942-2014; Aggarwal, Bharat/G-3388-2013
FU National Institutes of Health [CA-16672, CA-124787-01A2]; Center for
   Targeted Therapy of The University of Texas MD Anderson Cancer Center;
   American Cancer Society [IRG-08-061-01]; University of Texas School of
   Public Health [RP101503]
FX This work was supported, in whole or in part, by National Institutes of
   Health Core Grant CA-16672 and Program Project Grant CA-124787-01A2 (to
   B. B. A.). This work was also supported by grants from the Center for
   Targeted Therapy of The University of Texas MD Anderson Cancer Center
   (to B. B. A. and to S. Z.), American Cancer Society Grant IRG-08-061-01
   (to S. Z.), and University of Texas Health Innovation for Cancer
   Prevention Research Predoctoral Fellowship RP101503 from The University
   of Texas School of Public Health (to S. S. P.).
CR Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003
   Barath Z, 2006, IN VIVO, V20, P645
   Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200
   Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566
   CHATURVEDI MM, 1994, LYMPHOKINE CYTOK RES, V13, P309
   Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724
   Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010
   ELLIS GP, 1978, J MED CHEM, V21, P1120, DOI 10.1021/jm00209a006
   FALTYNEK CR, 1995, J ENZYM INHIB, V9, P111, DOI 10.3109/14756369509042811
   FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200
   Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1
   Gupta SC, 2011, MOL PHARMACOL, V80, P769, DOI 10.1124/mol.111.073122
   Gupta SC, 2010, J BIOL CHEM, V285, P35406, DOI 10.1074/jbc.M110.161984
   Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004
   Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s
   Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8
   Ishihara M, 2005, IN VIVO, V19, P119
   Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200
   Kawase M, 2007, IN VIVO, V21, P829
   Khan KM, 2010, EUR J MED CHEM, V45, P4058, DOI 10.1016/j.ejmech.2010.05.065
   Khan KM, 2009, BIOORGAN MED CHEM, V17, P2983, DOI 10.1016/j.bmc.2009.03.020
   Liang MC, 2006, BIOCHEM PHARMACOL, V71, P634, DOI 10.1016/j.bcp.2005.11.013
   Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086
   Nakano K, 2004, ANTICANCER RES, V24, P711
   Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090
   Nawrot-Modranka J, 2006, EUR J MED CHEM, V41, P1301, DOI 10.1016/j.ejmech.2006.06.004
   Pandey MK, 2007, J BIOL CHEM, V282, P17340, DOI 10.1074/jbc.C700890200
   Prasad S, 2010, J BIOL CHEM, V285, P26987, DOI 10.1074/jbc.M110.121061
   Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2
   Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101
   Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520
   Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353
   Sersen F, 2008, MED CHEM, V4, P355, DOI 10.2174/157340608784872262
   Shim YS, 2003, BIOORG MED CHEM LETT, V13, P2561, DOI 10.1016/S0960-894X(03)00479-7
   Simeonidis S, 1999, P NATL ACAD SCI USA, V96, P49, DOI 10.1073/pnas.96.1.49
   Sung B, 2007, MOL PHARMACOL, V71, P1703, DOI 10.1124/mol.107.034512
   Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200
   Vos TA, 1999, HEPATOLOGY, V29, P421, DOI 10.1002/hep.510290231
   Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315
NR 42
TC 20
Z9 21
U1 2
U2 8
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 2
PY 2012
VL 287
IS 1
BP 245
EP 256
DI 10.1074/jbc.M111.274613
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 870PW
UT WOS:000298682400025
PM 22065587
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Longo, UG
   Loppini, M
   Forriol, F
   Romeo, G
   Maffulli, N
   Denaro, V
AF Longo, Umile Giuseppe
   Loppini, Mattia
   Forriol, Francisco
   Romeo, Giovanni
   Maffulli, Nicola
   Denaro, Vincenzo
TI RETRACTED: Advances in Meniscal Tissue Engineering(Retracted article.
   See vol. 35, pg. 5576, 2016)
SO STEM CELLS INTERNATIONAL
LA English
DT Review; Retracted Publication
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTOR TREATMENT; COLLAGEN-GAG MATRICES;
   PLATELET-RICH PLASMA; SMOOTH-MUSCLE ACTIN; KNEE-JOINT MENISCUS; HUMAN
   BONE-MARROW; IN-VITRO; GENE-THERAPY; ARTICULAR-CARTILAGE
AB Meniscal tears are the most common knee injuries and have a poor ability of healing. In the last few decades, several techniques have been increasingly used to optimize meniscal healing. Current research efforts of tissue engineering try to combine cell-based therapy, growth factors, gene therapy, and reabsorbable scaffolds to promote healing of meniscal defects. Preliminary studies did not allow to draw definitive conclusions on the use of these techniques for routine management of meniscal lesions. We performed a review of the available literature on current techniques of tissue engineering for the management of meniscal tears.
C1 [Longo, Umile Giuseppe; Loppini, Mattia; Romeo, Giovanni; Denaro, Vincenzo] Campus Biomed Univ Rome, Dept Orthopaed & Trauma Surg, I-00128 Rome, Italy.
   [Longo, Umile Giuseppe; Loppini, Mattia; Romeo, Giovanni; Denaro, Vincenzo] Univ Campus Biomed Roma, CIR, I-00128 Rome, Italy.
   [Forriol, Francisco] Univ CEU San Pablo, Madrid 28003, Spain.
   [Maffulli, Nicola] Mile End Hosp, Barts & London Sch Med & Dent, Ctr Sports & Exercise Med, London E1 4DG, England.
RP Longo, UG (reprint author), Campus Biomed Univ Rome, Dept Orthopaed & Trauma Surg, Via Alvaro Portillo 200, I-00128 Rome, Italy.
EM g.longo@unicampus.it
RI Denaro, Vincenzo/K-9567-2016; Longo, Umile Giuseppe/K-9147-2016;
   Loppini, Mattia/J-5620-2018
OI Denaro, Vincenzo/0000-0003-4739-9795; Longo, Umile
   Giuseppe/0000-0003-4063-9821; Loppini, Mattia/0000-0001-8569-0669;
   Forriol, Francisco/0000-0002-4307-2237; Romeo,
   Giovanni/0000-0002-3444-5142
CR Adams Samuel B Jr, 2005, J Knee Surg, V18, P25
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ARNOCZKY SP, 1983, AM J SPORT MED, V11, P131, DOI 10.1177/036354658301100305
   Arnoczky SP, 1999, CLIN ORTHOP RELAT R, pS244
   Bell E, 1995, Tissue Eng, V1, P163, DOI 10.1089/ten.1995.1.163
   Buma P, 2004, BIOMATERIALS, V25, P1523, DOI 10.1016/S0142-9612(03)00499-X
   COLLIER S, 1995, OSTEOARTHR CARTILAGE, V3, P127, DOI 10.1016/S1063-4584(05)80045-7
   Cook JL, 2005, CLIN ORTHOP RELAT R, P88, DOI 10.1097/01.blo.0000165735.49510.a9
   Cucchiarini M, 2009, GENE THER, V16, P1363, DOI 10.1038/gt.2009.91
   Deorosan B., 2011, STEM CELLS INT, V2011
   Elder BD, 2009, OSTEOARTHR CARTILAGE, V17, P114, DOI 10.1016/j.joca.2008.05.006
   Englund M, 2001, RHEUMATOLOGY, V40, P631, DOI 10.1093/rheumatology/40.6.631
   EVANS CH, 1995, J BONE JOINT SURG AM, V77A, P1103, DOI 10.2106/00004623-199507000-00021
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   Forriol F, 2009, INJURY, V40, P12
   Fox DB, 2010, RES VET SCI, V88, P326, DOI 10.1016/j.rvsc.2009.07.015
   Gavrilov S, 2011, STEM CELLS INT, V2011
   Gerich T G, 1996, Knee Surg Sports Traumatol Arthrosc, V4, P180, DOI 10.1007/BF01577414
   GHOSH P, 1987, CLIN ORTHOP RELAT R, P52
   Gimble J. M., 2010, STEM CELLS INT, V2010
   Goto H, 2000, OSTEOARTHR CARTILAGE, V8, P266, DOI 10.1053/joca.1999.0300
   Gunja NJ, 2010, J TISSUE ENG REGEN M, V4, P115, DOI 10.1002/term.221
   Hidaka C, 2002, TISSUE ENG, V8, P93, DOI 10.1089/107632702753503090
   Huey DJ, 2011, BIOMATERIALS, V32, P2052, DOI 10.1016/j.biomaterials.2010.11.041
   Im HJ, 2003, J BIOL CHEM, V278, P25386, DOI 10.1074/jbc.M302048200
   Ionescu LC, 2011, TISSUE ENG PT A, V17, P193, DOI [10.1089/ten.tea.2010.0272, 10.1089/ten.TEA.2010.0272]
   Ishida K, 2007, TISSUE ENG, V13, P1103, DOI 10.1089/ten.2006.0193
   Izuta Y, 2005, KNEE, V12, P217, DOI 10.1016/j.knee.2001.06.001
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Katkov I.I., 2011, STEM CELLS INT, V2011
   Kelly C., 2011, STEM CELLS INT, V2011
   Kimbrel E. A., 2011, STEM CELLS INT, V2011
   Klimkiewicz JJ, 2002, ARTHROSCOPY, V18, P14, DOI 10.1053/jars.2002.36505
   Klompmaker J, 1996, BIOMATERIALS, V17, P1685, DOI 10.1016/0142-9612(96)87648-4
   Longo UG, 2011, BRIT MED BULL, V98, P31, DOI 10.1093/bmb/ldq030
   Longo UG, 2010, BRIT MED BULL, V94, P165, DOI 10.1093/bmb/ldp051
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Mansilla E, 2011, STEM CELLS INT, V2011, DOI DOI 10.4061/2011/943216
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Messner K, 1998, J ANAT, V193, P161, DOI 10.1046/j.1469-7580.1998.19320161.x
   Minehara H, 2011, CELL TISSUE BANK, V12, P199, DOI 10.1007/s10561-010-9185-5
   Mitsuyasu RT, 2011, STEM CELLS INT, V2011
   Mueller SM, 1999, BIOMATERIALS, V20, P701, DOI 10.1016/S0142-9612(98)00189-6
   Mueller SM, 1999, J BIOMED MATER RES, V45, P157, DOI 10.1002/(SICI)1097-4636(19990605)45:3<157::AID-JBM1>3.0.CO;2-B
   Musgrave Douglas S, 2002, J Am Acad Orthop Surg, V10, P6
   Nakata K, 2001, CLIN ORTHOP RELAT R, pS208
   Narimatsu H., 2011, STEM CELLS INT, V2011
   Noth U, 2002, J ORTHOPAED RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9
   Ohishi M, 2010, J CELL BIOCHEM, V109, P277, DOI 10.1002/jcb.22399
   Oreffo ROC, 2005, STEM CELL REV, V1, P169, DOI 10.1385/SCR:1:2:169
   OZKAYNAK E, 1992, J BIOL CHEM, V267, P25220
   Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023
   Pangborn CA, 2005, TISSUE ENG, V11, P1141, DOI 10.1089/ten.2005.11.1141
   Peretti GM, 2004, AM J SPORT MED, V32, P146, DOI 10.1177/0095399703258790
   Petersen W, 2005, ANN ANAT, V187, P509, DOI 10.1016/j.aanat.2005.04.010
   Petropoulou A. D., 2011, STEM CELLS INT, V2011, DOI DOI 10.4061/2011/610514
   Port J, 1996, AM J SPORT MED, V24, P547, DOI 10.1177/036354659602400422
   Shintani N, 2007, ARTHRITIS RHEUM, V56, P1869, DOI 10.1002/art.22701
   Starke C, 2009, ARTHROSCOPY, V25, P1033, DOI 10.1016/j.arthro.2008.12.010
   Steinert AF, 2007, TISSUE ENG, V13, P2227, DOI 10.1089/ten.2006.0270
   Stewart K, 2007, TISSUE ENG, V13, P271, DOI 10.1089/ten.2006.0242
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   Sweigart MA, 2001, TISSUE ENG, V7, P111, DOI 10.1089/107632701300062697
   Szomor ZL, 2000, J BONE JOINT SURG AM, V82A, P80, DOI 10.2106/00004623-200001000-00010
   Tanaka T, 1999, KNEE SURG SPORT TR A, V7, P75, DOI 10.1007/s001670050125
   Tekkatte C, 2011, STEM CELLS INT, DOI 10.4061/2011/504723
   Teven C. M., 2011, STEM CELLS INT, V2011, DOI DOI 10.4061/2011;/201371
   Thorwarth M, 2006, BONE, V38, P30, DOI 10.1016/j.bone.2005.06.020
   Tumia NS, 2004, AM J SPORT MED, V32, P915, DOI 10.1177/0363546503261710
   van Tienen TG, 2009, CLIN SPORT MED, V28, P143, DOI 10.1016/j.csm.2008.08.003
   Verdonk PCM, 2005, OSTEOARTHR CARTILAGE, V13, P548, DOI 10.1016/j.joca.2005.01.010
   Vincent T, 2002, P NATL ACAD SCI USA, V99, P8259, DOI 10.1073/pnas.122033199
   Weinand C, 2006, ARCH ORTHOP TRAUM SU, V126, P599, DOI 10.1007/s00402-005-0100-7
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   Wyatt TJ, 2011, STEM CELLS INT, V2011
   Yamada Y, 2004, TISSUE ENG, V10, P955, DOI 10.1089/1076327041348284
   Zaleskas JM, 2001, EXP CELL RES, V270, P21, DOI 10.1006/excr.2001.5325
   Zellner J, 2010, J BIOMED MATER RES A, V94A, P1150, DOI 10.1002/jbm.a.32796
   ZHANG Z, 1988, Arthroscopy, V4, P151
NR 81
TC 1
Z9 1
U1 1
U2 9
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-966X
EI 1687-9678
J9 STEM CELLS INT
JI Stem Cells Int.
PY 2012
AR UNSP 420346
DI 10.1155/2012/420346
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA 209PU
UT WOS:000323772300001
PM 25098366
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT S
AU Sun, G
   Bai, ZG
   Yang, L
   Zhang, J
   Gong, FM
AF Sun, Gang
   Bai, Zhigang
   Yang, Lei
   Zhang, Jing
   Gong, Fanming
BE Wang, LH
   Xu, G
TI RETRACTED: Studies of the Numerical Simulation of Sediment Scour for
   Wind Power Station in Intertidal Zone (Retracted Article)
SO ADVANCES IN INDUSTRIAL AND CIVIL ENGINEERING, PTS 1-4
SE Advanced Materials Research
LA English
DT Proceedings Paper; Retracted Publication
CT Global Conference on Civil, Structural and Environmental Engineering /
   3rd International Symp on Multi-field Coupling Theory of Rock and Soil
   Media and its Applications
CY OCT 20-21, 2012
CL China Three Gorges Univ, Yichang, PEOPLES R CHINA
SP China Three Gorges Univ, Chinese Soc Rock Mech & Engn, Geoenvironmental Engn Branch, Chinese Soc Rock Mech & Engn, Ground Rock Engn Comm, Chinese Soc Mech, Fluid Mech Comm, Hubei Soc Rock Mech & Engn, Minist Educ, Key Lab Geol Hazards Three Gorges Reservoir Area, Hubei Three Gorges Reservoir Area Landslides Observat & Res Stn, SW Petr Univ, NE Petr Univ, Wuhan Polytechn Univ, Hubei Polytechn Univ, CnTech Co Ltd
HO China Three Gorges Univ
DE Wind power station in intertidal zone; Sediment model;
   Erosion-deposition model; Scour hole
ID SUSPENDED SEDIMENT; WAVES
AB Dafeng wind power station was chosen as the study area. 2D mathematical model of total sediment transport and erosion-deposition model were established by considering the joint action of wave and current. The models were verified by the measured data of the project. The verified model was applied to simulate the engineering problem. The transformation of flow field was calculated firstly, and then the erosion-deposition of engineering zone and the thickness of scour near foundation piles were simulated respectively in terms of the following three different conditions: normal condition, under the action of strong southeast wind and the action of uttermost east wave. The results of simulation can provide strong basis for the project.
C1 [Sun, Gang; Bai, Zhigang; Gong, Fanming] Tianjin Univ, State Key Lab Hydraul Engn Simulat & Safety, Tianjin 300072, Peoples R China.
   [Yang, Lei] CCCC Water Transportat Consultants Co Ltd, Beijing 100007, Peoples R China.
   [Zhang, Jing] Tianjin Univ, Sch Management & Econ, Tianjin 300072, Peoples R China.
RP Sun, G (reprint author), Tianjin Univ, State Key Lab Hydraul Engn Simulat & Safety, Tianjin 300072, Peoples R China.
EM sungang1988@yahoo.cn; zgbai_tju@163.com; lyang_tju@163.com;
   zjing@tju.edu.cn; gongfanming1203@126.com
CR Dou Guoren, 1995, SCI CHINA SER A, V25, P995
   FREDSOE J, 1985, J WATERW PORT C-ASCE, V111, P1041, DOI 10.1061/(ASCE)0733-950X(1985)111:6(1041)
   Huang Pengfei, 2009, MECH ELECT INFORM, V24, P96
   MCLEAN SR, 1992, J GEOPHYS RES-OCEANS, V97, P5759, DOI 10.1029/91JC02933
   NIELSEN P, 1986, COAST ENG, V10, P23, DOI 10.1016/0378-3839(86)90037-2
NR 5
TC 0
Z9 0
U1 2
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-536-2
J9 ADV MATER RES-SWITZ
PY 2012
VL 594-597
BP 130
EP +
DI 10.4028/www.scientific.net/AMR.594-597.130
PG 2
WC Engineering, Environmental; Engineering, Civil
SC Engineering
GA BFB34
UT WOS:000319084400026
DA 2018-12-27
ER

PT S
AU Sun, G
   Yu, JX
   Yang, Y
   Bian, XH
   Li, ZB
AF Sun, Gang
   Yu, Jianxing
   Yang, Yuan
   Bian, Xuehang
   Li, Zhibo
BE Wang, LH
   Xu, G
TI RETRACTED: Studies of the Buckling Propagation of Deep-sea Pipeline with
   Local Defect (Retracted Article)
SO ADVANCES IN INDUSTRIAL AND CIVIL ENGINEERING, PTS 1-4
SE Advanced Materials Research
LA English
DT Proceedings Paper; Retracted Publication
CT Global Conference on Civil, Structural and Environmental Engineering /
   3rd International Symp on Multi-field Coupling Theory of Rock and Soil
   Media and its Applications
CY OCT 20-21, 2012
CL China Three Gorges Univ, Yichang, PEOPLES R CHINA
SP China Three Gorges Univ, Chinese Soc Rock Mech & Engn, Geoenvironmental Engn Branch, Chinese Soc Rock Mech & Engn, Ground Rock Engn Comm, Chinese Soc Mech, Fluid Mech Comm, Hubei Soc Rock Mech & Engn, Minist Educ, Key Lab Geol Hazards Three Gorges Reservoir Area, Hubei Three Gorges Reservoir Area Landslides Observat & Res Stn, SW Petr Univ, NE Petr Univ, Wuhan Polytechn Univ, Hubei Polytechn Univ, CnTech Co Ltd
HO China Three Gorges Univ
DE Buckling propagation; Ring model; ABAQUS; Full-scale test
ID PRESSURE
AB During the period of pipe laying, buckling instability often occurs because of local defect which is caused by initial ovality or collision. With initial defect such as local ovality, local buckling will propagate along the pipe's axial direction rapidly under the external hydrostatic pressure. Theoretical model was established firstly, building 2D discrete ring model and mechanical model of collapse of deep-sea pipeline. The relationship of collapse process of pipeline cross-section and buckling propagation pressure was obtained from the analysis. Furthermore, buckling propagation process was simulated by the finite element software-ABAQUS. Finally, deep-sea pipeline buckling propagation experiment was conducted based on Deep-water Structure Laboratory of Tianjin University. The results of theoretical analysis, numerical simulation and experiment are relatively consistent which can provide reliable foundation for buckling propagation study.
C1 [Sun, Gang; Yu, Jianxing; Yang, Yuan; Bian, Xuehang; Li, Zhibo] Tianjin Univ, State Key Lab Hydraul Engn Simulat & Safety, Tianjin 300072, Peoples R China.
RP Sun, G (reprint author), Tianjin Univ, State Key Lab Hydraul Engn Simulat & Safety, Tianjin 300072, Peoples R China.
EM sungang1988@yahoo.cn; yjxtju@126.com; bensonyang@yeah.net;
   tjltbxh@163.com; 13752557780@163.com
CR Croll J. G. A., 1985, CONSTRUCT STEEL RES, V5, P103
   DYAU JY, 1993, INT J SOLIDS STRUCT, V30, P463, DOI 10.1016/0020-7683(93)90181-6
   KYRIAKIDES S, 1981, J PRESS VESS-T ASME, V103, P328, DOI 10.1115/1.3263410
   Ma Chengti, 1994, CHINA OFFSHORE OIL G, V6, P2
   Malo KA, 2001, INT J MECH SCI, V43, P1209, DOI 10.1016/S0020-7403(00)00061-8
NR 5
TC 0
Z9 0
U1 1
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-536-2
J9 ADV MATER RES-SWITZ
PY 2012
VL 594-597
BP 2701
EP 2705
DI 10.4028/www.scientific.net/AMR.594-597.2701
PG 5
WC Engineering, Environmental; Engineering, Civil
SC Engineering
GA BFB34
UT WOS:000319084401221
DA 2018-12-27
ER

PT B
AU Sequeira, S
AF Sequeira, S.
BE Chova, LG
   Martinez, AL
   Torres, IC
TI RETRACTED: NEW APPROACH IN EDUCATION - PROJECT "DESAFIARTE" (Retracted
   Article)
SO 5TH INTERNATIONAL CONFERENCE OF EDUCATION, RESEARCH AND INNOVATION
   (ICERI 2012)
LA English
DT Proceedings Paper; Retracted Publication
CT 5th International Conference of Education, Research and Innovation
   (ICERI)
CY NOV 19-21, 2012
CL Madrid, SPAIN
DE Education; software; mobile; learning; technology; school book
AB Nowadays, technological tools are an essential methodological component to any educational level due to its multi tasks.
   Having in mind the evolution of technology inside classrooms and the proximity that is increasing between young students and technology environment, it is clear the need to build tools that promote learning, appealing to new technology. This paper (highlights not only the development of the multiplatform but also the development of the mobile application).
   From the assumptions above, appeared the project "DesafiArte", that aims the development of support material in order to recreate diverse learning situations which include direct contact with knowledge, by using also new technologies of information and communication. It's important to underline that this project doesn't want to displace books and others material of registration, training and learning ... We advocated that the two approaches together can, assuredly, help students to achieve success ... And doing it, having fun.
   It is a project built to develop primary school students' skill, doing evaluation of the knowledge acquired, in a playful way, and also seems like a site that collects and provides students with the necessary information for the school subjects. The principal goal is to address and explore the syllabus of the primary school recommended by the Portuguese Ministry of Education. These matters are adjusted to the daily lives of children. It is also an objective of this project that students be aware of the importance of not only of matters of school subjects but also can learn from different knowledge of the daily life, for understanding be significant.
   The project was thought and designed to all kinds of shapes and devices. It is possible use the "DesafiArte" on paper, using like a school book, and it is also possible to run in desktops, laptops, netbooks, smart phones and tablets, always with the same fluidity and equivalent functionality.
   All interactions user/machine was carefully studied to conceive an intuitive and appealing layout to children in this age group. It optimizes both conventional use (keyboard/mouse) and touch screens available in the classrooms, for instance, interactive board. The interactive board was the first target of development.
   In fact, the main objectives of this project is not only to include all the students in the learning process but also to create a mentality that esteem the effort and respect the students' learning rate.
   The fast development of the technologies of information and communication become possible the creation of diverse virtual environments. Meanwhile, at the moment, one of the biggest challenges is related to the growth of new educational methodologies that favour the cognitive and social development of individuals. It is an objective to create collective and collaborative knowledge.
   It is our will to make a strong contribution to the training of citizens, make them become more participatory, critical, confident and self-contained. Due to the use of the project it is expected a great impact of paradigmatic nature in the school area.
C1 [Sequeira, S.] Univ Aveiro Edubox, Aveiro, Portugal.
EM sandrasequeira@ua.pt
NR 0
TC 0
Z9 0
U1 1
U2 7
PU IATED-INT ASSOC TECHNOLOGY EDUCATION & DEVELOPMENT
PI VALENICA
PA LAURI VOLPI 6, VALENICA, BURJASSOT 46100, SPAIN
BN 978-84-616-0763-1
PY 2012
BP 1887
EP 1887
PG 1
WC Education & Educational Research
SC Education & Educational Research
GA BEW64
UT WOS:000318422201131
DA 2018-12-27
ER

PT B
AU Rios, YD
AF Del Aguila Rios, Y.
BE Chova, LG
   Martinez, AL
   Torres, IC
TI RETRACTED: RESEARCH PROJECT "CYBER TEACHING PRACTICE AND STUDENTS'
   ACADEMIC PLAGIARISM OF COMPULSORY SECONDARY EDUCATION IN WESTERN OF
   ANDALUSIA: A QUALITATIVE APPROACH" (Retracted Article)
SO 5TH INTERNATIONAL CONFERENCE OF EDUCATION, RESEARCH AND INNOVATION
   (ICERI 2012)
LA English
DT Proceedings Paper; Retracted Publication
CT 5th International Conference of Education, Research and Innovation
   (ICERI)
CY NOV 19-21, 2012
CL Madrid, SPAIN
DE Teaching practice; Web 2.0; Academic plagiarism
AB The main objective of this work is:
   a) Analyze and understand the relationship between teaching practice and plagiarism and cyber-plagiarism of students of Secondary Education (ESO) in Western Andalusia (Cadiz, Huelva and Sevilla): A qualitative approach.
   Academic plagiarism among students of secondary school, involving researchers from the University of Cadiz (UCA) and the University of the Balearic Islands (UIB) have been taken for studying the relationship between teaching practice and plagiarism and cyber-plagiarism.
   The general objective is specified into the specific objetives:
   a.1.) To investigate and describe teaching strategies that guide practice of teaching.
   a.2.) To identify teaching strategies that promote the practice of plagiarism and cyber plagiarism between high school students.
   a.3.) To analyze approaches that are used on secondary education.
   a.4.) To know the teacher beliefs about plagiarism and cyber-plagiarism.
   a.5.) To Understand and analyze new places and forms of learning that are appearing around ICT and its impact on the cyber-plagiarism.
   a.6.) To know mechanisms used by teachers to detect plagiarism and cyber-plagiarism. Educational and technological means are implemented to detect it.
   a.7.) To analyze control mechanisms used in schools against plagiarism and cyber-plagiarism.
   In conclusion, researches and studies on plagiarism and cyber-plagiarism are focused on students as user of this practice. However, there are some references found about factors of plagiarism and cyber-plagiarism. Since this practice has been described in many ways, teaching and learning practice could be the key. This work is interested in know what happens in this dimension, how does teaching practice affects to plagiarism and cyber-plagiarism?
   "younger generation, from the earliest ages, learn to live in a world where access to information and culture takes place in a very different ways ... It must be recognized that in this sence, the information has better quality, current, relevant, attractive and better explained than in schools" (Torres, 2006:119).
C1 [Del Aguila Rios, Y.] Univ Cadiz, Cadiz, Spain.
EM yessica.delaguila@uca.es
NR 0
TC 0
Z9 0
U1 2
U2 10
PU IATED-INT ASSOC TECHNOLOGY EDUCATION & DEVELOPMENT
PI VALENICA
PA LAURI VOLPI 6, VALENICA, BURJASSOT 46100, SPAIN
BN 978-84-616-0763-1
PY 2012
BP 2943
EP 2943
PG 1
WC Education & Educational Research
SC Education & Educational Research
GA BEW64
UT WOS:000318422202152
DA 2018-12-27
ER

PT B
AU Al-Hinaai, SNS
AF Al-Hinaai, Samiya Nasser Said
BE Chova, LG
   Martinez, AL
   Torres, IC
TI RETRACTED: WHAT IS THE IMPORTANCE AND IMPACT OF ILLUSTRATIONS IN
   CHILDREN'S BOOKS? AN INVESTIGATION INTO CHILDREN'S RESPONSES TO
   ILLUSTRATIONS (Retracted Article)
SO 5TH INTERNATIONAL CONFERENCE OF EDUCATION, RESEARCH AND INNOVATION
   (ICERI 2012)
LA English
DT Proceedings Paper; Retracted Publication
CT 5th International Conference of Education, Research and Innovation
   (ICERI)
CY NOV 19-21, 2012
CL Madrid, SPAIN
DE Illustrations; picture books; children's books; analyze pictures; impact
   of illustrations; investigation in illustrations
AB This paper sought to investigate the importance of illustrations in children's books and children's responses to them. The project raises some key issues related to children's books and illustrations, such as the importance of pictures for children, the impact of illustrations on children, and factors to analyze pictures. Based on responses of a group focus discussion and individual discussions with six 9-year-old students (3males and 3 females), this paper explores the role of illustrations in children's world. It also investigates their analyses and responses to pictures. In addition, it examines the situations of children's books and illustrations in Oman. The results show that illustrations play a vital role in children's books. Most children prefer colorful pictures than black and white. The study finds that pictures help children comprehend the text better. Specialists believe that there is limited number of Omani children's books, but the awareness of the importance of illustrations has increased among Omanis. This study suggests having a center of collections of illustrated Omani folktales and fairytales. This center will help to save Omani culture and heritage in a way that most children like.
C1 [Al-Hinaai, Samiya Nasser Said] Middle East Coll, Muscat, Oman.
EM salhinaai@mec.edu.om
CR Cleaver B. P., 1993, CHILDRENS RESPONSE S
   Dodge T, 2003, BRIEF SURVEY STRUCTU
   Hall S., 1990, USING PICTURE STORYB
   Marshall M R., 1988, INTRO WORLD CHILDREN
   Paris A. H., 2001, CHILDRENS COMPREHENS
   Schwarcz J., 1982, WAYS ILLUSTRATOR
   Segun M., 1988, IMPORTANCE ILLUSTRAT
   Stewig J., 1972, CHILDRENS PREFERENCE
NR 8
TC 0
Z9 0
U1 1
U2 4
PU IATED-INT ASSOC TECHNOLOGY EDUCATION & DEVELOPMENT
PI VALENICA
PA LAURI VOLPI 6, VALENICA, BURJASSOT 46100, SPAIN
BN 978-84-616-0763-1
PY 2012
BP 3949
EP 3954
PG 6
WC Education & Educational Research
SC Education & Educational Research
GA BEW64
UT WOS:000318422203149
DA 2018-12-27
ER

PT B
AU Abdulkareem, Y
   Adediran, AA
AF Abdulkareem, Yunusa
   Adediran, Amos Adekunle
BE Chova, LG
   Martinez, AL
   Torres, IC
TI RETRACTED: QUALITY ASSURANCE OF TEACHERS IN THE ASSESSMENT OF SOCIAL
   STUDIES CURRICULUM OF SECONDARY SCHOOLS IN ABEOKUTA METROPOLIS IN OGUN
   STATE, NIGERIA (Retracted Article)
SO 5TH INTERNATIONAL CONFERENCE OF EDUCATION, RESEARCH AND INNOVATION
   (ICERI 2012)
LA English
DT Proceedings Paper; Retracted Publication
CT 5th International Conference of Education, Research and Innovation
   (ICERI)
CY NOV 19-21, 2012
CL Madrid, SPAIN
DE Assurance; Assessment; Quality; Curriculum; Metropolis
AB Assessment is a technique or method used to make a student understand the current knowledge that student possesses. Assessment helps and shapes students' disposition towards learning and influence their motivations to learn. "Assessment provides cogent information on social studies curriculum for students learning ability of easy accountability, internal programme, decision-making" monitoring students' progress and helping them to structure their learning. Quality assurance of teacher will make the teachers to be in front line to lead the education reform by taking advantage of the power of assessment to improve standard, by employing quality assessment methods in their classroom practice. The essential keys to improve academic standards in schools lies in the teacher's ability to provide an accountability oriented assessment. That is, teachers to become high-quality-assessment literate person who are able to tap the true benefit of assessment to maximize students achievement and confidently provide authentic evidence of students achievement profiles for public accountability. The study was therefore carried out to ensure the quality assurance of teachers in the assessment of the Social Studies curriculum in Secondary Schools in Abeokuta Metropolis of Ogun State, Nigeria. Two research questions were formulated and answered in this study. Survey research and evaluation designs were involved. The sample for the study was 57. A 20 cluster item questionnaires and 35 multiple choice test items were developed and used to collect data. The data collected were analyzed using percentages, means and performance gap analysis to answer the research question. Conclusively, the importance of assessment of secondary school social studies curriculum can not be over emphasized because it is a well established fact that the status and kind of assessment used in appraising phenomenon for reaching implication not only for students' achievements, but also for the nature of school procedure in an institution. Based on the result of the study, it was recommended among other things that, teachers should be sponsored by the government to attend seminars, workshops and conferences to update themselves in order to improve the quality of their teaching skills.
EM speaktoa3@yahoo.com; speaktoa3@gmail.com
CR Adediran A. A., 2007, THESIS OLABISI ONABA
   Iyang-Abia M. E., 2004, SOCIAL STUDIES TECHN
   Kochhar S. K., 1988, TEACHING SOCIAL STUD
   Muodumogu C. A., 2003, JOS ED FORUM J DEP A
   National Policy on Education, 2004, P39 40
   Obemeata J. O., 1981, ACE SERIES
   Orakwe I. T. C., 2000, SOCIAL STUDIES ED BA
   Wronski S. P., 1975, SOCIAL STUDIES MANIF
NR 8
TC 0
Z9 0
U1 1
U2 1
PU IATED-INT ASSOC TECHNOLOGY EDUCATION & DEVELOPMENT
PI VALENICA
PA LAURI VOLPI 6, VALENICA, BURJASSOT 46100, SPAIN
BN 978-84-616-0763-1
PY 2012
BP 4579
EP 4584
PG 6
WC Education & Educational Research
SC Education & Educational Research
GA BEW64
UT WOS:000318422204084
DA 2018-12-27
ER

PT B
AU Bhatnagar, A
   Yadav, A
AF Bhatnagar, Aahana
   Yadav, Anubhuti
BE Chova, LG
   Martinez, AL
   Torres, IC
TI RETRACTED: MEDIA STUDIES IN SCHOOL CURRICULUM: OBSTACLES, CHALLENGES AND
   POSSIBILITIES (Retracted Article)
SO 5TH INTERNATIONAL CONFERENCE OF EDUCATION, RESEARCH AND INNOVATION
   (ICERI 2012)
LA English
DT Proceedings Paper; Retracted Publication
CT 5th International Conference of Education, Research and Innovation
   (ICERI)
CY NOV 19-21, 2012
CL Madrid, SPAIN
AB Media studies as subject has entered the boundaries of schools little late but at last. Disregarding media from the school curriculum has always bothered many experts who are working in the field of media studies. Many initiatives were started to introduce children, parents and teachers to the concepts of media studies but all happened out of schools. One of the key point made by the NCF 2005 i.e. connecting knowledge to the life outside the school, has actually opened the door for media studies, a subject which has never in the past was given its due importance in school curriculum. It was realized that students' media experiences are as important as their experience with their parents, peers and teachers and by allowing them to bring their media experiences in classroom, a creative environment can be created where they could get a chance to discuss issues which are very integral to their life. Media is a very important part of students' lives. They spend great deal of time watching TV, listening to Radio, surfing net, reading magazines and newspapers and also take pride in owning a sophisticated toy called mobile phone which gives them an opportunity to do all these activities when they are on move. These medium bombard them with images, words and sound. These media messages are designed to win their heart and rule their mind. Students are also learning a lot from media. Mass media teach whether or not media makers intend to do so and students learn from it whether they are aware of it or not. Students are learning so much intentionally or unintentionally that it can be termed as omnipresent non school textbook. In fact children learn in variety of ways through experience, making and doing things, experimentation, reading discussion asking listening, thinking and reflecting and expressing themselves in speech writing and in movement. They require opportunities of all these kind in the course of their development. The sources through which they learn are innumerable, it is necessary for the educators to explore and understand all those sources through which children learn. Media is one of them. Yes, it is a non formal textbook or we can say another school away from school. But what role does these non formal textbook have in school. Can schools afford to ignore these textbooks which are very important part of their lives? This raises unavoidable challenges for schools and teachers. Can school teachers join hand with informal teachers and teach. As part of their mission to help young people to become better informed and analytical thinkers educators should seriously consider media studies as essential part of school system.
   This paper focuses on why media should be a part of school curriculum, how it can be introduced, the present scenario, challenges it can face and some strategies to overcome those challenges.
C1 [Bhatnagar, Aahana; Yadav, Anubhuti] Guru Gobind Singh Indraprastha Univ, Mahubala Inst Elect Media, New Delhi, India.
EM aahana.bhatnagar@gmail.com
CR AGGARWAL BINOD C, 1999, CHILDRENS TELEVISION
   BERRY GL, 1993, CHILDREN TELEVISION
   Brown J., 1991, TELEVISION CRITICAL
   FIROZ MD, 2005, TELEVISION INDIA VAL
   Hobbs R, 1998, J COMMUN, V48, P9
   Perse E. M., 2001, MEDIA EFFECTS SOC
   Potter W. James, 2005, MEDIA LITERACY
   SCHWARZ GRETCHEN, 2005, MEDIA LIT TRANSFORMI
   SINGLETON-TUNER ROGER, 1994, TELEVISION CHILDREN
   TUCKER RICHARD N., 1986, INTEGRATION MEDIA CU
NR 10
TC 0
Z9 0
U1 1
U2 2
PU IATED-INT ASSOC TECHNOLOGY EDUCATION & DEVELOPMENT
PI VALENICA
PA LAURI VOLPI 6, VALENICA, BURJASSOT 46100, SPAIN
BN 978-84-616-0763-1
PY 2012
BP 5255
EP 5259
PG 5
WC Education & Educational Research
SC Education & Educational Research
GA BEW64
UT WOS:000318422205039
DA 2018-12-27
ER

PT B
AU O'Sullivan, J
AF O'Sullivan, Jill
BE Chova, LG
   Martinez, AL
   Torres, IC
TI RETRACTED: VALIDATING ACADEMIC TRAINING VERSUS ORGANIZATIONAL TRAINING:
   AN ANALYSIS IN THE ENTERPRISE RESOURCE PLANNING (ERP) FIELD (Retracted
   Article)
SO 5TH INTERNATIONAL CONFERENCE OF EDUCATION, RESEARCH AND INNOVATION
   (ICERI 2012)
LA English
DT Proceedings Paper; Retracted Publication
CT 5th International Conference of Education, Research and Innovation
   (ICERI)
CY NOV 19-21, 2012
CL Madrid, SPAIN
ID INFORMATION-SYSTEMS; KNOWLEDGE; IMPLEMENTATION; PROGRAMS
AB Enterprise Resource Planning (ERP) systems are packaged software applications that support most of an organization's informational needs within and across functional areas of the organization. Modern ERP systems serve as the foundation for a wide range of e-business models within one company, as well as throughout the value chain. ERP programs are core software used by companies to coordinate information in every area of business. This is important because ERP helps manage companywide business processes through the utilization of a common database and shared management reporting tools.
   This study explored industry ERP training of employees new to ERP, and compared this latter group to college students prepared with ERP skills from a college ERP class.
   University and industry collaborations allow for a hands-on experience in the classroom that replicates industry applications by using real world tools. This synergistic relationship provides opportunities for students to acquire knowledge using a tangible tool that imitates what is utilized in the industry. The study also noted that schools supported by several ERP vendor initiatives are increasingly integrating enterprise systems in their curricula.
   The implications of these findings are extremely beneficial in the advancement of ERP education at the college level. The revolutionary nature of this study provides decisive details that are necessary for the advancement of this field. The resultant data identifies pertinent information that businesses consider valuable in their employees' ERP training. This noteworthy correlation, between college prepared students and employees new to ERP who have gone through ERP training, examined case studies of students who are now in the workforce. This study also exposes these students' distinct advantage because of their ERP learning experience, and compares it to companies' ERP training practices. The intent, as in any educational environment, is not only to help students attain an understanding of the material, but to also master that material in the environment in which they will be required to use it.
C1 [O'Sullivan, Jill] Farmingdale State Coll, Sch Business, Farmingdale, NY USA.
EM osullija@farmingdale.edu
CR Aberdeen Group, MEAS BUS BEN TIM VAL
   Aberdeen Group, SAAS ERP TRENDS OBS
   Aberdeen Group, 2010, ERP COMPL MAN
   [Anonymous], 2008, POLICY REPORT
   [Anonymous], 2010, MANUFACTRURING EXECU
   [Anonymous], 2010, PM100 WINNERS
   [Anonymous], 2010, TRENDS OBSERVATIONS
   Antonucci Y. L., 2009, ASSESSING YOUR SAP P
   Antonucci Yvonne, 2000, DEV INT BUSINESS BUS
   APICS, 2008, APICS DICT
   Becerra-Fernandez I, 2000, COMMUN ACM, V43, P39, DOI 10.1145/332051.332066
   Bingi P, 1999, INFORM SYST MANAGE, V16, P7, DOI 10.1201/1078/43197.16.3.19990601/31310.2
   Blackstone John H., 2010, APICS DICT
   Bonwell Charles C., 1991, ERIC LCCN, V0000
   Boyle TA, 2007, J EDUC BUS, V82, P267, DOI 10.3200/JOEB.82.5.267-275
   Bradford M., 2003, COMMUNICATIONS ASS I, V12, P437
   Cameron Kim S., DIAGNOSING CHANGING
   Cannon D. M., 2004, J ED BUSINESS, V80, P93, DOI DOI 10.3200/J0EB.80.2.93-101
   CHICKERING AW, 1989, BIOCHEM EDUC, V17, P140, DOI 10.1016/0307-4412(89)90094-0
   Cronan T. P., 2009, ITRIWP1221008 ERP U
   Cronan T.P., 2009, INFORM TECHNOLOGY RE
   Davenport T., 2000, MISSION CRITICAL REA
   Davenport TH, 1998, HARVARD BUS REV, V76, P121
   Davenport TH, 2001, CALIF MANAGE REV, V43, P117, DOI 10.2307/41166078
   Davis C. H., 2004, J INFORM SYSTEMS ED
   Eckartz S, 2009, CONCEPTUAL FRAMEWORK
   Eckartz Silja, 2009, CROSS ORG ERP MANAGE, P1599
   Esteves Jose, 2001, COMMUNICATIONS AIS, V7
   Fedorowitz J., 2004, J INFORM SYSTEMS ED, V15, P235
   Gable G. G., 1999, 3 ANN SAP AS PAC I H
   Hlupic Vlatka, 2000, SIMULATION SOFTWARE
   Infor, INF ENT SOFTW SOL CR
   Infor and IBM, 2007, INF IBM DEL SOL MIDS
   Koch C., SURPRISE SURPRISE
   Komarraju M, 2010, J COLL STUDENT DEV, V51, P332, DOI 10.1353/csd.0.0137
   Microsoft Corporation, MICR DYN
   Moad Jeff, PM100 WINNERS MANUFA
   Monk EF, 2009, CONCEPTS ENTERPRISE
   National Workforce Center for Emerging Technologies (NWCET) and through Bellevue Community, 2004, APPL INF TECHN TREND
   Nelson Robert, 2001, FDN COURSE ERP BUSIN
   O'Sullivan Jill, 2009, ENTERPRISE RESOURCE
   Oracle Corporation, HIST OR CORP
   Packer M., 2010, MANUFACTURING EXECUT, P24
   Prouty Kevin, ERP COMPLEX MANUFACT
   Ptak Carol A., 2004, ERP TOOLS TECHNIQUES
   Rienzo Thomas F, CONCEPTUAL CHANGE RE
   Ritchie-Dunham J., STRATEGIC SUPPLY CHA, V2, P1260
   Rynes SL, 2001, ACAD MANAGE J, V44, P340, DOI 10.2307/3069460
   Sager J., 2006, J INFORM SYSTEMS ED, V17, P151
   Sager J., 2006, J INFORM SYSTEMS ED, V17
   Salas E, 2001, ANNU REV PSYCHOL, V52, P471, DOI 10.1146/annurev.psych.52.1.471
   SAP Corporation, HIST SAP OUR CO SAP
   Scott Judy, 1999, ERP EFFECTIVENESS CL
   Seethamraju R., 2007, J INFORM SYSTEMS ED, V18, P69
   Shtub A, 2001, INT J PROD RES, V39, P567, DOI 10.1080/00207540010009714
   Stewart John, EVALUATING AGILE PRI
   Steyn E. A., 2004, THESIS RAND AFRIKAAN
   Swan G, 2009, J EDUC COMPUT RES, V41, P431, DOI 10.2190/EC.41.4.c
   Swan Gerry, SOCIAL STUDIES RES P, V4
   Swan Gerry, 2009, J COMPUTING TEACHER, V25, P107
   The State Education Department, 2009, TRANSF TEACH ENS EQ
   Tinto V., 1993, LEAVING COLL RETHINK
   Watson E., 1999, J COMMUNICATIONS AIS, V1
   Wittrock M. C., 1970, HIGH EDUC, V9, P69
NR 64
TC 0
Z9 0
U1 1
U2 5
PU IATED-INT ASSOC TECHNOLOGY EDUCATION & DEVELOPMENT
PI VALENICA
PA LAURI VOLPI 6, VALENICA, BURJASSOT 46100, SPAIN
BN 978-84-616-0763-1
PY 2012
BP 5756
EP 5773
PG 18
WC Education & Educational Research
SC Education & Educational Research
GA BEW64
UT WOS:000318422205114
DA 2018-12-27
ER

PT B
AU Carneiro, P
   Machado, J
   Soares, F
AF Carneiro, Paulo
   Machado, Jose
   Soares, Filomena
BE Chova, LG
   Martinez, AL
   Torres, IC
TI RETRACTED: HIGH TECHNOLOGICAL SKILLS TEACHING IN AUTOMATION DOMAIN USING
   COMPETENCY-BASED EDUCATION (Retracted Article)
SO 5TH INTERNATIONAL CONFERENCE OF EDUCATION, RESEARCH AND INNOVATION
   (ICERI 2012)
LA English
DT Proceedings Paper; Retracted Publication
CT 5th International Conference of Education, Research and Innovation
   (ICERI)
CY NOV 19-21, 2012
CL Madrid, SPAIN
DE Competency-Based Education; High Technological Skills Teaching;
   Automation; Simulation
AB This paper is devoted to explain the entire process concerning to create technological skills teaching in automation domain, using a HIL (Hardware-In-the-Loop) and SIL (Software-In-the-Loop) simulation approach.
   Hardware-In-the-Loop was developed at University of Minho, configuration of the test bench is the following: a controller OMRON CP1L; a plant simulation model built in OMRON CP1L; the convertor MDW-45; the physical connection between components done using a serial port RS-422; the communication between processes (MDW-45); PC with serial port RS-232; the adaptor USB to serial port RS-232. Software-In-the-Loop use only a Computer with your inherent Software.
   The software tools used for all the tasks involved - for improving the skills of the students are CX-One (Cx-programmer, Cx-Simulator and Cx-Designer) and CX-Supervisor from OMRON.
   The entire process concerning the teaching activities, described before, is composed by the following seven steps:
   1) An industrial automation problem is proposed to the students;
   2) The students develop the formal specification for the controller of the system, using SFC formalism;
   3) The students develop the formal behavior of the physical part of the system using timed automata formalism;
   4) The controller specification is translated to a PLC programs;
   5) The plant behavior specification is translated to a PLC programs;
   6) The controller specification and plant behavior specification are further simulated using CX-One, more specifically, CX-Programmer to HIL, and using Cx-Programmer with Cx-Simulator to SIL;
   7) After simulation - and now using CX-Supervisor to HIL, and Cx-Designer to SIL - the programs are inserted on the PLCs that are linked in closed loop configuration, in the developed test bench, and students see the real program running in a real controller.
   This paper is devoted to explain, in detail, the presented methodology and, also, on highlighting the benefits of the developed test bench specifically for the mentioned purpose.
   With this approach the students can state all the benefits of the approach CBA applied to the very specific matter of Hardware-in-the-loop and Software-In-the-Loop simulation bellowing to Industrial Automation domain.
C1 [Carneiro, Paulo; Machado, Jose] Univ Minho, Dept Mech Engn, Res Ctr CT2M, P-4719 Braga, Portugal.
EM a52761@alunos.uminho.pt; jmachado@dem.uminho.pt; fsoares@dei.uminho.pt
RI Machado, Jose/L-9312-2013
OI Machado, Jose/0000-0002-4917-2474
CR Bencomo SD, 2004, ANNU REV CONTROL, V28, P115, DOI 10.1016/j.arcontrol.2003.12.002
   Carnevali G., 2003, P 5 IFAC INT S INT C, P39
   Chioran D., 2011, MECAHITECH 11 INT C
   Hansen E., 1990, ED TECHNOLOGY    SEP, P13
   Stefanovic M, 2011, COMPUT APPL ENG EDUC, V19, P538, DOI 10.1002/cae.20334
NR 5
TC 0
Z9 0
U1 1
U2 7
PU IATED-INT ASSOC TECHNOLOGY EDUCATION & DEVELOPMENT
PI VALENICA
PA LAURI VOLPI 6, VALENICA, BURJASSOT 46100, SPAIN
BN 978-84-616-0763-1
PY 2012
BP 5893
EP 5902
PG 10
WC Education & Educational Research
SC Education & Educational Research
GA BEW64
UT WOS:000318422205133
DA 2018-12-27
ER

PT J
AU Carpinteri, A
   Manuello, A
AF Carpinteri, A.
   Manuello, A.
TI RETRACTED: An indirect evidence of piezonuclear fission reactions:
   Geomechanical and geochemical evolution in the Earth's crust(Retracted
   article. See vol.20, pg.480, 2017)
SO PHYSICAL MESOMECHANICS
LA English
DT Article; Retracted Publication
DE neutron emissions; piezonuclear reactions; rocks crashing; plate
   tectonics; element evolution; great oxidation event; carbon pollution
ID CARBON-DIOXIDE LEVELS; CONTINENTAL-CRUST; PHANEROZOIC TIME; ATMOSPHERIC
   CO2; STABLE-ISOTOPES; OCEAN; MODEL; COMPRESSION; NEUTRONS; SILICON
AB Piezonuclear reactions, which occur in inert and nonradioactive elements, are induced by high pressure and, in particular, by brittle fracture phenomena in solids under compression. These low energy reactions generally take place in nuclei with an atomic weight that is lower or equal to that of iron (Fe). The experimental evidence, obtained from repeatable measurements of neutron emissions, can be also recognized considering the anomalous chemical balances of the major events that have affected the Earth's crust, oceans and atmosphere, over the last four billion years. These anomalies include: (i) the abrupt variations in the most abundant elements in correspondence to the formation of tectonic plates; (ii) the Great Oxidation Event (2.7 to 2.4 billion years ago), with a sharp increase in atmospheric oxygen and the subsequent origin of life; (iii) the increase of carbon and nytrogen concentrations in the primordial atmosphere.
   Natural piezonuclear reactions are induced by fault sliding and plate subduction phenomena.
C1 [Carpinteri, A.; Manuello, A.] Politecn Torino, Dept Struct Engn & Geotech, I-10129 Turin, Italy.
RP Carpinteri, A (reprint author), Politecn Torino, Dept Struct Engn & Geotech, I-10129 Turin, Italy.
EM alberto.carpinteri@polito.it
CR Aki K., 1983, EARTHQUAKES OBSERVAT
   Anbar AD, 2008, SCIENCE, V322, P1481, DOI 10.1126/science.1163100
   Arata Y, 2002, P JPN ACAD B-PHYS, V78, P201, DOI 10.2183/pjab.78.201
   Arata Y, 1995, P JPN ACAD B-PHYS, V71, P304, DOI 10.2183/pjab.71.304
   Basile-Doelsch I, 2006, J GEOCHEM EXPLOR, V88, P252, DOI 10.1016/j.gexplo.2005.08.050
   Basile-Doelsch I, 2005, NATURE, V433, P399, DOI 10.1038/nature03217
   Bergman R.A., 2004, AM J SCI, V301, P182
   Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182
   BERNER RA, 1990, SCIENCE, V249, P1382, DOI 10.1126/science.249.4975.1382
   BROECKER WS, 1985, BUILD HABITABLE PLAN
   Buesseler KO, 2008, SCIENCE, V319, P162, DOI 10.1126/science.1154305
   Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839
   Cardone F, 2009, PHYS LETT A, V373, P4158, DOI 10.1016/j.physleta.2009.09.026
   Cardone F., 2007, DEFORMED SPACETIME
   Cardone F, 2009, PHYS LETT A, V373, P862, DOI 10.1016/j.physleta.2008.12.060
   Carpinteri A, 2011, STRAIN, V47, P282, DOI 10.1111/j.1475-1305.2010.00767.x
   Carpinteri A, 2011, STRAIN, V47, P267, DOI 10.1111/j.1475-1305.2010.00766.x
   Carpinteri A, 2009, STRAIN, V45, P332, DOI 10.1111/j.1475-1305.2008.00615.x
   CARPINTERI A, 1990, INT J FRACTURE, V44, P57, DOI 10.1007/BF00012552
   CARPINTERI A, 1989, J MECH PHYS SOLIDS, V37, P567, DOI 10.1016/0022-5096(89)90029-X
   Carpinteri A, 2009, ENG FAIL ANAL, V16, P2530, DOI 10.1016/j.engfailanal.2009.04.024
   Catling David C, 2009, Scientific American (International Edition), V300, P24
   Condie KC, 1976, PLATE TECTONICS CRUS
   De la Rocha CL, 2000, GEOCHIM COSMOCHIM AC, V64, P2467, DOI 10.1016/S0016-7037(00)00373-2
   Doglioni C., 2007, ENCICLOPEDIA SCI TEC, P595
   Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103
   EGAMI F, 1974, J MOL EVOL, V4, P113, DOI 10.1007/BF01732017
   Favero G, 1996, COORDIN CHEM REV, V149, P367, DOI 10.1016/S0010-8545(96)90040-5
   Fischer H, 1999, SCIENCE, V283, P1712, DOI 10.1126/science.283.5408.1712
   Foing B., 2005, ASTROBIOLOGICAL 0223
   Fowler C. M. R, 2005, SOLID EARTH INTRO GL
   Galimov EM, 2005, EARTH PLANET SC LETT, V233, P263, DOI 10.1016/j.epsl.2005.01.026
   Hawkesworth CJ, 2006, NATURE, V443, P811, DOI 10.1038/nature05191
   Hazen RM, 2008, AM MINERAL, V93, P1693, DOI 10.2138/am.2008.2955
   Holland HD, 1984, CHEM EVOLUTION ATMOS
   Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838
   KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665
   Kelemen PB, 2009, SCI AM, V300, P52, DOI 10.1038/scientificamerican0209-52
   Kholodov VN, 2008, GEOL ORE DEPOSIT+, V50, P299, DOI 10.1134/S107570150804003X
   Kolb E., 2000, BLIND WATCHERS SKY P
   Kolb E., 2005, ARXIVHEPTH0503117V1, P1
   Konhauser KO, 2009, NATURE, V458, P750, DOI 10.1038/nature07858
   Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058
   Kuzhevskij BM, 2003, NAT HAZARD EARTH SYS, V3, P637, DOI 10.5194/nhess-3-637-2003
   Kuzhevskij BM, 2003, NAT HAZARD EARTH SYS, V3, P255, DOI 10.5194/nhess-3-255-2003
   Liu L., 2007, EARTH PLANET SC LETT, V227, P179
   Lunine E.J.I., 1998, EARTH EVOLUTION HABI
   Monnin E, 2004, EARTH PLANET SC LETT, V224, P45, DOI 10.1016/j.epsl.2004.05.007
   *NAT AC SCI, 1975, MED BIOL EFF ENV POL
   Pardon E., 2008, PURE APPL GEOPHYS, V165, P95
   Ragueneau O, 2000, GLOBAL PLANET CHANGE, V26, P317, DOI 10.1016/S0921-8181(00)00052-7
   Rothman DH, 2002, P NATL ACAD SCI USA, V99, P4167, DOI 10.1073/pnas.022055499
   Roy I, 2001, COMPUT GEOSCI-UK, V27, P357, DOI 10.1016/S0098-3004(00)00101-1
   Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014<4:CAAPD0>2.0.C0;2
   RUDNICK RL, 1995, REV GEOPHYS, V33, P267, DOI 10.1029/95RG01302
   Saito MA, 2009, NATURE, V458, P714, DOI 10.1038/458714a
   Sigman DM, 2004, NATURE, V428, P59, DOI 10.1038/nature02357
   Taleyarkhan RP, 2002, SCIENCE, V295, P1868, DOI 10.1126/science.1067589
   TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262
   Taylor SR, 2009, PLANETARY CRUSTS: THEIR COMPOSITION, ORIGIN AND EVOLUTION, P1
   Townsend AR, 2010, SCI AM, V302, P64, DOI 10.1038/scientificamerican0210-64
   Vola G., 2010, MINERAL, V79, P45
   Volodichev N. N., 2000, ASTRON VESTN, V34, P188
   Williams RJP, 2003, J THEOR BIOL, V220, P323, DOI 10.1006/jtbi.2003.3152
   Yamaguchi K.E., 2005, FRONT RES EARTH EVOL, V2, P44
   [Ярошевский А.А. Yaroshevsky A.A.], 2006, [Геохимия, Geokhimiya], P54
   Yung Y.L., 1999, PHOTOCHEMISTRY PLANE
NR 67
TC 7
Z9 7
U1 4
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1029-9599
EI 1990-5424
J9 PHYS MESOMECH
JI Phys. Mesomech.
PD JAN
PY 2012
VL 15
IS 1-2
BP 37
EP 46
DI 10.1134/S1029959912010043
PG 10
WC Mechanics; Materials Science, Characterization & Testing
SC Mechanics; Materials Science
GA 139SV
UT WOS:000318605500004
DA 2018-12-27
ER

PT S
AU Sun, G
   Yu, JX
   Yang, Y
   Bian, XH
   Li, ZB
AF Sun, Gang
   Yu, Jianxing
   Yang, Yuan
   Bian, Xuehang
   Li, Zhibo
BE Zhao, SB
   Xie, YM
TI RETRACTED: Development of the Buckling Propagation Analysis System and
   Experiments Design of Deep-sea Pipeline (Retracted Article)
SO INNOVATION IN CIVIL ENGINEERING, ARCHITECTURE AND SUSTAINABLE
   INFRASTRUCTURE
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Civil Engineering, Architecture and
   Sustainable Infrastructure (ICCEASI 2012)
CY SEP 22-24, 2012
CL Zhengzhou, PEOPLES R CHINA
SP N China Univ Water Resources & Elect Power, RMIT Univ, Zhengzhou Univ, Wuhan Univ, Dalian Univ Technol, Changsha Univ Sci & Technol, China Civil Engn Soc, Fiber Concrete Comm, China Assoc Engn Construct Standardizat, Concrete Specialist Comm, Henan Civil Engn & Architecture Soc, Henan Highway & Transportat Soc
DE re-development; buckling propagation; numerical simulation; experiments
   design
AB Finite element software-MSC, Patran and ABAQUS were re-developed by using VB.NET to establish Buckling Propagation Analysis System of Deep-sea Pipeline. Based on the results of numerical simulation and DNV standard, the experiment scheme based on Deep Water Structure Laboratory of Tianjin University was designed, which can provide basis for the prediction of buckling propagation pressure and design of the buckle arrestor.
C1 [Sun, Gang; Yu, Jianxing; Yang, Yuan; Bian, Xuehang; Li, Zhibo] Tianjin Univ, State Key Lab Hydraul Engn Simulat & Safety, Tianjin 300072, Peoples R China.
RP Sun, G (reprint author), Tianjin Univ, State Key Lab Hydraul Engn Simulat & Safety, Tianjin 300072, Peoples R China.
EM sungang1988@yahoo.cn; yjx2000@tju.edu.cn; bensonyang@yeah.net;
   tjltbxh@163.com; 13752557780@163.com
CR Croll J. G. A., 1985, CONSTRUCT STEEL RES, V5, P103
   Kyriakides S, 2000, INT J SOLIDS STRUCT, V37, P6843, DOI 10.1016/S0020-7683(99)00317-0
   Kyriakides S., 1994, ADV APPL MECH, V30, P99
   MALO KA, 2001, MECH SCI, V43, P1209
   Xue JH, 2006, FINITE ELEM ANAL DES, V42, P1211, DOI 10.1016/j.finel.2006.05.003
NR 5
TC 0
Z9 0
U1 2
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-534-8
J9 APPL MECH MATER
PY 2012
VL 238
BP 362
EP 365
DI 10.4028/www.scientific.net/AMM.238.362
PG 4
WC Engineering, Civil
SC Engineering
GA BEE82
UT WOS:000316308900079
DA 2018-12-27
ER

PT J
AU Calisto, KL
   Camacho, AC
   Mittestainer, FC
   Carvalho, BM
   Guadagnini, D
   Carvalheira, JB
   Saad, MJ
AF Calisto, Kelly L.
   Camacho, Angelica C.
   Mittestainer, Francine C.
   Carvalho, Bruno M.
   Guadagnini, Dioze
   Carvalheira, Jose B.
   Saad, Mario J.
TI RETRACTED: Diacerhein attenuates the inflammatory response and improves
   survival in a model of severe sepsis (Retracted article. See vol. 20,
   278, 2016)
SO CRITICAL CARE
LA English
DT Article; Retracted Publication
ID FACTOR-KAPPA-B; INSULIN-RECEPTOR SUBSTRATE-1; OSTEOARTHRITIC
   CHONDROCYTES; ORGAN DYSFUNCTION; MONONUCLEAR-CELLS; PROTEIN-KINASE;
   ACTIVATION; RESISTANCE; OBESITY; STRESS
AB Introduction: Hyperglycemia and insulin resistance have been associated with a worse outcome in sepsis. Although tight glycemic control through insulin therapy has been shown to reduce morbidity and mortality rates, the effect of intensive insulin therapy in patients with severe sepsis is controversial because of the increased risk of serious adverse events related to hypoglycemia. Recently, knowledge about diacerhein, an anthraquinone drug with powerful antiinflammatory properties, revealed that this drug improves insulin sensitivity, mediated by the reversal of chronic subclinical inflammation. The aim of the present study was to evaluate whether the antiinflammatory effects of diacerhein after onset of sepsis-induced glycemic alterations is beneficial and whether the survival rate is prolonged in this situation.
   Methods: Diffuse sepsis was induced by cecal ligation and puncture surgery (CLP) in male Wistar rats. Blood glucose and inflammatory cytokine levels were assessed 24 hours after CLP. The effect of diacerhein on survival of septic animals was investigated in parallel with insulin signaling and its modulators in liver, muscle, and adipose tissue.
   Results: Here we demonstrated that diacerhein treatment improves survival during peritoneal-induced sepsis and inhibits sepsis-induced insulin resistance by improving insulin signaling via increased insulin-receptor substrate-1-associated phosphatidylinositol 3-kinase activity and Akt phosphorylation. Diacerhein also decreases the activation of endoplasmic reticulum stress signaling that involves upregulation of proinflammatory pathways, such as the I kappa B kinase and c-Jun NH2-terminal kinase, which blunts insulin-induced insulin signaling in liver, muscle, and adipose tissue. Additionally, our data show that this drug promoted downregulation of proinflammatory signaling cascades that culminate in transcription of immunomodulatory factors such interleukin (IL)-1 beta, IL-6, and tumor necrosis factor-alpha.
   Conclusions: This study demonstrated that diacerhein treatment increases survival and attenuates the inflammatory response with a significant effect on insulin sensitivity. On the basis of efficacy and safety profile, diacerhein represents a novel antiinflammatory therapy for management of insulin resistance in sepsis and a potential approach for future clinical trials.
C1 [Calisto, Kelly L.; Camacho, Angelica C.; Mittestainer, Francine C.; Carvalho, Bruno M.; Guadagnini, Dioze; Carvalheira, Jose B.; Saad, Mario J.] State Univ Campinas UNICAMP, FCM, Dept Internal Med, Campinas, SP, Brazil.
RP Saad, MJ (reprint author), State Univ Campinas UNICAMP, FCM, Dept Internal Med, Cidade Univ Zeferino Vaz, Campinas, SP, Brazil.
EM msaad@fcm.unicamp.br
RI Calisto, Kelly/J-9681-2016
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); INCT-CNPq
   (Instituto Nacional de Ciencia e Tecnologia-Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico)
FX We acknowledge the excellent technical assistance of Luis Janieri,
   Josimo Pinheiro, and Ramon Zorzeto. This study was supported by FAPESP
   (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) and INCT-CNPq
   (Instituto Nacional de Ciencia e Tecnologia-Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico).
CR Aljada A, 2006, METABOLISM, V55, P1177, DOI 10.1016/j.metabol.2006.04.016
   Almog Y, 2003, CHEST, V124, P740, DOI 10.1378/chest.124.2.740
   Arcaroli J, 2006, AM J RESP CRIT CARE, V173, P1335, DOI 10.1164/rccm.200603-341OC
   Arkan MC, 2005, NAT MED, V11, P191, DOI [10.1038/nm1185, 10.1068/nm1185]
   Arnalich F, 2000, INFECT IMMUN, V68, P1942, DOI 10.1128/IAI.68.4.1942-1945.2000
   Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604
   Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648
   BOITTIN M, 1993, REV RHUM, V60, pS68
   BONE RC, 1992, CRIT CARE MED, V20, P864
   Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57
   Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716
   Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959
   Dandona P, 2001, J CLIN ENDOCR METAB, V86, P3257, DOI 10.1210/jc.86.7.3257
   Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D
   Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013
   Dandona P, 2010, DIABETES CARE, V33, P2416, DOI 10.2337/dc10-0929
   de Isla N, 2010, BIO-MED MATER ENG, V20, P227, DOI 10.3233/BME-2010-0636
   Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309
   Dellinger RP, 1997, CHEST, V111, P744
   DELPINO A, 1992, CANCER BIOCHEM BIOPH, V12, P241
   DELROSSO M, 1990, INT J TISSUE REACT, V12, P91
   Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393
   Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383
   Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200
   Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943
   Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002
   Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200
   Kidd LB, 2008, J PHARMACOL EXP THER, V326, P348, DOI 10.1124/jpet.108.138891
   Kim I, 2001, FASEB J, V15, P126, DOI 10.1096/fj.01-0556fje
   Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559
   Kyle UG, 2010, INTENS CARE MED, V36, P312, DOI 10.1007/s00134-009-1703-1
   Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/01.shk.0000043614.39685.6f
   Lin YJ, 2009, ANTI-CANCER DRUG, V20, P65, DOI 10.1097/CAD.0b013e3283182913
   Maitra SR, 2000, SHOCK, V13, P379, DOI 10.1097/00024382-200005000-00006
   Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y
   Marshall John C, 2004, Curr Opin Crit Care, V10, P250, DOI 10.1097/01.ccx.0000134877.60312.f3
   Martel-Pelletier J, 1998, J RHEUMATOL, V25, P753
   Mendes AF, 2002, PHARMACOL TOXICOL, V91, P22, DOI 10.1034/j.1600-0773.2002.910104.x
   MIAN M, 1987, J PHARM PHARMACOL, V39, P845, DOI 10.1111/j.2042-7158.1987.tb05131.x
   Mohanty P, 2000, J CLIN ENDOCR METAB, V85, P2970, DOI 10.1210/jc.85.8.2970
   Moore AR, 1998, OSTEOARTHR CARTILAGE, V6, P19, DOI 10.1053/joca.1997.0088
   Nicolas P, 1998, CLIN PHARMACOKINET, V35, P347, DOI 10.2165/00003088-199835050-00002
   Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Park YC, 1997, BIOCHEM BIOPH RES CO, V240, P692, DOI 10.1006/bbrc.1997.7722
   Pelletier JP, 1998, J RHEUMATOL, V25, P2417
   Pelletier JP, 1998, ARTHRITIS RHEUM-US, V41, P1275, DOI 10.1002/1529-0131(199807)41:7<1275::AID-ART19>3.0.CO;2-T
   Pelletier JP, 2001, J RHEUMATOL, V28, P814
   Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214
   Schabbauer G, 2004, ARTERIOSCL THROM VAS, V24, P1963, DOI 10.1161/01.ATV.0000143096.15099.ce
   Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069
   Smith GN, 1999, ARTHRITIS RHEUM, V42, P545, DOI 10.1002/1529-0131(199904)42:3<545::AID-ANR20>3.0.CO;2-4
   Tamura T, 2002, EUR J PHARMACOL, V448, P81, DOI 10.1016/S0014-2999(02)01898-8
   Terblanche M, 2006, LANCET INFECT DIS, V6, P242, DOI 10.1016/S1473-3099(06)70439-X
   Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595
   Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506
   Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307
   Yang KY, 2003, AM J RESP CRIT CARE, V167, P1567, DOI 10.1164/rccm.200207-664OC
   Yin MJ, 1998, NATURE, V396, P77
   Zhao L, 2008, BIOCHEM PHARMACOL, V75, P1515, DOI 10.1016/j.bcp.2007.12.014
NR 66
TC 11
Z9 12
U1 2
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1466-609X
EI 1364-8535
J9 CRIT CARE
JI Crit. Care
PY 2012
VL 16
IS 4
AR R158
DI 10.1186/cc11478
PG 13
WC Critical Care Medicine
SC General & Internal Medicine
GA 066CP
UT WOS:000313197800045
PM 22897821
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Guan, Q
   Du, B
   Teng, ZZ
   Gillard, J
   Chen, SY
AF Guan, Qiu
   Du, Bin
   Teng, Zhongzhao
   Gillard, Jonathan
   Chen, Shengyong
TI RETRACTED: Bayes Clustering and Structural Support Vector Machines for
   Segmentation of Carotid Artery Plaques in Multicontrast MRI (Retracted
   article. See vol. 2014, 836280, 2014)
SO COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE
LA English
DT Article; Retracted Publication
ID MAGNETIC-RESONANCE; IMAGES
AB Accurate segmentation of carotid artery plaque in MR images is not only a key part but also an essential step for in vivo plaque analysis. Due to the indistinct MR images, it is very difficult to implement the automatic segmentation. Two kinds of classification models, that is, Bayes clustering and SSVM, are introduced in this paper to segment the internal lumen wall of carotid artery. The comparative experimental results show the segmentation performance of SSVM is better than Bayes.
C1 [Guan, Qiu; Du, Bin; Chen, Shengyong] Zhejiang Univ Technol, Coll Comp Sci, Hangzhou 310023, Zhejiang, Peoples R China.
   [Teng, Zhongzhao; Gillard, Jonathan] Univ Cambridge, Dept Radiol, Cambridge CB2 0SP, England.
RP Chen, SY (reprint author), Zhejiang Univ Technol, Coll Comp Sci, Hangzhou 310023, Zhejiang, Peoples R China.
EM sy@ieee.org
OI Teng, Zhongzhao/0000-0003-3973-6157
FU National Science Foundation of China (NSFC) [61173096, 61103140,
   51075367]; Doctoral Fund of Ministry of Education of China
   [20113317110001]; Zhejiang Provincial S and T Department [2010R10006,
   2010C33095]
FX The work was supported in part by the National Science Foundation of
   China (NSFC no. 61173096, 61103140, and 51075367), Doctoral Fund of
   Ministry of Education of China (20113317110001), and Zhejiang Provincial
   S and T Department (2010R10006, 2010C33095).
CR Adame IM, 2004, MAGN RESON MATER PHY, V16, P227, DOI 10.1007/s10334-003-0030-8
   Chen SY, 2011, IET IMAGE PROCESS, V5, P273, DOI 10.1049/iet-ipr.2007.0110
   Chen SY, 2011, IEEE T BIO-MED ENG, V58, P480, DOI 10.1109/TBME.2010.2087331
   Chen SY, 2010, SENSORS-BASEL, V10, P11428, DOI 10.3390/s101211428
   Chen Y., 2006, P 16 INT C PATT REC, V1, P747
   Clarke SE, 2006, STROKE, V37, P93, DOI 10.1161/01.STR.0000196985.38701.0c
   Karmonik C, 2009, IEEE T BIO-MED ENG, V56, P352, DOI 10.1109/TBME.2008.2003100
   Liu F, 2006, MAGN RESON MED, V55, P659, DOI 10.1002/mrm.20814
   Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867
   Sadat U, 2009, ATHEROSCLEROSIS, V207, P434, DOI 10.1016/j.atherosclerosis.2009.05.002
   Teng ZZ, 2012, ATHEROSCLEROSIS, V223, P321, DOI 10.1016/j.atherosclerosis.2012.06.015
   Teng ZZ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-64
   Trivedi RA, 2004, EUR J VASC ENDOVASC, V28, P207, DOI 10.1016/S1078-5884(04)00219-9
   Vukadinovic D, 2012, INT J CARDIOVAS IMAG, V28, P877, DOI 10.1007/s10554-011-9890-6
NR 14
TC 2
Z9 2
U1 3
U2 20
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1748-670X
EI 1748-6718
J9 COMPUT MATH METHOD M
JI Comput. Math. Method Med.
PY 2012
AR 549102
DI 10.1155/2012/549102
PG 6
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA 061ID
UT WOS:000312840800001
PM 23365619
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Wu, Y
   Zhu, WD
AF Wu, Yong
   Zhu, Weidong
TI RETRACTED: An integrated theoretical model for determinants of knowledge
   sharing behaviours (Retracted article. See vol. 43, pg. 835, 2014)
SO KYBERNETES
LA English
DT Article; Retracted Publication
DE China; Employees behaviour; Organizational behaviour; Knowledge sharing;
   Theory of Planned Behavior model
ID ORGANIZATIONAL CAPABILITY; VIRTUAL COMMUNITIES; PLANNED BEHAVIOR;
   MANAGEMENT; TECHNOLOGY; ATTITUDES; NETWORKS; RESOURCE; CREATION; SUCCESS
AB Purpose - Knowledge sharing has been recognized as a positive force for the survival of an organization but the factors that promote or discourage knowledge sharing behaviors in the organizational context are poorly understood. The purpose of this paper is to enhance our collective understanding of the factors affecting knowledge sharing behaviors of knowledge workers in the organizational context.
   Design/methodology/approach - Drawing from multiple streams of research including social psychology, organizational learning, knowledge management, information systems and so forth, this research developed an integrated theoretical model. The Theory of Planned Behavior model, motivation theory, social exchange theory, economic exchange theory and self determination theory were employed here. In total, 180 responses from ten companies in China were collected.
   Findings - The theoretical model was validated within the context of a single empirical study. The findings provided significant statistical support for the research model, accounting for about 60 percent of the variance in the behavioral intention to share knowledge and 41 percent variance in the actual knowledge sharing behavior. In total, 11 of the 12 hypothesized relationships were supported.
   Originality/value - This exploratory research attempted to fill the void in the integrative research by investigating the most crucial factors that influence the knowledge sharing behaviors of knowledge workers.
C1 [Wu, Yong] Hefei Univ Technol, Sch Management, Hefei, Peoples R China.
   [Zhu, Weidong] Hefei Univ Technol, Sch Econ, Hefei, Peoples R China.
RP Wu, Y (reprint author), Hefei Univ Technol, Sch Management, Hefei, Peoples R China.
EM wuyong@hfut.edu.cn
FU National Science Foundation of China [71071048]
FX The authors acknowledge support from the National Science Foundation of
   China (71071048).
CR Ajzen I, 2001, ANNU REV PSYCHOL, V52, P27, DOI 10.1146/annurev.psych.52.1.27
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Ajzen I, 1980, UNDERSTANDING ATTITU
   Alavi M, 2001, MIS QUART, V25, P107, DOI 10.2307/3250961
   Ardichvili A., 2003, Journal of Knowledge Management, V7, P64, DOI 10.1108/13673270310463626
   Aubert BA, 2004, INFORM MANAGE-AMSTER, V41, P921, DOI 10.1016/j.im.2003.09.001
   Bandyopadhyay S, 2007, DECIS SUPPORT SYST, V43, P349, DOI 10.1016/j.dss.2006.10.006
   Barclay D., 2009, TECHNOLOGY STUDIES R, V2, P285
   Blau P. M., 1967, EXCHANGE POWER SOCIA
   Bock GW, 2005, MIS QUART, V29, P87
   Brown JS, 2001, ORGAN SCI, V12, P198, DOI 10.1287/orsc.12.2.198.10116
   Buckman R.H., 1998, J BUS STRAT, V19, P11
   CHIN WW, 1998, QUANT METH SER, P295, DOI DOI 10.1016/J.AAP.2008.12.010
   Chiu CM, 2006, DECIS SUPPORT SYST, V42, P1872, DOI 10.1016/j.dss.2006.04.001
   Chow C. W., 2000, J MANAGEMENT ACCOUNT, P65, DOI DOI 10.2308/JMAR.2000.12.1.65
   Connelly EC, 2003, LEADERSHIP ORG DEV J, V24, P294, DOI DOI 10.1108/01437730310485815
   Constant D, 1996, ORGAN SCI, V7, P119, DOI 10.1287/orsc.7.2.119
   CONSTANT D, 1994, INFORM SYST RES, V5, P400, DOI 10.1287/isre.5.4.400
   Davenport T. H., 1998, WORKING KNOWLEDGE OR
   Davenport T.H., 1999, WORKING KNOWLEDGE OR, P23
   Deluga RJ, 1998, GROUP ORGAN MANAGE, V23, P189, DOI 10.1177/1059601198232006
   Fey CF, 2008, STRATEG MANAGE J, V29, P1301, DOI 10.1002/smj.712
   FORNELL C, 1982, J MARKETING RES, V19, P440, DOI 10.2307/3151718
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Frey B. S., 2002, SUCCESSFUL MANAGEMEN
   Gagne M, 2009, HUM RESOUR MANAGE, V48, P571, DOI 10.1002/hrm.20298
   Gee Woo Bock, 2002, Information Resources Management Journal, V15, P14, DOI 10.4018/irmj.2002040102
   GRANT RM, 1991, CALIF MANAGE REV, V33, P114, DOI 10.2307/41166664
   Grant RM, 1996, ORGAN SCI, V7, P375, DOI 10.1287/orsc.7.4.375
   Gray P. H., 2001, Information Technology & People, V14, P368, DOI 10.1108/09593840110411167
   Gupta AK, 2000, SLOAN MANAGE REV, V42, P71
   Hackney R, 2008, INFORM SYST MANAGE, V25, P356, DOI 10.1080/10580530802384654
   Hair Jr J. F., 1998, MULTIVARIATE DATA AN
   Haldin-Herrgard T., 2000, J INTELLECT CAP, V1, P357, DOI DOI 10.1108/14691930010359252
   Hinds PJ, 2003, SHARING EXPERTISE: BEYOND KNOWLEDGE MANAGEMENT, P3
   Howard W.R., 2010, KYBERNETES, V39, P844
   Hsu MH, 2007, INT J HUM-COMPUT ST, V65, P153, DOI 10.1016/j.ijhcs.2006.09.003
   Janz BD, 2003, DECISION SCI, V34, P351, DOI 10.1111/1540-5915.02328
   Jeon S, 2011, J KNOWL MANAG, V15, P251, DOI 10.1108/13673271111119682
   Kankanhalli A, 2005, MIS QUART, V29, P113
   King WR, 2008, OMEGA-INT J MANAGE S, V36, P131, DOI 10.1016/j.omega.2005.10.006
   Kollock P., 1999, COMMUNITIES CYBERSPA, P220
   Lee H, 2003, J MANAGE INFORM SYST, V20, P179
   Lee JN, 2001, INFORM MANAGE, V38, P323, DOI 10.1016/S0378-7206(00)00074-4
   Markus ML, 2001, J MANAGE INFORM SYST, V18, P57
   McDermott R., 2001, J KNOWLEDGE MANAGEME, V5, P76, DOI DOI 10.1108/13673270110384428
   Morris MG, 2005, IEEE T ENG MANAGE, V52, P69, DOI 10.1109/TEM.2004.839967
   Nonaka I, 1998, CALIF MANAGE REV, V40, P40, DOI 10.2307/41165942
   Olson DL, 2010, HUM ECOL RISK ASSESS, V16, P478, DOI 10.1080/10807031003779898
   Orlikowski W. J., 1993, Information Society, V9, P237
   Osterloh M, 2000, ORGAN SCI, V11, P538, DOI 10.1287/orsc.11.5.538.15204
   Perrott Bruce E., 2007, Business Horizons, V50, P523, DOI 10.1016/j.bushor.2007.08.002
   Renzl B, 2008, OMEGA-INT J MANAGE S, V36, P206, DOI 10.1016/j.omega.2006.06.005
   Ryu S, 2003, EXPERT SYST APPL, V25, P113, DOI 10.1016/S0957-4174(03)00011-3
   TAYLOR S, 1995, INFORM SYST RES, V6, P144, DOI 10.1287/isre.6.2.144
   Teng D., 2005, ACAD MANAGEMENT EXEC, V14, P113
   THOMPSON RL, 1991, MIS QUART, V15, P125, DOI 10.2307/249443
   Trkman P, 2012, J STRATEGIC INF SYST, V21, P1, DOI 10.1016/j.jsis.2011.11.001
   Tsai CH, 2010, TECHNOL FORECAST SOC, V77, P840, DOI 10.1016/j.techfore.2010.01.011
   von Krogh G, 1998, CALIF MANAGE REV, V40, P133, DOI 10.2307/41165947
   Wang S., 2009, HUMAN RESOURCE MANAG, V13, P1
   Wasko MM, 2005, MIS QUART, V29, P35
   Wasko MM, 2000, J STRATEGIC INF SYST, V9, P155
   Wu D, 2010, J OPER RES SOC, V61, P179, DOI 10.1057/jors.2008.144
   Wu DD, 2010, EUR J OPER RES, V207, P856, DOI 10.1016/j.ejor.2010.05.008
   Wu DD, 2010, TECHNOL FORECAST SOC, V77, P857, DOI 10.1016/j.techfore.2010.01.015
NR 66
TC 23
Z9 23
U1 5
U2 75
PU EMERALD GROUP PUBLISHING LTD
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 0368-492X
EI 1758-7883
J9 KYBERNETES
JI Kybernetes
PY 2012
VL 41
IS 10
BP 1462
EP 1482
DI 10.1108/03684921211276675
PG 21
WC Computer Science, Cybernetics
SC Computer Science
GA 055RJ
UT WOS:000312434100007
DA 2018-12-27
ER

PT J
AU Zhang, GJ
   Chen, LP
   Ha, WT
AF Zhang, Guojun
   Chen, Liping
   Ha, Weitao
TI RETRACTED: Service Selection of Ensuring Transactional Reliability and
   QoS for Web Service Composition (Retracted article. See 863485, 2014)
SO MATHEMATICAL PROBLEMS IN ENGINEERING
LA English
DT Article; Retracted Publication
AB Service-Oriented Architecture (SOA) provides a flexible framework of service composition. Using standard-based protocols, composite service can be constructed by integrating component services independently. As component services are developed by different organization and offer diverse transactional properties and QoS characteristics, it is a challenging problem how to select suitable component services which ensure reliable execution of composite Web service and construct the optimal composite Web service. In this paper, we propose a selection approach that combines transactional properties of ensuring reliability and QoS characteristics. In the selection approach, we build automaton model to implement transactional-aware service selection and use the model to guarantee reliable execution of composite Web service. We also define aggregation functions, and use a Multiple-Attribute Decision-Making approach for the utility function to achieve Qos-based optimal service selection. Finally, two scenarios of experiments are presented to demonstrate the validity of the selection approach.
C1 [Zhang, Guojun] Weinan Normal Univ, Coll Commun Engn, Weinan 714000, Shaanxi, Peoples R China.
   [Zhang, Guojun; Chen, Liping; Ha, Weitao] Weinan Normal Univ, Ctr Network Engn Technol, Weinan 714000, Shaanxi, Peoples R China.
   [Chen, Liping; Ha, Weitao] Weinan Normal Univ, Coll Math & Informat Sci, Weinan 714000, Shaanxi, Peoples R China.
RP Zhang, GJ (reprint author), Weinan Normal Univ, Coll Commun Engn, W Chaoyang St, Weinan 714000, Shaanxi, Peoples R China.
EM wnchlp@gmail.com
FU Shaanxi Education Department Foundation of China [12JK0745, 12JK0746]
FX This work is partially supported by Shaanxi Education Department
   Foundation of China, (no. 12JK0745 and no. 12JK0746).
CR Albert P, 2005, 2005 IEEE International Conference on Web Services, Vols 1 and 2, Proceedings, P285
   Alonso G., 1996, P 8 IEEE S PAR DISTR
   [Anonymous], 2009, YET ANOTHER WORKFLOW
   [Anonymous], 2010, BUSINESS PROCESS EXE
   Bhiri S, 2005, P 14 INT C WORLD WID, P138
   Bunting D., 2003, ARJUNA FUJITSU IONA
   Elmagarmid A., 1992, T MODELS ADV DATABAS
   Gamma E., 1995, DESIGN PATTERNS ELEM
   Gioldasis N, 2002, WISE 2002: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON WEB INFORMATION SYSTEMS ENGINEERING, P115, DOI 10.1109/WISE.2002.1181649
   I. Bea and Microsoft, 2003, BUSINESS PROCESS EXE
   Kavantzas N., 2004, WEB SERVICES CHOREOG
   LANGWORTHY D, WEB SERVICES ATOMIC
   LANGWORTHY D, WEB SERVICES BUSINES
   Medjahed B, 2003, VLDB J, V12, P59, DOI 10.1007/s00778-003-0087-z
   Mehrotra S., 2012, P 12 INT C DISTR COM, P56
   Yoon KP, 1995, MULTIPLE ATTRIBUTE D
NR 16
TC 2
Z9 2
U1 3
U2 29
PU HINDAWI PUBLISHING CORP
PI NEW YORK
PA 315 MADISON AVE 3RD FLR, STE 3070, NEW YORK, NY 10017 USA
SN 1024-123X
EI 1563-5147
J9 MATH PROBL ENG
JI Math. Probl. Eng.
PY 2012
AR 641361
DI 10.1155/2012/641361
PG 15
WC Engineering, Multidisciplinary; Mathematics, Interdisciplinary
   Applications
SC Engineering; Mathematics
GA 054DF
UT WOS:000312323500001
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU He, MH
   Zhang, DM
   Gao, YH
AF He Min-Hua
   Zhang Duan-Ming
   Gao Yi-Hua
TI RETRACTED: Electron-beam induced abnormal expansion in a silica-shelled
   gallium microball-nanotube structure (Retracted Article)
SO ACTA PHYSICA SINICA
LA Chinese
DT Article; Retracted Publication
DE electron-beam irradiation; gallium filling nanotube; abnormal expansion;
   ionization effect
ID CARBON NANOTUBES
AB Under electron-beam irradiation of heteroshape-heteroscale structure of silica-shelled Ga microball-nanotube, an abnormally large and fast volume expansion of liquid Ga is observed. First, we analyze the processes and phenomena about experiment, and the abnormal expansion process can be regarded as a quasi-static process. Then in the framework of quasi-static thermodynamics, according to the Fourier heat conduction law the relative volume variation with temperature is further quantitatively discussed, and the relative expansion rate and expansion coefficient in system are obtained. At the same time it is found that abnormal expansion coefficient of system under electron-beam irradiation is 5-9 times the general thermal expansion coefficient. Finally, it is pointed out that the abnormal expansion is due to the gallium atom ionization effect and the retention effect resulting from a few electrons retaining in the liquid gallium system under electron-beam irradiation. In essence, both ionization effect and the retention effect make the particle densities of liquid systems increased dramatically, resulting in volume expansion abnormally large and fast of liquid Ga.
C1 [He Min-Hua] Wuhan Inst Technol, Sch Sci, Wuhan 430073, Peoples R China.
   [Zhang Duan-Ming; Gao Yi-Hua] Huazhong Univ Sci & Technol, Sch Phys, Wuhan 430074, Peoples R China.
RP He, MH (reprint author), Wuhan Inst Technol, Sch Sci, Wuhan 430073, Peoples R China.
EM zhangduanming@163.com
RI ling, peng/D-1464-2012
OI ling, peng/0000-0002-7902-4384
FU National Natural Science Foundation of China [51102103, 10774053,
   11074082]; Science and Technology Research Foundation of Education
   Department of Habei Province, China [Q20121512]
FX Project supported by the National Natural Science Foundation of China
   (Grant Nos. 51102103, 10774053, 11074082) and the Science and Technology
   Research Foundation of Education Department of Habei Province, China
   (Grant No. Q20121512).
CR Costa PMFJ, 2008, NANO LETT, V8, P3120, DOI 10.1021/nl8012506
   Gao YH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3625427
   Gao YH, 2002, NATURE, V415, P599, DOI 10.1038/415599a
   Golberg D, 2007, ADV MATER, V19, P1937, DOI 10.1002/adma.200700126
   Holmberg VC, 2009, SCIENCE, V326, P405, DOI 10.1126/science.1178179
   Isihara A., 1991, CONDENSED MATTER PHY
   Li ZW, 2012, ACTA PHYS SIN-CH ED, V61
   Sun L, 2006, SCIENCE, V312, P1199, DOI 10.1126/science.1124594
   Sun M, 2010, J PHYS CHEM C, V114, P134, DOI 10.1021/jp908797d
   Svensson K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.145901
   Wang Y, 2012, CHINESE PHYS B, V21, DOI 10.1088/1674-1056/21/1/014212
   Williams D B, 1996, TRANSMISSION ELECT M, P112
   Yokota T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.265504
   Zhang JY, 2000, MAT SCI SEMICON PROC, V3, P345, DOI 10.1016/S1369-8001(00)00054-8
   Zheng C.K., 2009, PLASMA PHYS
   Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104
   Zhu XH, 2010, ACTA PHYS SIN-CH ED, V59, P7961
NR 17
TC 0
Z9 0
U1 6
U2 20
PU CHINESE PHYSICAL SOC
PI BEIJING
PA P O BOX 603, BEIJING 100080, PEOPLES R CHINA
SN 1000-3290
J9 ACTA PHYS SIN-CH ED
JI Acta Phys. Sin.
PY 2012
VL 61
IS 18
AR 186102
DI 10.7498/aps.61.186102
PG 5
WC Physics, Multidisciplinary
SC Physics
GA 047JQ
UT WOS:000311836700049
DA 2018-12-27
ER

PT J
AU Singh, AK
   Chawla, R
   Yadav, LDS
AF Singh, Atul K.
   Chawla, Ruchi
   Yadav, Lal Dhar S.
TI RETRACTED: Convenient access to strained trisubstituted 2-azetines from
   enals and chloramine-T in aqueous media(Retracted article. See vol 15,
   pg 3488, 2013)
SO GREEN CHEMISTRY
LA English
DT Article; Retracted Publication
ID DIELS-ALDER REACTIONS; ENTRY; N-ACETYL-2-AZETINE
AB A new, convenient and ecofriendly one-pot procedure for the synthesis of trisubstituted 2-azetines from alpha,beta-unsaturated enals and chloramine-T using iodine and K2CO3 in aqueous media is reported. Easily accessible substrates, operational simplicity, wide substrate scope and ambient temperature are salient features of the present investigation.
C1 [Singh, Atul K.; Chawla, Ruchi; Yadav, Lal Dhar S.] Univ Allahabad, Dept Chem, Green Synth Lab, Allahabad 211002, Uttar Pradesh, India.
RP Singh, AK (reprint author), Univ Allahabad, Dept Chem, Green Synth Lab, Allahabad 211002, Uttar Pradesh, India.
EM ldsyadav@hotmail.com
CR Bartnik R, 1998, J CHEM CRYSTALLOGR, V28, P119, DOI 10.1023/A:1022489729966
   Bremner D. H., 1985, SYNTHETIC REAGENTS, V6, P9
   Burtoloso ACB, 2006, TETRAHEDRON LETT, V47, P6377, DOI 10.1016/j.tetlet.2006.06.174
   CAMPBELL MM, 1978, CHEM REV, V78, P65, DOI 10.1021/cr60311a005
   Chawla R, 2012, TETRAHEDRON LETT, V53, P3382, DOI 10.1016/j.tetlet.2012.04.101
   Chawla R, 2012, GREEN CHEM, V14, P1308, DOI 10.1039/c2gc16664j
   Dave PR, 1998, TETRAHEDRON LETT, V39, P5481, DOI 10.1016/S0040-4039(98)01138-1
   Dave PR, 1999, TETRAHEDRON LETT, V40, P443, DOI 10.1016/S0040-4039(98)02506-4
   De Kimpe N., 1996, COMPREHENSIVE HETERO, V1
   Grieco P. A., 1998, ORGANIC SYNTHESIS WA
   JUNG ME, 1991, J ORG CHEM, V56, P6729, DOI 10.1021/jo00024a001
   Legrand N, 2000, TETRAHEDRON LETT, V41, P9815, DOI 10.1016/S0040-4039(00)01777-9
   Li C. J., 1997, ORGANIC REACTIONS AQ
   MARCHAND AP, 1994, J ORG CHEM, V59, P1608, DOI 10.1021/jo00086a008
   Minakata S, 2011, CHEM COMMUN, V47, P1905, DOI 10.1039/c0cc03855e
   Minakata S, 2009, ACCOUNTS CHEM RES, V42, P1172, DOI 10.1021/ar900059r
   Osborne D, 2002, TETRAHEDRON LETT, V43, P5469, DOI 10.1016/S0040-4039(02)01049-3
   Singh A. K., 2012, SYNTHESIS-STUTTGART, P2353
   Singh A. K., 2012, SYNTHESIS-STUTTGART, P591
   Singh AK, 2012, CHEM COMMUN, V48, P3766, DOI 10.1039/c2cc00069e
   Stevenson PJ, 2007, ARKIVOC, P129
   Stevenson PJ, 2002, CHEM COMMUN, P444, DOI 10.1039/b110242g
NR 22
TC 3
Z9 3
U1 3
U2 23
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9262
EI 1463-9270
J9 GREEN CHEM
JI Green Chem.
PY 2012
VL 14
IS 12
BP 3325
EP 3328
DI 10.1039/c2gc36331c
PG 4
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY
SC Chemistry; Science & Technology - Other Topics
GA 041PH
UT WOS:000311413200014
DA 2018-12-27
ER

PT J
AU Li, PC
   Chiu, YW
   Lin, YM
   Day, CH
   Hwang, GY
   Pai, PY
   Tsai, FJ
   Tsai, CH
   Kuo, YC
   Chang, HC
   Liu, JY
   Huang, CY
AF Li, Ping-Chun
   Chiu, Yung-Wei
   Lin, Yueh-Min
   Day, Cecilia Hsuan
   Hwang, Guang-Yuh
   Pai, Peiying
   Tsai, Fuu-Jen
   Tsai, Chang-Hai
   Kuo, Yu-Chun
   Chang, Hsiao-Chuan
   Liu, Jer-Yuh
   Huang, Chih-Yang
TI RETRACTED: Herbal Supplement Ameliorates Cardiac Hypertrophy in Rats
   with CCl4-Induced Liver Cirrhosis (Retracted article. See art no
   5276749, 2017)
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article; Retracted Publication
ID HEART-FAILURE; OCIMUM-GRATISSIMUM; EXPRESSION PROFILES; JAK/STAT
   PATHWAY; GENE-EXPRESSION; SILYMARIN; CARDIOMYOPATHY; INTERLEUKIN-6;
   ACTIVATION; PREVENTION
AB We used the carbon tetrachloride (CCl4) induced liver cirrhosis model to test the molecular mechanism of action involved in cirrhosis-associated cardiac hypertrophy and the effectiveness of Ocimum gratissimum extract (OGE) and silymarin against cardiac hypertrophy. We treated male wistar rats with CCl4 and either OGE (0.02 g/kg B. W. or 0.04 g/kg B. W.) or silymarin (0.2 g/kg B. W.). Cardiac eccentric hypertrophy was induced by CCl4 along with cirrhosis and increased expression of cardiac hypertrophy related genes NFAT, TAGA4, and NBP, and the interleukin-6 (IL-6) signaling pathway related genes MEK5, ERK5, JAK, and STAT3. OGE or silymarin co-treatment attenuated CCl4-induced cardiac abnormalities, and lowered expression of genes which were elevated by this hepatotoxin. Our results suggest that the IL-6 signaling pathway may be related to CCl4-induced cardiac hypertrophy. OGE and silymarin were able to lower liver fibrosis, which reduces the chance of cardiac hypertrophy perhaps by lowering the expressions of IL-6 signaling pathway related genes. We conclude that treatment of cirrhosis using herbal supplements is a viable option for protecting cardiac tissues against cirrhosis-related cardiac hypertrophy.
C1 [Liu, Jer-Yuh] China Med Univ Hosp, Ctr Mol Med, Taichung 40402, Taiwan.
   [Li, Ping-Chun] China Med Univ Hosp, Div Cardiovasc Surg, Taichung 40402, Taiwan.
   [Li, Ping-Chun; Hwang, Guang-Yuh] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.
   [Chiu, Yung-Wei] Tungs Taichung MetroHarbor Hosp, Emergency Dept, Taichung 43503, Taiwan.
   [Chiu, Yung-Wei] Tungs Taichung MetroHarbor Hosp, Ctr Hyperbar Oxygen Therapy, Taichung 43503, Taiwan.
   [Chiu, Yung-Wei] Chung Shan Med Univ, Inst Med, Taichung 40201, Taiwan.
   [Lin, Yueh-Min] Changhua Christian Hosp, Dept Pathol, Changhua 50006, Taiwan.
   [Day, Cecilia Hsuan] MeiHo Univ, Dept Nursing, Pingtung 91202, Taiwan.
   [Pai, Peiying] China Med Univ Hosp, Dept Cardiol, Taichung 40402, Taiwan.
   [Tsai, Fuu-Jen; Huang, Chih-Yang] China Med Univ, Grad Inst Chinese Med Sci, Taichung 40402, Taiwan.
   [Tsai, Chang-Hai] Asia Univ, Dept Healthcare Adm, Taichung 41354, Taiwan.
   [Kuo, Yu-Chun; Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan.
   [Chang, Hsiao-Chuan] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan.
   [Liu, Jer-Yuh] China Med Univ, Grad Inst Canc Biol, Taichung 40402, Taiwan.
   [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan.
RP Liu, JY (reprint author), China Med Univ Hosp, Ctr Mol Med, Taichung 40402, Taiwan.
EM jyl@mail.cmu.edu.tw; cyhuang@mail.cmu.edu.tw
RI Tsai, Fuu-Jen/J-4140-2015
FU National Science Council, China [NSC 98-2320-B-039-042-MY3]; Taiwan
   Department of Health Clinical Trial and Research Center of Excellence
   [DOH101-TD-B-111-004];  [CMU97-203];  [CMU98-asia-12]
FX The authors thank Dr. Edwin L. Cooper for reading the paper and making
   suggestions. This work was supported by grants from the National Science
   Council, China (NSC 98-2320-B-039-042-MY3), by the Taiwan Department of
   Health Clinical Trial and Research Center of Excellence
   (DOH101-TD-B-111-004) and in part by the (CMU97-203 and CMU98-asia-12),
   Taiwan.
CR Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012
   Aguiyi JC, 2000, FITOTERAPIA, V71, P444, DOI 10.1016/S0367-326X(00)00143-X
   Ai W, 2010, J CELL BIOCHEM, V110, P1111, DOI 10.1002/jcb.22623
   ATAL CK, 1986, J ETHNOPHARMACOL, V18, P133, DOI 10.1016/0378-8741(86)90025-5
   Ayisi NK, 2003, ANTIVIR RES, V58, P25, DOI 10.1016/S0166-3542(02)00166-3
   Beisvag V, 2009, EUR J CARDIOV PREV R, V16, P690, DOI 10.1097/HJR.0b013e32833158a2
   Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002
   Cameron SJ, 2004, FEBS LETT, V566, P255, DOI 10.1016/j.febslet.2004.03.120
   Ceolotto G, 2008, HEPATOLOGY, V48, P1913, DOI 10.1002/hep.22533
   Chaturvedi P, 2007, BRIT J BIOMED SCI, V64, P10, DOI 10.1080/09674845.2007.11732748
   Chen H. M., 2011, EVID-BASED COMPL ALT
   Chiu CC, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/736752
   Chung H, 2005, TOXICOL APPL PHARM, V208, P242, DOI 10.1016/j.taap.2005.03.002
   Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z
   George S, 2009, J MED FOOD, V12, P1154, DOI 10.1089/jmf.2008.0066
   GOULD L, 1969, J CLIN INVEST, V48, P860, DOI 10.1172/JCI106044
   Helmy A, 2000, GASTROENTEROLOGY, V118, P565, DOI 10.1016/S0016-5085(00)70263-0
   Hernandez-Munoz R, 2001, HEPATOLOGY, V34, P677, DOI 10.1053/jhep.2001.27949
   Hirano T, 1998, Int Rev Immunol, V16, P249
   HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862
   Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100
   Kanda T, 2004, JPN HEART J, V45, P183, DOI 10.1536/jhj.45.183
   Kaneko K, 1997, RES COMMUN MOL PATH, V97, P3
   KELBAEK H, 1984, AM J CARDIOL, V54, P852, DOI 10.1016/S0002-9149(84)80220-9
   Kodama H, 1997, CIRC RES, V81, P656
   Kong SW, 2005, PHYSIOL GENOMICS, V21, P34, DOI 10.1152/physiolgenomics.00226.2004
   KOWALSKI HJ, 1953, J CLIN INVEST, V32, P1025, DOI 10.1172/JCI102813
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Liu J. Y., 2011, EVID-BASED COMPL ALT
   McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x
   MOURELLE M, 1989, FUND CLIN PHARMACOL, V3, P183, DOI 10.1111/j.1472-8206.1989.tb00449.x
   MURIEL P, 1992, J APPL TOXICOL, V12, P439, DOI 10.1002/jat.2550120613
   MURIEL P, 1990, J APPL TOXICOL, V10, P275, DOI 10.1002/jat.2550100408
   Nangia-Makker P, 2007, INT J CANCER, V121, P884, DOI 10.1002/ijc.22733
   Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757
   Ogata A, 1999, Rinsho Byori, V47, P321
   Skoumal R, 2011, J MOL CELL CARDIOL, V50, P634, DOI 10.1016/j.yjmcc.2011.01.001
   Theocharidou E, 2012, LIVER INT, V32, P1327, DOI 10.1111/j.1478-3231.2011.02751.x
   Timoh T, 2011, TRANSPL P, V43, P1649, DOI 10.1016/j.transproceed.2011.01.188
   Valenzuela Alfonso, 1994, Biological Research, V27, P105
   Weng YJ, 2010, MOL CELL BIOCHEM, V345, P241, DOI 10.1007/s11010-010-0578-3
   Zavecz JH, 2010, CARDIOVASC TOXICOL, V10, P117, DOI 10.1007/s12012-010-9069-8
NR 42
TC 12
Z9 12
U1 3
U2 12
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2012
AR 139045
DI 10.1155/2012/139045
PG 9
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 038EK
UT WOS:000311157800001
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Wiggins, KM
   Moerdyk, JP
   Bielawski, CW
AF Wiggins, Kelly M.
   Moerdyk, Jonathan P.
   Bielawski, Christopher W.
TI RETRACTED: Homonuclear bond activation using a stable N, N
   '-diamidocarbene (Retracted article. See vol. 6, pg. 3634, 2015)
SO CHEMICAL SCIENCE
LA English
DT Article; Retracted Publication
ID C-C BOND; PERSISTENT TRIPLET CARBENES; TRANSITION-METAL-COMPLEXES;
   FRUSTRATED LEWIS PAIRS; HETEROCYCLIC CARBENE; CATALYZED ADDITION;
   ORGANIC-SYNTHESIS; SULFUR BOND; DISULFIDES; REACTIVITY
AB The activation of molecules possessing homonuclear bonds (i.e., X-X, where X Br, O, S, or C) using a stable N, N'-diamidocarbene (DAC) is described. Exposing bromine to the DAC at 25 degrees C afforded a substituted tetrahydropyrimidinium salt in good yield (70%). In contrast, treatment of the DAC with benzoyl peroxide or various disulfides afforded the corresponding diamidoketal or diamidothioketal products, respectively, under mild conditions (25 degrees C) and in good yield (60-80%). Mechanistic and kinetic studies of the latter reactions were consistent with a concerted process involving the nucleophilic attack of the DAC on the aforementioned substrates. While the diamidoketal decomposed to the corresponding urea (91% yield) at 25 degrees C, the diamidothioketals produced a thiolate which induced rearrangement to the corresponding ring-opened thioesters (78-90% yield) at elevated temperatures (60 degrees C). The DAC also inserted into the C(O)-C(O) bond of cyclic and acyclic diones as well as the C(O)-CR bond of a cyclopropenone under mild conditions (25-60 degrees C); the corresponding products were subsequently isolated in good yield (75-90%).
C1 [Wiggins, Kelly M.; Moerdyk, Jonathan P.; Bielawski, Christopher W.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.
RP Bielawski, CW (reprint author), Univ Texas Austin, Dept Chem & Biochem, 1 Univ Stn A1590, Austin, TX 78712 USA.
EM bielawski@cm.utexas.edu
FU National Science Foundation [CHE-0645563]; Robert A. Welch Foundation
   [F-1621]; Sloan Foundation
FX We are grateful to the National Science Foundation (CHE-0645563), the
   Robert A. Welch Foundation (F-1621), and the Sloan Foundation for their
   generous support.
CR Alonso F, 2004, CHEM REV, V104, P3079, DOI 10.1021/cr0201068
   ANDO W, 1972, J ORG CHEM, V37, P1721, DOI 10.1021/jo00976a010
   BATEMAN L, 1958, J CHEM SOC, P2866, DOI 10.1039/jr9580002866
   Beletskaya I, 2006, CHEM REV, V106, P2320, DOI 10.1021/cr050530j
   Beletskaya I, 1999, CHEM REV, V99, P3435, DOI 10.1021/cr9902594
   Beletskaya IP, 2007, EUR J ORG CHEM, P3431, DOI 10.1002/ejoc.200700119
   Benhamou L, 2010, ORGANOMETALLICS, V29, P2616, DOI 10.1021/om1003607
   Blake GA, 2012, ORGANOMETALLICS, V31, P3373, DOI 10.1021/om3001586
   Braun M, 2012, ORGANOMETALLICS, V31, P1927, DOI 10.1021/om201235c
   Braun M, 2010, ORGANOMETALLICS, V29, P4418, DOI 10.1021/om100728n
   CASERIO MC, 1985, J ORG CHEM, V50, P4390, DOI 10.1021/jo00222a041
   Cesar V, 2008, J AM CHEM SOC, V130, P11286, DOI 10.1021/ja804296t
   Cesar V, 2012, CHEM COMMUN, V48, P2349, DOI 10.1039/c2cc17870b
   Cesar V, 2010, CHEM-EUR J, V16, P11432, DOI 10.1002/chem.201000870
   Cesar V, 2010, EUR J INORG CHEM, P361, DOI 10.1002/ejic.200901113
   Clark PD, 1997, CATAL LETT, V47, P73, DOI 10.1023/A:1019067929473
   Cole ML, 2002, NEW J CHEM, V26, P1296, DOI 10.1039/b204422f
   CRABTREE RH, 1985, CHEM REV, V85, P245, DOI 10.1021/cr00068a002
   DESIRAJU GR, 1989, J AM CHEM SOC, V111, P8725, DOI 10.1021/ja00205a027
   Di Bussolo V, 2004, IND ENG CHEM RES, V69, P8702
   Diaper C. M, 2005, SCI SYNTH, V18, P1249
   Dong DW, 2005, J ORG CHEM, V70, P4535, DOI 10.1021/jo050271y
   Droge T, 2010, ANGEW CHEM INT EDIT, V49, P6940, DOI 10.1002/anie.201001865
   Dureen MA, 2009, INORG CHEM, V48, P9910, DOI 10.1021/ic901590s
   DUVIGNEAUD V, 1953, J AM CHEM SOC, V75, P4879
   FIELD L, 1975, J ORG CHEM, V40, P2774, DOI 10.1021/jo00907a015
   Frey GD, 2007, SCIENCE, V316, P439, DOI 10.1126/science.1141474
   Hartung J, 2002, SYNTHESIS-STUTTGART, P1469, DOI 10.1055/s-2002-33335
   Hirai K, 2009, CHEM REV, V109, P3275, DOI 10.1021/cr800518t
   Hobbs MG, 2010, CHEM-EUR J, V16, P14520, DOI 10.1002/chem.201001698
   Hobbs MG, 2010, NEW J CHEM, V34, P1295, DOI 10.1039/b9nj00771g
   HOFFMANN RW, 1971, ANGEW CHEM INT EDIT, V10, P529, DOI 10.1002/anie.197105291
   HOSPELHORN VD, 1954, J AM CHEM SOC, V76, P2827, DOI 10.1021/ja01639a066
   Hudnall TW, 2010, ORGANOMETALLICS, V29, P4569, DOI 10.1021/om1007665
   Hudnall TW, 2010, CHEM COMMUN, V46, P4288, DOI 10.1039/c0cc00638f
   Hudnall TW, 2010, J ORG CHEM, V75, P2763, DOI 10.1021/jo100427g
   Iglesias M, 2008, ORGANOMETALLICS, V27, P3279, DOI 10.1021/om800179t
   Ines B, 2010, ANGEW CHEM INT EDIT, V49, P8389, DOI 10.1002/anie.201004149
   JENNINGS PW, 1994, CHEM REV, V94, P2241, DOI 10.1021/cr00032a003
   Jun CH, 2004, PURE APPL CHEM, V76, P577, DOI 10.1351/pac200476030577
   JUN CH, 2004, CHEM SOC REV, V33, P610, DOI DOI 10.1039/B308864M
   Kirmse W, 2003, ANGEW CHEM INT EDIT, V42, P2117, DOI 10.1002/anie.200301638
   KOCH HP, 1949, J CHEM SOC, P401, DOI 10.1039/jr9490000401
   Kondo T, 2000, CHEM REV, V100, P3205, DOI 10.1021/cr9902749
   LECHER HZ, 1955, J ORG CHEM, V20, P475, DOI 10.1021/jo01122a010
   Lide D. R., 2012, CRC HDB CHEM PHYS, P9
   Luo Y.-R., 2012, CRC HDB CHEM PHYS, P9
   March J., 1992, ADV ORG CHEM, P406
   Martin D, 2011, CHEM SCI, V2, P389, DOI 10.1039/c0sc00388c
   Martin D, 2012, ANGEW CHEM INT EDIT, V51, P6172, DOI 10.1002/anie.201202137
   Melaimi M, 2010, ANGEW CHEM INT EDIT, V49, P8810, DOI 10.1002/anie.201000165
   Mitzel TM, 2002, J ORG CHEM, V67, P136, DOI 10.1021/jo015992l
   Miura M., 2005, TOP ORGANOMETAL CHEM, V14, P1, DOI DOI 10.1007/B104133
   Moerdyk JP, 2012, J AM CHEM SOC, V134, P6116, DOI 10.1021/ja3014105
   Moerdyk JP, 2012, NAT CHEM, V4, P275, DOI 10.1038/nchem.1267
   MOSS RA, 1976, J CHEM SOC CHEM COMM, P950, DOI 10.1039/c39760000950
   MOSS RA, 1981, J AM CHEM SOC, V103, P2413, DOI 10.1021/ja00399a049
   Murakami M, 1996, J AM CHEM SOC, V118, P8285, DOI 10.1021/ja9604525
   Murakami M, 2011, CHEM COMMUN, V47, P1100, DOI 10.1039/c0cc02566f
   Nair V, 2006, J ORG CHEM, V71, P2313, DOI 10.1021/jo052429k
   Ogawa A, 2000, J ORGANOMET CHEM, V611, P463, DOI 10.1016/S0022-328X(00)00469-1
   Park YJ, 2008, ACCOUNTS CHEM RES, V41, P222, DOI 10.1021/ar700133y
   PARKER AJ, 1959, CHEM REV, V59, P583, DOI 10.1021/cr50028a003
   Prabharasuth R, 2001, J ORG CHEM, V66, P5256, DOI 10.1021/jo010247u
   REED LJ, 1959, ORGANIC SULFUR COMPO, V1
   RUSSELL KE, 1954, J AM CHEM SOC, V76, P395, DOI 10.1021/ja01631a024
   Rybtchinski B, 1999, ANGEW CHEM INT EDIT, V38, P870, DOI 10.1002/(SICI)1521-3773(19990401)38:7<870::AID-ANIE870>3.0.CO;2-3
   RYLE AP, 1955, BIOCHEM J, V60, P535, DOI 10.1042/bj0600535
   Sawada Y, 2004, J ORG CHEM, V69, P2899, DOI 10.1021/jo0498009
   Scholl M, 1999, ORG LETT, V1, P953, DOI 10.1021/ol990909q
   SCHONBERG A, 1968, TETRAHEDRON LETT, P2487
   Schulz S, 2010, MAR DRUGS, V8, P2976, DOI 10.3390/md8122976
   Seiser T, 2009, ORG BIOMOL CHEM, V7, P2835, DOI 10.1039/b904405a
   Stephan DW, 2008, ORG BIOMOL CHEM, V6, P1535, DOI 10.1039/b802575b
   Stephan DW, 2010, ANGEW CHEM INT EDIT, V49, P46, DOI 10.1002/anie.200903708
   Thiel V, 2010, ORG BIOMOL CHEM, V8, P234, DOI 10.1039/b909133e
   Tomioka H, 1997, ACCOUNTS CHEM RES, V30, P315, DOI 10.1021/ar9602157
   Usugi S, 2004, ORG LETT, V6, P601, DOI 10.1021/ol036391e
   Vignolle J, 2009, CHEM REV, V109, P3333, DOI 10.1021/cr800549j
   WALLING C, 1957, FREE RADICALS SOLUTI
   Warkentin J., 1998, MACROMOL S, V134, P167
   Warkentin J, 2009, ACCOUNTS CHEM RES, V42, P205, DOI 10.1021/ar800072h
   Winter C, 2009, ANGEW CHEM INT EDIT, V48, P2460, DOI 10.1002/anie.200805578
   WORMELL RL, 1951, NATURE, V167, P817, DOI 10.1038/167817a0
   Yamagiwa N, 2007, BIOORG MED CHEM LETT, V17, P6197, DOI 10.1016/j.bmcl.2007.09.021
   Yamaguchi M, 2008, CHEM COMMUN, P35, DOI 10.1039/b710136h
   ZORA M, 1993, ORGANOMETALLICS, V12, P248, DOI 10.1021/om00026a002
   Zora M, 1999, ORGANOMETALLICS, V18, P4429, DOI 10.1021/om9905198
NR 88
TC 20
Z9 20
U1 6
U2 49
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2041-6520
EI 2041-6539
J9 CHEM SCI
JI Chem. Sci.
PY 2012
VL 3
IS 10
BP 2986
EP 2992
DI 10.1039/c2sc20639k
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 996MU
UT WOS:000308094100011
DA 2018-12-27
ER

PT J
AU Eul, M
   Pottgen, R
AF Eul, Matthias
   Poettgen, Rainer
TI RETRACTED: The solid solution CeAgxZn11-x (x <= 2.5) (Retracted article.
   See vol. 90, pg. 1711, 2015)
SO ZEITSCHRIFT FUR KRISTALLOGRAPHIE-CRYSTALLINE MATERIALS
LA English
DT Article; Retracted Publication
DE Solid Solution; Crystal Structure; Magnetic Properties
ID INTERMEDIATE-VALENT CERIUM; BACD11-TYPE STRUCTURE; CRYSTAL-STRUCTURE;
   ZINC-COMPOUNDS; COMPOUND; NAZN13; SUPERSTRUCTURE; EUAGXAL11-X;
   REFINEMENT; BEHAVIOR
AB Samples of the solid solution CeAgxZn11-x were prepared from the elements by high-frequency melting in sealed tantalum ampoules. The solid solution extends to about x approximate to 2.5. The samples crystallize with the tetragonal BaCd11 type structure, space group I4(1)/amd. The structure of CeAg2.03Zn8.97 was refined from single crystal X-ray diffractometer data: a = 1079.5(2), c = 694.5(1) pm, wR2 = 0.0226, 385F(2) values, and 21 variables. Two of the three crystallographically independent zinc sites of the CeZn11 structure show Zn/Ag mixing: 73(2)% Ag + 27(2)% Zn on 4b and 16.2(8)% Ag + 83.8(8)% Zn on 32i. Temperature dependent susceptibility data on the CeAg1.5Zn9.5 sample showed Curie-Weiss paramagnetism and an experimental magnetic moment of 2.58 mu(B)/Ce atom, indicating stable trivalent cerium. No magnetic ordering was evident down to 3 K.
C1 [Eul, Matthias; Poettgen, Rainer] Univ Munster, Inst Anorgan & Analyt Chem, D-48149 Munster, Germany.
RP Pottgen, R (reprint author), Univ Munster, Inst Anorgan & Analyt Chem, Corrensstr 30, D-48149 Munster, Germany.
EM pottgen@uni-muenster.de
FU Deutsche Forschungsgemeinschaft
FX This work was supported by the Deutsche Forschungsgemeinschaft.
CR CONTARDI V, 1983, J LESS-COMMON MET, V90, pL25, DOI 10.1016/0022-5088(83)90081-4
   CORDIER G, 1988, J MAGN MAGN MATER, V76-7, P653, DOI 10.1016/0304-8853(88)90517-3
   DENYSYUK OV, 1994, J SOLID STATE CHEM, V109, P172, DOI 10.1006/jssc.1994.1087
   Donohue J., 1974, STRUCTURES ELEMENTS
   Emsley J., 1999, ELEMENTS
   FRANK FC, 1958, ACTA CRYSTALLOGR, V11, P184, DOI 10.1107/S0365110X58000487
   FRANK FC, 1959, ACTA CRYSTALLOGR, V12, P483, DOI 10.1107/S0365110X59001499
   Gross N, 2002, CHEM MATER, V14, P2725, DOI 10.1021/cm021112n
   Haussermann U, 1998, J AM CHEM SOC, V120, P3867, DOI 10.1021/ja973335y
   Hermes W, 2008, Z NATURFORSCH B, V63, P537
   Hermes W, 2011, CHEM MATER, V23, P1096, DOI 10.1021/cm1016504
   Hoffmann RD, 2009, Z KRISTALLOGR, V224, P446, DOI 10.1524/zkri.2009.1183
   Kalychak YM, 2001, CHEM-EUR J, V7, P5343, DOI 10.1002/1521-3765(20011217)7:24<5343::AID-CHEM5343>3.0.CO;2-#
   KITAGAWA J, 1994, J PHYS SOC JPN, V63, P1281, DOI 10.1143/JPSJ.63.1281
   Kussmann D, 1998, Z ANORG ALLG CHEM, V624, P1727, DOI 10.1002/(SICI)1521-3749(1998110)624:11<1727::AID-ZAAC1727>3.0.CO;2-0
   Linsinger S, 2010, Z NATURFORSCH B, V65, P1185
   LOTT BG, 1966, ACTA CRYSTALLOGR, V20, P733, DOI 10.1107/S0365110X66001774
   Mishra R, 2008, Z ANORG ALLG CHEM, V634, P470, DOI 10.1002/zaac.200700448
   NAKAZAWA Y, 1993, J PHYS SOC JPN, V62, P3003, DOI 10.1143/JPSJ.62.3003
   Nesper R, 1991, ANGEW CHEM, V103, P805
   Niepmann D, 2001, Z NATURFORSCH B, V56, P1
   Olcese G.L., 1963, Atti della Accademia Nazionale dei Lincei. Rendiconti, Classe di Scienze Fisiche, Matematiche e Naturali, V35, P48
   PARTHE E, 1990, ELEMENTS INORGANIC S
   PEARSON WB, 1980, Z KRISTALLOGR, V152, P23, DOI 10.1524/zkri.1980.152.1-2.23
   Pottgen R, 1996, J MAGN MAGN MATER, V152, P196, DOI 10.1016/0304-8853(95)00430-0
   Pottgen R., 1999, GIT LABOR FACHZEITSC, V43, P133
   Riecken JF, 2007, Z ANORG ALLG CHEM, V633, P1094, DOI 10.1002/zaac.200700066
   SANDERSON MJ, 1953, ACTA CRYSTALLOGR, V6, P627, DOI 10.1107/S0365110X53001745
   Sheldrick G. M., 1997, SHELXL 97 PROGRAM RE
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277
   SHELDRICK GM, 1997, SHELXS 97 PROGRAM DE
   Singh S, 2001, J ALLOY COMPD, V317, P560, DOI 10.1016/S0925-8388(00)01388-8
   Wang F, 2010, CHEM MATER, V22, P1798, DOI 10.1021/cm903300y
   Wang F, 2009, CHEM MATER, V21, P230, DOI 10.1021/cm803021u
   YVON K, 1977, J APPL CRYSTALLOGR, V10, P73, DOI 10.1107/S0021889877012898
   Zelinska O, 2004, Z KRIST-NEW CRYST ST, V219, P357
   Zhak OV, 1999, J ALLOY COMPD, V291, P175, DOI 10.1016/S0925-8388(99)00253-4
NR 38
TC 0
Z9 0
U1 4
U2 9
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 2194-4946
EI 2196-7105
J9 Z KRIST-CRYST MATER
JI Z. Krist.-Cryst. Mater.
PY 2012
VL 227
IS 8
BP 540
EP 544
DI 10.1524/zkri.2012.1522
PN 2
PG 5
WC Crystallography
SC Crystallography
GA 010FY
UT WOS:000309081300006
DA 2018-12-27
ER

PT J
AU Lehner, AJ
   Braitsch, M
   Rohr, C
AF Lehner, Anna J.
   Braitsch, Milan
   Roehr, Caroline
TI RETRACTED: Hydrates of the alkali trioxidomonosulfidomolybdates and
   -tungstates: K-2[(Mo/W)O3S] center dot 1.5 H2O and (Rb/Cs)(2)[(Mo/W)O3S]
   center dot H2O (Retracted article. See vol. 90, pg. 1713, 2015)
SO ZEITSCHRIFT FUR KRISTALLOGRAPHIE-CRYSTALLINE MATERIALS
LA English
DT Article; Retracted Publication
DE Oxidosulfidomolybdates; Oxidosulfidotungstates; Hydrates
ID TRANSITION-METAL CHALCOGENIDES; VIBRATIONAL-SPECTRA; (NH4)2WO2S2
AB The trioxidomonosulfidomolybdate and -tungstate anions [(Mo/W)O3S](2-) are the first products formed when passing H2S gas through a solution of the oxidometalates. Their potassium, rubidium and cesium salt hydrates form as crystalline precipitates from these solutions depending on pH, the polarity of the solvent, educt concentrations and temperature. The structures of the sesqui(K) and mono- (Rb, Cs) hydrates have been determined by means of X-ray single crystal diffraction data. The potassium sesquihydrates K-2[(Mo/W)O3S] center dot 1.5 H2O are isotypic and crystallize with a new structure type (monoclinic, space group C2/c, M = Mo/W: a = 987.0(2)/993.13(11), b = 831.75(14)/831.10(11), c = 1868.9(4)/1865.2(2) pm, beta = 99.34(2)/9.153(8)degrees, R1 = 0.0352/0.0390). In the crystal structure the [(Mo/W)O3S](2-) anions are connected via hydrogen bonds to form columns along the c direction. Channels containing only water molecules run along the [101] direction. The dehydration process proceeds in a topotactic reaction between 60 to 95 degrees C and yields crystals of the anhydrous salts K-2[(Mo/W)O3S]. The two different K+ cations exhibit a 5 + 3 and 5 + 2 O/S coordination. The heavier alkali metal cations form the four monohydrates (Rb/Cs)(2) [(Mo/W)O3S] center dot H2O (trigonal rhombohedral, space group R (3) over barm) with lattice parameters for the Rb/Cs molybdates of a = 621.17(6)/643.3(4), c = 3377.9(4)/3566(4) pm (R1 = 0.0505/0.0660) and the tungstates of a = 642.80(3)/624.62(10), c = 3532.8(3)/3388.6(8) pm (R1 = 0.0348/0.0734). In the structures the 3m symmetrical tetrahedra are arranged to form double layers in such a way, that the O-3 bases of the tetrahedra are pointing towards each other in a staggered conformation. These double layers are stacked in the c direction in a rhombohedral sequence. In these hydrates, there are no distinct hyrdogen bonds. Instead, partially disordered pairs of H2O molecules are situated in large cavities between the double layers. With a number of 10, the cation coordination sphere is increased compared to the K salts. The crystallographic results are confirmed by vibrational spectroscopy (Raman/IR) and thermal analytical studies of the new compounds.
C1 [Lehner, Anna J.; Braitsch, Milan; Roehr, Caroline] Univ Freiburg, Inst Anorgan & Analyt Chem, D-79104 Freiburg, Germany.
RP Rohr, C (reprint author), Univ Freiburg, Inst Anorgan & Analyt Chem, Albertstr 21, D-79104 Freiburg, Germany.
EM caroline@ruby.chemie.uni-freiburg.de
FU Deutsche Forschungsgemeinschaft; Adolf-Messer-Stiftung; Verband der
   Chemischen Industrie
FX The authors would like to thank the 'Deutsche Forschungsgemeinschaft'
   and the 'Adolf-Messer-Stiftung' for financial support. AJL gratefully
   acknowledges the financial support from the 'Verband der Chemischen
   Industrie'.
CR AYMONINO PJ, 1969, Z ANORG ALLG CHEM, V371, P295, DOI 10.1002/zaac.19693710511
   Bernard J.-C., 1961, SOC CHIM, V5, P810
   Bernard J.-C., 1961, SOC CHIM, V5, P818
   Bernard J.-C., 1961, SOC CHIM, V5, P813
   Berzelius J. J., 1826, ANN PHYS, V83, P261
   Berzelius J. J., 1826, ANN PHYS, V84, P267
   Burnett M. N., 1996, ORNL6895
   CORLEIS E, 1886, LIEBIGS ANN CHEM, V232, P244
   DOWTY E, 1987, PHYS CHEM MINER, V14, P67, DOI 10.1007/BF00311150
   Dowty E., 2009, VIBRATZ V2 2
   El-Wareth A, 2006, SYNTHETIC COMMUN, V36, P987, DOI 10.1080/00397910500501243
   Finger LW, 2007, J APPL CRYSTALLOGR, V40, P188, DOI 10.1107/S0021889806051557
   GONZALEZ F, 1972, J CHEM SOC DALTON, P1416, DOI 10.1039/dt9720001416
   KREBS B, 1970, Z NATURFORSCH PT B, VB 25, P222
   KRUSS G, 1884, LIEBIGS ANN CHEM, V225, P1
   KUTZLER FW, 1981, J AM CHEM SOC, V103, P6083, DOI 10.1021/ja00410a016
   Lehner A.J., 2011, Z KRISTALLOGR, V31, P89
   Lehner A.J., 2010, ACTA CRYSTALLOGR A, VA66, pS186
   Lehner A.J., 2012, UNPUB
   Lehner A.J., 2012, Z ANORG ALLG C UNPUB
   Lehner AJ, 2012, Z NATURFORSCH B, V67, P127, DOI 10.5560/ZNB.2012.67b0127
   LEROY MJF, 1971, B SOC CHIM FR, P1183
   MULLER A, 1970, Z ANORG ALLG CHEM, V375, P87, DOI 10.1002/zaac.19703750113
   MULLER A, 1978, SPECTROCHIM ACTA A, V34, P361
   MULLER A, 1969, Z NATURFORSCH PT B, VB 24, P1482
   MULLER A, 1966, Z ANORG ALLG CHEM, V348, P71, DOI 10.1002/zaac.19663480109
   MULLER A, 1969, Z ANORG ALLG CHEM, V371, P136, DOI 10.1002/zaac.19693710305
   MULLER A, 1980, Z ANORG ALLG CHEM, V468, P193, DOI 10.1002/zaac.19804680124
   MULLER A, 1981, ANGEW CHEM, V93, P957
   Muller A., 1973, STRUCT BOND, P23
   Perel'man F.M., 1961, RUSS J INORG CHEM, V6, P1023
   SCHMIDT KH, 1974, COORDIN CHEM REV, V14, P115, DOI 10.1016/S0010-8545(00)80393-8
   Schnabel S, 2005, Z NATURFORSCH B, V60, P479
   Schnabel S., 2005, ACTA CRYSTALLOGR, pC383
   Schnabel S, 2008, Z NATURFORSCH B, V63, P819
   Schulze H., 1972, THESIS U DORTMUND
   SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551
   Sheldrick G. M., 1997, SHELXL 97 PROGRAM RE
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   STOE &Cie GmbH Darmstadt (Germany), 2005, X SHAP VERS 1 03 CRY
   Weinstock N., 1973, THESIS U DORTMUND
   Wells AF, 1995, STRUCTURAL INORGANIC
NR 42
TC 3
Z9 3
U1 4
U2 10
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 2194-4946
EI 2196-7105
J9 Z KRIST-CRYST MATER
JI Z. Krist.-Cryst. Mater.
PY 2012
VL 227
IS 8
BP 557
EP 568
DI 10.1524/zkri.2012.1495
PN 2
PG 12
WC Crystallography
SC Crystallography
GA 010FY
UT WOS:000309081300009
DA 2018-12-27
ER

PT J
AU Liu, G
   Xu, D
   Jiang, M
   Yuan, WE
AF Liu, Guang
   Xu, Dong
   Jiang, Mier
   Yuan, Weien
TI RETRACTED: Preparation of bioactive interferon alpha-loaded
   polysaccharide nanoparticles using a new approach of temperature-induced
   water phase/water-phase emulsion (Retracted article. See vol. 13, pg.
   2277, 2018)
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article; Retracted Publication
DE activity of interferon alpha-2b; interferon alpha-2b; stability of
   interferon alpha-2b; dextran; nanoparticles
ID BOVINE SERUM-ALBUMIN; SUSTAINED-RELEASE; PROTEIN DELIVERY;
   DRUG-DELIVERY; BIODEGRADABLE MICROSPHERES; PLGA MICROSPHERES; STABILITY;
   MICROPARTICLES; GAMMA; OIL
AB The aim of this study was to develop a temperature-induced polyethylene glycol (PEG) water phase/polysaccharide water-phase emulsion approach for preparing interferon alpha-2b (IFN alpha-2b)-loaded polysaccharide nanoparticles. IFN alpha-2b was first added to a mixture of an aqueous solution of PEG and polysaccharide. The mixture solution was stirred in a magnetic stirrer at a rate of 2000 rpm for 45 seconds at 0 degrees C +/- 0.5 degrees C. The solution was then prefrozen at different temperatures. The polysaccharide and IFN alpha-2b partitioned in the polysaccharide phase were preferentially separated out as the dispersed phase from the mixture solution during the prefreezing process. Then the prefrozen sample was freeze-dried to powder form. In order to remove the PEG, the powder was washed with dichloromethane. Once IFN alpha-2b was loaded into the polysaccharide nanoparticles, these nanoparticles could gain resistance to vapor-water and water-oil interfaces to protect IFN alpha-2b. The antiviral activity of the polysaccharide nanoparticles in vitro was highly preserved (above 97%), while the antiviral activity of IFN alpha-2b-loaded polysaccharide nanoparticles using the control water-in-oil-in-water method was only 71%. The antiviral activity of the IFN alpha-2b from blood samples was also determined on the basis of the activity to inhibit the cytopathic effects of the Sindbis virus on Follicular Lymphoma cells (FL). The antiviral activity in vivo was also highly preserved (above 97%). These polysaccharide nanoparticles could be processed to different formulations according to clinical requirements.
C1 [Liu, Guang; Jiang, Mier] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Vasc Surg, Shanghai 200011, Peoples R China.
   [Xu, Dong; Yuan, Weien] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China.
RP Jiang, M (reprint author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Vasc Surg, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.
EM mierjiang@yahoo.com.cn; yuanweien@126.com
FU National Natural Science Foundation of China [81170292, 81100223]; PhD
   Programs Foundation of the Ministry of Education of China
   [20090073120085]
FX The authors are grateful to the National Natural Science Foundation of
   China (81170292 and 81100223) and the PhD Programs Foundation of the
   Ministry of Education of China (20090073120085) for financial support.
   We also appreciate the help from faculties of the Instrumental Analysis
   Centre (IAC) of Shanghai Jiao Tong University.
CR Almeida AJ, 2007, ADV DRUG DELIVER REV, V59, P478, DOI 10.1016/j.addr.2007.04.007
   Bayraktar Y, 1996, J VIRAL HEPATITIS, V3, P129, DOI 10.1111/j.1365-2893.1996.tb00003.x
   Binsalamah ZM, 2011, INT J NANOMED, V6, P2667, DOI 10.2147/IJN.S25175
   Blanco-Prieto MJ, 2004, J CONTROL RELEASE, V96, P437, DOI 10.1016/j.jconrel.2004.02.015
   Breen ED, 2001, PHARMACEUT RES, V18, P1345, DOI 10.1023/A:1013054431517
   Castellanos IJ, 2001, J PHARM PHARMACOL, V53, P1099, DOI 10.1211/0022357011776487
   Cleland JL, 1996, PHARMACEUT RES, V13, P1464, DOI 10.1023/A:1016063109373
   Costantino HR, 2000, PHARMACEUT RES, V17, P1374, DOI 10.1023/A:1007570030368
   Crotts G, 1997, J CONTROL RELEASE, V44, P123, DOI 10.1016/S0168-3659(96)01511-8
   De Koker S, 2012, CHEM SOC REV, V41, P2867, DOI 10.1039/c2cs15296g
   DEGLING L, 1993, PHARMACEUT RES, V10, P783, DOI 10.1023/A:1018936522266
   Diwan M, 2003, INT J PHARMACEUT, V252, P111, DOI 10.1016/S0378-5173(02)00636-1
   GOMI K, 1985, JPN J CANCER RES, V76, P224
   Gu Z, 2011, CHEM SOC REV, V40, P3638, DOI 10.1039/c0cs00227e
   Jin T, 2008, J CONTROL RELEASE, V128, P50, DOI 10.1016/j.jconrel.2008.02.010
   Jung S, 2009, CHEM COMMUN, P5003, DOI 10.1039/b906268h
   Kim J, 2003, NANO LETT, V3, P1219, DOI 10.1021/nl034404b
   Kirkwood JM, 2002, LANCET, V359, P978, DOI 10.1016/S0140-6736(02)08001-7
   Lam XM, 2000, J CONTROL RELEASE, V67, P281, DOI 10.1016/S0168-3659(00)00224-8
   Lavasanifar A, 2002, ADV DRUG DELIVER REV, V54, P169, DOI 10.1016/S0169-409X(02)00015-7
   Lee JS, 2010, J MATER CHEM, V20, P8894, DOI 10.1039/c0jm01389g
   LEGHA SS, 1987, J CLIN ONCOL, V5, P1240, DOI 10.1200/JCO.1987.5.8.1240
   Lu W, 1995, PDA J Pharm Sci Technol, V49, P13
   Ma WX, 2012, INT J NANOMED, V7, P1475, DOI 10.2147/IJN.S29506
   Muhrer G, 2003, BIOTECHNOL PROGR, V19, P549, DOI 10.1021/bp0256317
   Mukherjee B, 2008, INT J NANOMED, V3, P487
   Ramakrishna R, 2010, ASIA-PAC J CLIN ONCO, V6, P210, DOI 10.1111/j.1743-7563.2010.01295.x
   Ren TT, 2011, MICRO NANO LETT, V6, P70, DOI 10.1049/mnl.2010.0107
   Rong XF, 2011, EUR J PHARM SCI, V43, P334, DOI 10.1016/j.ejps.2011.05.011
   Sanchez A, 2003, EUR J PHARM SCI, V18, P221, DOI 10.1016/S0928-0987(03)00019-8
   Shinde UP, 2012, J MATER CHEM, V22, P6072, DOI 10.1039/c2jm15419f
   Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9
   TABATA Y, 1989, PHARMACEUT RES, V6, P422, DOI 10.1023/A:1015991617704
   Taluja A, 2007, J MATER CHEM, V17, P4002, DOI 10.1039/b706939a
   Tan Q, 2011, INT J NANOMED, V6, P929, DOI 10.2147/IJN.S18753
   Uchida T, 1996, CHEM PHARM BULL, V44, P235
   Xu D, 2012, NANO-MICRO LETT, V4, P118, DOI 10.3786/nml.v4i2.p118-123
   Yang SX, 2009, EXPERT OPIN DRUG DEL, V6, P1123, DOI 10.1517/17425240903156374
   Yoshikawa Y, 1999, J DRUG TARGET, V6, P449, DOI 10.3109/10611869908996851
   Yoshioka S, 1997, PHARMACEUT RES, V14, P736, DOI 10.1023/A:1012194220970
   Yuan WE, 2007, INT J PHARM, V339, P76, DOI 10.1016/j.ijpharm.2007.02.018
   Yuan WE, 2012, INT J NANOMED, V7, P257, DOI 10.2147/IJN.S27621
   Yuan WE, 2011, INT J NANOMED, V6, P3139, DOI 10.2147/IJN.S26006
   Yuan WE, 2010, COLLOID SURFACE B, V79, P326, DOI 10.1016/j.colsurfb.2010.04.004
   Yuan WE, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/14/145601
   Yuan WE, 2009, INT J PHARMACEUT, V366, P154, DOI 10.1016/j.ijpharm.2008.09.007
   Yuan WE, 2009, EUR J PHARM SCI, V36, P212, DOI 10.1016/j.ejps.2008.08.009
   Zaslavsky B, 1995, AQUEOUS 2 PHASE PART
NR 48
TC 5
Z9 5
U1 3
U2 15
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2012
VL 7
BP 4841
EP 4848
DI 10.2147/IJN.S35502
PG 8
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 000PZ
UT WOS:000308400400001
PM 22973103
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Mokhtari, B
   Pourabdollah, K
AF Mokhtari, Bahram
   Pourabdollah, Kobra
TI RETRACTED: Emulsion Liquid Membranes for Effective Inclusion Extraction
   of Alkali Metals by Nanobaskets of Calixarene (Retracted article. See
   vol. 43, pg. 1576, 2013)
SO SYNTHESIS AND REACTIVITY IN INORGANIC METAL-ORGANIC AND NANO-METAL
   CHEMISTRY
LA English
DT Article; Retracted Publication
DE nano-basket; alkali metals; calixarene; emulsion liquid membrane;
   inclusion
ID IONIZABLE NANO-BASKETS; DIFFERENTIAL-PULSE VOLTAMMETRY; COMPETITIVE
   SOLVENT-EXTRACTION; S-BLOCK METALS; EARTH METALS; SEPARATION;
   OPTIMIZATION; TRANSPORT; RECOVERY; PHENOL
AB Nano-assisted inclusion separation of alkali metals from basic solutions was reported by inclusion-facilitated emulsion liquid membrane process. The novelty of this study is application of nano-baskets of calixarene in the selective and efficient separation of alkali metals as both the carrier and the surfactant. For this aim, diacid p-tert-calix[4]arene in the cone conformation was synthesized and the inclusion-extraction parameters were optimized. The selectivity of membrane over more than 10 interfering cations was examined and the results revealed that under the optimized operating condition, the degree of inclusion-extraction of alkali metals was as high as 98-99%.
C1 [Mokhtari, Bahram; Pourabdollah, Kobra] Islamic Azad Univ, RCRC, Shahreza Branch, Shahreza, Isfahan Provinc, Iran.
RP Pourabdollah, K (reprint author), Islamic Azad Univ, RCRC, Shahreza Branch, POB 8648146411,Pasdaran St, Shahreza, Isfahan Provinc, Iran.
EM pourabdollah@iaush.ac.ir
FU Shahreza branch, Islamic Azad University; Iran Nanotechnology Initiative
   Council
FX This work was supported by Shahreza branch, Islamic Azad University and
   Iran Nanotechnology Initiative Council.
CR Baeyer A, 1872, CHEM BER, V5, P280
   Bandyopadhyaya R, 1998, CHEM ENG SCI, V53, P2799, DOI 10.1016/S0009-2509(98)00110-9
   Bayraktar E, 2001, PROCESS BIOCHEM, V37, P169, DOI 10.1016/S0032-9592(01)00192-3
   Bhowal A, 2001, J MEMBRANE SCI, V188, P1, DOI 10.1016/S0376-7388(00)00586-X
   BORWANKAR RP, 1988, AICHE J, V34, P753, DOI 10.1002/aic.690340506
   Chakraborty M, 2003, COLLOID SURFACE A, V224, P65, DOI 10.1016/S0927-7757(03)00260-7
   Correia PFMM, 2003, J MEMBRANE SCI, V225, P41, DOI 10.1016/S0376-7388(03)00319-3
   Demirci A, 2003, BIOTECHNOL BIOENG, V83, P749, DOI 10.1002/bit.10722
   DING XC, 1991, J MEMBRANE SCI, V59, P183
   FLORENCE AT, 1981, J COLLOID INTERF SCI, V79, P243, DOI 10.1016/0021-9797(81)90066-7
   FRANKENFELD JW, 1981, SEPAR SCI TECHNOL, V16, P385, DOI 10.1080/01496398108068528
   GUTSCHE CD, 1978, J ORG CHEM, V43, P4905, DOI 10.1021/jo00419a052
   Habaki H, 2002, J MEMBRANE SCI, V208, P89, DOI 10.1016/S0376-7388(02)00179-5
   Hou WQ, 1996, CHEM ENG SCI, V51, P5043
   Ikeda H, 2003, CHEM-EUR J, V9, P4907, DOI 10.1002/chem.200304816
   ITOH H, 1990, BIOTECHNOL BIOENG, V35, P853, DOI 10.1002/bit.260350902
   Kaghazchi T, 2006, DESALINATION, V190, P161, DOI 10.1016/j.desal.2005.06.031
   Kumbasar RA, 2008, J MEMBRANE SCI, V325, P712, DOI 10.1016/j.memsci.2008.08.044
   Lee SC, 2008, J IND ENG CHEM, V14, P207, DOI 10.1016/j.jiec.2007.09.005
   LI NN, 1968, Patent No. 3410794
   Mohagheghi E, 2008, SEP SCI TECHNOL, V43, P3075, DOI 10.1080/01496390802219612
   Mokhtari B., 2012, J CHIL CHEM SOC, V58, P827
   Mokhtari B., 2011, ELECTROANAL, V24, P696
   Mokhtari B, 2012, J LIQ CHROMATOGR R T, V35, P2910, DOI 10.1080/10826076.2011.643524
   Mokhtari B, 2013, DRUG CHEM TOXICOL, V36, P119, DOI 10.3109/01480545.2011.653490
   Mokhtari B, 2012, J SCI FOOD AGR, V92, P2679, DOI 10.1002/jsfa.5688
   Mokhtari B, 2012, J CHIN CHEM SOC-TAIP, V59, P1058, DOI 10.1002/jccs.201100737
   Mokhtari B, 2012, ELECTROCHIM ACTA, V76, P363, DOI 10.1016/j.electacta.2012.05.028
   Mokhtari B, 2012, CAN J CHEM, V90, P560, DOI 10.1139/V2012-020
   Mokhtari B, 2012, B KOREAN CHEM SOC, V33, P1509, DOI 10.5012/bkcs.2012.33.5.1509
   Mokhtari B, 2012, SUPRAMOL CHEM, V24, P255, DOI 10.1080/10610278.2012.655278
   Mokhtari B, 2012, J INCL PHENOM MACRO, V74, P183, DOI 10.1007/s10847-011-0099-z
   Mokhtari B, 2012, J INCL PHENOM MACRO, V73, P1, DOI 10.1007/s10847-011-0062-z
   Mokhtari B, 2012, DESALINATION, V292, P1, DOI 10.1016/j.desal.2012.02.004
   Mokhtari B, 2011, J COORD CHEM, V64, P4079, DOI 10.1080/00958972.2011.636040
   Mokhtari B, 2011, J COORD CHEM, V64, P4029, DOI 10.1080/00958972.2011.635790
   Mokhtari B, 2012, J ELECTROCHEM SOC, V159, pK61, DOI 10.1149/2.048203jes
   Mokhtari B, 2011, J COORD CHEM, V64, P3081, DOI 10.1080/00958972.2011.613462
   Mokhtari B, 2011, J COORD CHEM, V64, P3189, DOI 10.1080/00958972.2011.616930
   Mokhtari B, 2012, J THERM ANAL CALORIM, V110, P1043, DOI 10.1007/s10973-011-2014-7
   Mokhtari B, 2012, J INCL PHENOM MACRO, V73, P269, DOI 10.1007/s10847-011-0052-1
   Mokhtari B, 2011, SUPRAMOL CHEM, V23, P696, DOI 10.1080/10610278.2011.605452
   Mokhtari B, 2011, B KOREAN CHEM SOC, V32, P3979, DOI 10.5012/bkcs.2011.32.11.3979
   Mokhtari B, 2011, B KOREAN CHEM SOC, V32, P3855, DOI 10.5012/bkcs.2011.32.11.3855
   Mokhtari B, 2011, ASIAN J CHEM, V23, P4717
   Mokhtari B, 2011, CHROMATOGRAPHIA, V73, P829, DOI 10.1007/s10337-011-1954-1
   Mokhtari B, 2011, J RADIOANAL NUCL CH, V287, P921, DOI 10.1007/s10967-010-0881-1
   Mokhtari B, 2011, J COORD CHEM, V64, P743, DOI 10.1080/00958972.2011.555538
   Mokhtari B, 2011, J INCL PHENOM MACRO, V69, P1, DOI 10.1007/s10847-010-9848-7
   Ortiz I, 2003, IND ENG CHEM RES, V42, P5891, DOI 10.1021/ie030212f
   Oshima T, 2003, J MEMBRANE SCI, V217, P87, DOI 10.1016/S0376-7388(03)00078-4
   Othman N, 2006, J MEMBRANE SCI, V282, P171, DOI 10.1016/j.memsci.2006.05.020
   Park Y, 2006, WATER RES, V40, P1763, DOI 10.1016/j.watres.2006.03.005
   REIS MTA, 1993, J MEMBRANE SCI, V84, P201
   STRZELBICKI J, 1984, SEPAR SCI TECHNOL, V19, P321, DOI 10.1080/01496398408068586
   Vasudevan M, 1996, IND ENG CHEM RES, V35, P1085, DOI 10.1021/ie950328e
   Venkateswaran P, 2005, HYDROMETALLURGY, V78, P107, DOI 10.1016/j.hydromet.2004.10.021
   Wan YH, 2002, J MEMBRANE SCI, V196, P185, DOI 10.1016/S0376-7388(01)00554-3
   Wang ZH, 1996, J MEMBRANE SCI, V109, P25, DOI 10.1016/0376-7388(95)00156-5
   YORDANOV B, 2007, J MEMBRANE SCI, V305, P313
   Zinke A, 1944, BER DTSCH CHEM GES, V77, P264, DOI 10.1002/cber.19440770322
NR 61
TC 10
Z9 10
U1 3
U2 13
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1553-3174
EI 1553-3182
J9 SYNTH REACT INORG M
JI Synth. React. Inorg. Met.-Org. Nano-Metal Chem.
PY 2012
VL 42
IS 7
BP 1013
EP 1021
DI 10.1080/15533174.2012.654879
PG 9
WC Chemistry, Inorganic & Nuclear; Nanoscience & Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA 990RU
UT WOS:000307649800020
DA 2018-12-27
ER

PT J
AU Law, BMF
   Shek, DTL
AF Law, Ben M. F.
   Shek, Daniel T. L.
TI RETRACTED: Process Evaluation of a Positive Youth Development Program in
   Hong Kong Based on Different Cohorts (Retracted article. See 806752,
   2014)
SO SCIENTIFIC WORLD JOURNAL
LA English
DT Article; Retracted Publication
ID EXPERIMENTAL IMPLEMENTATION PHASE; EFFECTIVE PREVENTION PROGRAMS;
   PROJECT PATHS; SOUTH-AFRICA; CULTURAL-ADAPTATION; SECONDARY-2 PROGRAM;
   OUTCOME EVALUATION; BRIDGING SCIENCE; INTERVENTION; FIDELITY
AB There are only a few process evaluation studies on positive youth development programs, particularly in the Chinese context. This study aims to examine the quality of implementation of a positive youth development program (the Project P. A. T. H. S.: Positive Adolescent Training through Holistic Social Programmes) and investigate the relationships among program adherence, process factors, implementation quality, and perceived program success. Process evaluation of 97 classroom-based teaching units was conducted in 62 schools from 2005 to 2009. Findings based on different cohorts generally showed that there were high overall program adherence and implementation quality. Program adherence and implementation process were highly correlated with quality and success of the program. Multiple regression analyses further showed that both implementation process and program adherence are significant predictors of program quality and success. Theoretical and practical implications of the findings are discussed.
C1 [Law, Ben M. F.] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Hong Kong, Peoples R China.
   [Shek, Daniel T. L.] Hong Kong Polytech Univ, Dept Appl Social Sci, Hong Kong, Hong Kong, Peoples R China.
   [Shek, Daniel T. L.] Hong Kong Polytech Univ, Publ Policy Res Inst, Hong Kong, Hong Kong, Peoples R China.
   [Shek, Daniel T. L.] E China Normal Univ, Dept Social Work, Shanghai 200062, Peoples R China.
   [Shek, Daniel T. L.] Kiang Wu Nursing Coll Macau, Macau, Peoples R China.
   [Shek, Daniel T. L.] Univ Kentucky, Coll Med, Kentucky Childrens Hosp, Div Adolescent Med,Dept Pediat, Lexington, KY USA.
RP Law, BMF (reprint author), Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Hong Kong, Peoples R China.
EM blaw@hku.hk
RI Shek, Daniel/N-9576-2014
OI Shek, Daniel/0000-0003-3359-6229
FU Hong Kong Jockey Club Charities Trust
FX The preparation for this paper and the Project P. A. T. H. S. were
   financially supported by the Hong Kong Jockey Club Charities Trust.
CR Allicock M, 2010, PATIENT EDUC COUNS, V81, P37, DOI 10.1016/j.pec.2009.11.018
   Beets M, 2008, PREV SCI, V9, P264, DOI 10.1007/s11121-008-0100-2
   Bertens MGBC, 2009, PATIENT EDUC COUNS, V75, P77, DOI 10.1016/j.pec.2008.09.002
   Bowes D, 2009, HEALTH PROMOT PRACT, V10, P394, DOI 10.1177/1524839907307886
   Braun SM, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-74
   Carswell Steven B, 2009, Educ Treat Children, V32, P445
   Cohen AN, 2010, J GEN INTERN MED, V25, P32, DOI 10.1007/s11606-009-1136-0
   Collaborative for Academic, 2010, SOC EM LEARN IMPL GU
   Dane AV, 1998, CLIN PSYCHOL REV, V18, P23, DOI 10.1016/S0272-7358(97)00043-3
   Domitrovich CE, 2000, J EDUC PSYCHOL CONS, V11, P193, DOI 10.1207/S1532768XJEPC1102_04
   Eisenberg M, 2009, HEALTH PROMOT PRACT, V10, P284, DOI 10.1177/1524839907301405
   Elliott DS, 2004, PREV SCI, V5, P47, DOI 10.1023/B:PREV.0000013981.28071.52
   Fagan AA, 2008, AM J COMMUN PSYCHOL, V41, P235, DOI 10.1007/s10464-008-9176-x
   Ferguson YO, 2009, AIDS EDUC PREV, V21, P141, DOI 10.1521/aeap.2009.21.2.141
   Franzen S, 2009, J PREV INTERV COMMUN, V37, P289, DOI 10.1080/10852350903196290
   Fraze J L, 2009, Public Health, V123 Suppl 1, pe23, DOI 10.1016/j.puhe.2009.08.006
   Gnich W, 2008, ADDICTION, V103, P1866, DOI 10.1111/j.1360-0443.2008.02316.x
   Griffin SF, 2010, HEALTH EDUC RES, V25, P325, DOI 10.1093/her/cyp017
   Harachi TW, 1999, AM J COMMUN PSYCHOL, V27, P711
   Hargreaves J, 2010, HEALTH EDUC RES, V25, P27, DOI 10.1093/her/cyp054
   Hart A, 2009, AM J HEALTH PROMOT, V23, P324, DOI 10.4278/ajhp.07022818
   Huryk LA, 2010, J NURS MANAGE, V18, P606, DOI 10.1111/j.1365-2834.2010.01084.x
   Johnson CC, 2010, J OCCUP ENVIRON MED, V52, pS14, DOI 10.1097/JOM.0b013e3181c81ade
   Karwalajtys T, 2009, J COMMUN HEALTH, V34, P336, DOI 10.1007/s10900-009-9149-5
   Konkle-Parker DJ, 2010, PATIENT EDUC COUNS, V78, P91, DOI 10.1016/j.pec.2009.04.010
   Kumpfer KL, 2008, EVAL HEALTH PROF, V31, P226, DOI 10.1177/0163278708315926
   Kwong K, 2009, J SMOK CESS, V4, P92, DOI 10.1375/jsc.4.2.92
   Leung T. K. P., 2003, EUR J MARKETING, V37, P1575, DOI DOI 10.1108/03090560310495366
   Louis RMS, 2008, ACCIDENT ANAL PREV, V40, P295, DOI 10.1016/j.aap.2007.06.004
   Mair FS, 2008, CHRONIC ILLN, V4, P110, DOI 10.1177/1742395308092482
   Muckelbauer R, 2009, CHILD CARE HLTH DEV, V35, P851, DOI 10.1111/j.1365-2214.2009.00993.x
   Mukoma W, 2009, SCAND J PUBLIC HEALT, V37, P37, DOI 10.1177/1403494808090631
   Nation M, 2003, AM PSYCHOL, V58, P449, DOI 10.1037/0003-066X.58.6-7.449
   Painter JE, 2010, HEALTH PROMOT PRACT, V11, p42S, DOI 10.1177/1524839909360171
   Quintiliani L, 2010, ADDICT BEHAV, V35, P1036, DOI 10.1016/j.addbeh.2010.06.003
   Ringwalt CL, 2003, HEALTH EDUC BEHAV, V30, P375, DOI 10.1177/1090198103253627
   Salmela S, 2009, HEALTH EDUC RES, V24, P237, DOI 10.1093/her/cyn015
   Saul J, 2008, AM J COMMUN PSYCHOL, V41, P165, DOI 10.1007/s10464-008-9169-9
   Saunders RP, 2005, HEALTH PROMOT PRACT, V6, P134, DOI 10.1177/1524839904273387
   Scheirer M. A., 1994, HDB PRACTICAL PROGRA
   Shek D. T. L., 2009, INT PUBLIC HLTH J, V1, P237
   Shek DTL, 2008, THESCIENTIFICWORLDJO, V8, P61, DOI 10.1100/tsw.2008.22
   Shek DTL, 2008, THESCIENTIFICWORLDJO, V8, P83, DOI 10.1100/tsw.2008.23
   Shek DTL, 2008, THESCIENTIFICWORLDJO, V8, P13, DOI 10.1100/tsw.2008.2
   Shek DTL, 2007, THESCIENTIFICWORLDJO, V7, P1024, DOI 10.1100/tsw.2007.161
   Shek DTL, 2006, THESCIENTIFICWORLDJO, V6, P2264, DOI 10.1100/tsw.2006.355
   Shek Daniel T L, 2006, Int J Adolesc Med Health, V18, P299
   Shek Daniel T L, 2006, Int J Adolesc Med Health, V18, P341
   Shek DTL, 2011, THESCIENTIFICWORLDJO, V11, P546, DOI 10.1100/tsw.2011.33
   Shek DTL, 2011, THESCIENTIFICWORLDJO, V11, P253, DOI 10.1100/tsw.2011.6
   Shek Daniel T L, 2008, Int J Adolesc Med Health, V20, P449, DOI 10.1515/IJAMH.2008.20.4.449
   Shek DTL, 2008, THESCIENTIFICWORLDJO, V8, P980, DOI 10.1100/tsw.2008.120
   Shevil E, 2009, PATIENT EDUC COUNS, V76, P77, DOI 10.1016/j.pec.2008.11.007
   Small S.A, 2007, WHAT WORKS WISCONSIN, V4, P1
   Stewart D., 2008, INT J MENT HEALTH PR, V10, P32, DOI DOI 10.1080/14623730.2008.9721755
   Tobler NS, 1999, SCHOOL PSYCHOL INT, V20, P105, DOI 10.1177/0143034399201008
   Wandersman A, 2008, AM J COMMUN PSYCHOL, V41, P171, DOI 10.1007/s10464-008-9174-z
   Wegner L, 2008, HEALTH EDUC RES, V23, P1085, DOI 10.1093/her/cym064
   Wilson DK, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-79
   Yamada J, 2010, WORLDV EVID-BASED NU, V7, P158, DOI 10.1111/j.1741-6787.2010.00182.x
   Zakrzewski S, 2009, ASSESS EVAL HIGH EDU, V34, P439, DOI 10.1080/02602930802071064
   Zani B, 2009, J PREV INTERV COMMUN, V38, P55, DOI 10.1080/10852350903393459
NR 62
TC 3
Z9 3
U1 2
U2 17
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1537-744X
J9 SCI WORLD J
JI Sci. World J.
PY 2012
AR 736730
DI 10.1100/2012/736730
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 982TJ
UT WOS:000307068000001
PM 22666147
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Chaney, S
AF Chaney, Sarah
TI RETRACTED: Swallow: Foreign Bodies, Their Ingestion, Inspiration, and
   the Curious Doctor who Extracted Them (Retracted article. See vol. 59,
   pg. 648, 2015)
SO MEDICAL HISTORY
LA English
DT Book Review; Retracted Publication
C1 [Chaney, Sarah] UCL, London WC1E 6BT, England.
RP Chaney, S (reprint author), UCL, London WC1E 6BT, England.
CR CAPPELLO M, 2011, SWALLOW FOREIGN BODI
NR 1
TC 1
Z9 1
U1 3
U2 6
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0025-7273
EI 2048-8343
J9 MED HIST
JI Med. Hist.
PD JAN
PY 2012
VL 56
IS 1
BP 107
EP 108
DI 10.1017/S0025727300000405
PG 2
WC Health Care Sciences & Services; History & Philosophy Of Science
SC Health Care Sciences & Services; History & Philosophy of Science
GA 971WU
UT WOS:000306237200017
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Landete, JM
AF Landete, J. M.
TI RETRACTED: Updated Knowledge about Polyphenols: Functions,
   Bioavailability, Metabolism, and Health (Retracted article. See vol. 55,
   pg. 1792, 2015)
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review; Retracted Publication
DE Polyphenols; functional food; antioxidant; bioavailability; health
ID GREEN TEA POLYPHENOLS; DIETARY FLAVONOID GLYCOSIDES;
   LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; RED WINE; IN-VITRO;
   PHENOLIC-COMPOUNDS; HUMAN PLASMA; (-)-EPIGALLOCATECHIN GALLATE;
   LACTOBACILLUS-PLANTARUM
AB Polyphenols are important constituents of food products of plant origin. Fruits, vegetables, and beverages are the main sources of phenolic compounds in the human diet. These compounds are directly related to sensory characteristics of foods such as flavor, astringency and color. Polyphenols are extensively metabolized both in tissues and by the colonic microbiota. Normally, the circulating polyphenols are glucuronidated and/or sulphated and no free aglycones are found in plasma. The presence of phenolic compounds in the diet is beneficial to health due to their antioxidant, anti-inflammatory, and vasodilating properties. The health effects of polyphenols depend on the amount consumed and their bioavailability. Moreover, polyphenols are able to kill or inhibit the growth of microorganisms such as bacteria, fungi, or protozoans. Some dietary polyphenols may have significant effects on the colonic flora providing a type of prebiotic effect. The anti-nutrient properties of polyphenols are also discussed in this paper. The antioxidant, anti-inflammatory, vasodilating, and prebiotic properties of polyphenols make them potential functional foods.
C1 CSIC, IATA, Dept Biotecnol Alimentos, Paterna 46980, Valencia, Spain.
RP Landete, JM (reprint author), CSIC, IATA, Dept Biotecnol Alimentos, Avda Agustin Escardino 7, Paterna 46980, Valencia, Spain.
EM btclan@iata.csic.es
FU Spanish Ministry of Science and Innovation [AGL2007-60975,
   CSD2007-00063]; "Juan de la Cierva" (MICINN, Spain)
FX This work was financed by funds of the AGL2007-60975 and Consolider
   Fun-C-Food CSD2007-00063 from the Spanish Ministry of Science and
   Innovation. Landete, JM. has a postdoctoral contract of the programme
   "Juan de la Cierva" (MICINN, Spain).
CR Aherne SA, 2002, NUTRITION, V18, P75, DOI 10.1016/S0899-9007(01)00695-5
   Ahmad N, 2000, ARCH BIOCHEM BIOPHYS, V376, P338, DOI 10.1006/abbi.2000.1742
   Aquilano K, 2008, NEUROCHEM RES, V33, P2416, DOI 10.1007/s11064-008-9697-6
   Arts ICW, 2001, EPIDEMIOLOGY, V12, P668, DOI 10.1097/00001648-200111000-00015
   Athar M, 2007, TOXICOL APPL PHARM, V224, P274, DOI 10.1016/j.taap.2006.12.025
   Atmaca A, 2008, MENOPAUSE, V15, P748, DOI 10.1097/gme.0b013e31815c1e7f
   Avila M, 2009, FOOD RES INT, V42, P1453, DOI 10.1016/j.foodres.2009.07.026
   BARRY TN, 1986, BRIT J NUTR, V55, P123, DOI 10.1079/BJN19860016
   Bell JRC, 2000, AM J CLIN NUTR, V71, P103
   Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S
   BOKKENHEUSER VD, 1987, BIOCHEM J, V248, P953, DOI 10.1042/bj2480953
   Bravo L, 1998, NUTR REV, V56, P317
   Cantuti-Castelvetri I, 2000, INT J DEV NEUROSCI, V18, P367, DOI 10.1016/S0736-5748(00)00008-3
   Castillo-Pichardo L, 2009, CLIN EXP METASTAS, V26, P505, DOI 10.1007/s10585-009-9250-2
   Chan MMY, 1998, BIOCHEM PHARMACOL, V55, P1955, DOI 10.1016/S0006-2952(98)00114-2
   Chang YC, 1995, J NAT PROD, V58, P1892, DOI 10.1021/np50126a014
   Chun OK, 2005, J SCI FOOD AGR, V85, P1715, DOI 10.1002/jsfa.2176
   Corder R, 2006, NATURE, V444, P566, DOI 10.1038/444566a
   Cotelle Nicole, 2001, Current Topics in Medicinal Chemistry, V1, P569, DOI 10.2174/1568026013394750
   Crespy V, 2001, J NUTR, V131, P3227
   Crouvezier S, 2001, CYTOKINE, V13, P280, DOI 10.1006/cyto.2000.0837
   Crozier A, 1997, J AGR FOOD CHEM, V45, P590, DOI 10.1021/jf960339y
   DAVIES NT, 1979, P NUTR SOC, V38, P121, DOI 10.1079/PNS19790016
   de Pascual-Teresa S, 2000, J AGR FOOD CHEM, V48, P5331, DOI 10.1021/jf000549h
   Dehkharghanian M, 2009, DAIRY SCI TECHNOL, V89, P485, DOI 10.1051/dst/2009024
   Diebolt M, 2001, HYPERTENSION, V38, P159, DOI 10.1161/01.HYP.38.2.159
   Dimitrios B, 2006, TRENDS FOOD SCI TECH, V17, P505, DOI 10.1016/j.tifs.2006.04.004
   Diplock AT, 1998, BRIT J NUTR, V80, pS77, DOI 10.1079/BJN19980106
   Donovan JL, 2001, J NUTR, V131, P1753
   Erlund I, 2000, EUR J CLIN PHARMACOL, V56, P545, DOI 10.1007/s002280000197
   FERRANDIZ ML, 1991, AGENTS ACTIONS, V32, P283, DOI 10.1007/BF01980887
   Fisher NDL, 2003, J HYPERTENS, V21, P2281, DOI 10.1097/01.hjh.0000084783.15238.eb
   Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211
   FRANKEL EN, 1993, LANCET, V341, P1103, DOI 10.1016/0140-6736(93)92472-6
   FUHRMAN B, 1995, AM J CLIN NUTR, V61, P549
   Fujimoto N, 2002, INT J ONCOL, V20, P1233
   Ganan M, 2009, FOOD CONTROL, V20, P739, DOI 10.1016/j.foodcont.2008.09.012
   Gee JM, 2001, CURR MED CHEM, V8, P1245, DOI 10.2174/0929867013372256
   GOTO K, 1998, ANN LONG TERM CARE, V6, P43
   GUGLER R, 1975, EUR J CLIN PHARMACOL, V9, P229, DOI 10.1007/BF00614022
   Halliwell B, 1999, NUTR REV, V57, P104
   Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004
   HARA H, 1995, J VET MED SCI, V57, P45, DOI 10.1292/jvms.57.45
   Hara H., 1997, J CELL BIOCHEM, V27, P52
   Hara-Kudo Y, 2005, J SCI FOOD AGR, V85, P2354, DOI 10.1002/jsfa.2259
   HERTOG MGL, 1993, NUTR CANCER, V20, P21, DOI 10.1080/01635589309514267
   Hsu FL, 2000, PLANTA MED, V66, P228, DOI 10.1055/s-2000-8561
   Hurrell RF, 1999, BRIT J NUTR, V81, P289
   Ishihara N, 2001, LIVEST PROD SCI, V68, P217, DOI 10.1016/S0301-6226(00)00233-5
   Ishimi Y, 2000, BIOCHEM BIOPH RES CO, V274, P697, DOI 10.1006/bbrc.2000.3175
   Ito Y, 2008, J AGR FOOD CHEM, V56, P12122, DOI 10.1021/jf802142n
   Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218
   Joseph JA, 2007, ANN NY ACAD SCI, V1100, P470, DOI 10.1196/annals.1395.052
   Justesen U, 1997, CANCER LETT, V114, P165, DOI 10.1016/S0304-3835(97)04651-X
   Justesen U., 2000, Scandinavian Journal of Nutrition/Naringsforskning, V44, P158
   Kang OH, 2009, PHARMACOL RES, V59, P330, DOI 10.1016/j.phrs.2009.01.009
   Karakaya S, 2004, CRIT REV FOOD SCI, V44, P453, DOI 10.1080/10408690490886683
   KATIYAR SK, 1995, J INVEST DERMATOL, V105, P394, DOI 10.1111/1523-1747.ep12321030
   Katiyar SK, 1996, INT J ONCOL, V8, P221
   KATIYAR SK, 1992, CANCER RES, V52, P6890
   Kaur C, 2001, INT J FOOD SCI TECH, V36, P703, DOI 10.1046/j.1365-2621.2001.00513.x
   Kuhnau J, 1976, World Rev Nutr Diet, V24, P117
   KUHR S, 1991, Z LEBENSM UNTERS FOR, V192, P526, DOI 10.1007/BF01202507
   KUMPULAINEN JT, 2001, 3 INT C NAT ANT ANT, P24
   Larrosa M, 2009, J AGR FOOD CHEM, V57, P2211, DOI 10.1021/jf803638d
   Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004
   Liu IM, 2000, BRIT J PHARMACOL, V129, P631, DOI 10.1038/sj.bjp.0703082
   Lopez-Velez M, 2003, CRIT REV FOOD SCI, V43, P233, DOI 10.1080/10408690390826509
   Lule SU, 2005, FOOD REV INT, V21, P367, DOI 10.1080/87559120500222862
   Lutz U, 1997, FUND APPL TOXICOL, V39, P131, DOI 10.1006/faat.1997.2354
   Ma DF, 2008, EUR J CLIN NUTR, V62, P155, DOI 10.1038/sj.ejcn.1602748
   Manach C, 2003, EUR J CLIN NUTR, V57, P235, DOI 10.1038/sj.ejcn.1601547
   Manach C, 2004, AM J CLIN NUTR, V79, P727
   Manach C, 2005, CURR OPIN LIPIDOL, V16, P77, DOI 10.1097/00041433-200502000-00013
   Manach C, 1998, FEBS LETT, V426, P331, DOI 10.1016/S0014-5793(98)00367-6
   Landete JM, 2007, J FOOD PROTECT, V70, P2670, DOI 10.4315/0362-028X-70.11.2670
   Martin A, 2000, J GERONTOL A-BIOL, V55, pB144, DOI 10.1093/gerona/55.3.B144
   Matsumoto M, 1999, CARIES RES, V33, P441, DOI 10.1159/000016549
   Matthews S, 1997, PHYTOCHEMISTRY, V45, P405, DOI 10.1016/S0031-9422(96)00873-4
   Medina E, 2009, INT J FOOD SCI TECH, V44, P1286, DOI 10.1111/j.1365-2621.2009.01950.x
   Mukherjee S, 2009, CURR NUTR FOOD SCI, V5, P149, DOI 10.2174/157340109788185580
   Mulder TP, 2005, AM J CLIN NUTR, V81, p256S, DOI 10.1093/ajcn/81.1.256S
   Nakajima Daito, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P285, DOI 10.2114/jpa.20.285
   Nemeth K, 2003, EUR J NUTR, V42, P29, DOI 10.1007/s00394-003-0397-3
   Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3
   Nigdikar SV, 1998, AM J CLIN NUTR, V68, P258
   Nohynek LJ, 2006, NUTR CANCER, V54, P18, DOI 10.1207/s15327914nc5401_4
   Nomura M, 2000, CARCINOGENESIS, V21, P1885, DOI 10.1093/carcin/21.10.1885
   Othman N. B., 2008, Bioresource Technology, V99, P2996
   Padilla E, 2005, EUR J PHARMACOL, V517, P84, DOI 10.1016/j.ejphar.2005.04.044
   Pan TH, 2003, DRUG AGING, V20, P711, DOI 10.2165/00002512-200320100-00001
   Pandey KB, 2009, CURR NUTR FOOD SCI, V5, P249, DOI 10.2174/157340109790218058
   Parkar SG, 2008, INT J FOOD MICROBIOL, V124, P295, DOI 10.1016/j.ijfoodmicro.2008.03.017
   Perron NR, 2009, CELL BIOCHEM BIOPHYS, V53, P75, DOI 10.1007/s12013-009-9043-x
   Peters U, 2001, AM J EPIDEMIOL, V154, P495, DOI 10.1093/aje/154.6.495
   Picherit C, 2000, J NUTR, V130, P1675
   Pietta P., 1996, SPECIAL PUBLICATION, P249, DOI Royal Society of Chemistry
   Piskula MK, 1999, FEBS LETT, V447, P287, DOI 10.1016/S0014-5793(99)00307-5
   Puupponen-Pimia R, 2005, J APPL MICROBIOL, V98, P991, DOI 10.1111/j.1365-2672.2005.02547.x
   Rasheed A, 1998, ARCH PHARM RES, V21, P348, DOI 10.1007/BF02975300
   Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022
   Rodriguez H, 2008, FOOD CHEM, V107, P1393, DOI 10.1016/j.foodchem.2007.09.067
   Rodriguez H, 2009, INT J FOOD MICROBIOL, V132, P79, DOI [10.1016/j.ijfoodmicro.2009.03.02, 10.1016/j.ijfoodmicro.2009.03.025]
   Vaquero MJR, 2007, FOOD CONTROL, V18, P93, DOI 10.1016/j.foodcont.2005.08.010
   Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957
   Rowland I, 2003, BRIT J NUTR, V89, pS45, DOI 10.1079/BJN2002796
   RUF JC, 1995, ARTERIOSCL THROM VAS, V15, P140, DOI 10.1161/01.ATV.15.1.140
   Russo P, 2001, NUTR METAB CARDIOVAS, V11, P25
   Santangelo Carmela, 2007, Ann Ist Super Sanita, V43, P394
   Saura-Calixto F, 2007, FOOD CHEM, V101, P492, DOI 10.1016/j.foodchem.2006.02.006
   Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S
   Scalbert A, 2005, AM J CLIN NUTR, V81, p215S, DOI 10.1093/ajcn/81.1.215S
   Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6
   Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096
   Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899
   Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d
   Setchell KDR, 2001, J NUTR, V131, p1362S, DOI 10.1093/jn/131.4.1362S
   Sharma A, 1996, NAHRUNG, V40, P182, DOI 10.1002/food.19960400404
   Simons AL, 2005, J AGR FOOD CHEM, V53, P4258, DOI 10.1021/jf0500177
   Spencer JPE, 2003, J NUTR, V133, p3255S
   STENSVOLD I, 1992, PREV MED, V21, P546, DOI 10.1016/0091-7435(92)90062-M
   Stevenson DE, 2007, CELL MOL LIFE SCI, V64, P2900, DOI 10.1007/s00018-007-7237-1
   Stoclet JC, 2004, EUR J PHARMACOL, V500, P299, DOI 10.1016/j.ejphar.2004.07.034
   Sturgeon C, 2002, CLIN CHEM, V48, P1151
   Sun GY, 1999, NEUROREPORT, V10, P93, DOI 10.1097/00001756-199901180-00018
   Tipoe George L., 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P135
   Tomas-Barberan FA, 2000, J SCI FOOD AGR, V80, P1024, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1024::AID-JSFA567>3.3.CO;2-J
   Vinson JA, 2001, J AGR FOOD CHEM, V49, P5315, DOI 10.1021/jf0009293
   Vinson JA, 2005, J AM COLL NUTR, V24, P44, DOI 10.1080/07315724.2005.10719442
   Vinson JA, 2002, ADV EXP MED BIOL, V505, P113
   WAGHORN GC, 1987, BRIT J NUTR, V57, P115, DOI 10.1079/BJN19870015
   Walle T, 2004, FREE RADICAL BIO MED, V36, P829, DOI 10.1016/j.freeradbiomed.2004.01.002
   Wang WB, 2006, J MED MICROBIOL, V55, P1313, DOI 10.1099/jmm.0.46661-0
   Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]
   Yang CS, 2001, ANNU REV NUTR, V21, P381, DOI 10.1146/annurev.nutr.21.1.381
   Zern TL, 2005, J NUTR, V135, P2291
   Zhu QY, 1999, J AGR FOOD CHEM, V47, P2020, DOI 10.1021/jf9809941
   Zunino SJ, 2007, J NUTR, V137, P1216
NR 138
TC 177
Z9 183
U1 8
U2 202
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PY 2012
VL 52
IS 10
BP 936
EP 948
DI 10.1080/10408398.2010.513779
PG 13
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA 968IW
UT WOS:000305973300004
PM 22747081
DA 2018-12-27
ER

PT J
AU Krznaric, Z
   Bender, DV
   Kunovic, A
   Kekez, D
   Stimac, D
AF Krznaric, Zeljko
   Bender, Darija Vranesic
   Kunovic, Ana
   Kekez, Domina
   Stimac, Davor
TI RETRACTED: Gut Microbiota and Obesity (Retracted article. See vol. 32,
   pg. 314, 2014)
SO DIGESTIVE DISEASES
LA English
DT Article; Retracted Publication
DE Obesity; Microbiota; Firmicutes; Bacteroidetes; Probiotics; Prebiotics
ID DIET-INDUCED OBESITY; LACTOBACILLUS-GASSERI SBT2055; WEIGHT-LOSS;
   ADIPOCYTE SIZE; MICE; OVERWEIGHT; DISEASE; ADULTS; RATS; SUPPLEMENTATION
AB The human gut hosts more than 100 trillion microorganisms, encompassing thousands of species. In adults, Bacteroidetes and Firmicutes are the most prevalent phyla. Experimental data in animal and observational studies in obese patients suggest that obesity is associated with substantial changes in the composition and metabolic function of the gut microbiota. The initial findings linked obesity with the decreased relative proportion of Bacteroidetes to Firmicutes. There are some authors who suggest that probiotics and prebiotics can modulate obesity-host metabolism in obesity and obesity-related disorders. Copyright (C) 2012 S. Karger AG, Basel
C1 [Krznaric, Zeljko] Univ Hosp Ctr Zagreb, Dept Gastroenterol & Hepatol, Ctr Clin Nutr, HR-10000 Zagreb, Croatia.
   [Krznaric, Zeljko; Bender, Darija Vranesic; Kunovic, Ana; Kekez, Domina] Univ Zagreb, Sch Med, Dept Gastroenterol & Hepatol, Zagreb 41001, Croatia.
   [Stimac, Davor] Univ Hosp Rijeka, Dept Internal Med, Rijeka, Croatia.
RP Krznaric, Z (reprint author), Univ Hosp Ctr Zagreb, Dept Gastroenterol & Hepatol, Ctr Clin Nutr, Kispaticeva 12, HR-10000 Zagreb, Croatia.
EM zeljko.krznaric1@zg.t-com.hr
RI Stimac, Davor/S-7420-2018
OI Stimac, Davor/0000-0001-8243-2453
CR Abrams SA, 2007, J PEDIATR-US, V151, P293, DOI 10.1016/j.jpeds.2007.03.043
   Andoh A, 2009, CURR PHARM DESIGN, V15, P2066, DOI 10.2174/138161209788489186
   Andreasen AS, 2010, BRIT J NUTR, V104, P1831, DOI 10.1017/S0007114510002874
   Aronsson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013087
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104
   Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095
   Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164
   Delzenne NM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S10
   Delzenne NM, 2010, INT DAIRY J, V20, P277, DOI 10.1016/j.idairyj.2009.11.006
   Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155
   Genta S, 2009, CLIN NUTR, V28, P182, DOI 10.1016/j.clnu.2009.01.013
   Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505
   Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19
   Kang JH, 2010, J MICROBIOL, V48, P712, DOI 10.1007/s12275-010-0363-8
   Karlsson CLJ, 2011, BRIT J NUTR, V106, P887, DOI 10.1017/S0007114511001036
   Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085
   Lee HY, 2006, BBA-MOL CELL BIOL L, V1761, P736, DOI 10.1016/j.bbalip.2006.05.007
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/nature4441022a
   Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106
   Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556
   Nadal I, 2009, INT J OBESITY, V33, P758, DOI 10.1038/ijo.2008.260
   Naito E, 2011, J APPL MICROBIOL, V110, P650, DOI 10.1111/j.1365-2672.2010.04922.x
   Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080
   Neyrinck AM, 2010, CURR OPIN CLIN NUTR, V13, P722, DOI 10.1097/MCO.0b013e32833ec3fb
   Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465
   Rastmanesh R, 2011, CHEM-BIOL INTERACT, V189, P1, DOI 10.1016/j.cbi.2010.10.002
   Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112
   Sato M, 2008, BRIT J NUTR, V99, P1013, DOI 10.1017/S0007114507839006
   Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167
   Takemura N, 2010, EXP BIOL MED, V235, P849, DOI 10.1258/ebm.2010.009377
   Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9
   Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106
   Zoetendal EG, 2006, MOL MICROBIOL, V59, P1639, DOI 10.1111/j.1365-2958.20006.05056.x
NR 40
TC 16
Z9 16
U1 2
U2 18
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0257-2753
EI 1421-9875
J9 DIGEST DIS
JI Dig. Dis.
PY 2012
VL 30
IS 2
BP 196
EP 200
DI 10.1159/000336965
PG 5
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 964FR
UT WOS:000305679900012
PM 22722438
DA 2018-12-27
ER

PT J
AU Cardenas, WHZ
   Mamani, JB
   Sibov, TT
   Caous, CA
   Amaro, E
   Gamarra, LF
AF Cardenas, Walter H. Z.
   Mamani, Javier B.
   Sibov, Tatiana T.
   Caous, Cristofer A.
   Amaro, Edson, Jr.
   Gamarra, Lionel F.
TI RETRACTED: Particokinetics: computational analysis of the
   superparamagnetic iron oxide nanoparticles deposition process (Retracted
   article. See vol. 7, pg. 5107, 2012)
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article; Retracted Publication
DE magnetite; nanoparticles; diffusion; sedimentation; agglomerates;
   computational modeling; cellular labeling; magnetic resonance imaging
ID IN-VITRO; MAGNETIC NANOPARTICLES; PARTICLE-SIZE; HYPERTHERMIA; THERAPY;
   ENDOCYTOSIS; TOXICITY; DELIVERY; CANCER; AGENTS
AB Background: Nanoparticles in suspension are often utilized for intracellular labeling and evaluation of toxicity in experiments conducted in vitro. The purpose of this study was to undertake a computational modeling analysis of the deposition kinetics of a magnetite nanoparticle agglomerate in cell culture medium.
   Methods: Finite difference methods and the Crank-Nicolson algorithm were used to solve the equation of mass transport in order to analyze concentration profiles and dose deposition. Theoretical data were confirmed by experimental magnetic resonance imaging.
   Results: Different behavior in the dose fraction deposited was found for magnetic nanoparticles up to 50 nm in diameter when compared with magnetic nanoparticles of a larger diameter. Small changes in the dispersion factor cause variations of up to 22% in the dose deposited. The experimental data confirmed the theoretical results.
   Conclusion: These findings are important in planning for nanomaterial absorption, because they provide valuable information for efficient intracellular labeling and control toxicity. This model enables determination of the in vitro transport behavior of specific magnetic nanoparticles, which is also relevant to other models that use cellular components and particle absorption processes.
C1 [Cardenas, Walter H. Z.; Mamani, Javier B.; Sibov, Tatiana T.; Caous, Cristofer A.; Amaro, Edson, Jr.; Gamarra, Lionel F.] Hosp Israelita Albert Einstein, Inst Cerebro, BR-05651901 Sao Paulo, Brazil.
RP Cardenas, WHZ (reprint author), Hosp Israelita Albert Einstein, Inst Cerebro, Av Albert Einstein 627-701,Piso Chinuch 2S, BR-05651901 Sao Paulo, Brazil.
EM walter.cardenas@einstein.br
RI Amaro Jr, Edson/B-6653-2009
OI Amaro Jr, Edson/0000-0002-5889-1382; gamarra, lionel/0000-0002-3910-0047
FU Albert Einstein Israeli Institute of Teaching and Research (IIEPAE);
   Coordination of Improvement of Higher Education Personnel (CAPES);
   National Counsel of Technological and Scientific Development (CNPq);
   Financier of Studies and Projects (FINEP); Sao Paulo Research Fundation
   (FAPESP)
FX This work was supported by Albert Einstein Israeli Institute of Teaching
   and Research (IIEPAE). The financial support from the Brazilian
   agencies: Coordination of Improvement of Higher Education Personnel
   (CAPES), National Counsel of Technological and Scientific Development
   (CNPq), Financier of Studies and Projects (FINEP), and Sao Paulo
   Research Fundation (FAPESP).
CR Alger JR, 2001, J MAGN RESON IMAGING, V14, P586, DOI 10.1002/jmri.1223
   Bachmann R, 2002, J MAGN RESON IMAGING, V16, P190, DOI 10.1002/jmri.10149
   Bergna HE, 2006, COLLOIDAL SILICA FUN
   Bonnemain B, 1998, J DRUG TARGET, V6, P167, DOI 10.3109/10611869808997890
   Boutry S, 2009, CONTRAST MEDIA MOL I, V4, P299, DOI 10.1002/cmmi.291
   Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI [10.1038/nnano.2011.58, 10.1038/NNANO.2011.58]
   Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451
   Decuzzi P, 2008, BIOPHYS J, V94, P3790, DOI 10.1529/biophysj.107.120238
   Frienlander SK, 2003, NANOPARTICLE AEROSOL
   Gregory J., 2006, PARTICLES WATER PROP
   Gupta AK, 2004, IEEE T NANOBIOSCI, V3, P66, DOI 10.1109/TNB.2003.820277
   Heine DR, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3419071
   Ito A, 2005, J BIOSCI BIOENG, V100, P1, DOI 10.1263/jbb.100.1
   Ito A, 2004, CANCER LETT, V212, P167, DOI 10.1016/j.canlet.2004.03.038
   Johnson CP, 1996, ENVIRON SCI TECHNOL, V30, P1911, DOI 10.1021/es950604g
   Jordan A, 2001, J MAGN MAGN MATER, V225, P118, DOI 10.1016/S0304-8853(00)01239-7
   Kato H, 2009, TOXICOL IN VITRO, V23, P927, DOI 10.1016/j.tiv.2009.04.006
   Kircher MF, 2003, CANCER RES, V63, P6838
   Kong G, 2000, CANCER RES, V60, P4440
   Kopelman R, 2005, J MAGN MAGN MATER, V293, P404, DOI 10.1016/j.jmmm.2005.02.061
   Limbach LK, 2005, ENVIRON SCI TECHNOL, V39, P9370, DOI 10.1021/es051043o
   Morrison ID, 2002, COLLOIDAL DISPERSION
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339
   Portet D, 2001, J COLLOID INTERF SCI, V238, P37, DOI 10.1006/jcis.2001.7500
   Press WH, 1992, NUMERICAL RECIPES FO, V1, P42
   Sayes CM, 2007, TOXICOL SCI, V97, P163, DOI 10.1093/toxsci/kfm018
   Smoluchowski Mv, 1916, KOLLOID Z, V18, P190
   Sousa MH, 2001, J MAGN MAGN MATER, V225, P67, DOI 10.1016/S0304-8853(00)01229-4
   Sterling MC, 2005, WATER RES, V39, P1818, DOI 10.1016/j.watres.2005.02.007
   Sun W, 2008, ANAL BIOANAL CHEM, V391, P2119, DOI 10.1007/s00216-008-2162-1
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   Teeguarden JG, 2007, TOXICOL SCI, V95, P300, DOI 10.1093/toxsci/kfl165
   Wilhelm C, 2002, LANGMUIR, V18, P8148, DOI 10.1021/la0257337
   Wu EX, 2004, J MAGN RESON IMAGING, V19, P50, DOI 10.1002/jmri.10426
   Zhang S, 2008, ADV MATER, V20, P1
NR 36
TC 4
Z9 4
U1 2
U2 24
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2012
VL 7
BP 2699
EP 2712
DI 10.2147/IJN.S30074
PG 14
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 965IU
UT WOS:000305761900001
PM 22745539
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Yousefi, Y
   Muminov, KK
AF Yousefi, Yousef
   Muminov, Khikmat Kh
TI RETRACTED: Quadrupole Excitation in Tunnel Splitting Oscillation in
   Nanoparticle Mn-12 (Retracted article. See 191840, 2015)
SO ADVANCES IN CONDENSED MATTER PHYSICS
LA English
DT Article; Retracted Publication
ID MAGNETIZATION; MOLECULES
AB We analyze the interference between tunneling paths that occur for a spin system with special Hamiltonian both for dipole and quadrupole excitations. Using an instanton approach, we find that as the strength of the second-order transverse anisotropy is increased, the tunnel splitting for both excitations is modulated, with zeros occurring periodically and the number of quenching points for quadrupole excitation decreasing. This effect results from the interference of four tunneling paths connecting easy-axis spin orientations and occurs in the absence of any magnetic field.
C1 [Yousefi, Yousef; Muminov, Khikmat Kh] Acad Sci Republ Tajikistan, Phys Tech Inst, Dushanbe, Tajikistan.
RP Yousefi, Y (reprint author), Acad Sci Republ Tajikistan, Phys Tech Inst, Aini Ave 299-1, Dushanbe, Tajikistan.
EM yousof54@yahoo.com
CR BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023
   CHUDNOVSKY EM, 1988, PHYS REV LETT, V60, P661, DOI 10.1103/PhysRevLett.60.661
   Chudnovsky EM, 2000, EUROPHYS LETT, V50, P395, DOI 10.1209/epl/i2000-00282-0
   Felsager B., 1998, GEOMETRY PARTICLE FI
   Foss-Feig MS, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/27002
   Friedman JR, 1996, PHYS REV LETT, V76, P3830, DOI 10.1103/PhysRevLett.76.3830
   Garg A., 2003, PHYS REV B, V67
   Hernandez JM, 1996, EUROPHYS LETT, V35, P301, DOI 10.1209/epl/i1996-00570-7
   Thomas L, 1996, NATURE, V383, P145, DOI 10.1038/383145a0
NR 9
TC 1
Z9 1
U1 2
U2 9
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-8108
EI 1687-8124
J9 ADV COND MATTER PHYS
JI Adv. Condens. Matter Phys.
PY 2012
AR 530765
DI 10.1155/2012/530765
PG 4
WC Physics, Condensed Matter
SC Physics
GA 954GI
UT WOS:000304934200001
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Li, YP
   Han, GY
AF Li, Yanping
   Han, Gaoyi
TI RETRACTED: Ionic liquid-functionalized graphene for fabricating an
   amperometric acetylcholinesterase biosensor (Retracted article. See vol.
   138, pg. 7422, 2013)
SO ANALYST
LA English
DT Article; Retracted Publication
ID DIRECT ELECTROCHEMISTRY; MODIFIED ELECTRODE; ORGANOPHOSPHOROUS
   PESTICIDES; HORSERADISH-PEROXIDASE; GOLD NANOPARTICLES; GLUCOSE-OXIDASE;
   NERVE AGENTS; CHITOSAN; CARBARYL; NANOCOMPOSITES
AB This work reports a sensitive amperometric biosensor for organophosphate pesticides (OPs) fabricated by modifying a glassy carbon electrode with acetylcholinesterase (AChE) immobilized on ionic lwiquid-functionalized graphene (IL-G). The functionalized graphene sheets had good dispersibility and longterm stability in various solvents. The as-prepared biosensor showed high affinity to acetylthiocholine (ATCl) with a Michaelis-Menten constant (K-m) value of 0.77 mM. Furthermore, based on the inhibition by OPs of the enzymatic activity of the immobilized AChE, and using carbaryl as a model compound, the inhibition of carbaryl was proportional to its concentration ranging from 0.0025 to 0.48 and 0.48 to 1.42 mu g mL(-1) with a detection limit of 0.8 ng mL(-1) (S/N = 3). The developed biosensor exhibited a good performance for OPs detection, including good reproducibility and acceptable stability, which provided a new and promising tool for the analysis of enzyme inhibitors.
C1 [Li, Yanping; Han, Gaoyi] Shanxi Univ, Inst Mol Sci Chem Biol & Mol Engn, Lab Educ Minist, Taiyuan 030006, Peoples R China.
RP Han, GY (reprint author), Shanxi Univ, Inst Mol Sci Chem Biol & Mol Engn, Lab Educ Minist, Taiyuan 030006, Peoples R China.
EM han_gaoyis@sxu.edu.cn
FU National Natural Science Foundation of China [21073115, 20604014];
   Natural Science Foundation of Shanxi province [2007021008]; Program for
   New Century Excellent Talents in University of China; Program for the
   Top Young and Middle-aged Innovative Talents of Higher Learning
   Institutions of Shanxi province (TYMIT and TYAL)
FX The authors thank the National Natural Science Foundation of China
   (21073115 and 20604014), Natural Science Foundation (2007021008) of
   Shanxi province, the Program for New Century Excellent Talents in
   University (NCET-10-0926) of China and the Program for the Top Young and
   Middle-aged Innovative Talents of Higher Learning Institutions of Shanxi
   province (TYMIT and TYAL).
CR Arduini F, 2006, ANAL CHIM ACTA, V580, P155, DOI 10.1016/j.aca.2006.07.052
   BERNABEI M, 1993, BIOSENS BIOELECTRON, V8, P265, DOI 10.1016/0956-5663(93)80014-G
   Bunch JS, 2007, SCIENCE, V315, P490, DOI 10.1126/science.1136836
   Chen H, 2008, ADV MATER, V20, P3557, DOI 10.1002/adma.200800757
   Chen J, 2005, CHEM-EUR J, V11, P1467, DOI 10.1002/chem.200400956
   Chen PS, 2006, TALANTA, V69, P669, DOI 10.1016/j.talanta.2005.10.042
   Du D, 2007, SENSOR ACTUAT B-CHEM, V127, P531, DOI 10.1016/j.snb.2007.05.006
   Du D, 2007, BIOSENS BIOELECTRON, V23, P130, DOI 10.1016/j.bios.2007.03.008
   Du D, 2007, COLLOID SURFACE B, V58, P145, DOI 10.1016/j.colsurfb.2007.03.006
   Du D, 2007, J ELECTROANAL CHEM, V605, P53, DOI 10.1016/j.jelechem.2007.03.013
   Du D, 2010, SENSOR ACTUAT B-CHEM, V146, P337, DOI 10.1016/j.snb.2010.02.053
   Du D, 2010, SENSOR ACTUAT B-CHEM, V143, P524, DOI 10.1016/j.snb.2009.09.051
   Du D, 2008, J ELECTROANAL CHEM, V623, P81, DOI 10.1016/j.jelechem.2008.06.020
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Gilje S, 2007, NANO LETT, V7, P3394, DOI 10.1021/nl0717715
   Gong JM, 2009, ELECTROCHEM COMMUN, V11, P1873, DOI 10.1016/j.elecom.2009.08.005
   Gong JM, 2009, BIOSENS BIOELECTRON, V24, P2285, DOI 10.1016/j.bios.2008.11.012
   Guo HL, 2009, ACS NANO, V3, P2653, DOI 10.1021/nn900227d
   Joshi PP, 2005, ANAL CHEM, V77, P3183, DOI 10.1021/ac0484169
   Kang XH, 2009, BIOSENS BIOELECTRON, V25, P901, DOI 10.1016/j.bios.2009.09.004
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Li XL, 2008, NAT NANOTECHNOL, V3, P538, DOI 10.1038/nnano.2008.210
   Lin TJ, 2006, BIOSENS BIOELECTRON, V22, P513, DOI 10.1016/j.bios.2006.05.007
   Liu GD, 2006, ANAL CHEM, V78, P835, DOI 10.1021/ac051559q
   Liu T, 2011, SENSOR ACTUAT B-CHEM, V160, P1255, DOI 10.1016/j.snb.2011.09.059
   Liu Y, 2006, SENSOR ACTUAT B-CHEM, V115, P109, DOI 10.1016/j.snb.2005.08.048
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Lu XB, 2006, ELECTROCHEM COMMUN, V8, P874, DOI 10.1016/j.elecom.2006.03.026
   Maleki N, 2006, ANAL CHEM, V78, P3820, DOI 10.1021/ac060070+
   Mohanty N, 2008, NANO LETT, V8, P4469, DOI 10.1021/nl802412n
   Moraes FC, 2009, TALANTA, V79, P1406, DOI 10.1016/j.talanta.2009.06.013
   Mulchandani A, 1998, ANAL CHEM, V70, P4140, DOI 10.1021/ac9805201
   Shan CS, 2010, BIOSENS BIOELECTRON, V25, P1504, DOI 10.1016/j.bios.2009.11.009
   Shan CS, 2009, ANAL CHEM, V81, P2378, DOI 10.1021/ac802193c
   Shang NG, 2008, ADV FUNCT MATER, V18, P3506, DOI 10.1002/adfm.200800951
   Sinha R, 2010, ANAL CHIM ACTA, V661, P195, DOI 10.1016/j.aca.2009.12.020
   Sotiropoulou S, 2005, BIOSENS BIOELECTRON, V20, P2347, DOI 10.1016/j.bios.2004.08.026
   Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969
   Sun W, 2007, ELECTROCHEM COMMUN, V9, P1159, DOI 10.1016/j.elecom.2007.01.003
   Tsogas GZ, 2006, ANAL CHIM ACTA, V573, P354, DOI 10.1016/j.aca.2005.11.058
   Wang K, 2011, ANALYST, V136, P3349, DOI 10.1039/c1an15227k
   Wang K, 2011, ANAL CHIM ACTA, V695, P84, DOI 10.1016/j.aca.2011.03.042
   Wang K, 2011, BIOSENS BIOELECTRON, V26, P2252, DOI 10.1016/j.bios.2010.09.043
   Wang Y, 2011, J MATER CHEM, V21, P5319, DOI 10.1039/c0jm03441j
   Wei D, 2008, ANAL CHIM ACTA, V607, P126, DOI 10.1016/j.aca.2007.12.011
   Williams G, 2008, ACS NANO, V2, P1487, DOI 10.1021/nn800251f
   Yang HF, 2009, CHEM COMMUN, P3880, DOI 10.1039/b905085j
   Zhang MG, 2004, ANAL CHEM, V76, P5045, DOI 10.1021/ac049519u
   Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235
NR 49
TC 15
Z9 15
U1 5
U2 72
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
EI 1364-5528
J9 ANALYST
JI Analyst
PY 2012
VL 137
IS 13
BP 3160
EP 3165
DI 10.1039/c2an35065c
PG 6
WC Chemistry, Analytical
SC Chemistry
GA 953ZN
UT WOS:000304913100035
PM 22624144
DA 2018-12-27
ER

PT J
AU Albada, A
   van Dulmen, S
   Bensing, JM
   Ausems, MGEM
AF Albada, Akke
   van Dulmen, Sandra
   Bensing, Jozien M.
   Ausems, Margreet G. E. M.
TI RETRACTED: Effects of a pre-visit educational website on information
   recall and needs fulfilment in breast cancer genetic counselling, a
   randomized controlled trial (Retracted article. See vol. 14, 402, 2012)
SO BREAST CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID MEDICAL INFORMATION; PSYCHOSOCIAL-ASPECTS; OVARIAN-CANCER;
   COMMUNICATION; SUSCEPTIBILITY; CONSULTATION; SATISFACTION; PREFERENCES;
   MEMORY; IMPACT
AB Introduction: Pre-visit education which helps counselees to prepare for their first visit for breast cancer genetic counseling might enhance information recall and needs fulfilment. This study assessed the effects of a pre-visit website with tailored information and question prompt sheet (QPS), named E-info gene(ca).
   Methods: A total of 197 counselees were randomized to receive usual care (UC) or UC plus E-info gene(ca). All counselees completed a pre- and post-visit questionnaire and visits were videotaped. We studied effects on counselees' information recall, knowledge about breast cancer and heredity, fulfillment of needs, risk perception alignment, anxiety and perceived personal control, using multilevel regression analyses.
   Results: Intent-to-treat analysis showed that counselees in the intervention group (n = 103) had higher levels of recall of information from the consultation (beta = .32; confidence interval (CI): .04 to .60; P = .02; d = .17) and post-visit knowledge of breast cancer and heredity (beta = .30; CI: .03 to .57; P = .03) than counselees in the UC group (n = 94). Also, intervention group counselees reported better fulfilment of information needs (beta = .31; CI:.03 to .60; P = .03). The effects of the intervention were strongest for those counselees who did not receive an indication for DNA testing. Their recall scores showed a larger increase (beta = .95; CI:.32 to 1.59; P = .003; d = .30) and their anxiety levels dropped more in the intervention compared to the UC group (beta = -.60; CI: -1.12 to -.09; P = .02). No intervention effects were found after the first visit on risk perception alignment or perceived personal control.
   Conclusions: This study shows that pre-counseling education, using tailored information technology, leads to more effective first visits for breast cancer genetic counseling, in particular for counselees who received no indication for DNA testing and, therefore, had no indication for a second visit. Future study should focus on the effects of a pre-visit website on the outcomes after a complete series of visits.
C1 [Albada, Akke; van Dulmen, Sandra; Bensing, Jozien M.] NIVEL Netherlands Inst Hlth Serv Res, NL-3500 BN Utrecht, Netherlands.
   [van Dulmen, Sandra] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 EZ Nijmegen, Netherlands.
   [Bensing, Jozien M.] Univ Utrecht, Dept Psychol, NL-3584 CS Utrecht, Netherlands.
   [Ausems, Margreet G. E. M.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 AB Utrecht, Netherlands.
RP Albada, A (reprint author), NIVEL Netherlands Inst Hlth Serv Res, Otterstr 118-124, NL-3500 BN Utrecht, Netherlands.
EM a.albada@nivel.nl
RI Dulmen, A.M./L-4287-2015
OI Dulmen, A.M./0000-0002-1651-7544
FU Dutch Cancer Society [Nivel2006-3469]
FX We want to thank all counselees who participated in this study. We also
   owe our gratitude to the clinical geneticists, genetic counselors and
   residents in clinical genetics of the department of Medical Genetics of
   the UMC Utrecht, in particular, Angela Schoemaker and Ivette Wieffer who
   arranged the logistics of the study. We are grateful to Anita Wallet,
   secretary of the department of Medical Genetics and Doortje Saya,
   secretary of Nivel, for organizing many practicalities of the study.
   This study was funded by a grant from the Dutch Cancer Society
   (Nivel2006-3469).
CR Albada A, GENET MED
   Albada A, 2011, J COMMUN GENET, V2, P233, DOI 10.1007/s12687-011-0061-1
   Albada A, 2011, J CANCER EDUC, V26, P670, DOI 10.1007/s13187-011-0227-x
   Albada A, 2009, J GENET COUNS, V18, P326, DOI 10.1007/s10897-009-9221-4
   Association of Comprehensive Cancer Centres, 2008, GUID MAMM CARC
   Biesecker BB, 2001, CLIN GENET, V60, P323, DOI 10.1034/j.1399-0004.2001.600501.x
   Braithwaite D, 2004, J NATL CANCER I, V96, P122, DOI 10.1093/jnci/djh017
   Butow Phyllis N, 2004, J Genet Couns, V13, P403, DOI 10.1023/B:JOGC.0000044201.73103.4f
   Claes E, 2003, AM J MED GENET A, V116A, P11, DOI 10.1002/ajmg.a.10868
   Cohen J., 1988, STAT POWER ANAL BEHA, P1
   Cull A, 1998, BRIT J CANCER, V77, P830, DOI 10.1038/bjc.1998.135
   Dimoska A, 2008, CANCER-AM CANCER SOC, V113, P225, DOI 10.1002/cncr.23543
   Duric Vlatka, 2003, J Genet Couns, V12, P243, DOI 10.1023/A:1023284219871
   Ellington Lee, 2005, J Genet Couns, V14, P377, DOI 10.1007/s10897-005-3660-3
   Fallowfield L, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2174
   Festinger L, 1962, THEORY COGNITIVE DIS
   Green MJ, 2004, JAMA-J AM MED ASSOC, V292, P442, DOI 10.1001/jama.292.4.442
   Green MJ, 2005, GENET MED, V7, P221, DOI 10.1097/01.GIM.0000159905.13125.86
   Higgins JFE, 2006, COCHRANE HDB SYSTEMA, V42
   Hopwood P, 2005, CURR OPIN ONCOL, V17, P340, DOI 10.1097/01.cco.0000166653.15546.06
   Howe A, 1997, FAM PRACT, V14, P233, DOI 10.1093/fampra/14.3.233
   Hox JJ, 2002, MULTILEVEL ANAL TECH
   Jansen J, 2008, GERONTOLOGIST, V48, P149, DOI 10.1093/geront/48.2.149
   Jansen J, 2008, J CLIN ONCOL, V26, P5450, DOI 10.1200/JCO.2007.15.2322
   Kausmeyer Dana T, 2006, J Genet Couns, V15, P409, DOI 10.1007/s10897-006-9039-2
   Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219
   LEY P, 1982, BRIT J CLIN PSYCHOL, V21, P241, DOI 10.1111/j.2044-8260.1982.tb00562.x
   Lobb EA, 2002, BRIT J CANCER, V87, P502, DOI 10.1038/sj.bjc.6600484
   Maas C. J. M., 2005, METHODOLOGY, V1, P86, DOI DOI 10.1027/1614-2241.1.3.86
   McPherson CJ, 2001, J PUBLIC HEALTH MED, V23, P227, DOI 10.1093/pubmed/23.3.227
   Metcalfe A, 2009, FAM CANCER, V8, P403, DOI 10.1007/s10689-009-9256-6
   Michie S, 2005, HEALTH EDUC BEHAV, V32, P589, DOI 10.1177/1090198105278562
   Michie S, 1997, PATIENT EDUC COUNS, V32, P101, DOI 10.1016/S0738-3991(97)00050-5
   Petty Richard E, 1986, ADV EXPT SOCIAL PSYC, V19, P123, DOI DOI 10.1016/S0065-2601(08)60214-2
   Pieterse AH, 2005, AM J MED GENET A, V137A, P27, DOI 10.1002/ajmg.a.30839
   Pieterse AH, 2005, BRIT J CANCER, V92, P1671, DOI 10.1038/sj.bjc.6602570
   Pieterse Arwen H, 2007, J Genet Couns, V16, P85, DOI 10.1007/s10897-006-9048-1
   Poeterse A, 2005, PSYCHO-ONCOL, V14, P361, DOI 10.1002/pon.853
   Roter DL, 2007, SOC SCI MED, V65, P1442, DOI 10.1016/j.socscimed.2007.05.033
   Rothman Alexander J., 1999, Journal of the National Cancer Institute Monographs, P44
   Ruiter RAC, 2006, HEALTH PSYCHOL, V25, P300, DOI 10.1037/0278-6133.25.3.300
   Ryhanen AM, 2010, PATIENT EDUC COUNS, V79, P5, DOI 10.1016/j.pec.2009.08.005
   Saleh M, 2009, J GENET COUNS, V18, P436, DOI 10.1007/s10897-009-9234-z
   Smerecnik CMR, 2009, J GENET COUNS, V18, P217, DOI 10.1007/s10897-008-9210-z
   Smets EMA, 2006, AM J MED GENET A, V140A, P843, DOI 10.1002/ajmg.a.31185
   Sousa D. A., 2006, BRAIN LEARNS
   Spielberger CD, 1983, MANUAL STATE TRAIT A
   STOET Association Clinical Genetics Netherlands Working group Clinical Oncogenetics, 2010, GUID DIAGN PREV
   Thomson AM, 2001, EUR J ORTHODONT, V23, P169, DOI 10.1093/ejo/23.2.169
   van der Meulen N, 2008, PSYCHO-ONCOLOGY, V17, P857, DOI 10.1002/pon.1290
   van Weert JCM, 2011, CRIT REV ONCOL HEMAT, V80, P145, DOI 10.1016/j.critrevonc.2010.10.010
   Vos J, 2011, FAM CANCER, V10, P87, DOI 10.1007/s10689-010-9385-y
   Wang C, 2004, SOC SCI MED, V58, P1427, DOI 10.1016/S0277-9536(03)00337-X
NR 53
TC 13
Z9 14
U1 4
U2 22
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1465-542X
EI 1465-5411
J9 BREAST CANCER RES
JI Breast Cancer Res.
PY 2012
VL 14
IS 2
AR R37
DI 10.1186/bcr3133
PG 11
WC Oncology
SC Oncology
GA 952DZ
UT WOS:000304771800012
PM 22394647
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Gao, YB
   Kim, HG
   Sohn, HY
   Kim, CW
AF Gao, Yubo
   Kim, Hang Goo
   Sohn, Hong Yong
   Kim, Chan Wook
TI RETRACTED: Gaseous Pre-reduction for the Magnetic Beneficiation of
   Ferruginous Low-grade Mn Ore (Retracted article. See vol. 54, pg. 2939,
   2014)
SO ISIJ INTERNATIONAL
LA English
DT Article; Retracted Publication
DE manganese ore; upgrading; selective reduction; magnetic separation;
   ferromanganese; manganese mineral
ID MANGANESE ORE
AB Because of intensive mining of high-grade manganese ores for a long time while leaving behind the low-grade ores, the utilization of the latter has become necessary. In this study, ferruginous low-grade manganese ore was selectively reduced by CO, which converted iron oxide to Fe3O4 while manganese oxide was reduced to MnO. The iron-rich component was then separated by magnetic separation. The effects of sample particle size and various reduction parameters on the efficiency of magnetic separation were studied. Under the optimum experimental conditions, the manganese content in the ore increased from around 36% to more than 44%, and almost 50% of iron was removed at a Mn loss of around 5%.
C1 [Gao, Yubo; Kim, Hang Goo; Sohn, Hong Yong] Univ Utah, Dept Met Engn, Salt Lake City, UT 84112 USA.
   [Kim, Chan Wook] Res Inst Ind Sci & Technol, Pohang, South Korea.
RP Gao, YB (reprint author), Univ Utah, Dept Met Engn, Salt Lake City, UT 84112 USA.
FU Research Institute of Industrial Science and Technology (RIST), Pohang,
   Korea
FX The authors would like to thank POSCO for supplying the manganese ore
   and for chemical analysis of sample manganese ore. This research was
   supported by Research Institute of Industrial Science and Technology
   (RIST), Pohang, Korea.
CR Anacleto N, 2004, ISIJ INT, V44, P1615, DOI 10.2355/isijinternational.44.1615
   Berger P. D., 2002, EXPT DESIGN APPL MAN, P314
   Harben P. W., 1998, MANGANESE USES MARKE, P25
   Kothari S. V., 1993, US Patent, Patent No. 5270022
   SHARMA T, 1992, INT J MINER PROCESS, V35, P191, DOI 10.1016/0301-7516(92)90033-S
   Swamy YV, 1998, MINER METALL PROC, V15, P34, DOI 10.1007/BF03403222
NR 6
TC 4
Z9 4
U1 2
U2 11
PU IRON STEEL INST JAPAN KEIDANREN KAIKAN
PI TOKYO
PA TEKKO KAIKAN-5F, 3-2-10, NIHONBASHI-KAYABACHO, TOKYO, CHUO-KU 103-0025,
   JAPAN
SN 0915-1559
EI 1347-5460
J9 ISIJ INT
JI ISIJ Int.
PY 2012
VL 52
IS 5
BP 759
EP 763
DI 10.2355/isijinternational.52.759
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 948QD
UT WOS:000304516800002
OA Bronze
DA 2018-12-27
ER

PT J
AU Ivanova, B
   Spiteller, M
AF Ivanova, Bojidarka
   Spiteller, Michael
TI RETRACTED: Gas-phase stabilized metal complexes of cyclic peptides -
   theoretical versus experimental study (Retracted article. See vol. 65,
   pg. 4441, 2012)
SO JOURNAL OF COORDINATION CHEMISTRY
LA English
DT Article; Retracted Publication
DE Cyclic peptides; Metal-organic complexes stable in gas-phase; Mass
   spectrometry
ID ELECTROSPRAY MASS-SPECTROMETRY; DENSITY-FUNCTIONAL THEORY; HETEROCYCLIC
   CARBENE COMPLEXES; GAUSSIAN-BASIS SETS; AMINO-ACIDS; SILVER
   NANOPARTICLES; ENDOPHYTIC FUNGUS; CRYSTAL-STRUCTURE; INFRARED-SPECTRA;
   HUMIC SUBSTANCES
AB This article deals with the experimental and theoretical study of the coordination ability and processes of glycyl-penta and hexahomopeptides and corresponding cyclic derivatives with the Ag-I, Zn-II, and Cu-II. Special attention is focused on the observed cyclic small peptide analogues as well as corresponding complexes. These phenomena are studied experimentally by electrospray ionization and matrix-assisted laser desorption ionization mass spectrometric methods. Considering the physical and chemical properties of gas-phase stabilized systems, precisely calculated thermodynamic parameters, physical properties, and structures by the quantum chemical DFT methods are performed. Conformational preferences of the obtained peptide species as well as the complexes are presented. The coordination ability is elucidated in condense phase by electronic absorption, infrared, and Raman spectroscopies, nuclear magnetic resonance, and thermal methods. The Ag-I/Ag-III redox process observed during the interaction with the peptides is discussed.
C1 [Ivanova, Bojidarka; Spiteller, Michael] Univ Dortmund, Inst Environm Res, Fac Chem, Dept Environm Chem & Analyt Chem, D-44227 Dortmund, Germany.
RP Ivanova, B (reprint author), Univ Dortmund, Inst Environm Res, Fac Chem, Dept Environm Chem & Analyt Chem, Otto Hahn Str 6, D-44227 Dortmund, Germany.
EM B.Ivanova@infu.tu-dortmund.de
FU Deutscher Akademischer Austausch Dienst (DAAD); Deutsche
   Forschungsgemeinschaft (DFG) [SPP 255/21-1, SPP/22-1]
FX The authors thank the Deutscher Akademischer Austausch Dienst (DAAD) for
   a grant within the priority program "Stability Pact South-Eastern
   Europe'' and thank the Deutsche Forschungsgemeinschaft (DFG) for Grants
   SPP 255/21-1 and SPP/22-1. The authors also thank the central
   instrumental laboratories for structural analysis at Technological
   University Dortmund (TUD, Germany) and the analytical and computational
   laboratories at the Institute of Environmental Research (INFU) at the
   TUD.
CR ADAMS DM, 1967, METAL LIGAND RELATED
   Autschbach J, 2003, INORG CHEM, V42, P2867, DOI 10.1021/ic020580w
   Awouafack MD, 2010, PLANTA MED, V76, P640, DOI 10.1055/s-0029-1240619
   Awouafack MD, 2011, J NAT PROD, V74, P272, DOI 10.1021/np1005218
   Baker C, 2005, J NANOSCI NANOTECHNO, V5, P244, DOI 10.1166/jnn.2005.034
   Barry SD, 2009, CAN J CHEM, V87, P942, DOI 10.1139/V09-034
   Beck W, 2009, Z NATURFORSCH B, V64, P1221
   BEGUIN C, 1981, ORG MAGN RESONANCE, V16, P129, DOI 10.1002/mrc.1270160214
   Bertram A, 2007, NAT PROD REP, V24, P18, DOI 10.1039/b612600f
   Biswas A., ACTA CRYSTALLOGR B, V24B, P40
   BLESSING RH, 1995, ACTA CRYSTALLOGR A, V51, P33, DOI 10.1107/S0108767394005726
   BOUSSARD G, 1979, BIOPOLYMERS, V18, P1297, DOI 10.1002/bip.1979.360180602
   Breithaupt H, 1999, NAT BIOTECHNOL, V17, P1165, DOI 10.1038/70705
   Brown TL, 2000, ANAL CHEM, V72, P384, DOI 10.1021/ac9902087
   Burnum KE, 2008, ANNU REV ANAL CHEM, V1, P689, DOI 10.1146/annurev.anchem.1.031207.112841
   Charalambous J., 1975, MASS SPECTROMETRY ME
   Cho S, 2011, J PHYS CHEM A, V115, P3990, DOI 10.1021/jp109174f
   Clark SM, 2004, ANAL CHEM, V76, P1257, DOI 10.1021/ac0352301
   Clark SM, 2003, J AM SOC MASS SPECTR, V14, P430, DOI 10.1016/S1044-0305(03)00123-5
   Clark SM, 2002, RAPID COMMUN MASS SP, V16, P1454, DOI 10.1002/rcm.732
   Claydon MA, 1996, NAT BIOTECHNOL, V14, P1584, DOI 10.1038/nbt1196-1584
   Cole RB, 2000, J MASS SPECTROM, V35, P763, DOI 10.1002/1096-9888(200007)35:7<763::AID-JMS16>3.0.CO;2-#
   Cole RB, 2010, ELECTROSPRAY MALDI M
   Cooper J, 2002, INORG CHEM, V41, P6614, DOI 10.1021/ic020294k
   Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094
   COTTON FA, 1965, INORG CHEM, V4, P1696, DOI 10.1021/ic50034a005
   Dale M., 1996, DALTON T, V771
   Dale MJ, 1997, ORGANOMETALLICS, V16, P197, DOI 10.1021/om960592n
   Davies J., 2000, CYCLIC POLYM
   Duax WL, 1996, BIOPOLYMERS, V40, P141, DOI 10.1002/(SICI)1097-0282(1996)40:1<141::AID-BIP6>3.0.CO;2-W
   DURIG JR, 1966, SPECTROCHIM ACTA, V22, P1091, DOI 10.1016/0371-1951(66)80199-6
   DURIG JR, 1965, SPECTROCHIM ACTA, V21, P1367, DOI 10.1016/0371-1951(65)80046-7
   ECKART K, 1985, J AM CHEM SOC, V107, P6765, DOI 10.1021/ja00310a003
   ECKART K, 1994, MASS SPECTROM REV, V13, P23, DOI 10.1002/mas.1280130104
   Erin H., 2011, TRENDS BIOTECHNOL, V29, P136
   Esquenazi E, 2009, NAT PROD REP, V26, P1521, DOI 10.1039/b915674g
   FAIRLIE DP, 1995, CURR MED CHEM, V2, P654
   FAULKNER DJ, 1988, NAT PROD REP, V5, P613, DOI 10.1039/np9880500613
   FEENEY J, 1974, CHEM COMMUN, P465
   FELTHAM RD, 1964, SPECTROCHIM ACTA, V20, P1081, DOI 10.1016/0371-1951(64)80108-9
   Fernandes C, 2010, DALTON T, V39, P5094, DOI 10.1039/c000256a
   Frisch M. J., 1998, GAUSSIAN 98 REVISION
   Frisch M.J., 2009, GAUSSIAN 09W REVISIO
   FUSETANI N, 1991, J AM CHEM SOC, V113, P7811, DOI 10.1021/ja00020a080
   GANEM B, 1991, J AM CHEM SOC, V113, P7818, DOI 10.1021/ja00020a085
   GILPIN JA, 1959, ANAL CHEM, V31, P935
   Glinski M, 2006, MASS SPECTROM REV, V25, P173, DOI 10.1002/mas.20063
   GRATHWOHL C, 1975, HELV CHIM ACTA, V58, P415, DOI 10.1002/hlca.19750580210
   GRIFFITH WP, 1966, J CHEM SOC A, P899, DOI 10.1039/j19660000899
   GRIFFITH WP, 1965, J CHEM SOC, P3694, DOI 10.1039/jr9650003694
   GROSS ML, 1982, TETRAHEDRON LETT, V23, P5381
   HEADGORDON M, 1988, CHEM PHYS LETT, V153, P503, DOI 10.1016/0009-2614(88)85250-3
   Hehre W. J, 1986, AB INITIO MOL ORBITA
   Henderson W, 1998, POLYHEDRON, V17, P4291, DOI 10.1016/S0277-5387(98)00246-0
   IHARA M, 1992, J CARDIOVASC PHARM, V20, pS11, DOI 10.1097/00005344-199204002-00005
   Ivanova B., 2011, TALANTA IN PRESS
   Ivanova B., 2011, J PHARM BIOMED ANAL, DOI [10.1016/j.jpba.2011.10.028, DOI 10.1016/J.JPBA.2011.10.028]
   Ivanova B, 2012, BIOPOLYMERS, V97, P134, DOI 10.1002/bip.21714
   Ivanova B, 2011, J MOL STRUCT, V1004, P303, DOI 10.1016/j.molstruc.2011.08.027
   Ivanova B, 2011, POLYHEDRON, V30, P241, DOI 10.1016/j.poly.2010.10.008
   Ivanova BB, 2011, J MOL STRUCT, V1003, P1, DOI 10.1016/j.molstruc.2011.06.043
   Ivanova BB, 2010, BIOPOLYMERS, V93, P727, DOI 10.1002/bip.21437
   Jensen F., 1999, INTRO COMPUTATIONAL
   Johnson R., 2001, PROTEOME RES MASS SP
   Jonsson AP, 2001, CELL MOL LIFE SCI, V58, P868, DOI 10.1007/PL00000907
   Jorge FE, 2003, INORG CHEM, V42, P8902, DOI 10.1021/ic034997t
   KAINOSHO M, 1975, BIOCHEM BIOPH RES CO, V64, P425, DOI 10.1016/0006-291X(75)90270-3
   KAINOSHO M, 1975, J AM CHEM SOC, V97, P5630, DOI 10.1021/ja00852a077
   Kelley C. T., 1999, ITERATIVE METHODS OP, V18
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Kindler BLJ, 2010, EUR J ORG CHEM, P2084, DOI 10.1002/ejoc.200901311
   Klaus U, 2000, ENVIRON SCI TECHNOL, V34, P3514, DOI 10.1021/es9913129
   Kohil R., 2002, NATURE, V418, P658
   Kolev T, 2006, INORG CHIM ACTA, V359, P4367, DOI 10.1016/j.ica.2006.05.034
   Kolev T, 2008, J COORD CHEM, V61, P1897, DOI 10.1080/00958970701787687
   Koleva BB, 2007, INORG CHIM ACTA, V360, P2224, DOI 10.1016/j.ica.2006.11.002
   Koleva BB, 2008, J COORD CHEM, V61, P3534, DOI 10.1080/00958970802108817
   Koleva BB, 2008, TRANSIT METAL CHEM, V33, P911, DOI 10.1007/s11243-008-9132-5
   Kondo F, 1996, CHEM RES TOXICOL, V9, P1355, DOI 10.1021/tx960085a
   Kusari S, 2008, J NAT PROD, V71, P159, DOI 10.1021/np070669k
   Kusari S, 2011, NAT PROD REP, V28, P1203, DOI 10.1039/c1np00030f
   Kusari S, 2011, J NAT PROD, V74, P764, DOI 10.1021/np1008398
   Kusari S, 2011, PHYTOCHEM ANALYSIS, V22, P128, DOI 10.1002/pca.1258
   Kusari S, 2009, J NAT PROD, V72, P1825, DOI 10.1021/np9002977
   Kusari S, 2009, PHYTOCHEMISTRY, V70, P1222, DOI 10.1016/j.phytochem.2009.07.022
   Kusari S, 2009, J NAT PROD, V72, P2, DOI 10.1021/np800455b
   Lambert C., 1999, J AM SOC MASS SPECTR, V10, P732
   Lamshoft M, 2012, INORG CHIM ACTA, V382, P96, DOI 10.1016/j.ica.2011.10.015
   Lamshoft M, 2011, TALANTA, V85, P2562, DOI 10.1016/j.talanta.2011.08.008
   Lamshoft M, 2011, J COORD CHEM, V64, P2419, DOI 10.1080/00958972.2011.598926
   Lamshoft M, 2011, POLYHEDRON, V30, P2564, DOI 10.1016/j.poly.2011.07.003
   LAUSSAC JP, 1983, BIOCHEM J, V209, P533, DOI 10.1042/bj2090533
   Li Y, 2008, ANAL CHEM, V80, P407, DOI 10.1021/ac701703f
   Lisa H., 2011, ANAL BIOANAL CHEM, V401, P17
   Litzow MR, 1973, MASS SPECTROMETRY IN
   Liu JJ, 2008, J INORG BIOCHEM, V102, P303, DOI 10.1016/j.jinorgbio.2007.09.003
   Madsen K., 2004, INFORM MATH MODELLIN
   McDonald J., 1979, CAN J MAG RES, V34, P207
   McIntyre C, 1997, J MASS SPECTROM, V32, P328, DOI 10.1002/(SICI)1096-9888(199703)32:3<328::AID-JMS480>3.0.CO;2-M
   MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980
   MEDVETZ DA, 2008, MET BASED DRUGS, DOI DOI 10.1155/2008/384010
   MERALDI JP, 1972, HELV CHIM ACTA, V55, P1962, DOI 10.1002/hlca.19720550614
   MEULEMANS R, 1971, ACTA CRYSTALL B-STRU, VB 27, P1187, DOI 10.1107/S0567740871003728
   MODDER JF, 1992, INORG CHEM, V31, P1238, DOI 10.1021/ic00033a021
   Moniatte M., 1997, J AM SOC MASS SPECTR, V8, P1046
   Nakamoto K., 1978, INFRARED RAMAN SPECT
   Ngoka LCM, 1999, INT J MASS SPECTROM, V182, P289, DOI 10.1016/S1387-3806(98)14248-3
   OLAH GA, 1962, J AM CHEM SOC, V84, P1695, DOI 10.1021/ja00868a040
   OLAH GA, 1962, J AM CHEM SOC, V84, P1688, DOI 10.1021/ja00868a039
   OSTERBERG R, 1968, J BIOL CHEM, V243, P3038
   Pacholski ML, 1999, CHEM REV, V99, P2977, DOI 10.1021/cr980137w
   PAPAYANNOPOULOS IA, 1995, MASS SPECTROM REV, V14, P49, DOI 10.1002/mas.1280140104
   PARTHASARATHY R, 1969, ACTA CRYSTALL B-STRU, VB 25, P509, DOI 10.1107/S0567740869002482
   Patil S, 2010, EUR J INORG CHEM, P1020, DOI 10.1002/ejic.200900889
   PELAH Z, 1963, J AM CHEM SOC, V85, P2470, DOI 10.1021/ja00899a029
   PERLY B, 1983, BIOPOLYMERS, V22, P1853, DOI 10.1002/bip.360220804
   Pfeifer T, 2001, J CHROMATOGR A, V926, P151, DOI 10.1016/S0021-9673(01)00805-6
   Piccolo A, 2003, ANAL BIOANAL CHEM, V377, P1047, DOI 10.1007/s00216-003-2186-5
   Politzer P., 1981, CHEM APPL ATOMIC MOL
   POWELL DB, 1961, SPECTROCHIM ACTA, V17, P68, DOI 10.1016/0371-1951(61)80012-X
   POWELL DB, 1956, CHEM IND-LONDON, P314
   Puri SC, 2005, J NAT PROD, V68, P1717, DOI 10.1021/np0502802
   Rajkovic S, 2009, DALTON T, P8370, DOI 10.1039/b908182h
   Ray S, 2007, J AM CHEM SOC, V129, P15042, DOI 10.1021/ja075889z
   Reetz JE, 2011, APIDOLOGIE, V42, P596, DOI 10.1007/s13592-011-0049-1
   Rompp A, 2011, ANAL BIOANAL CHEM, V401, P65, DOI 10.1007/s00216-011-4990-7
   ROSEN MK, 1992, ANGEW CHEM INT EDIT, V31, P384, DOI 10.1002/anie.199203841
   Satoh T, 1997, J BIOL CHEM, V272, P12175, DOI 10.1074/jbc.272.18.12175
   Schultz NE, 2008, J COMPUT CHEM, V29, P185, DOI 10.1002/jcc.20717
   Schwalbe H, 2000, HELV CHIM ACTA, V83, P1079, DOI 10.1002/1522-2675(20000607)83:6<1079::AID-HLCA1079>3.0.CO;2-W
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360
   SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277
   Siciliano TJ, 2011, J ORGANOMET CHEM, V696, P1066, DOI 10.1016/j.jorganchem.2010.10.054
   Sinha TK, 2008, NAT METHODS, V5, P57, DOI 10.1038/NMETH1147
   Skold K, 2002, PROTEOMICS, V2, P447, DOI 10.1002/1615-9861(200204)2:4<447::AID-PROT447>3.0.CO;2-A
   Spek AL, 2003, J APPL CRYSTALLOGR, V36, P7, DOI 10.1107/S0021889802022112
   Spiteller G., 1966, MASSSPEKTROMETRISHE
   Sriram MI, 2010, INT J NANOMED, V5, P753, DOI 10.2147/IJN.S11727
   Stephens PJ, 2005, CHIRALITY, V17, pS52, DOI 10.1002/chir.20109
   Stephens PJ, 2003, CHIRALITY, V15, pS57, DOI 10.1002/chir.10270
   STORM DR, 1977, ANNU REV BIOCHEM, V46, P723, DOI 10.1146/annurev.bi.46.070177.003451
   STRANDBERG B, 1961, Z KRISTALLOGR, V116, P266
   Teyssot ML, 2009, DALTON T, P6894, DOI 10.1039/b906308k
   Thati B, 2007, CANCER LETT, V248, P321, DOI 10.1016/j.canlet.2006.08.009
   TOMER KB, 1984, ANAL CHEM, V56, P880, DOI 10.1021/ac00270a006
   TRUONG TN, 1995, CHEM PHYS LETT, V240, P253, DOI 10.1016/0009-2614(95)00541-B
   VANDYKE MI, 1991, BIOTECHNOL ADV, V9, P241, DOI 10.1016/0734-9750(91)90006-H
   WIBERG KB, 1992, J PHYS CHEM-US, V96, P10756, DOI 10.1021/j100205a032
   Williams SM, 2004, J AM SOC MASS SPECTR, V15, P1039, DOI 10.1016/j.jasms.2004.03.15
   WILSON EB, 1962, J CHEM PHYS, V36, P2232, DOI 10.1063/1.1732864
   Wipf P, 2000, TETRAHEDRON, V56, P9143, DOI 10.1016/S0040-4020(00)00767-5
   WIPF P, 1994, ANGEW CHEM INT EDIT, V33, P1516, DOI 10.1002/anie.199415161
   WOON DE, 1993, J CHEM PHYS, V98, P1358, DOI 10.1063/1.464303
   Yates JR, 1998, J MASS SPECTROM, V33, P1
   Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s
   YIOTAKIS A, 1994, J MED CHEM, V37, P2713, DOI 10.1021/jm00043a011
   Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x
   Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a
   Zhu HL, 2003, INORG CHEM COMMUN, V6, P1113, DOI 10.1016/S1387-7003(03)00205-3
NR 160
TC 7
Z9 7
U1 3
U2 20
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0095-8972
EI 1029-0389
J9 J COORD CHEM
JI J. Coord. Chem.
PY 2012
VL 65
IS 9
BP 1548
EP 1568
DI 10.1080/00958972.2012.676166
PG 21
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 946BI
UT WOS:000304323000008
DA 2018-12-27
ER

PT J
AU Storp, J
   Stolle, C
   Ivanova, BB
   Spiteller, M
AF Storp, Jueergen
   Stolle, Cornelia
   Ivanova, Bojidarka B.
   Spiteller, Michael
TI RETRACTED: Crystal structures and physical properties of
   5-sulfosalicylate and violurate metal-organic crystals - experimental
   versus theoretical study (Retracted article. See vol. 65, pg. 4442,
   2012)
SO JOURNAL OF COORDINATION CHEMISTRY
LA English
DT Article; Retracted Publication
DE Metal-organic crystals; 5-Sulfosalicylates; Violurates; Optical
   properties; Quantum chemistry; Mass spectrometry
ID IONIZATION MASS-SPECTROMETRY; LASER-DESORPTION IONIZATION; COORDINATION
   POLYMERS; ELECTROSPRAY-IONIZATION; CARBOXYLATE LIGANDS; SINGLE-CRYSTAL;
   HYDROGEN-BONDS; ACID; FRAMEWORKS; CHEMISTRY
AB Crystal structures, theoretical, and experimental physical properties of six coordination compounds of violuric and 5-sulfosalicylic acid (5SSA) with silver and potassium ions (1-6) are reported. The correlation between crystallographic data of the potassium violurate methanol solvate (2), potassium 5-sulfosalicylicilate salts (3 and 4), the redeterminated structure for the potassium violurate dihydrate (1), and the already reported complexes of silver(I) with 5SSA (5 and 6) as well as the optical properties in the condensed phase was performed using the electronic-absorption, diffuse reflectance and fluorescence spectroscopies. The vibration characteristics of the crystals were studied by solid-state Raman spectroscopy. Special attention is focused on elucidation of the specific excitation phenomena within the THz-region, allowing unambiguously defining of the metal-organic polymorphs. The physical behavior and related processes under soft electrospray ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI) mass spectrometric conditions are elucidated by corresponding methods, including imaging mass spectrometry (MS). A discussion on the stabilization of complex species and adducts in the gas phase depending on the type of metal ion was performed, with a view to their further application as matrices in the MALDI-Orbitrap MS method. The thermal properties were elucidated using the thermogravimetric and differential scanning calorimetric methods. Quantum chemical DFT calculations of the optical properties and selected thermodynamic quantities in solid-state were performed, supporting and elucidating some of the observed phenomena.
C1 [Storp, Jueergen; Stolle, Cornelia; Ivanova, Bojidarka B.; Spiteller, Michael] Univ Dortmund, Inst Environm Res, D-44221 Dortmund, Germany.
RP Ivanova, BB (reprint author), Univ Dortmund, Inst Environm Res, Otto Hahn Str 6, D-44221 Dortmund, Germany.
EM B.Ivanova@infu.uni-dortmund.de
CR Amabilino DB, 1995, CHEM REV, V95, P2725, DOI 10.1021/cr00040a005
   Autschbach J, 2003, INORG CHEM, V42, P2867, DOI 10.1021/ic020580w
   Batten SR, 1998, ANGEW CHEM INT EDIT, V37, P1460, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1460::AID-ANIE1460>3.0.CO;2-Z
   Batten SR, 2003, COORDIN CHEM REV, V246, P103, DOI 10.1016/S0010-8545(03)00119-X
   BLESSING RH, 1995, ACTA CRYSTALLOGR A, V51, P33, DOI 10.1107/S0108767394005726
   Bosshard C, 1999, CHEM PHYS, V245, P377, DOI 10.1016/S0301-0104(99)00134-2
   Bosshard C., 1993, ORGANIC NONLINEAR OP
   Carlucci L, 2003, COORDIN CHEM REV, V246, P247, DOI 10.1016/S0010-8545(03)00126-7
   Caulder DL, 1999, ACCOUNTS CHEM RES, V32, P975, DOI 10.1021/ar970224v
   Coe BJ, 2006, ACCOUNTS CHEM RES, V39, P383, DOI 10.1021/ar050225k
   Cole RB, 2010, ELECTROSPRAY MALDI M
   Constantopoulos TL, 1999, J AM SOC MASS SPECTR, V10, P625, DOI 10.1016/S1044-0305(99)00031-8
   DALTON, 2011, MOL EL STRUCT PROGR
   Desiraju G. R., 2003, CRYSTAL DESIGN STRUC
   Dey S, 2011, TRANSIT METAL CHEM, V36, P631, DOI 10.1007/s11243-011-9512-0
   Eddaoudi M, 2001, ACCOUNTS CHEM RES, V34, P319, DOI 10.1021/ar000034b
   Enke CG, 1997, ANAL CHEM, V69, P4885, DOI 10.1021/ac970095w
   Frisch M.J., 2009, GAUSVIEW03
   Fujita M, 1999, ACCOUNTS CHEM RES, V32, P53, DOI 10.1021/ar9701068
   GILLIER H, 1965, B SOC CHIM FR, P2373
   Gillier H., 1962, INT TABLES XRAY CRYS, VIII, P202
   GIMON ME, 1992, ORG MASS SPECTROM, V27, P827, DOI 10.1002/oms.1210270711
   Hagrman PJ, 1999, ANGEW CHEM INT EDIT, V38, P2639
   Harsha SS, 2010, J PHYS CHEM A, V114, P3489, DOI 10.1021/jp911135u
   HEADGORDON M, 1988, CHEM PHYS LETT, V153, P503, DOI 10.1016/0009-2614(88)85250-3
   Inoue K, 2001, ANGEW CHEM INT EDIT, V40, P4242, DOI 10.1002/1521-3773(20011119)40:22<4242::AID-ANIE4242>3.0.CO;2-H
   Inoue K, 1996, J AM CHEM SOC, V118, P1803, DOI 10.1021/ja952301s
   Ivanova B., 2011, J PHARM BIOMED ANAL, DOI [10.1016/j.jpba.2011.10.028, DOI 10.1016/J.JPBA.2011.10.028]
   Ivanova BB, 2010, STRUCT CHEM, V21, P989, DOI 10.1007/s11224-010-9635-5
   Ivanova BB, 2010, CRYST GROWTH DES, V10, P2470, DOI 10.1021/cg100284r
   Ivanova BB, 2010, J PHYS CHEM A, V114, P5099, DOI 10.1021/jp1002758
   Ivanova B, 2012, BIOPOLYMERS, V97, P134, DOI 10.1002/bip.21714
   Ivanova B, 2011, POLYHEDRON, V30, P241, DOI 10.1016/j.poly.2010.10.008
   Ivanova BB, 2012, TALANTA, V94, P9, DOI 10.1016/j.talanta.2011.12.016
   Ivanova BB, 2010, BIOPOLYMERS, V93, P727, DOI 10.1002/bip.21437
   Janiak C, 2003, DALTON T, P2781, DOI 10.1039/b305705b
   Jansen C., 2005, APPL OPTICS, V49, pE48
   Jensen F., 1999, INTRO COMPUTATIONAL
   Kelley C. T., 1999, FRONTIERS APPL MATH
   Kitagawa S, 2005, CHEM SOC REV, V34, P109, DOI 10.1039/b313997m
   Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610
   Knochenmuss R, 1996, RAPID COMMUN MASS SP, V10, P871, DOI 10.1002/(SICI)1097-0231(19960610)10:8<871::AID-RCM559>3.0.CO;2-R
   Lamshoft M, 2011, TALANTA, V85, P2562, DOI 10.1016/j.talanta.2011.08.008
   LAWRANCE GA, 1986, CHEM REV, V86, P17, DOI 10.1021/cr00071a002
   Lehn J. -M., 1995, SUPRAMOLECULAR CHEM
   Leininger S, 2000, CHEM REV, V100, P853, DOI 10.1021/cr9601324
   Li YQ, 1998, ACTA PHYS-CHIM SIN, V14, P778, DOI 10.3866/PKU.WHXB19980903
   Liu CS, 2006, CRYST GROWTH DES, V6, P656, DOI 10.1021/cg050336q
   Lu ZD, 2006, CRYSTENGCOMM, V8, P847, DOI 10.1039/b612147k
   Lu ZD, 2007, CRYST GROWTH DES, V7, P268, DOI 10.1021/cg060287x
   Ma JF, 2005, CRYST GROWTH DES, V5, P807, DOI 10.1021/cg049723a
   Ma JF, 2003, INORG CHEM COMMUN, V6, P581, DOI 10.1016/S1387-7003(03)00044-3
   Madsen K., 2004, INFORM MATH MODELLIN
   MARDER SR, 1989, SCIENCE, V245, P626, DOI 10.1126/science.245.4918.626
   Matsuda R, 2005, NATURE, V436, P238, DOI 10.1038/nature03852
   Moulton B, 2001, CHEM REV, V101, P1629, DOI 10.1021/cr9900432
   Nalwa H. S., 1997, NONLINEAR OPTICS ORG, P89
   OLAH GA, 1962, J AM CHEM SOC, V84, P1688, DOI 10.1021/ja00868a039
   Oppenheim KC, 2010, J PHYS CHEM A, V114, P12513, DOI 10.1021/jp107597q
   Oppenheimer SR, 2010, J PROTEOME RES, V9, P2182, DOI 10.1021/pr900936z
   Park KM, 2002, CHEM-EUR J, V8, P498, DOI 10.1002/1521-3765(20020118)8:2<498::AID-CHEM498>3.0.CO;2-M
   Politzer P., 1981, CHEM APPL ATOMIC MOL
   PRESTONSCHAFFTER LM, 1994, J AM SOC MASS SPECTR, V5, P800, DOI 10.1016/1044-0305(94)87002-0
   ROBSON R, 1992, SUPRAMOLECULAR ARCHI, pCH19
   Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360
   Shimizu GKH, 1998, CHEM MATER, V10, P3282, DOI 10.1021/cm980409b
   Siebert KJ, 2002, PHYS MED BIOL, V47, P3743, DOI 10.1088/0031-9155/47/21/310
   Siegel PH, 2002, IEEE T MICROW THEORY, V50, P910, DOI 10.1109/22.989974
   Smith G, 2005, ACTA CRYSTALLOGR C, V61, pO105, DOI 10.1107/S0108270104033451
   Smith G, 2005, ACTA CRYSTALLOGR E, V61, pO313, DOI 10.1107/S1600536805000152
   Spek AL, 2003, J APPL CRYSTALLOGR, V36, P7, DOI 10.1107/S0021889802022112
   Theuer M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3430740
   Wan Y., 2006, INORG CHEM, V42, P4985
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   WILSON EB, 1962, J CHEM PHYS, V36, P2232, DOI 10.1063/1.1732864
   Wolff JJ, 1999, ADV PHYS ORG CHEM, V32, P121, DOI 10.1016/S0065-3160(08)60007-6
   Wu CD, 2005, ANGEW CHEM INT EDIT, V44, P1958, DOI 10.1002/anie.200462711
   Wu G, 2010, Z ANORG ALLG CHEM, V636, P652, DOI 10.1002/zaac.200900302
   Yang Y, 2010, TRANSIT METAL CHEM, V35, P263, DOI 10.1007/s11243-009-9322-9
   Ye BH, 2005, COORDIN CHEM REV, V249, P545, DOI 10.1016/j.ccr.2004.07.006
   Zeng MH, 2005, ANGEW CHEM INT EDIT, V44, P3079, DOI 10.1002/anie.200462463
   Zhang JP, 2005, J AM CHEM SOC, V127, P5495, DOI 10.1021/ja042222t
   Zhang JP, 2005, CHEM-EUR J, V11, P552, DOI 10.1002/chem.200400756
   Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a
   Zyss J., 1993, MOL NONLINEAR OPTICS
NR 85
TC 4
Z9 4
U1 5
U2 29
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0095-8972
EI 1029-0389
J9 J COORD CHEM
JI J. Coord. Chem.
PY 2012
VL 65
IS 12
BP 2055
EP 2073
DI 10.1080/00958972.2012.689294
PG 19
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 946DB
UT WOS:000304328900002
DA 2018-12-27
ER

PT J
AU Mokhtari, B
   Pourabdollah, K
AF Mokhtari, Bahram
   Pourabdollah, Kobra
TI RETRACTED: Dispersive enhancement in liquid-liquid microextraction by
   dual supramolecular role of nano-baskets (Retracted article. See vol.
   25, pg. 533, 2013)
SO SUPRAMOLECULAR CHEMISTRY
LA English
DT Article; Retracted Publication
DE nano-basket; porphyrin; calixarene; liquid-liquid; microextraction
ID ATOMIC-ABSORPTION-SPECTROMETRY; ARABIAN CRUDE OILS; S-BLOCK METALS;
   VANADYL PORPHYRINS; SOLVENT-EXTRACTION; GAS CHROMATOGRAPHY; WATER;
   PETROPORPHYRINS; CALIXARENES; NICKEL
AB The novelties of this approach are introducing the self-settled dispersive liquid phase microextraction technique to remove the centrifuging step, conducting the dispersive liquid phase microextraction in complex organic systems, applicability of water as disperser phase and inclusion microextraction of charged porphyrins by calix[4]arenes, which act as the settling agents as well as the inclusion ligands. The p-tert-calix[4] arene bearing di-[N-(X)sulphonyl carboxamide] and di-(1-propoxy) in ortho-cone conformation was synthesized and used as novel nano-baskets. The related parameters including ligand concentration, volume of water disperser, salt effect and extraction time were optimised. The linear range, detection limit (S/N = 3) and precision (RSD, n = 6) were determined to be 0.2-50, 0.07 mu g l(-1) and 5.3%, respectively. The established method was applied to determine the target compound in five samples of live crude oil, and was sampled from an Iranian offshore field. The results revealed that the new approach is a competitive analytical tool and an alternative to the traditional methods in the crude oil and related systems. Moreover, in those systems that the inclusion separation is not requested, it is possible to use a tertiary system including a proper extraction agent/solvent and nano-basket phase, as settling agent, along with the aqueous disperser in the organic systems.
C1 [Mokhtari, Bahram; Pourabdollah, Kobra] Islamic Azad Univ, Dept Chem Engn, Shahreza Branch, Shahreza, Iran.
RP Pourabdollah, K (reprint author), Islamic Azad Univ, Dept Chem Engn, Shahreza Branch, Shahreza, Iran.
EM pourabdollah@iaush.ac.ir
FU Islamic Azad University (Shahreza branch); Iran Nanotechnology
   Initiative Council
FX This work was supported by Islamic Azad University (Shahreza branch) and
   Iran Nanotechnology Initiative Council.
CR ALI MF, 1993, ENERG FUEL, V7, P179, DOI 10.1021/ef00038a003
   BAKER EW, 1967, J AM CHEM SOC, V89, P3631, DOI 10.1021/ja00990a050
   El-Sabagh SM, 1998, FUEL PROCESS TECHNOL, V57, P65, DOI 10.1016/S0378-3820(98)00068-X
   Farajzadeh MA, 2009, J SEP SCI, V32, P3191, DOI 10.1002/jssc.200900109
   Fu LY, 2009, CHROMATOGRAPHIA, V70, P1697, DOI 10.1365/s10337-009-1356-9
   HAJIBRAHIM SK, 1982, INT J ENVIRON AN CH, V12, P123, DOI 10.1080/03067318208071575
   Hashemi P, 2010, J CHIN CHEM SOC-TAIP, V57, P111, DOI 10.1002/jccs.201000018
   HOLDEN PN, 1991, GEOCHIM COSMOCHIM AC, V55, P3893, DOI 10.1016/0016-7037(91)90084-I
   Ion RM, 2010, ENVIRON ENG MANAG J, V9, P827
   Kozani RR, 2007, TALANTA, V72, P387, DOI 10.1016/j.talanta.2006.10.039
   Lepri FG, 2006, ANAL CHIM ACTA, V558, P195, DOI 10.1016/j.aca.2005.10.083
   Mokhtari B., 2012, J INCL PHENOM MACROC, DOI 10.1007s10847-011-0062-z
   Mokhtari B, 2011, J COORD CHEM, V64, P4029, DOI 10.1080/00958972.2011.635790
   Mokhtari B, 2011, J COORD CHEM, V64, P3081, DOI 10.1080/00958972.2011.613462
   Mokhtari B, 2011, J COORD CHEM, V64, P3189, DOI 10.1080/00958972.2011.616930
   Mokhtari B, 2012, J THERM ANAL CALORIM, V110, P1043, DOI 10.1007/s10973-011-2014-7
   Mokhtari B, 2012, J INCL PHENOM MACRO, V73, P269, DOI 10.1007/s10847-011-0052-1
   Mokhtari B, 2011, SUPRAMOL CHEM, V23, P696, DOI 10.1080/10610278.2011.605452
   Mokhtari B, 2012, J SEP SCI, V35, P79, DOI 10.1002/jssc.201100673
   Mokhtari B, 2011, B KOREAN CHEM SOC, V32, P3979, DOI 10.5012/bkcs.2011.32.11.3979
   Mokhtari B, 2011, B KOREAN CHEM SOC, V32, P3855, DOI 10.5012/bkcs.2011.32.11.3855
   Mokhtari B, 2011, ASIAN J CHEM, V23, P4717
   Mokhtari B, 2011, CHROMATOGRAPHIA, V73, P829, DOI 10.1007/s10337-011-1954-1
   Mokhtari B, 2011, J RADIOANAL NUCL CH, V287, P921, DOI 10.1007/s10967-010-0881-1
   Mokhtari B, 2011, J COORD CHEM, V64, P743, DOI 10.1080/00958972.2011.555538
   Mokhtari B, 2011, J INCL PHENOM MACRO, V69, P1, DOI 10.1007/s10847-010-9848-7
   Mokhtari B, 2011, TALANTA, V87, P118, DOI 10.1016/j.talanta.2011.09.050
   Pourabdollah K, 2011, OIL GAS SCI TECHNOL, V66, P1005, DOI 10.2516/ogst/2011109
   Pourabdollah K., 2012, ENERGY SO A IN PRESS
   Pourabdollah K, 2012, SPECTROSC LETT, V45, P541, DOI 10.1080/00387010.2011.597481
   Pourabdollah K, 2012, J THERM ANAL CALORIM, V107, P1353, DOI 10.1007/s10973-011-1668-5
   Pourabdollah K, 2011, MEASUREMENT, V44, P2028, DOI 10.1016/j.measurement.2011.08.013
   Pourabdollah K, 2011, SPECTROCHIM ACTA A, V84, P22, DOI 10.1016/j.saa.2011.08.004
   Pourabdollah K, 2010, ENERG FUEL, V24, P4396, DOI 10.1021/ef100617p
   Premovic PI, 1997, FUEL, V76, P267, DOI 10.1016/S0016-2361(96)00201-3
   Premovic PI, 2000, J SERB CHEM SOC, V65, P113
   Premovic PI, 2000, FUEL, V79, P813, DOI 10.1016/S0016-2361(99)00205-7
   Ramalho JB, 2009, CHEM CHEM TECHOL, V3, P53
   Rezaee M, 2006, J CHROMATOGR A, V1116, P1, DOI 10.1016/j.chroma.2006.03.007
   Rondon M, 2006, ENERG FUEL, V20, P1600, DOI 10.1021/ef060017o
   Saitoh K., 2001, ANAL SCI           S, V17, P1511
   Salehizadeh Hossein, 2007, Iranian Journal of Biotechnology, V5, P226
   Shirkhanloo H, 2010, J CHIN CHEM SOC-TAIP, V57, P1035, DOI 10.1002/jccs.201000144
   Treibs A, 1934, LIEBIGS ANN CHEM, V509, P103
   Zho QX, 2008, J CHROMATOGR A, V1188, P148, DOI 10.1016/j.chroma.2008.02.094
NR 45
TC 21
Z9 22
U1 3
U2 26
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1061-0278
EI 1029-0478
J9 SUPRAMOL CHEM
JI Supramol. Chem.
PY 2012
VL 24
IS 4
BP 255
EP 263
DI 10.1080/10610278.2012.655278
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 945KP
UT WOS:000304272400006
DA 2018-12-27
ER

PT J
AU Zhou, X
   Zhang, YF
   Chen, JC
   Xu, WT
AF Zhou, Xiang
   Zhang, Yufeng
   Chen, Jianchang
   Xu, Weiting
TI RETRACTED: Use of Non-benzodiazepine Hypnotics Is Associated with
   Decreased Risk of Coronary Artery Disease (Retracted article. See vol.
   52, pg. 1153, 2013)
SO INTERNAL MEDICINE
LA English
DT Article; Retracted Publication
DE coronary artery disease; non-benzodiazepine; angiography
ID HEART-DISEASE; INSOMNIA
AB Background It has been reported that the use of benzodiazepines (BDZs) is associated with an increased risk of coronary artery disease (CAD). However, it is still unclear whether or not non-BDZs use has the same adverse effect on the cardiovascular system.
   Methods We conducted a hospital-based case-control study with 864 CAD patients and 1,008 controls to explore the association between non-BDZs use and CAD risk in Chinese Han population.
   Results Non-BDZs use was found to be associated with a decreased risk of CAD (adjusted odds ratio, OR=0.73; 95% confidence interval, CI=0.54-0.98). Adjusted ORs were 0.91 (95% CI=0.63-1.32) for using non-BDZs 0 to 5 years, 0.64 (95% CI=0.38-0.97) for 5 to 10 years, and 0.42 (95% CI=0.18-0.85) for >10 years. The risk of CAD tended to decrease with an increase in duration of non-BDZs use (p<0.001 for trend).
   Conclusion Our study demonstrates that non-BDZs use is associated with a decreased risk of CAD. The potential cardiovascular protective mechanisms of non-BDZs should be investigated further.
C1 [Zhou, Xiang; Chen, Jianchang; Xu, Weiting] Soochow Univ, Affiliated Hosp 2, Dept Cardiol, Suzhou, Peoples R China.
RP Chen, JC (reprint author), Soochow Univ, Affiliated Hosp 2, Dept Cardiol, Suzhou, Peoples R China.
EM shaoh@163.com
CR Austen WG, 1975, CIRCULATION, V51, pS5
   Gensini GF, 1998, EUR HEART J, V19, pA53
   Knopp RH, 2002, AM J CARDIOL, V89, p28E
   Kubzansky LD, 2000, J PSYCHOSOM RES, V48, P323, DOI 10.1016/S0022-3999(99)00091-4
   LAPANE KL, 1995, EPIDEMIOLOGY, V6, P376, DOI 10.1097/00001648-199507000-00008
   Nabi H, 2010, BIOL PSYCHIAT, V67, P378, DOI 10.1016/j.biopsych.2009.07.040
   Price JF, 1997, EPIDEMIOLOGY, V8, P584, DOI 10.1097/00001648-199709000-00018
   Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034
   SANTAMORE WP, 1988, ANN BIOMED ENG, V16, P367, DOI 10.1007/BF02364624
   SCHARF MB, 1994, J CLIN PSYCHIAT, V55, P192
   Schwartz S, 1999, J PSYCHOSOM RES, V47, P313, DOI 10.1016/S0022-3999(99)00029-X
   Virmani Renu, 1998, Comprehensive Therapy, V24, P519
   Vogelzangs N, 2010, J AFFECT DISORDERS, V125, P241, DOI 10.1016/j.jad.2010.02.112
   WILSON PWF, 1994, AM J HYPERTENS, V7, pS7, DOI 10.1093/ajh/7.7.7S
NR 14
TC 3
Z9 3
U1 4
U2 10
PU JAPAN SOC INTERNAL MEDICINE
PI TOKYO
PA 34-3 3-CHOME HONGO BUNKYO-KU, TOKYO, 113, JAPAN
SN 0918-2918
EI 1349-7235
J9 INTERNAL MED
JI Intern. Med.
PY 2012
VL 51
IS 8
BP 829
EP 832
DI 10.2169/internalmedicine.51.6942
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA 940YE
UT WOS:000303928200003
PM 22504234
OA Bronze
DA 2018-12-27
ER

PT J
AU Boyle, B
   Charles, M
AF Boyle, Bill
   Charles, Marie
TI RETRACTED: 'In my Liverpool home': an investigation into the
   institutionalised invisibility of Liverpool's black citizens (Retracted
   article. See vol. 29, pg. 144, 2014)
SO JOURNAL OF EDUCATION POLICY
LA English
DT Article; Retracted Publication
DE equity/social justice; race; employment; teacher training
AB Reviewing the 22 years that have elapsed since Gifford's 1989 report labelled Liverpool as racist, the authors focus on the fact that in a city which has had a British African Caribbean (BAC) community for over 400 years, there is minimum representation of that community in the city's workforce. The authors investigate two major forms of employment in the city, i.e. the teaching workforce and the city's Council workforce and one major route to employability, i.e. Higher Education Institutions in the city. They set out an evidenced argument which demonstrates the under-representation of the BAC community in two of the city's major areas of employment. The authors hypothesise that this under-representation is grounded in institutional and structural racism.
C1 [Boyle, Bill; Charles, Marie] Univ Manchester, Sch Educ, Manchester, Lancs, England.
   [Charles, Marie] Univ Manchester, CFAS, Manchester, Lancs, England.
RP Boyle, B (reprint author), Univ Manchester, Sch Educ, Manchester, Lancs, England.
EM bill.boyle@manchester.ac.uk
CR [Anonymous], 1973, SELECT COMMITTEE REP
   [Anonymous], 2001, NATL CENSUS
   [Anonymous], 1981, W INDIAN CHILDREN OU
   Bell D., 1992, FACES BOTTOM WELL PE
   Bertrand M., 2003, WORKING PAPER SERIES, P3
   Bhavnani R., 2006, TACKLING ROOTS RACIS
   Boyle B, 2011, J BLACK STUD, V42, P427, DOI 10.1177/0021934710376937
   Burgess S., 2009, 09221 U BRIST CTR MA
   Carmichael F., 2000, INT REV APPL EC, V14, P71, DOI DOI 10.1080/026921700101498
   Carrington B., 2000, ETHNICITY PROFESSION
   Charles M., 2004, THESIS U LIVERPOOL
   Clay D., 2008, CHANGING FACE COMMUN, P88
   Clay D., 1993, MAINSTREAM ED BLACK
   Costello R., 2001, BLACK LIVERPOOL EARL
   Crozier G, 2005, BRIT J SOCIOL EDUC, V26, P585, DOI 10.1080/01425690500293520
   DCSF, 2009, STAT AN UN TEACH WOR
   DFES, 2004, SCH WORKF ENGL
   Ferguson RF, 2003, URBAN EDUC, V38, P460, DOI 10.1177/0042085903038004006
   Fielding M., 2000, CHALLENGE EQUALITY A
   General Teaching Council, 2002, COD PROF VAL PRACT
   Gewirtz S, 2008, EUR EDUC RES J, V7, P39, DOI 10.2304/eerj.2008.7.1.39
   Gifford A., 1989, LOOSEN SHACKLES 1 RE
   Gillborn D., 2000, BLACK MINORITY ETHNI
   Gillborn D, 2009, POWER EDUC, V1, P125, DOI 10.2304/power.2009.1.1.125
   Gordon G., 2008, BICULTURAL COMPETENC
   Gunaratnam Y., 2003, RES RACE ETHNICITY M
   John G., 2006, TAKING STAND
   Liverpool City Council, 1993, MAINSTREAM ED BLACK
   Liverpool Council, 2010, WORKF ETHN DAT
   Marley D., 2009, TIMES ED SUPPLE 1106
   Maylor U., 2003, MINORITY ETHNIC TEAC
   Mirza H.S., 2005, TELL IT IT IS SCH FA
   Mufti M., 1998, B ED FDN ACCESS EVAL, P1
   Murtha V., 2002, ACCESS TEACHING COUR
   Nelson William E., 2000, BLACK ATLANTIC POLIT
   OECD, 2010, INT SEM TECH ED DIV
   Osler A., 1997, ED CAREERS BLACK TEA
   Pilkington A., 2009, RACEING FORWARD TRAN
   Robbins M., 1995, J MULTICULTURAL TEAC, V14, P13
   Ryoo JJ, 2009, POWER EDUC, V1, P132, DOI 10.2304/power.2009.1.1.132
   Swann L., 1985, ED ALL REPORT COMMIT
   Ward H., 2009, TIMES ED SUPPLE 1120
   West C., 1999, CORNELL W READER
   Wilson M.G., 2005, BUS REV, V7, P65
NR 44
TC 1
Z9 1
U1 1
U2 7
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0268-0939
EI 1464-5106
J9 J EDUC POLICY
JI J. Educ. Policy
PY 2012
VL 27
IS 3
BP 335
EP 348
DI 10.1080/02680939.2011.594094
PG 14
WC Education & Educational Research
SC Education & Educational Research
GA 937KD
UT WOS:000303656500004
DA 2018-12-27
ER

PT J
AU Faraji, G
   Jafarzadeh, H
AF Faraji, G.
   Jafarzadeh, H.
TI RETRACTED: Accumulative Torsion Back (ATB) Processing as a New Plastic
   Deformation Technique (Retracted article. See vol. 30, pg. 272, 2015)
SO MATERIALS AND MANUFACTURING PROCESSES
LA English
DT Article; Retracted Publication
DE Accumulative; FEM; Hardness; Strain
ID EXTRUSION; ALLOY; ECAP; AL
AB A new plastic deformation technique based on accumulative torsion back (ATB) processing is proposed. The principle of ATB is that the material is subjected to the repetitive shear deformation by utilizing alternate twisting with a simple twist instrument. The process was investigated experimentally on commercially pure aluminium. Additionally, simulation of the process was also carried out, using the commercial finite element code ABAQUS/Explicit. Moreover, effects of process parameters such as twisting angle and number of passes on the results were studied. Results show that the ATB method is capable of imposing high strain values via strain accumulation by repeating the process, which is of great importance in producing ultrafine-grained or nanostructured materials. Elimination of the friction, low process loads, high productivity, and simple instrument are four important advantages of the ATB processing.
C1 [Faraji, G.; Jafarzadeh, H.] Univ Tehran, Univ Coll Engn, Dept Mech Engn, Tehran, Iran.
RP Jafarzadeh, H (reprint author), Univ Tehran, Univ Coll Engn, Dept Mech Engn, POB 11155-4563, Tehran, Iran.
EM h.jafarzadeh@ut.ac.ir
CR Asadi P., 2011, INT J MAT M IN PRESS
   Asadi P, 2010, INT J ADV MANUF TECH, V51, P247, DOI 10.1007/s00170-010-2600-z
   Beygelzimer Y, 2009, MAT SCI ENG A-STRUCT, V503, P14, DOI 10.1016/j.msea.2007.12.055
   Faraji G, 2012, MATER DESIGN, V35, P251, DOI 10.1016/j.matdes.2011.09.057
   Fatemi-Varzaneh SM, 2009, MAT SCI ENG A-STRUCT, V504, P104, DOI 10.1016/j.msea.2008.10.027
   Lee WB, 2006, COMPOS SCI TECHNOL, V66, P1513, DOI 10.1016/j.compscitech.2005.11.023
   Loucif A, 2010, MAT SCI ENG A-STRUCT, V527, P4864, DOI 10.1016/j.msea.2010.04.027
   Raab GJ, 2004, MAT SCI ENG A-STRUCT, V382, P30, DOI 10.1016/j.msea.2004.04.021
   Reihanian M, 2008, MATER CHARACT, V59, P1312, DOI 10.1016/j.matchar.2007.11.006
   Shirdel A, 2010, MATER DESIGN, V31, P946, DOI 10.1016/j.matdes.2009.07.035
   Yoon SC, 2009, INT J MATER RES, V100, P1715, DOI 10.3139/146.110236
   Zhang J, 2007, MATER SCI FORUM, V546-549, P2293, DOI 10.4028/www.scientific.net/MSF.546-549.2293
NR 12
TC 12
Z9 12
U1 3
U2 12
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1042-6914
EI 1532-2475
J9 MATER MANUF PROCESS
JI Mater. Manuf. Process.
PY 2012
VL 27
IS 5
BP 507
EP 511
DI 10.1080/10426914.2011.593235
PG 5
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 936SS
UT WOS:000303610900006
DA 2018-12-27
ER

PT J
AU Qiu, HJ
   Huang, XR
AF Qiu, Huajun
   Huang, Xirong
TI RETRACTED: Nanoporous PtFe surface alloy architecture for enhanced
   methanol electro-oxidation (Retracted article. See vol. 22, pg. 25504,
   2012)
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article; Retracted Publication
ID OXYGEN REDUCTION REACTION; IRON-OXIDE NANOPARTICLES; FUEL-CELLS; FEPT
   NANOPARTICLES; CO OXIDATION; FORMIC-ACID; CATALYSTS; CARBON; SIZE;
   NANOCRYSTALS
AB By selectively dealloying PtFeAl ternary alloy in 0.5 M NaOH solution, a novel nanoporous PtFe (np-PtFe) alloy with nanorod-like morphology and inherent three-dimensional bicontinuous ligament-pore structure was successfully fabricated. X-Ray diffraction and electron microscope characterization demonstrated the crystal nature of the alloy ligament with ligament size down to similar to 3 nm. NaOH concentration plays a key role in the formation of a uniform PtFe alloy structure. Dealloying solution with a low NaOH concentration (0.5 M) is suitable for the formation of a pure PtFe alloy structure, while Fe3O4/np-PtFe nanocomposite is obtained when using a high NaOH concentration (>= 2 M). The np-PtFe alloy can be facilely converted into a nanoporous near-surface alloy structure with a Pt-rich surface and PtFe alloy core by a second dealloying process in dilute HNO3 solution. Electrochemical measurements show that the nanoporous near-surface alloy has greatly enhanced catalytic activity and durability towards methanol electro-oxidation compared with the state-of-the-art Pt/C catalyst. The peak current density of methanol electro-oxidation on the nanoporous surface alloy is about five times that on Pt/C. More importantly, continuous potential cycling from 0.6 to 0.9 V (vs. RHE) in 0.5 M H2SO4 aqueous solution demonstrates that the np-PtFe surface alloy has a better structural stability than commercial Pt/C. With evident advantages of facile preparation and enhanced electrocatalytic activity and durability, the np-PtFe surface alloy holds great potential as an anode catalyst in direct methanol fuel cells.
C1 [Qiu, Huajun; Huang, Xirong] Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China.
   [Qiu, Huajun] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637457, Singapore.
RP Qiu, HJ (reprint author), Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China.
EM qiuhuajun@gmail.com
FU Nanyang Technological University; Shandong University
FX This work was supported by Nanyang Technological University and Shandong
   University.
CR Antolini E, 2006, J POWER SOURCES, V160, P957, DOI 10.1016/j.jpowsour.2006.03.006
   Borup R, 2007, CHEM REV, V107, P3904, DOI 10.1021/cr050182l
   Chen LY, 2009, ADV FUNCT MATER, V19, P1221, DOI 10.1002/adfm.200801239
   Chen M, 2004, J AM CHEM SOC, V126, P8394, DOI 10.1021/ja047648m
   Chen W, 2007, LANGMUIR, V23, P11303, DOI 10.1021/la7016648
   Chen ZW, 2007, ANGEW CHEM INT EDIT, V46, P4060, DOI 10.1002/anie.200700894
   Cuesta A, 2006, J ELECTROANAL CHEM, V586, P184, DOI 10.1016/j.jelechem.2005.10.006
   Ding Y, 2004, ADV MATER, V16, P1897, DOI 10.1002/adma.200400792
   Erlebacher J, 2004, J ELECTROCHEM SOC, V151, pC614, DOI 10.1149/1.1784820
   Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529
   EVANS BJ, 1990, HYPERFINE INTERACT, V57, P1815, DOI 10.1007/BF02405727
   Guo JW, 2005, ELECTROCHIM ACTA, V51, P754, DOI 10.1016/j.electacta.2005.05.056
   Ho D, 2011, ACCOUNTS CHEM RES, V44, P875, DOI 10.1021/ar200090c
   Housmans THM, 2005, J ELECTROANAL CHEM, V575, P39, DOI 10.1016/j.jelechem.2004.09.002
   Hsieh CT, 2009, J POWER SOURCES, V188, P347, DOI 10.1016/j.jpowsour.2008.12.031
   Hyeon T, 2001, J AM CHEM SOC, V123, P12798, DOI 10.1021/ja016812s
   Kabbabi A, 1998, J ELECTROANAL CHEM, V444, P41, DOI 10.1016/S0022-0728(97)00558-5
   Knudsen J, 2007, J AM CHEM SOC, V129, P6485, DOI 10.1021/ja0700855
   Koenigsmann C, 2011, J AM CHEM SOC, V133, P9783, DOI 10.1021/ja111130t
   Koenigsmann C, 2011, ENERG ENVIRON SCI, V4, P1161, DOI 10.1039/c0ee00197j
   Koh S, 2007, J AM CHEM SOC, V129, P12624, DOI 10.1021/ja0742784
   Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e
   Liang HW, 2011, ADV MATER, V23, P1467, DOI 10.1002/adma.201004377
   Liang X, 2006, ADV FUNCT MATER, V16, P1805, DOI 10.1002/adfm.200500884
   Liu LF, 2010, J MATER CHEM, V20, P5621, DOI 10.1039/c0jm00113a
   Liu LF, 2009, NANO LETT, V9, P4352, DOI 10.1021/nl902619q
   Liu XM, 2006, MATER LETT, V60, P2979, DOI 10.1016/j.matlet.2006.02.027
   Mani P, 2011, J POWER SOURCES, V196, P666, DOI 10.1016/j.jpowsour.2010.07.047
   Nandwana V, 2007, J PHYS CHEM C, V111, P4185, DOI 10.1021/jp068330e
   Prabhuram J, 2006, J PHYS CHEM B, V110, P5245, DOI 10.1021/jp0567063
   Qi Z, 2011, J MATER CHEM, V21, P9716, DOI 10.1039/c1jm10412h
   Qiu HJ, 2012, ACS APPL MATER INTER, V4, P1404, DOI 10.1021/am201659n
   Qiu HJ, 2010, BIORESOURCE TECHNOL, V101, P9415, DOI 10.1016/j.biortech.2010.07.097
   Qiu HJ, 2009, J PHYS CHEM C, V113, P2521, DOI 10.1021/jp8090304
   Rao CV, 2009, J PHYS CHEM C, V113, P18907, DOI 10.1021/jp9041606
   Shui JI, 2011, ADV FUNCT MATER, V21, P3357, DOI 10.1002/adfm.201100723
   Siani A, 2006, LANGMUIR, V22, P5160, DOI 10.1021/la053476a
   SIERADZKI K, 1993, J ELECTROCHEM SOC, V140, P2868, DOI 10.1149/1.2220924
   Simmonds MC, 1998, CORROS SCI, V40, P43, DOI 10.1016/S0010-938X(97)00109-1
   Snyder J, 2008, ADV MATER, V20, P4883, DOI 10.1002/adma.200702760
   Stamenkovic VR, 2007, NAT MATER, V6, P241, DOI 10.1038/nmat1840
   Stamenkovic VR, 2006, J AM CHEM SOC, V128, P8813, DOI 10.1021/ja0600476
   Stephens IEL, 2011, J AM CHEM SOC, V133, P5485, DOI 10.1021/ja111690g
   Strasser P, 2010, NAT CHEM, V2, P454, DOI [10.1038/NCHEM.623, 10.1038/nchem.623]
   Su FB, 2005, CHEM MATER, V17, P3960, DOI 10.1021/cm0502222
   Subhramannia M, 2008, J MATER CHEM, V18, P5858, DOI 10.1039/b811149a
   Tassa C, 2011, ACCOUNTS CHEM RES, V44, P842, DOI 10.1021/ar200084x
   Teng XW, 2003, J AM CHEM SOC, V125, P14559, DOI 10.1021/ja0376700
   Toda T, 1999, J ELECTROANAL CHEM, V460, P258, DOI 10.1016/S0022-0728(98)00361-1
   Wakisaka M, 2008, J PHYS CHEM C, V112, P2750, DOI 10.1021/jp0766499
   Wang JX, 2011, J AM CHEM SOC, V133, P13551, DOI 10.1021/ja204518x
   Wang JX, 2009, J AM CHEM SOC, V131, P17298, DOI 10.1021/ja9067645
   Wang RM, 2009, J PHYS CHEM C, V113, P4395, DOI 10.1021/jp811280k
   Wang XG, 2011, J PHYS CHEM C, V115, P4456, DOI 10.1021/jp110011w
   Wang ZL, 2000, J PHYS CHEM B, V104, P1153, DOI 10.1021/jp993593c
   Watanabe M, 2000, J PHYS CHEM B, V104, P1762, DOI 10.1021/jp993001q
   Xu CX, 2012, J POWER SOURCES, V199, P124, DOI 10.1016/j.jpowsour.2011.10.075
   Xu CX, 2010, NANOSCALE, V2, P906, DOI 10.1039/b9nr00351g
   Xu CX, 2010, PHYS CHEM CHEM PHYS, V12, P239, DOI 10.1039/b917788d
   Zhang L, 2011, ACS NANO, V5, P4407, DOI 10.1021/nn201443p
   Zhang ZH, 2011, NANOSCALE, V3, P1663, DOI 10.1039/c0nr00830c
   Zhang ZH, 2009, J PHYS CHEM C, V113, P12629, DOI 10.1021/jp811445a
   Zhang ZH, 2009, J PHYS CHEM C, V113, P1308, DOI 10.1021/jp808569g
   Zhao F, 2009, J AM CHEM SOC, V131, P5350, DOI 10.1021/ja900202t
   Zielasek V, 2006, ANGEW CHEM INT EDIT, V45, P8241, DOI 10.1002/anie.200602484
NR 65
TC 15
Z9 15
U1 5
U2 73
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2012
VL 22
IS 15
BP 7602
EP 7608
DI 10.1039/c2jm16106k
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 914NK
UT WOS:000301957300067
DA 2018-12-27
ER

PT J
AU Yuan, WE
   Liu, ZG
AF Yuan, Weien
   Liu, Zhenguo
TI RETRACTED: Controlled-release and preserved bioactivity of proteins from
   (self-assembled) core-shell double-walled microspheres (Retracted
   article. See vol. 13, pg. 2275, 2018)
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article; Retracted Publication
DE protein delivery; protein stability; core-shell microspheres; dextran
   nanoparticles
ID ERODING POLYMER MATRICES; SUSTAINED-RELEASE; BIODEGRADABLE MICROSPHERES;
   PLGA MICROSPHERES; DRUG-DELIVERY; MICROPARTICLES; ENCAPSULATION;
   FABRICATION; PREDICTION; PARTICLES
AB In order to address preserved protein bioactivities and protein sustained-release problems, a method for preparing double-walled microspheres with a core (protein-loaded nanoparticles with a polymer-suspended granule system-formed core) and a second shell (a polymer-formed shell) for controlled drug release and preserved protein bioactivities has been developed using (solid-in-oil phase-in-hydrophilic oil-in-water (S/O/O-h/W)) phases. The method, based on our previous microsphere preparation method (solid-in-oil phase-in-hydrophilic oil-in-water (S/O/O-h/W), employs different concentric poly(D,L-lactide-co-glycolide), poly(D,L-lactide), and protein-loaded nanoparticles to produce a suspended liquid which then self-assembles to form shell-core microspheres in the hydrophilic oil phase, which are then solidified in the water phase. Variations in the preparation parameters allowed complete encapsulation by the shell phase, including the efficient formation of a poly(D, L-lactide) shell encapsulating a protein-loaded nanoparticle-based poly(D,L-lactide-co-glycolide) core. This method produces core-shell double-walled microspheres that show controlled protein release and preserved protein bioactivities for 60 days. Based upon these results, we concluded that the core-shell double-walled microspheres might be applied for tissue engineering and therapy for chronic diseases, etc.
C1 [Yuan, Weien; Liu, Zhenguo] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Neurol, Shanghai 200092, Peoples R China.
   [Yuan, Weien] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China.
RP Liu, ZG (reprint author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Neurol, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.
EM yuanweien@126.com; zhenguoliu2004@yahoo.com.cn
RI Yuan, Weien/F-4399-2012
FU National Science Foundation of China Committee [81071025, 81171203];
   Shanghai Science and Technology Committee of Science and Technology
   [1052nm03900, 11nm0503300]; Shanghai Committee of Science and
   Technology, China [09JC14 11000]; PhD Programs Foundation of Ministry of
   Education of China [20090073120085]; Shanghai Jiao Tong University
   [IPP2090]
FX The study was supported by the Project of National Science Foundation of
   China Committee (81071025 and 81171203), Shanghai Science and Technology
   Committee of Science and Technology Special Nanotechnology Grant (No.
   1052nm03900 and No. 11nm0503300), the Key Foundational Program of the
   Shanghai Committee of Science and Technology, China (No. 09JC14 11000),
   PhD Programs Foundation of Ministry of Education of China (No.
   20090073120085), and University Student Renovation Project of Shanghai
   Jiao Tong University (IPP2090). And we also appreciate the generous help
   from faculty members of the Institute of Instrumental Analysis Centre
   (IAC) of Shanghai Jiao Tong University.
CR Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Babu VR, 2006, INT J PHARM, V325, P55, DOI 10.1016/j.ijpharm.2006.06.020
   Berkland C, 2004, J BIOMED MATER RES A, V70A, P576, DOI 10.1002/jbm.a.30114
   Berkland C, 2004, J CONTROL RELEASE, V96, P101, DOI 10.1016/j.jconrel.2004.01.018
   Choi DH, 2010, J CONTROL RELEASE, V147, P193, DOI 10.1016/j.jconrel.2010.07.103
   Ciombor DM, 2006, J MICROENCAPSUL, V23, P183, DOI 10.1080/0265204050043287
   Cleland JL, 1999, TRENDS BIOTECHNOL, V17, P25, DOI 10.1016/S0167-7799(98)01272-4
   Cleland JL, 1997, J CONTROL RELEASE, V47, P135, DOI 10.1016/S0168-3659(96)01625-2
   Fu K, 2003, J PHARM SCI, V92, P1582, DOI 10.1002/jps.10414
   Jain R, 1998, DRUG DEV IND PHARM, V24, P703, DOI 10.3109/03639049809082719
   Jin T, 2008, J CONTROL RELEASE, V128, P50, DOI 10.1016/j.jconrel.2008.02.010
   King WJ, 2011, ACTA BIOMATER, V7, P975, DOI 10.1016/j.actbio.2010.10.026
   Kokai LE, 2010, J CONTROL RELEASE, V141, P168, DOI 10.1016/j.jconrel.2009.09.003
   Lee GS, 2011, ACTA BIOMATER, V7, P3178, DOI 10.1016/j.actbio.2011.04.008
   Lee TH, 2002, J CONTROL RELEASE, V83, P437, DOI 10.1016/S0168-3659(02)00235-3
   Lee WL, 2011, J CONTROL RELEASE, V151, P229, DOI 10.1016/j.jconrel.2011.02.012
   Mathiowitz E, 1989, United States Patent, Patent No. 5985354
   Matsumoto A, 1997, J CONTROL RELEASE, V48, P19, DOI 10.1016/S0168-3659(97)00031-X
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Ren TT, 2011, MICRO NANO LETT, V6, P70, DOI 10.1049/mnl.2010.0107
   Rothstein SN, 2008, J MATER CHEM, V18, P1873, DOI 10.1039/b718277e
   Rothstein SN, 2009, BIOMATERIALS, V30, P1657, DOI 10.1016/j.biomaterials.2008.12.002
   Srinivasan C, 2005, J MICROENCAPSUL, V22, P127, DOI 10.1080/02652040400026400
   Tan EC, 2005, J COLLOID INTERF SCI, V291, P135, DOI 10.1016/j.jcis.2005.04.089
   van de Weert M, 2000, PHARM RES-DORDR, V17, P1159, DOI 10.1023/A:1026498209874
   VOLKIN DB, 1989, PROTEIN FUNCTION PRA, P1
   WISE D L, 1987, Advanced Drug Delivery Reviews, V1, P19, DOI 10.1016/0169-409X(87)90067-6
   Yuan WE, 2007, INT J PHARM, V339, P76, DOI 10.1016/j.ijpharm.2007.02.018
   Yuan WE, 2010, COLLOID SURFACE B, V79, P326, DOI 10.1016/j.colsurfb.2010.04.004
   Yuan WE, 2009, INT J PHARMACEUT, V366, P154, DOI 10.1016/j.ijpharm.2008.09.007
   Yuan WE, 2009, EUR J PHARM SCI, V36, P212, DOI 10.1016/j.ejps.2008.08.009
NR 31
TC 30
Z9 33
U1 3
U2 32
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2012
VL 7
BP 257
EP 270
DI 10.2147/IJN.S27621
PG 14
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 924PG
UT WOS:000302703200001
PM 22287838
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Chirica, I
   Beznea, EF
AF Chirica, Ionel
   Beznea, Elena-Felicia
TI RETRACTED: A Numerical Model for Torsion Analysis of Composite Ship
   Hulls (Retracted article. See 910305, 2014)
SO MATHEMATICAL PROBLEMS IN ENGINEERING
LA English
DT Article; Retracted Publication
ID THIN-WALLED-BEAMS; WARPING TORSION; MACRO-ELEMENTS
AB A new methodology based on a macroelement model proposed for torsional behaviour of the ship hull made of composite material is proposed in this paper. A computer program has been developed for the elastic analysis of linear torsion. The results are compared with the FEM-based licensed soft COSMOS/M results and measurements on the scale simplified model of a container ship, made of composite materials.
C1 [Chirica, Ionel; Beznea, Elena-Felicia] Dunarea de Jos Univ Galati, Galati 800008, Romania.
RP Chirica, I (reprint author), Dunarea de Jos Univ Galati, Domneasca St 47, Galati 800008, Romania.
EM ionel.chirica@ugal.ro
FU UEFISCDI [512/2008]
FX This paper has been supported by UEFISCDI, project number PNII-IDEI code
   512/2008 (2008-2011)
CR Chirica I, 2011, COMP MATER SCI, V50, P1381, DOI 10.1016/j.commatsci.2010.08.012
   Hu YR, 1996, COMPUT STRUCT, V61, P897, DOI 10.1016/0045-7949(96)00058-2
   IDER SK, 1988, J APPL MECH-T ASME, V55, P899, DOI 10.1115/1.3173739
   Kawai T., 1986, REPORT I IND SCI U T, V32
   Kollbrunner C. F., 1969, TORSION STRUCTURES
   LIBRESCU L, 2006, THIN WALLED COMPOSIT
   Musat S. D., 1995, P 3 INT C BOUND FIN, V1, P149
   Musat SD, 1999, INT J NUMER METH ENG, V44, P853, DOI 10.1002/(SICI)1097-0207(19990228)44:6<853::AID-NME534>3.0.CO;2-P
   Musat SD, 1996, COMMUN NUMER METH EN, V12, P873, DOI 10.1002/(SICI)1099-0887(199612)12:12<873::AID-CNM27>3.0.CO;2-E
   Nie W, 2006, J MAR SCI APPL, V5, P11
   Pedersen P. T. A., 1982, T ROYAL I NAVAL ARCH, P267
   SENJANOVIC I, 1992, COMPUT STRUCT, V43, P31, DOI 10.1016/0045-7949(92)90077-D
   Senjanovic I, 2009, MAR STRUCT, V22, P387, DOI 10.1016/j.marstruc.2009.03.004
   Senjanovic I., 2011, OCEAN SYSTEMS ENG, V1, P73
   Smith C. S., 1990, DESIGN MARINE STRUCT
   Timoshenko S. P, 1961, THEORY ELASTIC STABI
   Trautz M., 2009, P IASS S VAL SPAIN, P203
   Vlasov V. Z., 1961, THIN WALLED ELASTIC
   Yonghao P., 1993, J TIANJIN U, P51
NR 19
TC 3
Z9 3
U1 2
U2 21
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1024-123X
EI 1563-5147
J9 MATH PROBL ENG
JI Math. Probl. Eng.
PY 2012
AR 212346
DI 10.1155/2012/212346
PG 17
WC Engineering, Multidisciplinary; Mathematics, Interdisciplinary
   Applications
SC Engineering; Mathematics
GA 924FU
UT WOS:000302678000001
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Wanda, K
   Natalia, K
   Ewa, N
   Ryszard, K
   Jan, W
   Wladyslaw, P
AF Wanda, Konczewicz
   Natalia, Kryszak
   Ewa, Nowaczkiewicz
   Ryszard, Kozlowski
   Jan, Wojtysiak
   Wladyslaw, Podsiedlik
TI RETRACTED: Degumming Bast Fibrous Plants by Osmosis Phenomena as a
   Promising Method in Primary Processing (Retracted article. See vol. 569,
   pg. 167, 2012)
SO MOLECULAR CRYSTALS AND LIQUID CRYSTALS
LA English
DT Article; Retracted Publication
DE Degumming; lignocellulosic fibres; osmotic degumming; review
ID FIBER
AB This article reviews the methods of degumming lignocellulosic plants. The following degumming methods are used: biological, chemical, mechanical and physical - retting in warm and cold water retting, dew retting, chemical treatment by acid and base, use of electromagnetic pulses and most promising - osmotic degumming with ultrasound. The paper presents the newest methods of degumming, especially the method of osmotic degumming combined with ultrasound. This new method, developed by Institute of Natural Fibres and Medicinal Plants, is a typical pro-ecological method, because degumming water after cleaning has to be recycled. The retting water has no odour and biochemical oxygen demand and chemical oxygen demand parameters are not high. For better cost-efficiency the osmotic degumming method can be applied also for degumming green decorticated fibres.
C1 [Wanda, Konczewicz; Natalia, Kryszak; Ewa, Nowaczkiewicz] Inst Nat Fibres & Med Plants, Poznan, Poland.
   [Ryszard, Kozlowski] Inst Engn Polymers Mat & Dyes, Piastow, Poland.
   [Jan, Wojtysiak; Wladyslaw, Podsiedlik] Inst Sustainable Technol, Dept Text Technol, Radom, Poland.
RP Wanda, K (reprint author), Inst Nat Fibres & Med Plants, Poznan, Poland.
EM wanda.konczewicz@iwnirz.pl
CR Bozzini A., 2010, COMMUNICATION
   Kaniewski R, 2008, PRZEM CHEM, V87, P1206
   Kessler RW, 1998, BIOMASS BIOENERG, V14, P237, DOI 10.1016/S0961-9534(97)10040-X
   Konczewicz W., 2006, INT C NATURAL FIBRES
   Konczewicz W., 2009, 10 INT COTT C NAT FI, V92
   Konczewicz W, 2007, TEXTILES FOR SUSTAINABLE DEVELOPMENT, P95
   Kozlowski R., 2005, 11 INT C REN RES PLA
   Kozlowski R., 2005, LEN KONOPIE, p[5, 27]
   Kozlowski R., 2001, J NAT FIBERS, V45, P85
   Kozlowski R., 2006, J NAT FIBERS, V3, P113
   Kozlowski R., 2003, INT C FAO EUR RES NE
   Kozlowski R., 1967, PRACTITIONERS LIB IP, V3/67
   Kozlowski R, 2001, J NAT FIBERS, V45, P93
   Kozlowski R, 2006, BIOTECHNOL LETT, V28, P761, DOI 10.1007/s10529-006-9044-4
   Schilling E., 1951, FLAX
   Shekhar Sharma HS, 1992, BIOL PROCESSING FLAX
   Siwcow A. N., 1953, PRIMARY PROCESSING B
   Szalkowski Z., 1978, TEXTILE ENG MANUAL
   Zylinski T., 1958, NAUKA WTOKNIE
NR 19
TC 1
Z9 1
U1 3
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1542-1406
EI 1563-5287
J9 MOL CRYST LIQ CRYST
JI Mol. Cryst. Liquid Cryst.
PY 2012
VL 556
SI SI
BP 264
EP 274
DI 10.1080/15421406.2012.635976
PG 11
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA 919DM
UT WOS:000302301500022
DA 2018-12-27
ER

PT J
AU Amirhossein, M
   Aliakbar, R
   Ramin, NN
   Simin, N
   Mohammadhadii, D
   Mahmood, A
AF Amirhossein, Mahvi
   Aliakbar, Roodbari
   Ramin, Nabizadeh Nodehi
   Simin, Naseri
   Mohammadhadii, Dehghani
   Mahmood, Alimohammadi
TI RETRACTED: Improvement of Landfill Leachate Biodegradability with
   Ultrasonic Process (Retracted article. See 483946, 2014)
SO E-JOURNAL OF CHEMISTRY
LA English
DT Article; Retracted Publication
DE Biodegradability; Improve; Leachate; Ultrasonic
ID BIOLOGICAL TREATMENT; FENTON
AB Leachate from mature landfills is typically characterized by high ammonium (NH4+) content, low biodegradability (low BOD5/COD ratio) and high fraction of refractory and large organic molecules such as humic and fulvic acids. Mature leachate effluents are known to contain recalcitrant and/or non-biodegradable organic substances and biological processes are not efficient in these cases. A promising alternative to complete oxidation of biorecalcitrant leachate is the use of ultrasonic process as pre-treatment to convert initially biorecalcitrant compounds to more readily biodegradable intermediates, followed by biological oxidation of these intermediates to biomass and water. The objectives of this study are to investigate the effect of son catalysts process on biodegradability improvement. Results showed that when applied as relatively brief pre-treatment systems, the sonocatalysis processes induce several modifications of the matrix, which results in significant enhancement of its biodegradability. For this reason, the integrated chemical-biological systems proposed here represent a suitable solution for the treatment of landfill leachate samples with an efficient remediation of the relevant parameters (COD, TOC).
C1 [Amirhossein, Mahvi; Ramin, Nabizadeh Nodehi; Simin, Naseri; Mohammadhadii, Dehghani; Mahmood, Alimohammadi] Univ Tehran Med Sci, Natl Inst Hlth Res, Tehran, Iran.
   [Aliakbar, Roodbari] Univ Tehran Med Sci, Sch Publ Hlth, Tehran, Iran.
   [Aliakbar, Roodbari] Univ Tehran Med Sci, Environm Res Ctr, Tehran, Iran.
RP Amirhossein, M (reprint author), Univ Tehran Med Sci, Natl Inst Hlth Res, Tehran, Iran.
EM roodbari@shmu.ac.ir
CR Anglada A, 2011, WATER RES, V45, P828, DOI 10.1016/j.watres.2010.09.017
   Aziz HA, 2011, DESALINATION, V276, P278, DOI 10.1016/j.desal.2011.03.063
   Chianese A, 1999, WATER RES, V33, P647, DOI 10.1016/S0043-1354(98)00240-1
   CHIANG LC, 1995, WATER RES, V29, P671, DOI 10.1016/0043-1354(94)00146-X
   Cortez S, 2011, J ENVIRON MANAGE, V92, P749, DOI 10.1016/j.jenvman.2010.10.035
   de Morais JL, 2005, J HAZARD MATER, V123
   Guo JS, 2010, J HAZARD MATER, V178, P699, DOI 10.1016/j.jhazmat.2010.01.144
   Kargi F, 2004, ENZYME MICROB TECH, V34, P422, DOI 10.1016/j.enzmictec.2003.11.016
   Kargi F, 2003, PROCESS BIOCHEM, V38, P1413, DOI 10.1016/S0032-9592(03)00030-X
   Kurniawan TA, 2009, WATER RES, V43, P4079, DOI 10.1016/j.watres.2009.06.060
   Leao S., 2004, Computers, Environment and Urban Systems, V28, P353, DOI 10.1016/S0198-9715(03)00043-7
   Lim PE, 2010, CHEM ENG J, V159, P123, DOI 10.1016/j.cej.2010.02.064
   Mahini A. Salman, 2006, International Journal of Environmental Science and Technology, V3, P435, DOI 10.1007/BF03325953
   Ogundiran OO, 2008, INT J ENVIRON SCI TE, V5, P243, DOI 10.1007/BF03326018
   Pilli S, 2011, ULTRASON SONOCHEM, V18, P1, DOI 10.1016/j.ultsonch.2010.02.014
   ROBINSON HD, 1983, WATER RES, V17, P1537, DOI 10.1016/0043-1354(83)90010-6
   Scullion J, 2007, WATER RES, V41, P4129, DOI 10.1016/j.watres.2007.05.043
   Sun YJ, 2010, ULTRASON SONOCHEM, V17, P654, DOI 10.1016/j.ultsonch.2009.12.005
   Vilar VJP, 2011, WATER RES, V45, P2647, DOI 10.1016/j.watres.2011.02.019
   Wang CT, 2009, J HAZARD MATER, V164, P81, DOI 10.1016/j.jhazmat.2008.07.122
NR 20
TC 1
Z9 1
U1 2
U2 15
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0973-4945
J9 E-J CHEM
JI E-J. Chem.
PY 2012
VL 9
IS 2
BP 766
EP 771
DI 10.1155/2012/820971
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 917FZ
UT WOS:000302159300034
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Qiu, HJ
   Li, L
   Lang, QL
   Zou, FX
   Huang, XR
AF Qiu, Huajun
   Li, Liang
   Lang, Qiaolin
   Zou, Feixue
   Huang, Xirong
TI RETRACTED: Aligned nanoporous PtNi nanorod-like structures for
   electrocatalysis and biosensing (Retracted article. See vol. 2, pg.
   13042, 2012)
SO RSC ADVANCES
LA English
DT Article; Retracted Publication
ID OXYGEN REDUCTION REACTION; METHANOL ELECTROOXIDATION; CARBON NANOTUBES;
   HORSERADISH-PEROXIDASE; POROUS GOLD; SOL-GEL; ALLOY; CATALYSTS; SURFACE;
   NANOPARTICLES
AB We describe the one-step dealloying of PtNiAl ternary alloy to fabricate aligned nanoporous PtNi (np-PtNi) nanorod-like structures with predetermined alloy composition. Electron microscopy and X-ray diffraction characterizations demonstrate that the selective etching of Al from PtNiAl alloy with multiphases generates aligned np-PtNi alloy nanorods. The formation of nanoporous nanorod-like structures with uniform PtNi alloy ligament should be due to the fast diffusion, self assembly and strong interaction between Pt and Ni during the dealloying process. With the ligament size less than 5 nm, the np-PtNi nanorods exhibit remarkably improved electrocatalytic activity towards ethanol oxidation and H2O2 oxidation/reduction compared with the commercial Pt/C catalyst. When coupled with glucose oxidase, the enzyme modified np-PtNi electrode can sensitively detect glucose over a wide linear range (0.5-21 mM).
C1 [Qiu, Huajun; Zou, Feixue; Huang, Xirong] Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China.
   [Li, Liang; Lang, Qiaolin] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao 266101, Peoples R China.
   [Qiu, Huajun] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 637457, Singapore.
RP Qiu, HJ (reprint author), Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China.
EM qiuhuajun@gmail.com
FU Nanyang Technological University; Shandong University
FX This work was supported by Nanyang Technological University and Shandong
   University. H.Q. thanks the great help from Profs. Y. Ding, Z. Zhang and
   Dr. C. Xu.
CR Adzic R. R., 2007, ELECTROCHIM ACTA, V52, P2257
   Biener J, 2008, ADV MATER, V20, P1211, DOI 10.1002/adma.200701899
   Chakraborty S, 2009, BIOSENS BIOELECTRON, V24, P3264, DOI 10.1016/j.bios.2009.04.015
   Chen AC, 2010, CHEM REV, V110, P3767, DOI 10.1021/cr9003902
   Chen HJ, 2007, BIOSENS BIOELECTRON, V22, P1811, DOI 10.1016/j.bios.2006.08.013
   Chen LY, 2010, ADV FUNCT MATER, V20, P2279, DOI 10.1002/adfm.201000326
   Chen LY, 2009, ADV FUNCT MATER, V19, P1221, DOI 10.1002/adfm.200801239
   Ding Y, 2004, ADV MATER, V16, P1897, DOI 10.1002/adma.200400792
   Ding Y, 2009, MRS BULL, V34, P569, DOI 10.1557/mrs2009.156
   Dong YP, 2006, J PHYS CHEM B, V110, P18408, DOI 10.1021/jp062396s
   Erlebacher J, 2004, J ELECTROCHEM SOC, V151, pC614, DOI 10.1149/1.1784820
   Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529
   Gao HL, 2011, ELECTROCHIM ACTA, V56, P2024, DOI 10.1016/j.electacta.2010.11.090
   Gao W, 2007, J PHYS CHEM C, V111, P12213, DOI 10.1021/jp0722814
   Ge XB, 2007, CHEM MATER, V19, P5827, DOI 10.1021/cm702335f
   Huang JF, 2009, CHEM COMMUN, P1270, DOI 10.1039/b819658c
   Ji CX, 2003, J PHYS CHEM B, V107, P4494, DOI 10.1021/jp0222200
   Koenigsmann C, 2011, J AM CHEM SOC, V133, P9783, DOI 10.1021/ja111130t
   Koh S, 2007, J POWER SOURCES, V172, P50, DOI 10.1016/j.jpowsour.2007.01.002
   Laocharoensuk R, 2007, ACS NANO, V1, P403, DOI 10.1021/nn700255x
   Li XD, 2005, NANO LETT, V5, P1982, DOI 10.1021/nl0513885
   Liu F, 2004, J PHYS CHEM B, V108, P17959, DOI 10.1021/jp0472360
   Liu LF, 2010, J MATER CHEM, V20, P5621, DOI 10.1039/c0jm00113a
   Liu LF, 2009, NANO LETT, V9, P4352, DOI 10.1021/nl902619q
   Liu SN, 2007, J ELECTROANAL CHEM, V602, P103, DOI 10.1016/j.jelechem.2006.12.003
   Male KB, 2007, ANALYST, V132, P1254, DOI 10.1039/b712478c
   Park KW, 2002, J PHYS CHEM B, V106, P1869, DOI 10.1021/jp013168v
   Qiu HJ, 2008, J PHYS CHEM C, V112, P14781, DOI 10.1021/jp805600k
   Qiu HJ, 2012, ACS APPL MATER INTER, V4, P1404, DOI 10.1021/am201659n
   Qiu HJ, 2011, CHEMPHYSCHEM, V12, P2118, DOI 10.1002/cphc.201100205
   Qiu HJ, 2010, BIORESOURCE TECHNOL, V101, P9415, DOI 10.1016/j.biortech.2010.07.097
   Qiu HJ, 2009, BIOSENS BIOELECTRON, V24, P3014, DOI 10.1016/j.bios.2009.03.011
   Qiu HJ, 2009, J PHYS CHEM C, V113, P2521, DOI 10.1021/jp8090304
   Qiu HJ, 2009, BIORESOURCE TECHNOL, V100, P3837, DOI 10.1016/j.biortech.2009.03.016
   Shin TY, 2008, CHEM MATER, V20, P5682, DOI 10.1021/cm800859k
   Shui JI, 2011, ADV FUNCT MATER, V21, P3357, DOI 10.1002/adfm.201100723
   SIERADZKI K, 1993, J ELECTROCHEM SOC, V140, P2868, DOI 10.1149/1.2220924
   Snyder J, 2010, NAT MATER, V9, P904, DOI [10.1038/NMAT2878, 10.1038/nmat2878]
   Stamenkovic VR, 2007, NAT MATER, V6, P241, DOI 10.1038/nmat1840
   Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941
   Strasser P, 2010, NAT CHEM, V2, P454, DOI [10.1038/NCHEM.623, 10.1038/nchem.623]
   Sun YG, 2004, J AM CHEM SOC, V126, P3892, DOI 10.1021/ja039734c
   Tang S, 2010, BIOSENS BIOELECTRON, V26, P432, DOI 10.1016/j.bios.2010.07.105
   Trinh TT, 2011, RSC ADV, V1, P100, DOI 10.1039/c1ra00012h
   Wang J, 2003, ANAL CHEM, V75, P2075, DOI 10.1021/ac030007+
   Wang J, 2003, J AM CHEM SOC, V125, P2408, DOI 10.1021/ja028951v
   Wang JX, 2009, J AM CHEM SOC, V131, P17298, DOI 10.1021/ja9067645
   Wang L, 2011, J AM CHEM SOC, V133, P9674, DOI 10.1021/ja202655j
   Wang L, 2011, CHEM MATER, V23, P2457, DOI 10.1021/cm200382s
   Wang RY, 2012, ENERG ENVIRON SCI, V5, P5281, DOI 10.1039/c1ee02243a
   Wittstock A, 2010, SCIENCE, V327, P319, DOI 10.1126/science.1183591
   Xiao L, 2011, RSC ADV, V1, P1358, DOI 10.1039/c1ra00378j
   Xu CX, 2011, ACS APPL MATER INTER, V3, P4626, DOI 10.1021/am201057t
   Yajima T, 2004, J PHYS CHEM B, V108, P2654, DOI 10.1021/jp037215q
   Yoo SH, 2007, ADV MATER, V19, P1612, DOI 10.1002/adma.200602551
   Zhang J, 2007, SCIENCE, V315, P220, DOI 10.1126/science.1134569
   Zhang JT, 2007, J PHYS CHEM C, V111, P10382, DOI 10.1021/jp072333p
   Zhang L, 2011, ACS NANO, V5, P4407, DOI 10.1021/nn201443p
   Zhang ZH, 2009, J MATER CHEM, V19, P6042, DOI 10.1039/b904052h
   Zhang ZH, 2009, J PHYS CHEM C, V113, P12629, DOI 10.1021/jp811445a
   Zhang ZH, 2009, J PHYS CHEM C, V113, P1308, DOI 10.1021/jp808569g
   Zhou CM, 2010, ELECTROCHEM COMMUN, V12, P1210, DOI 10.1016/j.elecom.2010.06.021
   Zhou M, 2009, ANAL CHEM, V81, P5603, DOI 10.1021/ac900136z
   Zhou XW, 2011, J POWER SOURCES, V196, P5844, DOI 10.1016/j.jpowsour.2011.02.088
   Zou YJ, 2008, BIOSENS BIOELECTRON, V23, P1010, DOI 10.1016/j.bios.2007.10.009
NR 65
TC 14
Z9 14
U1 5
U2 84
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2012
VL 2
IS 8
BP 3548
EP 3554
DI 10.1039/c2ra01308h
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 915KM
UT WOS:000302023500066
DA 2018-12-27
ER

PT J
AU Inui, H
   Gion, K
   Utani, Y
   Wakai, T
   Kodama, S
   Eun, H
   Kim, YS
   Ohkawa, H
AF Inui, Hideyuki
   Gion, Keiko
   Utani, Yasushi
   Wakai, Taketo
   Kodama, Susumu
   Eun, Heesoo
   Kim, Yun-Seok
   Ohkawa, Hideo
TI RETRACTED: Assays of dioxins and dioxin-like compounds in actually
   contaminated soils using transgenic tobacco plants carrying a
   recombinant mouse aryl hydrocarbon receptor-mediated beta-glucuronidase
   reporter gene expression system (Retracted article. See vol. 47, pg.
   759, 2012)
SO JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART B-PESTICIDES FOOD
   CONTAMINANTS AND AGRICULTURAL WASTES
LA English
DT Article; Retracted Publication
DE Biochemical assay; dioxin; aryl hydrocarbon receptor; transgenic plants;
   polychlorinated biphenyl
ID CUCURBITA-PEPO; AH RECEPTOR; BIOASSAY; P,P'-DDE
AB The transgenic tobacco plant XD4V-26 carrying the recombinant mouse aryl hydrocarbon receptor XD4V-mediated beta-glucuronidase (GUS) reporter gene expression system was used for assay of dioxins and dioxin-like compounds consisting of polychlorinated dibenzeno-p-dioxins, polychlorinated dibenzofurans, and coplanar polychlorinated biphenyls (Co-PCBs) in actually contaminated soils. The transgenic tobacco plant XD4V-26 showed a significant dose-dependent induced GUS activity when cultured on MS medium containing PCB126 [toxic equivalency factor (TEF) = 0.1]. In contrast, PCB169 and PCB180, which have 0.03 of TEF and unassigned TEF values, respectively, did not significantly induce GUS activity under the same conditions as with PCB126. When the tobacco plants were cultivated for up to 5 weeks on actually contaminated soils with dioxins and dioxin-like compounds collected from the periphery of an incinerator used for disposal of residential and industrial wastes, GUS activity in the leaves was dose-dependently increased. The plants clearly detected 360 pg-TEQ g(-1) of dioxins and dioxin-like compounds in this assay. There was a positive correlation between GUS activity and TEQ value of dioxins and dioxin-like compounds in the plants. This assay does not require any extraction and purification processes for the actually contaminated soil samples.
C1 [Ohkawa, Hideo] Kobe Univ, Res Ctr Environm Genom, Kita Ku, Kobe, Hyogo 6511255, Japan.
   [Inui, Hideyuki; Utani, Yasushi; Wakai, Taketo; Kodama, Susumu; Ohkawa, Hideo] Kobe Univ, Grad Sch Sci & Technol, Kobe, Hyogo 6511255, Japan.
   [Eun, Heesoo; Kim, Yun-Seok] Natl Inst Agroenvironm Sci, Chem Anal Res Ctr, Tsukuba, Ibaraki 305, Japan.
RP Ohkawa, H (reprint author), Kobe Univ, Res Ctr Environm Genom, Kita Ku, Kashio Dai 14-14, Kobe, Hyogo 6511255, Japan.
EM hideo.ohkawa@gmail.com
FU Bio-oriented Technology Research Advancement Institution (BRAIN);
   Ministry of Education, Culture, Sports, Science and Technology of Japan
   [17208029]
FX We thank Masayuki Hattori, Tomohito Arao, Shozo Endo, and Emiko Iizumi
   for technical assistance and useful discussions. This work was funded in
   part through the Bio-oriented Technology Research Advancement
   Institution (BRAIN) and a Grant-in-Aid for Scientific Research A from
   the Ministry of Education, Culture, Sports, Science and Technology of
   Japan (No. 17208029).
CR Anderson JW, 2005, ENVIRON SCI TECHNOL, V39, P17, DOI 10.1021/es049283b
   Chen GS, 2004, ENVIRON TOXICOL, V19, P480, DOI 10.1002/tox.20053
   Heath-Pagliuso S, 1998, BIOCHEMISTRY-US, V37, P11508, DOI 10.1021/bi980087p
   HULSTER A, 1994, ENVIRON SCI TECHNOL, V28, P1110, DOI 10.1021/es00055a021
   Inui H, 2008, CHEMOSPHERE, V73, P1602, DOI 10.1016/j.chemosphere.2008.08.013
   Jeong HG, 2002, FOOD CHEM TOXICOL, V40, P1685, DOI 10.1016/S0278-6915(02)00099-6
   Kim YS, 2008, ARCH ENVIRON CON TOX, V54, P395, DOI 10.1007/s00244-007-9036-y
   Kodama S, 2007, PLANTA, V227, P37, DOI 10.1007/s00425-007-0592-1
   Kodama S, 2009, PLANT BIOTECHNOL J, V7, P119, DOI 10.1111/j.1467-7652.2008.00378.x
   Long M, 2003, TOXICOLOGY, V194, P77, DOI 10.1016/j.tox.2003.08.001
   Shimazu Sayuri, 2010, J Environ Sci Health B, V45, P773, DOI 10.1080/03601234.2010.515166
   Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055
   van der Plas SA, 2000, TOXICOL APPL PHARM, V169, P255, DOI 10.1006/taap.2000.9058
   White JC, 2006, J ENVIRON QUAL, V35, P992, DOI 10.2134/jeq2005.0271
   White JC, 2003, ENVIRON POLLUT, V124, P71, DOI 10.1016/S0269-7491(02)00409-8
   White JC, 2002, ENVIRON TOXICOL CHEM, V21, P550, DOI 10.1002/etc.5620210312
   Windal I, 2005, ENVIRON SCI TECHNOL, V39, P7357, DOI 10.1021/es0504993
NR 17
TC 7
Z9 7
U1 3
U2 15
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0360-1234
EI 1532-4109
J9 J ENVIRON SCI HEAL B
JI J. Environ. Sci. Health Part B-Pestic. Contam. Agric. Wastes
PY 2012
VL 47
IS 1
BP 59
EP 65
DI 10.1080/03601234.2012.611018
PG 7
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA 916AD
UT WOS:000302067900008
PM 22022789
DA 2018-12-27
ER

PT J
AU Rosoi, GN
AF Rosoi, Georgiana Nicoleta
TI RETRACTED: Financial integration and international transmission of
   business cycles: evidence from dynamic correlations (Retracted article.
   See vol. 19, pg. 1649, 2012)
SO APPLIED ECONOMICS LETTERS
LA English
DT Article; Retracted Publication
DE business cycle; transmission; financial integration; dynamic correlation
ID SYNCHRONIZATION; FACTS; TRADE
AB I estimate determinants of dynamic correlations of output comovement of Organisation for Economic Co-operation and Development (OECD) countries between 1992 and 2010. I show that trade intensity, degree of financial integration and specialization pattern have significantly different effects on comovements at different frequencies. This can bias the results using aggregate data or statistical filters. For example, financial integration is showed to have the highest positive effect for middle business frequencies, while it is insignificant for short-term frequencies.
RP Rosoi, GN (reprint author), 103 Castle Rd, Chatham ME4 5HX, Kent, England.
EM georgianarosoi@yahoo.com
CR Backus D., 1995, FRONTIERS BUSINESS C, P331
   Baxter M, 1999, REV ECON STAT, V81, P575, DOI 10.1162/003465399558454
   Benati L., 2001, 142 BANK ENGL
   Canova F, 1998, J MONETARY ECON, V41, P475, DOI 10.1016/S0304-3932(98)00006-3
   Croux C, 2001, REV ECON STAT, V83, P232, DOI 10.1162/00346530151143770
   Frankel JA, 1998, ECON J, V108, P1009, DOI 10.1111/1468-0297.00327
   HARVEY AC, 1993, J APPL ECONOM, V8, P231, DOI 10.1002/jae.3950080302
   Imbs J, 2004, REV ECON STAT, V86, P723, DOI 10.1162/0034653041811707
   Inklaar R, 2008, EUR ECON REV, V52, P646, DOI 10.1016/j.euroecorev.2007.05.003
   La Porta R, 1998, J POLIT ECON, V106, P1113, DOI 10.1086/250042
NR 10
TC 0
Z9 0
U1 2
U2 16
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1350-4851
EI 1466-4291
J9 APPL ECON LETT
JI Appl. Econ. Lett.
PY 2012
VL 19
IS 8
BP 735
EP 738
DI 10.1080/13504851.2011.597719
PG 4
WC Economics
SC Business & Economics
GA 910QY
UT WOS:000301657300008
DA 2018-12-27
ER

PT J
AU Malley, S
   Scroggins, J
   Bohon, SA
AF Malley, Sara
   Scroggins, Jennifer
   Bohon, Stephanie A.
TI RETRACTED: US EPA Enforcement of Environmental Regulations in Tennessee:
   2005-2008 (Retracted article. See vol. 26, pg. 1, 2013)
SO SOCIETY & NATURAL RESOURCES
LA English
DT Article; Retracted Publication
DE environmental crime; environmental hazards; environmental inequity;
   environmental injustice; environmental justice; environmental racism;
   environmental regulation; US environmental protection agency
ID JUSTICE; QUALITY; EQUITY; IMPACT; WASTE
AB Despite its responsibility to handle compliance and enforcement concerns, the U.S. Environmental Protection Agency (EPA) has become more concerned with protecting the interests of those it is supposed to be regulating than with the communities affected by environmental hazards. This research adds to the debate over environmental justice and injustice by examining U.S. EPA enforcement activity in Tennessee and the relationship between a Census place's race and income structure and the monetary fine (if any) assessed to a violating facility in that census place. Data were taken from the US. EPA Enforcement and Compliance History Online Database and the U. S. Census, and both logistic and truncated regression techniques were utilized to model outcomes. The results provide evidence for environmental racism with regard to whether or not a fine was assessed: however, the amount of fine assessed appears unrelated to the racial and economic structure of the places where violations occurred.
C1 [Malley, Sara] Univ Tennessee, Dept Sociol, Knoxville, TN 37996 USA.
   Univ Tennessee, Ctr Study Social Justice, Knoxville, TN 37996 USA.
RP Malley, S (reprint author), Univ Tennessee, Dept Sociol, 901 McClung Tower, Knoxville, TN 37996 USA.
EM smalley2@utk.edu
CR Atlas M, 2001, LAW SOC REV, V35, P633, DOI 10.2307/3185398
   Atlas M, 2007, LAW SOC REV, V41, P939, DOI 10.1111/j.1540-5893.2007.00330.x
   BAILEY C, 1993, SOCIOL SPECTRUM, V13, P89, DOI 10.1080/02732173.1993.9982018
   Boen J. R., 2006, STAT MED, V8, P1413
   Brulle R.J., 2006, ANNU REV PUBL HEALTH, V27, P1
   Bullard R. D., 2009, CONTAMINATED COMMUNI
   Bullard R. D., 2006, TOXIC TERROR TENNESS
   Bullard R.D., 2007, GRASSROOTS STRUGGLES
   Bullard R. D., 2007, POSTER CHILD ENV RAC
   Bullard R. D., 1996, ST JOHNS J LEGAL COM, V9, P445
   CABLE S, 1993, SOC PROBL, V40, P464, DOI 10.1525/sp.1993.40.4.03x0092n
   Elliott L., 1996, GENDERED NEW WORLD O, P13
   Halsey M., 1997, CURRENT ISSUES CRIMI, V8, P217
   JENSEN C, 1993, CENSORED NEWS DIDNT
   Kendall DT, 2001, HARVARD ENVIRON LAW, V25, P405
   Lavelle M., 1992, NATL LAW J, V21, pS1
   LENARD ML, 1975, MATH PROGRAM, V9, P69, DOI 10.1007/BF01681331
   Lynch Michael J., 2004, SOC NATUR RESOUR, V17, P333
   MEYER CR, 1983, ENVIRON HEALTH PERSP, V48, P9, DOI 10.2307/3429446
   Mohai P, 2009, ANNU REV ENV RESOUR, V34, P405, DOI [10.1146/annurev-environ-082508-094348, 10.1146/annurev.environ.082508-094348]
   Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5
   Pinderhughes R, 1996, SOCIOL PERSPECT, V39, P231, DOI 10.2307/1389310
   Rankin KK, 2007, ECOL LAW QUART, V34, P837
   RECHTSCHAFFEN C, 2002, ENV JUSTICE LAW POLI
   Ringquist EJ, 1998, J POLIT, V60, P1148, DOI 10.2307/2647735
   Schnaiberg Allan, 2000, ENV SOC ENDURING CON
   Scott AJ, 2006, WORLD DEV, V34, P1517, DOI 10.1016/j.worlddev.2006.01.003
   Simon DR, 2000, AM BEHAV SCI, V43, P633, DOI 10.1177/00027640021955469
   U.S. Environmental Protection Agency, 2003, DICKS COUNT LANDF RE
   U.S. Environmental Protection Agency, 2006, 5 YEAR REV
   U.S. Environmental Protection Agency, 2002, SCARB COMM DRAFT SAM
   URQUHART NS, 1993, STATISTICS FOR THE ENVIRONMENT, P71
   Zeckhauser RJ, 1996, ANN AM ACAD POLIT SS, V545, P144, DOI 10.1177/0002716296545001015
NR 33
TC 8
Z9 8
U1 1
U2 13
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0894-1920
J9 SOC NATUR RESOUR
JI Soc. Nat. Resour.
PY 2012
VL 25
IS 1-3
BP 87
EP 96
DI 10.1080/08941920.2011.572146
PG 10
WC Environmental Studies; Planning & Development; Sociology
SC Environmental Sciences & Ecology; Public Administration; Sociology
GA 908TN
UT WOS:000301515500007
DA 2018-12-27
ER

PT J
AU Della Pia, EA
   Elliott, M
   Jones, DD
   Macdonald, JE
AF Della Pia, Eduardo Antonio
   Elliott, Martin
   Jones, D. Dafydd
   Macdonald, J. Emyr
TI RETRACTED: Orientation-Dependent Electron Transport in a Single Redox
   Protein(Retracted article. See vol. 11, pg. 3421, 2017)
SO ACS NANO
LA English
DT Article; Retracted Publication
DE single-molecule conductance; molecular electronics; nanobioelectronics;
   scanning tunneling microscopy; cytochrome b(562); protein engineering
ID MOLECULE CONDUCTANCE; TUNNELING SPECTROSCOPY; UNRELATED PROTEINS;
   CYTOCHROME B(562); CHARGE-TRANSPORT; DOMAIN INSERTION; DNA-BINDING;
   JUNCTIONS; WIRES; CONDUCTIVITY
AB The redox-active protein cytochrome b(562) has been engineered to introduce pairs of thiol groups In the form of cysteine residues at specified sites. Successful STM imaging of the molecules adsorbed on a gold surface indicated that one thiol group controls the orientation of the molecule and that the protein maintains its native form under the experimental conditions. Stable protein gold STM tip electrical contact was directly observed to form via the second free thiol group in current voltage and current distance measurements. Proteins with thiol contacts positioned across the protein's short axis displayed a conductance of (3.48 +/- 0.05) x 10(-5) G(0). However proteins with thiol groups placed along the long axis reproducibly yielded two distinct values of (1.95 +/- 0.03) x 10(-5) G(0) and (357 +/- 0.11) x 10(-5) G(0), suggesting that the placement of the asymmetrically located haem within the protein influences electron transfer. In contrast, the unengineered wild-type cytochrome b(562) had conductance values at least 1 order of magnitude less. Here we show that an electron transfer protein engineered to bind gold surfaces can be controllably oriented and electrically contacted to metallic electrodes, a prerequisite for potential integration into electronic circuits.
C1 [Della Pia, Eduardo Antonio; Elliott, Martin; Macdonald, J. Emyr] Cardiff Univ, Sch Phys & Astron, Cardiff CF10 3XQ, S Glam, Wales.
   [Della Pia, Eduardo Antonio; Jones, D. Dafydd] Cardiff Univ, Sch Biosci, Cardiff CF10 3XQ, S Glam, Wales.
RP Elliott, M (reprint author), Cardiff Univ, Sch Phys & Astron, Cardiff CF10 3XQ, S Glam, Wales.
EM martin.elliott@astro.cf.ac.uk; jonesdd@cardiff.ac.uk
RI Della Pia, Eduardo Antonio/F-5572-2014
OI Della Pia, Eduardo Antonio/0000-0002-3136-9471; Elliott,
   Martin/0000-0002-9254-9898; Macdonald, John/0000-0001-5504-1692
FU Cardiff University; BBRSC [BB/E001084]; EPSRC [EP/D076072/1];
   Engineering and Physical Sciences Research Council [EP/D076072/1]
FX E.A.D.P. was supported by a Cardiff University Richard Whipp
   Interdisciplinary Research studentship. This work was supported by BBRSC
   (Grant BB/E001084 to D.D.J.) and EPSRC (EP/D076072/1 to J.E.M. and
   M.E.).
CR Artes JM, 2011, ACS NANO, V5, P2060, DOI 10.1021/nn103236e
   Ashwell GJ, 2010, ACS NANO, V4, P7401, DOI 10.1021/nn102460z
   Bennett N, 2010, SMALL, V6, P2604, DOI 10.1002/smll.201001046
   Chen F, 2007, ANNU REV PHYS CHEM, V58, P535, DOI 10.1146/annurev.physchem.58.032806.104523
   Claridge SA, 2011, ACS NANO, V5, P693, DOI 10.1021/nn103298x
   Cui XD, 2001, SCIENCE, V294, P571, DOI 10.1126/science.1064354
   Della Pia E.A., SMALL UNPUB
   Della Pia EA, 2011, NANO LETT, V11, P176, DOI 10.1021/nl103334q
   Edwards WR, 2010, BIOCHEMISTRY-US, V49, P6541, DOI 10.1021/bi100793y
   Edwards WR, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn363
   Galipeau K.K., 2011, ACS NANO, V5, P4835
   Haick H, 2008, PROG SURF SCI, V83, P217, DOI 10.1016/j.progsurf.2008.04.002
   Haiss W, 2004, PHYS CHEM CHEM PHYS, V6, P4330, DOI 10.1039/b404929b
   Haiss W, 2006, NAT MATER, V5, P995, DOI 10.1038/nmat1781
   Haiss W, 2009, J PHYS CHEM C, V113, P5823, DOI 10.1021/jp811142d
   HAMADA K, 1995, J MOL BIOL, V247, P947, DOI 10.1006/jmbi.1995.0192
   Hipps KW, 2001, SCIENCE, V294, P536, DOI 10.1126/science.1065708
   Hook F, 2008, ACS NANO, V2, P2428, DOI 10.1021/nn800800v
   Jones DD, 2005, ANGEW CHEM INT EDIT, V44, P6337, DOI 10.1002/anie.200463035
   Jones DD, 2004, CHEMBIOCHEM, V5, P964, DOI 10.1002/cbic.200300569
   Kim Y, 2011, ACS NANO, V5, P4104, DOI 10.1021/nn200759s
   Li C, 2008, J AM CHEM SOC, V130, P318, DOI 10.1021/ja0762386
   Li XL, 2006, J AM CHEM SOC, V128, P2135, DOI 10.1021/ja057316x
   Li-Li L., 2011, ACS NANO, V5, P2257
   Nichols RJ, 2010, PHYS CHEM CHEM PHYS, V12, P2801, DOI 10.1039/b922000c
   Pobelov IV, 2008, J AM CHEM SOC, V130, P16045, DOI 10.1021/ja8054194
   Ron I, 2010, J AM CHEM SOC, V132, P4131, DOI 10.1021/ja907328r
   Sedghi G, 2008, J AM CHEM SOC, V130, P8582, DOI 10.1021/ja802281c
   Sen A, 2010, ACS NANO, V4, P6404, DOI 10.1021/nn101840a
   Song H, 2011, ADV MATER, V23, P1583, DOI 10.1002/adma.201004291
   Steinmann P, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1862342
   Tao NJ, 2006, NAT NANOTECHNOL, V1, P173, DOI 10.1038/nnano.2006.130
   Ulgut B, 2008, CHEM REV, V108, P2721, DOI 10.1021/cr068060w
   van Zalinge H, 2006, CHEMPHYSCHEM, V7, P94, DOI 10.1002/cphc.200500413
   Vilan A, 2007, J PHYS CHEM C, V111, P4431, DOI 10.1021/jp066846s
   Wang YH, 2009, ACS NANO, V3, P1049, DOI 10.1021/nn900448g
   Xiao XY, 2004, NANO LETT, V4, P267, DOI 10.1021/nl035000m
NR 37
TC 24
Z9 24
U1 2
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD JAN
PY 2012
VL 6
IS 1
BP 355
EP 361
DI 10.1021/nn2036818
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 879YH
UT WOS:000299368300045
PM 22088136
DA 2018-12-27
ER

PT J
AU Herrera-Merchan, A
   Arranz, L
   Ligos, JM
   de Molina, A
   Dominguez, O
   Gonzalez, S
AF Herrera-Merchan, A.
   Arranz, L.
   Ligos, J. M.
   de Molina, A.
   Dominguez, O.
   Gonzalez, S.
TI RETRACTED: Ectopic expression of the histone methyltransferase Ezh2 in
   haematopoietic stem cells causes myeloproliferative disease (Retracted
   article. See vol. 8, Art no 14005, 2017)
SO NATURE COMMUNICATIONS
LA English
DT Article; Retracted Publication
ID IN-VIVO; MYELODYSPLASTIC SYNDROMES; SOMATIC MUTATIONS; GENE-EXPRESSION;
   DNA METHYLATION; LEUKEMIC-CELLS; SELF-RENEWAL; CANCER; PROTEINS; MICE
AB Recent evidence shows increased and decreased expression of Ezh2 in cancer, suggesting a dual role as an oncogene or tumour suppressor. To investigate the mechanism by which Ezh2-mediated H3K27 methylation leads to cancer, we generated conditional Ezh2 knock-in (Ezh2-KI) mice. Here we show that induced Ezh2 haematopoietic expression increases the number and proliferation of repopulating haematopoietic stem cells. Ezh2-KI mice develop myeloproliferative disorder, featuring excessive myeloid expansion in bone marrow and spleen, leukocytosis and splenomegaly. Competitive and serial transplantations demonstrate progressive myeloid commitment of Ezh2-KI haematopoietic stem cells. Transplanted self-renewing haematopoietic stem cells from Ezh2-KI mice induce myeloproliferative disorder, suggesting that the Ezh2 gain-of-function arises in the haematopoietic stem cell pool, and not at later stages of myelopoiesis. At the molecular level, Ezh2 regulates haematopoietic stem cell-specific genes such as Evi-1 and Ntrk3, aberrantly found in haematologic malignancies. These results demonstrate a stem cell-specific Ezh2 oncogenic role in myeloid disorders, and suggest possible therapeutic applications in Ezh2-related haematological malignancies.
C1 [Herrera-Merchan, A.; Arranz, L.; Gonzalez, S.] Spanish Natl Cardiovasc Res Ctr CNIC, Stem Cell Aging Grp, E-28029 Madrid, Spain.
   [Ligos, J. M.] Spanish Natl Cardiovasc Res Ctr CNIC, Cell Unit, E-28029 Madrid, Spain.
   [de Molina, A.] Spanish Natl Cardiovasc Res Ctr CNIC, Anim Unit, E-28029 Madrid, Spain.
   [Dominguez, O.] Spanish Natl Canc Res Ctr CNIO, Genom Unit, E-28029 Madrid, Spain.
RP Gonzalez, S (reprint author), Spanish Natl Cardiovasc Res Ctr CNIC, Stem Cell Aging Grp, E-28029 Madrid, Spain.
EM sgonzalez@cnic.es
RI Gonzalez, Susana/I-3154-2015
OI Gonzalez, Susana/0000-0002-7443-6195
FU Human Frontiers Science Program Organization; Spanish Ministry of
   Science and Innovation [SAF2010-15386]; Spanish Ministry of Health [FIS
   PI06/0627]; Pro-CNIC Foundation
FX We are grateful to Giovanna Giovinazzo, Luis-Miguel Criado, Maria
   Montoya and their teams (CNIC) for technical support. We also thank
   Simon Bartlett (CNIC) for English editing, Dr Serrano for helpful
   discussion, and Purificacion Arribas for her wonderful technical
   assistance. S. Gonzalez is funded by the Human Frontiers Science Program
   Organization, the Spanish Ministries of Science and Innovation
   (SAF2010-15386) and Health (FIS PI06/0627) The CNIC is supported by the
   Ministry of Science and Innovation and the Pro-CNIC Foundation.
CR Akala OO, 2006, CURR OPIN GENET DEV, V16, P496, DOI 10.1016/j.gde.2006.08.011
   Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343
   Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127
   Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507
   Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736
   Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101
   Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716
   Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960
   Cleary ML, 2009, BEST PRACT RES CL HA, V22, P483, DOI 10.1016/j.beha.2009.08.005
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6
   de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005
   Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621
   Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496
   Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785
   Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585
   Gonzalez S, 2008, CELL CYCLE, V7, P2601, DOI 10.4161/cc.7.16.6541
   Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797
   Goyama S, 2010, LEUKEMIA, V24, P81, DOI 10.1038/leu.2009.202
   Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002
   Herrera-Merchan A, 2010, CELL CYCLE, V9, P3277, DOI 10.4161/cc.9.16.12598
   Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029
   Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001
   Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238
   Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750
   Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.02.010
   Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784
   Martin-Perez D, 2010, BLOOD, V116, P5465, DOI 10.1182/blood-2010-05-267096
   Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518
   Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015
   Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620
   Ogilvy S, 1999, BLOOD, V94, P1855
   Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972
   Passegue E, 2006, DEV CELL, V10, P415, DOI 10.1016/j.devcel.2006.03.002
   Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967
   Paul TA, 2010, BLOOD, V115, P3098, DOI 10.1182/blood-2009-07-233858
   Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002
   Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950
   Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107
   Tam WF, 2008, BLOOD, V112, P1981, DOI 10.1182/blood-2007-07-103010
   Tefferi A, 2007, CELL CYCLE, V6, P550, DOI 10.4161/cc.6.5.3919
   Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541
   Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431
   Warr MR, 2011, WIRES SYST BIOL MED, V3, P681, DOI 10.1002/wsbm.145
   Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941
   Xu F, 2011, ANN HEMATOL, V90, P643, DOI 10.1007/s00277-010-1128-5
   Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208
NR 49
TC 82
Z9 85
U1 3
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN
PY 2012
VL 3
AR 623
DI 10.1038/ncomms1623
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 887IV
UT WOS:000299921000021
PM 22233633
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Montironi, R
   Scarpelli, M
   Mazzucchelli, R
   Cheng, L
   Lopez-Beltran, A
AF Montironi, Rodolfo
   Scarpelli, Marina
   Mazzucchelli, Roberta
   Cheng, Liang
   Lopez-Beltran, Antonio
TI RETRACTED: The spectrum of morphology in non-neoplastic prostate
   including cancer mimics (Retracted article. See vol. 64, pg. 1048, 2014)
SO HISTOPATHOLOGY
LA English
DT Review; Retracted Publication
DE adenosis (atypical adenomatous hyperplasia); atrophy; basal cell
   hyperplasia; clear cell cribriform hyperplasia; prostate cancer;
   prostate cancer mimics
ID ATYPICAL ADENOMATOUS HYPERPLASIA; NEEDLE-BIOPSY SPECIMENS; BASAL-CELL
   HYPERPLASIA; COA-RACEMASE P504S; SCLEROSING ADENOSIS; NEPHROGENIC
   ADENOMA; HISTOLOGIC FEATURES; BENIGN MIMICKERS; PARTIAL ATROPHY;
   URINARY-TRACT
AB The spectrum of morphology in non-neoplastic prostate includes lesions of prostatic epithelial origin, the most common being atrophy, including partial atrophy, adenosis (atypical adenomatous hyperplasia), basal cell hyperplasia and crowded benign glands, as well as those of non-prostatic origin, such as seminal vesicle epithelium. These lesions often mimic lower-grade prostatic adenocarcinoma whereas others, such as granulomatous prostatitis, for example, are in the differential diagnosis of adenocarcinoma, Gleason grades 4 or 5. Diagnostic awareness of the salient histomorphological and relevant immunohistochemical features of these prostatic pseudoneoplasms is critical to avoid rendering false positive diagnoses of malignancy.
C1 [Montironi, Rodolfo; Scarpelli, Marina; Mazzucchelli, Roberta] Polytech Univ Marche Reg, United Hosp, Sch Med, Sect Pathol Anat, I-60126 Ancona, Italy.
   [Cheng, Liang] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA.
   [Lopez-Beltran, Antonio] Reina Sofia Univ Hosp, Dept Pathol, Cordoba, Spain.
   [Lopez-Beltran, Antonio] Fac Med, Cordoba, Spain.
RP Montironi, R (reprint author), Polytech Univ Marche Reg, United Hosp, Sch Med, Sect Pathol Anat, Via Conca 71, I-60126 Ancona, Italy.
EM r.montironi@univpm.it
CR ALGUACILGARCIA A, 1986, AM J SURG PATHOL, V10, P795, DOI 10.1097/00000478-198611000-00007
   Amin MB, 1996, MODERN PATHOL, V9, P791
   Berney DM, 2007, HISTOPATHOLOGY, V51, P452, DOI 10.1111/j.1365-2559.2007.02819.x
   Bostwick DG, 2007, ARCH PATHOL LAB MED, V131, P360
   Bostwick DG, 2003, MODERN PATHOL, V16, P630, DOI 10.1097/01.MP.0000074733.10777.78
   BOSTWICK DG, 1993, HUM PATHOL, V24, P819, DOI 10.1016/0046-8177(93)90131-Y
   Brimo F, 2011, ARCH PATHOL IN PRESS
   Cheng L, 2000, CANCER, V88, P853, DOI 10.1002/(SICI)1097-0142(20000215)88:4<853::AID-CNCR16>3.0.CO;2-H
   Cheng L, 1998, CANCER RES, V58, P389
   Cheng L, 2010, HISTOPATHOLOGY, V56, P627, DOI 10.1111/j.1365-2559.2010.03525.x
   Chuang AY, 2007, AM J SURG PATHOL, V31, P1225, DOI 10.1097/PAS.0b013e31802be3c2
   Cina SJ, 1997, AM J SURG PATHOL, V21, P289, DOI 10.1097/00000478-199703000-00004
   COLLINA G, 1992, HISTOPATHOLOGY, V20, P505
   De Marzo AM, 2006, AM J SURG PATHOL, V30, P1281, DOI 10.1097/01.pas.0000213289.50660.be
   Doll JA, 1999, AM J PATHOL, V155, P967, DOI 10.1016/S0002-9440(10)65196-6
   FRAUENHOFFER EE, 1991, AM J CLIN PATHOL, V95, P446, DOI 10.1093/ajcp/95.4.446
   Gaudin PB, 1995, AM J CLIN PATHOL, V104, P620
   GAUDIN PB, 1994, AM J SURG PATHOL, V18, P863, DOI 10.1097/00000478-199409000-00001
   GAUDIN PB, 1995, AM J SURG PATHOL, V19, P737, DOI 10.1097/00000478-199507000-00001
   GOLDSTEIN NS, 1995, HUM PATHOL, V26, P887, DOI 10.1016/0046-8177(95)90012-8
   GRIGNON DJ, 1992, AM J SURG PATHOL, V16, P383, DOI 10.1097/00000478-199204000-00007
   GRIGNON DJ, 1993, AM J SURG PATHOL, V17, P287, DOI 10.1097/00000478-199303000-00009
   Hameed O, 2005, SEMIN DIAGN PATHOL, V22, P88, DOI 10.1053/j.semdp.2005.11.001
   Hameed O, 2010, ARCH PATHOL LAB MED, V134, P427, DOI 10.1043/1543-2165-134.3.427
   Herawi M, 2005, AM J SURG PATHOL, V29, P874, DOI 10.1097/01.pas.0000159520.36806.3e
   Howarth SM, 2005, HISTOPATHOLOGY, V47, P114, DOI 10.1111/j.1365-2559.2005.02043.x
   Humphrey PA, 1998, AM J SURG PATHOL, V22, P1239, DOI 10.1097/00000478-199810000-00009
   JONES EC, 1991, AM J SURG PATHOL, V15, P1171, DOI 10.1097/00000478-199112000-00008
   Levi AW, 2000, AM J SURG PATHOL, V24, P1039, DOI 10.1097/00000478-200008000-00001
   Magi-Galluzzi C, 2003, AM J SURG PATHOL, V27, P206, DOI 10.1097/00000478-200302000-00009
   Milord RA, 2000, AM J SURG PATHOL, V24, P1378, DOI 10.1097/00000478-200010000-00007
   Montironi R, 2005, J CLIN PATHOL, V58, P290, DOI 10.1136/jcp.2004.019596
   Oppenheimer JR, 1998, AM J SURG PATHOL, V22, P440, DOI 10.1097/00000478-199804000-00008
   Paner GP, 2008, ARCH PATHOL LAB MED, V132, P1388, DOI 10.1043/1543-2165(2008)132[1388:BPIDIP]2.0.CO;2
   Przybycin CG, 2008, AM J SURG PATHOL, V32, P58, DOI 10.1097/PAS.0b013e318093e3f6
   Rahemtullah A, 2006, ADV ANAT PATHOL, V13, P247, DOI 10.1097/01.pap.0000213047.69564.c2
   Saboorian MH, 1997, AM J SURG PATHOL, V21, P1069, DOI 10.1097/00000478-199709000-00011
   Schowinsky JT, 2006, AM J SURG PATHOL, V30, P866, DOI 10.1097/01.pas.0000213274.60962.63
   Speights VO, 1996, BRIT J UROL, V77, P408, DOI 10.1046/j.1464-410X.1996.89315.x
   Srigley JR, 2004, MODERN PATHOL, V17, P328, DOI 10.1038/modpathol.3800055
   Tong GX, 2008, AM J SURG PATHOL, V32, P1380, DOI 10.1097/PAS.0b013e31816b1020
   Tong GX, 2006, MODERN PATHOL, V19, P356, DOI 10.1038/modpathol.3800535
   Wang HLL, 2002, AM J SURG PATHOL, V26, P1066, DOI 10.1097/01.PAS.0000020460.78859.86
   Yang XMJ, 2003, UROLOGY, V62, P282, DOI 10.1016/S0090-4295(03)00259-0
   Yang XMJ, 2003, HUM PATHOL, V34, P462, DOI 10.1016/S0046-8177(03)00121-7
   Yang XMJ, 2002, AM J SURG PATHOL, V26, P921, DOI 10.1097/00000478-200207000-00011
   Zhou M, 2003, AM J SURG PATHOL, V27, P772, DOI 10.1097/00000478-200306000-00007
NR 47
TC 15
Z9 17
U1 2
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0309-0167
EI 1365-2559
J9 HISTOPATHOLOGY
JI Histopathology
PD JAN
PY 2012
VL 60
IS 1
BP 41
EP 58
DI 10.1111/j.1365-2559.2011.04000.x
PG 18
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA 867TO
UT WOS:000298477700004
PM 22212077
DA 2018-12-27
ER

PT J
AU Liang, S
   Lan, XL
   Zhang, YX
   Xu, XM
   Li, B
AF Liang, Sheng
   Lan, Xiaoli
   Zhang, Yongxue
   Xu, Xuemin
   Li, Biao
TI RETRACTED: Fully automatic synthesis of [F-18]FES for reporter gene hERL
   expression imaging (Retracted article. See vol. 33, pg. 562, 2012)
SO NUCLEAR MEDICINE COMMUNICATIONS
LA English
DT Article; Retracted Publication
DE F-18-FES; fully automatic synthesis; PET; report gene imaging
ID POSITRON-EMISSION-TOMOGRAPHY; BREAST-CANCER; FLUOROESTRADIOL; THERAPY;
   SYSTEM
AB We have developed a fully automatic method for the synthesis of 16 alpha-[F-18] fluoroestradiol ([F-18]FES) using a TRACERlab FXFN module. Following [F-18] fluorination, the intermediate was hydrolyzed with a mixture of 2 N HCl in acetonitrile (CH3CN) and then neutralized with sodium bicarbonate (NaHCO3). After HPLC purification, the decay-corrected radiochemical yield of [F-18] FES was 50 +/- 2.35% (n = 4), which was stable up to 96.1 +/- 0.3% (n=4) at 8 h. This new fully automated synthesis method provided high and reproducible yields and the produced [F-18] FES could be used to monitor in-vivo human estrogen receptor a ligand binding domain gene expression using PET images. Nucl Med Commun 33:29-33 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
C1 [Liang, Sheng; Li, Biao] Shanghai Jiao Tong Univ, Dept Nucl Med, Ruijin Hosp, Sch Med, Shanghai 200025, Peoples R China.
   [Liang, Sheng; Xu, Xuemin; Li, Biao] Shanghai Jiao Tong Univ, Med X Ruijin Small Anim PET CT Res Ctr, Inst Med 10, Shanghai 200025, Peoples R China.
   [Lan, Xiaoli; Zhang, Yongxue] Huazhong Sci & Technol Univ, Dept Nucl Med, Xiehe Hosp, Sch Med, Wuhan, Peoples R China.
RP Li, B (reprint author), Shanghai Jiao Tong Univ, Dept Nucl Med, Ruijin Hosp, Sch Med, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.
EM lb10363@rjh.com.cn
FU Shanghai Municipal Nature Science Foundation [09ZR1419300, 09431900900];
   Shanghai Leading Academic Discipline Project [S30203]; China National
   Natural Science Foundation [81000622, 81071181]
FX This work was supported by Shanghai Municipal Nature Science Foundation
   (09ZR1419300 & 09431900900), Shanghai Leading Academic Discipline
   Project (S30203), and China National Natural Science Foundation
   (81000622 & 81071181). The authors thank Jun Wu from GE Health System
   (China) for technical assistance.
CR BRODACK JW, 1986, J NUCL MED, V27, P714
   Furukawa T, 2006, NUCL MED BIOL, V33, P145, DOI 10.1016/j.nucmedbio.2005.07.013
   KIESEWETTER DO, 1984, J ORG CHEM, V49, P4900, DOI 10.1021/jo00199a031
   Lim JL, 1996, NUCL MED BIOL, V23, P911, DOI 10.1016/S0969-8051(96)00126-6
   Linden HM, 2006, J CLIN ONCOL, V24, P2793, DOI 10.1200/JCO.2005.04.3810
   MCGUIRE AH, 1991, J NUCL MED, V32, P1526
   Mori T, 2006, NUCL MED BIOL, V33, P281, DOI 10.1016/j.nucmedbio.2005.11.002
   Mortimer JE, 1996, CLIN CANCER RES, V2, P933
   Oh SJ, 2007, APPL RADIAT ISOTOPES, V65, P676, DOI 10.1016/j.apradiso.2006.06.016
   Romer J, 1999, NUCL MED BIOL, V26, P473, DOI 10.1016/S0969-8051(98)00098-5
   Takamatsu S, 2005, NUCL MED BIOL, V32, P821, DOI 10.1016/j.nucmedbio.2005.06.010
NR 11
TC 2
Z9 2
U1 3
U2 17
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0143-3636
EI 1473-5628
J9 NUCL MED COMMUN
JI Nucl. Med. Commun.
PD JAN
PY 2012
VL 33
IS 1
BP 29
EP 33
DI 10.1097/MNM.0b013e32834d3b92
PG 5
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 872ZL
UT WOS:000298850000005
PM 22044863
DA 2018-12-27
ER

PT J
AU Yao, YD
   Ge, JL
AF Yao, Y. D.
   Ge, J. L.
TI RETRACTED: Seepage Features of Non-Darcy Flow in Low-Permeability
   Reservoirs (Retracted article. See vol. 31, pg. 1413, 2013)
SO PETROLEUM SCIENCE AND TECHNOLOGY
LA English
DT Article; Retracted Publication
DE dimensionless analysis; dimensionless criteria coefficient; displacement
   experiment; low-permeability reservoirs; non-Darcy flow
AB The authors selected 28 representative cores from Changqing low-permeability oilfield to conduct core displacement experiment using simulated oil and formation water, and analyzed the data with a dimensionless analysis method. The results shows that non-Darcy flow does exist in low-permeability reservoirs, and it depends not only on the level of permeability, but also on the combined effect of displacing fluid, porous media, and external force. The rules and judgment criteria of fluid flow in low-permeability reservoirs were proposed, which can provide theoretical basis for well-testing interpretation and productivity evaluation in low-permeability reservoirs.
C1 [Yao, Y. D.] China Univ Petr, Dept Petr Engn, MOE Key Lab Petr Engn, Beijing 102249, Peoples R China.
RP Yao, YD (reprint author), China Univ Petr, Dept Petr Engn, MOE Key Lab Petr Engn, 18 Fuxue Rd, Beijing 102249, Peoples R China.
EM yaoyuedong@163.com
FU National Natural Science Foundation of China [40974055]
FX The authors would like to express their gratitude to the National
   Natural Science Foundation of China; this work was supported by the
   National Natural Science Foundation of China (Grant No. 40974055)
   entitled "Mechanism and Application of Non-Darcy Flow in
   Low-Permeability Reservoirs." The authors would also like to extend
   their gratitude to their colleagues Dr. Qi Dashen, Shang Genhua, and Liu
   Xuewei for their generous help, cooperation, and encouragement.
CR Deng Y, 2001, ACTA PETROLEI SINICA, V22, P72
   Huang Y. Z., 1998, SEEPAGE MECH LOW PER
   Li D. P., 1998, SPE INT C EXH BEIJ C
   Li DP, 1997, DEV LOW PERMEABILITY
   Ren X. J., 2009, J LIAONING TECHNIC S, V28, P273
   Yan Q.L., 1990, J XIAN PETROLEUM I, V5, P1
   Yang Q. L., 2007, THESIS CAS
NR 7
TC 5
Z9 5
U1 3
U2 15
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1091-6466
EI 1532-2459
J9 PETROL SCI TECHNOL
JI Pet. Sci. Technol.
PY 2012
VL 30
IS 2
BP 170
EP 175
DI 10.1080/10916461003792294
PG 6
WC Energy & Fuels; Engineering, Chemical; Engineering, Petroleum
SC Energy & Fuels; Engineering
GA 886XE
UT WOS:000299886800006
DA 2018-12-27
ER

PT J
AU Phupong, V
   Sonthirathi, V
AF Phupong, Vorapong
   Sonthirathi, Vatinee
TI RETRACTED: Placental alpha-microglobulin-1 rapid immunoassay for
   detection of premature rupture of membranes (Retracted article. See vol.
   38, pg. 962, 2012)
SO JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
LA English
DT Article; Retracted Publication
DE assay; diagnosis; placental alpha microglobulin-1; rupture of membranes
ID FACTOR BINDING PROTEIN-1; AMNIOTIC-FLUID; CLINICAL-SIGNIFICANCE; FETAL
   MEMBRANES; NITRAZINE TEST; PH; IGFBP-1; PAMG-1; BLOOD; WOMEN
AB Aim: The aim of the present study was to compare the efficacy of placental alpha-microglobulin-1 (PAMG-1) rapid immunoassay with conventional standard methods for the diagnosis of rupture of membranes (ROM).
   Material and Methods: A prospective observational study was performed in patients with symptoms or signs of premature rupture of membranes (PROM) at the Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University. Conventional standard methods were performed to establish the diagnosis and were compared with PAMG-1 immunoassay results. ROM was diagnosed if visualization of fluid leaking from the cervical os or two of the following three conditions were present: positive nitrazine test, ferning test, and nile blue test. The diagnosis of ROM was confirmed by reviewing the medical records after delivery.
   Results: One hundred patients (gestational age 36.5 +/- 3.5 weeks, range 22-41 weeks of gestation) were recruited into the study. Seventy-six percent were preterm and 24% were at term. PAMG-1 immunoassay had a sensitivity of 97.2%, specificity of 69%, positive predictive value (PPV) of 90.8%, negative predictive value (NPV) of 90.9% and an accuracy of 89%. In contrast, conventional combined standard methods had a sensitivity of 88.7%, specificity of 96.6%, PPV of 98.4%, NPV of 77.8%, and accuracy of 91% for the diagnosis of ROM.
   Conclusion: PAMG-1 immunoassay is a rapid method for the diagnosis of ROM. PAMG-1 has a higher sensitivity than conventional standard methods for the diagnosis of ROM.
C1 [Phupong, Vorapong; Sonthirathi, Vatinee] Chulalongkorn Univ, Fac Med, Dept Obstet & Gynecol, Bangkok 10330, Thailand.
RP Phupong, V (reprint author), Chulalongkorn Univ, Fac Med, Dept Obstet & Gynecol, Rama IV Rd, Bangkok 10330, Thailand.
EM vorapong.p@chula.ac.th
CR ACOG, 1998, INT J GYNECOL OBSTET, V63, P75
   BOLTOVSKAYA M N, 1991, Byulleten' Eksperimental'noi Biologii i Meditsiny, V112, P397
   Chen FCK, 2008, AM J PERINAT, V25, P243, DOI 10.1055/s-2008-1066876
   Cousins LM, 2005, AM J PERINAT, V22, P317, DOI 10.1055/s-2005-870896
   DAVIDSON KM, 1991, CLIN OBSTET GYNECOL, V34, P715, DOI 10.1097/00003081-199112000-00007
   Erdemoglu E, 2004, ACTA OBSTET GYN SCAN, V83, P622, DOI 10.1111/j.0001-6349.2004.00343.x
   FRIEDMAN ML, 1969, AM J OBSTET GYNECOL, V104, P544, DOI 10.1016/S0002-9378(16)34244-2
   Gaucherand P, 1997, ACTA OBSTET GYN SCAN, V76, P536, DOI 10.3109/00016349709024579
   GORODESKI IG, 1982, J PERINAT MED, V10, P286, DOI 10.1515/jpme.1982.10.6.286
   Lee SM, 2009, J MATERN-FETAL NEO M, V22, P305, DOI 10.1080/14767050902801694
   Lee SE, 2007, OBSTET GYNECOL, V109, P634, DOI 10.1097/01.AOG.0000252706.46734.0a
   Mercer BM, 2000, AM J OBSTET GYNECOL, V183, P738, DOI 10.1067/mob.2000.106766
   PHUPONG V, 2003, J PAEDIAT OBSTET GYN, V29, P25
   Phupong Vorapong, 2000, Journal of the Medical Association of Thailand, V83, P640
   REECE EA, 1984, OBSTET GYNECOL, V64, P248
   ROSEMOND RL, 1990, OBSTET GYNECOL, V75, P338
   Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085
   Tagore S, 2010, J PERINAT MED, V38, P609, DOI 10.1515/JPM.2010.099
NR 18
TC 2
Z9 4
U1 2
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1341-8076
EI 1447-0756
J9 J OBSTET GYNAECOL RE
JI J. Obstet. Gynaecol. Res.
PD JAN
PY 2012
VL 38
IS 1
BP 226
EP 230
DI 10.1111/j.1447-0756.2011.01688.x
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 873KS
UT WOS:000298882800036
PM 22070530
DA 2018-12-27
ER

PT J
AU Zhang, DG
   Zhang, XD
AF Zhang, De-gan
   Zhang, Xiao-dan
TI RETRACTED: A New Service-Aware Computing Approach for Mobile Application
   with Uncertainty (Retracted article. See vol. 7, pg. 1, 2013)
SO APPLIED MATHEMATICS & INFORMATION SCIENCES
LA English
DT Article; Retracted Publication
DE pervasive computing; Dempster-Shafer; Random Set; evidence reasoning
AB It is known to all that service-aware computing is an important part of pervasive computing for Web-based mobile application with uncertainty. Because multi-source service-aware evidence information with uncertainty is dynamic and changing randomly, in order to ensure the QoS of different mobile application fields based on Web, we modified the fusion method of evidence information after considering context's reliability, time-efficiency, and relativity, which has improved the classical fusion rule of D-S (Dempster-Shafer) Evidence Theory when being used in the pervasive computing paradigm. We call it EDS. After extending the process, we overcome the drawbacks of classical D-S Evidence Theory. All these suggested technologies have been successfully used in our service-aware computing projects. We compare EDS with relative methods, such as Random Set Theory (RST), Bayesian Theory (BT). By comparisons, the more validity of new service-aware computing approach based on EDS has been tested successfully. The efficiency of our researches has been shown by our many application practices.
C1 [Zhang, De-gan] Tianjin Univ Technol, Minist Educ, Key Lab Comp Vis & Syst, Tianjin 300384, Peoples R China.
   [Zhang, De-gan] Inst Sci & Tech Informat China, Beijing 100038, Peoples R China.
RP Zhang, DG (reprint author), Inst Sci & Tech Informat China, Beijing 100038, Peoples R China.
EM zhangshenyang@126.com; zhangshenyang@126.com
CR CIANCARINI P, 2002, IEEE T SOFTWARE ENG, V24, P363
   COEN M, 1999, IEEE INTELL SYST APP, V4, P8
   DANNY BL, 2001, COMMUN ACM, V42, P86
   DAVID K, 2002, ACM OPERATING SYSTEM, V33, P7
   DONALD JP, UBICOMP2007
   DU QD, 2000, P 3 INT C INF FUS, V1
   FISHER J, 1999, APPL OPTICS, V28, P371
   Goodman I, 1997, MATH DATA FUSION
   HARNEY RC, 1990, PRACTICAL ISSUES MUL, P1306
   JULIO CT, 2008, INT J MODELING IDENT, V4, P101
   KANG YH, 1998, DATA FUSION THEORY A
   Khelifi A, 2009, IEEE T LEARN TECHNOL, V2, P239, DOI 10.1109/TLT.2009.13
   Limongelli C, 2009, IEEE T LEARN TECHNOL, V2, P203, DOI 10.1109/TLT.2009.25
   Liu XZ, 2009, IEEE T SERV COMPUT, V2, P167, DOI 10.1109/TSC.2009.11
   MAHAVIR S, 2008, INT J MODELING IDENT, V3, P148
   MAHLER R, 2007, P 6 JOINT SERV DAT F, P357
   Milojicic D, 1999, IEEE CONCURR, V7, P80, DOI 10.1109/MCC.1999.788786
   MOREFIELD CL, 1977, IEEE T AUTOMAT CONTR, V22, P302, DOI 10.1109/TAC.1977.1101500
   MORI S, 1986, IEEE T AUTOMAT CONTR, V31, P401, DOI 10.1109/TAC.1986.1104306
   MUSICK S, 2005, SPIE P, V3374, P26
   PAUL C, 2000, IEEE PERS COMMUN, V10, P44
   REID DB, 1979, IEEE T AUTOMAT CONTR, V24, P843, DOI 10.1109/TAC.1979.1102177
   Rosenkrantz DJ, 2009, IEEE T SERV COMPUT, V2, P183, DOI 10.1109/TSC.2009.18
   SAHA FT, 2007, IEEE T AERO ELEC SYS, V34, P200
   Satyanarayanan M, 2001, IEEE PERS COMMUN, V8, P10, DOI 10.1109/98.943998
   Segev A, 2009, IEEE T SERV COMPUT, V2, P210, DOI 10.1109/TSC.2009.14
   Shi YC, 2003, IEEE PERVAS COMPUT, V2, P47, DOI 10.1109/MPRV.2003.1203753
   SIMON S, 2002, LECT NOTES COMPUT SC, V2414, P181
   TAKASUGI K, 2001, ADAPTIVE SYSTEM SERV, V1, P75
   TAN ZX, 1995, DETECTION TECHNOLOGY, P15
   WANG PT, 2008, J INFORM COMPUTATION, V4, P559
   WANG YQ, 2007, LNCS, V4843, P512
   WEISER M, 1991, SCI AM, V265, P94, DOI 10.1038/scientificamerican0991-94
   Wen XB, 2008, SENSORS-BASEL, V8, P1704, DOI 10.3390/s8031704
   XU LY, 2002, P 2 INT C INF FUS, V2
   XU LY, 1999, P 2 INT C INF FUS, V2
   ZHANG DG, 2006, 4 INF FUS INT C MONT, V8
   ZHANG DG, 2006, INT J DISTANCE E LEA, V4, P108
   ZHANG DG, 2004, LNCS, V8, P178
   ZHANG DG, 2003, LNCS, V8, P110
   ZHANG DG, 2004, CHINESE J COMPUT JUL
   ZHANG DG, 2004, LNCS, V8, P156
   ZHANG DG, 2005, LNCS, V12, P90
   ZHANG DG, 2008, J INFORM COMPUTATION, V5, P171
NR 44
TC 18
Z9 20
U1 1
U2 14
PU NATURAL SCIENCES PUBLISHING CORP-NSP
PI NEW YORK
PA 19 W 34 ST, SUITE 1018, NEW YORK, NY 10001 USA
SN 2325-0399
J9 APPL MATH INFORM SCI
JI Appl. Math. Inf. Sci.
PD JAN
PY 2012
VL 6
IS 1
BP 9
EP 21
PG 13
WC Mathematics, Applied; Physics, Mathematical
SC Mathematics; Physics
GA 865VF
UT WOS:000298338300002
DA 2018-12-27
ER

PT J
AU Shyu, KG
   Chen, SC
   Wang, BW
   Cheng, WP
   Hung, HF
AF Shyu, Kou-Gi
   Chen, Shih-Chung
   Wang, Bao-Wei
   Cheng, Wen-Pin
   Hung, Huei-Fong
TI RETRACTED: Mechanism of the inhibitory effect of atorvastatin on leptin
   expression induced by angiotensin II in cultured human coronary artery
   smooth muscle cells(Retracted article.See vol.130,pg.1842, 2016)
SO CLINICAL SCIENCE
LA English
DT Article; Retracted Publication
DE angiotensin II; atherosclerosis; leptin; smooth muscle cell; statin
ID SMOOTH-MUSCLE-CELLS; CARDIOVASCULAR-DISEASE; ENDOTHELIAL-CELLS; PLASMA
   LEPTIN; ATHEROSCLEROSIS; HYPERTENSION; STRETCH; GROWTH; ADIPOCYTES;
   ACTIVATION
AB Leptin contributes to the pathogenesis of atherosclerosis. Ang II (angiotensin II), a proatherogenic cytokine, increases leptin synthesis in cultured adipocytes. Statin suppresses leptin expression in adipocytes and human coronary artery endothelial cells. However, the effect of Ang II and statin on leptin expression in VSMCs (vascular smooth muscle cells), the major cell types in atheroma, is poorly understood. Thus the aim of the present study was to investigate the molecular mechanism of atorvastatin for reducing leptin expression after Ang II stimulation in VSMCs. VSMCs from human coronary artery were cultured. Ang II stimulation increased leptin protein and mRNA and phospho-JNK (c-Jun N-terminal kinase) expression. Exogenous addition of Dp44mT (2,2'-dipyridyl-N,N-dimethylsemicarbazone) and mevalonate increased leptin protein expression similarly to Ang II. Atorvastatin, SP600125, JNK siRNA (small interfering RNA) and NAC (N-acetylcysteine) completely attenuated the leptin and phospho-JNK protein expression induced by Ang II. Ang II significantly increased ROS (reactive oxygen species) formation in human VSMCs. Addition of atorvastatin and NAC significantly attenuated the formation of ROS induced by Ang II. Addition of atorvastatin and SP600125 inhibited the phosphorylation of RacI induced by Ang II. The gel shift and promoter activity assay showed that Ang II increased AP-I (activator protein-I)-binding activity and leptin promoter activity, while SP600125, NAC and atorvastatin inhibited the AP-I -binding activity and leptin promoter activity induced by Ang II. Ang II significantly increased the migration and proliferation of cultured VSMCs, while addition of atorvastatin, SP600125, NAC and leptin siRNA before Ang II stimulation significantly inhibited the migration and proliferation of VSMCs induced by Ang II. Ang II significantly increased secretion of leptin from human VSMCs, and addition of SP600125, atorvastatin and NAC before Ang II stimulation almost completely inhibited the leptin secretion induced by Ang II. In conclusion, Ang II induces leptin expression in human VSMCs, and atorvastatin could inhibit the leptin expression induced by Ang II. The inhibitory effect of atorvastatin on Ang II-induced leptin expression was mediated by Rac, ROS and JNK pathways.
C1 [Shyu, Kou-Gi; Wang, Bao-Wei; Cheng, Wen-Pin; Hung, Huei-Fong] Shin Kong Wu Ho Su Mem Hosp, Div Cardiol, Taipei, Taiwan.
   [Shyu, Kou-Gi] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan.
   [Chen, Shih-Chung] New Taipei City Hosp, Dept Cardiol, Taipei, Taiwan.
   [Chen, Shih-Chung] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan.
RP Hung, HF (reprint author), Shin Kong Wu Ho Su Mem Hosp, Div Cardiol, Taipei, Taiwan.
EM shyukg@tmu.edu.rw
FU Pfizer, Taiwan; Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
   [SKH-8302-99DR-02]
FX This work was supported by Pfizer, Taiwan (research grant to H.F.H.) and
   Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan[grant number
   SKH-8302-99DR-02].
CR Asferg C, 2010, AM J HYPERTENS, V23, P327, DOI 10.1038/ajh.2009.244
   Beltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003
   Bodary PF, 2005, ARTERIOSCL THROM VAS, V25, P119, DOI 10.1161/01.ATV.0000173306.47722.ec
   Bohlen F, 2007, VASC PHARMACOL, V46, P67, DOI 10.1016/j.vph.2006.06.014
   Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059
   Bouloumie A, 1999, FASEB J, V13, P1231
   Cassis LA, 2004, ENDOCRINOLOGY, V145, P169, DOI 10.1210/en.2003-0767
   Chang H, 2003, BIOCHEM BIOPH RES CO, V302, P95, DOI 10.1016/S0006-291X(03)00111-6
   De Rosa S, 2009, J VASC RES, V46, P609, DOI 10.1159/000226229
   Dubey Laxman, 2006, Exp Clin Cardiol, V11, P269
   Fortuno A, 2002, ENDOCRINOLOGY, V143, P3555, DOI 10.1210/en.2002-220075
   Golomb BA, 2008, ARCH INTERN MED, V168, P721, DOI 10.1001/archinte.168.7.721
   Huang F, 2010, ACTA BIOCH BIOPH SIN, V42, P325, DOI 10.1093/abbs/gmq025
   Kishi T, 2010, CIRC J, V74, P2552, DOI 10.1253/circj.CJ-10-1024
   Koh KK, 2008, CIRCULATION, V117, P3238, DOI 10.1161/CIRCULATIONAHA.107.741645
   Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9
   Maeda T, 2009, J BIOCHEM, V145, P771, DOI 10.1093/jb/mvp035
   Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje
   Oda Akihiko, 2001, Kobe Journal of Medical Sciences, V47, P141
   Rodriguez A, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/105489
   Schafer K, 2004, ARTERIOSCL THROM VAS, V24, P112, DOI 10.1161/01.ATV.0000105904.02142.e7
   Shan J, 2008, P NATL ACAD SCI USA, V105, P19006, DOI 10.1073/pnas.0809743105
   Shankar A, 2010, HYPERTENSION, V56, P623, DOI 10.1161/HYPERTENSIONAHA.109.148213
   Shyu KG, 2005, HYPERTENSION, V46, P614, DOI 10.1161/01.HYP.0000175811.79863.e2
   Shyu KG, 2001, J FORMOS MED ASSOC, V100, P741
   Singhal A, 2002, CIRCULATION, V106, P1919, DOI 10.1161/01.CIR.0000033219.24717.52
   Skurk T, 2005, OBES RES, V13, P969, DOI 10.1038/oby.2005.113
   Sugiyama A, 2007, J ATHEROSCLER THROMB, V14, P226, DOI 10.5551/jat.E444
   Sun YM, 2010, PEPTIDES, V31, P1205, DOI 10.1016/j.peptides.2010.03.023
   Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093
   von Eynatten M, 2005, DIABETES CARE, V28, P754, DOI 10.2337/diacare.28.3.754
   Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061
   Wang BW, 2003, CARDIOVASC RES, V59, P460, DOI 10.1016/S0008-6363(03)00428-0
   Wolk R, 2004, J AM COLL CARDIOL, V44, P1819, DOI 10.1016/j.jacc.2004.07.050
   Zeidan A, 2005, J PHARMACOL EXP THER, V315, P1075, DOI 10.1124/jpet.105.091561
   Zhao SP, 2005, CLIN CHIM ACTA, V360, P133, DOI 10.1016/j.cccn.2005.04.021
NR 36
TC 20
Z9 22
U1 2
U2 5
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0143-5221
EI 1470-8736
J9 CLIN SCI
JI Clin. Sci.
PD JAN
PY 2012
VL 122
IS 1-2
BP 33
EP 42
DI 10.1042/CS20110114
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 874RC
UT WOS:000298974800004
PM 21806545
DA 2018-12-27
ER

PT J
AU George, J
   Sun, J
   D'Armiento, J
AF George, Joseph
   Sun, Jie
   D'Armiento, Jeanine
TI RETRACTED: Transgenic expression of human matrix metalloproteinase-1
   attenuates pulmonary arterial hypertension in mice(Retracted article.
   See vol. 131, pg. 25, 2017)
SO CLINICAL SCIENCE
LA English
DT Article; Retracted Publication
DE matrix metalloproteinase-1 (MMP-1) transgene; monocrotaline; occlusion;
   pulmonary arterial hypertension.
ID MUSCLE-CELLS; SMOOTH; PATHOGENESIS; MECHANISMS; DISEASE; MICE
AB PAH (pulmonary arterial hypertension) is a debilitating and life-threatening disease, often affecting young people. We specifically expressed human MMP-1 (matrix metalloproteinase-1) in mouse macrophages and examined its effects in attenuating the decompensating features of MCT (monocrotaline)-induced PAH. Measurement of RV (right ventricular) pressure revealed a 2.5-fold increase after treatment with MCT, which was reduced to 1.5-fold in MMP-1 transgenic mice. There was conspicuous pulmonary inflammation with chronic infiltration of mononuclear cells after the administration of MCT, which was significantly diminished in transgenic mice. Furthermore, transgenic mice showed decreased collagen deposition compared with WT (wild-type). Staining for Mac-3 (macrophage-3) and alpha-SMA (alpha-smooth muscle actin) revealed extensive infiltration of macrophages and medial hypertrophy of large pulmonary vessels with complete occlusion of small arteries respectively. These changes were markedly reduced in MMP-1 transgenic mice compared with WT. Western blotting for molecules involved in cell multiplication and proliferation depicted a significant decrease in the lung tissue of transgenic mice after the treatment with MCT. In conclusion, the present study demonstrated that transgenic expression of human MMP-1 decreased proliferation of smooth muscle cells and prevented excessive deposition of collagen in the pulmonary arterial tree. Our results indicate that up-regulation of MMP-1 could attenuate the debilitation of human PAH and provide an option for therapeutic intervention.
C1 [George, Joseph; Sun, Jie; D'Armiento, Jeanine] Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA.
RP George, J (reprint author), Mt Sinai Sch Med, Div Liver Dis, Dept Med, 1425 Madison Ave, New York, NY 10029 USA.
EM joseph.george@mssm.edu
FU National Institutes of Health [HL086936]
FX This work was supported by the National Institutes of Health [grant
   number HL086936 (to J.D'A.)].
CR Asosingh K, 2008, AM J PATHOL, V172, P615, DOI 10.2353/ajpath.2008.070705
   Benisty JI, 2004, CHEST, V126, P1255, DOI 10.1378/chest.126.4.1255
   Boutet K, 2008, Ther Adv Respir Dis, V2, P249, DOI 10.1177/1753465808094762
   Chen Chu-Huang, 2004, Current Vascular Pharmacology, V2, P33, DOI 10.2174/1570161043476500
   Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH569, DOI 10.1152/ajpheart.00180.2008
   Davies RJ, 2008, CHEST, V134, P1271, DOI 10.1378/chest.08-1341
   Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488
   Foronjy RF, 2008, HYPERTENS RES, V31, P725, DOI 10.1291/hypres.31.725
   Frisdal E, 2001, EUR RESPIR J, V18, P838, DOI 10.1183/09031936.01.00084601
   George J, 2011, J HYPERTENS, V29, P299, DOI 10.1097/HJH.0b013e328340a0e4
   Hongo M, 2005, J CARDIOVASC PHARM, V46, P452, DOI 10.1097/01.fjc.0000176728.74690.09
   Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jaac.2004.02.029
   Humbert M, 2008, VASC PHARMACOL, V49, P113, DOI 10.1016/j.vph.2008.06.003
   Jeffery TK, 2002, PROG CARDIOVASC DIS, V45, P173, DOI 10.1053/pcad.2002.130041
   Kolettis Theofilos, 2007, Hellenic J Cardiol, V48, P206
   Lee Dong Seok, 2010, Korean Circ J, V40, P659, DOI 10.4070/kcj.2010.40.12.659
   Lemaitre V, 2001, J CLIN INVEST, V107, P1227, DOI 10.1172/JCI9626
   Lepetit H, 2005, EUR RESPIR J, V25, P834, DOI 10.1183/09031936.05.00072504
   Lykouras Dimosthenis, 2008, Inflammation & Allergy Drug Targets, V7, P260, DOI 10.2174/187152808786848351
   Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152
   Novotna J, 2002, PHYSIOL RES, V51, P323
   Ohbayashi H, 2002, CURR PROTEIN PEPT SC, V3, P409, DOI 10.2174/1389203023380549
   Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017
   Perros F, 2005, SEM RESP CRIT CARE M, V26, P355, DOI 10.1055/s-2005-916149
   Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452
   Rabinovitch M, 2007, ANNU REV PATHOL-MECH, V2, P369, DOI 10.1146/annurev.pathol.2.010506.092033
   Raiesdana A, 2006, ANN MED, V38, P95, DOI 10.1080/07853890600622143
   Satoh M, 2008, J PHARM PHARM SCI, V11, P118
   Tajsic T, 2011, COMPR PHYSIOL, V1, P295, DOI 10.1002/cphy.c100026
   Tuder RM, 2007, CLIN CHEST MED, V28, P23, DOI 10.1016/j.ccm.2006.11.010
   VOELKEL NF, 1997, PRIMARY PULMONARY HY, P83
   Wright JL, 2007, AM J PHYSIOL-LUNG C, V292, pL125, DOI 10.1152/ajplung.00539.2005
   Zaidi SHE, 2002, CIRCULATION, V105, P516, DOI 10.1161/hc0402.102866
   Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157572.70560.7b
NR 34
TC 8
Z9 10
U1 2
U2 9
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0143-5221
EI 1470-8736
J9 CLIN SCI
JI Clin. Sci.
PD JAN
PY 2012
VL 122
IS 1-2
BP 83
EP 92
DI 10.1042/CS20110295
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 874RC
UT WOS:000298974800009
PM 21793800
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Petrini, M
   Azzara, A
AF Petrini, Mario
   Azzara, Antonio
TI RETRACTED: Lithium in the treatment of neutropenia (Retracted article.
   See vol. 19, pg. 241, 2012)
SO CURRENT OPINION IN HEMATOLOGY
LA English
DT Review; Retracted Publication
DE CD34; engraftment; neutropenia; stem cell mobilization; stem cell
   transplantation
ID SHWACHMAN-DIAMOND-SYNDROME; CLOZAPINE-INDUCED NEUTROPENIA; CANINE CYCLIC
   HEMATOPOIESIS; COLONY-STIMULATING ACTIVITY; FELTYS-SYNDROME; STEM-CELLS;
   INDUCED GRANULOCYTOSIS; LEUKOCYTE CHEMOTAXIS; CARBONATE THERAPY;
   RADIATION-INJURY
AB Purpose of review
   The capacity of lithium to induce neutrophilia and increase circulating CD34(+) cells of marrow origin has long been known. Lithium has been the object of hematological investigations for many years, but no definitive use in hematology has yet emerged.
   Recent findings
   We review the evidence that lithium increases granulocyte colony-stimulating factor (G-CSF) and augments G-CSF effects, showing its potential use in stem cell mobilization and engraftment of stem cell transplantation.
   Summary
   We suggest possible therapeutic uses of lithium in neutropenia. In bone marrow transplantation, preharvest lithium-assisted hematopoietic stem cell mobilization may be useful as well.
C1 [Petrini, Mario; Azzara, Antonio] Univ Pisa AOUP, Unit Haematol, Dept Oncol Transplants & Adv Technol Med, Pisa, Italy.
RP Petrini, M (reprint author), Osped S Chiara, Dipartimento Oncol, Via Roma 64, I-56122 Pisa, Italy.
EM mario.petrini@med.unipi.it
FU University of Pisa; AIL
FX This study was supported by the University of Pisa funding (ex-60%) and
   AIL.
CR Amano I, 1999, Rinsho Ketsueki, V40, P46
   AZZARA A, 1991, ACTA HAEMATOL-BASEL, V85, P100
   Azzara A, 2003, BRIT J HAEMATOL, V123, P369, DOI 10.1046/j.1365-2141.2003.04616.x
   AZZARA A, 1986, INT J IMMUNOTHER, V2, P233
   AZZARA A, 1988, BRIT J HAEMATOL, V70, P502, DOI 10.1111/j.1365-2141.1988.tb02525.x
   AZZARA A, 1987, HAEMATOLOGICA, V72, P121
   Azzara A, 1986, HEMAT REV COMMUN S, P48
   Ballin A, 1998, BRIT J HAEMATOL, V100, P219, DOI 10.1046/j.1365-2141.1998.00537.x
   BARRETT AJ, 1977, LANCET, V2, P1357
   BHATTACHARYYA B, 1976, BIOCHEM BIOPH RES CO, V73, P383, DOI 10.1016/0006-291X(76)90719-1
   Bielecka AM, 2008, PHARMACOL REP, V60, P771
   BLUM SF, 1979, NEW ENGL J MED, V300, P677
   Brunoni AR, 2008, PROG NEURO-PSYCHOPH, V32, P2006, DOI 10.1016/j.pnpbp.2008.09.005
   Capodicasa E, 2000, IMMUNOPHARM IMMUNOT, V22, P671, DOI 10.3109/08923970009016431
   CARULLI G, 1985, ACTA HAEMATOL-BASEL, V74, P81
   CARULLI G, 1984, ACTA HAEMATOL-BASEL, V72, P408
   CHAN HSL, 1981, AM J MED, V70, P1073, DOI 10.1016/0002-9343(81)90871-8
   CHARRON DJ, 1979, NEW ENGL J MED, V301, P557
   Cohen M S, 1980, Adv Exp Med Biol, V127, P335
   COHEN MS, 1979, BLOOD, V53, P913
   DOUKAS MA, 1989, INT J CELL CLONING, V7, P168, DOI 10.1002/stem.5530070304
   Esposito D, 2005, ENCEPHALE, V31, P262
   Focosi D, 2009, J LEUKOCYTE BIOL, V85, P20, DOI 10.1189/jlb.0608388
   Friedenberg W R, 1980, Adv Exp Med Biol, V127, P389
   FRIEDENBERG WR, 1980, CANCER-AM CANCER SOC, V45, P91, DOI 10.1002/1097-0142(19800101)45:1<91::AID-CNCR2820450116>3.0.CO;2-#
   GALLICCHIO VS, 1984, ACTA RADIOL ONCOL, V23, P361, DOI 10.3109/02841868409136034
   GALLICCHIO VS, 1986, EXP HEMATOL, V14, P395
   GALLICCHIO VS, 1995, ANTIVIR RES, V26, P189, DOI 10.1016/0166-3542(94)00075-J
   GALLICCHIO VS, 1981, EXP HEMATOL, V9, P804
   GALLICCHIO VS, 1989, P SOC EXP BIOL MED, V190, P109
   GALLICCHIO VS, 1983, EXP HEMATOL, V11, P553
   GALLICCHIO VS, 1987, INT J CELL CLONING, V5, P122, DOI 10.1002/stem.5530050204
   GALLICCHIO VS, 1993, J INTERN MED, V233, P259, DOI 10.1111/j.1365-2796.1993.tb00985.x
   GALLICCHIO VS, 1985, INT J RADIAT BIOL, V47, P581, DOI 10.1080/09553008514550811
   GEISLER A, 1984, CURRENT TRENDS LITHI
   GUPTA RC, 1975, ARTHRITIS RHEUM, V18, P179, DOI 10.1002/art.1780180217
   Hammond W P, 1980, Adv Exp Med Biol, V127, P167
   HAMMOND WP, 1987, BLOOD, V69, P117
   HAMMOND WP, 1980, BLOOD, V55, P26
   HAMMOND WP, 1982, BLOOD, V59, P179
   HARKER WG, 1977, BLOOD, V49, P263
   IL'IN N V, 1986, Terapevticheskii Arkhiv, V58, P65
   ISHII E, 1983, SCAND J HAEMATOL, V31, P193
   JOHNKE RM, 1991, INT J CELL CLONING, V9, P78, DOI 10.1002/stem.5530090110
   JOYCE RA, 1984, BRIT J HAEMATOL, V56, P307, DOI 10.1111/j.1365-2141.1984.tb03958.x
   Kanaan RA, 2006, J CLIN PSYCHIAT, V67, P756, DOI 10.4088/JCP.v67n0509
   Kast R, 2007, BONE MARROW TRANSPL, V429, P33
   Kazim S, 1993, Rom J Physiol, V30, P231
   Kikuchi K, 2011, HUM PSYCHOPHARM CLIN, V26, P358, DOI 10.1002/hup.1215
   KONCHALOVSKY MV, 1989, GEMATOL TRANSFUZIOL, V34, P16
   LEVITT LJ, 1980, NEW ENGL J MED, V302, P713, DOI 10.1056/NEJM198003273021303
   LYMAN GH, 1980, NEW ENGL J MED, V302, P257, DOI 10.1056/NEJM198001313020503
   MacGregor R R, 1980, Adv Exp Med Biol, V127, P347
   MANT MJ, 1986, ARCH INTERN MED, V146, P277, DOI 10.1001/archinte.146.2.277
   Mattai A, 2009, HUM PSYCHOPHARM CLIN, V24, P584, DOI 10.1002/hup.1056
   MORLEY DC, 1978, CAN MED ASSOC J, V118, P288
   NINANE J, 1984, INT J CELL CLONING, V2, P216, DOI 10.1002/stem.5530020402
   Nykiel Sherry, 2010, Clin Schizophr Relat Psychoses, V4, P138, DOI 10.3371/CSRP.4.2.5
   Palominao A, 2010, ANN CLIN PSYCHIATRY, V22, P205
   Papetti F, 2004, ENCEPHALE, V30, P578
   Pasquali L, 2010, BEHAV PHARMACOL, V21, P473, DOI 10.1097/FBP.0b013e32833da5da
   PEREZ HD, 1980, CLIN IMMUNOL IMMUNOP, V16, P308, DOI 10.1016/0090-1229(80)90136-1
   PETRINI M, 1986, INT J TISSUE REACT, V8, P391
   Petrini M, 1999, J NEURAL TRANSM, V106, P569, DOI 10.1007/s007020050180
   RICHMAN CM, 1981, EXP HEMATOL, V9, P449
   Robinson W A, 1980, Adv Exp Med Biol, V127, P281
   ROSSOF AH, 1979, EXP HEMATOL, V7, P255
   ROTHSTEIN G, 1978, NEW ENGL J MED, V298, P178, DOI 10.1056/NEJM197801262980402
   SCHAPIRA DV, 1977, ARTHRITIS RHEUM, V20, P1556, DOI 10.1002/art.1780200821
   Silva R, 2007, NEUROSCI LETT, V429, P33, DOI 10.1016/j.neulet.2007.09.062
   Sporn A, 2003, J CHILD ADOL PSYCHOP, V13, P401, DOI 10.1089/104454603322572697
   STEIN RS, 1978, ANN INTERN MED, V88, P809, DOI 10.7326/0003-4819-88-6-809_2
   STEIN RS, 1979, BLOOD, V54, P636
   STEIN RS, 1977, BLOOD, V50, P161
   TISMAN G, 1973, BRIT J HAEMATOL, V24, P767, DOI 10.1111/j.1365-2141.1973.tb01704.x
   TURNER A, 1978, BLOOD, V52, P234
   Wang Q, 2011, CELL RES, V21, P1424, DOI 10.1038/cr.2011.108
   WILLIAMS DM, 1984, AM J CLIN PATHOL, V81, P120, DOI 10.1093/ajcp/81.1.120
NR 78
TC 16
Z9 18
U1 2
U2 14
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1065-6251
EI 1531-7048
J9 CURR OPIN HEMATOL
JI Curr. Opin. Hematol.
PD JAN
PY 2012
VL 19
IS 1
BP 52
EP 57
DI 10.1097/MOH.0b013e32834da93b
PG 6
WC Hematology
SC Hematology
GA 863GY
UT WOS:000298152000009
PM 22123660
DA 2018-12-27
ER

PT J
AU Johnson, CS
   Smeesters, D
   Wheeler, SC
AF Johnson, Camille S.
   Smeesters, Dirk
   Wheeler, S. Christian
TI RETRACTED: Visual Perspective Influences the Use of Metacognitive
   Information in Temporal Comparisons (Retracted article. See vol. 103,
   pg. 605, 2012)
SO JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY
LA English
DT Article; Retracted Publication
DE temporal comparison; visual perspective; self-concept; ease of
   retrieval; construal level
ID MEMORY PERSPECTIVE; NO GAIN; SELF; EASE; RETRIEVAL; IDENTITY; IMAGERY;
   AVAILABILITY; FREQUENCY; LOOKING
AB Four studies test the proposition that when people look back to past selves as a means of gauging current status, the visual perspective they assume determines the kind of information that they consider in making their judgments of change. In this way, visual perspective, coupled with the kind of change for which people are looking, determines how much change is perceived. The studies demonstrate that in the first-person perspective, experiential information is weighted more heavily than content information, whereas in the third-person perspective, the converse is true. In addition, the effects of perceived change on behavior are revealed, such that greater perceived positive change is associated with behaviors that are congruent with that change, whereas greater perceived negative change is associated with behaviors that are incongruent with that change. Theoretical implications, as well as implications for behavioral interventions, are discussed.
C1 [Johnson, Camille S.] San Jose State Univ, Dept Management & Org, San Jose, CA 95192 USA.
   [Smeesters, Dirk] Erasmus Univ, Rotterdam Sch Management, Rotterdam, Netherlands.
   [Wheeler, S. Christian] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.
RP Johnson, CS (reprint author), San Jose State Univ, Dept Management & Org, 1 Washington Sq, San Jose, CA 95192 USA.
EM Camille.Johnson@sjsu.edu
CR ALBERT S, 1977, PSYCHOL REV, V84, P485, DOI 10.1037/0033-295X.84.6.485
   BELK RW, 1988, J CONSUM RES, V15, P139, DOI 10.1086/209154
   Caruso EM, 2008, J EXP SOC PSYCHOL, V44, P148, DOI 10.1016/j.jesp.2006.11.003
   Carver C. S., 1998, SELF REGULATION BEHA
   CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752
   DeMarree KG, 2005, J PERS SOC PSYCHOL, V89, P657, DOI 10.1037/0022-3514.89.5.657
   Dijksterhuis A, 1998, J PERS SOC PSYCHOL, V75, P862, DOI 10.1037//0022-3514.75.4.862
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   FRANK MG, 1989, J PERS SOC PSYCHOL, V57, P399, DOI 10.1037/0022-3514.57.3.399
   Gao L, 2009, J CONSUM RES, V36, P29, DOI 10.1086/596028
   HASTIE R, 1986, PSYCHOL REV, V93, P258, DOI 10.1037/0033-295X.93.3.258
   Herzog SM, 2007, J EXP SOC PSYCHOL, V43, P483, DOI 10.1016/j.jesp.2006.05.008
   HSEE CK, 1991, J PERS SOC PSYCHOL, V60, P341, DOI 10.1037/0022-3514.60.3.341
   Johnson CS, 2007, J PERS SOC PSYCHOL, V92, P1051, DOI 10.1037/0022-3514.92.6.1051
   Johnson CS, 2007, EUR J SOC PSYCHOL, V37, P258, DOI 10.1002/ejsp.361
   Koo M, 2008, J PERS SOC PSYCHOL, V94, P183, DOI 10.1037/0022-3514.94.2.183
   Kuhn MH, 1954, AM SOCIOL REV, V19, P68, DOI 10.2307/2088175
   LeBoeuf RA, 2010, ORGAN BEHAV HUM DEC, V111, P48, DOI 10.1016/j.obhdp.2009.08.004
   Libby LK, 2007, PSYCHOL SCI, V18, P199, DOI 10.1111/j.1467-9280.2007.01872.x
   Libby LK, 2009, J EXP PSYCHOL GEN, V138, P503, DOI 10.1037/a0016795
   Libby LK, 2005, J PERS SOC PSYCHOL, V88, P50, DOI 10.1037/0022-3514.88.1.50
   Libby LK, 2002, J PERS SOC PSYCHOL, V82, P167, DOI 10.1037//0022-3514.82.2.167
   Lorey B, 2009, EXP BRAIN RES, V194, P233, DOI 10.1007/s00221-008-1693-1
   Mussweiler T, 2000, J PERS SOC PSYCHOL, V79, P23, DOI 10.1037/0022-3514.79.1.23
   PELHAM BW, 1994, COGNITIVE PSYCHOL, V26, P103, DOI 10.1006/cogp.1994.1004
   Petty R. E, 1981, ATTITUDES PERSUASION
   Preacher K. J., 2004, ANN M SOC PERS SOC P
   Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316
   Reed A, 2004, J CONSUM RES, V31, P286, DOI 10.1086/422108
   Rothman AJ, 2000, HEALTH PSYCHOL, V19, P64, DOI 10.1037/0278-6133.19.Suppl1.64
   SCHOUTEN JW, 1991, J CONSUM RES, V17, P412, DOI 10.1086/208567
   SCHWARZ, 1998, PERSONALITY SOCIAL P, V2, P87, DOI DOI 10.1207/S15327957PSPR0202_2
   SCHWARZ N, 1991, J PERS SOC PSYCHOL, V61, P195, DOI 10.1037/0022-3514.61.2.195
   Shaeffer E. M., 2009, SHIFTING PERSPECTIVE
   Stapel DA, 2001, J EXP SOC PSYCHOL, V37, P134, DOI 10.1006/jesp.2000.1440
   Tesser A, 2000, PERS SOC PSYCHOL B, V26, P1476, DOI 10.1177/01461672002612003
   Tormala ZL, 2002, PERS SOC PSYCHOL B, V28, P1700, DOI 10.1177/014616702237651
   Trope J., 2007, SOCIAL PSYCHOL HDB B, V2, P353
   Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963
   Tsai CI, 2011, J CONSUM RES, V37, P807, DOI 10.1086/655855
   TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9
   Vasquez NA, 2007, PERS SOC PSYCHOL B, V33, P1392, DOI 10.1177/0146167207304541
   WICKLUND RA, 1982, SYMBOLIC SELF COMPLE
   Wilson AE, 2000, J PERS SOC PSYCHOL, V78, P928, DOI 10.1037//0022-3514.78.5.928
   Wilson AE, 2001, J PERS SOC PSYCHOL, V80, P572, DOI 10.1037//0022-3514.80.4.572
NR 46
TC 3
Z9 5
U1 2
U2 19
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0022-3514
EI 1939-1315
J9 J PERS SOC PSYCHOL
JI J. Pers. Soc. Psychol.
PD JAN
PY 2012
VL 102
IS 1
BP 32
EP 50
DI 10.1037/a0026106
PG 19
WC Psychology, Social
SC Psychology
GA 868XL
UT WOS:000298559500004
PM 22059849
DA 2018-12-27
ER

PT J
AU Akbar, M
   Brunner, M
   Balean, G
   Grieser, T
   Bruckner, T
   Loew, M
   Furstenberg, CH
   Raiss, P
AF Akbar, Michael
   Brunner, Manuela
   Balean, Gabriel
   Grieser, Thomas
   Bruckner, Thomas
   Loew, Markus
   Fuerstenberg, Carl Hans
   Raiss, Patric
TI RETRACTED: Etiology of rotator cuff tears in paraplegic patients: a
   case-control study (Retracted article. See vol. 21, pg. 983, 2012)
SO JOURNAL OF SHOULDER AND ELBOW SURGERY
LA English
DT Article; Retracted Publication
DE Paraplegia; shoulder; rotator cuff tear; RCT; wheelchair; spinal cord
   injury
ID SPINAL-CORD-INJURY; LONG-TERM PARAPLEGIA; UPPER EXTREMITY PAIN;
   UPPER-LIMB FUNCTION; SHOULDER PAIN; WHEELCHAIR USERS; ASYMPTOMATIC
   SHOULDERS; INDEPENDENCE; PREVALENCE; ADULTS
AB Background: The purpose of this study was to investigate the etiology and the demographic and functional characteristics of rotator cuff tears (RCTs) in 100 paraplegic patients as compared with 100 able-bodied volunteers.
   Methods: The magnetic resonance imaging examination results of 200 shoulders in each group were analyzed. Clinical examination included the Constant score and a visual analog scale for pain intensity.
   Results: The prevalence of RCTs was 63% in paraplegic patients versus 15% in able-bodied volunteers (P < .0001). All RCTs in the paraplegic group were associated with symptoms. Among the patients with RCTs, full-thickness tears were detected in 78% of cases in the paraplegic patient group versus 73% of cases in the volunteer group. The rate of partial-thickness tears was 22% in the paraplegic group versus 27% in the volunteer group. Paraplegic patients had a lower Constant score; Disabilities of the Arm, Shoulder and Hand score; and range of motion and a higher pain intensity than the volunteer cohort. The mean tear width in paraplegic patients was 14.4 mm (range, 8-28 mm) versus 9.9 mm (range, 8-14 mm) in the volunteers (P < .01).
   Conclusion: The etiology of RCTs in paraplegic patients seems to be based on wear-and-tear mechanisms rather than aging. These results are important for our understanding of shoulder pathology in long-term paraplegic patients and show the impact of this problem.
   Level of evidence: Level II, Retrospective Case-Control Study, Prognosis Study. (C) 2012 Journal of Shoulder and Elbow Surgery Board of Trustees.
C1 [Akbar, Michael; Brunner, Manuela; Balean, Gabriel; Grieser, Thomas; Fuerstenberg, Carl Hans; Raiss, Patric] Univ Heidelberg, Dept Orthopaed & Trauma Surg, Heidelberg, Germany.
   [Bruckner, Thomas] Univ Heidelberg, Dept Biometr & Informat, Heidelberg, Germany.
   [Loew, Markus] ATOS Clin Heidelberg, Dept Shoulder & Elbow Surg, Heidelberg, Germany.
RP Raiss, P (reprint author), Orthopad Univ Heidelberg, Schlierbacher Landstr 200 A, D-69118 Heidelberg, Germany.
EM Patric.Raiss@med.uni-heidelberg.de
CR Akbar M, 2010, J BONE JOINT SURG AM, V92A, P23, DOI 10.2106/JBJS.H.01373
   BAYLEY JC, 1987, J BONE JOINT SURG AM, V69A, P676, DOI 10.2106/00004623-198769050-00006
   CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160
   Curtis KA, 1999, ARCH PHYS MED REHAB, V80, P453, DOI 10.1016/S0003-9993(99)90285-X
   Curtis KA, 1999, SPINAL CORD, V37, P421, DOI 10.1038/sj.sc.3100860
   Dalyan M, 1999, SPINAL CORD, V37, P191, DOI 10.1038/sj.sc.3100802
   Escobedo EM, 1997, AM J ROENTGENOL, V168, P919, DOI 10.2214/ajr.168.4.9124140
   HASTINGS J, 2004, PHYS MED REH CLIN N, V15, P699, DOI DOI 10.1016/J.PMR.2003.12.005
   Hastings Jennifer, 2004, Phys Med Rehabil Clin N Am, V15, P699
   Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L
   Kim HM, 2009, J BONE JOINT SURG AM, V91, P289, DOI DOI 10.2106/JBJS.H.00219
   Kulig K, 1998, CLIN ORTHOP RELAT R, P132, DOI 10.1097/00003086-199809000-00016
   Lal S, 1998, SPINAL CORD, V36, P186, DOI 10.1038/sj.sc.3100608
   Matsen Frederick A 3rd, 2008, N Engl J Med, V358, P2138, DOI 10.1056/NEJMcp0800814
   McColl MA, 1997, SPINAL CORD, V35, P818, DOI 10.1038/sj.sc.3100546
   MILGROM C, 1995, J BONE JOINT SURG BR, V77B, P296
   MINIACI A, 1995, AM J SPORT MED, V23, P142, DOI 10.1177/036354659502300202
   *NAT SPIN CORD INJ, 2006, SPIN CORD INJ FACTS
   NEPOMUCENO C, 1979, ARCH PHYS MED REHAB, V60, P605
   NEUMANN CH, 1992, AM J ROENTGENOL, V158, P1281, DOI 10.2214/ajr.158.6.1590124
   NICHOLS PJR, 1979, SCAND J REHABIL MED, V11, P29
   Oh LS, 2007, CLIN ORTHOP RELAT R, P52, DOI 10.1097/BLO.0b013e31802fc175
   PENTLAND WE, 1994, PARAPLEGIA, V32, P219, DOI 10.1038/sc.1994.41
   PENTLAND WE, 1994, PARAPLEGIA, V32, P211, DOI 10.1038/sc.1994.40
   SHER JS, 1995, J BONE JOINT SURG AM, V77A, P10, DOI 10.2106/00004623-199501000-00002
   SIE IH, 1992, ARCH PHYS MED REHAB, V73, P44
   SILFVERSKIOLD J, 1991, CLIN ORTHOP RELAT R, P141
   Subbarao J V, 1995, J Spinal Cord Med, V18, P9
   Tempelhof S, 1999, J SHOULDER ELB SURG, V8, P296, DOI 10.1016/S1058-2746(99)90148-9
   UHTHOFF HK, 1987, P 3 INT C SURG SHOUL, P211
   WRIGHT V, 1965, ANN RHEUM DIS, V24, P419, DOI 10.1136/ard.24.5.419
   WYLIE EJ, 1988, PARAPLEGIA, V26, P101, DOI 10.1038/sc.1988.20
   Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835
NR 33
TC 1
Z9 1
U1 1
U2 6
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1058-2746
J9 J SHOULDER ELB SURG
JI J. Shoulder Elbow Surg.
PD JAN
PY 2012
VL 21
IS 1
BP 23
EP 28
DI 10.1016/j.jse.2011.07.013
PG 6
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 875CW
UT WOS:000299008800012
PM 22014611
DA 2018-12-27
ER

PT J
AU Tang, Y
   Tong, JY
   Zhang, YL
   Wang, L
   Hu, SB
   Li, WP
   Lv, Y
AF Tang, Ying
   Tong, Jinying
   Zhang, Yunlei
   Wang, Lei
   Hu, Shengbiao
   Li, Wenping
   Lv, Yuan
TI RETRACTED: Preliminary comparing the toxicities of the hybrid cry1Acs
   fused with different heterogenous genes provided guidance for the fusion
   expression of Cry proteins (Retracted article. See vol. 31, pg. 539,
   2015)
SO WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
LA English
DT Article; Retracted Publication
DE Bacillus thuringiensis; cry1Ac; tchiB hwtx-I; Fusion expression
ID CHITINASE-ENCODING GENES; BACILLUS-THURINGIENSIS; CRYSTAL PROTEINS;
   TOXIN; ISRAELENSIS; MANAGEMENT; BACTERIA; BINDING; MODEL
AB In order to provide guidance for selecting suitable heterogenous gene that can efficiently enhance toxicity or broaden insecticidal spectrum of Cry1Ac through fusion expression, two hybrid cry1Acs fused with chitinase-encoding gene tchiB and neurotoxin gene hwtx-1 respectively were constructed and their toxicities were compared. A Bacillus thuringiensis strain harboring the cry1Ac gene in vector pHT315 was used as control. Bioassay revealed that LC50 (after 72 h) of Cry1Ac protoxin was 41.01 mu g mL(-1), while the hybrid cry1Acs fused with tchiB and hwtx-1 were 4.89 and 23.14 mu g mL(-1), which were 8.23- and 1.77-fold higher than Cry1Ac protoxin in terms of relative toxicity respectively. Both fusion crystals had a higher toxicity than the original Cry1Ac protein and the toxicity of hybrid cry1Acs fused with hwtx-1 experienced a more significant increase than that fused with tchiB.
C1 [Tong, Jinying; Wang, Lei; Lv, Yuan] Hunan Normal Univ, Dept Epidemiol, Coll Med, Changsha 410081, Hunan, Peoples R China.
   [Tang, Ying; Zhang, Yunlei; Hu, Shengbiao; Li, Wenping; Lv, Yuan] Hunan Normal Univ, Coll Life Sci, Hunan Prov Key Lab Microbial Mol Biol, State Key Lab Breeding Base Microbial Mol Biol, Changsha 410081, Hunan, Peoples R China.
RP Lv, Y (reprint author), Hunan Normal Univ, Dept Epidemiol, Coll Med, Changsha 410081, Hunan, Peoples R China.
EM Ly598598@126.com
FU National Natural Science Foundation of China [30870064, 30970066]; Hunan
   Provincial Natural Science Foundation [10JJ3058]; Hunan Provincial
   Education Department [08A036]
FX This work was supported by National Natural Science Foundation of China
   (30870064; 30970066), Hunan Provincial Natural Science Foundation
   (10JJ3058), and Scientific Research Fund of Hunan Provincial Education
   Department (08A036).
CR BOSCH D, 1994, BIO-TECHNOL, V12, P915, DOI 10.1038/nbt0994-915
   Chen SC, 2010, GENE, V458, P1, DOI 10.1016/j.gene.2010.02.006
   Ding XZ, 2008, CURR MICROBIOL, V56, P442, DOI 10.1007/s00284-008-9112-1
   Ding XueZhi, 2001, Chinese Journal of Biological Control, V17, P163
   Downing KJ, 2000, APPL ENVIRON MICROB, V66, P2804, DOI 10.1128/AEM.66.7.2804-2810.2000
   Fitches E, 2004, J INSECT PHYSIOL, V50, P61, DOI 10.1016/j.jinsphys.2003.09.010
   Guo SanDui, 1999, Scientia Agricultura Sinica, V32, P1
   HILDER VA, 1987, NATURE, V330, P160, DOI 10.1038/330160a0
   Jenkins JL, 2000, J BIOL CHEM, V275, P14423, DOI 10.1074/jbc.275.19.14423
   Kaur S, 2000, WORLD J MICROB BIOT, V16, P781, DOI 10.1023/A:1008931207374
   Lee KY, 2006, PROTEOMICS, V6, P1512, DOI 10.1002/pmic.200500298
   Lee MK, 1999, APPL ENVIRON MICROB, V65, P4513
   Lertcanawanichakul M, 2004, CURR MICROBIOL, V48, P175, DOI 10.1007/s00284-003-4119-0
   Liao CY, 2002, J INVERTEBR PATHOL, V80, P55, DOI 10.1016/S0022-2011(02)00035-6
   QIU LN, 2003, BIOTECHNOLOGY, V13, P47
   Rajendra W, 2006, BBA-GEN SUBJECTS, V1760, P158, DOI 10.1016/j.bbagen.2005.11.008
   Rausell C, 2004, BIOCHEMISTRY-US, V43, P166, DOI 10.1021/bi035527d
   Ryzhov V, 2000, APPL ENVIRON MICROB, V66, P3828, DOI 10.1128/AEM.66.9.3828-3834.2000
   Sampson MN, 1998, MICROBIOL-UK, V144, P2189, DOI 10.1099/00221287-144-8-2189
   Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Sirichotpakorn N, 2001, J INVERTEBR PATHOL, V78, P160, DOI 10.1006/jipa.2001.5058
   WANG FX, 2009, J INVERTEBR PATHOL, V101, P119
   Wiwat C, 1996, GENE, V179, P119, DOI 10.1016/S0378-1119(96)00575-6
   Xia LQ, 2009, CURR MICROBIOL, V58, P52, DOI 10.1007/s00284-008-9265-y
   XIA LQ, 2002, BIOTECHNOL B, V2, P35
   Xu Y, 2008, J AM MOSQUITO CONTR, V24, P219, DOI 10.2987/5666.1
   YU JX, 1999, ACTA SCI NATURALIUM, V38, P52
   ZHANG SH, 2001, MED MATH STAT
NR 29
TC 5
Z9 5
U1 3
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0959-3993
EI 1573-0972
J9 WORLD J MICROB BIOT
JI World J. Microbiol. Biotechnol.
PD JAN
PY 2012
VL 28
IS 1
BP 397
EP 400
DI 10.1007/s11274-011-0825-0
PG 4
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 869LO
UT WOS:000298599700045
PM 22806817
DA 2018-12-27
ER

PT J
AU Kyriakidou, O
AF Kyriakidou, Olivia
TI RETRACTED: Fitting into technical organizations? Exploring the role of
   gender in construction and engineering management in Greece (Retracted
   article)
SO CONSTRUCTION MANAGEMENT AND ECONOMICS
LA English
DT Article; Retracted Publication
DE Management; marginalization; professional identity; women
AB While there is growing interest in professional identity construction, little is known about how marginalization may influence the development of professional identity of minority professionals, such as women engineers holding middle and upper management positions in construction management. Professional identity is defined as one's professional self-concept based on attributes, beliefs, values, motives and experiences. The development of professional identity under conditions of marginalization presents an interesting puzzle. Professional roles are defined as prestigious and provide the role holder with autonomy and, often, a degree of privilege. However, marginalized professionals are often accorded little prestige and/ or privilege because their identities are perceived as inferior. Thus, the purpose of the study is to build and enrich theory around the development of professional identity under conditions of marginalized gender identity. To accomplish this goal, the study of narratives by 33 prominent Greek women civil engineers with careers in construction management explores what it means to be both women and engineers holding high management positions in their organizations. The analysis of the findings revealed a redefinition rather than an adaptation process as a central task for the professional identity construction of women managers in engineering which involved three redefinition tasks: redefining occupational rhetorics, disadvantage, and the self.
C1 [Kyriakidou, Olivia] Athens Univ Econ & Business, Dept Business Adm, Patision 76, Athens 10434, Greece.
RP Kyriakidou, O (reprint author), Athens Univ Econ & Business, Dept Business Adm, Patision 76, Athens 10434, Greece.
EM okyriakidou@aueb.gr
CR Alvesson M, 2003, LEADERSHIP QUART, V14, P359, DOI 10.1016/S1048-9843(03)00031-6
   Alvesson M, 2002, J MANAGE STUD, V39, P619, DOI 10.1111/1467-6486.00305
   Arthur M., 1989, HDB CAREER THEORY, P7, DOI [10.1017/CBO9780511625459, DOI 10.1017/CB09780511625459.003]
   Arthur M. B., 1999, NEW CAREERS INDIVIDU
   Arthur MB, 2008, HUM RELAT, V61, P163, DOI 10.1177/0018726707087783
   BAGILHOLE B, 1993, BRIT J SOCIOL EDUC, V14, P261, DOI 10.1080/0142569930140303
   Bendl R, 2008, BRIT J MANAGE, V19, pS50, DOI 10.1111/j.1467-8551.2008.00571.x
   Beraud A., 2003, J ENG EDUC, V28, P435
   Billing YD, 2011, GENDER WORK ORGAN, V18, P298, DOI 10.1111/j.1468-0432.2010.00546.x
   Bolton S, 2008, WORK EMPLOY SOC, V22, P281, DOI 10.1177/0950017008089105
   Broadbridge A, 2008, BRIT J MANAGE, V19, pS38, DOI 10.1111/j.1467-8551.2008.00570.x
   Brown AD, 2011, CONSTR MANAG ECON, V29, P83, DOI 10.1080/01446193.2010.531028
   Burke R.J., 2002, ADV WOMENS CAREERS
   Butler J, 1999, THEOR CULT SOC, V16, P11, DOI 10.1177/02632769922050520
   Butler J., 1990, GENDER TROUBLE FEMIN
   Catalyst, 2008, CAT 2008 CENS FORT 5
   Charles M., 2005, OCCUPATIONAL GHETTOS
   Cohen L, 2006, J VOCAT BEHAV, V69, P189, DOI 10.1016/j.jvb.2006.02.002
   CROCKER J, 1989, PSYCHOL REV, V96, P608, DOI 10.1037//0033-295X.96.4.608
   Crocker J., 1993, SOCIAL PSYCHOL STIGM, P153
   Dainty A. R. J., 2000, CONSTRUCTION MANAGEM, V18, P239, DOI DOI 10.1080/014461900370861
   Davidson M.J., 2000, WOMEN MANAGEMENT CUR
   DENZIN NK, 1989, INTERPRETIVE INTERAC
   Dryburgh H, 1999, GENDER SOC, V13, P664, DOI 10.1177/089124399013005006
   Eisenhart M. A., 1998, WOMENS SCI LEARNING
   Eurostat, 2006, LAB FORC SURV RES
   Evetts J., 1997, WOMEN MANAGEMENT REV, V12, P228, DOI DOI 10.1108/09649429710182440
   EVETTS J., 1996, GENDER CAREER SCI EN
   Faulkner W, 2000, SOC STUD SCI, V30, P759, DOI 10.1177/030631200030005005
   Fine GA, 1996, ADMIN SCI QUART, V41, P90, DOI 10.2307/2393987
   Gale A. W., 1999, WOMEN MANAGEMENT REV, V14, P273, DOI DOI 10.1108/09649429910291122
   Gecas V., 1995, SOCIOL PERSPECT, P336
   Goffman E., 1959, STIGMA NOTES MANAGEM
   Greed C., 2000, GENDER WORK ORGAN, V7, P181, DOI DOI 10.1111/1468-0432.00106
   GREY C, 1994, SOCIOLOGY, V28, P479, DOI 10.1177/0038038594028002007
   Hall DT, 2002, CAREER CREATIVITY EX, P159
   Henwood Flis, 1998, GENDER ED, V10, P35, DOI DOI 10.1080/09540259821087
   Ibarra H, 1999, ADMIN SCI QUART, V44, P764, DOI 10.2307/2667055
   Ibarra H., 2007, HDB CAREER STUDIES, P268
   Kanter R. M, 1977, MEN WOMEN CORPORATIO
   KANTER RM, 1988, RES ORGAN BEHAV, V10, P169
   Korte RF, 2009, HUM RESOUR DEV Q, V20, P285, DOI 10.1002/hrdq.20016
   Kostavara-Papariga K., 2006, EPOHI, V5, P2
   Kreiner GE, 2006, ACAD MANAGE J, V49, P1031, DOI 10.5465/AMJ.2006.22798186
   Kvande E, 1999, EUR J WOMENS STUD, V6, P305, DOI 10.1177/135050689900600304
   Labour Statistics, 2008, LABORSTA
   Lane N., 1997, SCI CONSTRUCTION WOM, P37
   LANGFORD D.A., 1995, HUMAN RESOURCES MANA
   Lieblich A., 1998, NARRATIVE RES READIN
   Lu SL, 2010, CONSTR MANAG ECON, V28, P125, DOI 10.1080/01446190903280450
   Miles M B., 1994, QUALITATIVE DATA ANA
   NKOMO SM, 1992, ACAD MANAGE REV, V17, P487, DOI 10.2307/258720
   Patton M. Q., 1990, QUALITATIVE EVALUATI
   Patton M.Q., 2002, QUALITATIVE RES EVAL
   Petraki-Kottis A., 2004, WOMEN MANAGEMENT WOR, P39
   Pinel EC, 1999, J PERS SOC PSYCHOL, V76, P114, DOI 10.1037/0022-3514.76.1.114
   Piore MJ, 2006, IND RELAT, V45, P299, DOI 10.1111/j.1468-232X.2006.00439.x
   Powell A., 2006, Equal Opportunities International, V25, P688, DOI 10.1108/02610150610719146
   Powell A, 2009, GENDER WORK ORGAN, V16, P411, DOI 10.1111/j.1468-0432.2008.00406.x
   Prasad P., 2007, HDB CAREER STUDIES, P169
   Pratt MG, 2006, ACAD MANAGE J, V49, P235, DOI 10.5465/AMJ.2006.20786060
   Schein E.H., 1978, CAREER DYNAMICS MATC
   Seidman T.E., 1991, INTERVIEWING QUALITA
   SNOW DA, 1987, AM J SOCIOL, V92, P1336, DOI 10.1086/228668
   Stratigaki M., SOCIAL POLITICS, V11, P30
   Technical Chamber of Greece, 2003, EMPL PROF SIT ENG U
   Wasserman V, 2011, ORGAN SCI, V22, P503, DOI 10.1287/orsc.1100.0583
   WATSON T, 2002, INT STUDIES MANAGEME, V32, P93
   Wrzesniewski A, 2001, ACAD MANAGE REV, V26, P179, DOI 10.5465/AMR.2001.4378011
NR 69
TC 6
Z9 6
U1 0
U2 0
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0144-6193
EI 1466-433X
J9 CONSTR MANAG ECON
JI Constr. Manag. Econ.
PY 2012
VL 30
IS 10
BP 845
EP 856
DI 10.1080/01446193.2012.714870
PG 12
WC Business
SC Business & Economics
GA V97IR
UT WOS:000213326000004
DA 2018-12-27
ER

PT J
AU Miki, M
   Katayama, K
AF Miki, Motohiro
   Katayama, Kazuhiko
TI RETRACTED: In silico 3D structure analysis accelerates the solution of a
   real viral structure and antibodies docking mechanism (Retracted
   article. See vol. 6, 1138, 2015)
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article; Retracted Publication
DE Norwalk virus; monoclonal antibody; x-ray crystallography; in silico
   modeling; cryo-electron microscopy
AB Norwalk virus (NoV) is responsible for most outbreaks of non-bacterial gastroenteritis. NoV is genetically diverse and show antigenically variable. Recently, we produced a monoclonal antibody called 5B-18 that reacts broadly with NoV genogroup II (GII). We suspected the 5B-18 binds to a conformational epitope on 3D structure of virion. X-ray crystallography showed us that 5B-18 binds to NoV at the P domain, which protrudes from the capsid surface of the virion. However, there seems to be no space that would allow the IgG to approach the virion. To solve this problem, we used cryo-electron microscopy to examine NoV GII virus-like particles (VLPs). The P domain rises up higher in NoV GII than in NoV GI, and it seems to form an outer layer around the virion. Finally, using in silico modeling we found the 5B-18 Fab arms and NoV P region are quite flexible, so that 5B-18 can bind the NoV virion from bottom of P domain. This study demonstrates the shortcomings of studying biological phenomenon by only one technique. Each method has limitations. Multiple methods and modeling in silico are the keys to solving structural problems.
C1 [Miki, Motohiro; Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Tokyo 2080011, Japan.
   [Miki, Motohiro] Denka Seiken Co Ltd, Niigata, Japan.
RP Katayama, K (reprint author), Natl Inst Infect Dis, Dept Virol 2, Tokyo 2080011, Japan.
EM katayama@nih.go.jp
CR Ausar SF, 2006, J BIOL CHEM, V281, P19478, DOI 10.1074/jbc.M603313200
   Bhella D, 2008, J VIROL, V82, P8051, DOI 10.1128/JVI.00550-08
   Bhella D, 2011, J VIROL, V85, P11381, DOI 10.1128/JVI.05621-11
   Guix S, 2007, J VIROL, V81, P12238, DOI 10.1128/JVI.01489-07
   Hansman GS, 2012, J VIROL, V86, P3635, DOI 10.1128/JVI.06868-11
   Hansman GS, 2011, J VIROL, V85, P6687, DOI 10.1128/JVI.00246-11
   Hansman GS, 2006, J GEN VIROL, V87, P909, DOI 10.1099/vir.0.81532-0
   Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508
   LAMBDEN PR, 1993, SCIENCE, V259, P516, DOI 10.1126/science.8380940
   Li XA, 2010, VIRUS RES, V151, P142, DOI 10.1016/j.virusres.2010.04.005
   Lindesmith LC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002705
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287
   PRASAD BVV, 1994, J MOL BIOL, V240, P256, DOI 10.1006/jmbi.1994.1439
   Taube S, 2010, J VIROL, V84, P5695, DOI 10.1128/JVI.00316-10
   Varghese R, 2004, J VIROL, V78, P12320, DOI 10.1128/JVI.78.22.12320-12332.2004
   Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05
   XI JA, 1990, SCIENCE, V250, P1580, DOI 10.1126/science.2177224
   XI JA, 1992, J VIROL, V66, P6527
   Yoda T, 2003, J CLIN MICROBIOL, V41, P2367, DOI 10.1128/JCM.41.6.2367-2371.2003
   Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015
NR 21
TC 2
Z9 2
U1 2
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PY 2012
VL 3
AR 387
DI 10.3389/fmicb.2012.00387
PG 6
WC Microbiology
SC Microbiology
GA V31DF
UT WOS:000208863600388
PM 23133439
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Ghaleb, A
   Khorasani, A
   Mangar, D
AF Ghaleb, Ahmed
   Khorasani, Arjang
   Mangar, Devanand
TI RETRACTED: Post-dural puncture headache (Retracted article. See vol. 9,
   pg. 173, 2016)
SO INTERNATIONAL JOURNAL OF GENERAL MEDICINE
LA English
DT Review; Retracted Publication
DE post-dural puncture headache; gauge; needles; cause; risk; incidence
AB Since August Bier reported the first case in 1898, post-dural puncture headache (PDPH) has been a problem for patients following dural puncture. Clinical and laboratory research over the last 30 years has shown that use of smaller-gauge needles, particularly of the pencil-point design, are associated with a lower risk of PDPH than traditional cutting point needle tips (Quincke-point needle). A careful history can rule out other causes of headache. A postural component of headache is the sine qua non of PDPH. In high-risk patients , 50 years, post-partum, in the event a large-gauge needle puncture is initiated, an epidural blood patch should be performed within 24-48 hours of dural puncture. The optimum volume of blood has been shown to be 12-20 mL for adult patients. Complications caused by autologous epidural blood patching (AEBP) are rare.
C1 [Ghaleb, Ahmed] Univ Arkansas Med Sci, Dept Anesthesiol, Little Rock, AR USA.
   [Khorasani, Arjang] Advocate Illinois Mason Med Ctr, Anesthesiol Residency Program, Chicago, IL USA.
   [Mangar, Devanand] Tampa Gen Hosp, Florida Gulf Bay Anesthesiol, Tampa, FL USA.
RP Ghaleb, A (reprint author), Univ Arkansas Med Sci, 4301 West Markham,Slot 515, Little Rock, AR 72205 USA.
EM ghalebahmed@uams.edu
CR ABOULEISH E, 1975, ANESTH ANALG, V54, P459
   Abram SE, 1999, ANESTHESIOLOGY, V91, P1937, DOI 10.1097/00000542-199912000-00047
   Al-Metwalli RR, 2008, ANAESTHESIA, V63, P847, DOI 10.1111/j.1365-2044.2008.05494.x
   ANDREWS PJD, 1992, BRIT J ANAESTH, V69, P401, DOI 10.1093/bja/69.4.401
   Armon C, 2005, NEUROLOGY, V65, P510, DOI 10.1212/01.wnl.0000173034.96211.1b
   Bader AM, 1998, ANESTHESIOL CLIN N A, V16, P459
   BARRIOSALARCON J, 1989, REGION ANESTH, V14, P78
   BEARDS SC, 1993, BRIT J ANAESTH, V71, P182, DOI 10.1093/bja/71.2.182
   CAMANN WR, 1990, ANESTH ANALG, V70, P181
   CARP H, 1994, ANESTH ANALG, V79, P180
   Carter BL, 2000, ANESTHESIOLOGY, V92, P272, DOI 10.1097/00000542-200001000-00043
   CHEEK TG, 1988, BRIT J ANAESTH, V61, P340, DOI 10.1093/bja/61.3.340
   COLLIER BB, 1994, BRIT J ANAESTH, V72, P366, DOI 10.1093/bja/72.3.366-c
   COLONNAROMANO P, 1989, ANESTH ANALG, V69, P522
   CRAWFORD JS, 1980, ANAESTHESIA, V35, P513, DOI 10.1111/j.1365-2044.1980.tb03834.x
   Crul BJP, 1999, ANESTHESIOLOGY, V91, P576, DOI 10.1097/00000542-199908000-00039
   Diaz JH, 2001, REGION ANESTH PAIN M, V26, P582, DOI 10.1053/rapm.2001.28275
   DIGIOVANNI AJ, 1970, ANESTH ANAL CURR RES, V49, P268
   DIGIOVANNI AJ, 1972, ANESTH ANAL CURR RES, V51, P226
   DJURHUUS H, 1995, ACTA ANAESTH SCAND, V39, P613, DOI 10.1111/j.1399-6576.1995.tb04136.x
   DRIPPS RD, 1954, JAMA-J AM MED ASSOC, V156, P1486, DOI 10.1001/jama.1954.02950160016005
   Duffy PJ, 1999, CAN J ANAESTH, V46, P878, DOI 10.1007/BF03012979
   Errando CL, 2001, REGION ANESTH PAIN M, V26, P178, DOI 10.1053/rapm.2001.19412
   Evans RW, 1998, NEUROL CLIN, V16, P83, DOI 10.1016/S0733-8619(05)70368-6
   Fassoulaki A, 1991, Anaesthesiol Reanim, V16, P375
   GIELEN M, 1989, REGION ANESTH, V14, P101
   Gormley JB, 1960, ANESTHESIOLOGY, V21, P565
   Harrington BE, 2004, REGION ANESTH PAIN M, V29, P136, DOI 10.1016/j.rapm.2003.12.023
   Hodgson C, 1997, ANAESTHESIA, V52, P808
   Horlocker T T, 2000, Anesthesiol Clin North America, V18, P461, DOI 10.1016/S0889-8537(05)70172-3
   KEENER EB, 1959, J NEUROSURG, V16, P424, DOI 10.3171/jns.1959.16.4.0424
   Lambert DH, 1997, REGION ANESTH, V22, P66, DOI 10.1016/S1098-7339(06)80058-1
   LEIVERS D, 1990, ANESTHESIOLOGY, V73, P1287, DOI 10.1097/00000542-199012000-00038
   LIU S, 1995, ANESTHESIOLOGY, V82, P1474, DOI 10.1097/00000542-199506000-00019
   LOESER EA, 1978, ANESTHESIOLOGY, V49, P147
   LOWE DM, 1990, BRIT J ANAESTH, V65, P721, DOI 10.1093/bja/65.5.721
   LYBECKER H, 1995, ACTA ANAESTH SCAND, V39, P605, DOI 10.1111/j.1399-6576.1995.tb04135.x
   Maurer K, 2003, ACTA ANAESTH SCAND, V47, P878, DOI 10.1034/j.1399-6576.2003.00173.x
   MCGRADY EM, 1991, ANAESTHESIA, V46, P794, DOI 10.1111/j.1365-2044.1991.tb09802.x
   Mokri B, 1997, MAYO CLIN PROC, V72, P400, DOI 10.4065/72.5.400
   Nishio I, 2004, ANESTHESIOLOGY, V100, P158, DOI 10.1097/00000542-200401000-00025
   NORRIS MC, 1989, ANESTHESIOLOGY, V70, P729, DOI 10.1097/00000542-198905000-00002
   OSTHEIME.GW, 1974, ANESTHESIOLOGY, V41, P307, DOI 10.1097/00000542-197409000-00021
   PALAHNIUK RJ, 1979, CAN ANAESTH SOC J, V26, P132, DOI 10.1007/BF03013783
   QUAYNOR H, 1985, BRIT J ANAESTH, V57, P538, DOI 10.1093/bja/57.5.538
   READY LB, 1989, ANESTH ANALG, V69, P457
   Reina MA, 1997, REGION ANESTH, V22, P161, DOI 10.1016/S1098-7339(06)80036-2
   Reina MA, 2000, REGION ANESTH PAIN M, V25, P393, DOI 10.1053/rapm.2000.7622
   REYNOLDS F, 1993, BRIT MED J, V306, P874, DOI 10.1136/bmj.306.6882.874
   ROSENBERG PH, 1985, ANESTH ANALG, V64, P501
   Safa-Tisseront V, 2001, ANESTHESIOLOGY, V95, P334, DOI 10.1097/00000542-200108000-00012
   Stevens RA, 1996, REGIONAL ANAESTHESIA, P352
   Strachan A, 1998, BRIT MED J, V316, P1018
   STRIDE PC, 1993, ANAESTHESIA, V48, P247, DOI 10.1111/j.1365-2044.1993.tb06913.x
   SZEINFELD M, 1986, ANESTHESIOLOGY, V64, P820, DOI 10.1097/00000542-198606000-00028
   TAIVAINEN T, 1993, ACTA ANAESTH SCAND, V37, P702, DOI 10.1111/j.1399-6576.1993.tb03793.x
   Thoennissen J, 2001, CAN MED ASSOC J, V165, P1311
   THORNBERRY EA, 1988, BRIT J ANAESTH, V60, P195, DOI 10.1093/bja/60.2.195
   Tobias MD, 1996, ANESTH ANALG, V82, P766, DOI 10.1097/00000539-199604000-00016
   TRIVEDI NS, 1993, J CLIN ANESTH, V5, P42, DOI 10.1016/0952-8180(93)90086-T
   Turnbull DK, 2003, BRIT J ANAESTH, V91, P718, DOI 10.1093/bja/aeg231
   Vakharia SB, 1997, ANESTH ANALG, V84, P585, DOI 10.1097/00000539-199703000-00022
   VANDAM LD, 1956, JAMA-J AM MED ASSOC, V161, P586, DOI 10.1001/jama.1956.02970070018005
   WALPOLE JB, 1975, ANAESTHESIA, V30, P783, DOI 10.1111/j.1365-2044.1975.tb00956.x
NR 64
TC 22
Z9 23
U1 0
U2 0
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-7074
J9 INT J GEN MED
JI Int. J. Gen. Med.
PY 2012
VL 5
BP 45
EP 51
DI 10.2147/IJGM.S17834
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA V05IK
UT WOS:000213866100008
PM 22287846
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Kovacic, MP
   Rotar, NZ
   Erjavec, K
AF Kovacic, Melita Poler
   Rotar, Nada Zgrabljic
   Erjavec, Karmen
TI RETRACTED: Information Literacy in Croatia: An Ideological Approach
   (Retracted article. See vol. 12, pg. 161, 2013)
SO JOURNAL OF LANGUAGE IDENTITY AND EDUCATION
LA English
DT Article; Retracted Publication
DE information literacy; media education; ideology; new information and
   communication technologies; high schools; Croatia
ID DIGITAL DIVIDE
AB New information and communication technologies were widely perceived as something that would lead post-socialist European countries towards the technologically developed information society. In this article, a critical perspective is taken in examining information literacy as an ideological form. The deconstruction of ideological practice was performed using a text-based examination of the genealogy of justifying discourse, as found in official documents and policy statements regarding information literacy in Croatia. Croatian information literacy is too narrowly conceptualized as a means of preparing students for the demands of the EU and the global market, ensuring their employability and increasing the country's economic competitiveness. Further, in-depth interviews with 25 Croatian gymnasium professors showed how the ideology of information literacy is embodied in their beliefs. They aligned themselves with the neo-liberal imperative of ongoing retraining and saw information literacy as a means of providing students with technical skills.
C1 [Kovacic, Melita Poler] Univ Ljubljana, Fac Social Sci, SI-1000 Ljubljana, Slovenia.
   [Rotar, Nada Zgrabljic] Univ Zadar, Zadar, Croatia.
RP Kovacic, MP (reprint author), Univ Ljubljana, Fac Social Sci, Kardeljeva Pl 5, SI-1000 Ljubljana, Slovenia.
EM melita.poler-kovacic@fdv.uni-lj.si
CR [Anonymous], 2004, TRANS COUNTR KNOWL S
   [Anonymous], 1996, PATH INF SOC CENTR E
   [Anonymous], 2005, CURR INF SPLOSN GIMN
   Apple M., 1995, TRANSFORMING SCH, P345
   Apple M., 1997, LITERACY TECHNOLOGY, P559
   Apple M. W., 1990, IDEOLOGY CURRICULUM
   Bawden D, 2001, J DOC, V57, P218, DOI 10.1108/EUM0000000007083
   Bell D., 1973, COMING POSTINDUSTRIA
   Bourdieu P, 2001, RADICAL PHILOS, P2
   Brenner Neil, 2002, SPACES NEOLIBERALISM
   Castells Manuel, 1996, INFORM AGE EC SOC CU
   Correia A. M. R., 2002, UNESCO US NAT COMM L
   Croatian Bureau of Statistics, 2011, WOM MEN CROAT
   Erjavec K., 2006, MEDIA DEV, V51, P3
   Flichy P., 1995, DYNAMICS MODERN COMM
   Garnham N., 2002, 2001 BUGS C GLOB PLU
   Golding P., 1990, PUBLIC COMMUNICATION, P84
   Goodson I., 1992, CURRICULUM J, V3, P261
   Goodson I. F., 1984, NEW DIRECTIONS ED LE, P325
   Goodson I. F., 1995, TRANSFORMING SCH, P309
   Goodson IF, 1996, BRIT J SOCIOL EDUC, V17, P65, DOI 10.1080/0142569960170105
   Hall S., 1985, CRITICAL STUDIES MAS, V2, P91
   Hepworth M., 2000, NEW REV ACAD LIB, V6, P21
   Hepworth M., 2000, INFORM LITERACY WORL, P51
   Kenway J, 1996, COMP EDUC, V32, P217, DOI 10.1080/03050069628858
   Lasic-Lazic J., 2006, INFORM USE INFORM SO, P91
   Lloyd A, 2006, J DOC, V62, P570, DOI 10.1108/00220410610688723
   Lyon D., 1988, INFORM SOC
   Martin M, 1991, HELLO CENTRAL GENDER
   Negroponte N., 1995, BEING DIGITAL
   Neill M., 1995, RESISTING VIRTUAL LI
   Peterffy A., 2002, LIFELONG LEARNING IN, P367
   Plant S., 1998, ZEROES ONES
   Rasmussen T., 1995, MODERNE MASKINER
   Roach Colleen, 1997, CULTURAL IMPERIALISM, P94
   Robinson K., 1989, TECHNICAL FIX
   Rose N, 2001, THEOR CULT SOC, V18, P1, DOI 10.1177/02632760122052020
   Schiller H., 1995, RESISTING VIRTUAL LI
   Schutt Russell K., 2001, INVESTIGATING SOCIAL
   Selwyn N, 1999, INTERNET RES, V9, P225, DOI 10.1108/10662249910274629
   Servaes J., 2003, EUROPEAN INFORM SOC
   Servon LJ, 2001, J URBAN AFF, V23, P279, DOI 10.1111/0735-2166.00089
   Skogerbo T., 2004, PUBLIC, V11, P45
   Spiranec S, 2010, J DOC, V66, P140, DOI 10.1108/00220411011016407
   Sredisnji drzavni ured za razvojnu strategiju i koordinaciju fondova Europske unije, 2006, STRAT OKV RAZV 2006
   Sundin O, 2008, J DOC, V64, P24, DOI 10.1108/00220410810844141
   Tuominen K, 2005, LIBR QUART, V75, P329, DOI 10.1086/497311
   van Dijk J, 2003, INFORM SOC, V19, P315, DOI 10.1080/01972240390227895
   van Zoonen L, 2002, EUR J COMMUN, V17, P5, DOI 10.1177/0267323102017001605
   Virkus S, 2003, INFORM RES, V8
   Vreg F., 1991, TEORIJA PRAKSA, V28, P11
   Webster F., 1995, THEORIES INFORM SOC
   Williams R, 1975, TELEVISION
   Winner L., 1986, WHALE REACTOR
   Zgrabljic Rotar N., 2010, PERSPEKTIVE CJELOZIV, P60
NR 55
TC 3
Z9 3
U1 2
U2 19
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1534-8458
EI 1532-7701
J9 J LANG IDENTITY EDUC
JI J. Lang. Identity Educ.
PY 2012
VL 11
IS 3
BP 151
EP 166
DI 10.1080/15348458.2012.686372
PG 16
WC Education & Educational Research; Linguistics; Language & Linguistics
SC Education & Educational Research; Linguistics
GA 975PY
UT WOS:000306524500001
DA 2018-12-27
ER

PT J
AU Bamidele, O
AF Bamidele, Oluwaseun
TI RETRACTED: Disarmament, Demobilization, and Reintegration of Children in
   Armed Conflict (Retracted article. See vol. 28, pg. 267, 2016)
SO PEACE REVIEW-A JOURNAL OF SOCIAL JUSTICE
LA English
DT Article; Retracted Publication
C1 [Bamidele, Oluwaseun] Faith Acad, Dept Liberal Arts & Social Sci, Civic Educ Unit, Independent Res, Ota, Ogun State, Nigeria.
RP Bamidele, O (reprint author), Faith Acad, Dept Liberal Arts & Social Sci, Civic Educ Unit, Independent Res, Ota, Ogun State, Nigeria.
EM oluwaseun.bamidele@gmail.com
CR Brett Rachel, 1996, CHILDREN INVISIBLE S
   CAIRNS E, 1996, CHILDREN POLITICAL V
   Cockerill A. W., 1984, SONS BRAVE STORY BOY
   Conoir Yvan, 2008, DISARMAMENT DEMOBILI
   Farley Maggie, 2001, LOS ANGELES TIMES, pA3
   Goodwill-Gill Guy, 1994, CHILD SOLDIERS ROLE
   Kuper Jenny, 1997, INT LAW CHILD CIVILI
NR 7
TC 1
Z9 1
U1 0
U2 0
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1040-2659
EI 1469-9982
J9 PEACE REV
JI Peace Rev.
PY 2012
VL 24
IS 3
BP 284
EP 291
DI 10.1080/10402659.2012.704251
PG 8
WC International Relations
SC International Relations
GA V67UP
UT WOS:000211329000005
DA 2018-12-27
ER

PT J
AU Lu, WL
   Huang, KC
   Hung, PK
   Houng, MP
AF Lu, Wei-Lun
   Huang, Kuo-Chan
   Hung, Pin-Kun
   Houng, Mau-Phon
TI RETRACTED: Study of textured ZnO:Al thin film and its optical properties
   for thin film silicon solar cells (Retracted article. See vol. 74, pg.
   535, 2013)
SO JOURNAL OF PHYSICS AND CHEMISTRY OF SOLIDS
LA English
DT Article; Retracted Publication
DE Thin films; X-ray diffraction; Electrical properties; Optical properties
ID ZINC-OXIDE FILMS; AMORPHOUS-SILICON; ETCHING BEHAVIOR
AB The study addresses the optical properties and morphologies of Al-doped ZnO (AZO) films textured by the chemical wet-etching method using three different acid solutions: HCl, HNO3, and H3PO4. An initial AZO film was sputtered on a glass substrate by rf magnetron sputtering. The film surface was then textured by wet-etching using diluted HCl, HNO3, or H3PO4. The average transmittance of all the posttreated ZnO:Al films remains around 75-80% as measured by a UV-vis analyzer. A haze ratio calculation shows that the light scattering properties can be significantly controlled by varying the etchant species, acid concentration, and etching time. Further, the HNO3 etchant gives the highest haze ratio of 43.0% at a wavelength of 550 nm. Compared with solar cells deposited on non-textured ZnO:Al films, a significant enhancement in the short-circuit current density of 17.8% for the a-Si solar cells with textured ZnO:Al films was achieved. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Lu, Wei-Lun; Huang, Kuo-Chan; Hung, Pin-Kun; Houng, Mau-Phon] Natl Cheng Kung Univ, Inst Microelect, Dept Elect Engn, Tainan 701, Taiwan.
RP Houng, MP (reprint author), Natl Cheng Kung Univ, Inst Microelect, Dept Elect Engn, 1 Dasyue Rd, Tainan 701, Taiwan.
EM mphoung@eembox.ncku.edu.tw
FU National Science Council of Taiwan [NSC-97-2221-E-006-239-MY2]
FX The authors would like to thank Dr. Gwo-Sen Lin at NexPower Technology
   Corporation for his helpful discussion. They also want to thank Mr.
   Yu-Yao Chen, the CTO at E-HENG Technology Co., Ltd., for technical
   assistance. This work was also supported by the National Science Council
   of Taiwan under Contract number NSC-97-2221-E-006-239-MY2.
CR Agashe C, 2004, J APPL PHYS, V95, P1911, DOI 10.1063/1.1641524
   Berginski M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2715554
   IGASAKI Y, 1991, J APPL PHYS, V69, P2190, DOI 10.1063/1.348748
   Jeong SH, 2003, THIN SOLID FILMS, V435, P78, DOI 10.1016/S0040-6090(03)00376-6
   KIM HK, 1992, APPL PHYS LETT, V61, P2524, DOI 10.1063/1.108169
   Kluth O, 2003, THIN SOLID FILMS, V442, P80, DOI 10.1016/S0040-6090(03)00949-0
   Kluth O, 1999, THIN SOLID FILMS, V351, P247, DOI 10.1016/S0040-6090(99)00085-1
   Lu WL, 2011, MATER CHEM PHYS, V127, P358, DOI 10.1016/j.matchemphys.2011.02.019
   Lupan O, 2009, SOL ENERG MAT SOL C, V93, P1417, DOI 10.1016/j.solmat.2009.03.012
   Mehta M, 2011, J ELECTROCHEM SOC, V158, pH119, DOI 10.1149/1.3519999
   Muller J, 2004, SOL ENERGY, V77, P917, DOI 10.1016/j.solener.2004.03.015
   Muller J, 2001, SOL ENERG MAT SOL C, V66, P275, DOI 10.1016/S0927-0248(00)00184-7
   Park KC, 1997, THIN SOLID FILMS, V305, P201, DOI 10.1016/S0040-6090(97)00215-0
   Rech B, 2006, THIN SOLID FILMS, V511, P548, DOI 10.1016/j.tsf.2005.12.161
   Rech B, 1999, APPL PHYS A-MATER, V69, P155, DOI 10.1007/s003390050986
   STAEBLER DL, 1977, APPL PHYS LETT, V31, P292, DOI 10.1063/1.89674
   STUTZMANN M, 1985, PHYS REV B, V32, P23, DOI 10.1103/PhysRevB.32.23
   VANDEPOL FCM, 1991, THIN SOLID FILMS, V204, P349, DOI 10.1016/0040-6090(91)90074-8
   Wei XQ, 2007, MATER CHEM PHYS, V101, P285, DOI 10.1016/j.matchemphys.2006.05.005
NR 19
TC 4
Z9 6
U1 2
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-3697
EI 1879-2553
J9 J PHYS CHEM SOLIDS
JI J. Phys. Chem. Solids
PD JAN
PY 2012
VL 73
IS 1
BP 52
EP 56
DI 10.1016/j.jpcs.2011.09.018
PG 5
WC Chemistry, Multidisciplinary; Physics, Condensed Matter
SC Chemistry; Physics
GA 859QR
UT WOS:000297891400010
DA 2018-12-27
ER

PT J
AU Narayanan, R
   Kim, HN
   Narayanan, NK
   Nargi, D
   Narayanan, B
AF Narayanan, Rajkishen
   Kim, Hye Na
   Narayanan, Narayanan K.
   Nargi, Dominick
   Narayanan, Bhagavathi
TI RETRACTED: Epidermal growth factor-stimulated human cervical cancer cell
   growth is associated with EGFR and cyclin D1 activation, independent of
   COX-2 expression levels (Retracted article. See vol. 50, pg. 337, 2017)
SO INTERNATIONAL JOURNAL OF ONCOLOGY
LA English
DT Article; Retracted Publication
DE EGFR; COX-2; cyclin D; human papillomavirus; cervical cancer
ID FACTOR RECEPTOR; UTERINE CERVIX; CYCLOOXYGENASE-2; CARCINOMA;
   PAPILLOMAVIRUSES; TRANSFORMATION; PATHWAY; SKIN
AB Cervical cancer constitutes the second most common cancer in women. It is evident from earlier studies that epidermal growth factor (EGF) is a mitogen, in that it mimics the function of estrogen by mediating cross-talk with other oncoproteins. Although epidermal growth factor receptor (EGFR) is highly expressed in breast and ovarian tumor tissues, its regulation by the exogenous source of its ligand EGF in human papillomavirus (HPV)-associated cervical cancer remains unclear. In this study, we addressed the question of whether EGF is required for the proliferation of HPV-positive cervical cancer cells and what mechanisms are involved. To determine this, we conducted a series of studies using HPV-positive human cervical cancer cells, CaSki and HeLa, and stimulated the cells with EGF. Our findings suggest that 6 h of stimulation with 10 ng/ml of EGF is sufficient to induce cell cycle progression associated with a significant increase in DNA synthesis, EGFR, COX-2 and cyclin D1 levels. Consistently, cellular localization and Western blot analysis for p-EGFR (Try-1045) protein showed an increase after EGF stimulation. Using siRNA gene knockdown assays we have shown that cyclin D1 siRNA has a significant negative effect on EGFR and inhibit cell growth independent of COX-2 levels. In summary, our findings reveal that an exogenous EGF stimulation may enhance HPV-related cervical cancer cell proliferation by activating EGFR and cyclin D1 that is independent of COX-2 levels, suggesting that the inhibitors of EGFR and cyclin D1 may be effective against cervical cancer cell proliferation.
C1 [Narayanan, Rajkishen; Kim, Hye Na; Narayanan, Narayanan K.; Nargi, Dominick; Narayanan, Bhagavathi] NYU, Dept Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA.
RP Narayanan, B (reprint author), NYU, Dept Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA.
EM bhagavathi.narayanan@nyumc.org
FU National Institutes of Health (NIH)/National Cancer Institute (NCI)
   (USPHS) [CA106296]; NIH/NCI [CA106296-05S1]
FX The study was supported, in part by the National Institutes of Health
   (NIH)/National Cancer Institute (NCI) (USPHS) grant CA106296, and the
   American Recovery & Reinvestment Act of 2009 (ARRA) from NIH/NCI grant
   CA106296-05S1 for B.A. Narayanan. We thank Mr. Al Bowers, New York
   University School of Medicine, Analytical Facility Core at the
   Department of Environmental Medicine, Tuxedo, NY for his assistance with
   flow cytometric analysis.
CR Almadori G, 2001, CLIN CANCER RES, V7, P3988
   Brake T, 2003, CANCER RES, V63, P8173
   Clarke B, 2001, GYNECOL ONCOL, V82, P238, DOI 10.1006/gyno.2001.6306
   COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3
   Emlet DR, 1997, J BIOL CHEM, V272, P4079, DOI 10.1074/jbc.272.7.4079
   Fogarty GB, 2007, BRIT J DERMATOL, V156, P92, DOI 10.1111/j.1365-2133.2006.07603.x
   Fosslien E, 2000, CRIT REV CL LAB SCI, V37, P431, DOI 10.1080/10408360091174286
   Grandis JR, 1998, J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824
   HAUSEN HZ, 1988, MOL CARCINOGEN, V1, P147, DOI 10.1002/mc.2940010302
   Jalili A, 2008, J DTSCH DERMATOL GES, V6, P1066, DOI [10.1111/j.1610-0387.2008.06861.x, 10.1111/j.1610-0387.2008.6861.x]
   Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO2005.04.8306
   Kim GE, 2004, CLIN CANCER RES, V10, P1366, DOI 10.1158/1078-0432.CCR-0497-03
   Kim SH, 2009, CARCINOGENESIS, V30, P753, DOI 10.1093/carcin/bgp066
   Kulkarni S, 2001, CLIN CANCER RES, V7, P429
   Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000
   Levin ER, 2003, MOL ENDOCRINOL, V17, P309, DOI 10.1210/me.2002.0368
   MILLER RG, 1981, SIMULTANEOUS STATIST, P37
   Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641
   Nahta R, 2002, CANCER RES, V62, P2267
   Narayanan BA, 2003, CLIN CANCER RES, V9, P3503
   Narayanan BA, 2006, MOL CANCER THER, V5, P1117, DOI 10.1158/1535-7163.MCT-05-0520
   Reissmann PT, 1999, J CANCER RES CLIN, V125, P61, DOI 10.1007/s004320050243
   Robles AI, 1998, GENE DEV, V12, P2469, DOI 10.1101/gad.12.16.2469
   Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456
   Sales KJ, 2001, J CLIN ENDOCR METAB, V86, P2243, DOI 10.1210/jc.86.5.2243
   SHERR CJ, 1995, P ASSOC AM PHYSICIAN, V107, P181
   Subbaramaiah K, 2007, CANCER RES, V67, P3976, DOI 10.1158/0008-5472.CAN-06-4273
   YOKOTA K, 1986, J BIOL CHEM, V261, P5410
   zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798
   zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690
NR 30
TC 20
Z9 20
U1 2
U2 11
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1019-6439
EI 1791-2423
J9 INT J ONCOL
JI Int. J. Oncol.
PD JAN
PY 2012
VL 40
IS 1
BP 13
EP 20
DI 10.3892/ijo.2011.1211
PG 8
WC Oncology
SC Oncology
GA 853CM
UT WOS:000297403800002
PM 21946890
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Sabeti, SA
   Pahlevaninezhad, M
   Soleymani, M
   Panjepour, M
AF Sabeti, S. A.
   Pahlevaninezhad, M.
   Soleymani, M.
   Panjepour, M.
TI RETRACTED: The effect of temperature on the grain growth of
   nanocrystalline metals and its simulation by molecular dynamics method
   (Retracted article. See vol. 126, pg. 528, 2017)
SO COMPUTATIONAL MATERIALS SCIENCE
LA English
DT Article; Retracted Publication
DE Nanocrystals; Equation of state thermodynamic model; Grain growth;
   Molecular dynamics simulation; Critical size of grain
ID SUBCRITICAL PHASE-BEHAVIOR; EQUATION-OF-STATE; SIMULTANEOUS PREDICTION;
   N-ALKANES; THERMODYNAMIC PROPERTIES; MIXTURES; STABILITY; SIZE;
   MICROSTRUCTURE; TRANSFORMATION
AB In this study, the thermodynamic stability of the grain boundaries and the grain growth of nanocrystalline Palladium (Pd) at various temperatures were investigated. For this purpose, the Gibbs free energy curves of grain boundaries were plotted in terms of the excess volume by the use of the equation of state (EOS) and Song's thermodynamic models. The results showed that, according to the prediction of these models, the nanocrystalline growth in metals was stopped at the grain sizes less than the critical grain size. Also, the results of the temperature variations and its effect on the Gibbs free energy curves showed that by the increase of the temperature, the possibility for the stoppage of grain growth is facilitated and the critical grain size is increased. To investigate the validity of the mentioned predictions, the molecular dynamics atomic simulation was employed. The results obtained from the simulation, confirmed the predicted effect of temperature on grain growth of nanocrystalline Pd and showed that the EOS model is more accurate for the prediction of grain growth than Song's model. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Sabeti, S. A.; Pahlevaninezhad, M.; Soleymani, M.; Panjepour, M.] Isfahan Univ Technol, Dept Mat Engn, Esfahan 8415683111, Iran.
RP Panjepour, M (reprint author), Isfahan Univ Technol, Dept Mat Engn, Esfahan 8415683111, Iran.
EM panjepour@cc.iut.ac.ir
OI Soleymani, Meysam/0000-0003-1585-5880
CR BARRON THK, 1980, ADV PHYS, V29, P609, DOI 10.1080/00018738000101426
   Charitidis C, 2005, COMP MATER SCI, V33, P296, DOI 10.1016/j.commatsci.2004.12.014
   Chatterjee PP, 1999, J APPL PHYS, V86, P5912, DOI 10.1063/1.371612
   Enyashin AN, 2010, COMP MATER SCI, V49, P782, DOI 10.1016/j.commatsci.2010.06.023
   FECHT HJ, 1990, PHYS REV LETT, V65, P610, DOI 10.1103/PhysRevLett.65.610
   FECHT HJ, 1990, ACTA METALL MATER, V38, P1927, DOI 10.1016/0956-7151(90)90304-Y
   Ferreira O, 2004, J CHEM THERMODYN, V36, P1105, DOI 10.1016/j.jct.2004.07.001
   GERTSMAN VY, 1994, SCRIPTA METALL MATER, V30, P577, DOI 10.1016/0956-716X(94)90432-4
   GLEITER H, 1989, PROG MATER SCI, V33, P223, DOI 10.1016/0079-6425(89)90001-7
   Gleiter H, 2000, ACTA MATER, V48, P1, DOI 10.1016/S1359-6454(99)00285-2
   GRUNTHER B, 1992, SCRIPTA METALL MATER, V27, P833
   Liu F, 2007, MAT SCI ENG A-STRUCT, V457, P13, DOI 10.1016/j.msea.2007.01.142
   Liu F, 2004, SCRIPTA MATER, V51, P521, DOI 10.1016/j.scriptamat.2004.05.042
   Lu K, 1996, MAT SCI ENG R, V16, P161, DOI 10.1016/0927-796X(95)00187-5
   LU K, 1995, PHYS REV B, V51, P18, DOI 10.1103/PhysRevB.51.18
   Meng Q, 2002, ACTA MATER, V50, P4563, DOI 10.1016/S1359-6454(02)00284-7
   Millett PC, 2007, ACTA MATER, V55, P2329, DOI 10.1016/j.actamat.2006.11.028
   Nazarov A. A., 2003, HDB NANOSCIENCE ENG, P22
   Padgett CW, 2009, COMP MATER SCI, V46, P491, DOI 10.1016/j.commatsci.2009.03.036
   Polishuk I, 2004, CHEM ENG SCI, V59, P633, DOI 10.1016/j.ces.2003.10.015
   Polishuk I, 2003, CHEM ENG SCI, V58, P4363, DOI 10.1016/S0009-2509(03)00318-X
   Polishuk I, 2003, CHEM ENG SCI, V58, P2529, DOI 10.1016/S0009-2509(03)00101-5
   Polishuk I, 2001, CHEM ENG SCI, V56, P6485, DOI 10.1016/S0009-2509(01)00307-4
   Rajgarhia RK, 2008, MOL SIMULAT, V34, P35, DOI 10.1080/08927020701730427
   ROSE JH, 1984, PHYS REV B, V29, P2963, DOI 10.1103/PhysRevB.29.2963
   Sabeti SA, 2011, COMP MATER SCI, V50, P2865, DOI 10.1016/j.commatsci.2011.05.001
   Sabeti SA, 2011, COMP MATER SCI, V50, P2104, DOI 10.1016/j.commatsci.2011.02.016
   Salati A, 2011, J PHYS CHEM SOLIDS, V72, P104, DOI 10.1016/j.jpcs.2010.11.009
   Song XY, 2006, ACTA MATER, V54, P5541, DOI 10.1016/j.actamat.2006.07.040
   Tjong SC, 2004, MAT SCI ENG R, V45, P1, DOI 10.1016/j.mser.2004.07.001
   WAGNER M, 1992, PHYS REV B, V45, P635, DOI 10.1103/PhysRevB.45.635
   Weertman J. R., 2007, NANOSTRUCTURED MAT P, P537
   WEISSMULLER J, 1993, NANOSTRUCT MATER, V3, P261, DOI 10.1016/0965-9773(93)90088-S
   Weissmuller J, 1995, NANOSTRUCT MATER, V6, P105, DOI 10.1016/0965-9773(95)00034-8
   Zhou L, 2004, COMP MATER SCI, V30, P314, DOI 10.1016/j.commatsci.2004.02.013
NR 35
TC 5
Z9 5
U1 4
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-0256
EI 1879-0801
J9 COMP MATER SCI
JI Comput. Mater. Sci.
PD JAN
PY 2012
VL 51
IS 1
BP 233
EP 240
DI 10.1016/j.commatsci.2011.07.019
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 837OY
UT WOS:000296214300030
DA 2018-12-27
ER

PT J
AU Bahi, A
AF Bahi, A.
TI RETRACTED: THE PRE-SYNAPTIC METABOTROPIC GLUTAMATE RECEPTOR 7 "mGluR7"
   IS A CRITICAL MODULATOR OF ETHANOL SENSITIVITY IN MICE (Retracted
   article. See vol. 223, pg. 488, 2012)
SO NEUROSCIENCE
LA English
DT Article; Retracted Publication
DE AMN082; CPP; drinking in the dark; ethanol; mGluR7; two-bottle choice
ID HANDLING-INDUCED CONVULSIONS; NUCLEUS-ACCUMBENS; PURKINJE NEURONS;
   AGONIST LY379268; MESSENGER-RNA; PHARMACOLOGICAL CHARACTERIZATION;
   6-HYDROXYDOPAMINE LESIONS; INDUCED REINSTATEMENT; SEEKING BEHAVIOR;
   CALCIUM SIGNALS
AB Recent studies demonstrated that the metabotropic glutamate receptor subtype 7 "mGluR7" activation may reduce motivational aspects of ethanol dependence. We investigated the role of mGlu7 receptor in ethanol-related behaviors using the allosteric agonist AMN082 in mice. Results have shown that mGluR7 activation increased the sedative effect of ethanol as measured by the duration of loss of righting reflex (LORR) and reduced the severity of ethanol-induced withdrawal. Importantly, the protective effect of the drug on alcohol-induced withdrawal was found when the AMN082 was injected before, but not after, injection of ethanol suggesting that mGluR7 activation prevented development of dependence rather than producing an anti-convulsant effect. In addition, ethanol-induced locomotor stimulation was blocked by following mGluR7 activation. Furthermore, mice injected with AMN082 consumed less ethanol in a two-bottle free-choice paradigm and in a drinking in the dark (DID) model. Impairment in reward mechanisms in AMN082-injected mice was confirmed by the lack of ethanol-induced conditioned place preference (CPP). Follow-up control experiments have shown that plasma alcohol concentrations of AMN082 and vehicle-treated mice were similar. Taken together, these findings provide evidence for the crucial role of mGluR7 in ethanol-related behaviors, especially in voluntary alcohol drinking and alcohol reward. Thus, pharmacological targeting mGluR7 with AMN082-like compounds might be a potential means to tackle ethanol abuse and alcoholism in the future. (C) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.
C1 United Arab Emirates Univ, Dept Anat, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.
RP Bahi, A (reprint author), United Arab Emirates Univ, Dept Anat, Fac Med & Hlth Sci, Tawam Med Campus, Al Ain, U Arab Emirates.
EM amine.bahi@uaeu.ac.ae
CR Adams CL, 2008, INT J NEUROPSYCHOPH, V11, P229, DOI 10.1017/S1461145707007845
   Albasanz JL, 2005, NEUROBIOL DIS, V20, P685, DOI 10.1016/j.nbd.2005.05.001
   Backstrom P, 2005, EUR J PHARMACOL, V528, P110, DOI 10.1016/j.ejphar.2005.10.051
   Bahi A., ADDICT BIOL IN PRESS
   BECKER HC, 1993, ALCOHOL CLIN EXP RES, V17, P94, DOI 10.1111/j.1530-0277.1993.tb00731.x
   Blednov YA, 2004, ALCOHOL, V34, P251, DOI 10.1016/j.alcohol.2004.10.003
   Bolonna AA, 2001, SCHIZOPHR RES, V47, P99, DOI 10.1016/S0920-9964(99)00235-2
   Bushell Trevor J, 2002, ScientificWorldJournal, V2, P730
   Chaki S, 2006, NEUROSCI LETT, V404, P182, DOI 10.1016/j.neulet.2006.05.043
   Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205
   Cozzoli DK, 2009, J NEUROSCI, V29, P8655, DOI 10.1523/JNEUROSCI.5900-08.2009
   CRABBE JC, 1991, BRAIN RES, V550, P1, DOI 10.1016/0006-8993(91)90397-E
   Crabbe JC, 2011, ALCOHOL, V45, P427, DOI 10.1016/j.alcohol.2010.12.001
   De Rover M, 2008, NEUROSCIENCE, V154, P1318, DOI 10.1016/j.neuroscience.2008.04.055
   FAHIKE C, 1994, PHARM BIOCH BEHAV, V47, P345
   Fendt M, 2008, MOL PSYCHIATR, V13, P970, DOI 10.1038/sj.mp.4002073
   Ferraguti F, 1999, EUR J NEUROSCI, V11, P2073, DOI 10.1046/j.1460-9568.1999.00626.x
   Ganda C, 2009, INT J NEUROPSYCHOPH, V12, P1283, DOI 10.1017/S1461145709990356
   Gass JT, 2009, BIOL PSYCHIAT, V65, P717, DOI 10.1016/j.biopsych.2008.11.001
   Greco B, 2010, J PHARMACOL EXP THER, V332, P1064, DOI 10.1124/jpet.109.162115
   Gruol DL, 1997, BRAIN RES, V773, P82, DOI 10.1016/S0006-8993(97)00912-8
   Gyetvai B, 2011, NEUROCHEM RES, V36, P1087, DOI 10.1007/s11064-011-0452-z
   Hendrickson LM, 2009, PSYCHOPHARMACOLOGY, V204, P563, DOI 10.1007/s00213-009-1488-5
   Herzig V, 2004, NEUROPHARMACOLOGY, V47, P973, DOI 10.1016/j.neuropharm.2004.07.037
   Holscher C, 2005, LEARN MEMORY, V12, P450, DOI 10.1101/lm.98305
   Ikemoto S, 1997, ALCOHOL CLIN EXP RES, V21, P1042, DOI 10.1111/j.1530-0277.1997.tb04251.x
   Joslyn G, 2010, ALCOHOL CLIN EXP RES, V34, P800, DOI 10.1111/j.1530-0277.2010.01152.x
   Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515
   Kalivas PW, 2003, PSYCHOPHARMACOLOGY, V168, P44, DOI 10.1007/s00213-003-1393-2
   KINZIE JM, 1995, NEUROSCIENCE, V69, P167, DOI 10.1016/0306-4522(95)00244-D
   Klugmann M, 2008, BEHAV PHARMACOL, V19, P485, DOI 10.1097/FBP.0b013e32830c369f
   Knackstedt LA, 2009, CURR OPIN PHARMACOL, V9, P59, DOI 10.1016/j.coph.2008.12.003
   Kotlinska J, 2006, BEHAV PHARMACOL, V17, P1, DOI 10.1097/01.fbp.0000181600.95405.c7
   KUFAHL PR, NEUROPSYCHO IN PRESS
   Li X, 2008, NEUROPHARMACOLOGY, V54, P542, DOI 10.1016/j.neuropharm.2007.11.005
   Li X, 2010, J NEUROCHEM, V114, P1368, DOI 10.1111/j.1471-4159.2010.06851.x
   Li X, 2009, NEUROPSYCHOPHARMACOL, V34, P1783, DOI 10.1038/npp.2008.236
   Lominac KD, 2006, DRUG ALCOHOL DEPEN, V85, P142, DOI 10.1016/j.drugalcdep.2006.04.003
   Martin-Fardon R, 2009, J PHARMACOL EXP THER, V329, P1084, DOI 10.1124/jpet.109.151357
   Mitsukawa K, 2005, P NATL ACAD SCI USA, V102, P18712, DOI 10.1073/pnas.0508063102
   Miyatake M, 2005, EUR J NEUROSCI, V22, P1476, DOI 10.1111/j.1460-9568.2005.04325.x
   NAKANISHI S, 1994, EXS, V71, P71
   Netzeband JG, 2002, ALCOHOL CLIN EXP RES, V26, P386, DOI 10.1097/00000374-200203000-00013
   Netzeband JG, 1997, J NEUROPHYSIOL, V78, P63
   Nielsen DM, 1999, BRAIN RES, V823, P59, DOI 10.1016/S0006-8993(99)01099-9
   Nishi N, 2000, BRIT J PHARMACOL, V130, P1664, DOI 10.1038/sj.bjp.0703464
   Obara I, 2009, ALCOHOL CLIN EXP RES, V33, P1924, DOI 10.1111/j.1530-0277.2009.01030.x
   OHISHI H, 1995, J COMP NEUROL, V360, P555, DOI 10.1002/cne.903600402
   Ohtsuki T, 2008, SCHIZOPHR RES, V101, P9, DOI 10.1016/j.schres.2008.01.027
   Olive MF, 2008, ALCOHOL, V42, P191, DOI 10.1016/j.alcohol.2008.01.007
   Olive M Foster, 2009, Curr Drug Abuse Rev, V2, P83
   Palucha A, 2007, PSYCHOPHARMACOLOGY, V194, P555, DOI 10.1007/s00213-007-0856-2
   RASSNICK S, 1993, BRAIN RES, V623, P16, DOI 10.1016/0006-8993(93)90004-7
   Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007
   Rizzo SJS, 2011, J PHARMACOL EXP THER, V338, P345, DOI 10.1124/jpet.110.177378
   Salling MC, 2008, PHARMACOL BIOCHEM BE, V91, P14, DOI 10.1016/j.pbb.2008.06.006
   Sidhpura N, 2010, BIOL PSYCHIAT, V67, P804, DOI 10.1016/j.biopsych.2010.01.005
   Siegl S, 2008, NEUROREPORT, V19, P1147, DOI 10.1097/WNR.0b013e328307f295
   Simonyi A, 1996, NEUROREPORT, V7, P2115, DOI 10.1097/00001756-199609020-00010
   Simonyi A, 2004, ALCOHOL CLIN EXP RES, V28, P1419, DOI 10.1097/01.ALC.0000139825.35438.A4
   Suzuki G, 2007, J PHARMACOL EXP THER, V323, P147, DOI 10.1124/jpet.107.124701
   Szumlinski KK, 2008, BIOCHEM PHARMACOL, V75, P112, DOI 10.1016/j.bcp.2007.07.031
   Szumlinski KK, 2006, CURR OPIN NEUROBIOL, V16, P251, DOI 10.1016/j.conb.2006.05.002
   THOMSEN C, 1994, J NEUROCHEM, V62, P2492
   Vadasz C, 2007, GENOMICS, V90, P690, DOI 10.1016/j.ygeno.2007.08.006
   Xie XH, 2009, PSYCHOPHARMACOLOGY, V203, P501, DOI 10.1007/s00213-008-1392-4
NR 66
TC 8
Z9 8
U1 3
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4522
EI 1873-7544
J9 NEUROSCIENCE
JI Neuroscience
PD DEC 29
PY 2011
VL 199
BP 13
EP 23
DI 10.1016/j.neuroscience.2011.10.029
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 863ZH
UT WOS:000298206300002
PM 22056957
DA 2018-12-27
ER

PT J
AU Wang, GB
   Wang, WY
   Zhao, JN
   Ni, YL
   Zhou, XP
   Zhang, WF
AF Wang, Guobin
   Wang, Wenyuan
   Zhao, Jinning
   Ni, Yunlan
   Zhou, Xinping
   Zhang, Weifang
TI RETRACTED: Ghrelin prevents neuronal apoptosis and cognitive impairments
   in sepsis-associated encephalopathy (Retracted article. See vol. 23, pg.
   405, 2012)
SO NEUROREPORT
LA English
DT Article; Retracted Publication
DE apoptosis; cognitive impairment; ghrelin; neuronal cultures; sepsis
ID UNACYLATED GHRELIN; CELLS; PATHWAYS; ERK1/2; BRAIN; DEATH
AB The present study explored the effect of ghrelin in protecting neurons from apoptosis in sepsis-associated encephalopathy. Ghrelin (100 nM) increased the cell viability treated with lipopolysaccharide (1.0 mu g/ml, 24 h). The expression of p-Akt and Bcl-2 were decreased and caspase-3 increased both in lipopolysaccharide-treated primary hippocampal cultures and in the cecal ligation and perforation model, which were alleviated in the presence of ghrelin. In vitro, the protecting effect of ghrelin was almost abolished by the Akt inhibitor, SH-5. In vivo, the cecal ligation and perforation rats exhibited emotional, learning, and memory deficits. Administration of ghrelin attenuated the cognitive deficits significantly. These results indicate that ghrelin alleviates neuronal apoptosis and subsequent cognitive impairments in sepsis-associated encephalopathy through the Akt pathway. NeuroReport 22:959-964 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
C1 [Wang, Guobin; Ni, Yunlan; Zhou, Xinping; Zhang, Weifang] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Surg,Intens Care Unit, Hangzhou 310003, Zhejiang, Peoples R China.
   [Wang, Wenyuan; Zhao, Jinning] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China.
RP Zhang, WF (reprint author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Surg,Intens Care Unit, Qingchun Rd 79, Hangzhou 310003, Zhejiang, Peoples R China.
EM weifangzhang@yahoo.com.cn
FU Zhejiang University; Zhejiang Health Bureau Scientific Research
   Foundation, Hangzhou, P.R. China
FX This study was supported by the Research Grant of Zhejiang University
   (2010) and a research grant (to Dr Guobin Wang) from Zhejiang Health
   Bureau Scientific Research Foundation, Hangzhou, P.R. China.
CR Andrews ZB, 2011, TRENDS NEUROSCI, V34, P31, DOI 10.1016/j.tins.2010.10.001
   Baldanzi G, 2002, J CELL BIOL, V159, P1029, DOI 10.1083/jcb.200207165
   Chung H, 2008, J ENDOCRINOL, V198, P511, DOI 10.1677/JOE-08-0160
   Comim CM, 2008, MITOCHONDRION, V8, P313, DOI 10.1016/j.mito.2008.07.002
   d'Avila JC, 2008, CRIT CARE MED, V36, P1925, DOI 10.1097/CCM0b013e3181760c4b
   Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656
   Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266
   Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943
   Iacobone Emanuele, 2009, Crit Care Med, V37, pS331, DOI 10.1097/CCM.0b013e3181b6ed58
   Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230
   Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004
   Memos N, 2009, BRAIN RES, V1264, P119, DOI 10.1016/j.brainres.2009.01.053
   Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010
   Siami S, 2008, CRIT CARE CLIN, V24, P67, DOI 10.1016/j.ccc.2007.10.001
   Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531
   Weberpals M, 2009, J NEUROSCI, V29, P14177, DOI 10.1523/JNEUROSCI.3238-09.2009
   Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-5110C
   Wu RQ, 2005, CARDIOVASC RES, V68, P318, DOI 10.1016/j.cardiores.2005.06.011
   Wu RQ, 2003, INT J MOL MED, V12, P777
   Xu ZW, 2008, TOXICOLOGY, V247, P133, DOI 10.1016/j.tox.2008.02.018
NR 20
TC 13
Z9 14
U1 3
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0959-4965
EI 1473-558X
J9 NEUROREPORT
JI Neuroreport
PD DEC 21
PY 2011
VL 22
IS 18
BP 959
EP 964
DI 10.1097/WNR.0b013e32834d38ce
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA 850TD
UT WOS:000297221200005
PM 22027512
DA 2018-12-27
ER

PT J
AU Anand, P
   Sung, B
   Kunnumakkara, AB
   Rajasekharan, KN
   Aggarwal, BB
AF Anand, Preetha
   Sung, Bokyung
   Kunnumakkara, Ajaikumar B.
   Rajasekharan, Kallikat N.
   Aggarwal, Bharat B.
TI RETRACTED: Suppression of pro-inflammatory and proliferative pathways by
   diferuloylmethane (curcumin) and its analogues dibenzoylmethane,
   dibenzoylpropane, and dibenzylideneacetone: Role of Michael acceptors
   and Michael donors (Retracted article. See vol. 102, pg. 144, 2016)
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article; Retracted Publication
DE Curcumin analogues; NF-kappa B; Cell proliferation; Michael acceptor
ID NF-KAPPA-B; DNA-ADDUCTS; PROSTATE-CANCER; BETA-DIKETONES; GROWTH-FACTOR;
   SENCAR MICE; CELLS; EXPRESSION; INHIBITION; INDUCTION
AB Curcumin, a diferuloylmethane, has been shown to exhibit anti-inflammatory and anti-proliferative activities. Whereas curcumin has both a Michael acceptor and a Michael donor units, its analogues dibenzoylmethane (DBM, a component of licorice) and dibenzoylpropane (DBP) have a Michael donor but not a Michael acceptor unit, and the analogue dibenzylideneacetone (DBA) has a Michael acceptor unit. In the current report, we investigated the potency of DBM, DBP, and DBA in relation to curcumin for their ability to suppress TNF-induced NF-kappa B activation, NF-kappa B-regulated gene products, and cell proliferation. We found that all four agents were active in suppressing NF-kappa B activation; curcumin was most active and DBM was least active. When examined for its ability to inhibit the direct DNA binding activity of p65, a subunit of NF-kappa B, only DBP inhibited the binding. For inhibition of TNF-induced IKK activation, DBA was most active. For suppression of TNF-induced expression of NF-kappa B-regulated gene products such as COX-2 (inflammation marker), cyclin D1 (proliferation marker), and VEGF (angiogenesis marker), DBA and curcumin were more active than DBM. Similarly for suppression of proliferation of leukemia (KBM-5), T cell leukemia (Jurkat), prostate (DU145), and breast (MDA-MB-231) cancer cells, curcumin and DBA were most active and DBP was least active. Overall, our results indicate that although curcumin and its analogues. exhibit activities to suppress inflammatory pathways and cellular proliferation, a lack of Michael acceptor units in DBM and DBP can reduce their activities. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Anand, Preetha; Sung, Bokyung; Kunnumakkara, Ajaikumar B.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Unit 1950, Houston, TX 77030 USA.
   [Rajasekharan, Kallikat N.] Univ Kerala, Dept Chem, Thiruvananthapuram 695034, Kerala, India.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Unit 1950, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Kunnumakkara, Ajaikumar/H-8566-2012; Aggarwal, Bharat/G-3388-2013
OI Kunnumakkara, Ajaikumar/0000-0001-9121-6816; 
FU National Institutes of Health (NIH) [CA-16 672, CA-124787-01A2]; Center
   for Targeted Therapy of MD Anderson Cancer Center
FX We thank Michael Worley and the Department of Scientific Publications
   for carefully editing the manuscript and providing valuable comments.
   Dr. Aggarwal is the Ransom Horne, Jr, Professor of Cancer Research. This
   work was supported by a core grant from the National Institutes of
   Health (CA-16 672), a program project grant from the National Institutes
   of Health (NIH CA-124787-01A2), and a grant from the Center for Targeted
   Therapy of MD Anderson Cancer Center.
CR Anand P, 2008, CANCER RES, V68, P8861, DOI 10.1159/0008-5472.CAN-08-1902
   Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585
   Ebert B, 2007, TOXICOL SCI, V96, P227, DOI 10.1093/toxsci/kfl147
   Hinz M, 1999, MOL CELL BIOL, V19, P2690
   Hong JI, 2004, CARCINOGENESIS, V25, P1671, DOI 10.1093/carcin/bgh165
   Huang MT, 1998, CARCINOGENESIS, V19, P1697, DOI 10.1093/carcin/19.9.1697
   HUANG MT, 1988, CANCER RES, V48, P5941
   Jackson KM, 2007, ANTICANCER RES, V27, P1483
   Jackson KM, 2002, CANCER LETT, V178, P161, DOI 10.1016/S0304-3835(01)00844-8
   Lin CC, 2006, CARCINOGENESIS, V27, P131, DOI 10.1093/carcin/bgi199
   Lin CC, 2001, CANCER LETT, V168, P125, DOI 10.1016/S0304-3835(01)00506-7
   Lin Chuan-Chuan, 2001, Proceedings of the National Science Council Republic of China Part B Life Sciences, V25, P158
   Mabjeesh NJ, 2003, BIOCHEM BIOPH RES CO, V303, P279, DOI 10.1016/S0006-291X(03)00336-X
   MacDonald CJ, 2001, CANCER RES, V61, P3919
   Mullally JE, 2002, MOL PHARMACOL, V62, P351, DOI 10.1124/mol.62.2.351
   Nakano K, 2004, ANTICANCER RES, V24, P711
   Nogueira Marisa A., 2003, Farmaco (Lausanne), V58, P1163, DOI 10.1016/S0014-827X(03)00195-2
   Pan MH, 2003, J AGR FOOD CHEM, V51, P3977, DOI 10.1021/jf034094i
   Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641
   Shen G, 2007, CANCER RES, V67, P9937, DOI 10.1158/0008-5472.CAN-07-1112
   Singletary K, 1998, CARCINOGENESIS, V19, P1039, DOI 10.1093/carcin/19.6.1039
   Singletary K, 2000, CANCER LETT, V155, P47, DOI 10.1016/S0304-3835(00)00412-2
   Thimmulappa RK, 2008, MED CHEM, V4, P473, DOI 10.2174/157340608785700199
   Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315
   Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015
NR 25
TC 31
Z9 35
U1 2
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD DEC 15
PY 2011
VL 82
IS 12
BP 1901
EP 1909
DI 10.1016/j.bcp.2011.09.001
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 849RE
UT WOS:000297142000011
PM 21924245
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Jungebluth, P
   Alici, E
   Baiguera, S
   Le Blanc, K
   Blomberg, P
   Bozoky, B
   Crowley, C
   Einarsson, O
   Grinnemo, KH
   Gudbjartsson, T
   Le Guyader, S
   Henriksson, G
   Hermanson, O
   Juto, JE
   Leidner, B
   Lilja, T
   Liska, J
   Luedde, T
   Lundin, V
   Moll, G
   Nilsson, B
   Roderburg, C
   Stromblad, S
   Sutlu, T
   Teixeira, AI
   Watz, E
   Seifalian, A
   Macchiarini, P
AF Jungebluth, Philipp
   Alici, Evren
   Baiguera, Silvia
   Le Blanc, Katarina
   Blomberg, Pontus
   Bozoky, Bela
   Crowley, Claire
   Einarsson, Oskar
   Grinnemo, Karl-Henrik
   Gudbjartsson, Tomas
   Le Guyader, Sylvie
   Henriksson, Gert
   Hermanson, Ola
   Juto, Jan Erik
   Leidner, Bertil
   Lilja, Tobias
   Liska, Jan
   Luedde, Tom
   Lundin, Vanessa
   Moll, Guido
   Nilsson, Bo
   Roderburg, Christoph
   Stromblad, Staffan
   Sutlu, Tolga
   Teixeira, Ana Isabel
   Watz, Emma
   Seifalian, Alexander
   Macchiarini, Paolo
TI RETRACTED: Tracheobronchial transplantation with a stem-cell-seeded
   bioartificial nanocomposite: a proof-of-concept study (Retracted
   article. See vol. 392, pg. 11. 2018)
SO LANCET
LA English
DT Article; Retracted Publication
ID LUNG TRANSPLANTATION; AIRWAY COMPLICATIONS; BONE-MARROW; MANAGEMENT;
   MOBILIZATION; RESECTION; TUMORS; GRAFT
AB Background Tracheal tumours can be surgically resected but most are an inoperable size at the time of diagnosis; therefore, new therapeutic options are needed. We report the clinical transplantation of the tracheobronchial airway with a stem-cell-seeded bioartificial nanocomposite.
   Methods A 36-year-old male patient, previously treated with debulking surgery and radiation therapy, presented with recurrent primary cancer of the distal trachea and main bronchi. After complete tumour resection, the airway was replaced with a tailored bioartificial nanocomposite previously seeded with autologous bone-marrow mononuclear cells via a bioreactor for 36 h. Postoperative granulocyte colony-stimulating factor filgrastim (10 mu g/kg) and epoetin beta (40 000 UI) were given over 14 days. We undertook flow cytometry, scanning electron microscopy, confocal microscopy epigenetics, multiplex, miRNA, and gene expression analyses.
   Findings We noted an extracellular matrix-like coating and proliferating cells including a CD105+ subpopulation in the scaffold after the reseeding and bioreactor process. There were no major complications, and the patient was asymptomatic and tumour free 5 months after trans plantation. The bioartificial nanocomposite has patent anastomoses, lined with a vascularised neomucosa, and was partly covered by nearly healthy epithelium. Post-operatively, we detected a mobilisation of peripheral cells displaying increased mesenchymal stromal cell phenotype, and upregulation of epoetin receptors, antiapoptotic genes, and miR-34 and miR-449 biomarkers. These findings, together with increased levels of regenerative-associated plasma factors, strongly suggest stem-cell homing and cell-mediated wound repair, extracellular matrix remodelling, and neovascularisation of the graft.
   Interpretation Tailor-made bioartificial scaffolds can be used to replace complex airway defects. The bioreactor reseeding process and pharmacological-induced site-specific and graft-specific regeneration and tissue protection are key factors for successful clinical outcome.
C1 [Jungebluth, Philipp; Baiguera, Silvia; Grinnemo, Karl-Henrik; Macchiarini, Paolo] Karolinska Inst, Adv Ctr Translat Regenerat Med, SE-14186 Stockholm, Sweden.
   [Alici, Evren; Sutlu, Tolga] Karolinska Inst, Cell & Gene Therapy Ctr, Dept Med, Div Hematol, SE-14186 Stockholm, Sweden.
   [Le Blanc, Katarina; Moll, Guido; Watz, Emma] Karolinska Inst, Lab Med, SE-14186 Stockholm, Sweden.
   [Le Guyader, Sylvie; Stromblad, Staffan] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, SE-14186 Stockholm, Sweden.
   [Hermanson, Ola; Lilja, Tobias] Karolinska Inst, Linnaeus Ctr Dev Biol Regenerat Med, Dept Neurosci, SE-14186 Stockholm, Sweden.
   [Leidner, Bertil] Karolinska Inst, Dept Clin Sci Intervent & Technol, SE-14186 Stockholm, Sweden.
   [Lundin, Vanessa; Teixeira, Ana Isabel] Karolinska Inst, Dept Cell & Mol Biol, SE-14186 Stockholm, Sweden.
   [Jungebluth, Philipp; Henriksson, Gert; Juto, Jan Erik; Macchiarini, Paolo] Karolinska Univ Hosp, Div Ear Nose & Throat, Stockholm, Sweden.
   [Blomberg, Pontus] Karolinska Univ Hosp, Clin Res Ctr, Stockholm, Sweden.
   [Bozoky, Bela] Karolinska Univ Hosp, Div Pathol, Stockholm, Sweden.
   [Grinnemo, Karl-Henrik; Liska, Jan] Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, Stockholm, Sweden.
   [Leidner, Bertil] Karolinska Univ Hosp, Dept Radiol Huddinge, Stockholm, Sweden.
   [Watz, Emma] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden.
   [Crowley, Claire; Seifalian, Alexander] UCL, Ctr Nanotechnol & Regenerat Med, London, England.
   [Einarsson, Oskar] Univ Iceland, Landspitali Univ Hosp, Fac Med, Dept Pulmonol, Reykjavik, Iceland.
   [Gudbjartsson, Tomas] Univ Iceland, Landspitali Univ Hosp, Fac Med, Dept Cardiothorac Surg, Reykjavik, Iceland.
   [Luedde, Tom; Roderburg, Christoph] Univ Hosp RWTH Aachen, Dept Med 3, Aachen, Germany.
   [Nilsson, Bo] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.
RP Macchiarini, P (reprint author), Karolinska Inst, Adv Ctr Translat Regenerat Med ACTREM, European Airway Inst, Div Ear Nose & Throat CLINTEC, Alfred Nobels Alle 8, SE-14186 Stockholm, Sweden.
EM paolo.macchiarini@ki.se
RI Seifalian, Alexander/I-6028-2013; Sutlu, Tolga/E-1190-2012; Sutlu,
   Tolga/K-4783-2014; Moll, Guido/Q-1044-2018; Macchiarini,
   Paolo/E-6878-2013
OI Seifalian, Alexander/0000-0002-1180-3322; Sutlu,
   Tolga/0000-0002-7813-8734; Moll, Guido/0000-0001-6173-5957; Grinnemo,
   Karl-Henrik/0000-0001-6717-3393; Nilsson, Bo/0000-0003-0057-2730; Le
   Guyader, Sylvie/0000-0002-8812-8046; Alici, Evren/0000-0001-5307-6648;
   Hermanson, Ola/0000-0001-9320-7921
FU European Commission [280584-2BIOtracheaCP-FPFP7-NMP-2011-SMALL-5]; Knut
   and Alice Wallenberg Foundation; Swedish Research Council; StratRegen;
   Vinnova Foundation; Radiumhemmet; Clinigene EU Network of Excellence;
   Swedish Cancer Society; Centre for Biosciences (The Live Cell imaging
   Unit); UCL Business; Centre for Biosciences; 
   [ERC-2007-Stg/208237-Luedde-Med3-Aachen]
FX European Commission, Knut and Alice Wallenberg Foundation, Swedish
   Research Council, StratRegen, Vinnova Foundation, Radiumhemmet,
   Clinigene EU Network of Excellence, Swedish Cancer Society, Centre for
   Biosciences (The Live Cell imaging Unit), and UCL Business.; The
   European Commission (FP7 EU Project:
   280584-2BIOtracheaCP-FPFP7-NMP-2011-SMALL-5), the Knut and Alice
   Wallenberg Foundation, Swedish Research Council, and the StratRegen
   funded preclinical and postoperative in-vitro studies, gene expression,
   cell characterisation, and imaging. The Vinnova Foundation,
   Radiumhemmet, and Clinigene EU Network of Excellence funded multiplex
   and flow cytometric analyses. The Swedish Cancer Society supported the
   epigenetic studies. The Centre for Biosciences, the Knut and Alice
   Wallenberg Foundation, and the Swedish Research Council supported the
   Live Cell imaging Unit at the Department of Biosciences and Nutrition,
   Karolinska Institutet, used for live cell imaging.
   ERC-2007-Stg/208237-Luedde-Med3-Aachen funded the miRNA studies. The UCL
   Business supported the development of the three-dimensional
   nanocomposite scaffold. We thank all the health professionals of the
   Karolinska University Hospital in Huddinge, Stockholm, Sweden, without
   whom the transplantation could not have been done; Harvard Apparatus
   (Hollison, MA, USA) and Hugo Sachs Elektronik-Harvard Apparatus GmbH
   (March-Hugstetten, Germany) for supporting us with the bioreactor and
   the supervision of its use; Peter Guntner, for image analysis and
   measurements for scaffold production, and Anders Svensson, for
   three-dimensional volume image rendering, both from the Department of
   Radiology, Karolinska University Hospital Huddinge, Stockholm, Sweden;
   all the staff of the Landspitali University Hospital in Reykjavik, for
   the excellent support with the preoperative and postoperative care of
   the patient; Alessandra Bianco and Costantino Del Gaudio from Department
   of Science and Chemical Technologies, Intrauniversitary Consortium for
   Material Science Technology (INSTM), Research Unit Tor Vergata, Rome,
   Italy, for bi-dimensional and three-dimensional mathematical model for
   tracheal lateral area assessment; Iyadh Douagi from the Center of
   Hematology and Regenerative Medicine, Department of Medicine, Karolinska
   Insitutet for his assistance with flow cytometry; and Ulrika Felldin
   from ACTREM, Karolinska Institutet for her assistance with cell
   isolation.
CR Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Bader A, 2010, J CELL MOL MED, V14, P1877, DOI 10.1111/j.1582-4934.2010.01073.x
   Baiguera S, 2010, BIOMATERIALS, V31, P8931, DOI 10.1016/j.biomaterials.2010.08.005
   Behrend M, 2002, J INVEST SURG, V15, P227, DOI 10.1080/08941930290086010
   Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161
   de Mel A, 2009, BIO-MED MATER ENG, V19, P317, DOI 10.3233/BME-2009-0597
   Gaissert HA, 2010, SURG CLIN N AM, V90, P1065, DOI 10.1016/j.suc.2010.06.004
   Gilbert TW, 2008, ANN THORAC SURG, V86, P967, DOI 10.1016/j.athoracsur.2008.04.071
   Go T, 2010, J THORAC CARDIOV SUR, V139, P437, DOI 10.1016/j.jtcvs.2009.10.002
   Grillo HC., 2004, SURG TRACHEA BRONCHI, P791
   Hannoush EJ, 2011, J TRAUMA, V71, P283, DOI 10.1097/TA.0b013e318222f380
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Kshettry VR, 1997, ANN THORAC SURG, V63, P1576, DOI 10.1016/S0003-4975(97)83852-0
   Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870
   Macchiarini P, 2006, LANCET ONCOL, V7, P83, DOI 10.1016/S1470-2045(05)70541-6
   Macchiarini P, 2006, ANN THORAC SURG, V82, P1989, DOI 10.1016/j.ahoracsur.2006.07.016
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Mansilla E, 2006, TRANSPLANT P, V38, P967, DOI 10.1016/j.transproceed.2006.02.053
   Marquez-Curtis LA, 2011, STEM CELL REV REP, V7, P590, DOI 10.1007/s12015-010-9212-8
   Moll G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021703
   Pham C, 2007, BURNS, V33, P946, DOI 10.1016/j.burns.2007.03.020
   Pitchford SC, 2009, CELL STEM CELL, V4, P62, DOI 10.1016/j.stem.2008.10.017
   Puchalski J, 2011, CLIN CHEST MED, V32, P357, DOI 10.1016/j.ccm.2011.03.001
   Santacruz Jose Fernando, 2009, Proc Am Thorac Soc, V6, P79, DOI 10.1513/pats.200808-094GO
   Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   Sigurdsson MI, 2011, AM J RESP CRIT CARE, V183, P681, DOI 10.1164/ajrccm.183.5.681b
NR 28
TC 295
Z9 315
U1 7
U2 156
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD DEC 10
PY 2011
VL 378
IS 9808
BP 1997
EP 2004
DI 10.1016/S0140-6736(11)61715-7
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA 863DY
UT WOS:000298144200023
PM 22119609
DA 2018-12-27
ER

PT J
AU Lu, YZ
   Roy, S
   Nuovo, G
   Ramaswamy, B
   Miller, T
   Shapiro, C
   Jacob, ST
   Majumder, S
AF Lu, Yuanzhi
   Roy, Satavisha
   Nuovo, Gerard
   Ramaswamy, Bhuvaneswari
   Miller, Tyler
   Shapiro, Charles
   Jacob, Samson T.
   Majumder, Sarmila
TI RETRACTED: Anti-microRNA-222 (Anti-miR-222) and-181B Suppress Growth of
   Tamoxifen-resistant Xenografts in Mouse by Targeting TIMP3 Protein and
   Modulating Mitogenic Signal (Retracted article. See vol. 293, pg. 3588,
   2018)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER CELLS; CONVERTING-ENZYME TACE;
   ENDOCRINE THERAPY; ANTIESTROGEN RESISTANCE; GENE-EXPRESSION;
   LUNG-CANCER; METASTASIS; MECHANISMS; MICRORNAS
AB We have shown earlier that miR-221 and -222 are up-regulated in tamoxifen-resistant MCF-7 (OHTR) cells and Her2-positive human breast tumors when compared with Her2 negative tumors. In this study, we report markedly enhanced expression of miR-181b in OHTR cells and endocrine-resistant tumors. Further, anti-miR-222 or -181b in combination with tamoxifen suppressed growth of tamoxifen-resistant xenografts in mice. Luciferase reporter assay and expression analysis showed that TIMP3, a tissue metalloproteinase inhibitor, is a common target of miR-221/222 and -181b. In situ hybridization and immunohistochemical analysis demonstrated reciprocal relationships between TIMP3 and miR-221/222/181b expression in primary human breast carcinomas. Ectopic expression of TIMP3 inhibited growth of the OHTR cells, and its depletion in MCF-7 cells reduced sensitivity to tamoxifen in vitro and in vivo. EGF-induced MAPK and AKT phosphorylation were significantly higher in OHTR cells and miR-221/222-overexpressing MCF-7 cells than in control cells, which suggests modulation of mitogenic signaling by TIMP3 and the miRs. On the contrary, phosphoMAPK and phosphoAKT levels were diminished in TIMP3-overexpressing OHTR cells and increased in TIMP3-depleted MCF-7 cells. Low levels of estrogen or tamoxifen elicited similar differences in phosphoMAPK levels in these cells. Reduced levels of TIMP3 facilitated growth of tamoxifen-resistant cells by alleviating its inhibitory effect on ADAM10 and ADAM17, which are critical for OHTR cell growth. In conclusion, miR-221/222 and -181b facilitate growth factor signaling in tamoxifen-resistant breast cancer by down-regulating TIMP3, and corresponding anti-miRs can be used to render these tumors responsive to tamoxifen.
C1 [Jacob, Samson T.] Ohio State Univ, Dept Mol & Cellular Biochem, Tzagournis Med Res Facil 646, Columbus, OH 43210 USA.
   [Nuovo, Gerard] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.
   [Ramaswamy, Bhuvaneswari; Shapiro, Charles; Jacob, Samson T.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.
   [Lu, Yuanzhi; Ramaswamy, Bhuvaneswari; Shapiro, Charles; Jacob, Samson T.; Majumder, Sarmila] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA.
   [Majumder, Sarmila] Ohio State Univ, Dept Mol & Cellular Biochem, Tzagournis Med Res Facil 690D, Columbus, OH 43210 USA.
RP Jacob, ST (reprint author), Ohio State Univ, Dept Mol & Cellular Biochem, Tzagournis Med Res Facil 646, 420 W 12th Ave, Columbus, OH 43210 USA.
EM Samson.Jacob@osumc.edu; Sarmila.majumder@osumc.edu
RI Ramaswamy, Bhuvaneswari/E-3919-2011
OI Miller, Tyler E/0000-0002-1269-1895
FU NCI, National Institutes of Health from the USPHS [CA137567]
FX This work was supported, in whole or in part, by NCI, National
   Institutes of Health Grant CA137567 from the USPHS.
CR Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X
   Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655
   Di Leva G, 2010, JNCI-J NATL CANCER I, V102, P706, DOI 10.1093/jnci/djq102
   Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404
   *EARL BREAST CANC, 1998, LANCET, V351, P1451, DOI DOI 10.1016/S0140-6736(97)11423-4
   Edwards DR, 2004, J PATHOL, V202, P391, DOI 10.1002/path.1548
   Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666
   Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020
   Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
   Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6
   Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760
   Helleman J, 2008, CLIN CANCER RES, V14, P5555, DOI 10.1158/1078-0432.CCR-08-0555
   HENDERSON BE, 1988, CANCER RES, V48, P246
   Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023
   Jordan NJ, 2004, BREAST CANCER RES TR, V87, P167, DOI 10.1023/B:BREA.0000041623.21338.47
   KEY TJA, 1988, EUR J CANCER CLIN ON, V24, P29, DOI 10.1016/0277-5379(88)90173-3
   Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394
   Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206
   Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200
   Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200
   Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200
   Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786
   Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917
   PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102
   Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191
   Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447
   Span PN, 2004, J PATHOL, V202, P395, DOI 10.1002/path.1528
   Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112
   Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200
   Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468
   Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100
   Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646
   Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808
   Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026
   Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367
   Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200
   Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200
NR 39
TC 74
Z9 76
U1 0
U2 15
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 9
PY 2011
VL 286
IS 49
BP 42292
EP 42302
DI 10.1074/jbc.M111.270926
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 863QI
UT WOS:000298180900039
PM 22009755
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Di Fulvio, S
   Azakir, BA
   Therrien, C
   Sinnreich, M
AF Di Fulvio, Sabrina
   Azakir, Bilal A.
   Therrien, Christian
   Sinnreich, Michael
TI RETRACTED: Dysferlin Interacts with Histone Deacetylase 6 and Increases
   alpha-Tubulin Acetylation (Retracted article. See vol. 13, artn no.
   e0192239, 2018)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID GIRDLE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MEMBRANE REPAIR; MICROTUBULE
   ARRAY; HDAC6 INHIBITOR; C2 DOMAINS; T-TUBULE; DIFFERENTIATION;
   EXPRESSION; DYNAMICS
AB Dysferlin is a multi-C2 domain transmembrane protein involved in a plethora of cellular functions, most notably in skeletal muscle membrane repair, but also in myogenesis, cellular adhesion and intercellular calcium signaling. We previously showed that dysferlin interacts with alpha-tubulin and microtubules in muscle cells. Microtubules are heavily reorganized during myogenesis to sustain growth and elongation of the nascent muscle fiber. Microtubule function is regulated by posttranslational modifications, such as acetylation of its alpha-tubulin subunit, which is modulated by the histone deacetylase 6 (HDAC6) enzyme. In this study, we identified HDAC6 as a novel dysferlin-binding partner. Dysferlin prevents HDAC6 from deacetylating alpha-tubulin by physically binding to both the enzyme, via its C2D domain, and to the substrate, alpha-tubulin, via its C2A and C2B domains. We further show that dysferlin expression promotes alpha-tubulin acetylation, as well as increased microtubule resistance to, and recovery from, Nocodazole-and cold-induced depolymerization. By selectively inhibiting HDAC6 using Tubastatin A, we demonstrate that myotube formation was impaired when alpha-tubulin was hyperacetylated early in the myogenic process; however, myotube elongation occurred when alpha-tubulin was hyperacetylated in myotubes. This study suggests a novel role for dysferlin in myogenesis and identifies HDAC6 as a novel dysferlin-interacting protein.
C1 [Di Fulvio, Sabrina; Azakir, Bilal A.; Sinnreich, Michael] Neuromuscular Res Grp, Dept Neurol, Dept Biomed, Basel, Switzerland.
   [Therrien, Christian; Sinnreich, Michael] McGill Univ, Neuromuscular Res Grp, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada.
RP Di Fulvio, S (reprint author), Neuromuscular Res Grp, Dept Neurol, Dept Biomed, Basel, Switzerland.
EM michael.sinnreich@unibas.ch
OI Therrien, Christian/0000-0001-5138-1323
FU Myosuisse, l'Association francaise contre les myopathies (AFM) [14994];
   MDAC-ALS-CIHR Partnership; Swiss National Science Foundation (SNF)
   [31003A_130286]; l'Association francaise contre les myopathies (AFM)
   [15111]
FX This study was supported by Myosuisse, l'Association francaise contre
   les myopathies (AFM) (grant number 14994), MDAC-ALS-CIHR Partnership and
   the Swiss National Science Foundation (SNF) (grant number
   31003A_130286). The first author is funded by l'Association francaise
   contre les myopathies (AFM) (grant number 15111). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4
   Azakir BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010122
   Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001
   Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573
   Bashir R, 1998, NAT GENET, V20, P37
   Bazzaro M, 2008, CLIN CANCER RES, V14, P7340, DOI 10.1158/1078-0432.CCR-08-0642
   Belanto JJ, 2010, NEUROMUSCULAR DISORD, V20, P111, DOI 10.1016/j.nmd.2009.12.003
   Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200
   Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v
   Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589
   Covian-Nares JF, 2010, J CELL SCI, V123, P1884, DOI 10.1242/jcs.066084
   Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200
   de Luna N, 2006, J BIOL CHEM, V281, P17092, DOI 10.1074/jbc.M601885200
   de Morree A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013854
   Demonbreun AR, 2011, HUM MOL GENET, V20, P779, DOI 10.1093/hmg/ddq522
   Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155
   Evans V, 2008, HUM GENE THER, V19, P569, DOI 10.1089/hum.2007.169
   Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553
   Guerin CM, 2009, DEVELOPMENT, V136, P1411, DOI 10.1242/dev.031823
   GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275
   Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100
   Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com
   Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a
   Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.3.CO;2-S
   Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033
   Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com
   Klinge L, 2010, MUSCLE NERVE, V41, P166, DOI 10.1002/mus.21166
   Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021
   Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051
   Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200
   Liu J, 1998, NAT GENET, V20, P31
   Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407
   Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08
   Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761
   Musa H, 2003, J MUSCLE RES CELL M, V24, P301
   Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014
   Rey M, 2011, EUR J CELL BIOL, V90, P128, DOI 10.1016/j.ejcb.2010.09.004
   Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106
   SAITOH O, 1988, CELL TISSUE RES, V252, P263
   Sharma A, 2010, ARTERIOSCL THROM VAS, V30, P2196, DOI 10.1161/ATVBAHA.110.208108
   Spangenburg EE, 2004, ENDOCRINOLOGY, V145, P2054, DOI 10.1210/en.2003-1476
   Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r
   Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431
   Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260
   Wu Y, 2010, J BIOL CHEM, V285, P3554, DOI 10.1074/jbc.M109.063354
   Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033
   Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115
   Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813
NR 48
TC 26
Z9 26
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 8
PY 2011
VL 6
IS 12
AR e28563
DI 10.1371/journal.pone.0028563
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 863KY
UT WOS:000298163600035
PM 22174839
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Zeng, Y
   Tan, M
   Kohyama, J
   Sneddon, M
   Watson, JB
   Sun, YE
   Xie, CW
AF Zeng, Yan
   Tan, Miao
   Kohyama, Jun
   Sneddon, Marissa
   Watson, Joseph B.
   Sun, Yi E.
   Xie, Cui-Wei
TI RETRACTED: Epigenetic Enhancement of BDNF Signaling Rescues Synaptic
   Plasticity in Aging (Retracted article. See vol. 33, pg. 19735, 2013)
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article; Retracted Publication
ID LONG-TERM POTENTIATION; HISTONE DEACETYLASE INHIBITORS;
   PROTEIN-KINASE-II; NEUROTROPHIC FACTOR; MEMORY FORMATION; GLUTAMATE
   RECEPTORS; MICE; ACETYLATION; GENE; ACTIVATION
AB Aging-related cognitive declines are well documented in humans and animal models. Yet the synaptic and molecular mechanisms responsible for cognitive aging are not well understood. Here we demonstrated age-dependent deficits in long-term synaptic plasticity and loss of dendritic spines in the hippocampus of aged Fisher 344 rats, which were closely associated with reduced histone acetylation, upregulation of histone deacetylase (HDAC) 2, and decreased expression of a histone acetyltransferase. Further analysis showed that one of the key genes affected by such changes was the brain-derived neurotrophic factor (Bdnf) gene. Age-dependent reductions in H3 and H4 acetylation were detected within multiple promoter regions of the Bdnf gene, leading to a significant decrease in BDNF expression and impairment of downstream signaling in the aged hippocampus. These synaptic and signaling deficits could be rescued by enhancing BDNF and trkB expression via HDAC inhibition or by directly activating trkB receptors with 7,8-dihydroxyflavone, a newly identified, selective agonist for trkB. Together, our findings suggest that age-dependent declines in chromatin histone acetylation and the resulting changes in BDNF expression and signaling are key mechanisms underlying the deterioration of synaptic function and structure in the aging brain. Furthermore, epigenetic or pharmacological enhancement of BDNF-trkB signaling could be a promising strategy for reversing cognitive aging.
C1 [Zeng, Yan; Tan, Miao; Kohyama, Jun; Sneddon, Marissa; Watson, Joseph B.; Sun, Yi E.; Xie, Cui-Wei] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.
RP Xie, CW (reprint author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci, 760 Westwood Plaza,Box 77, Los Angeles, CA 90024 USA.
EM cxie@mednet.ucla.edu
FU National Institute of Health [R01AG017542, P30AG028748, R21MH089518];
   Japan Society for the Promotion of Science
FX This study was supported by National Institute of Health Grants
   R01AG017542 and P30AG028748 to C.-W.X. and R21MH089518 to Y.E.S. J.K. is
   a Research Fellow supported by the Japan Society for the Promotion of
   Science. We thank Xin Liu and Mochtar Pribadi for help with ELISA and
   Golgi staining.
CR Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139
   Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132
   BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0
   Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269
   Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772
   Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134
   Granger R, 1996, SYNAPSE, V22, P332, DOI 10.1002/(SICI)1098-2396(199604)22:4<332::AID-SYN4>3.0.CO;2-C
   Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925
   Haggarty SJ, 2011, NEUROBIOL LEARN MEM, V96, P41, DOI 10.1016/j.nlm.2011.04.009
   Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262
   Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a
   Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9
   Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107
   Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001
   Johnson OL, 2006, BRAIN RES, V1113, P1, DOI 10.1016/j.brainres.2006.06.116
   Jourdain P, 2003, J NEUROSCI, V23, P10645
   Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1
   Kern A, 2009, BBA-GEN SUBJECTS, V1790, P1124, DOI 10.1016/j.bbagen.2009.07.016
   Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035
   KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856
   Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604
   Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200
   Liu X, 2010, J MED CHEM, V53, P8274, DOI 10.1021/jm101206p
   Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603
   Lynch G, 2006, AGEING RES REV, V5, P255, DOI 10.1016/j.arr.2006.03.008
   Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842
   METSIS M, 1993, P NATL ACAD SCI USA, V90, P8802, DOI 10.1073/pnas.90.19.8802
   Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738
   Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197
   Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2
   Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135
   Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299
   Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3
   Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088
   POLEVODA B, 2002, GENOME BIOL, V3
   Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785
   Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007
   Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011
   Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104
   SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648
   Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001
   Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X
   Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007
   TAPLEY P, 1992, ONCOGENE, V7, P371
   THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593
   TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O
   Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007
   Xie CW, 2000, P NATL ACAD SCI USA, V97, P8116, DOI 10.1073/pnas.140204597
   Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286
   Zeng Y, 2010, J ALZHEIMERS DIS, V21, P823, DOI 10.3233/JAD-2010-100264
NR 50
TC 87
Z9 95
U1 3
U2 25
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD DEC 7
PY 2011
VL 31
IS 49
BP 17800
EP 17810
DI 10.1523/JNEUROSCI.3878-11.2011
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 861QX
UT WOS:000298035400006
PM 22159096
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Warne, JP
   Alemi, F
   Reed, AS
   Varonin, JM
   Chan, H
   Piper, ML
   Mullin, ME
   Myers, MG
   Corvera, CU
   Xu, AW
AF Warne, James P.
   Alemi, Farzad
   Reed, Alison S.
   Varonin, Jillian M.
   Chan, Helen
   Piper, Merisa L.
   Mullin, Mark E.
   Myers, Martin G., Jr.
   Corvera, Carlos U.
   Xu, Allison W.
TI RETRACTED: Impairment of Central Leptin-Mediated PI3K Signaling
   Manifested as Hepatic Steatosis Independent of Hyperphagia and Obesity
   (Retracted article. See vol. 21, pg. 648, 2015)
SO CELL METABOLISM
LA English
DT Article; Retracted Publication
ID INSULIN-RESISTANCE; ADIPOSE-TISSUE; LIPID-METABOLISM; NERVOUS-SYSTEM;
   FOOD-INTAKE; MICE; LIVER; RECEPTOR; NEURONS; HYPOTHALAMUS
AB Hepatic steatosis is generally thought to develop via peripheral mechanisms associated with obesity. We show that chronic central infusion of leptin suppresses hepatic lipogenic gene expression and reduces triglyceride content via stimulation of hepatic sympathetic activity. This leptin function is independent of feeding and body weight but requires phosphatidylinositol 3-kinase (PI3K) signaling. Attenuation of leptin-induced PI3K signaling, brought about by transgenic expression of phosphatase and tensin homolog (PTEN) in leptin receptor neurons, leads to decreased hepatic sympathetic tone and increased triglyceride levels without affecting adiposity or hepatic insulin signaling. Central leptin's effects on hepatic norepinephrine levels and triglyceride content are blunted in these mutant mice. Simultaneous downregulation of PI3K and signal transducer and activator of transcription-3 (Stat3) in leptin receptor neurons does not exacerbate obesity but causes more severe hepatic steatosis. Together, our results indicate that central cellular leptin resistance in PI3K signaling manifests as hepatic steatosis without causing obesity.
C1 [Warne, James P.; Reed, Alison S.; Varonin, Jillian M.; Chan, Helen; Piper, Merisa L.; Mullin, Mark E.; Xu, Allison W.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.
   [Alemi, Farzad; Corvera, Carlos U.] Univ Calif San Francisco, San Francisco VA Med Ctr, Dept Surg, San Francisco, CA 94143 USA.
   [Myers, Martin G., Jr.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA.
   [Myers, Martin G., Jr.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.
RP Xu, AW (reprint author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.
EM axu@diabetes.ucsf.edu
FU NIH [R01DK080427, T32DK07161, DERC P30 DK063720]
FX We thank Drs. Michael Schwartz, Robert Farese, Jr., Jacquelyn Maher, and
   Jamila Newton for their evaluation of the manuscript. This work was
   supported by research grant from the NIH (R01DK080427 to A.W.X.) and, in
   part, by a NIH Pediatric Endocrine Training grant (T32DK07161) to A.S.R.
   This work was also supported, in part, by core facilities funded by NIH
   DERC P30 DK063720.
CR Baskin DG, 1999, DIABETES, V48, P828, DOI 10.2337/diabetes.48.4.828
   Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388
   Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013
   Biddinger SB, 2006, DIABETES, V55, P2032, DOI 10.2337/db05-0742
   BRODIE BB, 1966, J PHARMACOL EXP THER, V154, P493
   Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775
   Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527
   Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914
   Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.062904.144924
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694
   Gallardo N, 2007, ENDOCRINOLOGY, V148, P5604, DOI 10.1210/en.2007-0933
   Guo KY, 2007, ENDOCRINOLOGY, V148, P3987, DOI 10.1210/en.2007-0261
   KNEHANS AW, 1983, AM J PHYSIOL, V244, pE567
   Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073
   Leshan RL, 2006, OBESITY, V14, P208
   LINN TC, 1981, ARCH BIOCHEM BIOPHYS, V209, P613, DOI 10.1016/0003-9861(81)90320-9
   Metlakunta AS, 2008, ENDOCRINOLOGY, V149, P1121, DOI 10.1210/en.2007-1307
   Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200
   Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005
   Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707
   Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002
   Piper ML, 2008, MOL ENDOCRINOL, V22, P751, DOI 10.1210/me.2007-0389
   Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275
   Prieur X, 2008, ENDOCRINOLOGY, V149, P5432, DOI 10.1210/en.2008-0498
   Rahmouni K, 2003, J NEUROSCI, V23, P5998
   Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024
   Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JC125977
   SALMON DMW, 1973, BIOCHEM J, V136, P551, DOI 10.1042/bj1360551
   Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200
   Satoh N, 1999, DIABETES, V48, P1787, DOI 10.2337/diabetes.48.9.1787
   Scherer T, 2011, CELL METAB, V13, P183, DOI 10.1016/j.cmet.2011.01.008
   Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025
   Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007
   SPECTOR S, 1965, J PHARMACOL EXP THER, V147, P86
   Stanley S, 2010, P NATL ACAD SCI USA, V107, P7024, DOI 10.1073/pnas.1002790107
   Takeda K, 1998, J IMMUNOL, V161, P4652
   Tang-Christensen M, 1999, J CLIN ENDOCR METAB, V84, P711, DOI 10.1210/jc.84.2.711
   Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010
   Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008
   Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010
   Yi CX, 2010, BBA-MOL BASIS DIS, V1802, P416, DOI 10.1016/j.bbadis.2010.01.006
NR 44
TC 30
Z9 31
U1 2
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD DEC 7
PY 2011
VL 14
IS 6
BP 791
EP 803
DI 10.1016/j.cmet.2011.11.001
PG 13
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 862VO
UT WOS:000298122400012
PM 22152304
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Gijsbers, R
   Vets, S
   De Rijck, J
   Ocwieja, KE
   Ronen, K
   Malani, N
   Bushman, FD
   Debyser, Z
AF Gijsbers, Rik
   Vets, Sofie
   De Rijck, Jan
   Ocwieja, Karen E.
   Ronen, Keshet
   Malani, Nirav
   Bushman, Frederic D.
   Debyser, Zeger
TI RETRACTED: Role of the PWWP Domain of Lens Epithelium-derived Growth
   Factor (LEDGF)/p75 Cofactor in Lentiviral Integration Targeting
   (Retracted article. See vol. 293, pg. 114, 2018)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSCRIPTIONAL COACTIVATOR LEDGF/P75;
   NUCLEAR-LOCALIZATION SIGNAL; DNA-BINDING DOMAIN; HIV-1 INTEGRASE; HUMAN
   GENOME; CHROMATIN-BINDING; SITE SELECTION; IN-VITRO; RETROVIRAL
   INTEGRATION
AB LEDGF/p75 is a chromatin-interacting, cellular cofactor of HIV integrase that dictates lentiviral integration site preference. In this study we determined the role of the PWWP domain of LEDGF/p75 in tethering and targeting of the lentiviral pre-integration complex, employing potent knockdown cell lines allowing analysis in the absence of endogenous LEDGF/p75. Deletion of the PWWP domain resulted in a diffuse subnuclear distribution pattern, loss of interaction with condensed chromatin, and failure to rescue proviral integration, integration site distribution, and productive virus replication. Substitution of the PWWP domain of LEDGF/p75 with that of hepatoma-derived growth factor or HDGF-related protein-2 rescued viral replication and lentiviral integration site distribution in LEDGF/p75-depleted cells. Replacing all chromatin binding elements of LEDGF/p75 with full-length hepatoma-derived growth factor resulted in more integration in genes combined with a preference for CpG islands. In addition, we showed that any PWWP domain targets SMYD1-like sequences. Analysis of integration preferences of lentiviral vectors for epigenetic marks indicates that the PWWP domain is critical for interactions specifying the relationship of integration sites to regions enriched in specific histone post-translational modifications.
C1 [Gijsbers, Rik; Vets, Sofie; De Rijck, Jan; Debyser, Zeger] Katholieke Univ Leuven, Div Mol Med, B-3000 Louvain, Belgium.
   [Ocwieja, Karen E.; Ronen, Keshet; Malani, Nirav; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.
RP Gijsbers, R (reprint author), Kapucijnenvoer 33,VCTB 5, B-3000 Louvain, Belgium.
EM rik.gijsbers@med.kuleuven.be; zeger.debyser@med.kuleuven.be
RI De Rijck, Jan/A-2729-2013
OI Bushman, Frederic/0000-0003-4740-4056
FU National Institutes of Health [A152845, A166290, 132 A1007324, T32
   A1-07324-17]; KU Leuven Research Council [OT/09/047]; Institute for the
   Promotion of Innovation through Science and Technology in Flanders
   (IWT-Vlaanderen) Cell-CoVir SBO [60813]; Flanders Research Foundation
   (FWO) [G.0530.08]; European Commission THINC [HEALTH-F3-2008-201032];
   Institute for the Promotion of Innovation through Science and Technology
   in Flanders (IWT-Vlaanderen); Amfar
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants A152845 and A166290 (to F. D. B.), 132 A1007324 (to K. E.
   O.), and T32 A1-07324-17] (to K. R.). This work was also supported by KU
   Leuven Research Council Grant OT/09/047, Institute for the Promotion of
   Innovation through Science and Technology in Flanders (IWT-Vlaanderen)
   Cell-CoVir SBO Grant 60813, Flanders Research Foundation (FWO) Grant
   G.0530.08, European Commission THINC Grant HEALTH-F3-2008-201032 (to Z.
   D.), a predoctoral fellowship from Institute for the Promotion of
   Innovation through Science and Technology in Flanders (IWT-Vlaanderen)
   (to S. V.), and a Mathilde-Krim postdoctoral fellowship from Amfar (to
   J. D. R.).
CR Astiazaran P., 2011, RETROVIROLOGY, V8, P27
   Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009
   Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157
   Botbol YR, 2008, NUCLEIC ACIDS RES, V36, P1237, DOI 10.1093/nar/gkm1127
   Brady T, 2009, AIDS, V23, P1461, DOI 10.1097/QAD.0b013e32832caf28
   Brady TL, 2008, MOL CELL BIOL, V28, P1230, DOI 10.1128/MCB.01502-07
   Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725
   Brown-Bryan TA, 2008, MOL CANCER RES, V6, P1293, DOI 10.1158/1541-7786.MCR-08-0125
   Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200
   Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094
   Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506921402
   Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937
   Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200
   Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200
   Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885
   Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370
   Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329
   Dal J., 2007, MOL CELL, V27, P289
   De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06
   De Rijck J, 2010, NUCLEIC ACIDS RES, V38, P6135, DOI 10.1093/nar/gkq410
   Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06
   Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433
   Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200
   Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14
   Ferris AL, 2010, P NATL ACAD SCI USA, V107, P3135, DOI 10.1073/pnas.0914142107
   Garcia-Rivera JA, 2010, J VIROL, V84, P740, DOI 10.1128/JVI.01043-09
   Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778
   Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34
   Gijsbers R, 2010, MOL THER, V18, P552, DOI 10.1038/mt.2010.36
   Hacker CV, 2006, MOL THER, V14, P536, DOI 10.1016/j.ymthe.2006.06.006
   Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784
   Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933
   Hombrouck A, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030047
   Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200
   Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188
   Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032
   Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200
   Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004
   Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319
   Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073
   Lukasik SM, 2006, PROTEIN SCI, V15, P314, DOI 10.1110/ps.051751706
   Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200
   Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517
   Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340
   Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5
   McNeely M, 2011, J MOL BIOL, V410, P811, DOI 10.1016/j.jmb.2011.03.073
   Meehan AM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000522
   Meekings KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000027
   Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234
   Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263
   Nameki N, 2005, PROTEIN SCI, V14, P756, DOI 10.1110/ps.04975305
   Narezkina A, 2004, J VIROL, V78, P11656, DOI 10.1128/JVI.78.21.11656-11663.2004
   Olsen JC, 1998, GENE THER, V5, P1481, DOI 10.1038/sj.gt.3300768
   PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6
   PRUSS D, 1994, J BIOL CHEM, V269, P25031
   PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O
   Purdy MM, 2010, ARCH BIOCHEM BIOPHYS, V498, P13, DOI 10.1016/j.abb.2010.03.007
   Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008
   Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108
   Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4
   Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422
   Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107
   Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08
   Silvers RM, 2010, HUM GENE THER, V21, P337, DOI 10.1089/hum.2009.134
   Singh DP, 2006, J MOL BIOL, V355, P379, DOI 10.1016/j.jmb.2005.10.054
   Slater LM, 2003, J MOL BIOL, V330, P571, DOI 10.1016/S0022-2836(03)00470-4
   Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6
   Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338
   Tsutsui KM, 2011, NUCLEIC ACIDS RES, V39, P5067, DOI 10.1093/nar/gkr088
   Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052
   Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022
   Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006
   Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299
   Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020
   Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797
   Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907
   Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154
   Wu X, 2002, CELL DEATH DIFFER, V9, P915, DOI 10.1038/sj.cdd.4401063
   Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413
   Xie WW, 2001, MOL CELL BIOL, V21, P6606, DOI 10.1128/MCB.21.19.6606-6614.2001
   Yang J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-101
   Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033
   Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004
   Zielske SP, 2006, J VIROL, V80, P7275, DOI 10.1128/JVI.02470-05
NR 84
TC 36
Z9 36
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 2
PY 2011
VL 286
IS 48
BP 41812
EP 41825
DI 10.1074/jbc.M111.255711
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 861YR
UT WOS:000298057500064
PM 21987578
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Biswas, S
   Nayak, M
   Kanojiya, S
   Batra, S
AF Biswas, Subhasish
   Nayak, Maloy
   Kanojiya, Sanjeev
   Batra, Sanjay
TI RETRACTED: Copper-Catalyzed Cascade Reaction for Practical and Efficient
   Synthesis of Alkyl 2H-Isoindole-1-carboxylates(Retracted article. See
   vol.358,pg.3482,2016)
SO ADVANCED SYNTHESIS & CATALYSIS
LA English
DT Article; Retracted Publication
DE a-arylation; copper; heterocycles; isoindoles
ID ONE-POT SYNTHESIS; ALPHA-ARYLATION; COUPLING REACTIONS; ACID-ESTERS;
   ISOINDOLE; DERIVATIVES; NITRILES
AB The copper-catalyzed cascade reaction comprising the condensation/a-arylation between 2-halobenzaldehydes and a-amino acid esters provides a straightforward methodology for the efficient synthesis of alkyl 2H-isoindole-1-carboxylates.
C1 [Biswas, Subhasish; Nayak, Maloy; Batra, Sanjay] Cent Drug Res Inst, CSIR, Med & Proc Chem Div, POB 173, Lucknow 226001, Uttar Pradesh, India.
   [Kanojiya, Sanjeev] Cent Drug Res Inst, CSIR, Sophisticated Analyt Instruments Facil, Lucknow 226001, Uttar Pradesh, India.
RP Batra, S (reprint author), Cent Drug Res Inst, CSIR, Med & Proc Chem Div, POB 173, Lucknow 226001, Uttar Pradesh, India.
EM batra_san@yahoo.co.uk
RI Batra, Sanjay/C-3040-2009
FU CSIR, New Delhi
FX Two of the authors (SB and MN) gratefully acknowledge the financial
   support from CSIR, New Delhi in the form of fellowships. The SAIF
   division, CDRI is gratefully acknowledged for providing the spectral and
   analytical data.
CR Amon M, 2007, CHEMMEDCHEM, V2, P708, DOI 10.1002/cmdc.200600270
   Biswas S, 2010, TETRAHEDRON, V66, P7781, DOI 10.1016/j.tet.2010.07.078
   Cai Q, 2010, ORG LETT, V12, P1500, DOI 10.1021/ol1002225
   Cao CS, 2011, EUR J ORG CHEM, P1570, DOI 10.1002/ejoc.201001428
   Chen ZH, 2006, ORG LETT, V8, P273, DOI 10.1021/ol0526468
   Culkin DA, 2003, ACCOUNTS CHEM RES, V36, P234, DOI 10.1021/ar0201106
   Diana P, 2008, J MED CHEM, V51, P2387, DOI 10.1021/jm070834t
   Diana P, 2007, BIOORGAN MED CHEM, V15, P343, DOI 10.1016/j.bmc.2006.09.054
   Duan SF, 2008, ORG LETT, V10, P1541, DOI 10.1021/ol800242n
   Gaertzen O, 2002, J ORG CHEM, V67, P465, DOI 10.1021/jo0107756
   GIROLAMO C, 2008, Patent No. 0748704
   He CA, 2010, J AM CHEM SOC, V132, P8273, DOI 10.1021/ja1033777
   Hennessy EJ, 2002, ORG LETT, V4, P269, DOI 10.1021/ol017038g
   Heugebaert TSA, 2009, ORG LETT, V11, P5018, DOI 10.1021/ol902031f
   Hu Y., 2009, ANGEW CHEM, V121, P5556
   Hu YM, 2009, ANGEW CHEM INT EDIT, V48, P5448, DOI 10.1002/anie.200901246
   Hui BWO, 2009, ORG LETT, V11, P729, DOI 10.1021/ol802816k
   JIN Z, 2010, Patent No. 101906062
   JIN Z, 2010, CHEM ABS, V154
   Johansson C. C. C., 2010, ANGEW CHEM, V122, P686
   Johansson CCC, 2010, ANGEW CHEM INT EDIT, V49, P676, DOI 10.1002/anie.200903424
   Liu JL, 2011, CHINESE J CHEM, V29, P309, DOI 10.1002/cjoc.201190083
   Mi BX, 2003, CHEM MATER, V15, P3148, DOI 10.1021/cm030292d
   Nayak M, 2010, ADV SYNTH CATAL, V352, P3431, DOI 10.1002/adsc.201000662
   Ohmura T, 2009, J AM CHEM SOC, V131, P6070, DOI 10.1021/ja901095h
   Phipps RJ, 2008, J AM CHEM SOC, V130, P8172, DOI 10.1021/ja801767s
   Rao HH, 2011, SYNLETT, P745, DOI 10.1055/s-0030-1259919
   Reeves JT, 2010, J ORG CHEM, V75, P992, DOI 10.1021/jo9025644
   Rincon R, 2008, SYNLETT, P911, DOI 10.1055/s-2008-1042934
   Sole D, 2010, J ORG CHEM, V75, P6267, DOI 10.1021/jo101054j
   Sole D, 2009, ORG BIOMOL CHEM, V7, P3382, DOI 10.1039/b909701e
   Spergel SH, 2010, J ORG CHEM, V75, P5316, DOI 10.1021/jo100623d
   Wang F, 2011, J ORG CHEM, V76, P3174, DOI 10.1021/jo200014v
   Xie XA, 2005, ORG LETT, V7, P4693, DOI 10.1021/ol0518838
   Xu W, 2011, ORG LETT, V13, P1274, DOI 10.1021/ol1030266
   Yasmin N, 2010, SYNLETT, P924, DOI 10.1055/s-0029-1219563
   Yip SF, 2007, ORG LETT, V9, P3469, DOI 10.1021/ol701473p
   You J., 2003, ANGEW CHEM, V115, P5205
   You JS, 2003, ANGEW CHEM INT EDIT, V42, P5051, DOI 10.1002/anie.200351954
   YU C, 2009, ANGEW CHEM, V121, P5556
   Zhou BW, 2010, SYNTHESIS-STUTTGART, P2794, DOI 10.1055/s-0030-1258146
NR 41
TC 8
Z9 8
U1 2
U2 24
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1615-4150
EI 1615-4169
J9 ADV SYNTH CATAL
JI Adv. Synth. Catal.
PD DEC
PY 2011
VL 353
IS 18
BP 3330
EP 3334
DI 10.1002/adsc.201100451
PG 5
WC Chemistry, Applied; Chemistry, Organic
SC Chemistry
GA 865TC
UT WOS:000298332200013
DA 2018-12-27
ER

PT J
AU Kim, HN
   Narayanan, NK
   Lasano, S
   Narayanan, B
AF Kim, Hye Na
   Narayanan, Narayanan K.
   Lasano, Salamia
   Narayanan, Bhagavathi
TI RETRACTED: Modulation of PGE(2)-induced EP4 Expression on Snail
   Signaling and the Impact on Epithelial-Mesenchymal Transition:
   Significance of EP4 Antagonism (Retracted article. See vol. 38, pg.
   3785, 2018)
SO ANTICANCER RESEARCH
LA English
DT Article; Retracted Publication
DE Prostate cancer; PGE(2); EP4; p-Akt; Snail; epithelial-mesencymal
   transition
ID METASTATIC PROSTATE-CANCER; TRANSCRIPTION FACTOR SNAIL; TGF-BETA;
   CELL-LINES; CYCLIN D1; RECEPTORS; CYCLOOXYGENASE-2; GROWTH;
   CARCINOGENESIS; PTEN
AB Background: Although significant accumulation of prostaglandin E-2 (PGE(2)) in the human prostate cancer tissues has been reported, there is lack of substantial evidence regarding the key role of PGE(2)-induced E-prostanoid-4 receptor (EP4) on Snail, a master regulator of epithelial mesenchymal transition (EMT). In this study, we investigated a novel connection between PGE(2)-induced EP4 and Snail (encodes DNA binding zinc finger protein that acts as transcriptional repressor) signaling in prostate cancer. Materials and Methods: To investigate the key role of serum PGE(2), EP4, p-Akt and Snail in prostate cancer progression, we used prostate-specific phosphatase and tensin homolog (PTEN) -knockout (PTEN-KO) mice of different age groups from 4 to 28 weeks. To determine the EP4-specific interaction with Snail in prostate cancer, we used cell-based assays, including siRNA knockdown, and treatment with EP4 antagonist. Results: An interaction between EP4 with Snail was evident in prostate-specific PTEN-KO mice that showed an elevated level of PGE(2) in the serum and of EP4, p-Akt and Snail in the tissues. Prostate cancer cells transfected with EP4-siRNA and treatments with EP4 antagonist suggest a link between EP4, and Snail activation, potentially via p-Akt. Cells treated with EP4 antagonist exhibited a significant decrease in Snail, mesenchymal markers and cell migration, and cell cycle arrest with a gain in E-cadherin levels. Conclusion: Our findings provide key evidence that support there being a role of PGE(2)/EP4/p-Akt in Snail signaling and conferring cell survival advantage. Cancer progression via EMT can be reversed by an EP4 antagonist in this model of prostate cancer.
C1 [Kim, Hye Na; Narayanan, Narayanan K.; Lasano, Salamia; Narayanan, Bhagavathi] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA.
RP Narayanan, B (reprint author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA.
EM Bhagavathi.Narayanan@nyumc.org
CR Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477
   Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907
   Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034
   Baygi ME, 2010, CELL BIOL TOXICOL, V26, P553, DOI 10.1007/s10565-010-9163-5
   Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025
   CHAUDRY AA, 1994, INT J CANCER, V57, P176, DOI 10.1002/ijc.2910570208
   Cherukuri DP, 2007, EXP CELL RES, V313, P2969, DOI 10.1016/j.yexcr.2007.06.004
   Chun KS, 2007, CANCER RES, V67, P2015, DOI 10.1158/0008-5472.CAN-06-3617
   De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011
   De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090
   Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200
   Fulton AM, 2006, CANCER RES, V66, P9794, DOI 10.1158/0008-5472.CAN-06-2067
   Heeboll S, 2009, APMIS, V117, P196, DOI 10.1111/j.1600-0463.2008.00007.x
   Hemavathy K, 2000, GENE, V257, P1, DOI 10.1016/S0378-1119(00)00371-1
   Hull MA, 2004, MOL CANCER THER, V3, P1031
   Jain S, 2008, CANCER RES, V68, P7750, DOI 10.1158/0008-5472.CAN-07-6689
   Jiao J, 2007, CANCER RES, V67, P6083, DOI 10.1158/0008-5472.CAN-06-4202
   Lee J, 2010, FERTIL STERIL, V93, P2498, DOI 10.1016/j.fertnstert.2010.01.038
   Ma XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348
   Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001
   MILLER RG, 1981, SIMULTANEOUS STATIST, P37
   Narayanan BA, 2003, CLIN CANCER RES, V9, P3503
   Narayanan BA, 2007, CLIN CANCER RES, V13, P5965, DOI 10.1158/1078-0432.CCR-07-0744
   Narayanan BA, 2006, MOL CANCER THER, V5, P1117, DOI 10.1158/1535-7163.MCT-05-0520
   Narayanan NK, 2009, INT J CANCER, V125, P1, DOI 10.1002/ijc.24336
   Narumiya S, 1999, PHYSIOL REV, V79, P1193
   Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317
   Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004
   Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9
   Sheng HM, 2001, J BIOL CHEM, V276, P14498, DOI 10.1074/jbc.M010093200
   Sheng SJ, 2009, J CELL PHYSIOL, V218, P451, DOI 10.1002/jcp.21616
   Smith AP, 2009, ONCOGENE, V28, P422, DOI 10.1038/onc.2008.395
   Stern DF, 2004, CLIN CANCER RES, V10, P6407, DOI 10.1158/1078-0432.CCR-04-1783
   Sugar Linda M, 2006, Can J Urol, V13 Suppl 1, P46
   Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200
   Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200
   TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419
   Terada N, 2010, CANCER RES, V70, P1606, DOI 10.1158/0008-5472.CAN-09-2984
   Tian MZ, 2010, FASEB J, V24, P1105, DOI 10.1096/fj.09-141341
   Wallace Jeanne M, 2002, Integr Cancer Ther, V1, P7, DOI 10.1177/153473540200100102
   Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0
   Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173
NR 42
TC 9
Z9 10
U1 0
U2 4
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0250-7005
EI 1791-7530
J9 ANTICANCER RES
JI Anticancer Res.
PD DEC
PY 2011
VL 31
IS 12
BP 4347
EP 4357
PG 11
WC Oncology
SC Oncology
GA 868HM
UT WOS:000298514300040
PM 22199300
DA 2018-12-27
ER

PT J
AU Ibrahim, NM
   Eweis, EA
   El-Beltagi, HS
   Abdel-Mobdy, YE
AF Ibrahim, Nabil M.
   Eweis, Esam A.
   El-Beltagi, Hossam Saad
   Abdel-Mobdy, Yasmin E.
TI RETRACTED: The Effect of Lead Acetate Toxicity on Experimental Male
   Albino Rat (Retracted article. See vol. 151, pg. 156, 2013)
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article; Retracted Publication
DE Lead; Toxicity; ALT; AST; Cholinesterase; T3; T4
ID ANTIOXIDANT ENZYMES; FLAX CULTIVARS; STRESS; LIVER; EXPOSURE; DEFENSE;
   LEAVES; L.
AB The toxic effect of Pb ion (lead acetate) was investigated using male albino rats, which was ingested at 1/20, 1/40, and 1/60 sublethal doses. Relative to normal control, the ingestion of Pb2+ induced significant stimulation in ALT and AST activity. In addition, total soluble protein and albumin contents of plasma were decreased, while the content of globulin was changed by the Pb2+ treatments. The cholinesterase activity was inhibited, but the activities of alkaline and acid phosphates as well as lactate dehydrogenase were stimulated as a result of lead acetate intoxication. These observations were gradually paralleled across the experiment dose of the three doses of intoxicated Pb2+. In the case of blood picture, Pb2+ ingestion significantly reduced the contents of hemoglobin and RBC count of intoxicated rat's blood, while the plasma levels of T3 and T4 and blood WBC count were insignificantly decreased or unchanged. All results of the present study showed that the Pb2+ ingestion was more effective in the case of the high dose (1/20 LD50) than that of the low dose (1/60 LD50) ingestion relative to the normal healthy control. The results of the present work advice the need to avoid exposure of humans to the lead compound to avoid injurious hazard risk.
C1 [El-Beltagi, Hossam Saad] Cairo Univ, Dept Biochem, Fac Agr, Cairo, Egypt.
   [Ibrahim, Nabil M.; Eweis, Esam A.; Abdel-Mobdy, Yasmin E.] Cairo Univ, Fac Agr, Dept Econ Entomol & Pesticides, Cairo, Egypt.
RP El-Beltagi, HS (reprint author), Cairo Univ, Dept Biochem, Fac Agr, POB 12613,Gamma St, Cairo, Egypt.
EM lbltg@yahoo.com
FU Faculty of Agriculture; Cairo University
FX The authors would like to thank the management of the Faculty of
   Agriculture and Cairo University for the ongoing cooperation to support
   research and for providing the funds and facilities necessary to achieve
   the desired goals of the research.
CR Abdou ZA, 2007, J BIOL CHEM ENV SCI, V2, P481
   Abou-Donia MA, 2008, GLOBAL VET, V2, P280
   Aboul-Enein A. M., 2010, J APPL SCI RES, V6, P600
   Adegbesan BO, 2007, BIOL TRACE ELEM RES, V116, P219, DOI 10.1007/s12011-007-9029-8
   Afify Abd El-Moneim M. R., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P359, DOI 10.1016/S2221-1691(11)60080-4
   Afify AMR, 2011, FRESEN ENVIRON BULL, V20, P1084
   Aly AA, 2010, GRASAS ACEITES, V61, P288, DOI 10.3989/gya.111509
   ANTINIO MT, 2003, TOXICOL LETT, V143, P331
   Babson AL, 1959, AM J CLIN PATHOL, V32, P89
   Badalzadeh R, 2009, BIOL MED, V1, P75
   Baht R V, 1997, World Health Stat Q, V50, P132
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chapra IJ, 1972, J LAB CLIN MED, V80, P729
   Commission of the European Communities, 2002, OFFICIAL J EUROPEAN
   Correia PRM, 2000, ANAL CHIM ACTA, V405, P205, DOI 10.1016/S0003-2670(99)00761-8
   DECRA JA, 1975, PRACTICAL HEMATOLOGY, P32
   Demirezen D, 2006, MEAT SCI, V74, P255, DOI 10.1016/j.meatsci.2006.03.012
   Dito W. R., 1979, CLIN ENZYMOL, P1
   DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2
   Duruibe JO, 2007, INT J PHYS SCI, V2, P112
   El Beltagi HS, 2010, NOT BOT HORTI AGROBO, V38, P76
   El-Beltagi H. S., 2010, Notulae Scientia Biologicae, V2, P76
   El-Beltagi HS, 2008, J NAT FIBERS, V5, P316, DOI 10.1080/15440470802252487
   El-Lman GL, 1960, ARCH BIOCHEM BIOPHYS, V82, P88
   ELBELTAGI HS, 2011, RADIAT PHYS CHEM, V80, P965
   Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x
   Frankel S, 1963, CLIN LAB METHODS, P1102
   Goel A, 2007, TOXICOL LETT, V169, P26, DOI 10.1016/j.toxlet.2006.07.342
   HAYES DF, 1991, TOXICOLOGY, V167, P173
   Hayes W. J., 1991, HDB PESTICIDE TOXICO
   IWEGBUE GMA, 2008, BULG J VET MED, V11, P275
   Jendrassik L, 1953, BRAYS CLIN LAB METHO, P357
   Korenekova Beata, 2002, Veterinarski Arhiv, V72, P259
   Lane-Pert W., 1971, LAB ANIMAL PRINCIPLE, P142
   Malecka A, 2001, ACTA BIOCHIM POL, V48, P687
   MCINTIRE MS, 1972, SCIENCE, V177, P520, DOI 10.1126/science.177.4048.520
   Mohamed AA, 2009, ELECT J ENV AGR FOOD, V8, P969
   MUDIPALLI A, 2009, LEAD HEPATOTOXICITY
   MURREY RK, 2006, HARPERS ILLUSTRATED
   Noriega GO, 2003, BBA-MOL BASIS DIS, V1638, P173, DOI 10.1016/S0925-4439(03)00081-4
   Omaye S. T., 2004, Pesticide, veterinary and other residues in food, P1, DOI 10.1533/9781855739109.1
   Pitot C.H., 1996, CASARETT DOULLS TOXI, P201
   PREMACHANDRA BN, 1976, CLIN CHIM ACTA, V43, P70
   Ritman S., 1957, AM J CLIN PATHOL, V28, P56
   Salama ZAER, 2009, NOT BOT HORTI AGROBO, V37, P122
   *SAS I INC, 2000, SAS STAT US GUID
   SEDDIK L, 2010, EUR J SCI RES, V42, P139
   Shehab GG, 2010, NOT BOT HORTI AGROBO, V38, P139
   Stohs Sidney J., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P201
   TRINDER P, 1969, CLIN BIOCHEM, V6, P24
   Uzbekov MG, 2007, B EXP BIOL MED+, V144, P783, DOI 10.1007/s10517-007-0431-1
   WALLER RA, 1969, J AM STAT ASSOC, V64, P1484, DOI 10.2307/2286085
   *WHO, 1972, IARC MON EV CARC RIS, V1, P80
   WISE RR, 1987, PLANT PHYSIOL, V83, P227
   Xienia U, 2000, BIOCHIM BIOPHYS ACTA, V149, P295
   YOUSIF AS, 2009, AFRICAN J ENV SCI TE, V3, P78
   Zhang FQ, 2007, CHEMOSPHERE, V67, P44, DOI 10.1016/j.chemosphere.2006.10.007
NR 57
TC 21
Z9 23
U1 2
U2 21
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0163-4984
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD DEC
PY 2011
VL 144
IS 1-3
BP 1120
EP 1132
DI 10.1007/s12011-011-9149-z
PG 13
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 863UF
UT WOS:000298192900109
PM 21766233
DA 2018-12-27
ER

PT J
AU Briones, TL
   Rogozinska, M
   Woods, J
AF Briones, Teresita L.
   Rogozinska, Magdalena
   Woods, Julie
TI RETRACTED: Modulation of Ischemia-Induced NMDAR1 Activation by
   Environmental Enrichment Decreases Oxidative Damage (Retracted article.
   See vol. 32, pg. 863, 2015)
SO JOURNAL OF NEUROTRAUMA
LA English
DT Article; Retracted Publication
DE complex environment; NMDAR1; oxidative DNA damage; oxidative stress;
   protein oxidation
ID GLOBAL CEREBRAL-ISCHEMIA; INDUCED NEURONAL DEATH; NITRIC-OXIDE SYNTHASE;
   HIPPOCAMPAL CA1; RAT HIPPOCAMPUS; GENE-EXPRESSION; BRAIN-REGIONS; NR1
   KNOCKOUT; DNA-DAMAGE; RECEPTOR
AB In this study, we examined whether enriched environment (EE) housing has direct neuroprotective effects on oxidative damage following transient global cerebral ischemia. Fifty-two adult male Wistar rats were included in the study and received either ischemia or sham surgery. Once fully awake, rats in each group were randomly assigned to either: EE housing or socially paired housing (CON). Animals remained in their assigned environment for 7 days, and then were killed. Our data showed that glutamate receptor expression was significantly higher in the hippocampus of the ischemia CON group than in the ischemia EE group. Furthermore, the oxidative DNA damage, protein oxidation, and neurodegeneration in the hippocampus of the ischemia CON group were significantly increased compared to the ischemia EE group. These results suggest that EE housing possibly modulated the ischemia-induced glutamate excitotoxicity, which then attenuated the oxidative damage and neurodegeneration in the ischemia EE rats.
C1 [Briones, Teresita L.] Wayne State Univ, Dept Adult Hlth, Detroit, MI 48202 USA.
   [Briones, Teresita L.; Rogozinska, Magdalena; Woods, Julie] Univ Illinois, Dept Biobehav Hlth Sci, Chicago, IL USA.
RP Briones, TL (reprint author), Wayne State Univ, Dept Adult Hlth, 5557 Cass Ave,Room 344, Detroit, MI 48202 USA.
EM tbriones@wayne.edu
FU National Institutes of Health, NINR [RO1 NR007666]
FX This work was supported by the National Institutes of Health, NINR grant
   # RO1 NR007666. We are grateful for the assistance of Maggie Wadowska in
   animal handling and tissue imaging.
CR ABE K, 1995, STROKE, V26, P1478, DOI 10.1161/01.STR.26.8.1478
   Andin J, 2007, BRAIN RES, V1174, P18, DOI 10.1016/j.brainres.2007.06.101
   ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8
   Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x
   Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
   Belayev A, 2003, BRAIN RES, V964, P121, DOI 10.1016/S0006-8993(02)04089-1
   Briones T L, 2000, Biol Res Nurs, V1, P299, DOI 10.1177/109980040000100406
   Briones Teresita L, 2005, Biol Res Nurs, V6, P167, DOI 10.1177/1099800404271328
   Briones TL, 2006, BEHAV BRAIN RES, V171, P17, DOI 10.1016/j.bbr.2006.03.011
   Briones TL, 2006, EXP NEUROL, V198, P530, DOI 10.1016/j.expneurol.2005.12.032
   Briones TL, 2006, BEHAV BRAIN RES, V168, P261, DOI 10.1016/j.bbr.2005.11.015
   Briones TL, 2004, BRAIN RES, V997, P137, DOI 10.1016/j.brainres.2003.10.030
   Candelario-Jalil E, 2001, NEUROSCI RES, V41, P233, DOI 10.1016/S0168-0102(01)00282-6
   Cardozo-Pelaez F, 2000, FREE RADICAL BIO MED, V28, P779, DOI 10.1016/S0891-5849(00)00172-6
   Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002
   CHOI DW, 1990, REV NEUROSCI, V13, P171
   Crozier RA, 2008, J NEUROPHYSIOL, V100, P3264, DOI 10.1152/jn.90418.2008
   Cui ZZ, 2005, EUR J NEUROSCI, V22, P755, DOI 10.1111/j.1460-9568.2005.04257.x
   Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8
   CULCASI M, 1994, J BIOL CHEM, V269, P12589
   ELIASSON MJ, 1997, NAT MED, P1089
   Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002
   Fang KM, 2008, J NEUROCHEM, V104, P1177, DOI 10.1111/j.1471-4159.2007.05022.x
   Gruart A, 2007, GENES BRAIN BEHAV, V6, P24, DOI 10.1111/j.1601-183X.2007.00319.x
   Hou ST, 2002, INT REV CYTOL, V221, P93
   Hu BR, 2000, J NEUROSCI, V20, P3191, DOI 10.1523/JNEUROSCI.20-09-03191.2000
   Iadecola C, 1996, STROKE, V27, P1373, DOI 10.1161/01.STR.27.8.1373
   Kannan, 2000, Pathophysiology, V7, P153, DOI 10.1016/S0928-4680(00)00053-5
   Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034
   Kirino T, 2000, NEUROPATHOLOGY, V20, pS95
   LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0
   Li CX, 2007, BRAIN RES BULL, V71, P568, DOI 10.1016/j.brainresbull.2006.11.011
   Madara JC, 2008, J NEUROPHYSIOL, V100, P3175, DOI 10.1152/jn.90880.2008
   Martin LJ, 2008, J NEUROPATH EXP NEUR, V67, P377, DOI 10.1097/NEN.0b013e31816ff780
   MATSUO Y, 1995, J CEREBR BLOOD F MET, V15, P941, DOI 10.1038/jcbfm.1995.119
   MORONI F, 2008, FEBS J, V276, P36
   Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071
   Pereira LO, 2009, BRAIN RES, V1247, P188, DOI 10.1016/j.brainres.2008.10.017
   Saucier DM, 2010, BEHAV BRAIN RES, V214, P48, DOI 10.1016/j.bbr.2010.04.039
   Sharma RA, 2001, CLIN CANCER RES, V7, P1894
   Taylor JM, 2004, CLIN EXP PHARMACOL P, V31, P397, DOI 10.1111/j.1440-1681.2004.04017.x
   Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9
   Wang Q, 2005, MOL NUTR FOOD RES, V49, P443, DOI 10.1002/mnfr.200500019
   Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6
   Wang Q, 2009, J NUTR BIOCHEM, V20, P369, DOI 10.1016/j.jnutbio.2008.04.007
   Wang X, 2010, FRONT AGING NEUROSCI, V2, P1
   Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001
   Wood DA, 2005, BRAIN RES, V1042, P176, DOI 10.1016/j.brainres.2005.02.029
   Xu XH, 2009, EXP BIOL MED, V234, P296, DOI 10.3181/0804-RM-128
NR 49
TC 21
Z9 22
U1 2
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0897-7151
EI 1557-9042
J9 J NEUROTRAUM
JI J. Neurotrauma
PD DEC
PY 2011
VL 28
IS 12
BP 2485
EP 2492
DI 10.1089/neu.2011.1842
PG 8
WC Critical Care Medicine; Clinical Neurology; Neurosciences
SC General & Internal Medicine; Neurosciences & Neurology
GA 865DS
UT WOS:000298291600008
PM 21612313
OA Green Published
DA 2018-12-27
ER

PT J
AU Peng, JG
   Xue, S
   Yan, Z
   Wu, X
   Zhan, L
AF Peng, Jiegang
   Xue, S.
   Yan, Z.
   Wu, X.
   Zhan, L.
TI RETRACTED: INVESTIGATION OF HIGH-COERCIVITY FePt-C NANOGRANULAR FILMS
   FOR PERPENDICULAR MAGNETIC RECORDING (PMR) MEDIA (Retracted article. See
   vol. 11, 1293001, 2012)
SO NANO
LA English
DT Article; Retracted Publication
DE FePt granular film; L1(0)-FePt-phase; perpendicular magnetic recording
   media; thermal stability
ID THIN-FILMS; TEMPERATURE
AB In this work, we studied FePt-C nanogranular films for ultrahigh-density perpendicular recording media towards 1 Tbits/in(2) because they have high magnetocrystalline anisotropy at its L1(0)-phase. We deposit Fe52Pt48-C50% (7.2 nm) films on oxidized silicon substrates at 400 degrees C and various Ar pressures. Results show that at the Ar pressure of 0.50 Pa, the FePt-C granular film has the best granular structure and MH loop shape with a perpendicular coercivity of 20 kOe. The average grain size of the optimized film is 6.4 +/- 1.5 nm. We studied the thermal stability of the optimized film and obtained the energy barrier E-b of 340k(B)T at room temperature, meaning excellent thermal stability as magnetic recording media.
C1 [Peng, Jiegang] Univ Elect Sci & Technol China, Sch Automat Engn, Chengdu 610054, Peoples R China.
   [Xue, S.] Zhanjiang Normal Coll, Dept Phys, Zhanjiang 524048, Peoples R China.
   [Yan, Z.] Shanghai Univ Engn Sci, Dept Mat Engn, Shanghai 201600, Peoples R China.
   [Wu, X.; Zhan, L.] Univ Elect Sci & Technol China, Sch Appl Phys, Chengdu 610054, Peoples R China.
RP Peng, JG (reprint author), Univ Elect Sci & Technol China, Sch Automat Engn, Chengdu 610054, Peoples R China.
EM pengjieganguestc@163.com
FU National Natural Science Foundation of China [61074182]
FX This study is mainly supported by the National Natural Science
   Foundation of China under the grant number of 61074182.
CR Alex M, 2001, IEEE T MAGN, V37, P1244, DOI 10.1109/20.950808
   Chen JS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789790
   CHEN JS, 2009, J APPL PHYS, V105
   Chen SC, 2011, IEEE T MAGN, V47, P524, DOI 10.1109/TMAG.2011.2107315
   Ding YF, 2005, APPL PHYS A-MATER, V81, P1485, DOI 10.1007/s00339-005-3262-9
   LU PL, 1995, IEEE T MAGN, V31, P2767, DOI 10.1109/20.490145
   Maeda T, 2002, APPL PHYS LETT, V80, P2147, DOI 10.1063/1.1463213
   Ruigrok JJM, 2000, J APPL PHYS, V87, P5398, DOI 10.1063/1.373356
   SHARROCK MP, 1994, J APPL PHYS, V76, P6413, DOI 10.1063/1.358282
   Srinivasan K, 2008, J APPL PHYS, V103, DOI 10.1063/1.2832649
   Tsai JL, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3293444
   Yan ML, 2003, APPL PHYS LETT, V83, P3332, DOI 10.1063/1.1621071
   ZHANG L, 2011, J APPL PHYS, V109
   Zhang L, 2010, J MAGN MAGN MATER, V322, P2658, DOI 10.1016/j.jmmm.2010.04.003
   Zhang L, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/8/085714
   Zhang LX, 2006, PROG NAT SCI, V16, P16
NR 16
TC 4
Z9 4
U1 3
U2 19
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1793-2920
EI 1793-7094
J9 NANO
JI Nano
PD DEC
PY 2011
VL 6
IS 6
BP 569
EP 574
DI 10.1142/S179329201100286X
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 863TP
UT WOS:000298191300006
DA 2018-12-27
ER

PT J
AU Zheng, DX
AF Zheng De-Xian
TI RETRACTED: A Highlight of Recent Advance in Immunology (Retracted
   article. See vol. 39, pg. 294, 2012)
SO PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Retracted Publication
ID INTERFERON-PRODUCING CELLS; INFLAMMATORY RESPONSES; IMMUNE; MOLECULES;
   TRAF
C1 Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Med, Beijing 100005, Peoples R China.
RP Zheng, DX (reprint author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Med, Beijing 100005, Peoples R China.
EM zhengdx@tom.com
CR Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988
   Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349
   CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327
   Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633
   Liu X, 2010, PROG BIOCHEM BIOPHYS, V37, P817, DOI 10.3724/SP.J.1206.2010.00139
   Liu Y, 2010, SCI CHINA LIFE SCI, V53, P169, DOI 10.1007/s11427-010-0044-1
   Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633
   Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835
   Sun B, 2009, PROG BIOCHEM BIOPHYS, V36, P1516, DOI 10.3724/SP.J.1206.2009.00213
   Tang F, 2010, SCI CHINA LIFE SCI, V53, P172, DOI 10.1007/s11427-010-0045-0
   Tang H, 2010, SCI CHINA LIFE SCI, V53, P190, DOI 10.1007/s11427-010-0040-5
   Wang SD, 2010, SCI CHINA LIFE SCI, V53, P183, DOI 10.1007/s11427-010-0043-2
   Wang YY, 2010, SCI CHINA LIFE SCI, V53, P159, DOI 10.1007/s11427-010-0050-3
   Zhang LG, 2010, SCI CHINA LIFE SCI, V53, P195, DOI 10.1007/s11427-010-0059-7
NR 14
TC 1
Z9 1
U1 5
U2 12
PU CHINESE ACAD SCIENCES, INST BIOPHYSICS
PI BEIJING
PA 15 DATUN RD, CHAOYAND DISTRICT, BEIJING, 100101, PEOPLES R CHINA
SN 1000-3282
J9 PROG BIOCHEM BIOPHYS
JI Prog. Biochem. Biophys.
PD DEC
PY 2011
VL 38
IS 12
BP 1111
EP 1112
DI 10.3724/SP.J.1206.2011.00488
PG 2
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 868HL
UT WOS:000298514200005
DA 2018-12-27
ER

PT J
AU Deray, K
   Simoff, S
AF Deray, Kristine
   Simoff, Simeon
TI RETRACTED: Designing for healthy living: Supporting reflectivity on
   interactions in healthcare (Retracted article. See vol. 82, pg. 276,
   2013)
SO INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS
LA English
DT Article; Retracted Publication
DE Collaborative technologies; Patient centered healthcare; Embodied
   interaction; Interaction analytics
ID COMMUNICATION
AB The design of an efficient and effective healthcare services is part of the design for healthy living. Contemporary models of health rely on a deeper involvement of the patient in the decision-making through the steps of the health journey. In these methods, the quality of practitioner-patient interaction is central to the successful processes and patient participation. The quality of these interactions and the ability of both medical practitioners and patients to reflect on each session is part of the design strategies for healthy living. Interactions rely on extensive, effective and empowering communication between practitioner and patient. The purpose of this work is to address the recognition of this importance, evidenced from the broad and diverse communication training for practitioners, by enabling the capture of information about the quality of these interactions. Captured information has to be encoded in a way that enables computer reasoning with it, as well as delivered to patients and practitioners in ways that allow quick interpretation from respective sides. We present the mechanics of the development of a visual language and analysis system enabling visual reasoning about the quality of interactions. The visual knowledge representation is designed based on aspects of human movement. Such design is justified from the fact that human possess implicit knowledge about human movement. The paper presents KIA ( Kinetic Inter-Acting) encoding system that is the foundation of the visual language and respective visual analysis method. KIA enables both humans and machines to utilise information about how interactions unfold, which is necessary for practitioner-patient interaction. The paper concludes with discussion of KIA approach and technology in terms of the implications for designing for healthy living. Crown Copyright (C) 2011 Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Deray, Kristine] Univ Technol Sydney, Dept Design, Sydney, NSW 2007, Australia.
   [Simoff, Simeon] Univ Western Sydney, Sch Comp & Math, Sydney, NSW, Australia.
RP Deray, K (reprint author), Univ Technol Sydney, Dept Design, Sydney, NSW 2007, Australia.
EM kristine.deray@uts.edu.au; s.simoff@uws.edu.au
FU University of Technology Sydney; University of Western Sydney
FX This research is supported by the University of Technology Sydney, and
   the University of Western Sydney.
CR Ahlen G, 2007, FAM PRACT, V24, P498, DOI 10.1093/fampra/cmm043
   Anderson ML, 2003, ARTIF INTELL, V149, P91, DOI 10.1016/S0004-3702(03)00054-7
   Armstrong D., 2003, OUTLINE SOCIOLOGY AP
   Aukes L.C., 2009, ED HLTH, V22, P1
   Ball T., MANAGING CHANGE  SUM, P1
   Bolster D, 2010, INT J NURS STUD, V47, P154, DOI 10.1016/j.ijnurstu.2009.05.021
   Bunt L, 2009, HUMAN FACTOR TRANSFO
   Christensen C.M., 2009, INNOVATORS PRESCRIPT
   Davis C.M., 2005, PATIENT PRACTITIONER
   Deray K., 2009, J COMPUTING ENG, V3, P1
   Deray K., 2009, MULTIMODAL HUMAN COM
   Deray K., 2007, VISUAL LANGUAGES INT, P205
   Deray K., P HIC 2006 IN PRESS
   Deray K., 2010, P 14 INT C INF VIS L
   Deray K, 2008, LECT NOTES COMPUT SC, V5232, P238, DOI 10.1007/978-3-540-87991-6_29
   Dhillon B.S., 2005, P 5 INT C MOD SIM OP
   Dunbar-Jacob J, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P571
   Eichelberg M, 2005, ACM COMPUT SURV, V37, P277, DOI 10.1145/1118890.1118891
   Ellingson LL, 2002, COMMUN RES TRENDS, V21, P1
   Ficery K., 2010, ACC101616112114
   Ford S, 2000, SOC SCI MED, V50, P553, DOI 10.1016/S0277-9536(99)00308-1
   Glover V.M.D., 2005, JOURNEY WELLNESS DES
   Hoerbst A, 2010, APPL CLIN INFORM, V1, P149, DOI 10.4338/ACI-2010-02-R-0009
   Hunter I, 2008, HLTH E NEWS, V21, P10
   Jaimes A, 2007, COMPUT VIS IMAGE UND, V108, P116, DOI 10.1016/j.cviu.2006.10.019
   Johnson M, 1980, METAPHORS WE LIVE BY
   KORSCH BM, 1972, SCI AM, V227, P66, DOI 10.1038/scientificamerican0872-66
   Lucia A.P., 2011, P 15 INT C INF VIS L
   Maes P., 1988, METALEVEL ARCHITECTU
   Mauksch LB, 2008, ARCH INTERN MED, V168, P1387, DOI 10.1001/archinte.168.13.1387
   McKinlay JB, 2002, J HEALTH SOC BEHAV, V43, P92, DOI 10.2307/3090247
   Newlove J., 2004, LABAN FOR ALL
   Noirhomme-Fraiture M, 2008, LECT NOTES COMPUT SC, V4404, P236, DOI 10.1007/978-3-540-71080-6_15
   Pendleton D., 1983, DOCTOR PATIENT COMMU, P5
   Perakyla A, 1998, SOC PSYCHOL QUART, V61, P301, DOI 10.2307/2787032
   Pfeifer R., 2007, BODY SHAPES WAY WE T
   Pike WA, 2009, INFORM VISUAL, V8, P263, DOI 10.1057/ivs.2009.22
   Raman T.V., 2003, WORKSH PRINC MULT US
   Reeves LM, 2004, COMMUN ACM, V47, P57, DOI 10.1145/962081.962106
   Roberts C, 2005, MED EDUC, V39, P632, DOI 10.1111/j.1365-2929.2005.02171.x
   Roter D, 2006, DOCTORS TALKING PATI
   Rycroft-Malone J., 2002, PATIENT PARTICIPATIO
   SCHIFFRIN D, 2003, HDB DISCOURSE ANAL
   Thomas J.J., 2005, ILLUMINATING PATH RE
   Watzlawick P., 1967, PRAGMATICS HUMAN COM
   Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322
   Wylie Jacqueline L, 2004, J Healthc Qual, V26, P14
   Zurita L., 2004, MEDINFO 2004
NR 48
TC 1
Z9 1
U1 3
U2 13
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1386-5056
EI 1872-8243
J9 INT J MED INFORM
JI Int. J. Med. Inform.
PD DEC
PY 2011
VL 80
IS 12
BP E230
EP E244
DI 10.1016/j.ijmedinf.2011.08.013
PG 15
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA 862HQ
UT WOS:000298081500004
PM 21983222
DA 2018-12-27
ER

PT J
AU Baine, AMT
   Hori, T
   Chen, F
   Gardner, LB
   Uemoto, S
   Nguyen, JH
AF Baine, Ann-Marie T.
   Hori, Tomohide
   Chen, Feng
   Gardner, Lindsay B.
   Uemoto, Shinji
   Nguyen, Justin H.
TI RETRACTED: Fulminant liver failure models with subsequent encephalopathy
   in the mouse (Retracted article. See vol. 11, pg. 202, 2012)
SO HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
LA English
DT Article; Retracted Publication
DE animal model; acute liver failure; azoxymethane; galactosamine; tumor
   necrosis factor-alpha
ID TUMOR-NECROSIS-FACTOR; ACUTE HEPATIC-FAILURE; INDUCED LETHAL HEPATITIS;
   ANIMAL-MODELS; MILD HYPOTHERMIA; BRAIN EDEMA; MICE; TRANSPLANTATION;
   MANAGEMENT; RATS
AB BACKGROUND: A reliable model of fulminant liver failure (FLF) is urgently required in this research field. This study aimed to develop a murine FLF model.
   METHODS: We used three groups of male C57BL/6 mice: control, with azoxymethane treatment (AOM group), and with galactosamine and tumor necrosis factor-alpha treatment (Gal+TNF-alpha group). The effects of body temperature (BT) control on survival in all three groups were investigated. Using BT control, we compared the survival, histopathological findings and biochemical/coagulation profiles between the two experimental groups. The effects of hydration on international normalized ratios of prothrombin time (PT-INRs) were also checked. Dose-dependent survival curves were constructed for both experimental groups. Neurological behavior was assessed using a coma scale.
   RESULTS: No unexpected BT effects were seen in the control group. The AOM group, but not the Gal+TNF-alpha group, showed a significant difference in survival curves between those with and without BT care. Histopathological assessment showed consistent FLF findings in both experimental groups with BT care. There were significant differences between the experimental groups in aspartate aminotransferase levels and PT-INRs, and significant differences in PT-INRs between the sufficiently and insufficiently hydrated groups. There were significant differences between FLF models in the duration of each coma stage, with significant differences in stages 1 and 3 as percentages of the disease state (stages 1-4). The two FLF models with BT care showed different survival curves in the dose-dependent survival study.
   CONCLUSIONS: AOM provides a good FLF model, but requires a specialized environment and careful BT control. Other FLF models may also be useful, depending on the research purpose. Thoughtful attention to caregiving and close observation are indispensable for successful FLF models.
C1 [Baine, Ann-Marie T.; Hori, Tomohide; Chen, Feng; Gardner, Lindsay B.] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL 32224 USA.
   [Nguyen, Justin H.] Mayo Clin Florida, Div Transplant Surg, Dept Transplantat, Jacksonville, FL 32224 USA.
   [Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatopancreatobiliary Surg, Kyoto 6068507, Japan.
   [Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Div Transplant Surg, Kyoto 6068507, Japan.
   [Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Div Pediat Surg, Kyoto 6068507, Japan.
RP Hori, T (reprint author), Mayo Clin Florida, Dept Neurosci, Birdsall Res Bldg 323,3rd Floor,4500 San Pablo Rd, Jacksonville, FL 32224 USA.
EM hori.tomohide@mayo.edu
FU Deason Foundation (Mayo Clinic CD CRT-II); AHA [0655589B]; NIH
   [R0INS051646-01A2]; Uehara Memorial Foundation [200940051]
FX This work was partly supported by grants from the Deason Foundation
   (Sandra and Eugene Davenport, Mayo Clinic CD CRT-II), the AHA
   (0655589B), the NIH (R0INS051646-01A2), and the Uehara Memorial
   Foundation (200940051).
CR Azoulay D, 2001, ANN SURG, V234, P723, DOI 10.1097/00000658-200112000-00003
   Belanger M, 2006, NEUROCHEM INT, V48, P434, DOI 10.1016/j.neuint.2005.11.022
   Bemeur C, 2010, METAB BRAIN DIS, V25, P241, DOI 10.1007/s11011-010-9201-2
   Bemeur C, 2010, METAB BRAIN DIS, V25, P23, DOI 10.1007/s11011-010-9186-x
   BLITZER BL, 1978, GASTROENTEROLOGY, V74, P664
   Butterworth RF, 2011, HEPATOLOGY, V53, P1372, DOI 10.1002/hep.24228
   CHAPMAN RW, 1990, LANCET, V335, P32, DOI 10.1016/0140-6736(90)90150-4
   Chen F, 2011, HEPATOLOGY, V53, P1294, DOI 10.1002/hep.24161
   Chen F, 2009, HEPATOLOGY, V50, P1914, DOI 10.1002/hep.23203
   de Miranda AS, 2010, ARQ NEURO-PSIQUIAT, V68, P597, DOI 10.1590/S0004-282X2010000400022
   Ellis A, 1996, SEMIN LIVER DIS, V16, P379, DOI 10.1055/s-2007-1007251
   EMOND JC, 1989, GASTROENTEROLOGY, V96, P1583, DOI 10.1016/0016-5085(89)90530-1
   Farmer DG, 2003, ANN SURG, V237, P666, DOI 10.1097/00000658-200305000-00009
   FRANCAVILLA A, 1989, GASTROENTEROLOGY, V96, P470, DOI 10.1016/0016-5085(89)91573-4
   GUBERNATIS G, 1991, WORLD J SURG, V15, P660, DOI 10.1007/BF01789221
   HOOFNAGLE JH, 1995, HEPATOLOGY, V21, P240, DOI 10.1016/0270-9139(95)90434-4
   Tunon MJ, 2009, WORLD J GASTROENTERO, V15, P3086, DOI 10.3748/wjg.15.3086
   KELLY JH, 1992, HEPATOLOGY, V15, P329, DOI 10.1002/hep.1840150225
   LAQUEUR GL, 1963, J NATL CANCER I, V31, P919
   LEE WM, 1993, NEW ENGL J MED, V329, P1862, DOI 10.1056/NEJM199312163292508
   LEIST M, 1995, AM J PATHOL, V146, P1220
   Libert C, 1999, CYTOKINE, V11, P617, DOI 10.1006/cyto.1998.0462
   MADDISON JE, 1987, GASTROENTEROLOGY, V93, P1062, DOI 10.1016/0016-5085(87)90570-1
   Mark AL, 2010, ANN SURG, V252, P591, DOI 10.1097/SLA.0b013e3181f4e479
   Matkowskyj KA, 1999, AM J PHYSIOL-GASTR L, V277, pG455, DOI 10.1152/ajpgi.1999.277.2.G455
   MUNOZ SJ, 1993, SEMIN LIVER DIS, V13, P395
   Newsome PN, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-34
   Newsome PN, 2000, LIVER TRANSPLANT, V6, P21, DOI 10.1016/S1527-6465(00)80029-5
   Nguyen JH, 2006, J HEPATOL, V44, P1105, DOI 10.1016/j.jhep.2005.09.019
   OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4
   Rahman TM, 2002, J SURG RES, V106, P264, DOI 10.1006/jsre.2002.6476
   Reuben A, 2010, HEPATOLOGY, V52, P2065, DOI 10.1002/hep.23937
   Shimojima N, 2008, J INVEST SURG, V21, P101, DOI 10.1080/08941930802043565
   Shito M, 2001, DIGEST DIS SCI, V46, P1700, DOI 10.1023/A:1010653504568
   SIELAFF TD, 1995, HEPATOLOGY, V21, P796, DOI 10.1002/hep.1840210329
   Song HL, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-70
   Stuart WD, 2011, HEPATOLOGY, V53, P1618, DOI 10.1002/hep.24239
   Takenaka K, 1998, DIGEST DIS SCI, V43, P887, DOI 10.1023/A:1018898905478
   TERBLANCHE J, 1991, DIGEST DIS SCI, V36, P770, DOI 10.1007/BF01311235
   TRABER P, 1989, GASTROENTEROLOGY, V96, P885
   Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642
   VANLEENHOFF JW, 1974, S AFR MED J, V48, P1201
   Vaquero J, 2007, NAT CLIN PRACT GASTR, V4, P528, DOI 10.1038/ncpgasthep0927
   Wielockx B, 2001, NAT MED, V7, P1202, DOI 10.1038/nm1101-1202
   WRIGHT N, 1984, BIOL EPITHELIAL CELL, P805
   Wullaert A, 2005, HEPATOLOGY, V42, P381, DOI 10.1002/hep.20785
   Yamamoto S, 2006, J SURG RES, V134, P307, DOI 10.1016/j.jss.2005.11.588
   ZIMMERMANN C, 1989, HEPATOLOGY, V9, P594, DOI 10.1002/hep.1840090414
NR 48
TC 2
Z9 3
U1 1
U2 11
PU ZHEJIANG UNIV SCH MEDICINE
PI HANGZHOU
PA FIRST AFFILIATED HOSPITAL, 79 QINGCHUN RD, HANGZHOU, 310003, PEOPLES R
   CHINA
SN 1499-3872
EI 2352-9377
J9 HEPATOB PANCREAT DIS
JI Hepatob. Pancreatic. Dis. Int.
PD DEC
PY 2011
VL 10
IS 6
BP 611
EP 619
DI 10.1016/S1499-3872(11)60104-5
PG 9
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 856SY
UT WOS:000297664900007
PM 22146625
DA 2018-12-27
ER

PT J
AU Curiel-Lewandrowski, C
   Yamasaki, H
   Si, CP
   Jin, XY
   Zhang, YJ
   Richmond, J
   Tuzova, M
   Wilson, K
   Sullivan, B
   Jones, D
   Ryzhenko, N
   Little, F
   Kupper, TS
   Center, DM
   Cruikshank, WW
AF Curiel-Lewandrowski, Clara
   Yamasaki, Hisato
   Si, Chuan Ping
   Jin, Xiaoyi
   Zhang, Yujun
   Richmond, Jillian
   Tuzova, Marina
   Wilson, Kevin
   Sullivan, Beth
   Jones, David
   Ryzhenko, Nataliya
   Little, Frederick
   Kupper, Thomas S.
   Center, David M.
   Cruikshank, William W.
TI RETRACTED: Loss of nuclear pro-IL-16 facilitates cell cycle progression
   in human cutaneous T cell lymphoma (Retracted article. See vol. 124, pg.
   5085, 2014)
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article; Retracted Publication
ID UBIQUITIN-MEDIATED DEGRADATION; SEZARY-SYNDROME; MYCOSIS-FUNGOIDES;
   UP-REGULATION; PDZ DOMAIN; EXPRESSION; SKP2; P27(KIP1); PATHWAY;
   LYMPHOCYTES
AB Cutaneous T cell lymphomas (CTCLs) represent a heterogeneous group of non-Hodgkin lymphomas that affect the skin. The pathogenesis of these conditions is poorly understood. For example, the signaling mechanisms contributing to the dysregulated growth of the neoplastic T cells are not well defined. Here, we demonstrate that loss of nuclear localization of pro-IL-16 facilitates CTCL cell proliferation by causing a decrease in expression of the cyclin dependent-kinase inhibitor p27Kipl. The decrease in p27Kipl expression was directly attributable to an increase in expression of S-phase kinase-associated protein 2 (Skp2). Regulation of Skp2 is in part attributed to the nuclear presence of the scaffold protein pro-IL-16. T cells isolated from 11 patients with advanced CTCL, but not those from healthy controls or patients with T cell acute lymphocytic leukemia (T-ALL), demonstrated reduction in nuclear pro-IL-16 levels. Sequence analysis identified the presence of mutations in the 5' end of the PDZ1 region of pro-IL-16, a domain required for association of pro-IL-16 with the nuclear chaperone HSC70 (also known as HSPA8). HSC70 knockdown led to loss of nuclear translocation by pro-IL-16 and subsequent increases in Skp2 levels and decreases in p27Kipl levels, which ultimately enhanced T cell proliferation. Thus, our data indicate that advanced CTCL cell growth is facilitated, at least in part, by mutations in the scaffold protein pro-IL-16, which directly regulates Skp2 synthesis.
C1 [Yamasaki, Hisato; Si, Chuan Ping; Jin, Xiaoyi; Zhang, Yujun; Richmond, Jillian; Tuzova, Marina; Wilson, Kevin; Ryzhenko, Nataliya; Little, Frederick; Center, David M.; Cruikshank, William W.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA.
   [Curiel-Lewandrowski, Clara] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Dermatol,Cutaneous Oncol Program, Boston, MA 02215 USA.
   [Curiel-Lewandrowski, Clara] Univ Arizona, Dermatol Sect, Tucson, AZ USA.
   [Curiel-Lewandrowski, Clara] Univ Arizona, Arizona Canc Ctr, Skin Canc Inst, Tucson, AZ USA.
   [Sullivan, Beth] Duke Med Sch, Dept Mol Genet & Microbiol, Durham, NC USA.
   [Jones, David; Kupper, Thomas S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA.
RP Cruikshank, WW (reprint author), Boston Univ, Sch Med, Ctr Pulm, R-3,715 Albany St, Boston, MA 02118 USA.
EM bcruiksh@bu.edu
FU NIH NCI; Harvard University; SPORE in Skin Cancer; NCI; Alan and Janice
   Levin Endowed Chair in Cancer Research, University of Arizona
FX This work was supported by NIH NCI institutional support (to W.W.
   Cruikshank) and Harvard University, SPORE in Skin Cancer, Career
   Development Award from the NCI (to T.S. Kupper) and the Alan and Janice
   Levin Endowed Chair in Cancer Research, University of Arizona (to C.
   Curiel-Lewandrowski).
CR Amati B, 1999, NAT CELL BIOL, V1, pE91, DOI 10.1038/12087
   Appleman LJ, 2006, CELL CYCLE, V5, P2123, DOI 10.4161/cc.5.18.3139
   Asadullah K, 2000, EXP DERMATOL, V9, P248, DOI 10.1034/j.1600-0625.2000.009004248.x
   Bagui TK, 2009, CELL CYCLE, V8, P115, DOI 10.4161/cc.8.1.7527
   Blaschke S, 2001, J RHEUMATOL, V28, P12
   Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013
   Center DM, 2004, J IMMUNOL, V172, P1654, DOI 10.4049/jimmunol.172.3.1654
   CENTER DM, 2001, CURR PROTOC IMMUNOL, pCH6
   Chromy LR, 2003, P NATL ACAD SCI USA, V100, P10477, DOI 10.1073/pnas.1832245100
   Chupp GL, 1998, J IMMUNOL, V161, P3114
   Contassot E, 2008, BLOOD, V111, P4780, DOI 10.1182/blood-2007-08-109074
   Cruikshank W W, 1998, Int Rev Immunol, V16, P523, DOI 10.3109/08830189809043007
   Cruikshank W, 2008, CRIT REV IMMUNOL, V28, P467
   Dehan E, 2005, CANCER CELL, V7, P209, DOI 10.1016/j.ccr.2005.02.014
   Dobbeling U, 1998, BLOOD, V92, P252
   Fischer TC, 2004, J INVEST DERMATOL, V122, P579, DOI 10.1111/j.0022-202X.2004.22301.x
   Foss F, 2004, CURR OPIN ONCOL, V16, P421, DOI 10.1097/00001622-200409000-00002
   Furuhata A, 2009, BIOCHEM BIOPH RES CO, V383, P411, DOI 10.1016/j.bbrc.2009.04.015
   Garrett-Engele CM, 2007, PLOS GENET, V3, P2415, DOI 10.1371/journal.pgen.0030219
   Green DS, 2009, J VIROL, V83, P5765, DOI 10.1128/JVI.00130-09
   Guo DM, 2009, LEUKEMIA RES, V33, P678, DOI 10.1016/j.leukres.2008.10.026
   Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102
   Hwang ST, 2008, LANCET, V371, P945, DOI 10.1016/S0140-6736(08)60420-1
   Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4
   Kim HS, 1999, CYTOGENET CELL GENET, V84, P93, DOI 10.1159/000015224
   Klemke CD, 2009, CANCER RES, V69, P4175, DOI 10.1158/0008-5472.CAN-08-4631
   Lansigan F, 2008, HEMATOL ONCOL CLIN N, V22, P979, DOI 10.1016/j.hoc.2008.07.014
   Lee M, 2007, CANCER IMMUNOL IMMUN, V56, P783, DOI 10.1007/s00262-006-0239-2
   Lim MS, 2002, BLOOD, V100, P2950, DOI 10.1182/blood.V100.8.2950
   Lwin T, 2007, BLOOD, V110, P1631, DOI 10.1182/blood-2006-11-060350
   Lynch EA, 2003, J IMMUNOL, V171, P4965, DOI 10.4049/jimmunol.171.10.4965
   Mao X, 2003, GENE CHROMOSOME CANC, V36, P250, DOI 10.1002/gcc.10152
   Mao X, 2002, BRIT J DERMATOL, V147, P464, DOI 10.1046/j.1365-2133.2002.04966.x
   Mao X, 2008, J CUTAN PATHOL, V35, P899, DOI 10.1111/j.1600-0560.2007.00924.x
   Marzec M, 2008, BLOOD, V111, P2181, DOI 10.1182/blood-2006-06-095182
   McCann SA, 2007, NURS CLIN N AM, V42, P421, DOI 10.1016/j.cnur.2007.07.002
   McFadden C, 2007, J IMMUNOL, V179, P6439, DOI 10.4049/jimmunol.179.10.6439
   Muhlhahn P, 1998, NAT STRUCT BIOL, V5, P682, DOI 10.1038/1376
   Ni X, 2005, J INVEST DERMATOL, V124, P741, DOI 10.1111/j.0022-202X.2005.23657.x
   Pierson DM, 2008, CYTOM PART B-CLIN CY, V74B, P341, DOI 10.1002/cyto.b.20431
   Qin JZ, 2001, J INVEST DERMATOL, V117, P583, DOI 10.1046/j.0022-202x.2001.01436.x
   Qin JZ, 2001, BLOOD, V98, P2778, DOI 10.1182/blood.V98.9.2778
   Ren FC, 2005, J IMMUNOL, V174, P2738, DOI 10.4049/jimmunol.174.5.2738
   Richmond J, 2011, J CLIN IMMUNOL, V31, P39, DOI 10.1007/s10875-010-9464-8
   Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05
   Scarisbrick JJ, 2002, J INVEST DERMATOL, V118, P493, DOI 10.1046/j.0022-202x.2001.01682.x
   Scott SA, 2004, LEUKEMIA RES, V28, P1293, DOI 10.1016/j.leukres.2004.03.019
   Seki R, 2003, AM J HEMATOL, V73, P230, DOI 10.1002/ajh.10379
   van Doorn R, 2005, J CLIN ONCOL, V23, P3886, DOI 10.1200/JCO.2005.11.353
   Vonderheid EC, 2003, HEMATOL ONCOL CLIN N, V17, P1367, DOI 10.1016/S0889-8588(03)00120-5
   Wain EM, 2005, GENE CHROMOSOME CANC, V42, P184, DOI 10.1002/gcc.20115
   Wilson KC, 2005, CELL IMMUNOL, V237, P17, DOI 10.1016/j.cellimm.2005.09.003
   Wilson KC, 2003, VIROLOGY, V306, P60, DOI 10.1016/S0042-6822(02)00056-9
   Wilson KC, 2002, BIOCHEMISTRY-US, V41, P14306, DOI 10.1021/bi020163v
   Wolowiec D, 2009, EUR J HAEMATOL, V82, P260, DOI 10.1111/j.1600-0609.2008.01196.x
   Wu JQ, 2009, J INVEST DERMATOL, V129, P1165, DOI 10.1038/jid.2008.309
   Xiang-Lan M, 2008, TRANSL RES, V151, P303, DOI 10.1016/j.trsl.2008.04.004
   Yamanaka K, 2006, BLOOD, V107, P2440, DOI 10.1182/blood-2005-03-1139
   Yamanaka K, 2006, CLIN CANCER RES, V12, P376, DOI 10.1158/1078-0432.CCR-05-1777
   Zhang CL, 2007, HUM PATHOL, V38, P995, DOI 10.1016/j.humpath.2006.10.021
   Zhang XM, 2002, CELL RES, V12, P363, DOI 10.1038/sj.cr.7290138
   Zhang YJ, 1998, J BIOL CHEM, V273, P1144, DOI 10.1074/jbc.273.2.1144
   Zhang YJ, 2001, J BIOL CHEM, V276, P1299, DOI 10.1074/jbc.M008513200
   Zhang YJ, 2008, J IMMUNOL, V180, P402, DOI 10.4049/jimmunol.180.1.402
NR 64
TC 13
Z9 14
U1 2
U2 9
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD DEC
PY 2011
VL 121
IS 12
BP 4838
EP 4849
DI 10.1172/JCI41769
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 855XL
UT WOS:000297599500031
PM 22080865
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Barnett, RLE
AF Barnett, R. -L. Etienne
TI RETRACTED: The proofs of a Roche labyrinth (Retracted article. See vol.
   42, pg. 359, 2015)
SO NEOHELICON
LA French
DT Article; Retracted Publication
AB In the textualized universe of Denis Roche, the poetic impulse is inextricably linked to the unstable framework in which such matter is cast. Utterances of language translate the power of transgression. The text is birthed as an object of inquiry, ultimately to be dismantled: the poem is both A << inadmissible A >> and A << inexistant A >> . As a self-fixed interrogator focused upon the residual matter that it is and which it only can be, it is no longer subservient to the references it struggles to invoke, much less to signify. Writing, then, as an unending auto-reflexive process of annihilation and reification, and subsists, as such, to the sole extent that it disassociates from all conventional voices of articulation. More obtusely, to poeticize is to re-transcribe-otherly and with abruptness-the withered sputtering(s) of the artistic imperative. Poetry, like photography, aims and frames, slices the world into sequences and images-partial, scattered, at once undone so as to be resuscitated, briefly, again. The extant is eschewed. At stake and at center-stage: a propelled form of motivity, speed, accelerations and dead-stops, an aleatory array of unremitting shifts, A << instantan,es A >>-obstinately un-emblematic. Raging or controlled, the poem or the photo can only be a non-representational sliver, the transitory residue of an infinite combinatorics of possibles. Hence, arbitrary breaches, clamoring interruptions, ludic contortions of incompleteness. A curious dynamic.
C1 [Barnett, R. -L. Etienne] Univ Atlanta, Off Univ Provost & Execut Vice President Operat, Atlanta, GA 30360 USA.
   [Barnett, R. -L. Etienne] CNRS, F-75005 Paris, France.
RP Barnett, RLE (reprint author), Univ Atlanta, Off Univ Provost & Execut Vice President Operat, Atlanta, GA 30360 USA.
EM RL_Barnett@msn.com
CR Barthes R., 1984, BRUISSEMENT LANGUE
   Benjamin Walter, 1991, ECRITS FRANCAIS
   Boulez Pierre, 1963, PENSER MUSIQUE AUJOU
   Diderot D, 1758, DISCOURS POESIE DRAM
   Kandinsky W, 1926, POINT LIGNE PLAN
   Roche D, 1969, CARNAC MESAVENTURES
   Roche D, 1990, HEXAMERON
   Roche D, 1996, EMBARQUEMENT MERCURE
   Roche D, 1962, FORESTIERE AMAZONIDE
   Roche D, 1964, IDEES CENTESIMALES M
   Roche D, 1988, PHOTOLALIES
   Roche D, 1963, RECITS COMPLETS TEL
   Roche D, 1964, EROS ENERGUMENE TEL
   Roche D, 2007, PHOTOGRAPHIE EST INT
   Roche D, 1976, FICTION CIE
   Roche D, 1978, ANTEFIXE FRANCOISE P
   Roche D, 1972, MECRIT TEL QUEL
   Roche D, 1972, POURRISSEMENTS POETI
   Roche D, 1992, DANS MAISON SPHINX
   Roche D, 1988, PROSE AU DEVANT FEMM
   Roche D, 1981, LEGENDES D ROCHE
   Roche D, 1988, ECRITS MOMENTANES CH
   Roche D, 1999, BOITIER MELANCOLIE
   Roche D, 1991, ELLIPSE LAPS
   Roche D, 1980, QUOI SERT LVNX RIEN
   Roche D, 1985, CONVERSATIONS AVEC T
   Roche D, 1986, VARESE
   Roche D, 1988, LETT OUVERTE QUELQUE
   Roche Denis, 1982, DISPARITION LUCIOLES
   Roche Denis, 1995, POESIE EST INADMISSI
   Roche Denis, 1978, NOTRE ANTEFIXE
   Roche Denis, 1980, DEPOTS SAVOIR TECHNI
NR 32
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0324-4652
EI 1588-2810
J9 NEOHELICON
JI Neohelicon
PD DEC
PY 2011
VL 38
IS 2
BP 457
EP 464
DI 10.1007/s11059-011-0111-z
PG 8
WC Literature
SC Literature
GA 852KB
UT WOS:000297355600018
DA 2018-12-27
ER

PT J
AU Hagiwara, S
   Iwasaka, H
   Hasegawa, A
   Hidaka, S
   Uno, A
   Kaori, U
   Uchida, T
   Noguchi, T
AF Hagiwara, Satoshi
   Iwasaka, Hideo
   Hasegawa, Akira
   Hidaka, Seigo
   Uno, Aya
   Kaori, Ueo
   Uchida, Tomohisa
   Noguchi, Takayuki
TI RETRACTED: Continuous Hemodiafiltration Therapy Ameliorates LPS-Induced
   Systemic Inflammation in a Rat Model (Retracted article. See vol. 200,
   pg. 408, 2016)
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article; Retracted Publication
DE systemic inflammation; TNF-alpha; interleukin-6; high mobility group box
   1 protein (HMGB1); lung injury; liver injury
ID ORGAN DYSFUNCTION; RESPONSE SYNDROME; SEPSIS; HEMOFILTRATION; INHIBITOR;
   CYTOKINE; FAILURE; BEDSIDE; INJURY; BENCH
C1 [Hagiwara, Satoshi; Iwasaka, Hideo; Hasegawa, Akira; Hidaka, Seigo; Uno, Aya; Kaori, Ueo; Noguchi, Takayuki] Oita Univ, Fac Med, Dept Anesthesiol & Intens Care Med, Yufu City, Oita 8795593, Japan.
   [Uchida, Tomohisa] Oita Univ, Fac Med, Dept Mol Pathol, Yufu City, Oita 8795593, Japan.
RP Hagiwara, S (reprint author), Oita Univ, Fac Med, Dept Anesthesiol & Intens Care Med, 1-1 Idaigaoka Hasamamachi, Yufu City, Oita 8795593, Japan.
EM saku@med.oita-u.ac.jp
FU Kakenhi
FX The authors thank Hiroaki Kawazato and Aiko Yasuda for their helpful
   advice on the preparation of tissue specimens. They thank Dr. Tomohisa
   Uchida for scoring both lung and liver tissue specimens. This study was
   supported by a Grant-in-Aid for Scientific Research (Kakenhi).
CR Bellomo R, 1996, SEMIN DIALYSIS, V9, P88, DOI 10.1111/j.1525-139X.1996.tb00631.x
   BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002
   Bone RC, 1996, CRIT CARE MED, V24, P163, DOI 10.1097/00003246-199601000-00026
   Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009
   CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001
   Clark W R, 1992, ASAIO J, V38, pM664, DOI 10.1097/00002480-199207000-00120
   Fink MP, 2007, CRIT CARE, V11, DOI 10.1186/cc6088
   Hagiwara S, 2009, INFLAMM RES, V58, P198, DOI 10.1007/s00011-008-8131-5
   Hagiwara S, 2009, INTENS CARE MED, V35, P1471, DOI 10.1007/s00134-009-1545-x
   Hagiwara S, 2009, CRIT CARE MED, V37, P626, DOI 10.1097/CCM.0b013e3181958d91
   Heijnen BHM, 2003, SURGERY, V134, P806, DOI 10.1016/S0039-6060(03)00125-9
   Karlsson S, 2008, INTENS CARE MED, V34, P1046, DOI 10.1007/s00134-008-1032-9
   Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune
   Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139
   MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301
   Murakami K, 2002, SHOCK, V18, P236, DOI 10.1097/00024382-200209000-00006
   Nakada T, 2008, MOL MED, V14, P257, DOI 10.2119/2007-00108.Nakada
   Page B, 2005, CRIT CARE, V9, pR755, DOI 10.1186/cc3886
   Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523
   Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632
   Silva E, 2008, CLINICS, V63, P109
   Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248
NR 22
TC 7
Z9 8
U1 2
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
EI 1095-8673
J9 J SURG RES
JI J. Surg. Res.
PD DEC
PY 2011
VL 171
IS 2
BP 791
EP 796
DI 10.1016/j.jss.2010.07.029
PG 6
WC Surgery
SC Surgery
GA 847FS
UT WOS:000296957900075
PM 20851419
DA 2018-12-27
ER

PT J
AU Hunton, JE
   Hoitash, R
   Thibodeau, JC
AF Hunton, James E.
   Hoitash, Rani
   Thibodeau, Jay C.
TI RETRACTED: The Relationship between Perceived Tone at the Top and
   Earnings Quality (Retracted article. See vol. 31, pg. 937, 2014)
SO CONTEMPORARY ACCOUNTING RESEARCH
LA English
DT Correction; Retracted Publication
ID INTERNAL CONTROL DEFICIENCIES; ACCRUAL ESTIMATION ERRORS; SARBANES-OXLEY
   ACT; AUDIT COMMITTEE; CORPORATE GOVERNANCE; ETHICAL LEADERSHIP;
   EMPIRICAL-ANALYSIS; DECISION-MAKING; PERFORMANCE; MANAGEMENT
AB This study examines the relationship between the strength of an organization's tone at the top and the quality of its reported earnings using a unique combination of survey and archival data related to 123 public companies. Tone at the top is assessed by surveying midlevel financial reporting managers' perceptions about upper management's attitude toward improving internal control quality, making ethical decisions, and meeting or beating earnings targets. The survey data is linked to archival indicators of internal control, corporate governance and earnings quality. The results suggest that tone at the top perceptions are positively associated with higher quality boards, greater CEO age, and lower CEO compensation; interestingly, CFO attributes (age, tenure, and compensation) are not significantly associated with perceived tone at the top. The findings also indicate that tone at the top perceptions and audit committee quality are positively associated with earnings quality. While there is no significant relationship between tone at the top perceptions and SOX Section 404 internal control deficiency disclosures, such perceptions are positively related to Section 302 disclosures, suggesting that tone at the top perceptions increase as upper management voluntarily tests and reports more internal control material weaknesses. This study contributes to extant corporate governance literature by associating a key subjective aspect of the internal control environment (tone at the top perceptions) with archival indicators of earnings quality, supports a recommendation of the COSO (2010) report encouraging auditors to assess top management's integrity, and stimulates future tone at the top research.
C1 [Hunton, James E.; Hoitash, Rani; Thibodeau, Jay C.] Bentley Univ, Waltham, MA 02452 USA.
RP Hunton, JE (reprint author), Bentley Univ, Waltham, MA 02452 USA.
CR Abbott LJ, 2004, AUDITING-J PRACT TH, V23, P69, DOI 10.2308/aud.2004.23.1.69
   Adams RB, 2005, REV FINANC STUD, V18, P1403, DOI 10.1093/rfs/hhi030
   Archambeaut D., 2001, INT J AUDITING, V5, P33
   Ashbaugh-Skaife H, 2008, ACCOUNT REV, V83, P217, DOI 10.2308/accr.2008.83.1.217
   Ashbaugh-Skaife H, 2007, J ACCOUNT ECON, V44, P166, DOI 10.1016/j.jacceco.2006.10.001
   Ashbaugh-Skaife H, 2009, J ACCOUNT RES, V47, P1, DOI 10.1111/j.1475-679X.2008.00315.x
   Barker VL, 2002, MANAGE SCI, V48, P782, DOI 10.1287/mnsc.48.6.782.187
   Beasley M., 2000, ACCOUNT HORIZ, V14, P441, DOI DOI 10.2308/ACCH.2000.14.4.441
   Beasley MS, 1996, ACCOUNT REV, V71, P443
   Bebchuk L. A, 2008, CEO CENTRALITY
   Bebchuk LA, 2003, J ECON PERSPECT, V17, P71, DOI 10.1257/089533003769204362
   Bedard J., 2004, AUDITING-J PRACT TH, V23, P15, DOI [10.2308/aud.2004.23.2.13, DOI 10.2308/AUD.2004.23.2.13]
   Bedard JC, 2011, ACCOUNT REV, V86, P825, DOI 10.2308/accr.00000036
   Berson Y, 2008, J ORGAN BEHAV, V29, P615, DOI 10.1002/job.499
   Bertrand M, 2003, Q J ECON, V118, P1169, DOI 10.1162/003355303322552775
   Blue Ribbon Committee (BRC), 1999, REP REC BLUE RIBB CO
   Booth P, 2004, ACCOUNT ORG SOC, V29, P473, DOI 10.1016/S0361-3682(03)00012-6
   Brown ME, 2005, ORGAN BEHAV HUM DEC, V97, P117, DOI 10.1016/j.obhdp.2005.03.002
   Brown ME, 2006, LEADERSHIP QUART, V17, P595, DOI 10.1016/j.leaqua.2006.10.004
   Bushman R, 2004, J ACCOUNT ECON, V37, P167, DOI 10.1016/j.jacceco.2003.09.005
   Carcello C, 2008, AUDIT COMMITTEE FINA
   Center for Audit Quality (CAQ), 2010, DET DET FIN REP FRAU
   Cheng S, 2008, J FINANC ECON, V87, P157, DOI 10.1016/j.jfineco.2006.10.006
   Committee of Sponsoring Organizations of the Treadway Commission (COSO), 1992, EX SUMM INT CONTR IN
   Committee of Sponsoring Organizations of the Treadway Commission (COSO), 2004, EX SUMM ENT RISK MAN
   Committee of Sponsoring Organizations of the Treadway Commission (COSO), 2010, FRAUD FIN REP 1998 2
   Core JE, 1999, J FINANC ECON, V51, P371, DOI 10.1016/S0304-405X(98)00058-0
   Dechow P., 1996, CONTEMP ACCOUNT RES, V13, P1, DOI DOI 10.1111/J.1911-3846.1996.TB00489.X
   DECHOW PM, 1995, ACCOUNT REV, V70, P193
   Dechow PM, 2002, ACCOUNT REV, V77, P35, DOI 10.2308/accr.2002.77.s-1.35
   DECHOW PM, 1991, J ACCOUNT ECON, V14, P51, DOI 10.1016/0167-7187(91)90058-S
   Deshpande SP, 1997, J BUS ETHICS, V16, P79, DOI 10.1023/A:1017917420433
   Dhaliwal D. S, 2009, AUDIT COMMITTEE FINA
   Doyle J, 2007, J ACCOUNT ECON, V44, P193, DOI 10.1016/j.acceco.2006.10.003
   Doyle JT, 2007, ACCOUNT REV, V82, P1141, DOI 10.2308/accr.2007.82.5.1141
   Ecker F, 2006, ACCOUNT REV, V81, P749
   Faleye O, 2011, J FINANC ECON, V101, P160, DOI 10.1016/j.jfineco.2011.02.010
   Fama EF, 1997, J FINANC ECON, V43, P153, DOI 10.1016/S0304-405X(96)00896-3
   FAMA EF, 1983, J LAW ECON, V26, P301, DOI 10.1086/467037
   Farber DB, 2005, ACCOUNT REV, V80, P539, DOI 10.2308/accr.2005.80.2.539
   Finkelstein S, 1998, ACAD MANAGE J, V41, P179, DOI 10.2307/257101
   Francis J, 2005, J ACCOUNT ECON, V39, P295, DOI 10.1016/j.jacceco.2004.06.003
   Goyal VK, 2002, J CORP FINANC, V8, P49, DOI 10.1016/S0929-1199(01)00028-1
   HAMBRICK DC, 1984, ACAD MANAGE REV, V9, P193, DOI 10.2307/258434
   Hammersley J. S, 2010, FAILURE REMEDIATE PR
   Hammersley JS, 2008, REV ACCOUNT STUD, V13, P141, DOI 10.1007/s11142-007-9046-z
   Hogan CE, 2008, CONTEMP ACCOUNT RES, V25, P219, DOI 10.1506/car.25.1.9
   Hoitash R, 2008, AUDITING-J PRACT TH, V27, P105, DOI 10.2308/aud.2008.27.1.105
   Hoitash U, 2009, ACCOUNT REV, V84, P839, DOI 10.2308/accr.2009.84.3.839
   Hunt TG, 1997, J BUS ETHICS, V16, P195, DOI 10.1023/A:1017987224590
   Hymowitz C, 2005, WALL STREET J   0926, pB1
   Jianakoplos NA, 2006, SOUTH ECON J, V72, P981, DOI 10.2307/20111864
   JONES JJ, 1991, J ACCOUNTING RES, V29, P193, DOI 10.2307/2491047
   JUSSIM L, 1991, PSYCHOL REV, V98, P54, DOI 10.1037//0033-295X.98.1.54
   KALBERS LP, 1993, AUDITING-J PRACT TH, V12, P24
   Kim I, 2010, MEASURING SECURITIES
   Klein A, 2002, J ACCOUNT ECON, V33, P375, DOI 10.1016/S0165-4101(02)00059-9
   Kothari SP, 2005, J ACCOUNT ECON, V39, P163, DOI 10.1016/j.jacceco.2004.11.002
   Krishnan GV, 2008, CONTEMP ACCOUNT RES, V25, P827, DOI 10.1506/car.25.3.7
   Krishnan J, 2005, ACCOUNT REV, V80, P649, DOI 10.2308/accr.2005.80.2.649
   Larcker DF, 2007, ACCOUNT REV, V82, P963, DOI 10.2308/accr.2007.82.4.963
   LIEBERMAN MB, 1990, MANAGE SCI, V36, P1193, DOI 10.1287/mnsc.36.10.1193
   Livnat J, 2006, J ACCOUNTING RES, V44, P177, DOI 10.1111/j.1475-679X.2006.00196.x
   MacCrimmon K., 1986, TAKING RISKS
   McMullen D.A., 1996, J ACCOUNTANCY, V182, P79
   McNichols MF, 2002, ACCOUNT REV, V77, P61, DOI 10.2308/accr.2002.77.s-1.61
   MENON K, 1994, J ACCOUNT PUBLIC POL, V13, P121, DOI 10.1016/0278-4254(94)90016-7
   MERCHANT KA, 1990, ACCOUNT ORG SOC, V15, P297, DOI 10.1016/0361-3682(90)90021-L
   PINCUS K, 1989, J ACCOUNT PUBLIC POL, V8, P239, DOI 10.1016/0278-4254(89)90014-8
   Public Company Accounting Oversight Board (PCAOB), 2007, AUD STAND 5 AUD INT
   Rotemberg JJ, 2000, RAND J ECON, V31, P693, DOI 10.2307/2696355
   Schwartz MS, 2005, J BUS ETHICS, V58, P79, DOI 10.1007/s10551-005-1390-y
   Securities and Exchange Commission (SEC), 2003, DISCL REQ SECT 406 4
   Shen W, 2002, ACAD MANAGE J, V45, P1195, DOI 10.2307/3069434
   Trevino LK, 1999, CALIF MANAGE REV, V41, P131, DOI 10.2307/41165990
   U. S. House of Representatives, 2002, SARB OXL ACT SARBOX
   WALLY S, 1994, ACAD MANAGE J, V37, P932, DOI 10.2307/256605
   Weaver GR, 1999, ACAD MANAGE J, V42, P41, DOI 10.2307/256873
   Weber J, 2010, J BUS ETHICS, V92, P167, DOI 10.1007/s10551-009-0157-2
   Xie B, 2003, J CORP FINANC, V9, P295, DOI 10.1016/S0929-1199(02)00006-8
   Yermack D, 1996, J FINANC ECON, V40, P185, DOI 10.1016/0304-405X(95)00844-5
   ZHANG Y, 2007, J ACCOUNTING PUBLIC, V26, P300, DOI DOI 10.1016/J.JACCPUBPOL.2007.03.001
NR 82
TC 25
Z9 25
U1 5
U2 61
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0823-9150
EI 1911-3846
J9 CONTEMP ACCOUNT RES
JI Contemp. Account. Res.
PD WIN
PY 2011
VL 28
IS 4
BP 1190
EP +
DI 10.1111/j.1911-3846.2011.01100.x
PG 36
WC Business, Finance
SC Business & Economics
GA 840DP
UT WOS:000296418800006
DA 2018-12-27
ER

PT J
AU Sato, Y
   Iwamoto, J
   Honda, Y
AF Sato, Yoshihiro
   Iwamoto, Jun
   Honda, Yoshiaki
TI RETRACTED: Once-weekly risedronate for prevention of hip fracture in
   women with Parkinson's disease: a randomised controlled trial (Retracted
   article. See vol. 89, 2018)
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Article; Retracted Publication
ID VITAMIN-D DEFICIENCY; BONE MASS; POSTMENOPAUSAL OSTEOPOROSIS; ETIDRONATE
   THERAPY; ELDERLY-PATIENTS; RISK-FACTORS; ALENDRONATE; STROKE
AB Background Incidence of a fracture, particularly in the hip joint, is high in Parkinson's disease (PD), owing to the immobilisation-induced bone resorption and vitamin D deficiency with reduced bone mineral density (BMD). The authors previously demonstrated the lowered incidence of hip fractures in PD by daily administration of risedronate and vitamin D.
   Methods This randomised, double-blind, placebo-controlled study was conducted to determine the efficacy of 17.5 mg once-weekly risedronate in the prevention of hip fracture in women with PD. Patients were randomly assigned to 17.5 mg risedronate once a week (n=136) or a placebo (n=136) combined with daily 1000 IU of ergocalciferol. Incidence of hip fractures was compared between the two groups during the 2-year follow-up.
   Results Hip fractures occurred in 15 patients in the placebo group and 3 patients in the risedronate group. The RR for hip fractures in the risedronate group as compared with the placebo group was 0.20 (95% CI 0.06 to 0.66). In the risedronate group, serum calcium levels decreased during the follow-up, while the levels in the placebo group increased. BMD increased by 3.4% in the risedronate group and decreased by 3.2% in the placebo group (p<0.01).
   Conclusions Treatment with once-weekly risedronate and ergocalciferol prevents hip fractures in older women with PD.
C1 [Sato, Yoshihiro; Honda, Yoshiaki] Mitate Hosp, Dept Neurol, Tagawa 8260041, Japan.
   [Iwamoto, Jun] Keio Univ, Sch Med, Inst Integrated Sports Med, Tokyo, Japan.
RP Sato, Y (reprint author), Mitate Hosp, Dept Neurol, 3237 Yugeta, Tagawa 8260041, Japan.
EM y-sato@ktarn.or.jp
FU Mitate Hospital, Tagawa, Japan
FX This study was partially supported by the Mitate Hospital, Tagawa,
   Japan.
CR AITA JF, 1982, JAMA-J AM MED ASSOC, V247, P515, DOI 10.1001/jama.247.4.515
   Cramer JA, 2005, CURR MED RES OPIN, V21, P1453, DOI 10.1185/030079905X61875
   GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905
   MATSUMOTO C, 1994, CALCIFIED TISSUE INT, V55, P324, DOI 10.1007/BF00299308
   Mortensen L, 1998, J CLIN ENDOCR METAB, V83, P396, DOI 10.1210/jc.83.2.396
   Ramnemark A, 1998, OSTEOPOROSIS INT, V8, P92, DOI 10.1007/s001980050053
   Rosen CJ, 2005, J BONE MINER RES, V20, P141, DOI 10.1359/JBMR.040920
   Sato Y, 2002, BONE, V31, P114, DOI 10.1016/S8756-3282(02)00783-4
   Sato Y, 2000, J BONE MINER RES, V15, P2487, DOI 10.1359/jbmr.2000.15.12.2487
   Sato Y, 1997, NEUROLOGY, V49, P1273, DOI 10.1212/WNL.49.5.1273
   Sato Y, 2004, AM J PHYS MED REHAB, V83, P298, DOI 10.1097/01.PHM.0000122877.28631.23
   Sato Y, 2001, J NEUROL SCI, V182, P89, DOI 10.1016/S0022-510X(00)00458-5
   Sato Y, 2007, NEUROLOGY, V68, P911, DOI 10.1212/01.wnl.0000257089.50476.92
   Sato Y, 2006, MOVEMENT DISORD, V21, P924, DOI 10.1002/mds.20825
   TAGGART H, 1995, AGE AGEING, V24, P326, DOI 10.1093/ageing/24.4.326
NR 15
TC 11
Z9 11
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 1468-330X
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD DEC
PY 2011
VL 82
IS 12
BP 1390
EP 1393
DI 10.1136/jnnp.2011.244574
PG 4
WC Clinical Neurology; Psychiatry; Surgery
SC Neurosciences & Neurology; Psychiatry; Surgery
GA 844RX
UT WOS:000296766100019
PM 21825080
DA 2018-12-27
ER

PT J
AU Palgunadi, J
   Indarto, A
AF Palgunadi, Jelliarko
   Indarto, Antonius
TI RETRACTED: Room temperature ionic liquids for propyne-propylene
   separations: Solubility behaviors and selectivity investigation
   (Retracted article. See vol. 91, pg. 226, 2013)
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article; Retracted Publication
DE Propyne; Propylene; Separation; Solubility; Selectivity; Thermochemistry
ID REGULAR SOLUTION THEORY; GAS SOLUBILITY; AB-INITIO; HYDROGENATION;
   CATALYSTS; PALLADIUM; NITROGEN; DIOXIDE; METHANE; SOLVENT
AB Room temperature ionic liquids (RTILs) have been discovered as very promising media for acetylene-ethylene separation. In this work, propyne and propylene solubility behaviors in dialkylimidazolium-based RTILs bearing various kinds of anions have been investigated for the feasible extraction process of propyne from propylene mixture. Solubility-molar volume relationship supported by thermodynamic analysis indicated that physical absorption mechanism plays dominantly in determining the propylene solubility. Meanwhile, unlike the acetylene solubility, which is controlled almost exclusively by hydrogen bonding interaction (chemical interaction) between the anion of RTIL and the solute, the solubility of propyne is a result from a tradeoff between chemical and physical interactions. Generally speaking, the trend of the ideal absorption selectivity for propyne over propylene is close to the acetylene-ethylene case where the higher the hydrogen bond basicity and the smaller the molar volume of RTIL results in the greater the selectivity for propyne. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Indarto, Antonius] Inst Teknol Bandung, Dept Chem Engn, Bandung 40132, Indonesia.
   [Palgunadi, Jelliarko] Kyung Hee Univ, Dept Chem, Seoul 130701, South Korea.
   [Palgunadi, Jelliarko] Kyung Hee Univ, Res Inst Basic Sci, Seoul 130701, South Korea.
RP Indarto, A (reprint author), Inst Teknol Bandung, Dept Chem Engn, Labtek 10,Kampus ITB,Jalan Ganesha 10, Bandung 40132, Indonesia.
EM jelliarko@gmail.com; antonius.indarto@che.itb.ac.id
OI Indarto, Antonius/0000-0002-8650-3973
CR Buckl K., 2008, PROPYNE ULLMANNS ENC
   Burkhardt H, 2004, J SPACECRAFT ROCKETS, V41, P762, DOI 10.2514/1.2672
   Camper D, 2006, IND ENG CHEM RES, V45, P445, DOI 10.1021/ie0506668
   Camper D, 2005, IND ENG CHEM RES, V44, P1928, DOI 10.1021/ie049312r
   Camper D, 2004, IND ENG CHEM RES, V43, P3049, DOI 10.1021/ie034097k
   Camper D, 2006, IND ENG CHEM RES, V45, P6279, DOI 10.1021/ie060177n
   Crowhurst L, 2003, PHYS CHEM CHEM PHYS, V5, P2790, DOI 10.1039/b303095d
   Dymond J. H., 2002, VIRIAL COEFFICIENTS
   Eisele P., 2008, PROPENE ULLMANNS ENC
   Finotello A, 2008, IND ENG CHEM RES, V47, P3453, DOI 10.1021/ie0704142
   Gwinner B, 2006, IND ENG CHEM RES, V45, P5044, DOI 10.1021/ie0580396
   Holbrey JD, 2002, GREEN CHEM, V4, P407, DOI 10.1039/b204469b
   JACKSON SD, 1995, J CHEM SOC FARADAY T, V91, P3269, DOI 10.1039/ft9959103269
   Jacquemin J, 2006, J CHEM THERMODYN, V38, P490, DOI 10.1016/j.jct.2005.07.002
   Kennedy DR, 2004, APPL CATAL A-GEN, V259, P109, DOI 10.1016/j.apcata.2003.09.018
   Kim JH, 2010, PHYS CHEM CHEM PHYS, V12, P14196, DOI 10.1039/c004140h
   KRAUSE D, 1989, J SOLUTION CHEM, V18, P823, DOI 10.1007/BF00685062
   Kuhlmann E, 2007, GREEN CHEM, V9, P233, DOI 10.1039/b611974c
   Liu CQ, 1997, J MEMBRANE SCI, V137, P139, DOI 10.1016/S0376-7388(97)00191-9
   Mardyukov A, 2009, J PHYS CHEM A, V113, P1086, DOI 10.1021/jp806675n
   Palgunadi J, 2011, J PHYS CHEM B, V115, P1067, DOI 10.1021/jp108351f
   Palgunadi J, 2010, CHEM ENG PROCESS, V49, P192, DOI 10.1016/j.cep.2009.12.009
   Palgunadi J, 2009, THERMOCHIM ACTA, V494, P94, DOI 10.1016/j.tca.2009.04.022
   Sanchez-Garcia E, 2004, J PHYS CHEM A, V108, P11846, DOI 10.1021/jp0485082
   Scovazzo P, 2004, IND ENG CHEM RES, V43, P6855, DOI 10.1021/ie049601f
   Shiflett MB, 2010, IND ENG CHEM RES, V49, P1370, DOI 10.1021/ie901254f
   Sims P.F., 1996, US Patent, Patent No. 5744071
   Sundararajan K, 2007, J MOL STRUCT, V833, P150, DOI 10.1016/j.molstruc.2006.09.012
   Tempel DJ, 2008, J AM CHEM SOC, V130, P400, DOI 10.1021/ja077233b
   Wilkes J.S., 2008, IONIC LIQUIDS SYNTHE, V1
NR 30
TC 7
Z9 7
U1 3
U2 42
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD DEC 1
PY 2011
VL 66
IS 23
BP 6039
EP 6047
DI 10.1016/j.ces.2011.08.030
PG 9
WC Engineering, Chemical
SC Engineering
GA 836FY
UT WOS:000296097200027
DA 2018-12-27
ER

PT J
AU Luo, HJ
   Huang, WY
   Wang, DY
   Wang, HJ
   Nie, K
AF Luo, HongLin
   Huang, Weiyi
   Wang, Dongying
   Wang, Haoju
   Nie, Kui
TI RETRACTED: The absence of MyD88 has no effect on the induction of
   alternatively activated macrophage during Fasciola hepatica infection
   (Retracted article. See vol. 13, 3, 2011)
SO BMC IMMUNOLOGY
LA English
DT Article; Retracted Publication
ID INTESTINAL NEMATODE INFECTION; INNATE IMMUNE-RESPONSES; HELMINTH
   INFECTION; TYPE-2 INFLAMMATION; MURINE MACROPHAGES; ARGINASE ISOFORMS;
   LEISHMANIA-MAJOR; TRICHURIS-MURIS; DENDRITIC CELLS; MYELOID CELLS
AB Background: Alternatively activated macrophages (AAM phi) play important roles in allergies and responses to parasitic infections. However, whether signaling through toll-like receptors (TLRs) plays any role in AAM phi induction when young Fasciola hepatica penetrates the liver capsule and migrates through the liver tissue is still unclear.
   Results: The data show that the lack of myeloid differentiation factor 88 (MyD88) has no effect on the AAM phi derived from the bone marrow (BMM phi) in vitro and does not impair the mRNA expression of arginase-1, resistin-like molecule (RELM alpha), and Ym1 in BMM phi s. The Th2 cytokine production bias in splenocytes was not significantly altered in F. hepatica-infected mice in the absence of MyD88 in vitro and in the pleural cavity lavage in vivo. In addition, MyD88-deficiency has no effect on the arginase production of the F. hepatica elicited macrophages (Fe M phi s), production of RELM alpha and Ym1 proteins and mRNA expression of Ym1 and RELM alpha of macrophages in the peritoneal cavity 6 weeks post F. hepatica infection.
   Conclusions: The absence of MyD88 has no effect on presence of AAM phi 6 weeks post F. hepatica infection.
C1 [Luo, HongLin; Wang, Haoju; Nie, Kui] Southwest Univ, Coll Anim Sci & Technol, Lab Infect & Immunol Res, Chongqing, Peoples R China.
   [Huang, Weiyi; Wang, Dongying] Guangxi Univ, Coll Anim Sci & Technol, Dept Parasitol, Nanning 530004, Peoples R China.
   [Wang, Dongying] Ecole Natl Vet Alfort, UMR BIPAR, ENVA, Maisons Alfort, France.
RP Luo, HJ (reprint author), Southwest Univ, Coll Anim Sci & Technol, Lab Infect & Immunol Res, Chongqing, Peoples R China.
EM lhl200296@yahoo.cn
FU China Scholarship Council (CSC); Fundamental Research Funds for the
   Central Universities [XDJK2009B001]
FX This work was supported by China Scholarship Council (CSC) and the
   Fundamental Research Funds for the Central Universities (XDJK2009B001).
   We are grateful to Nick Green for excellent technical assistance and
   Professor Wang hong for reading of the manuscript.
CR Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1415
   Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7
   Carvalho L, 2009, IMMUNOLOGY, V126, P28, DOI 10.1111/j.1365-2567.2008.03008.x
   Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008
   Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593
   Clery D, 1996, VET PARASITOL, V62, P71, DOI 10.1016/0304-4017(95)00858-6
   Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5
   deSchoolmeester ML, 2006, INFECT IMMUN, V74, P6280, DOI 10.1128/IAI.01609-05
   Donnelly S, 2005, INFECT IMMUN, V73, P166, DOI 10.1128/IAI.73.1.166-173.2005
   Donnelly S, 2010, J BIOL CHEM, V285, P3383, DOI 10.1074/jbc.M109.060368
   Dransfield Ian, 1996, P149
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340
   Flynn RJ, 2007, VET IMMUNOL IMMUNOP, V120, P31, DOI 10.1016/j.vetimm.2007.07.003
   Flynn RJ, 2008, INFECT IMMUN, V76, P678, DOI 10.1128/IAI.00732-07
   Gause WC, 2003, TRENDS IMMUNOL, V24, P269, DOI 10.1016/S1471-4906(03)00101-7
   Goodridge HS, 2005, J IMMUNOL, V174, P284, DOI 10.4049/jimmunol.174.1.284
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gupta R, 2004, PARASITOLOGY, V129, P311, DOI 10.1017/S0031182004005682
   Guzman-Morales J, 2011, BIOCHEM BIOPH RES CO, V405, P538, DOI 10.1016/j.bbrc.2011.01.063
   Helmby H, 2003, EUR J IMMUNOL, V33, P2974, DOI 10.1002/eji.200324264
   Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4
   Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046
   Jedlina L, 2011, EXP PARASITOL, V128, P291, DOI 10.1016/j.exppara.2011.02.004
   Jenkins SJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/262609
   Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039
   Kane CM, 2008, INFECT IMMUN, V76, P5754, DOI 10.1128/IAI.00497-08
   Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850
   Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017
   Kawashima R, 2006, GASTROENTEROLOGY, V131, P130, DOI 10.1053/j.gastro.2006.04.022
   Koide N, 2007, J ENDOTOXIN RES, V13, P167, DOI 10.1177/0968051907080894
   Layland LE, 2005, EUR J IMMUNOL, V35, P3248, DOI 10.1002/eji.200526273
   Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271
   Louis CA, 1999, AM J PHYSIOL-REG I, V276, pR237
   Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001
   Mori M, 2000, BIOCHEM BIOPH RES CO, V275, P715, DOI 10.1006/bbrc.2000.3169
   Morimoto M, 2004, J IMMUNOL, V172, P2424, DOI 10.4049/jimmunol.172.4.2424
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Munder M, 1999, J IMMUNOL, V163, P3771
   Munder M, 1998, J IMMUNOL, V160, P5347
   Muraille E, 2003, J IMMUNOL, V170, P4237, DOI 10.4049/jimmunol.170.8.4237
   Nair MG, 2006, J IMMUNOL, V177, P1393, DOI 10.4049/jimmunol.177.3.1393
   Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0
   Raes G, 2005, J IMMUNOL, V174, P6561, DOI 10.4049/jimmunol.174.11.6561
   Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629
   Raesl G, 2007, CURR OPIN IMMUNOL, V19, P454, DOI 10.1016/j.coi.2007.05.007
   Reece JJ, 2006, INFECT IMMUN, V74, P4970, DOI 10.1128/IAI.00687-06
   Revaz-Breton M, 2010, EUR J IMMUNOL, V40, P1697, DOI 10.1002/eji.200939821
   Rodriguez-Sosa M, 2002, INFECT IMMUN, V70, P3656, DOI 10.1128/IAI.70.7.3656-3664.2002
   Siracusa MC, 2008, J LEUKOCYTE BIOL, V84, P1422, DOI 10.1189/jlb.0308199
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502
   Sugawara Y, 2011, J VET MED SCI, V73, P511, DOI 10.1292/jvms.10-0269
   Sun C, 2011, J CELL PHYSL
   Sutherland TE, 2009, CLIN EXP ALLERGY, V39, P943, DOI 10.1111/j.1365-2222.2009.03243.x
   Taylor MD, 2006, J IMMUNOL, V176, P6918, DOI 10.4049/jimmunol.176.11.6918
   Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200
   Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262
NR 58
TC 1
Z9 1
U1 3
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2237
EI 1471-2172
J9 BMC IMMUNOL
JI BMC Immunol.
PD NOV 11
PY 2011
VL 12
AR 63
DI 10.1186/1471-2172-12-63
PG 11
WC Immunology
SC Immunology
GA 854CY
UT WOS:000297473500001
PM 22074389
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Tu, XA
   Zhuang, JT
   Wang, WW
   Zhao, L
   Zhao, LY
   Zhao, JQ
   Deng, CH
   Qiu, SP
   Zhang, YY
AF Tu, Xiangan
   Zhuang, Jintao
   Wang, Wenwei
   Zhao, Liang
   Zhao, Liangyun
   Zhao, Jiquan
   Deng, Chunhua
   Qiu, Shaopeng
   Zhang, Yuanyuan
TI RETRACTED: Screening and identification of a renal carcinoma specific
   peptide from a phage display peptide library (Retracted article. See
   vol. 31, 21, 2012)
SO JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
LA English
DT Article; Retracted Publication
DE Renal cell carcinoma; Phage display; Peptide; Targeting
ID CELL CARCINOMA; SELECTION; CANCER
AB Background: Specific peptide ligands to cell surface receptors have been extensively used in tumor research and clinical applications. Phage display technology is a powerful tool for the isolation of cell-specific peptide ligands. To screen and identify novel markers for renal cell carcinoma, we evaluated a peptide that had been identified by phage display technology.
   Methods: A renal carcinoma cell line A498 and a normal renal cell line HK-2 were used to carry out subtractive screening in vitro with a phage display peptide library. After three rounds of panning, there was an obvious enrichment for the phages specifically binding to the A498 cells, and the output/input ratio of phages increased about 100 fold. A group of peptides capable of binding specifically to the renal carcinoma cells were obtained, and the affinity of these peptides to the targeting cells and tissues was studied.
   Results: Through a cell-based ELISA, immunocytochemical staining, immunohistochemical staining, and immunofluorescence, the Phage ZT-2 and synthetic peptide ZT-2 were shown to specifically bind to the tumor cell surfaces of A498 and incision specimens, but not to normal renal tissue samples.
   Conclusion: A peptide ZT-2, which binds specifically to the renal carcinoma cell line A498 was selected from phage display peptide libraries. Therefore, it provides a potential tool for early diagnosis of renal carcinoma or targeted drug delivery in chemotherapy.
C1 [Tu, Xiangan; Zhuang, Jintao; Wang, Wenwei; Zhao, Liang; Zhao, Liangyun; Zhao, Jiquan; Deng, Chunhua; Qiu, Shaopeng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510700, Guangdong, Peoples R China.
   [Zhang, Yuanyuan] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Tu, XA (reprint author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510700, Guangdong, Peoples R China.
EM txabs9988@163.com; yzhang@wfubmc.edu
FU National Natural Science Foundation of China [81172432]; Guangdong
   Natural Science Foundation of the People's Republic of China
   [9151802904000002]; Scientific and Technical Project of Guangdong
   Province of the People's Republic of China [2008B030301082]; Doctoral
   Initiating Project; Natural Scientific Foundation of Guangdong Province
   of the People's Republic of China [7301521]
FX This work was supported by National Natural Science Foundation of China
   (No. 81172432), The Project Supported by Guangdong Natural Science
   Foundation of the People's Republic of China (No. 9151802904000002),
   Scientific and Technical Project of Guangdong Province of the People's
   Republic of China (2008B030301082), Doctoral Initiating Project, and
   Natural Scientific Foundation of Guangdong Province of the People's
   Republic of China (No. 7301521)
CR Barry MA, 1996, NAT MED, V2, P299, DOI 10.1038/nm0396-299
   Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172
   Davis Ian D, 2007, Cancer Immun, V7, P13
   Du B, 2006, BIOCHEM BIOPH RES CO, V342, P956, DOI 10.1016/j.bbrc.2006.02.050
   Eichelberg C, 2009, EUR UROL, V55, P851, DOI 10.1016/j.eururo.2009.01.003
   Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006
   Langer M., 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P71, DOI 10.2174/1568011013354877
   Pande J, 2010, BIOTECHNOL ADV, V28, P849, DOI 10.1016/j.biotechadv.2010.07.004
   Romanov VI, 2001, PROSTATE, V47, P239
   Shadidi M, 2002, FASEB J, V16, P256, DOI 10.1096/fj.02-0280fje
   Tunuguntla HSGR, 2008, J UROLOGY, V179, P2096, DOI 10.1016/j.juro.2008.01.083
   Xu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009625
   Yang XA, 2005, LAB INVEST, V85, P205, DOI 10.1038/labinvest.3700220
   Zhang J, 2007, CHINESE MED J-PEKING, V120, P2049
NR 15
TC 4
Z9 6
U1 2
U2 18
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-9966
J9 J EXP CLIN CANC RES
JI J. Exp. Clin. Cancer Res.
PD NOV 10
PY 2011
VL 30
AR 105
DI 10.1186/1756-9966-30-105
PG 6
WC Oncology
SC Oncology
GA 854UO
UT WOS:000297520300001
PM 22071019
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Huang, X
   Kushekhar, K
   Nolte, I
   Kooistra, W
   Visser, L
   Bouwman, I
   Kouprie, N
   Veenstra, R
   van Imhoff, G
   Olver, B
   Houlston, RS
   Poppema, S
   Diepstra, A
   Hepkema, B
   van den Berg, A
AF Huang, Xin
   Kushekhar, Kushi
   Nolte, Ilja
   Kooistra, Wierd
   Visser, Lydia
   Bouwman, Ilby
   Kouprie, Niels
   Veenstra, Rianne
   van Imhoff, Gustaaf
   Olver, Bianca
   Houlston, Richard S.
   Poppema, Sibrand
   Diepstra, Arjan
   Hepkema, Bouke
   van den Berg, Anke
TI RETRACTED: Multiple HLA class I and II associations in classical Hodgkin
   lymphoma and EBV status defined subgroups (Retracted article. See vol.
   118, pg. 5211, 2011)
SO BLOOD
LA English
DT Article; Retracted Publication
ID EPSTEIN-BARR-VIRUS; NASOPHARYNGEAL CARCINOMA; T-LYMPHOCYTES; DISEASE;
   ALLELES; EPIDEMIOLOGY; RECOGNITION; GENES; TOOL
AB The pathogenesis of classical Hodgkin lymphoma (cHL) involves environmental and genetic factors. To explore the role of the human leukocyte antigen (HLA) genes, we performed a case-control genotyping study in 338 Dutch cHL patients and more than 5000 controls using a PCR-based sequence-specific oligonucleotide probe hybridization approach. HLA-A68 and HLA-DR11 (5) were significantly increased in the cHL patient population compared with the controls. Three class II associations were observed in the EBV- cHL population with an increase of HLA-DR15 (2) and a decrease of HLA-DR4 and HLA-DR7. Allele frequencies of HLA-A1, HLA-B37, and HLA-DR10 were significantly increased in the EBV+ cHL population; these alleles are in strong linkage disequilibrium and form a common haplotype in whites. The allele frequency of HLA-A2 was significantly decreased in the EBV- cHL population. Sequence-specific oligonucleotide probe analysis revealed significant differences between EBV+ and EBV- cHL patients for 19 probes that discriminate between HLA-A*01 and HLA-A*02. In conclusion, the HLA-A1 and HLA-A2 antigens and not specific single nucleotide variants shared by multiple alleles are responsible for the association with EBV+ cHL. Furthermore, several new protective and predisposing HLA class I and II associations for the EBV+, the EBV-, and the entire cHL population were identified. (Blood. 2011;118(19):5211-5217)
C1 [Huang, Xin; Kushekhar, Kushi; Kooistra, Wierd; Visser, Lydia; Veenstra, Rianne; Poppema, Sibrand; Diepstra, Arjan; van den Berg, Anke] Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands.
   [Huang, Xin] Peking Univ, Dept Pathol, Hlth Sci Ctr, Beijing 100871, Peoples R China.
   [Nolte, Ilja] Univ Groningen, Unit Genet Epidemiol & Bioinformat, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands.
   [Bouwman, Ilby; Kouprie, Niels; Hepkema, Bouke] Univ Groningen, Dept Lab Med, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands.
   [van Imhoff, Gustaaf] Univ Groningen, Dept Hematol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands.
   [Olver, Bianca; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.
RP van den Berg, A (reprint author), Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Hanzepl 1,POB 30-001, NL-9700 RB Groningen, Netherlands.
EM a.van.den.berg01@umcg.nl
RI van den Berg, Anke/H-1718-2011; Poppema, Sibrand/D-1204-2012
OI van den Berg, Anke/0000-0002-8894-2638; Houlston,
   Richard/0000-0002-5268-0242
FU University Medical Center Groningen; Dutch Cancer Society
   [KWF:RUG2009-4313]
FX This work was supported by a Bernoulli Bursary, University Medical
   Center Groningen, and the Dutch Cancer Society (grant KWF:RUG2009-4313).
CR BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345
   Burt RD, 1996, CANCER EPIDEM BIOMAR, V5, P879
   Cano P, 2007, HUM IMMUNOL, V68, P392, DOI 10.1016/j.humimm.2007.01.014
   Cartwright RA, 2004, HEMATOL ONCOL, V22, P11, DOI 10.1002/hon.723
   Depil S, 2004, ANN BIOL CLIN-PARIS, V62, P639
   Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3
   DIEPSTRA A, 2005, EUR J HAEMATOL S, V66, P34
   Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696
   GAVIOLI R, 1992, P NATL ACAD SCI USA, V89, P5862, DOI 10.1073/pnas.89.13.5862
   Ghodke Y, 2005, EUR J EPIDEMIOL, V20, P475, DOI 10.1007/s10654-005-5081-x
   HAFEZ MM, 1985, INT J CANCER, V36, P19, DOI 10.1002/ijc.2910360104
   Hansen J A, 1977, Prog Clin Biol Res, V16, P217
   Harty LC, 2002, BLOOD, V99, P690, DOI 10.1182/blood.V99.2.690
   Helmberg W, 1998, TISSUE ANTIGENS, V51, P587, DOI 10.1111/j.1399-0039.1998.tb03000.x
   Hildesheim A, 2002, J NATL CANCER I, V94, P1780
   Hjalgrim H, 2010, P NATL ACAD SCI USA, V107, P6400, DOI 10.1073/pnas.0915054107
   Kruger S, 2003, J IMMUNOTHER, V26, P212, DOI 10.1097/00002371-200305000-00005
   Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542
   Landgren O, 2007, HEMATOL ONCOL CLIN N, V21, P825, DOI 10.1016/j.hoc.2007.07.001
   Lee SP, 1997, J IMMUNOL, V158, P3325
   MARSHALL WH, 1977, INT J CANCER, V19, P450, DOI 10.1002/ijc.2910190403
   MURRAY RJ, 1988, J VIROL, V62, P3747
   Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934
   Niens M, 2006, CANCER EPIDEM BIOMAR, V15, P2280, DOI 10.1158/1055-9965.EPI-06-0476
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405
   ROBERTSON SJ, 1987, CANCER, V59, P1314, DOI 10.1002/1097-0142(19870401)59:7<1314::AID-CNCR2820590714>3.0.CO;2-V
   Sonmez M, 2010, INTERNAL MED, V49, P607, DOI 10.2169/internalmedicine.49.2873
   Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594
   Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501
   Voo KS, 2004, J EXP MED, V199, P459, DOI 10.1084/jem.20031219
NR 31
TC 3
Z9 3
U1 2
U2 10
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 10
PY 2011
VL 118
IS 19
BP 5211
EP 5217
DI 10.1182/blood-2011-04-342998
PG 7
WC Hematology
SC Hematology
GA 845ZN
UT WOS:000296867100022
PM 21921049
OA Other Gold
DA 2018-12-27
ER

PT J
AU De Domenico, I
   Lo, E
   Yang, BL
   Korolnek, T
   Hamza, I
   Ward, DM
   Kaplan, J
AF De Domenico, Ivana
   Lo, Eric
   Yang, Baoli
   Korolnek, Tamara
   Hamza, Iqbal
   Ward, Diane Mcvey
   Kaplan, Jerry
TI RETRACTED: The Role of Ubiquitination in Hepcidin-Independent and
   Hepcidin-Dependent Degradation of Ferroportin (Retracted article. See
   vol. 15, pg. 927, 2012)
SO CELL METABOLISM
LA English
DT Article; Retracted Publication
ID IRON-REGULATORY PROTEINS; DMT1 REGULATION; EXPRESSION; BINDING; BRAIN;
   MICE; HEMOCHROMATOSIS; INTERNALIZATION; UBIQUITYLATION; ACCUMULATION
AB The iron exporter ferroportin (Fpn) is essential to transfer iron from cells to plasma. Systemic iron homeostasis in vertebrates is regulated by the hepcidin-mediated internalization of Fpn. Here, we demonstrate a second route for Fpn internalization; when cytosolic iron levels are low, Fpn is internalized in a hepcidin-independent manner dependent upon the E3 ubiquitin ligase Nedd4-2 and the Nedd4-2 binding protein Nfdip-1. Retention of cell-surface Fpn through reductions in Nedd4-2 results in cell death through depletion of cytosolic iron. Nedd4-2 is also required for internalization of Fpn in the absence of ferroxidase activity as well as for the entry of hepcidin-induced Fpn into the multivesicular body. C. elegans lacks hepcidin genes, and C. elegans Fpn expressed in mammalian cells is not internalized by hepcidin but is internalized in response to iron deprivation in a Nedd4-2-dependent manner, supporting the hypothesis that Nedd4-2-induced internalization of Fpn is evolutionarily conserved.
C1 [Lo, Eric; Ward, Diane Mcvey; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.
   [De Domenico, Ivana] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA.
   [Yang, Baoli] Univ Iowa, Dept Obstet & Gynecol, Carver Coll Med, Iowa City, IA 52242 USA.
   [Korolnek, Tamara; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.
   [Kaplan, Jerry] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA.
RP Kaplan, J (reprint author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.
EM jerry.kaplan@path.utah.edu
FU National Institutes of Health (NIH) [DK070947, DK090257]
FX The authors express their appreciation to members of the Kaplan lab for
   critically reading the manuscript. This work is supported by National
   Institutes of Health (NIH) grant DK070947 to J.K. and NIH grant DK090257
   to I.D.D.
CR Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005
   Aydemir F, 2009, J NUTR, V139, P434, DOI 10.3945/jn.108.094052
   Beutler E, 2000, BLOOD, V96, P4071
   CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457
   DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915
   De Domenico I, 2008, CELL METAB, V8, P146, DOI 10.1016/j.cmet.2008.07.002
   De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735
   De Domenico I, 2007, MOL BIOL CELL, V18, P2569, DOI 10.1091/mbc.E07-01-0060
   De Domenico I, 2009, P NATL ACAD SCI USA, V106, P3800, DOI 10.1073/pnas.0900453106
   Fernandes A, 2009, BLOOD, V114, P437, DOI 10.1182/blood-2008-03-146134
   Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x
   Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953
   Foot NJ, 2011, BLOOD, V117, P638, DOI 10.1182/blood-2010-07-295287
   Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006
   Hadziahmetovic M, 2011, INVEST OPHTH VIS SCI, V52, P109, DOI 10.1167/iovs.10-6113
   Hanninen MM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-36
   Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137
   Howitt J, 2009, P NATL ACAD SCI USA, V106, P15489, DOI 10.1073/pnas.0904880106
   Jeong SY, 2009, J NEUROSCI, V29, P570, DOI 10.1523/JNEUROSCI.5443-08.2009
   Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108
   Lee PL, 2009, ANNU REV PATHOL-MECH, V4, P489, DOI 10.1146/annurev.pathol.4.110807.092205
   Malik B, 2006, AM J PHYSIOL-RENAL, V290, pF1285, DOI 10.1152/ajprenal.00432.2005
   Malik IA, 2011, CELL TISSUE RES, V344, P299, DOI 10.1007/s00441-011-1152-3
   Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342
   Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742
   Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008
   Sile S, 2006, CURR OPIN NEPHROL HY, V15, P511, DOI 10.1097/01.mnh.0000242177.36953.be
   Troadec MB, 2010, BLOOD, V116, P4657, DOI 10.1182/blood-2010-04-278614
   Wang Q, 2008, ENDOCRINOLOGY, V149, P3920, DOI 10.1210/en.2007-1626
   Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84
   Yin ZB, 2010, J NEUROCHEM, V112, P1190, DOI 10.1111/j.1471-4159.2009.06534.x
   Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006
NR 32
TC 15
Z9 16
U1 3
U2 19
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD NOV 2
PY 2011
VL 14
IS 5
BP 635
EP 646
DI 10.1016/j.cmet.2011.09.008
PG 12
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 849RG
UT WOS:000297142200009
PM 22019085
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Cristovao-Ferreira, S
   Navarro, G
   Brugarolas, M
   Perez-Capote, K
   Vaz, SH
   Fattorini, G
   Conti, F
   Lluis, C
   Ribeiro, JA
   McCormick, PJ
   Casado, V
   Franco, R
   Sebastiao, AM
AF Cristovao-Ferreira, Sofia
   Navarro, Gemma
   Brugarolas, Marc
   Perez-Capote, Kamil
   Vaz, Sandra H.
   Fattorini, Giorgia
   Conti, Fiorenzo
   Lluis, Carmen
   Ribeiro, Joaquim A.
   McCormick, Peter J.
   Casado, Vicent
   Franco, Rafael
   Sebastiao, Ana M.
TI RETRACTED: Modulation of GABA Transport by Adenosine A(1)R-A(2A)R
   Heteromers, Which Are Coupled to Both G(s)- and G(i/o)-Proteins
   (Retracted article. See vol. 33, pg. 1292, 2013)
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article; Retracted Publication
ID PLASMA-MEMBRANE TRANSPORTER; RECEPTOR HETEROMERS;
   NEUROMUSCULAR-JUNCTION; SIGNAL-TRANSDUCTION; ADENYLATE-CYCLASE; OPIOID
   RECEPTORS; CEREBRAL-CORTEX; PROTEIN-KINASE; ACTIVATION; A(2A)
AB Astrocytes play a key role in modulating synaptic transmission by controlling the available extracellular GABA via the GAT-1 and GAT-3 GABA transporters (GATs). Using primary cultures of rat astrocytes, we show here that an additional level of regulation of GABA uptake occurs via modulation of the GATs by the adenosine A(1) (A(1)R) and A(2A) (A(2A)R) receptors. This regulation occurs through a complex of heterotetramers (two interacting homodimers) of A(1)R-A(2A)R that signal via two different G-proteins, G(s) and G(i/o), and either enhances (A(2A)R) or inhibits (A(1)R) GABA uptake. These results provide novel mechanistic insight into how G-protein-coupled receptor heteromers signal. Furthermore, we uncover a previously unknown mechanism in which adenosine, in a concentration-dependent manner, acts via a heterocomplex of adenosine receptors in astrocytes to significantly contribute to neurotransmission at the tripartite (neuron-glia-neuron) synapse.
C1 [Cristovao-Ferreira, Sofia; Vaz, Sandra H.; Ribeiro, Joaquim A.; Sebastiao, Ana M.] Univ Lisbon, Fac Med, Inst Pharmacol & Neurosci, P-1649028 Lisbon, Portugal.
   [Cristovao-Ferreira, Sofia; Vaz, Sandra H.; Ribeiro, Joaquim A.; Sebastiao, Ana M.] Univ Lisbon, Inst Mol Med, Unit Neurosci, P-1649028 Lisbon, Portugal.
   [Navarro, Gemma; Brugarolas, Marc; Perez-Capote, Kamil; Lluis, Carmen; McCormick, Peter J.; Casado, Vicent] Univ Barcelona, Fac Biol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08028 Barcelona, Spain.
   [Navarro, Gemma; Brugarolas, Marc; Perez-Capote, Kamil; Lluis, Carmen; McCormick, Peter J.; Casado, Vicent] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain.
   [Fattorini, Giorgia; Conti, Fiorenzo] Univ Politecn Marche, Dept Neurosci, I-60026 Ancona, Italy.
   [Conti, Fiorenzo] Univ Politecn Marche, Fdn Med Mol, I-60026 Ancona, Italy.
   [Franco, Rafael] Univ Navarra, Ctr Invest Med Aplicada, Div Neurosci, Lab Cell & Mol Neuropharmacol, Pamplona 31008, Spain.
RP Sebastiao, AM (reprint author), Univ Lisbon, Fac Med, Inst Pharmacol & Neurosci, Ave Prof Egas Moniz,Edificio Egas Moniz, P-1649028 Lisbon, Portugal.
EM anaseb@fm.ul.pt
RI Franco, Rafael/C-3694-2015; Fattorini, Giorgia/B-2989-2009; Casado,
   Vicent/K-1660-2014
OI Franco, Rafael/0000-0003-2549-4919; Fattorini,
   Giorgia/0000-0002-2497-2942; Casado, Vicent/0000-0002-1764-3825;
   McCormick, Peter/0000-0002-2225-5181; Ribeiro,
   Joaquim/0000-0002-9330-3507; Brugarolas, Marc/0000-0002-2277-1266;
   Sebastiao, Ana M/0000-0001-9030-6115
FU Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/38099/2007]; COST
   [B30]; Spanish Ministerio de Ciencia y Tecnologia [SAF2008-03229-E,
   SAF2008-00146]; PRIN; Universita Politecnica delle Marche
FX This study was supported by Fundacao para a Ciencia e a Tecnologia (FCT)
   project grants, COST B30 action, Spanish Ministerio de Ciencia y
   Tecnologia Grants SAF2008-03229-E and SAF2008-00146, and funds from PRIN
   and Universita Politecnica delle Marche (F.C.). P.J.M. is a Ramon y
   Cajal Fellow. S.C.-F. received FCT Fellowship SFRH/BD/38099/2007. We
   acknowledge the technical help obtained from Jasmina Jimenez (Molecular
   Neurobiology Laboratory, Barcelona University, Barcelona, Spain).
CR ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0
   AWAD JA, 1983, J BIOL CHEM, V258, P2960
   Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3
   BOKOCH GM, 1984, CELL, V39, P301, DOI 10.1016/0092-8674(84)90008-4
   Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200
   Ciruela F, 2006, J NEUROSCI, V26, P2080, DOI 10.1523/JNEUROSCI.3574-05.2006
   Ciruela F, 2004, ANAL CHEM, V76, P5354, DOI 10.1021/ac049295f
   CORREIADESA P, 1994, EUR J PHARMACOL, V271, P349, DOI 10.1016/0014-2999(94)90793-5
   CUNHA RA, 1994, BRAIN RES, V649, P208, DOI 10.1016/0006-8993(94)91066-9
   Ferrada C, 2009, BRIT J PHARMACOL, V157, P64, DOI 10.1111/j.1476-5381.2009.00152.x
   Ferre S, 2010, PROG MOL BIOL TRANSL, V91, P41, DOI 10.1016/S1877-1173(10)91002-8
   Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131
   Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928
   Fredholm BB, 2001, PHARMACOL REV, V53, P527
   GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050
   Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803
   Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199
   HERTZ L, 1987, MODEL SYSTEMS DEV AG, P19, DOI DOI 10.1007/978-1-4613-2037-1_
   Ji X D, 1999, Drug Des Discov, V16, P217
   Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898
   Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1
   KRNJEVIC K, 1967, EXP BRAIN RES, V3, P320, DOI 10.1007/BF00237558
   Linden J, 1999, MOL PHARMACOL, V56, P705
   Lopes LV, 1999, J NEUROPHYSIOL, V82, P3196
   MINELLI A, 1995, J NEUROSCI, V15, P7734
   Minelli A, 1996, J NEUROSCI, V16, P6255
   Moreno E, 2011, J BIOL CHEM, V286, P5846, DOI 10.1074/jbc.M110.161489
   Ongini E, 1999, N-S ARCH PHARMACOL, V359, P7, DOI 10.1007/PL00005326
   Orru M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016088
   Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200
   Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pna5.0604049104
   RIBEIRO JA, 1987, J PHYSIOL-LONDON, V384, P571, DOI 10.1113/jphysiol.1987.sp016470
   Sarrio S, 2000, MOL CELL BIOL, V20, P5164, DOI 10.1128/MCB.20.14.5164-5174.2000
   Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671
   Sebastiao AM, 2000, TRENDS PHARMACOL SCI, V21, P341, DOI 10.1016/S0165-6147(00)01517-0
   Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667
   SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688
   WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455
NR 38
TC 9
Z9 9
U1 3
U2 18
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD NOV 2
PY 2011
VL 31
IS 44
BP 15629
EP 15639
DI 10.1523/JNEUROSCI.2526-11.2011
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 844ES
UT WOS:000296731100001
PM 22049406
OA Bronze
DA 2018-12-27
ER

PT J
AU Hepguler, S
   Cetin, A
   Sahin, T
   Kara, A
AF Hepguler, Simin
   Cetin, Alp
   Sahin, Toros
   Kara, Asil
TI RETRACTED: Osteoporotic hip fracture costs in the elderly Turkish
   population (vol 45, pg 316, 2011) (Retracted article. See vol. 46, pg.
   324, 2012)
SO ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA
LA English
DT Correction; Retracted Publication
C1 [Hepguler, Simin] Ege Univ, Dept Physiotherapy & Rehabil, Fac Med, Izmir, Turkey.
   [Cetin, Alp] Hacettepe Univ, Fac Med, Dept Physiotherapy & Rehabil, TR-06100 Ankara, Turkey.
   [Sahin, Toros; Kara, Asil] Sanofi Aventis Turkey, Istanbul, Turkey.
RP Hepguler, S (reprint author), Ege Univ, Tip Fak, Fiz Tedavi & Rehabil Bolumu, TR-35100 Izmir, Turkey.
EM simin.hepguler@ege.edu.tr
CR Hepguler S, 2011, ACTA ORTHOP TRAUMATO, V45, P316, DOI 10.3944/AOTT.2011.2543
NR 1
TC 2
Z9 2
U1 4
U2 16
PU TURKISH ASSOC ORTHOPAEDICS TRAUMATOLOGY
PI ISTANBUL
PA SEHREMINI MAH KOYUNCU SK CIGDEM APT NO 4 D 5 FATIH, ISTANBUL, 00000,
   TURKEY
SN 1017-995X
J9 ACTA ORTHOP TRAUMATO
JI Acta Orthop. Traumatol. Turc.
PD NOV-DEC
PY 2011
VL 45
IS 6
BP 472
EP 472
DI 10.3944/AOTT.2011.2543errl
PG 1
WC Orthopedics
SC Orthopedics
GA 895XP
UT WOS:000300530300018
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Kirksey, L
AF Kirksey, Lee
TI RETRACTED: Unrecognized High Brachial Artery Bifurcation is Associated
   with Higher Rate of Dialysis Access Failure(Retracted article. See vol.
   30, pg. 183, 2017)
SO SEMINARS IN DIALYSIS
LA English
DT Article; Retracted Publication
ID CATHETERS
AB A thorough consideration of all factors contributing to successful dialysis access creation is necessary to achieve optimal outcomes. A high bifurcation of the brachial artery (brachioradial variant) occurs in greater than 20% of patients. Dialysis access was created in 22 limbs with this variant15 fistula, and 7 prosthetic grafts. Nonmaturation occurred in 33% of fistula. Early thromboses occurred in 29% of prosthetic bridge grafts. In this experience, the brachioradial variant is associated with a relatively higher rate of fistula nonmaturation and prosthetic graft thromboses. These findings reinforce the critical role of preoperative imaging studies in dialysis access creation. A sound algorithm for the surgical management of the brachioradial variation facilitates decision making and will improve dialysis access outcomes.
C1 Penn Presbyterian Med Ctr, 51 N 39th St PHI Suite 2D, Philadelphia, PA 19104 USA.
RP Kirksey, L (reprint author), Penn Presbyterian Med Ctr, 51 N 39th St PHI Suite 2D, Philadelphia, PA 19104 USA.
EM lee.kirk-sey@uphs.upenn.edu
CR [Anonymous], 2001, Am J Kidney Dis, V37, pS137
   Banerjee S, 2009, THESCIENTIFICWORLDJO, V9, P1294, DOI 10.1100/tsw.2009.145
   Lacson E, 2007, AM J KIDNEY DIS, V50, P379, DOI 10.1053/j.qjkd.2007.06.006
   Lok CE, 2007, CLIN J AM SOC NEPHRO, V2, P1043, DOI 10.2215/CJN.01080307
   MCCORMACK LJ, 1953, SURG GYNECOL OBSTET, V96, P43
   National Kidney Foundation, 1997, AM J KIDNEY DIS S, V30, pS150
   Patel ST, 2003, J VASC SURG, V38, P439, DOI 10.1016/S0741-5214(03)00732-8
   Rodriguez-Niedenfuhr M, 2001, J ANAT, V199, P547, DOI 10.1046/j.1469-7580.2001.19950547.x
   Tordoir J, 2007, NEPHROL DIAL TRANSPL, V22, P88, DOI 10.1093/ndt/gfm021
   Woo K, 2009, J VASC SURG, V50, P1405, DOI 10.1016/j.jvs.2009.07.090
NR 10
TC 11
Z9 11
U1 3
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0894-0959
EI 1525-139X
J9 SEMIN DIALYSIS
JI Semin. Dial.
PD NOV-DEC
PY 2011
VL 24
IS 6
BP 698
EP 702
DI 10.1111/j.1525-139X.2011.00923.x
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 862LW
UT WOS:000298093600020
PM 21895770
DA 2018-12-27
ER

PT J
AU Ping, J
   Gao, AM
   Qin, HQ
   Wei, XN
   Bai, J
   Liu, L
   Li, XH
   Li, RW
   Ao, Y
   Wang, H
AF Ping, Jie
   Gao, Ai-mei
   Qin, Hai-quan
   Wei, Xiao-ning
   Bai, Jing
   Liu, Lian
   Li, Xiao-hai
   Li, Rui-wen
   Ao, Ying
   Wang, Hui
TI RETRACTED: Indole-3-Carbinol Enhances the Resolution of Rat Liver
   Fibrosis and Stimulates Hepatic Stellate Cell Apoptosis by Blocking the
   Inhibitor of kappa B Kinase alpha/Inhibitor of kappa B-alpha/Nuclear
   Factor-kappa B Pathway (Retracted article. See vol. 342, pg. 233, 2012)
SO JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
LA English
DT Article; Retracted Publication
ID BREAST-CANCER CELLS; TRANSCRIPTIONAL ACTIVITY; IN-VITRO; ACTIVATION;
   EXPRESSION; MECHANISMS; REVERSAL; PHARMACOKINETICS; PROLIFERATION;
   FIBROGENESIS
AB Hepatic stellate cells (HSC) play a pivotal role in liver fibrosis, and the clearance of activated HSC by apoptosis is associated with the resolution of liver fibrosis. The development of strategies that promote this process in a selective way is therefore important. We evaluated the effects of indole-3-carbinol (I3C), a nutritional component derived from vegetables from the Brassica family, on liver fibrosis and HSC apoptosis. The in vivo therapeutic effects of I3C were monitored in three rat models of liver fibrosis induced by porcine serum, bile duct ligation, or multiple hepatotoxic factors, and its proapoptotic effect and molecular mechanism were studied in vitro in HSC-T6, a rat HSC line. The results showed that I3C treatment significantly reduced the number of activated HSC in the livers of rats with liver fibrosis. In histopathology, I3C reduced hepatocyte degeneration and necrosis, accelerated collagen degradation, and promoted the reversal of liver fibrosis. I3C prescribed to HSC-T6 resulted in morphologic alterations typical of apoptosis and DNA cleavage to a nucleosomal ladder. Moreover, I3C significantly increased the HSC-T6 apoptosis rate and the expression ratio of Bax to Bcl-2. High-throughput protein array analysis indicated that the tumor necrosis factor-alpha/nuclear factor-kappa B (NF-kappa B) signal pathway participated in I3C-induced HSC-T6 apoptosis. Western blot and electrophoretic mobility-shift assay confirmed that I3C inhibited the phosphorylation of inhibitor of kappa B kinase alpha and inhibitor of kappa B-alpha and NF-kappa B DNA binding activity. In conclusion, I3C could promote the reverse process of liver fibrosis in vivo and induce apoptosis of activated HSC in vitro, which indicates the use of I3C as a potential therapeutic agent in liver fibrosis treatment.
C1 [Ping, Jie; Gao, Ai-mei; Qin, Hai-quan; Wei, Xiao-ning; Liu, Lian; Li, Xiao-hai; Li, Rui-wen; Ao, Ying; Wang, Hui] Wuhan Univ, Dept Pharmacol, Basic Med Sch, Wuhan 430072, Hubei, Peoples R China.
   [Ping, Jie; Wang, Hui] Wuhan Univ, Res Ctr Food & Drug Evaluat, Wuhan 430072, Hubei, Peoples R China.
   [Bai, Jing] Wuhan Univ, Div Sci Tech Project Adm, Off Sci Res, Wuhan 430072, Hubei, Peoples R China.
RP Wang, H (reprint author), 185 DongHu Rd, Wuhan 430071, Peoples R China.
EM wanghui19@whu.edu.cn
FU National Nature Science Foundation of China [30800931, 30371666];
   Natural Science Foundation of Hubei Province, China [2008CDB117]
FX This work was supported by the National Nature Science Foundation of
   China [Grants 30800931, 30371666] and the Natural Science Foundation of
   Hubei Province, China [Grant 2008CDB117].
CR Acharya Asha, 2010, Recent Pat Food Nutr Agric, V2, P166, DOI 10.2174/1876142911002020166
   Aggarwal BB, 2005, CELL CYCLE, V4, P1201, DOI 10.4161/cc.4.9.1993
   Ahmad A, 2010, CURR DRUG TARGETS, V11, P652, DOI 10.2174/138945010791170923
   Anderton MJ, 2004, CLIN CANCER RES, V10, P5233, DOI 10.1158/1078-0432.CCR-04-0163
   Aronchik I, 2010, CANCER RES, V70, P4961, DOI 10.1158/0008-5472.CAN-09-3349
   Arthur MJP, 2002, GASTROENTEROLOGY, V122, P1525, DOI 10.1053/gast.2002.33367
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bonis PAL, 2001, NEW ENGL J MED, V344, P452, DOI 10.1056/NEJM200102083440610
   Bradlow HL, 2010, IN VIVO, V24, P387
   Donald S, 2004, INT J CANCER, V111, P961, DOI 10.1002/ijc.20356
   Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4
   Fowell AJ, 2006, DIGEST DIS, V24, P174, DOI 10.1159/000090320
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974
   Guo Y, 2010, CLIN EXP PHARMACOL P, V37, P1107, DOI 10.1111/j.1440-1681.2010.05450.x
   Gutierrez-Reyes G, 2007, ARCH MED RES, V38, P644, DOI 10.1016/j.arcmed.2006.10.001
   Hsu JC, 2006, BIOCHEM PHARMACOL, V72, P1714, DOI 10.1016/j.bcp.2006.08.012
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Issa R, 2001, GUT, V48, P548, DOI 10.1136/gut.48.4.548
   Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x
   Lang A, 2000, J HEPATOL, V33, P49, DOI 10.1016/S0168-8278(00)80159-2
   Lee JI, 2003, J HEPATOL, V39, P960, DOI 10.1016/S0168-8278(03)00411-2
   Lemos QT, 2010, MEM I OSWALDO CRUZ, V105, P611, DOI 10.1590/S0074-02762010000500002
   Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728
   O'Connell MA, 2008, BRIT J PHARMACOL, V153, P403, DOI 10.1038/sj.bjp.0707580
   Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003
   Ping J, 2011, EUR J PHARMACOL, V650, P656, DOI 10.1016/j.ejphar.2010.10.057
   Rahman KMW, 2007, MOL CANCER THER, V6, P2757, DOI 10.1158/1535-7163.MCT-07-0336
   Reed GA, 2005, CANCER EPIDEM BIOMAR, V14, P1953, DOI 10.1158/1055-9965.EPI-05-0121
   Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101
   Shen AG, 2009, J RAMAN SPECTROSC, V40, P550, DOI 10.1002/jrs.2163
   SHERTZER HG, 1987, EXP MOL PATHOL, V47, P211, DOI 10.1016/0014-4800(87)90076-1
   STRESSER DM, 1995, DRUG METAB DISPOS, V23, P965
   Takada Y, 2005, BLOOD, V106, P641, DOI 10.1182/blood-2004-12-4589
   Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2
   Tsai JT, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/293642
   Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4
   Vogel S, 2000, J LIPID RES, V41, P882
   Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992
   Wang H, 2006, PHARMACOL RES, V53, P28, DOI 10.1016/j.phrs.2005.08.005
   Zhang LJ, 2010, J CELL BIOCHEM, V110, P219, DOI 10.1002/jcb.22529
   Zhang XL, 2006, WORLD J GASTROENTERO, V12, P6376, DOI 10.3748/wjg.v12.i39.6376
   Zheng SZ, 2004, BIOCHEM J, V384, P149, DOI 10.1042/BJ20040928
NR 43
TC 11
Z9 15
U1 5
U2 20
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0022-3565
EI 1521-0103
J9 J PHARMACOL EXP THER
JI J. Pharmacol. Exp. Ther.
PD NOV
PY 2011
VL 339
IS 2
BP 694
EP 703
DI 10.1124/jpet.111.179820
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 840TS
UT WOS:000296464800039
PM 21862660
OA Bronze
DA 2018-12-27
ER

PT J
AU Perez-Soler, R
   Zou, YY
   Li, TH
   Ling, YH
AF Perez-Soler, Roman
   Zou, Yiyu
   Li, Tianhong
   Ling, Yi He
TI RETRACTED: The Phosphatase Inhibitor Menadione (Vitamin K3) Protects
   Cells from EGFR Inhibition by Erlotinib and Cetuximab (Retracted
   article. See vol. 19, pg. 4901, 2013)
SO CLINICAL CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID GROWTH-FACTOR RECEPTOR; METASTATIC COLORECTAL-CANCER; PHASE-III TRIAL;
   LUNG-CANCER; TYROSINE PHOSPHATASES; PLUS CETUXIMAB; SERINE/THREONINE
   PHOSPHATASES; CUTANEOUS TOXICITIES; CHEMOKINE EXPRESSION; SKIN
   INFLAMMATION
AB Purpose: Skin toxicity is the main side effect of epidermal growth factor receptor (EGFR) inhibitors, often leading to dose reduction or discontinuation. We hypothesized that phosphatase inhibition in the skin keratinocytes may prevent receptor dephosphorylation caused by EGFR inhibitors and be used as a new potential strategy for the prevention or treatment of this side effect.
   Experimental Design: Menadione (Vitamin K3) was used as the prototype compound to test our hypothesis. HaCat human skin keratinocyte cells and A431 human squamous carcinoma cells were used. EGFR inhibition was measured by Western blotting and immunofluorescence. Phosphatase inhibition and reactive oxygen species (ROS) generation were measured by standard ELISA and fluorescence assays.
   Results: Menadione caused significant and reversible EGFR activation in a dose-dependent manner starting at nontoxic concentrations. EGFR activation by menadione was associated with reversible protein tyrosine phosphatase inhibition, which seemed to be mediated by ROS generation as exposure to antioxidants prevented both menadione-induced ROS generation and phosphatase inhibition. Short-term coincubation of cells with nontoxic concentrations of menadione and the EGFR inhibitors erlotinib or cetuximab prevented EGFR dephosphorylation. Seventy-two-hour coincubation of cells with the highest nontoxic concentration of menadione and erlotinib provided for a fourfold cell growth inhibitory protection in HaCat human keratinocyte cells.
   Conclusions: Menadione at nontoxic concentrations causes EGFR activation and prevents EGFR dephosphorylation by erlotinib and cetuximab. This effect seems to be mediated by ROS generation and secondary phosphatase inhibition. Mild oxidative stress in skin keratinocytes by topical menadione may protect the skin from the toxicity secondary to EGFR inhibitors without causing cytotoxicity. Clin Cancer Res; 17(21); 6766-77. (C)2011 AACR.
C1 [Perez-Soler, Roman] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Montefiore Med Ctr, Dept Oncol, Bronx, NY 10467 USA.
   [Li, Tianhong] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA.
RP Perez-Soler, R (reprint author), Albert Einstein Coll Med, Albert Einstein Canc Ctr, Montefiore Med Ctr, Dept Oncol, Hofheimer-100,111 E 210th St, Bronx, NY 10467 USA.
EM rperezso@montefiore.org
FU NIH [CA 113360]; Talon Therapeutics, Inc.
FX The work was supported by NIH CA 113360 and a grant from Talon
   Therapeutics, Inc. to R. Perez-Soler.
CR Abdelmohsen K, 2003, J BIOL CHEM, V278, P38360, DOI 10.1074/jbc.M306785200
   Amador ML, 2004, CANCER RES, V64, P9139, DOI 10.1158/0008-5472.CAN-04-1036
   Balagula Y, 2010, INVEST NEW DRUGS
   Blanchetot C, 2002, EMBO J, V21, P493, DOI 10.1093/emboj/21.4.493
   Blaskovich MAT, 2009, CURR MED CHEM, V16, P2095, DOI 10.2174/092986709788612693
   Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422
   Boyer MJ, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.18_suppl.lba7523
   Brown AP, 2008, TOXICOL PATHOL, V36, P410, DOI 10.1177/0192623308315827
   Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02A646
   Busse D, 2000, J BIOL CHEM, V275, P6987, DOI 10.1074/jbc.275.10.6987
   Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1
   Chan EC, 2009, PHARMACOL THERAPEUT, V122, P97, DOI 10.1016/j.pharmthera.2009.02.005
   Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118
   Clark G.M., 2003, P AN M AM SOC CLIN, V22, P196
   Cohen EEW, 2003, J CLIN ONCOL, V21, P1980, DOI 10.1200/JCO.2003.10.051
   Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025
   Deplanque G, 2010, J CLIN ONCOL, V28
   DOdorico A, 1997, CARCINOGENESIS, V18, P43, DOI 10.1093/carcin/18.1.43
   Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038
   Guttman-Yassky E, 2010, EUR J CANCER, V46, P2010, DOI 10.1016/j.ejca.2010.04.028
   Iyer R, 2010, EXPERT OPIN PHARMACO, V11, P1943, DOI 10.1517/14656566.2010.496453
   Janjigian YY, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7525
   Jatoi A, 2008, CANCER-AM CANCER SOC, V113, P847, DOI 10.1002/cncr.23621
   Kobayashi T, 1998, J INVEST DERMATOL, V111, P616, DOI 10.1046/j.1523-1747.1998.00331.x
   Koivisto L, 2006, EXP CELL RES, V312, P2791, DOI 10.1016/j.yexcr.2006.05.009
   Koyama N, 2006, CLIN CANCER RES, V12, P2025, DOI 10.1158/1078-0432.CCR-04-2392
   Kuban-Jankowska Alicja, 2010, Postepy Biochem, V56, P269
   Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970
   Lacouture ME, 2010, J CLIN ONCOL, V28, P1351, DOI 10.1200/JCO.2008.21.7828
   Li TH, 2009, TARGET ONCOL, V4, P107, DOI 10.1007/s11523-009-0114-0
   LING YH, 1993, CANCER RES, V53, P1583
   Luu M, 2007, PHOTODERMATOL PHOTO, V23, P42, DOI 10.1111/j.1600-0781.2007.00273.x
   Lynch TJ, 2007, ONCOLOGIST, V12, P610, DOI 10.1634/theoncologist.12-5-610
   Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938
   Mascia F, 2003, AM J PATHOL, V163, P303, DOI 10.1016/S0002-9440(10)63654-1
   Mascia F, 2010, J INVEST DERMATOL, V130, P682, DOI 10.1038/jid.2009.336
   Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209
   McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140
   Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525
   MORRISON H, 1984, BIOCHEM PHARMACOL, V33, P1763, DOI 10.1016/0006-2952(84)90347-2
   MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x
   Pace RC, 1942, AM J MED SCI, V203, P566
   Pastore S, 2005, J IMMUNOL, V174, P5047, DOI 10.4049/jimmunol.174.8.5047
   Peng A, 2010, ONCOGENE, V29, P5977, DOI 10.1038/onc.2010.371
   Perez-Soler R, 2005, J CLIN ONCOL, V23, P5235, DOI 10.1200/JCO.2005.00.6916
   Perez-Soler R, 2005, ONCOLOGIST, V10, P345, DOI 10.1634/theoncologist.10-5-345
   Perez-Soler R, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7610
   Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057
   Perez-Soler R, 2007, ASCO M ABSTR, V25, P9124
   Perez-Soler R, 2006, PROCEED ASCO, V24, P129
   Peus D, 1997, J INVEST DERMATOL, V109, P751, DOI 10.1111/1523-1747.ep12340759
   Pinto C, 2011, ASCO GASTR CANC S
   Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981
   Rodeck U, 2009, J CELL PHYSIOL, V218, P32, DOI 10.1002/jcp.21585
   Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004
   Sata N, 1997, FREE RADICAL BIO MED, V23, P844, DOI 10.1016/S0891-5849(97)00064-6
   Scope A, 2007, J CLIN ONCOL, V25, P5390, DOI 10.1200/JCO.2007.12.6987
   Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753
   Stoll SW, 1998, ONCOGENE, V16, P1493, DOI 10.1038/sj.onc.1201657
   Surguladze D, 2009, CANCER RES, V69, P5643, DOI 10.1158/0008-5472.CAN-09-0487
   Tiganis T, 2010, TRENDS PHARM SCI
   ULBRICH AP, 1961, J AM OSTEOPATH ASSOC, V60, P370
   Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620
   Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656
   Vintonyak VV, 2009, CURR OPIN CHEM BIOL, V13, P272, DOI 10.1016/j.cbpa.2009.03.021
   Wacker B, 2007, CLIN CANCER RES, V13, P3913, DOI 10.1158/1078-0432.CCR-06-2610
   West HL, 2006, J CLIN ONCOL, V24, P1807, DOI 10.1200/JCO.2005.04.9890
   Woodworth CD, 2005, MOL CANCER THER, V4, P650, DOI 10.1158/1535-7163.MCT-04-0238
   Xu YR, 2010, MOL BIOL CELL, V21, P29, DOI 10.1091/mbc.E09-08-0710
   Yang C, 2010, J CLIN ONCOL, V28, p15S
   Yoshi SS, 2010, CANCER, V116, P3916
NR 71
TC 22
Z9 23
U1 2
U2 16
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1078-0432
EI 1557-3265
J9 CLIN CANCER RES
JI Clin. Cancer Res.
PD NOV 1
PY 2011
VL 17
IS 21
BP 6766
EP 6777
DI 10.1158/1078-0432.CCR-11-0545
PG 12
WC Oncology
SC Oncology
GA 842TS
UT WOS:000296624000020
PM 21914790
OA Bronze
DA 2018-12-27
ER

PT J
AU Berglund, ED
   Lustig, DG
   Baheza, RA
   Hasenour, CM
   Lee-Young, RS
   Donahue, EP
   Lynes, SE
   Swift, LL
   Charron, MJ
   Damon, BM
   Wasserman, DH
AF Berglund, Eric D.
   Lustig, Daniel G.
   Baheza, Richard A.
   Hasenour, Clinton M.
   Lee-Young, Robert S.
   Donahue, E. Patrick
   Lynes, Sara E.
   Swift, Larry L.
   Charron, Maureen J.
   Damon, Bruce M.
   Wasserman, David H.
TI RETRACTED: Hepatic Glucagon Action Is Essential for Exercise-Induced
   Reversal of Mouse Fatty Liver (Retracted article. See vol. 65, pg. 2463,
   2016)
SO DIABETES
LA English
DT Article; Retracted Publication
ID ADIPOSE-TISSUE INFLAMMATION; ACTIVATED PROTEIN-KINASE; INSULIN
   SENSITIVITY; IN-VIVO; NONALCOHOLIC STEATOHEPATITIS; METABOLIC-RESPONSE;
   MUSCULAR WORK; OBESE MICE; PPAR-ALPHA; DIET
AB OBJECTIVE-Exercise is an effective intervention to treat fatty liver. However, the mechanism(s) that underlie exercise-induced reductions in fatty liver are unclear. Here we tested the hypothesis that exercise requires hepatic glucagon action to reduce fatty liver.
   RESEARCH DESIGN AND METHODS-C57BL/6 mice were fed high-fat diet (HFD) and assessed using magnetic resonance, biochemical, and histological techniques to establish a timeline for fatty liver development over 20 weeks. Glucagon receptor null gcgr(-/-)) and wild-type (gcgr(+/+)) littermate mice were subsequently fed HFD to provoke moderate fatty liver and then performed either 10 or 6 weeks of running wheel or treadmill exercise, respectively.
   RESULTS-Exercise reverses progression of HFD-induced fatty liver in gcgr(+/+) mice. Remarkably, such changes are absent in gcgr(-/-) mice, thus confirming the hypothesis that exercise-stimulated hepatic glucagon receptor activation is critical to reduce HFD-induced fatty liver.
   CONCLUSIONS-These findings suggest that therapies that use antagonism of hepatic glucagon action to reduce blood glucose may interfere with the ability of exercise and perhaps other interventions to positively affect fatty liver. Diabetes 60:2720-2729, 2011
C1 [Berglund, Eric D.; Lustig, Daniel G.; Hasenour, Clinton M.; Lee-Young, Robert S.; Donahue, E. Patrick; Lynes, Sara E.; Damon, Bruce M.; Wasserman, David H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.
   [Baheza, Richard A.; Damon, Bruce M.] Vanderbilt Univ, Sch Med, Dept Radiol & Radiol Sci, Nashville, TN 37212 USA.
   [Swift, Larry L.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA.
   [Charron, Maureen J.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY USA.
   [Damon, Bruce M.] Vanderbilt Univ, Sch Med, Inst Imaging Sci, Nashville, TN 37212 USA.
   [Wasserman, David H.] Vanderbilt Univ, Sch Med, Natl Inst Hlth, Vanderbilt Mouse Metab Phenotyping Ctr, Nashville, TN 37212 USA.
RP Berglund, ED (reprint author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.
EM berglunde@gmail.com
FU National Institutes of Health [R01-DK-050277, U24-DK-59637]
FX This work was supported by National Institutes of Health grants
   R01-DK-050277 and U24-DK-59637.
CR Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x
   Baba CS, 2006, J GASTROEN HEPATOL, V21, P191, DOI 10.1111/j.1440-1746.2005.04233.x
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Berglund ED, 2010, AM J PHYSIOL-ENDOC M, V299, pE607, DOI 10.1152/ajpendo.00263.2010
   Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650
   Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007
   Corbin IR, 2009, BBA-MOL CELL BIOL L, V1791, P757, DOI 10.1016/j.bbalip.2009.02.014
   Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fueger PT, 2007, J PHYSIOL-LONDON, V582, P801, DOI 10.1113/jphysiol.2007.132902
   Gauthier MS, 2004, INT J OBESITY, V28, P1064, DOI 10.1038/sj.ijo.0802628
   Gauthier MS, 2003, J APPL PHYSIOL, V94, P2127, DOI 10.1152/japplphysiol.01164.2002
   Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100
   George AS, 2009, HEPATOLOGY, V50, P68, DOI 10.1002/hep.22940
   GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211
   Ito M, 2007, HEPATOL RES, V37, P50, DOI 10.1111/j.1872-034X.2007.00008.x
   Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129
   Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200
   Krishna MG, 2000, AM J PHYSIOL-ENDOC M, V279, pE638
   Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565
   Lee KY, 2006, OBESITY, V14, P1294, DOI 10.1038/oby.2006.147
   Lee-Young RS, 2011, INT J OBESITY, V35, P982, DOI 10.1038/ijo.2010.220
   Lee-Young RS, 2010, AM J PHYSIOL-REG I, V298, pR1399, DOI 10.1152/ajpregu.00004.2010
   Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048
   Lightfoot JT, 2004, PHYSIOL GENOMICS, V19, P270, DOI 10.1152/physiolgenomics.00125.2004
   Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008
   MACDONALD IA, 1985, J NEUROSCI METH, V13, P239, DOI 10.1016/0165-0270(85)90072-X
   MORGAN CR, 1962, P SOC EXP BIOL MED, V110, P29
   MORRISON WR, 1964, J LIPID RES, V5, P600
   Sinclair EM, 2008, GASTROENTEROLOGY, V135, P2096, DOI 10.1053/j.gastro.2008.07.075
   Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009
   Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959
   Tetri LH, 2008, AM J PHYSIOL-GASTR L, V295, pG987, DOI 10.1152/ajpgi.90272.2008
   Uebanso T, 2009, AM J PHYSIOL-ENDOC M, V297, pE76, DOI 10.1152/ajpendo.00014.2009
   van der Heijden GJ, 2010, OBESITY, V18, P384, DOI 10.1038/oby.2009.274
   van Raalte DH, 2004, PHARM RES-DORDR, V21, P1531, DOI 10.1023/B:PHAM.0000041444.06122.8d
   Vieira VJ, 2009, CYTOKINE, V46, P339, DOI 10.1016/j.cyto.2009.03.006
   Vieira VJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1164, DOI 10.1152/ajpendo.00054.2009
   Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008
   WASSERMAN DH, 1989, AM J PHYSIOL, V257, pE108
   WASSERMAN DH, 1985, J APPL PHYSIOL, V59, P1272
   WASSERMAN DH, 1984, J CLIN INVEST, V74, P1404, DOI 10.1172/JCI111551
   WASSERMAN DH, 1989, DIABETES, V38, P799, DOI 10.2337/diabetes.38.6.799
NR 43
TC 21
Z9 22
U1 2
U2 5
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD NOV
PY 2011
VL 60
IS 11
BP 2720
EP 2729
DI 10.2337/db11-0455
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 847EL
UT WOS:000296954600010
PM 21885872
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Dinant, S
   Schurink, CAM
   Deckers, JW
   Severin, JA
AF Dinant, Sander
   Schurink, Carolina A. M.
   Deckers, Jaap W.
   Severin, Juliette A.
TI RETRACTED: Aortic Homograft Endocarditis Caused by Campylobacter jejuni
   (Retracted article. See vol. 53, pg. 757, 2015)
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article; Retracted Publication
ID BACTEREMIA; FETUS; RESISTANCE; INFECTION
AB We report the first case of homograft endocarditis caused by Campylobacter jejuni, which was treated successfully with antibiotic therapy and valve replacement. To our knowledge, only two other cases of C. jejuni endocarditis, involving native valves, have been reported in the medical literature.
C1 [Dinant, Sander; Schurink, Carolina A. M.; Severin, Juliette A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Med Microbiol & Infect Dis, NL-3015 CE Rotterdam, Netherlands.
   [Schurink, Carolina A. M.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, NL-3015 CE Rotterdam, Netherlands.
   [Deckers, Jaap W.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Cardiol, NL-3015 CE Rotterdam, Netherlands.
RP Dinant, S (reprint author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Med Microbiol & Infect Dis, S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.
EM s_dinant@hotmail.com
CR CACHOT JT, 1989, REV CLIN ESP, V184, P114
   Callahan, 1998, Cancer Control, V5, P357
   DEGUEVARA CL, 1994, J CLIN PATHOL, V47, P174
   Gazaigne L, 2008, EUR J CLIN MICROBIOL, V27, P185, DOI 10.1007/s10096-007-0415-0
   Ge B, 2002, J ANTIMICROB CHEMOTH, V50, P487, DOI 10.1093/jac/dkf162
   Gibreel A, 2006, J ANTIMICROB CHEMOTH, V58, P243, DOI 10.1093/jac/dkl210
   GOMEZGARCES JL, 1995, ANTIMICROB AGENTS CH, V39, P542, DOI 10.1128/AAC.39.2.542
   HAGENSEE ME, 1994, BONE MARROW TRANSPL, V13, P349
   Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753
   Miki K, 2005, INTERNAL MED, V44, P1055, DOI 10.2169/internalmedicine.44.1055
   NAVARRO F, 1993, CLIN INFECT DIS, V17, P815, DOI 10.1093/clinids/17.4.815-a
   Pigrau C, 1997, CLIN INFECT DIS, V25, P1414, DOI 10.1086/516127
   PONKA A, 1980, ACTA MED SCAND, V208, P495
   Wallet F, 2007, JPN J INFECT DIS, V60, P200
NR 14
TC 3
Z9 3
U1 2
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD NOV
PY 2011
VL 49
IS 11
BP 4016
EP 4017
DI 10.1128/JCM.00935-11
PG 2
WC Microbiology
SC Microbiology
GA 842RM
UT WOS:000296617300056
PM 21940472
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Takahashi, K
   Ikeda, N
   Nonoguchi, N
   Kajimoto, Y
   Miyatake, SI
   Hagiya, Y
   Ogura, SI
   Nakagawa, H
   Ishikawa, T
   Kuroiwa, T
AF Takahashi, Kenkichi
   Ikeda, Naokado
   Nonoguchi, Naosuke
   Kajimoto, Yoshinaga
   Miyatake, Shin-Ichi
   Hagiya, Yuichiro
   Ogura, Shun-Ichiro
   Nakagawa, Hiroshi
   Ishikawa, Toshihisa
   Kuroiwa, Toshihiko
TI RETRACTED: Enhanced expression of coproporphyrinogen oxidase in
   malignant brain tumors: CPOX expression and 5-ALA-induced fluorescence
   (Retracted article. See vol. 15, pg. 969, 2013)
SO NEURO-ONCOLOGY
LA English
DT Article; Retracted Publication
DE coproporphyrinogen oxidase; malignant glioma; metastatic brain tumor;
   photodynamic diagnosis
ID ABC TRANSPORTER ABCG2; 5-AMINOLEVULINIC ACID; PHOTODYNAMIC THERAPY;
   INTRAOPERATIVE DETECTION; GLIOBLASTOMA-MULTIFORME; ENDOSCOPIC DETECTION;
   GUIDED RESECTION; IN-VITRO; CANCER; HEME
AB In photodynamic diagnosis, 5-aminolevulinic acid (5-ALA) is widely used for the fluorescence-guided resection of malignant brain tumors, where 5-ALA is converted to protoporphyrin IX, which exhibits strong fluorescence. Little is known, however, about the detailed molecular mechanisms underlying 5-ALA-induced fluorescence. To resolve this issue, we analyzed transcriptome profiles for the genes encoding enzymes, transporters, and a transcription factor involved in the porphyrin-biosynthesis pathway. By quantitative real-time (qRT)-PCR, we measured the mRNA levels of those genes in a total of 20 tumor samples that had been surgically resected from brain tumor patients at the Department of Neurosurgery of Osaka Medical College from 2008 to 2009. We selected 10 tumor samples with no 5-ALA-induced fluorescence, among which 2 were glioblastomas and 8 were metastatic brain tumors. Another 10 tumor samples were selected with strong fluorescence, among which 7 were glioblastomas and 3 were metastatic brain tumors. The qRT-PCR analysis study of these latter 10 samples revealed predominantly high levels of the mRNA of the coproporphyrinogen oxidase (CPOX) gene. The high mRNA level of CPOX expression was significantly well correlated with the phenotype of strong 5-ALA-induced fluorescence (P = .0003). These findings were further confirmed by immunohistochemical studies with a CPOX-specific antibody. It is concluded that induction of CPOX gene expression is one of the key molecular mechanisms underlying the 5-ALA-induced fluorescence of malignant brain tumors. The induction mechanism for the CPOX gene in brain tumors remains to be elucidated.
C1 [Takahashi, Kenkichi; Ikeda, Naokado; Nonoguchi, Naosuke; Kajimoto, Yoshinaga; Miyatake, Shin-Ichi; Kuroiwa, Toshihiko] Osaka Med Coll, Dept Neurosurg, Osaka 5698686, Japan.
   [Hagiya, Yuichiro; Ogura, Shun-Ichiro; Nakagawa, Hiroshi; Ishikawa, Toshihisa] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan.
   [Ishikawa, Toshihisa] RIKEN, Omics Sci Ctr, Yokohama, Kanagawa, Japan.
RP Ikeda, N (reprint author), Osaka Med Coll, Dept Neurosurg, 2-7 Daigaku Machi, Osaka 5698686, Japan.
EM neu094@poh.osaka-med.ac.jp
OI Nonoguchi, Naosuke/0000-0002-4140-2415
FU Japanese Ministry of Education [20591729, 19591709, 20791022]; Japan
   Science and Technology Agency (JST)
FX The study was supported by grants-in-aid for scientific research (C)
   (20591729) and (C) (19591709) and by a grant-in-aid for young scientists
   (B) (20791022) from the Japanese Ministry of Education. Additional
   support was provided by a grant from the Japan Science and Technology
   Agency (JST) Research Project.
CR An R, 2009, PHARM RES-DORDR, V26, P449, DOI 10.1007/s11095-008-9738-5
   Anand S, 2009, CLIN CANCER RES, V15, P3333, DOI 10.1158/1078-0432.CCR-08-3054
   BOTTOMLEY SS, 1988, SEMIN HEMATOL, V25, P282
   Ennis SR, 2003, BRAIN RES, V959, P226, DOI 10.1016/S0006-8993(02)03749-6
   Gupta N, 2006, BIOCHEM BIOPH RES CO, V343, P571, DOI 10.1016/j.bbrc.2006.02.172
   Kajimoto Y, 2007, J NEUROSURG, V106, P1070, DOI 10.3171/jns.2007.106.6.1070
   Kaneko S, 2001, NEUROL SURG TOKYO, V29, P1019
   KENNEDY JC, 1990, J PHOTOCH PHOTOBIO B, V6, P143, DOI 10.1016/1011-1344(90)85083-9
   Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200
   Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001
   Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125
   Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190
   LIPSON RL, 1961, J THORAC CARDIOV SUR, V42, P623
   LIPSON RL, 1967, CANCER, V20, P2255, DOI 10.1002/1097-0142(196712)20:12<2255::AID-CNCR2820201229>3.0.CO;2-U
   LIPSON RL, 1964, DIS CHEST, V46, P676, DOI 10.1378/chest.46.6.676
   LIPSON RL, 1960, ARCH DERMATOL, V82, P508, DOI 10.1001/archderm.1960.01580040026005
   Liu WG, 2007, CLIN CANCER RES, V13, P2463, DOI 10.1158/1078-0432.CCR-06-1599
   Miyatake SI, 2007, NEUROSURGERY, V61, P82, DOI 10.1227/01.NEU.0000255434.47044.41
   Robey RW, 2005, CANCER BIOL THER, V4, P187
   Sinha AK, 2006, BRIT J CANCER, V95, P485, DOI 10.1038/sj.bjc.6603273
   Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9
   Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003
   Stummer W, 1998, NEUROSURGERY, V42, P518, DOI 10.1097/00006123-199803000-00017
   Stummer W, 2003, ACT NEUR S, V88, P9
   Utsuki S, 2006, J NEUROSURG, V104, P618, DOI 10.3171/jns.2006.104.4.618
   Wakabayashi K, 2006, DRUG METAB REV, V38, P371, DOI 10.1080/03602530600727947
NR 26
TC 29
Z9 30
U1 2
U2 18
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1522-8517
EI 1523-5866
J9 NEURO-ONCOLOGY
JI Neuro-Oncology
PD NOV
PY 2011
VL 13
IS 11
BP 1234
EP 1243
DI 10.1093/neuonc/nor116
PG 10
WC Oncology; Clinical Neurology
SC Oncology; Neurosciences & Neurology
GA 848CH
UT WOS:000297025500008
PM 21824890
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Ohno, S
   Shibayama, M
   Sato, M
   Tokunaga, A
   Yoshida, N
AF Ohno, Satona
   Shibayama, Masaki
   Sato, Mitsuharu
   Tokunaga, Akinori
   Yoshida, Nobuaki
TI RETRACTED: Polypyrimidine tract-binding protein regulates the cell cycle
   through IRES-dependent translation of CDK11(p58) in mouse embryonic stem
   cells (Retracted article. See vol. 15, pg. 2992, 2016)
SO CELL CYCLE
LA English
DT Article; Retracted Publication
DE polypyrimidine tract-binding protein; PTB; embryonic stem cells; M
   phase; IRES-dependent translation; CDK11(p58); PITSLRE
ID RIBOSOME ENTRY SITE; SISTER-CHROMATID COHESION; MESSENGER-RNA; INTERNAL
   INITIATION; N-RAS; MITOSIS; KINASE; UNR; SHUGOSHIN; ROLES
AB Polypyrimidine tract-binding protein (PTB/PTBP1/hnRNP I) is a member of the heterogeneous nuclear ribonucleoprotein family that binds specifically to pyrimidine-rich sequences of RNAs. Although PTB is a multifunctional protein involved in RNA processing and internal ribosome entry site (IRE S)-dependent translation, the role of PTB in early mouse development is unclear. Ptb knockout mice exhibit embryonic lethality shortly after implantation and Ptb(-/-) embryonic stem (ES) cells have a severe proliferation defect that includes a prolonged G(2)/M phase. The present study shows that PTB promotes M phase progression by the direct repression of CDK11(p58) IRE S activity in ES cells. The protein expression and IRE S activity of CDK11(p58) in Ptb(-/-) ES cells is higher than that of wild-type ES cells, indicating that PTB is involved in the repression of CDK11(p58) expression through IRE S-dependent translation in ES cells. Interestingly, CDK11(p58) IRE S activity is activated by upstream of N-Ras (UNR) in 293T and NIH3T3 cells, whereas UNR is not present in the Cdk11 mRNA-protein complex in ES cells. In addition, PTB interacts directly with the IRE S region of CDK11(p58) in ES cells. These results suggest that PTB regulates the precise expression of CDK11(p58) through direct interaction with CDK11(p58) IRE S and promotes M phase progression in ES cells.
C1 [Ohno, Satona; Shibayama, Masaki; Sato, Mitsuharu; Tokunaga, Akinori; Yoshida, Nobuaki] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Dev Genet, Tokyo, Japan.
RP Yoshida, N (reprint author), Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Dev Genet, Tokyo, Japan.
EM nobuaki@ims.u-tokyo.ac.jp
FU MEXT, Japan
FX We thank H. Jacquemin-Sablon for providing us with anti-UNR rabbit
   antibody and H. Niwa for the pHPCAGGS plasmid. We are grateful to M.
   Ozawa for his valuable discussion. This work was supported in part by
   the Global COE Program "Center of Education and Research for the
   Advanced Genome-Based Medicine-For personalized medicine and the control
   of worldwide infectious diseases" MEXT, Japan.
CR Berke JD, 2001, NEURON, V32, P277, DOI 10.1016/S0896-6273(01)00465-2
   Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720
   BUNNELL BA, 1990, P NATL ACAD SCI USA, V87, P7467, DOI 10.1073/pnas.87.19.7467
   Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8
   Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004
   Cho SC, 2005, MOL CELL BIOL, V25, P1283, DOI 10.1128/MCB.25.4.1283-1297.2005
   Cornelis S, 2005, NUCLEIC ACIDS RES, V33, P3095, DOI 10.1093/nar/gki611
   Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7
   Dickinson LA, 2002, J BIOL CHEM, V277, P25465, DOI 10.1074/jbc.M202266200
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803
   Fluckiger AC, 2006, STEM CELLS, V24, P1832, DOI 10.1634/stemcells.2005-0194
   GHETTI A, 1992, NUCLEIC ACIDS RES, V20, P3671, DOI 10.1093/nar/20.14.3671
   GIL A, 1991, GENE DEV, V5, P1224, DOI 10.1101/gad.5.7.1224
   Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200
   He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307
   Hu DL, 2007, J CELL SCI, V120, P2424, DOI 10.1242/jcs.007963
   Hunt SL, 1999, GENE DEV, V13, P437, DOI 10.1101/gad.13.4.437
   Johansson H, 2010, CELL CYCLE, V9, P2160, DOI 10.4161/cc.9.11.11841
   Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044
   Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099
   Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472
   Kosinski PA, 2003, J IMMUNOL, V170, P979, DOI 10.4049/jimmunol.170.2.979
   LAHTI JM, 1995, MOL CELL BIOL, V15, P1
   Liberman N, 2009, CELL CYCLE, V8, P204, DOI 10.4161/cc.8.2.7384
   Loyer P, 1998, J CELL SCI, V111, P1495
   McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086
   Mitchell SA, 2001, MOL CELL BIOL, V21, P3364, DOI 10.1128/MCB.21.10.3364-3374.2001
   Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045
   PATTON JG, 1991, GENE DEV, V5, P1237, DOI 10.1101/gad.5.7.1237
   Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639
   PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3
   Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201
   SAVATIER P, 1994, ONCOGENE, V9, P809
   Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641
   Schepens B, 2007, EMBO J, V26, P158, DOI 10.1038/sj.emboj.7601468
   Shibayama M, 2009, FEBS J, V276, P6658, DOI 10.1111/j.1742-4658.2009.07380.x
   Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102
   Tinton SA, 2005, BIOCHEM J, V385, P155, DOI 10.1042/BJ20040963
   Tischendorf JJW, 2004, ARCH VIROL, V149, P1955, DOI 10.1007/s00705-004-0341-8
   UETSUKI T, 1989, J BIOL CHEM, V264, P5791
   Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390
   Wang C, 2008, J BIOL CHEM, V283, P20277, DOI 10.1074/jbc.M803682200
   Watanabe Y, 2005, PHILOS T ROY SOC B, V360, P515, DOI 10.1098/rstb.2004.1607
   White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131
NR 45
TC 23
Z9 25
U1 1
U2 6
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4101
EI 1551-4005
J9 CELL CYCLE
JI Cell Cycle
PD NOV 1
PY 2011
VL 10
IS 21
BP 3706
EP 3713
DI 10.4161/cc.10.21.17903
PG 8
WC Cell Biology
SC Cell Biology
GA 842DZ
UT WOS:000296572100025
PM 22037210
DA 2018-12-27
ER

PT J
AU McCarthy, Y
   Dow, JM
   Ryan, RP
AF McCarthy, Yvonne
   Dow, J. Maxwell
   Ryan, Robert P.
TI RETRACTED: The Ax21 Protein Is a Cell-Cell Signal That Regulates
   Virulence in the Nosocomial Pathogen Stenotrophomonas maltophilia
   (Retracted article. See vol. 199, 2017)
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article; Retracted Publication
ID XA21-MEDIATED INNATE IMMUNITY; COMPLETE GENOME; XANTHOMONAS
AB Stenotrophomonas maltophilia encodes proteins related to the Rax proteins of Xanthomonas oryzae, which are required for the synthesis and secretion of the Ax21 protein. Here we show that Ax21 acts as a cell-cell signal to regulate a diverse range of functions, including virulence, in this nosocomial pathogen.
C1 [Ryan, Robert P.] Univ Coll Cork, BIOMERIT Res Ctr, Dept Microbiol, Biosci Inst, Cork, Ireland.
RP Ryan, RP (reprint author), Univ Coll Cork, BIOMERIT Res Ctr, Dept Microbiol, Biosci Inst, Cork, Ireland.
EM r.ryan@ucc.ie
OI Ryan, Rober/0000-0002-7353-0913
FU Science Foundation of Ireland (SFI) [SFI 07/IN.1/B955, SFI
   09/SIRG/B1654]; Wellcome Trust [093314\Z\10\A]
FX The work of our laboratories is supported in part by grants awarded by
   the Science Foundation of Ireland to J.M.D. (SFI 07/IN.1/B955) and to
   R.P.R. (SFI 09/SIRG/B1654) and by The Wellcome Trust (093314\Z\10\A).
CR Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11
   Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74
   Fouhy Y, 2007, J BACTERIOL, V189, P4964, DOI 10.1128/JB.00310-07
   Han SW, 2011, CURR OPIN MICROBIOL, V14, P62, DOI 10.1016/j.mib.2010.12.006
   Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438
   McCarthy Y, 2010, MOL MICROBIOL, V77, P1220, DOI 10.1111/j.1365-2958.2010.07285.x
   Park CJ, 2010, CELL MICROBIOL, V12, P1017, DOI 10.1111/j.1462-5822.2010.01489.x
   Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558
   Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163
   Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103
   Winzer K, 2002, CURR OPIN MICROBIOL, V5, P216, DOI 10.1016/S1369-5274(02)00304-1
NR 11
TC 22
Z9 23
U1 2
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD NOV
PY 2011
VL 193
IS 22
BP 6375
EP 6378
DI 10.1128/JB.05949-11
PG 4
WC Microbiology
SC Microbiology
GA 843XF
UT WOS:000296709600028
PM 21908663
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Malhotra, D
   Thimmulappa, RK
   Mercado, N
   Ito, K
   Kombairaju, P
   Kumar, S
   Ma, JF
   Feller-Kopman, D
   Wise, R
   Barnes, P
   Biswal, S
AF Malhotra, Deepti
   Thimmulappa, Rajesh K.
   Mercado, Nicolas
   Ito, Kazuhiro
   Kombairaju, Ponvijay
   Kumar, Sarvesh
   Ma, Jinfang
   Feller-Kopman, David
   Wise, Robert
   Barnes, Peter
   Biswal, Shyam
TI RETRACTED: Denitrosylation of HDAC2 by targeting Nrf2 restores
   glucocorticosteroid sensitivity in macrophages from COPD patients
   (Retracted article. See vol. 124, pg. 5521, 2014)
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article; Retracted Publication
ID OBSTRUCTIVE PULMONARY-DISEASE; SMOKE-INDUCED EMPHYSEMA; HISTONE
   DEACETYLASE 2; OXIDATIVE STRESS; NITRIC-OXIDE; INFLAMMATORY RESPONSE;
   S-NITROSYLATION; GENE-EXPRESSION; INHIBITION; EXACERBATIONS
AB Chronic obstructive pulmonary disease (COPD), which is caused primarily by cigarette smoking, is a major health problem worldwide. The progressive decline in lung function that occurs in COPD is a result of persistent inflammation of the airways and destruction of the lung parenchyma. Despite the key role of inflammation in the pathogenesis of COPD, treatment with corticosteroids - normally highly effective antiinflanunatory drugs - has little therapeutic benefit. This corticosteroid resistance is largely caused by inactivation of histone deacetylase 2 (HDAC2), which is critical for the transrepressive activity of the glucocorticoid receptor (GR) that mediates the antiinflanunatory effect of corticosteroids. Here, we show that in alveolar macrophages from patients with COPD, S-nitrosylation of HDAC2 is increased and that this abolishes its GR-transrepression activity and promotes corticosteroid insensitivity. Cys-262 and Cys-274 of HDAC2 were found to be the targets of S-nitrosylation, and exogenous glutathione treatment of macrophages from individuals with COPD restored HDAC2 activity. Treatment with sulforaphane, a small-molecule activator of the transcription factor nuclear factor erythroid 2-related factor 2 (NRF2), was also able to denitrosylate HDAC2, restoring dexamethasone sensitivity in alveolar macrophages from patients with COPD. These effects of sulforaphane were glutathione dependent. We conclude that NRF2 is a novel drug target for reversing corticosteroid resistance in COPD and other corticosteroid-resistant inflammatory diseases.
C1 [Malhotra, Deepti; Thimmulappa, Rajesh K.; Kombairaju, Ponvijay; Kumar, Sarvesh; Ma, Jinfang; Biswal, Shyam] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.
   [Mercado, Nicolas; Ito, Kazuhiro; Barnes, Peter] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.
   [Feller-Kopman, David; Wise, Robert; Biswal, Shyam] Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD 21287 USA.
RP Biswal, S (reprint author), 615 N Wolfe St, Baltimore, MD 21205 USA.
EM rthimmul@jhsph.edu; sbiswal@jhsph.edu
OI Wise, Robert/0000-0002-8353-2349
FU NIH [HL081205]; National Heart, Lung, and Blood Institute Specialized
   Centers of Clinically Oriented Research [P50HL084945]; Flight Attendant
   Medical Research Institute; National Cancer Institute [P50 CA058184];
   National Institute on Environmental Health Sciences [P50ES015903,
   ES03819, U01HL105569, P50HL107169, P01ES018176]; Grace Anne Dorney fund
   for tobacco-related disease research
FX We thank Christopher Harvey for helping with the procurement of patient
   alveolar macrophages during initial optimization studies and Deborah
   McClellan for editorial assistance. We thank Thomas Kensler and Masayuki
   Yamamoto for providing Nrf2<SUP>-/-</SUP> mice. This work was supported
   by NIH grant HL081205 (to S. Biswal), National Heart, Lung, and Blood
   Institute Specialized Centers of Clinically Oriented Research grant
   P50HL084945, the Flight Attendant Medical Research Institute (to S.
   Biswal and R.K. Thimmulappa), National Cancer Institute lung spore grant
   P50 CA058184 (to S. Biswal), and National Institute on Environmental
   Health Sciences grants P50ES015903, ES03819, U01HL105569, P50HL107169,
   and P01ES018176. The authors acknowledge the support of the Grace Anne
   Dorney fund for tobacco-related disease research.
CR Adcock IM, 2005, ANTIOXID REDOX SIGN, V7, P144, DOI 10.1089/ars.2005.7.144
   Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC
   Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x
   Barnes PJ, 2010, RESPIRATION, V80, P89, DOI 10.1159/000315416
   Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3
   Barnes PJ, 2009, ANNU REV PHYSIOL, V71, P451, DOI 10.1146/annurev.physiol.010908.163257
   Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407
   Barnes PJ, 2003, ANNU REV MED, V54, P113, DOI 10.1146/annurev.med.54.101601.152209
   Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764
   Blake DJ, 2010, AM J RESP CELL MOL, V42, P524, DOI 10.1165/rcmb.2009-0054OC
   Brindicci C, 2010, AM J RESP CRIT CARE, V181, P21, DOI 10.1164/rccm.200904-0493OC
   Burge PS, 2000, BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297
   Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631
   Colussi C, 2008, P NATL ACAD SCI USA, V105, P19183, DOI 10.1073/pnas.0805514105
   Cosio BG, 2009, THORAX, V64, P424, DOI 10.1136/thx.2008.103432
   Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416
   Crimi E, 2006, FREE RADICAL BIO MED, V40, P398, DOI 10.1016/j.freeradbiomed.2005.10.054
   Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899
   Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847
   Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946
   Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007
   Fourquet S, 2010, J BIOL CHEM, V285, P8463, DOI 10.1074/jbc.M109.051714
   FREEDMAN JE, 1995, J CLIN INVEST, V96, P394, DOI 10.1172/JCI118047
   Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181
   Gow AJ, 2004, AM J PHYSIOL-LUNG C, V287, pL262, DOI 10.1152/ajplung.00295.2003
   Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042
   Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145
   Hu CQ, 2011, CHEM RES TOXICOL, V24, P515, DOI 10.1021/tx100389r
   Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466
   Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046
   Ito K., 2001, FASEB Journal, V15, P1110
   JAFFREY SR, 2001, SCI STKE, P11
   Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046
   Kensler TW, 2005, CANCER EPIDEM BIOMAR, V14, P2605, DOI 10.1158/1055-9965.EPI-05-0368
   Korhonen R, 2002, MOL PHARMACOL, V62, P698, DOI 10.1124/mol.62.3.698
   Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005
   Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC
   Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212
   Malhotra D, 2009, AM J RESP CRIT CARE, V180, P1196, DOI 10.1164/rccm.200903-0324OC
   Mathers CD, 2009, BRIT MED BULL, V92, P7, DOI 10.1093/bmb/ldp028
   Meja KK, 2008, AM J RESP CELL MOL, V39, P312, DOI 10.1165/rcmb.2008-0012OC
   Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL402, DOI 10.1152/ajplung.00207.2010
   Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502
   Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238
   Osoata GO, 2009, BIOCHEM BIOPH RES CO, V384, P366, DOI 10.1016/j.bbrc.2009.04.128
   Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013
   Pakala SB, 2010, J BIOL CHEM, V285, P23590, DOI 10.1074/jbc.M110.139469
   Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101
   Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146
   Rangasamy T, 2009, AM J PHYSIOL-LUNG C, V296, pL888, DOI 10.1152/ajplung.90369.2008
   Schonhoff C. M., 2011, CURR PROTOC PROTEIN
   Seemungal Terence A R, 2009, Int J Chron Obstruct Pulmon Dis, V4, P203
   Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353
   Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001
   Shapiro TA, 2006, NUTR CANCER, V55, P53, DOI 10.1207/s15327914nc5501_7
   Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026
   Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106
   Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC
   Thimmulappa RK, 2002, CANCER RES, V62, P5196
   To Y, 2010, AM J RESP CRIT CARE, V182, P897, DOI 10.1164/rccm.200906-0937OC
NR 60
TC 86
Z9 89
U1 4
U2 27
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD NOV
PY 2011
VL 121
IS 11
BP 4289
EP 4302
DI 10.1172/JCI45144
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 840ZY
UT WOS:000296482700013
PM 22005302
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Zhao, BH
   Shen, HQ
   Liu, F
   Liu, S
   Niu, JJ
   Guo, F
   Sun, XL
AF Zhao, Benhua
   Shen, Heqing
   Liu, Feng
   Liu, Sheng
   Niu, Jianjun
   Guo, Fei
   Sun, Xueli
TI RETRACTED: Exposure to organochlorine pesticides is independent risk
   factor of hepatocellular carcinoma: A case-control study (Retracted
   article. See vol. 22, pg. 539, 2012)
SO JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY
LA English
DT Article; Retracted Publication
DE case-control study; human exposure; organochlorine pesticides; primary
   hepatocellular carcinoma; risk factor interaction
ID HEPATITIS-B-VIRUS; REPUBLIC-OF-CHINA; PRIMARY LIVER-CANCER;
   POLYCHLORINATED-BIPHENYLS; AFLATOXIN EXPOSURE; UNITED-STATES;
   BREAST-MILK; MORTALITY; DDT; STATISTICS
AB Primary hepatocellular carcinoma (HCC) is highly prevalent in China. Although hepatitis B virus (HBV) and aflatoxin B1 (AFB1) are considered the major risk factors, among the high-risk cohorts only a small fraction develops liver cancer. Therefore, we investigated if organochlorine pesticides (OCPs) exposure contributed to HCC risk in the Xiamen population. The questionnaire database was built from 346 HCC cases and 961 healthy controls during 2007-2009. The serum levels of alpha-, beta-, gamma-, delta-HCH, p, p'-DDT, p, p'-DDE, o, p'-DDT and p, p'-DDD were measured by gas chromatography-tandem mass spectrometer and statistical analysis was done using SPSS16. Significantly, we observed p, p'-DDT, p, p'-DDE, and at first time beta-HCH displayed quartile dose-dependent HCC risk trends; p, p'-DDT showed positive (i.e., synergistic) interactions with HBV, diabetes mellitus, AFB1 and polycyclic aromatic hydrocarbon (PAH) exposure, but negative (i.e., antagonistic) interaction with heavy drinking; p, p'-DDE had positive interaction with PAH but negative interaction with HBV and p, p'-DDT; and beta-HCH was positively interacted with p, p'-DDT but negatively interacted with heavy drinking and diabetes. p, p'-DDT, p, p'-DDE and beta-HCH were independent HCC risk factors. Because of their synergistic interactions with other factors, the high level exposure combined with common AFB1 and HBV exposure in the investigated area may greatly enhance the risk of HCC. Journal of Exposure Science and Environmental Epidemiology (2011) 21, 601-608; doi: 10.1038/jes.2011.24; published online 13 July 2011
C1 [Shen, Heqing; Liu, Feng] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen 361021, Peoples R China.
   [Zhao, Benhua; Liu, Sheng; Guo, Fei] Xiamen Univ, Coll Med, Xiamen 361005, Peoples R China.
   [Niu, Jianjun] Xiamen Ctr Dis Control & Prevent, Xiamen 361021, Peoples R China.
   [Sun, Xueli] Zhangzhou Ctr Dis Control & Prevent, Xiamen 363000, Peoples R China.
RP Shen, HQ (reprint author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, 1799 Jimei Rd, Xiamen 361021, Peoples R China.
EM hqshen@iue.ac.cn
RI Shen, Heqing/H-9338-2013; Liu, Feng/G-9955-2011
OI Shen, Heqing/0000-0002-6544-4919; 
FU Chinese Academy of Sciences (CAS); Xiamen Municipal Science and
   Technology Program [3502Z20073015]; CAS/SAFEA [KZCX2-YW-T08]; Ministry
   of Science and Technology of the People's Republic of China for Combined
   Pollution and Ecosystem Health in Urban Agglomeration [2009DFB90120]
FX The work was supported by Chinese Academy of Sciences (CAS) 100 Talents
   Program for Human Exposure to Environmental Pollutant and Health Effect,
   Xiamen Municipal Science and Technology Program (3502Z20073015),
   CAS/SAFEA International Partnership Program for Creative Research Teams
   (KZCX2-YW-T08) and Ministry of Science and Technology of the People's
   Republic of China for Combined Pollution and Ecosystem Health in Urban
   Agglomeration (2009DFB90120). We thank all the persons who contributed
   their samples and work in this study. We also thank Prof. Jay Gan
   (Department of Environmental Sciences, University of California,
   Riverside, USA) for his help in improving the English and his nice
   comments on the report.
CR Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753
   Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x
   CHU FS, 1994, APPL ENVIRON MICROB, V60, P847
   Cocco P, 2005, CANCER RES, V65, P9588, DOI 10.1158/0008-5472.CAN-05-1487
   Cocco P, 1997, ARCH ENVIRON HEALTH, V52, P299, DOI 10.1080/00039899709602202
   Cocco P, 2000, ENVIRON HEALTH PERSP, V108, P1, DOI 10.2307/3454288
   Codru N, 2007, ENVIRON HEALTH PERSP, V115, P1442, DOI 10.1289/ehp.10315
   Dekoning EP, 2000, J EXPO ANAL ENV EPID, V10, P285, DOI 10.1038/sj.jea.7500090
   Deng Z.L., 1997, J CANC RES, V9, P167
   Donato F, 2002, AM J EPIDEMIOL, V155, P323, DOI 10.1093/aje/155.4.323
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   El-Shahawi MS, 2010, TALANTA, V80, P1587, DOI 10.1016/j.talanta.2009.09.055
   Eskenazi B, 2009, ENVIRON HEALTH PERSP, V117, P1359, DOI 10.1289/ehp.11748
   FIGATALAMANCA I, 1993, INT J EPIDEMIOL, V22, P674, DOI 10.1093/ije/22.4.674
   Garcia M., 2007, GLOBAL CANC FACTS FI
   Hassan MM, 2008, INT J CANCER, V123, P1883, DOI 10.1002/ijc.23730
   Imai Y, 2010, J VIRAL HEPATITIS, V17, P185, DOI 10.1111/j.1365-2893.2009.01163.x
   Jaga Kushik, 2003, Int J Occup Med Environ Health, V16, P7
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006
   Kirk GD, 2000, J NATL CANCER I, V92, P148, DOI 10.1093/jnci/92.2.148
   KITAGAWA T, 1984, CARCINOGENESIS, V5, P1653, DOI 10.1093/carcin/5.12.1653
   Li FQ, 2001, J AGR FOOD CHEM, V49, P4122, DOI 10.1021/jf010143k
   Liu L.F., 2010, FRONT MED CHINA, V4, P6
   Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388
   McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004
   McGlynn KA, 2006, J NATL CANCER I, V98, P1005, DOI 10.1093/jnci/djj266
   MORGAN DP, 1971, ARCH ENVIRON HEALTH, V22, P301, DOI 10.1080/00039896.1971.10665848
   Niu J.J., 2010, CHIN J EPIDEMIOL, V31, P6
   Onishchenko N, 2008, J NEUROCHEM, V106, P1378, DOI 10.1111/j.1471-4159.2008.05484.x
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440
   POPRC, 2007, RISK PROF BET HEX AD
   QIAN GS, 1994, CANCER EPIDEM BIOMAR, V3, P3
   Qiu XH, 2005, ENVIRON SCI TECHNOL, V39, P4385, DOI 10.1021/es050342a
   Qu CX, 2007, J NATL CANCER I, V99, P1240, DOI 10.1093/jnci/djm084
   Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321
   SHEN FM, 1991, AM J HUM GENET, V49, P88
   Shen H, 2008, HUM REPROD, V23, P201, DOI 10.1093/humrep/dem199
   Shen HQ, 2007, CHEMOSPHERE, V67, pS256, DOI 10.1016/j.chemosphere.2006.05.106
   Sundberg SE, 2006, J CHROMATOGR B, V831, P99, DOI 10.1016/j.jchromb.2005.11.037
   Szymanska K, 2009, CANCER EPIDEM BIOMAR, V18, P1638, DOI 10.1158/1055-9965.EPI-08-1102
   Vetter W, 1997, J CHROMATOGR A, V774, P143, DOI 10.1016/S0021-9673(97)00296-3
   Wang JS, 2001, CANCER EPIDEM BIOMAR, V10, P143
   Wang J, 2007, BIOMED ENVIRON SCI, V20, P483
   Wang X Q, 1988, Biomed Environ Sci, V1, P138
   Welzel TM, 2007, CANCER EPIDEM BIOMAR, V16, P1279, DOI 10.1158/1055-9965.EPI-06-0853
   *WHO, ENV HLTH CRIT, V123
   WHO-IDF, 2006, DEF DIAGN DIAB MELL
   Willett KL, 1998, ENVIRON SCI TECHNOL, V32, P2197, DOI 10.1021/es9708530
   WILLIAMS GM, 1984, CARCINOGENESIS, V5, P1689, DOI 10.1093/carcin/5.12.1689
   Wu HC, 2008, CARCINOGENESIS, V29, P971, DOI 10.1093/carcin/bgn057
   Wu HC, 2007, CANCER LETT, V252, P104, DOI 10.1016/j.canlet.2006.12.010
   Yang L, 2005, EUR J CANCER PREV, V14, P329, DOI 10.1097/00008469-200508000-00004
   YEH FS, 1989, CANCER RES, V49, P2506
   Zhao Ben-Hua, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P427
NR 55
TC 9
Z9 9
U1 2
U2 18
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1559-0631
EI 1559-064X
J9 J EXPO SCI ENV EPID
JI J. Expo. Sci. Environ. Epidemiol.
PD NOV-DEC
PY 2011
VL 21
IS 6
BP 601
EP 608
DI 10.1038/jes.2011.24
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 842DW
UT WOS:000296571700006
PM 21750577
OA Bronze
DA 2018-12-27
ER

PT J
AU Lichtenthaler, U
   Frishammar, J
AF Lichtenthaler, Ulrich
   Frishammar, Johan
TI RETRACTED: The Impact of Aligning Product Development and Technology
   Licensing: A Contingency Perspective (Retracted article. See vol. 33,
   pg. 377, 2016)
SO JOURNAL OF PRODUCT INNOVATION MANAGEMENT
LA English
DT Article; Retracted Publication
ID INTELLECTUAL PROPERTY-RIGHTS; RESEARCH-AND-DEVELOPMENT; RESOURCE-BASED
   VIEW; INNOVATION PERFORMANCE; FINANCIAL PERFORMANCE; MANUFACTURING
   FIRMS; EMPIRICAL-ANALYSIS; MARKET; STRATEGY; EXPLOITATION
AB In recent years, many firms have started to actively license out technology, either exclusively or in addition to applying the technology in their own products. While some pioneering firms have achieved substantial benefits from outlicensing, many others fear weakening their competitive position in the markets for their products by selling "corporate crown jewels." This paper addresses the effects of an integrated technology exploitation strategy, which refers to aligning technology licensing and product development, on a firm's financial performance, i.e., return on sales in the subsequent year. Drawing on a contingency perspective, the study further examines the moderating effects of four external contingency factors related to the appropriability regime and the technology markets in the relationship between an integrated strategy and firm performance. While the product markets refer to the markets for physical products, the technology markets refer to markets for disembodied technological knowledge. Quantitative analyses of new survey and financial data from 122 industrial firms with a one-year lag are presented, and they show a positive effect of an integrated technology exploitation strategy on subsequent firm performance. This positive effect is stronger under conditions that are characterized by effective patent protection, high technological turbulence, high transaction frequency in the technology markets, and strong competition in the technology markets. The main finding of the paper is that, due to interdependencies with a firm's product development activities, it is not beneficial to manage licensing as a stand-alone activity. Instead, integrated strategies help firms to overcome managerial difficulties and to capture value from open innovation. The results have major implications for both management and research into technology exploitation, licensing, open innovation, and technology markets.
C1 [Lichtenthaler, Ulrich] WHU, Otto Beisheim Sch Management Innovat & Org, D-56179 Vallendar, Germany.
   [Frishammar, Johan] Lulea Univ Technol, Lulea, Sweden.
RP Lichtenthaler, U (reprint author), WHU, Otto Beisheim Sch Management Innovat & Org, Burgpl 2, D-56179 Vallendar, Germany.
EM lichtenthaler@whu.edu
CR ADAM Y, 1988, J PROD INNOVAT MANAG, V5, P32, DOI 10.1111/1540-5885.510032
   Adner R, 2006, HARVARD BUS REV, V84, P98
   Agrawal A, 2006, STRATEGIC MANAGE J, V27, P63, DOI 10.1002/smj.508
   Anand BN, 2000, J IND ECON, V48, P103
   Andersen B, 2008, RES POLICY, V37, P12, DOI 10.1016/j.respol.2007.02.024
   Arora A, 2010, IND CORP CHANGE, V19, P775, DOI 10.1093/icc/dtq022
   Artz KW, 2010, J PROD INNOVAT MANAG, V27, P725, DOI 10.1111/j.1540-5885.2010.00747.x
   Baruch Y, 1999, HUM RELAT, V52, P421, DOI 10.1023/A:1016905407491
   Belderbos R, 2010, J PROD INNOVAT MANAG, V27, P869, DOI 10.1111/j.1540-5885.2010.00757.x
   Benner MJ, 2009, J PROD INNOVAT MANAG, V26, P473, DOI 10.1111/j.1540-5885.2009.00675.x
   Boyd DE, 2010, J PROD INNOVAT MANAG, V27, P593, DOI 10.1111/j.1540-5885.2010.00737.x
   Brooke M. Z., 1994, LICENSING
   Burton R., 1997, STRATEGIC ORG DIAGNO
   Calantone R, 2003, J PROD INNOVAT MANAG, V20, P90, DOI 10.1111/1540-5885.2002003
   Calantone RJ, 2007, J PROD INNOVAT MANAG, V24, P230, DOI 10.1111/j.1540-5885.2007.00247.x
   CARROLL GR, 1993, STRATEGIC MANAGE J, V14, P237, DOI 10.1002/smj.4250140402
   Cassiman B, 2006, MANAGE SCI, V52, P68, DOI 10.1287/rrmsc.1050.0470
   Chesbrough H, 2003, OPEN INNOVATION NEW
   Chesbrough H, 2007, CALIF MANAGE REV, V49, P45, DOI 10.2307/41166394
   Cohen J., 2003, APPL MULTIPLE REGRES
   Contractor F.J., 1981, INT TECHNOLOGY LICEN
   DAVIS JL, 2001, EDISON BOARDROOM LEA
   Di Benedetto CA, 1999, J PROD INNOVAT MANAG, V16, P530, DOI 10.1016/S0737-6782(99)00014-4
   Donaldson L., 2001, CONTINGENCY THEORY O
   Easterby-Smith M, 2008, J MANAGE STUD, V45, P677, DOI 10.1111/j.1467-6486.2008.00773.x
   Faems D, 2010, J PROD INNOVAT MANAG, V27, P785, DOI 10.1111/j.1540-5885.2010.00752.x
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fosfuri A, 2006, STRATEGIC MANAGE J, V27, P1141, DOI 10.1002/smj.562
   Frishammar J, 2005, J PROD INNOVAT MANAG, V22, P251, DOI 10.1111/j.0737-6782.2005.00121.x
   Gambardella A, 2001, MARKETS TECHNOLOGY E
   Gambardella A, 2007, RES POLICY, V36, P1163, DOI 10.1016/j.respol.2007.07.006
   Gans JS, 2008, MANAGE SCI, V54, P982, DOI 10.1287/mnsc.1070.0814
   Gans JS, 2003, RES POLICY, V32, P333, DOI 10.1016/S0048-7333(02)00103-8
   Grandori A., 2001, ORG EC BEHAV
   Griffin A, 2009, J PROD INNOVAT MANAG, V26, P222, DOI 10.1111/j.1540-5885.2009.00347.x
   Grindley PC, 1997, CALIF MANAGE REV, V39, P8, DOI 10.2307/41165885
   Hair J., 2006, MULTIVARIATE DATA AN
   Hall BH, 2005, RAND J ECON, V36, P16
   Harabi N, 1995, RES POLICY, V24, P981, DOI 10.1016/0048-7333(94)00812-4
   Hendricks KB, 2005, MANAGE SCI, V51, P695, DOI 10.1287/mnsc.1040.0353
   HILL CWL, 1992, ORGAN SCI, V3, P428, DOI 10.1287/orsc.3.3.428
   Hodgkinson GP, 2006, LONG RANGE PLANN, V39, P479, DOI 10.1016/j.lrp.2006.07.003
   Hoegl M, 2007, J PROD INNOVAT MANAG, V24, P156, DOI 10.1111/j.1540-5885.2007.00240.x
   JAWORSKI BJ, 1993, J MARKETING, V57, P53, DOI 10.2307/1251854
   Judge WQ, 1998, J MANAGE STUD, V35, P241, DOI 10.1111/1467-6486.00092
   Kandwhalla P., 1977, DESIGN ORG
   Kearns GS, 2007, IEEE T ENG MANAGE, V54, P628, DOI 10.1109/TEM.2007.906848
   Kim N, 2010, J PROD INNOVAT MANAG, V27, P519, DOI 10.1111/j.1540-5885.2010.00733.x
   Kotabe M, 1996, J MARKETING, V60, P73, DOI 10.2307/1251889
   Lambe CJ, 1997, J PROD INNOVAT MANAG, V14, P102, DOI 10.1111/1540-5885.1420102
   Lattin J. M, 2003, ANAL MULTIVARIATE DA
   Laursen K, 2006, STRATEGIC MANAGE J, V27, P131, DOI 10.1002/smj.507
   Lawrence P. R., 1967, ORG ENV
   Lee J, 2003, MANAGE SCI, V49, P553, DOI 10.1287/mnsc.49.4.553.14417
   Lee RP, 2009, J PROD INNOVAT MANAG, V26, P97, DOI 10.1111/j.1540-5885.2009.00337.x
   LEVIN RC, 1987, BROOKINGS PAP ECO AC, P783
   Lichtenthaler U, 2007, CALIF MANAGE REV, V49, P67, DOI 10.2307/41166406
   Lichtenthaler U, 2010, RES POLICY, V39, P55, DOI 10.1016/j.respol.2009.11.011
   Lichtenthaler U, 2009, STRATEG ORGAN, V7, P183, DOI 10.1177/1476127009102672
   Lichtenthaler U, 2009, R&D MANAGE, V39, P317, DOI 10.1111/j.1467-9310.2009.00561.x
   March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71
   Markman GD, 2008, J MANAGE STUD, V45, P1401, DOI 10.1111/j.1467-6486.2008.00803.x
   Mazzoleni R, 1998, RES POLICY, V27, P273, DOI 10.1016/S0048-7333(98)00048-1
   Motohashi K, 2008, RES POLICY, V37, P1548, DOI 10.1016/j.respol.2007.12.014
   Nagaoka S, 2006, RES POLICY, V35, P1347, DOI 10.1016/j.respol.2006.05.007
   Pisano GP, 2007, CALIF MANAGE REV, V50, P278, DOI 10.2307/41166428
   Poetz MK, 2010, J PROD INNOVAT MANAG, V27, P897, DOI 10.1111/j.1540-5885.2010.00759.x
   PRICE M, 1986, HDB ORG MEASUREMENT
   Ray G, 2004, STRATEGIC MANAGE J, V25, P23, DOI 10.1002/smj.366
   Rivette K, 2000, REMBRANDTS ATTIC UNL
   Rothaermel FT, 2004, STRATEGIC MANAGE J, V25, P201, DOI 10.1002/smj.376
   Sahay A, 2003, J PROD INNOVAT MANAG, V20, P338, DOI 10.1111/1540-5885.00033
   Santos FA, 2005, ORGAN SCI, V16, P491, DOI 10.1287/orsc.1050.0152
   Scott W.R., 1987, ORG RATIONAL NATURAL
   Silverman BS, 1999, MANAGE SCI, V45, P1109, DOI 10.1287/mnsc.45.8.1109
   Swan KS, 2003, J PROD INNOVAT MANAG, V20, P485, DOI 10.1111/1540-5885.00044
   Teece DJ, 2007, STRATEG MANAGE J, V28, P1319, DOI 10.1002/smj.640
   Teece DJ, 2006, RES POLICY, V35, P1131, DOI 10.1016/j.respol.2006.09.009
   Woodward J., 1965, IND ORG THEORY PRACT
NR 79
TC 7
Z9 8
U1 2
U2 64
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0737-6782
EI 1540-5885
J9 J PROD INNOVAT MANAG
JI J. Prod. Innov. Manage.
PD NOV
PY 2011
VL 28
SU 1
BP 89
EP 103
DI 10.1111/j.1540-5885.2011.00863.x
PG 15
WC Business; Engineering, Industrial; Management
SC Business & Economics; Engineering
GA 840DF
UT WOS:000296417800007
DA 2018-12-27
ER

PT J
AU Banihashemian, K
   Pour, RE
   Moazzen, M
AF Banihashemian, Kourosh
   Pour, Razieh Etesami
   Moazzen, Mansour
TI RETRACTED: Frontal acquired brain injury, substance abuse and their
   common psychological symptoms in the Iranian population (Retracted
   article. See vol. 27, pg. 1215, 2013)
SO BRAIN INJURY
LA English
DT Article; Retracted Publication
DE Frontal brain injury; substance abuse; symptoms
ID ALZHEIMER-DISEASE; DRUG-USE; EXECUTIVE DYSFUNCTION; BEHAVIORAL SYMPTOMS;
   PARKINSONS-DISEASE; SELF-AWARENESS; CONSEQUENCES; IMPAIRMENT; ADDICTION;
   IMPACT
AB Primary objective: To compare the scores from the Iranian version of the Frontal Systems Behavioral Scale (FSBS) with the norms collected for the American, English-speaking population and to examine the ability of the FSBS to discriminate between acquired brain injury and addiction.
   Research design: Multivariate analysis of variance (MANOVA) and post hoc Bonferroni tests.
   Methods and procedures: 120 subjects (41 patients with frontal acquired brain injury [FABI], 47 abstinent Substance Abusers (SA), and 32 healthy controls from the Iranian population) were selected. An Iranian version of the FSBS was administered to all participants.
   Main outcomes and results: Patients with FABI and SA had higher scores than the control group on the FSBS total score; patients with FABI scored significantly higher than SA, and SA significantly higher than controls. While SA had greater subscales of executive dysfunction than controls, patients with FABI had higher scores than SA and the control group in the subscales of disinhibition, apathy, and executive dysfunction.
   Conclusions: Two clinical samples of Iranian participants had detective behavioral problems associated with frontal systems dysfunction based on Iranian version of the FSBS, which makes this scale a useful instrument for the detection of behavioral problems.
C1 [Banihashemian, Kourosh; Pour, Razieh Etesami] Payam e Nour Univ, Jahrom Branch, Tehran, Iran.
   [Moazzen, Mansour] Payam e Nour Univ, Khavaran Branch, Tehran, Iran.
RP Banihashemian, K (reprint author), Iran Jahrom Azadegan Blv Payam E Nour Univ, Jahrom, Iran.
EM kouroshcpsp@yahoo.com
CR Boyle PA, 2003, AM J GERIAT PSYCHIAT, V11, P214, DOI 10.1176/appi.ajgp.11.2.214
   Cahn-Weiner DA, 2002, NEUROPSY NEUROPSY BE, V15, P79, DOI 10.1097/01.WNN.0000012908.05122.F4
   Caracuel-Romero A, 2005, REHABILITACION MADR, V32, P95
   Garavan H, 2005, TRENDS COGN SCI, V9, P195, DOI 10.1016/j.tics.2005.02.008
   Goverover Y, 2005, MULT SCLER J, V11, P203, DOI 10.1191/1352458505ms1153oa
   Grace J., 2001, FRONTAL SYSTEMS BEHA
   Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655
   Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281
   Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584
   Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88
   Ministerio de Sanidad y Consumo, 2004, PLAN NAC DROG INF 20
   Norton LE, 2001, AM J GERIAT PSYCHIAT, V9, P41
   Puente AE, 2000, HDB MULTICULTURAL ME, P419
   Rymer S, 2002, ALZ DIS ASSOC DIS, V16, P248, DOI 10.1097/00002093-200210000-00006
   Saint-Cyr JA, 2000, BRAIN, V123, P2091, DOI 10.1093/brain/123.10.2091
   Spinella M, 2004, INT J NEUROSCI, V114, P1323, DOI 10.1080/00207450490476011
   Spinella M, 2003, ADDICT BIOL, V8, P67, DOI 10.1080/1355621031000069909
   Stout JC, 2001, J INT NEUROPSYCH SOC, V7, P92, DOI 10.1017/S1355617701711095
   Stout JC, 2003, AM J GERIAT PSYCHIAT, V11, P683
   Velligan DI, 2002, PSYCHIAT RES, V113, P227, DOI 10.1016/S0165-1781(02)00264-0
   Verdejo-Garcia A, 2004, NEUROPSYCHOL REV, V14, P1, DOI 10.1023/B:NERV.0000026647.71528.83
   Verdejo-Garcia A, 2008, PSYCHIAT RES, V158, P172, DOI 10.1016/j.psychres.2006.08.001
   Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486
   Verdejo-Garcia A, 2006, ADDICT BEHAV, V31, P1373, DOI 10.1016/j.addbeh.2005.11.003
NR 24
TC 2
Z9 2
U1 4
U2 12
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0269-9052
EI 1362-301X
J9 BRAIN INJURY
JI Brain Inj.
PD NOV
PY 2011
VL 25
IS 12
BP 1249
EP 1255
DI 10.3109/02699052.2011.608208
PG 7
WC Neurosciences; Rehabilitation
SC Neurosciences & Neurology; Rehabilitation
GA 829WF
UT WOS:000295615200012
PM 21932995
DA 2018-12-27
ER

PT J
AU Sarkola, T
   Redington, AN
   Slorach, C
   Hui, W
   Bradley, T
   Jaeggi, E
AF Sarkola, Taisto
   Redington, Andrew N.
   Slorach, Cameron
   Hui, Wei
   Bradley, Timothy
   Jaeggi, Edgar
TI RETRACTED: Assessment of vascular phenotype using a novel very high
   resolution ultrasound technique in adolescents after aortic coarctation
   repair and/or stent implantation: relationship to central haemodynamics
   and left ventricular mass (Retracted article. See vol. 99, pg. 1063,
   2013)
SO HEART
LA English
DT Article; Retracted Publication
ID BLOOD-PRESSURE-MEASUREMENT; ASCENDING AORTA; PULSE-WAVE; DYSFUNCTION;
   ARTERIES; DISEASE; VELOCITY; CHILDREN; ADULTS; IMPACT
AB Objectives The objective was to determine the severity of residual cardiovascular abnormalities in youths after coarctation of the aorta (CoA) repair and their relation to regional blood pressure (BP).
   Design Prospective cross-sectional study in tertiary health care setting.
   Methods Thirty-six CoAs (age 1661 years; neonatal surgery only: n=16; surgery and/or stent implantation: n=20) and 37 age-matched controls were examined by very-high resolution ultrasound, echocardiography and applanation tonometry.
   Results CoA was associated with increased right arm systolic BP (p<0.001), intima-media thickness (IMT) in the common carotid (p<0.001), right brachial (p<0.05) and radial (p<0.05) arteries and ascending aortic stiffness (p<0.05). Carotid IMT correlated positively with age at first intervention (r=0.36, p<0.05). With left subclavian flap type repair, left arm systolic BP (p<0.001) and left brachial (p<0.001), radial (p<0.001) and ulnar (p<0.05) arterial IMTs were all reduced. When adjusted for BP, body mass index, age and gender, only carotid IMT (p<0.001) and LV-mass (p=0.013) of stented patients, as well as left arm arterial IMTs (p<0.01) in subclavian flap type repair patients remained different from controls. The significant associations of stented patients disappeared after adjustment for later patient age at intervention (median 8.7 vs 0.03 years, p<0.001). Residual arm-leg BP gradients correlated positively with carotid and brachial IMT.
   Conclusion CoA repair in early childhood is associated with increased preductal arterial IMT, LV mass and ascending aortic stiffness in adolescents. The more pronounced cardiovascular abnormalities after CoA stent implantation are likely related to the older patient age at the time of intervention.
C1 [Sarkola, Taisto; Redington, Andrew N.; Slorach, Cameron; Hui, Wei; Bradley, Timothy; Jaeggi, Edgar] Univ Toronto, Hosp Sick Children, Div Cardiol, Labatt Family Heart Ctr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
   [Sarkola, Taisto] Univ Helsinki, Cent Hosp, Div Cardiol, Childrens Hosp, Helsinki, Finland.
   [Redington, Andrew N.; Jaeggi, Edgar] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada.
RP Jaeggi, E (reprint author), Univ Toronto, Hosp Sick Children, Div Cardiol, Labatt Family Heart Ctr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM edgar.jaeggi@sickkids.ca
FU Sigrid Juselius Foundation; Instrumentarium Foundation; Societatis
   Medicorum Fennicae; Finnish Cultural Foundation; Finnish Foundation for
   Cardiovascular Research; Stockmann Foundation
FX The study was supported by grants from the Sigrid Juselius Foundation,
   the Instrumentarium Foundation, Societatis Medicorum Fennicae, the
   Finnish Cultural Foundation, the Finnish Foundation for Cardiovascular
   Research and the Stockmann Foundation. The 25 MHz and 35 MHz probes were
   loaned to the investigators by Visualsonics<SUP>R</SUP> (Toronto,
   Canada). The company had no other role in the study.
CR Bramwell JC, 1922, LANCET, V1, P891
   Brili S, 2005, ATHEROSCLEROSIS, V182, P97, DOI 10.1016/j.atherosclerosis.2005.01.030
   Celermajer DS, 2002, HEART, V88, P113, DOI 10.1136/heart.88.2.113
   Chen SSM, 2008, HEART, V94, P919, DOI 10.1136/hrt.2006.109389
   COHEN M, 1989, CIRCULATION, V80, P840, DOI 10.1161/01.CIR.80.4.840
   de Divitiis M, 2003, J AM COLL CARDIOL, V41, P2259, DOI 10.1016/S0735-1097(03)00480-7
   de Divitiis M, 2001, CIRCULATION, V104, pI165
   DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X
   GARDINER HM, 1994, CIRCULATION, V89, P1745, DOI 10.1161/01.CIR.89.4.1745
   Kuczmarski R. J., 2000, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114
   Lam YY, 2009, HEART, V95, P733, DOI 10.1136/hrt.2008.158287
   Meyer AA, 2005, EUR HEART J, V26, P617, DOI 10.1093/eurheartj/ehi037
   O'Sullivan JJ, 2002, HEART, V88, P163, DOI 10.1136/heart.88.2.163
   Pickering TG, 2005, HYPERTENSION, V45, P142, DOI [10.1161/01.HYP.0000150859.47929.8e, 10.1161/01.CIR.0000154900.76284.F6]
   Rajzer MW, 2008, J HYPERTENS, V26, P2001, DOI 10.1097/HJH.0b013e32830a4a25
   Sarkola T, 2010, ATHEROSCLEROSIS, V212, P516, DOI 10.1016/j.atherosclerosis.2010.06.043
   STEFANADIS C, 1990, EUR HEART J, V11, P990, DOI 10.1093/oxfordjournals.eurheartj.a059639
   Vogt M, 2005, CIRCULATION, V111, P3269, DOI 10.1161/CIRCULATIONAHA.104.529792
   Vriend JWJ, 2006, AM HEART J, V151, P242, DOI 10.1016/j.ahj.2005.02.013
NR 19
TC 1
Z9 1
U1 1
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1355-6037
EI 1468-201X
J9 HEART
JI Heart
PD NOV
PY 2011
VL 97
IS 22
BP 1870
EP 1875
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 837LF
UT WOS:000296203800012
PM 21917665
DA 2018-12-27
ER

PT J
AU Kayee, P
   Sonthiphand, P
   Rongsayamanont, C
   Limpiyakorn, T
AF Kayee, Pantip
   Sonthiphand, Puntipar
   Rongsayamanont, Chaiwat
   Limpiyakorn, Tawan
TI RETRACTED: Archaeal amoA Genes Outnumber Bacterial amoA Genes in
   Municipal Wastewater Treatment Plants in Bangkok (Retracted article. See
   vol. 72, pg. 262, 2016)
SO MICROBIAL ECOLOGY
LA English
DT Article; Retracted Publication
ID AMMONIA-OXIDIZING BACTERIA; IN-SITU HYBRIDIZATION; WATER
   TREATMENT-PLANT; REAL-TIME PCR; ACTIVATED-SLUDGE; OXYGEN CONCENTRATIONS;
   NITRIFYING BACTERIA; MARINE-SEDIMENTS; RIBOSOMAL-RNA; BLACK-SEA
AB The contribution of ammonia-oxidizing archaea (AOA) to nitrogen removal in wastewater treatment plants (WWTPs) remains unknown. This study investigated the abundance of archaeal (AOA) and bacterial (ammonia-oxidizing bacteria (AOB)) amoA genes in eight of Bangkok's municipal WWTPs. AOA amoA genes (3.28 x 10(7) +/- 1.74 x 10(7)-2.23 x 10(11) +/- 1.92 x 10(11) copies l(-1) sludge) outnumbered AOB amoA genes in most of the WWTPs even though the plants' treatment processes, influent and effluent characteristics, removal efficiencies, and operation varied. An estimation of the ammonia-oxidizing activity of AOA and AOB suggests that AOA involved in autotrophic ammonia oxidation in the WWTPs. Statistical analysis shows that the numbers of AOA amoA genes correlated negatively to the ammonium levels in effluent wastewater, while no correlation was found between the AOA amoA gene numbers and the oxygen concentrations in aeration tanks. An analysis of the AOB sequences shows that AOB found in the WWTPs limited to only two AOB clusters which exhibit high or moderate affinity to ammonia. In contrast to AOB, AOA sequences of various clusters were retrieved, and they were previously recovered from a variety of environments, such as thermal and marine environments.
C1 [Limpiyakorn, Tawan] Chulalongkorn Univ, Fac Engn, Dept Environm Engn, Bangkok 10330, Thailand.
   [Kayee, Pantip; Sonthiphand, Puntipar; Rongsayamanont, Chaiwat; Limpiyakorn, Tawan] Chulalongkorn Univ, Natl Ctr Excellence Environm & Hazardous Waste Ma, Bangkok 10330, Thailand.
   [Kayee, Pantip; Sonthiphand, Puntipar; Rongsayamanont, Chaiwat] Chulalongkorn Univ, Int Postgrad Programs Environm Management, Grad Sch, Bangkok 10330, Thailand.
RP Limpiyakorn, T (reprint author), Chulalongkorn Univ, Fac Engn, Dept Environm Engn, Phayathai Rd, Bangkok 10330, Thailand.
EM tawan.l@chula.ac.th
FU Chulalongkorn University; Thailand Research Fund [MRG5280086]; Office of
   the Higher Education Commission; National Research Council of Thailand
FX This work has been supported by the 90th Anniversary of Chulalongkorn
   University Fund (Ratchadaphiseksomphot Endowment Fund). We also
   acknowledge financial support from the Thailand Research Fund (grant no.
   MRG5280086), Office of the Higher Education Commission, and National
   Research Council of Thailand. We would like to show our appreciation to
   the Bangkok Metropolitan Administration (BMA) for providing sludge from
   their municipal WWTPs and Professor Chongrak Polprasert for his
   guidance.
CR Aakra A, 1999, INT J SYST BACTERIOL, V49, P123, DOI 10.1099/00207713-49-1-123
   BELSER LW, 1980, FEMS MICROBIOL LETT, V7, P213, DOI 10.1111/j.1574-6941.1980.tb01628.x
   Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118
   Bollmann A, 2002, APPL ENVIRON MICROB, V68, P4751, DOI 10.1128/AEM.68.10.4751-4757.2002
   Bollmann A, 2001, FEMS MICROBIOL ECOL, V37, P211, DOI 10.1111/j.1574-6941.2001.tb00868.x
   Coolen MJL, 2007, ENVIRON MICROBIOL, V9, P1001, DOI 10.1111/j.1462-2920.2006.01227.x
   Daims H, 2001, APPL ENVIRON MICROB, V67, P5810, DOI 10.1128/AEM.67.12.5810-5818.2001
   de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x
   Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x
   Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102
   Gieseke A, 2001, APPL ENVIRON MICROB, V67, P1351, DOI 10.1128/AEM.67.3.1351-1362.2001
   Harms G, 2003, ENVIRON SCI TECHNOL, V37, P343, DOI 10.1021/es0257164
   Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105
   Kasuga I, 2010, WATER RES, V44, P5039, DOI 10.1016/j.watres.2010.07.015
   Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911
   KOOPS HP, 1991, J GEN MICROBIOL, V137, P1689, DOI 10.1099/00221287-137-7-1689
   KOOPS HP, 2003, PROKARYOTES EVOLVING
   Kowalchuk GA, 1997, APPL ENVIRON MICROB, V63, P1489
   LAANBROEK HJ, 1994, ARCH MICROBIOL, V161, P156, DOI 10.1007/BF00276477
   Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104
   Li BK, 2004, WATER RES, V38, P1248, DOI 10.1016/j.watres.2003.11.019
   Limpiyakorn T, 2006, WATER SCI TECHNOL, V54, P91, DOI 10.2166/wst.2006.376
   Limpiyakorn T, 2005, FEMS MICROBIOL ECOL, V54, P205, DOI 10.1016/j.femsec.2005.03.017
   Limpiyakorn T, 2006, APPL MICROBIOL BIOT, V72, P1004, DOI 10.1007/s00253-006-0366-x
   Limpiyakorn T, 2011, BIORESOURCE TECHNOL, V102, P3694, DOI 10.1016/j.biortech.2010.11.085
   MARTENSHABBENA M, 2009, NATURE, V461, P976
   Norton JM, 2002, ARCH MICROBIOL, V177, P139, DOI 10.1007/s00203-001-0369-z
   Offre P, 2009, FEMS MICROBIOL ECOL, V70, P99, DOI 10.1111/j.1574-6941.2009.00725.x
   Okabe S, 1999, APPL ENVIRON MICROB, V65, P3182
   Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10
   Park HD, 2007, J APPL MICROBIOL, V102, P1401, DOI 10.1111/j.1365-2672.2006.03176.x
   Park HD, 2006, APPL ENVIRON MICROB, V72, P5643, DOI 10.1128/AEM.00402-06
   Park SJ, 2008, EXTREMOPHILES, V12, P605, DOI 10.1007/s00792-008-0165-7
   Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704
   Satoh H, 2003, BIOTECHNOL BIOENG, V83, P604, DOI 10.1002/bit.10717
   Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005
   Sonthiphand P, 2011, APPL MICROBIOL BIOT, V89, P843, DOI 10.1007/s00253-010-2902-y
   STECH G, 1995, FEMS MICROBIOL ECOL, V17, P177
   SUWA Y, 1994, WATER RES, V28, P1523, DOI 10.1016/0043-1354(94)90218-6
   Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x
   Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857
   Wagner M, 1998, WATER SCI TECHNOL, V37, P441, DOI 10.1016/S0273-1223(98)00143-7
   Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107
   Weidler GW, 2007, APPL ENVIRON MICROB, V73, P259, DOI 10.1128/AEM.01570-06
   Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x
   Zhang T, 2009, J APPL MICROBIOL, V107, P970, DOI 10.1111/j.1365-2672.2009.04283.x
NR 46
TC 34
Z9 42
U1 4
U2 56
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0095-3628
EI 1432-184X
J9 MICROB ECOL
JI Microb. Ecol.
PD NOV
PY 2011
VL 62
IS 4
BP 776
EP 788
DI 10.1007/s00248-011-9893-9
PG 13
WC Ecology; Marine & Freshwater Biology; Microbiology
SC Environmental Sciences & Ecology; Marine & Freshwater Biology;
   Microbiology
GA 840YZ
UT WOS:000296479700004
PM 21706196
DA 2018-12-27
ER

PT J
AU Park, B
   Sung, B
   Yadav, VR
   Chaturvedi, MM
   Aggarwal, BB
AF Park, Byoungduck
   Sung, Bokyung
   Yadav, Vivek R.
   Chaturvedi, Madan M.
   Aggarwal, Bharat B.
TI RETRACTED: Triptolide, histone acetyltransferase inhibitor, suppresses
   growth and chemosensitizes leukemic cells through inhibition of gene
   expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway
   (Retracted article. See vol. 102, pg. 141, 2016)
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article; Retracted Publication
DE Triptolide; TNF; NF-kappa B; CBP/p300
ID NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; ALPHA KINASE ACTIVATION;
   DOWN-REGULATION; CONSTITUTIVE ACTIVATION; TRIPTERYGIUM-WILFORDII;
   INDUCED APOPTOSIS; COX-2 EXPRESSION; PHOSPHORYLATION; INDUCTION
AB Triptolide, a diterpene triepoxide, from the Chinese herb Tripterygium wilfordii Hook.f, exerts its anti-inflammatory and immunosuppressive activities by inhibiting the transcription factor nuclear factor-kappa B (NF-kappa B) pathway, through a mechanism not yet fully understood. We found that triptolide, in nanomolar concentrations, suppressed both constitutive and inducible NF-kappa B activation, but did not directly inhibit binding of p65 to the DNA. The diterpene did block TNF-induced ubiquitination, phosphorylation, and degradation of I kappa B alpha, the inhibitor of NF-kappa B and inhibited acetylation of p65 through suppression of binding of p65 to CBP/p300. Triptolide also inhibited the I kappa B alpha kinase (IKK) that activates NF-kappa B and phosphorylation of p65 at serine 276, 536. Furthermore, the NF-kappa B reporter activity induced by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK beta was abolished by the triepoxide. Triptolide also abrogated TNF-induced expression of cell survival proteins (XIAP, Bcl-x(L), Bcl-2, survivin, cIAP-1 and cIAP-2), cell proliferative proteins (cyclin D1, c-myc and cyclooxygenase-2), and metastasis proteins (ICAM-1 and MMP-9). This led to enhancement of apoptosis induced by TNF, taxol, and thalidomide by the diterpene and to suppression of tumor invasion. Overall, our results demonstrate that triptolide can block the inflammatory pathway activated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK, sensitizes cells to apoptosis, and inhibits invasion of tumor cells. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Park, Byoungduck; Sung, Bokyung; Yadav, Vivek R.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.
   [Chaturvedi, Madan M.] Univ Delhi, Dept Zool, Lab Chromatin Biol, Delhi 110007, India.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Aggarwal, Bharat/G-3388-2013
FU National Institutes of Health (NIH) [CA-124787-01A2]; Clayton Foundation
   for Research, USA
FX Dr. Aggarwal is the Ransom Home, Jr., Professor of Cancer Research. This
   work was supported by a grant from a program project grant from National
   Institutes of Health (NIH CA-124787-01A2), and a grant from Clayton
   Foundation for Research, USA.
CR Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003
   Aggarwal BB, 2007, J CELL BIOCHEM, V102, P580, DOI 10.1002/jeb.21500
   Berenson A., 2006, NY TIMES, pC2
   Berenson Alex, 2006, N Y Times Web, pC2
   Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320
   Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5
   Carter BZ, 2008, BLOOD, V111, P3742, DOI 10.1182/blood-2007-05-091504
   Carter BZ, 2006, BLOOD, V108, P630, DOI 10.1182/blood-2005-09-3898
   Chang HJ, 2007, ANTICANCER RES, V27, P3411
   Chang WT, 2001, J BIOL CHEM, V276, P2221, DOI 10.1074/jbc.M009713200
   Chen BJ, 2001, LEUKEMIA LYMPHOMA, V42, P253, DOI 10.3109/10428190109064582
   Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005
   Choi YJ, 2003, BIOCHEM PHARMACOL, V66, P273, DOI 10.1016/S0006-2952(03)00282-X
   DUYAO MP, 1992, J BIOL CHEM, V267, P16288
   FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884
   Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1
   Giri DK, 1998, J BIOL CHEM, V273, P14008, DOI 10.1074/jbc.273.22.14008
   Gong YT, 2008, J NEUROCHEM, V107, P779, DOI 10.1111/j.1471-4159.2008.05653.x
   Guttridge DC, 1999, MOL CELL BIOL, V19, P5785
   Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574
   Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945
   Jiang XH, 2001, ONCOGENE, V20, P8009, DOI 10.1038/sj.onc.1204981
   Kantarjian HM, 2006, ANN INTERN MED, V145, P913, DOI 10.7326/0003-4819-145-12-200612190-00008
   Lallena MJ, 1999, MOL CELL BIOL, V19, P2180
   Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319
   Lee KY, 1999, J BIOL CHEM, V274, P13451, DOI 10.1074/jbc.274.19.13451
   Liotta L A, 1982, Cancer Metastasis Rev, V1, P277, DOI 10.1007/BF00124213
   Liu QY, 2007, MOL IMMUNOL, V44, P2686, DOI 10.1016/j.molimm.2006.12.003
   Liu QY, 2006, BIOCHEM BIOPH RES CO, V345, P1122, DOI 10.1016/j.bbrc.2006.05.024
   Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812
   Mukhopadhyay A, 2002, J BIOL CHEM, V277, P30622, DOI 10.1074/jbc.M204748200
   Nasuhara Y, 1999, J BIOL CHEM, V274, P19965, DOI 10.1074/jbc.274.28.19965
   Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090
   Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077
   Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641
   Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200
   Shamon LA, 1997, CANCER LETT, V112, P113, DOI 10.1016/S0304-3835(96)04554-5
   Shao Xue-ting, 2004, Zhejiang Da Xue Xue Bao Yi Xue Ban, V33, P160
   Shi XP, 2009, CLIN CANCER RES, V15, P1686, DOI 10.1158/1078-0432.CCR-08-2141
   Takada Y, 2005, ONCOGENE, V24, P6957, DOI 10.1038/sj.onc.1208845
   VANDESTOLPE A, 1994, J BIOL CHEM, V269, P6185
   Vispe S, 2009, MOL CANCER THER, V8, P2780, DOI 10.1158/1535-7163.MCT-09-0549
   Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680
   Wang W, 2007, CLIN CANCER RES, V13, P4891, DOI 10.1158/1078-0432.CCR-07-0416
   Wang ZP, 2009, EXP MOL MED, V41, P717, DOI 10.3858/emm.2009.41.10.078
   Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200
   Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315
   Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769
   Yang SM, 2003, MOL CANCER THER, V2, P65
   Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0
   Zhu WB, 2009, MOL PHARMACOL, V75, P812, DOI 10.1124/mol.108.052605
NR 51
TC 24
Z9 29
U1 2
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD NOV 1
PY 2011
VL 82
IS 9
BP 1134
EP 1144
DI 10.1016/j.bcp.2011.07.062
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 835ZO
UT WOS:000296076000010
PM 21820422
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Sarkola, T
   Redington, AN
   Slorach, C
   Hui, W
   Bradley, T
   Jaeggi, E
AF Sarkola, Taisto
   Redington, Andrew N.
   Slorach, Cameron
   Hui, Wei
   Bradley, Timothy
   Jaeggi, Edgar
TI RETRACTED: Assessment of vascular phenotype using a novel
   very-high-resolution ultrasound technique in adolescents after aortic
   coarctation repair and/or stent implantation: relationship to central
   haemodynamics and left ventricular mass (Retracted article. See vol. 98,
   pg. 92, 2011)
SO HEART
LA English
DT Article; Retracted Publication
ID BLOOD-PRESSURE-MEASUREMENT; ASCENDING AORTA; PULSE-WAVE; ARTERIES;
   DISEASE; DYSFUNCTION; VELOCITY; CHILDREN; ADULTS; IMPACT
AB Objectives Coarctation of the aorta (CoA) has been associated with abnormal vascular function, increased blood pressure (BP) and premature cardiovascular disease even after a successful intervention. The objective was to determine the severity of residual cardiovascular abnormalities in youths after CoA repair and their relation to regional BP.
   Design Cross-sectional study in tertiary healthcare setting.
   Methods Thirty-six youths with CoA (age 16 +/- 1 years; neonatal surgery only: n=16; surgery and/or stent implantation: n=20) and 37 age-matched controls were prospectively examined using a very-high-resolution vascular ultrasound imaging, echocardiography and applanation tonometry.
   Results CoA was associated with increased right arm systolic BP (p<0.001), intima-media thickness (IMT) in the common carotid (p<0.001), right brachial (p<0.05) and radial (p<0.05) arteries and ascending aortic stiffness (p<0.05). Carotid IMT correlated positively with age at first intervention (r-0.36, p<0.05). With left subclavian flap-type repair, left-arm systolic BP (p<0.001) and left brachial (p<0.001), radial (p<0.001) and ulnar (p<0.05) arterial IMTs were all reduced. When adjusted for BP, body mass index, age and gender, only carotid IMT (p<0.001) and left ventricular mass (p=0.013) of stented patients, as well as left-arm arterial IMTs (p<0.01) in subclavian flap-type repair patients, remained different from the controls. The significant associations of the stented patients disappeared after the adjustment for later patient age at intervention (median 8.7 vs 0.03 years, p<0.001). Residual arm-leg BP gradients correlated positively with carotid and brachial IMT. No differences between the CoA patients and the controls were found for arterial adventitial thicknesses, lumen dimensions, thigh systolic BP, abdominal aorta and carotid stiffness and right carotid to radial pulse wave velocity.
   Conclusion CoA repair in early childhood is associated with increased preductal arterial IMT, left ventricular mass and ascending aortic stiffness in adolescents. The more pronounced cardiovascular abnormalities after CoA stent implantation are likely related to older patient age at the time of intervention.
C1 [Sarkola, Taisto; Redington, Andrew N.; Slorach, Cameron; Hui, Wei; Bradley, Timothy; Jaeggi, Edgar] Univ Toronto, Hosp Sick Children, Labatt Family Heart Ctr, Div Cardiol, Toronto, ON M5G 1X8, Canada.
   [Sarkola, Taisto] Helsinki Univ Cent Hosp, Childrens Hosp, Div Cardiol, Helsinki, Finland.
   [Redington, Andrew N.; Jaeggi, Edgar] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada.
RP Jaeggi, E (reprint author), Univ Toronto, Hosp Sick Children, Labatt Family Heart Ctr, Div Cardiol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM edgar.jaeggi@sickkids.ca
RI Grindell, Eleanor/F-8728-2011
OI Bradley, Timothy/0000-0003-2948-0506
FU Sigrid Juselius Foundation; Instrumentarium Foundation; Societatis
   Medicorum Fennicae; Finnish Cultural Foundation; Finnish Foundation for
   Cardiovascular Research; Stockmann Foundation; Visualsonics (Toronto,
   Canada)
FX The study was supported by grants from the Sigrid Juselius Foundation,
   the Instrumentarium Foundation, Societatis Medicorum Fennicae, the
   Finnish Cultural Foundation, the Finnish Foundation for Cardiovascular
   Research and the Stockmann Foundation. The 25 and 35 MHz probes were
   loaned to the investigators by Visualsonics (Toronto, Canada). The
   company had no other role in the study.
CR Bramwell JC, 1922, LANCET, V1, P891
   Brili S, 2005, ATHEROSCLEROSIS, V182, P97, DOI 10.1016/j.atherosclerosis.2005.01.030
   Celermajer DS, 2002, HEART, V88, P113, DOI 10.1136/heart.88.2.113
   Chen SSM, 2008, HEART, V94, P919, DOI 10.1136/hrt.2006.109389
   COHEN M, 1989, CIRCULATION, V80, P840, DOI 10.1161/01.CIR.80.4.840
   de Divitiis M, 2003, J AM COLL CARDIOL, V41, P2259, DOI 10.1016/S0735-1097(03)00480-7
   de Divitiis M, 2001, CIRCULATION, V104, pI165
   DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X
   GARDINER HM, 1994, CIRCULATION, V89, P1745, DOI 10.1161/01.CIR.89.4.1745
   Kuczmarski Robert J, 2002, Vital Health Stat 11, P1
   Lam YY, 2007, HEART, V93, P1441, DOI 10.1136/hrt.2006.106377
   Meyer AA, 2005, EUR HEART J, V26, P617, DOI 10.1093/eurheartj/ehi037
   O'Sullivan JJ, 2002, HEART, V88, P163, DOI 10.1136/heart.88.2.163
   Pickering TG, 2005, HYPERTENSION, V45, P142, DOI [10.1161/01.HYP.0000150859.47929.8e, 10.1161/01.CIR.0000154900.76284.F6]
   Rajzer MW, 2008, J HYPERTENS, V26, P2001, DOI 10.1097/HJH.0b013e32830a4a25
   Sarkola T, 2010, ATHEROSCLEROSIS, V212, P516, DOI 10.1016/j.atherosclerosis.2010.06.043
   STEFANADIS C, 1990, EUR HEART J, V11, P990, DOI 10.1093/oxfordjournals.eurheartj.a059639
   Vogt M, 2005, CIRCULATION, V111, P3269, DOI 10.1161/CIRCULATIONAHA.104.529792
   Vriend JWJ, 2006, AM HEART J, V151, P242, DOI 10.1016/j.ahj.2005.02.013
NR 19
TC 18
Z9 20
U1 0
U2 11
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1355-6037
EI 1468-201X
J9 HEART
JI Heart
PD NOV
PY 2011
VL 97
IS 21
BP 1788
EP 1793
DI 10.1136/hrt.2011.226241
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 829VK
UT WOS:000295612600014
PM 21795301
DA 2018-12-27
ER

PT J
AU Shen, K
   Ji, Y
   Chen, GQ
   Huang, B
   Zhang, X
   Wu, S
   Yu, GP
   Wang, XC
AF Shen, Kai
   Ji, Yong
   Chen, Guo-Qiang
   Huang, Bin
   Zhang, Xian
   Wu, Song
   Yu, Gui-Ping
   Wang, Xiao-Chen
TI RETRACTED: Expression and clinical significance of the DNA repair enzyme
   MYH in esophageal squamous cell carcinoma (Retracted article. See vol.
   11, pg.2071, 2016)
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article; Retracted Publication
DE esophageal squamous cell carcinoma; MYH; 8-oxoguanine
ID BASE EXCISION-REPAIR; CANCER; GLYCOSYLASE; POLYPOSIS; MUTATIONS;
   MISMATCH; PATHWAY; OGG1
AB MYH is an important enzyme in combating DNA oxidative stress in the occurrence and development of various types of tumors. To investigate the correlation between expression of the DNA repair enzyme MYH in esophageal squamous cell carcinoma and 8-oxoguanine (8-oxoG) oxidative damage, as well as the clinical significance of altered MYH expression, tissues from 175 esophageal carcinoma cases were investigated in the present study. MYH expression and 8-oxoG oxidative damage in squamous cell carcinoma and adjacent normal tissue were assessed by immunohistochemistry and Western blotting. In 82.9% (145/175) of the cases, MYH protein expression in esophageal squamous cell carcinoma was lower than that of adjacent normal tissue (t=4.24, P<0.001). Additionally, 8-oxoG staining was higher in the tumors than in the normal tissue. Lower expression of MYH in esophageal squamous cell carcinoma was associated with depth of invasion, venous invasion, TNM stage and lymph node metastasis (P<0.05). In conclusion, a lower MYH expression level in esophageal cell carcinoma tissue was inversely associated with more severe 8-oxoG oxidative damage, suggesting that changes in MYH activity correspond to increased DNA damage in tumor cells. The use of MYH expression as a postoperative index for esophageal squamous cell carcinoma may guide the formulation of individualized chemotherapy for patients after surgery.
C1 [Shen, Kai; Ji, Yong; Chen, Guo-Qiang; Huang, Bin; Zhang, Xian; Wu, Song; Yu, Gui-Ping; Wang, Xiao-Chen] Dongnan Univ, Jiangyin Peoples Hosp, Dept Cardiothorac Surg, Jiangyin 214400, Jiangsu, Peoples R China.
RP Shen, K (reprint author), Dongnan Univ, Jiangyin Peoples Hosp, Dept Cardiothorac Surg, 163 Shoushan, Jiangyin 214400, Jiangsu, Peoples R China.
EM shenkai0625@126.com
CR Balaguer F, 2007, CLIN GASTROENTEROL H, V5, P379, DOI 10.1016/j.cgh.2006.12.025
   Baudhuin LM, 2006, J CANCER RES CLIN, V132, P159, DOI 10.1007/s00432-005-0056-6
   Bonde P, 2007, ANN THORAC SURG, V83, P433, DOI 10.1016/j.athoracsur.2006.06.090
   Bonde P, 2007, J THORAC CARDIOV SUR, V133, P74, DOI 10.1016/j.jtcvs.2006.06.050
   Boparai KS, 2008, GASTROENTEROLOGY, V135, P2014, DOI 10.1053/j.gastro.2008.09.020
   Dalhus B, 2011, STRUCTURE, V19, P117, DOI 10.1016/j.str.2010.09.023
   de Ferro SM, 2009, DIS COLON RECTUM, V52, P742, DOI 10.1007/DCR.0b013e318199db93
   Hagiwara A, 2005, ONCOL REP, V13, P1009
   JASSON K, 2010, GENOME INTEGR, V1, P12
   Lu AL, 2006, FRONT BIOSCI-LANDMRK, V11, P3062, DOI 10.2741/2033
   Russo MT, 2004, CANCER RES, V64, P4411, DOI 10.1158/0008-5472.CAN-04-0355
   Shin EJ, 2007, J CANCER RES CLIN, V133, P373, DOI 10.1007/s00432-006-0181-x
   Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724
   Wang N, 2009, MOL BIOL REP, V36, P357, DOI 10.1007/s11033-007-9187-y
   Yang HJ, 2001, NUCLEIC ACIDS RES, V29, P743, DOI 10.1093/nar/29.3.743
NR 15
TC 2
Z9 2
U1 1
U2 5
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD NOV-DEC
PY 2011
VL 2
IS 6
BP 1117
EP 1120
DI 10.3892/etm.2011.320
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 828ZG
UT WOS:000295543400015
PM 22977630
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU DeVisser, A
   Yang, C
   Herring, A
   Martinez, JA
   Rosales-Hernandez, A
   Poliakov, I
   Ayer, A
   Garven, A
   Zaver, S
   Rincon, N
   Xu, KV
   Tuor, UI
   Schmidt, AM
   Toth, C
AF DeVisser, Adriena
   Yang, Christina
   Herring, Amanda
   Martinez, Jose A.
   Rosales-Hernandez, Alma
   Poliakov, Ilia
   Ayer, Amit
   Garven, Alexandra
   Zaver, Shaila
   Rincon, Natalia
   Xu, Kevin
   Tuor, Ursula I.
   Schmidt, Ann Marie
   Toth, Cory
TI RETRACTED: Differential impact of diabetes and hypertension in the
   brain: Adverse effects in grey matter (Retracted article. See vol. 68,
   pg. 229, 2014)
SO NEUROBIOLOGY OF DISEASE
LA English
DT Article; Retracted Publication
DE Diabetes; Hypertension; Cerebral atrophy; White matter abnormalities;
   Vascular disease; Insulin receptor
ID COGNITIVE FUNCTION; PROGENITOR PROLIFERATION; SYNAPTIC PLASTICITY;
   ROTTERDAM SCAN; RATS; MELLITUS; RECEPTOR; HYPERINTENSITIES; POPULATION;
   NEURONS
AB Diabetes mellitus types 1 and 2 (DM1 and DM2) and/or hypertension (HTN) can contribute to cognitive decline, cerebral atrophy and white matter abnormalities in humans. Adult rat models of streptozotocin-induced DM1 and genetic strains of DM2 and HTN were used to investigate relative contributions of DM and HTN for alterations in cerebral structure and function as well as insulin receptor biology using cognitive testing, magnetic resonance imaging (MRI), and histological and molecular methods. The effects of DM1 or DM2 were generally similar. DM was associated with earlier onset of cognitive impairment than with HTN alone. DM was independently correlated with brain atrophy, whereas HTN had minimal effects on brain volume. The combination of DM and HTN led to identifiable mild hippocampal neuronal loss while either DM or HTN led to synaptic loss. Only DM led to downregulation of the insulin receptor pathways' activation. In contrast, only HTN was associated with vascular luminal reduction and restricted cerebral perfusion on MRI. The impacts of DM and HTN in the brain differ, while their separate contributions can lead to some additive adverse effects within rodent brain grey matter. (C) 2011 Elsevier Inc. All rights reserved.
C1 [DeVisser, Adriena; Yang, Christina; Herring, Amanda; Martinez, Jose A.; Rosales-Hernandez, Alma; Poliakov, Ilia; Ayer, Amit; Garven, Alexandra; Zaver, Shaila; Rincon, Natalia; Xu, Kevin; Tuor, Ursula I.; Toth, Cory] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada.
   [DeVisser, Adriena; Yang, Christina; Herring, Amanda; Martinez, Jose A.; Rosales-Hernandez, Alma; Poliakov, Ilia; Ayer, Amit; Garven, Alexandra; Zaver, Shaila; Rincon, Natalia; Xu, Kevin; Tuor, Ursula I.; Toth, Cory] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada.
   [Tuor, Ursula I.] Univ Calgary, Natl Res Council, Inst Biodiagnost W, Calgary, AB T2N 4N1, Canada.
   [Tuor, Ursula I.] Univ Calgary, Expt Imaging Ctr, Calgary, AB T2N 4N1, Canada.
   [Schmidt, Ann Marie] Columbia Univ, Dept Surg, New York, NY USA.
RP Toth, C (reprint author), Univ Calgary, Dept Clin Neurosci, Room 155,3330 Hosp Dr,NW, Calgary, AB T2N 4N1, Canada.
EM corytoth@shaw.ca
FU Alberta Heritage Foundation for Medical Research (AHFMR)
FX This study was supported by an operating grant from the Alberta Heritage
   Foundation for Medical Research (AHFMR). C.T. is a Clinical Investigator
   of the Alberta Heritage Foundation for Medical Research (AHFMR).
CR Akisaki T, 2006, DIABETES-METAB RES, V22, P376, DOI 10.1002/dmrr.632
   Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8
   Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259
   Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4
   Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014
   Cui QL, 2007, J NEUROCHEM, V100, P1480, DOI 10.1111/j.1471-4159.2006.04329.x
   Dahlquist G, 2007, DIABETOLOGIA, V50, P957, DOI 10.1007/s00125-007-0615-2
   De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106
   de Groot JC, 2000, ANN NEUROL, V47, P145
   Dhamoon MS, 2009, NEUROLOGY, V72, P292, DOI 10.1212/01.wnl.0000344246.91081.2c
   Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661
   Francis G, 2009, DIABETES, V58, P934, DOI 10.2337/db08-1287
   Francis GJ, 2008, BRAIN, V131, P3311, DOI 10.1093/brain/awn288
   Hassing LB, 2004, AGE AGEING, V33, P355, DOI 10.1093/ageing/afh100
   Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200
   Huang TJ, 2005, MOL CELL NEUROSCI, V28, P42, DOI 10.1016/j.mcn.2004.08.009
   Jacobson AM, 2007, NEW ENGL J MED, V356, P1842
   Kamal A, 2006, BRAIN RES, V1073, P276, DOI 10.1016/j.brainres.2005.12.070
   Kim-Mitsuyama S, 2005, STROKE, V36, P1077, DOI 10.1161/01.STR.0000163084.16505.e3
   Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810
   LAUNER LJ, 1995, JAMA-J AM MED ASSOC, V274, P1846, DOI 10.1001/jama.274.23.1846
   Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200
   Leinninger GM, 2004, FASEB J, V18, P1544, DOI 10.1096/fj.04-1581fje
   Li ZG, 2007, DIABETES, V56, P1817, DOI 10.2337/db07-0171
   Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4
   Meneses A, 1996, PHYSIOL BEHAV, V60, P341, DOI 10.1016/0031-9384(96)00027-3
   MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4
   OHINMAA A, 2004, CAN J DIABETES, V28, P116
   Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506
   Qiao M, 2004, MAGN RESON MATER PHY, V17, P117, DOI 10.1007/s10334-004-0058-4
   Rafikova O, 2008, METABOLISM, V57, P1434, DOI 10.1016/j.metabol.2008.05.014
   Reed T, 2000, NEUROEPIDEMIOLOGY, V19, P76, DOI 10.1159/000026242
   RYAN CM, 1993, J CLIN EXP NEUROPSYC, V15, P685, DOI 10.1080/01688639308402589
   RYAN CM, 1993, DIABETOLOGIA, V36, P329, DOI 10.1007/BF00400236
   Sabbatini M, 2002, MECH AGEING DEV, V123, P547, DOI 10.1016/S0047-6374(01)00362-1
   SCHMIDT R, 1993, NEUROLOGY, V43, P2490, DOI 10.1212/WNL.43.12.2490
   Schmidt R, 2004, DIABETES, V53, P687, DOI 10.2337/diabetes.53.3.687
   Schoenle EJ, 2002, DIABETOLOGIA, V45, P108, DOI 10.1007/s125-002-8250-6
   Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101
   Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5
   Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055
   Terry AV, 2000, NEUROSCIENCE, V101, P357, DOI 10.1016/S0306-4522(00)00377-8
   Toth C, 2006, NEUROBIOL DIS, V23, P445, DOI 10.1016/j.nbd.2006.03.015
   van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x
   Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2
   Yang C, 2011, NEUROBIOL DIS, V42, P446, DOI 10.1016/j.nbd.2011.02.007
NR 46
TC 17
Z9 19
U1 2
U2 23
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 1095-953X
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD NOV
PY 2011
VL 44
IS 2
BP 161
EP 173
DI 10.1016/j.nbd.2011.06.005
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA 820WX
UT WOS:000294937900001
PM 21742034
DA 2018-12-27
ER

PT J
AU Tada, K
   Haruyama, J
   Yang, HX
   Chshiev, M
   Matsui, T
   Fukuyama, H
AF Tada, K.
   Haruyama, J.
   Yang, H. X.
   Chshiev, M.
   Matsui, T.
   Fukuyama, H.
TI RETRACTED: Graphene magnet realized by hydrogenated graphene nanopore
   arrays (Retracted article. See vol. 100, 099904, 2012)
SO APPLIED PHYSICS LETTERS
LA English
DT Article; Retracted Publication
ID NANORIBBONS; ZIGZAG; STATE; EDGES
AB The so-called zigzag edge of graphenes theoretically has localized electrons due to the presence of flat energy bands near the Fermi level. The localized electron spins are strongly polarized, resulting in ferromagnetism. We fabricate graphenes with honeycomb-like arrays of hydrogen-terminated and low-defect hexagonal nanopores by a nonlithographic method using nanoporous alumina templates. We report large-magnitude room-temperature ferromagnetism caused by electron spins localizing at the zigzag nanopore edges. This promises to be a realization of rare-element free, controllable, transparent, flexible, and mono-atomic layer magnets and novel spintronic devices. (C) 2011 American Institute of Physics. [doi: 10.1063/1.3653286]
C1 [Tada, K.; Haruyama, J.] Aoyama Gakuin Univ, Fac Sci & Engn, Kanagawa 2525258, Japan.
   [Yang, H. X.; Chshiev, M.] CEA CNRS UJF Grenoble 1 Grenoble INP, SPINTEC, F-38054 Grenoble 9, France.
   [Matsui, T.; Fukuyama, H.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1138656, Japan.
RP Haruyama, J (reprint author), Aoyama Gakuin Univ, Fac Sci & Engn, 5-10-1 Fuchinobe, Kanagawa 2525258, Japan.
EM J-haru@ee.aoyama.ac.jp
RI Haruyama, Junji/I-9773-2014
FU High-Technology Research Center in MEXT; French ANR "Nanosim-Graphene
   and Grenoble Nanosciences Foundation"
FX The authors thank K. Fujita, Y. Hashimoto, E. Endo, Y. Iye, S.
   Katsumoto, M. Yamamoto, S. Tarucha, K. Wakabayashi, M. Koshino, T. Ando,
   T. Enoki, J. Akimitsu, T. Muranaka, T. Yamaoka, N. Nagaosa, H. Aokai, P.
   Kim, X. Jia, M. S. Dresselhaus, and S. Roche for their technical
   contribution, fruitful discussions, and encouragement. This work at
   Aoyama Gakuin was partly supported by a Grant-in-aid for Scientific
   Research and a High-Technology Research Center Project for private
   universities in MEXT. This work was partially supported by French ANR
   PNANO project "Nanosim-Graphene and Grenoble Nanosciences Foundation".
CR Bai JW, 2010, NAT NANOTECHNOL, V5, P190, DOI [10.1038/NNANO.2010.8, 10.1038/nnano.2010.8]
   Fujita M, 1996, J PHYS SOC JPN, V65, P1920, DOI 10.1143/JPSJ.65.1920
   Han MY, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.056801
   Hong J., 2011, SMALL, V9, P1175
   Jia XT, 2009, SCIENCE, V323, P1701, DOI 10.1126/science.1166862
   Krauss B, 2010, NANO LETT, V10, P4544, DOI 10.1021/nl102526s
   Kusakabe K, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.092406
   Lee H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.174431
   LIEB EH, 1989, PHYS REV LETT, V62, P1201, DOI 10.1103/PhysRevLett.62.1201
   Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954
   Shimizu T, 2011, NAT NANOTECHNOL, V6, P45, DOI 10.1038/NNANO.2010.249
   Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803
   Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180
   Soriano D, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.016602
   Takesue I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.057001
   Wang XR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206803
   Yang L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.186801
   Yazyev OV, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/5/056501
   You YM, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3005599
NR 19
TC 23
Z9 23
U1 3
U2 49
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0003-6951
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD OCT 31
PY 2011
VL 99
IS 18
AR 183111
DI 10.1063/1.3653286
PG 3
WC Physics, Applied
SC Physics
GA 843GD
UT WOS:000296659400084
DA 2018-12-27
ER

PT J
AU Krishna, MJ
   Gophane, A
   Ravindran, C
   Ingole, BS
   Anjeneyulu, Y
   Deepti, D
   Meena, RM
AF Krishna, M. J.
   Gophane, A.
   Ravindran, C.
   Ingole, B. S.
   Anjeneyulu, Y.
   Deepti, D.
   Meena, R. M.
TI RETRACTED: Identification of a marine zoanthid Zoanthus sansibaricus
   (Carlgren) from the intertidal rocky shore of Anjuna (Goa) using
   morphological and molecular analyses (Retracted article. See vol. 102,
   pg. 339, 2012)
SO CURRENT SCIENCE
LA English
DT Article; Retracted Publication
DE Intertidal rocky shore; morphological and molecular analysis; zoanthid
   diversity; Zoanthus sansibaricus
ID ANTHOZOA-HEXACORALLIA; DNA TAXONOMY; AUSTRALIA; ALKALOIDS; PALYTOXIN;
   PROTEINS; CORALS; GENERA
AB Zoanthids comprise the order Zoanthidae, which are benthic organisms and belong to the phylum Cnidaria. These can be distinguished from other orders, under the same subclass of Hexacorallia, by the presence of embedded sand and detritus in their mesoglea, which help strengthen their structure. These organisms are becoming increasingly important in biochemistry and other research fields. Their inclusion of both calcium and silica results in the need for both decalcification and desilification for internal morphological examinations. With the availability of the standardized techniques using hydrofluoric acid treatment, this is now possible. Recent studies utilizing molecular (16S mt rDNA) methods have brought a clearer understanding of the zoanthid diversity. Though collection and documentation of data have started all over the world regarding clarifying zoanthid taxonomy, zoanthids from the Indian coasts have not yet been explored in dual perspective. The present study is based on morphological, histological and molecular analyses of identifying a marine zoanthid from one of the coasts of India to the species level as Zoanthus sansibaricus (family Zoanthidae).
C1 [Krishna, M. J.] Goa Coll Pharm, Dept Pharmacognosy, Panaji 403001, Goa, India.
   [Gophane, A.; Ravindran, C.; Ingole, B. S.; Meena, R. M.] Natl Inst Oceanog, Div Biol Oceanog, Panaji 403004, Goa, India.
   [Anjeneyulu, Y.] Jackson State Univ, Jackson, MS 39217 USA.
   [Deepti, D.] Univ Pune, Dept Zool, Pune 411007, Maharashtra, India.
RP Krishna, MJ (reprint author), Goa Coll Pharm, Dept Pharmacognosy, 18th June Rd, Panaji 403001, Goa, India.
EM mythilikrishna2007@yahoo.in
CR Babu UV, 1997, J NAT PROD, V60, P1307, DOI 10.1021/np970267k
   Bucklin A, 2003, MAR BIOL, V142, P333, DOI 10.1007/s00227-002-0943-1
   Burnett WJ, 1997, CORAL REEFS, V16, P55, DOI 10.1007/s003380050060
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   Daly M, 1668, ZOOTAXA, P1
   Fautin D. G, HEXACORALLIANS WORLD
   Fukuzawa S., 1995, HETEROCYCL COMMUN, V1, P207
   Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101
   Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218
   Herberts C., 1972, Tethys, VNo. 3, P69
   Hoffmann K, 2008, TOXICON, V51, P1535, DOI 10.1016/j.toxicon.2008.03.009
   Krishna M, 2009, CURR SCI INDIA, V97, P1022
   MOORE RE, 1971, SCIENCE, V172, P495, DOI 10.1126/science.172.3982.495
   Nalsh G. E., 1971, ZOOL J LINN SOC-LOND, V50, P161
   Parameswaran P.S., 2001, Journal of the Indian Institute of Science, V81, P169
   Peters D, 1996, J FLUORINE CHEM, V79, P161, DOI 10.1016/S0022-1139(96)03484-7
   RAO CB, 1989, HETEROCYCLES, V28, P103
   RAO CB, 1984, J AM CHEM SOC, V106, P7983, DOI 10.1021/ja00337a062
   RAO CB, 1985, J ORG CHEM, V50, P3757, DOI 10.1021/jo00220a016
   Ravindran J, 2001, DIS AQUAT ORGAN, V47, P219, DOI 10.3354/dao047219
   Reimer JD, 2008, CORAL REEFS, V27, P935, DOI 10.1007/s00338-008-0389-0
   Reimer JD, 2006, ZOOL SCI, V23, P261, DOI 10.2108/zsj.23.261
   Reimer JD, 2006, ZOOL SCI, V23, P87, DOI 10.2108/zsj.23.87
   Reimer James Davis, 2010, Galaxea - Tokyo, V12, P23
   Reimer JD, 2010, MAR BIOTECHNOL, V12, P605, DOI 10.1007/s10126-009-9249-3
   Reimer JD, 2004, ZOOL SCI, V21, P517, DOI 10.2108/zsj.21.517
   ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088
   RYLAND JS, 1991, HYDROBIOLOGIA, V216, P117, DOI 10.1007/BF00026451
   Ryland JS, 2004, HYDROBIOLOGIA, V530, P411, DOI 10.1007/s10750-004-2641-0
   Ryland JS, 2004, HYDROBIOLOGIA, V530, P179, DOI 10.1007/s10750-004-2685-1
   Sinniger F, 2005, MAR BIOL, V147, P1121, DOI 10.1007/s00227-005-0016-3
   Sinniger Frederic, 2010, Marine Biodiversity, V40, P57, DOI 10.1007/s12526-009-0034-3
   Sinniger F, 2008, ZOOL SCI, V25, P1253, DOI 10.2108/zsj.25.1253
   Stewart CN, 2006, TRENDS BIOTECHNOL, V24, P155, DOI 10.1016/j.tibtech.2006.02.002
   Swain TD, 2009, ZOOTAXA, P41
   Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1
   Uchida H., 2001, TBS BRITANNICA, P124
   Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716
NR 38
TC 1
Z9 1
U1 2
U2 16
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD OCT 25
PY 2011
VL 101
IS 8
BP 1079
EP 1086
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 835RN
UT WOS:000296053600023
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Kim, JS
   Smith-Garvin, JE
   Koretzky, GA
   Jordan, MS
AF Kim, Jiyeon S.
   Smith-Garvin, Jennifer E.
   Koretzky, Gary A.
   Jordan, Martha S.
TI RETRACTED: The requirements for natural Th17 cell development are
   distinct from those of conventional Th17 cells (Retracted article. See
   vol 211, pg 1919, 2014)
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article; Retracted Publication
ID T-CELLS; POSITIVE SELECTION; THYMIC CORTEX; ROR-GAMMA; DIFFERENTIATION;
   LINEAGE; MICE; INFLAMMATION; ALPHA; INTERLEUKIN-17
AB CD4(+) T helper 17 (Th17) cells play a critical role in the adaptive immune response against extracellular pathogens. Most studies to date have focused on understanding the differentiation of Th17 cells from naive CD4(+) T cells in peripheral effector sites. However, Th17 cells are present in the thymus. In this study, we demonstrate that a population of Th17 cells, natural Th17 cells (nTh17 cells), which acquire effector function during development in the thymus before peripheral antigen exposure, shows preferential usage of T cell receptor V beta 3. nTh17 cells are dependent on major histocompatibility complex (MHC) class II for thymic selection, yet unlike conventional CD4(+) T cells, MHC class II expression on thymic cortical epithelium is not sufficient for their development, rather expression on medullary epithelium is necessary. Differential signaling requirements for IL-17 priming further distinguish nTh17 from conventional Th17 cells. Collectively, our findings define a Th17 population, poised to rapidly produce cytokines, that is developmentally distinct from conventional Th17 cells and that potentially functions at the interface of innate and adaptive immunity.
C1 [Jordan, Martha S.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Kim, Jiyeon S.; Smith-Garvin, Jennifer E.; Koretzky, Gary A.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.
   [Koretzky, Gary A.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA.
RP Jordan, MS (reprint author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
EM koretzky@mail.med.upenn.edu; jordanm@mail.med.upenn.edu
FU National Institutes of Health [K01AR52802, R37 GM053256]
FX This work was supported by National Institutes of Health grants
   K01AR52802 (to M. S. Jordan) and R37 GM053256 (to G. A. Koretzky).
CR Azuara V, 1997, EUR J IMMUNOL, V27, P544, DOI 10.1002/eji.1830270228
   Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427
   Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397
   Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800
   Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447
   Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009
   Gordon SM, 2011, J IMMUNOL, V186, P4573, DOI 10.4049/jimmunol.1100037
   Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254
   Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014
   Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874
   Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035
   Jordan MS, 2008, IMMUNITY, V28, P359, DOI 10.1016/j.immuni.2008.01.010
   Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302
   Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669
   Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712
   Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750
   Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710
   LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097
   Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0
   Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105
   Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783
   Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020
   McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001
   Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551
   Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189
   Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261
   Powolny-Budnicka I, 2011, IMMUNITY, V34, P364, DOI 10.1016/j.immuni.2011.02.019
   Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803
   Tanaka S, 2009, J IMMUNOL, V183, P7523, DOI 10.4049/jimmunol.0803828
   Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016
   Yin L, 2003, J MED VIROL, V71, P446, DOI 10.1002/jmv.10504
NR 31
TC 32
Z9 33
U1 2
U2 7
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD OCT 24
PY 2011
VL 208
IS 11
BP 2201
EP 2207
DI 10.1084/jem.20110680
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 841TX
UT WOS:000296537800007
PM 21948082
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Kazemimoghadam, M
   Mohammadi, T
AF Kazemimoghadam, Mansoor
   Mohammadi, Toraj
TI RETRACTED: A modeling approach based on the Maxwell-Stefan theory for
   pervaporation using home made nanopore NaA zeolite membranes (Retracted
   article.See vol.399,pg.203,2016)
SO DESALINATION
LA English
DT Article; Retracted Publication
DE Pervaporation; Separation; Zeolite NaA membrane; Nanopore
ID VAPOR PERMEATION; DEHYDRATION
AB The recent development of solvent and temperature-resistant. hydrophilic zeolite NaA membranes has made it possible to overcome the limitations of hydrophilic polymeric membranes. Zeolite membranes have uniform and molecular-sized pores, and they separate molecules based on differences in the molecules' adsorption and diffusion properties. Strong electrostatic interaction between ionic sites and water molecules makes the zeolite NaA membrane very hydrophilic. Zeolite NaA membranes are thus well suited for separating liquid-phase mixtures by pervaporation. Total flux for unsymmetrical dimethylhydrazine (UDMH)-water mixtures was found to vary from 0.329 to 0.215 kg/m(2).h with increasing UDMH concentration from 1 to 20 wt.%. Ionic sites of the NaA zeolite matrix play a very important role in water transport through the membrane. These sites act both as water sorption and transport sites. Surface diffusion of water occurs in an activated fashion through these sites. The precise nanoporous structure of the zeolite cage helps in a partial molecular sieving of the large solvent molecules leading to high separation factors. A comparison between experimental flux and calculated flux using Stephan Maxwell (S.M.) correlation was made and a linear trend was found to exist for water flux through the membrane with UDMH concentration. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Kazemimoghadam, Mansoor; Mohammadi, Toraj] Iran Univ Sci & Technol, Fac Chem Engn, A Res Lab Separat Proc, Tehran, Iran.
RP Kazemimoghadam, M (reprint author), Iran Univ Sci & Technol, Fac Chem Engn, A Res Lab Separat Proc, Tehran, Iran.
EM mzkazemi@gmail.com
RI Mohammadi, Toraj/R-6407-2017
OI Mohammadi, Toraj/0000-0003-0455-3254
CR Aguado S, 2009, MICROPOR MESOPOR MAT, V120, P170, DOI 10.1016/j.micromeso.2008.08.062
   Amnuaypanich S, 2009, CHEM ENG SCI, V64, P4908, DOI 10.1016/j.ces.2009.07.028
   Churl H., 2010, J MEMBRANE SCI, V364, P138
   Hogendoorn JA, 2001, COMPUT CHEM ENG, V25, P1251, DOI 10.1016/S0098-1354(01)00697-4
   Huang Z, 2006, SEP PURIF TECHNOL, V51, P126, DOI 10.1016/j.seppur.2006.01.005
   Krishna R, 2002, CHEM ENG J, V87, P1, DOI 10.1016/S1385-8947(01)00187-5
   Li YS, 2007, SEP PURIF TECHNOL, V57, P140, DOI 10.1016/j.seppur.2007.03.027
   Malekpour A, 2008, DESALINATION, V225, P199, DOI 10.1016/j.desal.2007.02.096
   Pera-Titus M, 2006, J MEMBRANE SCI, V278, P401, DOI 10.1016/j.memsci.2005.11.026
   Pera-Titus M, 2006, CATAL TODAY, V118, P73, DOI 10.1016/j.cattod.2005.12.006
   Ravindra R, 2000, POLYMER, V41, P2795, DOI 10.1016/S0032-3861(99)00487-5
   Ravindra R, 1999, J APPL POLYM SCI, V72, P689, DOI 10.1002/(SICI)1097-4628(19990502)72:5<689::AID-APP10>3.0.CO;2-2
   Ravindra R, 1999, J POLYM SCI POL PHYS, V37, P1969, DOI 10.1002/(SICI)1099-0488(19990815)37:16<1969::AID-POLB2>3.3.CO;2-I
   Ravindra R, 1999, POLYMER, V40, P1159, DOI 10.1016/S0032-3861(98)00274-2
   Sato K, 2008, J MEMBRANE SCI, V307, P181, DOI 10.1016/j.memsci.2007.09.017
   Sorenson SG, 2011, J MEMBRANE SCI, V366, P413, DOI 10.1016/j.memsci.2010.10.043
   Speronello B.K., 1986, [No title captured], Patent No. [4 628 042, 4628042]
   Speronello K., 1986, U. S. Patent, Patent No. 4601997
   Sridhar S, 2000, IND ENG CHEM RES, V39, P2485, DOI 10.1021/ie990776c
   Sridhar S, 2001, POLYM INT, V50, P1156, DOI 10.1002/pi.761
   Van Hoof V, 2006, SEP PURIF TECHNOL, V48, P304, DOI 10.1016/j.seppur.2005.06.019
NR 21
TC 4
Z9 4
U1 5
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0011-9164
EI 1873-4464
J9 DESALINATION
JI Desalination
PD OCT 17
PY 2011
VL 281
BP 298
EP 305
DI 10.1016/j.desal.2011.08.005
PG 8
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA 853AZ
UT WOS:000297399900042
DA 2018-12-27
ER

PT J
AU Chen, ZB
   Nie, SK
   Ren, NQ
   Chen, ZQ
   Wang, HC
   Cui, MH
AF Chen, Zhao-Bo
   Nie, Shu-Kai
   Ren, Nan-Qi
   Chen, Zhi-Qiang
   Wang, Hong-Cheng
   Cui, Min-Hua
TI RETRACTED: Improving the efficiencies of simultaneous organic substance
   and nitrogen removal in a multi-stage loop membrane bioreactor-based
   PWWTP using an on-line Knowledge-Based Expert System (Retracted article.
   See vol. 47, pg. 955, 2013)
SO WATER RESEARCH
LA English
DT Article; Retracted Publication
DE Multi-stage loop membrane bioreactor (MLMBR); Pharmaceutical wastewater;
   Simultaneous nitrification and denitrification (SND); BP artificial
   neural network; Real time; Knowledge-Based Expert System (KBES)
ID WASTE-WATER TREATMENT; SUPPORT VECTOR MACHINES; TREATMENT PLANTS; MODEL
   SELECTION; OPERATION; RECOGNITION; DIAGNOSIS; KERNELS; TIME
AB The results of the use of an expert system (ES) to control a novel multi-stage loop membrane bioreactor (MLMBR) for the simultaneous removal of organic substances and nutrients are reported. The study was conducted at a bench-scale plant for the purpose of meeting new discharge standards (GB21904-2008) for the treatment of chemical synthesis-based pharmaceutical wastewater (1200-9600 mg/L COD, 500-2500 mg/L BOD5, 50-200 mg/L NH4+-LN and 105-400 mg/L TN in the influent water) by developing a distributed control system. The system allows various expert operational approaches to be deployed with the goal of minimizing organic substances and nitrogen levels in the outlet while using the minimum amount of energy. The proposed distributed control system, which is supervised by a Knowledge-Based Expert System (KBES) constructed with G2 (a tool for expert system development) and a back propagation BP artificial neural network, permits the on-line implementation of every operating strategy of the experimental system. A support vector machine (SVM) is applied to achieve pattern recognition. A set of experiments involving variable sludge retention time (SRT), hydraulic retention time (HRT) and dissolved oxygen (DO) was carried out. Using the proposed system, the amounts of COD, TN and NH4+-N in the effluent decreased by 55%, 62% and 38%, respectively, compared to the usual operating conditions. These improvements were achieved with little energy cost because the performance of the treatment plant was optimized using operating rules implemented in real time. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Chen, Zhao-Bo; Ren, Nan-Qi; Chen, Zhi-Qiang] Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150090, Peoples R China.
   [Chen, Zhao-Bo; Nie, Shu-Kai; Wang, Hong-Cheng; Cui, Min-Hua] Harbin Inst Technol, Sch Mat Sci & Chem Engn, Harbin 150001, Peoples R China.
RP Ren, NQ (reprint author), Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, POB 2614,202 Haihe Rd, Harbin 150090, Peoples R China.
EM rnq@hit.edu.cn
FU National Natural Science Foundation of China [50908062]; State Key
   Laboratory of Urban Water Resource and Environment [HIT-QAK201103];
   Special Fund for Basic Scientific Research of Central Colleges
   [HEUCP101020]; Harbin innovation Science Foundation for Youths
   [2008RFQXS023]
FX This work was supported by the National Natural Science Foundation of
   China (No. 50908062), the State Key Laboratory of Urban Water Resource
   and Environment (No. HIT-QAK201103), the Special Fund for Basic
   Scientific Research of Central Colleges (HEUCP101020) and Harbin
   innovation Science Foundation for Youths (2008RFQXS023). The authors are
   grateful to the Research Center of Environmental Biotechnology in Harbin
   Institute of Technology for their technical and logistic assistance.
CR Adankon MM, 2009, PATTERN RECOGN, V42, P3264, DOI 10.1016/j.patcog.2008.10.023
   Amari S, 1999, NEURAL NETWORKS, V12, P783, DOI 10.1016/S0893-6080(99)00032-5
   APHA, 1998, STAND METH EX WAT WA
   Ayat NE, 2005, PATTERN RECOGN, V38, P1733, DOI 10.1016/j.patcog.2005.03.011
   BARNETT MW, 1992, ISA T, V31, P53, DOI 10.1016/0019-0578(92)90009-8
   Chen Z, 2008, WATER RES, V42, P3385, DOI 10.1016/j.watres.2008.04.020
   de Graaff MS, 2011, WATER RES, V45, P375, DOI 10.1016/j.watres.2010.08.023
   de Silva DGV, 1998, WATER SCI TECHNOL, V38, P505, DOI 10.1016/S0273-1223(98)00551-4
   Fenu A, 2010, WATER RES, V44, P4272, DOI 10.1016/j.watres.2010.06.007
   Frias-Martinez E, 2006, ENG APPL ARTIF INTEL, V19, P693, DOI 10.1016/j.engappai.2005.12.006
   Henze M, 1997, WATER SCI TECHNOL, V35, P1, DOI 10.1016/S0273-1223(97)00223-0
   Huyskens C, 2008, J MEMBRANE SCI, V323, P185, DOI 10.1016/j.memsci.2008.06.021
   Isaacs S., 1999, WATER QUALITY IN JAN, P42
   Ladiges G, 1996, WATER SCI TECHNOL, V33, P265, DOI 10.1016/0273-1223(96)00483-0
   Lv G, 2005, ELECTR POW SYST RES, V75, P9, DOI 10.1016/j.epsr.2004.07.013
   Maeda K., 1989, Future Generation Computer Systems, V5, P29, DOI 10.1016/0167-739X(89)90017-4
   Magureanu M, 2010, WATER RES, V44, P3445, DOI 10.1016/j.watres.2010.03.020
   Radjenovic J, 2009, WATER RES, V43, P831, DOI 10.1016/j.watres.2008.11.043
   Reif R, 2008, DESALINATION, V221, P511, DOI 10.1016/j.desal.2007.01.111
   Roberts JA, 2000, INT BIODETER BIODEGR, V46, P37, DOI 10.1016/S0964-8305(00)00058-5
   Serra P., 1993, Control Engineering Practice, V1, P329, DOI 10.1016/0967-0661(93)91624-6
   Shieh MD, 2008, EXPERT SYST APPL, V35, P531, DOI 10.1016/j.eswa.2007.07.043
   Smola AJ, 1998, NEURAL NETWORKS, V11, P637, DOI 10.1016/S0893-6080(98)00032-X
   Steyer JP, 1997, WATER SCI TECHNOL, V36, P209, DOI 10.1016/S0273-1223(97)00525-8
   Steyer JP, 1999, WATER RES, V33, P2059, DOI 10.1016/S0043-1354(98)00430-8
   Sun DD, 2007, DESALINATION, V208, P101, DOI 10.1016/j.desal.2006.04.076
   Szafnicki K, 1998, WATER RES, V32, P2480, DOI 10.1016/S0043-1354(97)00441-7
   Tambosi JL, 2010, DESALINATION, V261, P148, DOI 10.1016/j.desal.2010.05.014
   Tang CJ, 2011, WATER RES, V45, P201, DOI 10.1016/j.watres.2010.08.036
   Vapnik V, 2009, NEURAL NETWORKS, V22, P544, DOI 10.1016/j.neunet.2009.06.042
   Wagner WP, 2002, KNOWL-BASED SYST, V15, P439, DOI 10.1016/S0950-7051(02)00026-6
   Wang XY, 2008, SIGNAL PROCESS, V88, P2193, DOI 10.1016/j.sigpro.2008.03.005
   Watts P., 1991, Engineering Applications of Artificial Intelligence, V4, P151, DOI 10.1016/0952-1976(91)90055-B
   Wisniewski C, 1999, BIOCHEM ENG J, V3, P61, DOI 10.1016/S1369-703X(98)00046-1
   Yao Y, 2003, PATTERN RECOGN, V36, P397
NR 35
TC 11
Z9 13
U1 6
U2 50
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0043-1354
J9 WATER RES
JI Water Res.
PD OCT 15
PY 2011
VL 45
IS 16
BP 5266
EP 5278
DI 10.1016/j.watres.2011.07.032
PG 13
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA 826WR
UT WOS:000295386800056
PM 21862097
DA 2018-12-27
ER

PT J
AU Alexandre, J
   Pasipoularides, P
AF Alexandre, Jean
   Pasipoularides, Pavlos
TI RETRACTED: Spherically symmetric solutions, Newton's Law, and the
   infrared limit lambda -> 1 in covariant Horava-Lifshitz gravity
   (Retracted article. See vol. 86, 049905, 2012)
SO PHYSICAL REVIEW D
LA English
DT Article; Retracted Publication
ID COSMOLOGY
AB In this note we examine whether spherically symmetric solutions in covariant Horava-Lifshitz gravity can reproduce Newton's Law in the IR limit lambda -> 1. We adopt the position that the auxiliary field A is independent of the space-time metric [J. Alexandre and P. Pasipoularides, Phys. Rev. D 83, 084030 (2011).][J. Greenwald, V. H. Satheeshkumar, and A. Wang, J. Cosmol. Astropart. Phys. 12 (2010) 007.], and we assume, as in [A. M. da Silva, Classical Quantum Gravity 28, 055011 (2011).], that lambda is a running coupling constant. We show that under these assumptions, spherically symmetric solutions fail to restore the standard Newtonian physics in the IR limit lambda -> 1, unless lambda does not run, and has the fixed value lambda = 1. Finally, we comment on the Horava and Melby-Thompson approach [P. Horava and C. M. Melby-Thompson, Phys. Rev. D 82, 064027 (2010).] in which A is assumed as a part of the space-time metric in the IR.
C1 [Alexandre, Jean] Kings Coll London, Dept Phys, London WC2R 2LS, England.
   [Pasipoularides, Pavlos] Natl Tech Univ Athens, Dept Phys, GR-15773 Athens, Greece.
RP Alexandre, J (reprint author), Kings Coll London, Dept Phys, London WC2R 2LS, England.
EM jean.alexandre@kcl.ac.uk; paul@central.ntua.gr
FU Royal Society, UK
FX We would like to thank A. Wang for useful comments. This work is
   supported by the Royal Society, UK.
CR Alexandre J, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.045002
   Alexandre J, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.084030
   ANAGNOSTOPOULOS K, ARXIV10070355
   BELLORIN J, ARXIV10040055
   Bellorin J, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.044003
   Blas D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.181302
   Bogdanos C, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/7/075005
   Borzou A, 2011, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2011/05/006
   Capasso D, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.124058
   Charmousis C, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/08/070
   da Silva AM, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/5/055011
   GREENWALD J, ARXIV11054259
   Greenwald J, 2010, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2010/12/007
   Gruss E, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/8/085007
   Horava P, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/03/020
   Horava P, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.064027
   Horava P, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.084008
   Huang YQ, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.104012
   Iorio L, 2011, INT J MOD PHYS D, V20, P1079, DOI 10.1142/S0218271811019281
   Kimpton I, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2010)014
   Kiritsis E, 2009, NUCL PHYS B, V821, P467, DOI 10.1016/j.nuclphysb.2009.05.005
   Kluson J, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1690-6
   Kluson J, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.044049
   KLUSON J, ARXIV11015880
   Kobakhidze A, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.064011
   Koutsoumbas G, 2010, J PHYS CONF SER, V259, DOI 10.1088/1742-6596/259/1/012050
   Koutsoumbas G, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.044046
   Koutsoumbas G, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.124014
   Li M, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/08/015
   Lin K, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.044051
   Pons JM, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.044011
   Saridakis EN, 2011, INT J MOD PHYS D, V20, P1485, DOI 10.1142/S0218271811019670
   Sotiriou TP, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/10/033
   Sotiriou TP, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.251601
   Wang AZ, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.044031
   ZHU T, ARXIV11081237
NR 36
TC 6
Z9 6
U1 2
U2 11
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 2470-0010
EI 2470-0029
J9 PHYS REV D
JI Phys. Rev. D
PD OCT 11
PY 2011
VL 84
IS 8
AR 084020
DI 10.1103/PhysRevD.84.084020
PG 6
WC Astronomy & Astrophysics; Physics, Particles & Fields
SC Astronomy & Astrophysics; Physics
GA 841QP
UT WOS:000296527800007
DA 2018-12-27
ER

PT J
AU Lee, WS
   Lin, CF
   Chen, TH
   Chen, HW
AF Lee, Woei-Shyan
   Lin, Chi-Feng
   Chen, Tao-Hsing
   Chen, Hong-Wei
TI RETRACTED: Effects of temperature and strain rate on deformation
   behaviour of Inconel 718 alloy (Retracted article. See vol.137, pg. 434,
   2012)
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article; Retracted Publication
DE Alloys; Cold working; High strain-rate test; Mechanical properties
ID MECHANICAL-BEHAVIOR; FCC METALS; SUPERALLOY; STRESS; ALUMINUM;
   COMPRESSION; CRYSTALS; FRACTURE; 304L
AB Cylindrical Inconel 718 specimens are compressed dynamically at temperatures ranging from 150 to 550 degrees C and strain rates in the range of 1000-5000s(-1) using a compressive split Hopkinson pressure bar. It is found that the flow stress increases with increasing strain rate, but decreases with increasing temperature. The highest work hardening rate is observed in the specimen impacted at the lowest temperature (-150 degrees C) and the highest strain rate (5000s(-1)). However, the work hardening rate is weakened by the deformation-induced temperature rise under high strain and strain rate conditions. The strain rate sensitivity increases with increasing strain rate, but decreases with increasing temperature. The activation energy varies as a function of the strain rate and temperature, and has a maximum value of 40 klmol(-1) under the considered test conditions. The greatest thermal softening effect occurs in the specimens deformed at the highest strain rate of 5000s(-1) at temperatures of 150 degrees C and 25 degrees C, respectively. The microstructural observations confirm that the mechanical response of Inconel 718 is directly related to the effects of the strain rate and temperature on the evolution of the impacted microstructure. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Lee, Woei-Shyan; Chen, Hong-Wei] Natl Cheng Kung Univ, Dept Mech Engn, Tainan 701, Taiwan.
   [Lin, Chi-Feng] Natl Ctr High Performance Comp, Hsin Shi 744, Tainan County, Taiwan.
   [Chen, Tao-Hsing] Natl Kaohsiung Univ Appl Sci, Dept Mech Engn, Kaohsiung 807, Taiwan.
RP Lee, WS (reprint author), Natl Cheng Kung Univ, Dept Mech Engn, Tainan 701, Taiwan.
EM wslee@mail.ncku.edu.tw
CR Chiddister JL, 1963, EXPT MECHANICS, V3, P81, DOI DOI 10.1007/BF02325890
   CHIEM CY, 1983, MATER SCI ENG, V57, P233, DOI 10.1016/0025-5416(83)90213-6
   CONRAD H, 1960, ACTA METALL MATER, V8, P128, DOI 10.1016/0001-6160(60)90097-3
   FERGUSON WG, 1967, J APPL PHYS, V38, P1863, DOI 10.1063/1.1709772
   FOLLANSBEE PS, 1988, ACTA METALL MATER, V36, P81, DOI 10.1016/0001-6160(88)90030-2
   FOLLANSBEE PS, 1985, METALS HDB, V8, P190
   Geng L, 2007, MATER DESIGN, V28, P978, DOI 10.1016/j.matdes.2005.11.020
   Kapoor R, 1998, MECH MATER, V27, P1, DOI 10.1016/S0167-6636(97)00036-7
   Krupp U, 2004, MAT SCI ENG A-STRUCT, V387, P409, DOI 10.1016/j.msea.2004.05.053
   Lee WS, 2008, J MECH BEHAV BIOMED, V1, P336, DOI 10.1016/j.jmbbm.2008.01.002
   Lee WS, 2009, MATER CHEM PHYS, V113, P734, DOI 10.1016/j.matchemphys.2008.08.016
   Lee WS, 2002, METALL MATER TRANS A, V33, P2801, DOI 10.1007/s11661-002-0265-4
   Lee WS, 1998, MAT SCI ENG A-STRUCT, V241, P48, DOI 10.1016/S0921-5093(97)00471-1
   Lee WS, 1998, J MATER PROCESS TECH, V75, P127, DOI 10.1016/S0924-0136(97)00302-6
   Liang RQ, 1999, INT J PLASTICITY, V15, P963, DOI 10.1016/S0749-6419(99)00021-2
   LIJUN W, 2003, J MATER PROCESS TECH, V137, P17
   LINDHOLM US, 1964, J MECH PHYS SOLIDS, V12, P317, DOI 10.1016/0022-5096(64)90028-6
   MATAYA MC, 1994, METALL MATER TRANS A, V25, P2737, DOI 10.1007/BF02649226
   Ogawa K., 1988, Journal of the Society of Materials Science, Japan, V37, P1171
   Ping DH, 2007, MAT SCI ENG A-STRUCT, V456, P99, DOI 10.1016/j.msea.2007.01.090
   Prasad K, 2010, MATER DESIGN, V31, P4502, DOI 10.1016/j.matdes.2010.04.019
   SEEGER A, 1955, PHILOS MAG, V46, P1194
   SHI L, 1995, ACTA METALL MATER, V43, P453, DOI 10.1016/0956-7151(94)00279-Q
   Song JH, 2007, KEY ENG MATER, V340-341, P283, DOI 10.4028/www.scientific.net/KEM.340-341.283
   SWEET JN, 1987, INT J THERMOPHYS, V8, P593, DOI 10.1007/BF00503645
   TANAKA K, 1979, HIGH VELOCITY DEFORM, P98
   Thomas A, 2006, J MATER PROCESS TECH, V177, P469, DOI 10.1016/j.jmatprotec.2006.04.072
   Urdanpilleta M, 2005, MATER TRANS, V46, P1711, DOI 10.2320/matertrans.46.1711
   Wang Y, 2008, MAT SCI ENG A-STRUCT, V497, P479, DOI 10.1016/j.msea.2008.07.046
   Xue H, 2003, J MATER PROCESS TECH, V137, P17, DOI 10.1016/S0924-0136(02)01055-5
   ZERILLI FJ, 1992, ACTA METALL MATER, V40, P1803, DOI 10.1016/0956-7151(92)90166-C
   Zhang JM, 1997, J MATER PROCESS TECH, V70, P252, DOI 10.1016/S0924-0136(97)00073-3
NR 32
TC 3
Z9 3
U1 2
U2 24
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD OCT 3
PY 2011
VL 129
IS 3
BP 832
EP 839
DI 10.1016/j.matchemphys.2011.05.019
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 809YL
UT WOS:000294092500028
DA 2018-12-27
ER

PT J
AU Zampetaki, A
   Willeit, P
   Yin, X
   Drozdov, I
   Willeit, J
   Kiechl, S
   Mayr, M
AF Zampetaki, A.
   Willeit, P.
   Yin, X.
   Drozdov, I.
   Willeit, J.
   Kiechl, S.
   Mayr, M.
TI RETRACTED: PROSPECTIVE STUDY ON PLASMA MICRORNAS AND RISK OF MYOCARDIAL
   INFARCTION (Retracted article. See vol. 97, pg. 1895, 2011)
SO HEART
LA English
DT Meeting Abstract; Retracted Publication
C1 [Zampetaki, A.; Yin, X.; Drozdov, I.; Mayr, M.] Kings Coll London, British Heart Fdn Ctr, London WC2R 2LS, England.
   [Willeit, P.; Willeit, J.; Kiechl, S.] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria.
NR 0
TC 0
Z9 0
U1 2
U2 9
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1355-6037
EI 1468-201X
J9 HEART
JI Heart
PD OCT
PY 2011
VL 97
IS 20
BP 16
EP 16
DI 10.1136/heartjnl-2011-300920b.45
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 823XW
UT WOS:000295162300052
DA 2018-12-27
ER

PT J
AU Parhi, P
   Mohanty, C
   Sahoo, SK
AF Parhi, Priyambada
   Mohanty, Chandana
   Sahoo, Sanjeeb Kumar
TI RETRACTED: Enhanced cellular uptake and in vivo pharmacokinetics of
   rapamycin-loaded cubic phase nanoparticles for cancer therapy (Retracted
   article. See vol. 9, pg. 7078, 2013)
SO ACTA BIOMATERIALIA
LA English
DT Article; Retracted Publication
DE Apoptosis; Bioavailability; Biocompatibility; Rapamycin; Cubic phase
   nanoparticles
ID MAMMALIAN TARGET; DRUG-DELIVERY; ORAL DELIVERY; LUNG-CANCER; PACLITAXEL;
   APOPTOSIS; PATHWAY; CELLS; MTOR; TISSUE
AB To date cancer is considered as one of the most devastating diseases due to its high rate of mortality. Preclinical studies have demonstrated that the Akt/mTOR (mammalian target of rapamycin) pathway is activated in cancers and inhibition of this pathway has great potential in anti-cancer therapy. Rapamycin, one of the most potent anti-cancer drugs, blocks Akt/mTOR function and has anti-proliferative activity in several cancers. To circumvent problems associated with rapamycin due to its poor water solubility, poor oral bioavailability, low accessibility to cancer tissues and systemic toxicity, rapamycin-loaded cubic nanoparticles (NP) were formulated with vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) as an emulsifier for oral delivery. Cubic NP were characterised and these particles demonstrated better cytotoxicity and apoptosis compared with native rapamycin under in vitro conditions due to their enhanced cellular uptake. The molecular impact of particulate systems on the Akt/mTOR pathway were elucidated by immunoblotting. Down-regulation of different anti-apoptotic genes of this pathway indicates activation of apoptotic signals leading to MIA PaCa cell death. An in vivo study demonstrated enhanced bioavailability of rapamycin in cubic NP in comparison with native rapamycin in a mouse model with no toxicity and good biocompatibility of void cubic NP at a higher dose of oral administration. Thus, rapamycin-loaded cubic NP can be used as an effective drug delivery system to produce better rapamycin therapeutics for the treatment of cancers. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Parhi, Priyambada; Mohanty, Chandana; Sahoo, Sanjeeb Kumar] Inst Life Sci, Bhubaneswar 751023, Orissa, India.
RP Sahoo, SK (reprint author), Inst Life Sci, Bhubaneswar 751023, Orissa, India.
EM sanjeebsahoo2005@gmail.com
FU Department of Biotechnology
FX Financial support to the Institute in the form of a TATA Innovative
   Fellowship from the Department of Biotechnology to S.K.S. is gratefully
   acknowledged.
CR Acharya S, 2009, BIOMATERIALS, V30, P5737, DOI 10.1016/j.biomaterials.2009.07.008
   Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887
   Bisht S, 2008, MOL CANCER THER, V7, P3878, DOI 10.1158/1535-7163.MCT-08-0476
   Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362
   Borner MM, 2002, EUR J CANCER, V38, P349, DOI 10.1016/S0959-8049(01)00371-9
   Bortner CD, 1999, J BIOL CHEM, V274, P21953, DOI 10.1074/jbc.274.31.21953
   Collnot EM, 2006, J CONTROL RELEASE, V111, P35, DOI 10.1016/j.jconrel.2005.11.005
   Costanzo PJ, 2006, LANGMUIR, V22, P2788, DOI 10.1021/la0522909
   Das M, 2011, ACTA BIOMATER, V7, P355, DOI 10.1016/j.actbio.2010.08.010
   Das M, 2009, EXPERT OPIN DRUG DEL, V6, P285, DOI 10.1517/17425240902780166
   Dilnawaz F, 2010, BIOMATERIALS, V31, P3694, DOI 10.1016/j.biomaterials.2010.01.057
   Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886
   Feng SS, 2009, BIOMATERIALS, V30, P3297, DOI 10.1016/j.biomaterials.2009.02.045
   Feng SS, 2004, CURR MED CHEM, V11, P413, DOI 10.2174/0929867043455909
   Ganguly S, 2004, INT J PHARM, V276, P83, DOI 10.1016/j.ijpharm.2004.02.014
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Hawkins MJ, 2008, ADV DRUG DELIVER REV, V60, P876, DOI 10.1016/j.addr.2007.08.044
   Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091
   Hosoi H, 1999, CANCER RES, V59, P886
   Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1
   Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P223, DOI 10.1016/S0169-409X(02)00018-2
   Kenerson HL, 2002, CANCER RES, V62, P5645
   Lo YI, 2003, J CONTROL RELEASE, V90, P37, DOI 10.1016/S0168-3659(03)00163-9
   Ma WW, 2007, DRUG TODAY, V43, P659, DOI 10.1358/dot.2007.43.10.1148059
   Misra R, 2010, EUR J PHARM SCI, V39, P152, DOI 10.1016/j.ejps.2009.11.010
   Misra R, 2009, NANOMEDICINE-UK, V4, P519, DOI 10.2217/NNM.09.28
   Mohanty C, 2010, BIOMATERIALS, V31, P6597, DOI 10.1016/j.biomaterials.2010.04.062
   Mohanty C, 2010, NANOMEDICINE-UK, V5, P433, DOI [10.2217/nnm.10.9, 10.2217/NNM.10.9]
   Muller RH, 2004, J BIOTECHNOL, V113, P151, DOI 10.1016/j.jbiotec.2004.06.007
   MUTHUKKUMAR S, 1995, TRANSPLANTATION, V60, P264, DOI 10.1097/00007890-199508000-00010
   Napoli KL, 1997, CLIN BIOCHEM, V30, P135, DOI 10.1016/S0009-9120(96)00157-9
   Panyam J, 2003, INT J PHARM, V262, P1, DOI 10.1016/S0378-5173(03)00295-3
   Parveen S, 2010, ACTA BIOMATER, V6, P3120, DOI 10.1016/j.actbio.2010.02.010
   Qanungo S, 2005, CARCINOGENESIS, V26, P958, DOI 10.1093/carcin/bgi040
   Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192
   Sahoo SK, 2007, NANOMED-NANOTECHNOL, V3, P20, DOI 10.1016/j.nano.2006.11.008
   Sahoo SK, 2005, MOL PHARMACEUT, V2, P373, DOI 10.1021/mp050032z
   Sahoo SK, 2004, INT J CANCER, V112, P335, DOI 10.1002/ijc.20405
   Sahoo SK, 2003, DRUG DISCOV TODAY, V8, P1112, DOI 10.1016/S1359-6446(03)02903-9
   Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396
   Seufferlein T, 1996, CANCER RES, V56, P3895
   Simamora P, 2001, INT J PHARM, V213, P25, DOI 10.1016/S0378-5173(00)00617-7
   Singh A, 2011, ACS APPL MATER INTER, V3, P842, DOI 10.1021/am101196v
   Smolewski P, 2006, ANTI-CANCER DRUG, V17, P487, DOI 10.1097/00001813-200606000-00001
   Spicer P. T., 2003, ENCY NANOSCIENCE NAN, P881
   Tkachenko AG, 2003, J AM CHEM SOC, V125, P4700, DOI 10.1021/ja0296935
   Trickler WJ, 2008, AAPS PHARMSCITECH, V9, P486, DOI 10.1208/s12249-008-9063-7
   Trickler WJ, 2009, PHARM RES-DORDR, V26, P1963, DOI 10.1007/s11095-009-9911-5
   Vandana M, 2009, NANOMEDICINE-UK, V4, P773, DOI 10.2217/NNM.09.54
   Vega F, 2006, CANCER RES, V66, P6589, DOI 10.1158/0008-5472.CAN-05-3018
   von Pawel J, 2001, J CLIN ONCOL, V19, P1743, DOI 10.1200/JCO.2001.19.6.1743
   Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006/1211
   Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050
   Zhang SQ, 2010, BIOCHEM BIOPH RES CO, V398, P337, DOI 10.1016/j.bbrc.2010.06.017
   Zhang Z, 2006, INT J PHARM, V324, P191, DOI 10.1016/j.ijpharm.2006.06.013
NR 55
TC 14
Z9 15
U1 5
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2011
VL 7
IS 10
BP 3656
EP 3669
DI 10.1016/j.actbio.2011.06.015
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 825RZ
UT WOS:000295301100014
PM 21704741
DA 2018-12-27
ER

PT J
AU Frush, S
   Li, ZW
   Potts, EN
   Du, WL
   Eu, JP
   Garantziotis, S
   He, YW
   Foster, WM
   Hollingsworth, JW
AF Frush, Sarah
   Li, Zhuowei
   Potts, Erin N.
   Du, Wanglei
   Eu, Jerry P.
   Garantziotis, Stavros
   He, You-Wen
   Foster, W. Michael
   Hollingsworth, John W.
TI RETRACTED: The Role of the Extracellular Matrix Protein Mindin in Airway
   Response to Environmental Airways Injury (Retracted article. See vol.
   124, pg. A69, 2016)
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article; Retracted Publication
DE airway smooth muscle; endotoxin; innate immunity; lipopolysaccharide;
   LPS; lung; mindin; ozone; Tlr4; toll-like receptor
ID INDUCED LUNG INFLAMMATION; TOLL-LIKE RECEPTOR-4; OZONE EXPOSURE; GRAIN
   DUST; FLOW OBSTRUCTION; DAILY MORTALITY; CUTTING EDGE; GUINEA-PIG; MOUSE
   LUNG; TLR4
AB Background: Our previous work demonstrated that the extracellular matrix protein mindin contributes to allergic airways disease. However, the role of mindin in non-allergic airways disease has not previously been explored.
   Objectives: We hypothesized that mindin would contribute to airways disease after inhalation of either lipopolysaccharide (LPS) or ozone.
   Methods: We exposed C57BL/6J and mindin-deficient ((-/-)) mice to aerosolized LPS (0.9 mu g/m(3) for 2.5 hr), saline, ozone (1 ppm for 3 hr), or filtered air (FA). All mice were evaluated 4 hr after LPS/saline exposure or 24 hr after ozone/FA exposure. We characterized the physiological and biological responses by analysis of airway hyperresponsiveness (AHR) with a computer-controlled small-animal ventilator (FlexiVent), inflammatory cellular recruitment, total protein in bronchoalveolar lavage fluid (BALF), pro-inflammatory cytokine profiling, and ex vivo bronchial ring studies.
   Results: After inhalation of LPS, mindin(-/-) mice demonstrated significantly reduced total cell and neutrophil recruitment into the airspace compared with their wild-type counter-parts. Mindin(-/-) mice also exhibited reduced pro-inflammatory cytokine production and lower AHR to methacholine challenge by FlexiVent. After inhalation of ozone, mice had no detectible differences in cellular inflammation or total BALF protein dependent on mindin. However, mindin(-/-) mice were protected from increased pro-inflammatory cytokine production and AHR compared with their C57BL/6J counter-parts. After ozone exposure, bronchial rings derived from mindin(-/-) mice demonstrated reduced constriction in response to carbachol.
   Conclusions: These data demonstrate that the extracellular matrix protein mindin modifies the airway response to both LPS and ozone. Our data support a conserved role of mindin in production of pro-inflammatory cytokines and the development of AHR in two divergent models of reactive airways disease, as well as a role of mindin in airway smooth muscle contractility after exposure to ozone.
C1 [Frush, Sarah; Li, Zhuowei; Potts, Erin N.; Du, Wanglei; Eu, Jerry P.; Foster, W. Michael; Hollingsworth, John W.] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Dept Med, Durham, NC 27710 USA.
   [Garantziotis, Stavros] NIEHS, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA.
   [He, You-Wen; Hollingsworth, John W.] Duke Univ, Dept Immunol, Durham, NC 27710 USA.
RP Hollingsworth, JW (reprint author), Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Dept Med, Box 103004, Durham, NC 27710 USA.
EM john.hollingsworth@duke.edu
RI Garantziotis, Stavros/A-6903-2009
OI Garantziotis, Stavros/0000-0003-4007-375X
FU National Institutes of Health [ES016126, ES02046, ES016347, HL081825]
FX This work was supported by National Institutes of Health grants to
   J.W.H. (ES016126, ES02046), W.M.F. (ES016347), and J.P.E. (HL081825).
CR Balmes JR, 1996, AM J RESP CRIT CARE, V153, P904, DOI 10.1164/ajrccm.153.3.8630571
   Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372
   Brass DM, 2008, AM J RESP CELL MOL, V39, P584, DOI 10.1165/rcmb.2007-0448OC
   Chassin C, 2009, J IMMUNOL, V183, P2669, DOI 10.4049/jimmunol.0900506
   Cho HY, 2001, AM J PHYSIOL-LUNG C, V280, pL537
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401
   DRISCOLL KE, 1993, TOXICOL APPL PHARM, V119, P306, DOI 10.1006/taap.1993.1074
   Du WL, 2005, J BIOL CHEM, V280, P26287, DOI 10.1074/jbc.M502925200
   Garantziotis S, 2010, AM J RESP CRIT CARE, V181, P666, DOI 10.1164/rccm.200903-0381OC
   Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200
   Gryparis A, 2004, AM J RESP CRIT CARE, V170, P1080, DOI 10.1164/rccm.200403-333OC
   HATCH GE, 1994, AM J RESP CRIT CARE, V150, P676, DOI 10.1164/ajrccm.150.3.8087337
   He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021
   Hollingsworth JW, 2004, AM J RESP CRIT CARE, V170, P126, DOI 10.1164/rccm.200311-1499OC
   Hoshino K, 1999, J IMMUNOL, V162, P3749
   *I LAB AN RES, 1996, GUID CAR US LAB AN
   Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f
   Jagielo PJ, 1996, CHEST, V110, P263, DOI 10.1378/chest.110.1.263
   Jia W, 2005, BLOOD, V106, P3854, DOI 10.1182/blood-2005-04-1658
   Johnston RA, 2005, AM J PHYSIOL-LUNG C, V288, pL390, DOI 10.1152/ajplung.00007.2004
   Johnston RA, 2005, AM J PHYSIOL-LUNG C, V288, pL61, DOI 10.1152/ajplung.00101.2004
   KATSOUYANNI K, 1995, EUR RESPIR J, V8, P1030
   Kleeberger SR, 1997, NAT GENET, V17, P475, DOI 10.1038/ng1297-475
   Kleeberger SR, 2000, AM J RESP CELL MOL, V22, P620, DOI 10.1165/ajrcmb.22.5.3912
   Kline JN, 2000, J APPL PHYSIOL, V89, P1172
   Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3
   Li H, 2006, EMBO J, V25, P4097, DOI 10.1038/sj.emboj.7601289
   Li ZW, 2009, J LEUKOCYTE BIOL, V85, P124, DOI 10.1189/jlb.0208135
   O'Grady NP, 2001, AM J RESP CRIT CARE, V163, P1591, DOI 10.1164/ajrccm.163.7.2009111
   Park JW, 2004, AM J RESP CELL MOL, V30, P830, DOI 10.1165/rcmb.2003.0373OC
   Parodi S, 2005, PUBLIC HEALTH, V119, P844, DOI 10.1016/j.puhe.2004.10.007
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Qureshi ST, 2006, J IMMUNOL, V176, P4950, DOI 10.4049/jimmunol.176.8.4950
   SCHWARTZ DA, 1994, AM J PHYSIOL-LUNG C, V267, pL609
   Schwartz DA, 1996, CHEST, V109, pS57, DOI 10.1378/chest.109.3_Supplement.57S
   Shore SA, 2001, AM J RESP CRIT CARE, V164, P602, DOI 10.1164/ajrccm.164.4.2001016
   Simpson JCG, 1999, ANN OCCUP HYG, V43, P107, DOI 10.1093/annhyg/43.2.107
   WEINMANN GG, 1995, AM J RESP CRIT CARE, V151, P33, DOI 10.1164/ajrccm.151.1.7812569
   WEINMANN GG, 1995, AM J RESP CRIT CARE, V152, P988, DOI 10.1164/ajrccm.152.3.7663815
   Wieland CW, 2005, J IMMUNOL, V175, P6042, DOI 10.4049/jimmunol.175.9.6042
   WIESTER MJ, 1988, TOXICOL APPL PHARM, V96, P140, DOI 10.1016/0041-008X(88)90256-6
   Yang IA, 2005, AM J RESP CRIT CARE, V171, P171, DOI 10.1164/rccm.200402-194OC
   Yoshida M, 2002, PULM PHARMACOL THER, V15, P111, DOI 10.1006/pupt.2001.0324
   Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834
   Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139
NR 45
TC 6
Z9 7
U1 1
U2 5
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD OCT
PY 2011
VL 119
IS 10
BP 1403
EP 1408
DI 10.1289/ehp.1003339
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 827CA
UT WOS:000295402400024
PM 21684833
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Freund, Y
   Chenevier-Gobeaux, C
   Leumani, F
   Doumenc, B
   Claessens, Y
   Cosson, C
   Riou, B
   Ray, P
AF Freund, Y.
   Chenevier-Gobeaux, C.
   Leumani, F.
   Doumenc, B.
   Claessens, Y.
   Cosson, C.
   Riou, B.
   Ray, P.
TI RETRACTED: Concomitant Measurement of Copeptin and High Sensitivity
   Troponin for Fast and Reliable Rule Out of Acute Myocardial
   infarction(Retracted article. See vol. 38, pg. 733, 2012)
SO ANNALS OF EMERGENCY MEDICINE
LA English
DT Meeting Abstract; Retracted Publication
CT Scientific Assembly Research Forum of the
   American-College-of-Emergency-Physicians
CY OCT 15-16, 2011
CL San Francisco, CA
SP Amer Coll Emergency Phys
C1 Grp Hosp Pitie Salpetriere, F-75634 Paris, France.
   Hop Cochin, F-75674 Paris, France.
   Hop Bicetre, Paris, France.
NR 0
TC 2
Z9 2
U1 3
U2 10
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-0644
J9 ANN EMERG MED
JI Ann. Emerg. Med.
PD OCT
PY 2011
VL 58
IS 4
SU S
BP S190
EP S190
DI 10.1016/j.annemergmed.2011.06.061
PG 1
WC Emergency Medicine
SC Emergency Medicine
GA 827ID
UT WOS:000295421300037
DA 2018-12-27
ER

PT J
AU Foldes, G
   Mioulane, M
   Chahine, MN
   Schneider, MD
   Harding, SE
AF Foldes, G.
   Mioulane, M.
   Chahine, M. N.
   Schneider, M. D.
   Harding, S. E.
TI RETRACTED: HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES
   SERVE AS IN VITRO MODEL OF CARDIAC HYPERTROPHY (Retracted article. See
   vol. 99, pg. 00, 2013)
SO HEART
LA English
DT Meeting Abstract; Retracted Publication
C1 [Foldes, G.; Mioulane, M.; Chahine, M. N.; Schneider, M. D.; Harding, S. E.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.
NR 0
TC 3
Z9 3
U1 3
U2 14
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1355-6037
EI 1468-201X
J9 HEART
JI Heart
PD OCT
PY 2011
VL 97
IS 20
BP 11
EP 11
DI 10.1136/heartjnl-2011-300920b.29
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 823XW
UT WOS:000295162300036
DA 2018-12-27
ER

PT J
AU Kimura, T
   Mogi, C
   Sato, K
   Tomura, H
   Ohta, H
   Im, DS
   Kuwabara, A
   Kurose, H
   Murakami, M
   Okajima, F
AF Kimura, Takao
   Mogi, Chihiro
   Sato, Koichi
   Tomura, Hideaki
   Ohta, Hideo
   Im, Doon-Soon
   Kuwabara, Atsushi
   Kurose, Hitoshi
   Murakami, Masami
   Okajima, Fumikazu
TI RETRACTED: p2y5/LPA(6) attenuates LPA(1)-mediated VE-cadherin
   translocation and cell-cell dissociation through G(12/13)
   protein-Src-Rap1 (Retracted article. See vol. 94, pg. 163, 2012)
SO CARDIOVASCULAR RESEARCH
LA English
DT Article; Retracted Publication
DE Endothelial cell; Vascular endothelial cadherin; Lysophosphatidic acid;
   p2y5/LPA(6)
ID PROTEIN-COUPLED RECEPTOR; SIGNAL-REGULATED KINASE;
   LOW-DENSITY-LIPOPROTEIN; LYSOPHOSPHATIDIC ACID; ENDOTHELIAL-CELLS;
   GLIOMA-CELLS; CANCER CELLS; ACTIVATION; LPA; PHOSPHORYLATION
AB Aims We investigated the mechanisms of action of lysophosphatidic acid (LPA) to regulate vascular endothelial (VE)-cadherin dynamics and cell-cell contact.
   Methods and results While a low concentration of LPA stimulated VE-cadherin internalization and subsequent cell-cell dissociation, a high concentration of LPA masked the disruptive actions on VE-cadherin and protected the barrier function in human vascular endothelial cells. Knockdown experiments of major LPA receptor subtypes, i.e. LPA(1) and p2y5 (also termed LPA(6)), with their specific small interfering RNAs, showed that LPA(1) and LPA(6) mediate the LPA-induced disruptive and protective actions on barrier integrity, respectively. LPA(6)-mediated tube formation, reflecting stabilization of barrier integrity, was confirmed by in vitro angiogenesis assay. The LPA(1)-mediated disruptive actions were inhibited by pertussis toxin, dominant-negative Rac1, and inhibitors for c-Jun NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38MAPK), but not by dominant-negative RhoA. In contrast, the LPA(6)-mediated protective actions were associated with activation of Src and Rap1 and attenuated by abrogation of their activities. Further characterization showed that Rap1 is located downstream of Src and dependent on C3G, a Rap1 guanine nucleotide exchange factor. Finally, an LPA antagonist significantly inhibited lactic acid-induced limb lesions in vivo, which may be attributed to dysfunction of endothelial cells.
   Conclusion LPA induced disruption and protection of VE-cadherin integrity through LPA(1)-Gi protein-Rac1-JNK/p38MAPK and LPA(6)-G12/13 protein-Src-C3G-Rap1 pathways, respectively.
C1 [Kimura, Takao; Mogi, Chihiro; Sato, Koichi; Tomura, Hideaki; Okajima, Fumikazu] Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gumma 3718512, Japan.
   [Kimura, Takao; Murakami, Masami] Gunma Univ, Grad Sch Med, Dept Clin Lab Med, Maebashi, Gumma 3718511, Japan.
   [Ohta, Hideo] Kyowa Hakko Kirin Co Ltd, Dev Div, Dept Clin Sci, Tokyo 1008185, Japan.
   [Im, Doon-Soon] Pusan Natl Univ, Coll Pharm, Pharmacol Lab, Pusan 609735, South Korea.
   [Kuwabara, Atsushi] Takasaki Univ Hlth & Welf, Dept Nursing, Fac Hlth Care, Takasaki, Gumma 3700033, Japan.
   [Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 8128582, Japan.
RP Okajima, F (reprint author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, 3-39-15 Showa Machi, Maebashi, Gumma 3718512, Japan.
EM fokajima@showa.gunma-u.ac.jp
FU Japan Society for the Promotion of Science; Takeda Science Foundation;
   National Research Foundation of Korea [NRF-2010-616-E00015]; Institute
   for Molecular and Cellular Regulation, Gunma University [10004]; 2010
   Japan-Korean Joint Research Project [E00015]
FX This work was funded by grants from Grants-in-Aid for Scientific
   Research from the Japan Society for the Promotion of Science, Takeda
   Science Foundation, and the National Research Foundation of Korea Grant
   (NRF-2010-616-E00015). This work was also supported in part by the joint
   research programme of the Institute for Molecular and Cellular
   Regulation, Gunma University (10004) and by 2010 Japan-Korean Joint
   Research Project Grant (E00015).
CR Amerongen GPV, 2000, ARTERIOSCL THROM VAS, V20, pE127, DOI 10.1161/01.ATV.20.12.e127
   Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478
   Bunda S, 2009, J BIOL CHEM, V284, P16633, DOI 10.1074/jbc.M109.008748
   Cote M, 1997, ENDOCRINOLOGY, V138, P3299, DOI 10.1210/en.138.8.3299
   Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005
   Fukuyama T, 2006, ONCOGENE, V25, P8, DOI 10.1038/sj.onc.1209010
   Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486
   Gavard J, 2009, FEBS LETT, V583, P1, DOI 10.1016/j.febslet.2008.11.032
   Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779
   Ishida H, 1999, BIOL PHARM BULL, V22, P822
   Khanna P, 2010, AM J PHYSIOL-CELL PH, V298, pC1140, DOI 10.1152/ajpcell.00242.2009
   Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040
   Kimura T, 2006, CELL SIGNAL, V18, P841, DOI 10.1016/j.cellsig.2005.07.011
   Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071
   Knezevic II, 2009, J BIOL CHEM, V284, P5381, DOI 10.1074/jbc.M808958200
   Malchinkhuu E, 2005, ONCOGENE, V24, P6676, DOI 10.1038/sj.onc.1208805
   Maruyama Y, 2002, CIRC RES, V91, P961, DOI 10.1161/01.RES.0000043282.39776.7C
   Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143
   Minnear FL, 2001, AM J PHYSIOL-LUNG C, V281, pL1337
   Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894
   Napoli C, 2000, FASEB J, V14, P1996, DOI 10.1096/fj.99-0986com
   Neidlinger NA, 2006, J BIOL CHEM, V281, P775, DOI 10.1074/jbc.M505790200
   Nwariaku FE, 2004, BLOOD, V104, P3214, DOI 10.1182/blood-2004-05-1868
   Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533
   Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994
   Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010
   Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84
   Sato K, 1999, MOL PHARMACOL, V55, P126
   Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4
   Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100
   Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931
   Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086
   Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200
   Teo ST, 2009, IUBMB LIFE, V61, P791, DOI 10.1002/iub.220
   Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664
   van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05
   Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001
   Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003
   Williams JR, 2009, J BIOL CHEM, V284, P17304, DOI 10.1074/jbc.M109.003194
   Yamada T, 2004, J BIOL CHEM, V279, P6595, DOI 10.1074/jbc.M308133200
   Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200
   Yin F, 2005, INVEST OPHTH VIS SCI, V46, P1927, DOI 10.1167/iovs.04-1256
NR 42
TC 7
Z9 9
U1 2
U2 17
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0008-6363
EI 1755-3245
J9 CARDIOVASC RES
JI Cardiovasc. Res.
PD OCT 1
PY 2011
VL 92
IS 1
BP 149
EP 158
DI 10.1093/cvr/cvr154
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 821IT
UT WOS:000294969000020
PM 21632882
OA Bronze
DA 2018-12-27
ER

PT J
AU Barone, A
   Ricci, M
   Calvo-Guirado, JL
   Covani, U
AF Barone, A.
   Ricci, M.
   Calvo-Guirado, J. L.
   Covani, U.
TI RETRACTED: Bone remodelling after regenerative procedures around
   implants placed in fresh extraction sockets: an experimental study in
   Beagle dogs (Retracted article. See vol. 29, pg. 539, 2018)
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article; Retracted Publication
DE bone remodelling; guided bone regeneration
ID VERTICAL RIDGE AUGMENTATION; TOOTH EXTRACTION; BIO-OSS; TISSUE
   FORMATION; IMMEDIATE; MEMBRANE; FLAP; PRESERVATION; SITES; XENOGRAFT
AB Introduction: After a tooth extraction, the height of the buccal wall tends to decrease. The literature indicates that regenerative techniques (guided bone regenerative [GBR] techniques) have succeeded in improving the bone levels. Therefore, this experiment set out to compare the physiological bone remodelling in Beagle dog models after implant placement in a fresh extraction socket, with and without the application of regenerative procedure.
   Materials and methods: Five dogs were used in this study. Test and control sites were randomly selected. The experimental teeth (fourth pre-molar and first molar) were hemi-sected removing the distal roots and placing implants. Porcine bone was placed to fill the gap around the implant on the test sites and a reabsorbable membrane was used to cover the area. The dogs were put down at different times (2 weeks, 1 month and 3 months). The measurements were taken immediately and at 2, 4, 12 weeks after implant placement. Student's test for paired data was used to compare the means of the clinical measurements.
   Results: At 2 weeks: On the control sites, few signs of resorption were detected at the first molar only, while at the test sites bone levels were placed at the implant shoulder or above.
   At 4 weeks: On the control site, slight bone remodelling was observed, while on the test site minor signs of resorption or an increase of bone levels were detected.
   At 12 weeks: The alveolar crest on the control sites showed various degrees of remodelling. On the test sites stable bone levels or an increase of bone crest was observed.
   Conclusion: With the limits of this study, the findings showed that GBR techniques were able to limit resorption of the alveolar crest after tooth extraction. A pattern of bone remodelling after tooth extraction and implant placement was observed in the control sites (no GBR) as well as in test sites (GBR), and although the exact cause of this is unclear, surgical trauma could play a role. Further studies are necessary to confirm these results and to clarify the precise causes of bone remodelling in fresh extraction sockets.
C1 [Barone, A.; Covani, U.] Versilia Hosp, Ist Stomatol Tirreno, Lido Di Camaiore, LU, Italy.
   [Barone, A.] Univ Genoa, Dept Oral Pathol, Genoa, Italy.
   [Ricci, M.] Univ Genoa, Nanoworld Inst, Genoa, Italy.
   [Calvo-Guirado, J. L.] Univ Murcia, Dept Implantol, Murcia, Spain.
   [Covani, U.] Univ Pisa, Dept Surg, Pisa, Italy.
RP Ricci, M (reprint author), Osped Versilia, Ist Stomatol Tirreno, Via Aurelia 335, Lido Di Camaiore, Lucca, Italy.
EM ricci.massimiliano@yahoo.it
RI Barone, Antonio/O-2738-2013
OI Barone, Antonio/0000-0003-1226-7565
CR Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P606, DOI 10.1111/j.1600-0501.2006.01315.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P545, DOI 10.1111/j.1600-0501.2008.01703.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Barone A, 2008, J PERIODONTOL, V79, P1370, DOI [10.1902/jop.2008.070628, 10.1902/jop.2008.070628 ]
   Blanco J, 2008, J CLIN PERIODONTOL, V35, P640, DOI 10.1111/j.1600-051X.2008.01237.x
   Botticelli D, 2006, CLIN ORAL IMPLAN RES, V17, P351, DOI 10.1111/j.1600-0501.2006.01270.x
   BRAGGER U, 1988, J CLIN PERIODONTOL, V15, P558, DOI 10.1111/j.1600-051X.1988.tb02129.x
   Canullo L, 2006, INT J PERIODONT REST, V26, P355
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Cornelini R, 2005, INT J PERIODONT REST, V25, P439
   Covani U, 2004, J PERIODONTOL, V75, P1605, DOI 10.1902/jop.2004.75.12.1605
   Covani U, 2007, J PERIODONTOL, V78, P810, DOI 10.1902/jop.2007.060254
   de Sanctis M, 2009, J CLIN PERIODONTOL, V36, P705, DOI 10.1111/j.1600-051X.2009.01427.x
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   Fickl S, 2008, CLIN ORAL IMPLAN RES, V19, P1111, DOI 10.1111/j.1600-0501.2008.01575.x
   Fickl S, 2009, J CLIN PERIODONTOL, V36, P898, DOI 10.1111/j.1600-051X.2009.01463.x
   Froum Stuart, 2004, Implant Dent, V13, P153
   JOHNSON K, 1969, Australian Dental Journal, V14, P241
   Lam RV, 1960, J PROSTHET DENT, V10, P25, DOI DOI 10.1016/0022-3913(60)90083-4
   Lekovic V, 1997, J PERIODONTOL, V68, P563, DOI 10.1902/jop.1997.68.6.563
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Paolantonio M, 2001, J PERIODONTOL, V72, P1560, DOI 10.1902/jop.2001.72.11.1560
   Parma-Benfenati S, 1998, J PERIODONTOL, V69, P834, DOI 10.1902/jop.1998.69.7.834
   Piattelli A, 1996, BIOMATERIALS, V17, P1725, DOI 10.1016/0142-9612(96)87653-8
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P496
   Simion M, 1998, INT J PERIODONT REST, V18, P9
   Simion M, 2007, CLIN ORAL IMPLAN RES, V18, P620, DOI 10.1111/j.1600-0501.2007.01389.x
   STAFFILENO H, 1966, J PERIODONTOL, V37, P117, DOI 10.1902/jop.1966.37.2.117
   Tinti C, 1996, INT J PERIODONT REST, V16, P221
   Tinti C, 1998, INT J PERIODONT REST, V18, P435
   Tinti C, 1997, INT J PERIODONT REST, V17, P52
   Vance GS, 2004, INT J ORAL MAX IMPL, V19, P491
   Vasilic Nikola, 2003, J Okla Dent Assoc, V93, P33
   Vignoletti F, 2009, J CLIN PERIODONTOL, V36, P688, DOI 10.1111/j.1600-051X.2009.01439.x
   WILDERMAN MN, 1963, J PERIODONTOL, V34, P487, DOI 10.1902/jop.1963.34.6.487
   WOOD DL, 1972, J PERIODONTOL, V43, P141, DOI 10.1902/jop.1972.43.3.141
   Zitzmann NU, 2001, INT J ORAL MAX IMPL, V16, P355
NR 44
TC 31
Z9 32
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD OCT
PY 2011
VL 22
IS 10
BP 1131
EP 1137
DI 10.1111/j.1600-0501.2010.02084.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 820ST
UT WOS:000294926400004
PM 21251082
DA 2018-12-27
ER

PT J
AU Palanisamy, N
   Anuradha, CV
AF Palanisamy, Nallasamy
   Anuradha, Carani Venkataraman
TI RETRACTED: Soy protein prevents renal damage in a fructose-induced model
   of metabolic syndrome via inhibition of NF-kB in male rats (Retracted
   article. See vol. 28, pg. 835, 2013)
SO PEDIATRIC NEPHROLOGY
LA English
DT Article; Retracted Publication
DE Kidney; Soy protein; Fructose; Insulin resistance; Collagen
ID GROWTH-FACTOR-BETA; FACTOR-KAPPA-B; GLYCATION END-PRODUCTS;
   INSULIN-RESISTANCE; GENE-EXPRESSION; DIABETIC-NEPHROPATHY; NEPHROTIC
   SYNDROME; KIDNEY; FIBROSIS; INFLAMMATION
AB The study determines the effect of soy protein on inflammatory status and expression of nuclear factor-kappa B (NF-kappa B P-65) and receptor for advanced glycation end products (RAGE) in a metabolic syndrome (MS) model. MS was induced in adult male rats by feeding them a high fructose diet (60 g/100 g diet). The rats were randomised into six groups by feeding one of the following semi-synthetic diets for 60 days: corn starch (60%) and casein (20%; CCD), fructose (60%) and casein (20%; FCD), fructose (60%) and soy protein (20%; FSD) or corn starch (60%) and soy protein (20%; CSD). The expression of NF-kappa B P-65, transforming growth factor-beta 1 (TGF-beta 1) and RAGE, histochemical localization of alpha-smooth muscle actin (alpha-SMA), tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) assays, collagen deposition and ultrastructural analysis were performed. FCD rats displayed inflammatory changes and increased expression of growth factors and nuclear factors. FSD rats showed reduction in inflammation, fibrogenesis, collagen deposition, NF-kappa B activation and mitigated the ultrastructural changes. Soy protein prevents inflammation and early nephropathic changes in the MS model secondary to the attenuation of NF-kappa B activation.
C1 [Palanisamy, Nallasamy; Anuradha, Carani Venkataraman] Annamalai Univ, Dept Biochem & Biotechnol, Fac Sci, Annamalainagar 608002, Tamil Nadu, India.
RP Palanisamy, N (reprint author), Annamalai Univ, Dept Biochem & Biotechnol, Fac Sci, Annamalainagar 608002, Tamil Nadu, India.
EM nalpybiochem@gmail.com
FU Indian Council of Medical Research (ICMR), New Delhi
FX The financial support in the form of a Senior Research Fellowship to Mr.
   N. Palanisamy from the Indian Council of Medical Research (ICMR), New
   Delhi is gratefully acknowledged. The authors thank Mr. Manickam M,
   Sakthi Sugars Pvt Ltd, a division of Sakthi Soya Pvt Ltd, Coimbatore,
   India for providing soy protein. The authors are also thankful to Dr.
   Ramamurthy, Director, National Centre for Ultrafast Process, Dr. Rama
   Gopalan, Head, Department of Pathology, University of Madras, Chennai,
   India for their help in immunohistochemistry and confocal microscopy.
CR Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039
   Azadbakht L, 2003, EUR J CLIN NUTR, V57, P1292, DOI 10.1038/sj.ejcn.1601688
   Barma P, 2009, BBA-MOL BASIS DIS, V1792, P190, DOI 10.1016/j.bbadis.2008.11.014
   Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7
   Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458
   Chang JW, 2006, NEPHRON EXP NEPHROL, V103, pE156, DOI 10.1159/000092906
   Chen L, 2008, INFLAMM RES, V57, P199, DOI 10.1007/s00011-006-6190-z
   COLEMAN DL, 1992, KIDNEY INT, V41, P604, DOI 10.1038/ki.1992.91
   Dalla Vestra M, 2005, J AM SOC NEPHROL, V16, pS78, DOI 10.1681/ASN.2004110961
   Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013
   Elliott SS, 2002, AM J CLIN NUTR, V76, P911
   Gilani GS, 2005, J AOAC INT, V88, P967
   IJpelaar DHT, 2008, AM J PHYSIOL-RENAL, V294, pF758, DOI 10.1152/ajprenal.00457.2007
   Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629
   Lavigne C, 2000, AM J PHYSIOL-ENDOC M, V278, pE491
   Lazar MA, 2006, NAT MED, V12, P43, DOI 10.1038/nm0106-43
   Levi B, 1998, J NUTR, V128, P1442
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maddox DA, 2002, KIDNEY INT, V61, P96, DOI 10.1046/j.1523-1755.2002.00091.x
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   Moynagh PN, 2005, J CELL SCI, V118, P4389
   Navarro JF, 2006, AM J NEPHROL, V26, P562, DOI 10.1159/000098004
   Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048
   Ng YY, 1998, KIDNEY INT, V54, P864, DOI 10.1046/j.1523-1755.1998.00076.x
   NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x
   Ortiz A, 1995, Adv Nephrol Necker Hosp, V24, P53
   Palanisamy N, 2008, RENAL FAILURE, V30, P645, DOI 10.1080/08860220802134532
   Palanisamy N, 2010, CAN J PHYSIOL PHARM, V88, P28, DOI 10.1139/Y09-110
   Pat B, 2007, VIRCHOWS ARCH, V450, P41, DOI 10.1007/s00428-006-0335-x
   PAZ MA, 1969, BIOCHEM BIOPH RES CO, V34, P221, DOI 10.1016/0006-291X(69)90635-4
   Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669
   RAO P, 1989, ANAL BIOCHEM, V181, P18, DOI 10.1016/0003-2697(89)90387-4
   Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF423, DOI 10.1152/ajprenal.00124.2006
   SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139
   Sinha S, 2004, J BIOL CHEM, V279, P41294, DOI 10.1074/jbc.M406514200
   Smoyer WE, 1998, J MOL MED, V76, P172, DOI 10.1007/s001090050206
   Tan HW, 2008, ACTA PHARMACOL SIN, V29, P1051, DOI 10.1111/j.1745-7254.2008.00843.x
   Tomobe K, 1998, AM J KIDNEY DIS, V31, P55, DOI 10.1053/ajkd.1998.v31.pm9428452
   Ton ALY, 2007, SEMIN NEPHROL, V27, P130, DOI 10.1016/j.semnephrol.2007.01.006
   Tovar AR, 2002, J NUTR, V132, P2562
   Trujillo J, 2008, AM J PHYSIOL-RENAL, V295, pF1574, DOI 10.1152/ajprenal.90385.2008
   Vanden Berghe W, 2006, CANCER RES, V66, P4852, DOI 10.1158/0008-5472.CAN-05-2957
   Vasdev S, 1998, MOL CELL BIOCHEM, V181, P1, DOI 10.1023/A:1006844222963
   Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Zhou GH, 2004, AM J PATHOL, V165, P2033, DOI 10.1016/S0002-9440(10)63254-3
   Zhuo JL, 1999, HYPERTENSION, V33, P347, DOI 10.1161/01.HYP.33.1.347
NR 48
TC 3
Z9 4
U1 4
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0931-041X
EI 1432-198X
J9 PEDIATR NEPHROL
JI Pediatr. Nephrol.
PD OCT
PY 2011
VL 26
IS 10
BP 1809
EP 1821
DI 10.1007/s00467-011-1882-1
PG 13
WC Pediatrics; Urology & Nephrology
SC Pediatrics; Urology & Nephrology
GA 814RA
UT WOS:000294473500009
PM 21533627
DA 2018-12-27
ER

PT J
AU Turkyilmazoglu, M
AF Turkyilmazoglu, M.
TI RETRACTED: Exact solutions for the incompressible viscous
   magnetohydrodynamic fluid of a rotating disk flow (Retracted article.
   See vol. 50, pg. 3135, 2015)
SO MECCANICA
LA English
DT Article; Retracted Publication
DE Exact solution; Rotating-disk flow; Magnetohydrodynamic flow; Shear
   stresses; Heat transfer
ID INSTABILITY
AB The main interest of the present paper is to generate exact solutions to the steady Navier-Stokes equations for the incompressible Newtonian viscous electrically conducting fluid flow motion due to a disk rotating with a constant angular speed. In place of the traditional von Karman's axisymmetric evolution of the flow, the rotational non-axisymmetric stationary conducting flow is taken into consideration here. As a consequence, for an external uniform magnetic field applied perpendicular to the plane of the disk, the governing equations allow an exact solution to develop, which is influenced by a fixed point on the disk and also is bounded everywhere in the normal direction to the wall.
   The three-dimensional equations of motion are treated analytically yielding derivation of exact solutions, which differ from those of corresponding to the classical von Karman's conducting flow. Making use of this solution, analytical formulas for the angular velocity components as well as for the wall shear stresses are extracted. The critical peripheral locations at which extrema of the local skin friction occur are also determined. It is proved from the analytical results that for the specific flow the properly defined thicknesses decay as the magnetic field strength increases in magnitude.
   Interaction of the resolved flow field with the surrounding temperature is further analyzed via the energy equation. The temperature field is shown to accord with the dissipation and the Joule heating. According to the Fourier's heat law, a constant heat transfer from the disk to the fluid occurs, though decreases for small magnetic fields because of the dominance of Joule heating, it eventually increases for growing magnetic field parameters.
C1 Hacettepe Univ, Dept Math, TR-06532 Ankara, Turkey.
RP Turkyilmazoglu, M (reprint author), Hacettepe Univ, Dept Math, TR-06532 Ankara, Turkey.
EM turkyilm@hotmail.com
CR Ariel PD, 2002, Z ANGEW MATH MECH, V82, P235, DOI 10.1002/1521-4001(200204)82:4<235::AID-ZAMM235>3.0.CO;2-L
   Asghar S, 2007, MECCANICA, V42, P141, DOI 10.1007/sl 1012-006-9027-5
   Batchelor G. K., 1967, INTRO FLUID DYNAMICS
   BERKER R, 1982, INT J ENG SCI, V20, P217, DOI 10.1016/0020-7225(82)90017-9
   Cochran WG, 1934, P CAMB PHILOS SOC, V30, P365
   Ghosh SK, 2009, MECCANICA, V44, P741, DOI 10.1007/s11012-009-9210-6
   GREGORY N, 1955, PHILOS TR R SOC S-A, V248, P155, DOI 10.1098/rsta.1955.0013
   Guria M, 2010, MECCANICA, V45, P23, DOI 10.1007/s11012-009-9218-y
   HALL P, 1986, P ROY SOC LOND A MAT, V406, P93, DOI 10.1098/rspa.1986.0066
   Jarre S, 1996, PHYS FLUIDS, V8, P496, DOI 10.1063/1.868803
   Karman TV, 1921, Z ANGEW MATH MECH, V1, P233, DOI DOI 10.1002/ZAMM.19210010401
   Leray J, 1934, ACTA MATH-DJURSHOLM, V63, P193, DOI 10.1007/BF02547354
   RAJAGOPAL KR, 1988, INT J ENG SCI, V30, P143
   Schlichting H., 1979, BOUNDARY LAYER THEOR
   SCHMID B, 2001, MATH UNLIMITED 2001
   SHERMAN RS, 1990, VISCOUS FLOW
   Sparrow E. M., 1962, J APPL MECH, V29, P181, DOI DOI 10.1016/0045-7930(88)90005-9
   SPARROW EM, 1959, ASME, V81, P249
   THACKER WI, 1988, COMPUT FLUIDS, V16, P183
   TURKYILMAZOGLU M, 1998, THESIS U MANCHESTER
NR 20
TC 2
Z9 3
U1 3
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0025-6455
EI 1572-9648
J9 MECCANICA
JI Meccanica
PD OCT
PY 2011
VL 46
IS 5
BP 1085
EP 1092
DI 10.1007/s11012-010-9362-4
PG 8
WC Mechanics
SC Mechanics
GA 793JV
UT WOS:000292818600015
DA 2018-12-27
ER

PT J
AU Yang, PZ
   Wang, X
   Liu, T
AF Yang Peizhong
   Wang Xin
   Liu Tao
TI RETRACTED: Agent-based simulation of fire emergency evacuation with fire
   and human interaction model (Retracted article. See vol. 93, pg. 50,
   2012)
SO SAFETY SCIENCE
LA English
DT Article; Retracted Publication
DE Agent-based simulation; Fire emergency evacuation; Fire and human
   interaction; Grid resolution; FDS plus Evac
ID WAITING TIME; COMPUTER; CHINA
AB Fire emergency evacuation in an underground mass transit station is a great concern especially in developing countries. The interaction between fire and human is very important in the analysis of fire emergency evacuation. In this study, an agent-based fire and human interaction model is used. The grid resolution is analyzed to determine an appropriate grid size that will optimize the solution accuracy and time. Different fire locations, heat release rates, occupant loadings, ventilation conditions and material properties are considered under fire condition in an underground subway station. It shows that the heat release rate has a weak influence on fire emergency evacuation, but the fire location, occupant loading, ventilation condition and material property have a great influence on fire emergency evacuation. Furthermore, the five parameters have a coupled function on fire emergency evacuation. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Yang Peizhong; Wang Xin; Liu Tao] Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai 200240, Peoples R China.
RP Yang, PZ (reprint author), Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai 200240, Peoples R China.
EM pzyang@sjtu.edu.cn
FU National Natural Science Foundation of China [61073088, 50875166];
   Shanghai Municipal; Shanghai Supercomputer Center
FX This work was supported by the National Natural Science Foundation of
   China (Nos. 61073088, 50875166), the Shanghai Municipal Information
   Fund, and the Shanghai Supercomputer Center.
CR Ando K, 1988, RAILWAY RES REV, V45, P8
   Baum HR, 1989, P 2 INT S, P129
   Cheng XD, 2009, BUILD ENVIRON, V44, P864, DOI 10.1016/j.buildenv.2008.06.012
   Chow WK, 2008, SAFETY SCI, V46, P844, DOI 10.1016/j.ssci.2007.01.015
   Chow WK, 2007, BUILD ENVIRON, V42, P3757, DOI 10.1016/j.buildenv.2006.08.001
   Frantzich H., 2003, 3126 LUND U DEP FIR
   Fruin JJ, 1971, PEDESTRIAN PLANNING
   Galea ER, 2008, J FIRE PROT ENG, V18, P85, DOI 10.1177/1042391507079343
   Galea ER, 1996, TOXICOLOGY, V115, P63, DOI 10.1016/S0300-483X(96)03495-6
   GALEA ER, 1994, FIRE SAFETY J, V22, P341, DOI 10.1016/0379-7112(94)90040-X
   GALEA ER, 2008, 9 INT S FIR SAF SCI, P465
   GROSSHANDLER W, 2005, 2 NCSTAR NAT I STAND, V1
   Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023
   HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282
   HELBING D, 2002, SIMULATION PEDESTRIA, P21
   HELIOVAARA S, 2008, P 4 INT C PED EV DYN
   HELIOVAARA S, 2007, THESIS HELSINKI U TE
   HOSTIKKA S, 2007, VTT WORKING PAPERS, V82
   Jiang CS, 2010, SAFETY SCI, V48, P445, DOI 10.1016/j.ssci.2009.12.004
   Jiang CS, 2009, BUILD ENVIRON, V44, P169, DOI 10.1016/j.buildenv.2008.02.006
   Kang K, 2007, FIRE SAFETY J, V42, P218, DOI 10.1016/j.firesaf.2006.10.003
   KORHONEN T, 2008, FIRE DYNAMICS SIMULA
   Ma TG, 2003, FIRE SAFETY J, V38, P467, DOI 10.1016/S0379-7112(02)00082-6
   MCGRATTAN K, 2006, NIST SPECIAL PUBLICA, V1019
   McGrattan K. B., 2006, NIST SPECIAL PUBLICA, V1018
   *MIN CONSTR, 2001, GB5000842001 MIN CON
   *MIN CONSTR, 2003, GB501572003 MIN CONS
   Oven VA, 2009, FIRE SAFETY J, V44, P1, DOI 10.1016/j.firesaf.2008.02.005
   PAN X, 2006, THESIS STANFORD U CA
   Pauls J. L., 1980, FIRES HUMAN BEHAV, P227
   Predtechenskii V. M, 1978, PLANNING FOOT TRAFFI
   Purser DA., 1995, SFPE HDB FIRE PROTEC
   Shi CL, 2012, SAFETY SCI, V50, P1319, DOI 10.1016/j.ssci.2010.07.017
   SIMO H, 2007, VTT TIEDOTTEITA RES, V2421
   Thompson P., 2003, P 2 INT C PED EV DYN, P173
   THOMPSON PA, 1995, FIRE SAFETY J, V24, P131, DOI 10.1016/0379-7112(95)00019-P
   Werner T, 2003, PEDESTRIAN EVACUATIO, P17
NR 37
TC 11
Z9 14
U1 2
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-7535
EI 1879-1042
J9 SAFETY SCI
JI Saf. Sci.
PD OCT
PY 2011
VL 49
IS 8-9
BP 1130
EP 1141
DI 10.1016/j.ssci.2011.03.003
PG 12
WC Engineering, Industrial; Operations Research & Management Science
SC Engineering; Operations Research & Management Science
GA 794LK
UT WOS:000292898000008
DA 2018-12-27
ER

PT J
AU Turkyilmazoglu, M
AF Turkyilmazoglu, M.
TI RETRACTED: Exact solutions for the incompressible viscous
   magnetohydrodynamic fluid of a rotating-disk flow with Hall current
   (Retracted article. See vol.104, pg.121, 2018)
SO INTERNATIONAL JOURNAL OF NON-LINEAR MECHANICS
LA English
DT Article; Retracted Publication
DE Exact solutions; Magnetohydrodynamic flow; Rotating disk; Hall effect;
   Heat transfer
ID NAVIER-STOKES EQUATIONS; BOUNDARY-LAYER; INSTABILITY; INJECTION; SUCTION
AB The focus of the present study is to obtain exact solutions for the flow of a viscous hydromagnetic fluid due to the rotation of an infinite disk in the presence of an axial uniform steady magnetic field with the inclusion of Hall current effect. In place of the traditional von Karman's axisymmetric evolution of the flow, the rotational non-axisymmetric stationary conducting flow is taken into consideration here, whose governing equations allow an exact solution to develop bounded everywhere in the normal direction to the wall.
   The three-dimensional equations of motion are treated analytically yielding derivation of exact solutions, which differ from those of corresponding to the classical von Karman's conducting flow. Making use of this solution, analytical formulas for the angular velocity components, for the current density field as well as for the wall shear stresses are extracted. The critical peripheral locations at which extrema of the local skin friction occur are also determined. It is proved from the analytical results that for the specific flow the properly defined thicknesses decay as the magnetic field strength increases in magnitude, approaching their hydrodynamic value in the limit of large Hall numbers.
   Interaction of the resolved flow field with the surrounding temperature is further analyzed via the energy equation. The temperature field is shown to accord with the dissipation function. According to the Fourier's heat law, a constant heat transfer from the disk to the fluid occurs, though it increases by the presence of magnetic field, the increase is slowed down by the Hall effect eventually reaching its hydrodynamic limit. (C) 2011 Elsevier Ltd. All rights reserved.
C1 Hacettepe Univ, Dept Math, TR-06532 Ankara, Turkey.
RP Turkyilmazoglu, M (reprint author), Hacettepe Univ, Dept Math, TR-06532 Ankara, Turkey.
EM turkyilm@hotmail.com
CR AboulHassan AL, 1997, PHYS LETT A, V228, P286, DOI 10.1016/S0375-9601(97)00086-8
   ACKROYD JAD, 1978, J ENG MATH, V12, P207, DOI 10.1007/BF00036459
   Ariel PD, 2002, Z ANGEW MATH MECH, V82, P235, DOI 10.1002/1521-4001(200204)82:4<235::AID-ZAMM235>3.0.CO;2-L
   Asghar S, 2007, MECCANICA, V42, P141, DOI 10.1007/sl 1012-006-9027-5
   Attia HA, 2001, APPL MATH MODEL, V25, P1089, DOI 10.1016/S0307-904X(01)00033-6
   Batchelor G. K., 1967, INTRO FLUID DYNAMICS
   BERKER R, 1982, INT J ENG SCI, V20, P217, DOI 10.1016/0020-7225(82)90017-9
   Bodewadt UT, 1940, Z ANGEW MATH MECH, V20, P241, DOI 10.1002/zamm.19400200502
   Cochran WG, 1934, P CAMB PHILOS SOC, V30, P365
   CRAMER K, 1973, MAGNETOFLUID DYNAMIC
   Edward R. Bendon, 1966, J FLUID MECH, V24, P781
   Federov B.I., 1976, J ENG PHYS, V31, P1448
   GREGORY N, 1955, PHILOS TR R SOC S-A, V248, P155, DOI 10.1098/rsta.1955.0013
   HALL P, 1986, P ROY SOC LOND A MAT, V406, P93, DOI 10.1098/rspa.1986.0066
   Hayat T, 2001, ACTA MECH, V151, P127, DOI 10.1007/BF01272530
   Jarre S, 1996, PHYS FLUIDS, V8, P496, DOI 10.1063/1.868803
   Jasmine HA, 2005, J ENG MATH, V52, P337, DOI 10.1007/s10665-005-2732-6
   KOHAMA Y, 1984, ACTA MECH, V50, P193, DOI 10.1007/BF01170959
   Polyanin AD, 2001, DOKL PHYS, V46, P726, DOI 10.1134/1.1415590
   RAJAGOPAL KR, 1984, INT J ENG SCI, V22, P451, DOI 10.1016/0020-7225(84)90079-X
   RAJAGOPAL KR, 1988, INT J ENG SCI, V30, P143
   RILEY N, 1964, Q J MECH APPL MATH, V17, P331, DOI 10.1093/qjmam/17.3.331
   ROGERS MH, 1960, J FLUID MECH, V7, P617, DOI 10.1017/S0022112060000335
   Sai KS, 2000, ACTA MECH, V140, P57, DOI 10.1007/BF01175980
   Schlichting H., 1979, BOUNDARY LAYER THEOR
   SHERMAN RS, 1990, VISCOUS FLOW
   Sparrow E. M., 1962, J APPL MECH, V29, P181, DOI DOI 10.1016/0045-7930(88)90005-9
   SPARROW EM, 1959, ASME, V81, P249
   THACKER WI, 1988, COMPUT FLUIDS, V16, P183
   Tsangaris S, 2006, INT J ENG SCI, V44, P1498, DOI 10.1016/j.ijengsci.2006.08.010
   Turkyilmazoglu M, 2009, ZAMM-Z ANGEW MATH ME, V89, P490, DOI 10.1002/zamm.200800120
   Turkyilmazoglu M, 2009, INT J NONLIN MECH, V44, P352, DOI 10.1016/j.ijnonlinmec.2008.12.007
   TURKYILMAZOGLU M, 1998, THESIS U MANCHESTER
   von Karman T, 1921, Z ANGEW MATH MECH, V1, P233
   ZANDBERGEN PJ, 1987, ANNU REV FLUID MECH, V19, P465, DOI 10.1146/annurev.fluid.19.1.465
NR 35
TC 12
Z9 12
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7462
EI 1878-5638
J9 INT J NONLIN MECH
JI Int. J. Non-Linear Mech.
PD OCT
PY 2011
VL 46
IS 8
BP 1042
EP 1048
DI 10.1016/j.ijnonlinmec.2011.04.023
PG 7
WC Mechanics
SC Mechanics
GA 788JU
UT WOS:000292442000007
DA 2018-12-27
ER

PT J
AU Kim, YK
   Yeo, J
   Ha, M
   Kim, B
   Kim, VN
AF Kim, Young-Kook
   Yeo, Jinah
   Ha, Minju
   Kim, Boseon
   Kim, V. Narry
TI RETRACTED: Cell Adhesion-Dependent Control of MicroRNA Decay (Retracted
   article. See vol. 46, pg. 896, 2012)
SO MOLECULAR CELL
LA English
DT Article; Retracted Publication
ID SMALL RNAS; BIOGENESIS; FAMILY; EXPRESSION; DROSOPHILA; TURNOVER;
   CLEAVAGE; REVEALS; GROWTH; CANCER
AB Mammalian microRNAs (miRNAs) are highly stable in most cell types, and their decay mechanism remains largely unknown. Here we report that some miRNAs degrade rapidly upon the loss of cell adhesion. When cells are grown at low density or cells are detached by trypsinization or EGTA treatment, mature miR-141 is downregulated while miR-200c from a common primary transcript (pri-miR-200c-141) remains unaffected. Blockade of transcription by Actinomycin D leads to rapid depletion of miR-141 with a half-life of <1 hr when cells are detached, indicating that the regulation occurs via RNA decay. A sequence motif (UGUCU) in the center of miR-141 is necessary for the regulation. We further find that many other miRNAs including miR-200a, miR-34a, miR-29b, miR-301a, and miR-21 are degraded upon cell splitting. Induced destruction of persistent regulatory molecules such as miRNAs may increase cellular plasticity and facilitate cellular remodeling in response to the changes in cell adhesion.
C1 [Kim, Young-Kook; Yeo, Jinah; Ha, Minju; Kim, Boseon; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.
   [Kim, V. Narry] Seoul Natl Univ, Bioinformat Inst, Seoul 151742, South Korea.
RP Kim, VN (reprint author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.
EM narrykim@snu.ac.kr
OI Ha, Minju/0000-0003-2328-415X
FU Creative Research Initiatives Program [20100000021]; National Research
   Foundation (NRF) of Korea [20100020415]; Ministry of Education, Science,
   and Technology of Korea
FX We would like to thank Dr. Walton Jones and members of the Kim
   laboratory for their helpful discussion and critical comments on the
   manuscripts. We also thank Zissimos Mourelatos for his generous gift of
   the Ago antibody. This work was supported by the Creative Research
   Initiatives Program (20100000021) and the National Honor Scientist
   Program (20100020415) through the National Research Foundation (NRF) of
   Korea and the BK21 Research Fellowships (J.Y., M.H., and B.K.) from the
   Ministry of Education, Science, and Technology of Korea.
CR Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058
   Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197
   Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008
   Cortez MA, 2010, GENE CHROMOSOME CANC, V49, P981, DOI 10.1002/gcc.20808
   Das SK, 2010, P NATL ACAD SCI USA, V107, P11948, DOI 10.1073/pnas.0914143107
   Fagiani E, 2007, CANCER RES, V67, P3064, DOI 10.1158/0008-5472.CAN-06-2301
   Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148
   Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722
   Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235
   Hwang HW, 2009, P NATL ACAD SCI USA, V106, P7016, DOI 10.1073/pnas.0811523106
   Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020
   Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020
   Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632
   Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018
   Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957
   Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385
   Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476
   Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284
   Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X
   McFadyen MCE, 2001, BRIT J CANCER, V85, P242, DOI 10.1054/bjoc.2001.1907
   Mohan S, 2003, ONCOGENE, V22, P5270, DOI 10.1038/sj.onc.1206592
   Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029
   Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728
   Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018
   Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2
   van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089
   Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434
NR 31
TC 25
Z9 27
U1 2
U2 24
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1097-2765
J9 MOL CELL
JI Mol. Cell
PD SEP 16
PY 2011
VL 43
IS 6
SI SI
BP 1005
EP 1014
DI 10.1016/j.molcel.2011.07.031
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 825VI
UT WOS:000295309800015
PM 21925388
OA Bronze
DA 2018-12-27
ER

PT J
AU Decca, RS
AF Decca, Ricardo S.
TI RETRACTED: MEASUREMENT OF THE CASIMIR INTERACTION BETWEEN A Au SPHERE
   AND Au GRATINGS (Retracted article. See vol. 27, 1293001, 2012)
SO INTERNATIONAL JOURNAL OF MODERN PHYSICS A
LA English
DT Article; Proceedings Paper; Retracted Publication
CT 8th Alexander Friedmann International Seminar on Gravitation and
   Cosmology and Satellite Symposium on the Casimir Effect
CY MAY 30-JUN 03, 2011
CL Rio de Janeiro, BRAZIL
DE Casimir force modification; boundary conditions
ID MU-M RANGE; FORCE; CONSTRAINTS
AB The measurements between a Au coated sphere and Au gratings with different structural parameters are presented. While the main effect of the grating is to reduce the interaction observed between the same sphere and a Au plane at the same distance, it is observed that the reduction is non-trivial. While at small separations the interaction is greater than what is expected from purely geometrical effects, at large separations the effect not only becomes smaller but it also presents a faster decay than the corresponding geometrical contribution.
C1 Indiana Univ Purdue Univ Indianapolis, Dept Phys, Indianapolis, IN 46202 USA.
RP Decca, RS (reprint author), Indiana Univ Purdue Univ Indianapolis, Dept Phys, Indianapolis, IN 46202 USA.
EM rdecca@iupui.edu
FU National Science Foundation [PHY-0701636]; Los Alamos National
   Laboratory [49423-001-07]; DARPA; Nanosacale Imaging Center at IUPUI
FX The author acknowledges support from the National Science Foundation
   through Grant PHY-0701636, from Los Alamos National Laboratory through
   Contract 49423-001-07, and from DARPA through the Casimir Effect
   Enhancement program. Support from the Nanosacale Imaging Center at IUPUI
   is also acknowledged. The author is indebted with D. Lopez, V. Aksyuk,
   S. T. Koev and I.-W. Jung for providing the gratings to perform the
   measurements. He also recognizes discussions with D. A. R. Dalvit and F.
   Intravaia.
CR Bao Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.250402
   Bezerra VB, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.022119
   Bordag M, 2000, PHYS REV LETT, V85, P503, DOI 10.1103/PhysRevLett.85.503
   Bostrom M, 2000, PHYS REV LETT, V84, P4757, DOI 10.1103/PhysRevLett.84.4757
   Bressi G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.041804
   Casimir H. B. G., 1948, KON NED AKAD WET, V51, P793
   Chan HB, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.030401
   Chan HB, 2001, SCIENCE, V291, P1941, DOI 10.1126/science.1057984
   Chen F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.101801
   Chen F, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.032113
   Chen F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035338
   Chen F, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.170402
   Chen F, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.022103
   Chen F, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.020101
   Chen F, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.019905
   Chiu HC, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.115417
   Chiu HC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.121402
   Decca RS, 2007, EUR PHYS J C, V51, P963, DOI 10.1140/epjc/s10052-007-0346-z
   Decca RS, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.077101
   Decca RS, 2009, INT J MOD PHYS A, V24, P1748, DOI 10.1142/S0217751X09045327
   Decca RS, 2005, ANN PHYS-NEW YORK, V318, P37, DOI 10.1016/j.aop.2005.03.007
   Decca RS, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.116003
   Genet C, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.012110
   Geyer B, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.062102
   Jourdan G, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/31001
   Lamoreaux SK, 1997, PHYS REV LETT, V78, P5, DOI 10.1103/PhysRevLett.78.5
   Lamoreaux SK, 1998, PHYS REV LETT, V81, P5475, DOI 10.1103/PhysRevLett.81.5475
   Lopez D, 2005, BELL LABS TECH J, V10, P61, DOI 10.1002/bltj.20104
   Munday JN, 2009, NATURE, V457, P170, DOI 10.1038/nature07610
   Popescu M, 2010, J PHYS CONF SER, V253, DOI 10.1088/1742-6596/253/1/012014
   Roy A, 1999, PHYS REV LETT, V82, P4380, DOI 10.1103/PhysRevLett.82.4380
   Svetovoy VB, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035439
   Svetovoy VB, 2000, MOD PHYS LETT A, V15, P1437, DOI 10.1142/S0217732300001699
   Svetovoy VB, 2000, MOD PHYS LETT A, V15, P1013, DOI 10.1142/S021773230000102X
   Torricelli G, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.010101
NR 35
TC 4
Z9 4
U1 5
U2 12
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0217-751X
EI 1793-656X
J9 INT J MOD PHYS A
JI Int. J. Mod. Phys. A
PD SEP 10
PY 2011
VL 26
IS 22
SI SI
BP 3910
EP 3917
DI 10.1142/S0217751X1105436X
PG 8
WC Physics, Nuclear; Physics, Particles & Fields
SC Physics
GA 818DO
UT WOS:000294731500021
DA 2018-12-27
ER

PT J
AU Gu, M
   Miyoshi, K
   Dubner, R
   Guo, W
   Zou, SP
   Ren, K
   Noguchi, K
   Wei, F
AF Gu, Ming
   Miyoshi, Kan
   Dubner, Ronald
   Guo, Wei
   Zou, Shiping
   Ren, Ke
   Noguchi, Koichi
   Wei, Feng
TI RETRACTED: Spinal 5-HT3 Receptor Activation Induces Behavioral
   Hypersensitivity via a Neuronal-Glial-Neuronal Signaling Cascade
   (Retracted article. See vol. 32, pg. 18270, 2012)
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article; Retracted Publication
ID DESCENDING PAIN FACILITATION; ROSTRAL VENTROMEDIAL MEDULLA;
   PERIPHERAL-NERVE INJURY; SUPERFICIAL DORSAL-HORN; NEUROPATHIC PAIN;
   PERSISTENT PAIN; RETICULARIS-GIGANTOCELLULARIS; PATHOLOGICAL PAIN; NMDA
   RECEPTOR; RAT MODEL
AB Recent studies indicate that the descending serotonin (5-HT) system from the rostral ventromedial medulla (RVM) in the brainstem and the 5-HT3 receptor subtype in the spinal dorsal horn are involved in enhanced descending pain facilitation after tissue and nerve injury. However, the mechanisms underlying the activation of the 5-HT3 receptor and its contribution to facilitation of pain remain unclear. In the present study, activation of spinal 5-HT3 receptor by intrathecal injection of a selective 5-HT3 receptor agonist, SR57227, induced spinal glial hyperactivity, neuronal hyperexcitability, and pain hypersensitivity in rats. We found that there was neuron-to-microglia signaling via chemokine fractalkine, microglia to astrocyte signaling via the cytokine IL-18, astrocyte to neuronal signaling by IL-1 beta, and enhanced activation of GluN (NMDA) receptors in the spinal dorsal horn. In addition, exogenous brain-derived neurotrophic factor-induced descending pain facilitation was accompanied by upregulation of CD11b and GFAP expression in the spinal dorsal horn after microinjection in the RVM, and these events were significantly prevented by functional blockade of spinal 5-HT3 receptors. Enhanced expression of spinal CD11b and GFAP after hindpaw inflammation was also attenuated by molecular depletion of the descending 5-HT system by intra-RVM Tph-2 shRNA interference. Thus, these findings offer new insights into the cellular and molecular mechanisms at the spinal level responsible for descending 5-HT-mediated pain facilitation during the development of persistent pain after tissue and nerve injury. Newpain therapies should focus on prime targets of descending facilitation-induced glial involvement, and in particular the blocking of intercellular signaling transduction between neuron and glia.
C1 [Gu, Ming; Dubner, Ronald; Guo, Wei; Zou, Shiping; Ren, Ke; Wei, Feng] Univ Maryland, Sch Dent, Program Neurosci, Dept Neural & Pain Sci, Baltimore, MD 21201 USA.
   [Miyoshi, Kan; Noguchi, Koichi] Univ Hyogo, Inst Adv Med Sci, Dept Anat & Neurosci, Nishinomiya, Hyogo 6638501, Japan.
RP Wei, F (reprint author), Univ Maryland, Sch Dent, Program Neurosci, Dept Neural & Pain Sci, Baltimore, MD 21201 USA.
EM fwei@umaryland.edu
FU National Institutes of Health [DE18573, NS059028, NS060735]
FX This work was supported by National Institutes of Health Grants DE18573,
   NS059028, and NS060735.
CR Aira Z, 2010, NEUROSCIENCE, V168, P831, DOI 10.1016/j.neuroscience.2010.04.032
   ALHAIDER AA, 1991, J NEUROSCI, V11, P1881
   Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0
   Burgess SE, 2002, J NEUROSCI, V22, P5129, DOI 10.1523/JNEUROSCI.22-12-05129.2002
   Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009
   Colburn RW, 1997, J NEUROIMMUNOL, V79, P163, DOI 10.1016/S0165-5728(97)00119-7
   Conte D, 2005, NEUROSCIENCE, V134, P165, DOI 10.1016/j.neuroscience.2005.02.013
   DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5
   Dogrul A, 2009, BRAIN RES, V1280, P52, DOI 10.1016/j.brainres.2009.05.001
   FIELDS HL, 1991, ANNU REV NEUROSCI, V14, P219, DOI 10.1146/annurev.ne.14.030191.001251
   Fukushima T, 2009, J NEUROPHYSIOL, V102, P1459, DOI 10.1152/jn.91160.2008
   Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016
   Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008
   Geranton SM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-35
   Guo W, 2006, J NEUROSCI, V26, P126, DOI 10.1523/JNEUROSCI.3686-05.2006
   Guo W, 2002, J NEUROSCI, V22, P6208
   Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007
   HAMMOND DL, 1985, J PHYSIOL-LONDON, V359, P151, DOI 10.1113/jphysiol.1985.sp015579
   HAMMOND DL, 1984, BRAIN RES, V298, P329, DOI 10.1016/0006-8993(84)91432-X
   Hamon Michel, 1999, P203
   Hansson E, 2004, NEUROCHEM RES, V29, P989, DOI 10.1023/B:NERE.0000021243.86287.43
   Huang J, 2008, NEUROSCI LETT, V441, P1, DOI 10.1016/j.neulet.2008.04.105
   HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4
   Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9
   Jeong CY, 2004, EUR J PHARMACOL, V502, P205, DOI 10.1016/j.ejphar.2004.08.048
   Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008
   KIA HK, 1995, NEUROREPORT, V6, P257, DOI 10.1097/00001756-199501000-00008
   Lagraize SC, 2010, NEUROSCIENCE, V171, P1341, DOI 10.1016/j.neuroscience.2010.09.040
   Lindia JA, 2005, J PAIN, V6, P434, DOI 10.1016/j.jpain.2005.02.001
   Lopez-Garcia JA, 2006, CURR TOP MED CHEM, V6, P1987, DOI 10.2174/156802606778522159
   Michael GJ, 1997, J NEUROSCI, V17, P8476
   Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6
   Milligan ED, 2008, J NEUROIMMUNOL, V198, P113, DOI 10.1016/j.jneuroim.2009.04.01l
   Milligan ED, 2004, EUR J NEUROSCI, V20, P2294, DOI 10.1111/j.1460-9568.2004.03709.x
   Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533
   Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008
   Morales R, 1998, J COMP NEUROL, V402, P385
   Okazaki R, 2008, ANESTH ANALG, V107, P1064, DOI 10.1213/ane.0b013e31817e7a59
   Paxinos G, 2005, RAT BRAIN STEREOTAXI
   Pertovaara A, 1996, NEUROSCI LETT, V218, P127, DOI 10.1016/S0304-3940(96)13136-0
   Pertovaara A, 2000, Prog Brain Res, V129, P231
   Peters CM, 2010, BRAIN RES, V1352, P83, DOI 10.1016/j.brainres.2010.07.020
   Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4
   Raghavendra V, 2003, PAIN, V104, P655, DOI 10.1016/S0304-3959(03)00138-6
   Rahman W, 2006, PAIN, V123, P264, DOI 10.1016/j.pain.2006.02.033
   Rahman W, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-45
   Reeve AJ, 2000, EUR J PAIN-LONDON, V4, P247, DOI 10.1053/eujp.2000.0177
   Ren K, 2008, CURR OPIN ANESTHESIO, V21, P570, DOI 10.1097/ACO.0b013e32830edbdf
   Ren K, 2007, MOL NEUROBIOL, V35, P224, DOI 10.1007/s12035-007-0028-8
   Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234
   ROBERTS MHT, 1984, NEUROPHARMACOLOGY, V23, P1529, DOI 10.1016/0028-3908(84)90097-2
   Sawynok J, 1996, BEHAV BRAIN RES, V73, P63
   Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992
   Staniland AA, 2010, J NEUROCHEM, V114, P1143, DOI 10.1111/j.1471-4159.2010.06837.x
   Sung CS, 2005, J NEUROCHEM, V94, P742, DOI 10.1111/j.1471-4159.2005.03226.x
   Suzuki R, 2002, NAT NEUROSCI, V5, P1319, DOI 10.1038/nn966
   TECOTT LH, 1993, P NATL ACAD SCI USA, V90, P1430, DOI 10.1073/pnas.90.4.1430
   Urban MO, 1999, NEUROSCIENCE, V90, P349, DOI 10.1016/S0306-4522(99)00002-0
   Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x
   WANG H, 2010, OPEN PAIN J, P144
   Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3
   Wei F, 1999, PAIN, V80, P127, DOI 10.1016/S0304-3959(98)00212-7
   Wei F, 2008, J NEUROSCI, V28, P10482, DOI 10.1523/JNEUROSCI.3593-08.2008
   Wei F, 2010, J NEUROSCI, V30, P8624, DOI 10.1523/JNEUROSCI.5389-09.2010
   YAKSH TL, 1979, J PHARMACOL EXP THER, V208, P446
   Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002
   Zhang RX, 2008, NEUROSCIENCE, V154, P1533, DOI 10.1016/j.neuroscience.2008.04.072
   ZHUO M, 1991, BRAIN RES, V550, P35, DOI 10.1016/0006-8993(91)90402-H
NR 68
TC 19
Z9 21
U1 3
U2 12
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD SEP 7
PY 2011
VL 31
IS 36
BP 12823
EP 12836
DI 10.1523/JNEUROSCI.1564-11.2011
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA 817JA
UT WOS:000294666900013
PM 21900561
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Vogeli, M
   Lemus, JA
   Serrano, D
   Blanco, G
   Tella, JL
AF Voegeli, Matthias
   Lemus, Jesus A.
   Serrano, David
   Blanco, Guillermo
   Tella, Jose L.
TI RETRACTED: An island paradigm on the mainland: host population
   fragmentation impairs the community of avian pathogens (Retracted
   article. See vol. 282, 20152004, 2015)
SO PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article; Retracted Publication
DE habitat fragmentation; emerging infectious diseases; host population
   size; host-pathogen metapopulation models; Chersophilus duponti;
   Dupont's lark
ID LARK CHERSOPHILUS-DUPONTI; PARASITE PREVALENCE; HABITAT FRAGMENTATION;
   BLOOD PARASITES; ATLANTIC FOREST; DIVERSITY; DISEASE; METAPOPULATION;
   CONSERVATION; WILDLIFE
AB Emergent infectious diseases represent a major threat for biodiversity in fragmented habitat networks, but their dynamics in host metapopulations remain largely unexplored. We studied a large community of pathogens (including 26 haematozoans, bacteria and viruses as determined through polymerase chain reaction assays) in a highly fragmented mainland bird metapopulation. Contrary to recent studies, which have established that the prevalence of pathogens increase with habitat fragmentation owing to crowding and habitat-edge effects, the analysed pathogen parameters were neither dependent on host densities nor related to the spatial structure of the metapopulation. We provide, to our knowledge, the first empirical evidence for a positive effect of host population size on pathogen prevalence, richness and diversity. These new insights into the interplay between habitat fragmentation and pathogens reveal properties of a host-pathogen system resembling island environments, suggesting that severe habitat loss and fragmentation could lower pathogen pressure in small populations.
C1 [Voegeli, Matthias; Lemus, Jesus A.; Serrano, David; Tella, Jose L.] CSIC, Estac Biol Donana, Dept Conservat Biol, Seville 41092, Spain.
   [Voegeli, Matthias] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 5E2, Canada.
   [Lemus, Jesus A.; Blanco, Guillermo] CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain.
RP Vogeli, M (reprint author), CSIC, Estac Biol Donana, Dept Conservat Biol, C Americo Vespucio S-N, Seville 41092, Spain.
EM matthias.voegeli@usask.ca
RI Serrano, David/B-5352-2013; Blanco, Guillermo/L-3170-2014; Tella,
   Jose/I-3707-2015
OI Serrano, David/0000-0001-6205-386X; Blanco,
   Guillermo/0000-0001-5742-4929; Tella, Jose/0000-0002-3038-7424
FU CSIC; MICINN; Junta de Andalucia [P07RNM 02918, C3L2007-61395/BOS]
FX We thank M. Mendez, P. Laiolo, M. A. Carrero and I. Afan for their help
   in fieldwork. M. V. was supported by an I3P pre-doctoral (CSIC) and a
   post-doctoral (MICINN) fellowship. Funds were provided by Junta de
   Andalucia Excellence Project P07RNM 02918 and project C3L2007-61395/BOS.
   R. Jovani, J. Potti, P. Laiolo, G. Escudero and two anonymous reviewers
   provided helpful comments.
CR Alcaide M, 2010, MOL ECOL, V19, P691, DOI 10.1111/j.1365-294X.2009.04507.x
   Anderson R, 1991, INFECT DIS HUMANS DY
   Barrett LG, 2008, TRENDS ECOL EVOL, V23, P678, DOI 10.1016/j.tree.2008.06.017
   Begon M, 2003, J ANIM ECOL, V72, P343, DOI 10.1046/j.1365-2656.2003.00705.x
   Blanco G, 2001, J AVIAN BIOL, V32, P271, DOI 10.1111/j.0908-8857.2001.320310.x
   Bordes F, 2009, OIKOS, V118, P801, DOI 10.1111/j.1600-0706.2008.17169.x
   Burnham K. P., 2002, MODEL SELECTION MULT
   Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x
   Colwell RK, 2009, ESTIMATES STAT ESTIM
   Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443
   DAVIDSON F, 2008, AVIAN IMMUNOLOGY
   de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x
   Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x
   Gillespie TR, 2006, CONSERV BIOL, V20, P441, DOI 10.1111/j.1523-1739.2006.00290
   Gog J, 2002, P ROY SOC B-BIOL SCI, V269, P671, DOI 10.1098/rspb.2001.1667
   Gompper ME, 1998, CONSERV BIOL, V12, P730, DOI 10.1046/j.1523-1739.1998.97196.x
   HANSKI I, 1994, ECOLOGY, V75, P747, DOI 10.2307/1941732
   Hanski I., 1997, METAPOPULATION BIOL
   Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556
   Hudson PJ, 2002, ECOLOGY WILDLIFE DIS
   Jovani R, 2006, TRENDS PARASITOL, V22, P214, DOI 10.1016/j.pt.2006.02.011
   Laiolo P, 2008, ANIM CONSERV, V11, P433, DOI 10.1111/j.1469-1795.2008.00202.x
   Laiolo P, 2006, ECOLOGY, V87, P1203, DOI 10.1890/0012-9658(2006)87[1203:LBADOT]2.0.CO;2
   Laiolo P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001822
   Laiolo P, 2007, FRONT ECOL ENVIRON, V5, P68, DOI 10.1890/1540-9295(2007)5[68:EOACIF]2.0.CO;2
   Laiolo P, 2006, ENVIRON CONSERV, V33, P223, DOI 10.1017/S0376892906003146
   Lindstrom KM, 2004, P ROY SOC B-BIOL SCI, V271, P1513, DOI 10.1098/rspb.2004.2752
   Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004
   Lopez JE, 2005, J PARASITOL, V91, P32, DOI 10.1645/GE-323R
   Mbora DNM, 2009, J ANIM ECOL, V78, P210, DOI 10.1111/j.1365-2656.2008.01481.x
   McCallum H, 2002, P ROY SOC B-BIOL SCI, V269, P2041, DOI 10.1098/rspb.2002.2079
   MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3
   MOORING MS, 1992, BEHAVIOUR, V123, P173, DOI 10.1163/156853992X00011
   Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x
   Puttker T, 2008, ECOL RES, V23, P207, DOI 10.1007/s11284-007-0366-z
   Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x
   Ryder JJ, 2007, OIKOS, V116, P2017, DOI 10.1111/j.2007.0030-1299.15863.x
   Sebaio F, 2010, BIRD CONSERV INT, V20, P432, DOI 10.1017/S0959270910000110
   Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106
   Svensson LME, 2009, PARASITOLOGY, V136, P1121, DOI 10.1017/S0031182009990497
   Swinton J., 2002, P83
   Tella JL, 2005, ORYX, V39, P90, DOI 10.1017/S0030605305000165
   Thomas N, 2007, INFECT DIS WILD BIRD
   Valkiunas G, 2006, J PARASITOL, V92, P418, DOI 10.1645/GE-3547RN.1
   Vogeli M, 2007, ARDEOLA, V54, P69
   Vogeli M, 2010, BIOL CONSERV, V143, P1057, DOI 10.1016/j.biocon.2009.12.040
   Vogeli M, 2008, OIKOS, V117, P1816, DOI 10.1111/j.1600-0706.2008.17225.x
   Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x
NR 48
TC 10
Z9 10
U1 2
U2 53
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8452
EI 1471-2954
J9 P ROY SOC B-BIOL SCI
JI Proc. R. Soc. B-Biol. Sci.
PD SEP 7
PY 2011
VL 278
IS 1718
BP 2668
EP 2676
DI 10.1098/rspb.2010.1227
PG 9
WC Biology; Ecology; Evolutionary Biology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA 797QK
UT WOS:000293142200016
PM 21270030
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Ben-Ami, I
   Yao, Z
   Naor, Z
   Seger, R
AF Ben-Ami, Ido
   Yao, Zhong
   Naor, Zvi
   Seger, Rony
TI RETRACTED: G(q) Protein-induced Apoptosis Is Mediated by AKT Kinase
   Inhibition That Leads to Protein Kinase C-induced c-Jun N-terminal
   Kinase Activation (Retracted article. See vol. 292, pg. 8848, 2017)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID GONADOTROPIN-RELEASING-HORMONE; G-ALPHA-Q; GROWTH-FACTOR RECEPTOR;
   PROSTATE-CANCER CELLS; COUPLED RECEPTORS; SIGNALING PATHWAYS;
   CARDIAC-HYPERTROPHY; NEGATIVE REGULATION; HELA-CELLS; IN-VITRO
AB G(q) protein-coupled receptors (G(q)PCRs) regulate various cellular processes, including mainly proliferation and differentiation. In a previous study we found that in prostate cancer cells, the G(q)PCR of gonadotropin-releasing hormone (GnRH) induces apoptosis by reducing the PKC-dependent AKT activity and elevating JNK phosphorylation. Because it was thought that GqPCRs mainly induce activation of AKT, we first undertook to examine how general this phenomenon is. In a screen of 21 cell lines we found that PKC activation results in the reduction of AKT activity, which correlates nicely with JNK activation and in some cases with apoptosis. To understand further the signaling pathways involved in this stimulation, we studied in detail SVOG-4O and alpha T3-1 cells. We found that prostaglandin F2 alpha and GnRH agonist (GnRH-a) indeed induce significant G(q) and PKC-dependent apoptosis in these cells. This is mediated by two signaling branches downstream of PKC, which converge at the level of MLK3 upstream of JNK. One branch consists of c-Src activation of the JNK cascade, and the second involves reduction of AKT activity that alleviates its inhibitory effect on MLK3 to allow the flow of the c-Src signal to JNK. At the MAPKK level, we found that the signal is transmitted by MKK7 and not MKK4. Our results present a general mechanism that mediates a G(q)PCR-induced, death receptor-independent, apoptosis in physiological, as well as cancer-related systems.
C1 [Ben-Ami, Ido; Yao, Zhong; Seger, Rony] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.
   [Ben-Ami, Ido] Tel Aviv Univ, Sackler Sch Med, Assaf Harofeh Med Ctr, Dept Obstet & Gynecol, IL-69978 Ramat Aviv, Israel.
   [Naor, Zvi] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Ramat Aviv, Israel.
RP Seger, R (reprint author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.
EM rony.seger@weizmann.ac.il
FU European Union [LSHC CT-2006-037731]; Israel Science Foundation
FX This work was supported by a grants from the European Union Sixth
   Framework Program (GROWTHSTOP, LSHC CT-2006-037731) and from the Israel
   Science Foundation.
CR Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275
   Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140
   Althoefer H, 1997, J BIOL CHEM, V272, P24380, DOI 10.1074/jbc.272.39.24380
   Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200
   Benard O, 2001, J BIOL CHEM, V276, P4554, DOI 10.1074/jbc.M006995200
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Bridges TM, 2008, ACS CHEM BIOL, V3, P530, DOI 10.1021/cb800116f
   Cigola E, 1997, EXP CELL RES, V231, P363, DOI 10.1006/excr.1997.3477
   Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301
   Dobkin-Bekman M, 2009, MOL ENDOCRINOL, V23, P1850, DOI 10.1210/me.2008-0260
   Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069
   Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056
   Figueroa C, 2003, J BIOL CHEM, V278, P47922, DOI 10.1074/jbc.M307357200
   Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313
   Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001
   Kim AH, 2002, NEURON, V35, P697, DOI 10.1016/S0896-6273(02)00821-8
   Kim HG, 2008, NEUROSIGNALS, V16, P165, DOI 10.1159/000111561
   Kraus S, 2006, CANCER LETT, V234, P109, DOI 10.1016/j.canlet.2005.02.038
   Kraus S, 2004, CANCER RES, V64, P5736, DOI 10.1158/0008-5472.CAN-04-1156
   Kraus S, 2003, J BIOL CHEM, V278, P32618, DOI 10.1074/jbc.M303886200
   Kraus S, 2001, ARCH MED RES, V32, P499, DOI 10.1016/S0188-4409(01)00331-9
   Levi NL, 1998, MOL ENDOCRINOL, V12, P815, DOI 10.1210/me.12.6.815
   Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893
   Luttrell LM, 2002, J CELL SCI, V115, P455
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Matsubara H, 2000, J CLIN ENDOCR METAB, V85, P1620, DOI 10.1210/jc.85.4.1620
   Miyamoto S, 2005, J BIOL CHEM, V280, P38505, DOI 10.1074/jbc.M505223200
   Mizuno N, 2009, NEUROSIGNALS, V17, P42, DOI 10.1159/000186689
   Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5
   New DC, 2007, FEBS J, V274, P6025, DOI 10.1111/j.1742-4658.2007.06116.x
   Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089
   Offermanns S, 1997, NATURE, V389, P183
   Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200
   Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392
   Rose A, 2004, J BIOL CHEM, V279, P52500, DOI 10.1074/jbc.M404571200
   Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246
   RUEDA BR, 1995, BIOL REPROD, V52, P305, DOI 10.1095/biolreprod52.2.305
   Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5
   Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022
   Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501
   Ueda H, 2004, EXP CELL RES, V298, P207, DOI 10.1016/j.yexcr.2004.04.015
   Ueda H, 2001, J BIOL CHEM, V276, P42527, DOI 10.1074/jbc.M102529200
   Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016
   Wu EHT, 2006, FEBS J, V273, P2388, DOI 10.1111/j.1742-4658.2006.05245.x
   Wu J, 2002, BBA-MOL CELL BIOL L, V1582, P100, DOI 10.1016/S1388-1981(02)00143-9
NR 45
TC 13
Z9 13
U1 1
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 2
PY 2011
VL 286
IS 35
BP 31022
EP 31031
DI 10.1074/jbc.M111.247726
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 812HT
UT WOS:000294283600080
PM 21757743
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Canonne, J
   Marino, D
   Jauneau, A
   Pouzet, C
   Briere, C
   Roby, D
   Rivas, S
AF Canonne, Joanne
   Marino, Daniel
   Jauneau, Alain
   Pouzet, Cecile
   Briere, Christian
   Roby, Dominique
   Rivas, Susana
TI RETRACTED: The Xanthomonas Type III Effector XopD Targets the
   Arabidopsis Transcription Factor MYB30 to Suppress Plant Defense
   (Retracted article. See vol. 30, pg. 253, 2018)
SO PLANT CELL
LA English
DT Article; Retracted Publication
ID HYPERSENSITIVE CELL-DEATH; PSEUDOMONAS-SYRINGAE; INNATE IMMUNITY;
   NUCLEAR-BODY; PROTEINS; CAMPESTRIS; GENES; REPRESSION; RESISTANCE;
   SYSTEM
AB Plant and animal pathogens inject type III effectors (T3Es) into host cells to suppress host immunity and promote successful infection. XopD, a T3E from Xanthomonas campestris pv vesicatoria, has been proposed to promote bacterial growth by targeting plant transcription factors and/or regulators. Here, we show that XopD from the B100 strain of X. campestris pv campestris is able to target MYB30, a transcription factor that positively regulates Arabidopsis thaliana defense and associated cell death responses to bacteria through transcriptional activation of genes related to very-long-chain fatty acid (VLCFA) metabolism. XopD specifically interacts with MYB30, resulting in inhibition of the transcriptional activation of MYB30 VLCFA-related target genes and suppression of Arabidopsis defense. The helix-loop-helix domain of XopD is necessary and sufficient to mediate these effects. These results illustrate an original strategy developed by Xanthomonas to subvert plant defense and promote development of disease.
C1 [Canonne, Joanne; Marino, Daniel; Roby, Dominique; Rivas, Susana] INRA, Lab Interact Plantes Microorganismes, UMR 441, F-31326 Castanet Tolosan, France.
   [Canonne, Joanne; Marino, Daniel; Roby, Dominique; Rivas, Susana] CNRS, Lab Interact Plantes Microorganismes, UMR 2594, F-31326 Castanet Tolosan, France.
   [Jauneau, Alain; Pouzet, Cecile] Federat Rech 3450, Plateforme Imagerie, Pole Biotechnol Vegetale, F-31326 Castanet Tolosan, France.
   [Briere, Christian] Univ Paul Sabatier 5546, Univ Toulouse, CNRS, UMR, F-31326 Castanet Tolosan, France.
RP Rivas, S (reprint author), INRA, Lab Interact Plantes Microorganismes, UMR 441, F-31326 Castanet Tolosan, France.
EM susana.rivas@toulouse.inra.fr
RI Marino, Daniel/C-5433-2012; Marino, Daniel/K-1109-2014
OI Marino, Daniel/0000-0002-8788-6646
FU French Ministry of National Education and Research; French Agence
   Nationale de la Recherche-Jeunes Chercheurs [ANR JC08_324792]
FX We thank Mary Beth Mudgett for the kind gift of pEZRK-LCY vectors and
   the Agrobacterium strain expressing HA-LeSUMO and Laurent Noel for pK18
   vectors and Xcc8004* and Xcc8004*Delta hrcV strains. We thank Laurent
   Deslandes for providing the YFP<INF>N</INF> (I152L) vector. We also
   thank Laurent Deslandes, Stephane Genin, and Laurent Noel for helpful
   discussions and critical reading of the manuscript. J.C. was funded by a
   grant from the French Ministry of National Education and Research. This
   work was supported by a French Agence Nationale de la Recherche-Jeunes
   Chercheurs grant (ANR JC08_324792) to S.R.
CR Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731
   Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685
   Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224
   Buell CR, 1997, PLANT J, V12, P21, DOI 10.1046/j.1365-313X.1997.12010021.x
   Canonne J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015773
   Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008
   Cunnac S, 2011, P NATL ACAD SCI USA, V108, P2975, DOI 10.1073/pnas.1013031108
   Daniel X, 1999, PLANT J, V20, P57, DOI 10.1046/j.1365-313X.1999.00578.x
   Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100
   Deslandes L, 2011, PLANT SIGNAL BEHAV, V6, P42, DOI 10.4161/psb.6.1.13978
   Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005
   Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647
   Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006
   FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986
   Froidure S, 2010, P NATL ACAD SCI USA, V107, P15281, DOI 10.1073/pnas.1009056107
   Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x
   Jones JB, 1998, ANNU REV PHYTOPATHOL, V36, P41, DOI 10.1146/annurev.phyto.36.1.41
   Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286
   Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956
   Kazan K, 2006, TRENDS PLANT SCI, V11, P109, DOI 10.1016/j.tplants.2006.01.004
   Kim JG, 2008, PLANT CELL, V20, P1915, DOI 10.1105/tpc.108.058529
   Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519
   Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000
   Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867
   Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239
   Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x
   Okada S, 2009, PLANT CELL PHYSIOL, V50, P1049, DOI 10.1093/pcp/pcp056
   Oke V, 1999, MOL MICROBIOL, V32, P837, DOI 10.1046/j.1365-2958.1999.01402.x
   Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705
   Raffaele S, 2006, FEBS LETT, V580, P3498, DOI 10.1016/j.febslet.2006.05.027
   Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858
   Rossier O, 1999, P NATL ACAD SCI USA, V96, P9368, DOI 10.1073/pnas.96.16.9368
   Rossier O, 2000, MOL MICROBIOL, V38, P828, DOI 10.1046/j.1365-2958.2000.02173.x
   SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7
   Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485
   Tashiro S, 2004, MOL CELL BIOL, V24, P3473, DOI 10.1128/MCB.24.8.3473-3484.2004
   Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199
   Vorholter FJ, 2003, J BIOTECHNOL, V106, P193, DOI 10.1016/j.jbiotec.2003.08.011
   Wang L, 2010, EMBO J, V29, P1903, DOI 10.1038/emboj.2010.76
   Wengelnik K, 1999, J BACTERIOL, V181, P6828
   Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006
   Zhong S, 2000, NAT CELL BIOL, V2, pE85
   Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003
NR 43
TC 76
Z9 86
U1 2
U2 24
PU AMER SOC PLANT BIOLOGISTS
PI ROCKVILLE
PA 15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA
SN 1040-4651
EI 1532-298X
J9 PLANT CELL
JI Plant Cell
PD SEP
PY 2011
VL 23
IS 9
BP 3498
EP 3511
DI 10.1105/tpc.111.088815
PG 14
WC Biochemistry & Molecular Biology; Plant Sciences; Cell Biology
SC Biochemistry & Molecular Biology; Plant Sciences; Cell Biology
GA 844HU
UT WOS:000296739100033
PM 21917550
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Shin, SG
AF Shin, Soon-Gi
TI RETRACTED: Effect of Carbon Content on the Electrical Conductivity of
   Carbon Black-Filled PMC with Various Matrices (Retracted article. See
   vol. 14, pg. 217, 2018)
SO ELECTRONIC MATERIALS LETTERS
LA English
DT Article; Retracted Publication
DE conductivity; carbon black; polymer; composites; surface tension
ID PERCOLATION-THRESHOLD; MECHANICAL-PROPERTIES; COMPOSITES; POWDER
AB The electrical conductivity of carbon black-filled polymer matrix composites (PMC) with various matrices was studied as a function of carbon content to find the break point of the relationship between carbon content and conductivity. Conductivity jumps by as much as ten orders of magnitude at the break point. The critical carbon content corresponding to the break point varies depending on the matrix species and tends to increase with increase in the surface tension of the matrix. To explain the dependency of the critical carbon content on the matrix species, a simple equation was derived under some assumptions, the most important of which is that when the interfacial excess energy introduced by particles of carbon black into the matrix reaches a universal value (Delta q(c)), the particles of carbon black begin to coagulate so as to avoid any further increase of the energy and to form networks which facilitate electrical conduction. The equation well explains the dependency through surface tension, as long as the difference of the surface tensions between the particles of carbon black and the matrix is not very small.
C1 Kangwon Natl Univ, Coll Samcheok, Dept Adv Mat Engn, Samcheok Si 245711, Gangwon, South Korea.
RP Shin, SG (reprint author), Kangwon Natl Univ, Coll Samcheok, Dept Adv Mat Engn, Samcheok Si 245711, Gangwon, South Korea.
EM ssg@kangwon.ac.kr
CR BALBERG I, 1987, PHYS REV LETT, V59, P1305, DOI 10.1103/PhysRevLett.59.1305
   Flory P. J., 1953, PRINCIPLES POLYM CHE
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   Ishida A., 1995, J CERAM SOC JPN, V103, P6
   Kim MJ, 2008, ELECTRON MATER LETT, V4, P57
   Kim SW, 2009, J KOREAN INST MET MA, V47, P50
   Kitazaki Y., 1972, J ADHES SOC JPN, V8, P131
   MATSUSHITA R, 1977, J MATER SCI, V12, P509, DOI 10.1007/BF00540275
   MIYASAKA K, 1982, J MATER SCI, V17, P1610, DOI 10.1007/BF00540785
   MUKHOPADHYAY R, 1976, J APPL POLYM SCI, V20, P2575, DOI 10.1002/app.1976.070200927
   Nakamura S., 1997, Transactions of the Institute of Electrical Engineers of Japan, Part A, V117-A, P371
   Reboul J. P., 1982, CARBON BLACK POLYM C, P80
   Shin SG, 2010, KOREAN J MET MATER, V48, P867, DOI 10.3365/KJMM.2010.48.09.867
   Shin SG, 2010, ELECTRON MATER LETT, V6, P65, DOI 10.3365/eml.2010.06.065
   Sircar A. K., 1977, RUBBER CHEM TECH, V50, P735
   SONG Y, 1986, PHYS REV B, V33, P904, DOI 10.1103/PhysRevB.33.904
   Tanioka A., 1982, J POLYM SCI, P883
   VERHELST WF, 1977, RUBBER CHEM TECHNOL, V50, P735, DOI 10.5254/1.3535171
   WILLIAMS ML, 1955, J AM CHEM SOC, V77, P3701, DOI 10.1021/ja01619a008
NR 19
TC 5
Z9 5
U1 2
U2 7
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881,
   SOUTH KOREA
SN 1738-8090
EI 2093-6788
J9 ELECTRON MATER LETT
JI Electron. Mater. Lett.
PD SEP
PY 2011
VL 7
IS 3
BP 237
EP 241
DI 10.1007/s13391-011-0911-3
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 837KY
UT WOS:000296202600011
DA 2018-12-27
ER

PT J
AU Shin, SG
   Kwon, IK
AF Shin, Soon-Gi
   Kwon, In-Kyu
TI RETRACTED: Effect of Temperature on the Dielectric Properties of Carbon
   Black-Filled Polyethylene Matrix Composites below the Percolation
   Threshold (Retracted article. See vol. 14, pg. 219, 2018)
SO ELECTRONIC MATERIALS LETTERS
LA English
DT Article; Retracted Publication
DE composites; effective medium approximation theory; electrical
   properties; electrical conductivity
ID CONDUCTIVITY
AB The temperature dependence of dielectric properties of carbon black-filled polyethylene matrix composites below the percolation threshold was studied based on the effect medium approximation theory (EMA theory). Although the literature on calculation based on the EMA theory by changing the parameters is vast, an overall discussion taking into account the EMA theory is required to explain the dielectric properties of the composites and their temperature dependence. Changes of the dielectric properties of carbon black-filled PMC and their temperature dependence below the percolation threshold for the volume fraction of carbon black have been discussed based on the EMA theory. The composites satisfy the universal law of conductivity above the percolation threshold, whereas it gives the critical exponent of s = 1 for dielectric constant below percolation threshold. The rates of the decrement of both % changes of dielectric constant and dielectric loss factor for temperature become larger with an increase in the volume fraction below percolation threshold. By incorporating the effect of thermal expansion into the EMA theory, the temperature dependence of dielectric properties is successfully explained.
C1 [Kwon, In-Kyu] Kangwon Natl Univ, Coll Samcheok, Dept Fire Protect Engn, Samcheok Si 245711, Gangwon, South Korea.
   [Shin, Soon-Gi] Kangwon Natl Univ, Coll Samcheok, Dept Adv Mat Engn, Samcheok Si 245711, Gangwon, South Korea.
RP Kwon, IK (reprint author), Kangwon Natl Univ, Coll Samcheok, Dept Fire Protect Engn, Samcheok Si 245711, Gangwon, South Korea.
EM kwonik@kangwon.ac.kr
CR BANHEGYI G, 1988, COLLOID POLYM SCI, V266, P11, DOI 10.1007/BF01451527
   Bruggeman DAG, 1935, ANN PHYS-BERLIN, V24, P636
   EFROS AL, 1976, PHYS STATUS SOLIDI B, V76, P475, DOI 10.1002/pssb.2220760205
   EHRBURGERDOLLE F, 1994, CARBON, V32, P1363, DOI 10.1016/0008-6223(94)90123-6
   Ichinose N., 2006, HDB ELECT MAT, P309
   KIRKPATRICK S, 1973, REV MOD PHYS, V45, P574, DOI 10.1103/RevModPhys.45.574
   Nakai T., 1994, IMC 1994 P OM, P167
   Nakamura S, 1997, JPN J APPL PHYS 1, V36, P5163, DOI 10.1143/JJAP.36.5163
   Shin S. G., 2010, KOR J MAT RES, V20, P42
   Shin SG, 2009, KOR J MATER RES, V19, P644, DOI 10.3740/MRSK.2009.19.12.644
   Shin SG, 2010, KOREAN J MET MATER, V48, P867, DOI 10.3365/KJMM.2010.48.09.867
   Shin SG, 2010, ELECTRON MATER LETT, V6, P65, DOI 10.3365/eml.2010.06.065
   Stauffer D., 1992, INTRO PERCOLATION TH, P1
   Withers P. J., 2007, CONCISE ENCY COMPOSI, P223
NR 14
TC 14
Z9 15
U1 2
U2 15
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881,
   SOUTH KOREA
SN 1738-8090
EI 2093-6788
J9 ELECTRON MATER LETT
JI Electron. Mater. Lett.
PD SEP
PY 2011
VL 7
IS 3
BP 249
EP 254
DI 10.1007/s13391-011-0913-1
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 837KY
UT WOS:000296202600013
DA 2018-12-27
ER

PT J
AU Carpinteri, A
   Niccolini, G
   Lacidogna, G
   Manuello, A
AF Carpinteri, A.
   Niccolini, G.
   Lacidogna, G.
   Manuello, A.
TI RETRACTED: Acoustic emission of the Syracuse Athena temple: timescale
   invariance from microcracking to earthquakes(Retracted article. See Artn
   no.059701, 2011)
SO JOURNAL OF STATISTICAL MECHANICS-THEORY AND EXPERIMENT
LA English
DT Article; Retracted Publication
DE critical exponents and amplitudes (experiment); fracture (experiment)
ID FRACTURE; CRITICALITY; ROCK
AB We show the results of acoustic-emission (AE) monitoring of the Cathedral of Syracuse in Sicily (Southern Italy), built around the surviving elements of a Doric temple dedicated to Athena from the 5th century BC.
   We wired up a single pillar of the 2500-year-old cathedral for four months and then compared the AE data with earthquake records, observing a time correlation between the AE bursts and the sequence of nearby earthquakes and a similar scaling for the related magnitude distributions.
   We found that the distribution of times between events-whether earthquakes or acoustic emissions-fell onto the same curve, over a wide range of timescales and energies, when scaled appropriately.
   A similar 'universal scaling law' has been shown for collections of earthquakes of a range of sizes in different regions, so the new results appear to extend the law to the much smaller energy scales of a single pillar. These pieces of evidence suggest a correlation between the aging process and the local seismic activity, and that more careful monitoring of the cathedral is warranted.
C1 [Niccolini, G.] Ist Nazl Ric Metrol, Thermodynam Div, I-10135 Turin, Italy.
   [Carpinteri, A.; Lacidogna, G.; Manuello, A.] Politecn Torino, Dept Struct Engn, I-10129 Turin, Italy.
RP Niccolini, G (reprint author), Ist Nazl Ric Metrol, Thermodynam Div, Str Cacce 91, I-10135 Turin, Italy.
EM alberto.carpinteri@polito.it; g.niccolini@inrim.it;
   giuseppe.lacidogna@polito.it; amedeo.manuellobertetto@polito.it
RI Lacidogna, Giuseppe/L-8217-2015
OI Lacidogna, Giuseppe/0000-0002-0192-3793
CR Bak P, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.178501
   Carpinteri A, 2007, NAT HAZARD EARTH SYS, V7, P251, DOI 10.5194/nhess-7-251-2007
   Carpinteri A, 2009, CHAOS SOLITON FRACT, V41, P843, DOI 10.1016/j.chaos.2008.04.010
   Corral A, 2006, LECT NOTES PHYS, V705, P191, DOI 10.1007/3-540-35375-5_8
   Davidsen J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.125502
   DIODATI P, 1991, PHYS REV LETT, V67, P2239, DOI 10.1103/PhysRevLett.67.2239
   Gregori GP, 2005, NAT HAZARD EARTH SYS, V5, P777, DOI 10.5194/nhess-5-777-2005
   Guarino A, 2002, EUR PHYS J B, V26, P141, DOI 10.1140/epjb/e20020075
   Hainzl S, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2002JB001865
   KAGAN YY, 1994, PHYSICA D, V77, P160, DOI 10.1016/0167-2789(94)90132-5
   Kagan YY, 1999, B SEISMOL SOC AM, V89, P1147
   LOCKNER D, 1993, INT J ROCK MECH MIN, V30, P883, DOI 10.1016/0148-9062(93)90041-B
   Niccolini G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.108503
   Niccolini G, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046115
   Niccolini G, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026101
   Richter C. F., 1958, ELEMENTARY SEISMOLOG
   SCHOLZ CH, 1968, J GEOPHYS RES, V73, P1417, DOI 10.1029/JB073i004p01417
   Turcotte DL, 2003, GEOPHYS J INT, V152, P718, DOI 10.1046/j.1365-246X.2003.01884.x
   UTSU T, 1995, J PHYS EARTH, V43, P1, DOI 10.4294/jpe1952.43.1
   Weiss J, 2003, SURV GEOPHYS, V24, P185, DOI 10.1023/A:1023293117309
NR 20
TC 0
Z9 0
U1 2
U2 7
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1742-5468
J9 J STAT MECH-THEORY E
JI J. Stat. Mech.-Theory Exp.
PD SEP
PY 2011
AR P09009
DI 10.1088/1742-5468/2011/09/P09009
PG 7
WC Mechanics; Physics, Mathematical
SC Mechanics; Physics
GA 827XK
UT WOS:000295463000011
DA 2018-12-27
ER

PT J
AU Jie, PF
   Zhu, N
   Na, W
   Li, DY
AF Jie Pengfei
   Zhu Neng
   Na Wei
   Li Deying
TI RETRACTED: Establishment and solution of the model for loop pipeline
   network with multiple heat sources (Retracted article. See vol. 45, pg.
   1077, 2012)
SO ENERGY
LA English
DT Article; Retracted Publication
DE District heating system; Hydraulic model; Graph theory; MKP method
ID ENERGY-CONSERVATION MEASURES; SYSTEM
AB The District heating system (DHS) can effectively save energy, so it has been widely used and promoted on a global scale. There are still a series of problems. In order to improve the problem of high energy consumption during transportation, it is necessary to study the hydraulic characteristics of DHS. Through the survey of OHS in different cities, it was found that the form of the heating network was toward a loop pipeline network (LPN) with multiple heat sources. Previous hydraulic models of the dendritic pipeline network (DPN) were expressed. As for LPN with multiple heat sources, deficiencies of treatment were analyzed. It was pointed out that LPN with multiple heat sources was a spatial network. Graph theory was applied to the establishment of the spatial network. And the hydraulic model of LPN with multiple heat sources was established. MKP was used to solve the mathematical model. The actual engineering case was used to verify the accuracy of the model and its solution method, which provided a theoretic and practical basis for the study of the hydraulic characteristics of the DHS. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Jie Pengfei; Zhu Neng] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.
   [Na Wei; Li Deying] Beijing Univ Civil Engn & Architecture, Sch Environm & Energy Engn, Beijing 100044, Peoples R China.
RP Jie, PF (reprint author), Tianjin Univ, Sch Environm Sci & Engn, Weijin Rd 92, Tianjin 300072, Peoples R China.
EM jiefeifeifei@126.com
CR Arvastson L., 2001, STOCHASTIC MODELING
   Cai WH, 2006, J DYN SYST-T ASME, V128, P820, DOI 10.1115/1.2363411
   Cao Liming, 1995, GRAPH THEORY ITS APP, P65
   Difs K, 2010, ENERGY, V35, P3194, DOI 10.1016/j.energy.2010.04.001
   Gabrielaitiene Irina, 2007, ENERGY CONVERSION MA, V48, P78
   Gustafsson J, 2010, APPL ENERG, V87, P1996, DOI 10.1016/j.apenergy.2009.12.015
   Iacobescu F, 2011, ENERG POLICY, V39, P269, DOI 10.1016/j.enpol.2010.09.039
   Li Xiangli, 2004, HV AC, V34, P97
   Liu Zuanwu, 2006, APPL GRAPH THEORY
   Marik K, 2008, ENERGY, V33, P858, DOI 10.1016/j.energy.2007.12.004
   Ping He, 1993, HEATING ENG, P183
   Qin Xuzhong, 2000, ASHRAE T, V106, P270
   Qin Xuzhong, 1999, HEATING VENTILATING, V29, P2
   Rao RV, 2006, MAT SCI ENG A-STRUCT, V431, P248, DOI 10.1016/j.msea.2006.06.006
   Shimoda Y, 2007, ENERGY, V32, P1617, DOI 10.1016/j.energy.2007.01.007
   Sun Zongyu, 2002, DEV RES HYDRAULIC CA
   Tang Zhen, 1987, INTRO ROUNDING ERROR, P26
   Wang Peng, P 2009 IEEE IEEM, P233
   Wang Xiaoxia, 2004, HV AC, V34, P131
   Wu Shilin, 2010, ERROR ANAL DATA PROC, P117
   Xu BP, 2009, BUILD ENVIRON, V44, P249, DOI 10.1016/j.buildenv.2008.03.002
   Xu Junming, 2000, GRAPH THEORY ITS APP, P59
   Zetterberg A, 2010, LANDSCAPE URBAN PLAN, V95, P181, DOI 10.1016/j.landurbplan.2010.01.002
NR 23
TC 0
Z9 1
U1 5
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-5442
EI 1873-6785
J9 ENERGY
JI Energy
PD SEP
PY 2011
VL 36
IS 9
BP 5547
EP 5555
DI 10.1016/j.energy.2011.07.018
PG 9
WC Thermodynamics; Energy & Fuels
SC Thermodynamics; Energy & Fuels
GA 824ZZ
UT WOS:000295242000014
DA 2018-12-27
ER

PT J
AU Malvandi, AM
   Mehrzad, J
   Moghaddam, MS
AF Malvandi, Amir Mohammad
   Mehrzad, Jalil
   Moghaddam, Masoud Saleh
TI RETRACTED: Gene Expression Quantification of Toll like Receptors 2, 4
   and Co-molecules in Human Glioblastoma Cell Line (U87-MG): Toward a New
   In vitro Model of Inflammation (Retracted article. See vol. 17, pg. 546,
   2014)
SO IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES
LA English
DT Article; Retracted Publication
DE Human glioblastoma cell line (U87-MG); Innate immunity; Quantitative
   RT-PCR Toll-like receptors
ID DENDRITIC CELLS; IMMUNE CELLS; KAPPA-B; PATHWAY; TUMOR; ACTIVATE;
   CANCER; TLR4; HYALURONAN; PROMOTES
AB Objective(s)
   Pattern recognition receptors (PRRs) are the main part in the innate immune response. Human glioblastoma cell line (U87-MG) is an established adherent cell line model of this common cancer; due to genetic variations between individuals it is likely more suitable for investigating molecular aspects of innate immunity. Therefore, we undertook a novel characterization of the immune phenotype of U87-MG toward establishing a base for future researches.
   Materials and Methods
   In this study, U87-MG cells where cultured in a normal condition, to investigate levels of toll-like receptor 2 (TLR2), TLR4, myeloid differentiation factor-88 (MyD88) and CD14 transcripts expression in these cells. Both RT-PCR and qPCR were applied to detect and quantify the expression levels of these genes in U87-MG cells and compare them to their levels in the peripheral blood mononuclear cells (PBMC) of healthy individuals, as a common reference.
   Results
   Expression level of TLR2 and TLR4 are not significantly different in U87-MG cells in comparison to PBMC. Also, expression levels of MyD88 and CD14 in U87-MG cells are significantly lower than their levels in PBMC. Furthermore, expression levels of MyD88 and CD14 in both PBMC and U87-MG are significantly lower than TLR2 and TLR4 transcripts.
   Conclusion
   The data reveal expression of TLR4, CD14, MyD88 and TLR2 genes in U87-MG cell line, for the first time. Expression detection of these genes in human glioblastoma cell line might have a potential for diagnosis of inflammatory mechanisms in immune mediated disorders of in vitro models of human brain inflammatory disease.
C1 [Malvandi, Amir Mohammad; Moghaddam, Masoud Saleh] Payam Noor Univ Mashhad, Dept Biochem, Fac Sci, Mashhad, Iran.
   [Malvandi, Amir Mohammad] ACECR, Dept Stem Cells & Dev Biol, Royan Inst Stem Cell Biol & Technol, Tehran, Iran.
   [Mehrzad, Jalil] Ferdowsi Univ Mashhad, Dept Pathobiol, Fac Vet Med, Mashhad, Iran.
RP Malvandi, AM (reprint author), Payam Noor Univ Mashhad, Dept Biochem, Fac Sci, Mashhad, Iran.
EM amalvandi@royaninstitute.org
OI Mehrzad, Jalil/0000-0001-8174-5431; Malvandi, Amir
   Mohammad/0000-0003-1243-2372
FU Payam Noor University's research department; Iranian National Elite
   Foundation (BMN)
FX This project was supported by a grant from Payam Noor University's
   research department and a grant from Iranian National Elite Foundation
   (BMN).
CR Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609
   Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200
   Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434
   Cao L, 2009, NEUROSCIENCE, V158, P896, DOI 10.1016/j.neuroscience.2008.10.004
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Dybdahl B, 2002, CIRCULATION, V105, P685, DOI 10.1161/hc0602.103617
   Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008
   Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989
   Hotfilder M, 2000, ANTICANCER RES, V20, P4445
   Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904
   Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784
   Huang B, 2007, CANCER RES, V67, P4346, DOI 10.1158/0008-5472.CAN-06-4067
   Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315
   Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233
   Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623
   Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010
   Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067
   Matijevic T, 2010, CURR PHARM DESIGN, V16, P1081, DOI 10.2174/138161210790963779
   Nadeau S, 2000, J NEUROSCI, V20, P3456, DOI 10.1523/JNEUROSCI.20-09-03456.2000
   Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558
   Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2
   Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200
   Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135
   Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005
   Pombo-Suarez M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-17
   Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021
   Ru LB, 2005, ARTHRITIS RHEUM-US, V52, P2936, DOI 10.1002/art.21238
   Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JC123755
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887
   Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200
   Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200
   Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200
   Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278
NR 40
TC 3
Z9 3
U1 0
U2 9
PU MASHHAD UNIV MED SCIENCES
PI MASHHAD
PA VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 -
   445, MASHHAD, 00000, IRAN
SN 2008-3866
EI 2008-3874
J9 IRAN J BASIC MED SCI
JI Iran. J. Basic Med. Sci.
PD SEP-OCT
PY 2011
VL 14
IS 5
BP 428
EP 435
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 826KL
UT WOS:000295352900005
PM 23492674
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Larkin, GL
   Beautrais, AL
AF Larkin, Gregory Luke
   Beautrais, Annette L.
TI RETRACTED: A preliminary naturalistic study of low-dose ketamine for
   depression and suicide ideation in the emergency department (Retracted
   article. See vol. 20, pg. 611, 2017)
SO INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
LA English
DT Article; Retracted Publication
DE Depression; emergency department; ketamine; MADRS; suicide ideation
ID D-ASPARTATE ANTAGONIST; RATING-SCALE; PREVENTION; TRIAL
AB We examined the preliminary feasibility, tolerability and efficacy of single-dose, intravenous (i.v.) ketamine in depressed emergency department (ED) patients with suicide ideation (SI). Fourteen depressed ED patients with SI received a single i.v. bolus of ketamine (0.2 mg/kg) over 1-2 min. Patients were monitored for 4 h, then re-contacted daily for 10 d. Treatment response and time to remission were evaluated using the Montgomery-Asberg Depression Rating Scale (MADRS) and Kaplan-Meier survival analysis, respectively. Mean MADRS scores fell significantly from 40.4 (S.E.M. = 1.8) at baseline to 11.5 (S.E.M. = 2.2) at 240 min. Median time to MADRS score <= 10 was 80 min (interquartile range 0.67-24 h). SI scores (MADRS item 10) decreased significantly from 3.9 (S.E.M. = 0.4) at baseline to 0.6 (S.E.M. = 0.2) after 40 min post-administration; SI improvements were sustained over 10 d. These data provide preliminary, open-label support for the feasibility and efficacy of ketamine as a rapid-onset antidepressant in the ED.
C1 [Larkin, Gregory Luke; Beautrais, Annette L.] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT USA.
RP Larkin, GL (reprint author), 227 Church St, New Haven, CT 06519 USA.
EM gregor.larkin@gmail.com
FU Connecticut College of Emergency Physicians'
FX This work was supported by Connecticut College of Emergency Physicians'
   funding. The study was registered in ClinicalTrials.gov by Yale
   University (Record 0909005766).
CR BECK AT, 1988, J CLIN PSYCHOL, V44, P499, DOI 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6
   Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9
   DiazGranados N., 2010, ARCH GEN PSYCHIAT, V67, P793
   Frueh BC, 2000, ADM POLICY MENT HLTH, V28, P147, DOI 10.1023/A:1026611608299
   Krystal JH, 2010, ARCH GEN PSYCHIAT, V67, P1110, DOI 10.1001/archgenpsychiatry.2010.138
   Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287
   Mathew SJ, 2010, INT J NEUROPSYCHOPH, V13, P71, DOI 10.1017/S1461145709000169
   Meltzer HY, 2003, ARCH GEN PSYCHIAT, V60, P82, DOI 10.1001/archpsyc.60.1.82
   MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382
   Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018
   OVERALL JE, 1962, PSYCHOL REP, V10, P799
   Phelps LE, 2009, BIOL PSYCHIAT, V65, P181, DOI 10.1016/j.biopsych.2008.09.029
   Price RB, 2009, BIOL PSYCHIAT, V66, P522, DOI 10.1016/j.biopsych.2009.04.029
   ROT MAH, 2010, BIOL PSYCHIAT, V67, P139, DOI DOI 10.1016/J.BIOPSYCH.2009.08.038
   Sharma V, 2001, CAN J PSYCHIAT, V46, P704
   Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi
   Tondo L, 2009, EPIDEMIOL PSICHIAT S, V18, P179, DOI 10.1017/S1121189X00000439
   YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429
   Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856
NR 19
TC 154
Z9 155
U1 2
U2 21
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1461-1457
EI 1469-5111
J9 INT J NEUROPSYCHOPH
JI Int. J. Neuropsychopharmacol.
PD SEP
PY 2011
VL 14
IS 8
BP 1127
EP 1131
DI 10.1017/S1461145711000629
PG 5
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 815XY
UT WOS:000294564500010
PM 21557878
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Bao, B
   Wang, ZW
   Ali, S
   Kong, DJ
   Banerjee, S
   Ahmad, A
   Li, YW
   Azmi, AS
   Miele, L
   Sarkar, FH
AF Bao, Bin
   Wang, Zhiwei
   Ali, Shadan
   Kong, Dejuan
   Banerjee, Sanjeev
   Ahmad, Aamir
   Li, Yiwei
   Azmi, Asfar S.
   Miele, Lucio
   Sarkar, Fazlul H.
TI RETRACTED: Over-Expression of FoxM1 Leads to Epithelial-Mesenchymal
   Transition and Cancer Stem Cell Phenotype in Pancreatic Cancer Cells
   (Retracted article. See vol. 117, pg. 1963, 2016)
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article; Retracted Publication
DE FOXM1; EMT PHENOTYPE; MIRNAS; CSC-SELF-RENEWAL; GENISTEIN
ID M1 TRANSCRIPTION FACTOR; PROSTATE-CANCER; E-CADHERIN; DOWN-REGULATION;
   MIR-200 FAMILY; BREAST-CANCER; REPRESSORS ZEB1; UP-REGULATION;
   TUMOR-CELLS; PROGRESSION
AB FoxM1 is known to play important role in the development and progression of many malignancies including pancreatic cancer. Studies have shown that the acquisition of epithelial-to-mesenchymal transition (EMT) phenotype and induction of cancer stem cell (CSC) or cancer stem-like cell phenotypes are highly inter-related, and contributes to drug resistance, tumor recurrence, and metastasis. The molecular mechanism(s) by which FoxM1 contributes to the acquisition of EMT phenotype and induction of CSC self-renewal capacity is poorly understood. Therefore, we established FoxM1 over-expressing pancreatic cancer (AsPC-1) cells, which showed increased cell growth, clonogenicity, and cell migration. Moreover, over-expression of FoxM1 led to the acquisition of EMT phenotype by activation of mesenchymal cell markers, ZEB1, ZEB2, Snail2, E-cadherin, and vimentin, which is consistent with increased sphere-forming (pancreatospheres) capacity and expression of CSC surface markers (CD44 and EpCAM). We also found that over-expression of FoxM1 led to decreased expression of miRNAs (let-7a, let-7b, let-7c, miR-200b, and miR-200c); however, re-expression of miR-200b inhibited the expression of ZEB1, ZEB2, vimentin as well as FoxM1, and induced the expression of E-cadherin, leading to the reversal of EMT phenotype. Finally, we found that genistein, a natural chemo-preventive agent, inhibited cell growth, clonogenicity, cell migration and invasion, EMT phenotype, and formation of pancreatospheres consistent with reduced expression of CD44 and EpCAM. These results suggest, for the first time, that FoxM1 over-expression is responsible for the acquisition of EMT and CSC phenotype, which is in part mediated through the regulation of miR-200b and these processes, could be easily attenuated by genistein. J. Cell. Biochem. 112: 2296-2306, 2011. (C) 2011 Wiley-Liss, Inc.
C1 [Sarkar, Fazlul H.] Wayne State Univ, Dept Pathol, Karmanos Canc Inst, Sch Med, Detroit, MI 48201 USA.
   [Ali, Shadan] Wayne State Univ, Div Hematol Oncol, Karmanos Canc Inst, Detroit, MI 48201 USA.
   [Miele, Lucio] Univ Mississippi, Inst Canc, Jackson, MS 39216 USA.
RP Sarkar, FH (reprint author), Wayne State Univ, Dept Pathol, Karmanos Canc Inst, Sch Med, 740 HWCRC,4100 John R St, Detroit, MI 48201 USA.
EM fsarkar@med.wayne.edu
OI Miele, Lucio/0000-0002-5853-7287; AZMI, ASFAR/0000-0003-1178-9505
FU National Cancer Institute NIH [5R01CA131151, 3R01CA131151-02S1,
   5R01CA132794]; Puschelberg foundation; Guido foundation
FX Grant sponsor: National Cancer Institute, NIH Grants; Grant numbers:
   5R01CA131151, 3R01CA131151-02S1, 5R01CA132794.; The authors thank
   Puschelberg and Guido foundations for their generous financial support.
   Grant support was provided by National Cancer Institute, NIH grants
   5R01CA131151, 3R01CA131151-02S1, and 5R01CA132794 (F. H. Sarkar).
CR Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598
   Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42
   Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511
   Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349
   Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005
   Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410
   Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1
   DESMOULIERE A, 1995, CELL BIOL INT, V19, P471, DOI 10.1006/cbir.1995.1090
   Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429
   Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006
   Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559
   Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851
   Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722
   Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004
   Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223
   Ischenko I, 2010, LANGENBECK ARCH SURG, V395, P1, DOI 10.1007/s00423-009-0502-z
   Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138
   Katoh M, 2004, INT J ONCOL, V25, P1495
   Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003
   Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076
   Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277
   Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445
   Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101
   Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200
   Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217
   Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006
   Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702
   Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5
   Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045
   Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298
   MAHATO R, 2010, PHARM RES IN PRESS
   Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512
   Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608
   Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131
   Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907
   Regenbrecht CRA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-49
   Sarkar FH, 2009, MINERVA CHIR, V64, P489
   Sarkar FH, 2006, MINI-REV MED CHEM, V6, P401, DOI 10.2174/138955706776361439
   Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682
   Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965
   Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200
   Wang XH, 2001, HEPATOLOGY, V33, P1404, DOI 10.1053/jhep.2001.24666
   Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265
   Wang ZW, 2011, J CELL BIOCHEM, V112, P78, DOI 10.1002/jcb.22770
   Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001
   Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006
   Wang ZW, 2010, CANCER LETT, V292, P141, DOI 10.1016/j.canlet.2009.11.012
   Wang ZW, 2008, ANTICANCER RES, V28, P3621
   Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009
NR 49
TC 148
Z9 157
U1 2
U2 29
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD SEP
PY 2011
VL 112
IS 9
BP 2296
EP 2306
DI 10.1002/jcb.23150
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 818QN
UT WOS:000294769500013
PM 21503965
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Bergstrom, A
AF Bergstrom, Arne
TI RETRACTED: Frozen time in hyperbolic spacetime motion (Retracted
   article. See vol. 84, 059801, 2011)
SO PHYSICA SCRIPTA
LA English
DT Article; Retracted Publication
AB According to the Lorentz transformation and as clearly seen from the Minkowski diagram, hyperbolic spacetime motion of a test object relative to a stationary reference frame can be performed in a specific way such that time becomes frozen in the moving frame of the test object. In that case, time can be arranged to become frozen even at moderate relativistic velocities, in contrast to the minute traditional relativistic time dilation at such velocities. In the appendix, we give a simple illustration, in Minkowski form, of how time in a frame in hyperbolic motion can become frozen to a complete standstill relative to a stationary frame.
C1 B&E Sci Ltd, Seaford BN25 4PA, England.
RP Bergstrom, A (reprint author), B&E Sci Ltd, Seaford BN25 4PA, England.
EM arne.bergstrom@physics.org
CR AHARONI J, 1985, SPECIAL THEORY RELAT, P21
   MISNER C, 1973, GRAVITATION, P167
   MISNER CW, 1973, GRAVITATION, pCH6
   MOLLER C, 1982, THEORY RELATIVITY, P74
   PAULI W, 1981, THEORY RELATIVITY, P75
   PAULI W, 1981, THEORY RELATIVITY, P10
   TOLMAN R, 1987, RELATIVITY THERMODYN, P22
NR 7
TC 1
Z9 1
U1 3
U2 10
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0031-8949
EI 1402-4896
J9 PHYS SCRIPTA
JI Phys. Scr.
PD SEP
PY 2011
VL 84
IS 3
AR 035004
DI 10.1088/0031-8949/84/03/035004
PG 5
WC Physics, Multidisciplinary
SC Physics
GA 818CY
UT WOS:000294728700004
DA 2018-12-27
ER

PT J
AU Liu, J
   Vohs, KD
   Smeesters, D
AF Liu, Jia (Elke)
   Vohs, Kathleen D.
   Smeesters, Dirk
TI RETRACTED: Money and Mimicry: When Being Mimicked Makes People Feel
   Threatened (Retracted article. See vol. 25, pg. 1153, 2014)
SO PSYCHOLOGICAL SCIENCE
LA English
DT Editorial Material; Retracted Publication
ID CONSEQUENCES; BEHAVIOR
C1 [Liu, Jia (Elke)] Univ Groningen, Dept Mkt, NL-9700 AV Groningen, Netherlands.
   [Vohs, Kathleen D.] Univ Minnesota, Dept Mkt, Minneapolis, MN 55455 USA.
   [Smeesters, Dirk] Erasmus Univ, Dept Mkt Management, NL-3000 DR Rotterdam, Netherlands.
RP Liu, J (reprint author), Univ Groningen, Dept Mkt, POB 800, NL-9700 AV Groningen, Netherlands.
EM jia.liu@rug.nl
CR Brehm J. W., 1966, THEORY PSYCHOL REACT
   Chartrand TL, 2009, ADV EXP SOC PSYCHOL, V41, P219, DOI 10.1016/S0065-2601(08)00405-X
   DeMarree KG, 2005, J PERS SOC PSYCHOL, V89, P657, DOI 10.1037/0022-3514.89.5.657
   van Baaren RB, 2003, J PERS SOC PSYCHOL, V84, P1093, DOI 10.1037/0022-3514.84.5.1093
   Vohs KD, 2008, CURR DIR PSYCHOL SCI, V17, P208, DOI 10.1111/j.1467-8721.2008.00576.x
   Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491
   WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063
   Zhou XY, 2009, PSYCHOL SCI, V20, P700, DOI 10.1111/j.1467-9280.2009.02353.x
NR 8
TC 8
Z9 10
U1 3
U2 29
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0956-7976
EI 1467-9280
J9 PSYCHOL SCI
JI Psychol. Sci.
PD SEP
PY 2011
VL 22
IS 9
BP 1150
EP 1151
DI 10.1177/0956797611418348
PG 2
WC Psychology, Multidisciplinary
SC Psychology
GA 817XE
UT WOS:000294709500010
PM 21821823
DA 2018-12-27
ER

PT J
AU Teramoto, H
   Shiogama, K
   Mizutani, Y
   Inada, K
   Kamahora, T
   Makino, M
   Tsutsumi, Y
AF Teramoto, Hidemi
   Shiogama, Kazuya
   Mizutani, Yasuyoshi
   Inada, Ken-ichi
   Kamahora, Toshio
   Makino, Masanao
   Tsutsumi, Yutaka
TI RETRACTED: Molecular Epidemiology of a Hepatitis C Virus Outbreak in a
   Leprosy Sanatorium in Japan (Retracted article. See vol. 53, pg. 2003,
   2015)
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article; Retracted Publication
ID HEPATOCELLULAR-CARCINOMA; INFECTION; SEQUENCE; NS5B
AB The hepatitis C virus (HCV) outbreak that occurred between 1940 and 1999 in a closed leprosy sanatorium located on a small island in Japan was analyzed. The analysis of 318 nucleotides in the NS5B region of HCV allowed us to establish the existence of at least three different HCV strains in this sanatorium.
C1 [Teramoto, Hidemi] Kojin Hosp, Dept Internal Med, Moriyama Ku, Nagoya, Aichi 4638530, Japan.
   [Shiogama, Kazuya; Mizutani, Yasuyoshi; Inada, Ken-ichi; Tsutsumi, Yutaka] Fujita Hlth Univ, Sch Med, Dept Pathol 1, Toyoake, Aichi 47011, Japan.
   [Kamahora, Toshio] Tottori Univ, Fac Med, Div Virol Microbiol & Pathol, Yonago, Tottori 683, Japan.
   [Makino, Masanao] Natl Sanat Oku Komyo En, Setouchi, Japan.
RP Teramoto, H (reprint author), Kojin Hosp, Dept Internal Med, Moriyama Ku, 1-710 Shikenya, Nagoya, Aichi 4638530, Japan.
EM hteramoto@Kojin-hospital.jp
FU Japanese Ministry of Education, Culture, Sports, Science and Technology
   [21591303]
FX This work was supported by Grant-in Aid for Scientific Research (C)
   Project 21591303 (2009-2011), from the Japanese Ministry of Education,
   Culture, Sports, Science and Technology.
CR CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
   Higuchi M, 2002, JPN J INFECT DIS, V55, P69
   Hmaied F, 2007, J MED VIROL, V79, P1089, DOI 10.1002/jmv.20877
   Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012
   Kuntzen T, 2007, J VIROL, V81, P11658, DOI 10.1128/JVI.00995-07
   Mizoguchi N, 1996, J VIROL METHODS, V58, P71, DOI 10.1016/0166-0934(95)01989-8
   OKAMOTO H, 1992, J GEN VIROL, V73, P673, DOI 10.1099/0022-1317-73-3-673
   Sandres-Saune K, 2003, J VIROL METHODS, V109, P187, DOI 10.1016/S0166-0934(03)00070-3
   Shiogama K, 2010, J MED VIROL, V82, P556, DOI 10.1002/jmv.21612
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099
   TRAUTMAN JR, 1984, B NEW YORK ACAD MED, V60, P722
NR 12
TC 2
Z9 3
U1 2
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD SEP
PY 2011
VL 49
IS 9
BP 3358
EP 3360
DI 10.1128/JCM.00841-11
PG 3
WC Microbiology
SC Microbiology
GA 814AX
UT WOS:000294416000045
PM 21752972
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Floeth, FW
   Stoffels, G
   Herdmann, J
   Eicker, S
   Galldiks, N
   Steiger, HJ
   Langen, KJ
AF Floeth, Frank W.
   Stoffels, Gabriele
   Herdmann, Joerg
   Eicker, Sven
   Galldiks, Norbert
   Steiger, Hans-Jakob
   Langen, Karl-Josef
TI RETRACTED: Prognostic Value of F-18-FDG PET in Monosegmental Stenosis
   and Myelopathy of the Cervical Spinal Cord (Retracted article. See vol.
   52, pg. 1663, 2011)
SO JOURNAL OF NUCLEAR MEDICINE
LA English
DT Article; Retracted Publication
DE positron emission tomography; [F-18] fluorodeoxyglucose; [F-18] FDG PET;
   cervical myelopathy; degenerative spinal stenosis; spinal cord recovery
ID POSITRON-EMISSION-TOMOGRAPHY; SPONDYLOTIC MYELOPATHY; COMPRESSIVE
   MYELOPATHY; SIGNAL INTENSITY; LUNG-CANCER; FDG; RESOLUTION; MOUSE;
   IRRADIATION; METASTASES
AB MRI offers perfect visualization of spondylotic stenosis of the cervical spine, but morphologic imaging does not correlate with clinical symptoms and postoperative recovery after decompression surgery. In this prospective study, we investigated the role of F-18-FDG PET in patients with degenerative stenosis of the cervical spinal cord in relation to postsurgical outcome. Methods: Twenty patients with monosegmental spondylotic stenosis of the middle cervical spine (C3/C4 or C4/C5) showing intramedullary hyperintensity on T2-weighted MRI and clinical symptoms of myelopathy (myelopathic patients) were investigated by F-18-FDG PET. Maximum standardized uptake values (SUVmax) were measured at all levels of the cervical spine (C1-C7). Decompression surgery and anterior cervical fusion were performed on all patients, and clinical status (Japanese Orthopedic Association [JOA] score) was assessed before and 6 mo after surgery. The F-18-FDG data of 10 individuals without cervical spine pathology were used as a reference (controls). Results: The myelopathic patients showed a significant decrease in F-18-FDG uptake in the area of the lower cervical cord, compared with the control group (C7 SUVmax, 1.49 +/- 0.18 vs. 1.71 +/- 0.27, P = 0.01). Ten myelopathic patients exhibited focally increased F-18-FDG uptake at the level of the stenosis (SUVmax, 2.27 +/- 0.41 vs. 1.75 +/- 0.22, P = 0.002). The remaining 10 patients showed inconspicuous F-18-FDG uptake at the area of the stenosis. Postoperatively, the patients with focally increased F-18-FDG accumulation at the level of stenosis showed good clinical recovery and a significant improvement in JOA scores (13.6 +/- 2.3 vs. 9.5 +/- 2.5, P = 0.001), whereas no significant improvement was observed in the remaining patients (JOA score, 12.0 +/- 2.4 vs. 11.6 +/- 2.5, not statistically significant). Multiple regression analysis identified the presence of focally increased F-18-FDG uptake at the level of the stenosis as an independent predictor of postoperative outcome (P = 0.002). Conclusion: The results suggest that regional changes in F-18-FDG uptake have prognostic significance in compression-induced cervical myelopathy that may be helpful in decisions on the timing of surgery.
C1 [Langen, Karl-Josef] Forschungszentrum Julich, Inst Neurosci & Med, INM Med Imaging Phys 4, D-52425 Julich, Germany.
   [Galldiks, Norbert] Univ Hosp Cologne, Dept Neurol, Cologne, Germany.
   [Floeth, Frank W.; Herdmann, Joerg; Eicker, Sven; Steiger, Hans-Jakob] Univ Dusseldorf, Dept Neurosurg, Dusseldorf, Germany.
   [Floeth, Frank W.; Herdmann, Joerg] St Vinzenz Hosp, Dept Spine & Pain, Dusseldorf, Germany.
RP Langen, KJ (reprint author), Forschungszentrum Julich, Inst Neurosci & Med, INM Med Imaging Phys 4, D-52425 Julich, Germany.
EM k.j.langen@fz-juelich.de
RI Eicker, Sven/B-3341-2015; Langen, Karl-Josef/H-4396-2013
OI Langen, Karl-Josef/0000-0003-1101-5075
CR Alafifi T, 2007, J NEUROIMAGING, V17, P315, DOI 10.1111/j.1552-6569.2007.00119.x
   Baba H, 1996, J NEUROL, V243, P109, DOI 10.1007/BF02443999
   Baba H, 1997, J NEUROL, V244, P222, DOI 10.1007/s004150050076
   Baba H, 1999, SPINE, V24, P1449, DOI 10.1097/00007632-199907150-00010
   Boakye M, 2008, NEUROSURGERY, V62, P455, DOI 10.1227/01.NEU.0000297053.35400.E7
   Chamroonrat W, 2005, CLIN NUCL MED, V30, P560, DOI 10.1097/01.rlu.0000170040.63554.81
   de Rota JJF, 2007, J NEUROSURG-SPINE, V6, P17, DOI 10.3171/spi.2007.6.1.4
   DICHIRO G, 1983, J COMPUT ASSIST TOMO, V7, P937
   Dubey N, 2002, J NEUROL SCI, V205, P77, DOI 10.1016/S0022-510X(02)00225-3
   Esik O, 2004, PATHOL ONCOL RES, V10, P42, DOI 10.1007/BF02893408
   Esik O, 2003, STRAHLENTHER ONKOL, V179, P690, DOI 10.1007/s00066-003-1115-z
   Floeth FW, 2010, EUR RADIOL, V20, P2925, DOI 10.1007/s00330-010-1877-5
   Francken AB, 2005, EJSO-EUR J SURG ONC, V31, P197, DOI 10.1016/j.ejso.2004.08.009
   Gemmel F, 2006, EUR J NUCL MED MOL I, V33, P1226, DOI 10.1007/s00259-006-0098-2
   Gilbert JW, 2008, J NEUROSURG-SPINE, V8, P498, DOI 10.3171/SPI/2008/8/5/498
   Ito T, 1996, SPINE, V21, P827, DOI 10.1097/00007632-199604010-00010
   *JAP ORTH ASS, 1976, J JPN ORTHOP ASS, V49
   Kamoto Y, 1998, J COMPUT ASSIST TOMO, V22, P487, DOI 10.1097/00004728-199805000-00023
   Kato Y, 2008, J NEUROSURG-SPINE, V8, P436, DOI 10.3171/SPI/2008/8/5/436
   Komori T, 2001, CLIN NUCL MED, V26, P905, DOI 10.1097/00003072-200111000-00001
   Mastronardi L, 2007, J NEUROSURG-SPINE, V7, P615, DOI 10.3171/SPI-07/12/615
   Meltzer CC, 1998, J NUCL MED, V39, P1207
   Metser U, 2004, J NUCL MED, V45, P279
   Nakamoto Y, 2005, RADIOLOGY, V234, P879, DOI 10.1148/radiol.2343030301
   Nguyen NC, 2008, CLIN NUCL MED, V33, P356, DOI 10.1097/RLU.0b013e31816a784c
   Ota K, 2009, J NEUROL, V256, P1943, DOI 10.1007/s00415-009-5270-8
   Ozawa H, 2010, SPINAL CORD, V48, P415, DOI 10.1038/sc.2009.152
   Poggi MM, 2001, CLIN NUCL MED, V26, P837, DOI 10.1097/00003072-200110000-00006
   Popovich T, 2006, AM J NEURORADIOL, V27, P1201
   Suri Ashish, 2003, Spine J, V3, P33, DOI 10.1016/S1529-9430(02)00448-5
   Uchida K, 2004, J NEUROSURG-SPINE, V1, P72, DOI 10.3171/spi.2004.1.1.0072
   Uchida K, 1998, J NEUROL, V245, P781, DOI 10.1007/s004150050287
   Uchida K, 2009, J NEUROIMAGING, V19, P274, DOI 10.1111/j.1552-6569.2008.00284.x
   Uchida K, 2009, SPINE, V34, P1185, DOI 10.1097/BRS.0b013e31819e2919
   Wilmshurst JM, 2000, J CHILD NEUROL, V15, P465, DOI 10.1177/088307380001500708
NR 35
TC 11
Z9 11
U1 2
U2 14
PU SOC NUCLEAR MEDICINE INC
PI RESTON
PA 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA
SN 0161-5505
J9 J NUCL MED
JI J. Nucl. Med.
PD SEP 1
PY 2011
VL 52
IS 9
BP 1385
EP 1391
DI 10.2967/jnumed.111.091801
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 814TU
UT WOS:000294480900032
PM 21852356
OA Bronze
DA 2018-12-27
ER

PT J
AU Kobuchi, S
   Tanaka, R
   Shintani, T
   Suzuki, R
   Tsutsui, H
   Ohkita, M
   Ayajiki, K
   Matsumura, Y
AF Kobuchi, Shuhei
   Tanaka, Ryosuke
   Shintani, Takuya
   Suzuki, Rie
   Tsutsui, Hidenobu
   Ohkita, Mamoru
   Ayajiki, Kazuhide
   Matsumura, Yasuo
TI RETRACTED: Mechanisms Underlying the Renoprotective Effect of GABA
   against Ischemia/Reperfusion-Induced Renal Injury in Rats (Retracted
   article. See vol. 349, pg. 347, 2014)
SO JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
LA English
DT Article; Retracted Publication
ID GAMMA-AMINOBUTYRIC-ACID; SPONTANEOUSLY HYPERTENSIVE-RATS;
   PARAVENTRICULAR NUCLEUS; CELL INJURY; RECEPTORS; FAILURE; KIDNEY;
   PATHOPHYSIOLOGY; PATHOGENESIS; RESPONSES
AB The excitation of the renal sympathetic nervous system plays an important role in the development of ischemic acute kidney injury (AKI) in rats. We have reported that intravenous treatment with GABA has preventive effects on ischemia/reperfusion (I/R)induced renal dysfunction with histological damage in rats. However, detailed mechanisms of the action of GABA on the renal injury were still unknown. Therefore, in the present study, we aimed to clarify the detailed mechanisms of GABA in ischemic AKI in rats. Ischemic AKI was induced by clamping the left renal artery and vein for 45 min. Thereafter, the kidney was reperfused to produce I/R-induced injury. Intravenous or intracerebroventricular treatment with 3-[[[(3,4-dichlorophenyl)methyl]amino]propyl] diethoxymethyl) phosphinic acid (CGP52432), a GABA(B) receptor antagonist, abolished the suppressive effects of intravenously applied GABA on enhanced renal sympathetic nerve activity during ischemia, leading to the elimination of the renoprotective effects of GABA. Intracerebroventricular treatment with GABA or intravenous treatment with baclofen, a selective GABA, receptor agonist, prevented I/R-induced renal injury equivalent to intravenous treatment with GABA. However, intravenous treatment with bicuculline, a GABA(A) receptor antagonist, failed to affect the preventive effects of GABA on ischemic AKI. Therefore, we demonstrated the novel finding that the preventive effect of GABA on ischemic AKI through the suppression of enhanced renal sympathetic nerve activity induced by renal ischemia is presumably mediated via GABA, receptor stimulation in the central nervous system rather than peripheral GABA(B) receptor.
C1 [Kobuchi, Shuhei] Hyogo Univ Hlth Sci, Dept Pharm, Sch Pharm, Chuo Ku, Kobe, Hyogo 6508530, Japan.
   [Kobuchi, Shuhei; Tanaka, Ryosuke; Shintani, Takuya; Suzuki, Rie; Ohkita, Mamoru; Matsumura, Yasuo] Osaka Univ Pharmaceut Sci, Lab Pathol & Mol Pharmacol, Osaka 580, Japan.
   [Tsutsui, Hidenobu] Osaka Ohtani Univ, Fac Pharm, Lab Clin Pharmacol, Osaka, Japan.
RP Kobuchi, S (reprint author), Hyogo Univ Hlth Sci, Dept Pharm, Sch Pharm, Chuo Ku, 1-3-6 Minatojima, Kobe, Hyogo 6508530, Japan.
EM kobuchi-s@huhs.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology
FX This study was supported in part by a "High Technology Research Center"
   Project Mr Private Universities matching fund subsidy from the Ministry
   of Education, Culture, Sports, Science and Technology [2002-2006 and
   2007 2009].
CR Al-Awadi M, 2006, LIFE SCI, V79, P847, DOI 10.1016/j.lfs.2006.02.039
   AVANZINO GL, 1994, AM J PHYSIOL, V266, pH1722
   BOWERY NG, 1981, EUR J PHARMACOL, V71, P53, DOI 10.1016/0014-2999(81)90386-1
   Caramelo C, 1996, CIRC RES, V79, P1031, DOI 10.1161/01.RES.79.5.1031
   Coote JH, 2005, EXP PHYSIOL, V90, P169, DOI 10.1113/expphysiol.2004.029041
   Durgam VR, 1999, HYPERTENSION, V33, P530, DOI 10.1161/01.HYP.33.1.530
   Edelstein CL, 1997, KIDNEY INT, V51, P1341, DOI 10.1038/ki.1997.183
   Fujii T, 2003, EUR J PHARMACOL, V481, P241, DOI 10.1016/j.ejphar.2003.09.036
   Fujimura S, 1999, BRIT J PHARMACOL, V127, P109, DOI 10.1038/sj.bjp.0702524
   Gladkevich A, 2006, AUTON NEUROSCI-BASIC, V124, P1, DOI 10.1016/j.autneu.2005.11.002
   Hayakawa K, 2002, EUR J PHARMACOL, V438, P107, DOI 10.1016/S0014-2999(02)01294-3
   KERR DIB, 1995, PHARMACOL THERAPEUT, V67, P187, DOI 10.1016/0163-7258(95)00016-A
   Kim HY, 2004, FOOD CHEM TOXICOL, V42, P2009, DOI 10.1016/j.fct.2004.06.021
   Kimura M, 2002, JPN J PHARMACOL, V89, P388, DOI 10.1254/jjp.89.388
   Kobuchi S, 2009, EUR J PHARMACOL, V623, P113, DOI 10.1016/j.ejphar.2009.09.023
   Kurata H, 2006, J PHARMACOL EXP THER, V319, P640, DOI 10.1124/jpet.106.1102122
   Lattanzio MR, 2009, J AM OSTEOPATH ASSOC, V109, P13
   Li DP, 2007, J PHARMACOL EXP THER, V320, P615, DOI 10.1124/jpet.106.109538
   Lieberthal W, 1996, AM J PHYSIOL-RENAL, V271, pF477
   Lien YHH, 2003, LIFE SCI, V74, P543, DOI 10.1016/j.lfs.2003.08.001
   MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569
   PALACIOS JM, 1981, BRAIN RES, V222, P285, DOI 10.1016/0006-8993(81)91034-9
   PAXIONS G, 1998, RAT BRAIN STEREOTAXI
   Shokoji T, 2003, HYPERTENSION, V41, P266, DOI 10.1161/01.HYP.0000049621.85474.CF
   Sugiura T, 2008, J CARDIOVASC PHARM, V51, P223, DOI 10.1097/FJC.0b013e318161d758
   Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207
   Tjen-A-Looi SC, 2009, J APPL PHYSIOL, V106, P1793, DOI 10.1152/japplphysiol.00142.2009
NR 27
TC 13
Z9 15
U1 2
U2 11
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0022-3565
EI 1521-0103
J9 J PHARMACOL EXP THER
JI J. Pharmacol. Exp. Ther.
PD SEP
PY 2011
VL 338
IS 3
BP 767
EP 774
DI 10.1124/jpet.111.180174
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 810FK
UT WOS:000294110800005
PM 21632868
OA Bronze
DA 2018-12-27
ER

PT J
AU Cai, CZ
   Rodepeter, FR
   Rossmann, A
   Teymoortash, A
   Lee, JS
   Quint, K
   Di Fazio, P
   Ocker, M
   Werner, JA
   Mandic, R
AF Cai, Chengzhong
   Rodepeter, Fiona R.
   Rossmann, Annette
   Teymoortash, Afshin
   Lee, Jin-Seok
   Quint, Karl
   Di Fazio, Pietro
   Ocker, Matthias
   Werner, Jochen A.
   Mandic, Robert
TI RETRACTED: Nef from SIVmac239 decreases proliferation and migration of
   adenoid-cystic carcinoma cells and inhibits angiogenesis (Retracted
   article. See vol. 48, pg. 95, 2012)
SO ORAL ONCOLOGY
LA English
DT Article; Retracted Publication
DE ACC; CXCR4; Head and neck cancer; Nef; SDF-1 alpha; SIVmac239
ID CHEMOKINE RECEPTOR CXCR4; HUMAN-IMMUNODEFICIENCY-VIRUS; LYMPH-NODE
   METASTASIS; TUMOR-CELLS; T-CELLS; EXPRESSION; CANCER; PROTEIN; BREAST;
   HEAD
AB The HIV/SIV accessory protein Nef is known to down-modulate cell surface receptors that are required for virus entry such as CD4, CCR5 and CXCR4 to block lethal viral superinfection of the infected cell. The chemokine receptor CXCR4 also plays an important role in promoting cell proliferation, metastasis and tumor angiogenesis. Therefore it was of interest to evaluate if Nef can down-regulate CXCR4 in tumor cells since this could affect these critical prognostic parameters. The CXCR4-expressing cell line ACC3 that was derived from a salivary gland adenoid cystic carcinoma (ACC) of the head and neck was transfected with Nef from SIVmac239 and cell surface expression of the receptor was monitored by FACS analysis. Real time proliferation of cells was measured with the xCELLigence system (Roche, Mannheim, Germany). Cell migration was detected by an in vitro scratch assay. Similarly, COS-7 cells were co-transfected with CXCR4 and Nef and were treated as described for ACC3. In vitro tube formation was deployed to assess the effect of Nef on angiogenesis. siRNA was used for CXCR4 knockdown. Cell surface down-modulation of endogenous CXCR4 could be observed in ACC3 cells after Nef-transfection as well as in COS-7 cells after co-transfection of CXCR4 and Nef. Proliferation as well as migration of Nef-transfected ACC3 tumor cells appeared significantly reduced. In vitro tube formation was significantly lowered after Nef-transfection or CXCR4 knockdown with siRNA. SIV-Nef could serve as an interesting tool to study the biologic behavior of CXCR4-expressing tumors such as ACC. Deploying SIV-Nef thereby could help in the discovery of new therapeutic approaches for the treatment of ACC and other CXCR4-expressing tumors. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Cai, Chengzhong; Rodepeter, Fiona R.; Rossmann, Annette; Teymoortash, Afshin; Lee, Jin-Seok; Werner, Jochen A.; Mandic, Robert] Univ Hosp Giessen & Marburg, Dept Otorhinolaryngol Head & Neck Surg, D-35033 Marburg, Germany.
   [Quint, Karl; Di Fazio, Pietro; Ocker, Matthias] Univ Marburg, Inst Surg Res, D-35033 Marburg, Germany.
RP Mandic, R (reprint author), Univ Hosp Giessen & Marburg, Dept Otorhinolaryngol Head & Neck Surg, Campus Marburg,Baldingerstr, D-35033 Marburg, Germany.
EM mandic@med.uni-marburg.de
OI Di Fazio, Pietro/0000-0003-0091-8498; Ocker,
   Matthias/0000-0001-8263-6288
FU Alfred und Ursula Kulemann Stiftung (Philipps University Marburg,
   Germany)
FX We thank Ms. Roswitha Peldszus and Ms. Maria Sadowski (Dept. of
   Otorhinolaryngology, UKGM GmbH) and Mr. Thorsten Volkmann (Dept. of
   Hematology, Oncology and Immunology, UKGM GmbH) for their excellent
   technical assistance. This study was partly funded by the Alfred und
   Ursula Kulemann Stiftung (Philipps University Marburg, Germany).
CR Bachelder RE, 2002, CANCER RES, V62, P7203
   Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388
   Barbieri F, 2008, CLIN CANCER RES, V14, P5022, DOI 10.1158/1078-0432.CCR-07-4717
   BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X
   Bradley Patrick J, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P127, DOI 10.1097/00020840-200404000-00013
   Chaudhry A, 2009, J IMMUNOL, V183, P2415, DOI 10.4049/jimmunol.0804014
   CHENG J, 1995, VIRCHOWS ARCH, V426, P577
   Choe EY, 2002, J BIOL CHEM, V277, P46079, DOI 10.1074/jbc.M204698200
   Chummun S, 2001, BRIT J PLAST SURG, V54, P476, DOI 10.1054/bjps.2001.3636
   Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929
   Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300
   Doranz BJ, 2001, AIDS RES HUM RETROV, V17, P475, DOI 10.1089/08892220151126508
   GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0
   Gassmann P, 2009, NEOPLASIA, V11, P651, DOI 10.1593/neo.09272
   GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8
   Harrington Willie, 2009, Mol Cell Pharmacol, V1, P85
   Hrecka K, 2005, J VIROL, V79, P10650, DOI 10.1128/JVI.79.16.10650-10659.2005
   Huang MB, 2004, J VIROL, V78, P11084, DOI 10.1128/JVI.78.20.11084-11096.2004
   Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006
   Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
   Liotta LA, 2001, NATURE, V410, P24, DOI 10.1038/35065180
   Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448
   Mandic R, 2005, CLIN CANCER RES, V11, P6845, DOI 10.1158/1078-4032.CCR-05-0378
   Mandic R, 2001, MOL BIOL CELL, V12, P463, DOI 10.1091/mbc.12.2.463
   Meier R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001016
   Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058
   Muller A, 2006, INT J CANCER, V118, P2147, DOI 10.1002/ijc.21514
   Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016
   Murakami T, 2002, CANCER RES, V62, P7328
   Na IK, 2008, HUM PATHOL, V39, P1751, DOI 10.1016/j.humpath.2008.04.017
   Ndolo T, 2002, J VIROL, V76, P3587, DOI 10.1128/JVI.76.8.3587-3595.2002
   Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201
   Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007
   Pore N, 2006, CANCER BIOL THER, V5, P1563, DOI 10.4161/cbt.5.11.3485
   Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357
   Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338
   Scimone ML, 2004, J EXP MED, V199, P1113, DOI 10.1084/jem.20031645
   Stove V, 2005, J VIROL, V79, P11422, DOI 10.1128/JVI.79.17.11422-11433.2005
   Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498
   Sung B, 2008, CANCER RES, V68, P8938, DOI 10.1158/0008-5472.CAN-08-2155
   Teymoortash A, 2006, J CANCER RES CLIN, V132, P51, DOI 10.1007/s00432-005-0040-1
   Venzke S, 2006, J VIROL, V80, P11141, DOI 10.1128/JVI.01556-06
   Yasuoka H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-340
   Yoshitake N, 2008, BRIT J CANCER, V98, P1682, DOI 10.1038/sj.bjc.6604363
   Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004
NR 45
TC 5
Z9 5
U1 2
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1368-8375
EI 1879-0593
J9 ORAL ONCOL
JI Oral Oncol.
PD SEP
PY 2011
VL 47
IS 9
BP 847
EP 854
DI 10.1016/j.oraloncology.2011.06.502
PG 8
WC Oncology; Dentistry, Oral Surgery & Medicine
SC Oncology; Dentistry, Oral Surgery & Medicine
GA 812NG
UT WOS:000294299600012
PM 21763177
DA 2018-12-27
ER

PT J
AU Go, JW
   Kim, SH
   Yi, SY
   Cho, HK
AF Go, Jae Wan
   Kim, Shin Han
   Yi, Sang Yeop
   Cho, Han Kyoung
TI RETRACTED: Basal Cell Nevus Syndrome Showing Several Histologic Types of
   Basal Cell Carcinoma (Retracted article. See vol. 24, pg. 242, 2012)
SO ANNALS OF DERMATOLOGY
LA English
DT Article; Retracted Publication
DE Carcinoma, basal cell; Basal cell nevus syndrome; Neoplasms by
   histologic type
ID GORLIN SYNDROME
AB Basal cell nevus syndrome (BCNS), or Gorlin Syndrome, is an autosomal dominant disorder, characterized by multiple developmental abnormalities and associated with germline mutations in the PTCH gene. Patients show multiple and early onset basal cell carcinomas (BCCs) in skin, odontogenic cysts in the jaw, pits on palms and soles, medulloblastoma, hypertelorism, and calcification of the falx cerebri. Clinical features of BCCs in these patients are indistinguishable from ordinary BCCs. However, some patients show variable histologic findings in subtypes of BCCs, and only one case associated with several histologic types of BCCs in the syndrome has been reported in Korea. We present a case of BCNS characterized by multiple BCCs, odontogenic keratocysts, multiple palmar pits, and calcified falx cerebri. Histopathologic findings of BCCs showed several patterns, which were nodular, superficial, and pigmented types. (Ann Dermatol 23(S1) S36 similar to S40, 2011)
C1 [Go, Jae Wan; Kim, Shin Han; Cho, Han Kyoung] Kwandong Univ, Coll Med, Dept Dermatol, Myongji Hosp, Goyang 412270, South Korea.
   [Yi, Sang Yeop] Kwandong Univ, Coll Med, Dept Pathol, Myongji Hosp, Goyang 412270, South Korea.
RP Cho, HK (reprint author), Kwandong Univ, Coll Med, Dept Dermatol, Myongji Hosp, 697-24 Hwajeong Dong, Goyang 412270, South Korea.
EM dermy@kd.ac.kr
CR EVANS DGR, 1993, J MED GENET, V30, P460, DOI 10.1136/jmg.30.6.460
   GOLDSTEIN AM, 1994, AM J HUM GENET, V54, P765
   Gorlin RJ, 2004, GENET MED, V6, P530, DOI 10.1097/01.GIM.0000144188.15902.C4
   GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803
   GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002
   HAUCK RM, 1994, ANN PLAS SURG, V33, P102, DOI 10.1097/00000637-199407000-00022
   HOWELL JB, 1982, ARCH DERMATOL, V118, P824, DOI 10.1001/archderm.1982.01650220128018
   JOH G, 1992, KOREAN J DERMATOL, V30, P951
   KIM HM, 2007, KOREAN J PEDIAT, V50, P789
   Lo Muzio L, 1999, J AM DENT ASSOC, V130, P669
   Lo Muzio L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-32
   PARK JW, 2000, KOREAN J DERMATOL, V38, P1218
   ROH BH, 2006, KOREAN J DERMATOL, V44, P1030
   Ryu DJ, 2008, ANN DERMATOL, V20, P221, DOI 10.5021/ad.2008.20.4.221
   SHANLEY S, 1994, AM J MED GENET, V50, P282, DOI 10.1002/ajmg.1320500312
   TAK WJ, 2002, KOREAN J DERMATOL, V40, P682
   WHITE JC, 1894, J CUTAN GENITOURIN D, V12, P477
   YORDANOVA I, 2007, J IMAB ANN P SCI PAP, V1, P59
   ZACKHEIM HS, 1966, ARCH DERMATOL, V93, P317, DOI 10.1001/archderm.93.3.317
NR 19
TC 6
Z9 6
U1 3
U2 12
PU KOREAN DERMATOLOGICAL ASSOC
PI SEOUL
PA 305 SEOCHO NASAN, SUITE OFFICE 1330-16, SEOCHO-2-DONG, SEOCHO-GU, SEOUL,
   137-858, SOUTH KOREA
SN 1013-9087
J9 ANN DERMATOL
JI Ann. Dermatol.
PD SEP
PY 2011
VL 23
SU 1
BP S36
EP S40
DI 10.5021/ad.2011.23.S1.S36
PG 5
WC Dermatology
SC Dermatology
GA 829SC
UT WOS:000295603600010
PM 22028568
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Shirai, J
   Nakamura, M
   Tarui, N
   Hashimoto, T
   Ikeura, Y
AF Shirai, Junya
   Nakamura, Minoru
   Tarui, Naoki
   Hashimoto, Tadatoshi
   Ikeura, Yoshinori
TI RETRACTED: 3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor
   antagonists and their efficient synthesis (Retracted article. See vol.
   23, pg. 272, 2015)
SO BIOORGANIC & MEDICINAL CHEMISTRY
LA English
DT Article; Retracted Publication
DE Tachykinin; NK1 receptor; 3-Benzhydryl-4-piperidone; G-Protein coupled
   receptor (GPCR); 1,1-Diphenylmethane moiety
ID SUBSTANCE-P; POTENT
AB A series of novel 3-benzhydryl-4-piperidone derivatives were identified as potent tachykinin neurokinin-1 (NK1) receptor antagonists. An efficient and versatile synthesis of this series was achieved with a coupling reaction of 1-benzylpiperidones with benzhydryl bromides or benzhydrols in the presence of trifluoromethanesulfonate and a condensation reaction of piperidones with benzyl alcohols using ethyl o-phenylenephosphate. The 3-benzhydryl-4-piperidone skeleton, which has a 1,1-diphenylmethane moiety that is a known privileged substructure targeting G-protein coupled receptors, can be used for chemical library synthesis because of chemical accessibility and diversity. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Shirai, Junya; Nakamura, Minoru; Tarui, Naoki; Hashimoto, Tadatoshi; Ikeura, Yoshinori] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Yodogawa Ku, Osaka 5328686, Japan.
RP Shirai, J (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Yodogawa Ku, 2-17-85 Jusohonmachi, Osaka 5328686, Japan.
EM Shirai_Junya@takeda.co.jp
CR CASCIERI MA, 1992, MOL PHARMACOL, V42, P458
   CHANG MM, 1971, NATURE-NEW BIOL, V232, P86
   *CHEM COMP GROUP, 2009, MOL OP ENV VERS 2009
   EGLEZOS A, 1991, EUR J PHARMACOL, V209, P277, DOI 10.1016/0014-2999(91)90183-Q
   Elliott J, 1997, EXPERT OPIN THER PAT, V7, P43, DOI 10.1517/13543776.7.1.43
   EVANS BE, 1988, J MED CHEM, V31, P2235, DOI 10.1021/jm00120a002
   Hokfelt T, 2001, J INTERN MED, V249, P27, DOI 10.1046/j.0954-6820.2000.00773.x
   IKEURA Y, Patent No. 1553084
   Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5
   Lowe JA, 1996, MED RES REV, V16, P527, DOI 10.1002/(SICI)1098-1128(199611)16:6<527::AID-MED2>3.3.CO;2-0
   MAGGI CA, 1993, J AUTON PHARMACOL, V13, P23, DOI 10.1111/j.1474-8673.1993.tb00396.x
   McLean S, 1996, MED RES REV, V16, P297, DOI 10.1002/(SICI)1098-1128(199607)16:4<297::AID-MED1>3.0.CO;2-S
   Natsugari H, 1999, J MED CHEM, V42, P3982, DOI 10.1021/jm990220r
   OTSUKA M, 1993, PHYSIOL REV, V73, P229
   REGOLI D, 1994, PHARMACOL REV, V46, P551
   YAMAOKA M, Patent No. 1460062
   YOSHIMURA Y, 1992, J ANTIBIOT, V45, P721, DOI 10.7164/antibiotics.45.721
NR 17
TC 4
Z9 4
U1 2
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-0896
EI 1464-3391
J9 BIOORGAN MED CHEM
JI Bioorg. Med. Chem.
PD SEP 1
PY 2011
VL 19
IS 17
BP 5175
EP 5182
DI 10.1016/j.bmc.2011.07.014
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry
GA 808TT
UT WOS:000294002400010
PM 21807525
DA 2018-12-27
ER

PT J
AU Plotnikov, A
   Chuderland, D
   Karamansha, Y
   Livnah, O
   Seger, R
AF Plotnikov, Alexander
   Chuderland, Dana
   Karamansha, Yael
   Livnah, Oded
   Seger, Rony
TI RETRACTED: Nuclear Extracellular Signal-Regulated Kinase 1 and 2
   Translocation Is Mediated by Casein Kinase 2 and Accelerated by
   Autophosphorylation (Retracted article. See vol. 38, 2018)
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article; Retracted Publication
ID ACTIVATED PROTEIN-KINASE; NUCLEOCYTOPLASMIC TRANSPORT; CANCER-CELLS; MAP
   KINASE; CK2; ERK; CASCADE; IMPORT; GENE; PHOSPHORYLATION
AB The extracellular signal-regulated kinases (ERK) 1 and 2 (ERK1/2) are members of the mitogen-activated protein kinase [MAPK] family. Upon stimulation, these kinases translocate from the cytoplasm to the nucleus, where they induce physiological processes such as proliferation and differentiation. The mechanism of translocation of this kinase involves phosphorylation of two Ser residues within a nuclear translocation signal (NTS), which allows binding to importin7 and a subsequent penetration via nuclear pores. Here we show that the phosphorylation of both Ser residues is mediated mainly by casein kinase 2 (CK2) and that active ERK may assist in the phosphorylation of the N-terminal Ser. We also demonstrate that the phosphorylation is dependent on the release of ERK from cytoplasmic anchoring proteins. Crystal structure of the phosphomimetic ERK revealed that the NTS phosphorylation creates an acidic patch in ERK. Our model is that in resting cells ERK is bound to cytoplasmic anchors, which prevent its NTS phosphorylation. Upon stimulation, phosphorylation of the ERK TEY domain releases ERK and allows phosphorylation of its NTS by CK2 and active ERK to generate a negatively charged patch in ERK, binding to importin 7 and nuclear translocation. These results provide an important role of CK2 in regulating nuclear ERK activities.
C1 [Plotnikov, Alexander; Chuderland, Dana; Seger, Rony] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.
   [Karamansha, Yael; Livnah, Oded] Hebrew Univ Jerusalem, Dept Biol Chem, IL-91904 Jerusalem, Israel.
   [Karamansha, Yael; Livnah, Oded] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, IL-91904 Jerusalem, Israel.
RP Seger, R (reprint author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.
EM rony.seger@weizmann.ac.il
FU ISF research center of excellence [180/09]
FX This work was supported by the ISF research center of excellence number
   180/09 awarded to R.S. and O.L. R.S. is an Incumbent of the Yale S.
   Lewine and Ella Miller Lewine Professorial Chair for Cancer Research.
CR Bodart JFL, 2010, J CELL BIOCHEM, V109, P850, DOI 10.1002/jcb.22477
   Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664
   Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06
   Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155
   Casar B, 2008, MOL CELL, V31, P708, DOI 10.1016/j.molcel.2008.07.024
   Chuderland D, 2005, MOL BIOTECHNOL, V29, P57, DOI 10.1385/MB:29:1:57
   Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007
   Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1
   Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901
   Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541
   Gorlich D, 1997, CURR OPIN CELL BIOL, V9, P412, DOI 10.1016/S0955-0674(97)80015-4
   Hessenauer A, 2011, CELL SIGNAL, V23, P145, DOI 10.1016/j.cellsig.2010.08.014
   Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009
   Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743
   Kolch W, 2010, NAT REV CANCER, V10, P618, DOI 10.1038/nrc2900
   KUENZEL EA, 1987, J BIOL CHEM, V262, P9136
   LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886
   Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469
   Lorenzen JA, 2001, DEVELOPMENT, V128, P1403
   Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Niefind K, 2007, J MOL BIOL, V370, P427, DOI 10.1016/j.jmb.2007.04.068
   Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0
   Orlandini M, 1998, J BIOL CHEM, V273, P21291, DOI 10.1074/jbc.273.33.21291
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9
   PLOTNIKOV A, BIOCH BIOPH IN PRESS
   Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126
   Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392
   Reszka AA, 1997, MOL BIOL CELL, V8, P1219
   Romieu-Mourez R, 2002, CANCER RES, V62, P6770
   Rubinfeld H, 1999, J BIOL CHEM, V274, P30349, DOI 10.1074/jbc.274.43.30349
   Ruzzene M, 2010, BBA-PROTEINS PROTEOM, V1804, P499, DOI 10.1016/j.bbapap.2009.07.018
   Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146
   Shaul YD, 2006, J CELL BIOL, V172, P885, DOI 10.1083/jcb.200509063
   Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005
   Shaul YD, 2009, GENE DEV, V23, P1779, DOI 10.1101/gad.523909
   Smith ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009295
   St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2
   STURA EA, 1991, J CRYST GROWTH, V110, P270, DOI 10.1016/0022-0248(91)90896-D
   Tang XL, 2010, NUCLEIC ACIDS RES, V38, P6610, DOI 10.1093/nar/gkq547
   Tresini M, 2007, J BIOL CHEM, V282, P4136, DOI 10.1074/jbc.M604955200
   Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409
   Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200
   Wolf I, 2001, J BIOL CHEM, V276, P24490, DOI 10.1074/jbc.M103352200
   Xu X, 1999, MOL CELL BIOCHEM, V191, P65, DOI 10.1023/A:1006866412652
   Yao XH, 2008, J BIOL CHEM, V283, P22867, DOI 10.1074/jbc.M801320200
   Yao Z, 2009, BIOFACTORS, V35, P407, DOI 10.1002/biof.52
   Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200
   Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218
   Zehorai E, 2010, MOL CELL ENDOCRINOL, V314, P213, DOI 10.1016/j.mce.2009.04.008
NR 53
TC 56
Z9 56
U1 1
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD SEP
PY 2011
VL 31
IS 17
BP 3515
EP 3530
DI 10.1128/MCB.05424-11
PG 16
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 805NY
UT WOS:000293736600002
PM 21730285
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Mehrotra, M
   Sanyal, I
   Amla, DV
AF Mehrotra, Meenakshi
   Sanyal, Indraneel
   Amla, D. V.
TI RETRACTED: High-efficiency Agrobacterium-mediated transformation of
   chickpea (Cicer arietinum L.) and regeneration of insect-resistant
   transgenic plants (Retracted article. See vol. 32, pg. 1489, 2013)
SO PLANT CELL REPORTS
LA English
DT Article; Retracted Publication
DE Chickpea; Somatic embryogenesis; Mature embryonic axes;
   Agrobacterium-mediated transformation; Bacillus thuringiensis;
   Insect-resistant transgenic plants
ID SOMATIC EMBRYOGENESIS; GENETIC-TRANSFORMATION; BACILLUS-THURINGIENSIS;
   HELICOVERPA-ARMIGERA; TOMATO PLANTS; EMBRYO AXES; EXPRESSION; CULTURE;
   PROTEIN; COTTON
AB To develop an efficient genetic transformation system of chickpea (Cicer arietinum L.), callus derived from mature embryonic axes of variety P-362 was transformed with Agrobacterium tumefaciens strain LBA4404 harboring p35SGUS-INT plasmid containing the uidA gene encoding beta-glucuronidase (GUS) and the nptII gene for kanamycin selection. Various factors affecting transformation efficiency were optimized; as Agrobacterium suspension at OD600 0.3 with 48 h of co-cultivation period at 20A degrees C was found optimal for transforming 10-day-old MEA-derived callus. Inclusion of 200 mu M acetosyringone, sonication for 4 s with vacuum infiltration for 6 min improved the number of GUS foci per responding explant from 1.0 to 38.6, as determined by histochemical GUS assay. For introducing the insect-resistant trait into chickpea, binary vector pRD400-cry1Ac was also transformed under optimized conditions and 18 T-0 transgenic plants were generated, representing 3.6% transformation frequency. T-0 transgenic plants reflected Mendelian inheritance pattern of transgene segregation in T-1 progeny. PCR, RT-PCR, and Southern hybridization analysis of T-0 and T-1 transgenic plants confirmed stable integration of transgenes into the chickpea genome. The expression level of Bt-Cry protein in T-0 and T-1 transgenic chickpea plants was achieved maximum up to 116 ng mg(-1) of soluble protein, which efficiently causes 100% mortality to second instar larvae of Helicoverpa armigera as analyzed by an insect mortality bioassay. Our results demonstrate an efficient and rapid transformation system of chickpea for producing non-chimeric transgenic plants with high frequency. These findings will certainly accelerate the development of chickpea plants with novel traits.
C1 [Mehrotra, Meenakshi; Sanyal, Indraneel; Amla, D. V.] Natl Bot Res Inst, Plant Transgen Lab, Lucknow 226001, Uttar Pradesh, India.
RP Mehrotra, M (reprint author), Natl Bot Res Inst, Plant Transgen Lab, Rana Pratap Marg, Lucknow 226001, Uttar Pradesh, India.
EM mehrotrameenakshi@gmail.com
FU Council of Scientific and Industrial Research, New Delhi; CSIR Network
   [NWP0003, OLP0031]
FX We are thankful to Council of Scientific and Industrial Research, New
   Delhi for providing funds and research fellowships. We thankfully
   acknowledge Prof. I. Altosaar, Department of Biochemistry, University of
   Ottawa, Ottawa, Canada for providing synthetic modified Bt-cry1Ac gene.
   This work was carried out under the CSIR Network Project NWP0003 and
   OLP0031.
CR Agarwal S, 2008, TRANSGENIC RES, V17, P881, DOI 10.1007/s11248-008-9173-8
   Ahmed K, 1998, PAKISTAN J BIOL SCI, V1, P183
   Anwar F, 2010, AFR J BIOTECHNOL, V9, P782
   Araujo SD, 2004, PLANT CELL TISS ORG, V78, P123, DOI 10.1023/B:TICU.0000022540.98231.f8
   BABAOGLU M, 2000, AGBIOTECHNET, V2, P1
   BAKHSH A, 2009, AM EUR J AGR ENV SCI, V6, P1
   BARNA KS, 1993, PLANT CELL REP, V12, P521, DOI 10.1007/BF00236100
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Coram TE, 2007, FUNCT PLANT BIOL, V34, P861, DOI 10.1071/FP07169
   Dang W, 2007, PLANT SCI, V173, P381, DOI 10.1016/j.plantsci.2007.06.010
   Datta K, 1998, THEOR APPL GENET, V97, P20, DOI 10.1007/s001220050862
   Droste A, 2000, PLANT MOL BIOL REP, V18, P51, DOI 10.1007/BF02825294
   FONTANA GS, 1993, PLANT CELL REP, V12, P194, DOI 10.1007/BF00237052
   GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5
   Glaser JA, 2003, BIOTECHNOL ADV, V22, P45, DOI 10.1016/j.biotechadv.2003.08.016
   HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x
   Indurker S, 2007, PLANT CELL REP, V26, P755, DOI 10.1007/s00299-006-0283-6
   Jayanand B, 2003, IN VITRO CELL DEV-PL, V39, P171, DOI 10.1079/IVP2002387
   JEFFERSON RA, 1987, EMBO J, V6, P3901
   Kar S, 1996, PLANT CELL REP, V16, P32, DOI 10.1007/BF01275444
   Kar S, 1997, TRANSGENIC RES, V6, P177, DOI 10.1023/A:1018433922766
   Krishnamurthy KV, 2000, PLANT CELL REP, V19, P235, DOI 10.1007/s002990050005
   KUMAR VD, 1994, PLANT CELL REP, V13, P468, DOI 10.1007/BF00231969
   Leelavathi S, 2004, PLANT CELL REP, V22, P465, DOI 10.1007/s00299-003-0710-x
   Mandaokar AD, 2000, CROP PROT, V19, P307, DOI 10.1016/S0261-2194(00)00022-3
   MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x
   Nhut DT, 2006, SCI HORTIC-AMSTERDAM, V110, P93, DOI 10.1016/j.scienta.2006.05.015
   Pandey V, 2010, PLANT CELL REP, V29, P133, DOI 10.1007/s00299-009-0805-0
   Pathak MR, 2008, PLANT CELL TISS ORG, V93, P65, DOI 10.1007/s11240-008-9344-6
   Polowick PL, 2004, PLANT CELL REP, V23, P485, DOI 10.1007/s00299-004-0857-0
   Ramesh S, 2004, J BIOTECHNOL, V111, P131, DOI 10.1016/j.jbiotec.2004.04.004
   SAGARE AP, 1993, PLANT CELL REP, V12, P652, DOI 10.1007/BF00232818
   Sambrook J, 2001, MOL CLONING LAB MANU
   Sanyal I, 2005, PLANT SCI, V168, P1135, DOI 10.1016/j.plantsci.2004.12.015
   Sardana R, 1996, PLANT CELL REP, V15, P677, DOI 10.1007/BF00231923
   Sarmah BK, 2004, MOL BREEDING, V14, P73, DOI 10.1023/B:MOLB.0000037996.01494.12
   Senthil G, 2004, PLANT CELL REP, V23, P297, DOI 10.1007/s00299-004-0854-3
   SHARMA KK, 2005, IN VITRO CELL DEV, V4, P102
   Singh PK, 2004, TRANSGENIC RES, V13, P397, DOI 10.1007/s11248-004-4908-7
   Somers DA, 2003, PLANT PHYSIOL, V131, P892, DOI 10.1104/pp.102.017681
   Stewart CN, 1996, PLANT PHYSIOL, V112, P121, DOI 10.1104/pp.112.1.121
   SUHASINI K, 1994, PLANT SCI, V102, P189, DOI 10.1016/0168-9452(94)90037-X
   Suzuki S, 2001, PLANT SCI, V161, P89, DOI 10.1016/S0168-9452(01)00393-4
   Tewari-Singh N, 2004, PLANT CELL REP, V22, P576, DOI 10.1007/s00299-003-0730-6
   Trick HN, 1998, PLANT CELL REP, V17, P482, DOI 10.1007/s002990050429
   Wiebke Beatriz, 2006, Bragantia, V65, P543, DOI 10.1590/S0006-87052006000400002
   Wu SJ, 2008, PLANT MOL BIOL REP, V26, P174, DOI 10.1007/s11105-008-0032-9
   Yu TA, 2001, BOT BULL ACAD SINICA, V42, P281
NR 48
TC 17
Z9 17
U1 4
U2 32
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0721-7714
EI 1432-203X
J9 PLANT CELL REP
JI Plant Cell Reports
PD SEP
PY 2011
VL 30
IS 9
BP 1603
EP 1616
DI 10.1007/s00299-011-1071-5
PG 14
WC Plant Sciences
SC Plant Sciences
GA 806GO
UT WOS:000293794500003
PM 21516347
DA 2018-12-27
ER

PT J
AU Ernst, H
   Lichtenthaler, U
   Vogt, C
AF Ernst, Holger
   Lichtenthaler, Ulrich
   Vogt, Carsten
TI RETRACTED: The Impact of Accumulating and Reactivating Technological
   Experience on R & D Alliance Performance (Retracted article. See vol.
   49, pg. 1350, 2012)
SO JOURNAL OF MANAGEMENT STUDIES
LA English
DT Article; Retracted Publication
ID ABSORPTIVE-CAPACITY; STRATEGIC ALLIANCES; ORGANIZATIONAL INNOVATION;
   COMPETITIVE ADVANTAGE; DYNAMIC CAPABILITIES; PRODUCT DEVELOPMENT; PATH
   DEPENDENCE; FIRM-LEVEL; KNOWLEDGE; BIOTECHNOLOGY
AB Drawing on organizational learning theory, we distinguish the entrepreneurial processes of experience accumulation (i.e. gaining technological experience), and experience reactivation (i.e. leveraging the accumulated experience), as two essential stages of knowledge retention. While controlling for alliance experience, we further use new data of 196 biopharmaceutical R&D alliances to examine the effects of the technology recipient's accumulation and reactivation of technological experience on R&D alliance success. The patent-based experience measures at the level of specific technology fields provide strong support for distinguishing experience accumulation and reactivation, which positively interact in interorganizational learning. Experience reactivation strengthens the positive effects of experience accumulation on alliance performance, and it contributes to avoiding organizational inertia in intertemporal knowledge transfer. In particular, our newly developed technology-specific measures help to explain inconsistent findings of earlier studies, which often relied on firm-level R&D expenditures to capture the level of prior technological knowledge and absorptive capacity.
C1 [Ernst, Holger; Lichtenthaler, Ulrich; Vogt, Carsten] WHU Otto Beisheim Sch Management Technol & Innova, Vallendar, Germany.
RP Lichtenthaler, U (reprint author), WHU, Otto Beisheim Sch Management Innovat & Org, Burgpl 2, D-56179 Vallendar, Germany.
EM lichtenthaler@whu.edu
CR Argote L., 1999, ORG LEARNING CREATIN
   Baum JAC, 1998, MANAGE SCI, V44, P996, DOI 10.1287/mnsc.44.7.996
   Bayus BL, 2007, MANAGE SCI, V53, P1887, DOI 10.1287/mnsc.1070.0737
   Clarke J, 2011, J MANAGE STUD, V48, P1365, DOI 10.1111/j.1467-6486.2010.01002.x
   Clarysse B, 2011, J MANAGE STUD, V48, P1420, DOI [10.1111/j.1467-6486.2010.00991.x, 10.1111/J.1467-6486.2010.00991.X]
   COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553
   Colombo MG, 2003, STRATEGIC MANAGE J, V24, P1209, DOI 10.1002/smj.353
   Crossan MM, 2010, J MANAGE STUD, V47, P1154, DOI [10.1111/j.1467-6486.2009.00880.x, 10.1111/J.1467-6486.2009.00880.X]
   Dalziel T, 2011, J MANAGE STUD, V48, P1217, DOI 10.1111/j.1467-6486.2010.01003.x
   Delios A, 2001, ACAD MANAGE J, V44, P1028, DOI 10.2307/3069446
   Dimov D, 2010, J MANAGE STUD, V47, P1123, DOI 10.1111/j.1467-6486.2009.00874.x
   Dyer JH, 1998, ACAD MANAGE REV, V23, P660, DOI 10.2307/259056
   Easterby-Smith M, 2008, J MANAGE STUD, V45, P677, DOI 10.1111/j.1467-6486.2008.00773.x
   Foss NJ, 2010, J MANAGE STUD, V47, P455, DOI 10.1111/j.1467-6486.2009.00870.x
   GARUD R, 1994, STRATEGIC MANAGE J, V15, P365, DOI 10.1002/smj.4250150504
   Garud R, 2010, J MANAGE STUD, V47, P760, DOI 10.1111/j.1467-6486.2009.00914.x
   George BA, 2011, J MANAGE STUD, V48, P1291, DOI 10.1111/j.1467-6486.2010.01004.x
   George G, 2008, J MANAGE STUD, V45, P1448, DOI 10.1111/j.1467-6486.2008.00805.x
   GRILICHES Z, 1990, J ECON LIT, V28, P1661
   Grimpe C, 2010, J MANAGE STUD, V47, P1483, DOI 10.1111/j.1467-6486.2010.00946.x
   Haas MR, 2005, STRATEGIC MANAGE J, V26, P1, DOI 10.1002/smj.429
   Hagedoorn J, 2002, J MANAGE STUD, V39, P167, DOI 10.1111/1467-6486.00287
   Hansen MT, 1999, HARVARD BUS REV, V77, P106
   HITT MA, 1991, ACAD MANAGE J, V34, P693, DOI 10.2307/256412
   Hoang H, 2005, ACAD MANAGE J, V48, P332, DOI 10.5465/AMJ.2005.16928417
   HOSKISSON RE, 1988, STRATEGIC MANAGE J, V9, P605, DOI 10.1002/smj.4250090607
   Hoskisson RE, 2002, ACAD MANAGE J, V45, P697, DOI 10.2307/3069305
   Hoskisson RE, 2011, J MANAGE STUD, V48, P1141, DOI 10.1111/j.1467-6486.2010.00997.x
   Kale P, 2007, STRATEG MANAGE J, V28, P981, DOI 10.1002/smj.616
   Kaplan S, 2005, ORGAN SCI, V16, P509, DOI 10.1287/orsc.1050.0154
   Katila R, 2002, ACAD MANAGE J, V45, P1183, DOI 10.2307/3069433
   KOGUT B, 1992, ORGAN SCI, V3, P383, DOI 10.1287/orsc.3.3.383
   Lane PJ, 2006, ACAD MANAGE REV, V31, P833, DOI 10.5465/AMR.2006.22527456
   Lane PJ, 1998, STRATEGIC MANAGE J, V19, P461, DOI 10.1002/(SICI)1097-0266(199805)19:5<461::AID-SMJ953>3.0.CO;2-L
   Lanjouw JO, 2004, ECON J, V114, P441, DOI 10.1111/j.1468-0297.2004.00216.x
   LEONARDBARTON D, 1992, STRATEGIC MANAGE J, V13, P111, DOI 10.1002/smj.4250131009
   LEVITT B, 1988, ANNU REV SOCIOL, V14, P319, DOI 10.1146/annurev.so.14.080188.001535
   Li D, 2008, ACAD MANAGE J, V51, P315
   Li Y., 2010, J MANAGE STUD, V47, P1458
   Lichtenthaler U, 2010, CALIF MANAGE REV, V53, P154, DOI 10.1525/cmr.2010.53.1.154
   Lichtenthaler U, 2009, J MANAGE STUD, V46, P1315, DOI 10.1111/j.1467-6486.2009.00854.x
   Lichtenthaler U, 2009, ACAD MANAGE J, V52, P822, DOI 10.5465/AMJ.2009.43670902
   Loasby BJ, 2007, J MANAGE STUD, V44, P1078, DOI 10.1111/j.1467-6486.2007.00729.x
   Marsh SJ, 2006, J PROD INNOVAT MANAG, V23, P422, DOI 10.1111/j.1540-5885.2006.00214.x
   MCGEE JE, 1994, J BUS VENTURING, V9, P33, DOI 10.1016/0883-9026(94)90025-6
   Miller KD, 2002, STRATEGIC MANAGE J, V23, P689, DOI 10.1002/smj.245
   Mowery DC, 1998, RES POLICY, V27, P507, DOI 10.1016/S0048-7333(98)00066-3
   Mowery DC, 1996, STRATEGIC MANAGE J, V17, P77, DOI 10.1002/smj.4250171108
   Nerkar A, 2004, STRATEGIC MANAGE J, V25, P779, DOI 10.1002/smj.417
   Nerkar A, 2007, STRATEGIC MANAGE J, V28, P1155, DOI 10.1002/smj.643
   NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14
   Ofek E, 2001, MANAGE SCI, V47, P1441, DOI 10.1287/mnsc.47.11.1441.10249
   Park SH, 2001, ORGAN SCI, V12, P37, DOI 10.1287/orsc.12.1.37.10118
   PERKINS WS, 1990, J MARKETING RES, V27, P1, DOI 10.2307/3172546
   PISANO GP, 1990, ADMIN SCI QUART, V35, P153, DOI 10.2307/2393554
   Pisano GP, 2001, MANAGE SCI, V47, P752, DOI 10.1287/mnsc.47.6.752.9811
   Powell WW, 1996, ADMIN SCI QUART, V41, P116, DOI 10.2307/2393988
   Rasmussen E, 2011, J MANAGE STUD, V48, P1314, DOI 10.1111/J.1467-6486.2010.00995.X
   Roijakkers N, 2006, RES POLICY, V35, P431, DOI 10.1016/j.respol.2006.01.006
   Rothaermel FT, 2007, ORGAN SCI, V18, P898, DOI 10.1287/orsc.1070.0291
   Rothaermel FT, 2006, J BUS VENTURING, V21, P429, DOI 10.1016/j.jbusvent.2005.02.006
   Rothaermel FT, 2004, STRATEGIC MANAGE J, V25, P201, DOI 10.1002/smj.376
   Sampson RC, 2007, ACAD MANAGE J, V50, P364
   Sampson RC, 2005, STRATEGIC MANAGE J, V26, P1009, DOI [10.1002/smj.483, 10.1002/smj.493]
   Shane S, 2000, ORGAN SCI, V11, P448, DOI 10.1287/orsc.11.4.448.14602
   Sorensen JB, 2000, ADMIN SCI QUART, V45, P81, DOI 10.2307/2666980
   Stuart TE, 2000, STRATEGIC MANAGE J, V21, P791, DOI 10.1002/1097-0266(200008)21:8<791::AID-SMJ121>3.0.CO;2-K
   Stuart TE, 2007, RES POLICY, V36, P477, DOI 10.1016/j.respol.2007.02.016
   Sullivan DM, 2011, J MANAGE STUD, V48, P1169, DOI 10.1111/j.1467-6486.2010.00998.x
   Thomke S, 2002, STRATEGIC MANAGE J, V23, P619, DOI 10.1002/smj.242
   Tripsas M, 2000, STRATEGIC MANAGE J, V21, P1147, DOI 10.1002/1097-0266(200010/11)21:10/11<1147::AID-SMJ128>3.3.CO;2-I
   van Wijk R, 2008, J MANAGE STUD, V45, P830, DOI 10.1111/j.1467-6486.2008.00771.x
   Vergne JP, 2010, J MANAGE STUD, V47, P736, DOI 10.1111/j.1467-6486.2009.00913.x
   Volberda HW, 1996, ORGAN SCI, V7, P359, DOI 10.1287/orsc.7.4.359
   WALSH JP, 1991, ACAD MANAGE REV, V16, P57, DOI 10.2307/258607
   Wuyts S, 2004, J MARKETING, V68, P88, DOI 10.1509/jmkg.68.2.88.27787
   Zahra SA, 2002, ACAD MANAGE REV, V27, P185, DOI 10.5465/AMR.2002.6587995
   Zahra SA, 2006, J MANAGE STUD, V43, P917, DOI 10.1111/j.1467-6486.2006.00616.x
   Zollo M, 2002, ORGAN SCI, V13, P701, DOI 10.1287/orsc.13.6.701.503
NR 79
TC 12
Z9 12
U1 4
U2 88
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-2380
EI 1467-6486
J9 J MANAGE STUD
JI J. Manage. Stud.
PD SEP
PY 2011
VL 48
IS 6
SI SI
BP 1194
EP 1216
DI 10.1111/j.1467-6486.2010.00994.x
PG 23
WC Business; Management
SC Business & Economics
GA 796RG
UT WOS:000293068800003
DA 2018-12-27
ER

PT J
AU Hasan, F
   Ansari, MS
   Ahmad, N
AF Hasan, Fazil
   Ansari, M. Shafiq
   Ahmad, Nadeem
TI RETRACTED: Foraging of Host-Habitat and Superparasitism in Cotesia
   glomerata: A Gregarious Parasitoid of Pieris brassicae (Retracted
   article. See vol. 26, pg. 216, 2013)
SO JOURNAL OF INSECT BEHAVIOR
LA English
DT Article; Retracted Publication
DE Cotesia glomerata; host-habitat location; host response; parasitoid
   fitness; Pieris brassicae; superparasitism; host searching; brood size;
   survivorship
ID APANTELES-GLOMERATUS; CLUTCH SIZE; DEVELOPMENTAL STRATEGIES;
   SELF-SUPERPARASITISM; ENDOPARASITOID WASP; FOOD-CONSUMPTION; L
   HYMENOPTERA; EGG LOAD; BRACONIDAE; FITNESS
AB The study investigates differences in the oviposition pattern of a braconid parasitoid, Cotesia glomerata (Linn.) in Pieris brassicae (Linn.) in relation to their use of different cruciferous food plants. The response of P. brassicae to superparasitism and consequences for the parasitoid were examined in order to elucidate the ecological significance of this behaviour. Female parasitoid located various crucifers and searched for host more frequently almost on all the host plants tested i.e. cabbage, cauliflower, Chinese cabbage, broccoli and radish. According to the estimated relative number of female locating hosts, cabbage was the most attractive plant for C. glomerata and total number of eggs laid in host larvae feeding on it was higher than in larvae feeding on other plants. Laboratory experiments demonstrated that superparasitism reduced survivorship of P. brassicae larvae. Superparasitism lengthened parasitoid development and prolonged the feeding period of host larvae. Sex ratio and the body weight of emergent wasps correlated negatively with brood size. Despite a trade-off between maximising brood size and optimising the fitness of individual offspring, two or three ovipositions on P. brassicae larvae resulted in a greater female dry mass than did a single oviposition on the host. Thus, superparasitism might be of adaptive significance under certain circumstances, especially when host density is low and unparasitized hosts are rare in a habitat.
C1 [Hasan, Fazil; Ansari, M. Shafiq; Ahmad, Nadeem] Aligarh Muslim Univ, Fac Agr Sci, Dept Plant Protect, Aligarh 202002, Uttar Pradesh, India.
RP Hasan, F (reprint author), Aligarh Muslim Univ, Fac Agr Sci, Dept Plant Protect, Aligarh 202002, Uttar Pradesh, India.
EM fazilento10@gmail.com
FU UGC, New Delhi, India
FX Financial assistance from UGC, New Delhi, India during this research
   program is gratefully acknowledged. We are thankful to two anonymous
   reviewers for their constructive criticisms of earlier drafts. We are
   also grateful to Dr. Thomas L. Payne for his valuable comments during
   the review process.
CR BAI B, 1992, FUNCT ECOL, V6, P302, DOI 10.2307/2389521
   Bauer E, 1998, ENTOMOL EXP APPL, V88, P49, DOI 10.1046/j.1570-7458.1998.00345.x
   Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324
   BECKAGE NE, 1985, ANNU REV ENTOMOL, V30, P371
   BRODEUR J, 1995, PHYSIOL ENTOMOL, V20, P7, DOI 10.1111/j.1365-3032.1995.tb00794.x
   Brodeur J, 2004, ANNU REV ENTOMOL, V49, P27, DOI 10.1146/annurev.ento.49.061703.153618
   Caron V, 2010, B ENTOMOL RES, V100, P255, DOI 10.1017/S0007485309990198
   Chow A, 1996, ANIM BEHAV, V51, P859, DOI 10.1006/anbe.1996.0090
   CLOUTIER C, 1979, CAN J ZOOL, V57, P1605, DOI 10.1139/z79-210
   Cloutier C, 2000, ENTOMOL EXP APPL, V97, P29, DOI 10.1023/A:1004056818645
   Coleman RA, 1999, J APPL ENTOMOL, V123, P171, DOI 10.1046/j.1439-0418.1999.00334.x
   Darrouzet E, 2008, J INSECT BEHAV, V21, P181, DOI 10.1007/s10905-008-9118-3
   Dorn S, 2007, PHYSIOL ENTOMOL, V32, P199, DOI 10.1111/j.1365-3032.2007.00576.x
   DOUTT RL, 1959, ANNU REV ENTOMOL, V4, P161, DOI 10.1146/annurev.en.04.010159.001113
   DRIESSEN G, 1992, ECOL ENTOMOL, V17, P17, DOI 10.1111/j.1365-2311.1992.tb01034.x
   Edwards John P., 2001, P1
   ELLER FJ, 1990, ANN ENTOMOL SOC AM, V83, P504, DOI 10.1093/aesa/83.3.504
   Ellers J, 2000, AM NAT, V156, P650, DOI 10.1086/316990
   Elzinga JA, 2003, ENTOMOL EXP APPL, V108, P95, DOI 10.1046/j.1570-7458.2003.00072.x
   Fidgen JG, 2000, ECOL ENTOMOL, V25, P156, DOI 10.1046/j.1365-2311.2000.00248.x
   FLANDERS SE, 1953, J ECON ENTOMOL, V46, P266, DOI 10.1093/jee/46.2.266
   GAULD ID, 1988, BIOL J LINN SOC, V35, P351, DOI 10.1111/j.1095-8312.1988.tb00476.x
   Godfray H. C. J, 1994, PARASITOIDS BEHAV EV
   Gols R, 2009, PHYTOCHEM REV, V8, P187, DOI 10.1007/s11101-008-9104-6
   Gols R, 2009, OIKOS, V118, P733, DOI 10.1111/j.1600-0706.2008.17231.x
   Gu HN, 2003, ECOL ENTOMOL, V28, P422, DOI 10.1046/j.1365-2311.2003.00535.x
   HANOVER JW, 1975, ANNU REV ENTOMOL, V20, P75, DOI 10.1146/annurev.en.20.010175.000451
   HARDY ICW, 1992, J ANIM ECOL, V61, P121, DOI 10.2307/5515
   Harvey JA, 1998, PHYSIOL ENTOMOL, V23, P113, DOI 10.1046/j.1365-3032.1998.232072.x
   Harvey JA, 1999, J INSECT PHYSIOL, V45, P173, DOI 10.1016/S0022-1910(98)00113-9
   HARVEY JA, 1993, ECOL ENTOMOL, V18, P203, DOI 10.1111/j.1365-2311.1993.tb01091.x
   Harvey JA, 2000, OIKOS, V88, P621, DOI 10.1034/j.1600-0706.2000.880319.x
   Harvey JA, 2004, ECOL ENTOMOL, V29, P35, DOI 10.1111/j.0307-6946.2004.00568.x
   Harvey JA, 2000, ECOL ENTOMOL, V25, P267, DOI 10.1046/j.1365-2311.2000.00265.x
   HASAN F, 2011, J BIOL SCI, DOI DOI 10.1016/J.SJBS
   Hasan F, 2010, PHYTOPARASITICA, V38, P337, DOI 10.1007/s12600-010-0112-x
   HOLMES H B, 1972, Entomophaga, V17, P79, DOI 10.1007/BF02371075
   Horikoshi M, 1997, J CHEM ECOL, V23, P1505, DOI 10.1023/B:JOEC.0000006418.49537.5d
   IKAWA T, 1984, APPL ENTOMOL ZOOL, V19, P389, DOI 10.1303/aez.19.389
   IKAWA T, 1985, APPL ENTOMOL ZOOL, V20, P331, DOI 10.1303/aez.20.331
   JANSSEN A, 1989, FUNCT ECOL, V3, P469, DOI 10.2307/2389621
   Keasar T, 2006, ECOL ENTOMOL, V31, P277, DOI 10.1111/j.1365-2311.2006.00788.x
   KITANO H, 1986, J INSECT PHYSIOL, V32, P369, DOI 10.1016/0022-1910(86)90050-8
   KITANO H, 1978, J INSECT PHYSIOL, V24, P261, DOI 10.1016/0022-1910(78)90044-6
   Laing J.E., 1982, Biocontrol News and Information, V3, P7
   Lawrence Pauline O., 1993, P59
   LEMASURIER AD, 1990, ENTOMOL EXP APPL, V54, P65
   Mackauer M, 2001, FUNCT ECOL, V15, P335, DOI 10.1046/j.1365-2435.2001.00532.x
   Mayhew PJ, 1999, ANIM BEHAV, V58, P131, DOI 10.1006/anbe.1999.1106
   Nakamatsu Y, 2001, J INSECT PHYSIOL, V47, P573, DOI 10.1016/S0022-1910(00)00147-5
   OHSAKI N, 1994, ECOLOGY, V75, P59, DOI 10.2307/1939382
   Ohsaki N, 1999, RES POPUL ECOL, V41, P107, DOI 10.1007/PL00011975
   OHSAKI N, 1982, RES POPUL ECOL, V24, P193, DOI 10.1007/BF02515599
   PARKER F D, 1973, Environmental Entomology, V2, P216
   PARKER GA, 1984, THEOR POPUL BIOL, V26, P27, DOI 10.1016/0040-5809(84)90022-4
   Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029
   Potting RPJ, 1997, ENTOMOL EXP APPL, V82, P341, DOI 10.1046/j.1570-7458.1997.00148.x
   R-Development Core Team, 2010, R LANG ENV STAT COMP
   RAHMAN M, 1970, J ECON ENTOMOL, V63, P820, DOI 10.1093/jee/63.3.820
   Santolamazza-Carbone S, 2003, OECOLOGIA, V136, P365, DOI 10.1007/s00442-003-1269-5
   SATO Y, 1980, ENTOMOPHAGA, V25, P123, DOI 10.1007/BF02374314
   Sato Y, 2004, ECOL RES, V19, P445, DOI 10.1111/j.1440-1703.2004.00655.x
   SATO Y, 1987, ECOL ENTOMOL, V12, P291, DOI 10.1111/j.1365-2311.1987.tb01008.x
   SATO Y, 1979, PHYSIOL ENTOMOL, V4, P63, DOI 10.1111/j.1365-3032.1979.tb00178.x
   SATO Y, 1976, Applied Entomology and Zoology, V11, P165
   SATO Y, 1986, J INSECT PHYSIOL, V32, P281, DOI 10.1016/0022-1910(86)90040-5
   Schopf A, 1996, EUR J ENTOMOL, V93, P555
   SHIGA M, 1968, Kontyu, V36, P369
   Sirot E, 1997, BEHAV ECOL, V8, P226, DOI 10.1093/beheco/8.2.226
   SKINNER SW, 1985, BEHAV ECOL SOCIOBIOL, V17, P231, DOI 10.1007/BF00300141
   SLANSKY F, 1978, ENVIRON ENTOMOL, V7, P179, DOI 10.1093/ee/7.2.179
   SPEIRS DC, 1991, TRENDS ECOL EVOL, V6, P22, DOI 10.1016/0169-5347(91)90143-L
   SUZUKI Y, 1984, ANIM BEHAV, V32, P478, DOI 10.1016/S0003-3472(84)80284-5
   TAGAWA J, 1984, APPL ENTOMOL ZOOL, V19, P396, DOI 10.1303/aez.19.396
   TAGAWA J, 1992, APPL ENTOMOL ZOOL, V27, P306, DOI 10.1303/aez.27.306
   Tagawa J, 2000, ENTOMOL EXP APPL, V97, P193, DOI 10.1023/A:1004007802543
   Tena A, 2008, ANIM BEHAV, V76, P789, DOI 10.1016/j.anbehav.2008.05.007
   UENO T, 1994, ANIM BEHAV, V47, P988, DOI 10.1006/anbe.1994.1134
   VANALPHEN JJM, 1990, ANNU REV ENTOMOL, V35, P59, DOI 10.1146/annurev.en.35.010190.000423
   VANDIJKEN MJ, 1987, ENTOMOLOGIA EXPT APP, V30, P77
   VANDRIESCHE RG, 1988, J KANSAS ENTOMOL SOC, V61, P328
   VET LEM, 1994, J ANIM ECOL, V63, P807, DOI 10.2307/5258
   VINSON S B, 1978, Southwestern Entomologist, V3, P299
   Vinson S.B., 1984, P205
   VINSON SB, 1981, SEMIOCHEMICALS THEIR, P51
   VINSON SB, 1975, BIOCH COEVOLUTION PA, P14
   VISSER ME, 1994, J ANIM ECOL, V63, P963, DOI 10.2307/5273
   WEISSER WW, 1993, FUNCT ECOL, V7, P27, DOI 10.2307/2389864
   White JA, 2008, BIOL CONTROL, V46, P133, DOI 10.1016/j.biocontrol.2008.04.005
   WYLIE HG, 1983, CAN ENTOMOL, V115, P441, DOI 10.4039/Ent115441-4
   Yamada YY, 1998, OIKOS, V81, P209, DOI 10.2307/3547042
NR 91
TC 4
Z9 5
U1 3
U2 27
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0892-7553
EI 1572-8889
J9 J INSECT BEHAV
JI J. Insect Behav.
PD SEP
PY 2011
VL 24
IS 5
BP 363
EP 379
DI 10.1007/s10905-011-9262-z
PG 17
WC Entomology
SC Entomology
GA 791TV
UT WOS:000292690000004
DA 2018-12-27
ER

PT J
AU Selva, N
   Cortes-Avizanda, A
   Lemus, JA
   Blanco, G
   Mueller, T
   Heinrich, B
   Donazar, JA
AF Selva, Nuria
   Cortes-Avizanda, Ainara
   Lemus, Jesus A.
   Blanco, Guillermo
   Mueller, Thomas
   Heinrich, Bernd
   Donazar, Jose A.
TI RETRACTED: Stress associated with group living in a long-lived bird
   (Retracted article. See vol. 9, 20121184, 2013)
SO BIOLOGY LETTERS
LA English
DT Article; Retracted Publication
DE Bialowieza forest; common raven; Corvus corax; glucocorticoids;
   parasites; sociality
ID CORTICOSTERONE; HORMONES; COERULESCENS; BEHAVIOR; COSTS; LOAD; AGE
AB Many long-lived avian species adopt life strategies that involve a gregarious way of life at juvenile and sub-adult stages and territoriality during adulthood. However, the potential associated costs of these life styles, such as stress, are poorly understood. We examined the effects of group living, sex and parasite load on the baseline concentration of faecal stress hormone (corticosterone) metabolites in a wild population of common ravens (Corvus corax). Corticosterone concentrations were significantly higher in non-breeding gregarious ravens than in territorial adults. Among territorial birds, males showed higher stress levels than their mates. Parasite burdens did not affect hormone levels. Our results suggest a key role of the social context in the stress profiles of the two population fractions, and that group living may be more energetically demanding than maintaining a territory. These findings have implications for understanding hormonal mechanisms under different life styles and may inspire further research on the link between hormone levels and selective pressures modulating gregarious and territorial strategies in long-lived birds.
C1 [Selva, Nuria] Inst Nat Conservat PAS, PL-31120 Krakow, Poland.
   [Cortes-Avizanda, Ainara; Donazar, Jose A.] CSIC, Estn Biol Donana, Dept Conservat Biol, Seville 41092, Spain.
   [Lemus, Jesus A.; Blanco, Guillermo] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain.
   [Mueller, Thomas] Univ Maryland, Dept Biol, College Pk, MD 20742 USA.
   [Heinrich, Bernd] Univ Vermont, Dept Biol, Burlington, VT 05465 USA.
RP Selva, N (reprint author), Inst Nat Conservat PAS, Mickiewicza 33, PL-31120 Krakow, Poland.
EM nuriselva@gmail.com
RI Cortes-Avizanda, Ainara/C-6634-2013; Blanco, Guillermo/L-3170-2014
OI Cortes-Avizanda, Ainara/0000-0002-9674-6434; Blanco,
   Guillermo/0000-0001-5742-4929; Selva, Nuria/0000-0003-3389-201X;
   Donazar, Jose Antonio/0000-0002-9433-9755
FU CSIC-PAS [2006PL0013, 2008PL002];  [CGL2007-61395/BOS]
FX This study was supported by the Polish-Spanish joint research projects
   (CSIC-PAS) 2006PL0013 and 2008PL002 and by the project
   CGL2007-61395/BOS.
CR Angelier F, 2007, J ANIM ECOL, V76, P1181, DOI 10.1111/j.1365-2656.2007.01295.x
   Angelier F, 2006, GEN COMP ENDOCR, V149, P1, DOI 10.1016/j.ygcen.2006.04.006
   Apanius V, 1998, ADV STUD BEHAV, V27, P133
   Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3
   Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007
   Hau M, 2010, P ROY SOC B-BIOL SCI, V277, P3203, DOI 10.1098/rspb.2010.0673
   Heinrich B., 1999, MIND RAVEN
   Krause J, 2002, LIVING GROUPS
   Malueg AL, 2009, BEHAV ECOL SOCIOBIOL, V63, P687, DOI 10.1007/s00265-008-0702-5
   Mueller T, 2009, ECOGRAPHY, V32, P345, DOI 10.1111/j.1600-0587.2008.05694.x
   Raouf SA, 2006, ANIM BEHAV, V71, P39, DOI 10.1016/j.anbehav.2005.03.027
   Rubenstein DR, 2007, P R SOC B, V274, P967, DOI 10.1098/rspb.2006.0051
   SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7
   Schoech SJ, 1997, PHYSIOL ZOOL, V70, P68, DOI 10.1086/639545
   SCHOECH SJ, 1991, CONDOR, V93, P354, DOI 10.2307/1368951
   Sergio F, 2009, J ANIM ECOL, V78, P109, DOI 10.1111/j.1365-2656.2008.01484.x
   Silverin B, 1997, ANIM BEHAV, V53, P451, DOI 10.1006/anbe.1996.0295
   Stowe M, 2008, HORM BEHAV, V53, P208, DOI 10.1016/j.yhbeh.2007.09.021
   WASSER SK, 1994, J REPROD FERTIL, V101, P213
   Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557
   Young AJ, 2009, BIOL LETTERS, V5, P439, DOI 10.1098/rsbl.2009.0032
NR 21
TC 9
Z9 9
U1 2
U2 29
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1744-9561
J9 BIOL LETTERS
JI Biol. Lett.
PD AUG 23
PY 2011
VL 7
IS 4
BP 608
EP 610
DI 10.1098/rsbl.2010.1204
PG 3
WC Biology; Ecology; Evolutionary Biology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA 791CM
UT WOS:000292639100037
PM 21307048
OA Green Published
DA 2018-12-27
ER

PT J
AU Pavicic, M
AF Pavicic, Mladen
TI RETRACTED: Near-Deterministic Discrimination of All Bell States with
   Linear Optics (Retracted article. See vol. 109, pg. 079902, 2012)
SO PHYSICAL REVIEW LETTERS
LA English
DT Article; Retracted Publication
ID ENTANGLED PHOTON PAIRS; QUANTUM TELEPORTATION; BEAM SPLITTER;
   INTERFEROMETRY; INTERFERENCE; GENERATION; EFFICIENCY
AB For a reliable implementation of quantum teleportation, a near-deterministic (close to 100%) discrimination of all four Bell states of entangled qubits is required. One can carry it out with linear optical elements only if conditional dynamics are allowed. Here we present a setup in which we repeatedly disentangle and reentangle photons in three of four states, so as to separate photons in one of them, conditioned on keeping the other two at bay. The efficiency of a realistic implementation of our setup with current technology is over 90% for an ideal source of photons on demand.
C1 [Pavicic, Mladen] Univ Zagreb, Fac Civil Engn, Chair Phys, Zagreb 10001, Croatia.
   [Pavicic, Mladen] Harvard Univ, Dept Phys, Inst Theoret Atom Mol & Opt Phys, Cambridge, MA 02138 USA.
   [Pavicic, Mladen] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA.
RP Pavicic, M (reprint author), Univ Zagreb, Fac Civil Engn, Chair Phys, Zagreb 10001, Croatia.
EM mpavicic@grad.hr
FU Ministry of Science Education & Sport of Croatia [082-0982562-3160];
   U.S. National Science Foundation; Smithsonian Astrophysical Observatory
FX Supported by the Ministry of Science Education & Sport of Croatia
   (Project No. 082-0982562-3160) and by a U.S. National Science Foundation
   grant to the Institute for Theoretical Atomic, Molecular, and Optical
   Physics at Harvard University and Smithsonian Astrophysical Observatory.
   I thank my host Hossein Sadeghpour for his hospitality.
CR Barreiro JT, 2008, NAT PHYS, V4, P282, DOI 10.1038/nphys919
   Barz S, 2010, NAT PHOTONICS, V4, P553, DOI 10.1038/NPHOTON.2010.156
   BENNETT CH, 1992, PHYS REV LETT, V69, P2881, DOI 10.1103/PhysRevLett.69.2881
   BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895
   Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539
   Calderbank AR, 1996, PHYS REV A, V54, P1098, DOI 10.1103/PhysRevA.54.1098
   Calsamiglia J, 2001, APPL PHYS B-LASERS O, V72, P67, DOI 10.1007/s003400000484
   CAMPOS RA, 1989, PHYS REV A, V40, P1371, DOI 10.1103/PhysRevA.40.1371
   CAMPOS RA, 1990, PHYS REV A, V42, P4127, DOI 10.1103/PhysRevA.42.4127
   Dur W, 1999, PHYS REV A, V59, P169, DOI 10.1103/PhysRevA.59.169
   Hadfield RH, 2009, NAT PHOTONICS, V3, P696, DOI 10.1038/nphoton.2009.230
   Kim YH, 2001, PHYS REV LETT, V86, P1370, DOI 10.1103/PhysRevLett.86.1370
   Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009
   LANGE R, 1988, EUROPHYS LETT, V5, P619, DOI 10.1209/0295-5075/5/7/008
   LITA A, 2010, SPIE P SPIE INT SOC
   Lita AE, 2008, OPT EXPRESS, V16, P3032, DOI 10.1364/OE.16.003032
   Lutkenhaus N, 1999, PHYS REV A, V59, P3295, DOI 10.1103/PhysRevA.59.3295
   Ou Z. Y. J., 2007, MULTIPHOTON QUANTUM
   Paris MGA, 2000, PHYS LETT A, V273, P153, DOI 10.1016/S0375-9601(00)00477-1
   Pavicic M, 1997, OPT COMMUN, V142, P308, DOI 10.1016/S0030-4018(97)00285-X
   PAVICIC M, 1994, PHYS REV A, V50, P3486, DOI 10.1103/PhysRevA.50.3486
   PAVICIC M, 1994, PHYS REV LETT, V73, P3191, DOI 10.1103/PhysRevLett.73.3191
   Pavicic M., 2005, QUANTUM COMPUTATION
   Ralph TC, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.012314
   RARITY JG, 1990, PHYS REV LETT, V65, P1348, DOI 10.1103/PhysRevLett.65.1348
   Rosenberg D, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.061803
   Schuck C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.190501
   Vaidman L, 1999, PHYS REV A, V59, P116, DOI 10.1103/PhysRevA.59.116
   Wei TC, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.060305
   Yoshizawa A, 2004, APPL PHYS LETT, V85, P2457, DOI 10.1063/1.1799233
NR 30
TC 12
Z9 13
U1 2
U2 19
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 0031-9007
EI 1079-7114
J9 PHYS REV LETT
JI Phys. Rev. Lett.
PD AUG 17
PY 2011
VL 107
IS 8
AR 080403
DI 10.1103/PhysRevLett.107.080403
PG 5
WC Physics, Multidisciplinary
SC Physics
GA 808KQ
UT WOS:000293977000001
PM 21929149
DA 2018-12-27
ER

PT J
AU Rao, JS
   Kim, HW
   Kellom, M
   Greenstein, D
   Chen, M
   Kraft, AD
   Harry, GJ
   Rapoport, SI
   Basselin, M
AF Rao, Jagadeesh Sridhara
   Kim, Hyung-Wook
   Kellom, Matthew
   Greenstein, Dede
   Chen, Mei
   Kraft, Andrew David
   Harry, Gaylia Jean
   Rapoport, Stanley Isaac
   Basselin, Mireille
TI RETRACTED: Increased neuroinflammatory and arachidonic acid cascade
   markers, and reduced synaptic proteins, in brain of HIV-1 transgenic
   rats(Retracted article. See vol. 14, Artn no.95, 2017)
SO JOURNAL OF NEUROINFLAMMATION
LA English
DT Article; Retracted Publication
ID TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; CYTOSOLIC
   PHOSPHOLIPASE A(2); EXPRESSING TNF-ALPHA; NEURONAL CELL-DEATH;
   ALZHEIMERS-DISEASE; NITRIC-OXIDE; NEUROCOGNITIVE IMPAIRMENT; COGNITIVE
   IMPAIRMENT
AB Background: Cognitive impairment has been reported in human immune deficiency virus-1- (HIV-1-) infected patients as well as in HIV-1 transgenic (Tg) rats. This impairment has been linked to neuroinflammation, disturbed brain arachidonic acid (AA) metabolism, and synapto-dendritic injury. We recently reported upregulated brain AA metabolism in 7- to 9-month-old HIV-1 Tg rats. We hypothesized that these HIV-1 Tg rats also would show upregulated brain inflammatory and AA cascade markers and a deficit of synaptic proteins.
   Methods: We measured protein and mRNA levels of markers of neuroinflammation and the AA cascade, as well as pro-apoptotic factors and synaptic proteins, in brains from 7- to 9-month-old HIV-1 Tg and control rats.
   Results: Compared with control brain, HIV-1 Tg rat brain showed immunoreactivity to glycoprotein 120 and tat HIV-1 viral proteins, and significantly higher protein and mRNA levels of (1) the inflammatory cytokines interleukin-1 beta and tumor necrosis factor alpha, (2) the activated microglial/macrophage marker CD11b, (3) AA cascade enzymes: AA-selective Ca2+-dependent cytosolic phospholipase A(2) (cPLA(2))-IVA, secretory sPLA(2)-IIA, cyclooxygenase (COX)-2, membrane prostaglandin E-2 synthase, 5-lipoxygenase (LOX) and 15-LOX, cytochrome p450 epoxygenase, and (4) transcription factor NF-kappa Bp50 DNA binding activity. HIV-1 Tg rat brain also exhibited signs of cell injury, including significantly decreased levels of brain-derived neurotrophic factor (BDNF) and drebrin, a marker of post-synaptic excitatory dendritic spines. Expression of Ca2+-independent iPLA(2)-VIA and COX-1 was unchanged.
   Conclusions: HIV-1 Tg rats show elevated brain markers of neuroinflammation and AA metabolism, with a deficit in several synaptic proteins. These changes are associated with viral proteins and may contribute to cognitive impairment. The HIV-1 Tg rat may be a useful model for understanding progression and treatment of cognitive impairment in HIV-1 patients.
C1 [Rao, Jagadeesh Sridhara; Kim, Hyung-Wook; Kellom, Matthew; Chen, Mei; Rapoport, Stanley Isaac; Basselin, Mireille] NIA, Brain Physiol & Metab Sect, Bethesda, MD 20892 USA.
   [Greenstein, Dede] NIMH, NIH, Bethesda, MD 20892 USA.
   [Kraft, Andrew David; Harry, Gaylia Jean] Natl Inst Environm Hlth Sci, Lab Toxicol & Pharmacol, NIH, Res Triangle Pk, NC 27709 USA.
RP Rao, JS (reprint author), NIA, Brain Physiol & Metab Sect, Bethesda, MD 20892 USA.
EM jrao@mail.nih.gov
FU National Institute on Aging; National Institute of Mental Health
   National Institutes of Health, Bethesda, MD; National Institute of
   Environmental Health Sciences, National Institutes of Health, Research
   Triangle Park, NC
FX This research was entirely supported by the Intramural Research Programs
   of the National Institute on Aging and the National Institute of Mental
   Health National Institutes of Health, Bethesda, MD, and the National
   Institute of Environmental Health Sciences, National Institutes of
   Health, Research Triangle Park, NC. We thank the NIH Fellows Editorial
   Board for editing the manuscript.
CR Acquas E, 2004, NEUROTOX RES, V5, P605
   Alirezaei M, 2007, J NEUROSCI, V27, P11047, DOI 10.1523/JNEUROSCI.2733-07.2007
   Antonio V, 2002, BIOCHEM J, V368, P415, DOI 10.1042/BJ20020658
   Aoki C, 2005, J COMP NEUROL, V483, P383, DOI 10.1002/cne.20449
   BASSELIN M, J CEREB BLOOD FLOW M, V31, P486
   Basselin M, 2007, J NEUROCHEM, V102, P761, DOI 10.1111/j.1471-4159.2007.04593.x
   Basselin M, 2011, NEUROCHEM RES, V36, P139, DOI 10.1007/s11064-010-0282-4
   Beghi E, 1998, ITAL J NEUROL SCI, V19, P120, DOI 10.1007/BF02427570
   Blais V, 2001, J NEUROPATH EXP NEUR, V60, P893, DOI 10.1093/jnen/60.9.893
   Bonavia R, 2001, BIOCHEM BIOPH RES CO, V288, P301, DOI 10.1006/bbrc.2001.5743
   Caro AA, 2006, FREE RADICAL BIO MED, V40, P364, DOI 10.1016/j.freeradbiomed.2005.10.044
   Chang SL, 2007, J VIROL, V81, P8406, DOI 10.1128/JVI.00155-07
   Chuang DM, 2002, BIPOLAR DISORD, V4, P129, DOI 10.1034/j.1399-5618.2002.01179.x
   Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007
   Dandekar DH, 2004, NUCLEIC ACIDS RES, V32, P1270, DOI 10.1093/nar/gkh289
   Dwivedi Y, 2000, J PHARMACOL EXP THER, V295, P244
   Fang KM, 2008, J NEUROCHEM, V104, P1177, DOI 10.1111/j.1471-4159.2007.05022.x
   Farooqui AA, 2001, BRAIN RES REV, V38, P61, DOI 10.1016/S0169-328X(01)00214-5
   Fiore M, 1996, BRAIN BEHAV IMMUN, V10, P126, DOI 10.1006/brbi.1996.0013
   Fiore M, 2000, BEHAV BRAIN RES, V112, P165, DOI 10.1016/S0166-4328(00)00180-7
   Flora G, 2003, EXP NEUROL, V179, P60, DOI 10.1006/exnr.2002.8048
   Flora G, 2006, NEUROMOL MED, V8, P337, DOI 10.1385/NMM:8:3:337
   Foley Jessica, 2008, Curr HIV/AIDS Rep, V5, P204, DOI 10.1007/s11904-008-0029-x
   FORD AL, 1995, J IMMUNOL, V154, P4309
   Gemma C, 2007, REV NEUROSCIENCE, V18, P137
   GRAY F, 1991, ACTA NEUROPATHOL, V82, P229, DOI 10.1007/BF00294450
   Gregersen R, 2000, J CEREBR BLOOD F MET, V20, P53, DOI 10.1097/00004647-200001000-00009
   GRIFFIN DE, 1994, ANN NEUROL, V35, P592, DOI 10.1002/ana.410350513
   Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161
   HAREZLAK J, AIDS
   Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111
   Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008
   Haughey NJ, 2002, JAIDS, V31, pS55, DOI 10.1097/01.QAI.0000028065.79472.50
   Hauss-Wegrzyniak B, 1998, BRAIN RES, V780, P294, DOI 10.1016/S0006-8993(97)01215-8
   Hernandez M, 1999, J NEUROCHEM, V73, P1641, DOI 10.1046/j.1471-4159.1999.0731641.x
   Hernandez M, 2002, CIRC RES, V90, P38, DOI 10.1161/hh0102.102978
   HUANG SK, 1992, CELL TISSUE RES, V267, P493, DOI 10.1007/BF00319371
   Iliff JJ, 2010, PROSTAG OTH LIPID M, V91, P68, DOI 10.1016/j.prostaglandins.2009.06.004
   Julien C, 2008, J NEUROSCI RES, V86, P2292, DOI 10.1002/jnr.21667
   Kanmogne Georgette D, 2007, J Cereb Blood Flow Metab, V27, P123, DOI 10.1038/sj.jcbfm.9600330
   Kobayashi R, 2004, NEUROSCI RES, V49, P205, DOI 10.1016/j.neures.2004.02.014
   Kojima N, 1988, Brain Res, V464, P207
   Laflamme N, 1999, J NEUROSCI, V19, P10923
   Lahiri DK, 1998, MOL BRAIN RES, V58, P112, DOI 10.1016/S0169-328X(98)00115-6
   Lashomb AL, 2009, J NEUROVIROL, V15, P14, DOI 10.1080/13550280802232996
   Letendre SL, 2006, AIDS, V20, P1885, DOI 10.1097/01.aids.0000244208.49123.1b
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lukiw WJ, 2000, NEUROCHEM RES, V25, P1173, DOI 10.1023/A:1007627725251
   Maccarrone M, 1998, BIOCHEM J, V333, P45, DOI 10.1042/bj3330045
   Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618
   MASLIAH E, 1992, LAB INVEST, V66, P285
   Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001
   McCarthy M, 2006, J NEUROVIROL, V12, P333, DOI 10.1080/13550280600915347
   MOLLACE V, 1994, BIOCHEM BIOPH RES CO, V203, P87, DOI 10.1006/bbrc.1994.2152
   Moolwaney AS, 2005, MOL BRAIN RES, V137, P202, DOI 10.1016/j.molbrainres.2005.03.01
   MORII H, 1994, BIOCHEM BIOPH RES CO, V205, P6, DOI 10.1006/bbrc.1994.2621
   New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852
   Niederberger E, 2007, EUR J PHARMACOL, V559, P55, DOI 10.1016/j.ejphar.2006.11.074
   OKUDA S, 1994, NEUROSCIENCE, V63, P691, DOI 10.1016/0306-4522(94)90515-0
   Paramesparan Y, 2010, JAIDS-J ACQ IMM DEF, V55, P134, DOI 10.1097/QAI.0b013e3181d90e8c
   Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004
   Perry VH, 2010, ASN NEURO, V2, P281, DOI 10.1042/AN20100024
   Rao JS, 2007, J NEUROCHEM, V102, P1918, DOI 10.1111/j.1471-4159.2007.04648.x
   Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298
   Rothwell NJ, 1999, J PHYSIOL-LONDON, V514, P3, DOI 10.1111/j.1469-7793.1999.003af.x
   Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200
   Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213
   Schifitto G, 2006, NEUROLOGY, V66, P919, DOI 10.1212/01.wnl.0000204294.28189.03
   Schouten J, 2011, AIDS, V25, P561, DOI 10.1097/QAD.0b013e3283437f9a
   Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b
   Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200
   Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2
   Taylor DL, 2005, J NEUROSCI, V25, P2952, DOI 10.1523/JNEUROSCI.4456-04.2005
   Terry-Lorenzo RT, 2000, J BIOL CHEM, V275, P2439, DOI 10.1074/jbc.275.4.2439
   Vigorito M, 2007, J NEUROIMMUNE PHARM, V2, P319, DOI 10.1007/s11481-007-9078-y
   Viviani B, 2001, NEUROSCIENCE, V107, P51, DOI 10.1016/S0306-4522(01)00332-3
   Williams JR, 1998, PROSTAG LEUKOTR ESS, V58, P193, DOI 10.1016/S0952-3278(98)90113-2
   Xiong HG, 2000, J NEUROVIROL, V6, pS14
   Yagami T, 2006, CURR NEUROPHARMACOL, V4, P87, DOI 10.2174/157015906775203011
   Yagami T, 2002, MOL PHARMACOL, V61, P114, DOI 10.1124/mol.61.1.114
NR 80
TC 44
Z9 45
U1 2
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-2094
J9 J NEUROINFLAMM
JI J. Neuroinflamm.
PD AUG 16
PY 2011
VL 8
AR 101
DI 10.1186/1742-2094-8-101
PG 13
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA 822MZ
UT WOS:000295053500001
PM 21846384
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Le, RJ
   Fenstad, ER
   Maradit-Kremers, H
   McCully, RB
   Frantz, RP
   McGoon, MD
   Kane, GC
AF Le, Rachel J.
   Fenstad, Eric R.
   Maradit-Kremers, Hilal
   McCully, Robert B.
   Frantz, Robert P.
   McGoon, Michael D.
   Kane, Garvan C.
TI RETRACTED: Syncope in Adults With Pulmonary Arterial Hypertension
   (Retracted article. See vol. 59, pg. 1919, 2012)
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article; Retracted Publication
DE cardiac catheterization; echocardiography; mortality; prediction;
   pulmonary hypertension; syncope
ID OF-CARDIOLOGY; MANAGEMENT; ASSOCIATION; PATIENT
AB Objectives The aim of this study was to determine the prognostic significance of syncope in pulmonary arterial hypertension (PAH).
   Background Some patients with PAH have a history of syncope at presentation. The prognostic implications of syncope in PAH have not yet been well characterized.
   Methods This was a single-center cohort study of 378 patients with PAH seen at a dedicated pulmonary hypertension clinic over an 8-year period. All patients completed a standardized symptom assessment at the time of diagnosis.
   Results Forty-five (12%) patients had a history of syncope at the time of PAH diagnosis. There were no significant differences in sex, age, functional class, 6-min walk distance, or etiology of PAH in syncopal versus nonsyncopal patients. Syncopal patients presented with higher right atrial pressure and lower cardiac outputs with lower survival rates (1-, 3-, and 5-year rates): 69% (95% confidence interval [CI]: 54% to 81%); 51% (95% CI: 36% to 65%); and 37% (95% CI: 24% to 53%), respectively, compared with 82% (95% CI: 77% to 86%); 64% (95% CI: 64% to 69%); and 54% (95% CI: 48% to 59%), respectively, in nonsyncopal patients. Syncope was a significant predictor of mortality (hazard ratio: 1.94, 95% CI: 1.20 to 2.99), after adjusting for age, sex, functional class, 6-min walk distance, diffusing capacity of carbon monoxide, and right atrial pressure. Syncopal patients had similarly poor outcomes compared with nonsyncopal patients presenting with class 4 symptoms.
   Conclusions Syncope in PAH is associated with worsening right heart function and is an independent predictor of a poor prognosis. (J Am Coll Cardiol 2011;58:863-7) (C) 2011 by the American College of Cardiology Foundation
C1 [Kane, Garvan C.] Mayo Clin, Pulm Hypertens Clin, Div Cardiovasc Dis, Dept Med, Rochester, MN 55905 USA.
   [Maradit-Kremers, Hilal] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.
RP Kane, GC (reprint author), Mayo Clin, Pulm Hypertens Clin, Div Cardiovasc Dis, Dept Med, Gonda 5,200 1st St SW, Rochester, MN 55905 USA.
EM kane.garvan@mayo.edu
FU Pfizer; Mayo Clinic; United Therapeutics; Actelion; Gilead; Medtronic;
   LungRx
FX This work was supported in part by an unrestricted research grant from
   Pfizer to Dr. Maradit-Kremers and by the Mayo Clinic CR20 program to Dr.
   Kane. Dr. Frantz has received research and education grants, unrelated
   to this project, from United Therapeutics, Actelion, Pfizer, and Gilead.
   Unrelated to this project, Dr. McGoon has received research funding from
   Medtronic and Gilead; served on advisory, steering, and/or endpoint/data
   and safety monitoring board committees for Actelion, Gilead, LungRx, and
   Medtronic; and has received honoraria for speaking at conferences
   supported by Actelion and Gilead. All other authors have reported that
   they have no relationships relevant to the contents of this paper to
   disclose.
CR Carabello BA, 2002, CIRCULATION, V105, P1746, DOI 10.1161/01.CIR.0000015343.76143.13
   DRESSLER W, 1952, AM J MED SCI, V223, P131, DOI 10.1097/00000441-195202000-00003
   Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009
   HOWARTH S, 1953, BRIT HEART J, V15, P47
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S
   McGoon MD, 2009, MAYO CLIN PROC, V84, P191, DOI 10.1016/S0025-6196(11)60828-8
   McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004
   Mikhail GW, 2001, CIRCULATION, V104, P1326, DOI 10.1161/hc3601.095274
   Moledina S, 2010, HEART, V96, P1401, DOI 10.1136/hrt.2009.182378
   RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216
   Rich S, 1998, WORLD S PRIM PULM HY
   Rubin LJ, 2005, ANN INTERN MED, V143, P282, DOI 10.7326/0003-4819-143-4-200508160-00009
   SCOTT JP, 1991, CHEST, V99, P1284, DOI 10.1378/chest.99.5.1284
   Spirito P, 2009, CIRCULATION, V119, P1703, DOI 10.1161/CIRCULATIONAHA.108.798314
   Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415
   Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9
NR 17
TC 11
Z9 11
U1 2
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD AUG 16
PY 2011
VL 58
IS 8
BP 863
EP 867
DI 10.1016/j.jacc.2011.04.026
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 805MC
UT WOS:000293729600013
PM 21835323
OA Bronze
DA 2018-12-27
ER

PT J
AU Ling, YH
   Aracil, M
   Zou, YY
   Yuan, ZQ
   Lu, B
   Jimeno, J
   Cuervo, AM
   Perez-Soler, R
AF Ling, Yi-He
   Aracil, Miguel
   Zou, Yiyu
   Yuan, Ziqiang
   Lu, Bo
   Jimeno, Jose
   Cuervo, Ana Maria
   Perez-Soler, Roman
TI RETRACTED: PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death
   Associated with Features of Autophagy, Inhibition of the Akt/mTOR
   Signaling Pathway, and Activation of Death-Associated Protein Kinase
   (Retracted article. See vol. 19, pg. 4900, 2013)
SO CLINICAL CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID MALIGNANT GLIOMA-CELLS; ISOLATED RAT HEPATOCYTES; TUMOR-SUPPRESSOR
   GENES; DAP-KINASE; CANCER-CELLS; MAMMALIAN TARGET; INTERFERON-GAMMA;
   APOPTOSIS; INDUCTION; MACROAUTOPHAGY
AB Purpose: PM02734 (elisidepsin) is a synthetic marine-derived cyclic peptide of the kahalalide family currently in phase II clinical development. The mechanisms of cell death induced by PM02734 remain unknown.
   Experimental Design: Human non-small-cell lung cancer (NSCLC) cell lines H322 and A549 were used to evaluate PM02734-induced cytotoxicity, apoptosis, and autophagy, as well as effects on cell death-related signaling pathways.
   Results: PM02734 at clinically achievable concentrations (0.5-1 mu mol/L) was cytotoxic to H322 and A549 cells but did not cause nuclear fragmentation, PARP cleavage, or caspase activation, suggesting that classical apoptosis is not its main mechanism of cell death. In contrast, PM02734-induced cell death was associated with several characteristics of autophagy, including an increase in acidic vesicular organelle content, levels of GFP-LC3-positive puncta, elevation of the levels of Atg-5/12 and LC3-II, and an associated compromise of the autophagic flux resulting in increased number of autophagosomes and/or autolysosomes. Cotreatment with 3-methyladenine (3-MA) and downregulation of Atg-5 gene expression by siRNA partially inhibited PM02734-induced cell death. PM02734 caused inhibition of Akt/mTOR signaling pathways and cotreatment with the Akt inhibitor wortmannin or with the mTOR inhibitor rapamycin led to a significant increase in PM02734-induced cell death. Furthermore, PM02734 caused the activation of death-associated protein kinase (DAPK) by dephosphorylation at Ser308, and downregulation of DAPK expression with siRNA caused also a partial but significant reduction of PM02734-induced cell death. In vivo, PM02734 significantly inhibited subcutaneous A549 tumor growth in nude mice (P < 0.05) in association with induction of autophagy.
   Conclusions: Our data indicate that PM02734 causes cell death by a complex mechanism that involves increased autophagosome content, due for the most part to impairment of autophagic flux, inhibition of the Akt/mTOR pathway, and activation of DAPK. This unique mechanism of action justifies the continued development of this agent for the treatment of NSCLC. Clin Cancer Res; 17(16); 5353-66. (C)2011 AACR.
C1 [Ling, Yi-He; Zou, Yiyu; Perez-Soler, Roman] Albert Einstein Coll Med, Div Med Oncol, Bronx, NY 10467 USA.
   [Yuan, Ziqiang] Albert Einstein Coll Med, Dept Surg, Bronx, NY 10467 USA.
   [Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA.
   [Lu, Bo] Vanderbilt Univ, Dept Radiat Oncol, Nashville, TN USA.
   [Aracil, Miguel; Jimeno, Jose] Phamamar R&D, Madrid, Spain.
RP Perez-Soler, R (reprint author), Montefiore Med Ctr, Dept Oncol, 111 E 210st St,Hofheimer 100, Bronx, NY 10467 USA.
EM rperezso@montefiore.org
OI Cuervo, Ana Maria/0000-0002-0771-700X
FU NIH [CA84119, CA96515]; PharmaMar R D
FX This work was supported in part by NIH grants CA84119 and CA96515 and by
   PharmaMar R & D.
CR Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615
   Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002
   Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x
   Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1570
   Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595
   Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998
   Corcelle EA, 2009, FEBS J, V276, P6084, DOI 10.1111/j.1742-4658.2009.07332.x
   Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001
   Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099
   Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x
   Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X
   Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33
   Esteller M, 1999, CANCER RES, V59, P67
   Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121
   Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521
   Gulati P, 2007, BIOCHEM SOC T, V35, P236, DOI 10.1042/BST0350236
   Hamann MT, 1996, J ORG CHEM, V61, P6594, DOI 10.1021/jo960877+
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Harrison B, 2008, J BIOL CHEM, V283, P9999, DOI 10.1074/jbc.M706040200
   Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094
   Inbal B, 2000, MOL CELL BIOL, V20, P1044, DOI 10.1128/MCB.20.3.1044-1054.2000
   Janmaat ML, 2005, MOL PHARMACOL, V68, P502, DOI 10.1124/mol.105.011361
   Jin YJ, 2006, J BIOL CHEM, V281, P39033, DOI 10.1074/jbc.M605097200
   Jin YJ, 2001, J BIOL CHEM, V276, P39667, DOI 10.1074/jbc.M101886200
   Kadowaki M, 2009, METHOD ENZYMOL, V452, P199, DOI 10.1016/S0076-6879(08)03613-6
   Kanzawa T, 2003, CANCER RES, V63, P2103
   Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838
   Kim KW, 2006, J BIOL CHEM, V281, P36883, DOI 10.1074/jbc.M607094200
   Kim R, 2006, J PATHOL, V208, P319, DOI 10.1002/path.1885
   KISSIL JL, 1995, J BIOL CHEM, V270, P27932, DOI 10.1074/jbc.270.46.27932
   Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692
   Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738
   Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478
   Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008
   Ling YH, 2003, CLIN CANCER RES, V9, P1145
   Ling YH, 2009, EUR J CANCER, V45, P1855, DOI 10.1016/j.ejca.2009.03.003
   Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131
   Mizushima N, 2007, AUTOPHAGY, V3, P542
   Paglin S, 2001, CANCER RES, V61, P439
   Pelled D, 2002, J BIOL CHEM, V277, P1957, DOI 10.1074/jbc.M104677200
   Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823
   Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009
   Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200
   SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889
   Shamloo M, 2005, J BIOL CHEM, V280, P42290, DOI 10.1074/jbc.M505804200
   Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030
   Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640
   Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008
   Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246
NR 49
TC 45
Z9 46
U1 4
U2 20
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1078-0432
EI 1557-3265
J9 CLIN CANCER RES
JI Clin. Cancer Res.
PD AUG 15
PY 2011
VL 17
IS 16
BP 5353
EP 5366
DI 10.1158/1078-0432.CCR-10-1948
PG 14
WC Oncology
SC Oncology
GA 806VN
UT WOS:000293843700016
PM 21690574
OA Bronze
DA 2018-12-27
ER

PT J
AU Lopes, RJG
   Quinta-Ferreira, RM
AF Lopes, Rodrigo J. G.
   Quinta-Ferreira, Rosa M.
TI RETRACTED: Detoxification of high-strength liquid pollutants in an ozone
   bubble column reactor: Gas-liquid flow patterns, interphase mass
   transfer and chemical depuration(Retracted article. See vol. 233, pg.
   377, 2013)
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article; Retracted Publication
DE Euler-Lagrange; Bubble column reactor; Ozonation; Total organic carbon;
   Numerical simulation
ID CFD SIMULATION; MODELS; BEHAVIOR; TRENDS; BED
AB The contemporary status of computational flow modelling is encouraging the application of modern CFD codes to the design and investigation of multiphase reactors. Aiming to accomplish novel and stringent environmental regulations on the decontamination of high-strength wastewaters, here we present a comprehensive discrete bubble model for the ozonation of liquid pollutants. As long as a bubble column reactor can operate on a multitude of hydrodynamic regimes, first we developed an Euler-Lagrange CFD model coupling the transport processes such as momentum and mass transfer, and ozonation kinetics. The model has been reasonably accounted for the dependency of flow regimes and extent of interaction among gas and liquid phases. Second, a quantitative assessment between computed and experimental gas and liquid superficial velocities indicated that ozone velocity and concentration play a prominent role on the mineralization rate. We found that the process efficiency has been increased until it reveals a quasi-steady behavior which indicated that the reaction system happens to be noticeably reliant on oxidant concentrations under bubbly flow conditions. Finally, interstitial flow maps were effectively corroborated with total organic carbon concentration profiles as function of inlet bubble velocities and ozone concentrations. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Lopes, Rodrigo J. G.; Quinta-Ferreira, Rosa M.] Univ Coimbra, Dept Chem Engn, CIEPQPF, GERSE, P-3030790 Coimbra, Portugal.
RP Lopes, RJG (reprint author), Univ Coimbra, Dept Chem Engn, CIEPQPF, GERSE, Rua Silvio Lima, P-3030790 Coimbra, Portugal.
EM rodrigo@eq.uc.pt
FU Fundacao para a Ciencia e Tecnologia, Portugal
FX The authors gratefully acknowledged the financial support of Fundacao
   para a Ciencia e Tecnologia, Portugal.
CR Behkish A, 2007, CHEM ENG J, V128, P69, DOI 10.1016/j.cej.2006.10.016
   Bird R. B, 2002, TRANSPORT PHENOMENA
   Chiang PC, 1999, CHEMOSPHERE, V39, P55, DOI 10.1016/S0045-6535(98)00588-8
   DECKWER WD, 1992, BUBBLE COLUMN REACTO
   Doshi YK, 2005, CHEM ENG J, V112, P117, DOI 10.1016/j.cej.2005.07.004
   Dudukovic MP, 2002, CATAL REV, V44, P123, DOI 10.1081/CR-120001460
   Dudukovic MP, 1999, CATAL TODAY, V48, P5, DOI 10.1016/S0920-5861(98)00353-8
   Gaddis ES, 1999, CHEM ENG PROCESS, V38, P503, DOI 10.1016/S0255-2701(99)00046-X
   Gao MT, 2005, SEP PURIF TECHNOL, V42, P145, DOI 10.1016/j.seppur.2004.07.004
   Higuchi M, 2010, CHEM ENG J, V160, P284, DOI 10.1016/j.cej.2010.03.012
   Hoomans BPB, 1996, CHEM ENG SCI, V51, P99, DOI 10.1016/0009-2509(95)00271-5
   Lopes RJG, 2010, CHEM ENG J, V160, P293, DOI 10.1016/j.cej.2010.03.024
   Lopes RJG, 2009, CHEM ENG SCI, V64, P1806, DOI 10.1016/j.ces.2008.12.026
   Majumder SK, 2005, CHEM ENG J, V112, P45, DOI 10.1016/j.cej.2005.06.006
   Martin M, 2009, CHEM ENG J, V155, P272, DOI 10.1016/j.cej.2009.08.009
   Martin M, 2009, CHEM ENG J, V151, P79, DOI 10.1016/j.cej.2009.01.046
   Martins RC, 2010, CHEM ENG J, V165, P678, DOI 10.1016/j.cej.2010.09.060
   Pfleger D, 1999, CHEM ENG SCI, V54, P5091, DOI 10.1016/S0009-2509(99)00261-4
   Sanyal J, 2005, IND ENG CHEM RES, V44, P5063, DOI 10.1021/ie049555j
   Shimizu K, 2000, CHEM ENG J, V78, P21, DOI 10.1016/S1385-8947(99)00165-5
   Tabib MV, 2008, CHEM ENG J, V139, P589, DOI 10.1016/j.cej.2007.09.015
   Tomiyama A, 1997, NUCL ENG DES, V175, P77, DOI 10.1016/S0029-5493(97)00164-7
   Xu YL, 2010, CHEM ENG J, V156, P92, DOI 10.1016/j.cej.2009.10.002
NR 23
TC 3
Z9 5
U1 4
U2 37
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
EI 1873-3212
J9 CHEM ENG J
JI Chem. Eng. J.
PD AUG 1
PY 2011
VL 172
IS 1
BP 476
EP 486
DI 10.1016/j.cej.2011.06.043
PG 11
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 827OW
UT WOS:000295438800054
DA 2018-12-27
ER

PT J
AU Bogsan, CSB
   Florence, ACR
   Perina, N
   Barbuti, RC
   Navarro-Rodriguez, T
   Eisig, JN
   Oliveira, MN
AF Bogsan, Cristina Stewart B.
   Florence, Ana Carolina R.
   Perina, Natalia
   Barbuti, Ricardo C.
   Navarro-Rodriguez, Tomas
   Eisig, Jaime N.
   Oliveira, Marice N.
TI RETRACTED: Probiotics intake and metabolic syndrome: A proposal
   (Retracted article. See vol. 39, pg. 85, 2014)
SO TRENDS IN FOOD SCIENCE & TECHNOLOGY
LA English
DT Review; Retracted Publication
ID LACTOBACILLUS-GASSERI SBT2055; INSULIN-RESISTANCE; GUT MICROBIOTA;
   ADIPOSE-TISSUE; ADIPOCYTE SIZE; WEIGHT-LOSS; IKK-BETA; OBESITY;
   INFLAMMATION; DIET
AB Probiotics are practical tools to provide the modulation of microbiota. The ingestion of food or ingredients containing anti-inflammatory activity components as probiotics should be useful in obesity control and associated co-morbidities treatment. Metabolic syndrome is a metabolic dysfunction associated with visceral obesity and insulin resistance, in which the alterations in host microbiota interactions play an important role. Besides diet and physical activity, new strategies are necessary to control metabolic syndrome, and as consequence improving quality of life. This article revises the actual knowledge concerning probiotic intake and obesity as a proposal to control metabolic syndrome.
C1 [Bogsan, Cristina Stewart B.; Florence, Ana Carolina R.; Perina, Natalia; Oliveira, Marice N.] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Biochem Pharmaceut Technol, BR-05508000 Sao Paulo, Brazil.
   [Barbuti, Ricardo C.; Navarro-Rodriguez, Tomas; Eisig, Jaime N.] Univ Sao Paulo, Clin Hosp, Dept Gastroenterol, BR-05508000 Sao Paulo, Brazil.
RP Oliveira, MN (reprint author), Univ Sao Paulo, Fac Pharmaceut Sci, Dept Biochem Pharmaceut Technol, Av Prof Lineu Prestes 580,B16, BR-05508000 Sao Paulo, Brazil.
EM monolive@usp.br
RI Oliveira, Marice/C-4107-2013; Bogsan, Cristina/E-7911-2011;
   Navarro-Rodriguez, Tomas/I-3170-2012
OI Oliveira, Marice/0000-0003-4548-1840; Bogsan,
   Cristina/0000-0003-1778-4043; 
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)
FX We wish to thank FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico) for financial support.
CR Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836
   Arkan MC, 2005, NAT MED, V11, P191, DOI [10.1038/nm1185, 10.1068/nm1185]
   Backhed F, 2010, INT DAIRY J, V20, P259, DOI 10.1016/j.idairyj.2009.11.012
   Bukowska H, 1998, ATHEROSCLEROSIS, V137, P437
   Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166
   Camilleri M, 2006, GASTROENTEROLOGY, V130, P1421, DOI 10.1053/j.gastro.2005.08.062
   Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012
   Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016
   Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164
   CARVALHO KMB, 2009, OBESIDADE SINDROME M
   Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839
   DELZENNE N, 2009, NATURE REV MICROBIOL, V7, pR20
   Delzenne NM, 2005, BRIT J NUTR, V93, pS157, DOI 10.1079/BJN20041342
   DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460
   Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155
   Duvnjak L, 2009, J PHYSIOL PHARMACOL, V60, P19
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   FAO/WHO, 2002, GUID EV PROB FOOD RE
   Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Gotteland M, 2006, ALIMENT PHARM THER, V23, P1077, DOI 10.1111/j.1365-2036.2006.02868.x
   Greenberg Andrew S, 2006, Am J Clin Nutr, V83, p461S
   Hamad EM, 2009, BRIT J NUTR, V101, P716, DOI 10.1017/S0007114508043808
   Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042
   Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032
   Hill JO, 2009, AM J CLIN NUTR, V89, P477, DOI 10.3945/ajcn.2008.26566
   Hill JO, 2002, OBES RES, V10, p124S, DOI 10.1038/oby.2002.205
   Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje
   Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19
   Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005
   Kalliomaki M, 2008, ADV EXP MED BIOL, V635, P57, DOI 10.1007/978-0-387-09550-9_5
   Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534
   Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JC126498
   Karra E, 2009, J PHYSIOL-LONDON, V587, P19, DOI 10.1113/jphysiol.2008.164269
   Kondo S, 2010, BIOSCI BIOTECH BIOCH, V74, P1656, DOI 10.1271/bbb.100267
   LAHTINEN S, 2010, 3 INT S PROP BIF DAI, P42
   Lee HY, 2006, BBA-MOL CELL BIOL L, V1761, P736, DOI 10.1016/j.bbalip.2006.05.007
   Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Luoto R, 2010, INT J OBESITY, V34, P1531, DOI 10.1038/ijo.2010.50
   Luoto R, 2011, J PEDIATR GASTR NUTR, V52, P90, DOI 10.1097/MPG.0b013e3181f3457f
   Macfarlane S, 2004, ADV APPL MICROBIOL, V54, P261, DOI 10.1016/S0065-2164(04)54010-8
   Martin C, 2008, OBESITY, V16, pS88
   Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380
   Murphy KG, 2006, ENDOCR REV, V27, P719, DOI 10.1210/er.2006-0028
   Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611
   Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177
   Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x
   PUNARO GR, 2010, 1 JOINT S MICR HLTH
   Raoult D, 2008, EUR J CLIN MICROBIOL, V27, P631, DOI 10.1007/s10096-008-0490-x
   Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363
   Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105
   Sato M, 2008, BRIT J NUTR, V99, P1013, DOI 10.1017/S0007114507839006
   Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413
   Stienstra R, 2007, J HEPATOL, V46, pS278, DOI 10.1016/S0168-8278(07)62337-X
   Strowski MZ, 2009, GUT, V58, P1044, DOI 10.1136/gut.2009.179325
   Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI 10.1042/BST0331078
   Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Vasijevic T, 2008, INT DAIRY J, V18, P714, DOI 10.1016/j.idairyj.2008.03.004
   Verschuren PM, 2002, BRIT J NUTR, V88, pS125, DOI 10.1079/BJN2002675
   WANG ZT, 2006, J TRAUMA, P650
   Weisberg S, 2003, OBES RES, V11, pA6
   Wennersberg MH, 2009, AM J CLIN NUTR, V90, P960, DOI 10.3945/ajcn.2009.27664
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yin YN, 2010, WORLD J GASTROENTERO, V16, P3394, DOI 10.3748/wjg.v16.i27.3394
   Yu YH, 2005, CIRC RES, V96, P1042, DOI 10.1161/01.RES.0000165803.47776.38
   Zoetendal EG, 2001, SYST APPL MICROBIOL, V24, P405, DOI 10.1078/0723-2020-00060
NR 70
TC 7
Z9 7
U1 3
U2 24
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0924-2244
J9 TRENDS FOOD SCI TECH
JI Trends Food Sci. Technol.
PD AUG
PY 2011
VL 22
IS 8
BP 457
EP 464
DI 10.1016/j.tifs.2011.05.006
PG 8
WC Food Science & Technology
SC Food Science & Technology
GA 807VB
UT WOS:000293929800004
DA 2018-12-27
ER

PT J
AU Lee, KW
   Kim, SH
   Han, SS
   Kim, YK
   Cho, SY
   You, T
   Park, SJ
AF Lee, Kwang-Woong
   Kim, Seong Hoon
   Han, Sung-Sik
   Kim, Young-Kyu
   Cho, Seong Yeon
   You, Tae
   Park, Sang-Jae
TI RETRACTED: Use of an Upper Midline Incision for Living Donor Partial
   Hepatectomy: A Series of 143 Consecutive Cases (Retracted Article, see
   vol 18, pg 1129, 2012)
SO LIVER TRANSPLANTATION
LA English
DT Article; Retracted Publication
ID SITES
AB Over a period of 2 years, we used an upper midline incision (UMI) without laparoscopic assistance in 143 consecutive living donor partial hepatectomy (LDPH) procedures, regardless of the graft type or the donor age, sex, body mass index, or body shape. Here we report surgical recommendations based on our experience with the use of UMIs in this context. The celiac axis (CA) depth ratio (the depth-to-width ratio for the trunk at the CA) was measured to define the shape of the abdominal cavity. A questionnaire was used to assess satisfaction and cosmetic outcomes in this population of donors. One hundred forty-one of the grafts (98.6%) were right grafts or extended right grafts; there were no donor deaths. The mean time of the operation up to graft retrieval in 141 right side grafts was 3 hours 1 minute. All donors recovered fully and returned to their previous activities. Major complications occurred in 9 patients (6.4%) and included reoperation due to bleeding (4), the insertion of a percutaneous drain (4), and rhabdomyolysis (1). Male sex, a large graft (>900 kg), a fatty liver (large fatty changes >= 10%), and a deep truncal cavity (a CA depth ratio > 0.35) were significant risk factors for a long graft retrieval time. The use of a wound protector significantly reduced wound complications. The cosmetic outcomes were more satisfactory when a UMI preceded partial hepatectomy instead of a conventional J-shaped incision (P = 0.01). In conclusion, a UMI without laparoscopic assistance can be safely used for LDPH, regardless of the graft type or the donor characteristics. However, the procedure after a UMI is more difficult in male donors with large fatty livers and deep truncal cavities. Accordingly, these features can be used as exclusion criteria for surgeons not accustomed to this modified procedure. Liver Transpl 17:969-975, 2011. (C) 2011 AASLD.
C1 [Lee, Kwang-Woong] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 110744, South Korea.
   [Lee, Kwang-Woong; Kim, Seong Hoon; Han, Sung-Sik; Kim, Young-Kyu; Cho, Seong Yeon; You, Tae; Park, Sang-Jae] Natl Canc Ctr, Ctr Liver Canc, Goyang Si, Gyeonggi Do, South Korea.
RP Lee, KW (reprint author), Seoul Natl Univ, Coll Med, Dept Surg, 101 Daehak No, Seoul 110744, South Korea.
EM kwleegs@korea.com
RI Lee, Kwang-Woong/J-2776-2012
CR Baker TB, 2009, SURGERY, V146, P817, DOI 10.1016/j.surg.2009.05.022
   Horiuchi T, 2007, J TRAUMA, V62, P212, DOI 10.1097/01.ta.0000196704.78785.ae
   Horiuchi T, 2010, SURG INFECT, V11, P501, DOI 10.1089/sur.2009.072
   Kim SH, 2009, LIVER TRANSPLANT, V15, P193, DOI 10.1002/lt.21677
   Koffron AJ, 2006, AM J TRANSPLANT, V6, P2522, DOI 10.1111/j.1600-6143.2006.01498.x
   Sucullu I, 2009, SURG LAPARO ENDO PER, V19, P401, DOI 10.1097/SLE.0b013e3181bb8db7
   Suh KS, 2008, TRANSPL P, V40, P3529, DOI 10.1016/j.transproceed.2008.07.134
   Suh KS, 2009, WORLD J SURG, V33, P526, DOI 10.1007/s00268-008-9842-z
   Yamamoto N, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-109
   Yi NJ, 2007, LIVER TRANSPLANT, V13, P797, DOI 10.1002/lt.21030
NR 10
TC 19
Z9 20
U1 2
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1527-6465
EI 1527-6473
J9 LIVER TRANSPLANT
JI Liver Transplant.
PD AUG
PY 2011
VL 17
IS 8
BP 969
EP 975
DI 10.1002/lt.22337
PG 7
WC Gastroenterology & Hepatology; Surgery; Transplantation
SC Gastroenterology & Hepatology; Surgery; Transplantation
GA 800CU
UT WOS:000293337700012
PM 21584929
OA Bronze
DA 2018-12-27
ER

PT J
AU Harada, N
   Zhao, J
   Kurihara, H
   Nakagata, N
   Okajima, K
AF Harada, Naoaki
   Zhao, Juan
   Kurihara, Hiroki
   Nakagata, Naomi
   Okajima, Kenji
TI RETRACTED: Desalted deep-sea water improves cognitive function in mice
   by increasing the production of insulin-like growth factor-I in the
   hippocampus (Retracted article. See vol. 161, pg. 196, 2013)
SO TRANSLATIONAL RESEARCH
LA English
DT Article; Retracted Publication
ID IGF-I; CALCITONIN-GENE; RAT HIPPOCAMPUS; SENSORY NEURONS; NEUROGENESIS;
   RECEPTORS; PROTEIN; BRAIN; LIVER; CGRP
AB The stimulation of sensory neurons in the gastrointestinal (GI) tract improves cognitive function by increasing the hippocampal production of insulin-like growth factor-I (IGF-I) in mice. In the current study, we examined whether oral administration of desalted deep-sea water (DSW) increases the hippocampal production of IGF-I by stimulating sensory neurons in the GI tract, thereby improving cognitive function in mice. Desalted DSW increased calcitonin gene-related peptide (CGRP) release from dorsal root ganglion (DRG) neurons isolated from wild-type (WT) mice by activating transient receptor potential vanilloid 1. The plasma levels of IGF-I and tissue levels of CGRP, IGF-I, and IGF-I mRNA in the hippocampus were increased by oral administration of desalted DSW in WT mice. In these animals, nociceptive information originating from the GI tract was transmitted to the hippocampus via the spinothalamic pathway. Improvement of spatial learning was observed in WT mice after administration of desalted DSW. Distilled DSW showed results similar to those of desalted DSW in vitro and in vivo. None of the effects of desalted DSW in WT mice were observed after the administration of desalted DSW in CGRP-knockout (CGRP-/-) mice. No volatile compounds were detected in distilled DSW on GC-MS analysis. These observations suggest that desalted DSW may increase the hippocampal IGF-I production via sensory neuron stimulation in the GI tract, thereby improving cognitive function in mice. Such effects of desalted DSW might not be dependent on the minerals but are dependent on the function of the water molecule itself. (Translational Research 2011;158:106-117)
C1 [Okajima, Kenji] Nagoya City Univ, Grad Sch Med Sci, Dept Translat Med Sci Res, Mizuho Ku, Nagoya, Aichi 4678601, Japan.
   Univ Tokyo, Dept Physiol Chem & Metab, Grad Sch Med, Tokyo, Japan.
   Kumamoto Univ, Div Reprod Engn, Ctr Anim Resources & Dev, Kumamoto, Japan.
RP Okajima, K (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Translat Med Sci Res, Mizuho Ku, Kawasumi 1,Mizuho Cho, Nagoya, Aichi 4678601, Japan.
EM whynot@med.nagoya-cu.ac.jp
OI Nakagata, Naomi/0000-0002-5737-9993
CR Aberg MAI, 2000, J NEUROSCI, V20, P2896
   Ball P, 2008, CHEMPHYSCHEM, V9, P2677, DOI 10.1002/cphc.200800515
   Carro Eva, 2006, Keio Journal of Medicine, V55, P59, DOI 10.2302/kjm.55.59
   Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004
   Castle M, 2005, NEUROSCIENCE, V134, P657, DOI 10.1016/j.neuroscience.2005.04.031
   Conti E, 2004, CIRCULATION, V110, P2260, DOI 10.1161/01.CIR.0000144309.87183.FB
   DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68
   Dobolyi A, 2005, J COMP NEUROL, V489, P92, DOI 10.1002/cne.20618
   DRAY A, 1995, BRIT J ANAESTH, V75, P125, DOI 10.1093/bja/75.2.125
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   Franklin KBJ, 2008, MOUSE BRAIN STEREOTA
   Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357
   Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719
   Harada N, 2007, NEUROPHARMACOLOGY, V52, P1303, DOI 10.1016/j.neuropharm.2007.01.016
   Harada N, 2006, THROMB HAEMOSTASIS, V95, P788, DOI 10.1160/TH05-09-0636
   Harada N, 2009, TRANSL RES, V154, P90, DOI 10.1016/j.trsl.2009.05.001
   Hataguchi Y, 2005, EUR J CLIN NUTR, V59, P1093, DOI 10.1038/sj.ejcn.1602218
   Hou LF, 2001, J NEUROSCI RES, V66, P592, DOI 10.1002/jnr.1249
   Katsuda S, 2008, BIOL PHARM BULL, V31, P38, DOI 10.1248/bpb.31.38
   Klop EM, 2005, NEUROSCIENCE, V134, P189, DOI 10.1016/j.neuroscience.2005.03.035
   Lembo G, 1996, J CLIN INVEST, V98, P2648, DOI 10.1172/JCI119086
   Liu L, 1997, NEUROSCI LETT, V228, P29, DOI 10.1016/S0304-3940(97)00358-3
   Lopez-Lopez C, 2004, P NATL ACAD SCI USA, V101, P9833, DOI 10.1073/pnas.0400337101
   MAGGI CA, 1988, GEN PHARMACOL-VASC S, V19, P1, DOI 10.1016/0306-3623(88)90002-X
   Miyamura M, 2004, BIOL PHARM BULL, V27, P1784, DOI 10.1248/bpb.27.1784
   Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200
   Narimatsu N, 2009, J PHARMACOL EXP THER, V330, P2, DOI 10.1124/jpet.108.147280
   Oh-hashi Y, 2001, CIRC RES, V89, P983, DOI 10.1161/hh2301.100812
   Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3
   PERKINS MN, 1992, BRIT J PHARMACOL, V107, P329, DOI 10.1111/j.1476-5381.1992.tb12746.x
   Ramsey MM, 2005, J NEUROPHYSIOL, V94, P247, DOI 10.1152/jn.00768.2004
   ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0
   Sacca L, 2003, CLIN ENDOCRINOL, V59, P660, DOI 10.1046/j.1365-2265.2003.01780.x
   SCHWANDER JC, 1983, ENDOCRINOLOGY, V113, P297, DOI 10.1210/endo-113-1-297
   Shukitt-Hale B, 2004, NEUROBIOL AGING, V25, P223, DOI 10.1016/S0197-4580(03)00041-1
   Sidman RL, 1977, ATLAS MOUSE BRAIN SP
   Sirotkin AV, 2003, J REPROD DEVELOP, V49, P141, DOI 10.1262/jrd.49.141
   Streicher R, 1996, J BIOL CHEM, V271, P7128, DOI 10.1074/jbc.271.12.7128
   Svensson J, 2006, J ENDOCRINOL, V189, P617, DOI 10.1677/joe.1.06631
   Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298
   Tomomasa T, 2002, J PEDIATR GASTR NUTR, V34, P169, DOI 10.1097/00005176-200202000-00012
   van Amsterdam IMC, 2002, NAT STRUCT BIOL, V9, P48, DOI 10.1038/nsb736
   VanRossum D, 1997, NEUROSCI BIOBEHAV R, V21, P649, DOI 10.1016/S0149-7634(96)00023-1
   Vecchione C, 2001, HYPERTENSION, V37, P1480, DOI 10.1161/01.HYP.37.6.1480
   Ward SM, 2003, J COMP NEUROL, V465, P121, DOI 10.1002/cne.10801
   Yoshioka S, 2003, BIOL PHARM BULL, V26, P1552, DOI 10.1248/bpb.26.1552
   ZENOBI PD, 1993, DIABETOLOGIA, V36, P465, DOI 10.1007/BF00402285
NR 47
TC 5
Z9 5
U1 2
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1931-5244
EI 1878-1810
J9 TRANSL RES
JI Transl. Res.
PD AUG
PY 2011
VL 158
IS 2
BP 106
EP 117
DI 10.1016/j.trsl.2011.02.007
PG 12
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA 796MH
UT WOS:000293054900006
PM 21757155
DA 2018-12-27
ER

PT J
AU Bishay, SNG
AF Bishay, Sherif N. G.
TI RETRACTION: RETRACTED: Reconstruction of acute closed traumatic extensor
   hallucis longus tendon rupture in adolescents with spastic cerebral
   palsy (Retracted Article) (Retraction of Vol 5, Pg 315, 2011)
SO JOURNAL OF CHILDRENS ORTHOPAEDICS
LA English
DT Retraction; Retracted Publication
C1 [Bishay, Sherif N. G.] Natl Inst Neuromotor Syst, Dept Orthopaed, Giza, Egypt.
RP Bishay, SNG (reprint author), 51 Al Madina Al Menawara St, Giza, Egypt.
EM snbishai@hotmail.com
CR Bishay SNG, 2011, J CHILD ORTHOP, V5, P315, DOI 10.1007/s11832-011-0325-7
NR 1
TC 2
Z9 2
U1 0
U2 0
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 1863-2521
EI 1863-2548
J9 J CHILD ORTHOP
JI J. Child. Orthop.
PD AUG
PY 2011
VL 5
IS 4
BP 315
EP 315
DI 10.1007/s11832-011-0325-7
PG 1
WC Orthopedics; Pediatrics
SC Orthopedics; Pediatrics
GA V28CZ
UT WOS:000215406800011
PM 22852038
OA Green Published
DA 2018-12-27
ER

PT J
AU Rao, JS
   Rapoport, SI
   Kim, HW
AF Rao, J. S.
   Rapoport, S. I.
   Kim, H-W
TI RETRACTED: Altered neuroinflammatory, arachidonic acid cascade and
   synaptic markers in postmortem Alzheimer's disease brain (Retracted
   article. See vol. 7, art no e1127, 2017)
SO TRANSLATIONAL PSYCHIATRY
LA English
DT Article; Retracted Publication
DE Alzheimer's disease; arachidonic acid cascade; inflammation;
   synaptophysin; drebrin
ID CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA-PEPTIDES; SMOOTH-MUSCLE-CELLS;
   PHOSPHOLIPASE A(2); FRONTAL-CORTEX; DOCOSAHEXAENOIC ACID;
   NEURODEGENERATIVE DISEASES; COGNITIVE DEFICITS; PROSTAGLANDIN E-2;
   UNANESTHETIZED RATS
AB Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the leading cause of dementia in the elderly. A recent positron emission tomography imaging study demonstrated upregulated brain arachidonic acid (AA) metabolism in AD patients. Further, a mouse model of AD shows an increase in AA-releasing cytosolic phospholipase A(2) (cPLA(2)) in brain, and a reduction in cPLA(2) activity ameliorated cognitive deficits. These observations led us to hypothesize that there is an upregulation of AA cascade and neuroinflammatory markers in the brain of AD patients. To test this hypothesis, we measured protein and mRNA levels of AA cascade, neuroinflammatory and synaptic markers in postmortem frontal cortex from 10 AD patients and 10 age-matched controls. Consistent with our hypothesis, AD frontal cortex showed significant increases in protein and mRNA levels of cPLA(2)-IVA, secretory sPLA(2)-IIA, cyclooxygenase-1 and -2, membrane prostaglandin (PG) synthase-1 and lipoxygenase-12 and -15. Calcium-independent iPLA(2)-VIA and cytosolic PGE(2) synthase were decreased. In addition, interleukin-1 beta, tumor necrosis factor-alpha, glial fibrillary acidic protein and CD11b were increased. AD postmortem brain also showed signs of cellular injury, including decreased synaptophysin and drebrin, pre- and postsynaptic markers. These results indicate that increased AA cascade and inflammatory markers could contribute to AD pathology. Altered brain AA cascade enzymes could be considered therapeutic targets for future drug development. Translational Psychiatry (2011) 1, e31; doi:10.1038/tp.2011.27; published online 16 August 2011
C1 [Rao, J. S.; Rapoport, S. I.; Kim, H-W] NIA, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA.
RP Rao, JS (reprint author), NIA, Brain Physiol & Metab Sect, NIH, 9000 Rockville Pike,Bldg 9,Room 1S-126, Bethesda, MD 20892 USA.
EM HTUjrao@mail.nih.gov
FU PHS [R24MH068855]; Intramural Research Program of the National Institute
   on Aging, National Institutes of Health
FX We thank the Harvard Brain Bank, Boston, MA, USA, for providing the
   postmortem brain samples under PHS grant number R24MH068855. This
   research was entirely supported by the Intramural Research Program of
   the National Institute on Aging, National Institutes of Health. We also
   thank Dr Eugene Streicher and the Fellows' Editorial Board at the
   National Institutes of Health for reviewing the manuscript.
CR AKIYAMA H, 1994, TOHOKU J EXP MED, V174, P295, DOI 10.1620/tjem.174.295
   Antonio V, 2002, BIOCHEM J, V368, P415, DOI 10.1042/BJ20020658
   ARMSTRONG RA, 1995, NEUROSCI LETT, V195, P121, DOI 10.1016/0304-3940(95)11796-Y
   Armstrong RA, 1998, ALZ DIS ASSOC DIS, V12, P378, DOI 10.1097/00002093-199812000-00021
   Banati RB, 1997, BIOCHEM SOC T, V25, P683, DOI 10.1042/bst0250683
   Basselin M, 2008, NEUROCHEM RES, V33, P2229, DOI 10.1007/s11064-008-9700-2
   Basselin M, 2006, NEUROPSYCHOPHARMACOL, V31, P1659, DOI 10.1038/sj.npp.1300920
   Basselin M, 2010, J LIPID RES, V51, P3166, DOI 10.1194/jlr.M008334
   Bauer MKA, 1997, EUR J BIOCHEM, V243, P726, DOI 10.1111/j.1432-1033.1997.00726.x
   Bousserouel S, 2003, J LIPID RES, V44, P601, DOI 10.1194/jlr.M200092-JLR200
   BRINKMAN SD, 1984, BIOL PSYCHIAT, V19, P157
   Caro AA, 2006, FREE RADICAL BIO MED, V40, P364, DOI 10.1016/j.freeradbiomed.2005.10.044
   Chalbot S, 2010, NEUROSCI LETT, V478, P179, DOI 10.1016/j.neulet.2010.05.012
   Chalimoniuk M, 2007, ACTA BIOCHIM POL, V54, P611
   Choi K, 2008, J NEUROIMMUNOL, V195, P81, DOI 10.1016/j.jneuroim.2008.01.014
   Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   Dwivedi Y, 2000, J PHARMACOL EXP THER, V295, P244
   Esposito G, 2008, J NUCL MED, V49, P1414, DOI 10.2967/jnumed.107.049619
   Fischer B, 1996, Fortschr Med, V114, P161
   Frisoni GB, 1999, DEMENT GERIATR COGN, V10, P130, DOI 10.1159/000017113
   Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871
   Hampel H, 2002, J NEURAL TRANSM, V109, P837, DOI 10.1007/s007020200069
   Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008
   Hernandez M, 2002, CIRC RES, V90, P38, DOI 10.1161/hh0102.102978
   Hoshino T, 2007, J BIOL CHEM, V282, P32676, DOI 10.1074/jbc.M703087200
   Hull M, 2006, NEUROCHEM INT, V48, P663, DOI 10.1016/j.neuint.2005.08.013
   Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007
   Igarashi M, 2011, J ALZHEIMERS DIS, V24, P507, DOI 10.3233/JAD-2011-101608
   Ikonomovic MD, 2008, J HISTOCHEM CYTOCHEM, V56, P1065, DOI 10.1369/jhc.2008.951855
   Iliff JJ, 2010, PROSTAG OTH LIPID M, V91, P68, DOI 10.1016/j.prostaglandins.2009.06.004
   Kim HW, 2011, MOL PSYCHIATR, V16, P419, DOI 10.1038/mp.2009.137
   Kim H-W, 2007, SOC NEUR ABSTR, V707, p704/Z703
   Kobayashi R, 2004, NEUROSCI RES, V49, P205, DOI 10.1016/j.neures.2004.02.014
   Kojima N, 2007, NEUROSCI RES, V58, P1, DOI 10.1016/j.neures.2007.02.003
   Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7
   Kriem B, 2004, FASEB J, V18, P85, DOI 10.1096/fj.04-1807fje
   Lehtonen JYA, 1996, BIOCHEMISTRY-US, V35, P9407, DOI 10.1021/bi960148o
   LESLIE JB, 1985, J NEUROSURG, V63, P659, DOI 10.3171/jns.1985.63.5.0659
   Letendre SL, 2006, AIDS, V20, P1885, DOI 10.1097/01.aids.0000244208.49123.1b
   Lindberg C, 2005, J MOL NEUROSCI, V27, P1, DOI 10.1385/JMN:27:01:01
   Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420
   McGeer PL, 1998, ALZ DIS ASSOC DIS, V12, pS1
   McIntosh AM, 2009, ACTA PSYCHIAT SCAND, V119, P192, DOI 10.1111/j.1600-0447.2008.01286.x
   Mendes CT, 2009, EUR ARCH PSY CLIN N, V259, P16, DOI 10.1007/s00406-008-0828-5
   Montine TJ, 1999, NEUROLOGY, V53, P1495, DOI 10.1212/WNL.53.7.1495
   Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826
   MORII H, 1994, BIOCHEM BIOPH RES CO, V205, P6, DOI 10.1006/bbrc.1994.2621
   NEEDLEMAN P, 1976, SCIENCE, V193, P163, DOI 10.1126/science.945611
   NORDBERG A, 1986, NEUROSCI LETT, V72, P115, DOI 10.1016/0304-3940(86)90629-4
   O'Banion MK, 1999, CRIT REV NEUROBIOL, V13, P45, DOI 10.1615/CritRevNeurobiol.v13.i1.30
   Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812
   Paris D, 2000, NEUROSCI LETT, V278, P5, DOI 10.1016/S0304-3940(99)00901-5
   Pasinetti GM, 1998, NEUROSCIENCE, V87, P319, DOI 10.1016/S0306-4522(98)00218-8
   POMARA N, 1984, BIOL PSYCHIAT, V19, P919
   Pratico D, 2004, AM J PATHOL, V164, P1655, DOI 10.1016/S0002-9440(10)63724-8
   Quadros A, 2003, NEUROSCI LETT, V353, P66, DOI 10.1016/j.neulet.2003.08.076
   Rao JS, 2007, MOL PSYCHIATR, V12, P151, DOI 10.1038/sj.mp.4001887
   Rao JS, 2010, MOL PSYCHIATR, V15, P384, DOI 10.1038/mp.2009.47
   Rapoport SI, 2008, J NUTR, V138, P2515
   Rapoport SI, 2009, BRAIN RES REV, V61, P185, DOI 10.1016/j.brainresrev.2009.06.003
   Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1
   Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213
   Scheltens P, 2010, ALZHEIMERS DEMENT, V6, P1, DOI 10.1016/j.jalz.2009.10.003
   Schifitto G, 2006, NEUROLOGY, V66, P919, DOI 10.1212/01.wnl.0000204294.28189.03
   SOININEN H, 1995, NEUROSCI LETT, V187, P79, DOI 10.1016/0304-3940(95)11343-6
   Stephenson DT, 1996, NEUROBIOL DIS, V3, P51, DOI 10.1006/nbdi.1996.0005
   Strokin M, 2004, INT J DEV NEUROSCI, V22, P551, DOI 10.1016/j.ijdevneu.2004.07.002
   Sun GY, 2007, J NEUROCHEM, V103, P1, DOI 10.1111/j.1471-4159.2007.04670.x
   Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200
   Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2
   Tran POT, 2002, DIABETES, V51, P1772, DOI 10.2337/diabetes.51.6.1772
   Vervoordeldonk MJBM, 1996, FEBS LETT, V397, P108, DOI 10.1016/S0014-5793(96)01148-9
   Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1
   Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630
NR 75
TC 40
Z9 42
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 2158-3188
J9 TRANSL PSYCHIAT
JI Transl. Psychiatr.
PD AUG
PY 2011
VL 1
AR e31
DI 10.1038/tp.2011.27
PG 9
WC Psychiatry
SC Psychiatry
GA 971PF
UT WOS:000306215600004
PM 22832605
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Bao, B
   Wang, ZW
   Ali, S
   Kong, DJ
   Li, YW
   Ahmad, A
   Banerjee, S
   Azmi, AS
   Miele, L
   Sarkar, FH
AF Bao, Bin
   Wang, Zhiwei
   Ali, Shadan
   Kong, Dejuan
   Li, Yiwei
   Ahmad, Aamir
   Banerjee, Sanjeev
   Azmi, Asfar S.
   Miele, Lucio
   Sarkar, Fazlul H.
TI RETRACTED: Notch-1 induces epithelial-mesenchymal transition consistent
   with cancer stem cell phenotype in pancreatic cancer cells (Retracted
   article. See vol. 423, pg. 153, 2018)
SO CANCER LETTERS
LA English
DT Article; Retracted Publication
DE Notch-1; EMT phenotype; miRNAs; CSC-self renewal; Genistein
ID SIGNALING PATHWAY; PROSTATE-CANCER; DRUG-RESISTANCE; BREAST-CANCER;
   TARGETING NOTCH; DOWN-REGULATION; EXPRESSION; MIR-200; INHIBITION;
   DIFFERENTIATION
AB Activation of Notch-1 is known to be associated with the development and progression of human malignancies including pancreatic cancer. Emerging evidence suggest that the acquisition of epithelial-mesenchymal transition (EMT) phenotype and induction of cancer stem cell (CSC) or cancer stem-like cell phenotype are interrelated and contributes to tumor recurrence and drug resistance. The molecular mechanism(s) by which Notch-1 contributes to the acquisition of EMT phenotype and CSC self-renewal capacity has not been fully elucidated. Here we show that forced over-expression of Notch-1 leads to increased cell growth, clonogenicity, migration and invasion of AsPC-1 cells. Moreover, over-expression of Notch-1 led to the induction of EMT phenotype by activation of mesenchymal cell markers such as ZEB1, CD44, EpCAM, and Hes-1. Here we also report, for the first time, that over-expression of Notch-1 leads to increased expression of miR-21, and decreased expression of miR-200b, miR-200c, let-7a, let-7b, and let-7c. Re-expression of miR-200b led to decreased expression of ZEB1, and vimentin, and increased expression of E-cadherin. Over-expression of Notch-1 also increased the formation of pancreatospheres consistent with expression of CSC surface markers CD44 and EpCAM. Finally, we found that genistein, a known natural anti-tumor agent inhibited cell growth, clonogenicity, migration, invasion, EMT phenotype, formation of pancreatospheres and expression of CD44 and EpCAM. These results suggest that the activation of Notch-1 signaling contributes to the acquisition of EMT phenotype, which is in part mediated through the regulation of miR-200b and CSC self-renewal capacity, and these processes could be attenuated by genistein treatment. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Pathol, Detroit, MI 48201 USA.
   [Ali, Shadan] Wayne State Univ, Karrnanos Canc Inst, Div Hematol Oncol, Detroit, MI 48201 USA.
   [Miele, Lucio] Univ Missouri, Inst Canc, Jackson, MS USA.
RP Sarkar, FH (reprint author), Wayne State Univ, Sch Med, Karmanos Canc Inst, Dept Pathol, 740 HWCRC,4100 John R St, Detroit, MI 48201 USA.
EM fsarkar@med.wayne.edu
OI Miele, Lucio/0000-0002-5853-7287; AZMI, ASFAR/0000-0003-1178-9505
FU Puschelberg and Guido foundations; National Cancer Institute, NIH
   [5R01CA131151, 3R01CA131151-02S1, 5R01CA132794]
FX We thank Puschelberg and Guido foundations for their generous financial
   contribution. Grant Support: National Cancer Institute, NIH Grants
   5R01CA131151, 3R01CA131151-02S1, and 5R01CA132794 (F.H. Sarkar).
CR Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598
   Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63
   Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathol.3.121806.154300
   Billottet C, 2008, J CELL BIOCHEM, V104, P826, DOI 10.1002/jcb.21667
   Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046
   DeSano JT, 2009, AAPS J, V11, P682, DOI 10.1208/s12248-009-9147-7
   DESMOULIERE A, 1995, CELL BIOL INT, V19, P471, DOI 10.1006/cbir.1995.1090
   Edwards BK, 2005, J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289
   Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006
   Grudzien P, 2010, ANTICANCER RES, V30, P3853
   Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034
   Ischenko I, 2010, LANGENBECK ARCH SURG, V395, P1, DOI 10.1007/s00423-009-0502-z
   Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.1002/caac.20073, 10.3322/caac.20073]
   Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076
   Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277
   Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445
   Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101
   Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298
   Mahato R, 2010, PHARM RES
   Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771
   Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570
   Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6
   Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053
   Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5
   Okuyama R, 2008, J DERMATOL SCI, V49, P187, DOI 10.1016/j.jdermsci.2007.05.017
   Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823
   Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004
   Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907
   Phillips TM, 2007, NEOPLASIA, V9, P1122, DOI 10.1593/neo.07694
   Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069
   Sarkar FH, 2009, MINERVA CHIR, V64, P489
   Schreck KC, 2010, CLIN CANCER RES, V16, P6060, DOI 10.1158/1078-0432.CCR-10-1624
   Sethi S, 2011, AM J TRANSL RES, V3, P90
   Shou JY, 2001, CANCER RES, V61, P7291
   Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215
   Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012
   Sriuranpong V, 2001, CANCER RES, V61, P3200
   TAKEBE N, 2010, NAT REV CLIN ONCOL
   WANG Z, 2010, J CELL BIOCH
   Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803
   Wang ZW, 2010, BBA-REV CANCER, V1806, P258, DOI 10.1016/j.bbcan.2010.06.001
   Wang ZW, 2010, CURR DRUG TARGETS, V11, P745, DOI 10.2174/138945010791170860
   Wang ZW, 2010, CANCER LETT, V292, P141, DOI 10.1016/j.canlet.2009.11.012
   Wang ZW, 2009, CANCER LETT, V279, P8, DOI 10.1016/j.canlet.2008.09.030
   Wang ZW, 2008, ANTICANCER RES, V28, P3621
   Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299
   Wang ZW, 2006, INT J CANCER, V118, P1930, DOI 10.1002/ijc.21589
   Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009
NR 50
TC 213
Z9 223
U1 3
U2 55
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3835
EI 1872-7980
J9 CANCER LETT
JI Cancer Lett.
PD AUG 1
PY 2011
VL 307
IS 1
BP 26
EP 36
DI 10.1016/j.canlet.2011.03.012
PG 11
WC Oncology
SC Oncology
GA 784ST
UT WOS:000292179200004
PM 21463919
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Fetecau, C
   Fetecau, C
   Jamil, M
   Mahmood, A
AF Fetecau, C.
   Fetecau, Corina
   Jamil, M.
   Mahmood, A.
TI RETRACTED: Flow of fractional Maxwell fluid between coaxial cylinders
   (Retracted article. See vol. 82, pg. 1003, 2012)
SO ARCHIVE OF APPLIED MECHANICS
LA English
DT Article; Retracted Publication
DE Maxwell fluid; Fractional calculus; Coaxial cylinders; Velocity field;
   Time-dependent shear stress; Laplace and Hankel transforms
ID NON-NEWTONIAN FLUID; OLDROYD-B FLUID; TAYLOR-COUETTE FLOW;
   CIRCULAR-CYLINDER; HELICAL FLOWS; ANNULAR PIPE; TORSIONAL OSCILLATIONS;
   STARTING SOLUTIONS; UNSTEADY MOTIONS; ROTATIONAL FLOW
AB This paper deals with the study of unsteady flow of a Maxwell fluid with fractional derivative model, between two infinite coaxial circular cylinders, using Laplace and finite Hankel transforms. The motion of the fluid is produced by the inner cylinder that, at time t = 0(+), is subject to a time-dependent longitudinal shear stress. Velocity field and the adequate shear stress are presented under series form in terms of the generalized G and R functions. The solutions that have been obtained satisfy all imposed initial and boundary conditions. The corresponding solutions for ordinary Maxwell and Newtonian fluids are obtained as limiting cases of general solutions. Finally, the influence of the pertinent parameters on the fluid motion as well as a comparison between the three models is underlined by graphical illustrations.
C1 [Fetecau, C.; Fetecau, Corina; Mahmood, A.] Govt Coll Univ, Abdus Salam Sch Math Sci, Lahore, Pakistan.
   [Fetecau, C.] Tech Univ Iasi, Dept Math, Iasi, Romania.
   [Fetecau, Corina] Tech Univ Iasi, Dept Theoret Mech, Iasi, Romania.
   [Jamil, M.] NED Univ Engn & Technol, Dept Math, Karachi 75270, Pakistan.
RP Jamil, M (reprint author), Govt Coll Univ, Abdus Salam Sch Math Sci, Lahore, Pakistan.
EM jqrza26@yahoo.com
CR Akhtar W, 2008, B MATH SOC SCI MATH, V51, P93
   Athar M, 2010, NONLINEAR ANAL-MODEL, V15, P3
   BAGLEY RL, 1983, J RHEOL, V27, P201, DOI 10.1122/1.549724
   Bandelli R, 1995, INT J NONLINEAR MECH, V30, P817, DOI 10.1016/0020-7462(95)00035-6
   Bandelli R., 1995, ARCH MECH, V47, P661
   Chandrasekhar S., 1961, HYDRODYNAMIC HYDROMA
   Debnath L, 2007, INTEGRAL TRANSFORMS
   Drazin P. C., 1981, HYDROMAGNETIC STABIL
   Erdogan ME, 2003, INT J NONLINEAR MECH, V38, P1045, DOI 10.1016/S0020-7462(02)00051-3
   Fetecau C, 2007, ACTA MECH, V189, P53, DOI 10.1007/s00707-006-0407-7
   Fetecau C, 2004, INT J NONLINEAR MECH, V39, P225, DOI 10.1016/S0020-7462(02)00170-1
   Fetecau C, 2010, COMMUN NONLINEAR SCI, V15, P3931, DOI 10.1016/j.cnsns.2010.01.012
   Fetecau C, 2009, B MATH SOC SCI MATH, V52, P117
   Fetecau C, 2008, COMPUT MATH APPL, V56, P3096, DOI 10.1016/j.camwa.2008.07.003
   FETECAU C, 2005, INT J MATH MATH SCI, V19, P3185, DOI DOI 10.1155/1JMMS.2005.3185
   Fetecau C, 2007, P ROMANIAN ACAD A, V8, P77
   Fetecau C, 2008, J NON-NEWTON FLUID, V153, P191, DOI 10.1016/j.jnnfm.2008.02.005
   Fetecau C, 2010, Z ANGEW MATH PHYS, V61, P959, DOI 10.1007/s00033-009-0038-7
   Fetecau C, 2009, MATH REP, V11, P145
   FRIEDRICH C, 1991, RHEOL ACTA, V30, P151, DOI 10.1007/BF01134604
   Germant A., 1938, PHILOS MAG, V25, P540, DOI DOI 10.1155/2011/193813
   HAYAT T, 2006, COMMUN NONLINEAR SCI, V11, P297
   Heibig A, 2008, J MATH PHYS, V49, DOI 10.1063/1.2907578
   Khan M, 2009, NONLINEAR ANAL-REAL, V10, P1775, DOI 10.1016/j.nonrwa.2008.02.015
   Lorenzo C. F., 1999, NASATP1999209424
   MAKRIS N, 1993, J ENG MECH-ASCE, V119, P1663, DOI 10.1061/(ASCE)0733-9399(1993)119:8(1663)
   Podlubny I., 1999, FRACTIONAL DIFFERENT
   Qi HT, 2009, NONLINEAR ANAL-REAL, V10, P2700, DOI 10.1016/j.nonrwa.2008.07.008
   RAHAMAN KD, 1995, J NON-NEWTON FLUID, V57, P27, DOI 10.1016/0377-0257(94)01293-Q
   RAJAGOPAL KR, 1995, ACTA MECH, V113, P233, DOI 10.1007/BF01212645
   RAJAGOPAL KR, 1983, ACTA MECH, V49, P281, DOI 10.1007/BF01236358
   Samko SG, 1993, FRACTIONAL INTEGRALS
   Shah SHAM, 2010, NONLINEAR ANAL-REAL, V11, P547, DOI 10.1016/j.nonrwa.2009.01.012
   SHIFANG H, 2000, CONSTITUTIVE EQUATIO
   SRIVASTAVA PN, 1966, ARCH MECH, V18, P145
   TING TW, 1963, ARCH RATION MECH AN, V14, P1
   Tong DK, 2005, SCI CHINA SER G, V48, P485, DOI 10.1360/04yw0105
   Tong DK, 2005, INT J ENG SCI, V43, P281, DOI 10.1016/j.ijengsci.2004.09.007
   Wang SW, 2009, NONLINEAR ANAL-REAL, V10, P1087, DOI 10.1016/j.nonrwa.2007.11.027
   Waters N. D., 1970, Rheologica Acta, V9, P345, DOI 10.1007/BF01975401
   WATERS ND, 1971, J PHYS D, V4, P207
   Wood WP, 2001, J NON-NEWTON FLUID, V100, P115, DOI 10.1016/S0377-0257(01)00130-6
   Yu ZS, 1998, APPL MATH MECH-ENGL, V19, P717
NR 43
TC 34
Z9 34
U1 3
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0939-1533
EI 1432-0681
J9 ARCH APPL MECH
JI Arch. Appl. Mech.
PD AUG
PY 2011
VL 81
IS 8
BP 1153
EP 1163
DI 10.1007/s00419-011-0536-x
PG 11
WC Mechanics
SC Mechanics
GA 778WB
UT WOS:000291739000013
DA 2018-12-27
ER

PT J
AU Benyoucef, S
   Amrani, M
AF Benyoucef, Salah
   Amrani, Moussa
TI RETRACTED: Adsorption of phosphate ions onto low cost Aleppo pine
   adsorbent (Retracted article. See vol.424,pg.169,2007)
SO DESALINATION
LA English
DT Article; Retracted Publication
DE Sawdust; Adsorption isotherms; Phosphate; Aleppo pine; Kinetics;
   Thermodynamics
ID PHOSPHORUS ADSORPTION; WASTE-WATER; METAL-IONS; REMOVAL; ISOTHERM;
   EQUILIBRIUM; REACTOR; LIGNIN; MEDIA; ACID
AB In the present study, chemically modified Aleppo pine sawdust was used for the removal of phosphate from water. Sorption of phosphate ions onto biosorbent was studied using the batch technique. The effect of different parameters such as contact time, adsorbate concentration, and temperature was investigated. The adsorption kinetics data were best described by the pseudo-second-order rate equation, and equilibrium was achieved after 40 min. The Langmuir and Freundlich equations for describing adsorption equilibrium were applied to data. The constants and correlation coefficients of these isotherm models were calculated and compared. The adsorption isotherms obey the Freundlich equation. The thermodynamic parameters like free energy, enthalpy, and entropy changes for the adsorption of phosphate ions have been evaluated, and it has been found that the reaction was spontaneous and endothermic in nature. The low value of activated energy of adsorption, 3.088 KJ mol(-1), indicates that the phosphate ions are easily adsorbed on the sawdust. Results suggest that the prepared chemically modified Aleppo pine sawdust has potential in remediation of contaminated waters by phosphate. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Benyoucef, Salah; Amrani, Moussa] MHamed Bougara Univ, Fac Sci, Lab Soft Technol Recovering & Sustainable Dev, Boumerdes, Algeria.
RP Amrani, M (reprint author), MHamed Bougara Univ, Fac Sci, Lab Soft Technol Recovering & Sustainable Dev, Boumerdes, Algeria.
EM moussaamrani@yahoo.fr
CR Abolonskay A.V., 1965, HDB PRACTICAL WORK C
   Aksu Z, 2001, SEP PURIF TECHNOL, V21, P285, DOI 10.1016/S1383-5866(00)00212-4
   Ayoub GM, 2001, WATER ENVIRON RES, V73, P478, DOI 10.2175/106143001X139533
   Babu BV, 2008, ADSORPTION, V14, P85, DOI 10.1007/s10450-007-9057-x
   Basso MC, 2002, IND ENG CHEM RES, V41, P3580, DOI 10.1021/ie020023h
   Behrendt H, 1997, ARCH NAT CONSERV LAN, V35, P329
   Borgnino L, 2009, COLLOID SURFACE A, V341, P46, DOI 10.1016/j.colsurfa.2009.03.037
   Chitrakar R, 2006, J COLLOID INTERF SCI, V297, P426, DOI 10.1016/j.jcis.2005.11.011
   Degremont, 2005, MOM TECHN EAU
   Del Bubba M, 2003, WATER RES, V37, P3390, DOI 10.1016/S0043-1354(03)00231-8
   Duenas JF, 2003, J HAZARD MATER, V97, P193, DOI 10.1016/S0304-3894(02)00260-1
   Eberhardt TL, 2006, BIORESOURCE TECHNOL, V97, P2371, DOI 10.1016/j.biortech.2005.10.040
   EGGERS E, 1991, Water Science and Technology, V24, P333
   Gieseke A, 2002, WATER RES, V36, P501, DOI 10.1016/S0043-1354(01)00232-9
   GILES CH, 1974, J COLLOID INTERF SCI, V47, P755, DOI 10.1016/0021-9797(74)90252-5
   Guo XY, 2008, J HAZARD MATER, V151, P134, DOI 10.1016/j.jhazmat.2007.05.065
   Habib-ur-Rehman, 2006, J CHIN CHEM SOC-TAIP, V53, P1045, DOI 10.1002/jccs.200600139
   Hane J.S, 2003, 6 INT C ENV WAT LAND, P3
   Ho YS, 2006, WATER RES, V40, P119, DOI 10.1016/j.watres.2005.10.040
   Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0
   Karthikeyan K.G., 2002, ANN INT M CIGR 25 WO
   Khan MA, 2004, INT J ADHES ADHES, V24, P485, DOI 10.1016/j.ijadhadh.2004.01.003
   Krishnan KA, 2008, COLLOID SURFACE A, V317, P344, DOI 10.1016/j.colsurfa.2007.11.002
   Liu RX, 2002, J COLLOID INTERF SCI, V248, P268, DOI 10.1006/jcis.2002.8260
   Lyubchik S.I., 2004, COLLOID SURF A, V242, P51
   Mortula M, 2007, J ENVIRON ENG SCI, V6, P157, DOI 10.1139/S06-042
   Oguz E, 2003, WATER AIR SOIL POLL, V148, P279, DOI 10.1023/A:1025417901030
   Peleka EN, 2009, DESALINATION, V245, P357, DOI 10.1016/j.desal.2008.04.050
   Penetra RG, 1999, WATER SCI TECHNOL, V40, P137, DOI 10.1016/S0273-1223(99)00619-8
   Puckett L.J., 1995, ENVIRON SCI TECHNOL, V29, p408A
   Rana AK, 1997, J APPL POLYM SCI, V64, P1517, DOI 10.1002/(SICI)1097-4628(19970523)64:8<1517::AID-APP9>3.0.CO;2-K
   Reddad Z, 2002, ENVIRON SCI TECHNOL, V36, P2067, DOI 10.1021/es0102989
   Ruan HD, 2000, J ENVIRON QUAL, V29, P1875, DOI 10.2134/jeq2000.00472425002900060021x
   SIDIRAS DK, 1989, BIOMASS, V19, P289, DOI 10.1016/0144-4565(89)90073-5
   Weber W J, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yan LG, 2010, J HAZARD MATER, V179, P244, DOI 10.1016/j.jhazmat.2010.02.086
NR 36
TC 65
Z9 66
U1 4
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0011-9164
EI 1873-4464
J9 DESALINATION
JI Desalination
PD JUL 15
PY 2011
VL 275
IS 1-3
BP 231
EP 236
DI 10.1016/j.desal.2011.03.004
PG 6
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA 790JS
UT WOS:000292584900031
DA 2018-12-27
ER

PT J
AU Raj, L
   Ide, T
   Gurkar, AU
   Foley, M
   Schenone, M
   Li, XY
   Tolliday, NJ
   Golub, TR
   Carr, SA
   Shamji, AF
   Stern, AM
   Mandinova, A
   Schreiber, SL
   Lee, SW
AF Raj, Lakshmi
   Ide, Takao
   Gurkar, Aditi U.
   Foley, Michael
   Schenone, Monica
   Li, Xiaoyu
   Tolliday, Nicola J.
   Golub, Todd R.
   Carr, Steven A.
   Shamji, Alykhan F.
   Stern, Andrew M.
   Mandinova, Anna
   Schreiber, Stuart L.
   Lee, Sam W.
TI RETRACTED: Selective killing of cancer cells by a small molecule
   targeting the stress response to ROS (Retracted article. See vol. 561,
   pg. 420, 2018)
SO NATURE
LA English
DT Article; Retracted Publication
ID HUMAN TUMOR-CELLS; APOPTOSIS; GENE; MECHANISMS; INDUCTION; ONCOGENE;
   PROTEINS; ENZYMES; DEATH
AB Malignant transformation, driven by gain-of-function mutations in oncogenes and loss-of-function mutations in tumour suppressor genes, results in cell deregulation that is frequently associated with enhanced cellular stress (for example, oxidative, replicative, metabolic and proteotoxic stress, and DNA damage)(1). Adaptation to this stress phenotype is required for cancer cells to survive, and consequently cancer cells may become dependent upon non-oncogenes that do not ordinarily perform such a vital function in normal cells. Thus, targeting these non-oncogene dependencies in the context of a transformed genotype may result in a synthetic lethal interaction and the selective death of cancer cells(2). Here we used a cell-based small-molecule screening and quantitative proteomics approach that resulted in the unbiased identification of a small molecule that selectively kills cancer cells but not normal cells. Piperlongumine increases the level of reactive oxygen species (ROS) and apoptotic cell death in both cancer cells and normal cells engineered to have a cancer genotype, irrespective of p53 status, but it has little effect on either rapidly or slowly dividing primary normal cells. Significant antitumour effects are observed in piperlongumine-treated mouse xenograft tumour models, with no apparent toxicity in normal mice. Moreover, piperlongumine potently inhibits the growth of spontaneously formed malignant breast tumours and their associated metastases in mice. Our results demonstrate the ability of a small molecule to induce apoptosis selectively in cells that have a cancer genotype, by targeting a non-oncogene co-dependency acquired through the expression of the cancer genotype in response to transformation-induced oxidative stress(3-5).
C1 [Raj, Lakshmi; Ide, Takao; Gurkar, Aditi U.; Mandinova, Anna; Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.
   [Raj, Lakshmi; Ide, Takao; Gurkar, Aditi U.; Mandinova, Anna; Lee, Sam W.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA.
   [Foley, Michael; Schenone, Monica; Li, Xiaoyu; Tolliday, Nicola J.; Golub, Todd R.; Carr, Steven A.; Shamji, Alykhan F.; Stern, Andrew M.; Mandinova, Anna; Schreiber, Stuart L.; Lee, Sam W.] Broad Inst Harvard & MIT, Cambridge Ctr 7, Cambridge, MA 02142 USA.
RP Lee, SW (reprint author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Bldg 149,13th St, Charlestown, MA 02129 USA.
EM amandinova@partners.org; stuart_schreiber@harvard.edu;
   swlee@partners.org
OI Stern, Andrew/0000-0002-8437-2957
FU NIH [CA142805, CA127247, CA085681, CA080058]; National Cancer
   Institute's Initiative for Chemical Genetics [N01-CO-12400]; Cancer
   Target Discovery and Development Network [5 RC2 CA148399-02]; National
   Institutes of Health [RL1HG004671, RL1CA133834, RL1GM084437,
   UL1RR024924]
FX We thank K. Chu, L. Brown-Endres, E. Lerner and F. Neville for their
   help in preparing the manuscript, W. C. Hahn for BJ cell lines, V. Band
   for 76N cells, D. Beer for H1975 cells and K. Todorova, G. Wei, S. Ong,
   S. Norton and F. An for technical assistance. This project has been
   supported in part by grants CA142805, CA127247, CA085681 and CA080058
   from NIH. This research was supported by the National Cancer Institute's
   Initiative for Chemical Genetics Contract (N01-CO-12400) and Cancer
   Target Discovery and Development Network grant (5 RC2 CA148399-02), as
   well as the National Institutes of Health Genomics Based Drug
   Discovery-Target ID Project Grant (RL1HG004671, which is
   administratively linked to National Institutes of Health Grants
   RL1CA133834, RL1GM084437 and UL1RR024924). S.L.S. is an Investigator
   with the Howard Hughes Medical Institute.
CR Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005
   Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200
   Bezerra DP, 2007, TOXICOL IN VITRO, V21, P1, DOI 10.1016/j.tiv.2006.07.007
   Brown L, 2007, EMBO J, V26, P3410, DOI 10.1038/sj.emboj.7601779
   Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733
   Dinkova-Kostova AT, 2010, J BIOL CHEM, V285, P33747, DOI 10.1074/jbc.M110.163485
   Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082
   Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006
   GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954
   Hahn WC, 1999, NATURE, V400, P464
   Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140
   Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936
   Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024
   Margolin AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007454
   Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106
   Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021
   Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737
   Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x
   Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002
   Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767
   Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015
   SZATROWSKI TP, 1991, CANCER RES, V51, P794
   Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009
   Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803
   Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200
   Yap TA, 2011, CA-CANCER J CLIN, V61, P31, DOI 10.3322/caac.20095
   Yue P, 2006, CANCER BIOL THER, V5, P492, DOI 10.4161/cbt.5.5.2565
NR 27
TC 630
Z9 655
U1 21
U2 289
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUL 14
PY 2011
VL 475
IS 7355
BP 231
EP 234
DI 10.1038/nature10167
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 791UA
UT WOS:000292690500051
PM 21753854
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Jin, SW
   Chen, BX
   Ge, YS
   Yin, HB
   Fang, YP
AF Jin, Shou-Wen
   Chen, Bing-Xia
   Ge, Yu-Shuang
   Yin, Hua-Bing
   Fang, Yu-Ping
TI RETRACTED: Oxonium picrate (Retracted article. See vol. 67, pg. E16,
   2011)
SO ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
LA English
DT Article; Retracted Publication
AB The title compound, H3O+center dot C6H2N3O7-, consists of one picrate anion and one oxonium cation. The oxonium cation is located on a crystallographic twofold axis and both its H atoms are disordered, each over two symmetry-equivalent positions with occupancy ratios of 0.75. The picrate anions are also located on twofold axes bisecting the phenolate and p-nitro groups. pi-pi interactions between the rings of the picrates [centroid-to-centroid distances of 3.324 (2) angstrom] connect the anions to form stacks along the a-axis direction. The stacks are further joined together by the protonated water molecules through hydrogen bonds to form two-dimensional sheets extending parallel to the ab plane. The sheets are stacked on top of each other along the c-axis direction and connected through C-H center dot center dot center dot O interactions between the CH groups of the benzene rings and the picrate nitro groups, with C center dot center dot center dot O distances of 3.450 (2) angstrom.
C1 [Jin, Shou-Wen; Chen, Bing-Xia; Ge, Yu-Shuang; Yin, Hua-Bing; Fang, Yu-Ping] ZheJiang A&F Univ, Tianmu Coll, Linan 311300, Peoples R China.
RP Jin, SW (reprint author), ZheJiang A&F Univ, Tianmu Coll, Linan 311300, Peoples R China.
EM jingaoyf@yahoo.cn
FU Education Office Foundation of Zhejiang Province [Y201017321]; Zhejiang
   A F University
FX The authors gratefully acknowledge financial support from the Education
   Office Foundation of Zhejiang Province (project No. Y201017321) and from
   the Innovation Project of Zhejiang A & F University.
CR *BRUK AXS INC, 2002, SADABS SMART SAINT
   Harrison WTA, 2007, ACTA CRYSTALLOGR E, V63, pO3892, DOI 10.1107/S1600536807041219
   Jin SW, 2010, J MOL STRUCT, V975, P128, DOI 10.1016/j.molstruc.2010.04.006
   Muthamizhchelvan C., 2005, ANAL SCI, V21, pX61
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   Smith G, 2004, ACTA CRYSTALLOGR E, V60, pO1800, DOI 10.1107/S1600536804022603
NR 6
TC 2
Z9 2
U1 2
U2 18
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1600-5368
J9 ACTA CRYSTALLOGR E
JI Acta Crystallogr. Sect. E.-Struct Rep. Online
PD JUL
PY 2011
VL 67
BP O1694
EP U760
DI 10.1107/S1600536811022574
PN 7
PG 8
WC Crystallography
SC Crystallography
GA 817HS
UT WOS:000294663200064
PM 21837091
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Balasubramanian, L
   Subramanian, G
   Nazeer, TT
   Simpson, HS
   Rahuman, ST
   Raju, P
AF Balasubramanian, Lavanya
   Subramanian, Geetha
   Nazeer, Thayiba Thanveer
   Simpson, Hannah Shalini
   Rahuman, Shifina T.
   Raju, Preetha
TI RETRACTED: Cyanobacteria cultivation in industrial wastewaters and
   biodiesel production from their biomass: A review (Retracted article.
   See vol. 59, pg. 153, 2012)
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Review; Retracted Publication
DE biofuel; biomass; blue-green algae; cyanobacteria; lipids; wastewater
ID BLUE-GREEN-ALGAE; SPIRULINA-PLATENSIS; PHOSPHATE-UPTAKE;
   NITROGEN-SOURCES; WASTE-WATER; MICROALGAE; GROWTH; BIOFUELS;
   BIOTECHNOLOGY; ENHANCEMENT
AB As an alternative fuel biodiesel has become increasingly important due to diminishing petroleum reserves and adverse environmental consequences of exhaust gases from petroleum-fueled engines. Recently, research interest has focused on the production of biofuel from microalgae. Cyanobacteria appeared to be suitable candidates for cultivation in wastes and wastewaters because they produce biomass in satisfactory quantity and can be harvested relatively easily due to their size and structure. In addition, their biomass composition can be manipulated by several environmental and operational factors to produce biomass with concrete characteristics. Herein, we review the culture of cyanobacteria in wastewaters and also the potential resources that can be transformed into biodiesel successfully for meeting the ever-increasing demand for biodiesel production.
C1 [Balasubramanian, Lavanya; Subramanian, Geetha; Nazeer, Thayiba Thanveer; Simpson, Hannah Shalini; Rahuman, Shifina T.] Anna Univ Technol Tiruchirappalli, Dept Biotechnol, Tiruchchirappalli 620024, Tamil Nadu, India.
   [Raju, Preetha] Anna Univ Technol Tiruchirappalli, Dept Nanosci & Technol, Tiruchchirappalli 620024, Tamil Nadu, India.
RP Subramanian, G (reprint author), Anna Univ Technol Tiruchirappalli, Dept Biotechnol, Tiruchchirappalli 620024, Tamil Nadu, India.
EM sgeemur@yahoo.com
CR ANGELIDAKI I, 2003, BIOMETHANISATION, V2, P1
   BENEMANN JR, 1979, ENZYME MICROB TECH, V1, P83, DOI 10.1016/0141-0229(79)90103-0
   Bernet N, 2009, BIORESOURCE TECHNOL, V100, P5431, DOI 10.1016/j.biortech.2009.02.003
   Brennan L, 2010, RENEW SUST ENERG REV, V14, P557, DOI 10.1016/j.rser.2009.10.009
   Burton CH, 2007, LIVEST SCI, V112, P208, DOI 10.1016/j.livsci.2007.09.004
   CANIZARESVILLANUEVA RO, 1995, BIORESOURCE TECHNOL, V51, P111, DOI 10.1016/0960-8524(94)00099-M
   Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001
   Converti A, 2006, J IND MICROBIOL BIOT, V33, P8, DOI 10.1007/s10295-005-0025-8
   Costa JAV, 2001, WORLD J MICROB BIOT, V17, P439
   de Morais MG, 2007, J BIOTECHNOL, V129, P439, DOI 10.1016/j.jbiotec.2007.01.009
   De Oliveira MACL, 1999, AQUACULT INT, V7, P261, DOI 10.1023/A:1009233230706
   de-Bashan LE, 2010, BIORESOURCE TECHNOL, V101, P1611, DOI 10.1016/j.biortech.2009.09.043
   Demirbas A, 2010, ENERG CONVERS MANAGE, V51, P2738, DOI 10.1016/j.enconman.2010.06.010
   Demirel B, 2005, PROCESS BIOCHEM, V40, P2583, DOI 10.1016/j.procbio.2004.12.015
   FALKNER G, 1980, PLANTA, V149, P138, DOI 10.1007/BF00380874
   Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747
   FONTES AG, 1987, BIOMASS, V13, P33, DOI 10.1016/0144-4565(87)90070-9
   Grima EM, 2003, BIOTECHNOL ADV, V20, P491
   GROBBELAAR JU, 2004, BIOTECHNOL APPL PHYC, P97
   HOSSAIN ABM, 2008, AM J BIOCH BIOTECHNO, V4, P250, DOI DOI 10.3844/AJBBSP.2008.250.254
   Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x
   Imbeah M, 1998, BIORESOURCE TECHNOL, V63, P197, DOI 10.1016/S0960-8524(97)00165-X
   John RP, 2011, BIORESOURCE TECHNOL, V102, P186, DOI 10.1016/j.biortech.2010.06.139
   KHOJA T, 1971, ARCH MIKROBIOL, V79, P280, DOI 10.1007/BF00408790
   Li Y, 2008, BIOTECHNOL PROGR, V24, P815, DOI [10.1021/bp070371k, 10.1021/bp.070371k]
   Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1
   Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020
   MCKINNEY R, 2004, ENVIRONMENTAL
   MURATA N, 1989, J BIOENERG BIOMEMBR, V21, P61, DOI 10.1007/BF00762212
   Noue JL, 1988, BIOTECHNOL ADV, V6, P725
   Park J, 2010, BIORESOURCE TECHNOL, V101, P8649, DOI 10.1016/j.biortech.2010.06.142
   PATZEK T, 2005, NAT RESOUR RES, V163, P84
   PIORRECK M, 1984, PHYTOCHEMISTRY, V23, P207, DOI 10.1016/S0031-9422(00)80304-0
   Pittman JK, 2011, BIORESOURCE TECHNOL, V102, P17, DOI 10.1016/j.biortech.2010.06.035
   Raja R, 2008, CRIT REV MICROBIOL, V34, P77, DOI [10.1080/10408410802086783, 10.1080/10408410802086783 ]
   RICHMONT A, 1982, PLANT CELL PHYSL, V82, P1411
   RIGBY CH, 1980, J PHYCOL, V16, P389
   RIPPKA R, 1972, ARCH MIKROBIOL, V87, P93, DOI 10.1007/BF00424781
   Ritchie RJ, 1997, PLANT CELL PHYSIOL, V38, P1232, DOI 10.1093/oxfordjournals.pcp.a029110
   Rodjaroen S., 2007, J NAT SCI, V41, P570
   Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033
   Roig A, 2006, WASTE MANAGE, V26, P960, DOI 10.1016/j.wasman.2005.07.024
   Rosenberg JN, 2008, CURR OPIN BIOTECH, V19, P430, DOI 10.1016/j.copbio.2008.07.008
   Sassano CEN, 2010, BIOMASS BIOENERG, V34, P1732, DOI 10.1016/j.biombioe.2010.07.002
   Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8
   SEALE DB, 1987, WATER RES, V21, P625, DOI 10.1016/0043-1354(87)90072-8
   Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861
   SHAKEEL A, 2009, RENEW SUST ENERG REV, V13, P2361
   Sheehan J., 1998, 58024190 NRELTP
   Sialve B, 2009, BIOTECHNOL ADV, V27, P409, DOI 10.1016/j.biotechadv.2009.03.001
   SINGH G, 1995, APPL BIOCHEM BIOTECH, V50, P285, DOI 10.1007/BF02788098
   SMITH AJ, 1967, J BACTERIOL, V94, P972
   Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87
   TALBOT P, 1993, WATER RES, V27, P153, DOI 10.1016/0043-1354(93)90206-W
   Thajuddin N, 2005, CURR SCI INDIA, V89, P47
   Tsukahara K, 2005, J JPN PETROL INST, V48, P251, DOI 10.1627/jpi.48.251
   VONSHAK A, 2003, PHYSL CELL BIOL BIOT, P505
   Wang B, 2008, APPL MICROBIOL BIOT, V79, P707, DOI 10.1007/s00253-008-1518-y
   Westerman PW, 2005, BIORESOURCE TECHNOL, V96, P215, DOI 10.1016/j.biortech.2004.05.011
   Yang YF, 2004, RESOUR CONSERV RECY, V43, P21, DOI 10.1016/j.resconrec.2004.03.003
NR 60
TC 10
Z9 10
U1 3
U2 45
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
EI 1470-8744
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD JUL-AUG
PY 2011
VL 58
IS 4
BP 220
EP 225
DI 10.1002/bab.31
PG 6
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 816FI
UT WOS:000294583700002
PM 21838795
DA 2018-12-27
ER

PT J
AU Awatef, M
   Olfa, G
   Kacem, M
   Sami, L
   Makram, H
   Slim, BA
AF Awatef, Msolly
   Olfa, Gharbi
   Kacem, Mahmoudi
   Sami, Limem
   Makram, Hochlef
   Slim, Ben Ahmed
TI RETRACTED: Association between body mass index and risk of breast cancer
   in Tunisian women (Retracted article. See vol. 32, pg. 665, 2012)
SO ANNALS OF SAUDI MEDICINE
LA English
DT Article; Retracted Publication
ID POSTMENOPAUSAL WOMEN; MENSTRUAL EVENTS; SIZE; WEIGHT; OBESITY; HEIGHT;
   OVERWEIGHT; BUILD
AB BACKGROUND AND OBJECTIVES: The number of breast cancer in women has increased dramatically in Tunisia. The cause is perceived to stem from adaptation to a westernized life style which increases body mass index (BMI). This study aimed to investigate the association between BMI and breast cancer among Tunisian women.
   DESIGN AND SETTING: Hospital-based case control study of breast cancer patients seen between November 2006 and April 2009 at the University College Hospital Farhat Hached in Sousse, Tunisia.
   PATIENTS AND METHODS: Standardized questionnaires concerning BMI and other anthropometric data were completed on 400 breast cancer cases and 400 controls. The controls were frequency-matched to the cases by age.
   RESULTS: BMI at diagnosis was positively correlated with the risk of breast cancer among postmenopausal women (P<.001 for trend). When compared with women with a low BMI (<19), women with a BMI of 23-27 and 27-31 had a 1.7-fold (95% CI, 1.1-2.9) and 2.1-fold (95% CI, 1.1-3.9) increased risk of breast cancer, respectively, after adjustment for non-anthropometric risk factors. BMI at diagnosis was not related to the risk of breast cancer among premenopausal women. The odds ratios for premenopausal women with a BMI of 23-27 and 27-31 were 1.5 (95% CI, 0.8-2.8) and 1.3 (95% CI, 0.4-4.5), respectively. Furthermore, present BMI was not associated with breast cancer risk in either pre- and postmenopausal women.
   CONCLUSIONS: Weight control in obese women may be an effective measure of breast cancer prevention in postmenopausal women.
C1 [Awatef, Msolly; Olfa, Gharbi; Kacem, Mahmoudi; Sami, Limem; Makram, Hochlef; Slim, Ben Ahmed] Univ Coll Hosp, Dept Med Oncol, Farhat Hached, Sousse, Tunisia.
RP Awatef, M (reprint author), C1 175, Monastir 5000, Tunisia.
EM awatefmsolly@gmail.com
FU research unit "oncogenetique clinique", University of Medicine of
   Sousse, Tunisia [99/UR/0811]
FX This work was supported by the research unit "oncogenetique clinique"
   99/UR/0811, University of Medicine of Sousse; Tunisia.
CR BENAHMED S, 2002, BREAST CANC, V14, P231
   BRUNING PF, 1992, INT J CANCER, V51, P14, DOI 10.1002/ijc.2910510104
   CAMPBELL S, 2000, GYNAECOLOGY 10 TEACH
   CHU SY, 1991, J CLIN EPIDEMIOL, V44, P1197, DOI 10.1016/0895-4356(91)90152-Y
   Cold S, 1998, EUR J CANCER, V34, P1163, DOI 10.1016/S0959-8049(97)10167-8
   CONWAY MA, 1995, FLASHBULB MEMORIES
   de Vasconcelos A B, 2001, Sao Paulo Med J, V119, P62
   *EUREKALERT, OB WOM DIS BOTH BREA
   HARRIS RE, 1992, J NATL CANCER I, V84, P1575, DOI 10.1093/jnci/84.20.1575
   Hirose K, 1999, INT J CANCER, V80, P349, DOI 10.1002/(SICI)1097-0215(19990129)80:3<349::AID-IJC3>3.0.CO;2-8
   Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407
   Jung D, 2009, ASIAN NURS RES, V3, P31, DOI 10.1016/S1976-1317(09)60014-1
   Kamoun Myrvat, 2008, Tunis Med, V86, P649
   KAMPERT JB, 1988, AM J EPIDEMIOL, V128, P962
   KATOH A, 1994, BRIT J CANCER, V70, P928, DOI 10.1038/bjc.1994.422
   Lahmann PH, 2003, INT J CANCER, V103, P246, DOI 10.1002/ijc.10799
   Li CI, 2000, INT J EPIDEMIOL, V29, P208, DOI 10.1093/ije/29.2.208
   LUBIN F, 1985, AM J EPIDEMIOL, V122, P579, DOI 10.1093/oxfordjournals.aje.a114137
   Montazeri A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-278
   Morimoto LM, 2002, CANCER CAUSE CONTROL, V13, P741, DOI 10.1023/A:1020239211145
   MUST A, 1993, AM J EPIDEMIOL, V138, P56, DOI 10.1093/oxfordjournals.aje.a116777
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   PATHAK DR, 1992, AM J EPIDEMIOL, V135, P153, DOI 10.1093/oxfordjournals.aje.a116268
   Peacock SL, 1999, AM J EPIDEMIOL, V149, P339
   SCHATZKIN A, 1987, J NATL CANCER I, V78, P213
   Shu XO, 2001, INT J CANCER, V94, P449, DOI 10.1002/ijc.1487
   TAIOLI E, 1995, EUR J CANCER, V31A, P723, DOI 10.1016/0959-8049(95)00046-L
   TrenthamDietz A, 1997, AM J EPIDEMIOL, V145, P1011
   Tung HT, 1999, JPN J CLIN ONCOL, V29, P137, DOI 10.1093/jjco/29.3.137
   van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514
   VATTEN LJ, 1990, INT J CANCER, V45, P440, DOI 10.1002/ijc.2910450311
   VATTEN LJ, 1992, ACTA ONCOL, V31, P195, DOI 10.3109/02841869209088902
   World Health Organization, 1998, REP WHO CONS OB GEN
NR 33
TC 2
Z9 2
U1 2
U2 6
PU K FAISAL SPEC HOSP RES CENTRE
PI RIYADH
PA PUBLICATIONS OFFICE PO BOX 3354, RIYADH 11211, SAUDI ARABIA
SN 0256-4947
EI 1319-9226
J9 ANN SAUDI MED
JI Ann. Saudi Med.
PD JUL-AUG
PY 2011
VL 31
IS 4
BP 393
EP 397
DI 10.4103/0256-4947.83211
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 802HU
UT WOS:000293500900012
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Anumolu, R
   Gustafson, JA
   Magda, JJ
   Cappello, J
   Ghandehari, H
   Pease, LF
AF Anumolu, Rajasekhar
   Gustafson, Joshua A.
   Magda, Jules J.
   Cappello, Joseph
   Ghandehari, Hamidreza
   Pease, Leonard F., III
TI RETRACTED: Fabrication of Highly Uniform Nanoparticles from Recombinant
   Silk-Elastin-like Protein Polymers for Therapeutic Agent Delivery
   (Retracted article. See vol. 8, pg. 11899, 2014)
SO ACS NANO
LA English
DT Article; Retracted Publication
DE recombinant polymers; silk-elastin-like protein polymers; nanoparticles;
   hydrogels; jet-breakup; drug delivery; gas-phase electrophoretic
   mobility molecular analysis
ID DIFFERENTIAL MOBILITY ANALYSIS; BIPOLAR CHARGE-DISTRIBUTION; CONFINED
   IMPINGING JETS; ELECTROHYDRODYNAMIC ATOMIZATION; BLOCK-COPOLYMERS;
   DRUG-DELIVERY; ELECTROSPRAY-IONIZATION; BREAK-UP; HYDROGELS; PARTICLES
AB Here we generate silk-elastin-like protein (SELP) polymeric nanoparticles and demonstrate precise control over their dimensions using an electrospray differential mobility analyzer (ES-DMA). Electrospray produces droplets encompassing several polymer strands. Evaporation ensues, leading polymer strands to accumulate at the droplet Interface, forming a hollow nanoparticle. The resulting nanoparticle size distributions, which govern particle yield, depend on buffer concentration to the -1/3 power, polymer concentration to the 1/3 power, and ratio of silk-to-elastin blocks. Three recombinantly tuned ratios of 8:16, 4:8, and 4:16, respectively named SELP-815K, SELP-47K, and SELP-415K, are employed, with the latter ratio resulting in a thinner shell and larger diameter for the nanoparticles than the former. The DMA narrows the size distribution by electrostatically classifying the aerosolized nanoparticles. These highly uniform nanoparticles have variations of 1.2 and 1.4 nm for 24.0 and 36.0 nm particles, respectively. Transmission electron microscopy reveals the ninoparticles to be faceted, as a buckling instability releases compression energy arising from evaporation after the shell has formed by bending it. A thermodynamic equilibrium exists between compression and bending energies, where the facet length is half the particle diameter, in agreement with experiments. Rod-like particles also formed from polymer-stabilized filaments when the viscous length exceeds the jet radius at higher solution viscosities. The unusual uniformity in composition and dimension indicates the potential of these nanoparticles to deliver bioactive and imaging agents.
C1 [Anumolu, Rajasekhar; Magda, Jules J.; Pease, Leonard F., III] Univ Utah, Dept Chem Engn, Salt Lake City, UT 84112 USA.
   [Gustafson, Joshua A.; Ghandehari, Hamidreza] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   [Gustafson, Joshua A.; Ghandehari, Hamidreza; Pease, Leonard F., III] Univ Utah, Utah Ctr Nanomed, Nano Inst Utah, Salt Lake City, UT 84108 USA.
   [Magda, Jules J.] Univ Utah, Dept Mat Sci & Engn, Salt Lake City, UT 84112 USA.
   [Cappello, Joseph; Ghandehari, Hamidreza; Pease, Leonard F., III] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   [Pease, Leonard F., III] Univ Utah, Dept Internal Med, Salt Lake City, UT 84132 USA.
RP Pease, LF (reprint author), Univ Utah, Dept Chem Engn, Salt Lake City, UT 84112 USA.
EM pease@eng.utah.edu
OI Magda, Jules/0000-0002-1063-6526
FU University of Utah Chemical Engineering Department; College of
   Engineering; National Institutes of Health [R01CA107621]; University of
   Utah
FX L.F.P. recognizes a generous startup package from the University of Utah
   Chemical Engineering Department and College of Engineering that
   supported this work. Support was further provided by a grant from the
   National Institutes of Health (R01CA107621) and an interdisciplinary
   seed grant from the University of Utah.
CR Arnida, 2011, EUR J PHARM BIOPHARM, V77, P417, DOI 10.1016/j.ejpb.2010.11.010
   Bacher G, 2001, J MASS SPECTROM, V36, P1038, DOI 10.1002/jms.208
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   CHEN DR, 1995, J AEROSOL SCI, V26, P963, DOI 10.1016/0021-8502(95)00027-A
   Christanti Y, 2001, J NON-NEWTON FLUID, V100, P9, DOI 10.1016/S0377-0257(01)00135-5
   Christanti Y, 2002, J RHEOL, V46, P733, DOI 10.1122/1.1463418
   Cole KD, 2009, J CHROMATOGR A, V1216, P5715, DOI 10.1016/j.chroma.2009.05.083
   Dandu R, 2008, J BIOACT COMPAT POL, V23, P5, DOI 10.1177/0883911507085278
   Dandu R, 2009, POLYMER, V50, P366, DOI 10.1016/j.polymer.2008.11.047
   Dash B. C., J CONTROLLED RELEASE, V152, P382
   DELAMORA JF, 1994, J FLUID MECH, V260, P155, DOI 10.1017/S0022112094003472
   Dinerman AA, 2002, BIOMATERIALS, V23, P4203, DOI 10.1016/S0142-9612(02)00164-3
   Dinerman AA, 2002, J CONTROL RELEASE, V82, P277, DOI 10.1016/S0168-3659(02)00134-7
   EGGERS J, 1993, PHYS REV LETT, V71, P3458, DOI 10.1103/PhysRevLett.71.3458
   Elzey S, 2010, J NANOPART RES, V12, P1945, DOI 10.1007/s11051-009-9783-y
   Fischer BJ, 2002, LANGMUIR, V18, P60, DOI 10.1021/la015518a
   Fuchs N. A, 1963, GEOFIS PURA APPL, V56, p185~193, DOI DOI 10.1007/BF01993343
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Greish K, 2010, J GENE MED, V12, P572, DOI 10.1002/jgm.1469
   Gustafson J, 2009, J CONTROL RELEASE, V140, P256, DOI 10.1016/j.jconrel.2009.05.022
   Gustafson JA, 2010, ADV DRUG DELIVER REV, V62, P1509, DOI 10.1016/j.addr.2010.04.006
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   Hartman RPA, 2000, J AEROSOL SCI, V31, P65, DOI 10.1016/S0021-8502(99)00034-8
   Hogan CJ, 2007, COLLOID SURFACE A, V311, P67, DOI 10.1016/j.colsurfa.2007.05.072
   Hung L. -H., 2007, Journal of Medical and Biological Engineering, V27, P1
   Hwang D, 2009, INT J PHARMACEUT, V368, P215, DOI 10.1016/j.ijpharm.2008.10.021
   Johnson BK, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.118302
   Johnson BK, 2003, AICHE J, V49, P2264, DOI 10.1002/aic.690490905
   Johnson BK, 2003, AUST J CHEM, V56, P1021, DOI 10.1071/CH03115
   Knutson E. O., 1975, Journal of Aerosol Science, V6, P443, DOI 10.1016/0021-8502(75)90060-9
   Kolbe A, 2011, MACROMOL RAPID COMM, V32, P186, DOI 10.1002/marc.201000491
   Landau L D., 1959, THEORY ELASTICITY, V7, P62
   Lute Scott, 2008, PDA J Pharm Sci Technol, V62, P318
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Megeed Z, 2002, PHARMACEUT RES, V19, P954, DOI 10.1023/A:1016406120288
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Nagarsekar A, 2003, BIOMACROMOLECULES, V4, P602, DOI 10.1021/bm0201082
   Nagarsekar A, 2002, J BIOMED MATER RES, V62, P195, DOI 10.1002/jbm.10272
   Nagarsekar A, 1999, J DRUG TARGET, V7, P11, DOI 10.3109/10611869909085489
   Nie ZH, 2005, J AM CHEM SOC, V127, P8058, DOI 10.1021/ja042494w
   Parisse F, 1997, LANGMUIR, V13, P3598, DOI 10.1021/la951521g
   Pauchard L, 2003, EUROPHYS LETT, V62, P897, DOI 10.1209/epl/i2003-00457-7
   Pease LF, 2008, BIOTECHNOL BIOENG, V101, P1214, DOI 10.1002/bit.22017
   Pease LF, 2007, J PHYS CHEM C, V111, P17155, DOI 10.1021/jp075571t
   Pease LF, 2011, J NANOPART RES, V13, P2157, DOI 10.1007/s11051-010-9974-6
   Pease LF, 2009, SMALL, V5, P2894, DOI 10.1002/smll.200900928
   Rethore G, 2009, TISSUE ENG PART C-ME, V15, P605, DOI 10.1089/ten.TEC.2008.0581
   Saucy DA, 2004, ANAL CHEM, V76, P1045, DOI 10.1021/ac034138m
   Smith JN, 2002, J PHYS CHEM A, V106, P9957, DOI 10.1021/jp025723e
   Stolzenburg M. R., 1988, THESIS U MINNESOTA M
   Stolzenburg MR, 2008, AEROSOL SCI TECH, V42, P421, DOI 10.1080/02786820802157823
   Tsai DH, 2008, LANGMUIR, V24, P8483, DOI 10.1021/la7024846
   Valo H, 2009, SMALL, V5, P1791, DOI 10.1002/smll.200801907
   Widiyandari H, 2007, MACROMOL MATER ENG, V292, P495, DOI 10.1002/mame.200600427
   WIEDENSOHLER A, 1988, J AEROSOL SCI, V19, P387, DOI 10.1016/0021-8502(88)90278-9
   WIEDENSOHLER A, 1986, J AEROSOL SCI, V17, P413, DOI 10.1016/0021-8502(86)90118-7
   Wu YQ, 2009, BIOMACROMOLECULES, V10, P19, DOI 10.1021/bm801033f
   Yang SY, 2010, MICROFLUID NANOFLUID, V8, P303, DOI 10.1007/s10404-009-0461-2
   Yu AM, 2005, ADV MATER, V17, P1737, DOI 10.1002/adma.200402045
   Zhu ZX, 2007, LANGMUIR, V23, P10499, DOI 10.1021/la701420z
NR 61
TC 39
Z9 39
U1 5
U2 92
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD JUL
PY 2011
VL 5
IS 7
BP 5374
EP 5382
DI 10.1021/nn103585f
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 796ES
UT WOS:000293035200012
PM 21696150
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Yan, HJ
   Wang, RB
   Zhao, F
   Zhu, KL
   Jiang, SM
   Zhao, W
   Feng, R
AF Yan, Hongjiang
   Wang, Renben
   Zhao, Fen
   Zhu, Kunli
   Jiang, Shumei
   Zhao, Wei
   Feng, Rui
TI RETRACTED: Measurement of tumor volume by PET to evaluate prognosis in
   patients with advanced non-small cell lung cancer treated by
   non-surgical therapy (Retracted article. See vol. 53, pg. 592, 2012)
SO ACTA RADIOLOGICA
LA English
DT Article; Retracted Publication
DE Lung cancer; positron emission tomography (PET); metabolic tumor volume
   (MTV); prognostic factors
ID POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUES; DEPENDENT ROC
   CURVES; RADIATION-THERAPY; STAGE-III; FDG-PET; DEFINITION; SURVIVAL;
   RADIOTHERAPY; RESOLUTION
AB Background: Patients with advanced non-small cell lung cancer (NSCLC) seem to have disparity in prognosis. Accurate prediction of prognosis could be useful in the future to predict individual risk and to develop more aggressive or alternative treatment strategies.
   Purpose: To evaluate the prognostic value of metabolic tumor volume (MTV) measured by 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in patients with NSCLC.
   Material and Methods: We retrospectively reviewed 120 patients with pathologically proven NSCLC (61 squamous cell carcinomas and 59 adenocarcinomas) who underwent pretreatment 18F-FDG PET. MTV and maximum standardized uptake value (SUVmax) for the primary tumors were measured by 18F-FDG PET. Pretreatment variables (age, sex, American Joint Committee on Cancer [AJCC] stage, histological type, SUVmax, and MTV) were analyzed to identify their correlation with two-year survival. To further evaluate and compare the predictive value of PET parameters, MTV, and SUVmax, time-dependent receiver-operating characteristic curve (ROC) analysis was used.
   Results: In the univariate analysis, AJCC stage, histological type, MTV, and SUVmax of primary tumor were significant predictors of survival. On multivariate analysis, independent prognostic factors associated with decreased two-year survival were AJCC stage (hazard ratio [HR] 2.236, P = 0.003), histological type (HR 2.038, P = 0.004), and MTV (HR 1.016, P = 0.001). SUVmax was not a significant factor (HR 0.96, P = 0.490). On time-dependent ROC analysis, MTV showed good predictive performance for two-year survival consistently better than SUVmax.
   Conclusion: MN, a volumetric parameter of 18F-FDG PET, is an important independent prognostic factor for survival and a better predictor of survival than SUVmax for the primary tumor in patients with advanced NSCLC.
C1 [Yan, Hongjiang; Wang, Renben; Zhu, Kunli; Jiang, Shumei; Zhao, Wei; Feng, Rui] Shandong Tumor Hosp, Dept Radiat Oncol, Jinan, Peoples R China.
   [Zhao, Fen] Shandong Tumor Hosp, Dept Nucl Med, Jinan, Peoples R China.
RP Wang, RB (reprint author), Shandong Tumor Hosp, Dept Radiat Oncol, Jinan, Peoples R China.
EM wangrenben@tom.com
CR Basaki K, 2006, INT J RADIAT ONCOL, V64, P449, DOI 10.1016/j.ijrobp.2005.07.967
   Biehl KJ, 2006, J NUCL MED, V47, P1808
   Boellaard R, 2004, J NUCL MED, V45, P1519
   Bradley JD, 2002, INT J RADIAT ONCOL, V52, P49, DOI 10.1016/S0360-3016(01)01772-2
   Brown RS, 1999, J NUCL MED, V40, P556
   Cerfolio RJ, 2005, J THORAC CARDIOV SUR, V130, P151, DOI 10.1016/j.jtcvs.2004.11.007
   Davies A, 2007, LUNG CANCER, V55, P75, DOI 10.1016/j.lungcan.2006.09.010
   Eschmann SM, 2006, EUR J NUCL MED MOL I, V33, P263, DOI 10.1007/s00259-005-1953-2
   Greco C, 2007, LUNG CANCER, V57, P125, DOI 10.1016/j.lungcan.2007.03.020
   Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x
   Hoang JK, 2008, J CLIN ONCOL, V26, P1459, DOI 10.1200/JCO.2007.14.3628
   Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.1002/caac.20073, 10.3322/caac.20073]
   Kawaguchi T, 2010, J THORAC ONCOL, V5, P620, DOI 10.1097/JTO.0b013e3181d2dcd9
   Kim YS, 2010, NEOPLASMA, V57, P241, DOI 10.4149/neo_2010_03_241
   Lee P, 2007, INT J RADIAT ONCOL, V69, P328, DOI 10.1016/j.ijrobp.2007.04.036
   Miller TR, 2002, INT J RADIAT ONCOL, V53, P353, DOI 10.1016/S0360-3016(02)02705-0
   Nestle U, 2005, J NUCL MED, V46, P1342
   Sasaki R, 2005, J CLIN ONCOL, V23, P1136, DOI 10.1200/JCO.2005.06.129
   Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774
   Takamochi K, 2010, THORAC CARDIOV SURG, V58, P345, DOI 10.1055/s-0030-1249944
   UyBico SJ, 2010, RADIOGRAPHICS, V30, P1163, DOI 10.1148/rg.305095166
   Westerterp M, 2007, EUR J NUCL MED MOL I, V34, P392, DOI 10.1007/s00259-006-0224-1
   YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
   Zasadny KR, 1998, CLIN POSITRON IMAGIN, V1, P123
   Zheng YY, 2006, BIOMETRICS, V62, P279, DOI 10.1111/j.1541-0420.2005.00441.x
NR 25
TC 18
Z9 21
U1 3
U2 17
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0284-1851
EI 1600-0455
J9 ACTA RADIOL
JI Acta Radiol.
PD JUL
PY 2011
VL 52
IS 6
BP 646
EP 650
DI 10.1258/ar.2011.100462
PG 5
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 797SZ
UT WOS:000293151700012
PM 21508201
DA 2018-12-27
ER

PT J
AU Gao, F
   Kim, HW
   Igarashi, M
   Kiesewetter, D
   Chang, L
   Ma, KZ
   Rapoport, SI
AF Gao, Fei
   Kim, Hyung-Wook
   Igarashi, Miki
   Kiesewetter, Dale
   Chang, Lisa
   Ma, Kaizong
   Rapoport, Stanley I.
TI RETRACTED: Liver conversion of docosahexaenoic and arachidonic acids
   from their 18-carbon precursors in rats on a DHA-free but
   alpha-LNA-containing n-3 PUFA adequate diet (Retracted article. See vol.
   1851, pg. 238, 2015)
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
LA English
DT Article; Retracted Publication
DE Conversion; Arachidonic; Docosahexaenoic; Diet; Liver; Turnover
ID POLYUNSATURATED FATTY-ACIDS; LINOLENIC ACID; BRAIN PHOSPHOLIPIDS;
   ADULT-RATS; IN-VIVO; METABOLISM; DEPRIVATION; DESATURATION; VEGETARIANS;
   DEFICIENT
AB The long-chain polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA. 20:5n-3), docosahexaenoic acid (DHA, 22:6n-3), and arachidonic acid (AA, 20:4n-6), are critical for health. These PUFAs can be synthesized in liver from their plant-derived precursors, a-linolenic acid (alpha-LNA, 18:3n-3) and linoleic acid (LA, 18:2n-6). Vegetarians and vegans may have suboptimal long-chain n-3 PUFA status, and the extent of the conversion of alpha-LNA to EPA and DHA by the liver is debatable. We quantified liver conversion of DHA and other n-3 PUFAs from alpha-LNA in rats fed a DHA-free but alpha-LNA (n-3 PUFA) adequate diet, and compared results to conversion of LA to AA. [U-C-13]LA or [U-13C] alpha-LNA was infused intravenously for 2 h at a constant rate into unanesthetized rats fed a DHA-free alpha-LNA adequate diet, and published equations were used to calculate kinetic parameters. The conversion coefficient k* of DHA from alpha-LNA was much higher than for AA from LA (97.2 x 10(-3) vs. 10.6 x 10(-3) min(-1)), suggesting that liver elongation-desaturation is more selective for n-3 PUFA biosynthesis on a per molecule basis. The net daily secretion rate of DHA, 20.3 mu mol/day, exceeded the reported brain DHA consumption rate by 50-fold, suggesting that the liver can maintain brain DHA metabolism with an adequate dietary supply solely of alpha-LNA. This infusion method could be used in vegetarians or vegans to determine minimal daily requirements of EPA and DHA in humans. Published by Elsevier B.V.
C1 [Gao, Fei; Kim, Hyung-Wook; Igarashi, Miki; Chang, Lisa; Ma, Kaizong; Rapoport, Stanley I.] NIA, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA.
   [Kiesewetter, Dale] Natl Inst Biomed Imaging & Bioengn, Positron Emiss Tomog Radiochem Grp, NIH, Bethesda, MD 20892 USA.
RP Gao, F (reprint author), NIA, Brain Physiol & Metab Sect, NIH, 9000 Rockville Pike,Bldg 9,Room 1S126, Bethesda, MD 20892 USA.
EM gaof@mail.nih.gov
FU National Institute on Aging, National Institutes of Health
FX This work was supported by the Intramural Research Program of the
   National Institute on Aging, National Institutes of Health. The authors
   thank Dr. Ameer Taha for the comments on the manuscript and the National
   Institutes of Health Fellows Editorial Board for editorial assistance.
CR BEZARD J, 1994, REPROD NUTR DEV, V34, P539, DOI 10.1051/rnd:19940603
   BOURRE JM, 1989, NUTRITION, V5, P266
   BOURRE JM, 1993, J NUTR, V123, P1313
   BOURRE JM, 1989, J NUTR, V119, P1880
   BOURRE JM, 1989, J NUTR, V119, P15
   Brenna JT, 2002, CURR OPIN CLIN NUTR, V5, P127, DOI 10.1097/00075197-200203000-00002
   Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047
   Burdge GC, 2002, BRIT J NUTR, V88, P355, DOI 10.1079/BJN2002662
   Burdge GC, 2002, BRIT J NUTR, V88, P411, DOI 10.1079/BJN2002689
   Cunnane SC, 2001, WORLD REV NUTR DIET, V88, P178
   DEGEORGE JJ, 1989, J NEUROSCI RES, V24, P413, DOI 10.1002/jnr.490240311
   DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200
   DeMar JC, 2005, J NEUROCHEM, V94, P1063, DOI 10.1111/j.1471-4159.2005.03258.x
   DeMar JC, 2004, J NEUROCHEM, V91, P1125, DOI 10.1111/j.1471-4159.2004.02789.x
   El-Badry AM, 2007, J HEPATOL, V47, P718, DOI 10.1016/j.jhep.2007.08.005
   Emken EA, 1999, LIPIDS, V34, P785, DOI 10.1007/s11745-999-0424-2
   EMKEN EA, 1994, BBA-LIPID LIPID MET, V1213, P277, DOI 10.1016/0005-2760(94)00054-9
   Fitzpatrick FA, 2001, J CLIN INVEST, V107, P1347, DOI 10.1172/JCI13241
   Gao F, 2010, J LIPID RES
   Gao F, 2009, J LIPID RES, V50, P2463, DOI 10.1194/jlr.M900223-JLR200
   Gao F, 2009, J LIPID RES, V50, P749, DOI 10.1194/jlr.D800056-JLR200
   Gavino VC, 2003, LIPIDS, V38, P485, DOI 10.1007/s11745-003-1088-7
   Holman R T, 1986, Prog Clin Biol Res, V222, P211
   Igarashi M, 2007, J LIPID RES, V48, P1150, DOI 10.1194/jlr.M600549-JLR200
   Igarashi M, 2007, J LIPID RES, V48, P152, DOI 10.1194/jlr.M600396-JLR200
   Jump DB, 2005, J NUTR, V135, P2503
   Key TIJ, 2003, AM J CLIN NUTR, V78, p533S, DOI 10.1093/ajcn/78.3.533S
   Key TJ, 2009, AM J CLIN NUTR, V89, pS1613, DOI 10.3945/ajcn.2009.26736L
   Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481
   Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8
   Martinelli N, 2008, AM J CLIN NUTR, V88, P941
   Nakamura MT, 2003, PROSTAG LEUKOTR ESS, V68, P145, DOI 10.1016/S0952-3278(02)00264-8
   Pawlosky RJ, 2001, J LIPID RES, V42, P1257
   PURDON AD, 2007, NEURAL ENERGY UTILIZ, P401
   Purdon D, 1997, J LIPID RES, V38, P526
   RAPOPORT SI, 1982, AM J PHYSIOL, V242, pR339
   Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023
   Rapoport SI, 2010, PROSTAG LEUKOTR ESS, V82, P273, DOI 10.1016/j.plefa.2010.02.015
   Rapoport SI, 2009, PROSTAG LEUKOTR ESS, V81, P119, DOI 10.1016/j.plefa.2009.05.021
   Rosell MS, 2005, AM J CLIN NUTR, V82, P327
   SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903
   Serhan CN, 2004, PROSTAG OTH LIPID M, V73, P155, DOI 10.1016/j.prostaglandins.2004.03.005
   Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9
   Su HM, 2001, J LIPID RES, V42, P581
   Uauy R, 2001, LIPIDS, V36, P885, DOI 10.1007/s11745-001-0798-1
   VANCE JE, 1990, ANNU REV NUTR, V10, P337
   Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200
   Welch AA, 2010, AM J CLIN NUTR, V92, P1040, DOI 10.3945/ajcn.2010.29457
NR 48
TC 13
Z9 13
U1 1
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1388-1981
EI 0006-3002
J9 BBA-MOL CELL BIOL L
JI Biochim. Biophys. Acta Mol. Cell Biol. Lipids
PD JUL-AUG
PY 2011
VL 1811
IS 7-8
BP 484
EP 489
DI 10.1016/j.bbalip.2011.05.008
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 794ZM
UT WOS:000292941300008
PM 21651989
DA 2018-12-27
ER

PT J
AU Derosa, G
   Maffioli, P
   D'Angelo, A
   Fogari, E
   Bianchi, L
   Cicero, AFG
AF Derosa, Giuseppe
   Maffioli, Pamela
   D'Angelo, Angela
   Fogari, Elena
   Bianchi, Lucia
   Cicero, Arrigo F. G.
TI RETRACTED: Acarbose on insulin resistance after an oral fat load: a
   double-blind, placebo controlled study (Retracted article. See vol. 31,
   pg. 1248, 2017)
SO JOURNAL OF DIABETES AND ITS COMPLICATIONS
LA English
DT Article; Retracted Publication
DE Acarbose; Oral fat load; Insulin resistance; Adiponectin; Resistin
ID TYPE-2 DIABETIC-PATIENTS; ISCHEMIC-HEART-DISEASE; MYOCARDIAL-INFARCTION;
   ANTIDIABETIC AGENTS; GLUCOSE-TOLERANCE; EUROPEAN-SOCIETY; TASK-FORCE;
   FACTOR-VII; TNF-ALPHA; OBESITY
AB Aim: We evaluated the effects of acarbose on insulin resistance parameters in diabetic patients before and after a standardized oral fat load (OFL).
   Materials and methods: Patients were assigned to take acarbose 50 mg three times a day or placebo; after the first month, acarbose was titrated to 100 mg three times a day. We evaluated body mass index, glycemic control, fasting plasma insulin (FPI), post-prandial plasma insulin (PPI), homeostasis model assessment insulin resistance index (HOMA-IR), blood pressure, lipid profile, retinol binding protein-4 (RBP-4), adiponectin (ADN), tumor necrosis factor-a and resistin (r). Furthermore, at the baseline and at the end of the study, all patients underwent an OFL and an euglycemic hyperinsulinemic clamp.
   Results: We observed that acarbose was better than placebo in improving glycemic control and HOMA-IR and that it was also more effective in improving lipid profile, RBP-4 and ADN. Regarding FPI, PPI and r, we did not obtain any significant differences between the two groups. During the second OFL, performed after 7 months of therapy with acarbose, we observed a significant decrease of blood glucose, lipid profile and all insulin resistance parameters peaks compared with the OFL administered at baseline with acarbose, but not with placebo.
   Conclusion: Acarbose was more effective than placebo in improving glycemic and lipid profile and in reducing the post-OFL peaks of the various parameters including the insulin resistance biomarkers. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Derosa, Giuseppe; Maffioli, Pamela; D'Angelo, Angela; Fogari, Elena; Bianchi, Lucia; Cicero, Arrigo F. G.] Univ Pavia, Dept Internal Med & Therapeut, I-27100 Pavia, Italy.
RP Derosa, G (reprint author), Univ Pavia, Dept Internal Med & Therapeut, Ple C Golgi 2, I-27100 Pavia, Italy.
EM giuseppe.derosa@unipv.it
RI Maffioli, Pamela/E-9753-2012; Derosa, Giuseppe/F-2615-2012
OI Maffioli, Pamela/0000-0002-4285-6507; Derosa,
   Giuseppe/0000-0003-3573-4760; D'Angelo, Angela/0000-0003-3008-9264;
   Bianchi, Lucio/0000-0003-3620-6951; Fogari, Elena/0000-0002-9446-7546;
   Cicero, Arrigo/0000-0002-4367-3884
CR Alipour A, 2007, BIOCHEM SOC T, V35, P466, DOI 10.1042/BST0350466
   Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004
   Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0
   Bouskila M, 2005, INT J OBESITY, V29, pS17, DOI 10.1038/sj.ijo.0802908
   Bulcao C, 2006, CURR DIABETES REV, V2, P19, DOI 10.2174/157339906775473617
   Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360
   DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
   Delgado H, 2002, DIABETES METAB, V28, P195
   Derosa G, 2010, J CLIN PHARM THER, V35, P565, DOI 10.1111/j.1365-2710.2009.01132.x
   Derosa G, 2011, METABOLISM, V60, P421, DOI 10.1016/j.metabol.2010.03.010
   Derosa G, 2010, INTERNAL MED, V49, P1717, DOI 10.2169/internalmedicine.49.3401
   Derosa G, 2010, MICROVASC RES, V80, P110, DOI 10.1016/j.mvr.2010.03.012
   Derosa G, 2010, HYPERTENS RES, V33, P209, DOI 10.1038/hr.2009.212
   Derosa G, 2009, BIOMED PHARMACOTHER, V63, P723, DOI 10.1016/j.biopha.2009.04.044
   Derosa G, 2009, CURR MED RES OPIN, V25, P607, DOI [10.1185/03007990802711024, 10.1185/03007990802711024 ]
   Derosa G, 2009, HEART VESSELS, V24, P204, DOI 10.1007/s00380-008-1109-y
   FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605
   GOTTO AM, 2003, ILIB LIPID HDB CLIN, P1
   Halkes CJM, 2001, ARTERIOSCL THROM VAS, V21, P1526, DOI 10.1161/hq0901.095276
   Hanefeld M, 2004, EUR HEART J, V25, P10, DOI 10.1016/S0195-668X(03)00468-8
   Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Jackson MB, 2006, CLIN SCI, V110, P143, DOI 10.1042/CS20050243
   Jastrzebska M, 1999, NUTR METAB CARDIOVAS, V9, P33
   KARPE F, 1994, ATHEROSCLEROSIS, V106, P83, DOI 10.1016/0021-9150(94)90085-X
   Kinoshita T, 2000, CURR THER RES CLIN E, V61, P97, DOI 10.1016/S0011-393X(00)88531-8
   Krentz AJ, 2005, DRUGS, V65, P385, DOI 10.2165/00003495-200565030-00005
   Lichtenstein AH, 2006, ARTERIOSCL THROM VAS, V26, P2186, DOI 10.1161/01.ATV.0000238352.25222.5e
   Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724
   Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d
   Norata GD, 2007, ATHEROSCLEROSIS, V193, P321, DOI 10.1016/j.atherosclerosis.2006.09.015
   Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299
   Papanas N, 2009, CURR PHARM DESIGN, V15, P3179, DOI 10.2174/138161209789057995
   Parks E J, 2001, Curr Atheroscler Rep, V3, P462, DOI 10.1007/s11883-001-0036-5
   Rangwala SM, 2004, DIABETES, V53, P1937, DOI 10.2337/diabetes.53.8.1937
   Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43
   Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]
   Satoh H, 2004, J CLIN INVEST, V114, P224, DOI 10.1172/JCI200420785
   SILVEIRA A, 1994, ARTERIOSCLER THROMB, V14, P60, DOI 10.1161/01.ATV.14.1.60
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Tsai WC, 2004, CLIN SCI, V106, P315, DOI 10.1042/CS20030227
   Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335
   Winer B. J., 1971, STAT PRINCIPLES EXPT
NR 43
TC 16
Z9 18
U1 2
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8727
EI 1873-460X
J9 J DIABETES COMPLICAT
JI J. Diabetes Complications
PD JUL-AUG
PY 2011
VL 25
IS 4
BP 258
EP 266
DI 10.1016/j.jdiacomp.2011.01.003
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 796GW
UT WOS:000293040800010
PM 21367625
DA 2018-12-27
ER

PT J
AU Anderson, TD
   Robson, SA
   Jiang, XW
   Malmirchegini, GR
   Fierobe, HP
   Lazazzera, BA
   Clubb, RT
AF Anderson, Timothy D.
   Robson, Scott A.
   Jiang, Xiao Wen
   Malmirchegini, G. Reza
   Fierobe, Henri-Pierre
   Lazazzera, Beth A.
   Clubb, Robert T.
TI RETRACTED: Assembly of Minicellulosomes on the Surface of Bacillus
   subtilis (Retracted article. See vol. 84, unsp. e02429-17, 2018)
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article; Retracted Publication
ID THERMOCELLUM ENDOGLUCANASE CELD; EXTRACELLULAR SIGNALING PEPTIDE;
   COHESIN-DOCKERIN INTERACTION; INTEGRATING PROTEIN CIPA; WALL-ASSOCIATED
   PROTEASE; CLOSTRIDIUM-THERMOCELLUM; LIGNOCELLULOSIC BIOMASS;
   SACCHAROMYCES-CEREVISIAE; SYNERGISTIC INTERACTION; CELLULOSE HYDROLYSIS
AB To cost-efficiently produce biofuels, new methods are needed to convert lignocellulosic biomass into fermentable sugars. One promising approach is to degrade biomass using cellulosomes, which are surface-displayed multicellulase-containing complexes present in cellulolytic Clostridium and Ruminococcus species. In this study we created cellulolytic strains of Bacillus subtilis that display one or more cellulase enzymes. Proteins containing the appropriate cell wall sorting signal are covalently anchored to the peptidoglycan by coexpressing them with the Bacillus anthracis sortase A (SrtA) transpeptidase. This approach was used to covalently attach the Cel8A endoglucanase from Clostridium thermocellum to the cell wall. In addition, a Cel8A-dockerin fusion protein was anchored on the surface of B. subtilis via noncovalent interactions with a cell wall-attached cohesin module. We also demonstrate that it is possible to assemble multienzyme complexes on the cell surface. A three-enzyme-containing minicellulosome was displayed on the cell surface; it consisted of a cell wall-attached scaffoldin protein noncovalently bound to three cellulase-dockerin fusion proteins that were produced in Escherichia coli. B. subtilis has a robust genetic system and is currently used in a wide range of industrial processes. Thus, grafting larger, more elaborate minicellulosomes onto the surface of B. subtilis may yield cellulolytic bacteria with increased potency that can be used to degrade biomass.
C1 [Anderson, Timothy D.; Jiang, Xiao Wen; Malmirchegini, G. Reza; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.
   [Clubb, Robert T.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA.
   [Lazazzera, Beth A.; Clubb, Robert T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.
   [Lazazzera, Beth A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Fierobe, Henri-Pierre] CNRS, Chim Bacterienne Lab, IFR88, F-13277 Marseille, France.
RP Clubb, RT (reprint author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles E Young Dr, Los Angeles, CA 90095 USA.
EM rclubb@mbi.ucla.edu
FU National Institutes of Health [AI52217]; Department of Energy
   [DE-FC-03-87ER60615]
FX This work was supported in part by National Institutes of Health grant
   AI52217 and Department of Energy grant DE-FC-03-87ER60615.
CR BAYER EA, 1985, J BACTERIOL, V163, P552
   BAYER EA, 1994, TRENDS BIOTECHNOL, V12, P379, DOI 10.1016/0167-7799(94)90039-6
   Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065
   BRON S, 1990, MOL BIOL METHODS BAC, P75
   Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200
   Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125
   Caspi J, 2008, J BIOTECHNOL, V135, P351, DOI 10.1016/j.jbiotec.2008.05.003
   Cha J, 2007, J MICROBIOL BIOTECHN, V17, P1782
   Chang MCY, 2007, CURR OPIN CHEM BIOL, V11, P677, DOI 10.1016/j.cbpa.2007.08.039
   Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94
   Ciruela A, 1998, FEBS LETT, V422, P221, DOI 10.1016/S0014-5793(97)01590-1
   Doi RH, 2008, ANN NY ACAD SCI, V1125, P267, DOI 10.1196/annals.1419.002
   Ferreira LCS, 2005, AN ACAD BRAS CIENC, V77, P113, DOI 10.1590/S0001-37652005000100009
   Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200
   Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200
   Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603
   FRANCISCO JA, 1993, BIO-TECHNOL, V11, P491, DOI 10.1038/nbt0493-491
   Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005
   Gomez LD, 2008, NEW PHYTOL, V178, P473, DOI 10.1111/j.1469-8137.2008.02422.x
   Haimovitz R, 2008, PROTEOMICS, V8, P968, DOI 10.1002/pmic.200700486
   Harris D, 2010, PLANT BIOTECHNOL J, V8, P244, DOI 10.1111/j.1467-7652.2009.00481.x
   Harwood CR, 2008, TRENDS MICROBIOL, V16, P73, DOI 10.1016/j.tim.2007.12.001
   Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027
   Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016
   HSU JC, 1991, J AGR FOOD CHEM, V39, P1444, DOI 10.1021/jf00008a016
   JOLIFF G, 1989, APPL ENVIRON MICROB, V55, P2739
   Jung KH, 1998, J GEN APPL MICROBIOL, V44, P107, DOI 10.2323/jgam.44.107
   Kerr RA, 2008, SCIENCE, V322, P1178, DOI 10.1126/science.322.5905.1178
   Kim JH, 2005, BIOCHEM BIOPH RES CO, V334, P1248, DOI 10.1016/j.bbrc.2005.07.024
   Kim TH, 2009, METHODS MOL BIOL, V581, P79, DOI 10.1007/978-1-60761-214-8_6
   Kim Y, 2009, METHODS MOL BIOL, V581, P93, DOI 10.1007/978-1-60761-214-8_7
   Kim YS, 2000, APPL ENVIRON MICROB, V66, P788, DOI 10.1128/AEM.66.2.788-793.2000
   Lanigan-Gerdes S, 2008, J BACTERIOL, V190, P6668, DOI 10.1128/JB.00910-08
   Lanigan-Gerdes S, 2007, MOL MICROBIOL, V65, P1321, DOI 10.1111/j.1365-2958.2007.05869.x
   Lee SJ, 2000, APPL ENVIRON MICROB, V66, P476, DOI 10.1128/AEM.66.2.476-480.2000
   Lilly M, 2009, FEMS YEAST RES, V9, P1236, DOI 10.1111/j.1567-1364.2009.00564.x
   Lu YP, 2006, P NATL ACAD SCI USA, V103, P16165, DOI 10.1073/pnas.0605381103
   Maki M, 2009, INT J BIOL SCI, V5, P500
   Margeot A, 2009, CURR OPIN BIOTECH, V20, P372, DOI 10.1016/j.copbio.2009.05.009
   Margot P, 1996, MICROBIOL-UK, V142, P3437, DOI 10.1099/13500872-142-12-3437
   Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006
   Matsuoka S, 2007, J BACTERIOL, V189, P7190, DOI 10.1128/JB.00842-07
   Miller PS, 2010, ENVIRON TECHNOL, V31, P1005, DOI 10.1080/09593330903536113
   Mingardon F, 2007, APPL ENVIRON MICROB, V73, P7138, DOI 10.1128/AEM.01306-07
   Miras I, 2002, BIOCHEMISTRY-US, V41, P2115, DOI 10.1021/bi011854e
   Nguyen HD, 2006, J BIOTECHNOL, V122, P473, DOI 10.1016/j.jbiotec.2005.09.012
   Oussenko IA, 2004, J BACTERIOL, V186, P5376, DOI 10.1128/JB.186.16.5376-5383.2004
   Pages S, 1997, PROTEINS, V29, P517, DOI 10.1002/(SICI)1097-0134(199712)29:4<517::AID-PROT11>3.3.CO;2-I
   PEREGO M, 1988, MOL MICROBIOL, V2, P689, DOI 10.1111/j.1365-2958.1988.tb00079.x
   Pinheiro BA, 2009, BIOCHEM J, V424, P375, DOI 10.1042/BJ20091152
   Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005
   ROBSON LM, 1984, APPL ENVIRON MICROB, V47, P1039
   Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190
   SALAMITOU S, 1994, J BACTERIOL, V176, P2822
   Schaeffer F, 2002, BIOCHEMISTRY-US, V41, P2106, DOI 10.1021/bi011853m
   SCHAEFLER S, 1969, J BACTERIOL, V99, P434
   Schallmey M, 2004, CAN J MICROBIOL, V50, P1, DOI [10.1139/w03-076, 10.1139/W03-076]
   SCHWARZ WH, 1986, APPL ENVIRON MICROB, V51, P1293
   Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x
   Stephenson K, 1998, APPL ENVIRON MICROB, V64, P2875
   THAYER DW, 1978, J GEN MICROBIOL, V106, P13, DOI 10.1099/00221287-106-1-13
   Tobisch S, 1997, J BACTERIOL, V179, P496, DOI 10.1128/jb.179.2.496-506.1997
   TOKATLIDIS K, 1991, FEBS LETT, V291, P185, DOI 10.1016/0014-5793(91)81279-H
   Tsai SL, 2009, APPL ENVIRON MICROB, V75, P6087, DOI 10.1128/AEM.01538-09
   Wen F, 2010, APPL ENVIRON MICROB, V76, P1251, DOI 10.1128/AEM.01687-09
   Westers L, 2004, BBA-MOL CELL RES, V1694, P299, DOI 10.1016/j.bbammcr.2004.02.011
   Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007
   Wu SC, 2002, APPL ENVIRON MICROB, V68, P3261, DOI 10.1128/AEM.68.7.3261-3269.2002
   Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0
   Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003
   Zhao XB, 2009, APPL MICROBIOL BIOT, V82, P815, DOI 10.1007/s00253-009-1883-1
   Zverlov VV, 2005, PROTEOMICS, V5, P3646, DOI 10.1002/pmic.200401199
NR 72
TC 30
Z9 30
U1 1
U2 21
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD JUL
PY 2011
VL 77
IS 14
BP 4849
EP 4858
DI 10.1128/AEM.02599-10
PG 10
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 789IZ
UT WOS:000292510400017
PM 21622797
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Prasad, S
   Pandey, MK
   Yadav, VR
   Aggarwal, BB
AF Prasad, Sahdeo
   Pandey, Manoj K.
   Yadav, Vivek R.
   Aggarwal, Bharat B.
TI RETRACTED: Gambogic Acid Inhibits STAT3 Phosphorylation through
   Activation of Protein Tyrosine Phosphatase SHP-1: Potential Role in
   Proliferation and Apoptosis (Retracted article. See vol. 11, pg. 593,
   2018)
SO CANCER PREVENTION RESEARCH
LA English
DT Article; Retracted Publication
ID NF-KAPPA-B; TRANSCRIPTASE MESSENGER-RNA; MULTIPLE-MYELOMA CELLS;
   BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; CONSTITUTIVE ACTIVATION;
   TRANSFERRIN RECEPTOR; SIGNALING PATHWAY; MOLECULAR TARGETS; IN-VITRO
AB The transcription factor, STAT3, is associated with proliferation, survival, and metastasis of cancer cells. We investigated whether gambogic acid (GA), a xanthone derived from the resin of traditional Chinese medicine, Garcinia hanburyi (mangosteen), can regulate the STAT3 pathway, leading to suppression of growth and sensitization of cancer cells. We found that GA induced apoptosis in human multiple myeloma cells that correlated with the inhibition of both constitutive and inducible STAT3 activation. STAT3 phosphorylation at both tyrosine residue 705 and serine residue 727 was inhibited by GA. STAT3 suppression was mediated through the inhibition of activation of the protein tyrosine kinases Janus-activated kinase 1 (JAK1) and JAK2. Treatment with the protein tyrosine phosphatase (PTP) inhibitor pervanadate reversed the GA-induced downregulation of STAT3, suggesting the involvement of a PTP. We also found that GA induced the expression of the PTP SHP-1. Deletion of the SHP-1 gene by siRNA suppressed the ability of GA to inhibit STAT3 activation and to induce apoptosis, suggesting the critical role of SHP-1 in its action. Moreover, GA downregulated the expression of STAT3-regulated antiapoptotic (Bcl-2, Bcl-xL, and Mcl-1), proliferative (cyclin D1), and angiogenic (VEGF) proteins, and this correlated with suppression of proliferation and induction of apoptosis. Overall, these results suggest that GA blocks STAT3 activation, leading to suppression of tumor cell proliferation and induction of apoptosis. Cancer Prev Res; 4(7); 1084-94. (C)2011 AACR.
C1 [Prasad, Sahdeo; Pandey, Manoj K.; Yadav, Vivek R.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Pandey, Manoj/K-9706-2015; Aggarwal, Bharat/G-3388-2013
OI Pandey, Manoj/0000-0002-2767-2929; 
FU Clayton Foundation for Research; NIH [CA-106672, CA-124787-01A2]; Center
   for Targeted Therapy of MD Anderson Cancer Center
FX This work was supported by a grant from the Clayton Foundation for
   Research (B.B. Aggarwal), a core grant from the NIH (CA-106672), a
   program project grant from NIH (CA-124787-01A2), and a grant from Center
   for Targeted Therapy of MD Anderson Cancer Center.
CR Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063
   Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x
   Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604
   Berclaz G, 2001, INT J ONCOL, V19, P1155
   Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863
   Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898
   Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527
   Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5
   Buettner R, 2002, CLIN CANCER RES, V8, P945
   Chen J, 2008, LIFE SCI, V83, P103, DOI 10.1016/j.lfs.2008.05.003
   Chim CS, 2004, BLOOD, V103, P4630, DOI 10.1182/blood-2003-06-2007
   Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749
   Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074
   Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267
   Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752
   Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005
   Gu HG, 2008, INT IMMUNOPHARMACOL, V8, P1493, DOI 10.1016/j.intimp.2008.05.013
   Gu HY, 2009, J CANCER RES CLIN, V135, P1777, DOI 10.1007/s00432-009-0624-2
   Gunaje JJ, 2001, BIOCHEM BIOPH RES CO, V288, P252, DOI 10.1006/bbrc.2001.5759
   Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434
   He D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-343
   IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0
   Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221
   Kasibhatla S, 2005, P NATL ACAD SCI USA, V102, P12095, DOI 10.1073/pnas.0406731102
   Kim HK, 1998, MOL CELL BIOL, V18, P1525, DOI 10.1128/MCB.18.3.1525
   Li R, 2009, TOXICOLOGY, V262, P98, DOI 10.1016/j.tox.2009.04.059
   Lu N, 2007, CANCER LETT, V258, P80, DOI 10.1016/j.canlet.2007.08.015
   LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872
   Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A
   MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283
   Mu R, 2010, EUR J CANCER PREV, V19, P61, DOI 10.1097/CEJ.0b013e328333fb22
   Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090
   Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859
   Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj/onc/1205260
   Pandey MK, 2007, BLOOD, V110, P3517, DOI 10.1182/blood-2007-03-079616
   Pandey MK, 2010, INT J CANCER, V127, P282, DOI 10.1002/ijc.25059
   Pedranzini L, 2004, J CLIN INVEST, V114, P619, DOI 10.1172/JCI200422800
   Peeters SDPWM, 2005, MED ONCOL, V22, P183, DOI 10.1385/MO:22:2:183
   Qin YX, 2007, MOL CANCER THER, V6, P2429, DOI 10.1158/1535-7163.MCT-07-0147
   Rong JJ, 2010, CANCER LETT, V296, P55, DOI 10.1016/j.canlet.2010.03.016
   Sun S, 2002, J GEN VIROL, V83, P1651, DOI 10.1099/0022-1317-83-7-1651
   Tharappel JC, 2002, TOXICOL APPL PHARM, V179, P172, DOI 10.1006/taap.2001.9360
   Vultur A, 2005, MOL BIOL CELL, V16, P3832, DOI 10.1091/mbc.E04-12-1104
   Wang TT, 2008, CANCER LETT, V262, P214, DOI 10.1016/j.canlet.2007.12.004
   Wang X, 2009, PROTEOMICS, V9, P242, DOI 10.1002/pmic.200800155
   Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1190(03)00400-1
   Wu ZQ, 2004, BIOL PHARM BULL, V27, P1769, DOI 10.1248/bpb.27.1769
   Xu XY, 2009, INT J DERMATOL, V48, P186, DOI 10.1111/j.1365-4632.2009.03946.x
   Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X
   Yang Q. Z., 1994, CHIN J CLIN ONCOL, V21, P464
   Yi T, 2008, CANCER RES, V68, P1843, DOI 10.1158/0008-5472.CAN-07-5944
   YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555
   Yu J, 2006, CANCER CHEMOTH PHARM, V58, P434, DOI 10.1007/s00280-005-0177-2
   Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588
   Zhao L, 2004, BIOL PHARM BULL, V27, P998, DOI 10.1248/bpb.27.998
   Zhu XL, 2009, J CHEMOTHERAPY, V21, P666, DOI 10.1179/joc.2009.21.6.666
NR 56
TC 34
Z9 38
U1 2
U2 11
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1940-6207
EI 1940-6215
J9 CANCER PREV RES
JI Cancer Prev. Res.
PD JUL
PY 2011
VL 4
IS 7
BP 1084
EP 1094
DI 10.1158/1940-6207.CAPR-10-0340
PG 11
WC Oncology
SC Oncology
GA 788MN
UT WOS:000292449200016
PM 21490133
OA Bronze, Green Accepted
DA 2018-12-27
ER

PT J
AU Ramirez-Fernandez, MP
   Calvo-Guirado, JL
   Delgado-Ruiz, RA
   del Val, JEMS
   Gomez-Moreno, G
   Guardia, J
AF Piedad Ramirez-Fernandez, Ma
   Luis Calvo-Guirado, Jose
   Arcesio Delgado-Ruiz, Rafael
   Eduardo Mate-Sanchez del Val, Jose
   Gomez-Moreno, Gerardo
   Guardia, Javier
TI RETRACTED: Experimental model of bone response to xenografts of bovine
   origin (Endobon (R)): a radiological and histomorphometric study
   (Retracted article. See vol. 29, pg. 665, 2018)
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article; Retracted Publication
DE biomaterial; bone graft; bovine graft; xenografts
ID MAXILLARY SINUS AUGMENTATION; POROUS HYDROXYAPATITE; SPONGIFORM
   ENCEPHALOPATHY; IMPLANT PLACEMENT; DENTAL IMPLANTS; GRAFTS;
   RECONSTRUCTION; REGENERATION; BIOMATERIAL; SUBSTITUTE
AB Objective: To carry out a radiological and histomorphometric evaluation of bone response to bovine bone implants inserted in rabbits' tibiae.
   Materials and methods: Twenty New Zealand rabbits weighing 3900-4500 g were used. Twenty bovine bone implants (Endobon (R)) in granulated form of 500-1000 mu m granulometry were inserted in the proximal metaphyseal area of the animals' right tibia and 20 control areas were located in the proximal metaphyseal area. Following implantation, the animals were sacrificed in four groups of five, after 1 month, 2 months, 3 months and 4 months, respectively. Anteroposterior and lateral radiographs were taken. Samples were sectioned at 5 mu m and stained using Hematoxylin Eosin and Masson's trichromic.
   Results: After 4 months, radiological images showed complete repair of the bone defects. No healed or residual bone alterations attributable to the presence of the implant were observed. Histomorphometric analysis at 4 months showed the presence of a higher density of newly formed bone with mean values for new bone, residual graft material and non-mineralized connective tissue of 22.8 +/- 1.5%, 39.4 +/- 2.3% and 37.7 +/- 2.5%. There were no statistically significant differences in the length of cortical formation with bovine bone, 98.8 +/- 1.1%, compared with the control group, 99.1 +/- 0.7%, at the end of the study period.
   Conclusions: The biomaterial used in the study was shown to be biocompatible, osteoconductive and non-resorbable and as such a possible bone substitute that does not interfere with normal reparative bone processes.
C1 [Piedad Ramirez-Fernandez, Ma; Luis Calvo-Guirado, Jose] Univ Murcia, Fac Med & Dent, Dept Implant Dent, Murcia 30007, Spain.
   [Arcesio Delgado-Ruiz, Rafael; Eduardo Mate-Sanchez del Val, Jose] Univ Murcia, Fac Med & Dent, Dept Restorat Dent, Murcia 30007, Spain.
   [Gomez-Moreno, Gerardo; Guardia, Javier] Univ Granada, Sch Dent, Dept Pharmacol Interact, Granada, Spain.
RP Ramirez-Fernandez, MP (reprint author), Univ Murcia, Hosp Morales Meseguer, Fac Med & Dent, Dept Gen Dent, 2 Floor,Calle Marques de los Velez, Murcia 30007, Spain.
EM mpramirezfern@hotmail.com
RI Gomez-Moreno, Gerardo/L-8123-2014; Mate Sanchez de Va, Jose
   Eduardo/R-9750-2018
OI Gomez-Moreno, Gerardo/0000-0001-9094-4985; Mate Sanchez de Va, Jose
   Eduardo/0000-0002-4216-421X; RAMIREZ FERNANDEZ, MARIA
   PIEDAD/0000-0003-1913-9902
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Arcuri C, 2005, Minerva Stomatol, V54, P351
   Baer W, 2002, J HAND SURG-BRIT EUR, V27B, P101, DOI 10.1054/jhsb.2001.0686
   Bareille R, 2000, BIOMATERIALS, V21, P1345, DOI 10.1016/S0142-9612(00)00015-6
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Barone A, 2007, J ORAL MAXIL SURG, V65, P2039, DOI 10.1016/j.joms.2007.05.017
   Briem D, 2002, UNFALLCHIRURG, V105, P128, DOI 10.1007/s001130100303
   Cricchio Giovanni, 2003, Clin Implant Dent Relat Res, V5, P161, DOI 10.1111/j.1708-8208.2003.tb00198.x
   Cutter C Suzanne, 2006, J Long Term Eff Med Implants, V16, P249
   Di Stefano DA, 2009, CLIN IMPLANT DENT R, V11, P90, DOI 10.1111/j.1708-8208.2008.00104.x
   Ersanli S, 2004, J PERIODONTOL, V75, P750, DOI 10.1902/jop.2004.75.5.750
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Esposito M, 2010, EUR J ORAL IMPLANTOL, V3, P7
   Gierse H, 1999, ARCH ORTHOP TRAUM SU, V119, P349, DOI 10.1007/s004020050426
   Grimm J, 2001, ARCH ORTHOP TRAUM SU, V121, P158, DOI 10.1007/s004020000194
   Hing KA, 2004, J BIOMED MATER RES A, V68A, P187, DOI 10.1002/jbm.a.10050
   Hing KA, 1997, J MATER SCI-MATER M, V8, P731, DOI 10.1023/A:1018500309969
   Hising P, 2001, INT J ORAL MAX IMPL, V16, P90
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   Johansson LA, 2010, J ORAL MAXIL SURG, V68, P837, DOI 10.1016/j.joms.2009.07.093
   Kehr P, 2000, EUR J ORTHOP SURG TR, V10, P217
   Khodadadyan-Klostermann C, 2002, Acta Chir Orthop Traumatol Cech, V69, P16
   Lang NP, 2000, PLAST RECONSTR SURG, V105, P2273, DOI 10.1097/00006534-200005000-00074
   Liebendorfer A, 1997, Unfallchirurgie, V23, P60, DOI 10.1007/BF02628151
   Liljensten Elisabeth, 2003, Clin Implant Dent Relat Res, V5, P95, DOI 10.1111/j.1708-8208.2003.tb00190.x
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Motomiya M, 2007, EUR SPINE J, V16, P2215, DOI 10.1007/s00586-007-0501-0
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P514, DOI 10.1034/j.1600-0501.2002.130511.x
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Santos FA, 2010, CLIN IMPLANT DENT R, V12, P18, DOI 10.1111/j.1708-8208.2008.00126.x
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schnettler R, 1998, ORTHOPADE, V27, P80
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   van Steenberghe D, 2000, CLIN ORAL IMPLAN RES, V11, P210, DOI 10.1034/j.1600-0501.2000.011003210.x
   Wenz B, 2001, BIOMATERIALS, V22, P1599, DOI 10.1016/S0142-9612(00)00312-4
   Werber KD, 2000, J HAND SURG-AM, V25A, P833, DOI 10.1053/jhsu.2000.16354
   Wiltfang J, 1996, J CRANIO MAXILL SURG, V24, P300, DOI 10.1016/S1010-5182(96)80063-1
   Worth A, 2005, CLIN ORAL IMPLAN RES, V16, P379, DOI 10.1111/j.1600-0501.2005.01113.x
   Yamamichi N, 2008, INT J PERIODONT REST, V28, P163
NR 44
TC 9
Z9 10
U1 1
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUL
PY 2011
VL 22
IS 7
BP 727
EP 734
DI 10.1111/j.1600-0501.2010.02052.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 788ID
UT WOS:000292437700009
PM 21198892
DA 2018-12-27
ER

PT J
AU Ramirez-Fernandez, MP
   Calvo-Guirado, JL
   Delgado-Ruiz, RA
   del Val, JEMS
   Vicente-Ortega, V
   Meseguer-Olmos, L
AF Piedad Ramirez-Fernandez, Ma
   Luis Calvo-Guirado, Jose
   Arcesio Delgado-Ruiz, Rafael
   Eduardo Mate-Sanchez del Val, Jose
   Vicente-Ortega, Vicente
   Meseguer-Olmos, Luis
TI RETRACTED: Bone response to hydroxyapatites with open porosity of animal
   origin (porcine [OsteoBiol (R) mp3] and bovine [Endobon (R)]): a
   radiological and histomorphometric study (Retracted article. See vol.
   29, pg. 666, 2018)
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article; Retracted Publication
DE biomaterial; bone graft; bovine graft; bovine xenograft; porcine graft;
   porcine xenograft; xenografts
ID ALVEOLAR RIDGE; AUGMENTATION; BIOMATERIAL; IMPLANTS; EFFICACY; INGROWTH;
   DEFECTS; GRAFTS
AB Purpose: To carry out a radiological and histomorphometric evaluation of bone response to two xenografts of animal origin, one porcine, and the other bovine, inserted in rabbits' tibiae.
   Material and methods: Twenty New Zealand rabbits weighing 3900-4500 g were used. Twenty bovine bone grafts (Endobon (R)) in granulated form of 500-1000 mu m granulometry were inserted in the proximal metaphyseal area of the animals' right tibia, and 20 porcine bone grafts (OsteoBiol (R) Mp3) in granulated form of 600-1000 mu m granulometry were inserted in the proximal metaphyseal area of the animals' left tibia. Following graft insertion, the animals were sacrificed in four groups of five, after 1, 2, 3 and 4 months, respectively. Anteroposterior and lateral radiographs were taken. Samples were processed for observation under light microscopy. Histomorphometric measurements were presented as mean values +/- standard deviations.
   Results: At 4 months after treatment, the bone defects displayed radiological images that showed complete repair of osseous defects. Histomorphometric evaluation showed that for the porcine xenograft, the study averages for newly formed bone represented 22.8 +/- 1.8%, for residual graft material 23.6 +/- 3% and for connective tissue 53.5 +/- 2.5%, while for the bovine xenograft newly formed bone represented 23.1 +/- 1.8%, residual graft material 39.4 +/- 3% and non-mineralized connective tissue 37.5 +/- 2.5%.
   Conclusions: The biomaterials assessed in the study were shown to be biocompatible and osteoconductive. Collagenized porcine xenografts proved more resorbable than bovine xenografts. Both can be used as possible bone substitutes without interfering with normal reparative bone processes.
C1 [Piedad Ramirez-Fernandez, Ma; Luis Calvo-Guirado, Jose] Univ Murcia, Dept Implant Dent, Fac Med & Dent, Murcia 30007, Spain.
   [Arcesio Delgado-Ruiz, Rafael; Eduardo Mate-Sanchez del Val, Jose] Univ Murcia, Dept Restorat Dent, Fac Med & Dent, Murcia 30007, Spain.
   [Vicente-Ortega, Vicente] Univ Murcia, Fac Med, Dept Pathol, Inst Aging, Murcia 30007, Spain.
   [Meseguer-Olmos, Luis] Univ Murcia, Fac Med, Univ Hosp Virgen de la Arrixaca, Dept Traumatol, Murcia 30007, Spain.
RP Ramirez-Fernandez, MP (reprint author), Univ Murcia, Hosp Morales Meseguer, Fac Med & Dent, Dept Gen Dent, 2 Floor,Calle Marques de los Velez S-N, Murcia 30007, Spain.
EM mpramirezfern@hotmail.com
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X; RAMIREZ FERNANDEZ,
   MARIA PIEDAD/0000-0003-1913-9902; Meseguer-Olmo,
   Luis/0000-0003-3858-8148
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Arcuri C, 2005, Minerva Stomatol, V54, P351
   Barone A, 2007, J ORAL MAXIL SURG, V65, P2039, DOI 10.1016/j.joms.2007.05.017
   Briem D, 2002, UNFALLCHIRURG, V105, P128, DOI 10.1007/s001130100303
   Cardaropoli D, 2008, INT J PERIODONT REST, V28, P469
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Hing KA, 2004, J BIOMED MATER RES A, V68A, P187, DOI 10.1002/jbm.a.10050
   Kehr P, 2000, EUR J ORTHOP SURG TR, V10, P217
   Kim SH, 2004, J BIOMED MATER RES B, V68B, P69, DOI 10.1002/jbm.b.10084
   Liebendorfer A, 1997, Unfallchirurgie, V23, P60, DOI 10.1007/BF02628151
   Liljensten Elisabeth, 2003, Clin Implant Dent Relat Res, V5, P95, DOI 10.1111/j.1708-8208.2003.tb00190.x
   Motomiya M, 2007, EUR SPINE J, V16, P2215, DOI 10.1007/s00586-007-0501-0
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P514, DOI 10.1034/j.1600-0501.2002.130511.x
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Santos FA, 2010, CLIN IMPLANT DENT R, V12, P18, DOI 10.1111/j.1708-8208.2008.00126.x
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83
   Scarano A, 2011, CLIN IMPLANT DENT R, V13, P13, DOI 10.1111/j.1708-8208.2009.00176.x
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Wang W, 2009, ACTA BIOMATER, V5, P3132, DOI 10.1016/j.actbio.2009.04.036
   Werber KD, 2000, J HAND SURG-AM, V25A, P833, DOI 10.1053/jhsu.2000.16354
   Worth A, 2005, CLIN ORAL IMPLAN RES, V16, P379, DOI 10.1111/j.1600-0501.2005.01113.x
   Yamada Y, 2008, CLIN ORAL IMPLAN RES, V19, P1003, DOI 10.1111/j.1600-0501.2008.01554.x
NR 26
TC 24
Z9 25
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUL
PY 2011
VL 22
IS 7
BP 767
EP 773
DI 10.1111/j.1600-0501.2010.02058.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 788ID
UT WOS:000292437700014
PM 21244497
DA 2018-12-27
ER

PT J
AU Stapel, DA
   van der Linde, LAJG
AF Stapel, Diederik A.
   van der Linde, Lonneke A. J. G.
TI RETRACTED: What Drives Self-Affirmation Effects? On the Importance of
   Differentiating Value Affirmation and Attribute Affirmation (Retracted
   article. See vol. 103, pg. 505, 2012)
SO JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY
LA English
DT Article; Retracted Publication
DE self-affirmation; self-clarity; self-esteem; cognitive dissonance;
   social comparison
ID MORTALITY SALIENCE; SOCIAL COMPARISONS; ESTEEM; DISSONANCE; INFORMATION;
   OTHERS; CONFLUENCE; ACTIVATION; MECHANISMS; PSYCHOLOGY
AB In a series of studies, it is demonstrated that different types of self-affirmation procedures produce different effects. Affirming personally important values (value affirmation) increases self-clarity but not self-esteem. Affirming positive qualities of the self (attribute affirmation) increases self-esteem but not self-clarity (Study 1). As a consequence, attribute affirmation (which increases self-esteem) is more effective than value affirmation as a buffer against self-depreciating social comparison information. Attribute-affirmed participants more readily accept the self-evaluative consequences of threatening upward social comparisons than do value-affirmed participants (Study 2). However, value affirmation (which increases self-clarity) is a more effective buffer against dissonance threats. Value-affirmed participants showed less attitude change after writing a counterattitudinal essay than attribute-affirmed participants (Study 3).
C1 [Stapel, Diederik A.; van der Linde, Lonneke A. J. G.] Tilburg Univ, TIBER, Social Psychol Dept, NL-5000 LE Tilburg, Netherlands.
RP Stapel, DA (reprint author), Tilburg Univ, TIBER, Social Psychol Dept, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM d.a.stapel@uvt.nl
CR Adams G, 2006, J EXP SOC PSYCHOL, V42, P616, DOI 10.1016/j.jesp.2005.11.001
   Aronson E., 1968, THEORIES COGNITIVE C, P5
   ARONSON J, 1995, J PERS SOC PSYCHOL, V68, P986, DOI 10.1037/0022-3514.68.6.986
   Aronson J, 1999, SCI CON SER, P127, DOI 10.1037/10318-006
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Baumeister R. F., 2005, CULTURAL ANIMAL HUMA
   BAUMGARDNER AH, 1990, J PERS SOC PSYCHOL, V58, P1062, DOI 10.1037/0022-3514.58.6.1062
   Ben-Ari OT, 1999, J PERS SOC PSYCHOL, V76, P35, DOI 10.1037//0022-3514.76.1.35
   BERN DJ, 1972, ADV EXPT SOCIAL PSYC, V6, P1
   Campbell JD, 1996, J PERS SOC PSYCHOL, V70, P141, DOI 10.1037/0022-3514.70.6.1114
   CAMPBELL JD, 1990, J PERS SOC PSYCHOL, V59, P538, DOI 10.1037//0022-3514.59.3.538
   Cohen GL, 2007, J PERS SOC PSYCHOL, V93, P415, DOI 10.1037/0022-3514.93.3.415
   Cohen GL, 2000, PERS SOC PSYCHOL B, V26, P1151, DOI 10.1177/01461672002611011
   Crocker J, 2008, PSYCHOL SCI, V19, P740, DOI 10.1111/j.1467-9280.2008.02150.x
   ELLIOT AJ, 1994, J PERS SOC PSYCHOL, V67, P382, DOI 10.1037/0022-3514.67.3.382
   Fein S, 1997, J PERS SOC PSYCHOL, V73, P31, DOI 10.1037/0022-3514.73.1.31
   Festinger L., 1957, THEORY COGNITIVE DIS
   GERGEN KJ, 1967, P AM PSYCHOL ASSOC, V75, P207
   GREENBERG J, 1992, J PERS SOC PSYCHOL, V63, P913, DOI 10.1037//0022-3514.63.6.913
   Harber KD, 2005, PERS SOC PSYCHOL B, V31, P276, DOI 10.1177/0146167204271323
   Harris PR, 2010, SOC PERSONAL PSYCHOL, V4, P439, DOI 10.1111/j.1751-9004.2010.00270.x
   Harris PR, 2005, PERS SOC PSYCHOL B, V31, P1250, DOI 10.1177/014167205274694
   Harvey RD, 2000, J APPL SOC PSYCHOL, V30, P1790, DOI 10.1111/j.1559-1816.2000.tb02468.x
   Koole SL, 2007, J EXP SOC PSYCHOL, V43, P671, DOI 10.1016/j.jesp.2006.07.001
   Koole SL, 1999, J PERS SOC PSYCHOL, V77, P111, DOI 10.1037/0022-3514.77.1.111
   LINVILLE PW, 1987, J PERS SOC PSYCHOL, V52, P663, DOI 10.1037//0022-3514.52.4.663
   McGuire WJ, 1996, J PERS SOC PSYCHOL, V70, P1117, DOI 10.1037/0022-3514.70.6.1117
   McQueen A, 2006, SELF IDENTITY, V5, P289, DOI 10.1080/15298860600805325
   Miyake A, 2010, SCIENCE, V330, P1234, DOI 10.1126/science.1195996
   Muller D, 2005, J PERS SOC PSYCHOL, V89, P852, DOI 10.1037/0022-3514.89.6.852
   Napper L, 2009, SELF IDENTITY, V8, P45, DOI 10.1080/15298860802079786
   Noordewier MK, 2010, PERS SOC PSYCHOL B, V36, P642, DOI 10.1177/0146167209357746
   PELHAM BW, 1991, J PERS SOC PSYCHOL, V60, P518, DOI 10.1037//0022-3514.60.4.518
   Rosenberg M., 1965, SOC ADOLESCENT SELF
   Schimel J, 2004, SOC COGNITION, V22, P75, DOI 10.1521/soco.22.1.75.30984
   Schmeichel BJ, 2005, PERS SOC PSYCHOL B, V31, P658, DOI 10.1177/0146167204271567
   Schmeichel BJ, 2009, J PERS SOC PSYCHOL, V96, P770, DOI 10.1037/a0014635
   Schwinghammer SA, 2006, PERS SOC PSYCHOL B, V32, P27, DOI 10.1177/0146167205277096
   Sherman DAK, 2000, PERS SOC PSYCHOL B, V26, P1046, DOI 10.1177/01461672002611003
   Sherman DK, 2006, ADV EXP SOC PSYCHOL, V38, P183, DOI 10.1016/S0065-2601(06)38004-5
   Sherman DK, 2005, J PERS SOC PSYCHOL, V88, P108, DOI 10.1037/0022-3514.88.1.108
   Sherman DK, 2011, HDB SELF ENHANCEMENT, P128
   Spencer SJ, 2001, MOTIV EMOTION, V25, P41, DOI 10.1023/A:1010659805978
   Stapel DA, 2006, J PERS SOC PSYCHOL, V90, P258, DOI 10.1037/0022-3514.90.2.258
   Stapel DA, 2004, J PERS SOC PSYCHOL, V87, P860, DOI 10.1037/0022-3514.87.6.860
   Stapel DA, 2004, SOC COGNITION, V22, P147, DOI 10.1521/soco.22.1.147.30989
   Stapel DA, 2001, J PERS SOC PSYCHOL, V80, P766, DOI 10.1037//0022-3514.80.5.766
   STAPEL DA, 2010, SELF ACTIVATIO UNPUB
   STAPEL DA, 2010, PREDICTING WHA UNPUB
   Stapel DA, 2007, EUR J SOC PSYCHOL, V37, P824, DOI 10.1002/ejsp.390
   Steele Claude, 1988, ADV EXPT SOCIAL PSYC, P261, DOI DOI 10.1016/S0065-2601(08)60229-4
   STEELE CM, 1983, J PERS SOC PSYCHOL, V45, P5, DOI 10.1037/0022-3514.45.1.5
   STEELE CM, 1993, J PERS SOC PSYCHOL, V64, P885, DOI 10.1037//0022-3514.64.6.885
   Swann Jr W. B., 2010, HDB SOCIAL PSYCHOL, V1, P589
   TAFARODI RW, 1995, J PERS ASSESS, V65, P322, DOI 10.1207/s15327752jpa6502_8
   TAYLOR SE, 1989, PSYCHOL REV, V96, P569, DOI 10.1037//0033-295X.96.4.569
   Tesser A, 2000, PERS SOC PSYCHOL REV, V4, P290, DOI 10.1207/S15327957PSPR0404_1
   TESSER A, 1991, J EXP SOC PSYCHOL, V27, P501, DOI 10.1016/0022-1031(91)90023-Y
   Tesser A., 1988, ADV EXPT SOCIAL PSYC, P181, DOI DOI 10.1016/S0065-2601(08)60227-0
   van den Bos K, 2003, J PERS SOC PSYCHOL, V85, P482, DOI 10.1037/0022-3514.85.3.482
   Wakslak CJ, 2009, J EXP SOC PSYCHOL, V45, P927, DOI 10.1016/j.jesp.2009.05.002
   Wiesenfeld BM, 2001, ANXIETY STRESS COPIN, V14, P15, DOI 10.1080/10615800108248346
NR 62
TC 6
Z9 6
U1 3
U2 46
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0022-3514
EI 1939-1315
J9 J PERS SOC PSYCHOL
JI J. Pers. Soc. Psychol.
PD JUL
PY 2011
VL 101
IS 1
BP 34
EP 45
DI 10.1037/a0023172
PG 12
WC Psychology, Social
SC Psychology
GA 780YU
UT WOS:000291898600004
PM 21463078
DA 2018-12-27
ER

PT J
AU Yang, SX
   Gao, JM
   Zhang, AL
   Laatsch, H
AF Yang, Sheng-Xiang
   Gao, Jin-Ming
   Zhang, An-Ling
   Laatsch, Hartmut
TI RETRACTED: Sannastatin, a novel toxic macrolactam polyketide glycoside
   produced by actinomycete Streptomyces sannanensis (Retracted article.
   See vol. 27, pg. 4219, 2017)
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article; Retracted Publication
DE Ailuropoda melanoleuca; Streptomyces sannanensis; Sannastatin;
   20-Membered macrocyclic lactam; Toxic activity
ID MACROCYCLIC LACTAM; AMINOGLYCOSIDE ANTIBIOTICS; STRUCTURAL ELUCIDATION;
   VICENISTATIN; SANNAMYCIN
AB A new rare 20-membered macrocyclic lactam incorporating a diene conjugated olefin, designated sannastatin (1), together with the known structurally related vicenistatin (2), has been isolated from the cultures of Streptomyces sannanensis, a bacteria found in the feces of Ailuropoda melanoleuca. The structure of the new compound was established on the basis of extensive spectroscopic analyses including 1D- and 2D-NMR (H-1-H-1 COSY, TOCSY, HSQC, HMBC, and NOESY) experiments. Compounds 1 and 2 displayed significant growth inhibitory activity against the brine shrimp (Artemia salina) larvae. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Yang, Sheng-Xiang; Gao, Jin-Ming; Zhang, An-Ling] NW A&F Univ, Coll Sci, Res Ctr Nat Med Chem, Yangling 712100, Shaanxi, Peoples R China.
   [Yang, Sheng-Xiang; Laatsch, Hartmut] Univ Goettingen, Dept Organ Chem, D-37077 Gottingen, Germany.
   [Yang, Sheng-Xiang] Huainan Union Univ, Dept Chem Engn, Huainan 232038, Anhui, Peoples R China.
RP Gao, JM (reprint author), NW A&F Univ, Coll Sci, Res Ctr Nat Med Chem, Yangling 712100, Shaanxi, Peoples R China.
EM jinminggao@nwsuaf.edu.cn
RI Gao, Jin-Ming/K-5663-2014
FU Program for New Century Excellent Talents in University [NCET-05-0852]
FX This work was supported by the Program for New Century Excellent Talents
   in University (NCET-05-0852). We also thank F. Lissy for technical
   assistance and H. Frauendorf and R. Machinek, in the laboratory of
   institution for organic and biomolecular chemistry, University of
   Gottingen, Germany, for the MS and NMR measurements.
CR Arai H, 1998, TETRAHEDRON LETT, V39, P3181, DOI 10.1016/S0040-4039(98)00454-7
   DEUSHI T, 1979, J ANTIBIOT, V32, P1061, DOI 10.7164/antibiotics.32.1061
   DEUSHI T, 1980, J ANTIBIOT, V33, P1274, DOI 10.7164/antibiotics.33.1274
   Genilloud O, 2011, J IND MICROBIOL BIOT, V38, P375, DOI 10.1007/s10295-010-0882-7
   KOJIRI K, 1992, J ANTIBIOT, V45, P868, DOI 10.7164/antibiotics.45.868
   Li YQ, 2009, J ANTIBIOT, V62, P647, DOI 10.1038/ja.2009.95
   Matsushima Y, 1998, J ANTIBIOT, V51, P688, DOI 10.7164/antibiotics.51.688
   Mitchell SS, 2004, J NAT PROD, V67, P1400, DOI 10.1021/np049970g
   Otsuka M, 2000, TETRAHEDRON, V56, P8281, DOI 10.1016/S0040-4020(00)00792-4
   Qin JC, 2009, BIOORG MED CHEM LETT, V19, P1572, DOI 10.1016/j.bmcl.2009.02.025
   SHINDO K, 1993, J ANTIBIOT, V46, P1076, DOI 10.7164/antibiotics.46.1076
   Takahashi I, 1997, J ANTIBIOT, V50, P186, DOI 10.7164/antibiotics.50.186
   Tohyama S, 2004, TETRAHEDRON, V60, P3999, DOI 10.1016/j.tet.2004.03.027
   UMEZAWA I, 1981, J ANTIBIOT, V34, P259, DOI 10.7164/antibiotics.34.259
   WATANABE I, 1979, J ANTIBIOT, V32, P1066, DOI 10.7164/antibiotics.32.1066
   Zhang H, 2008, MOL PHARMACEUT, V5, P212, DOI 10.1021/mp7001329
NR 16
TC 13
Z9 16
U1 4
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD JUL 1
PY 2011
VL 21
IS 13
BP 3905
EP 3908
DI 10.1016/j.bmcl.2011.05.028
PG 4
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA 775PP
UT WOS:000291474300011
PM 21640585
DA 2018-12-27
ER

PT J
AU Al Mufargi, YS
   Mouch, CA
   Ziebarth, K
   Joeris, A
   Slongo, T
AF Al Mufargi, Yaqoub Sulaiman
   Mouch, Charles Adam
   Ziebarth, Kai
   Joeris, Alexander
   Slongo, Theddy
TI RETRACTED: An Unusual Cause of Paralysis of the Peroneal Nerve: A Report
   of 3 Cases (Retracted article. See vol. 32, pg. 748, 2012)
SO JOURNAL OF PEDIATRIC ORTHOPAEDICS
LA English
DT Article; Retracted Publication
DE peroneal nerve; intraneural ganglion; proximal tibiofibular joint;
   articular nerve branch
ID INTRANEURAL GANGLION; ARTICULAR BRANCH; CYST
AB We present 3 cases of a 12-year-old boy, an 8-year-old girl, and a 9-year-old boy with progressive paresis of the peroneal nerve. Peroneal intraneural ganglia are a rare cause of paralysis of the lower limb in children; more often these symptoms occur because of exostosis. Ultrasound imaging in both patients showed a cystic mass near the fibular neck. Magnetic resonance imaging examination revealed that the ganglion is communicating with the proximal tibiofibular joint. Surgical exploration in these patients confirmed a cystic formation involving the common peroneal nerve. The ganglion originates from the articular nerve branch to the proximal tibiofibular joint. Total recovery of nerve function was seen 2 years later for the first patient, whereas the other 2 showed immediate postoperative improvement of peroneal nerve function and complete recovery within 6 to 8 weeks. On the other hand, patients with exostosis showed varying outcomes. In children with symptoms suspicious of nerve compression, fast diagnosis and immediate treatment are necessary to ensure the best possible recovery.
C1 [Al Mufargi, Yaqoub Sulaiman; Slongo, Theddy] Bern Univ Children Hosp, Dept Pediat Surg, CH-3010 Bern, Switzerland.
   [Al Mufargi, Yaqoub Sulaiman; Ziebarth, Kai; Joeris, Alexander] Bern Univ Children Hosp, Dept Surg, CH-3010 Bern, Switzerland.
   [Mouch, Charles Adam] Univ Michigan, Ann Arbor, MI 48109 USA.
RP Al Mufargi, YS (reprint author), Bern Univ Children Hosp, Dept Pediat Surg, CH-3010 Bern, Switzerland.
EM yalmufargi@yahoo.com
OI Joeris, Alexander/0000-0002-7748-7115
CR Aprin Hormozan, 2007, Am J Orthop (Belle Mead NJ), V36, pE40
   Aulisa L, 1998, CHILD NERV SYST, V14, P222, DOI 10.1007/s003810050216
   Frank Darren A, 2008, Orthopedics, V31, P86
   Johnston JA, 2007, J PEDIATR ORTHOPED, V27, P944, DOI 10.1097/BPO.0b013e3181558c05
   Kili S, 2004, INJURY, V35, P938, DOI 10.1016/S0020-1383(03)00383-2
   McCarthy CL, 2004, SKELETAL RADIOL, V33, P187, DOI 10.1007/s00256-003-0741-y
   NICHOLSON TR, 1995, J CHILD NEUROL, V10, P213, DOI 10.1177/088307389501000310
   Rinaldi E, 1983, Ital J Orthop Traumatol, V9, P259
   Spinner RJ, 2003, J NEUROSURG, V99, P330, DOI 10.3171/jns.2003.99.2.0330
   Spinner RJ, 2003, J NEUROSURG, V99, P319, DOI 10.3171/jns.2003.99.2.0319
NR 10
TC 6
Z9 6
U1 2
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0271-6798
EI 1539-2570
J9 J PEDIATR ORTHOPED
JI J. Pediatr. Orthop.
PD JUL-AUG
PY 2011
VL 31
IS 5
BP E50
EP E52
DI 10.1097/BPO.0b013e31821f50cb
PG 3
WC Orthopedics; Pediatrics
SC Orthopedics; Pediatrics
GA 775AF
UT WOS:000291427700003
PM 21654448
DA 2018-12-27
ER

PT J
AU Togliatto, G
   Trombetta, A
   Dentelli, P
   Rosso, A
   Brizzi, MF
AF Togliatto, G.
   Trombetta, A.
   Dentelli, P.
   Rosso, A.
   Brizzi, M. F.
TI RETRACTED: MIR221/MIR222-driven post-transcriptional regulation of
   P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated
   vascular cell damage (Retracted article. See vol. 61, pg. 1236, 2018)
SO DIABETOLOGIA
LA English
DT Article; Retracted Publication
DE AGE; Cell cycle; Endothelial cells; High glucose; miRNAs; Vascular
   biology
ID ENDOTHELIAL PROGENITOR CELLS; GLYCATION END-PRODUCTS; TUMOR
   ANGIOGENESIS; STAT5 ACTIVATION; OXIDATIVE STRESS; CDK INHIBITORS;
   GROWTH-FACTOR; MICRORNAS; PROLIFERATION; EXPRESSION
AB MicroRNAs (miRNAs) are a novel group of small non-coding RNAs that regulate gene expression at the post-transcriptional level and act on their target mRNAs in a tissue- and cell-type-specific manner. Herein, the relevance of MIR221/MIR222 in high-glucose- and AGE-mediated vascular damage was investigated.
   Functional studies were performed using human mature endothelial cells and endothelial progenitor cells subjected to high glucose or AGE. Quantitative real-time amplification was performed to analyse MIR221/MIR222 expression in these experimental conditions. Luciferase assay was used to identify MIR221/MIR222 targets. Functional studies were performed in vitro and in vivo in mice using gain- and loss-of-function approaches.
   Using an in vivo mouse model we demonstrated that exposure to AGE and high glucose impaired vessel formation. Moreover, in vitro functional studies revealed that both high glucose and AGE inhibit cell-cycle progression by modulating the expression of P27KIP1 (also known as CDKN1B) and P57KIP2 (also known as CDKN1C), which encode cyclin-dependent kinase inhibitor 1B (p27, Kip1) (P27KIP1) and cyclin-dependent kinase inhibitor 1C (p57, Kip2) (P57KIP2), respectively. Crucial to AGE- and high-glucose-mediated cell-cycle arrest was the downregulation of MIR221/MIR222 expression. Luciferase assay showed that MIR221 and MIR222 specifically bind to the P27KIP1 and P57KIP2 mRNA 3'-untranslated regions, implicating P27KIP1 and P57KIP2 as MIR221/MIR222 targets. These results were confirmed by gain-of-function experiments in vitro, and by injecting mice with endothelial cells overexpressing MIR221 and MIR222.
   We provide evidence that high-glucose- and AGE-induced inhibition of vascular cell proliferation is controlled by MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2. These data add further insight to the possible contribution of miRNAs in vascular damage mediated by a high-glucose environment.
C1 [Togliatto, G.; Trombetta, A.; Dentelli, P.; Rosso, A.; Brizzi, M. F.] Univ Turin, Dept Internal Med, I-10126 Turin, Italy.
RP Brizzi, MF (reprint author), Univ Turin, Dept Internal Med, Corso Dogliotti 14, I-10126 Turin, Italy.
EM mariafelice.brizzi@unito.it
RI trombetta, antonella/J-7879-2016
OI trombetta, antonella/0000-0002-1752-2775
FU Italian Association for Cancer Research; Ricerca Finalizzata Regione
   Piemonte; Ministero dell'Universita e Ricerca Scientifica
FX This work was supported by grants of the Italian Association for Cancer
   Research, Ricerca Finalizzata Regione Piemonte and Ministero
   dell'Universita e Ricerca Scientifica to M. F. Brizzi. The authors have
   no conflicting financial interests.
CR Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devce1.2008.01.013
   Brizzi MF, 1999, CIRC RES, V84, P785
   Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997
   Callaghan MJ, 2005, ANTIOXID REDOX SIGN, V7, P1476, DOI 10.1089/ars.2005.7.1476
   Chen CH, 2000, CIRCULATION, V101, P171, DOI 10.1161/01.CIR.101.2.171
   Chen YH, 2007, DIABETES, V56, P1559, DOI 10.2337/db06-1103
   Critser PJ, 2010, CURR OPIN ORGAN TRAN, V15, P68, DOI 10.1097/MOT.0b013e32833454b5
   Defilippi P, 2005, J CELL BIOL, V168, P1099, DOI 10.1083/jcb.200405116
   DEJANA E, 1985, J CLIN INVEST, V75, P11, DOI 10.1172/JCI111661
   Dentelli P, 2007, BLOOD, V109, P4264, DOI 10.1182/blood-2006-06-029603
   Dentelli P, 2010, ARTERIOSCL THROM VAS, V30, P1562, DOI 10.1161/ATVBAHA.110.206201
   Fazi F, 2008, CARDIOVASC RES, V79, P553, DOI 10.1093/cvr/cvn151
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663
   Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1
   Gillies JK, 2007, CELL CYCLE, V6, P2005, DOI 10.4161/cc.6.16.4526
   Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817
   Havelange V, 2010, AM J HEMATOL, V85, P935, DOI 10.1002/ajh.21863
   Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Hristov M, 2008, PHARMACOL RES, V58, P148, DOI 10.1016/j.phrs.2008.07.008
   le Sage C, 2007, CELL CYCLE, V6, P2742, DOI 10.4161/cc.6.22.4900
   le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790
   Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363
   Nakamura N, 2000, FREE RADICAL BIO MED, V29, P17, DOI 10.1016/S0891-5849(00)00286-0
   *NAT RES COUNC, 1996, NIH PUBL, V9323
   Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889
   Pandey AK, 2009, CELL PHYSIOL BIOCHEM, V23, P221, DOI 10.1159/000218169
   Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369
   Rodino-Janeiro BK, 2010, DIABETES-METAB RES, V26, P550, DOI 10.1002/dmrr.1117
   Rubenstein DA, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-28
   Schatteman GC, 2007, AM J PHYSIOL-HEART C, V292, pH1, DOI 10.1152/ajpheart.00662.2006
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270
   Togliatto G, 2010, DIABETES, V59, P1016, DOI 10.2337/db09-0858
   Uberti B, 2010, ONCOGENE, V29, P6581, DOI 10.1038/onc.2010.384
   Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156
   Wautier JL, 2004, CIRC RES, V95, P233, DOI 10.1161/01.RES.0000137876.28454.64
   WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101
   Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217
   Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
   Yoder MC, 2009, BBA-REV CANCER, V1796, P50, DOI 10.1016/j.bbcan.2009.04.002
   Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357
   Zeoli A, 2008, BLOOD, V112, P350, DOI 10.1182/blood-2007-12-128215
NR 46
TC 55
Z9 60
U1 2
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD JUL
PY 2011
VL 54
IS 7
BP 1930
EP 1940
DI 10.1007/s00125-011-2125-5
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 774MZ
UT WOS:000291392000040
PM 21461636
OA Bronze
DA 2018-12-27
ER

PT J
AU Ma, YH
   Qu, Y
   Fei, Z
AF Ma, Yihui
   Qu, Yan
   Fei, Zhou
TI RETRACTED: Vascular Endothelial Growth Factor in Cerebral Ischemia
   (Retracted article. See vol. 90, pg. 1296, 2012)
SO JOURNAL OF NEUROSCIENCE RESEARCH
LA English
DT Review; Retracted Publication
DE VEGF; stroke; angiogenesis; neurogenesis; neuroprotection
ID BLOOD-BRAIN-BARRIER; FACTOR-INDUCED ANGIOGENESIS; FACTOR
   GENE-EXPRESSION; RAT-BRAIN; FACTOR VEGF; PERMEABILITY FACTOR; ARTERY
   OCCLUSION; IN-VIVO; INTRAVENTRICULAR INFUSION; STIMULATES NEUROGENESIS
AB Vascular endothelial growth factor (VEGF) is involved in many central nervous system disorders, including stroke, and confers neuroprotection in cerebral ischemia. In this Mini-Review, we examine in detail the in vitro and in vivo evidence for the role of VEGF in cerebral ischemia. VEGF is a therapeutic mediator for cerebral ischemia because of its angiogenic and neuroprotective effects. However, several studies indicate that the delivery route and the timing of VEGF delivery seem to determine the outcome of VEGF therapy after an ischemic insult. In the acute stage of cerebral ischemia, the effect of VEGF is considered controversial. Therefore, further work is necessary to identify a suitable therapeutic regime prior to phase II/III clinical trials. In addition, recent studies indicate that VEGF enhances neurogenesis after ischemia. Therefore, further investigation is necessary to clarify the exact role of VEGF in neurogenesis. (C) 2011 Wiley-Liss, Inc.
C1 [Ma, Yihui; Qu, Yan; Fei, Zhou] Fourth Mil Med Univ, Inst Neurosurg, Xijing Hosp, Xian 710033, Peoples R China.
RP Fei, Z (reprint author), Fourth Mil Med Univ, Inst Neurosurg, Xijing Hosp, Xian 710033, Peoples R China.
EM zhoufei@fmmu.edu.cn
CR Abumiya T, 2005, BRAIN RES, V1049, P95, DOI 10.1016/j.brainres.2005.05.011
   Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106
   Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6
   Bellomo M, 2003, PHARMACOL RES, V48, P309, DOI 10.1016/S1043-6618(03)00128-2
   Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798
   Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158
   Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2
   Chi OZ, 2007, EXP NEUROL, V204, P283, DOI 10.1016/j.expneurol.2006.11.001
   Chiba Yoshiyuki, 2008, Kobe J Med Sci, V54, pE136
   Chu K, 2005, NEUROSCI RES, V53, P384, DOI 10.1016/j.neures.2005.08.010
   Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003
   Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
   Fujita H, 2001, BRAIN RES, V914, P1, DOI 10.1016/S0006-8993(01)02765-2
   Gao P, 2009, STROKE, V40, P3596, DOI 10.1161/STROKEAHA.109.561050
   Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1
   Ha CH, 2009, MOL CELLS, V28, P1, DOI 10.1007/s10059-009-0109-9
   Hai J, 2003, NEUROSURGERY, V53, P963, DOI 10.1227/01.NEU.0000083594.10117.7A
   Harrigan MR, 2003, ACTA NEUROCHIR, V145, P49, DOI 10.1007/s00701-002-1035-1
   Harrigan MR, 2002, NEUROSURGERY, V50, P589, DOI 10.1097/00006123-200203000-00030
   Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009
   He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6
   Hermann DM, 2009, J CEREBR BLOOD F MET, V29, P1620, DOI 10.1038/jcbfm.2009.100
   HOUCK KA, 1992, J BIOL CHEM, V267, P26031
   Issbruecker Katja, 2003, FASEB Journal, V17, P262
   Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3
   Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499
   Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242
   Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098
   Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103
   Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856
   Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109
   KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987
   Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje
   Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006
   Kimura R, 2005, STROKE, V36, P1259, DOI 10.1161/01.STR.0000165925.20413.14
   Koyama Junji, 2010, Kobe J Med Sci, V56, pE1
   KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794
   Kumai Y, 2007, J CEREBR BLOOD F MET, V27, P1152, DOI 10.1038/sj.jcbfm.9600420
   Lee HT, 2010, J NEUROCHEM, V113, P79, DOI 10.1111/j.1471-4159.2010.06584.x
   Lee HT, 2009, J NEUROSCI, V29, P4356, DOI 10.1523/JNEUROSCI.5497-08.2009
   Lennmyr F, 1998, J NEUROPATH EXP NEUR, V57, P874, DOI 10.1097/00005072-199809000-00009
   Lennmyr F, 2005, ACTA ANAESTH SCAND, V49, P488, DOI 10.1111/j.1399-6576.2005.00646.x
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   Li SF, 2009, NEUROSURGERY, V65, P771, DOI 10.1227/01.NEU.0000349931.61771.52
   MAIESE K, 1993, J NEUROSCI, V13, P3034
   Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21
   Marti HH, 1998, P NATL ACAD SCI USA, V95, P15809, DOI 10.1073/pnas.95.26.15809
   Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4
   Mayhan WG, 1999, AM J PHYSIOL-CELL PH, V276, pC1148, DOI 10.1152/ajpcell.1999.276.5.C1148
   Miki Y, 2007, NEUROSURGERY, V61, P586, DOI 10.1227/01.NEU.0000280010.56943.37
   MONACCI WT, 1993, AM J PHYSIOL, V264, pC995
   Morbidelli L, 2010, AM J PHYSIOL-REG I, V298, pR824, DOI 10.1152/ajpregu.00222.2009
   Neufeld G, 1999, FASEB J, V13, P9
   Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4
   PARK JE, 1993, MOL BIOL CELL, V4, P1317
   Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675
   Plaschke K, 2008, EXP NEUROL, V214, P285, DOI 10.1016/j.expneurol.2008.08.014
   Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806
   Qin LL, 2006, J BIOL CHEM, V281, P32550, DOI 10.1074/jbc.M604853200
   Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121
   SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562
   SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0
   Shen FX, 2006, STROKE, V37, P2601, DOI 10.1161/01.STR.0000240407.14765.e8
   Shin YJ, 2008, ACTA NEUROPATHOL, V116, P517, DOI 10.1007/s00401-008-0423-x
   Shin YJ, 2010, NEUROSCI LETT, V469, P194, DOI 10.1016/j.neulet.2009.11.073
   Shraga-Heled N, 2007, FASEB J, V21, P915, DOI 10.1096/fj.06-6277com
   Stowe AM, 2008, J CEREBR BLOOD F MET, V28, P612, DOI 10.1038/sj.jcbfm.9600560
   Stowe AM, 2007, J CEREBR BLOOD F MET, V27, P76, DOI 10.1038/sj.jcbfm.9600320
   Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977
   Sun YJ, 2006, DEV BIOL, V289, P329, DOI 10.1016/j.ydbio.2005.10.016
   Taoufik E, 2008, P NATL ACAD SCI USA, V105, P6185, DOI 10.1073/pnas.0801447105
   TISCHER E, 1991, J BIOL CHEM, V266, P11947
   Udo H, 2008, J NEUROSCI, V28, P14522, DOI 10.1523/JNEUROSCI.3673-08.2008
   van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218
   Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223
   Vogel C, 2007, J CELL PHYSIOL, V212, P236, DOI 10.1002/jcp.21022
   Wan YQ, 2007, J NEUROSCI RES, V85, P73, DOI 10.1002/jnr.21091
   Wang T, 2004, INT J IMPOT RES, V16, P403, DOI 10.1038/sj.ijir.3901186
   Wang YM, 2007, J NEUROSCI RES, V85, P740, DOI 10.1002/jnr.21169
   Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325
   Wang YQ, 2009, NEUROCHEM INT, V55, P629, DOI 10.1016/j.neuint.2009.06.007
   Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009
   Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200
   Yano A, 2005, J NEUROSURG, V103, P104, DOI 10.3171/jns.2005.103.1.0104
   Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637
   Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369
   Zhang ZG, 2001, J CEREBR BLOOD F MET, V21, P541, DOI 10.1097/00004647-200105000-00008
   Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002
   Zhao YJ, 2010, NEUROL RES, V32, P748, DOI 10.1179/016164109X12445616596562
   Zhu YH, 2003, FASEB J, V17, P186, DOI 10.1096/fj.02-0515com
   Zhu YQ, 2005, STROKE, V36, P1533, DOI 10.1161/01.STR.0000170712.46106.2e
NR 93
TC 19
Z9 25
U1 4
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0360-4012
EI 1097-4547
J9 J NEUROSCI RES
JI J. Neurosci. Res.
PD JUL
PY 2011
VL 89
IS 7
BP 969
EP 978
DI 10.1002/jnr.22628
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 764IY
UT WOS:000290624300002
PM 21469168
DA 2018-12-27
ER

PT J
AU Chaturvedi, V
   Collison, LW
   Guy, CS
   Workman, CJ
   Vignali, DAA
AF Chaturvedi, Vandana
   Collison, Lauren W.
   Guy, Clifford S.
   Workman, Creg J.
   Vignali, Dario A. A.
TI RETRACTED: Cutting Edge: Human Regulatory T Cells Require IL-35 To
   Mediate Suppression and Infectious Tolerance (Retracted article. See
   vol. 191, pg. 2018, 2013)
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article; Retracted Publication
ID IN-VITRO; TREG; PROLIFERATION; EXPRESSION; INDUCTION; CONTACT; POTENT;
   FOXP3
AB Human regulatory T cells (T-reg) are essential for the maintenance of immune tolerance. However, the mechanisms they use to mediate suppression remain controversial. Although IL-35 has been shown to play an important role in T-reg-mediated suppression in mice, recent studies have questioned its relevance in human T-reg. In this study, we show that human T-reg express and require IL-35 for maximal suppressive capacity. Substantial upregulation of EBI3 and IL12A, but not IL10 and TGFB, was observed in activated human T-reg compared with conventional T cells (T-conv). Contact-independent T-reg-mediated suppression was IL-35 dependent and did not require IL-10 or TGF-beta. Lastly, human T-reg-mediated suppression led to the conversion of the suppressed T-conv into iTr35 cells, an IL-35-induced T-reg population, in an IL-35-dependent manner. Thus, IL-35 contributes to human T-reg-mediated suppression, and its conversion of suppressed target T-conv into IL-35-induced T-reg may contribute to infectious tolerance. The Journal of Immunology, 2011, 186: 6661-6666.
C1 [Chaturvedi, Vandana; Collison, Lauren W.; Guy, Clifford S.; Workman, Creg J.; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.
RP Vignali, DAA (reprint author), St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.
EM vignali.lab@stjude.org
FU National Institutes of Health [R01 AI39480, AI091977]; NovoNordisk;
   Individual National Research Service [F32 AI072816]; National Cancer
   Institute Comprehensive Cancer Center [CA21765]; American Lebanese
   Syrian Associated Charities
FX This work was supported by the National Institutes of Health (Grants R01
   AI39480 and AI091977 to D.A.A.V.), a sponsored research agreement from
   NovoNordisk (to D.A.A.V.), an Individual National Research Service award
   (F32 AI072816 to L.W.C.), a National Cancer Institute Comprehensive
   Cancer Center Support CORE grant (CA21765 to D.A.A.V.), and the American
   Lebanese Syrian Associated Charities (to D.A.A.V.).
CR Allan SE, 2008, MOL THER, V16, P194, DOI 10.1038/sj.mt.6300341
   Allan SE, 2008, EUR J IMMUNOL, V38, P3282, DOI 10.1002/eji.200838373
   Bardel E, 2008, J IMMUNOL, V181, P6898, DOI 10.4049/jimmunol.181.10.6898
   Bluestone JA, 2008, J CLIN IMMUNOL, V28, P677, DOI 10.1007/s10875-008-9242-z
   Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306
   Collison LW, 2011, METHODS MOL BIOL, V707, P21, DOI 10.1007/978-1-61737-979-6_2
   Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952
   Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646
   Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642
   Earle KE, 2005, CLIN IMMUNOL, V115, P3, DOI 10.1016/j.clim.2005.02.017
   GERSHON RK, 1971, IMMUNOLOGY, V21, P903
   Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394
   Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295
   Liu F, 2011, CLIN IMMUNOL, V139, P1, DOI 10.1016/j.clim.2010.12.012
   QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901
   Seyer M, 2010, EUR J IMMUNOL, V40, P321, DOI 10.1002/eji.200939527
   Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287
   Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343
   Waldmann H, 2006, IMMUNOL REV, V212, P301, DOI 10.1111/j.0105-2896.2006.00406.x
NR 19
TC 124
Z9 140
U1 11
U2 32
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD JUN 15
PY 2011
VL 186
IS 12
BP 6661
EP 6666
DI 10.4049/jimmunol.1100315
PG 6
WC Immunology
SC Immunology
GA 773LV
UT WOS:000291309700004
PM 21576509
OA Bronze, Green Accepted
DA 2018-12-27
ER

PT J
AU Cullinane, AR
   Curry, JA
   Carmona-Rivera, C
   Summers, CG
   Ciccone, C
   Cardillo, ND
   Dorward, H
   Hess, RA
   White, JG
   Adams, D
   Huizing, M
   Gahl, WA
AF Cullinane, Andrew R.
   Curry, James A.
   Carmona-Rivera, Carmelo
   Summers, C. Gail
   Ciccone, Carla
   Cardillo, Nicholas D.
   Dorward, Heidi
   Hess, Richard A.
   White, James G.
   Adams, David
   Huizing, Marjan
   Gahl, William A.
TI RETRACTED: A BLOC-1 Mutation Screen Reveals that PLDN Is Mutated in
   Hermansky-Pudlak Syndrome Type 9 (Retracted article. See vol. 100, pg.
   837, 2017)
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article; Retracted Publication
ID LYSOSOME-RELATED ORGANELLES; PROTEIN TRAFFICKING; COMPLEX; GENE;
   BIOGENESIS; MELANOSOMES; ENDOSOMES; DYSBINDIN; NONSENSE; PALLIDIN
AB Hermansky-Pudlak Syndrome (HPS) is an autosomal-recessive condition characterized by oculocutaneous albinism and a bleeding diathesis due to absent platelet delta granules. HPS is a genetically heterogeneous disorder of intracellular vesicle biogenesis. We first screened all our patients with HPS-like symptoms for mutations in the genes responsible for HPS-1 through HPS-6 and found no functional mutations in 38 individuals. We then examined all eight genes encoding the biogenesis of lysosome-related organelles complex-1, or BLOC-1, proteins in these individuals. This identified a homozygous nonsense mutation in PLDN in a boy with characteristic features of HPS. PLDN is mutated in the HPS mouse model pallid and encodes the protein pallidin, which interacts with the early endosomal t-SNARE syntaxin-13. We could not detect any full-length pallidin in our patient's cells despite normal mRNA expression of the mutant transcript. We could detect an alternative transcript that would skip the exon that harbored the mutation, but we demonstrate that if this transcript is translated into protein, although it correctly localizes to early endosomes, it does not interact with syntaxin-13. In our patient's melanocytes, the melanogenic protein TYRP1 showed aberrant localization, an increase in plasma-membrane trafficking, and a failure to reach melanosomes, explaining the boy's severe albinism and establishing his diagnosis as HPS-9.
C1 [Cullinane, Andrew R.; Curry, James A.; Carmona-Rivera, Carmelo; Ciccone, Carla; Cardillo, Nicholas D.; Dorward, Heidi; Hess, Richard A.; Adams, David; Huizing, Marjan; Gahl, William A.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.
   [Summers, C. Gail] Univ Minnesota, Dept Ophthalmol, Minneapolis, MN 55455 USA.
   [Summers, C. Gail] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.
   [White, James G.] Univ Minnesota, Dept Lab Med, Minneapolis, MN 55455 USA.
   [Adams, David; Gahl, William A.] NIH, Intramural Off Rare Dis Res, Off Director, Bethesda, MD 20892 USA.
RP Cullinane, AR (reprint author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.
EM andrew.cullinane@nih.gov
FU National Human Genome Research Institute, National Institutes of Health,
   Bethesda, MD, USA
FX We appreciate the excellent technical assistance of Roxanne Fischer. We
   thank Thomas Markello and Hannah Carlson-Donohoe for assistance with SNP
   arrays and E. Dell'Angelica for supplying the pallidin antibody. This
   study was supported by the Intramural Research Programs of the National
   Human Genome Research Institute, National Institutes of Health,
   Bethesda, MD, USA. All authors declare no conflicts of interest.
CR Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576
   Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775
   Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7
   Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379
   Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200
   Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58
   Huang LP, 1999, NAT GENET, V23, P329
   Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303
   Ilardi JM, 1999, NAT NEUROSCI, V2, P119
   Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042
   Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229
   Li Wei, 2007, Journal of Genetics and Genomics, V34, P669, DOI 10.1016/S1673-8527(07)60076-9
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310
   Morgan NV, 2006, AM J HUM GENET, V78, P160, DOI 10.1086/499338
   Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x
   Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300
   Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809
   Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066
   Suzuki T, 2002, NAT GENET, V30, P321, DOI [10.1038/ng835, 10.1038/ng994]
   Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x
   Yuzaki M, 2010, NEURON, V68, P4, DOI 10.1016/j.neuron.2010.09.036
   Zhang Q, 2003, NAT GENET, V33, P145, DOI 10.1038/ng1087
NR 23
TC 69
Z9 70
U1 2
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD JUN 10
PY 2011
VL 88
IS 6
BP 778
EP 787
DI 10.1016/j.ajhg.2011.05.009
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA 779HK
UT WOS:000291768500009
PM 21665000
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Prasad, AS
   Dhawan, MS
   Dolia, SN
   Samariya, A
   Reddy, VR
   Singhal, RK
   Predeep, P
AF Prasad, Arun S.
   Dhawan, M. S.
   Dolia, S. N.
   Samariya, Arvind
   Reddy, V. R.
   Singhal, R. K.
   Predeep, P.
TI RETRACTED: MAGNETIC BEHAVIOR OF FUNCTIONALLY MODIFIED SPINEL
   Ni0.4Ca0.6Fe2O4 NANOFERRITE (Retracted article. See vol. 28, 1493001,
   2014)
SO INTERNATIONAL JOURNAL OF MODERN PHYSICS B
LA English
DT Article; Retracted Publication
DE Ferrites; nanoparticles; polymerization; super-paramagnetism;
   ferrimagnetism; Mossbauer spectroscopy
AB Spinel nanoferrites of composition Ni0.4Ca0.6Fe2O4 have been synthesized by sol-gel method and subsequently coated with intrinsically conducting polymers such as polyaniline and polypyrrole separately, using chemical oxidative polymerization technique. The characterization of the composites has been per by X-ray diffraction and atomic force microscopy images. The room temperature DC electrical conductivity measurements are performed in order to understand the coating effectiveness and the nature of electrical conductivity of the composites. The Mossbauer spectroscopic studies reveal that the ferrimagnetic as well as super-paramagnetic states co-exist at room temperature (300 K) for all the samples which is found in good agreement with the DC magnetization measurement results, wherein the coercivity is observed in the M-H curves for all the samples at room temperature.
C1 [Prasad, Arun S.; Dhawan, M. S.; Dolia, S. N.; Samariya, Arvind; Singhal, R. K.] Univ Rajasthan, Dept Phys, Jaipur 302004, Rajasthan, India.
   [Prasad, Arun S.; Predeep, P.] Natl Inst Technol, Lab Unconvent Elect & Photon, Calicut 673601, Kerala, India.
   [Reddy, V. R.] UGC DAE Consortium Sci Res, Indore 452017, Madhya Pradesh, India.
RP Prasad, AS (reprint author), Univ Rajasthan, Dept Phys, Jaipur 302004, Rajasthan, India.
EM asp.physics@gmail.com
CR ALEXANDER L, 1974, XRAY DIFFRACTION PRO
   Ansari R, 2006, E-J CHEM, V3, P186, DOI DOI 10.1155/2006/860413
   AQUINO MI, 1995, NANOSTRUCT MATER, V5, P383
   BAHADUR D, 2008, J MAGN MAGN MATER, V320, P724
   Bertram H. N., 1994, THEORY MAGNETIC RECO
   BRAND RA, 1987, NUCL INSTRUM METH B, V28, P398, DOI 10.1016/0168-583X(87)90182-0
   GIBERT RG, 2002, PURE APPL CHEM, V74, P857
   Jiao QG, 2008, MOD PHYS LETT B, V22, P1497, DOI 10.1142/S0217984908016212
   Malini KA, 2004, B MATER SCI, V27, P361, DOI 10.1007/BF02704773
   MORUP S, 1980, APPLICATIONS MOSSBAU, V2, P1
   Sharma V, 2009, INT J MOD PHYS B, V23, P125, DOI 10.1142/S0217979209049528
   WOLFART EP, 1986, FERROMAGNETIC MAT HD, V2
NR 12
TC 2
Z9 2
U1 3
U2 23
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0217-9792
EI 1793-6578
J9 INT J MOD PHYS B
JI Int. J. Mod. Phys. B
PD JUN 10
PY 2011
VL 25
IS 14
BP 1971
EP 1980
DI 10.1142/S0217979211100679
PG 10
WC Physics, Applied; Physics, Condensed Matter; Physics, Mathematical
SC Physics
GA 779OP
UT WOS:000291788900010
DA 2018-12-27
ER

PT J
AU Lopez, E
   Lopez, I
   Ferreira, A
   Sequi, J
AF Lopez, Elena
   Lopez, Isabel
   Ferreira, Antonio
   Sequi, Julia
TI RETRACTED: Clinical and Technical Phosphoproteomic Research (Retracted
   article. See vol. 11, 16, 2013)
SO PROTEOME SCIENCE
LA English
DT Review; Retracted Publication
ID COMMON VARIABLE IMMUNODEFICIENCY;
   DESORPTION/IONIZATION-MASS-SPECTROMETRY; MITOCHONDRIAL
   OXIDATIVE-PHOSPHORYLATION; QUANTITATIVE PROTEOMIC ANALYSIS; ION
   AFFINITY-CHROMATOGRAPHY; X-LINKED AGAMMAGLOBULINEMIA; STAINED
   POLYACRYLAMIDE-GELS; SENSITIVE FLUORESCENT DYES; ISOBARIC TAGGING
   REAGENTS; BRUTONS TYROSINE KINASE
AB An encouraging approach for the diagnosis and effective therapy of immunological pathologies, which would include cancer, is the identification of proteins and phosphorylated proteins. Disease proteomics, in particular, is a potentially useful method for this purpose. A key role is played by protein phosphorylation in the regulation of normal immunology disorders and targets for several new cancer drugs and drug candidates are cancer cells and protein kinases. Protein phosphorylation is a highly dynamic process. The functioning of new drugs is of major importance as is the selection of those patients who would respond best to a specific treatment regime. In all major aspects of cellular life signalling networks are key elements which play a major role in inter-and intracellular communications. They are involved in diverse processes such as cell-cycle progression, cellular metabolism, cell-cell communication and appropriate response to the cellular environment. A whole range of networks that are involved in the regulation of cell development, differentiation, proliferation, apoptosis, and immunologic responses is contained in the latter. It is so necessary to understand and monitor kinase signalling pathways in order to understand many immunology pathologies. Enrichment of phosphorylated proteins or peptides from tissue or bodily fluid samples is required. The application of technologies such as immunoproteomic techniques, phosphoenrichments and mass spectrometry (MS) is crucial for the identification and quantification of protein phosphorylation sites in order to advance in clinical research. Pharmacodynamic readouts of disease states and cellular drug responses in tumour samples will be provided as the field develops. We aim to detail the current and most useful techniques with research examples to isolate and carry out clinical phosphoproteomic studies which may be helpful for immunology and cancer research. Different phosphopeptide enrichment and quantitative techniques need to be combined to achieve good phosphopeptide recovery and good up- and-down phosphoregulation protein studies.
C1 [Lopez, Elena] Hosp Univ 12 Octubre, Ctr Invest I 12, Madrid 28041, Spain.
   [Lopez, Isabel] Hosp Univ 12 Octubre, Dept Hematol, Madrid 28041, Spain.
   [Ferreira, Antonio] Hosp Univ La Paz, Dept Immunol, Madrid 28046, Spain.
   [Sequi, Julia] Hosp Carlos III, Dept Immunol, Madrid 28029, Spain.
RP Lopez, E (reprint author), Hosp Univ 12 Octubre, Ctr Invest I 12, Avda Cordoba S-N, Madrid 28041, Spain.
EM elena.lopez.villar@gmail.com
FU Ministerio de Ciencia e Innovacion de Espana; FLL (Fundacion Leucemia y
   Linfoma)
FX EL PhD was a recipient of a Post-doctoral fellowship of Ministerio de
   Ciencia e Innovacion de Espana. IL PhD was a recipient of a FLL
   (Fundacion Leucemia y Linfoma) grant. AF and JL are M. D. PhD with
   permanent positions from Spanish National Hospitals La Paz and Carlos
   III respectively.
CR Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200
   Alldridge LC, 1999, J BIOL CHEM, V274, P37620, DOI 10.1074/jbc.274.53.37620
   ANDERSSON L, 1986, ANAL BIOCHEM, V154, P250, DOI 10.1016/0003-2697(86)90523-3
   Araki R, 1999, CANCER RES, V59, P3543
   Ashman K, 2009, CLIN TRANSL ONCOL, V11, P356, DOI 10.1007/s12094-009-0369-z
   Bacchelli C, 2007, CLIN EXP IMMUNOL, V149, P401, DOI 10.1111/j.1365-2249.2007.03461.x
   Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102
   Barbey C, 2009, VET MICROBIOL, V135, P334, DOI 10.1016/j.vetmic.2008.09.086
   BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119
   Blaukat Andree, 2004, Methods Mol Biol, V259, P283
   Boja ES, 2009, J PROTEOME RES, V8, P4665, DOI 10.1021/pr900387b
   Boneh A, 2006, CELL MOL LIFE SCI, V63, P1236, DOI 10.1007/s00018-005-5585-2
   Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169
   Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601
   Chapel H, 2009, BRIT J HAEMATOL, V145, P709, DOI 10.1111/j.1365-2141.2009.07669.x
   Chen Ling-li, 2011, Chinese Journal of Pathology, V40, P17, DOI 10.3760/cma.j.issn.0529-5807.2011.01.005
   Chen YL, 2009, CANCER RES, V69, P3713, DOI 10.1158/0008-5472.CAN-08-2515
   Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127
   Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200
   Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799
   Connor PA, 1999, LANGMUIR, V15, P2402, DOI 10.1021/la980855d
   Connor PA, 1999, LANGMUIR, V15, P2916, DOI 10.1021/la980894p
   Cox David M, 2005, J Biomol Tech, V16, P83
   Craft GE, 2008, MOL CELL PROTEOMICS, V7, P1146, DOI 10.1074/mcp.M700351-MCP200
   Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725
   Di Vizio D, 2008, TUMORI J, V94, P633
   Dietz A, 2008, EUR ARCH OTO-RHINO-L, V265, pS3, DOI 10.1007/s00405-008-0697-6
   Dolado I, 2008, CANCER CELL, V14, P427, DOI 10.1016/j.ccr.2008.11.006
   Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301
   Figeys D, 1998, ANAL CHEM, V70, P3728, DOI 10.1021/ac980320p
   Futatani T, 1998, BLOOD, V91, P595
   Gafken PR, 2006, CELL COMMUN ADHES, V13, P249, DOI 10.1080/15419060601077917
   GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636
   Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001
   Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4
   Goldenthal MJ, 2004, MOL CELL BIOCHEM, V262, P1, DOI 10.1023/B:MCBI.0000038228.85494.3b
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902
   Gronborg M, 2002, MOL CELL PROTEOMICS, V1, P517, DOI 10.1074/mcp.M200010-MCP200
   Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200
   Gruhler Albrecht, 2008, V424, P101, DOI 10.1007/978-1-60327-064-9_9
   Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030
   Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x
   Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401
   Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8
   Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001
   Jensen SS, 2007, RAPID COMMUN MASS SP, V21, P3635, DOI 10.1002/rcm.3254
   Kanegane H, 2007, GENES IMMUN, V8, P663, DOI 10.1038/sj.gene.6364431
   Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186
   Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018
   Kleinnijenhuis AJ, 2007, ANAL CHEM, V79, P7450, DOI 10.1021/ac0707838
   Kondo T, 2003, PROTEOMICS, V3, P1758, DOI 10.1002/pmic.200300531
   Kondo T, 2006, NAT PROTOC, V1, P2940, DOI 10.1038/nprot.2006.421
   Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231
   Kweon HK, 2006, ANAL CHEM, V78, P1743, DOI 10.1021/ac0522355
   Larsen Martin R, 2004, Methods Mol Biol, V251, P245
   Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200
   Larsen MR, 2002, PROTEOMICS, V2, P1277, DOI 10.1002/1615-9861(200209)2:9<1277::AID-PROT1277>3.0.CO;2-P
   Larsen MR, 2004, MOL CELL PROTEOMICS, V3, P456, DOI 10.1074/mcp.M300105-MCP200
   Li SH, 1999, ANAL BIOCHEM, V270, P9, DOI 10.1006/abio.1999.4060
   Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j
   Lopez E., 2010, J INTEGRATED OMICS, P40, DOI [DOI 10.5584/JIOMICS.V1I1.40, 10.5584/jiomics.v1i1]
   Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065
   Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3
   Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x
   Matsuura K, 2006, PATHOL INT, V56, P368, DOI 10.1111/j.1440-1827.2006.01973.x
   McLachlin DT, 2001, CURR OPIN CHEM BIOL, V5, P591, DOI 10.1016/S1367-5931(00)00250-7
   McNamara LE, 2010, J R SOC INTERFACE, V7, pS107, DOI 10.1098/rsif.2009.0177.focus
   McNulty DE, 2008, MOL CELL PROTEOMICS, V7, P971, DOI 10.1074/mcp.M700543-MCP200
   Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x
   Moro L, 2007, INT J ONCOL, V30, P217
   Nagano K, 2010, YAKUGAKU ZASSHI, V130, P1701, DOI 10.1248/yakushi.130.1701
   Neville DCA, 1997, PROTEIN SCI, V6, P2436
   Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200
   OLERUP O, 1992, P NATL ACAD SCI USA, V89, P10653, DOI 10.1073/pnas.89.22.10653
   Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736
   Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005
   Pan-Hammarstrom Q, 2007, NAT GENET, V39, P429, DOI 10.1038/ng0407-429
   Pandey A, 2000, J BIOL CHEM, V275, P38633, DOI 10.1074/jbc.M007849200
   Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617
   Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y
   Radojkovic M, 2009, AM J MED SCI, V338, P527, DOI 10.1097/MAJ.0b013e3181b7f17c
   ROBERTS OG, 2005, PROTEOMICS, V5, P1746
   ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109
   Rong YF, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-68
   Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200
   Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046
   Sachon E, 2006, RAPID COMMUN MASS SP, V20, P1127, DOI 10.1002/rcm.2427
   Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600
   Salzer U, 2004, CLIN IMMUNOL, V113, P234, DOI 10.1016/j.clim.2004.07.002
   Schroeder MJ, 2005, J PROTEOME RES, V4, P1832, DOI 10.1021/pr0502020
   Shah Neil P, 2008, J Natl Compr Canc Netw, V6 Suppl 2, pS31
   Shaw J, 2003, PROTEOMICS, V3, P1181, DOI 10.1002/pmic.200300439
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   SMITH CIE, 1994, J IMMUNOL, V152, P557
   SMITH CIE, 2007, PRIMARY IMMUNODEFICI, P279
   Speicher K D, 2000, J Biomol Tech, V11, P74
   SPRINGER WR, 1991, ANAL BIOCHEM, V195, P172, DOI 10.1016/0003-2697(91)90314-J
   Steen H, 2001, J MASS SPECTROM, V36, P782, DOI 10.1002/jms.174
   Steen H, 2002, J AM SOC MASS SPECTR, V13, P996, DOI 10.1016/S1044-0305(02)00415-4
   Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104
   Stensballe A, 2001, PROTEOMICS, V1, P207, DOI 10.1002/1615-9861(200102)1:2<207::AID-PROT207>3.0.CO;2-3
   Sudo T, 1998, J BIOL CHEM, V273, P6351, DOI 10.1074/jbc.273.11.6351
   Swat A, 2009, MOL CELL BIOL, V29, P3332, DOI 10.1128/MCB.01955-08
   Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101
   Thingholm TE, 2008, MOL CELL PROTEOMICS, V7, P661, DOI 10.1074/mcp.M700362-MCP200
   Thingholm Tine E., 2009, V527, P67, DOI 10.1007/978-1-60327-834-8_6
   Thomson M, 2002, CELL MOL LIFE SCI, V59, P213, DOI 10.1007/s00018-002-8417-7
   TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F
   van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568
   van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748
   Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037
   VETRIE D, 1993, NATURE, V364, P362, DOI 10.1038/364362a0
   Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015
   VOLANAKIS JE, 1992, J CLIN INVEST, V89, P1914, DOI 10.1172/JCI115797
   Wang GH, 2006, J PROTEOME RES, V5, P1214, DOI 10.1021/pr050406g
   Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744
   Williamson BL, 2006, MOL CELL PROTEOMICS, V5, P337, DOI 10.1074/mcp.M500210-MCP200
   Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104
   Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094
   Wyttenbach A, 2006, MOL CELL PROTEOMICS, V5, P553, DOI 10.1074/mcp.T500028-MCP200
   Yu ZW, 2007, CANCER EPIDEM BIOMAR, V16, P553, DOI 10.1158/1055-9965.EPI-06-0121
   Zebisch A, 2007, CURR MED CHEM, V14, P601, DOI 10.2174/092986707780059670
   Zhang H, 2002, J BIOL CHEM, V277, P39379, DOI 10.1074/jbc.M206399200
   Zhang X, 2007, MOL CELL PROTEOMICS, V6, P2032, DOI 10.1074/mcp.M700278-MCP200
   Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200
   Zhang Yi, 2007, Methods Mol Biol, V359, P203
   Zhang ZY, 2005, BBA-PROTEINS PROTEOM, V1754, P100, DOI 10.1016/j.bbapap.2005.09.005
   Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299
   Zhou HJ, 2007, ELECTROPHORESIS, V28, P2201, DOI 10.1002/elps.200600718
   Zubarev RA, 2000, ANAL CHEM, V72, P563, DOI 10.1021/ac990811p
NR 133
TC 10
Z9 12
U1 6
U2 18
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-5956
J9 PROTEOME SCI
JI Proteome Sci.
PD JUN 2
PY 2011
VL 9
AR 27
DI 10.1186/1477-5956-9-27
PG 20
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 786RE
UT WOS:000292324800001
PM 21635771
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Chen, HJ
   Yuan, BQ
   Wang, SS
   Zhen, ZC
   Liu, Z
AF Chen, Hongjie
   Yuan, Bangqing
   Wang, Shousen
   Zhen, Zhaocong
   Liu, Zheng
TI RETRACTED: WITHDRAWN: Dual targeting of glioma U251 cells and
   neovasculature with a nanoparticle encoding vasohibin and RGD peptides
   prevents tumor angiogenesis and inhibits tumor growth (Retracted
   Article)
SO INTERNATIONAL IMMUNOPHARMACOLOGY
LA English
DT Correction; Retracted Publication
C1 [Chen, Hongjie; Wang, Shousen; Zhen, Zhaocong; Liu, Zheng] Fuzhou Gen Hosp Nanjing Command, Dept Neurosurg, Fuzhou 350025, Fujian, Peoples R China.
   [Chen, Hongjie] Fujian Med Univ, Fuzong Med Coll, Dept Neurosurg, Fuzhou 350025, Fujian, Peoples R China.
   [Yuan, Bangqing] 476th Hosp PLA, Fuzhou 350025, Fujian, Peoples R China.
RP Wang, SS (reprint author), Fuzhou Gen Hosp Nanjing Command, Dept Neurosurg, Fuzhou 350025, Fujian, Peoples R China.
EM wangshousen99@163.com
CR Chen HJ, 2011, INT IMMUNOPHARMACOL, V11, P778, DOI 10.1016/j.intimp.2011.01.035
NR 1
TC 1
Z9 2
U1 5
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-5769
J9 INT IMMUNOPHARMACOL
JI Int. Immunopharmacol.
PD JUN
PY 2011
VL 11
IS 6
BP 778
EP 778
DI 10.1016/j.intimp.2011.01.035
PG 1
WC Immunology; Pharmacology & Pharmacy
SC Immunology; Pharmacology & Pharmacy
GA 776AC
UT WOS:000291505900021
PM 21320638
DA 2018-12-27
ER

PT J
AU Ulivieri, S
   Toninelli, S
   Petrini, C
   Oliveri, G
AF Ulivieri, S.
   Toninelli, S.
   Petrini, C.
   Oliveri, G.
TI RETRACTED: Prevention of post-operative infection in spine surgery by
   wound irrigation with a solution of povidone-iodine and hydrogen
   peroxide (Retracted article. See vol. 55, pg. 293, 2011)
SO JOURNAL OF NEUROSURGICAL SCIENCES
LA English
DT Article; Retracted Publication
DE Povidone-iodine; Surgical wound infection; Spine
ID RESISTANT STAPHYLOCOCCUS-AUREUS; SURGICAL SITE INFECTIONS;
   CHLORHEXIDINE; OPERATION; FAECALIS; DISK
AB Starting from January 2008, we systematically irrigated the surgical wounds of patients undergoing spine surgery with a solution of povidone-iodine and hydrogen peroxide. We prospectively recorded the clinical data of patients who underwent spine surgery during 2008 and we compared the results with retrospectively reviewed clinical records of patients operated during 2007. Patients were analyzed for preoperative risk factors, type of surgical procedure, onset of infection, presentation, treatment and outcome. We performed 490 spine surgeries during 2008 and 460 during 2007. We recorded four postoperative infections in 2007 compared to none in 2008. We consider this solution of povidone-iodine plus hydrogen peroxide effective to further reduce the rate of post-operative infection in spine surgery.
C1 [Ulivieri, S.; Toninelli, S.; Petrini, C.; Oliveri, G.] Santa Maria Scotte Hosp, Dept Neurosurg, I-53100 Siena, Italy.
RP Ulivieri, S (reprint author), Santa Maria Scotte Hosp, Dept Neurosurg, Viale Bracci, I-53100 Siena, Italy.
EM simone.ulivieri@email.it
CR BERKELMAN RL, 1982, J CLIN MICROBIOL, V15, P635
   Block C, 2000, J HOSP INFECT, V46, P147, DOI 10.1053/jhin.2000.0805
   Cheng MT, 2005, SPINE, V30, P1689, DOI 10.1097/01.brs.0000171907.60775.85
   DAUCH WA, 1986, ACTA NEUROCHIR, V82, P43, DOI 10.1007/BF01456318
   Fleischer W, 1997, DERMATOLOGY, V195, P3, DOI 10.1159/000246022
   KAYSINGER KK, 1995, J ORTHOP TRAUMA, V9, P303, DOI 10.1097/00005131-199509040-00006
   LACEY RW, 1993, POSTGRAD MED J, V69, pS78
   Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X
   MCLURE AR, 1992, J HOSP INFECT, V21, P291, DOI 10.1016/0195-6701(92)90139-D
   Mizukami Y, 1993, Kansenshogaku Zasshi, V67, P1052
   Nichols RL, 2001, EMERG INFECT DIS, V7, P220, DOI 10.3201/eid0702.010214
   Niedner R, 1997, DERMATOLOGY, V195, P89, DOI 10.1159/000246038
   Olsen MA, 2003, J NEUROSURG, V98, P149, DOI 10.3171/spi.2003.98.2.0149
   Owens CD, 2008, J HOSP INFECT, V70, P3, DOI 10.1016/S0195-6701(08)60017-1
   Picada R, 2000, J SPINAL DISORD, V13, P42, DOI 10.1097/00002517-200002000-00009
   Reimer K, 2002, DERMATOLOGY, V204, P114, DOI 10.1159/000057738
   STAMBOUGH JL, 1992, J SPINAL DISORD, V5, P277, DOI 10.1097/00002517-199209000-00005
   Steinberg D, 1999, J ORAL REHABIL, V26, P151, DOI 10.1046/j.1365-2842.1999.00343.x
   STROHECKER J, 1985, J HOSP INFECT, V6, P123, DOI 10.1016/S0195-6701(85)80057-8
   TRONNIER V, 1992, ACTA NEUROCHIR, V117, P149, DOI 10.1007/BF01400612
   Weinstein MA, 2000, J SPINAL DISORD, V13, P422, DOI 10.1097/00002517-200010000-00009
NR 21
TC 6
Z9 6
U1 1
U2 13
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0390-5616
EI 1827-1855
J9 J NEUROSURG SCI
JI J. Neurosurg. Sci.
PD JUN
PY 2011
VL 55
IS 2
BP 89
EP 92
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 776VQ
UT WOS:000291567200002
PM 21623320
DA 2018-12-27
ER

PT J
AU Saleh, BS
   Nusair, H
   Al Zubadi, N
   Al Shloul, S
   Saleh, U
AF Saleh, Bassem S.
   Nusair, Hussam
   Al Zubadi, Nariman
   Al Shloul, Shams
   Saleh, Usama
TI RETRACTED: The nursing rounds system: Effect of patient's call light
   use, bed sores, fall and satisfaction level (Retracted article. See vol.
   19, pg. 108, 2013)
SO INTERNATIONAL JOURNAL OF NURSING PRACTICE
LA English
DT Article; Retracted Publication
DE call light; patient-care management; patient safety; patient
   satisfaction; rounds
AB The nursing rounds system: Effect of patient's call light use, bed sores, fall and satisfaction level
   The nursing round system (NRS) means checking patients on an hourly basis during the A (0700-2200 h) shift and once every 2 h during the B (2200-0700 h) by the assigned nursing staff. The overall goal of this prospective study is to implement an NRS in a major rehabilitation centre-Sultan Bin Abdulaziz Humanitarian City-in the Riyadh area of the Kingdom of Saudi Arabia. The purposes of this study are to measure the effect of the NRS on: (i) the use of patient call light; (ii) the number of incidences of patients' fall; (iii) the number of incidences of hospital-acquired bed sores; and (iv) the level of patients' satisfaction. All patients hospitalized in the male stroke unit will be involved in this study. For the period of 8 weeks (17 December 2009-17 February 2010) All Nursing staff on the unit will record each call light and the patient's need. Implementation of the NRS would start on 18 February 2010 and last for 8 weeks, until 18 April 2010. Data collected throughout this period will be compared with data collected during the 8 weeks period immediately preceding the implementation of the NRS (17 December 2009-17 February 2010) in order to measure the impact of the call light use. The following information were collected on all subjects involved in the study: (i) the Demographic Information Form; (ii) authors' developed NRS Audit Form; (iii) Patient Call Light Audit Form; (iv) Patient Fall Audit Record; (v) Hospital-Acquired Bed Sores Audit Form; and (vi) hospital developed Patient Satisfaction Records. The findings suggested that a significant reduction on the use of call bell (P < 0.001), a significant reduction of fall incidence (P < 0.01) while pressure ulcer reduced by 50% before and after the implementation of NRS. Also, the implementation of NRS increased patient satisfaction by 7/5 (P < 0.05).
C1 [Saleh, Bassem S.; Nusair, Hussam; Al Zubadi, Nariman; Al Shloul, Shams] Sultan Bin Abdulaziz Humanitarian City, Riyadh, Saudi Arabia.
   [Saleh, Usama] Herzing Univ, Undergrad Nursing Program, Menomonee Falls, WI USA.
RP Nusair, H (reprint author), Sultan Bin Abdulaziz Humanitarian City Nursing, Riyadh 11453, Saudi Arabia.
EM bassemhh@hotmail.com
CR COMLEY A, 2000, PAIN MANAGEMENT CLIN
   MEADE T, 2006, EFFECTS NURSING ROUN
   NA A, 2007, EFFECTS NURSING ROUN
   Sterman Ellen, 2003, Oncol Nurs Forum, V30, P857, DOI 10.1188/03.ONF.857-864
   Van Handel K, 1994, Orthop Nurs, V13, P13
NR 5
TC 9
Z9 9
U1 3
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1322-7114
J9 INT J NURS PRACT
JI Int. J. Nurs. Pract.
PD JUN
PY 2011
VL 17
IS 3
BP 299
EP 303
DI 10.1111/j.1440-172X.2011.01938.x
PG 5
WC Nursing
SC Nursing
GA 768DM
UT WOS:000290911700012
PM 21605271
DA 2018-12-27
ER

PT J
AU Barnett, RLE
AF Barnett, R. -L. Etienne
TI RETRACTED: Apories cioraniennes (Retracted article. See vol. 42, pg.
   359, 2015)
SO NEOHELICON
LA English
DT Article; Retracted Publication
DE Cioran; Language; Temporality; Postmodernism; Aporia; Void; Ellipsis;
   Syllogism; Nothingness
AB In the Cioranian universe, language and time, both inextricably bound, both chillingly perverse, constitute icons of what is, contextually, an inexorable vision of the human condition. The pairing progenerates specters, phantasms of the void, pernicious and vacuous. It is at the perilous, indeed, the perfidious nexus of enunciation and endlessness-each dreaded, yet each ineluctable-that the dyad adopts an onerous cast. To the extent that discourse configures a cipher of perpetuity, and in that, conversely, any trace of eternity conjures a ceaseless extension of the word, of that very word which begets and embodies postmodern aporia, there lurks in consequence of discourse emitted a palpable trepidation, a confrontation with the ultimate precipice, the unconscionable, inscrutable continuity of nothingness. The deconstructive imperative overtakes the text, from which there is neither scriptural nor metaphysical exit. A curious dynamic, a tangled skein of haunting refrain.
C1 Univ Atlanta, Off Univ Provost & Execut Vice President Operat, Atlanta, GA 30360 USA.
RP Barnett, RLE (reprint author), Univ Atlanta, Off Univ Provost & Execut Vice President Operat, Atlanta, GA 30360 USA.
EM RL_Barnett@msn.com
CR ALTER JB, 2005, TEXTE, V46, P217
   BARNETT RLE, 2007, DEGRES, V78, P102
   BARNETT RLE, 2005, LITTERATURES TOULOUS, V102, P44
   BOSSUET JB, 1907, ORAISONS FUNEBRES
   CIORAN EM, 1995, CEUVRES
   Cioran Emil, 1995, ENTRETIENS
   DERRIDA J, 1996, APORIES
   DODILLE NGL, 1997, LECT CIORAN
   Robin Regine, 1993, DEUIL ORIGINE LANGUE
   TANASECEU M, 2010, DISSOLUTION PHILOS E
NR 10
TC 1
Z9 1
U1 2
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0324-4652
EI 1588-2810
J9 NEOHELICON
JI Neohelicon
PD JUN
PY 2011
VL 38
IS 1
BP 177
EP 185
DI 10.1007/s11059-010-0081-6
PG 9
WC Literature
SC Literature
GA 762QG
UT WOS:000290493900011
DA 2018-12-27
ER

PT J
AU Mapelli, C
   Gruttadauria, A
   Danielsen, HK
   Hald, J
AF Mapelli, Carlo
   Gruttadauria, Andrea
   Danielsen, Hilmar K.
   Hald, John
TI RETRACTED: Investigation of the alpha ' -> gamma Transformation in a
   Martensitic Extra Low Carbon 12 wt.% Cr Steel by Dilatometeric
   Measurements (Retracted Article)
SO STEEL RESEARCH INTERNATIONAL
LA English
DT Article; Retracted Publication
DE hardness; heat treatment; JMAK; martensite; stainless steel
AB The aim of this study is focused on the analysis of phase transformations of 12 wt.% Cr steels. The analysis has been performed through a coupling of the results coming from dilatometry, optical microscopy and hardness measurements. The work has been focused on the alpha ' -> gamma transformation in a normalized martensitic stainless steel. The phase transformation temperatures have been well defined by isochronal dilatometry that allows to investigate the kinetics of the studied transformations, it permits also to measure the activation energy for the investigated transformations and to estimate JMAK parameters. By coupling the information obtained through the dilatometric techniques and the metallographic investigation the microstructural transformation mechanisms have been enlightened and discussed.
C1 [Mapelli, Carlo; Gruttadauria, Andrea] Politecn Milan, Dipartimento Meccan, Matteo VILLA, Milan, Italy.
   [Danielsen, Hilmar K.; Hald, John] Tech Univ Denmark, Lyngby, Denmark.
RP Mapelli, C (reprint author), Politecn Milan, Dipartimento Meccan, Matteo VILLA, Milan, Italy.
EM carlo.mapelli@polimi.it
CR BRIGGS JZ, 1977, SUPER 12 CR STEELS
   Christian J. W., 1975, THEORY TRANSFORMATIO
   Lee YK, 2003, MATER SCI TECH-LOND, V19, P393, DOI 10.1179/026708303225009742
   LOIER C, 1985, MATER SCI ENG, V68, P165, DOI 10.1016/0025-5416(85)90405-7
   MITTEMEIJER EJ, 1992, J MATER SCI, V27, P3977, DOI 10.1007/BF01105093
   Morra PV, 2001, J THERM ANAL CALORIM, V64, P905, DOI 10.1023/A:1011514727891
   Ragone D. V., 1995, THERMODYNAMICS MAT
   TOKUNAGA T, 2008, MAT SCI ENG
NR 8
TC 1
Z9 1
U1 3
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1611-3683
EI 1869-344X
J9 STEEL RES INT
JI Steel Res. Int.
PD JUN
PY 2011
VL 82
IS 6
BP 615
EP 625
DI 10.1002/srin.201000191
PG 11
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 773XB
UT WOS:000291343700003
DA 2018-12-27
ER

PT J
AU Johnson, CS
   Stapel, DA
AF Johnson, Camille S.
   Stapel, Diederik A.
TI RETRACTED: Happiness as alchemy: Positive mood leads to self-serving
   responses to social comparisons (Retracted article. See vol. 36, pg.
   180, 2012)
SO MOTIVATION AND EMOTION
LA English
DT Article; Retracted Publication
DE Social comparison; Positive mood; Self-evaluations; Assimilation and
   contrast; Self-serving bias
ID PSYCHOLOGY; IMPACT; HAPPY; ME; CONSEQUENCES; INFORMATION; EMOTIONS;
   CONTRAST; JUDGMENT; PEOPLE
AB People in a positive mood process information in ways that reinforce and maintain this positive mood. The current studies examine how positive mood influences responses to social comparisons and demonstrates that people in a positive mood interpret ambiguous information about comparison others in self-benefitting ways. Specifically, four experiments demonstrate that compared to negative mood or neutral mood participants, participants in a positive mood engage in effortful re-interpretations of ambiguously similar comparison targets so that they may assimilate to upward comparison targets and contrast from downward comparison targets.
C1 [Johnson, Camille S.] San Jose State Univ, San Jose, CA 95192 USA.
   [Stapel, Diederik A.] Tilburg Univ, NL-5000 LE Tilburg, Netherlands.
RP Johnson, CS (reprint author), San Jose State Univ, 1 Washington Sq, San Jose, CA 95192 USA.
EM Camille.Johnson@sjsu.edu
CR Avramova YR, 2008, J PERS SOC PSYCHOL, V95, P542, DOI 10.1037/a0012560
   BLESS H, 2001, BLACKWELL HDB SOCIAL, P479
   BROWN JD, 1992, J PERS SOC PSYCHOL, V62, P717, DOI 10.1037//0022-3514.62.5.717
   Caruso EM, 2009, P NATL ACAD SCI USA, V106, P20168, DOI 10.1073/pnas.0905362106
   CIALDINI RB, 1989, J PERS SOC PSYCHOL, V57, P626, DOI 10.1037/0022-3514.57.4.626
   Clore GL, 2001, HANDBOOK OF AFFECT AND SOCIAL COGNITION, P121
   Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202
   FINCH JF, 1989, PERS SOC PSYCHOL B, V15, P222, DOI 10.1177/0146167289152009
   Forster J, 2008, J PERS SOC PSYCHOL, V94, P579, DOI 10.1037/0022-3514.94.4.579
   Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037//0003-066X.56.3.218
   Fredrickson BL, 2002, PSYCHOL SCI, V13, P172, DOI 10.1111/1467-9280.00431
   Gasper K, 2002, PSYCHOL SCI, V13, P34, DOI 10.1111/1467-9280.00406
   Gasper K, 2003, J EXP SOC PSYCHOL, V39, P248, DOI 10.1016/S0022-1031(03)00023-4
   GILBERT DT, 1995, J PERS SOC PSYCHOL, V69, P227, DOI 10.1037/0022-3514.69.2.227
   Hirt ER, 2008, J PERS SOC PSYCHOL, V94, P214, DOI 10.1037/0022-3514.94.2.94.2.214
   Isbell LM, 2004, J EXP SOC PSYCHOL, V40, P341, DOI 10.1016/j.jesp.2003.06.003
   ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122
   JACCARD J, 1998, INTERACTION EFFECTS
   Johnson CS, 2007, EUR J SOC PSYCHOL, V37, P258, DOI 10.1002/ejsp.361
   JOHNSON CS, POSITIVE AFFEC UNPUB
   JOHNSON CS, SOCIAL PSYC IN PRESS
   KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747
   Krauth-Gruber S, 2000, PERS SOC PSYCHOL B, V26, P1587, DOI 10.1177/01461672002612012
   Lockwood P, 1997, J PERS SOC PSYCHOL, V73, P91, DOI 10.1037//0022-3514.73.1.91
   Lyubomirsky S, 1997, J PERS SOC PSYCHOL, V73, P1141, DOI 10.1037/0022-3514.73.6.1141
   Martin L. L., 2001, THEORIES MOOD COGNIT
   MILLER DT, 1988, J PERS SOC PSYCHOL, V55, P908, DOI 10.1037/0022-3514.55.6.908
   MOSAK HH, 1973, CURRENT PSYCHOTHERAP, P52
   MURRAY N, 1990, J PERS SOC PSYCHOL, V59, P411, DOI 10.1037/0022-3514.59.3.411
   Mussweiler T, 2003, PSYCHOL REV, V110, P472, DOI 10.1037/0033-295X.110.3.472
   SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513
   Schwarz Norbert, 1990, FEELINGS INFORM INFO
   Schwinghammer SA, 2006, PERS SOC PSYCHOL B, V32, P27, DOI 10.1177/0146167205277096
   Stapel DA, 2004, J PERS SOC PSYCHOL, V87, P468, DOI 10.1037/0022-3514.87.4.468
   Stapel DA, 2001, J PERS SOC PSYCHOL, V80, P766, DOI 10.1037//0022-3514.80.5.766
   Stapel DA, 2001, J EXP SOC PSYCHOL, V37, P134, DOI 10.1006/jesp.2000.1440
   Stapel DA, 2000, J PERS SOC PSYCHOL, V79, P1068, DOI 10.1037//0022-3514.79.6.1068
   Stapel DA, 2007, EUR J SOC PSYCHOL, V37, P824, DOI 10.1002/ejsp.390
   Stapel DA, 2007, PERS SOC PSYCHOL B, V33, P439, DOI 10.1177/0146167206296105
   Storbeck J, 2005, PSYCHOL SCI, V16, P785, DOI 10.1111/j.1467-9280.2005.01615.x
   Tamir M, 2007, PERS SOC PSYCHOL B, V33, P1124, DOI 10.1177/0146167207301030
   Trope Y, 2001, HANDBOOK OF AFFECT AND SOCIAL COGNITION, P256
   WILLS TA, 1981, PSYCHOL BULL, V90, P245, DOI 10.1037/0033-2909.90.2.245
   WOOD JV, 1989, J PERS SOC PSYCHOL, V106, P231
NR 44
TC 3
Z9 3
U1 1
U2 16
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0146-7239
EI 1573-6644
J9 MOTIV EMOTION
JI Motiv. Emot.
PD JUN
PY 2011
VL 35
IS 2
BP 165
EP 180
DI 10.1007/s11031-011-9216-y
PG 16
WC Psychology, Experimental; Psychology, Social
SC Psychology
GA 763HN
UT WOS:000290546500006
PM 21660089
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Noordewier, MK
   Stapel, DA
AF Noordewier, Marret K.
   Stapel, Diederik A.
TI RETRACTED: When failure feels better than success: Self-salience,
   self-consistency, and affect (Retracted article. See vol. 51, pg. 404,
   2012)
SO BRITISH JOURNAL OF SOCIAL PSYCHOLOGY
LA English
DT Article; Retracted Publication
ID ENHANCEMENT; VERIFICATION; FEEDBACK; DETERMINANTS; ESTEEM; TRUTH; BAD
AB People like self-consistent feedback because it induces feelings of predictability and control, but they like positive feedback because it induces positive self-esteem. We show that self-salience determines whether people are more consistency- or positivity-driven. When self-knowledge is salient, people's primary responses (i.e., under load) are consistency-driven (people with low self-esteem feel better after negative feedback than after positive feedback, whereas people with high self-esteem feel better after positive feedback than after negative feedback) and controlled responses are positivity-driven (people feel better after positive feedback than after negative feedback, regardless of self-consistency). Without salient self-knowledge this pattern reverses: people's primary responses are positivity-driven, whereas people's controlled responses are consistency-driven.
C1 [Noordewier, Marret K.] Tilburg Univ, Tilburg Ctr Cognit & Commun TICC, NL-5000 LE Tilburg, Netherlands.
   Tilburg Univ, Tilburg Inst Behav Econ Res, NL-5000 LE Tilburg, Netherlands.
RP Noordewier, MK (reprint author), Tilburg Univ, Tilburg Ctr Cognit & Commun TICC, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM m.k.noordewier@uvt.nl
CR Abelson R. P., 1968, THEORIES COGNITIVE C
   ARONSON E, 1962, J ABNORM PSYCHOL, V65, P178, DOI 10.1037/h0042291
   BREWER MB, 1996, J PERS SOC PSYCHOL, V74, P83
   Cooper J. M., 2007, COGNITIVE DISSONANCE
   DOOSJE B, 1995, J PERS SOC PSYCHOL, V69, P642, DOI 10.1037//0022-3514.69.4.642
   Dutton KA, 1997, J PERS SOC PSYCHOL, V73, P139, DOI 10.1037//0022-3514.73.1.139
   ELLIOT AJ, 1994, J PERS SOC PSYCHOL, V67, P382, DOI 10.1037/0022-3514.67.3.382
   Festinger L., 1957, THEORY COGNITIVE DIS
   GILBERT DT, 1989, THINKING LIGHTLY OTH
   Harmon-Jones Eddie, 1999, COGNITIVE DISSONANCE
   Heider F., 1958, PSYCHOL INTERPERSONA
   JUSSIM L, 1995, J EXP SOC PSYCHOL, V31, P322, DOI 10.1006/jesp.1995.1015
   MARECEK J, 1972, J PERS SOC PSYCHOL, V22, P98, DOI 10.1037/h0032399
   Noordewier MK, 2010, PERS SOC PSYCHOL B, V36, P642, DOI 10.1177/0146167209357746
   Rosenberg M., 1965, SOC ADOLESCENT SELF
   Schwinghammer SA, 2006, PERS SOC PSYCHOL B, V32, P27, DOI 10.1177/0146167205277096
   SEDIKIDES C, 1993, J PERS SOC PSYCHOL, V65, P317, DOI 10.1037/0022-3514.65.2.317
   Stapel DA, 2006, J PERS SOC PSYCHOL, V90, P258, DOI 10.1037/0022-3514.90.2.258
   Steele Claude, 1988, ADV EXPT SOCIAL PSYC, P261, DOI DOI 10.1016/S0065-2601(08)60229-4
   SWANN WB, 1989, J PERS SOC PSYCHOL, V57, P782, DOI 10.1037/0022-3514.57.5.782
   SWANN WB, 1992, J ABNORM PSYCHOL, V101, P293, DOI 10.1037//0021-843X.101.2.293
   SWANN WB, 1990, J PERS SOC PSYCHOL, V59, P17, DOI 10.1037//0022-3514.59.1.17
   SWANN WB, 1995, PERS SOC PSYCHOL B, V21, P1307, DOI 10.1177/01461672952112008
   SWANN WB, 1990, HDB MOTIVATION COGNI, V2
   TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037//0033-2909.103.2.193
   Tesser A., 1988, ADV EXPT SOCIAL PSYC, P181, DOI DOI 10.1016/S0065-2601(08)60227-0
   West S. G, 1991, MULTIPLE REGRESSION
   WOOD JV, 2005, J PERS SOC PSYCHOL, V39, P764
NR 28
TC 1
Z9 1
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0144-6665
EI 2044-8309
J9 BRIT J SOC PSYCHOL
JI Br. J. Soc. Psychol.
PD JUN
PY 2011
VL 50
IS 2
BP 321
EP 330
DI 10.1111/j.2044-8309.2010.02002.x
PG 10
WC Psychology, Social
SC Psychology
GA 759FX
UT WOS:000290227200008
PM 21361981
DA 2018-12-27
ER

PT J
AU Iwamoto, J
   Takeda, T
   Matsumoto, H
AF Iwamoto, Jun
   Takeda, Tsuyoshi
   Matsumoto, Hideo
TI RETRACTED: Efficacy of oral bisphosphonates for preventing hip fracture
   in disabled patients with neurological diseases: a meta-analysis of
   randomized controlled trials among the Japanese population (Retracted
   article. See vol. 33, pg. 1181, 2017)
SO CURRENT MEDICAL RESEARCH AND OPINION
LA English
DT Article; Retracted Publication
DE ALS; Bisphosphonate; Hip fracture; Immobilization; Parkinson's disease;
   Stroke
ID BONE-MINERAL DENSITY; VITAMIN-D; POSTMENOPAUSAL OSTEOPOROSIS;
   CLINICAL-TRIAL; ELDERLY-WOMEN; DOUBLE-BLIND; ALENDRONATE; RISEDRONATE;
   STROKE; THERAPY
AB Objective:
   Neurological diseases such as amyotrophic lateral sclerosis (ALS), stroke, and Parkinson's disease cause disability and immobilization that increases the risk of hip fracture. The purpose of the present study was to clarify the efficacy of oral bisphosphonates for preventing hip fracture in disabled patients with such neurological diseases.
   Methods:
   A literature search (PubMed) was done from 1995 to the present for randomized controlled trials (RCTs), and a meta-analysis was conducted.
   Results:
   Seven RCTs met the criteria, including two of etidronate (ALS and stroke), two of alendronate (stroke and Parkinson's disease), and three of risedronate (stroke and Parkinson's disease). All of the RCTs were performed on Japanese patients. According to the results of pooled data analysis, the relative risk (95% confidence interval) of hip fracture in patients receiving etidronate, alendronate, and risedronate treatment compared with placebo or active control treatment was 0.16 (0.03-0.87), 0.29 (0.10-0.80), and 0.24 (0.10-0.58), respectively, suggesting a reduction of risk by more than 70% with oral bisphosphonates. There was no statistical evidence of heterogeneity among RCTs, and publication bias was not identified by the funnel plot and Begg's rank correlation test. No severe adverse events due to oral bisphosphonate treatment were reported.
   Limitation:
   It remains uncertain whether the findings are relevant for Western patients with an increased risk of hip fracture due to neurological diseases.
   Conclusion:
   A meta-analysis of RCTs suggested that oral bisphosphonate treatment prevents hip fracture in disabled Japanese patients with neurological diseases, including ALS, stroke, and Parkinson's disease. Oral bisphosphonate treatment was well tolerated by such patients.
C1 [Iwamoto, Jun] Keio Univ, Sch Med, Inst Integrated Sports Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.
RP Iwamoto, J (reprint author), Keio Univ, Sch Med, Inst Integrated Sports Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.
EM jiwamoto@sc.itc.keio.ac.jp
RI Matsumoto, Hideo/A-2304-2014
CR Bischoff HA, 2001, HISTOCHEM J, V33, P19, DOI 10.1023/A:1017535728844
   Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999
   Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257
   Cranney A, 2002, ENDOCR REV, V23, P570, DOI 10.1210/er.2001-9002
   Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016
   Epstein S, 2005, MAYO CLIN PROC, V80, P379, DOI 10.4065/80.3.379
   Epstein S, 2007, BONE, V41, pS3, DOI 10.1016/j.bone.2007.03.006
   Fujita T, 2007, J BONE MINER METAB, V25, P130, DOI 10.1007/s00774-006-0738-4
   Higgins J. P., 2005, COCHRANE HDB SYSTEMA
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Iwamoto J, 2005, YONSEI MED J, V46, P456, DOI 10.3349/ymj.2005.46.4.456
   Iwamoto J, 2008, CURR MED RES OPIN, V24, P1379, DOI 10.1185/030079908X297321 
   Iwamoto J, 2007, EXPERT OPIN PHARMACO, V8, P2743, DOI 10.1517/14656566.8.16.2743
   Iwamoto J, 2006, CURR MED RES OPIN, V22, P919, DOI 10.1185/030079906X100276
   Iwamoto J, 2008, CLIN INTERV AGING, V3, P483, DOI 10.2147/CIA.S3177
   Liberman UA, 2006, INT J CLIN PRACT, V60, P1394, DOI 10.1111/j.1742-1241.2006.01148.x
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Ogura Y, 2004, J BONE MINER METAB, V22, P111, DOI 10.1007/s00774-003-0458-y
   ORIMO H, 1994, CALCIFIED TISSUE INT, V54, P370, DOI 10.1007/BF00305521
   ORIMO H, 1987, BONE MINER, V3, P47
   Orimo H, 2009, ARCH OSTEOPOROS, V4, P71, DOI DOI 10.1007/S11657-009-0031-Y
   Papapoulos SE, 2005, OSTEOPOROSIS INT, V16, P468, DOI 10.1007/s00198-004-1725-z
   Rogers MJ, 1999, BONE, V24, p73S, DOI 10.1016/S8756-3282(99)00070-8
   Sato Y, 2005, NEUROLOGY, V64, P811, DOI 10.1212/01.WNL.0000152871.65027.76
   Sato Y, 2005, CEREBROVASC DIS, V20, P187, DOI 10.1159/000087203
   Sato Y, 2005, ARCH INTERN MED, V165, P1743, DOI 10.1001/archinte.165.15.1743
   Sato Y, 2002, BONE, V30, P325, DOI 10.1016/S8756-3282(01)00645-7
   Sato Y, 2007, NEUROLOGY, V68, P911, DOI 10.1212/01.wnl.0000257089.50476.92
   Sato Y, 2006, BONE, V39, P1080, DOI 10.1016/j.bone.2006.04.025
   Sato Y, 2006, MOVEMENT DISORD, V21, P924, DOI 10.1002/mds.20825
   Sato Y, 2011, J STROKE CEREBROVASC, V20, P41, DOI 10.1016/j.jstrokecerebrovasdis.2009.10.007
   Sato Y, 2010, J STROKE CEREBROVASC, V19, P198, DOI 10.1016/j.jstrokecerebrovasdis.2009.04.006
   Shiraki M, 1998, ENDOCR J, V45, P191, DOI 10.1507/endocrj.45.191
   Uchida S, 2005, J BONE MINER METAB, V23, P382, DOI 10.1007/s00774-005-0616-5
   Wells GA, 2008, COCHRANE DB SYST REV, V23, DOI DOI 10.1002/14651858.CD001155.PUB2
NR 35
TC 4
Z9 4
U1 3
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0300-7995
EI 1473-4877
J9 CURR MED RES OPIN
JI Curr. Med. Res. Opin.
PD JUN
PY 2011
VL 27
IS 6
BP 1141
EP 1148
DI 10.1185/03007995.2011.570747
PG 8
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA 764YY
UT WOS:000290671800007
PM 21456887
DA 2018-12-27
ER

PT J
AU Fadaee, MJ
   Tabatabaei, R
AF Fadaee, M. J.
   Tabatabaei, R.
TI RETRACTED: Estimation of failure probability in water pipes network
   using statistical model (Retracted article. See vol. 20, pg. 183, 2012)
SO ENGINEERING FAILURE ANALYSIS
LA English
DT Article; Retracted Publication
DE Reliability function; Power law; Repairable system; Instantaneous
   failure intensity; MLE
ID DISTRIBUTION-SYSTEMS; REPAIRABLE SYSTEMS; MAIN; MAINTENANCE;
   METHODOLOGY; PATTERNS
AB In this paper, a statistical model is presented for decision making in repairing water pipes network. The water distribution system has been considered as a "repairable" system which is under repeating failure modes. From this, a practical model for anticipating the failure of the water pipes in repairable systems has been presented using the trend renewal process concept. In this process, the statistical law has been used for projecting the failure rate to account for the effects of repairs and for different failure modes in estimation of failure intensity. After finding the failures as a function of time, the reliability of the system efficiency is then estimated using survival analysis. At the end, a sample pipes network has been modeled using presented statistical model and the values of failure intensities with respect to time and the curve for reliability function has been found. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Tabatabaei, R.] Islamic Azad Univ, Kerman Branch, Dept Civil Engn, Kerman, Iran.
   [Fadaee, M. J.] Shahid Bahonar Univ Kerman, Dept Civil Engn, Kerman, Iran.
RP Tabatabaei, R (reprint author), Islamic Azad Univ, Kerman Branch, Dept Civil Engn, POB 76175-6114, Kerman, Iran.
EM tabatabaei68@yahoo.com
CR ALHUMOUD J, 1990, P 1990 NAT C HYDR EN, P204
   ANDREOU SA, 1987, ADV WATER RESOUR, V10, P2, DOI 10.1016/0309-1708(87)90002-9
   ANDREOU SA, 1987, ADV WATER RESOUR, V10, P11, DOI 10.1016/0309-1708(87)90003-0
   Cox DR, 1972, STOCHASTIC POINT PRO, P55
   GOULTER I, 1993, J WATER RES PL-ASCE, V119, P419, DOI 10.1061/(ASCE)0733-9496(1993)119:4(419)
   GUO H, 2006, S NEWP BEACH CAL US
   HERZ R, 1998, P 1 IWSA AISE INT C
   Hoyland A., 1994, SYSTEM RELIABILITY T
   Lawless JF, 1996, TECHNOMETRICS, V38, P131, DOI 10.2307/1270406
   LI D, 1992, WATER RESOUR RES, V28, P1053, DOI 10.1029/91WR03035
   Lindqvist BH, 2006, J STAT PLAN INFER, V136, P1701, DOI 10.1016/j.jspi.2004.10.033
   Lindqvist BH, 2003, TECHNOMETRICS, V45, P31, DOI 10.1198/004017002188618671
   Moglia M., 2006, ITCON, V11, P237
   Pulcini G, 2001, J QUAL TECHNOL, V33, P480
   Rostum J, 2000, THESIS NORWEGIAN U S
   SHAMIR U, 1979, J AM WATER WORKS ASS, V71, P248
   Walski T. M., 1987, WATER SUPPLY SYSTEM
   WALSKI TM, 1982, J AM WATER WORKS ASS, V74, P140
   Wengstrom T. R., 1993, COMP ANAL PIPE BREAK
NR 19
TC 6
Z9 6
U1 3
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1350-6307
J9 ENG FAIL ANAL
JI Eng. Fail. Anal.
PD JUN
PY 2011
VL 18
IS 4
BP 1184
EP 1192
DI 10.1016/j.engfailanal.2011.02.013
PG 9
WC Engineering, Mechanical; Materials Science, Characterization & Testing
SC Engineering; Materials Science
GA 768FW
UT WOS:000290920100005
DA 2018-12-27
ER

PT J
AU Andersson, L
   Myhre, S
   Bostrom, P
   Stahlman, M
   Vind, B
   Haversen, L
   Boren, J
   Hojlund, K
   Olofsson, SO
AF Andersson, L.
   Myhre, S.
   Bostrom, P.
   Stahlman, M.
   Vind, B.
   Haversen, L.
   Boren, J.
   Hojlund, K.
   Olofsson, S. -O.
TI RETRACTED: REDUCED SYNTAXIN-5 IN SKELETAL MUSCLE OF PATIENTS WITH TYPE 2
   DIABETES. A LINK BETWEEN LIPID STORAGE AND INSULIN RESISTANCE (Retracted
   article. See vol. 239, pg. 288, 2015)
SO ATHEROSCLEROSIS SUPPLEMENTS
LA English
DT Meeting Abstract; Retracted Publication
CT 79th Congress of the European-Atherosclerosis-Society (EAS)
CY JUN 26-29, 2011
CL Gothenburg, SWEDEN
SP European Atherosclerosis Soc (EAS)
C1 [Andersson, L.; Myhre, S.; Bostrom, P.; Stahlman, M.; Haversen, L.; Boren, J.; Olofsson, S. -O.] Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, Gothenburg, Sweden.
   [Vind, B.; Hojlund, K.] Odense Univ Hosp, Dept Endocrinol, Diabet Res Ctr, DK-5000 Odense, Denmark.
NR 0
TC 1
Z9 1
U1 3
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1567-5688
EI 1878-5050
J9 ATHEROSCLEROSIS SUPP
JI Atheroscler. Suppl.
PD JUN
PY 2011
VL 12
IS 1
MA 147
BP 33
EP 34
DI 10.1016/S1567-5688(11)70148-9
PG 2
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 890QG
UT WOS:000300159000148
PM 25604053
DA 2018-12-27
ER

PT J
AU Yoon, DH
   Lee, H
   Park, B
   Jang, G
AF Yoon, Dong-Hee
   Lee, Hansang
   Park, Byungju
   Jang, Gilsoo
TI RETRACTED: Enhancement of the power system efficiency using the
   hybrid-type harmonic filters for a KSTAR nuclear fusion experimental
   system (Retracted article. See vol. 86, pg. 2999, 2011)
SO FUSION ENGINEERING AND DESIGN
LA English
DT Article; Retracted Publication
DE KSTAR; Power quality; Power factor; Harmonic filters
ID CONSTRUCTION; TOKAMAK; DESIGN
AB The KSTAR system, which includes a large amount of nonlinear load, is a relatively high reactive power consumption load which injects harmonic currents into the power system which could result in the possibility for a power system perturbation to occur in the transmission lines, affecting nearby customers. In order to maintain the power quality and power factor in the inner system of the KSTAR system and the adjacent distribution lines, the assessment of the effect of the DC power supply in the KSTAR system is required for appropriate countermeasures to be put in place. In this paper, on the basis of a preliminary inspection of the power system near a KSTAR system, the simulation of a compensating device is performed for the prevention of abnormal voltage variations caused by a large amount of reactive and nonlinear load. In addition, through the comparison of the pre- and post-application of compensation devices in the actual power system, it is verified that a stable operation of the KSTAR nuclear fusion experimental system can be achieved. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Yoon, Dong-Hee; Lee, Hansang; Jang, Gilsoo] Korea Univ, Sch Elect Engn, Seoul 136701, South Korea.
   [Park, Byungju] PQ TECH INC, Suwon 443813, South Korea.
RP Jang, G (reprint author), Korea Univ, Sch Elect Engn, Anam Dong 5 Ga, Seoul 136701, South Korea.
EM gjang@korea.ac.kr
FU Korean Government [20100018462]
FX This work was supported by National Research Foundation of Korea Grant
   funded by the Korean Government (20100018462)
CR Anderson PM, 1996, SERIES COMPENSATION
   CHOI JH, 2008, NUCL ENG TECHNOLOGY, V40
   Dixon JW, 1995, IEEE T IND ELECTRON, V42, P636, DOI 10.1109/41.475504
   Herrera RS, 2009, IEEE T IND ELECTRON, V56, P2015, DOI 10.1109/TIE.2009.2014749
   JEONG SJ, 2003, APPL POW EL C EXP 20, V1, P256
   Kim KH, 2008, FUSION ENG DES, V83, P291, DOI 10.1016/j.fusengdes.2008.01.016
   Kumar V Suresh, 2008, Journal of Electrical Engineering & Technology, V3, P520
   Kyei J, 2002, IEEE T POWER DELIVER, V17, P828, DOI 10.1109/TPWRD.2002.1022811
   Lee GS, 2001, NUCL FUSION, V41, P1515, DOI 10.1088/0029-5515/41/10/318
   Oh YK, 2008, FUSION ENG DES, V83, P804, DOI 10.1016/j.fusengdes.2008.06.006
NR 10
TC 1
Z9 1
U1 1
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0920-3796
EI 1873-7196
J9 FUSION ENG DES
JI Fusion Eng. Des.
PD JUN
PY 2011
VL 86
IS 4-5
BP 373
EP 380
DI 10.1016/j.fusengdes.2011.03.021
PG 8
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA 785MU
UT WOS:000292233900015
DA 2018-12-27
ER

PT J
AU Bao, SY
   Jiang, R
   Kwan, WK
   Wang, BB
   Ma, X
   Song, YQ
AF Bao, Suying
   Jiang, Rui
   Kwan, WingKeung
   Wang, BinBin
   Ma, Xu
   Song, You-Qiang
TI RETRACTED: Evaluation of next-generation sequencing software in mapping
   and assembly (Retracted article. See vol. 56, pg. 687, 2011)
SO JOURNAL OF HUMAN GENETICS
LA English
DT Review; Retracted Publication
DE de novo assembly; next-generation sequencing; NGS platforms; NGS tools;
   short reads mapping
ID SHORT DNA-SEQUENCES; HUMAN GENOME; STRUCTURAL VARIATION; SHORT READS;
   ALIGNMENT; OLIGONUCLEOTIDES; ALGORITHM; BIOINFORMATICS; TECHNOLOGIES;
   CHALLENGES
AB Next-generation high-throughput DNA sequencing technologies have advanced progressively in sequence-based genomic research and novel biological applications with the promise of sequencing DNA at unprecedented speed. These new non-Sanger-based technologies feature several advantages when compared with traditional sequencing methods in terms of higher sequencing speed, lower per run cost and higher accuracy. However, reads from next-generation sequencing (NGS) platforms, such as 454/Roche, ABI/SOLiD and Illumina/Solexa, are usually short, thereby restricting the applications of NGS platforms in genome assembly and annotation. We presented an overview of the challenges that these novel technologies meet and particularly illustrated various bioinformatics attempts on mapping and assembly for problem solving. We then compared the performance of several programs in these two fields, and further provided advices on selecting suitable tools for specific biological applications. Journal of Human Genetics (2011) 56, 406-414; doi:10.1038/jhg.2011.43; published online 28 April 2011
C1 [Bao, Suying; Song, You-Qiang] Univ Hong Kong, Ctr Reprod Dev & Growth, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.
   [Jiang, Rui] Tsinghua Univ, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China.
   [Jiang, Rui] Tsinghua Univ, Dept Automat, Bioinformat Div, Beijing 100084, Peoples R China.
   [Jiang, Rui] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol, Beijing 100084, Peoples R China.
   [Kwan, WingKeung] Univ Hong Kong, Ctr Comp, Hong Kong, Hong Kong, Peoples R China.
   [Wang, BinBin; Ma, Xu] Natl Res Inst Family Planning, Beijing, Peoples R China.
RP Song, YQ (reprint author), Univ Hong Kong, Ctr Reprod Dev & Growth, Dept Biochem, 21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.
EM songy@hku.hk
RI Song, You-qiang/C-4401-2009; Sincan, Murat/A-3794-2010; Song,
   You-Qiang/E-5207-2011
OI Jiang, Rui/0000-0002-7533-3753
CR Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009
   Bashir A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000051
   Bateman A, 2009, BIOINFORMATICS, V25, P429, DOI 10.1093/bioinformatics/btp037
   Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517
   Bozdag D, 2009, INT PARALL DISTRIB P, P1033
   Bryant DW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-69
   Burrows M., 1994, TECHNICAL REPORT, V124
   Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908
   Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087
   Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128
   Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808
   Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]
   Chen YH, 2009, BIOINFORMATICS, V25, P2514, DOI 10.1093/bioinformatics/btp486
   Clement NL, 2010, BIOINFORMATICS, V26, P38, DOI 10.1093/bioinformatics/btp614
   Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207
   Eaves HL, 2009, BIOINFORMATICS, V25, P969, DOI 10.1093/bioinformatics/btp092
   Engstrand L, 2009, CLIN MICROBIOL INFEC, V15, P823, DOI 10.1111/j.1469-0691.2009.02962.x
   Flicek P, 2010, NAT METHODS, V7, P479, DOI 10.1038/nmeth0610-479b
   Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]
   Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107
   Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195
   Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767
   Horner DS, 2010, BRIEF BIOINFORM, V11, P181, DOI 10.1093/bib/bbp046
   Hossain MS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S16
   Hurd Paul J., 2009, Briefings in Functional Genomics & Proteomics, V8, P174, DOI 10.1093/bfgp/elp013
   Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451
   Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429
   Kim YJ, 2009, BIOINFORMATICS, V25, P1424, DOI 10.1093/bioinformatics/btp178
   Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108
   Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025
   Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109
   Lin H, 2008, BIOINFORMATICS, V24, P2431, DOI 10.1093/bioinformatics/btn416
   Malhis N, 2009, BIOINFORMATICS, V25, P6, DOI 10.1093/bioinformatics/btn565
   Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359
   Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   McHardy AC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000566
   Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001
   Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548
   Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001
   Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957
   Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196
   Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201
   Noe Laurent, 2010, Advances in Bioinformatics, P708501, DOI 10.1155/2010/708501
   Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098
   Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006
   Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026
   Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Schatz MC, 2009, BIOINFORMATICS, V25, P1363, DOI 10.1093/bioinformatics/btp236
   Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156
   Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544
   Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108
   Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533
   STADEN R, 1979, NUCLEIC ACIDS RES, V6, P2601, DOI 10.1093/nar/6.7.2601
   Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170
   Trapnell C, 2009, NAT BIOTECHNOL, V27, P455, DOI 10.1038/nbt0509-455
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629
   Weese D, 2009, GENOME RES, V19, P1646, DOI 10.1101/gr.088823.108
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
NR 68
TC 72
Z9 77
U1 4
U2 54
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1434-5161
EI 1435-232X
J9 J HUM GENET
JI J. Hum. Genet.
PD JUN
PY 2011
VL 56
IS 6
BP 406
EP 414
DI 10.1038/jhg.2011.43
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA 782RO
UT WOS:000292028000002
PM 21525877
OA Bronze
DA 2018-12-27
ER

PT J
AU Obokata, H
   Yamato, M
   Tsuneda, S
   Okano, T
AF Obokata, Haruko
   Yamato, Masayuki
   Tsuneda, Satoshi
   Okano, Teruo
TI RETRACTED: Reproducible subcutaneous transplantation of cell sheets into
   recipient mice (Retracted article. See vol. 11, pg. 616, 2016)
SO NATURE PROTOCOLS
LA English
DT Article; Retracted Publication
ID CULTURE DISHES; TISSUE; TEMPERATURE; MODEL; RECONSTRUCTION;
   REGENERATION; IMPLANTATION; RESPONSES; SURFACE; SIZE
AB Perfecting tissue engineering and cell sheet transplantation is an important step toward realizing regenerative medicine and is a growing area of research. Before being applied to clinical settings, it is important that these approaches are evaluated in vivo. Here we provide a detailed protocol for handling thin cell sheets, for a simple and highly reproducible subcutaneous transplantation of cell sheets into mice, and for the histological examination of regenerated tissues. Various aspects of transplants can be assessed, such as maintenance, differentiation and proliferation. An emphasis is placed on surgical precision and reproducibility. The resulting consistency between surgeries helps minimize artifacts from surgical variation and therefore enables researchers to not only observe and compare the interactions between host tissues but also to compare transplants among different host animals. A single transplantation can be carried out within similar to 10 min.
C1 [Obokata, Haruko; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ TWIns, Inst Adv Biomed Engn & Sci, Tokyo, Japan.
   [Obokata, Haruko; Tsuneda, Satoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan.
RP Okano, T (reprint author), Tokyo Womens Med Univ TWIns, Inst Adv Biomed Engn & Sci, Tokyo, Japan.
EM tokano@abmes.twmu.ac.jp
RI Okano, Teruo/J-4028-2012
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
FX This study was partially supported by: Grants-in-Aid for JSPS Fellows;
   the Formation of Innovation Center for Fusion of Advanced Technologies
   in the Special Coordination Funds for Promoting Science and Technology;
   and the Global COE program. All these grants are from from the Ministry
   of Education, Culture, Sports, Science and Technology, Japan.
CR Akizuki T, 2005, J PERIODONTAL RES, V40, P245, DOI 10.1111/j.1600-0765.2005.00799.x
   Aleckovic M, 2008, REPROD BIOMED ONLINE, V17, P270, DOI 10.1016/S1472-6483(10)60206-4
   Alexander M, 2002, CELL IMMUNOL, V220, P63, DOI 10.1016/S0008-8749(03)00024-8
   Ang LPK, 2010, INVEST OPHTH VIS SCI, V51, P758, DOI 10.1167/iovs.09-3379
   Asakawa N, 2010, BIOMATERIALS, V31, P3903, DOI 10.1016/j.biomaterials.2010.01.105
   BARRANDON Y, 1988, J INVEST DERMATOL, V91, P315, DOI 10.1111/1523-1747.ep12475646
   Boennelycke M, 2011, INT UROGYNECOL J, V22, P191, DOI 10.1007/s00192-010-1257-3
   Dressel R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002622
   Dunning K, 2011, BIOTECH HISTOCHEM, V86, P69, DOI 10.3109/10520295.2010.515496
   Elloumi-Hannachi I, 2010, J INTERN MED, V267, P54, DOI 10.1111/j.1365-2796.2009.02185.x
   Hasegawa M, 2005, TISSUE ENG, V11, P469, DOI 10.1089/ten.2005.11.469
   Hayashida Y, 2005, INVEST OPHTH VIS SCI, V46, P1632, DOI 10.1167/iovs.04-0813
   HUDSONPEACOCK MJ, 1995, J AM ACAD DERMATOL, V32, P1010, DOI 10.1016/0190-9622(95)91341-6
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Kayisli UA, 2007, REPROD SCI, V14, P825, DOI 10.1177/1933719107305865
   Kim SW, 2009, LARYNGOSCOPE, V119, P62, DOI 10.1002/lary.20025
   Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174
   Mori Graziela Garrido, 2009, Braz. Dent. J., V20, P17, DOI 10.1590/S0103-64402009000100002
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Obokata H, 2008, J BIOMED MATER RES A, V86A, P1088, DOI 10.1002/jbm.a.31659
   Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   Pirraco RP, 2011, TISSUE ENG PT A, V17, P1507, DOI 10.1089/ten.tea.2010.0470
   RONFARD V, 1991, BURNS, V17, P181, DOI 10.1016/0305-4179(91)90099-3
   Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Shiroyanagi Y, 2004, BJU INT, V93, P1069, DOI 10.1111/j.1464-410X.2004.04783.x
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Vaisman B, 2010, J BIOMED MATER RES A, V92A, P419, DOI 10.1002/jbm.a.32342
   Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517
   ZBRODOWSKI A, 1987, J HAND SURG-BRIT EUR, V12B, P189, DOI 10.1016/0266-7681(87)90011-8
   Zbrodowski A, 1995, Clin Anat, V8, P202, DOI 10.1002/ca.980080304
NR 33
TC 29
Z9 29
U1 3
U2 68
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-2189
EI 1750-2799
J9 NAT PROTOC
JI Nat. Protoc.
PD JUN
PY 2011
VL 6
IS 7
BP 1053
EP 1059
DI 10.1038/nprot.2011.356
PG 7
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 785QW
UT WOS:000292244800011
PM 21720318
DA 2018-12-27
ER

PT J
AU Yang, C
   DeVisser, A
   Martinez, JA
   Poliakov, I
   Rosales-Hernandez, A
   Ayer, A
   Garven, A
   Zaver, S
   Rincon, N
   Xu, K
   Tuor, UI
   Schmidt, AM
   Toth, C
AF Yang, Christina
   DeVisser, Adriena
   Martinez, Jose A.
   Poliakov, Ilia
   Rosales-Hernandez, Alma
   Ayer, Amit
   Garven, Alexandra
   Zaver, Shaila
   Rincon, Natalia
   Xu, Kevin
   Tuor, Ursula I.
   Schmidt, Ann Marie
   Toth, Cory
TI RETRACTED: Differential impact of diabetes and hypertension in the
   brain: Adverse effects in white matter (Retracted article. See vol. 68,
   pg. 228, 2014)
SO NEUROBIOLOGY OF DISEASE
LA English
DT Article; Retracted Publication
DE Diabetes; Hypertension; White matter abnormalities; Vascular disease;
   Receptor for advanced glycation end products
ID GLYCATION END-PRODUCTS; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; ROTTERDAM
   SCAN; CEREBRAL PERFUSION; OXIDANT STRESS; BLOOD-PRESSURE; RISK-FACTORS;
   RATS; POPULATION
AB Humans subjected to diabetes mellitus (DM) and/or hypertension (HTN) develop cognitive decline, cerebral atrophy and white matter abnormalities, but the relative effects of DM and HTN upon myelin and axonal integrity is unknown. We studied models of Type 1 (streptozotocin-induced) and Type 2 DM (ZDF) +/- HTN (ZSF-1, SHR) in adult rats using magnetic resonance imaging (MRI) and structural and molecular techniques. Type 1 or 2 DM independently led to loss of myelin associated with changes with MRI T2 and magnetization tensor ratios throughout white matter regions. HTN's effect on myelin loss was minimal. Loss of oligodendroglia and myelin proteins was only identified in either Type 1 or Type 2 DM. Activation of the signal transduction pathways initiated by the receptor for advanced glycation end products (AGEs), RAGE, including upregulation of the signal transducer nuclear factor (NF) kappa B only occurred with DM. Diabetes is a greater contributor to white matter loss than hypertension in the rat brain, while hypertension only plays a mild additive effect upon neurodegeneration in the presence of diabetes. (c) 2011 Elsevier Inc. All rights reserved.
C1 [Yang, Christina; DeVisser, Adriena; Martinez, Jose A.; Poliakov, Ilia; Rosales-Hernandez, Alma; Ayer, Amit; Garven, Alexandra; Zaver, Shaila; Rincon, Natalia; Xu, Kevin; Tuor, Ursula I.; Toth, Cory] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada.
   [Yang, Christina; DeVisser, Adriena; Martinez, Jose A.; Poliakov, Ilia; Rosales-Hernandez, Alma; Ayer, Amit; Garven, Alexandra; Zaver, Shaila; Rincon, Natalia; Xu, Kevin; Tuor, Ursula I.; Toth, Cory] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada.
   [Tuor, Ursula I.] Univ Calgary, Expt Imaging Ctr, Calgary, AB T2N 4N1, Canada.
   [Schmidt, Ann Marie] Columbia Univ, Dept Surg, New York, NY USA.
RP Toth, C (reprint author), Univ Calgary, Dept Clin Neurosci, Room 155,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
EM corytoth@shaw.ca
FU Alberta Heritage Foundation for Medical Research (AHFMR)
FX This study was supported by an operating grant from the Alberta Heritage
   Foundation for Medical Research (AHFMR). C.T. is a Clinical Investigator
   of the Alberta Heritage Foundation for Medical Research (AHFMR).
CR Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI [10.1016/j.neurobiolaging.2003.03.001, 10.1016/j.neurobiolaging.2003.08.001]
   Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792
   Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8
   Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4
   BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306
   Chaves CJ, 2000, STROKE, V31, P1090, DOI 10.1161/01.STR.31.5.1090
   Dahlquist G, 2007, DIABETOLOGIA, V50, P957, DOI 10.1007/s00125-007-0615-2
   de Groot JC, 2000, ANN NEUROL, V47, P145
   de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9
   de Leeuw FE, 2002, BRAIN, V125, P765, DOI 10.1093/brain/awf077
   de Leeuw FE, 2004, J NEUROL NEUROSUR PS, V75, P1270, DOI 10.1136/jnnp.2003.030189
   Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921
   Francis GJ, 2008, BRAIN, V131, P3311, DOI 10.1093/brain/awn288
   Gao L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-54
   Henning EC, 2010, J CEREBR BLOOD F MET, V30, P827, DOI 10.1038/jcbfm.2009.246
   Jacobson AM, 2007, NEW ENGL J MED, V356, P1842
   Kamal A, 2006, BRAIN RES, V1073, P276, DOI 10.1016/j.brainres.2005.12.070
   Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42
   Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810
   Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4
   Meneses A, 1996, PHYSIOL BEHAV, V60, P341, DOI 10.1016/0031-9384(96)00027-3
   MUSEN AM, 2007, NEW ENGL J MED, V356, P1842
   Qiao M, 2004, MAGN RESON MATER PHY, V17, P117, DOI 10.1007/s10334-004-0058-4
   Rafikova O, 2008, METABOLISM, V57, P1434, DOI 10.1016/j.metabol.2008.05.014
   Rosano C, 2010, NEUROBIOL AGING, V31, P1197, DOI 10.1016/j.neurobiolaging.2008.08.004
   RYAN CM, 1993, J CLIN EXP NEUROPSYC, V15, P685, DOI 10.1080/01688639308402589
   RYAN CM, 1993, DIABETOLOGIA, V36, P329, DOI 10.1007/BF00400236
   Sabbatini M, 2002, MECH AGEING DEV, V123, P547, DOI 10.1016/S0047-6374(01)00362-1
   Scartozzi M, 2007, J CLIN ONCOL, V25, P3930, DOI 10.1200/JCO.2007.11.5022
   SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175
   Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489
   SCHMIDT R, 1993, NEUROLOGY, V43, P2490, DOI 10.1212/WNL.43.12.2490
   Schoenle EJ, 2002, DIABETOLOGIA, V45, P108, DOI 10.1007/s125-002-8250-6
   Sjobeck M, 2003, NEUROPATH APPL NEURO, V29, P159, DOI 10.1046/j.1365-2990.2003.00456.x
   Steen E, 2005, J ALZHEIMERS DIS, V7, P63
   Tan LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003966
   Toth C, 2006, NEUROBIOL DIS, V23, P445, DOI 10.1016/j.nbd.2006.03.015
   Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2
   Wautier JL, 2001, DIABETES METAB, V27, P535
   Wuerfel J, 2004, BRAIN, V127, P111, DOI 10.1093/brain/awh007
   YAN SD, 1994, J BIOL CHEM, V269, P9889
NR 41
TC 20
Z9 21
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 1095-953X
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD JUN
PY 2011
VL 42
IS 3
BP 446
EP 458
DI 10.1016/j.nbd.2011.02.007
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA 757JQ
UT WOS:000290081700024
PM 21324363
DA 2018-12-27
ER

PT J
AU Eldefrawy, MH
   Khan, MK
   Alghathbar, K
   Tolba, AS
   Kim, KJ
AF Eldefrawy, Mohamed Hamdy
   Khan, Muhammad Khurram
   Alghathbar, Khaled
   Tolba, Ahmed Saleh
   Kim, Kyngn Jung
TI RETRACTED: Authenticated Key Agreement with Rekeying for Secured Body
   Sensor Networks (Retracted article. See vol. 11, pg. 7992, 2011)
SO SENSORS
LA English
DT Article; Retracted Publication
DE body sensor network; RSA; DHECC; rekeying
AB Many medical systems are currently equipped with a large number of tiny, non-invasive sensors, located on, or close to, the patient's body for health monitoring purposes. These groupings of sensors constitute a body sensor network (BSN). Key management is a fundamental service for medical BSN security. It provides and manages the cryptographic keys to enable essential security features such as confidentiality, integrity and authentication. Achieving key agreement in BSNs is a difficult task. Many key agreement schemes lack sensor addition, revocation, and rekeying properties, which are very important. Our proposed protocol circumvents these shortcomings by providing node rekeying properties, as well as node addition and revocation. It proposes a key distribution protocol based on public key cryptography-the RSA (Rivest, Shamir and Adleman) algorithm, and the DHECC (Diffie-Hellman Elliptic Curve Cryptography) algorithm. The proposed protocol does not trust individual sensors, and partially trusts the base station (hospital). Instead of loading full pair-wise keys into each node, after installation our protocol establishes pair-wise keys between nodes according to a specific routing algorithm. In this case, each node doesn't have to share a key with all of its neighbors, only those involved in the routing path; this plays a key role in increasing the resiliency against node capture attacks and the network storage efficiency. Finally we evaluate our algorithm from the BSN security viewpoint and evaluate its performance in comparison with other proposals.
C1 [Eldefrawy, Mohamed Hamdy; Khan, Muhammad Khurram; Alghathbar, Khaled; Tolba, Ahmed Saleh] King Saud Univ, Ctr Excellence Informat Assurance, Riyadh 11653, Saudi Arabia.
   [Alghathbar, Khaled] King Saud Univ, Dept Informat Syst, Coll Comp & Informat Sci, Riyadh 11653, Saudi Arabia.
   [Kim, Kyngn Jung] Woosuk Univ, Dept Child Dev & Welf, Jeonbuk 565701, South Korea.
RP Khan, MK (reprint author), King Saud Univ, Ctr Excellence Informat Assurance, POB 92144, Riyadh 11653, Saudi Arabia.
EM meldefrawy@ksu.edu.sa; mkhurram@ksu.edu.sa; kalghathbar@ksu.edu.sa;
   ahmedtolba@ksu.edu.sa; kkjung00@hanmail.net
RI KHAN, MUHAMMAD KHURRAM/E-4836-2014
OI KHAN, MUHAMMAD KHURRAM/0000-0001-6636-0533
CR Akcan H., 2006, P 5 ACM INT WORKSH D, P35
   Balfanz D., 2002, P NETW DISTR SYST SE
   BOKAREVA T, MINIHARDWARE SURVEY
   Boneh D, 2002, CRYPTOBYTES, V5, P1
   Camtepe S. A., 2005, TR0507 DEP COMP SCI
   Conti M., 2008, P 1 ACM C WIR NETW S
   DIFFIE W, 1976, IEEE T INFORM THEORY, V22, P644, DOI 10.1109/TIT.1976.1055638
   Du W., 2005, P 6 ACM INT S MOB AD, P58
   DU X, 2007, P IEEE INT C COMM 20, P3407
   Eldefrawy M. H., 2010, P INT C ANT SEC ID C, P1
   Eschenauer L, 2002, P 9 ACM C COMP COMM
   Gura N., 2004, P 2004 WORKSH CRYPT
   HAO C, 2009, P 8 IEEE INT C DEP A, P384
   HEALY M, 2008, P 7 IEEE C SENS IEEE
   JIANG C, 2007, P 21 INT C ADV INF N
   Khan MK, 2010, SENSORS-BASEL, V10, P2450, DOI 10.3390/s100302450
   Khurram Khan M., 2007, COMPUTER STANDARDS I, V29, P84
   KIM K, 2009, P NETW COMM CHENN IN, P396
   LEWIS N, 2007, P IEEE GLOB WASH DC
   Li M., 2010, POW EN SOC GEN M 201, P1, DOI DOI 10.1109/INFC0M.2010.546
   Liu D., 2005, ACM T INFORM SYSTEM, V8, P41, DOI DOI 10.1145/1053283
   Malan D., 2004, TR0404 HARV U COMP S
   Malasri K., 2007, P 1 ACM INT WORKSH S
   *NIST, 2001, 256 BIT ADV ENCR STA
   RIVEST RL, 1978, COMMUN ACM, V21, P120, DOI 10.1145/359340.359342
   STAJANO F, 2000, P 8 INT WORKSH SEC P
   SUN JY, 2011, P 31 IEEE INT C DIST
   Wander A. S., 2005, P 3 IEEE INT C PERV
   WANG H, 2005, WMCS200512 DEP COMP
   WATRO R, 2004, P 2 ACM WORKSH SEC A, P59, DOI DOI 10.1145/1029102.1029113
   XU C, 2009, P 2 INT C INF COMP S, P11
   Yang G.-Z., 2006, BODY SENSOR NETWORKS
   YANG Q, 2008, P 17 IEEE INT C COMP
   Yuce MR, 2010, SENSOR ACTUAT A-PHYS, V162, P116, DOI 10.1016/j.sna.2010.06.004
   PIC18F2550 DATA SHEE
   CAPACITOR DATA IC BY
NR 36
TC 4
Z9 4
U1 2
U2 10
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1424-8220
J9 SENSORS-BASEL
JI Sensors
PD JUN
PY 2011
VL 11
IS 6
BP 5835
EP 5849
DI 10.3390/s110605835
PG 15
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 782RB
UT WOS:000292026400019
PM 22163930
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Stapel, DA
   Noordewier, MK
AF Stapel, Diederik A.
   Noordewier, Marret K.
TI RETRACTED: THE MENTAL ROOTS OF SYSTEM JUSTIFICATION: SYSTEM THREAT, NEED
   FOR STRUCTURE, AND STEREOTYPING (Retracted article. See vol. 30, pg.
   NIL_0002, 2012)
SO SOCIAL COGNITION
LA English
DT Article; Retracted Publication
ID TERROR MANAGEMENT; BENEVOLENT SEXISM; PEOPLE STEREOTYPE; SELF;
   ACTIVATION; MORTALITY; THINKING; CONSEQUENCES; ENHANCEMENT; CONFLUENCE
AB In a series of correlational and experimental studies, it is shown that system justification motives result in stereotyping and that an important force behind this effect is an increased need for structure. People who perceive the system they are part of (e.g., their company) as unfair report a higher need for structure and are more likely to engage in stereotyping. Second, experimentally induced system threat increased structure needs which covaried with amplified negative and positive stereotyping effects, indicating that these effects served epistemic rather than self-enhancement needs. Third, the impact of system threat on stereotyping disappears when the desire to justify the system is satisfied through an alternative route. Implications for system justification theory are discussed and the importance of studying the impact of system justification motives on stereotype processes as well as stereotype contents is stressed.
C1 [Stapel, Diederik A.] Tilburg Univ, Tilburg Inst Behav Econ Res TIBER, Social Psychol Dept, NL-5000 LE Tilburg, Netherlands.
RP Stapel, DA (reprint author), Tilburg Univ, Tilburg Inst Behav Econ Res TIBER, Social Psychol Dept, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM d.a.stapel@uvt.nl
CR AVRAMOVA YR, 2010, J PERSONALI IN PRESS
   Bless H, 1996, EUR J SOC PSYCHOL, V26, P935, DOI 10.1002/(SICI)1099-0992(199611)26:6<935::AID-EJSP798>3.0.CO;2-N
   Fein S, 1997, J PERS SOC PSYCHOL, V73, P31, DOI 10.1037/0022-3514.73.1.31
   Festinger L., 1957, THEORY COGNITIVE DIS
   Fiske S. T., 1998, HDB SOCIAL PSYCHOL, V4, P357, DOI DOI 10.1002/9780470561119
   GILBERT DT, 1991, J PERS SOC PSYCHOL, V60, P509, DOI 10.1037/0022-3514.60.4.509
   Glick P, 2001, AM PSYCHOL, V56, P109, DOI 10.1037//0003-066X.56.2.109
   Govorun O, 2006, SOC COGNITION, V24, P111, DOI 10.1521/soco.2006.24.2.111
   Henry PJ, 2008, PSYCHOL INQ, V19, P114, DOI 10.1080/10478400802049951
   Jackman M. R., 1994, VELVET GLOVE PATERNA
   Jost J. T., 2003, EUROPEAN REV SOCIAL, V13, P111, DOI DOI 10.1080/10463280240000046
   Jost JT, 2005, SOC JUSTICE RES, V18, P305, DOI 10.1007/s11211-005-6827-z
   Jost JT, 2008, SOC PERSONAL PSYCHOL, V2, P171, DOI 10.1111/j.1751-9004.2007.00056.x
   Jost John T., 2008, HDB MOTIVATION SCI
   JOST JT, 1994, BRIT J SOC PSYCHOL, V33, P1, DOI 10.1111/j.2044-8309.1994.tb01008.x
   Jost JT, 2005, J PERS SOC PSYCHOL, V88, P498, DOI 10.1037/0022-3514.88.3.498
   Jost JT, 2005, CURR DIR PSYCHOL SCI, V14, P260, DOI 10.1111/j.0963-7214.2005.00377.x
   Jost JT, 2001, COGNITIVE SOCIAL PSYCHOLOGY, P89
   Kay AC, 2008, J PERS SOC PSYCHOL, V95, P18, DOI 10.1037/0022-3514.95.1.18
   Kay AC, 2007, ADV EXP SOC PSYCHOL, V39, P305, DOI 10.1016/S0065-2601(06)39006-5
   Kay AC, 2009, CURR DIR PSYCHOL SCI, V18, P264, DOI 10.1111/j.1467-8721.2009.01649.x
   Kay AC, 2005, PSYCHOL SCI, V16, P240, DOI 10.1111/j.0956-7976.2005.00810.x
   Kay AC, 2003, J PERS SOC PSYCHOL, V85, P823, DOI 10.1037/0022-3514.85.5.823
   Kruglanski A. W., 1996, PSYCHOL ACTION LINKI, P599
   Kruglanski A. W., 1989, LAY EPISTEMICS HUMAN
   Kunda Z, 2003, PSYCHOL BULL, V129, P522, DOI 10.1037/0033-2909.129.4.522
   Landau MJ, 2004, J PERS SOC PSYCHOL, V87, P190, DOI 10.1037/0022-3514.87.2.190
   Lerner M. J., 1980, BELIEF JUST WORLD FU
   LERNER MJ, 1966, J PERS SOC PSYCHOL, V4, P203, DOI 10.1037/h0023562
   Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93
   NEUBERG SL, 1993, J PERS SOC PSYCHOL, V65, P113, DOI 10.1037/0022-3514.65.1.113
   Noordewier MK, 2010, PERS SOC PSYCHOL B, V36, P642, DOI 10.1177/0146167209357746
   NOORDEWIER MK, 2010, WHAT PEOPLE IN PRESS
   Pendry LF, 1996, PERS SOC PSYCHOL B, V22, P249, DOI 10.1177/0146167296223003
   Proulx T, 2006, PSYCHOL INQ, V17, P309, DOI 10.1080/10478400701366985
   Proulx T, 2009, PSYCHOL SCI, V20, P1125, DOI 10.1111/j.1467-9280.2009.02414.x
   Renkema LJ, 2008, PERS SOC PSYCHOL B, V34, P553, DOI 10.1177/0146167207312465
   Russell B., 1900, CRITICAL EXPOSITION
   Schimel J, 1999, J PERS SOC PSYCHOL, V77, P905, DOI 10.1037/0022-3514.77.5.905
   SEARS DO, 1986, J PERS SOC PSYCHOL, V51, P515, DOI 10.1037/0022-3514.51.3.515
   Sherif M, 1966, COMMON PREDICAMENT S
   Stapel D. A., 2000, EUROPEAN B SOCIAL PS, V12, P4
   STAPEL DA, 2001, PERSONALITY SOCIAL P, V8, P915, DOI DOI 10.1177/0146167201278001
   Stapel DA, 2009, PSYCHOL INQ, V20, P245, DOI 10.1080/10478400903448516
   Tesser A, 2000, PERS SOC PSYCHOL REV, V4, P290, DOI 10.1207/S15327957PSPR0404_1
   TESSER A, 1991, J EXP SOC PSYCHOL, V27, P501, DOI 10.1016/0022-1031(91)90023-Y
   Thompson M. M., 1989, ANN M CAN PSYCH ASS
   ULLRICH J, 2007, SOCIAL JUSTICE RES, V20, P117, DOI DOI 10.1007/S11211-007-0035-Y
   van den Bos A, 2009, PERS SOC PSYCHOL B, V35, P101, DOI 10.1177/0146167208325773
   van den Bos K, 2009, PSYCHOL INQ, V20, P197, DOI 10.1080/10478400903333411
NR 50
TC 1
Z9 2
U1 1
U2 21
PU GUILFORD PUBLICATIONS INC
PI NEW YORK
PA 370 SEVENTH AVE, SUITE 1200, NEW YORK, NY 10001-1020 USA
SN 0278-016X
J9 SOC COGNITION
JI Soc. Cogn.
PD JUN
PY 2011
VL 29
IS 3
SI SI
BP 238
EP 254
DI 10.1521/soco.2011.29.3.238
PG 17
WC Psychology, Social
SC Psychology
GA 782JX
UT WOS:000292005700002
OA Bronze
DA 2018-12-27
ER

PT J
AU Takai, N
   Ueda, T
   Ishii, T
   Kira, N
   Nishida, M
   Nasu, K
   Narahara, H
AF Takai, Noriyuki
   Ueda, Tami
   Ishii, Terukazu
   Kira, Naoko
   Nishida, Masakazu
   Nasu, Kaei
   Narahara, Hisashi
TI RETRACTED: Erucylphosphocholine induces growth inhibition, cell cycle
   arrest, and apoptosis in human choriocarcinoma cells (Retracted article.
   See vol. 36, pg. 7295, 2015)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Cell cycle; Apoptosis; Choriocarcinoma; Erucylphosphocholine
ID MEMBRANE PHOSPHOLIPID-METABOLISM; OVARIAN-CANCER CELLS;
   HUMAN-TUMOR-CELLS; ANTICANCER ALKYLPHOSPHOLIPIDS; TROPHOBLASTIC DISEASE;
   HUMAN ENDOMETRIAL; HEXADECYLPHOSPHOCHOLINE; COMBINATION; MANAGEMENT;
   ANALOGS
AB A membrane-targeted, lipophilic ether lipid of synthetic phospholipid analog, erucylphosphocholine (ErPC), induces apoptosis in some lines of human tumor cells. We investigated the effect of ErPC in the choriocarcinoma cell line, BeWo. BeWo cells were treated with various concentrations of ErPC, and changes in cell growth, the cell cycle, apoptosis, and related parameters were examined. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed that BeWo cells were sensitive to the growth inhibitory effect of ErPC. Cell cycle analysis indicated that exposure to ErPC decreased the proportion of cells in the S phase and increased the proportion in the G0/G1 phases of the cell cycle. Induction of apoptosis was confirmed by Annexin V staining of externalized phosphatidylserine and by the loss of mitochondrial transmembrane potential. This induction occurred in conjunction with the altered expression of genes related to cell growth, malignant phenotype, and apoptosis. These results suggest that ErPC may serve as a therapeutic agent for the treatment of choriocarcinoma.
C1 [Takai, Noriyuki; Ueda, Tami; Ishii, Terukazu; Kira, Naoko; Nishida, Masakazu; Nasu, Kaei; Narahara, Hisashi] Oita Univ, Fac Med, Dept Obstet & Gynecol, Oita 8795593, Japan.
RP Takai, N (reprint author), Oita Univ, Fac Med, Dept Obstet & Gynecol, 1-1 Idaigaoka,Hasama Machi, Oita 8795593, Japan.
EM takai@oita-u.ac.jp
FU Japan Society of Gynecologic Oncology [FK344]; Ministry of Education,
   Culture, Sports, Science and Technology of Japan [21592139]; Oita
   University
FX This study was supported by a grant (project code FK344 to N.T.) from
   the Japan Society of Gynecologic Oncology, a Grant-in-Aid (No. 21592139
   to N.T.) for Scientific Research from the Ministry of Education,
   Culture, Sports, Science and Technology of Japan, and a Research Fund at
   the Discretion of the President, Oita University.
CR Berkovic D, 1995, EUR J CANCER, V31A, P2080, DOI 10.1016/0959-8049(95)00350-9
   Berkovic D, 2001, EUR J CANCER, V37, P503, DOI 10.1016/S0959-8049(00)00394-4
   BERKOWITZ RS, 1984, GYNECOL ONCOL, V19, P173, DOI 10.1016/0090-8258(84)90177-X
   Chen Y, 2001, CANCER RES, V61, P6437
   Erdlenbruch B, 1999, CANCER CHEMOTH PHARM, V44, P484, DOI 10.1007/s002800051122
   Georgieva MC, 2002, CANCER LETT, V182, P163, DOI 10.1016/S0304-3835(02)00088-5
   Handrick R, 2005, BIOCHEM PHARMACOL, V70, P837, DOI 10.1016/j.bcp.2005.06.021
   Jendrossek V., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P343, DOI 10.2174/1568011033482341
   Jendrossek V, 2003, ONCOGENE, V22, P2621, DOI 10.1038/sj.onc.1206355
   Jendrossek V, 2001, ANTICANCER RES, V21, P3389
   Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295
   Jones WB, 1997, INT J GYNECOL CANCER, V7, P27, DOI 10.1046/j.1525-1438.1997.00409.x
   Lucas L, 2001, ONCOGENE, V20, P1110, DOI 10.1038/sj.onc.1204216
   NOSEDA A, 1988, CANCER RES, V48, P1788
   Rimon G, 1997, J NEUROSCI RES, V48, P563, DOI 10.1002/(SICI)1097-4547(19970615)48:6<563::AID-JNR9>3.0.CO;2-8
   SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1
   SURWIT EA, 1980, OBSTET GYNECOL, V55, P565
   Takai N, 2004, CLIN CANCER RES, V10, P1141, DOI 10.1158/1078-0432.CCR-03-0100
   Takai N, 2008, GYNECOL ONCOL, V111, P336, DOI 10.1016/j.ygyno.2008.08.004
   Takai N, 2008, INT J MOL MED, V21, P637
   van Blitterswijk WJ, 2008, CURR PHARM DESIGN, V14, P2061, DOI 10.2174/138161208785294636
   van der Luit AH, 2007, MOL CANCER THER, V6, P2337, DOI 10.1158/1535-7163.MCT-07-0202
   Vink SR, 2007, CANCER TREAT REV, V33, P191, DOI 10.1016/j.ctrv.2006.12.001
   Wang YZ, 1998, INT J TISSUE REACT, V20, P101
NR 24
TC 3
Z9 3
U1 1
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD JUN
PY 2011
VL 32
IS 3
BP 569
EP 574
DI 10.1007/s13277-010-0152-3
PG 6
WC Oncology
SC Oncology
GA 763OX
UT WOS:000290570700017
PM 21213097
DA 2018-12-27
ER

PT J
AU Guo, JX
   Rao, N
   Liu, GX
   Yang, Y
   Wang, G
AF Guo, Jianxiu
   Rao, Nini
   Liu, Guangxiong
   Yang, Yong
   Wang, Gang
TI RETRACTED: Predicting Protein Folding Rates Using the Concept of Chou's
   Pseudo Amino Acid Composition (Retracted article. See vol. 33, pg. 2614,
   2012)
SO JOURNAL OF COMPUTATIONAL CHEMISTRY
LA English
DT Article; Retracted Publication
DE protein folding rate; pseudo-amino acid composition; sequence-based
   prediction; jackknife test; linear regression
ID SUBCELLULAR LOCATION PREDICTION; SECONDARY STRUCTURE-CONTENT; LONG-RANGE
   INTERACTIONS; SUPPORT VECTOR MACHINE; DISCRETE WAVELET TRANSFORM; ENZYME
   SUBFAMILY CLASSES; COUPLED RECEPTOR CLASSES; 2-STATE PROTEINS;
   APPROXIMATE ENTROPY; APOPTOSIS PROTEINS
AB One of the most important challenges in computational and molecular biology is to understand the relationship between amino acid sequences and the folding rates of proteins. Recent works suggest that topological parameters, amino acid properties, chain length and the composition index relate well with protein folding rates, however, sequence order information has seldom been considered as a property for predicting protein folding rates. In this study, amino acid sequence order was used to derive an effective method, based on an extended version of the pseudo-amino acid composition, for predicting protein folding rates without any explicit structural information. Using the jackknife cross validation test, the method was demonstrated on the largest dataset (99 proteins) reported. The method was found to provide a good correlation between the predicted and experimental folding rates. The correlation coefficient is 0.81 (with a highly significant level) and the standard error is 2.46. The reported algorithm was found to perform better than several representative sequence-based approaches using the same dataset. The results indicate that sequence order information is an important determinant of protein folding rates. (C) 2011 Wiley Periodicals, Inc. J Comput Chem 32: 1612-1617, 2011
C1 [Guo, Jianxiu; Rao, Nini; Liu, Guangxiong; Yang, Yong; Wang, Gang] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.
RP Rao, N (reprint author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.
EM raonn@uestc.edu.cn
FU National Natural Science Foundation of China [30900318, 60801058]
FX Contract/grant sponsor: National Natural Science Foundation of China;
   contract/grant numbers: 30900318, 60801058
CR Capriotti E, 2007, BIOINFORMATICS, V23, P385, DOI 10.1093/bioinformatics/btl610
   Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420
   Chou K.C., 2009, OPEN BIOINFORMATICS, V3, P31
   Chou K.C., 2009, NAT SCI, V1, P63, DOI DOI 10.4236/NS.2009.12011
   Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466
   Chou KC, 1999, PROTEINS, V34, P137, DOI 10.1002/(SICI)1097-0134(19990101)34:1<137::AID-PROT11>3.0.CO;2-O
   Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107
   CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488
   Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035
   Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494
   Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006
   Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931
   Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707
   Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q
   Debe DA, 1999, J MOL BIOL, V294, P619, DOI 10.1006/jmbi.1999.3278
   Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045
   Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007
   Eaton WA, 2000, ANNU REV BIOPH BIOM, V29, P327, DOI 10.1146/annurev.biophys.29.1.327
   Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016
   Fabian H, 2004, METHODS, V34, P28, DOI 10.1016/j.ymeth.2004.03.004
   Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2
   Finkelstein AV, 1997, FOLD DES, V2, P115, DOI 10.1016/S1359-0278(97)00016-3
   Fulton KF, 2005, NUCLEIC ACIDS RES, V33, pD279, DOI 10.1093/nar/gki016
   Galzitskaya OV, 2003, PROTEINS, V51, P162, DOI 10.1002/prot.10343
   Gao JAZ, 2010, PROTEINS, V78, P2114, DOI 10.1002/prot.22727
   Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681
   Gong HP, 2003, J MOL BIOL, V327, P1149, DOI 10.1016/S0022-2836(03)00211-0
   Gromiha MM, 2006, NUCLEIC ACIDS RES, V34, pW70, DOI 10.1093/nar/gkl043
   Gromiha MM, 2005, J CHEM INF MODEL, V45, P494, DOI 10.1021/ci049757q
   Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003
   Gromiha MM, 2001, J MOL BIOL, V310, P27, DOI 10.1006/jmbi.2001.4775
   Gromiha MM, 1997, J BIOL PHYS, V23, P151, DOI 10.1023/A:1004981409616
   Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693
   Gutin AM, 1996, PHYS REV LETT, V77, P5433, DOI 10.1103/PhysRevLett.77.5433
   Huang JT, 2006, PROTEINS, V63, P551, DOI 10.1002/prot.20911
   Huang LT, 2008, J COMPUT CHEM, V29, P1675, DOI 10.1002/jcc.20925
   Hui X, 2005, PROTEIN SCI, V14, P543, DOI 10.1110/ps.0411001705
   Ivankov DN, 2004, P NATL ACAD SCI USA, V101, P8942, DOI 10.1073/pnas.0402659101
   Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503
   Jiang XY, 2008, AMINO ACIDS, V34, P669, DOI 10.1007/s00726-008-0034-9
   Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443
   Jiang YF, 2009, J COMPUT CHEM, V30, P772, DOI 10.1002/jcc.21096
   Jiang ZT, 2002, POLYMER, V43, P6037, DOI 10.1016/S0032-3861(02)00501-3
   KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7
   Kumarevel TS, 2002, BIOPHYS CHEM, V99, P189, DOI 10.1016/S0301-4622(02)00183-7
   Landwehr N, 2005, MACH LEARN, V59, P161, DOI 10.1007/s10994-005-0466-3
   Lee S, 2006, PROTEINS, V62, P1107, DOI 10.1002/prot.20821
   Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930
   Li ZC, 2009, AMINO ACIDS, V37, P415, DOI 10.1007/s00726-008-0170-2
   Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681
   Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004
   Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4
   Ma BG, 2006, PROTEINS, V65, P362, DOI 10.1002/prot.21140
   Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102
   Maxwell KL, 2005, PROTEIN SCI, V14, P602, DOI 10.1110/ps.041205405
   Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1
   Nolting B, 2003, J THEOR BIOL, V223, P299, DOI 10.1016/S0022-5193(03)00091-2
   Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645
   Punta M, 2005, J MOL BIOL, V348, P507, DOI 10.1016/j.jmb.2005.02.068
   Qiu JD, 2010, PROTEIN PEPTIDE LETT, V17, P715, DOI 10.2174/092986610791190372
   Qiu JD, 2009, ANAL BIOCHEM, V390, P68, DOI 10.1016/j.ab.2009.04.009
   Shao H, 2003, PROTEIN PEPTIDE LETT, V10, P277, DOI 10.2174/0929866033478906
   SHEN HB, 2009, J BIOMED SCI ENG, V2, P136, DOI DOI 10.4236/JBISE.2009.23024
   TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009
   THIRUMALAI D, 1995, J PHYS I, V5, P1457, DOI 10.1051/jp1:1995209
   Viguera AR, 2002, P NATL ACAD SCI USA, V99, P5349, DOI 10.1073/pnas.072387799
   Weikl TR, 2003, J MOL BIOL, V332, P953, DOI 10.1016/S0022-2836(03)00884-2
   Zarrine-Afsar A, 2004, METHODS, V34, P41, DOI 10.1016/j.ymeth.2004.03.013
   Zeeb M, 2004, METHODS, V34, P65, DOI 10.1016/j.ymet.2004.03.014
   Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028
   Zhang GY, 2008, PROTEIN PEPTIDE LETT, V15, P1132, DOI 10.2174/092986608786071184
   Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015
   Zhang LX, 2005, BIOPHYS CHEM, V113, P9, DOI 10.1016/j.bpc.2004.07.036
   Zhang SW, 2008, AMINO ACIDS, V35, P591, DOI 10.1007/s00726-008-0086-x
   Zhang SW, 2008, AMINO ACIDS, V34, P565, DOI 10.1007/s00726-007-0010-9
   Zheng OY, 2008, PROTEIN SCI, V17, P1256, DOI 10.1110/ps.034660.108
   Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251
   Zhou GP, 1998, J PROTEIN CHEM, V17, P729, DOI 10.1023/A:1020713915365
   Zhou HY, 2002, BIOPHYS J, V82, P458, DOI 10.1016/S0006-3495(02)75410-6
   Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001
NR 80
TC 57
Z9 58
U1 4
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0192-8651
EI 1096-987X
J9 J COMPUT CHEM
JI J. Comput. Chem.
PD JUN
PY 2011
VL 32
IS 8
BP 1612
EP 1617
DI 10.1002/jcc.21740
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 748YM
UT WOS:000289429200012
PM 21328402
DA 2018-12-27
ER

PT J
AU Zhong, WZ
   Zhang, ZZ
   Qiao, W
   Fu, PC
   Liu, M
AF Zhong, Weizhang
   Zhang, Zhongzhi
   Qiao, Wei
   Fu, Pengcheng
   Liu, Man
TI RETRACTED: Comparison of chemical and biological pretreatment of corn
   straw for biogas production by anaerobic digestion (Retracted article.
   See vol. 51, pg. 518, 2013)
SO RENEWABLE ENERGY
LA English
DT Article; Retracted Publication
DE Biogas; Biological pretreatment; Chemical pretreatment; Corn straw;
   Pleurotus florida; Anaerobic digestion
ID RICE STRAW; WHEAT STRAW; ENERGY; DIGESTIBILITY; AMMONIA; BIOFUELS;
   CHINA; FIBER
AB In this work, the effects of corn straw pretreatments using Fungus Pleurotus florida and chemicals such as NaOH. ammonia, and urea on the biogasification performance by anaerobic digestion were compared. A laboratory-scale, single-phase and continuous anaerobic biogas digester was used for the evaluation. It was found that after different treatments, the compositional contents of corn straw such as lignin, cellulose, and hemicellulose would be degraded significantly, and that the physical structure of the lignocellulose matrix would also be changed. Our anaerobic digestion experiments showed that the biogas productivity was increased by all the pretreatments; and that the biogas production after NaOH treatment would be 207.07% and 16.58% higher than the raw corn straw and biologically pretreated ones, respectively. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Zhong, Weizhang; Zhang, Zhongzhi; Qiao, Wei; Fu, Pengcheng; Liu, Man] China Univ Petr, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China.
RP Zhang, ZZ (reprint author), China Univ Petr, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China.
EM bjzhwz@hotmail.com
CR Antizar-Ladislao B, 2008, BIOFUEL BIOPROD BIOR, V2, P455, DOI 10.1002/bbb.97
   *APHA, 1998, STAND METH EX WAT WA
   CHANDRA S, 2009, J AGR SCI, V77, P11
   Converti A, 2009, BIORESOURCE TECHNOL, V100, P5771, DOI 10.1016/j.biortech.2009.05.072
   Fredriksson H, 2006, AGR SYST, V89, P184, DOI 10.1016/j.agsy.2005.08.009
   HILLS DJ, 1981, AGR WASTES, V3, P179, DOI 10.1016/0141-4607(81)90026-3
   Li JF, 2003, BIOMASS BIOENERG, V25, P483, DOI 10.1016/S0961-9534(03)00086-2
   LIU JX, 1995, ANIM FEED SCI TECH, V52, P131, DOI 10.1016/0377-8401(94)00701-A
   Midilli A, 2006, ENERG POLICY, V34, P3623, DOI 10.1016/j.enpol.2005.08.003
   MULLER HW, 1986, APPL MICROBIOL BIOT, V24, P180
   National Bureau of Statistics of China, 2009, CHIN STAT YB 2009
   PATEL MM, 1992, J CHEM TECHNOL BIOT, V53, P253
   PLOCHL M, 2006, AGR ENG INT CIGR EJO
   Rajarathnam S, 2001, WORLD J MICROB BIOT, V17, P221, DOI 10.1023/A:1016603510901
   SANKAT CK, 1991, CAN AGR ENG, V33, P309
   VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2
   WAISS AC, 1972, J ANIM SCI, V35, P109
   WILSON RK, 1964, CAN J ANIM SCI, V44, P122, DOI 10.4141/cjas64-019
   XIN LZ, 1993, BIORESOURCE TECHNOL, V43, P13, DOI 10.1016/0960-8524(93)90076-N
   Yen HW, 2007, BIORESOURCE TECHNOL, V98, P130, DOI 10.1016/j.biortech.2005.11.010
   Zeng XY, 2007, RENEW SUST ENERG REV, V11, P976, DOI 10.1016/j.rser.2005.10.003
   Zhang RH, 1999, BIORESOURCE TECHNOL, V68, P235, DOI 10.1016/S0960-8524(98)00154-0
NR 22
TC 44
Z9 51
U1 4
U2 74
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-1481
J9 RENEW ENERG
JI Renew. Energy
PD JUN
PY 2011
VL 36
IS 6
BP 1875
EP 1879
DI 10.1016/j.renene.2010.12.020
PG 5
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA 722LN
UT WOS:000287433800029
DA 2018-12-27
ER

PT J
AU Bangash, MA
   Park, JM
   Melnikova, T
   Wang, DH
   Jeon, SK
   Lee, D
   Syeda, S
   Kim, J
   Kouser, M
   Schwartz, J
   Cui, YY
   Zhao, X
   Speed, HE
   Kee, SE
   Tu, JC
   Hu, JH
   Petralia, RS
   Linden, DJ
   Powell, CM
   Savonenko, A
   Xiao, B
   Worley, PF
AF Bangash, M. Ali
   Park, Joo Min
   Melnikova, Tatiana
   Wang, Dehua
   Jeon, Soo Kyeong
   Lee, Deidre
   Syeda, Sbaa
   Kim, Juno
   Kouser, Mehreen
   Schwartz, Joshua
   Cui, Yiyuan
   Zhao, Xia
   Speed, Haley E.
   Kee, Sara E.
   Tu, Jian Cheng
   Hu, Jia-Hua
   Petralia, Ronald S.
   Linden, David J.
   Powell, Craig M.
   Savonenko, Alena
   Xiao, Bo
   Worley, Paul F.
TI RETRACTED: Enhanced Polyubiquitination of Shank3 and NMDA Receptor in a
   Mouse Model of Autism (Retracted article. See vol. 152, pg. 367, 2013)
SO CELL
LA English
DT Article; Retracted Publication
ID SCAFFOLDING PROTEIN SHANK3; X MENTAL-RETARDATION; SPECTRUM DISORDERS;
   SCHIZOPHRENIA; MUTATIONS; HOMER; GENE; MICE; RECOGNITION; EXPRESSION
AB We have created a mouse genetic model that mimics a human mutation of Shank3 that deletes the C terminus and is associated with autism. Expressed as a single copy [Shank3(+/Delta C) mice], Shank3 Delta C protein interacts with the wild-type (WT) gene product and results in >90% reduction of Shank3 at synapses. This "gain-of-function" phenotype is linked to increased polyubiquitination of WT Shank3 and its redistribution into proteasomes. Similarly, the NR1 subunit of the NMDA receptor is reduced at synapses with increased polyubiquitination. Assays of postsynaptic density proteins, spine morphology, and synapse number are unchanged in Shank3(+/Delta C) mice, but the amplitude of NMDAR responses is reduced together with reduced NMDAR-dependent LTP and LTD. Reciprocally, mGluR-dependent LTD is markedly enhanced. Shank3(+/Delta C) mice show behavioral deficits suggestive of autism and reduced NMDA receptor function. These studies reveal a mechanism distinct from haploinsufficiency by which mutations of Shank3 can evoke an autism-like disorder.
C1 [Bangash, M. Ali; Park, Joo Min; Jeon, Soo Kyeong; Kim, Juno; Schwartz, Joshua; Tu, Jian Cheng; Hu, Jia-Hua; Linden, David J.; Xiao, Bo; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.
   [Melnikova, Tatiana; Lee, Deidre; Syeda, Sbaa; Savonenko, Alena] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
   [Melnikova, Tatiana; Lee, Deidre; Syeda, Sbaa; Savonenko, Alena] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Kouser, Mehreen; Speed, Haley E.; Kee, Sara E.; Powell, Craig M.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.
   [Kouser, Mehreen; Speed, Haley E.; Kee, Sara E.; Powell, Craig M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.
   [Wang, Dehua; Cui, Yiyuan; Zhao, Xia; Xiao, Bo] Sichuan Univ, State Key Lab Biotherapy, W China Hosp, Chengdu 610065, Peoples R China.
   [Petralia, Ronald S.] Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA.
RP Worley, PF (reprint author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.
EM pworley@jhmi.edu
FU National Institute of Neurological Disorders and Stroke
   [5R01NS070301-02]; National Institute of Mental Health
   [5P50MH084020-03]; National 973 Basic Research Program of China
   [20009CB941400, R21HD065290, R01MH081164]; Autism Speaks; Autism Science
   Foundation; Hartwell Foundation; NIDCD
FX M.A.B., A. S., B. X., and P. F. W. designed the study. M. A. B. executed
   and analyzed all the biochemistry, immunocytochemistry, and DiI
   experiments. B. X., M. A. B., D. W., Y.C., and X.Z. created the Shank3
   mouse. J.M.P., S.K.J., and J.K. did the electrophysiology experiments
   and analysis supervised by P. F. W. and D.J.L. R. S. P. did the electron
   microscopy. T. M., D. L., S. S., M. K., H. E. S., and S. E. K. did the
   behavior experiments and analysis supervised by A. S. and C. M. P.
   J.C.T. and J.-H.H. provided reagents. M. A. B., A. S., and P. F. W.
   wrote the manuscript and P. F. W. supervised the overall project. We
   thank Maria Papapavlou for administrative assistance; Holly Wellington,
   Ann Lawler, Johnisha Witherspoon, and Charles Hawkins for assistance in
   generating the Shank3(+/Delta C) mice; Uejin Kim, Jasmin Harpe, Matt Jo,
   Pennson Wang, Dakim Gaines, Olivia Tong, Julia Wynne, and Eugenia Cho
   for help with behavioral testing and data handling; Ya-Xian Wang for
   help with the electron microscopy preparation. This work was supported
   by National Institute of Neurological Disorders and Stroke grant
   5R01NS070301-02 (P. F. W.), National Institute of Mental Health Core
   grant 5P50MH084020-03 (P. F. W.), National 973 Basic Research Program of
   China 20009CB941400 (B. X.), R21HD065290 (C. M. P.), R01MH081164 (C. M.
   P.), Autism Speaks (C. M. P. and M. K.), The Autism Science Foundation
   (C. M. P. and H. S.), The Hartwell Foundation (C. M. P.), NIDCD
   Intramural Program (R. S. P.), and Weatherstone predoctoral fellowship
   from Autism Speaks (M.A.B.).
CR Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009
   Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9
   Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293
   Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0
   Condra JA, 2007, PSYCHIAT GENET, V17, P292, DOI 10.1097/YPG.0b013e3281ac2345
   DeLisi LE, 2002, AM J PSYCHIAT, V159, P803, DOI 10.1176/appi.ajp.159.5.803
   Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933
   Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013
   Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229
   Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107
   Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016
   Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050
   Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699
   Kanne SM, 2011, J AUTISM DEV DISORD, V41, P926, DOI 10.1007/s10803-010-1118-4
   Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102
   Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009
   Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522S90
   Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8
   NESSLINGER NJ, 1994, AM J HUM GENET, V54, P464
   Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008
   Rampon C, 2000, NAT NEUROSCI, V3, P238
   Rapoport J, 2009, J AM ACAD CHILD PSY, V48, P10, DOI 10.1097/CHI.0b013e31818b1c63
   Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005
   Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659
   Szumlinski KK, 2005, GENES BRAIN BEHAV, V4, P273, DOI 10.1111/j.1601-183X.2005.00120x
NR 25
TC 85
Z9 89
U1 5
U2 38
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 27
PY 2011
VL 145
IS 5
BP 758
EP 772
DI 10.1016/j.cell.2011.03.052
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 769MR
UT WOS:000291018600015
PM 21565394
OA Bronze, Green Accepted
DA 2018-12-27
ER

PT J
AU Winton, MJ
   Lee, EB
   Sun, E
   Wong, MM
   Leight, S
   Zhang, B
   Trojanowski, JQ
   Lee, VMY
AF Winton, Matthew J.
   Lee, Edward B.
   Sun, Eveline
   Wong, Margaret M.
   Leight, Susan
   Zhang, Bin
   Trojanowski, John Q.
   Lee, Virginia M. -Y.
TI RETRACTED: Intraneuronal APP, Not Free A beta Peptides in 3xTg-AD Mice:
   Implications for Tau versus A beta-Mediated Alzheimer Neurodegeneration
   (Retracted article. See vol. 35, pg. 3724, 2015)
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article; Retracted Publication
ID AMYLOID PRECURSOR PROTEIN; TRANSGENIC MICE; HUMAN NEURONS;
   AXONAL-TRANSPORT; MOUSE MODEL; A-BETA-42 ACCUMULATION;
   MONOCLONAL-ANTIBODIES; SECRETASE ACTIVITY; GAMMA-SECRETASE; HUMAN BRAIN
AB Alzheimer's disease (AD) is characterized by the accumulation of intraneuronal tau and extracellular amyloid-beta (A beta) peptide. A triple transgenic (Tg) mouse (3xTg-AD) was reported to develop A beta plaques and tau inclusions as well as remarkable accumulations of intracellular A beta that were suggested to be the initiators of AD pathogenesis. However, it was unclear whether the anti-A beta antibodies were able to distinguish A beta peptide from the same A beta epitopes within the amyloid precursor protein (APP). To further elucidate the identity of the immunoreactive intraneuronal material in 3xTg-AD mice, we conducted immunohistochemical, biochemical, and ultrastructural studies using a well characterized panel of antibodies that distinguish A beta within APP from cleaved A beta peptides. We found that the intraneuronal material shared epitopes with full-length APP but not free A beta. To demonstrate unequivocally that this intraneuronal material was not free A beta peptide, we generated 3xTg-AD mice deficient for beta-secretase (BACE), the protease required for A beta generation from APP. In the absence of A beta production, robust intraneuronal APP immunostaining was detected in the 3xTg-AD/BACE(-/-) mice. Finally, we found that the formation of tau lesions was not different between 3xTg-AD versus 3xTg-AD/BACE(-/-) mice, thereby demonstrating that tau pathology forms independently from A beta peptide generation in this mouse model. Although we cannot corroborate the presence of intraneuronal A beta peptide in 3xTg-AD mice, our findings warrant further study as to the role of aberrant APP accumulation in this unique model of AD.
C1 [Winton, Matthew J.; Lee, Edward B.; Sun, Eveline; Wong, Margaret M.; Leight, Susan; Zhang, Bin; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Inst Aging, Philadelphia, PA 19104 USA.
RP Lee, VMY (reprint author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Hosp Univ Penn, Maloney Bldg,3rd Floor,3600 Spruce St, Philadelphia, PA 19104 USA.
EM vmylee@upenn.edu
FU National Institutes of Health [AG17586, AG10124, AG00255]
FX This work was funded by grants from the National Institutes of Health
   (AG17586, AG10124, AG00255). J.Q.T. is the William Maul Measey-Truman G.
   Schnabel Jr. M.D. Professor of Geriatric Medicine and Gerontology.
   V.M.-Y.L. is the John H. Ware third Chair of Alzheimer's Disease
   Research at the University of Pennsylvania. We thank Dr. L.K. Kwong for
   her comments and assistance on this manuscript, and Drs. J. C. Carroll
   and C. J. Pike for providing mouse tissues.
CR Ando K, 1999, J NEUROSCI, V19, P4421
   BANCHER C, 1989, NEUROBIOL AGING, V10, P125, DOI 10.1016/0197-4580(89)90021-3
   Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010
   Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200
   Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064
   De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910
   Duff Karen, 2004, Briefings in Functional Genomics & Proteomics, V3, P47, DOI 10.1093/bfgp/3.1.47
   Echeverria V, 2004, J ALZHEIMERS DIS, V6, P209
   Flood DG, 2009, NEUROBIOL AGING, V30, P1078, DOI 10.1016/j.neurobiolaging.2007.10.006
   GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E
   Golde TE, 2005, NEURON, V45, P639, DOI 10.1016/j.neuron.2005.02.013
   Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1
   Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9
   GRUNDKEIQBAL I, 1989, P NATL ACAD SCI USA, V86, P2853, DOI 10.1073/pnas.86.8.2853
   Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99
   Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811
   Ishihara T, 2001, AM J PATHOL, V158, P555, DOI 10.1016/S0002-9440(10)63997-1
   IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8
   Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110
   Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200
   Kim K. S., 1988, NEUROSCI RES COMMUN, V2, P121
   LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21
   Lazarov O, 2007, J NEUROSCI, V27, P7011, DOI 10.1523/JNEUROSCI.4272-06.2007
   Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070
   Lee EB, 2003, J BIOL CHEM, V278, P4458, DOI 10.1074/jbc.M210105200
   Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115
   Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121
   McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006
   MERCKEN M, 1992, ACTA NEUROPATHOL, V84, P265, DOI 10.1007/BF00227819
   Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Osawa S, 2008, J BIOL CHEM, V283, P19283, DOI 10.1074/jbc.M705954200
   Pigino G, 2003, J NEUROSCI, V23, P4499
   RODRIGUEZ EM, 1984, HISTOCHEMISTRY, V81, P253, DOI 10.1007/BF00495636
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741
   Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114
   Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031
   SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290
   Suzuki T, 1997, BIOCHEMISTRY-US, V36, P4643, DOI 10.1021/bi962618k
   Tabira T, 2002, FRONT BIOSCI, V7, pA44, DOI 10.2741/tabira
   Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X
   Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966
   Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735
   Vercauteren FGG, 2004, MOL BRAIN RES, V132, P241, DOI 10.1016/j.molbrainres.2004.10.012
   Wang HY, 2002, NEUROBIOL AGING, V23, P213, DOI 10.1016/S0197-4580(01)00279-2
   Wegiel J, 2007, ACTA NEUROPATHOL, V113, P389, DOI 10.1007/s00401-006-0191-4
   WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3
   WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513
   Wirths O, 2002, BRAIN PATHOL, V12, P275, DOI 10.1111/j.1750-3639.2002.tb00442.x
   Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077
   Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107
   Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010
   Zhang B, 2004, J NEUROSCI, V24, P4657, DOI 10.1523/JNEUROSCI.0797-04.2004
   Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119
   Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007
NR 55
TC 83
Z9 84
U1 3
U2 16
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD MAY 25
PY 2011
VL 31
IS 21
BP 7691
EP 7699
DI 10.1523/JNEUROSCI.6637-10.2011
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA 768RX
UT WOS:000290956400011
PM 21613482
OA Bronze, Green Accepted
DA 2018-12-27
ER

PT J
AU Ullal, P
   Vilella-Mitjana, F
   Jarmuz, A
   Aragon, L
AF Ullal, Pranav
   Vilella-Mitjana, Felipe
   Jarmuz, Adam
   Aragon, Luis
TI RETRACTED: Rtt107 Phosphorylation Promotes Localisation to DNA
   Double-Stranded Breaks (DSBs) and Recombinational Repair between Sister
   Chromatids (Retracted article. See vol. 12, art no e0176035, 2017)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID SACCHAROMYCES-CEREVISIAE; SMC5/6 COMPLEX; HOMOLOGOUS RECOMBINATION;
   CHECKPOINT RESPONSES; REPLICATION FORKS; DAMAGE RESPONSE; PROTEINS;
   YEAST; COHESIN; LOCUS
AB Efficient repair of DNA double-stranded breaks (DSB) requires a coordinated response at the site of lesion. Nucleolytic resection commits repair towards homologous recombination, which preferentially occurs between sister chromatids. DSB resection promotes recruitment of the Mec1 checkpoint kinase to the break. Rtt107 is a target of Mec1 and serves as a scaffold during repair. Rtt107 plays an important role during rescue of damaged replication forks, however whether Rtt107 contributes to the repair of DSBs is unknown. Here we show that Rtt107 is recruited to DSBs induced by the HO endonuclease. Rtt107 phosphorylation by Mec1 and its interaction with the Smc5-Smc6 complex are both required for Rtt107 loading to breaks, while Rtt107 regulators Slx4 and Rtt101 are not. We demonstrate that Rtt107 has an effect on the efficiency of sister chromatid recombination (SCR) and propose that its recruitment to DSBs, together with the Smc5-Smc6 complex is important for repair through the SCR pathway.
C1 [Ullal, Pranav; Vilella-Mitjana, Felipe; Jarmuz, Adam; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, Cell Cycle Grp, MRC, Ctr Clin Sci, London, England.
RP Ullal, P (reprint author), Univ London Imperial Coll Sci Technol & Med, Cell Cycle Grp, MRC, Ctr Clin Sci, London, England.
EM luis.aragon@csc.mrc.ac.uk
RI Vilella, Felipe/C-2970-2018
FU European Research Council ERC [202337]; Medical Research Council UK;
   Medical Research Council [MC_U120074328]
FX This work was funded by European Research Council ERC starting grant
   202337 (LA) and by the Medical Research Council UK (LA). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Bermudez-Lopez M, 2010, NUCLEIC ACIDS RES, V38, P6502, DOI 10.1093/nar/gkq546
   Bork P, 1997, FASEB J, V11, P68
   Chin JK, 2006, DNA REPAIR, V5, P618, DOI 10.1016/j.dnarep.2006.02.005
   Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340
   De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466
   Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8
   Haber JE, 1998, TRENDS GENET, V14, P317, DOI 10.1016/S0168-9525(98)01501-7
   Herzberg K, 2006, MOL CELL BIOL, V26, P8396, DOI 10.1128/MCB.01317-06
   JENSEN R, 1983, P NATL ACAD SCI-BIOL, V80, P3035, DOI 10.1073/pnas.80.10.3035
   KADYK LC, 1992, GENETICS, V132, P387
   Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538
   Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8
   Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014
   Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015
   Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877
   Melo JA, 2001, GENE DEV, V15, P2809
   Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6
   Mozlin AM, 2008, GENETICS, V178, P113, DOI 10.1534/genetics.107.082677
   Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27
   Ohouo PY, 2010, MOL CELL, V39, P300, DOI 10.1016/j.molcel.2010.06.019
   Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349
   Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218
   Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961
   Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785
   Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740
   Rouse J, 2004, EMBO J, V23, P1188, DOI 10.1038/sj.emboj.7600129
   Sheedy DM, 2005, GENETICS, V171, P457, DOI 10.1534/genetics.105.044966
   STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4
   Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026
   Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239
   Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025
   Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027
   Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905
   Zappulla DC, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-40
NR 34
TC 9
Z9 9
U1 4
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 25
PY 2011
VL 6
IS 5
AR e20152
DI 10.1371/journal.pone.0020152
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 769IQ
UT WOS:000291006500032
PM 21647453
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Simone, RE
   Russo, M
   Catalano, A
   Monego, G
   Froehlich, K
   Boehm, V
   Palozza, P
AF Simone, Rossella E.
   Russo, Marco
   Catalano, Assunta
   Monego, Giovanni
   Froehlich, Kati
   Boehm, Volker
   Palozza, Paola
TI RETRACTED: Lycopene Inhibits NF-kB-Mediated IL-8 Expression and Changes
   Redox and PPAR gamma Signalling in Cigarette Smoke-Stimulated
   Macrophages (Retracted article. See vol. 9, e102411, 2014)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID OBSTRUCTIVE PULMONARY-DISEASE; TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B;
   BRONCHIAL EPITHELIAL-CELLS; PROLIFERATOR-ACTIVATED RECEPTORS;
   FACTOR-ALPHA; CYTOKINE RELEASE; INFLAMMATORY MEDIATORS;
   CLINICAL-IMPLICATIONS; LUNG FIBROBLASTS
AB Increasing evidence suggests that lycopene, the major carotenoid present in tomato, may be preventive against smoke-induced cell damage. However, the mechanisms of such a prevention are still unclear. The aim of this study was to investigate the role of lycopene on the production of the pro-inflammatory cytokine IL-8 induced by cigarette smoke and the possible mechanisms implicated. Therefore, human THP-1 macrophages were exposed to cigarette smoke extract (CSE), alone and following a 6-h pre-treatment with lycopene (0.5-2 mu M). CSE enhanced IL-8 production in a time-and a dose-dependent manner. Lycopene pre-treatment resulted in a significant inhibition of CSE-induced IL-8 expression at both mRNA and protein levels. NF-kB controlled the transcription of IL-8 induced by CSE, since PDTC prevented such a production. Lycopene suppressed CSE-induced NF-kB DNA binding, NF-kB/p65 nuclear translocation and phosphorylation of IKK alpha and IkB alpha. Such an inhibition was accompanied by a decrease in CSE-induced ROS production and NOX-4 expression. Lycopene further inhibited CSE-induced phosphorylation of the redox-sensitive ERK1/2, JNK and p38 MAPKs. Moreover, the carotenoid increased PPAR gamma levels which, in turn, enhanced PTEN expression and decreased pAKT levels in CSE-exposed cells. Such effects were abolished by the PPAR gamma inhibitor GW9662. Taken together, our data indicate that lycopene prevented CSE-induced IL-8 production through a mechanism involving an inactivation of NF-kB. NF-kB inactivation was accompanied by an inhibition of redox signalling and an activation of PPAR gamma signalling. The ability of lycopene in inhibiting IL-8 production, NF-kB/p65 nuclear translocation, and redox signalling and in increasing PPAR gamma expression was also found in isolated rat alveolar macrophages exposed to CSE. These findings provide novel data on new molecular mechanisms by which lycopene regulates cigarette smoke-driven inflammation in human macrophages.
C1 [Simone, Rossella E.; Catalano, Assunta; Palozza, Paola] Catholic Univ, Inst Gen Pathol, Rome, Italy.
   [Russo, Marco; Froehlich, Kati; Boehm, Volker] Univ Jena, Inst Nutr, Jena, Germany.
   [Monego, Giovanni] Catholic Univ, Sch Med, Inst Anat, Rome, Italy.
RP Palozza, P (reprint author), Catholic Univ, Inst Gen Pathol, Rome, Italy.
EM p.palozza@rm.unicatt.it
FU LYCOCARD, European Integrated Project [016213]
FX This work was supported by LYCOCARD, European Integrated Project no
   016213. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abboud RT, 1998, CHEST, V113, P1257, DOI 10.1378/chest.113.5.1257
   Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407
   Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703
   Bartalesi B, 2005, EUR RESPIR J, V25, P15, DOI 10.1183/09031936.04.00067204
   Barton BE, 1997, CLIN IMMUNOL IMMUNOP, V85, P16, DOI 10.1006/clin.1997.4420
   Bessler H, 2008, IMMUNOL INVEST, V37, P183, DOI 10.1080/08820130801967809
   Britton G, 1995, FASEB J, V9, P1551
   Caito S, 2008, ANTIOXID REDOX SIGN, V10, P253, DOI 10.1089/ars.2007.1889
   CARP H, 1978, AM REV RESPIR DIS, V118, P617
   Churg A, 2002, AM J RESP CRIT CARE, V166, P849, DOI 10.1164/rccm.200202-097OC
   Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035
   Culpitt SV, 2003, THORAX, V58, P942, DOI 10.1136/thorax.58.11.942
   DEFORGE LE, 1993, J BIOL CHEM, V268, P25568
   Demirjian L, 2006, BBA-MOL BASIS DIS, V1762, P592, DOI 10.1016/j.bbadis.2006.04.004
   DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0
   Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-01300C
   FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312
   Gesser B, 1996, J LEUKOCYTE BIOL, V59, P407
   Goetze S, 2002, BIOCHEM BIOPH RES CO, V293, P1431, DOI 10.1016/S0006-291X(02)00385-6
   Hu MY, 2008, NUTRITION, V24, P1030, DOI 10.1016/j.nut.2008.05.006
   Huang CS, 2007, J NUTR BIOCHEM, V18, P449, DOI 10.1016/j.jnutbio.2006.08.007
   HUGHES DA, 2000, J INFECT DIS, V182, P11
   Hung CF, 2008, EUR J PHARMACOL, V586, P275, DOI 10.1016/j.ejphar.2008.03.001
   JACOB K, 2008, BR J NUTR, V99, P1137
   Janssen-Heininger YMW, 1999, AM J RESP CELL MOL, V20, P942, DOI 10.1165/ajrcmb.20.5.3452
   Joo YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004562
   JORENS PG, 1992, AM J PHYSIOL, V263, pL708
   KARIMI K, 2006, RESP RES, V9, P7
   Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092
   Kim GY, 2004, IMMUNOLOGY, V113, P203, DOI 10.1046/j.1365-2567.2004.01945.x
   Li CJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1297, DOI 10.1152/ajplung.00194.2006
   Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1
   Liu C, 2006, J NUTR, V136, P106
   Liu XJ, 2007, ASIA PAC J CLIN NUTR, V16, P244
   Luscinskas FW, 2000, ANN NY ACAD SCI, V902, P288
   Masubuchi T, 1998, AM J PATHOL, V153, P1903, DOI 10.1016/S0002-9440(10)65704-5
   Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890
   Nadel JA, 2001, RESPIR RES, V2, P85, DOI 10.1186/rr43
   NAPOLITANO M, 2007, AM J PHYSIOL-ENDOC M, V293, P1820
   Numanami H, 2003, AM J RESP CELL MOL, V29, P613, DOI 10.1165/rcmb.2003-0113OC
   O'Donnell RA, 2004, THORAX, V59, P1032, DOI 10.1136/thx.2004.028043
   Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162
   Palozza P, 2005, APOPTOSIS, V10, P1445, DOI 10.1007/s10495-005-1393-2
   Palozza P, 2002, FREE RADICAL BIO MED, V33, P1724, DOI 10.1016/S0891-5849(02)01168-1
   Palozza P, 2010, CURR MED CHEM, V17, P2547, DOI 10.2174/092986710791556041
   PALOZZA P, 2011, J NUTR BIOC IN PRESS
   PALOZZA P, 2010, J NUTR BIOC IN PRESS
   Palozza P, 2008, CURR MED CHEM, V15, P844, DOI 10.2174/092986708783955400
   Palozza P, 2010, ARCH BIOCHEM BIOPHYS, V504, P26, DOI 10.1016/j.abb.2010.06.031
   Palozza P, 2010, J NUTR BIOCHEM, V21, P34, DOI 10.1016/j.jnutbio.2008.10.002
   Pang BS, 2003, CHINESE MED J-PEKING, V116, P514
   Pesci A, 1998, EUR RESPIR J, V12, P380, DOI 10.1183/09031936.98.12020380
   Phillips J, 2005, ATLA-ALTERN LAB ANIM, V33, P239
   Rahman I, 1996, THORAX, V51, P348, DOI 10.1136/thx.51.4.348
   Raza MW, 1999, FEMS IMMUNOL MED MIC, V24, P387, DOI 10.1016/S0928-8244(99)00019-X
   Rieusset J, 2001, FEBS LETT, V502, P98, DOI 10.1016/S0014-5793(01)02674-6
   Rusznak C, 2001, CLIN EXP ALLERGY, V31, P226, DOI 10.1046/j.1365-2222.2001.01000.x
   Sato E, 1999, AM J PHYSIOL-LUNG C, V277, pL1149, DOI 10.1152/ajplung.1999.277.6.L1149
   Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   Shao MXG, 2004, AM J PHYSIOL-LUNG C, V287, pL420, DOI 10.1152/ajplung.00019.2004
   Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9
   Sharoni Y, 2004, ARCH BIOCHEM BIOPHYS, V430, P89, DOI 10.1016/j.abb.2004.03.009
   Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200
   Srinivasan S, 2003, CIRC RES, V92, P371, DOI 10.1161/01.RES.0000061714.74668.5C
   Takeyama K, 2001, AM J PHYSIOL-LUNG C, V280, pL165
   Touyz RM, 2006, VASC PHARMACOL, V45, P19, DOI 10.1016/j.vph.2005.11.014
   Valenca SS, 2006, INT J EXP PATHOL, V87, P373, DOI 10.1111/j.1365-2613.2006.00492.x
   Walters MJ, 2005, MOL PHARMACOL, V68, P1343, DOI 10.1124/mol.105.012591
   West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147
   Xia XM, 1999, J CELL PHYSIOL, V178, P9, DOI 10.1002/(SICI)1097-4652(199901)178:1<9::AID-JCP2>3.0.CO;2-#
   YANG CM, 2011, J NUTR BIOC IN PRESS
   Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005
   Yeh SL, 2009, CHEM-BIOL INTERACT, V179, P386, DOI 10.1016/j.cbi.2008.12.006
   Zhang N, 2005, J BIOL CHEM, V280, P21400, DOI 10.1074/jbc.M411952200
NR 75
TC 65
Z9 70
U1 1
U2 23
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 19
PY 2011
VL 6
IS 5
AR e19652
DI 10.1371/journal.pone.0019652
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 766HI
UT WOS:000290771200013
PM 21625550
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Singh, CK
   Kumar, R
   Sinha, RP
   Misra, PC
AF Singh, Chandra K.
   Kumar, Rajesh
   Sinha, Rajeshwar P.
   Misra, Prakash C.
TI RETRACTED: Immunodiagnostic analysis of transgenic vegetative
   insecticidal protein in genetically modified crops/produce (Retracted
   article. See vol. 126, pg. 708, 2011)
SO FOOD CHEMISTRY
LA English
DT Article; Retracted Publication
DE Bacillus thuringiensis; Genetically modified crops; Vip3A protein; ELISA
ID BACILLUS-THURINGIENSIS; MODIFIED CROPS; GMOS; VIP3A
AB In the process of development of insect resistant genetically modified (GM) crops and also to evaluate the consistency in the expression of toxin under field conditions, immunological assays are commonly being used. We have developed immunoassay to support labelling of vegetative insecticidal protein (Vip3A) based GM produce. The developed ELISA for measurement of Vip3A is a triple antibody sandwich procedure utilising a polyclonal capture antibody (anti-Vip3A raised in mice) and a polyclonal detection antibody (anti-Vip3A raised in rabbits) followed by use of a third HRP-conjugated antispecies antibody (goat anti-rabbit IgG). The detection limit for the developed ELISA assay was 16 ppb of Vip3A protein. The quantification range was 31-500 ppb of Vip3A protein. The assay is sensitive, quick and reproducible can be utilise in regulating GM produce. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Singh, Chandra K.; Kumar, Rajesh] Indian Inst Toxicol Res CSIR, Lucknow 226001, Uttar Pradesh, India.
   [Sinha, Rajeshwar P.] Banaras Hindu Univ, Dept Bot, Varanasi 221005, Uttar Pradesh, India.
   [Misra, Prakash C.] Univ Lucknow, Dept Biochem, Lucknow 226007, Uttar Pradesh, India.
RP Kumar, R (reprint author), Indian Inst Toxicol Res CSIR, POB 80,MG Marg, Lucknow 226001, Uttar Pradesh, India.
EM rajitrc@gmail.com
FU Department of Biotechnology (DBT), New Delhi, India; Council of
   Scientific and Industrial Research (CSIR), New Delhi
FX This work was financially supported by Department of Biotechnology
   (DBT), New Delhi, India. Council of Scientific and Industrial Research
   (CSIR), New Delhi, is sincerely acknowledged for financial assistance to
   C.K.S. and R.K. (Senior Research Fellows). Authors are thankful to Dr.
   D.N. Kachru, IITR, Lucknow, India for the help during initial studies.
   Authors are also thankful to Dr. Raj K. Bhatnagar, ICGEB, New Delhi,
   India for providing recombinant clone.
CR *AGD INC, 2010, GMO TEST KITS
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CERA, 2012, GM CROP DAT
   *DESIGEN DIAGN, GMO KITS
   Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389
   Fantozzi A, 2007, J AGR FOOD CHEM, V55, P1071, DOI 10.1021/jf061506p
   Kumar R, 2010, FOOD CHEM, V122, P1298, DOI 10.1016/j.foodchem.2010.03.086
   Lee MK, 2003, APPL ENVIRON MICROB, V69, P4648, DOI 10.1128/AEM.69.8.4648-4657.2003
   Marmiroli N, 2008, ANAL BIOANAL CHEM, V392, P369, DOI 10.1007/s00216-008-2303-6
   *MILL, ENZ LINK IMM ASS
   *NEOG, GMO TEST KITS
   Rang C, 2005, APPL ENVIRON MICROB, V71, P6276, DOI 10.1128/AEM.71.10.6276-6281.2005
   *ROM LABS, 2010, AGRASTRIP GMO TESTS
   Singh CK, 2008, ANAL BIOANAL CHEM, V390, P377, DOI 10.1007/s00216-007-1714-0
   *STRAT DIAGN INC, 2010, GMO CHECK GEN MOD IN
   Terry CF, 2002, J AOAC INT, V85, P768
   Wang S, 2007, ENG LIFE SCI, V7, P149, DOI 10.1002/elsc.200620179
   Zel J, 2007, J AOAC INT, V90, P582
NR 18
TC 1
Z9 1
U1 3
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD MAY 15
PY 2011
VL 126
IS 2
BP 786
EP 792
DI 10.1016/j.foodchem.2010.11.077
PG 7
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 715BK
UT WOS:000286855200056
DA 2018-12-27
ER

PT J
AU Zou, JJ
   Zhang, XW
   Yang, HY
   Zhu, Y
   Ma, H
   Wang, S
AF Zou, Junjie
   Zhang, Xiwei
   Yang, Hongyu
   Zhu, Yi
   Ma, Hao
   Wang, Shui
TI RETRACTED: Rapamycin-loaded nanoparticles for inhibition of neointimal
   hyperplasia in experimental vein grafts (Retracted article. See vol. 7,
   17, 2012)
SO JOURNAL OF CARDIOTHORACIC SURGERY
LA English
DT Article; Retracted Publication
ID MUSCLE-CELL-MIGRATION; RANDOMIZED-TRIAL; IN-VITRO; ARTERY; PREVENTION;
   PROLIFERATION; DELIVERY; MODEL; ATHEROSCLEROSIS; PERFORMANCE
AB Background: Nanoparticles possess several advantages as a carrier system for intracellular delivery of therapeutic agents. Rapamycin is an immunosuppressive agent which also exhibits marked antiproliferative properties. We investigated whether rapamycin-loaded nanoparticles(NPs) can reduce neointima formation in a rat model of vein graft disease.
   Methods: Poly(lactic-co-glycolic acid) (PLGA) NPs containing rapamycin was prepared using an oil/water solvent evaporation technique. Nanoparticle size and morphology were determined by dynamic light scattering methodology and electron microscopy. In vitro cytotoxicity of blank, rapamycin-loaded PLGA (RPLGA) NPs was studied using MTT Assay. Excised rat jugular vein was treated ex vivo with blank-NPs, or rapamycin-loaded NPs, then interposed back into the carotid artery position using a cuff technique. Grafts were harvested at 21 days and underwent morphometric analysis as well as immunohistochemical analysis.
   Results: Rapamycin was efficiently loaded in PLGA nanoparticles with an encapsulation efficiency was 87.6%. The average diameter of NPs was 180.3 nm. The NPs-containing rapamycin at 1 ng/ml significantly inhibited vascular smooth muscular cells proliferation. Measurement of rapamycin levels in vein grafts shown that the concentration of rapamycin in vein grafts at 3 weeks after grafting were 0.9 +/- 0.1 mu g/g. In grafted veins without treatment intima-media thickness was 300.4 +/- 181.5 mu m after grafting 21 days. Whereas, Veins treated with rapamycin-loaded NPs showed a reduction of intimal-media thickness of 150.2 +/- 62.5 mu m (p = 0.001). CD-31 staining was used to measure luminal endothelial coverage in grafts and indicated a high level of endothelialization in 21 days vein grafts with no significant effect of blank or rapamycin-loaded NPs group.
   Conclusions: We conclude that sustained-release rapamycin from rapymycin loaded NPs inhibits vein graft thickening without affecting the reendothelialization in rat carotid vein-to-artery interposition grafts and this may be a promising therapy for the treatment of vein graft disease.
C1 [Zhu, Yi; Wang, Shui] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Div Vasc Surg, Nanjng, Jiangsu Prov, Peoples R China.
RP Wang, S (reprint author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Div Vasc Surg, Nanjng, Jiangsu Prov, Peoples R China.
EM wishlucky@163.com
CR Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446
   Butzal M, 2004, EXP CELL RES, V300, P65, DOI 10.1016/j.yexcr.2004.07.002
   Campeau L, 1999, CIRCULATION, V99, P3241, DOI 10.1161/01.CIR.99.25.3241
   Cejna M, 2001, J VASC INTERV RADIOL, V12, P351, DOI 10.1016/S1051-0443(07)61916-2
   Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058
   Fulton GJ, 1998, ANN VASC SURG, V12, P412, DOI 10.1007/s100169900177
   Haddadi A, 2008, J BIOMED MATER RES A, V84A, P885, DOI 10.1002/jbm.a.31373
   Hill RA, 2004, EUR HEART J, V25, P902, DOI 10.1016/j.ehj.2004.03.023
   Holt DW, 2000, CLIN THER, V22, pB38, DOI 10.1016/S0149-2918(00)89021-9
   Kawatsu S, 2007, ANN THORAC SURG, V84, P560, DOI 10.1016/j.athoracsur.2007.02.034
   Leroueil-Le Verger M, 1998, EUR J PHARM BIOPHARM, V46, P137, DOI 10.1016/S0939-6411(98)00015-0
   Moon JI, 2000, TRANSPLANT P, V32, P2026, DOI 10.1016/S0041-1345(00)01542-6
   Murphy GJ, 2007, J THORAC CARDIOV SUR, V134, P504, DOI 10.1016/j.jtcvs.2007.01.092
   Murphy GJ, 2007, CARDIOVASC RES, V73, P607, DOI 10.1016/j.cardiores.2006.11.015
   Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com
   Poon M, 1996, J CLIN INVEST, V98, P2277, DOI 10.1172/JCI119038
   Rajathurai T, 2010, CIRC-CARDIOVASC INTE, V3, P157, DOI 10.1161/CIRCINTERVENTIONS.109.864660
   Reddy MK, 2008, CIRC-CARDIOVASC INTE, V1, P209, DOI 10.1161/CIRCINTERVENTIONS.108.830018
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Schachner T, 2004, EUR J CARDIO-THORAC, V25, P585, DOI 10.1016/j.ejcts.2003.07.013
   Schachner T, 2004, ANN THORAC SURG, V77, P1580, DOI 10.1016/j.athoracsur.2003.10.008
   SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445
   Sun J, 2001, CIRCULATION, V103, P2967, DOI 10.1161/01.CIR.103.24.2967
   Walpoth BH, 2001, EUR J CARDIO-THORAC, V19, P487, DOI 10.1016/S1010-7940(01)00582-6
   Zou YP, 1998, AM J PATHOL, V153, P1301, DOI 10.1016/S0002-9440(10)65675-1
NR 25
TC 7
Z9 7
U1 1
U2 22
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1749-8090
J9 J CARDIOTHORAC SURG
JI J. Cardiothorac. Surg.
PD MAY 12
PY 2011
VL 6
AR 69
DI 10.1186/1749-8090-6-69
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 779XJ
UT WOS:000291815200001
PM 21569412
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Biosse-Duplan, M
   Stephens, S
   Lai, FPL
   Oelkers, M
   Rottner, K
   Horne, W
   Baron, R
AF Biosse-Duplan, M.
   Stephens, S.
   Lai, F. P. L.
   Oelkers, M.
   Rottner, K.
   Horne, W.
   Baron, R.
TI RETRACTED: In osteoclasts, dynamic microtubules and their associated
   protein EB1 control podosomes and bone resorption through cortactin
   (Retracted article. See vol. 55, pg. 512, 2013)
SO BONE
LA English
DT Meeting Abstract; Retracted Publication
CT 3rd Joint Meeting of the
   European-Calcified-Tissue-Society/International-Bone-and-Mineral-Society
CY MAY 07-11, 2011
CL Athens, GREECE
SP European Calcified Tissue Soc (ECTS), Int Bone & Mineral Soc (IBMS)
C1 [Biosse-Duplan, M.; Stephens, S.; Horne, W.; Baron, R.] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA.
   [Lai, F. P. L.] Inst Med Biol, Singapore, Singapore.
   [Oelkers, M.; Rottner, K.] Univ Bonn, Inst Genet, D-5300 Bonn, Germany.
   [Baron, R.] Harvard Univ, Sch Med, Dept Med, Endocrine Unit, Boston, MA USA.
NR 0
TC 2
Z9 2
U1 3
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
EI 1873-2763
J9 BONE
JI Bone
PD MAY 7
PY 2011
VL 48
SU 2
BP S97
EP S97
DI 10.1016/j.bone.2011.03.141
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 754TJ
UT WOS:000289879800122
PM 30011755
DA 2018-12-27
ER

PT J
AU Jimenez, G
   Lemus, JA
   Melendez, L
   Blanco, G
   Laiolo, P
AF Jimenez, Gerardo
   Lemus, Jesus A.
   Melendez, Leandro
   Blanco, Guillermo
   Laiolo, Paola
TI RETRACTED: Dampened behavioral and physiological responses mediate
   birds' association with humans (Retracted article. See vol. 30, pg.
   1372, 2016)
SO BIOLOGICAL CONSERVATION
LA English
DT Article; Retracted Publication
DE Behavioral plasticity; Biodiversity; Birds; Cantabrian Mountains;
   Corticosterone; Habituation; Mountains; Tourism
ID CHOUGH PYRRHOCORAX-PYRRHOCORAX; RED-BILLED CHOUGHS; ALPINE CHOUGH;
   STRESS-RESPONSE; CORTICOSTERONE METABOLITES; ANTHROPOGENIC STRESSORS;
   APHELOCOMA-COERULESCENS; FECAL GLUCOCORTICOIDS; FOOD SUPPLEMENTATION;
   MAGELLANIC PENGUINS
AB The study of the mechanisms involved in phenotypic adaptations or plasticity to environmental stressors may serve to evaluate contemporary ecological and evolutionary dynamics in threatened or growing wildlife populations. By addressing human disturbance as a main stressor agent, we investigated anti-predator response (flushing distance), social behavior (degree of gregarism), health (fecal pathogens), and endocrine status (fecal corticosterone levels) as potential mechanisms that permit birds to cope with anthropogenic impact in tourist areas. Our study models were species that are neither urbanized nor invasive, and that are typical of the high mountains of the Palearctic: the Alpine and the Red-billed chough (Pyrrhocorax graculus and P. pyrrhocorax), and the surrounding alpine bird community. Both chough species showed habituation, reduced flushing distances, fewer parasites and lower corticosterone levels in tourist than in non-tourist sites, and a significant variation in gregarious behavior. Behavioral and physiological adjustments permitted these corvids to optimize resource exploitation depending on habitat quality and in conditions of continuous disturbance. Human-induced changes in chough social behavior had no effect on local avian species richness, a surrogate measure for community diversity. Irrespectively of chough aggregations, bird diversity decreased significantly in recreational areas, thus not all community members tolerated human impact as choughs did. Our findings suggest that species that manage to coexist with humans primarily adjust traits that influence ecological interactions (social, foraging or antipredatory responses) and that vary rapidly (learned behaviors and physiological mechanisms that promote homeostasis). (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Jimenez, Gerardo; Melendez, Leandro; Laiolo, Paola] UO, CSIC, Res Unity Biodivers, PA, Oviedo 33071, Spain.
   [Lemus, Jesus A.; Blanco, Guillermo] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain.
   [Lemus, Jesus A.] CSIC, Estn Biol Donana, E-41080 Seville, Spain.
RP Laiolo, P (reprint author), UO, CSIC, Res Unity Biodivers, PA, Oviedo 33071, Spain.
EM paola@ebd.csic.es
RI Laiolo, Paola/B-6566-2014; Blanco, Guillermo/L-3170-2014; Leandro,
   Melendez/B-8511-2013; CSIC, EBD Donana/C-4157-2011
OI Laiolo, Paola/0000-0002-2009-6797; Blanco,
   Guillermo/0000-0001-5742-4929; CSIC, EBD Donana/0000-0003-4318-6602
FU FICYT [IB09-105]; Spanish Ministry of Science and Innovation
   [CGL2008-02749, CGL2009-12753-C02-01]
FX Funds were provided by projects of FICYT (IB09-105 to PL) and the
   Spanish Ministry of Science and Innovation (CGL2008-02749 to PL;
   CGL2009-12753-C02-01 to GB). We are grateful to the Parque Nacional de
   los Picos de Europa for providing permissions to access, and information
   on tourist numbers. We also thank M. Garcia, R. Cabria, and A. Segura
   for help during field work, and D. Alvarez and J.R. Obeso for passing
   information on Cantabrian chough populations. D. McCracken, T. Martin
   and two anonymous referees provided useful comments on an earlier
   version of this manuscript.
CR Alcaide M, 2010, MOL ECOL, V19, P691, DOI 10.1111/j.1365-294X.2009.04507.x
   Amo L, 2006, BIOL CONSERV, V131, P402, DOI 10.1016/j.biocon.2006.02.015
   Angelier F, 2010, BIOL LETTERS, V6, P846, DOI 10.1098/rsbl.2010.0376
   Angell T, 2005, J ECOL ANTHR, V9, P69, DOI DOI 10.5038/2162-4593.9.1.5)
   ARLETTAZ R, 2007, P ROYAL SOC B, V27, P1219
   BAGLIONE V, 1997, THESIS LEON U SPAIN
   Banda E, 2008, BIOL J LINN SOC, V94, P675, DOI 10.1111/j.1095-8312.2008.01020.x
   Banda E, 2009, OIKOS, V118, P991, DOI 10.1111/j.1600-0706.2009.17363.x
   Blanco G, 1997, BIOL CONSERV, V79, P117, DOI 10.1016/S0006-3207(96)00118-8
   Blanco G, 2006, J APPL ECOL, V43, P990, DOI 10.1111/j.1365-2664.2006.01200.x
   Blanco G, 2009, ENVIRON RES, V109, P405, DOI 10.1016/j.envres.2009.01.007
   Bonier F, 2007, BIOLOGY LETT, V3, P670, DOI 10.1098/rsbl.2007.0349
   Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013
   Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739
   Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x
   Clergeau P, 2006, BIOL CONSERV, V127, P336, DOI 10.1016/j.biocon.2005.06.035
   Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011
   CUEVAS JA, 2009, MUSEO NACL CIENCIAS
   Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2
   Delestrade A, 1999, ANIM BEHAV, V57, P299, DOI 10.1006/anbe.1998.0951
   Fowler GS, 1999, BIOL CONSERV, V90, P143, DOI 10.1016/S0006-3207(99)00026-9
   GARCIADORY MA, 1981, B CIENCIAS NATURALEZ, V28
   Hemmi JM, 2009, P R SOC B, V276, P4381, DOI 10.1098/rspb.2009.1452
   Herring G, 2009, J WILDLIFE MANAGE, V73, P1010, DOI 10.2193/2008-398
   Kerbiriou C, 2009, J APPL ECOL, V46, P657, DOI 10.1111/j.1365-2664.2009.01646.x
   Laiolo P, 2004, J APPL ECOL, V41, P294, DOI 10.1111/j.0021-8901.2004.00893.x
   Laiolo P, 2004, BIOL CONSERV, V115, P251, DOI 10.1016/S0006-3207(03)00145-9
   Laiolo P, 2001, IBIS, V143, P33, DOI 10.1111/j.1474-919X.2001.tb04167.x
   Laiolo P, 2011, P ROY SOC B-BIOL SCI, V278, P1072, DOI 10.1098/rspb.2010.1653
   Laiolo P, 2010, BIOL CONSERV, V143, P1635, DOI 10.1016/j.biocon.2010.03.025
   Laiolo P, 2009, BIOL J LINN SOC, V96, P846, DOI 10.1111/j.1095-8312.2008.01174.x
   Lemus JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013512
   Lemus JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001444
   Lobato E, 2008, HORM BEHAV, V53, P295, DOI 10.1016/j.yhbeh.2007.10.010
   Lord A, 2001, BIOL CONSERV, V98, P233, DOI 10.1016/S0006-3207(00)00158-0
   Martin TE, 1996, AM NAT, V147, P1028, DOI 10.1086/285891
   Martinez-Abrain A, 2010, BASIC APPL ECOL, V11, P312, DOI 10.1016/j.baae.2009.12.011
   Mostl E, 2005, ANN NY ACAD SCI, V1046, P17, DOI 10.1196/annals.1343.004
   Mullner A, 2004, BIOL CONSERV, V118, P549, DOI 10.1016/j.biocon.2003.10.003
   Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498
   Nagy L., 2009, BIOL ALPINE HABITATS
   Patthey P, 2008, J APPL ECOL, V45, P1704, DOI 10.1111/j.1365-2664.2008.01547.x
   R Development Core Team, 2009, R LANG ENV STAT COMP
   Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012
   Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152
   Rolando A, 2003, REV ECOL-TERRE VIE, V58, P337
   Rolando A, 1997, J ZOOL, V242, P299
   ROLANDO A, 2000, J ZOOL LOND, V252, P225
   Romero LM, 2002, GEN COMP ENDOCR, V128, P1
   Romero LM, 2002, BIOL CONSERV, V108, P371, DOI 10.1016/S0006-3207(02)00128-3
   Sachse K, 2009, VET MICROBIOL, V135, P2, DOI 10.1016/j.vetmic.2008.09.040
   Schoech SJ, 2004, HORM BEHAV, V46, P565, DOI 10.1016/j.yhbeh.2004.06.005
   Schoech SJ, 2007, GEN COMP ENDOCR, V154, P150, DOI 10.1016/j.ygcen.2007.05.027
   Selva N, 2011, BIOL LETTERS, V7, P608, DOI 10.1098/rsbl.2010.1204
   Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019
   Sih A, 2010, INTEGR COMP BIOL, V50, P934, DOI 10.1093/icb/icq148
   Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102
   Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251
   Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026
   Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7
   Stoen OG, 2010, EUR J WILDLIFE RES, V56, P789, DOI 10.1007/s10344-010-0378-9
   Stowe M, 2008, HORM BEHAV, V53, P208, DOI 10.1016/j.yhbeh.2007.09.021
   Storch I, 2003, WILDLIFE BIOL, V9, P301
   Tarlow EM, 2007, APPL ANIM BEHAV SCI, V102, P429, DOI 10.1016/j.applanim.2006.05.040
   Thiel D, 2008, J APPL ECOL, V45, P845, DOI 10.1111/j.1365-2664.2008.01465.x
   Thiel D, 2011, IBIS, V153, P122, DOI 10.1111/j.1474-919X.2010.01083.x
   Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006
   Van Meter PE, 2009, HORM BEHAV, V55, P329, DOI 10.1016/j.yhbeh.2008.11.001
   Walker BG, 2006, CONSERV BIOL, V20, P146, DOI 10.1111/j.1523-1739.2005.00271.x
   Washburn BE, 2003, CONDOR, V105, P696, DOI 10.1650/7216
   WASSER SK, 1988, BIOL REPROD, V39, P862, DOI 10.1095/biolreprod39.4.862
   Watson A, 2004, BIOL CONSERV, V116, P267, DOI 10.1016/S0006-3207(03)00197-6
   Yeh PJ, 2004, AM NAT, V164, P531, DOI 10.1086/423825
NR 73
TC 9
Z9 9
U1 5
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0006-3207
EI 1873-2917
J9 BIOL CONSERV
JI Biol. Conserv.
PD MAY
PY 2011
VL 144
IS 5
BP 1702
EP 1711
DI 10.1016/j.biocon.2011.03.003
PG 10
WC Biodiversity Conservation; Ecology; Environmental Sciences
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA 791MB
UT WOS:000292668200054
DA 2018-12-27
ER

PT J
AU Bhola, R
   Su, FY
   Krull, CE
AF Bhola, Rahul
   Su, Fengyun
   Krull, Catherine E.
TI RETRACTED: Functionalization of titanium based metallic biomaterials for
   implant applications (Retracted article. See vol. 22, pg. 2833, 2011)
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Retracted Publication
ID SELF-ASSEMBLED MONOLAYERS; CALCIUM-PHOSPHATE COATINGS; ELECTROCHEMICAL
   IMPEDANCE SPECTROSCOPY; CHEMICALLY TREATED TITANIUM; ANODIC OXIDE
   LAYERS; COLLAGEN TYPE-I; SURFACE MODIFICATION; OSTEOBLAST ADHESION;
   DENTAL IMPLANTS; CELL-ADHESION
AB Surface immobilization with active functional molecules (AFMs) on a nano-scale is a main field in the current biomaterial research. The functionalization of a vast number of substances and molecules, ranging from inorganic calcium phosphates, peptides and proteins, has been investigated throughout recent decades. However, in vitro and in vivo results are heterogeneous. This may be attributed partially to the limits of the applied immobilization methods. Therefore, this paper highlights the advantages and limitations of the currently applied methods for the biological nano-functionalization of titanium-based biomaterial surfaces. The second part describes a newer immobilization system, using the nanomechanical fixation of at least partially single-stranded nucleic acids (NAs) into an anodic titanium oxide layer as an immobilization principle and their hybridization ability for the functionalization of the surface with active functional molecules conjugated to the respective complementary NA strands.
C1 [Bhola, Rahul; Su, Fengyun; Krull, Catherine E.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
RP Bhola, R (reprint author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
EM bholar@umich.edu; krullc@umich.edu
CR Ahn JM, 2002, MINI-REV MED CHEM, V2, P463, DOI 10.2174/1389557023405828
   ALADJEM A, 1973, J MATER SCI, V8, P688, DOI 10.1007/BF00561225
   Alberti P, 2006, ORG BIOMOL CHEM, V4, P3383, DOI 10.1039/b605739j
   Andersen FF, 2008, NUCLEIC ACIDS RES, V36, P1113, DOI 10.1093/nar/gkm1124
   Auernheimer J, 2005, CHEMBIOCHEM, V6, P2034, DOI 10.1002/cbic.200500031
   Bagno A, 2007, BONE, V40, P693, DOI 10.1016/j.bone.2006.10.007
   Baleani M, 2000, ARTIF ORGANS, V24, P296, DOI 10.1046/j.1525-1594.2000.06486.x
   Beissenhirtz MK, 2006, ORG BIOMOL CHEM, V4, P3392, DOI 10.1039/b607033g
   BEUTNER R, 2007, BIOMATERIALIEN, V8, P25
   Beutner R, 2009, BIOMATERIALS, V30, P2774, DOI 10.1016/j.biomaterials.2009.01.047
   Borsari V, 2009, J BIOMED MATER RES A, V89A, P550, DOI 10.1002/jbm.a.31995
   Bozzini B, 2008, J MATER SCI-MATER M, V19, P3443, DOI 10.1007/s10856-008-3487-1
   Cheng XL, 2004, BIOMATERIALS, V25, P5395, DOI 10.1016/j.biomaterials.2003.12.045
   Clair S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2876421
   Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g
   De Giglio E, 2001, J BIOMAT SCI-POLYM E, V12, P63, DOI 10.1163/156856201744452
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Dieudonne SC, 2002, BIOMATERIALS, V23, P3041, DOI 10.1016/S0142-9612(02)00068-6
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Fujibayashi S, 2001, J BIOMED MATER RES, V56, P562, DOI 10.1002/1097-4636(20010915)56:4<562::AID-JBM1128>3.3.CO;2-D
   Gan L, 2004, BIOMATERIALS, V25, P5313, DOI 10.1016/j.biomaterials.2003.12.039
   Gao W, 1996, LANGMUIR, V12, P6429, DOI 10.1021/la9607621
   Gnauck M, 2007, LANGMUIR, V23, P377, DOI 10.1021/la0606648
   Guo KT, 2007, MINI-REV MED CHEM, V7, P701
   Guo KT, 2007, BIOMATERIALS, V28, P468, DOI 10.1016/j.biomaterials.2006.09.021
   He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597
   Henry P J, 1987, Int J Oral Maxillofac Implants, V2, P23
   Hofer R, 2001, LANGMUIR, V17, P4014, DOI 10.1021/la001756e
   Huang Hui, 2003, J Oral Implantol, V29, P73, DOI 10.1563/1548-1336(2003)029<0073:EOFORI>2.3.CO;2
   Iwasaki Y, 2003, COLLOID SURFACE B, V32, P77, DOI 10.1016/S0927-7765(03)00147-4
   Johnsen SP, 2006, J BONE JOINT SURG BR, V88B, P1303, DOI 10.1302/0301-620X.88B10.17399
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Jonasova L, 2002, BIOMATERIALS, V23, P3095, DOI 10.1016/S0142-9612(02)00043-1
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Kamkin AN, 1996, PROT MET+, V32, P214
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   KHALIL N, 1986, ELECTROCHIM ACTA, V31, P1279, DOI 10.1016/0013-4686(86)80148-7
   Khor KA, 2004, BIOMATERIALS, V25, P1177, DOI 10.1016/j.biomaterials.2003.08.008
   Khor KA, 2003, BIOMATERIALS, V24, P769, DOI 10.1016/S0142-9612(02)00413-1
   Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   Kim TI, 2008, CURR PHARM DESIGN, V14, P2201, DOI 10.2174/138161208785740171
   Klinger MM, 1998, CRIT REV ORAL BIOL M, V9, P449, DOI 10.1177/10454411980090040401
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Krupa D, 2005, ANAL BIOANAL CHEM, V381, P617, DOI 10.1007/s00216-004-2983-5
   Kunze J, 2005, Z PHYS CHEM, V219, P1561, DOI 10.1524/zpch.2005.219.11.1561
   Kweh SWK, 2002, BIOMATERIALS, V23, P775, DOI 10.1016/S0142-9612(01)00183-1
   Lappalainen R, 2005, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.blo.0000150000.75660.ff
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+
   Lee BH, 2002, J BIOMED MATER RES, V61, P466, DOI 10.1002/jbm.10190
   Leng YX, 2003, SURF SCI, V531, P177, DOI 10.1016/S0039-6028(03)00487-4
   Leng YX, 2000, THIN SOLID FILMS, V377, P573, DOI 10.1016/S0040-6090(00)01306-7
   Li H, 2004, SURF COAT TECH, V182, P227, DOI 10.1016/j.surfcoat.2003.08.081
   Liang FH, 2003, J MATER SCI LETT, V22, P1665, DOI 10.1023/B:JMSL.0000004643.03120.ca
   Liu HB, 2008, CHEMPHYSCHEM, V9, P1979, DOI 10.1002/cphc.200800381
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Liu XY, 2003, SURF COAT TECH, V172, P270, DOI 10.1016/S0257-8972(03)00344-X
   Liu XY, 2002, BIOMATERIALS, V23, P963, DOI 10.1016/S0142-9612(01)00210-1
   Liu XY, 2001, BIOMATERIALS, V22, P2007, DOI 10.1016/S0142-9612(00)00386-0
   Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005
   Liu Y, 2007, J DENT RES, V86, P84, DOI 10.1177/154405910708600114
   Liu Y, 2007, BIOMATERIALS, V28, P2677, DOI 10.1016/j.biomaterials.2007.02.003
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   Maitz MF, 2002, BIOMOL ENG, V19, P269, DOI 10.1016/S1389-0344(02)00039-4
   Mani G, 2008, LANGMUIR, V24, P6774, DOI 10.1021/la8003646
   Martin SM, 2004, J BIOMED MATER RES A, V70A, P10, DOI 10.1002/jbm.a.30052
   Matsue T, 2002, VACUUM, V66, P435, DOI 10.1016/S0042-207X(02)00167-7
   Michael J, 2007, J BIOMED MATER RES B, V80B, P146, DOI 10.1002/jbm.b.30579
   Michael J, 2009, BIOCONJUGATE CHEM, V20, P710, DOI 10.1021/bc800372e
   Michel R, 2002, LANGMUIR, V18, P3281, DOI 10.1021/la011715y
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Nagai M, 2002, DENT MATER J, V21, P250, DOI 10.4012/dmj.21.250
   Nishiguchi S, 2001, J BIOMED MATER RES, V54, P198, DOI 10.1002/1097-4636(200102)54:2<198::AID-JBM6>3.0.CO;2-7
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Ogawa T, 2003, INT J ORAL MAX IMPL, V18, P200
   Orban JM, 2000, MACROMOLECULES, V33, P4205, DOI 10.1021/ma9915780
   Park S.H., 2006, ANGEW CHEM, V118, P749
   Philippin G, 2003, APPL SURF SCI, V212, P530, DOI 10.1016/S0169-4332(03)00051-5
   Popa MV, 2008, J MATER SCI-MATER M, V19, P1, DOI 10.1007/s10856-007-3271-7
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Ratner B. D., 2001, TITANIUM MED, P1
   Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252
   Roehlecke C, 2001, CELLS TISSUES ORGANS, V168, P178, DOI 10.1159/000047833
   Roessler S, 2002, COLLOID SURFACE B, V26, P387, DOI 10.1016/S0927-7765(02)00025-5
   Roessler S, 2001, J MATER SCI-MATER M, V12, P871, DOI 10.1023/A:1012807621414
   Rossler S, 2003, J BIOMED MATER RES A, V64A, P655, DOI 10.1002/jbm.a.10330
   Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586
   Ruoslahti E, 2003, MATRIX BIOL, V22, P459, DOI 10.1016/S0945-053X(03)00083-0
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Scharnweber D, 2007, J MATER SCI-MATER M, V18, P391, DOI 10.1007/s10856-006-0704-7
   Scharnweber D, 2002, J MATER SCI-MATER M, V13, P1215, DOI 10.1023/A:1021118811893
   Scharnweber D, 2004, BIOMATERIALS, V25, P2371, DOI 10.1016/j.biomaterials.2003.09.025
   Scharnweber D, 2009, RECENT DEV ADV MED D, P101
   Schliephake H, 2002, INT J ORAL MAX SURG, V31, P469, DOI 10.1054/ijom.2002.0244
   Schliephake H, 2008, J MATER CHEM, V18, P2404, DOI [10.1039/b715355b, 10.1039/015355b]
   Schliephake H, 2009, CLIN ORAL IMPLAN RES, V20, P31, DOI 10.1111/j.1600-0501.2008.01603.x
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   SCHUTZ RW, 1997, SURFACE PERFORMANCE, P1
   Schwartz Z, 2008, J BONE JOINT SURG AM, V90A, P2485, DOI 10.2106/JBJS.G.00499
   Seeman NC, 1999, TRENDS BIOTECHNOL, V17, P437, DOI 10.1016/S0167-7799(99)01360-8
   SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Silverman BM, 2005, LANGMUIR, V21, P225, DOI 10.1021/la0482271
   SODEK J, 1992, INT CONGR SER, V1002, P297
   Spori DM, 2007, LANGMUIR, V23, P8053, DOI 10.1021/la700474v
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V68B, P149, DOI 10.1002/jbm.b.20003
   Takebe J, 2000, J BIOMED MATER RES, V51, P398, DOI 10.1002/1097-4636(20000905)51:3<398::AID-JBM14>3.0.CO;2-#
   Takeuchi M, 2003, BIOMATERIALS, V24, P1821, DOI 10.1016/S0142-9612(02)00576-8
   Tegoulia VA, 2001, LANGMUIR, V17, P4396, DOI 10.1021/la001790t
   Teng SH, 2008, J MATER SCI-MATER M, V19, P2453, DOI 10.1007/s10856-008-3370-0
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   Uchida M, 2004, SURF COAT TECH, V177, P627, DOI 10.1016/S0257-8972(03)00937-X
   Valentin Andreas H., 2004, Keio Journal of Medicine, V53, P166, DOI 10.2302/kjm.53.166
   van Steenberghe D, 2002, CLIN ORAL IMPLAN RES, V13, P617, DOI 10.1034/j.1600-0501.2002.130607.x
   Velten D, 2003, Z METALLKD, V94, P667, DOI 10.3139/146.030668
   Viornery C, 2002, LANGMUIR, V18, P2582, DOI 10.1021/la010908i
   VROMAN L, 1969, Journal of Biomedical Materials Research, V3, P669, DOI 10.1002/jbm.820030410
   Wach JY, 2008, CHEM-EUR J, V14, P10579, DOI 10.1002/chem.200801134
   Wang CX, 2003, BIOMATERIALS, V24, P3069, DOI 10.1016/S0142-9612(03)00154-6
   Wang CX, 2002, MATER LETT, V54, P30, DOI 10.1016/S0167-577X(01)00532-8
   Wang XX, 2002, BIOMATERIALS, V23, P1353, DOI 10.1016/S0142-9612(01)00254-X
   Wang XX, 2000, J BIOMED MATER RES, V52, P171, DOI 10.1002/1097-4636(200010)52:1<171::AID-JBM22>3.0.CO;2-O
   Wikesjo UME, 2008, J CLIN PERIODONTOL, V35, P1001, DOI 10.1111/j.1600-051X.2008.01321.x
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Xu GC, 2003, SURF COAT TECH, V169, P299, DOI 10.1016/S0257-8972(03)00113-0
   Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389
   Yao C, 2006, J NANOSCI NANOTECHNO, V6, P2682, DOI 10.1166/jnn.2006.447
   Yerokhin AL, 2000, SURF COAT TECH, V130, P195, DOI 10.1016/S0257-8972(00)00719-2
   Zhang M, 2007, SURF COAT TECH, V201, P7252, DOI 10.1016/j.surfcoat.2007.01.043
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zorn G, 2007, J MATER SCI-MATER M, V18, P1309, DOI 10.1007/s10856-006-0117-7
   Zorn G, 2005, CHEM MATER, V17, P4218, DOI 10.1021/cm050477f
   Zoulalian V, 2006, J PHYS CHEM B, V110, P25603, DOI 10.1021/jp066811s
NR 142
TC 16
Z9 18
U1 3
U2 36
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2011
VL 22
IS 5
BP 1147
EP 1159
DI 10.1007/s10856-011-4305-8
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 778KF
UT WOS:000291701900007
PM 21476077
DA 2018-12-27
ER

PT J
AU Ying, LQ
   Branchaud, BP
AF Ying, Lai-Qiang
   Branchaud, Bruce P.
TI RETRACTED: Facile Synthesis of Symmetric, Monofunctional Cyanine Dyes
   for Imaging Applications (Retracted article. See vol. 22, pg. 2198,
   2011)
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article; Retracted Publication
ID INFRARED FLUORESCENT-PROBES; IN-VIVO; LABELING REAGENTS; SUCCINIMIDYL
   ESTERS; CY5 DERIVATIVES; PROTEINS; TUMORS
AB Efficient syntheses of several members of a new class of symmetric, monocarboxylate-functionalized cyanine dyes have been developed. The synthesis is a simple two-step method, typically with greater than 60% yield and easy final product purification. The new monocarboxylate-functionalized cyanine dyes exhibit excellent water solubility and similar excitation and emission properties to those of Cy5 and Alexa Fluor 647. The application of the new dyes in cellular imaging has been demonstrated through direct conjugating of the dye with an antibody, then imaging of microtubules inside cells, visualized by near-infrared fluorescence microscopy.
C1 [Ying, Lai-Qiang; Branchaud, Bruce P.] Life Technol, Eugene, OR 97402 USA.
RP Ying, LQ (reprint author), Life Technol, 29851 Willow Creek Rd, Eugene, OR 97402 USA.
EM lai-qiang.ying@lifetech.com
CR Ballou B, 2005, CURR MED CHEM, V12, P795, DOI 10.2174/0929867053507324
   Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598
   Chen XY, 2004, CANCER RES, V64, P8009, DOI 10.1158/0008-5472.CAN-04-1956
   ERNST LA, 1989, CYTOMETRY, V10, P3, DOI 10.1002/cyto.990100103
   Flanagan JH, 1997, BIOCONJUGATE CHEM, V8, P751, DOI 10.1021/bc970113g
   Gruber HJ, 2000, BIOCONJUGATE CHEM, V11, P161, DOI 10.1021/bc990107f
   Gruber HJ, 2000, BIOCONJUGATE CHEM, V11, P696, DOI 10.1021/bc000015m
   Haugland R. P., 2002, HDB FLUORESCENT PROB
   Hilderbrand SA, 2005, BIOCONJUGATE CHEM, V16, P1275, DOI 10.1021/bc0501799
   Lee H, 2008, J ORG CHEM, V73, P723, DOI 10.1021/jo701793h
   MANK AJG, 1995, ANAL CHEM, V67, P1742, DOI 10.1021/ac00106a015
   MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001
   Mujumdar SR, 1996, BIOCONJUGATE CHEM, V7, P356, DOI 10.1021/bc960021b
   Pham W, 2005, BIOCONJUGATE CHEM, V16, P735, DOI 10.1021/bc049700+
   Sameiro M, 2009, CHEM REV, V109, P190, DOI 10.1021/cr0783840
   Shao FW, 2008, BIOCONJUGATE CHEM, V19, P2487, DOI 10.1021/bc800417b
   STEINBERG IZ, 1971, ANNU REV BIOCHEM, V40, P83, DOI 10.1146/annurev.bi.40.070171.000503
   STREKOWSKI L, 1992, J ORG CHEM, V57, P4578, DOI 10.1021/jo00043a009
   Toutchkine A, 2002, BIOCONJUGATE CHEM, V13, P387, DOI 10.1021/BC015558q
   Tung CH, 2002, CHEMBIOCHEM, V3, P784, DOI 10.1002/1439-7633(20020802)3:8<784::AID-CBIC784>3.0.CO;2-X
   Tung CH, 2005, MOL PHARMACEUT, V2, P92, DOI 10.1021/mp0499048
   Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933
   Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123
   WEST W, 1965, J PHYS CHEM-US, V69, P1894, DOI 10.1021/j100890a019
   Zaheer A, 2001, NAT BIOTECHNOL, V19, P1148, DOI 10.1038/nbt1201-1148
   Zaheer Atif, 2002, Mol Imaging, V1, P354, DOI 10.1162/153535002321093963
NR 26
TC 11
Z9 11
U1 3
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD MAY
PY 2011
VL 22
IS 5
BP 865
EP 869
DI 10.1021/bc2001006
PG 5
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 765GF
UT WOS:000290691600003
PM 21517120
DA 2018-12-27
ER

PT J
AU Chen, GY
   Zhang, YG
   Zhu, JL
   Cao, Y
   Pan, WP
AF Chen, Guoyan
   Zhang, Yanguo
   Zhu, Jiulong
   Cao, Yan
   Pan, Weiping
TI RETRACTED: Coal and Biomass Partial Gasification and Soot Properties in
   an Atmospheric Fluidized Bed (Retracted article. See vol. 31, pg. 1051,
   2017)
SO ENERGY & FUELS
LA English
DT Article; Retracted Publication
ID POLYCYCLIC AROMATIC-HYDROCARBONS; LAMINAR-FLOW REACTOR; AEROSOLS;
   PYROLYSIS; EMISSION; REACTIVITY; COMBUSTION; CHEMISTRY; KINETICS;
   SULFATE
AB Using air as the gasification medium, one kind of coal and one kind of biomass partial gasification studies were carried out in a laboratory-scale atmospheric fluidized bed with the various operating parameters. The effects of the O/C ratio, biomass/(coal + biomass) (F-b/F-m) ratio, and bed temperature on the fuel gas compositions and the high heating value (HHV) were reported in this paper. The results show that the concentrations of carbon monoxide, hydrogen, and methane and the HHV decrease with the rise of the O/C ratio and the decline of the F-b/F-m ratio for coal and biomass partial gasification. A rise of the bed temperature favors the semi-gasification reaction of coal, but the concentrations of carbon monoxide and methane and the HHV decrease with the rise of the bed temperature, except hydrogen. In addition, the gas HHVs are between 1.0 and 3.3 MJ N-1 m(-3). The gas yield and carbon conversion increase with the O/C ratio, F-b/F-m ratio, and bed temperature. The atomic percentage of carbon increases and the atomic percentage of oxygen decreases with the rise of the O/C ratio in fly ash. The concentration of soot decreases along with the O/C ratio in fly ash.
C1 [Chen, Guoyan; Zhang, Yanguo] Tsinghua Univ, Sch Mech Engn, Beijing 100084, Peoples R China.
   [Chen, Guoyan; Cao, Yan; Pan, Weiping] Western Kentucky Univ, ICSET, Bowling Green, KY 42101 USA.
   [Chen, Guoyan; Zhu, Jiulong] Fengquan Environm Protect Co, Fuzhou 350007, Peoples R China.
RP Chen, GY (reprint author), Tsinghua Univ, Sch Mech Engn, Beijing 100084, Peoples R China.
EM chenguoyan06@163.com
CR Ambrogio M, 2002, SEP PURIF TECHNOL, V27, P195, DOI 10.1016/S1383-5866(01)00182-4
   Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779
   BILBAO R, 1994, IND ENG CHEM RES, V33, P2846, DOI 10.1021/ie00035a039
   Bockhorn H., 1994, SOOT FORMATION COMBU
   Cooke WF, 1999, J GEOPHYS RES-ATMOS, V104, P22137, DOI 10.1029/1999JD900187
   CRUTZEN PJ, 1990, SCIENCE, V250, P1669, DOI 10.1126/science.250.4988.1669
   Fitzpatrick EM, 2007, PROCESS SAF ENVIRON, V85, P430, DOI 10.1205/psep07020
   Fletcher TH, 1997, PROG ENERG COMBUST, V23, P283, DOI 10.1016/S0360-1285(97)00009-9
   Frenklach M, 2002, PHYS CHEM CHEM PHYS, V4, P2028, DOI 10.1039/b110045a
   Frenklach M., 1994, SOOT FORMATION COMBU, P165
   Graf HF, 2004, SCIENCE, V303, P1309, DOI 10.1126/science.1094411
   Grant KE, 1999, ATMOS ENVIRON, V33, P2603, DOI 10.1016/S1352-2310(99)00077-1
   HAYNES BS, 1981, PROG ENERG COMBUST, V7, P229, DOI 10.1016/0360-1285(81)90001-0
   Huang JJ, 2003, ENERG FUEL, V17, P1474, DOI 10.1021/ef030052k
   Jamil K, 2004, FUEL, V83, P833, DOI 10.1016/j.fuel.2003.09.017
   Jones JM, 2005, J ENERGY INST, V78, P199, DOI 10.1179/014426005X50797
   KENNEDY IM, 1997, P COMBUST INST, V27, P1557
   Kim YJ, 2001, FUEL, V80, P1915, DOI 10.1016/S0016-2361(01)00052-7
   Krestinin AV, 2000, COMBUST FLAME, V121, P513, DOI 10.1016/S0010-2180(99)00167-4
   Lee JM, 1998, ENERGY, V23, P475, DOI 10.1016/S0360-5442(98)00011-5
   MCCLUNG JD, 1993, FLUID BED COMBUST, V2, P1047
   Molina A, 1998, FUEL, V77, P1831, DOI 10.1016/S0016-2361(98)00123-9
   NACHER LP, 2007, INHAL TOXICOL, V19, P67
   Ocampo A, 2003, FUEL, V82, P161, DOI 10.1016/S0016-2361(02)00253-3
   Penner JE, 1998, CLIM DYNAM, V14, P839, DOI 10.1007/s003820050259
   Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034
   Richter H, 2000, PROG ENERG COMBUST, V26, P565, DOI 10.1016/S0360-1285(00)00009-5
   Schaap M, 2007, ATMOS ENVIRON, V41, P5908, DOI 10.1016/j.atmosenv.2007.03.042
   Shinada O, 2002, ENERG CONVERS MANAGE, V43, P1221, DOI 10.1016/S0196-8904(02)00009-2
   Skjoth-Rasmussen MS, 2004, COMBUST FLAME, V136, P91, DOI 10.1016/j.combustflame.2003.09.011
   Skjoth-Rasmussen MS, 2003, P COMBUST INST, V29, P1329, DOI 10.1016/S1540-7489(02)80163-8
   Ye DP, 1998, FUEL, V77, P1209, DOI 10.1016/S0016-2361(98)00014-3
   [周静 Zhou Jing], 2002, [煤炭转化, Coal Conversion], V25, P66
   [周静 Zhou Jing], 2003, [煤炭转化, Coal Conversion], V26, P78
NR 34
TC 10
Z9 10
U1 7
U2 32
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0887-0624
EI 1520-5029
J9 ENERG FUEL
JI Energy Fuels
PD MAY
PY 2011
VL 25
IS 5
BP 1964
EP 1969
DI 10.1021/ef101754v
PG 6
WC Energy & Fuels; Engineering, Chemical
SC Energy & Fuels; Engineering
GA 764SC
UT WOS:000290651900004
DA 2018-12-27
ER

PT J
AU Li, JQ
   Wang, DF
   He, ZL
   Zhu, ZF
AF Li Junqi
   Wang Defang
   He Zuoli
   Zhu Zhenfeng
TI RETRACTED: Controlled Synthesis of Hierarchically Mesoporous TiO2 Hollow
   Microspheres with High Photocatalytic Activity (Retracted article. See
   vol. 94, pg. 3151, 2011)
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article; Retracted Publication
ID SENSITIZED SOLAR-CELLS; SURFACTANTS
AB Well-crystallized anatase-phase F-TiO2 hollow microspheres have been synthesized via a facile combination of sol-gel and solvothermal process. The microspheres exhibited a unique three-dimensional hierarchical architecture and demonstrated a significantly improved photocatalytic performance. The resulting sample was characterized by X-ray diffraction, scanning electron microscopy, transmission electron microscopy, X-ray photoelectron spectroscopy, N-2 adsorption, and an UV-Vis diffuse reflectance spectroscopy. On the basis of characterization results, we found that the excellent performances of the mesoporous F-TiO2 hollow microspheres in photocatalytic activities can be attributed to the combined effects of several factors, namely, the surface fluorination, the existence of accessible mesopores channels, and the increased light-harvesting abilities.
C1 [Li Junqi; Wang Defang; He Zuoli; Zhu Zhenfeng] Shaanxi Univ Sci & Technol, Sch Mat Sci & Engn, Xian 710021, Shaani, Peoples R China.
   [Li Junqi] Shaanxi Univ Sci & Technol, Minist Educ, Key Lab Auxiliary Chem & Technol Chem Ind, Xian 710021, Shaani, Peoples R China.
RP Li, JQ (reprint author), Shaanxi Univ Sci & Technol, Sch Mat Sci & Engn, Xian 710021, Shaani, Peoples R China.
EM lijunqi@sust.edu.cn
RI He, Zuoli/G-7427-2018
OI He, Zuoli/0000-0002-6175-2447
FU Shaanxi Provincial Department of Education [09JK352]; Shaanxi University
   of Science and Technology
FX This research was financially supported by a Special Fund from Shaanxi
   Provincial Department of Education (09JK352) and the Graduate Innovation
   Fund of Shaanxi University of Science and Technology.
CR Calleja G, 2004, IND ENG CHEM RES, V43, P2485, DOI 10.1021/ie030646a
   Caruso RA, 2001, ADV MATER, V13, P1577, DOI 10.1002/1521-4095(200110)13:20<1577::AID-ADMA1577>3.0.CO;2-S
   Chen DH, 2009, ADV MATER, V21, P2206, DOI 10.1002/adma.200802603
   Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868
   HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004
   Koo HJ, 2008, ADV MATER, V20, P195, DOI 10.1002/adma.200700840
   Liu B, 2004, J AM CHEM SOC, V126, P16744, DOI 10.1021/ja044825a
   Mitchell DT, 2002, J AM CHEM SOC, V124, P11864, DOI 10.1021/ja027247b
   Nishimura S, 2003, J AM CHEM SOC, V125, P6306, DOI 10.1021/ja034650p
   Pan JH, 2008, J AM CHEM SOC, V130, P11256, DOI 10.1021/ja803582m
   Park H, 2004, J PHYS CHEM B, V108, P4086, DOI 10.1021/jp036735i
   Peng Q, 2003, ANGEW CHEM INT EDIT, V42, P3027, DOI 10.1002/anie.200250695
   Qi LM, 2002, ADV MATER, V14, P300
   Stone VF, 1998, CHEM MATER, V10, P1468, DOI 10.1021/cm980050r
   Teo JJ, 2006, LANGMUIR, V22, P7369, DOI 10.1021/la060439q
   Valtchev V, 2002, CHEM MATER, V14, P956, DOI 10.1021/cm010927d
   Yin YX, 2007, J AM CERAM SOC, V90, P2384, DOI 10.1111/j.1551-2916.2007.01815.x
   Zeng HC, 2007, CURR NANOSCI, V3, P177
   Zhou JK, 2008, J PHYS CHEM C, V112, P5316, DOI 10.1021/jp709615x
NR 19
TC 3
Z9 3
U1 2
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-7820
EI 1551-2916
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD MAY
PY 2011
VL 94
IS 5
BP 1639
EP 1642
DI 10.1111/j.1551-2916.2010.04264.x
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 763CE
UT WOS:000290530200057
DA 2018-12-27
ER

PT J
AU Skinner, SJM
   Lin, H
   Geaney, MS
   Gorba, T
   Elliott, RB
   Tan, PLJ
AF Skinner, S. J. M.
   Lin, H.
   Geaney, M. S.
   Gorba, T.
   Elliott, R. B.
   Tan, P. L. J.
TI RETRACTED: Restoration of motor control and dopaminergic activity in
   rats with unilateral 6-hydroxy-dopamine lesions (Retracted article. See
   vol. 9, pg. 245, 2014)
SO REGENERATIVE MEDICINE
LA English
DT Article; Retracted Publication
DE amphetamine; behavior; choroid plexus cells; dopaminergic encapsulation;
   motor control; neuroregeneration; neurotrophin; Parkinson's disease;
   tyrosine hydroxylase
ID CHOROID-PLEXUS TRANSPLANTS; PARKINSONS-DISEASE; NEURODEGENERATIVE
   DISEASES; GROWTH; MODEL; GDNF; NEUROPROTECTION; MPTP; CERULOPLASMIN;
   STRIATUM
AB Aim: To restore motor function and dopaminergic activity in the nigrostriatum of rats with unilateral 6-hydroxy-dopamine lesions using implants of encapsulated porcine choroid plexus cells. Materials & methods: Neonatal porcine choroid plexus cells were prepared and maintained in culture, then encapsulated within alginate polyornithine capsules (600-660 mu m). Rats were unilaterally injected with 6-hydroxy-dopamine into the striatum. Those with lesions verified after 2 and 4 weeks were selected for experiments. Rats were implanted adjacent to the lesion with ten capsules 2-4 days later with (treated, n = 12) or without (control, n = 10) choroid plexus cells. Results: The choroid plexus cells were shown to produce a wide range of neurorestorative proteins. The treated group had a 60% improvement in motor behavior compared with the control group (p < 0.01). The treated group also had a significant improvement in nigrostriatal dopaminergic activity (31%, p < 0.02). Conclusion. Capsules containing porcine choroid plexus cells release therapeutic molecules that stimulate regeneration of the lesioned nigrostriatum in rats.
C1 [Skinner, S. J. M.; Lin, H.; Geaney, M. S.; Elliott, R. B.; Tan, P. L. J.] Living Cell Technol, Auckland, New Zealand.
   [Gorba, T.] Stem Cell Inc, Palo Alto, CA USA.
RP Skinner, SJM (reprint author), Living Cell Technol, Auckland, New Zealand.
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Blandini F, 2010, CELL TRANSPLANT, V19, P203, DOI 10.3727/096368909X479839
   Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X
   Borlongan CV, 2007, CELL TRANSPLANT, V16, P987, DOI 10.3727/000000007783472426
   Borlongan CV, 2004, STROKE, V35, P2206, DOI 10.1161/01.STR.0000138954.25825.0b
   de Chevigny A, 2008, STEM CELLS, V26, P2349, DOI 10.1634/stemcells.2008-0080
   Emborg ME, 2008, CELL TRANSPLANT, V17, P383
   Emerich DF, 2006, NEUROBIOL DIS, V23, P471, DOI 10.1016/j.nbd.2006.01.014
   Fahn S, 2010, MOVEMENT DISORD, V25, pS2, DOI 10.1002/mds.22796
   Falk T, 2009, NEUROSCI LETT, V458, P49, DOI 10.1016/j.neulet.2009.04.018
   Geraerts M, 2007, STEM CELLS, V25, P263, DOI 10.1634/stemcells.2006-0364
   Grandoso L, 2007, INT J PHARMACEUT, V343, P69, DOI 10.1016/j.ijpharm.2007.05.027
   Harvey BK, 2004, BRAIN RES, V1022, P88, DOI 10.1016/j.brainres.2004.06.072
   Hochstrasser H, 2005, FASEB J, V19, P1851, DOI 10.1096/fj.04-3486fje
   Hong Murray, 2008, Expert Rev Neurother, V8, P1125, DOI 10.1586/14737175.8.7.1125
   Ide C, 2001, EXP NEUROL, V167, P242, DOI 10.1006/exnr.2000.7566
   Kao SY, 2009, BIOCHEM BIOPH RES CO, V385, P434, DOI 10.1016/j.bbrc.2009.05.089
   Lazarovici P, 2006, CURR PHARM DESIGN, V12, P2609, DOI 10.2174/138161206777698738
   Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012
   Lindvall O, 2008, EXP NEUROL, V209, P82, DOI 10.1016/j.expneurol.2007.08.019
   Menza M, 2009, MOVEMENT DISORD, V24, P1325, DOI 10.1002/mds.22586
   Ming M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-53
   Peng J, 2008, NEUROSCIENCE, V153, P664, DOI 10.1016/j.neuroscience.2008.02.063
   Schober A, 2007, NEUROBIOL DIS, V25, P378, DOI 10.1016/j.nbd.2006.10.005
   Schulte-Herbruggen O, 2007, CURR MED CHEM, V14, P2318, DOI 10.2174/092986707781745578
   Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362
   Skinner SJM, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/065001
   Skinner SJM, 2006, XENOTRANSPLANTATION, V13, P284, DOI 10.1111/j.1399-3089.2006.00310.x
   Sohrabji F, 2006, FRONT NEUROENDOCRIN, V27, P404, DOI 10.1016/j.yfrne.2006.09.003
   Timmer M, 2007, J NEUROSCI, V27, P459, DOI 10.1523/JNEUROSCI.4493-06.2007
   Vassiliev V, 2005, BRAIN RES REV, V49, P633, DOI 10.1016/j.brainresrev.2005.03.003
   von Bohlen und Halbach O, 2009, ADV EXP MED BIOL, V651, P73
   von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007
   Yasuhara T, 2005, BRAIN RES, V1053, P10, DOI 10.1016/j.brainres.2005.05.027
   Zhang Hou-Liang, 2007, Neurosci Bull, V23, P137, DOI 10.1007/s12264-007-0020-3
NR 35
TC 8
Z9 8
U1 2
U2 11
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PD MAY
PY 2011
VL 6
IS 3
BP 319
EP 326
DI 10.2217/RME.11.15
PG 8
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 767DQ
UT WOS:000290835900009
PM 21548737
DA 2018-12-27
ER

PT J
AU Singh, K
   Agrawal, KN
   Bora, GC
AF Singh, Karan
   Agrawal, K. N.
   Bora, Ganesh C.
TI RETRACTED: Advanced techniques for Weed and crop identification for site
   specific Weed management (Retracted article. See vol. 111, pg. 139,
   2012)
SO BIOSYSTEMS ENGINEERING
LA English
DT Review; Retracted Publication
ID LEAF WATER-CONTENT; SPATIAL-DISTRIBUTION; SPECTRAL PROPERTIES;
   VEGETATION INDEXES; MACHINE VISION; CROP/WEED DISCRIMINATION; INDUCED
   FLUORESCENCE; WAVELET ANALYSIS; DIGITAL IMAGES; SHAPE-ANALYSIS
AB Weed management plays a major role in the production and economic benefits derived by agricultural industry worldwide. The monitoring of weed pressure, economic threshold, yield loss and environmental impact is critical for sustainable agriculture. Currently research is being carried out relating to weed mapping at field scale and the development of machine vision controlled equipment. Remote sensing and aerial imaging techniques utilised for site-specific weed management have limitations due to the accuracy of satellite imagery, its cost and timing. The advent of optoelectronic sensing and enhanced computing has provided a demand for the development of the real-time assessment and management of weeds in fields. The available technologies that can be used for developing a ground-sensor based system to assist in determination of weed pressure and economise on the application of herbicide under field conditions are reviewed. These technologies include image-based identification and spectroscopic methods for weed identification and threshold determination. The various methods studied and the concepts pursued by various researchers are discussed in the paper. Published by Elsevier Ltd on behalf of IAgrE.
C1 [Singh, Karan; Agrawal, K. N.; Bora, Ganesh C.] N Dakota State Univ, Fargo, ND 58102 USA.
RP Bora, GC (reprint author), N Dakota State Univ, 1221 Albrecht Blvd, Fargo, ND 58102 USA.
EM ganesh.bora@ndsu.edu
CR ALBERTO T, 2008, COMPUTERS ELECT AGR, V60, P144
   Alchanatis V, 2005, COMPUT ELECTRON AGR, V47, P243, DOI 10.1016/j.compag.2004.11.019
   ASSEMAT L, 1995, MEASURING LIGHT INTE
   BACHER B, 2001, THESIS ROYAL VET AGR
   Belzile C, 2004, P SOC PHOTO-OPT INS, V5271, P244, DOI 10.1117/12.519183
   Blackshaw RE, 1998, WEED SCI, V46, P127
   BOBILLET W, 2003, 4 EUR C PREC AGR BER
   Borregaard T, 2000, J AGR ENG RES, V75, P389, DOI 10.1006/jaer.1999.0519
   Brown RB, 2005, WEED SCI, V53, P252, DOI 10.1614/WS-04-068R1
   BROWN RB, 1994, T ASAE, V37, P297
   BROWN RB, 2000, 001121 ASAE
   Cerovic ZG, 1999, AGRONOMIE, V19, P543, DOI 10.1051/agro:19990701
   CHAPPELLE EW, 1985, APPL OPTICS, V24, P74, DOI 10.1364/AO.24.000074
   Chen YR, 2002, COMPUT ELECTRON AGR, V36, P173, DOI 10.1016/S0168-1699(02)00100-X
   Cho SI, 2002, BIOSYST ENG, V83, P275, DOI 10.1016/S1537-5110(02)00175-2
   Cousens RD, 1997, PROC BRIGHTON CROP, P613
   DAUGHTRY CST, 1985, REMOTE SENS ENVIRON, V17, P281, DOI 10.1016/0034-4257(85)90100-2
   Dieleman JA, 2000, WEED SCI, V48, P576
   El-Faki MS, 2000, T ASAE, V43, P1969
   FANGMING Z, 2009, ASABE ANN INT M REN
   FELTON WL, 1992, AGR ENG, V73, P9
   Feyaerts F, 2001, PATTERN RECOGN LETT, V22, P667, DOI 10.1016/S0167-8655(01)00006-X
   Fontaine V., 2006, Canadian Biosystems Engineering, V48, pG19
   FRANZ E, 1991, T ASAE, V34, P682
   FRANZ E, 1991, T ASAE, V34, P673
   Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3
   Gee C, 2008, COMPUT ELECTRON AGR, V60, P49, DOI 10.1016/j.compag.2007.06.003
   Gerhards R, 2006, WEED RES, V46, P185, DOI 10.1111/j.1365-3180.2006.00504.x
   Gerhards R, 1997, J AGRON CROP SCI, V178, P219, DOI 10.1111/j.1439-037X.1997.tb00494.x
   Gibson KD, 2004, WEED TECHNOL, V18, P742, DOI 10.1614/WT-03-170R1
   Gitelson AA, 1996, REMOTE SENS ENVIRON, V58, P289, DOI 10.1016/S0034-4257(96)00072-7
   Goel PK, 2003, COMPUT ELECTRON AGR, V38, P99, DOI 10.1016/S0168-1699(02)00138-2
   Gong P., 2003, IEEE T GEOSCIENCE RE, V41
   Gonzalez-Andujar JL, 2003, CROP PROT, V22, P629, DOI 10.1016/S0261-2194(02)00247-8
   GOUDY H, 1999, ONTARIO CORN PRODUCE, V15, P30
   Goudy HJ, 2001, WEED SCI, V49, P359, DOI 10.1614/0043-1745(2001)049[0359:EOSSWM]2.0.CO;2
   Goulas Y, 2004, APPL OPTICS, V43, P4488, DOI 10.1364/AO.43.004488
   GUYER DE, 1993, T ASAE, V36, P163
   HARALSON AE, 1997, ASAE ANN INT M MINN
   Hemming J, 2001, J AGR ENG RES, V78, P233, DOI 10.1006/jaer.2000.0639
   Henry WB, 2004, WEED TECHNOL, V18, P594, DOI 10.1614/WT-03-097R
   Hough P.V.C, 1962, U.S. Patent, Patent No. [3,069,654, 3069654]
   HUNT ER, 1989, REMOTE SENS ENVIRON, V30, P43, DOI 10.1016/0034-4257(89)90046-1
   Jiang ZY, 2007, P SOC PHOTO-OPT INS, V6679, P67905, DOI 10.1117/12.734933
   JOHANNSEN CJ, 2000, P 2 INT C GEOSP INF, V1, P1
   JOHNSON GA, 1995, WEED RES, V35, P197, DOI 10.1111/j.1365-3180.1995.tb02033.x
   JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256
   Jurado-Exposito M, 2003, WEED SCI, V51, P319, DOI 10.1614/0043-1745(2003)051[0319:MWSVAS]2.0.CO;2
   Keranen Mika, 2003, Precision Agriculture, V4, P53, DOI 10.1023/A:1021863005378
   Koger CH, 2003, REMOTE SENS ENVIRON, V86, P108, DOI 10.1016/S0034-4257(03)00071-3
   Lamb DW, 1999, WEED RES, V39, P481, DOI 10.1046/j.1365-3180.1999.00167.x
   Lamb DW, 2001, J AGR ENG RES, V78, P117, DOI 10.1006/jaer.2000.0630
   Lan Y, 2009, APPL ENG AGRIC, V25, P607
   Lass LW, 2005, WEED SCI, V53, P242, DOI 10.1614/WS-04-044R2
   Lichtenthaler HK, 1998, J PLANT PHYSIOL, V152, P272, DOI 10.1016/S0176-1617(98)80142-9
   Lindquist JL, 1998, WEED TECHNOL, V12, P7
   LONGCHAMPS L, 2009, PRECIS AGRIC, V11, P181
   Luschei EC, 2001, WEED SCI, V49, P536, DOI 10.1614/0043-1745(2001)049[0536:IACOFW]2.0.CO;2
   Lymburner L, 2000, PHOTOGRAMM ENG REM S, V66, P183
   MACK RS, 1998, J NEMATOL, V30, P431
   MATHANKER SK, 2007, ASABE ANN INT M MINN
   MATHANKER SK, 2008, ASABE ANN INT M RI U
   Medlin CR, 2000, WEED SCI, V48, P393, DOI 10.1614/0043-1745(2000)048[0393:URSTDW]2.0.CO;2
   MENGES RM, 1985, WEED SCI, V33, P569
   Moran M. S., 2000, P 2 INT C GEOSP INF, V1, P23
   Moran MS, 1997, REMOTE SENS ENVIRON, V61, P319, DOI 10.1016/S0034-4257(97)00045-X
   MORTENSEN DA, 1997, INTEGRATED WEED SOIL, P293
   NOBLE SD, 2001, CSAE SCGR NABEC M AI
   Noble SD, 2002, AIC 2002 M CSAE SCGR
   Okamoto H, 2009, ACTA HORTIC, V824, P49
   Okamoto H, 2007, WEED BIOL MANAG, V7, P31, DOI 10.1111/j.1445-6664.2006.00234.x
   Perez AJ, 2000, COMPUT ELECTRON AGR, V25, P197, DOI 10.1016/S0168-1699(99)00068-X
   Pinder JE, 1999, PHOTOGRAMM ENG REM S, V65, P495
   Piron A, 2008, COMPUT ELECTRON AGR, V62, P141, DOI 10.1016/j.compag.2007.12.007
   Piron A, 2009, COMPUT ELECTRON AGR, V69, P73, DOI 10.1016/j.compag.2009.07.001
   RAMON H, 2002, ASP APPL BIOL, V66, P147
   Rew LJ, 1996, WEED RES, V36, P283, DOI 10.1111/j.1365-3180.1996.tb01658.x
   Rew LJ, 2005, WEED SCI, V53, P236, DOI 10.1614/WS-04-097R
   Rew LJ, 2001, WEED RES, V41, P245, DOI 10.1046/j.1365-3180.2001.00235.x
   Ribeiro A, 2005, Precision Agriculture 05, P169
   ROBERT PC, 1997, P LAND SAT INF NEXT, P151
   Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7
   Rouse J. W, 1973, 3 ERTS S NASA
   Sabeenian R S, 2009, International Journal of Medical Engineering and Informatics, V1, P459, DOI 10.1504/IJMEI.2009.026813
   SHAPIRA U, 2010, CORE SPATIAL DATABAS, V38
   SHAUN RS, 2003, REMOTE SENS ENVIRON, V86, P433
   SHAW DR, 1991, WEED TECHNOL, V5, P125
   SHIBAYAMA M, 1991, REMOTE SENS ENVIRON, V36, P45, DOI 10.1016/0034-4257(91)90029-6
   Sogaard HT, 2003, COMPUT ELECTRON AGR, V38, P141, DOI 10.1016/S0168-1699(02)00140-0
   Stafford J. V., 1996, Precision agriculture. Proceedings of the 3rd International Conference, Minneapolis, Minnesota, USA, 23-26 June 1996., P465
   Stafford JV, 1996, COMPUT ELECTRON AGR, V14, P235, DOI 10.1016/0168-1699(95)00050-X
   TANGWONGKIT R, 2006, CIGR E J, V8, P1
   THENKABAIL PS, 1994, INT J REMOTE SENS, V15, P49, DOI 10.1080/01431169408954050
   Thenkabail PS, 2000, REMOTE SENS ENVIRON, V71, P158, DOI 10.1016/S0034-4257(99)00067-X
   Thorp K. R., 2004, Precision Agriculture, V5, P477, DOI 10.1007/s11119-004-5321-1
   TUCKER CJ, 1980, REMOTE SENS ENVIRON, V10, P23, DOI 10.1016/0034-4257(80)90096-6
   *USDA, 2003, FARM PROD EXP 2002 S
   *USDA, 2003, AGR CHEM US 2002 FIE
   Visser R, 1996, P SOC PHOTO-OPT INS, V2907, P120, DOI 10.1117/12.262852
   Vrindts E., 2002, Precision Agriculture, V3, P63, DOI 10.1023/A:1013326304427
   VRINDTS E, 1997, P 1 EUR C PREC AGR W, V1, P537
   Wang N, 2007, BIOSYST ENG, V98, P276, DOI 10.1016/j.biosystemseng.2007.08.007
   Wang N, 2001, T ASAE, V44, P409
   Wartenberg G., 1999, Landtechnik, V54, P340
   WIEGAND CL, 1990, AGRON J, V82, P623, DOI 10.2134/agronj1990.00021962008200030037x
   XAVIER PB, 2009, COMPUTERS ELECT AGR, V65, P176
   Yang Chun-Chieh, 2003, Precision Agriculture, V4, P5, DOI 10.1023/A:1021847103560
   ZHANG H, 2009, INT J AGR BIOL ENG, V2, P33, DOI DOI 10.3965/J.ISSN.1934-6344.2009.03.033-040
   Zhao DH, 2005, COMPUT ELECTRON AGR, V48, P155, DOI 10.1016/j.compag.2005.03.003
   ZHENGWEI Y, 2008, PECURA 17 FUTURE LAN
   Zwiggelaar R, 1998, CROP PROT, V17, P189, DOI 10.1016/S0261-2194(98)00009-X
NR 111
TC 10
Z9 12
U1 4
U2 46
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1537-5110
EI 1537-5129
J9 BIOSYST ENG
JI Biosyst. Eng.
PD MAY
PY 2011
VL 109
IS 1
BP 52
EP 64
DI 10.1016/j.biosystemseng.2011.02.002
PG 13
WC Agricultural Engineering; Agriculture, Multidisciplinary
SC Agriculture
GA 764CN
UT WOS:000290606100006
DA 2018-12-27
ER

PT J
AU Xu, RF
   Feng, XY
   Xie, X
   Xu, H
   Wu, DC
   Xu, LX
AF Xu, Ruifen
   Feng, Xuyang
   Xie, Xin
   Xu, Hao
   Wu, Daocheng
   Xu, Lixian
TI RETRACTED: Grafted Starch-Encapsulated Hemoglobin (GSEHb) Artificial Red
   Blood Cells Substitutes (Retracted Article)
SO BIOMACROMOLECULES
LA English
DT Correction; Retracted Publication
OI Wu, Daocheng/0000-0002-6183-539X
CR Xu RF, 2011, BIOMACROMOLECULES, V12, P1935, DOI 10.1021/bm200036j
NR 1
TC 3
Z9 3
U1 3
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2011
VL 12
IS 5
BP 1935
EP 1935
DI 10.1021/bm200036j
PG 1
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 759LP
UT WOS:000290246400061
DA 2018-12-27
ER

PT J
AU Zhang, HJ
   Siu, MKY
   Yeung, MCW
   Jiang, LL
   Mak, VCY
   Ngan, HYS
   Wong, OGW
   Zhang, HQ
   Cheung, ANY
AF Zhang, Hui-Juan
   Siu, Michelle K. Y.
   Yeung, Matthew C. W.
   Jiang, Li-Li
   Mak, Victor C. Y.
   Ngan, Hextan Y. S.
   Wong, Oscar G. W.
   Zhang, Hong-Quan
   Cheung, Annie N. Y.
TI RETRACTED: Overexpressed PAK4 promotes proliferation, migration and
   invasion of choriocarcinoma (Retracted article. See vol. 37, pg. 530,
   2016)
SO CARCINOGENESIS
LA English
DT Article; Retracted Publication
ID GESTATIONAL TROPHOBLASTIC DISEASE; ANCHORAGE-INDEPENDENT GROWTH;
   SERINE/THREONINE KINASE PAK4; GROUP-II PAKS; PROTEIN-KINASE;
   MATRIX-METALLOPROTEINASE; P21-ACTIVATED KINASES; CELL-PROLIFERATION;
   CANCER; ACTIVATION
AB Gestational trophoblastic disease (GTD) includes frankly malignant choriocarcinoma (CCA) and placental site trophoblastic tumor and potentially malignant hydatidiform mole. p21-Activated kinase (PAK) 4 promotes cell motility. This study investigated the role of PAK4 in the pathogenesis of GTD. PAK4 messenger RNA and protein expressions in clinical samples and cell lines of normal placentas and GTD were determined by quantitative real-time polymerase chain reaction and western blot, respectively. The effects of human chorionic gonadotropin (hCG) and phosphoinositide 3 kinase (PI3K) on the expression and activation of PAK4 were investigated by treating CCA JEG3 and JAR cells with anti-hCG antibody and PI3K inhibitor, respectively. The effects of PAK4 on CCA cell proliferation, migration and invasion were assessed by corresponding functional assays. We demonstrated overexpression of PAK4 in GTD and CCA cell lines at both RNA and protein level. hCG is one of the upstream regulators of PAK4 expression, whereas activation of PAK4 is PI3K/PKB dependent in JEG3 and JAR cells. Significant correlation was found between PAK4 expression and proliferation index minichromosome maintenance complex component 7 (P = 0.007). In JEG3 and JAR cells, stably transfected PAK4 increased proliferation, migration and invasion, whereas small interfering RNA knockdown of PAK4 decreased proliferation, migration and invasion along with downregulated CDK6 and membrane-type 1 matrix metalloproteinase (MT1-MMP) and upregulated p16. We further found PAK4-mediated transcription of MT1-MMP in CCA cells by luciferase reporter assay. Our results demonstrated for the first time that overexpressed PAK4 was involved in the pathogenesis of GTD, promoting proliferation and enhancing cell migration and invasion in CCA cells.
C1 [Zhang, Hui-Juan; Siu, Michelle K. Y.; Yeung, Matthew C. W.; Jiang, Li-Li; Mak, Victor C. Y.; Wong, Oscar G. W.; Cheung, Annie N. Y.] Univ Hong Kong, Dept Pathol, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.
   [Zhang, Hui-Juan] Shanghai Jiao Tong Univ, Dept Pathol, Int Peace Maternal & Child Hlth Hosp, Shanghai 200030, Peoples R China.
   [Ngan, Hextan Y. S.] Univ Hong Kong, Dept Obstet & Gynaecol, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.
   [Zhang, Hong-Quan] Peking Univ, Lab Mol Cell Biol & Tumor Biol, Dept Human Anat Histol & Embryol, Sch Basic Med Sci, Beijing 100191, Peoples R China.
   [Zhang, Hong-Quan] Peking Univ, Lab Canc Metastasis, Inst Syst Med, Beijing 100191, Peoples R China.
RP Cheung, ANY (reprint author), Univ Hong Kong, Dept Pathol, Queen Mary Hosp, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
EM anycheun@hkucc.hku.hk
OI Ngan, Hextan Y S/0000-0003-3945-159X
FU Research Grants Council of the Hong Kong Special Administrative Region
   [HKU 7503/06M]
FX Research Grants Council of the Hong Kong Special Administrative Region
   (HKU 7503/06M).
CR Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527
   Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109
   Au CWH, 2009, CANCER LETT, V281, P151, DOI 10.1016/j.canlet.2009.02.025
   Begum A, 2009, CANCER SCI, V100, P1908, DOI 10.1111/j.1349-7006.2009.01252.x
   Callow MG, 2002, J BIOL CHEM, V277, P550, DOI 10.1074/jbc.M105732200
   Cammarano MS, 2005, MOL CELL BIOL, V25, P9532, DOI 10.1128/MCB.25.21.9532-9542.2005
   Ching YP, 2007, CANCER RES, V67, P3601, DOI 10.1158/0008-5472.CAN-06-3994
   Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200
   Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002
   Eswaran J, 2009, CANCER METAST REV, V28, P209, DOI 10.1007/s10555-008-9181-4
   Feng HC, 2004, GYNECOL ONCOL, V94, P375, DOI 10.1016/j.ygyno.2004.04.019
   Feng Hui Chen, 2005, J Soc Gynecol Investig, V12, pe21, DOI 10.1016/j.jsgi.2005.02.008
   Finkelstein E, 2004, J CELL SCI, V117, P1533, DOI 10.1242/jcs.00986
   Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.0i.005
   Gimona M, 2009, CELL MOTIL CYTOSKEL, V66, P769, DOI 10.1002/cm.20415
   Gnesutta N, 2003, MOL CELL BIOL, V23, P7838, DOI 10.1128/MCB.23.21.7838-7848.2003
   Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200
   Gringel A, 2006, J CELL PHYSIOL, V209, P568, DOI 10.1002/jcp.20777
   Horowitz NS, 2009, SEMIN ONCOL, V36, P181, DOI 10.1053/j.seminoncol.2008.12.009
   Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892
   Lai CYL, 2004, MODERN PATHOL, V17, P40, DOI 10.1038/modpathol.3800010
   Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200
   Liao XY, 2009, MODERN PATHOL, V22, P839, DOI 10.1038/modpathol.2009.45
   Liu YY, 2008, MOL CANCER RES, V6, P1215, DOI 10.1158/1541-7786.MCR-08-0087
   Lohi J, 2000, GENE, V242, P75, DOI 10.1016/S0378-1119(99)00549-1
   Mahlamaki EH, 2004, NEOPLASIA, V6, P432, DOI 10.1593/nao.04130
   MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0
   Ngan HYS, 2004, INT J GYNECOL CANCER, V14, P202, DOI 10.1111/j.1048-891X.2004.014236.x
   PARADINAS FJ, 2003, GESTATIONAL TROPHOBL
   Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003
   Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001
   Russo AA, 1998, NATURE, V395, P237
   Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7
   Shih IM, 2007, LANCET ONCOL, V8, P642, DOI 10.1016/S1470-2045(07)70204-8
   SHIH IM, 2002, BLAUSTEINS PATHOLOGY, P1193
   Siu MKY, 2008, AM J PATHOL, V173, P1165, DOI 10.2353/ajpath.2008.080288
   Siu MKY, 2010, P NATL ACAD SCI USA, V107, P18622, DOI 10.1073/pnas.0907481107
   Siu MKY, 2010, AM J PATHOL, V176, P3015, DOI 10.2353/ajpath.2010.091263
   Siu MKY, 2010, INT J CANCER, V127, P21, DOI 10.1002/ijc.25005
   Wells CM, 2010, J CELL SCI, V123, P1663, DOI 10.1242/jcs.055707
   Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173
   Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080
   Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119
   Xue WC, 2004, J MOL DIAGN, V6, P326, DOI 10.1016/S1525-1578(10)60528-4
   Xue WC, 2003, HISTOPATHOLOGY, V43, P485, DOI 10.1046/j.1365-2559.2003.01728.x
   Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008
   Zhang HJ, 2009, INT J GYNECOL PATHOL, V28, P172, DOI 10.1097/PGP.0b013e318189555b
NR 47
TC 48
Z9 53
U1 2
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0143-3334
EI 1460-2180
J9 CARCINOGENESIS
JI Carcinogenesis
PD MAY
PY 2011
VL 32
IS 5
BP 765
EP 771
DI 10.1093/carcin/bgr033
PG 7
WC Oncology
SC Oncology
GA 760RH
UT WOS:000290341000015
PM 21325635
OA Bronze
DA 2018-12-27
ER

PT J
AU Chakrabarti, R
   Topf, HG
   Schroth, M
AF Chakrabarti, Raktima
   Topf, Hans-Georg
   Schroth, Michael
TI RETRACTED: Low Dose Lidocaine for Refractory Seizures in Preterm
   Neonates (Retracted article. See vol. 80, pg. 529, 2013)
SO INDIAN JOURNAL OF PEDIATRICS
LA English
DT Letter; Retracted Publication
C1 [Chakrabarti, Raktima; Topf, Hans-Georg; Schroth, Michael] Univ Erlangen Nurnberg, Neonatol Subdiv, Dept Paediat, D-91054 Erlangen, Germany.
RP Chakrabarti, R (reprint author), Univ Erlangen Nurnberg, Neonatol Subdiv, Dept Paediat, Loschgestr 15, D-91054 Erlangen, Germany.
EM dr_raktima@yahoo.com
CR DUPLIESSIS A, 2004, MANUAL NEONATAL CARE, P507
   Malingre MM, 2006, EUR J PEDIATR, V165, P598, DOI 10.1007/s00431-006-0136-x
   Van Rooij LGM, 2004, EUR J PEDIATR, V163, P637, DOI 10.1007/s00431-004-1513-y
   Vento M, 2010, ACTA PAEDIATR, V99, P497, DOI 10.1111/j.1651-2227.2009.01659.x
NR 4
TC 1
Z9 1
U1 3
U2 11
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0019-5456
EI 0973-7693
J9 INDIAN J PEDIATR
JI Indian J. Pediatr.
PD MAY
PY 2011
VL 78
IS 5
BP 625
EP 626
DI 10.1007/s12098-010-0331-7
PG 2
WC Pediatrics
SC Pediatrics
GA 760KM
UT WOS:000290323200017
PM 21207197
DA 2018-12-27
ER

PT J
AU Smeesters, D
   Liu, J
AF Smeesters, Dirk
   Liu, Jia (Elke)
TI RETRACTED: The effect of color (red versus blue) on assimilation versus
   contrast in prime-to-behavior effects (Retracted article. See vol. 49,
   pg. 315, 2013)
SO JOURNAL OF EXPERIMENTAL SOCIAL PSYCHOLOGY
LA English
DT Article; Retracted Publication
DE Color; Priming; Similarity focus; Assimilation; Contrast
ID STEREOTYPE ACTIVATION; SOCIAL JUDGMENT; MECHANISMS; CHOICE; CUES;
   PERFORMANCE; FOCUS; SELF
AB This paper examines whether color can modify the way that primed constructs affect behavior. Specifically, we tested the hypothesis that, compared to the color white, blue is more likely to lead to assimilative shifts in behavior, whereas red is more likely to lead to contrastive changes in behavior. In our experiment, previous findings were replicated in the white color condition: participants' behavior assimilated to primed stereotypes of (un)intelligence and contrasted away from primed exemplars of (un)intelligence. However, in the blue color condition, participants' behavior assimilated to the primed constructs, whereas in the red color condition, participants' behavior contrasted away from the primed constructs, irrespective of whether the primed constructs were stereotypes or exemplars. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Smeesters, Dirk] Erasmus Univ, Rotterdam, Netherlands.
   [Liu, Jia (Elke)] Univ Groningen, Groningen, Netherlands.
RP Smeesters, D (reprint author), Erasmus Univ, Rotterdam, Netherlands.
EM DSmeesters@rsm.nl
CR Berger J, 2008, J MARKETING RES, V45, P1, DOI 10.1509/jmkr.45.1.1
   Dijksterhuis A, 1998, J PERS SOC PSYCHOL, V75, P862, DOI 10.1037//0022-3514.75.4.862
   Dijksterhuis A, 1998, J PERS SOC PSYCHOL, V74, P865, DOI 10.1037/0022-3514.74.4.865
   Elliot AJ, 2007, CURR DIR PSYCHOL SCI, V16, P250, DOI 10.1111/j.1467-8721.2007.00514.x
   Elliot AJ, 2007, J EXP PSYCHOL GEN, V136, P154, DOI 10.1037/0096-3445.136.1.154
   Elliot AJ, 2009, PERS SOC PSYCHOL B, V35, P365, DOI 10.1177/0146167208328330
   Fehrman K., 2004, COLOR SECRET INFLUEN
   Forster J, 2008, J PERS SOC PSYCHOL, V94, P579, DOI 10.1037/0022-3514.94.4.579
   Forster J, 2009, J EXP PSYCHOL GEN, V138, P88, DOI 10.1037/a0014484
   Friedman RS, 2010, PSYCHOL BULL, V136, P875, DOI 10.1037/a0020495
   Friedman RS, 2005, J PERS SOC PSYCHOL, V88, P263, DOI 10.1067/0022-3514.88.2.263
   Hansen J, 2009, SOC COGNITION, V27, P76, DOI 10.1521/soco.2009.27.1.76
   Kay AC, 2004, ORGAN BEHAV HUM DEC, V95, P83, DOI 10.1016/j.obhdp.2004.06.003
   Maier MA, 2008, PERS SOC PSYCHOL B, V34, P1530, DOI 10.1177/0146167208323104
   Maimaran M, 2008, J MARKETING RES, V45, P731, DOI 10.1509/jmkr.45.6.731
   Mehta R, 2009, SCIENCE, V323, P1226, DOI 10.1126/science.1169144
   Mussweiler T, 2004, J PERS SOC PSYCHOL, V87, P832, DOI 10.1037/0022-3514.87.6.832
   Mussweiler T, 2003, PSYCHOL REV, V110, P472, DOI 10.1037/0033-295X.110.3.472
   Mussweiler T, 2001, PERS SOC PSYCHOL B, V27, P38, DOI 10.1177/0146167201271004
   Smeesters D, 2010, J CONSUM RES, V36, P930, DOI 10.1086/648688
   WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063
   Wheeler SC, 2007, PERS SOC PSYCHOL REV, V11, P234, DOI 10.1177/1088868307302223
   Wheeler SC, 2009, SOC PERSONAL PSYCHOL, V3, P566, DOI 10.1111/j.1751-9004.2009.00187.x
   Wheeler SC, 2001, PSYCHOL BULL, V127, P797, DOI 10.1037//0033-2909.127.6.797
   WHITFIELD TWA, 1990, GENET SOC GEN PSYCH, V116, P385
NR 25
TC 10
Z9 12
U1 3
U2 28
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-1031
EI 1096-0465
J9 J EXP SOC PSYCHOL
JI J. Exp. Soc. Psychol.
PD MAY
PY 2011
VL 47
IS 3
BP 653
EP 656
DI 10.1016/j.jesp.2011.02.010
PG 4
WC Psychology, Social
SC Psychology
GA 755IL
UT WOS:000289922500017
DA 2018-12-27
ER

PT J
AU Hathurusingha, S
AF Hathurusingha, Subhash
TI RETRACTED: Periodic variation in kernel oil content and fatty acid
   profiles of Calophyllum inophyllum L.: A medicinal plant in northern
   Australia (Retracted article. See vol. 46, pg. 268, 2013)
SO INDUSTRIAL CROPS AND PRODUCTS
LA English
DT Article; Retracted Publication
DE Calophyllum inophyllum; Fatty acid profiles; Kernel oil; Periodic
   variation
ID INHIBITORS; INDIA
AB Variation in oil contents and fatty acid profiles of a native Australian medicinal species Calophyllum inophyllum were studied in two different fruiting periods (winter 2008 and autumn 2009) and in three different northern Queensland provenances (Cardwell, Townsville, Yeppoon). Kernel oil was extracted by standard n-hexane double extraction and fatty acid profiles were determined by ISO 5508 and 5509 methods using gas chromatography. C. inophyllum provenances have demonstrated a significant (P < 0.05) periodic variation in oil contents and fatty acid profiles, and as a result may alter wound healing properties of Calophyllum oil. (c) 2011 Elsevier B.V. All rights reserved.
C1 CQ Univ, Ctr Plant & Water Sci, Rockhampton, Qld 4701, Australia.
RP Hathurusingha, S (reprint author), CQ Univ, Ctr Plant & Water Sci, Rockhampton, Qld 4701, Australia.
EM s.hathurusingha@cqu.edu.au
CR AHMAD S, 2000, PAK J BIOL SCI, V4, P2060
   Ajayi IA, 2008, FOOD CHEM, V106, P458, DOI 10.1016/j.foodchem.2007.05.093
   Augustus GDPS, 2001, IND CROP PROD, V13, P93, DOI 10.1016/S0926-6690(00)00056-X
   Azam MM, 2005, BIOMASS BIOENERG, V29, P293, DOI 10.1016/j.biombioe.2005.05.001
   BOWMAN WC, 1980, TXB PHARM
   BURKILL HM, 1994, FAMILIES E I, V20
   CANVIN DT, 1965, CAN J BOTANY, V43, P63, DOI 10.1139/b65-008
   Crane S, 2005, PHYTOCHEMISTRY, V66, P1825, DOI 10.1016/j.phytochem.2005.06.009
   Demurin Ya., 2000, Helia, V23, P87
   Dweck AC, 2002, INT J COSMETIC SCI, V24, P1
   Foxworthy FW, 1927, MALAYS FOREST REC, V29, P134
   Friday J.B., 2006, CALOPHYLLUM INOPHYLL
   GIBSON RA, 1983, LIPIDS, V18, P743, DOI 10.1007/BF02534631
   GRUBAUER G, 1989, J LIPID RES, V30, P323
   HASSAN F, 2003, HELIA, V2, P159
   Hathurusingha S, 2011, NEW FOREST, V41, P89, DOI 10.1007/s11056-010-9212-1
   Hilditch T.P., 1964, CHEM CONSTITUTION NA
   Kilham C., 2004, HERBALGRAM, V63, P10
   LAMER VK, 1962, RETARDATION EVAPORAT
   Little Jr E.L., 1989, USDA AGR HDB, V679
   Low T, 1990, BUSH MED PHARMACOPEI
   MAIDEN JH, 1975, USEFUL PLANTS AUSTR, P215
   NADKARNI KM, 1999, INDIAN MAT MED AYURV, V2
   Pallardy S. G., 1981, WATER DEFICITS PLANT, V6, P511
   PATIL AD, 1993, J MED CHEM, V36, P4131, DOI 10.1021/jm00078a001
   ROSE IA, 1988, AUST J AGR RES, V39, P163, DOI 10.1071/AR9880163
   Sahoo PK, 2007, FUEL, V86, P448, DOI 10.1016/j.fuel.2006.07.025
   Spino C, 1998, BIOORG MED CHEM LETT, V8, P3475, DOI 10.1016/S0960-894X(98)00628-3
   STACK CR, 1984, SEED PHYSL
   TAYLOR PB, 1994, J BIOL CHEM, V269, P6325
   *TOWNSV YEPP AUSTR, WEATH STAT DAT 2008
   WOLF RB, 1982, J AM OIL CHEM SOC, V59, P230, DOI 10.1007/BF02582182
NR 32
TC 6
Z9 6
U1 3
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0926-6690
EI 1872-633X
J9 IND CROP PROD
JI Ind. Crop. Prod.
PD MAY
PY 2011
VL 33
IS 3
BP 775
EP 778
DI 10.1016/j.indcrop.2011.01.022
PG 4
WC Agricultural Engineering; Agronomy
SC Agriculture
GA 757EA
UT WOS:000290066700033
DA 2018-12-27
ER

PT J
AU Moutafides, GM
   Economides, AA
AF Moutafides, George M.
   Economides, Anastasios A.
TI RETRACTED: Demand for broadband access in Greece (Retracted article. See
   vol. 14, pg. 147, 2014)
SO TELEMATICS AND INFORMATICS
LA English
DT Article; Retracted Publication
DE Demand forecasting; Broadband access; Correlation; Time-series
ID TECHNOLOGY
AB As broadband access networks are relatively new in Greece, it is really difficult and involves great risk to determine the potential market for broadband services. The intent of this paper is to add to the discussion of delivering fixed broadband lines to customers in Greece taking into account regulation issues, the strategic movements of the market key players and the commonly admitted inequality of broadband access availability between urban and rural areas. In addition, using time-series analysis and examining the correlations between the number of fixed broadband lines and specific demographic factors for the past three years (mid 2006 mid 2009), an attempt to estimate empirically the forthcoming demand for broadband lines is conducted. Population's income and effective competition are recognized as the strongest determinants of broadband development. In addition, it yields that demand for broadband will continue to have a positive trend for the years to come as people are becoming more and more familiar with new technologies, with youth being the pioneer to the use of innovative services that require broadband access. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Moutafides, George M.] Telecom Reg Imathia Pella & Pieria, Tech Issues Dept, HTOSA, Veria 59100, Greece.
   Univ Macedonia, Dept Informat Syst, Thessaloniki 54006, Greece.
   Univ Macedonia, Dept Ecom Sci, Thessaloniki 54006, Greece.
RP Moutafides, GM (reprint author), Telecom Reg Imathia Pella & Pieria, Tech Issues Dept, HTOSA, Mitropoleos 53, Veria 59100, Greece.
EM gmoutafidi@ote.gr; economid@uom.gr
RI Economides, Anastasios/F-8585-2012
OI Economides, Anastasios/0000-0001-8056-1024
CR Alleman J.H., 2003, DEMAND BROADBAND ACC
   BOSLAUGH S., 2008, STAT NUTSHELL
   Box G., 1994, TIME SERIES ANAL FOR
   Cerno L., 2005, DEMAND INTERNET ACCE
   Europe's Information Society i-2010, 2008, IMP BROADB GROWTH PR
   Europe's Information Society i-2010, 2009, BROADB ACC EU SIT JU
   Fildes R, 2002, INT J FORECASTING, V18, P489, DOI 10.1016/S0169-2070(02)00064-X
   Garbacz C, 2007, TELECOMMUN POLICY, V31, P276, DOI 10.1016/j.telpol.2007.03.007
   Hu W.M., 2006, NEW ESTIMATES BROADB
   Ida T, 2006, J REGUL ECON, V29, P5, DOI 10.1007/s11149-005-5124-y
   Information Society in Greece, DESCR INV 93 MEAS 4
   Kalantzis F., 2009, TELECOM POLICY, DOI [10.1016/j.telpol.2009.07.06, DOI 10.1016/J.TELPOL.2009.07.06]
   Koyck L.M., 1954, DISTRIBUTED LAGS INV
   Kratzig M., 2004, APPL TIME SERIES ECO, DOI [10.2277/0521547873, DOI 10.2277/0521547873]
   Lee CY, 2008, TECHNOL FORECAST SOC, V75, P91, DOI 10.1016/j.techfore.2006.12.001
   Loomis D., 1999, FUTURE TELECOMMUNICA, V21-42
   McBurney P., 2002, Telematics and Informatics, V19, P225, DOI 10.1016/S0736-5853(01)00004-1
   McQuarrie A, 1998, REGRESSION TIME SERI
   Observatory for the Greek Information Society, 2009, 6 MONTH REP BROADB
   Observatory for the Greek Information Society, 2010, 6 MONTH REP BROADB
   Preston P, 2007, TELECOMMUN POLICY, V31, P389, DOI 10.1016/j.telpol.2007.04.003
   Rappoport P., 2007, WORKSH CONV 15 16 JA
   Sohn SY, 2008, COMPUT IND ENG, V54, P45, DOI 10.1016/j.cie.2007.06.033
   Taylor L., 2002, 2002 M INT COMM FOR
   Trkman P, 2008, TELECOMMUN POLICY, V32, P101, DOI 10.1016/j.telpol.2007.11.001
   van Gorp AF, 2006, TELECOMMUN POLICY, V30, P96, DOI 10.1016/j.telpol.2005.05.009
   World Bank, 2009, INF COMM DEV 2009 EX
NR 27
TC 4
Z9 4
U1 2
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0736-5853
J9 TELEMAT INFORM
JI Telemat. Inform.
PD MAY
PY 2011
VL 28
IS 2
BP 125
EP 141
DI 10.1016/j.tele.2010.10.003
PG 17
WC Information Science & Library Science
SC Information Science & Library Science
GA 060CP
UT WOS:000312754400007
DA 2018-12-27
ER

PT J
AU Zhang, ZX
   Zhao, RP
   Tang, Y
   Wen, SR
   Wang, DS
   Qi, JP
AF Zhang, Zhaoxu
   Zhao, Ruiping
   Tang, Ying
   Wen, Shirong
   Wang, Desheng
   Qi, Jiping
TI RETRACTED: Fuzhisan, a Chinese Herbal Medicine, Inhibits
   Beta-Amyloid-Induced Neurotoxicity and Tau Phosphorylation Through
   Calpain/Cdk5 Pathway in Cultured Cortical Neurons (Retracted article.
   See vol. 37, pg. 902, 2012)
SO NEUROCHEMICAL RESEARCH
LA English
DT Article; Retracted Publication
DE Fuzhisan (FZS); Alzheimer's disease; Tau; Cyclin-dependent kinase 5
   (CDK5); p35; p25
ID PAIRED HELICAL FILAMENTS; DEPENDENT KINASE-5 ACTIVATOR;
   ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; CDK5 ACTIVITY; IN-VIVO; P25; P35;
   HYPERPHOSPHORYLATION; NEURODEGENERATION
AB It has been shown that beta-amyloid (A beta) induced hyperphosphorylation of tau is implicated in the pathogenesis of Alzheimer's disease (AD), and deregulation of cyclin-dependent kinase 5 (Cdk5) activity is involved in the abnormal tau phosphorylation. The cleavage of neuron-specific Cdk5 activator, p35, to p25, mediated by calpain and calcium, deregulates Cdk5 activity and promotes neurodegeneration. Fuzhisan (FZS), a Chinese herbal complex prescription that has been used for the treatment of AD for over 15 years, is known to enhance the cognitive ability in AD patients. In this study, we investigated the neuroprotective effects and potential molecular mechanisms of FZS against A beta(25-35)-induced toxicity in cultured cortical neurons. We revealed that FZS attenuated A beta(25-35)-induced neurotoxicity in a dose-dependent manner. FZS inhibited A beta(25-35)-induced activation of Cdk5 and decreased tau hyperphosphorylation although it did not directly inhibit Cdk5. In addition, FZS also blocked A beta(25-35)-induced calcium influx, calpain activation and decreased cleavage of p35 to p25.
C1 [Zhang, Zhaoxu; Tang, Ying; Wen, Shirong; Wang, Desheng] Harbin Med Coll, Affiliated Hosp 1, Dept Neurol, Harbin 150001, Peoples R China.
   [Zhao, Ruiping; Qi, Jiping] Harbin Med Coll, Affiliated Hosp 1, Dept Pathol, Harbin 150001, Peoples R China.
RP Wang, DS (reprint author), Harbin Med Coll, Affiliated Hosp 1, Dept Neurol, Harbin 150001, Peoples R China.
EM hydwangdesheng@hotmail.com; qijiping2003@163.com
FU National Natural Science Foundation of China [30973106]; Natural Science
   Foundation of HeiLongJiang Province [CB08C309]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 30973106) and Natural Science Foundation of
   HeiLongJiang Province (No. CB08C309).
CR Alvarez A, 1999, FEBS LETT, V459, P421, DOI 10.1016/S0014-5793(99)01279-X
   Alvarez A, 2001, EXP CELL RES, V264, P266, DOI 10.1006/excr.2001.5152
   Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423
   Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002
   BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5
   Chen XC, 2008, BRAIN RES, V1200, P99, DOI 10.1016/j.brainres.2007.12.029
   Cheung ZH, 2004, NEUROSCI LETT, V361, P47, DOI 10.1016/j.neulet.2003.12.117
   Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x
   Crespo-Biel N, 2009, NEUROPHARMACOLOGY, V56, P422, DOI 10.1016/j.neuropharm.2008.09.012
   Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5
   Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002
   Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1
   Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019
   Gang BZ, 2005, CHIN J APOPLEXY NERV, V22, P527
   Hsiao YH, 2008, J NEUROSCI RES, V86, P2685, DOI 10.1002/jnr.21710
   Kerokoski P, 2002, BIOCHEM BIOPH RES CO, V298, P693, DOI 10.1016/S0006-291X(02)02543-3
   Koh SH, 2008, BRAIN RES, V1188, P254, DOI 10.1016/j.brainres.2007.10.064
   KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4
   Le WD, 1997, J NEUROCHEM, V69, P978
   Lee KY, 1999, NEUROSCI RES, V34, P21, DOI 10.1016/S0168-0102(99)00026-7
   Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636
   LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488
   Leschik J, 2007, J NEUROCHEM, V101, P1303, DOI 10.1111/j.1471-4159.2006.04435.x
   Li GB, 2003, J NEUROCHEM, V84, P347, DOI 10.1046/j.1471-4159.2003.01526.x
   Li XL, 2008, EXP GERONTOL, V43, P853, DOI 10.1016/j.exger.2008.05.018
   Lopes JP, 2010, AGING CELL, V9, P64, DOI 10.1111/j.1474-9726.2009.00536.x
   Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200
   MANDELKOW EM, 1993, ANN NY ACAD SCI, V695, P209, DOI 10.1111/j.1749-6632.1993.tb23054.x
   Masliah E, 2001, J NEUROPATH EXP NEUR, V60, P357, DOI 10.1093/jnen/60.4.357
   Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9
   Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159
   Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199
   SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003
   Sul D, 2009, LIFE SCI, V84, P257, DOI 10.1016/j.lfs.2008.12.001
   Utreras E, 2009, NEUROSCIENCE, V161, P978, DOI 10.1016/j.neuroscience.2009.04.002
   Wen SR, 2005, CHIN J CLIN REHABIL, V9, P241
   Zhao JK, 2009, ARCH PHARM RES, V32, P989, DOI 10.1007/s12272-009-1703-2
   Zheng YL, 2005, EMBO J, V24, P209, DOI 10.1038/sj.emboj.7600441
   Zhou J, 2010, LIFE SCI, V86, P532, DOI 10.1016/j.lfs.2010.02.009
NR 39
TC 9
Z9 10
U1 3
U2 20
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0364-3190
J9 NEUROCHEM RES
JI Neurochem. Res.
PD MAY
PY 2011
VL 36
IS 5
BP 801
EP 811
DI 10.1007/s11064-011-0405-6
PG 11
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 746BC
UT WOS:000289215000014
PM 21243427
DA 2018-12-27
ER

PT J
AU Chung, IM
   Yeo, MA
   Kim, SJ
   Moon, HI
AF Chung, Ill-Min
   Yeo, Min-A
   Kim, Sun-Jin
   Moon, Hyung-In
TI RETRACTED: Anti-complement activity of essential oils from red and black
   rice bran (Retracted article. See vol. 63, pg. 766, 2012)
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article; Retracted Publication
DE Red and black rice bran; essential oils; complement system;
   anti-complement effects
ID AROMA
AB The volatile essential oils from red and black rice bran were obtained by hydrodistillation using a clevenger-type apparatus, and the components of that oil were analyzed by capillary gas chromatography-mass spectroscopy (GC-MS). The present study involved characterizing the chemical compositions, their amounts and the anti-complement activities of red and black rice bran. The red rice bran essential oils yield was 0.031%, and GC-MS analysis revealed that its major constituents were (E)-beta-ocimene (3.12%), nonanal (11.32%), (2E, 4E)-decadienal (2.54%), myristic acid (41.32%), geranyactone (2.41%) and methyl oleate (2.46%). The black rice bran essential oils yield was 0.053%, and GC-MS analysis revealed that its major constituents were nonanal (8.31%), acrylic acid (3.21%), 2-hydroxy-6-methylbenzaldehyde (2.81%), pelargonic acid (4.21%) and myrisitc acid (28.07%). The essential oils showed inhibitory activity against complement system with 50% inhibitory concentrations (IC50) values of 246 ppm (red rice bran) and 193 ppm (black rice bran). Also, myristic acid, nonanal, (E)-beta-ocimene and pelargonic acid were tested against complement system. Pelargonic acid was shown to moderate activity (50% inhibitory concentration = 132 mu M).
C1 [Moon, Hyung-In] Dongguk Univ, Coll Korean Med, Cardiovasc Med Res Ctr, Gyeong Ju 780714, South Korea.
   [Moon, Hyung-In] Wonkwang Univ Sanbon Med Ctr, Inam Neurosci Res Ctr, Kyonggi Do 435040, South Korea.
   [Chung, Ill-Min; Yeo, Min-A; Kim, Sun-Jin] Konkuk Univ, Dept Appl Life Sci, Seoul, South Korea.
RP Moon, HI (reprint author), Dongguk Univ, Coll Korean Med, Cardiovasc Med Res Ctr, Gyeong Ju 780714, South Korea.
EM himoon@wonkwang.ac.kr
FU National Agrobiodiversity Center, Rural Development Administration
FX This work was supported by the National Agrobiodiversity Center, Rural
   Development Administration in 2010.
CR Abourashed EA, 2009, LEUNGS ENCY COMMON N
   Bhattacharjee P, 2003, J SCI FOOD AGR, V83, P880, DOI 10.1002/jsfa.1420
   BUTTERY RG, 1988, J AGR FOOD CHEM, V36, P1006, DOI 10.1021/jf00083a025
   BUTTERY RG, 1982, CHEM IND-LONDON, P958
   Cheng SS, 2003, BIORESOURCE TECHNOL, V89, P99, DOI 10.1016/S0960-8524(03)00008-7
   *FAO, 2010, RIC MON
   Jung KY, 1998, BIOL PHARM BULL, V21, P1077
   LASURE A, 1994, PLANTA MED, V60, P276, DOI 10.1055/s-2006-959475
   Lee SM, 2003, ARCH PHARM RES, V26, P463, DOI 10.1007/BF02976863
   Min BS, 2003, BIOL PHARM BULL, V26, P1042, DOI 10.1248/bpb.26.1042
   Ogundele MO, 1999, INFLAMM RES, V48, P437, DOI 10.1007/s000110050484
   Ryu SN, 1998, J FOOD DRUG ANAL, V6, P729
   Widjaja R, 1996, J SCI FOOD AGR, V70, P151, DOI 10.1002/(SICI)1097-0010(199602)70:2<151::AID-JSFA478>3.0.CO;2-U
   Yoshihashi T, 2002, J FOOD SCI, V67, P619, DOI 10.1111/j.1365-2621.2002.tb10648.x
NR 14
TC 3
Z9 3
U1 1
U2 19
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD MAY
PY 2011
VL 62
IS 3
BP 215
EP 218
DI 10.3109/09637486.2010.503187
PG 4
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA 739XJ
UT WOS:000288754700004
PM 20673187
DA 2018-12-27
ER

PT J
AU Ji, ZX
   Sun, QS
   Xia, DS
AF Ji, Ze-Xuan
   Sun, Quan-Sen
   Xia, De-Shen
TI RETRACTED: A framework with modified fast FCM for brain MR images
   segmentation (Retracted article. See vol. 47, pg. 3979, 2014)
SO PATTERN RECOGNITION
LA English
DT Article; Retracted Publication
DE Brain MR image; Image segmentation; FCM; Anisotropic weight; Intensity
   inhomogeneity; Partial volume
ID C-MEANS ALGORITHM; PARTIAL VOLUME SEGMENTATION; MAGNETIC-RESONANCE
   IMAGES; TISSUE CLASSIFICATION; MODEL
AB Intensity inhomogeneity, noise and partial volume (PV) effect render a challenging task for segmentation of brain magnetic resonance (MR) images. Most of the current MR image segmentation methods focus on only one or two of the effects listed above. In this paper, a framework with modified fast fuzzy c-means for brain MR images segmentation is proposed to take all these effects into account simultaneously and improve the accuracy of image segmentations. Firstly, we propose a new automated method to determine the initial values of the centroids. Secondly, an adaptive method to incorporate the local spatial continuity is proposed to overcome the noise effectively and prevent the edge from blurring. The intensity inhomogeneity is estimated by a linear combination of a set of basis functions. Meanwhile, a regularization term is added to reduce the iteration steps and accelerate the algorithm. The weights of the regularization terms are all automatically computed to avoid the manually tuned parameter. Synthetic and real MR images are used to test the proposed framework. Improved performance of the proposed algorithm is observed where the intensity inhomogeneity, noise and PV effect are commonly encountered. The experimental results show that the proposed method has stronger anti-noise property and higher segmentation precision than other reported FCM-based techniques. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Ji, Ze-Xuan; Sun, Quan-Sen; Xia, De-Shen] Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing 210094, Peoples R China.
RP Sun, QS (reprint author), Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing 210094, Peoples R China.
EM jizexuan@hotmail.com; sunquansen@mail.njust.edu.cn
FU National Science Foundation of China; National Science Foundation of
   Jiangsu Province; Ministry of Education of China (RFDP) [60773172,
   BK2008411, 200802880017]
FX This work was supported by the National Science Foundation of China, the
   National Science Foundation of Jiangsu Province and Doctoral Fund of
   Ministry of Education of China (RFDP) under Grant no. 60773172,
   BK2008411 and 200802880017.
CR Ahmed MN, 2002, IEEE T MED IMAGING, V21, P193, DOI 10.1109/42.996338
   Bezdek J.C., 1981, PATTERN RECOGNITION
   BEZDEK JC, 1993, MED PHYS, V20, P1033, DOI 10.1118/1.597000
   Black MJ, 1999, LECT NOTES COMPUT SC, V1682, P259
   CAI W, 2007, PATTERN RECOGN, V40, P325
   Chen SC, 2004, IEEE T SYST MAN CY B, V34, P1907, DOI 10.1109/TSMCB.2004.831165
   CHOI HS, 1991, IEEE T MED IMAGING, V10, P395, DOI 10.1109/42.97590
   Dunn J. C., 1973, Journal of Cybernetics, V3, P32
   Hoppner F, 2003, INT J APPROX REASON, V32, P85, DOI 10.1016/S0888-613X(02)00078-6
   Horn R. A., 1985, MATRIX ANAL
   Kang BY, 2005, LECT NOTES ARTIF INT, V3613, P462
   Kang JY, 2009, DIGIT SIGNAL PROCESS, V19, P309, DOI 10.1016/j.dsp.2007.11.005
   Li X, 2005, MED PHYS, V32, P2337, DOI 10.1118/1.1944912
   Liew AWC, 2006, CURR MED IMAGING REV, V2, P91, DOI 10.2174/157340506775541604
   Liew AWC, 2005, IEEE T FUZZY SYST, V13, P444, DOI 10.1109/TFUZZ.2004.841748
   Mohabey A, 2000, PEACHFUZZ 2000 : 19TH INTERNATIONAL CONFERENCE OF THE NORTH AMERICAN FUZZY INFORMATION PROCESSING SOCIETY - NAFIPS, P338, DOI 10.1109/NAFIPS.2000.877448
   Pham DL, 1999, PATTERN RECOGN LETT, V20, P57, DOI 10.1016/S0167-8655(98)00121-4
   Powell M.J.D., 1981, APPROXIMATION THEORY
   Sikka K, 2009, MAGN RESON IMAGING, V27, P994, DOI 10.1016/j.mri.2009.01.024
   SZILAGYI L, 2008, THESIS BME BUDAPEST
   Van Leemput K, 2003, IEEE T MED IMAGING, V22, P105, DOI 10.1109/TMI.2002.806587
   Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270
   Vovk U, 2007, IEEE T MED IMAGING, V26, P405, DOI 10.1109/TMI.2006.891486
   Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747
   Zhu L, 2009, IEEE T SYST MAN CY B, V39, P578, DOI 10.1109/TSMCB.2008.2004818
NR 25
TC 41
Z9 49
U1 3
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0031-3203
EI 1873-5142
J9 PATTERN RECOGN
JI Pattern Recognit.
PD MAY
PY 2011
VL 44
IS 5
BP 999
EP 1013
DI 10.1016/j.patcog.2010.11.017
PG 15
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA 722WZ
UT WOS:000287467300001
DA 2018-12-27
ER

PT J
AU Turner, EC
   Kavanagh, DJ
   Mulvaney, EP
   McLean, C
   Wikstrom, K
   Reid, HM
   Kinsella, BT
AF Turner, Elizebeth C.
   Kavanagh, David J.
   Mulvaney, Eamon P.
   McLean, Caitriona
   Wikstroem, Katarina
   Reid, Helen M.
   Kinsella, B. Therese
TI RETRACTED: Identification of an Interaction between the TP alpha and TP
   beta Isoforms of the Human Thromboxane A(2) Receptor with Protein Kinase
   C-related Kinase (PRK) 1 IMPLICATIONS FOR PROSTATE CANCER (Retracted
   article. See vol. 293, pg. 12286, 2018)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID HUMAN-ERYTHROLEUKEMIA-CELLS; SMOOTH-MUSCLE; NITRIC-OXIDE; HUMAN
   THROMBOXANE-A(2)-RECEPTOR; HOMOLOGOUS DESENSITIZATION; MEDIATED
   DESENSITIZATION; INDEPENDENT MODULATION; NEGATIVE REGULATION; COUPLED
   RECEPTORS; RHO-KINASE
AB In humans, thromboxane (TX) A(2) signals through the TP alpha and TP beta isoforms of the TXA(2) receptor or TP. Here, the RhoA effector protein kinase C-related kinase (PRK) 1 was identified as an interactant of both TP alpha and TP beta involving common and unique sequences within their respective C-terminal (C)-tail domains and the kinase domain of PRK1 (PRK1(640-942)). Although the interaction with PRK1 is constitutive, agonist activation of TP alpha/TP beta did not regulate the complex per se but enhanced PRK1 activation leading to phosphorylation of its general substrate histone H1 in vitro. Altered PRK1 and TP expression and signaling are increasingly implicated in certain neoplasms, particularly in androgen-associated prostate carcinomas. Agonist activation of TP alpha/TP beta led to phosphorylation of histone H3 at Thr(11) (H3 Thr(11)), a previously recognized specific marker of androgen-induced chromatin remodeling, in the prostate LNCaP and PC-3 cell lines but not in primary vascular smooth muscle or endothelial cells. Moreover, this effect was augmented by dihydrotestosterone in androgen-responsive LNCaP but not in nonresponsive PC-3 cells. Furthermore, PRK1 was confirmed to constitutively interact with TP alpha/TP beta in both LNCaP and PC-3 cells, and targeted disruption of PRK1 impaired TP alpha/TP beta -mediated H3 Thr(11) phosphorylation in, and cell migration of, both prostate cell types. Collectively, considering the role of TXA(2) as a potent mediator of RhoA signaling, the identification of PRK1 as a bona fide interactant of TP alpha/TP beta, and leading to H3 Thr(11) phosphorylation to regulate cell migration, has broad functional significance such as within the vasculature and in neoplasms in which both PRK1 and the TPs are increasingly implicated.
C1 [Turner, Elizebeth C.; Kavanagh, David J.; Mulvaney, Eamon P.; McLean, Caitriona; Wikstroem, Katarina; Reid, Helen M.; Kinsella, B. Therese] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Sch Biomol & Biomed Sci, Dublin 4, Ireland.
RP Kinsella, BT (reprint author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Sch Biomol & Biomed Sci, Dublin 4, Ireland.
EM Therese.Kinsella@UCD.IE
OI Mulvaney, Eamon/0000-0003-3661-2116; Kinsella, B.
   Therese/0000-0003-3072-941X
FU Science Foundation of Ireland [05/IN.1/B19]; Health Research Board of
   Ireland [RP/2008/33]
FX This work was supported by Science Foundation of Ireland Grant
   05/IN.1/B19 and by Health Research Board of Ireland Grant RP/2008/33.
CR Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648
   Coyle AT, 2006, BIOCHEM PHARMACOL, V71, P1308, DOI 10.1016/j.bcp.2006.01.011
   Coyle AT, 2005, FEBS J, V272, P4754, DOI 10.1111/j.1742-4658.2005.04990.x
   Coyle AT, 2005, FEBS J, V272, P1036, DOI 10.1111/j.1742-4658.2004.04538.x
   Coyle AT, 2002, EUR J BIOCHEM, V269, P4058, DOI 10.1046/j.1432-1033.2002.03098.x
   Dassesse T, 2006, EUR UROL, V50, P1021, DOI 10.1016/j.eururo.2006.01.036
   Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095
   Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200
   Flynn P, 1998, J BIOL CHEM, V273, P2698, DOI 10.1074/jbc.273.5.2698
   Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0
   Galgano MT, 2009, HUM PATHOL, V40, P1434, DOI 10.1016/j.humpath.2009.02.008
   Gannon AM, 2008, J LIPID RES, V49, P2590, DOI 10.1194/jlr.M800256-JLR200
   Gannon AM, 2009, J CELL MOL MED, V13, P4571, DOI 10.1111/j.1582-4934.2008.00599.x
   Gannon AM, 2009, J MOL BIOL, V394, P29, DOI 10.1016/j.jmb.2009.09.007
   Gotoh Y, 2004, BIOCHEM BIOPH RES CO, V314, P688, DOI 10.1016/j.bbrc.2003.12.148
   Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200
   Harrison BC, 2010, FEBS LETT, V584, P1103, DOI 10.1016/j.febslet.2010.02.057
   Helley-Hickie LP, 2004, BRIT J PHARMACOL, V142, P203, DOI 10.1038/sj.bjp.0705695
   Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x
   Kaneko Y, 2006, HYPERTENS RES, V29, P665, DOI 10.1291/hypres.29.665
   Kato T, 2008, GENES CELLS, V13, P509, DOI 10.1111/j.1365-2443.2008.01182.x
   Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012
   Kelley-Hickie LP, 2007, BBA-MOL CELL RES, V1773, P970, DOI 10.1016/j.bbamcr.2007.03.012
   Kelley-Hickie LP, 2006, BBA-MOL CELL BIOL L, V1761, P1114, DOI 10.1016/j.bbalip.2006.07.012
   Kinsella BT, 2001, BIOCHEM SOC T, V29, P641, DOI 10.1042/BST0290641
   Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446
   Li XL, 2007, ARCH BIOCHEM BIOPHYS, V467, P20, DOI 10.1016/j.abb.2007.08.005
   Matsuzawa K, 1997, BIOCHEM BIOPH RES CO, V234, P621, DOI 10.1006/bbrc.1997.6669
   Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023
   Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668
   Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839
   Miggin SM, 1998, BBA-GEN SUBJECTS, V1425, P543, DOI 10.1016/S0304-4165(98)00109-3
   Mukai H, 2006, METHOD ENZYMOL, V406, P234, DOI 10.1016/S0076-6879(06)06017-4
   Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019
   Nakahata Norimichi, 2009, Folia Pharmacologica Japonica, V134, P259
   Nie DT, 2008, CANCER RES, V68, P115, DOI 10.1158/0008-5472.CAN-07-1018
   Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16
   Reid HM, 2011, CELL SIGNAL, V23, P700, DOI 10.1016/j.cellsig.2010.12.003
   Reid HM, 2010, J BIOL CHEM, V285, P18709, DOI 10.1074/jbc.M110.106476
   Reid HM, 2009, BRIT J PHARMACOL, V158, P830, DOI 10.1111/j.1476-5381.2009.00351.x
   Reid HM, 2003, J BIOL CHEM, V278, P51190, DOI 10.1074/jbc.M309314200
   RIEDER CL, 1992, J CELL SCI, V102, P387
   Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803
   Rochdi MD, 2004, J BIOL CHEM, V279, P18981, DOI 10.1074/jbc.M312621200
   Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144
   Sasaki M, 2007, PROSTAG OTH LIPID M, V83, P237, DOI 10.1016/j.prostaglandins.2006.12.001
   Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202
   Shibata H, 1996, FEBS LETT, V385, P221, DOI 10.1016/0014-5793(96)00385-7
   Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x
   Su C, 2007, CELL CYCLE, V6, P739, DOI 10.4161/cc.6.6.3985
   Tokue SI, 2009, PROSTAG OTH LIPID M, V89, P8, DOI 10.1016/j.prostaglandins.2009.02.001
   Torbett NE, 2003, J BIOL CHEM, V278, P32344, DOI 10.1074/jbc.M303532200
   Walsh MT, 2000, J BIOL CHEM, V275, P20412, DOI 10.1074/jbc.M907881199
   Wikstrom K, 2008, CELL SIGNAL, V20, P1497, DOI 10.1016/j.cellsig.2008.04.006
   Yoshinaga C, 1999, J BIOCHEM, V126, P475, DOI 10.1093/oxfordjournals.jbchem.a022476
   Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40
   Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702
NR 57
TC 21
Z9 21
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 29
PY 2011
VL 286
IS 17
BP 15440
EP 15457
DI 10.1074/jbc.M110.181180
PG 18
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 753OI
UT WOS:000289788300073
PM 21357687
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Singhal, RK
   Kumari, P
   Kumar, S
   Dolia, SN
   Xing, YT
   Alzamora, M
   Deshpande, UP
   Shripathi, T
   Saitovitch, E
AF Singhal, R. K.
   Kumari, P.
   Kumar, Sudhish
   Dolia, S. N.
   Xing, Y. T.
   Alzamora, M.
   Deshpande, U. P.
   Shripathi, T.
   Saitovitch, Elisa
TI RETRACTED: Room temperature ferromagnetism in pure and Co- and Fe-doped
   CeO2 dilute magnetic oxide: effect of oxygen vacancies and cation
   valence (Retracted article. See vol. 46, 399701, 2013)
SO JOURNAL OF PHYSICS D-APPLIED PHYSICS
LA English
DT Article; Retracted Publication
ID CERIUM DIOXIDE
AB The evolution of reversible room temperature ferromagnetism (RTFM) has been investigated in Co- and Fe-doped (5% each) and non-doped CeO2 polycrystalline samples. Specimens with different oxygen vacancy (V-O) concentration including the (i) as-synthesized, (ii) hydrogenated and (iii) re-annealed in air were investigated using SQUID magnetometry, x-ray diffraction and x-ray photoelectron spectroscopy. The influence of the electronic properties on the RTFM was examined/analysed systematically. Our findings confirm that the ferromagnetism observed in CeO2 originates due to the oxygen vacancies, supporting the V-O mediated ferromagnetic exchange mechanism. Additionally, the cationic (cerium and transition metal) valence states play a crucial role.
C1 [Singhal, R. K.; Kumari, P.; Dolia, S. N.] Univ Rajasthan, Dept Phys, Jaipur 302055, Rajasthan, India.
   [Kumar, Sudhish] MLS Univ, Dept Phys, Udaipur 313002, India.
   [Xing, Y. T.] Univ Fed Fluminense, Inst Fis, BR-24210346 Niteroi, RJ, Brazil.
   [Alzamora, M.; Saitovitch, Elisa] CBPF, Rio De Janeiro, Brazil.
   [Deshpande, U. P.; Shripathi, T.] UGC DAE CSR, Indore 452001, Madhya Pradesh, India.
RP Singhal, RK (reprint author), Univ Rajasthan, Dept Phys, Jaipur 302055, Rajasthan, India.
EM singhal46@yahoo.co.in
CR Coey JMD, 2005, NAT MATER, V4, P173, DOI 10.1038/nmat1310
   Coey JMD, 2004, APPL PHYS LETT, V84, P1332, DOI 10.1063/1.1650041
   CONESA JC, 1995, SURF SCI, V339, P337, DOI 10.1016/0039-6028(95)00595-1
   DOLIA SN, 2010, J APPL PHYS, V107
   Fernandes V, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121304
   Lee HJ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2171789
   Liu YL, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/16/165201
   Ohno H, 2008, NUCL INSTRUM METH B, V266, P3013, DOI 10.1016/j.nimb.2008.03.155
   Rodriguez-Carvajal J., 2003, FULLPROF VERSION 3 0
   Samariya A, 2010, APPL SURF SCI, V257, P585, DOI 10.1016/j.apsusc.2010.07.037
   Singhal RK, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3507290
   Singhal RK, 2010, J ALLOY COMPD, V496, P324, DOI 10.1016/j.jallcom.2010.02.005
   Song YQ, 2007, J APPL PHYS, V102, DOI 10.1063/1.2761847
   Sundaresan A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161306
   Thurber A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165206
   Tiwari A, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2193431
   UEDA K, 2001, APPL PHYS LETT, V79, P2
   Venkatesan M, 2004, NATURE, V430, P630, DOI 10.1038/430630a
   Wen QY, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/24/246205
   Wen QY, 2008, J APPL PHYS, V103, DOI 10.1063/1.2830072
NR 20
TC 18
Z9 20
U1 3
U2 41
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0022-3727
EI 1361-6463
J9 J PHYS D APPL PHYS
JI J. Phys. D-Appl. Phys.
PD APR 27
PY 2011
VL 44
IS 16
AR 165002
DI 10.1088/0022-3727/44/16/165002
PG 6
WC Physics, Applied
SC Physics
GA 746WI
UT WOS:000289278500003
DA 2018-12-27
ER

PT J
AU Wang, XB
   Zhang, B
   Wang, DZ
AF Wang, Xinbo
   Zhang, Bo
   Wang, David Zhigang
TI RETRACTED: Reductive and Transition-Metal-Free: Oxidation of Secondary
   Alcohols by Sodium Hydride (Retracted Article)
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Correction; Retracted Publication
CR Wang XB, 2011, J AM CHEM SOC, V133, P5160, DOI 10.1021/ja904224y
NR 1
TC 9
Z9 9
U1 5
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD APR 6
PY 2011
VL 133
IS 13
BP 5160
EP 5160
DI 10.1021/ja904224y
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 749TJ
UT WOS:000289492700076
DA 2018-12-27
ER

PT J
AU Trampe, D
   Stapel, DA
   Siero, FW
AF Trampe, Debra
   Stapel, Diederik A.
   Siero, Frans W.
TI RETRACTED: The Self-Activation Effect of Advertisements: Ads Can Affect
   Whether and How Consumers Think about the Self (Retracted article. See
   vol. 39, pg. 444, 2012)
SO JOURNAL OF CONSUMER RESEARCH
LA English
DT Article; Retracted Publication
ID SOCIAL-COMPARISON PROCESSES; ATTRACTIVE MODELS; IMPACT; IMAGES;
   PERSUASION; BEHAVIOR; WOMENS; POSSESSIONS; EXPLICIT; IMPLICIT
AB Comparing consumption with nonconsumption situations, we propose and test the self-activation effect of advertisements, which holds that attractiveness-relevant products in advertisements can increase consumer self-activation and lower consumer self-evaluation. Four experiments provide support for this effect by showing that after viewing advertised beauty-enhancing products, but not advertised problem-solving products, thoughts about the self are more salient and self-evaluations are lower, compared with viewing the same products outside of an advertisement context. The findings hold for different products and different manipulations. We also present evidence for the mediating role of appearance self-discrepancy activation as a potential mechanism underlying the effect. The findings suggest that advertisements for attractiveness-relevant products may at times constitute social comparison standards, with which consumers compare themselves.
C1 [Trampe, Debra] Univ Groningen, Dept Mkt, NL-9700 AV Groningen, Netherlands.
   [Stapel, Diederik A.] Tilburg Univ, TIBER, NL-5000 LE Tilburg, Netherlands.
   [Siero, Frans W.] Univ Groningen, NL-9712 TS Groningen, Netherlands.
RP Trampe, D (reprint author), Univ Groningen, Dept Mkt, POB 800, NL-9700 AV Groningen, Netherlands.
EM D.Trampe@rug.nl; D.A.Stapel@uvt.nl; F.W.Siero@rug.nl
CR Aaker JL, 1999, J MARKETING RES, V36, P45, DOI 10.2307/3151914
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   BELK RW, 1988, J CONSUM RES, V15, P139, DOI 10.1086/209154
   Bloch P. H., 1992, PSYCHOL MARKET, V9, P3, DOI DOI 10.1002/MAR.4220090103
   Bower AB, 2001, J ADVERTISING, V30, P1
   Bower AB, 2001, J ADVERTISING, V30, P51, DOI 10.1080/00913367.2001.10673645
   Brewer MB, 1996, J PERS SOC PSYCHOL, V71, P83, DOI 10.1037/0022-3514.71.1.83
   BROWN JD, 1992, J PERS SOC PSYCHOL, V62, P717, DOI 10.1037//0022-3514.62.5.717
   BURNKRANT RE, 1989, PERS SOC PSYCHOL B, V15, P628, DOI 10.1177/0146167289154015
   Dijksterhuis A, 2000, SOC COGNITION, V18, P55, DOI 10.1521/soco.2000.18.1.55
   Dittmar H, 2009, J SOC CLIN PSYCHOL, V28, P43, DOI 10.1521/jscp.2009.28.1.43
   Duval S., 1972, THEORY OBJECTIVE SEL
   Escalas JE, 2007, J CONSUM RES, V33, P421, DOI 10.1086/510216
   Fennis BM, 2009, J CONSUM RES, V35, P906, DOI 10.1086/593291
   Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202
   Folkes VS, 2002, ADV CONSUM RES, V29, P1
   Hafner M, 2009, J CONSUM PSYCHOL, V19, P619, DOI 10.1016/j.jcps.2009.06.004
   Halliwell E, 2006, PERS SOC PSYCHOL B, V32, P447, DOI 10.1177/01461687205284005
   Halliwell E, 2004, J SOC CLIN PSYCHOL, V23, P104, DOI 10.1521/jscp.23.1.104.26989
   Jaccard James J., 1998, SAGE U PAPERS SERIES, V107-18
   Krishnamurthy P, 1999, J CONSUM RES, V26, P55, DOI 10.1086/209550
   Lockwood P, 1997, J PERS SOC PSYCHOL, V73, P91, DOI 10.1037//0022-3514.73.1.91
   MACINNIS DJ, 1987, J CONSUM RES, V13, P473, DOI 10.1086/209082
   Mandel N, 2006, J CONSUM PSYCHOL, V16, P57, DOI 10.1207/s15327663jcp1601_8
   McQuarrie EF, 1999, J CONSUM RES, V26, P37, DOI 10.1086/209549
   MeyersLevy J, 1996, J CONSUM RES, V22, P408, DOI 10.1086/209458
   Nielsen A. C., 2009, MEDIA EXPENDITURES 2
   OGuinn TC, 1997, J CONSUM RES, V23, P278, DOI 10.1086/209483
   Peracchio LA, 2005, J CONSUM RES, V32, P29, DOI 10.1086/429599
   Phillips B. J., 2004, MARKETING THEORY, V4, P113, DOI DOI 10.1177/1470593104044089
   Phillips BJ, 1997, J ADVERTISING, V26, P77, DOI 10.1080/00913367.1997.10673524
   POLLAY RW, 1986, J MARKETING, V50, P18, DOI 10.2307/1251597
   RICHINS ML, 1991, J CONSUM RES, V18, P71, DOI 10.1086/209242
   RICHINS ML, 1994, J CONSUM RES, V21, P504, DOI 10.1086/209414
   SCHEIER MF, 1983, J EXP SOC PSYCHOL, V19, P205, DOI 10.1016/0022-1031(83)90038-0
   Schwinghammer SA, 2006, PERS SOC PSYCHOL B, V32, P27, DOI 10.1177/0146167205277096
   SCOTT LM, 1994, J CONSUM RES, V21, P252, DOI 10.1086/209396
   Smeesters D, 2006, J CONSUM RES, V32, P576, DOI 10.1086/500489
   Smeesters D, 2010, J CONSUM RES, V36, P930, DOI 10.1086/648688
   SOLOMON MR, 1983, J CONSUM RES, V10, P319, DOI 10.1086/208971
   Sperber Dan, 1986, RELEVANCE COMMUNICAT
   Stapel DA, 2004, J PERS SOC PSYCHOL, V87, P860, DOI 10.1037/0022-3514.87.6.860
   Stapel DA, 2004, J PERS SOC PSYCHOL, V87, P468, DOI 10.1037/0022-3514.87.4.468
   Stapel DA, 2004, SOC COGNITION, V22, P147, DOI 10.1521/soco.22.1.147.30989
   Stapel DA, 2001, J PERS SOC PSYCHOL, V80, P766, DOI 10.1037//0022-3514.80.5.766
   Stapel DA, 2001, J PERS SOC PSYCHOL, V81, P742, DOI 10.1037//0022-3514.81.4.742
   Suls J., 2000, HDB SOCIAL COMP
   Thompson J. K., 1999, EXACTING BEAUTY THEO
   Trampe D, 2007, J PERS SOC PSYCHOL, V92, P106, DOI 10.1037/0022-3514.92.1.106
   Wood JV, 1996, PERS SOC PSYCHOL B, V22, P520, DOI 10.1177/0146167296225009
NR 50
TC 4
Z9 4
U1 6
U2 45
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0093-5301
EI 1537-5277
J9 J CONSUM RES
JI J. Consum. Res.
PD APR
PY 2011
VL 37
IS 6
BP 1030
EP 1045
DI 10.1086/657430
PG 16
WC Business
SC Business & Economics
GA 858YT
UT WOS:000297840400008
DA 2018-12-27
ER

PT J
AU Boshra, V
   Moustafa, AM
AF Boshra, Vivian
   Moustafa, Amal M.
TI RETRACTED: Effect of preischemic treatment with fenofibrate, a
   peroxisome proliferator-activated receptor-alpha ligand, on hepatic
   ischemia-reperfusion injury in rats4 (Retracted article. See vol. 44,
   pg. 495, 2013)
SO JOURNAL OF MOLECULAR HISTOLOGY
LA English
DT Article; Retracted Publication
DE Fenofibrate PPAR alpha; Hepatic ischemia/reperfusion; Histopathology;
   Oxidative stress
ID OXIDATIVE STRESS; LIVER-INJURY; KUPFFER CELLS; ISCHEMIA/REPERFUSION;
   MECHANISMS; FIBROSIS; MONKEYS; MELATONIN; AGONIST; STROKE
AB Liver ischemia/reperfusion (I/R) injury is a serious clinical problem. The reactive oxygen species (ROS) and tumor necrosis factor alpha (TNF-alpha) are important mediators in liver I/R injury. This study was designed to investigate the effect of preischemic treatment with fenofibrate (Peroxisome proliferator-activated receptor-alpha agonist) on the oxidative stress and inflammatory response to hepatic I/R injury in rats. Hepatic I/R was induced by clamping the blood supply of the left lateral and median lobes of the liver for 60 min, followed by reperfusion for 4 h. Each animal group was pretreated with a single dose of fenofibrate (50 mg/kg body weight) intra-peritoneally 1 h before ischemia. At the end of reperfusion, blood samples and liver tissues were obtained to assess serum alanine aminotransferase (ALT), TNF-alpha, hepatic malondialdehyde (MDA) and superoxide dismutase activity (SOD). Liver specimens were obtained and processed for light and electron microscopic study. Hepatic I/R induced a significant elevation of serum ALT and TNF-alpha with significant elevation of hepatic MDA and reduction of SOD activity. Histopathological examination revealed hepatic inflammation, necrosis and apoptosis. Preischemic treatment with fenofibrate at a dose of 50 mg/kg significantly attenuated the biochemical and structural alterations of I/R-induced liver injury.
C1 [Boshra, Vivian] Mansoura Univ, Dept Clin Pharmacol, Fac Med, Mansoura, Egypt.
   [Moustafa, Amal M.] Mansoura Univ, Dept Histol & Cytol, Fac Med, Mansoura, Egypt.
RP Boshra, V (reprint author), Mansoura Univ, Dept Clin Pharmacol, Fac Med, Mansoura, Egypt.
EM vivianboshra@hotmail.com
CR Aasum E, 2008, J MOL CELL CARDIOL, V44, P201, DOI 10.1016/j.yjmcc.2007.08.020
   ANDUS T, 1991, HEPATOLOGY, V13, P364, DOI 10.1002/hep.1840130226
   Bancroft J D, 2008, THEORY PRACTICE HIST
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Baykara B, 2009, ACTA HISTOCHEM, V111, P42, DOI 10.1016/j.acthis.2008.03.002
   Bhalodia Y, 2010, RENAL FAILURE, V32, P1088, DOI 10.3109/0886022X.2010.504911
   Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6
   Chattopadhyay Pronobesh, 2009, Saudi J Gastroenterol, V15, P156, DOI 10.4103/1319-3767.45356
   Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216
   Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388
   Colletti LM, 1996, HEPATOLOGY, V23, P506
   Colton HM, 2004, TOXICOL SCI, V80, P183, DOI 10.1093/toxsci/kfh144
   CORTI A, 1992, BIOCHEM J, V284, P905, DOI 10.1042/bj2840905
   Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019
   Cui Mei Lan, 2010, J Korean Med Sci, V25, P577, DOI 10.3346/jkms.2010.25.4.577
   Garcia JJ, 1997, FEBS LETT, V408, P297, DOI 10.1016/S0014-5793(97)00447-X
   Gelosa P, 2010, J PHARMACOL EXP THER, V335, P324, DOI 10.1124/jpet.110.171090
   Guo QM, 2010, J CEREBR BLOOD F MET, V30, P70, DOI 10.1038/jcbfm.2009.185
   Hoivik DJ, 2004, CARCINOGENESIS, V25, P1757, DOI 10.1093/carcin/bgh182
   Hou XY, 2010, BIOCHEM BIOPH RES CO, V394, P653, DOI 10.1016/j.bbrc.2010.03.043
   Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002
   Jaeschke H, 1997, J LEUKOCYTE BIOL, V61, P647
   Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2
   Kihara K, 2005, LIVER TRANSPLANT, V11, P1574, DOI 10.1002/lt.20533
   Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x
   Kobayashi T, 2002, ARCH HISTOL CYTOL, V65, P251, DOI 10.1679/aohc.65.251
   Kwanyuen P, 2006, INT J TOXICOL, V25, P41, DOI 10.1080/10915810500488395
   LEIST M, 1994, J IMMUNOL, V153, P1778
   LIBEROPOULOS EN, 2010, OPEN CARDIOVASC MED, V28, P120
   Llacuna L, 2009, AM J PATHOL, V174, P1776, DOI 10.2353/ajpath.2009.080857
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Muriel P, 2009, HEPATOL INT, V3, P526, DOI 10.1007/s12072-009-9158-6
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Okaya T, 2004, AM J PHYSIOL-GASTR L, V286, pG606, DOI 10.1152/ajpgi.00191.2003
   Peters JM, 2000, CARCINOGENESIS, V21, P823, DOI 10.1093/carcin/21.4.823
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56
   Rodriguez-Iturbe B, 2004, AM J PHYSIOL-RENAL, V286, pF606, DOI 10.1152/ajprenal.00269.2003
   Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5
   Teoh NC, 2003, J GASTROEN HEPATOL, V18, P891, DOI 10.1046/j.1440-1746.2003.03056.x
   Toyama T, 2004, BIOCHEM BIOPH RES CO, V324, P697, DOI 10.1016/j.bbrc.2004.09.110
   Ushitora M, 2010, J CONTROL RELEASE, V142, P431, DOI 10.1016/j.jconrel.2009.11.024
   WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337
   Xu SQ, 2008, WORLD J GASTROENTERO, V14, P6936, DOI 10.3748/wjg.14.6936
NR 43
TC 11
Z9 12
U1 1
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1567-2379
EI 1567-2387
J9 J MOL HISTOL
JI J. Mol. Histol.
PD APR
PY 2011
VL 42
IS 2
BP 113
EP 122
DI 10.1007/s10735-011-9313-y
PG 10
WC Cell Biology
SC Cell Biology
GA 793QH
UT WOS:000292837700004
PM 21305343
DA 2018-12-27
ER

PT J
AU Oh, CS
   Han, CS
AF Oh, Chang-Sup
   Han, Chang-Suk
TI RETRACTED: A Study on the Microstructure of Precipitation Strengthened
   B2-ordered NiAl (Retracted article. See vol. 21, pg. 613, 2015)
SO METALS AND MATERIALS INTERNATIONAL
LA English
DT Article; Retracted Publication
DE intermetallics; aging; mechanical properties; transmission electron
   microscopy (TEM); fine precipitation
ID MARTENSITIC-TRANSFORMATION; ELECTRON-DIFFRACTION; ALLOYS; NI2AL;
   OXIDATION
AB Microstructural control to produce a multiphase structure and there by improve the high temperature strength as well as low temperature ductility of intermetallics has received much attention. A transmission electron microscopy investigation has been performed in the present work on the precipitation of supersaturated B2-ordered (Ni,Co)Al and alpha-Cr in B2-ordered beta-NiAl with different stoichiometry. Precipitation behavior and hardening were investigated by measuring the hardness variation. The hardness of (Ni,Co)Al and beta-NiAl increases appreciably by the fine precipitation of (Ni,Co)(2)Al and alpha-Cr, and overage softening occurs after prolonged aging. In the case of B2-ordered (Ni,Co)Al, the (Ni,Co)(2)Al phase has a hexagonal structure and takes a rod-like shape with the long axis of the rod parallel to the < 111 > directions of the B2 matrix. By aging at temperatures below 873 K, a long period superlattice structure appears in the hexagonal (Ni,Co)(2)Al phase. The orientation relationship between the (Ni,Co)(2)Al precipitates and the B2-(Ni,Co)Al matrix is found to be (0001)(p)//(111)B2 and [(1) over bar2 (1) over bar0](p)//[(1) over bar 10]B2, where the suffixes p and B2 denote the (Ni,Co)(2)Al precipitate and the B2-(Ni,Co)Al matrix, respectively. (Ni,Co)Al hardens appreciably by fine precipitation of the (Ni,Co)(2)Al phase. On the other hand, in the case of B2-NiAl, perfect lattice coherency is retained at the interfaces between the alpha-Cr particles and the matrix during the initial stage of aging. After prolonged aging, a loss of coherency occurs by the attraction of matrix dislocations to the particle/matrix interface followed by climbing around the particles.
C1 [Han, Chang-Suk] Hoseo Univ, Dept Def Sci & Technol, Asan 336795, Chungnam, South Korea.
   [Oh, Chang-Sup] Korea Inst Sci & Technol Informat, Reseat Program, Taejon 305806, South Korea.
RP Han, CS (reprint author), Hoseo Univ, Dept Def Sci & Technol, Asan 336795, Chungnam, South Korea.
EM hancs@hoseo.edu
CR Bei H., 2006, MAT RES SOC, V1124
   Campillo B., 2001, ADV MAT PROCESSING, P863
   Choi C. S., 1999, J KOREAN INST MET MA, V37, P170
   CLINE HE, 1971, ACTA METALL MATER, V19, P405, DOI 10.1016/0001-6160(71)90163-5
   FIELD RD, 1991, ACTA METALL MATER, V39, P2961, DOI 10.1016/0956-7151(91)90028-Y
   FIELD RD, 1989, MAT RES SOC S INT P, V133, P225
   Han SO, 2010, KOREAN J MET MATER, V48, P1070, DOI 10.3365/KJMM.2010.48.12.1070
   Hangen UD, 1999, INTERMETALLICS, V7, P501, DOI 10.1016/S0966-9795(98)00101-0
   HIPPSLEY CA, 1990, ACTA METALL MATER, V38, P2393, DOI 10.1016/0956-7151(90)90252-C
   HONG T, 1989, MATER RES SOC S P, V133, P573
   Hubert-Protopescu M., 1991, TERNARY ALLOYS, V4, P234
   ISHIDA K, 1991, METALL TRANS A, V22, P441, DOI 10.1007/BF02656811
   Ishida K., 1995, Mechanical Properties and Phase Transformations of Multiphase Intermetallic Alloys. Proceedings of a Symposium, P77
   Jeong SH, 1998, MET MATER-KOREA, V4, P1077, DOI 10.1007/BF03025979
   Kataeva NV, 2006, MAT SCI ENG A-STRUCT, V438, P312, DOI 10.1016/j.msea.2006.02.081
   Kim K. B., 1999, J KOREAN INST MET MA, V37, P794
   Lee HY, 2009, J KOREAN INST MET MA, V47, P267
   Matsuura K, 2001, MATER T JIM, V42, P263, DOI 10.2320/matertrans.42.263
   MUTO S, 1993, ACTA METALL MATER, V41, P2377, DOI 10.1016/0956-7151(93)90317-L
   PASCOE RT, 1968, J MET SCI, V2, P138
   REYNAUD F, 1976, J APPL CRYSTALLOGR, V9, P263, DOI 10.1107/S0021889876011333
   ROBERTSON IM, 1983, PHILOS MAG A, V48, P421, DOI 10.1080/01418618308234902
   ROGL P, 1991, TERNARY ALLOYS, V4, P400
   Song S. H., 2003, J KOREAN INST MET MA, V41, P813
   WALTER JL, 1969, T METALL SOC AIME, V245, P2073
NR 25
TC 2
Z9 2
U1 2
U2 15
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA KIM BLDG 6TH FLOOR, SEOCHO-DAERO 56 GIL 38, SEOCHO-GU, SEOUL 137-881,
   SOUTH KOREA
SN 1598-9623
EI 2005-4149
J9 MET MATER INT
JI Met. Mater.-Int.
PD APR
PY 2011
VL 17
IS 2
BP 215
EP 222
DI 10.1007/s12540-011-0405-8
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 789ZO
UT WOS:000292558500005
DA 2018-12-27
ER

PT J
AU Fry, LW
   Hannah, ST
   Noel, M
   Walumbwa, FO
AF Fry, Louis W.
   Hannah, Sean T.
   Noel, Michael
   Walumbwa, Fred O.
TI RETRACTED: Impact of spiritual leadership on unit performance (Retracted
   article. See vol. 25, pg. 1073, 2014)
SO LEADERSHIP QUARTERLY
LA English
DT Article; Retracted Publication
DE Spiritual leadership; Military; Workplace spirituality; Performance;
   Emergent leadership
ID TRANSFORMATIONAL LEADERSHIP; ETHICAL LEADERSHIP; MEMBER EXCHANGE; WORK;
   ANTECEDENTS; PERSPECTIVE; COMMITMENT; MULTILEVEL; WORKPLACE; AGREEMENT
AB Issues regarding workplace spirituality have received increased attention in the organizational sciences. The implications of workplace spirituality for leadership theory, research, and practice make this a fast growing area of new research and inquiry by scholars. The purpose of this research was to test a dynamic relationship between spiritual leadership and spiritual well-being (i.e., a sense of calling and membership), and key organizational outcomes in a sample of emerging military leaders. Using structural equation modeling (SEM), results revealed a positive and significant relationship between spiritual leadership and several unit-level outcomes, including organizational commitment and four measures of performance. These relationships were explained or mediated by spiritual well-being. Implications for research and practice are discussed. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Fry, Louis W.] Texas A&M Cent Texas, Killeen, TX 76549 USA.
   [Hannah, Sean T.] US Mil Acad, Ctr Army Profess & Eth, West Point, NY 10996 USA.
   [Noel, Michael] US Mil Acad, Dept Behav Sci & Leadership, West Point, NY 10996 USA.
   [Walumbwa, Fred O.] Arizona State Univ, WP Carey Sch Business, Dept Management, Tempe, AZ 85287 USA.
RP Fry, LW (reprint author), Texas A&M Cent Texas, 1901 S Clear Creek Rd, Killeen, TX 76549 USA.
EM lwfry@ct.tamus.edu; Sean.Hannah@usma.edu; michael.alan.noel@us.army.mil;
   Fred.Walumbwa@asu.edu
RI Meeuwsen, Sjaak/F-9186-2011; Karadag, Engin/D-8713-2014
CR ABURDENE P, 2005, MEGATRENDS 2010
   ALLEN CL, 1972, MIRACLE LOVE
   ALLEN NJ, 1990, J OCCUP PSYCHOL, V63, P1, DOI 10.1111/j.2044-8325.1990.tb00506.x
   ANDERSON P, 2000, J QUALITY PARTICIPAT, V23, P16
   ARBUKLE JL, 1999, AMOS 4 0 USERS GUIDE
   Avolio B. J., 1999, FULL LEADERSHIP DEV
   Balkundi P, 2005, LEADERSHIP QUART, V16, P941, DOI 10.1016/j.leaqua.2005.09.004
   Bliese P. D, 2000, MULTILEVEL THEORY RE, P349
   Boies K, 2006, LEADERSHIP QUART, V17, P246, DOI 10.1016/j.leaqua.2006.02.004
   BOLLEN K, 1991, PSYCHOL BULL, V110, P305, DOI 10.1037/0033-2909.110.2.305
   Bono JE, 2003, ACAD MANAGE J, V46, P554, DOI 10.2307/30040649
   BRINSFIELD JM, 2005, FUTURE ARMY PROFESSI, P464
   Brown ME, 2005, ORGAN BEHAV HUM DEC, V97, P117, DOI 10.1016/j.obhdp.2005.03.002
   Brown ME, 2006, LEADERSHIP QUART, V17, P595, DOI 10.1016/j.leaqua.2006.10.004
   Brown ME, 2006, J APPL PSYCHOL, V91, P954, DOI 10.1037/0021-9010.91.4.954
   Cash KC, 2000, ACAD MANAGE EXEC, V14, P124, DOI 10.5465/AME.2000.4468072
   Chen GL, 2002, J APPL PSYCHOL, V87, P549, DOI 10.1037//0021-9010.87.3.549
   Conger J. A., 1998, CHARISMATIC LEADERSH
   DAFT RL, 1998, FUSION LEADERSHIP UN
   Day DV, 2000, LEADERSHIP QUART, V11, P581, DOI 10.1016/S1048-9843(00)00061-8
   Dent EB, 2005, LEADERSHIP QUART, V16, P625, DOI 10.1016/j.leaqua.2005.07.002
   *DEP ARM, 2008, FIELD MAN 3 0 OP
   *DEP ARM, 2008, 5253701 TRADOC DEP A
   *DEP ARM, 1950, 6002 DA
   Drath W.H., 1998, CTR CREATIVE LEADERS, P403
   Duchon D, 2005, LEADERSHIP QUART, V16, P807, DOI 10.1016/j.leaqua.2005.07.008
   Dvir T, 2003, LEADERSHIP QUART, V14, P327, DOI 10.1016/S1048-9843(03)00018-3
   Ehrhart MG, 2004, PERS PSYCHOL, V57, P61, DOI 10.1111/j.1744-6570.2004.tb02484.x
   EISLER R, 2003, HDB WORKPLACE SPIRIT, P546
   ELM DR, 2003, HDB WORKPLACE SPIRIT, P277
   FILLEY AC, 1976, MANAGERIAL PROCESSES
   FLEISCHMAN PR, 1994, HEALING SPIRIT EXPLO
   Fry L. W., 2005, POSITIVE PSYCHOL BUS, P47
   Fry LW, 2008, ORGAN DYN, V37, P86, DOI 10.1016/j.orgdyn.2007.11.004
   Fry LW, 2008, SPIRITUALITY IN BUSINESS: THEORY, PRACTICE, AND FUTURE DIRECTIONS, P106
   Fry LW, 2005, LEADERSHIP QUART, V16, P835, DOI 10.1016/j.leaqua.2005.07.012
   Fry LW, 2005, LEADERSHIP QUART, V16, P619, DOI 10.1016/j.leaqua.2005.07.001
   Fry LW, 2003, LEADERSHIP QUART, V14, P693, DOI 10.1016/j.leaqua.2003.09.001
   FRY LW, 2005, AUTHENTIC LEADERSHIP, P183
   FRY LW, 2006, AC MAN ATL GEORG
   FRY LW, 2007, AC MAN PHIL PENNS
   FRY LW, 2007, INTEGRATING SPIRITUA, P70
   Galbraith J, 1977, ORG DESIGN
   Garcia-Zamor JC, 2003, PUBLIC ADMIN REV, V63, P355, DOI 10.1111/1540-6210.00295
   Gardner WL, 1998, ACAD MANAGE REV, V23, P32, DOI 10.2307/259098
   Giacalone R.A., 2003, HDB WORKPLACE SPIRIT, P3
   Hannah ST, 2009, LEADERSHIP QUART, V20, P897, DOI 10.1016/j.leaqua.2009.09.006
   Herold DM, 2008, J APPL PSYCHOL, V93, P346, DOI 10.1037/0021-9010.93.2.346
   Hogg MA, 2001, PERS SOC PSYCHOL REV, V5, P184, DOI 10.1207/S15327957PSPR0503_1
   Inglehart R., 1997, MODERNIZATION POSTMO
   JAMES LR, 1993, J APPL PSYCHOL, V78, P306, DOI 10.1037//0021-9010.78.2.306
   James William, 1999, VARIETIES RELIG EXPE
   JONES LB, 1995, JESUS CEO USING ANCI
   Judge TA, 2000, J APPL PSYCHOL, V85, P751, DOI 10.1037/0021-9010.85.5.751
   KLEIN KJ, 1994, ACAD MANAGE REV, V19, P195, DOI 10.2307/258703
   KLIMOSKI R, 1994, J MANAGE, V20, P403, DOI 10.1177/014920639402000206
   Kotter J. P., 1996, LEADING CHANGE
   Kozlowski S. W. J., 2000, MULTILEVEL THEORY RE, P3
   KOZLOWSKI SWJ, 1992, J APPL PSYCHOL, V77, P161, DOI 10.1037/0021-9010.77.2.161
   Law KS, 1998, ACAD MANAGE REV, V23, P741
   Liden RC, 2008, LEADERSHIP QUART, V19, P161, DOI 10.1016/j.leaqua.2008.01.006
   LITTLE RW, 1964, MILITARY CHANGING PA, P195
   Lord RG, 1999, ORGAN BEHAV HUM DEC, V78, P167, DOI 10.1006/obhd.1999.2832
   MACARTHUR JF, 1998, FOOTSTEPS FAITH
   MADDOCK RC, 1998, MOTIVATION EMOTIONS
   MAYER DM, 2006, SHARING NETWORK LEAD
   Mitroff I. I., 1999, SPIRITUAL AUDIT CORP
   Nanus B., 1992, VISIONARY LEADERSHIP
   Nyhan RC, 2000, AM REV PUBLIC ADM, V30, P87, DOI 10.1177/02750740022064560
   Pfeffer J., 2003, HDB WORKPLACE SPIRIT, P29
   Reave L, 2005, LEADERSHIP QUART, V16, P655, DOI 10.1016/j.leaqua.2005.07.003
   REDER MW, 1982, J ECON LIT, V20, P1
   Rousseau D. M., 1985, RES ORGAN BEHAV, V7, P1, DOI DOI 10.1177/0149206310371692
   Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68
   Sass J. S, 2000, COMMUNICATION STUDIE, V5, P195, DOI 10.1080/10510970009388520
   Schein E. H., 2004, ORG CULTURE LEADERSH
   Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89
   SHAMIR B, 1993, ORGAN SCI, V4, P577, DOI 10.1287/orsc.4.4.577
   SNYDER CR, 2008, HDB POSITIVE PSYCHOL
   Sparrowe RT, 1997, ACAD MANAGE REV, V22, P522, DOI 10.2307/259332
   SUSSKIND AM, 2006, SHARING NETWORK LEAD
   Sweeney P. J., 2007, FORGING WARRIORS CHA, P23
   VALAS H, 1993, LEARN INSTR, V3, P281, DOI DOI 10.1016/0959-4752(93)90020-Z
   *W POINT, 2002, 1101 USMA W POINT
   Walumbwa FO, 2008, J MANAGE, V34, P89, DOI 10.1177/0149206307308913
   Yammarino FJ, 2005, LEADERSHIP QUART, V16, P879, DOI 10.1016/j.leaqua.2005.09.002
NR 86
TC 47
Z9 51
U1 2
U2 51
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1048-9843
EI 1873-3409
J9 LEADERSHIP QUART
JI Leadersh. Q.
PD APR
PY 2011
VL 22
IS 2
SI SI
BP 259
EP 270
DI 10.1016/j.leaqua.2011.02.002
PG 12
WC Psychology, Applied; Management
SC Psychology; Business & Economics
GA 768GJ
UT WOS:000290921600002
DA 2018-12-27
ER

PT J
AU Boyle, B
   Charles, M
AF Boyle, Bill
   Charles, Marie
TI RETRACTED: "Tightening the Shackles": The Continued Invisibility of
   Liverpool's British African Caribbean Teachers (Retracted article. See
   vol. 29, pg. 144, 2014)
SO JOURNAL OF BLACK STUDIES
LA English
DT Article; Retracted Publication
DE Black teachers; inequity in data collection; representatives; history;
   Liverpool
AB This article reports on the researchers' findings 20 years after Lord Gifford's inquiry into race relations in the city after the 1980s Toxteth riots. Gifford reported on the prevalence of racial attitudes, racial abuse, and racial violence directed against the Black citizens of Liverpool. The authors' research focused on education and specifically the low percentage of Black teachers compared to the whole teaching workforce and the percentage Black population in the city. Accessing complete Black teaching data proved difficult and unearthed issues within policy and priority in the city authorities and led the researchers to begin to gather data to explore teacher training, entries and completions, and the lack of status of the Black teachers as measured through representation in senior leadership positions in schools.
C1 [Boyle, Bill] Univ Manchester, Sch Educ, CFAS, Manchester M13 9PL, Lancs, England.
RP Boyle, B (reprint author), Univ Manchester, Sch Educ, CFAS, Ellen Wilkinson Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.
EM bill.boyle@manchester.ac.uk
CR BOYLE B, 2009, TIMES ED SUPPLE 1120, P17
   Charles M., 2004, THESIS U LIVERPOOL
   CLAY D, 1993, MAINSTR ED BLACK LEA
   *COMM ENQ ED CHILD, 1985, SWANN REP ED ALL
   *DEP CHILDR, 2009, STAT AN UN TEACH WOR
   DFES, 2004, SCH WORKF ENGL
   Fielding M., 2000, CHALLENGE EQUALITY A
   *GEN TEACH COUNC, 2002, COD COND PRACT REG T
   GIFFORD A, 1989, 1 REPORT LIVERPOOL 8
   GILLBORN D, 2002, BLACK MINORITY ETHNI, P1
   GORDON G, 2007, BI CULTURAL COMPETEN
   MARLEY D, 2009, TIMES ED SUPPLE 1106, P7
   Maylor U., 2003, MINORITY ETHNIC TEAC
   *SEL COMM RAC REL, 1973, ED, V3
   2001, CENSUS 2001
NR 15
TC 1
Z9 1
U1 2
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0021-9347
EI 1552-4566
J9 J BLACK STUD
JI J. Black Stud.
PD APR
PY 2011
VL 42
IS 3
BP 427
EP 435
DI 10.1177/0021934710376937
PG 9
WC Ethnic Studies; Social Sciences, Interdisciplinary
SC Ethnic Studies; Social Sciences - Other Topics
GA 749JC
UT WOS:000289460100008
DA 2018-12-27
ER

PT J
AU Bodiga, S
   Wang, W
   Oudit, GY
AF Bodiga, Sreedhar
   Wang, Wang
   Oudit, Gavin Y.
TI RETRACTED: Use of ginseng to reduce post-myocardial adverse myocardial
   remodeling: applying scientific principles to the use of herbal
   therapies (Retracted article. See vol. 91, pg. 647, 2013)
SO JOURNAL OF MOLECULAR MEDICINE-JMM
LA English
DT Editorial Material; Retracted Publication
ID HEART-FAILURE; INFARCTION
C1 [Bodiga, Sreedhar; Oudit, Gavin Y.] Univ Alberta, Dept Med, Div Cardiol, Mazankowski Alberta Heart Inst, Edmonton, AB T6G 2S2, Canada.
   [Wang, Wang; Oudit, Gavin Y.] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2S2, Canada.
RP Bodiga, S (reprint author), Univ Alberta, Dept Med, Div Cardiol, Mazankowski Alberta Heart Inst, Edmonton, AB T6G 2S2, Canada.
EM gavin.oudit@ualberta.ca
OI Bodiga, Sreedhar/0000-0001-5692-7700
FU Canadian Institutes of Health Research
CR AWAD AE, 2009, AM J PHYSIOL-CELL PH, V298, pC679
   De Smet PAGM, 2002, NEW ENGL J MED, V347, P2046, DOI 10.1056/NEJMra020398
   Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918
   Jugdutt BI, 2010, CIRCULATION, V122, P103, DOI 10.1161/CIRCULATIONAHA.110.969410
   Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189
   Kassiri Z, 2005, THROMB HAEMOSTASIS, V93, P212, DOI 10.1160/TH04-08-0522
   Leung KW, 2006, J BIOL CHEM, V281, P36280, DOI 10.1074/jbc.M606698200
   Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014
   PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161
   Pouleur AC, 2010, CIRCULATION, V122, P597, DOI 10.1161/CIRCULATIONAHA.110.940619
   Sun H, 2004, CARDIOVASC RES, V62, P509, DOI 10.1016/j.cardiores.2004.01.029
   Wang M, 2005, PHYTOTHER RES, V19, P173, DOI 10.1002/ptr.1624
   YIN H, 2011, J MOL MED IN PRESS
NR 13
TC 6
Z9 6
U1 2
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0946-2716
J9 J MOL MED
JI J. Mol. Med.
PD APR
PY 2011
VL 89
IS 4
BP 317
EP 320
DI 10.1007/s00109-011-0736-4
PG 4
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA 752KD
UT WOS:000289689200001
PM 21340500
OA Bronze
DA 2018-12-27
ER

PT J
AU Yin, HQ
   Liu, ZQ
   Li, FH
   Ni, M
   Wang, B
   Qiao, Y
   Xu, XS
   Zhang, M
   Zhang, JD
   Lu, HX
   Zhang, Y
AF Yin, Huiqiu
   Liu, Zhaoqiang
   Li, Fuhai
   Ni, Mei
   Wang, Bo
   Qiao, Yun
   Xu, Xinsheng
   Zhang, Mei
   Zhang, Jidong
   Lu, Huixia
   Zhang, Yun
TI RETRACTED: Ginsenoside-Rg1 enhances angiogenesis and ameliorates
   ventricular remodeling in a rat model of myocardial infarction
   (Retracted article. See vol. 91, pg. 645, 2013)
SO JOURNAL OF MOLECULAR MEDICINE-JMM
LA English
DT Article; Retracted Publication
DE Rg1; Angiogenesis; Myocardial fibrosis; p38 mitogen-activated protein
   kinase; Phosphatidylinositol 3-kinase
ID NECROSIS-FACTOR-ALPHA; P38 MAP KINASE; EXTRACELLULAR-MATRIX;
   ENDOTHELIAL-CELLS; GLUCOCORTICOID-RECEPTOR; MECHANISMS; GINSENG;
   PATHWAY; HEART; INHIBITION
AB Ginsenoside-Rg1 (Rg1) has been used in the traditional Chinese medicine for over 2,000 years. The present study was performed to test our hypothesis that Rg1 provides pro-angiogenic and anti-fibrotic benefits in the ischemic myocardium in a rat model of myocardial infarction. The expression of vascular endothelial growth factor (VEGF) and phosphorylation/activation of PI3K, Akt, and p38 MAPK signaling pathways were examined in human umbilical vein endothelial cells and in the myocardial samples of rats. In addition, the expression levels of TNF-alpha and collagen I level, the number of newly formed blood vessels, the extent of myocardial fibrosis, and left ventricular function were measured in vivo. Our results demonstrated that administration of Rg1 increased VEGF expression levels, activated PI3K/Akt, and inhibited p38 MAPK in vitro and in vivo. Furthermore, Rg1 increased the density of newly formed vessels, decreased TNF-a and collagen I expression levels and area of myocardial fibrosis, and improved left ventricle function in vivo. PI3K inhibitor LY294002 significantly attenuated Rg1-enhanced VEGF expression and capillary density. As well, inhibition of p38 MAPK slightly increased VEGF expression in vitro and in vivo, increased capillary density, and decreased TNF-a and collagen I expression levels and area of myocardial fibrosis in vivo. Rg1-induced activation of PI3K/Akt also contributed to the downregulation of p38 MAPK. Thus, Rg1 is effective in promoting angiogenesis and attenuating myocardial fibrosis, resulting in ameliorated left ventricular function. The possible mechanisms may involve activation of PI3K/Akt, inhibition of p38 MAPK, and cross talk between the two signaling pathways.
C1 [Yin, Huiqiu; Li, Fuhai; Ni, Mei; Xu, Xinsheng; Zhang, Mei; Lu, Huixia; Zhang, Yun] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China.
   [Yin, Huiqiu; Li, Fuhai; Ni, Mei; Xu, Xinsheng; Zhang, Mei; Lu, Huixia; Zhang, Yun] Shandong Univ, Chinese Minist Hlth, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.
   [Yin, Huiqiu; Wang, Bo; Qiao, Yun; Zhang, Jidong] Shandong Univ, Dept Tradit Chinese Med, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.
   [Liu, Zhaoqiang] Shandong Univ, Dept Ophthalmol, Prov Hosp, Jinan 250100, Shandong, Peoples R China.
   [Li, Fuhai] Shandong Univ, Dept Pediat, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.
   [Xu, Xinsheng] Dongying Peoples Hosp, Dept Cardiol, Dongying, Shandong, Peoples R China.
RP Yin, HQ (reprint author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250100, Shandong, Peoples R China.
EM drjidongzhang@yahoo.com.cn; huixialv@gmail.com; zhangyun@sdu.edu.cn
FU National 973 Basic Research Program of China [2010CB732605]; National
   High-tech Research and Development Program of China [2006AA02A406];
   National Natural Science Foundation of China for Innovative Research
   Group [81021001]; National Natural Science of China [60831003]; National
   Natural Science Foundation of China [30700301, 30971096, 30972809];
   Fujian Medical University [09ZD019]; Foundation for Excellent Young
   Scientists of Shandong Province [BS2009SW026, 2008BS03017]; Natural
   Science Foundation of Shandong Province [ZR2010HQ012, ZR2009CZ003,
   Q2006C12]
FX This work was supported by the National 973 Basic Research Program of
   China (no. 2010CB732605). the National High-tech Research and
   Development Program of China (no. 2006AA02A406), the State Program of
   National Natural Science Foundation of China for Innovative Research
   Group (81021001), the State Key Program of National Natural Science of
   China (no. 60831003), the National Natural Science Foundation of China
   (nos. 30700301, 30971096, and 30972809), the Major Project of Fujian
   Medical University (09ZD019), the Foundation for Excellent Young
   Scientists of Shandong Province (BS2009SW026, 2008BS03017), and the
   Natural Science Foundation of Shandong Province (ZR2010HQ012,
   ZR2009CZ003, and Q2006C12).
CR Attele AS, 2002, DIABETES, V51, P1851, DOI 10.2337/diabetes.51.6.1851
   Blazquez C, 2004, CANCER RES, V64, P5617, DOI 10.1158/0008-5472.CAN-03-3927
   Bondeson J, 1997, GEN PHARMACOL-VASC S, V29, P127, DOI 10.1016/S0306-3623(96)00419-3
   Bozkurt B, 1998, CIRCULATION, V97, P1382, DOI 10.1161/01.CIR.97.14.1382
   Chan LS, 2009, EUR J PHARM SCI, V38, P370, DOI 10.1016/j.ejps.2009.08.008
   Chang Yuan S, 2003, Integr Cancer Ther, V2, P13, DOI 10.1177/1534735403251167
   Cheung LWT, 2011, CARDIOVASC RES, V89, P419, DOI 10.1093/cvr/cvq300
   Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103
   Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200
   Heeneman S, 2003, J PATHOL, V200, P516, DOI 10.1002/path.1395
   Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5
   Issbrucker K, 2003, FASEB J, V17, pA1242
   Jia L, 2009, CURR MED CHEM, V16, P2475, DOI 10.2174/092986709788682146
   Kanda S, 2007, CELL SIGNAL, V19, P472, DOI 10.1016/j.cellsig.2006.07.014
   Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703
   Leung KW, 2006, J BIOL CHEM, V281, P36280, DOI 10.1074/jbc.M606698200
   Li MX, 2005, CIRCULATION, V111, P2494, DOI 10.1161/01.CIR.0000165117.71483.0C
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104
   Lu MC, 2009, CELL BIOCHEM FUNCT, V27, P186, DOI 10.1002/cbf.1554
   Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1037/nrd.1132
   Monden Y, 2007, AM J PHYSIOL-HEART C, V293, pH743, DOI 10.1152/ajpheart.00166.2007
   Mottet D, 2003, J CELL PHYSIOL, V194, P30, DOI 10.1002/jcp.10176
   Ravingerova T, 2007, MOL CELL BIOCHEM, V297, P111, DOI 10.1007/s11010-006-9335-z
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x
   Sengupta S, 2004, CIRCULATION, V110, P1219, DOI 10.1161/01.CIR.0000140676.88412.CF
   Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154
   Swynghedauw B, 1999, PHYSIOL REV, V79, P215
   Urabe A, 2006, HYPERTENS RES, V29, P627, DOI 10.1291/hypres.29.627
   Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331
   Wei HJ, 2007, J CONTROL RELEASE, V120, P27, DOI 10.1016/j.jconrel.2007.04.005
   Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021
   Yamaguchi Y, 1997, EUR J PHARMACOL, V329, P37, DOI 10.1016/S0014-2999(97)10115-7
   Yin HQ, 2008, INFLAMMATION, V31, P65, DOI 10.1007/s10753-007-9050-2
NR 35
TC 24
Z9 32
U1 2
U2 27
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0946-2716
EI 1432-1440
J9 J MOL MED
JI J. Mol. Med.
PD APR
PY 2011
VL 89
IS 4
BP 363
EP 375
DI 10.1007/s00109-011-0723-9
PG 13
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA 752KD
UT WOS:000289689200005
PM 21327539
DA 2018-12-27
ER

PT J
AU Goel, GA
   Kandiel, A
   Achkar, JP
   Lashner, B
AF Goel, Gati A.
   Kandiel, Ahmed
   Achkar, Jean Paul
   Lashner, Bret
TI RETRACTED: Molecular Pathways Underlying IBD-Associated Colorectal
   Neoplasia: Therapeutic Implications (Retracted article. See vol. 109,
   pg. 455, 2014)
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Review; Retracted Publication
ID INFLAMMATORY-BOWEL-DISEASE; COLON-CANCER CELLS; DEXTRAN SULFATE SODIUM;
   COLITIS-ASSOCIATED NEOPLASIA; CHRONIC ULCERATIVE-COLITIS;
   NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; FACTOR RECEPTOR P55; MICROSATELLITE
   INSTABILITY; URSODEOXYCHOLIC ACID
AB Chronic inflammatory diseases, depending upon the duration and severity, are frequently associated with an increased risk of developing cancer. A classic paradigm is the enhanced risk of colorectal cancer (CRC) in patients with inflammatory bowel disease (IBD). Carcinogenesis is a multifactorial process that involves accumulation of genetic defects, protein modification, and cell-matrix interaction. In this review, we discuss aspects of chronic inflammation in IBD that influence the development of CRC and highlight the key molecular mediators involved in this process. Also, we identify potential targets that could facilitate earlier detection of dysplasia. The targeted manipulation of specific molecules or pathways could provide opportunities for the development of therapeutic and chemopreventive interventions, which may prove effective in arresting the progression of colitis-associated cancer (CAC), with clinical implications.
C1 [Goel, Gati A.] Cleveland Clin, Dept Internal Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.
   [Kandiel, Ahmed; Achkar, Jean Paul; Lashner, Bret] Cleveland Clin, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA.
RP Goel, GA (reprint author), Cleveland Clin, Dept Internal Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.
EM drgati@gmail.com
CR ALEXANDER RJ, 1995, DIGEST DIS SCI, V40, P485, DOI 10.1007/BF02064355
   Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303
   Assi K, 2008, GUT, V57, P931, DOI 10.1136/gut.2007.142778
   Balish E, 2002, AM J PATHOL, V160, P2253, DOI 10.1016/S0002-9440(10)61172-8
   Beatty PL, 2007, J IMMUNOL, V179, P735, DOI 10.4049/jimmunol.179.2.735
   Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020
   Bernstein CN, 2002, INFLAMM BOWEL DIS, V8, P356, DOI 10.1097/00054725-200209000-00007
   Boolbol SK, 1996, CANCER RES, V56, P2556
   Brackmann S, 2009, INFLAMM BOWEL DIS, V15, P9, DOI 10.1002/ibd.20542
   Brown JB, 2010, GASTROENTEROLOGY, V138, P595, DOI 10.1053/j.gastro.2009.10.038
   Canavan C, 2006, ALIMENT PHARM THERAP, V23, P1097, DOI 10.1111/j.1365-2036.2006.02854.x
   CARTWRIGHT CA, 1994, J CLIN INVEST, V93, P509, DOI 10.1172/JCI117000
   Chapkin RS, 2009, J NUTR BIOCHEM, V20, P649, DOI 10.1016/j.jnutbio.2008.07.001
   Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061
   Choo MK, 2008, ONCOL REP, V19, P595
   Chu EC, 2007, ALIMENT PHARM THER, V25, P1443, DOI 10.1111/j.1365-2036.2007.03336.x
   Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272
   D'Argenio G, 2006, FASEB J, V20, P568, DOI 10.1096/fj.05-4943fje
   Das KK, 2009, MOL PHARMACOL, V76, P183, DOI 10.1124/mol.109.056028
   Dhir M, 2008, J GASTROINTEST SURG, V12, P1745, DOI 10.1007/s11605-008-0633-5
   Eaden J, 2004, ALIMENT PHARM THERAP, V20, P24, DOI 10.1111/j.1365-2036.2004.02046.x
   Eaden J, 2000, ALIMENT PHARM THERAP, V14, P145
   EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1
   EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802
   Engle SJ, 2002, CANCER RES, V62, P6362
   Fichera A, 2007, J SURG RES, V142, P239, DOI 10.1016/j.jss.2007.02.038
   Fujiwara I, 2008, DIS COLON RECTUM, V51, P1387, DOI 10.1007/s10350-008-9212-9
   Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008
   Garg P, 2010, CANCER RES, V70, P792, DOI 10.1158/0008-5472.CAN-09-3166
   Garg P, 2009, AM J PHYSIOL-GASTR L, V296, pG175, DOI 10.1152/ajpgi.90454.2008
   Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013
   Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001
   Hachimine D, 2008, INT J ONCOL, V32, P1221
   Hahm KB, 2001, GUT, V49, P190, DOI 10.1136/gut.49.2.190
   Hanai H, 2009, CURR PHARM DESIGN, V15, P2087, DOI 10.2174/138161209788489177
   Hernandez Y, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-82
   Hu Y, 2005, INT J CANCER, V116, P870, DOI 10.1002/ijc.21107
   Inoue T., 2008, Inflammopharmacology, V16, P36, DOI 10.1007/s10787-007-1543-3
   Issa JPJ, 2001, CANCER RES, V61, P3573
   Itzkowitz SH, 2006, GASTROENTEROL CLIN N, V35, P553, DOI 10.1016/j.gtc.2006.07.002
   Jia Q, 2008, CANCER RES, V68, P3985, DOI 10.1158/0008-5472.CAN-07-6251
   Kado S, 2001, CANCER RES, V61, P2395
   Kanagarajan N, 2008, INFLAMM RES, V57, P34, DOI 10.1007/s00011-007-6177-4
   Kawabata K, 2006, BIOSCI BIOTECH BIOCH, V70, P3062, DOI 10.1271/bbb.60393
   KEWENTER J, 1978, ANN SURG, V188, P824, DOI 10.1097/00000658-197812000-00018
   Kitakata H, 2002, CANCER RES, V62, P6682
   Koelink PJ, 2009, CARCINOGENESIS, V30, P1217, DOI 10.1093/carcin/bgp113
   Kohno H, 2007, CLIN CANCER RES, V13, P2519, DOI 10.1158/1078-0432.CCR-06-2727
   Kukitsu T, 2008, CLIN CANCER RES, V14, P48, DOI 10.1158/1078-0432.CCR-07-1835
   LANGHOLZ E, 1992, GASTROENTEROLOGY, V103, P1444, DOI 10.1016/0016-5085(92)91163-X
   Lashner BA, 1997, GASTROENTEROLOGY, V112, P29, DOI 10.1016/S0016-5085(97)70215-4
   Lee JY, 2007, INT IMMUNOPHARMACOL, V7, P241, DOI 10.1016/j.intimp.2006.10.013
   Leedham SJ, 2009, GASTROENTEROLOGY, V136, P542, DOI 10.1053/j.gastro.2008.10.086
   Li QT, 2005, TRENDS IMMUNOL, V26, P318, DOI 10.1016/j.it.2005.04.003
   Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017
   Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176
   Li YH, 2009, CANCER SCI, V100, P2451, DOI 10.1111/j.1349-7006.2009.01335.x
   Liao J, 2008, MOL CARCINOGEN, V47, P638, DOI 10.1002/mc.20427
   Liao J, 2007, CARCINOGENESIS, V28, P446, DOI 10.1093/carcin/bgl154
   Liu RK, 2006, AM J PATHOL, V168, P757, DOI 10.2353/ajpath.2006.050907
   Liu ZG, 2005, CELL RES, V15, P24, DOI 10.1038/sj.cr.7290259
   Lutgens MWMD, 2008, GUT, V57, P1246, DOI 10.1136/gut.2007.143453
   Manfredi MA, 2008, INFLAMM BOWEL DIS, V14, P1091, DOI 10.1002/ibd.20419
   Matsumoto S, 2009, IMMUNOLOGY, V128, pe170, DOI 10.1111/j.1365-2567.2008.02942.x
   Mladenova D, 2011, GUT, V60, P350, DOI 10.1136/gut.2010.208314
   Mukawa K, 2008, ONCOL REP, V19, P393
   MUNKHOLM P, 2003, ALIMENT PHARMACOL S2, V18
   Nowak J, 2007, CARCINOGENESIS, V28, P1991, DOI 10.1093/carcin/bgm166
   Pangburn Heather A, 2005, J Carcinog, V4, P16, DOI 10.1186/1477-3163-4-16
   Pardi DS, 2003, GASTROENTEROLOGY, V124, P889, DOI 10.1053/gast.2003.50156
   Park J, 2010, WORLD J GASTRO ONCOL, V2, P169, DOI 10.4251/wjgo.v2.i4.169
   Pele LC, 2007, J NUTR, V137, P2475
   Phelip JM, 2008, INFLAMM BOWEL DIS, V14, P242, DOI 10.1002/ibd.20309
   Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]
   Popivanova BK, 2009, CANCER RES, V69, P7884, DOI 10.1158/0008-5472.CAN-09-1451
   PRIOR P, 1982, GUT, V23, P490, DOI 10.1136/gut.23.6.490
   Rath T, 2006, INFLAMM BOWEL DIS, V12, P1025, DOI 10.1097/01.mib.0000234133.97594.04
   Reddy S, 2006, NUTR CANCER, V55, P185, DOI 10.1207/s15327914nc5502_10
   Rutter MD, 2006, GASTROENTEROLOGY, V130, P1030, DOI 10.1053/j.gastro.2005.12.035
   Shah SA, 2005, EUR J CANCER, V41, P2160, DOI 10.1016/j.ejca.2005.06.015
   Shattuck-Brandt RL, 2000, GASTROENTEROLOGY, V118, P337, DOI 10.1016/S0016-5085(00)70216-2
   Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9
   Souza R F, 1996, Hum Cell, V9, P229
   Sturlan S, 2001, CARCINOGENESIS, V22, P665, DOI 10.1093/carcin/22.4.665
   Sun BC, 2005, WORLD J GASTROENTERO, V11, P2822, DOI 10.3748/wjg.v11.i18.2822
   Tahara T, 2005, J GASTROEN HEPATOL, V20, P710, DOI 10.1111/j.1400-1746.2005.03803.x
   Takeda J, 2004, ONCOL REP, V11, P981
   Taketo MM, 1998, INFLAMM RES, V47, pS112
   Taylor MT, 2000, CANCER RES, V60, P6607
   Tomita Y, 2004, INT J CANCER, V112, P927, DOI 10.1002/ijc.20493
   Ullman T, 2008, CLIN GASTROENTEROL H, V6, P1225, DOI 10.1016/j.cgh.2008.05.020
   Umetani N, 1999, JPN J CANCER RES, V90, P1081, DOI 10.1111/j.1349-7006.1999.tb00681.x
   Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026
   Vallbohmer Daniel, 2005, Clin Colorectal Cancer, V5 Suppl 1, pS19, DOI 10.3816/CCC.2005.s.003
   Velayos FS, 2005, AM J GASTROENTEROL, V100, P1345, DOI 10.1111/j.1572-0241.2005.41442.x
   Viret F, 2009, M S-MED SCI, V25, P13, DOI 10.1051/medsci/2009251s13
   VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901
   Wada K, 2009, ONCOL REP, V22, P1021, DOI 10.3892/or_00000530
   Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505
   Winther KV, 2004, CLIN GASTROENTEROL H, V2, P1088, DOI 10.1053/S1542-3565(04)00543-9
   Xiao D, 2006, MOL CANCER THER, V5, P60, DOI 10.1158/1535-7163.MCT-05-0260
   Yan B, 2006, CANCER RES, V66, P11565, DOI 10.1158/0008-5472.CAN-06-2540
   YARBRO CH, 2004, ONS NEWS, V19, P53
   Yoshizawa S, 2007, INFLAMM BOWEL DIS, V13, P865, DOI 10.1002/ibd.20112
   Zampino MG, 2007, CANCER, V110, P752, DOI 10.1002/cncr.22851
   Zhang M, 2006, INT IMMUNOPHARMACOL, V6, P1233, DOI 10.1016/j.intimp.2006.02.013
   Zhang R, 2007, CARCINOGENESIS, V28, P1122, DOI 10.1093/carcin/bgl224
NR 107
TC 29
Z9 30
U1 2
U2 8
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD APR
PY 2011
VL 106
IS 4
BP 719
EP 730
DI 10.1038/ajg.2014.3
PG 12
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 746GZ
UT WOS:000289232900015
PM 21386829
OA Bronze
DA 2018-12-27
ER

PT J
AU Pop, F
AF Pop, F.
TI RETRACTED: Chemical Stabilization of Oils Rich in Long-Chain
   Polyunsaturated Fatty Acids During Storage (Retracted article. See vol.
   18, pg. 299, 2012)
SO FOOD SCIENCE AND TECHNOLOGY INTERNATIONAL
LA English
DT Article; Retracted Publication
DE autoxidation; fish oil; antioxidants; encapsulation; storage
ID ENRICHED MILK EMULSIONS; IN-WATER EMULSIONS; PURIFIED FISH-OIL;
   OXIDATIVE STABILITY; ANTIOXIDANT ACTIVITY; ALPHA-TOCOPHEROL; LIPID
   OXIDATION; CARNOSIC ACID; FOOD INGREDIENTS; RAPESEED OIL
AB During the microencapsulation process, the fish oil undergoes multiple changes in its physical properties such as bulkiness and dispersibility in aqueous phase and dry matrix. Autoxidation already occurred in the first stages of the microencapsulation process itself during emulsification and spray-drying. An efficient stabilization was achieved using a ternary combination of lipophilic antioxidants, synergistic compounds and a trace metal chelator, e.g. a combination of tocopherols, rich in the delta-derivative and low in the alpha-derivative, with ascorbyl palmitate and lecithin. Trace metal chelation by, e.g. Citrem or lecithin in combination with ascorbyl palmitate proved to be of particular importance in the emulsion, but not during the storage of the microencapsulated oil. In the microencapsulated oil, the addition of rosemary extract rich in carnosic acid to ternary blends of tocopherols, ascorbyl palmitate and lecithin or Citrem significantly retarded autoxidation.
C1 North Univ, Dept Biol Chem, Baia Mare 430122, Romania.
RP Pop, F (reprint author), North Univ, Dept Biol Chem, 76 Victoriei Str, Baia Mare 430122, Romania.
EM flavia_maries@yahoo.com
CR Ahn JH, 2008, J FOOD ENG, V84, P327, DOI 10.1016/j.jfoodeng.2007.05.029
   Andersen AB, 2000, FOOD CHEM, V70, P499, DOI 10.1016/S0308-8146(00)00102-3
   Chaiyasit W, 2005, J AGR FOOD CHEM, V53, P4982, DOI 10.1021/jf0501239
   Chaiyasit W, 2007, CRIT REV FOOD SCI, V47, P299, DOI 10.1080/10408390600754248
   Desai KGH, 2005, DRY TECHNOL, V23, P1361, DOI 10.1081/DRT-200063478
   Drusch S, 2008, EUR J LIPID SCI TECH, V110, P351, DOI 10.1002/ejlt.200700195
   Drusch S, 2007, J AGR FOOD CHEM, V55, P11044, DOI 10.1021/jf072536a
   Faraji H, 2004, J AGR FOOD CHEM, V52, P7164, DOI 10.1021/jf035291k
   Frankel E, 1959, FETT SEIFEN ANSTR, V61, P1036
   Frankel EN, 1996, J SCI FOOD AGR, V72, P201, DOI 10.1002/(SICI)1097-0010(199610)72:2<201::AID-JSFA632>3.0.CO;2-Q
   Hamilton RJ, 1998, J AM OIL CHEM SOC, V75, P813, DOI 10.1007/s11746-998-0231-4
   HEIMANN W, 1957, FETT SEIFEN ANSTR, V59, P330
   Hopia AI, 1996, J AGR FOOD CHEM, V44, P2030, DOI 10.1021/jf950777p
   Horiuchi M, 1998, J AGR FOOD CHEM, V46, P5232, DOI 10.1021/jf980482m
   Hu M, 2004, FOOD CHEM, V88, P57, DOI 10.1016/j.foodchem.2004.01.022
   *INT DAIR FED, 1991, ANH MILK FAT DET PER
   Jacobsen C, 2008, TRENDS FOOD SCI TECH, V19, P76, DOI 10.1016/j.tifs.2007.08.001
   KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884
   Kulas E, 2001, J AM OIL CHEM SOC, V78, P361, DOI 10.1007/s11746-001-0269-0
   Kulas E, 2001, J AM OIL CHEM SOC, V78, P197, DOI 10.1007/s11746-001-0243-x
   Kulas E, 2001, J AGR FOOD CHEM, V49, P1724, DOI 10.1021/jf0011541
   Lampi AM, 1998, J AM OIL CHEM SOC, V75, P1699, DOI 10.1007/s11746-998-0319-x
   Let MB, 2005, J AGR FOOD CHEM, V53, P5429, DOI 10.1021/jf047960f
   Let MB, 2007, J AGR FOOD CHEM, V55, P1773, DOI 10.1021/jf062391s
   Makinen EM, 2000, LIPIDS, V35, P1215, DOI 10.1007/s11745-000-0638-3
   Masuda T, 2002, J AGR FOOD CHEM, V50, P5863, DOI 10.1021/jf025605o
   Orlien V, 2000, FOOD CHEM, V68, P191, DOI 10.1016/S0308-8146(99)00177-6
   RICHHEIMER SL, 1999, RECENT RES DEV OIL C, V3, P45
   Satue-Gracia MT, 2000, J AGR FOOD CHEM, V48, P4984, DOI 10.1021/jf0002490
   SHAHIDI F, 1993, CRIT REV FOOD SCI, V33, P501, DOI 10.1080/10408399309527645
   Shahidi F, 1998, DEV FOOD SCI, V40, P55
   Shaw LA, 2007, J AGR FOOD CHEM, V55, P3112, DOI 10.1021/jf063068s
   Ubbink J, 2006, TRENDS FOOD SCI TECH, V17, P244, DOI 10.1016/j.tifs.2006.01.007
   Velasco J, 2000, GRASAS ACEITES, V51, P261
   WESTERGAARD V, 2004, MILK POWDER TECHNOLO, P235
NR 35
TC 8
Z9 8
U1 5
U2 36
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1082-0132
EI 1532-1738
J9 FOOD SCI TECHNOL INT
JI Food Sci. Technol. Int.
PD APR
PY 2011
VL 17
IS 2
BP 111
EP 117
DI 10.1177/1082013210368738
PG 7
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA 749OF
UT WOS:000289477200004
PM 21447601
DA 2018-12-27
ER

PT J
AU Lammers, J
   Stapel, DA
AF Lammers, Joris
   Stapel, Diederik A.
TI RETRACTED: Racist biases in legal decisions are reduced by a justice
   focus (Retracted article. See vol. 42, pg. 666, 2012)
SO EUROPEAN JOURNAL OF SOCIAL PSYCHOLOGY
LA English
DT Article; Retracted Publication
ID WHITE JUROR BIAS; IMPRESSION-FORMATION; SOCIAL COGNITION; INDIVIDUATING
   PROCESSES; STEREOTYPE ACTIVATION; POLICE OFFICERS; IMPLICIT BIAS;
   PREJUDICE; RACE; ATTITUDES
AB Six studies investigate whether the effect of racist biases on judges' legal decisions on minority defendants is reduced by a "justice focus." Given that people associate legal decision-making with the need to do so in a colorblind manner, a justice focus blocks the effect of racist biases on legal decisions. Experiment 1 shows that explicit instructions to adopt a justice goal decrease biases. Experiment 2 shows that a primed justice focus also decreases biases. Experiments 3a and 3b show the role of pre-existing legal expertise, which makes people more susceptible a justice goal. Experiments 4a and 4b apply these findings by studying the role of a justice focus among professional courtroom judges. Together, these results demonstrate the importance of a justice focus in preventing racist biases in legal decision-making. Importantly, a justice focus is a necessary but no sufficient condition for the colorblind administration of justice. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Lammers, Joris] Tilburg Univ, TIBER, NL-5000 LE Tilburg, Netherlands.
RP Lammers, J (reprint author), Tilburg Univ, TIBER, Warandelaan 2, NL-5000 LE Tilburg, Netherlands.
EM j.lammers@uvt.nl
CR Aarts H, 2000, J PERS SOC PSYCHOL, V78, P53, DOI 10.1037//0022-3514.78.1.53
   ADAMS G, 2007, COMMEMORATING BROWN
   Austin RL, 2000, J RES CRIME DELINQ, V37, P200, DOI 10.1177/0022427800037002003
   Baldus D. C., 2002, NEBRASKA LAW REV, V81, P486
   Baldus David C., 1990, EQUAL JUSTICE DEATH
   BALDUS DC, 1983, J CRIM LAW CRIM, V74, P661, DOI 10.2307/1143133
   BANAJI MR, 1995, J PERS SOC PSYCHOL, V68, P181, DOI 10.1037//0022-3514.68.2.181
   Bargh J. A., 1994, HDB SOCIAL COGNITION, V2, P1
   Bargh J. A., 1990, HDB MOTIVATION COGNI, V2, P93
   Bargh J. A., 1996, PSYCHOL ACTION LINKI, P457
   Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066X.54.7.462
   Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014
   BARGH JA, 1994, INTEGRATIVE VIEWS MO, P71
   BRUNER JS, 1957, PSYCHOL REV, V64, P123, DOI 10.1037/h0043805
   Cohn ES, 2009, J APPL SOC PSYCHOL, V39, P1953, DOI 10.1111/j.1559-1816.2009.00511.x
   Correll J, 2002, J PERS SOC PSYCHOL, V83, P1314, DOI 10.1037//0022-3514.83.6.1314
   Correll J, 2007, J PERS SOC PSYCHOL, V92, P1006, DOI 10.1037/0022-3514.92.6.1006
   DEMUNIZ PJ, 1999, IMMIGRANTS COURTS, P158
   Devine PG, 2002, J PERS SOC PSYCHOL, V82, P835, DOI 10.1037//0022-3514.82.5.835
   DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.5.680
   Dovidio J.F., 1998, CONFRONTING RACISM P, P3
   Dovidio JF, 2005, ON THE NATURE OF PREJUDICE: FIFTY YEARS AFTER ALLPORT, P1, DOI 10.1002/9780470773963
   DWORKIN RONALD, 1977, TAKING RIGHTS SERIOU, pxi
   FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013
   FISKE ST, 1990, ADV EXP SOC PSYCHOL, V23, P1, DOI 10.1016/S0065-2601(08)60317-2
   Gaertner S. L., 1986, PREJUDICE DISCRIMINA, P61
   GILBERT DT, 1991, J PERS SOC PSYCHOL, V60, P509, DOI 10.1037/0022-3514.60.4.509
   Gordijn EH, 2001, J EXP SOC PSYCHOL, V37, P150, DOI 10.1006/jesp.2000.1443
   Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5
   Greenwald AG, 2003, J EXP SOC PSYCHOL, V39, P399, DOI 10.1016/S0022-1031(03)00020-9
   GREENWALD AG, 1992, AM PSYCHOL, V47, P766, DOI 10.1037/0003-066X.47.6.766
   Greenwald AG, 2006, CALIF LAW REV, V94, P945, DOI 10.2307/20439056
   GROSS S, 1989, DEATH DISCRIMINATION
   HIGGINS ET, 1987, ANNU REV PSYCHOL, V38, P369, DOI 10.1146/annurev.ps.38.020187.002101
   Holland RW, 2005, PSYCHOL SCI, V16, P689, DOI 10.1111/j.1467-9280.2005.01597.x
   Kang J, 2005, HARVARD LAW REV, V118, P1489
   Kunda Z, 2003, PSYCHOL BULL, V129, P522, DOI 10.1037/0033-2909.129.4.522
   Lane KA, 2007, ANNU REV LAW SOC SCI, V3, P427, DOI 10.1146/annurev.lawsocsci.3.081806.112748
   LEYENS JP, 1994, STEREOTYPES SOCIAL C
   Locke J, 1967, 2 TREATISES GOVT
   Lowery BS, 2001, J PERS SOC PSYCHOL, V81, P842, DOI 10.1037//0022-3514.81.5.842
   MacRae C. N., 1996, STEREOTYPES STEREOTY
   Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93
   Mitchell T, 2005, LAW HUMAN BEHAV, V29, P621, DOI 10.1007/s10979-005-8122-9
   Monteith M J, 1998, Pers Soc Psychol Rev, V2, P63, DOI 10.1207/s15327957pspr0201_4
   MONTEITH MJ, 1993, J PERS SOC PSYCHOL, V65, P469, DOI 10.1037/0022-3514.65.3.469
   Moskowitz GB, 1999, J PERS SOC PSYCHOL, V77, P167, DOI 10.1037/0022-3514.77.1.167
   Moskowitz GB, 2000, SOC COGNITION, V18, P151, DOI 10.1521/soco.2000.18.2.151
   MOSKOWITZ GB, 2004, ADV EXPT SOCIAL PSYC, V3, P317
   Mustard DB, 2001, J LAW ECON, V44, P285, DOI 10.1086/320276
   NEUBERG SL, 1987, J PERS SOC PSYCHOL, V53, P431, DOI 10.1037/0022-3514.53.3.431
   Nolan MA, 1999, EUR J SOC PSYCHOL, V29, P641, DOI 10.1002/(SICI)1099-0992(199908/09)29:5/6<641::AID-EJSP953>3.0.CO;2-8
   Oakes P., 1994, STEREOTYPING SOCIAL
   OTTEN S, 2006, EUROPEAN J SOCIAL PS, V37, P1000
   Payne BK, 2001, J PERS SOC PSYCHOL, V81, P181, DOI 10.1037//0022-3514.81.2.181
   PFEIFER JE, 1991, J APPL SOC PSYCHOL, V21, P1713, DOI 10.1111/j.1559-1816.1991.tb00500.x
   Plant EA, 2009, J PERS SOC PSYCHOL, V96, P640, DOI 10.1037/a0012960
   Pufendorf Samuel, 1991, DUTY MAN CITIZEN ACC
   Rachlinski JJ, 2009, NOTRE DAME LAW REV, V84, P1195
   Richeson JA, 2003, J EXP SOC PSYCHOL, V39, P177, DOI 10.1016/S0022-1031(02)00521-8
   Rousseau Jean-Jacques, 1997, SOCIAL CONTRACT OTHE
   SINCLAIR L, 1999, J PERS SOC PSYCHOL, V77, P805
   Sinclair S, 2005, J PERS SOC PSYCHOL, V89, P583, DOI 10.1037/0022-3514.89.4.583
   Sommers SR, 2007, LAW HUMAN BEHAV, V31, P261, DOI 10.1007/s10979-006-9048-6
   Sommers SR, 2006, J PERS SOC PSYCHOL, V90, P597, DOI 10.1037/0022-3514.90.4.597
   Sommers SR, 2001, PSYCHOL PUBLIC POL L, V7, P201, DOI 10.1037/1076-8971.7.1.201
   Sommers SR, 2000, PERS SOC PSYCHOL B, V26, P1367, DOI 10.1177/0146167200263005
   Spooner Lysander, 1845, UNCONSTITUTIONALITY
   SRULL TK, 1979, J PERS SOC PSYCHOL, V37, P1660, DOI 10.1037//0022-3514.37.10.1660
   SRULL TK, 1986, MOTIVATION COGNITION, P503
   STAPEL DA, 2001, PERSONALITY SOCIAL P, V8, P915, DOI DOI 10.1177/0146167201278001
   SWEENEY LT, 1992, BEHAV SCI LAW, V10, P179, DOI 10.1002/bsl.2370100204
   Tawney R. H., 1931, EQUALITY
   TRENCHARD H, 1995, CATOS LETT ESSAYS LI
   VRIJ A, 1992, J APPL SOC PSYCHOL, V22, P1546, DOI 10.1111/j.1559-1816.1992.tb00965.x
   *W VIRG, 2008, NOT COUNS JUDG
   Wegener DT, 2006, J PERS SOC PSYCHOL, V90, P42, DOI 10.1037/0022-3514.90.1.42
   Winkel FW, 1999, INT J LAW PSYCHIAT, V22, P273, DOI 10.1016/S0160-2527(99)00009-6
   YZERBYT VY, 1994, J PERS SOC PSYCHOL, V66, P48, DOI 10.1037//0022-3514.66.1.48
   2002, HUMAN RIGHTS WA 0222
NR 80
TC 3
Z9 4
U1 1
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0046-2772
EI 1099-0992
J9 EUR J SOC PSYCHOL
JI Eur. J. Soc. Psychol.
PD APR
PY 2011
VL 41
IS 3
BP 375
EP 387
DI 10.1002/ejsp.783
PG 13
WC Psychology, Social
SC Psychology
GA 748AK
UT WOS:000289362200012
DA 2018-12-27
ER

PT J
AU Nandakumar, V
   Vaid, M
   Tollefsbol, TO
   Katiyar, SK
AF Nandakumar, Vijayalakshmi
   Vaid, Mudit
   Tollefsbol, Trygve O.
   Katiyar, Santosh K.
TI RETRACTED: Aberrant DNA hypermethylation patterns lead to
   transcriptional silencing of tumor suppressor genes in UVB-exposed skin
   and UVB-induced skin tumors of mice (Retracted article. See vol. 39, pg.
   738, 2018)
SO CARCINOGENESIS
LA English
DT Article; Retracted Publication
ID GREEN TEA POLYPHENOLS; CPG BINDING-PROTEIN; ULTRAVIOLET-RADIATION;
   MELANOMA PATIENTS; METHYLATION; CANCER; CARCINOGENESIS; EPIGENETICS;
   ACTIVATION; REPRESSION
AB Overexposure of the human skin to solar ultraviolet (UV) radiation is the major etiologic factor for development of skin cancers. Here, we report the results of epigenetic modifications in UV-exposed skin and skin tumors in a systematic manner. The skin and tumor samples were collected after chronic exposure of the skin of SKH-1 hairless mice to UVB radiation using a well-established photocarcinogenesis protocol. We found a distinct DNA hypermethylation pattern in the UVB-exposed epidermal skin and UVB-induced skin tumors that was associated with the elevated expression and activity of the DNA methyltransferases (Dnmt) 1, Dnmt3a and Dnmt3b. To explore the role of hypermethylation in skin photocarcinogenesis, we focused on the p16(INK4a) and RASSF1A tumor suppressor genes, which are transcriptionally silenced on methylation. We established that the silencing of these genes in UVB-exposed epidermis and UVB-induced skin tumors is associated with a network of epigenetic modifications, including hypoacetylation of histone H3 and H4 and increased histone deacetylation, as well as recruitment of methyl-binding proteins, including MeCP2 and MBD1, to the methylated CpGs. Higher levels of DNA methylation and DNMT activity in human squamous cell carcinoma specimens than in normal human skin suggest that the data are relevant clinically. Our data indicate for the first time that UVB-induced DNA hypermethylation, enhanced Dnmt activity and histone modifications occur in UVB-exposed skin and UVB-induced skin tumors and suggest that these events are involved in the silencing of tumor suppressor genes and in skin tumor development.
C1 [Nandakumar, Vijayalakshmi; Vaid, Mudit; Katiyar, Santosh K.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.
   [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.
   [Katiyar, Santosh K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA.
RP Katiyar, SK (reprint author), Univ Alabama Birmingham, Dept Dermatol, 1670 Univ Blvd,Volker Hall 557, Birmingham, AL 35294 USA.
EM skatiyar@uab.edu
FU National Institutes of Health [CA140832]; Veterans Administration
FX National Institutes of Health (CA140832 to S.K.K.); Veterans
   Administration Merit Review Award (S.K.K.)
CR Allen NPC, 2007, ONCOGENE, V26, P6203, DOI 10.1038/sj.onc.1210440
   Antequera F., 1993, Experientia Supplementum (Basel), V64, P169
   Arbiser JL, 2004, J INVEST DERMATOL, V123, P788, DOI 10.1111/j.0022-202X.2004.23418.x
   Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200
   Bardeesy N, 2002, MOL CELL BIOL, V22, P635, DOI 10.1128/MCB.22.2.635-643.2002
   Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X
   Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354
   Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9
   BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0
   BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3
   Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077
   COUNTS JL, 1995, CELL, V83, P13, DOI 10.1016/0092-8674(95)90228-7
   Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256
   Cui X, 2006, TOXICOL SCI, V91, P372, DOI 10.1093/toxsci/kfj159
   Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651
   El-Osta A, 2002, MOL CELL BIOL, V22, P1844, DOI 10.1128/MCB.22.6.1844-1857.2002
   Fried L, 2008, PIGM CELL MELANOMA R, V21, P117, DOI 10.1111/j.1755-148X.2008.00451.x
   Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536
   Gonzalgo ML, 1998, CANCER RES, V58, P1245
   Goodman JI, 2002, ANNU REV PHARMACOL, V42, P501, DOI 10.1146/annurev.pharmtox.42.092001.141143
   Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971
   Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075
   Hoon DSB, 2004, ONCOGENE, V23, P4014, DOI 10.1038/sj.onc.1207505
   Issa JPJ, 2001, CANCER RES, V61, P3573
   Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025
   Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947
   Jones PA, 2002, ONCOGENE, V21, P5358, DOI 10.1038/sj.onc.1205597
   Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816
   Laird PW, 1996, ANNU REV GENET, V30, P441, DOI 10.1146/annurev.genet.30.1.441
   Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298
   Mantena SK, 2005, J NUTR, V135, P2871
   Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019
   Meeran SM, 2007, CANCER RES, V67, P3785, DOI 10.1158/0008-5472.CAN-06-3134
   Meeran SM, 2009, J INVEST DERMATOL, V129, P1258, DOI 10.1038/jid.2008.354
   Melnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015
   Mittal A, 2003, NEOPLASIA, V5, P555, DOI 10.1016/S1476-5586(03)80039-8
   Mori T, 2005, J CLIN ONCOL, V23, P9351, DOI 10.1200/JCO.2005.02.9876
   Mukhtar H, 1996, PHOTOCHEM PHOTOBIOL, V63, P355, DOI 10.1111/j.1751-1097.1996.tb03040.x
   Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000
   Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6
   Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655
   Sathyanarayana UG, 2007, CANCER LETT, V245, P112, DOI 10.1016/j.canlet.2005.12.042
   Sharma SD, 2007, MOL CANCER THER, V6, P995, DOI 10.1158/1535-7163.MCT-06-0661
   Tommasi S, 2005, CANCER RES, V65, P92
   Tommasi S, 1997, CANCER RES, V57, P4727
   Wade PA, 2001, BIOESSAYS, V23, P1131, DOI 10.1002/bies.10008
   Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8
   Zingg JM, 1997, CARCINOGENESIS, V18, P869, DOI 10.1093/carcin/18.5.869
NR 48
TC 56
Z9 59
U1 0
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0143-3334
EI 1460-2180
J9 CARCINOGENESIS
JI Carcinogenesis
PD APR
PY 2011
VL 32
IS 4
BP 597
EP 604
DI 10.1093/carcin/bgq282
PG 8
WC Oncology
SC Oncology
GA 745KM
UT WOS:000289164300021
PM 21186298
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Chan, MF
AF Chan, Moon Fai
TI RETRACTED: A randomised controlled study of the effects of music on
   sleep quality in older people (Retracted article. See vol. 20, pg. 2382,
   2011)
SO JOURNAL OF CLINICAL NURSING
LA English
DT Article; Retracted Publication
DE music; nurses; nursing; older people; Pittsburgh Sleep Quality Index;
   sleep
ID DEPRESSIVE SYMPTOMS; POSTOPERATIVE PAIN; CONTROLLED-TRIAL; ANXIETY;
   SURGERY; THERAPY; POPULATION
AB Aim.
   To determine the effect of music on sleep quality in older people.
   Background.
   Sleep disturbance is common in older people and its impacts on older adults along with its conventional treatment merit our attention as our population ages. Conventional pharmacological method might result dependence and impairment in psychomotor and cognitive function. Listening to music, which is a non-pharmacological method, might promote relaxation, induce distraction responses and promote sleep quality.
   Design.
   A randomised controlled study.
   Methods.
   The study was conducted from December 2006-January 2007. Forty-two older people (21 using music and 21 controls) completed the study in Hong Kong. Physiological (blood pressure and heart rate) and sleep quality variables were collected once a week for one month.
   Results.
   For all vital signs' results, no significant differences were found between both music and control groups within the four weeks. In the music group, there was statistically significant reduction in sleep scores at week 4. In control group, there was no statistically significant improvement of sleep scores in the four weeks. However, no significant difference was found between groups over the four weeks.
   Conclusion.
   Whilst there were no statistical differences between groups, there was some indication that music yielder higher improvement on sleep scores, which are worthier of further investigation in larger trials.
   Relevance to clinical practice.
   The implication of this study is that music listening can help nurses build therapeutic relationships with older people. Nurses are recommended to use music as part of their holistic caring for older people.
C1 Natl Univ Singapore, Alice Lee Ctr Nursing Studies, Singapore 117574, Singapore.
RP Chan, MF (reprint author), Natl Univ Singapore, Alice Lee Ctr Nursing Studies, Block E3A,Level 3,7 Engn Dr 1, Singapore 117574, Singapore.
EM nurcmf@nus.edu.sg
CR Allen G, 2007, ASS OPERATING ROOM N, V86, P671
   Arslan S, 2008, AUST J ADV NURS, V26, P46
   Ayoub CM, 2005, ANESTH ANALG, V100, P1316, DOI 10.1213/01.ANE.0000153014.46893.9B
   Broscious S K, 1999, Am J Crit Care, V8, P410
   BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
   Chan MF, 2007, HEART LUNG, V36, P431, DOI 10.1016/j.hrtlng.2007.05.003
   Chan Y.K., 2004, SLEEP BEHAV ELDERLY
   Chang SC, 2005, RES NURS HEALTH, V28, P453, DOI 10.1002/nur.20102
   Department of Health and Department of Community Medicine University of Hong Kong [DH & DCMUHK], 2003, COLL PROJ POP HLTH S
   GOLDSTEIN A, 1980, PHYSIOL PSYCHOL, V8, P126
   GUZZETTA CE, 1991, MUSIC PHYS TIME COME, P146
   Hoch C, 1986, Geriatr Nurs, V7, P24
   Ikonomidou Eleni, 2004, AORN J, V80, P269, DOI 10.1016/S0001-2092(06)60564-4
   Johnson J E, 1991, Appl Nurs Res, V4, P165
   Lai HL, 2005, J ADV NURS, V49, P234, DOI 10.1111/j.1365-2648.2004.03281.x
   Lee D, 2004, J CLIN NURS, V13, P297, DOI 10.1046/j.1365-2702.2003.00888.x
   Lee OKA, 2005, J CLIN NURS, V14, P609, DOI 10.1111/j.1365-2702.2004.01103.x
   Masuda T., 2005, NORD J MUSIC THER, V14, P4
   McCaffrey R, 2008, J PSYCHOSOC NURS, V46, P39, DOI 10.3928/02793695-20081001-08
   Mitchell AJ, 2005, AM J PSYCHIAT, V162, P1588, DOI 10.1176/appi.ajp.162.9.1588
   Mok Esther, 2003, AORN J, V77, P396, DOI 10.1016/S0001-2092(06)61207-6
   Mornhinweg G C, 1995, J Holist Nurs, V13, P248, DOI 10.1177/089801019501300306
   Nilsson U, 2003, ANAESTHESIA, V58, P699, DOI 10.1046/j.1365-2044.2003.03189_4.x
   Nilsson Ulrica, 2008, AORN J, V87, P780, DOI 10.1016/j.aorn.2007.09.013
   *NQUERY ADV, 2001, STAT SOL
   ONEILL O, 2002, J ADV PERIOPERATIONA, V1, P19
   Peng S-M, 2008, J ALTERN COMPLEM MED, V15, P53, DOI DOI 10.1089/ACM.2008.0243
   Roehrs T, 1994, PRINCIPLES PRACTICE, P486
   Sendelbach SE, 2006, J CARDIOVASC NURS, V21, P194, DOI 10.1097/00005082-200605000-00007
   Smolen D, 2002, APPL NURS RES, V15, P126, DOI 10.1053/apnr.2002.34140
   Spintge R, 1996, MUSICMEDICINE MMB, V2, P3
   Thaut M., 1990, MUSIC THERAPY TREATM, P3
   Tse MMY, 2005, J PAIN PALLIAT CARE, V19, P21, DOI 10.1300/J354v19n03_05
   Twiss Elizabeth, 2006, Nurs Crit Care, V11, P224, DOI 10.1111/j.1478-5153.2006.00174.x
   Vink Annemiek C, 2003, COCHRANE DB SYST REV
   Wang YW, 1997, THESIS CASE W RESERV
   Watkins G R, 1997, Clin Nurse Spec, V11, P43, DOI 10.1097/00002800-199703000-00003
   Wilson RS, 2004, J NEUROL NEUROSUR PS, V75, P126
   Witzke J, 2008, J GERONTOL NURS, V34, P45, DOI 10.3928/00989134-20081001-08
   WOO J, 1994, ACTA PSYCHIAT SCAND, V89, P8, DOI 10.1111/j.1600-0447.1994.tb01478.x
   Yeung A, 2004, J NERV MENT DIS, V192, P324, DOI 10.1097/01.nmd.0000120892.96624.00
   Yung PM, 2003, INT J STRESS MANAGE, V10, P64
   Zahran HS, 2005, MMWR-MORBID MORTAL W, V54, P31
NR 43
TC 13
Z9 13
U1 4
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1067
EI 1365-2702
J9 J CLIN NURS
JI J. Clin. Nurs.
PD APR
PY 2011
VL 20
IS 7-8
BP 979
EP 987
DI 10.1111/j.1365-2702.2010.03368.x
PG 9
WC Nursing
SC Nursing
GA 732EC
UT WOS:000288166500008
PM 21294797
DA 2018-12-27
ER

PT J
AU Noor, M
   Bowles, C
   Firouzi, A
   Simon, A
   Banner, NR
AF Noor, M.
   Bowles, C.
   Firouzi, A.
   Simon, A.
   Banner, N. R.
TI RETRACTED: Myocardial Recovery after Support with HeartMate I and
   HeartMate II Left Ventricular Assist Devices (Retracted article. See
   vol. 30, pg. 1423, 2011)
SO JOURNAL OF HEART AND LUNG TRANSPLANTATION
LA English
DT Meeting Abstract; Retracted Publication
CT 31st Annual Meeting and Scientific Sessions of the
   International-Society-for-Heart-and-Lung-Transplantation (ISHLT)
CY APR 12-16, 2011
CL San Diego, CA
SP Int Soc Heart & Lung Transplantat (ISHLT)
C1 [Noor, M.; Bowles, C.; Firouzi, A.; Simon, A.; Banner, N. R.] Royal Brompton & Harefield NHS Fdn Trust, Harefield Hosp, Dept Cardiopulm Transplantat, Harefield, Middx, England.
   [Noor, M.; Banner, N. R.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.
NR 0
TC 1
Z9 1
U1 3
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1053-2498
EI 1557-3117
J9 J HEART LUNG TRANSPL
JI J. Heart Lung Transplant.
PD APR
PY 2011
VL 30
IS 4
SU S
MA 207
BP S75
EP S76
DI 10.1016/j.healun.2011.01.214
PG 2
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery;
   Transplantation
SC Cardiovascular System & Cardiology; Respiratory System; Surgery;
   Transplantation
GA 742EO
UT WOS:000288924300208
DA 2018-12-27
ER

PT J
AU Kol, GR
   Tabi, CB
AF Kol, Guy Richard
   Tabi, Conrad Bertrand
TI RETRACTED: Application of the (G '/G)-expansion method to nonlinear
   blood flow in large vessels (Retracted article. See vol. 84, art. no.
   029701, 2011)
SO PHYSICA SCRIPTA
LA English
DT Article; Retracted Publication
ID BACKLUND TRANSFORMATION; EVOLUTION-EQUATIONS; SOLITON-SOLUTIONS; WAVES;
   TUBE
AB As is widely known today, Navier-Stokes equations are used to describe blood flow in large vessels. In the past several decades, and even in very recent works, these equations have been reduced to Korteweg-de Vries (KdV), modified KdV or Boussinesq equations. In this paper, we avoid such simplifications and investigate the analytical traveling wave solutions of the one-dimensional generic Navier-Stokes equations, through the (G'/G)-expansion method. These traveling wave solutions include hyperbolic functions, trigonometric functions and rational functions. Since some of them are not yet explored in the study of blood flow, we pay attention to hyperbolic function solutions and we show that the (G'/G)-expansion method presents a wider applicability that allows us to bring out the widely known blood flow behaviors. The biological implications of the found solutions are discussed accordingly.
C1 [Kol, Guy Richard] Univ Yaounde I, Lab Mech, Dept Phys, Fac Sci, Yaounde, Cameroon.
   [Tabi, Conrad Bertrand] Univ Yaounde I, Biophys Lab, Dept Phys, Fac Sci, Yaounde, Cameroon.
   [Tabi, Conrad Bertrand] Abdus Salam Int Ctr Theoret Phys, Trieste, Italy.
RP Kol, GR (reprint author), Univ Yaounde I, Lab Mech, Dept Phys, Fac Sci, POB 812, Yaounde, Cameroon.
EM contab408@hotmail.com
OI Tabi, Conrad Bertrand/0000-0001-6505-7866
CR Ablowitz MJ, 1991, SOLITONS NONLINEAR E
   Akio S, 1996, PHYS LETT A, V221, P395
   Banerjee RS, 1998, PHYS SCRIPTA, V57, P598, DOI 10.1088/0031-8949/57/5/008
   Bekir A, 2008, PHYS SCRIPTA, V77, DOI 10.1088/0031-8949/77/04/045008
   Blumgart HL, 1930, J CLIN INVEST, V9, P91, DOI 10.1172/JCI100296
   Chen JL, 2008, PHYS SCRIPTA, V77, DOI 10.1088/0031-8949/77/02/025002
   Dai CQ, 2008, PHYS SCRIPTA, V78, DOI 10.1088/0031-8949/78/01/015013
   Demiray H, 2005, EUR J MECH A-SOLID, V24, P337, DOI 10.1016/j.euromechsol.2004.12.002
   Demiray H, 2009, CHAOS SOLITON FRACT, V42, P358, DOI 10.1016/j.chaos.2008.12.014
   Duan WS, 1996, J PHYS SOC JPN, V65, P945, DOI 10.1143/JPSJ.65.945
   Dursun I., 2008, PHYS SCR, V77
   GARDNER CS, 1967, PHYS REV LETT, V19, P1095, DOI 10.1103/PhysRevLett.19.1095
   HASHIZUME Y, 1985, J PHYS SOC JPN, V54, P3305, DOI 10.1143/JPSJ.54.3305
   HASHIZUME Y, 1988, J PHYS SOC JPN, V57, P4160, DOI 10.1143/JPSJ.57.4160
   He JH, 2007, PHYS SCRIPTA, V76, P680, DOI 10.1088/0031-8949/76/6/016
   HIROTA R, 1971, PHYS REV LETT, V27, P1192, DOI 10.1103/PhysRevLett.27.1192
   Hu JQ, 2005, CHAOS SOLITON FRACT, V23, P391, DOI 10.1016/j.chaos.2004.02.044
   Mehdi D., 2007, PHYS SCR, V75, P778
   Tabi CB, 2008, PHYS SCRIPTA, V77, DOI 10.1088/0031-8949/77/4/045002
   Tabi CB, 2009, PHYS LETT A, V373, P2476, DOI 10.1016/j.physleta.2009.04.052
   Tsigaridas G, 2005, CHAOS SOLITON FRACT, V23, P1841, DOI 10.1016/j.chaos.2004.07.010
   Vakhnenko VO, 2003, CHAOS SOLITON FRACT, V17, P683, DOI 10.1016/S0960-0779(02)00483-6
   WADATI M, 1975, PROG THEOR PHYS, V53, P419, DOI 10.1143/PTP.53.419
   Wang ML, 2008, PHYS LETT A, V372, P417, DOI 10.1016/j.physleta.2007.07.051
   YOMOSA S, 1987, J PHYS SOC JPN, V56, P506, DOI 10.1143/JPSJ.56.506
   Zhang HQ, 2007, PHYS SCRIPTA, V76, P452, DOI 10.1088/0031-8949/76/5/009
   ZHENYA Y, 2008, PHYS SCR, V78
NR 27
TC 4
Z9 4
U1 2
U2 11
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0031-8949
EI 1402-4896
J9 PHYS SCRIPTA
JI Phys. Scr.
PD APR
PY 2011
VL 83
IS 4
AR 045803
DI 10.1088/0031-8949/83/04/045803
PG 6
WC Physics, Multidisciplinary
SC Physics
GA 741WU
UT WOS:000288897600029
DA 2018-12-27
ER

PT J
AU Luna-Vargas, MPA
   Faesen, AC
   van Dijk, WJ
   Rape, M
   Fish, A
   Sixma, TK
AF Luna-Vargas, Mark P. A.
   Faesen, Alex C.
   van Dijk, Willem J.
   Rape, Michael
   Fish, Alexander
   Sixma, Titia K.
TI RETRACTED: Ubiquitin-specific protease 4 is inhibited by its
   ubiquitin-like domain (Retracted article. See vol. 15, pg. 121, 2014)
SO EMBO REPORTS
LA English
DT Article; Retracted Publication
DE regulation; structure; Ubl; USP4
ID DEUBIQUITINATING ENZYME; STRUCTURAL BASIS; MODULE; RECOGNITION; COMPLEX;
   BINDING; USP4
AB USP4 is a member of the ubiquitin-specific protease (USP) family of deubiquitinating enzymes that has a role in spliceosome regulation. Here, we show that the crystal structure of the minimal catalytic domain of USP4 has the conserved USP-like fold with its typical ubiquitin-binding site. A ubiquitin-like (Ubl) domain inserted into the catalytic domain has autoregulatory function. This Ubl domain can bind to the catalytic domain and compete with the ubiquitin substrate, partially inhibiting USP4 activity against different substrates. Interestingly, other USPs, such as USP39, could relieve this inhibition.
C1 [Luna-Vargas, Mark P. A.; Faesen, Alex C.; van Dijk, Willem J.; Fish, Alexander; Sixma, Titia K.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands.
   [Luna-Vargas, Mark P. A.; Faesen, Alex C.; van Dijk, Willem J.; Fish, Alexander; Sixma, Titia K.] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands.
   [Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.
RP Sixma, TK (reprint author), Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.
EM t.sixma@nki.nl
OI Rape, Michael/0000-0003-4849-6343
FU European Union Network of Excellence; Dutch Cancer Society [KWF
   2008-4014]
FX We thank J. Lebbink for mass spectrometry, European Synchrotron
   Radiation Facility beamline scientists for assistance during X-ray data
   collection, A. Perrakis and P. Rucktooa for help with crystallographic
   analysis, R. G. Hibbert for help with SPR data analysis, and lab members
   for discussion and sharing of reagents. This study was supported by the
   European Union Network of Excellence project RUBICON and Dutch Cancer
   Society Project KWF 2008-4014.
CR Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003
   Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200
   Burroughs AM, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-4
   COPELAND RA, 2000, ENZYMES PRACTICAL IN, P270
   Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809
   GRAY DA, 1995, ONCOGENE, V10, P2179
   GUPTA K, 1993, ONCOGENE, V8, P2307
   Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958
   Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960
   Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6
   Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832
   Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010
   Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026
   Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731
   Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460
   Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823
   May MJ, 2004, J BIOL CHEM, V279, P45528, DOI 10.1074/jbc.M408579200
   Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818
   Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007
   Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2
   Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050
   Raasi Shahri, 2005, V301, P47
   Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012
   Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764
   Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049
   Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010
   Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042
   Sumimoto H, 2007, SCI STKE, DOI [10.1126/stke.4012007re6, DOI 10.1126/STKE.4012007RE6]
   Terasawa H, 2001, EMBO J, V20, P3947, DOI 10.1093/emboj/20.15.3947
   van Leuken RJ, 2008, CELL CYCLE, V7, P2710, DOI 10.4161/cc.7.17.6553
   Zhao B, 2009, J CELL MOL MED, V13, P1886, DOI 10.1111/j.1582-4934.2009.00682.x
   Zhu X, 2007, PROTEINS, V69, P1, DOI 10.1002/prot.21546
NR 32
TC 36
Z9 39
U1 3
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD APR
PY 2011
VL 12
IS 4
BP 365
EP 372
DI 10.1038/embor.2011.33
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 744DC
UT WOS:000289073200017
PM 21415856
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Watkins, SK
   Zhu, ZQ
   Riboldi, E
   Shafer-Weaver, KA
   Stagliano, KER
   Sklavos, MM
   Ambs, S
   Yagita, H
   Hurwitz, AA
AF Watkins, Stephanie K.
   Zhu, Ziqiang
   Riboldi, Elena
   Shafer-Weaver, Kim A.
   Stagliano, Katherine E. R.
   Sklavos, Martha M.
   Ambs, Stefan
   Yagita, Hideo
   Hurwitz, Arthur A.
TI RETRACTED: FOXO3 programs tumor-associated DCs to become tolerogenic in
   human and murine prostate cancer (Retracted article. See vol. 125, pg.
   2179, 2015)
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article; Retracted Publication
ID PLASMACYTOID DENDRITIC CELLS; ANTIGEN-PRESENTING CELLS; REGULATORY
   T-CELLS; DRAINING LYMPH-NODES; INDOLEAMINE 2,3-DIOXYGENASE; IN-VITRO;
   ANTITUMOR RESPONSES; SUPPRESSOR-CELLS; IMMUNE-RESPONSES; BREAST-CANCER
AB The limited success of cancer immunotherapy is often attributed to the loss of antigen-specific T cell function in situ. However, the mechanism for this loss of function is unknown. In this study, we describe a population of tumor-associated DCs (TADCs) in both human and mouse prostate cancer that tolerizes and induces suppressive activity in tumor-specific T cells. In tumors from human prostate cancer patients and transgenic adenocarcinoma of the mouse prostate (TRAMP) mice, TADCs expressed elevated levels of FOXO3 and Foxo3, respectively, which correlated with expression of suppressive genes that negatively regulate T cell function. Silencing FOXO3 and Foxo3 with siRNAs abrogated the ability of human and mouse TADCs, respectively, to tolerize and induce suppressive activity by T cells. Silencing Foxo3 in mouse TADCs was also associated with diminished expression of tolerogenic mediators, such as indoleamine-2,3-dioxygenase, arginase, and TGF-beta, and upregulated expression of costimulatory molecules and proinflammatory cytokines. Importantly, transfer of tumor-specific CD4(+) Th cells into TRAMP mice abrogated TADC tolerogenicity, which was associated with reduced Foxo3 expression. These findings demonstrate that FOXO3 may play a critical role in mediating TADC-induced immune suppression. Moreover, our results identify what we believe to be a novel target for preventing CTL tolerance and enhancing immune responses to cancer by modulating the immunosuppressive activity of TADCs found in the tumor microenvironment.
C1 [Riboldi, Elena] NCI, Canc & Inflammat Program, Expt Immunol Lab, Frederick, MD 21702 USA.
   [Watkins, Stephanie K.; Zhu, Ziqiang; Shafer-Weaver, Kim A.; Stagliano, Katherine E. R.; Sklavos, Martha M.; Hurwitz, Arthur A.] NCI, Tumor Immun & Tolerance Sect, Mol Immunoregulat Lab, Frederick, MD 21702 USA.
   [Shafer-Weaver, Kim A.] SAIC Frederick Inc, Frederick, MD USA.
   [Ambs, Stefan] NCI, Breast & Prostate Canc Unit, Human Carcinogenesis Lab, Frederick, MD 21702 USA.
   [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan.
RP Hurwitz, AA (reprint author), NCI, Canc & Inflammat Program, Expt Immunol Lab, 211 Bldg 567, Frederick, MD 21702 USA.
EM hurwitza@mail.nih.gov
FU NCI [Z01 BC 010954]; Center for Cancer Research; Office of Science and
   Technology Partnerships; Department of Defense
FX The authors would like to thank Joost Oppenheim, Giorgio Trinchieri,
   Jose Conejo-Garcia, Jay Berzofsky, Bill Murphy, and Nicholas Restifo for
   their helpful discussions and critical review of this manuscript and
   Scott Hudson for his assistance in uploading microarray data to GEO.
   This work was supported by the Intramural Research Program of the NCI
   under award Z01 BC 010954. Additional support was provided by the Center
   for Cancer Research, Office of Science and Technology Partnerships, and
   the Department of Defense Prostate Cancer Research Program.
CR Aalamian M, 2001, PROSTATE, V46, P68
   Adler AJ, 1998, J EXP MED, V187, P1555, DOI 10.1084/jem.187.10.1555
   Almand B, 2000, CLIN CANCER RES, V6, P1755
   Anderson MJ, 2007, J IMMUNOL, V178, P1268, DOI 10.4049/jimmunol.178.3.1268
   Banerjee DK, 2006, BLOOD, V108, P2655, DOI 10.1182/blood-2006-03-011353
   Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260
   Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028
   Chaput N, 2008, ONCOGENE, V27, P5920, DOI 10.1038/onc.2008.270
   Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2
   Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141
   Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729
   Enk AH, 1997, INT J CANCER, V73, P309, DOI 10.1002/(SICI)1097-0215(19971104)73:3<309::AID-IJC1>3.3.CO;2-B
   Esche C, 1999, J LEUKOCYTE BIOL, V66, P336
   Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083
   Fallarino F, 2003, ADV EXP MED BIOL, V527, P183
   Gabrilovich DI, 1997, CLIN CANCER RES, V3, P483
   Gough M, 2005, J IMMUNOL, V174, P5766, DOI 10.4049/jimmunol.174.9.5766
   GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439
   Hagymasi AT, 2007, J IMMUNOL, V179, P1524, DOI 10.4049/jimmunol.179.3.1524
   Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925
   June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446
   Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012
   Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z
   Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101
   Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737
   Lipscomb MW, 2009, J IMMUNOL, V183, P7250, DOI 10.4049/jimmunol.0901477
   Marrack P, 1998, IMMUNOL REV, V165, P279, DOI 10.1111/j.1600-065X.1998.tb01245.x
   Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457
   Muller AJ, 2007, CURR CANCER DRUG TAR, V7, P31, DOI 10.2174/156800907780006896
   Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583
   Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826
   Perez L, 2005, HISTOL HISTOPATHOL, V20, P1165, DOI 10.14670/HH-20.1165
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   Pinthus JH, 2003, CANCER RES, V63, P2470
   Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364
   Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609
   Shafer-Weaver KA, 2009, J IMMUNOL, V183, P4848, DOI 10.4049/jimmunol.0900848
   Shafer-Weaver KA, 2009, CANCER RES, V69, P6256, DOI 10.1158/0008-5472.CAN-08-4516
   Shang YC, 2009, CURR NEUROVASC RES, V6, P20, DOI 10.2174/156720209787466064
   Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911
   Singh V, 2009, J IMMUNOTHER, V32, P129, DOI 10.1097/CJI.0b013e31819144d7
   Sotomayor EM, 2001, BLOOD, V98, P1070, DOI 10.1182/blood.V98.4.1070
   Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587
   Stoitzner P, 2008, CANCER IMMUNOL IMMUN, V57, P1665, DOI 10.1007/s00262-008-0487-4
   Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359
   Treilleux I, 2004, CLIN CANCER RES, V10, P7466, DOI 10.1158/1078-0432.CCR-04-0684
   Troy AJ, 1998, CLIN CANCER RES, V4, P585
   Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357
   Wei S, 2005, CANCER RES, V65, P5020, DOI 10.1158/0008-5472.CAN-04-4043
   Yamazaki H, 2005, J IMMUNOL, V175, P1586, DOI 10.4049/jimmunol.175.3.1586
   Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734
   Zhang Y, 2010, CELL MOL IMMUNOL, V7, P389, DOI 10.1038/cmi.2010.28
   Zhou Q, 2010, BLOOD, V116, P2484, DOI 10.1182/blood-2010-03-275446
   Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339
NR 54
TC 93
Z9 94
U1 2
U2 12
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD APR
PY 2011
VL 121
IS 4
BP 1361
EP 1372
DI 10.1172/JCI44325
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 745OK
UT WOS:000289174600020
PM 21436588
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Lim, JW
AF Lim, Ji Won
TI RETRACTED: Results of Spectral-Domain Optical Coherence Tomography by
   Preferential Hyperacuity Perimeter in Patients after Idiopathic
   Epiretinal Membrane Surgery (Retracted Article. See vol 36, pg 590,
   2011)
SO CURRENT EYE RESEARCH
LA English
DT Article; Retracted Publication
DE Epiretinal membrane; Metamorphopsia; Preferential hyperacuity perimeter;
   Spectral-domain optical coherence tomography; Surgery
ID MACULAR DEGENERATION; METAMORPHOPSIA
AB Purpose: To evaluate spectral-domain optical coherence tomography (OCT) findings based on preferential hyperacuity perimeter (PHP) in patients after idiopathic epiretinal membrane surgery.
   Methods: Forty eyes of 40 patients undergoing surgery for idiopathic epiretinal membrane were included in the study. The best-corrected visual acuity, PHP, Amsler grid test, and OCT were assessed 3 months after surgery.
   Results: Patients were classified based on the defect of hyperacuity by PHP, as follows: hyperacuity defect (n = 18 eyes) and hyperacuity intact (n = 22 eyes). There was no difference in age, gender, duration of symptoms, and visual acuity. The average macular thickness and inner nuclear layer thickness in the hyperacuity defect group was thicker than the hyperacuity intact group (P = 0.041 and P = 0.045, respectively). A disrupted photoreceptor layer was more common in the hyperacuity defect group compared with the hyperacuity intact group (P = 0.001).
   Conclusion: With regard to metamorphopsia, a hyperacuity defect after epiretinal membrane surgery was associated with inner nuclear layer edema and photoreceptor disarrangement.
C1 Hallym Univ, Sacred Heart Hosp, Dept Ophthalmol, Chuncheon Si 200704, Kangwon Don, South Korea.
RP Lim, JW (reprint author), Hallym Univ, Sacred Heart Hosp, Dept Ophthalmol, 153 Kyo Dong, Chuncheon Si 200704, Kangwon Don, South Korea.
EM jiwoneye@hallym.or.kr
CR Alster Y, 2005, OPHTHALMOLOGY, V112, P1758, DOI 10.1016/j.ophtha.2005.06.008
   Arimura E, 2005, INVEST OPHTH VIS SCI, V46, P2961, DOI 10.1167/iovs.04-1104
   Bouwens MD, 2003, GRAEF ARCH CLIN EXP, V241, P89, DOI 10.1007/s00417-002-0613-5
   ENOCH JM, 1984, ARCH OPHTHALMOL-CHIC, V102, P1164, DOI 10.1001/archopht.1984.01040030942019
   Falkner-Radler CI, 2009, OPHTHAL SURG LAS IM, V40, P270, DOI 10.9999/15428877-20090430-08
   Goldstein M, 2005, RETINA-J RET VIT DIS, V25, P296
   Grewing R, 1996, BRIT J OPHTHALMOL, V80, P323, DOI 10.1136/bjo.80.4.323
   Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335
   Klatt C, 2006, OPHTHALMOLOGE, V103, P945, DOI 10.1007/s00347-006-1381-0
   Loewenstein A, 2003, OPHTHALMOLOGY, V110, P966, DOI 10.1016/S0161-6420(03)00074-5
   Massey SC, 2006, RETINA, P43
   Niwa T, 2003, INVEST OPHTH VIS SCI, V44, P1652, DOI 10.1167/iovs.02-0404
   Okamoto F, 2009, AM J OPHTHALMOL, V147, P869, DOI 10.1016/j.ajo.2008.11.018
   Tan O, 2008, OPHTHALMOLOGY, V115, P949, DOI 10.1016/j.ophtha.2007.08.011
   Watanabe A, 2009, OPHTHALMOLOGY, V116, P1788, DOI 10.1016/j.ophtha.2009.04.046
   WESTHEIMER G, 1987, AM J OPTOM PHYS OPT, V64, P567
NR 16
TC 4
Z9 4
U1 3
U2 14
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0271-3683
EI 1460-2202
J9 CURR EYE RES
JI Curr. Eye Res.
PD APR
PY 2011
VL 36
IS 4
BP 364
EP 369
DI 10.3109/02713683.2010.545499
PG 6
WC Ophthalmology
SC Ophthalmology
GA 735BW
UT WOS:000288389400011
PM 21291296
DA 2018-12-27
ER

PT J
AU Liu, LG
   Wei, X
   Yan, JT
   Pan, TC
AF Liu, Ligang
   Wei, Xiang
   Yan, Jiangtao
   Pan, Tiecheng
TI RETRACTED: Successful correction of congenital giant right coronary
   artery aneurysm with fistula to left ventricle (Retracted article. See
   vol. 12, pg. 1078, 2012)
SO INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY
LA English
DT Article; Retracted Publication
DE Coronary artery aneurysm; Coronary artery fistula
ID TRANSCATHETER COIL EMBOLIZATION
AB A 26-year-old male presented with radiographical evidence of enlargement of the right side of the heart. Echocardiography and computed tomography-scan revealed a diffuse, hugely enlarged right coronary artery (RCA) aneurysm, with the distal portion flowing directly into the left ventricle (LV). A radical correction operation was performed successfully. The RCA was reconstructed with an autograft of a greater saphenous vein after the aneurysm was removed and the RCA-to-LV fistula was closed. The postoperative course was uneventful and the patient was discharged on 12th day after operation. (C) 2011 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.
C1 [Liu, Ligang; Wei, Xiang; Pan, Tiecheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiothorac Surg, Wuhan 430030, Peoples R China.
   [Yan, Jiangtao] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Cardiol, Wuhan 430030, Peoples R China.
RP Wei, X (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiothorac Surg, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.
EM xwei_tjh@hotmail.com
CR FERNANDES ED, 1992, ANN THORAC SURG, V54, P732, DOI 10.1016/0003-4975(92)91019-6
   Gottesfeld S, 2004, J AM SOC ECHOCARDIOG, V17, P1319, DOI 10.1016/j.echo.2004.07.004
   Iglesias JF, 2010, J INVASIVE CARDIOL, V22, P142
   Inamura N, 2004, CIRC J, V68, P1227, DOI 10.1253/circj.68.1227
   Kanamitsu H, 2010, GEN THORAC CARDIOVAS, V58, P186, DOI 10.1007/s11748-009-0478-1
   Kaul U, 2005, Heart, V91, P234, DOI 10.1136/hrt.2004.045047
   Nakamura Y, 1998, INTERNAL MED, V37, P366, DOI 10.2169/internalmedicine.37.366
   Saglam H, 2008, TURK KARDIYOL DERN A, V36, P552
   Said Salah A M, 2006, Congenit Heart Dis, V1, P63, DOI 10.1111/j.1747-0803.2006.00012.x
   Tsuda E, 2005, HEART, V91, P177, DOI 10.1136/hrt.2003.025338
NR 10
TC 8
Z9 8
U1 2
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1569-9293
EI 1569-9285
J9 INTERACT CARDIOV TH
JI Interact Cardiovasc. Thorac. Surg.
PD APR
PY 2011
VL 12
IS 4
BP 639
EP 641
DI 10.1510/icvts.2010.257659
PG 3
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 022WS
UT WOS:000309995500052
PM 21220413
OA Bronze
DA 2018-12-27
ER

PT J
AU Ramos, CG
   Sousa, SA
   Grilo, AM
   Feliciano, JR
   Leitao, JH
AF Ramos, Christian G.
   Sousa, Silvia A.
   Grilo, Andre M.
   Feliciano, Joana R.
   Leitao, Jorge H.
TI RETRACTED: The Second RNA Chaperone, Hfq2, Is Also Required for Survival
   under Stress and Full Virulence of Burkholderia cenocepacia J2315
   (Retracted article. See vol. 196, pg. 3980, 2014)
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article; Retracted Publication
ID MANNOSE PYROPHOSPHORYLASE ACTIVITIES; SM-LIKE PROTEIN; ESCHERICHIA-COLI;
   CAENORHABDITIS-ELEGANS; CYSTIC-FIBROSIS; PHOSPHOMANNOSE ISOMERASE;
   PSEUDOMONAS-AERUGINOSA; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; GENE
   ENCODES
AB Burkholderia cenocepacia J2315 is a highly virulent and epidemic clinical isolate of the B. cepacia complex (Bcc), a group of bacteria that have emerged as important pathogens to cystic fibrosis patients. This bacterium, together with all Bcc strains and a few other prokaryotes, is unusual for encoding in its genome two distinct and functional Hfq-like proteins. In this work, we show results indicating that the 188-amino-acid Hfq2 protein is required for the full virulence and stress resistance of B. cenocepacia J2315, despite the presence on its genome of the functional 79-amino-acid Hfq protein encoded by the hfq gene. Similar to other Hfq proteins, Hfq2 is able to bind RNA. However, Hfq2 is unique in its ability to apparently form trimers in vitro. Maximal transcription of hfq was observed in B. cenocepacia J2315 cells in the early exponential phase of growth. In contrast, hfq2 transcription reached maximal levels in cells in the stationary phase, depending on the CepR quorum-sensing regulator. These results suggest that tight regulation of the expression of these two RNA chaperones is required to maximize the fitness and virulence of this bacterium. In addition, the ability of Hfq2 to bind DNA, not observed for Hfq, suggests that Hfq2 might play additional roles besides acting as an RNA chaperone.
C1 [Ramos, Christian G.; Sousa, Silvia A.; Grilo, Andre M.; Feliciano, Joana R.; Leitao, Jorge H.] Inst Super Tecn, Ctr Biol & Chem Engn, IBB Inst Biotechnol & Bioengn, P-1049001 Lisbon, Portugal.
RP Leitao, JH (reprint author), Inst Super Tecn, Ctr Biol & Chem Engn, IBB Inst Biotechnol & Bioengn, Torre Sul,Piso 6,Av Rovisco Pais, P-1049001 Lisbon, Portugal.
EM jorgeleitao@ist.utl.pt
RI Feliciano, Joana/K-1473-2016; Leitao, Jorge H./A-5122-2012; Ramos,
   Christian/A-8588-2010; Sousa, Silvia/G-8502-2011
OI Feliciano, Joana/0000-0002-4906-676X; Leitao, Jorge
   H./0000-0001-8850-274X; Ramos, Christian/0000-0003-0970-7750; Sousa,
   Silvia/0000-0001-9291-9169
FU Fundacao Ciencia e Tecnologia, Portugal [PTDC/BIA-MIC/65210/2006,
   PTDC/EBB-BIO/098352/2008]; Fundacao Calouste Gulbenkian
FX This work was supported by Fundacao Ciencia e Tecnologia, Portugal
   (contracts PTDC/BIA-MIC/65210/2006 and PTDC/EBB-BIO/098352/2008); a
   postdoctoral grant to S.A.S.; and a Fundacao Calouste Gulbenkian
   doctoral grant to C.G.R.
CR ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383
   Attia AS, 2008, INFECT IMMUN, V76, P2520, DOI 10.1128/IAI.01652-07
   BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X
   Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015
   BRENNER S, 1974, GENETICS, V77, P71
   CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4
   Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841
   GOVAN JRW, 1993, LANCET, V342, P15, DOI 10.1016/0140-6736(93)91881-L
   Govan JRW, 1996, MICROBIOL REV, V60, P539
   Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08
   KAJITANI M, 1994, J BACTERIOL, V176, P531
   Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256
   Kothe M, 2003, CELL MICROBIOL, V5, P343, DOI 10.1046/j.1462-5822.2003.00280.x
   Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921
   Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002
   Leitao JH, 2010, APPL MICROBIOL BIOT, V87, P31, DOI 10.1007/s00253-010-2528-0
   Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106
   MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0
   Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1
   Moreira LM, 2003, BIOCHEM BIOPH RES CO, V312, P323, DOI 10.1016/j.bbrc.2003.10.118
   Moskaleva O, 2010, ACTA CRYSTALLOGR F, V66, P760, DOI 10.1107/S1744309110017331
   Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635
   Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008
   Rajkowitsch L, 2007, RNA, V13, P2053, DOI 10.1261/rna.671807
   RAMOS CG, 2010, SMALL NONCODING RNAS
   Ramos CG, 2010, MICROB PATHOGENESIS, V48, P168, DOI 10.1016/j.micpath.2010.02.006
   Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451
   SAMBROOK J, 2001, MOL CLONING LAB MANU, pA8
   Schilling D, 2009, J BACTERIOL, V191, P5553, DOI 10.1128/JB.00490-09
   Schirmer F, 1997, J BACTERIOL, V179, P1329, DOI 10.1128/jb.179.4.1329-1336.1997
   Sousa SA, 2011, INT J MICROBIOL
   Sousa SA, 2008, APPL MICROBIOL BIOT, V80, P1015, DOI 10.1007/s00253-008-1612-1
   Sousa SA, 2007, BIOCHEM BIOPH RES CO, V353, P200, DOI 10.1016/j.bbrc.2006.12.016
   Sousa SA, 2010, MICROBIOL-SGM, V156, P896, DOI 10.1099/mic.0.035139-0
   Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415
   Updegrove TB, 2010, BBA-GENE REGUL MECH, V1799, P588, DOI 10.1016/j.bbagrm.2010.06.007
   Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1046/j.1365-2958.2003.03935.x
   VECCEREK B, 2008, NUCLEIC ACIDS RES, V36, P133
   Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172
   Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005
   Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3
NR 43
TC 22
Z9 22
U1 2
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD APR
PY 2011
VL 193
IS 7
BP 1515
EP 1526
DI 10.1128/JB.01375-10
PG 12
WC Microbiology
SC Microbiology
GA 734DW
UT WOS:000288314400003
PM 21278292
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Muller, G
AF Mueller, Guenter
TI RETRACTED: Take-over: multiple mechanisms of inter-adipocyte
   communication (Retracted article. See vol. 3, pg. 382, 2011)
SO JOURNAL OF MOLECULAR CELL BIOLOGY
LA English
DT Review; Retracted Publication
DE adipokines; fat cells; glycosylphosphatidylinositol; lipid droplets;
   lipid metabolism; microvesicles; obesity; type 2 diabetes
ID HUMAN ADIPOSE-TISSUE; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS;
   COMMITTED SUBCUTANEOUS PREADIPOCYTES; BASEMENT-MEMBRANE COMPONENTS;
   NECROSIS-FACTOR-ALPHA; RAT ADIPOCYTES; INSULIN-RESISTANCE; LIPID
   DROPLETS; HUMAN OBESITY; CELL-SIZE
AB Adipose tissue mass in mammals is thought to expand with an increase in both volume and total number of the adipocytes. Recent findings suggest that in normal-weight as well as obese individuals, the adipocyte number is set during adolescence prior to adulthood, whereas the subsequent increase in size predominantly drives obesity. The simultaneous existence of large and small adipocytes and their unsynchronized growth, even within the same adipose tissue depot, argues against simple filling-up of emerging adipocytes with lipids and lipid droplets (LDs). Consequently, it is tempting to speculate about signals sent by large adipocytes to order small adipocytes the take-over of the burden of lipid loading. Currently there is experimental evidence for three distinct types of inter-adipocyte signals, i.e. cell-to-cell contacts, adipokines, and other soluble factors and microvesicles. Very recently, microvesicles have been shown (i) to harbour the glycosylphosphatidylinositol-anchored (c) AMP-degrading phosphodiesterase Gce1 and 5'-nucleotidase CD73, (ii) to be released from large adipocytes, (iii) to interact with small adipocytes, and (iv) to transfer Gce1 and CD73 to plasma membranes and LDs of small adipocytes where they degrade (c) AMP. This sequence of events leads to the up-regulation of lipid storage in small adipocytes in response to the microvesicle-encoded 'take-over' signal from large adipocytes. A model is proposed for the maturation of small adipocytes driven by large ones along a gradient of those inter-adipocyte signals. Pharmacological modulation of inter-adipocyte communication and thereby adipocyte maturation may be useful for the therapy of metabolic diseases.
C1 Univ Munich, Dept Biol 1, Bioctr, Munich, Germany.
RP Muller, G (reprint author), Univ Munich, Dept Biol 1, Bioctr, Munich, Germany.
EM guenter.mueller@sanofi-aventis.com
OI Muller, Gunter/0000-0001-6178-8215
CR Abbasi F, 2004, DIABETES, V53, P585, DOI 10.2337/diabetes.53.3.585
   Aboulaich N, 2006, J BIOL CHEM, V281, P11446, DOI 10.1074/jbc.C500461200
   Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015
   Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479
   Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942
   Bahceci M, 2007, J ENDOCRINOL INVEST, V30, P210, DOI 10.1007/BF03347427
   BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733
   BENELLI R, 1994, ONCOL RES, V6, P251
   BJORNTORP P, 1974, METABOLISM, V23, P1091, DOI 10.1016/0026-0495(74)90076-6
   BJORNTORP P, 1975, AM J CLIN NUTR, V28, P445
   BJORNTORP P, 1970, EUR J CLIN INVEST, V1, P112, DOI 10.1111/j.1365-2362.1970.tb00607.x
   Blouin CM, 2008, BIOCHEM BIOPH RES CO, V376, P331, DOI 10.1016/j.bbrc.2008.08.154
   Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5
   Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111
   Brown LM, 1997, AM J PHYSIOL-CELL PH, V272, pC937
   Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051
   Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002
   Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200
   Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77
   CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531
   CUSHMAN SW, 1978, J LIPID RES, V19, P269
   Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111
   DeFronzo RA, 2004, INT J CLIN PRACT, V58, P9, DOI 10.1111/j.1368-504X.2004.00389.x
   DESPRES JP, 1984, J APPL PHYSIOL, V56, P1157
   Dugail I, 2007, CELL MOL LIFE SCI, V64, P2452, DOI 10.1007/s00018-007-7277-6
   Dugail I, 2003, HORM METAB RES, V35, P204, DOI 10.1055/s-2003-39475
   Elimam A, 2002, HORM RES, V58, P88, DOI 10.1159/000064659
   FAUST IM, 1978, AM J PHYSIOL, V235, pE279
   Fruhbeck G, 1997, BIOCHEM BIOPH RES CO, V240, P590, DOI 10.1006/bbrc.1997.7716
   Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200
   Guo KY, 2004, AM J PHYSIOL-REG I, V287, pR112, DOI 10.1152/ajpregu.00028.2004
   HAGER A, 1978, AM J CLIN NUTR, V31, P68
   Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925
   Hauner H, 2010, DIABETOLOGIA, V53, P223, DOI 10.1007/s00125-009-1605-3
   Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428
   HAZEN SA, 1995, J LIPID RES, V36, P868
   HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0
   HIRSCH J, 1970, FED PROC, V29, P1516
   HOLM G, 1975, J LIPID RES, V16, P461
   Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126
   Jacobi SK, 2004, J ENDOCRINOL, V182, P133, DOI 10.1677/joe.0.1820133
   Johannes L, 2010, CELL, V142, P507, DOI 10.1016/j.cell.2010.08.007
   JULIEN P, 1989, J LIPID RES, V30, P293
   KASHIWAGI A, 1985, METABOLISM, V34, P364, DOI 10.1016/0026-0495(85)90226-4
   Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623
   Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395
   Kiess W, 2008, BEST PRACT RES CL EN, V22, P135, DOI 10.1016/j.beem.2007.10.002
   Klimcakova E, 2010, OBES REV, V11, P446, DOI 10.1111/j.1467-789X.2009.00704.x
   Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009
   Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x
   Le Lay S, 2009, PROG LIPID RES, V48, P191, DOI 10.1016/j.plipres.2009.03.001
   LELAY S, 2008, BIOCHIM BIOPHYS ACTA, V1791, P514
   Lundgren M, 2007, DIABETOLOGIA, V50, P625, DOI 10.1007/s00125-006-0572-1
   Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912
   Martin S, 2005, SEMIN CELL DEV BIOL, V16, P163, DOI 10.1016/j.semcdb.2005.01.007
   McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y
   McLaughlin T, 2004, METABOLISM, V53, P495, DOI 10.1016/j.metabol.2003.10.032
   McLaughlin T, 2010, DIABETOLOGIA, V53, P369, DOI 10.1007/s00125-009-1496-3
   Monteiro R, 2007, DIABETOLOGIA, V50, P1569, DOI 10.1007/s00125-007-0636-x
   Monteiro R, 2006, OBES SURG, V16, P804, DOI 10.1381/096089206777346600
   Muller G, 2008, BRIT J PHARMACOL, V154, P901, DOI 10.1038/bjp.2008.146
   Muller G, 2010, BRIT J PHARMACOL, V160, P878, DOI 10.1111/j.1476-5381.2010.00724.x
   Muller G, 2009, BRIT J PHARMACOL, V158, P749, DOI 10.1111/j.1476-5381.2009.00360.x
   Muller G, 2008, EUR J PHARMACOL, V597, P6, DOI 10.1016/j.ejphar.2008.08.034
   Mueller G, 2008, MOL PHARMACOL, V73, P1513, DOI 10.1124/mol.107.043935
   Muller G, 2008, BIOCHEMISTRY-US, V47, P1259, DOI 10.1021/bi701413t
   Muller G, 2011, METABOLISM, V60, P1021, DOI 10.1016/j.metabol.2010.10.007
   Mueller Guenter, 2011, Archives of Physiology and Biochemistry, V117, P23, DOI 10.3109/13813455.2010.513393
   Muller G, 2010, RESULTS PROBL CELL D, V52, P27, DOI 10.1007/978-3-642-14426-4_3
   Mueller Guenter, 2010, Archives of Physiology and Biochemistry, V116, P28, DOI 10.3109/13813450903508812
   Muller G, 2009, CELL SIGNAL, V21, P324, DOI 10.1016/j.cellsig.2008.10.021
   Muller G, 2005, BIOCHEM PHARMACOL, V69, P761, DOI 10.1016//j.bcp.2004.11.014
   Muller G, 2002, MOL MED, V8, P120, DOI 10.1007/BF03402005
   Muller G, 1997, J BIOL CHEM, V272, P10585
   Nosjean O, 1997, BBA-REV BIOMEMBRANES, V1331, P153, DOI 10.1016/S0304-4157(97)00005-1
   OLEFSKY JM, 1977, J LIPID RES, V18, P459
   Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280
   Pasarica M, 2009, OBESITY, V17, P1976, DOI 10.1038/oby.2009.219
   Path G, 2001, J CLIN ENDOCR METAB, V86, P2281, DOI 10.1210/jc.86.5.2281
   Petersen EW, 2005, AM J PHYSIOL-ENDOC M, V288, pE155, DOI 10.1152/ajpendo.00257.2004
   Pfeiffer AFH, 2007, HORM METAB RES, V39, P734, DOI 10.1055/s-2007-990271
   Pilch PF, 2006, MOL PHARMACOL, V70, P779, DOI 10.1124/mol.106.026104
   Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737
   Pravenec M, 2008, INT J OBESITY, V32, P1848, DOI 10.1038/ijo.2008.192
   Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe
   REBUFFESCRIVE M, 1989, METABOLISM, V38, P453, DOI 10.1016/0026-0495(89)90198-4
   Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x
   SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705
   Saleh J, 1998, J LIPID RES, V39, P884
   Savage DB, 2005, HYPERTENSION, V45, P828, DOI 10.1161/01.HYP.0000163475.04421.e4
   Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106
   Shadid S, 2003, DIABETES CARE, V26, P3148, DOI 10.2337/diacare.26.11.3148
   Sims E A, 1968, Trans Assoc Am Physicians, V81, P153
   Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360
   STERN JS, 1972, LANCET, V2, P948
   Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023
   Tchoukalova Y, 2007, DIABETOLOGIA, V50, P151, DOI 10.1007/s00125-006-0496-9
   Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107
   Torii T, 2010, J BIOL CHEM, V285, P24270, DOI 10.1074/jbc.M110.125658
   Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022
   Unger RH, 2005, BIOCHIMIE, V87, P57, DOI 10.1016/j.biochi.2004.11.014
   Unger RH, 2003, ANNU REV PHYSIOL, V65, P333, DOI 10.1146/annurev.physiol.65.092101.142622
   VANDENBOSCH H, 1974, ANNU REV BIOCHEM, V43, P243
   Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563
   Wang MY, 2005, P NATL ACAD SCI USA, V102, P18011, DOI 10.1073/pnas.0509001102
   Wang S, 2010, J MOL CELL BIOL, V2, P128, DOI 10.1093/jmcb/mjq006
   Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10
   WASSERMANN F., 1965, HANDBOOK PHYSIOL, V5, P87
   Wueest S, 2009, DIABETOLOGIA, V52, P541, DOI 10.1007/s00125-008-1223-5
   Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004
NR 112
TC 6
Z9 7
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1674-2788
EI 1759-4685
J9 J MOL CELL BIOL
JI J. Mol. Cell Biol.
PD APR
PY 2011
VL 3
IS 2
BP 81
EP 90
DI 10.1093/jmcb/mjr003
PG 10
WC Cell Biology
SC Cell Biology
GA 747FX
UT WOS:000289306800003
PM 21459887
OA Bronze
DA 2018-12-27
ER

PT J
AU Puneet, P
   McGrath, MA
   Tay, HK
   Al-Riyami, L
   Rzepecka, J
   Moochhala, SM
   Pervaiz, S
   Harnett, MM
   Harnett, W
   Melendez, AJ
AF Puneet, Padmam
   McGrath, Mairi A.
   Tay, Hwee Kee
   Al-Riyami, Lamyaa
   Rzepecka, Justyna
   Moochhala, Shabbir M.
   Pervaiz, Shazib
   Harnett, Margaret M.
   Harnett, William
   Melendez, Alirio J.
TI RETRACTED: The helminth product ES-62 protects against septic shock via
   Toll-like receptor 4-dependent autophagosomal degradation of the adaptor
   MyD88 (Retracted article. See vol. 12, pg. 804, 2011)
SO NATURE IMMUNOLOGY
LA English
DT Article; Retracted Publication
ID INTENSIVE-CARE UNITS; SEVERE SEPSIS; SIGNAL-TRANSDUCTION; CYTOKINE
   PRODUCTION; SECRETED PRODUCT; INNATE IMMUNITY; ENDOTOXIN; EPIDEMIOLOGY;
   RESPONSES; DEFINITIONS
AB Sepsis is one of the most challenging health problems worldwide. Here we found that phagocytes from patients with sepsis had considerable upregulation of Toll-like receptor 4 (TLR4) and TLR2; however, shock-inducing inflammatory responses mediated by these TLRs were inhibited by ES-62, an immunomodulator secreted by the filarial nematode Acanthocheilonema viteae. ES-62 subverted TLR4 signaling to block TLR2- and TLR4-driven inflammatory responses via autophagosome-mediated downregulation of the TLR adaptor-transducer MyD88. In vivo, ES-62 protected mice against endotoxic and polymicrobial septic shock by TLR4-mediated induction of autophagy and was protective even when administered after the induction of sepsis. Given that the treatments for septic shock at present are inadequate, the autophagy-dependent mechanism of action by ES-62 might form the basis for urgently needed therapeutic intervention against this life-threatening condition.
C1 [Puneet, Padmam; Pervaiz, Shazib; Melendez, Alirio J.] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore.
   [Puneet, Padmam; Melendez, Alirio J.] Univ Liverpool, Ctr Drug Safety Studies, MRC, Inst Translat Med,Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England.
   [McGrath, Mairi A.; Tay, Hwee Kee; Harnett, Margaret M.] Univ Glasgow, Glasgow Biomed Res Ctr, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
   [Al-Riyami, Lamyaa; Rzepecka, Justyna; Harnett, William] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.
   [Moochhala, Shabbir M.] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore.
   [Pervaiz, Shazib] Natl Univ Singapore, Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore.
   [Pervaiz, Shazib] Singapore MIT Alliance, Singapore, Singapore.
RP Melendez, AJ (reprint author), Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore.
EM a.melendez-romero@liv.ac.uk
FU Medical Research Council UK [G0700794]; Biomedical Research Council of
   Singapore; Wellcome Trust; Biotechnology and Biological Sciences
   Research Council UK; American Asthma Foundation; Medical Research
   Council [G0700794]
FX Supported by the Medical Research Council UK (G0700794), the Biomedical
   Research Council of Singapore, the Wellcome Trust, the Biotechnology and
   Biological Sciences Research Council UK and the American Asthma
   Foundation.
CR Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1177/09680519010070030101
   Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565
   Balk RA, 2000, CRIT CARE CLIN, V16, P179, DOI 10.1016/S0749-0704(05)70106-8
   BONE RC, 1992, CRIT CARE MED, V20, P864
   BUSTIN M, 2002, SCI STKE, V151, pPE39
   Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107
   Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40
   Deretic V, 2009, CURR OPIN IMMUNOL, V21, P53, DOI 10.1016/j.coi.2009.02.002
   Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9
   Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010
   Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200
   Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC
   EXLEY AR, 1992, GUT, V33, P1126, DOI 10.1136/gut.33.8.1126
   Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106
   Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318
   Goodridge HS, 2005, J IMMUNOL, V174, P284, DOI 10.4049/jimmunol.174.1.284
   Goodridge HS, 2001, J IMMUNOL, V167, P940, DOI 10.4049/jimmunol.167.2.940
   Harnett MM, 2007, NAT REV IMMUNOL, V7, P897, DOI 10.1038/nri2188
   Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970
   Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180
   Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835
   HUBBARD WJ, 2005, SHOCK, V1, P52
   Ibrahim FBM, 2004, J BIOL CHEM, V279, P44802, DOI 10.1074/jbc.M403977200
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338
   Lee HM, 2011, J IMMUNOL, V186, P1248, DOI 10.4049/jimmunol.1001954
   Leon CG, 2008, PHARM RES-DORDR, V25, P1751, DOI 10.1007/s11095-008-9571-x
   Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799
   Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139
   McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127
   Melendez AJ, 2004, J IMMUNOL, V173, P1596, DOI 10.4049/jimmunol.173.3.1596
   Melendez AJ, 2007, NAT MED, V13, P1375, DOI 10.1038/nm1654
   MIZUSHIMA N, 2010, CELL, V1403, P313
   Morton AM, 2007, J IMMUNOL, V179, P8026, DOI 10.4049/jimmunol.179.12.8026
   O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079
   Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B
   PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227
   PHILLIP DR, 2004, CRIT CARE MED, V32, P282
   Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635
   Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383
   Salomao R, 2008, SHOCK S, V1, P73
   Sethu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010506
   Sha T, 2007, EUR J PHARMACOL, V571, P231, DOI 10.1016/j.ejphar.2007.06.027
   VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639
   Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248
   Weighardt H, 2002, J IMMUNOL, V169, P2823, DOI 10.4049/jimmunol.169.6.2823
   Weighardt H., 2008, IMMUNOBIOLOGY, V212, P715
NR 47
TC 25
Z9 30
U1 3
U2 22
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
J9 NAT IMMUNOL
JI Nat. Immunol.
PD APR
PY 2011
VL 12
IS 4
BP 344
EP U100
DI 10.1038/ni.2004
PG 10
WC Immunology
SC Immunology
GA 737UJ
UT WOS:000288593400013
PM 21358639
DA 2018-12-27
ER

PT J
AU Shomar, B
AF Shomar, B.
TI RETRACTED: Groundwater contaminations and health perspectives in
   developing world case study: Gaza Strip (Retracted article. See vol. 34,
   pg. 151, 2012)
SO ENVIRONMENTAL GEOCHEMISTRY AND HEALTH
LA English
DT Article; Retracted Publication
DE Chemical contamination; Gaza; War; Water-borne diseases
ID DRINKING-WATER; DEVELOPING-COUNTRIES; MICROBIAL-CONTAMINATION;
   GOVERNORATE; PESTICIDES; EXPOSURE; IMPACT
AB Groundwater is the only source of water in the Gaza Strip. The results of a 10-year monitoring program revealed that more than 90% of the available water is not suitable for drinking purposes as a result of elevated chemical contaminants as well as microbiological organisms. The archives of the local hospitals showed catastrophic records on diseases caused by water directly and indirectly. Methemoglobinemia and dental fluorosis are well-known diseases caused by elevated nitrate and fluoride, respectively. Water-borne diseases are currently high and will increase if water, sanitation, and food-control services are not restored, or are allowed to deteriorate further. Heavy use and misuse of banned and prohibited pesticides may show other hard diseases in the near future. Geography, politics, and war combine to make the Gaza Strip a worst-case scenario for water-resource planners. Urgent alternative water resources should be secured and the human health should be given the highest priority.
C1 Heidelberg Univ, Inst Earth Sci, D-69120 Heidelberg, Germany.
RP Shomar, B (reprint author), Heidelberg Univ, Inst Earth Sci, Neuenheimer Feld 236, D-69120 Heidelberg, Germany.
EM basem.shomar@geow.uni-heidelberg.de
FU Federal Ministry of Education and Research, BMBF, Germany
   (Forderkennzeichen) [02WT0534]
FX The author thanks Dr. Juliet VanEenwyk for her critical reading and
   comments on the manuscript. This research was funded by the Federal
   Ministry of Education and Research, BMBF, Germany (Forderkennzeichen:
   02WT0534).
CR Abu Amr SS, 2008, PUBLIC HEALTH, V122, P1275, DOI 10.1016/j.puhe.2008.02.009
   Abu Mourad TA, 2004, PUBLIC HEALTH, V118, P131, DOI 10.1016/j.puhe.2003.09.002
   ABUNASER A, 2003, RELATIONSHIP NITRATE
   AGHA R, 2000, ROUMANIAN ARCH MICRO, V59, P131
   *AMN, 2009, TROUBL WAT PAL DEN F
   Ashbolt NJ, 2004, TOXICOLOGY, V198, P229, DOI 10.1016/j.tox.2004.01.030
   Asian Development Bank (ADB), 2003, WAT ALL WAT POL AS D
   ASSAF K, 2004, GLOBAL ISSUE PAPERS, V11
   Baalousha H, 2005, ENVIRON GEOL, V48, P889, DOI 10.1007/s00254-005-0027-x
   Bohannon J, 2006, SCIENCE, V313, P1085, DOI 10.1126/science.313.5790.1085
   Howard G, 2003, WATER RES, V37, P3421, DOI 10.1016/S0043-1354(03)00235-5
   Hunter PR, 2009, SCI TOTAL ENVIRON, V407, P2621, DOI 10.1016/j.scitotenv.2009.01.018
   KAHAN D, 1987, AGR WATER RESOURCES, P181
   *MENA, 2000, PAL ENV STRAT MAIN R
   *MENA, 2002, ISR ENV VIOL W BANK
   Montgomery MA, 2007, ENVIRON SCI TECHNOL, V41, P17, DOI 10.1021/es072435t
   *PECDAR, 2003, PAL WAT STRAT PLANN
   *PEPA, 1994, GAZ ENV PROF 1, P1
   *PHG, 2009, RAP COMM BAS WAT SAN
   Pruss-Ustun A., 2008, SAFER WATER BETTER H
   Sachs Jeffrey, 2005, INVESTING DEV PRACTI
   Safi JM, 2002, SCI TOTAL ENVIRON, V284, P75, DOI 10.1016/S0048-9697(01)00868-3
   Schuster-Wallace C., 2008, SAFE WATER KEY GLOBA
   Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599
   Shomar B, 2006, ENVIRON GEOL, V50, P743, DOI 10.1007/s00254-006-0246-9
   Shomar B, 2004, J WATER HEALTH, V2, P23
   SHOMAR B, 2009, WATER POLIY IN PRESS
   Shomar B, 2008, SCI TOTAL ENVIRON, V398, P164, DOI 10.1016/j.scitotenv.2008.02.054
   Shomar BH, 2006, WATER AIR SOIL POLL, V171, P237, DOI 10.1007/s11270-005-9038-1
   *SIDA, 1999, STORM WAT SEW PROJ N
   Smith AH, 2004, TOXICOLOGY, V198, P39, DOI 10.1016/j.tox.2004.02.024
   Sobsey MD, 2008, ENVIRON SCI TECHNOL, V42, P4261, DOI 10.1021/es702746n
   UN Environment Programme [UNEP], 2009, ENV ASS GAZ STRIP FO
   *UNEP, 2009, REST REST GAZ STRIP
   *UNESCO, 2004, HP 6 SER GROUNDW, V6
   United Nations, 2007, MILL DEV GOALS REP 2
   *UNRWA, 2005, ANN REP DEV HLTH 200
   Weinthal E, 2005, GROUND WATER, V43, P653, DOI [10.1111/j.1745-6584.2005.00064.x, 10.1111/1745-6584.2005.00064.x]
   *WHO, 2009, GAZ STRIP IN HLTH NE
   *WHO, 2009, DIS RISK ASS INT GAZ
   WHO, 2006, GUID DRINK WAT QUAL, V1
   Yassin MM, 2006, PUBLIC HEALTH, V120, P1177, DOI 10.1016/j.puhe.2006.07.026
   Zeitoun M, 2009, GROUND WATER, V47, P146, DOI 10.1111/j.1745-6584.2008.00487.x
NR 43
TC 11
Z9 12
U1 2
U2 27
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0269-4042
EI 1573-2983
J9 ENVIRON GEOCHEM HLTH
JI Environ. Geochem. Health
PD APR
PY 2011
VL 33
IS 2
BP 189
EP 202
DI 10.1007/s10653-010-9332-8
PG 14
WC Engineering, Environmental; Environmental Sciences; Public,
   Environmental & Occupational Health; Water Resources
SC Engineering; Environmental Sciences & Ecology; Public, Environmental &
   Occupational Health; Water Resources
GA 733HB
UT WOS:000288252700008
PM 20577784
DA 2018-12-27
ER

PT J
AU El-Hashash, AHK
   Turcatel, G
   Al Alam, D
   Buckley, S
   Tokumitsu, H
   Bellusci, S
   Warburton, D
AF El-Hashash, Ahmed H. K.
   Turcatel, Gianluca
   Al Alam, Denise
   Buckley, Sue
   Tokumitsu, Hiroshi
   Bellusci, Saverio
   Warburton, David
TI RETRACTED: Eya1 controls cell polarity, spindle orientation, cell fate
   and Notch signaling in distal embryonic lung epithelium (Retracted
   article. See vol. 144, pg. 3849, 2017)
SO DEVELOPMENT
LA English
DT Article; Retracted Publication
DE Embryonic lung; Polarity; Eya1; Progenitor cells; Numb; Notch; Spindle
   orientation; Mouse
ID PROTEIN-KINASE-C; NEURAL STEM-CELLS; PROGENITOR CELLS; ASYMMETRIC
   SEGREGATION; BRANCHING MORPHOGENESIS; CRANIAL PLACODES; MAP KINASE;
   MOUSE LUNG; NUMB; DIVISION
AB Cell polarity, mitotic spindle orientation and asymmetric division play a crucial role in the self-renewal/differentiation of epithelial cells, yet little is known about these processes and the molecular programs that control them in embryonic lung distal epithelium. Herein, we provide the first evidence that embryonic lung distal epithelium is polarized with characteristic perpendicular cell divisions. Consistent with these findings, spindle orientation-regulatory proteins Insc, LGN (Gpsm2) and NuMA, and the cell fate determinant Numb are asymmetrically localized in embryonic lung distal epithelium. Interfering with the function of these proteins in vitro randomizes spindle orientation and changes cell fate. We further show that Eya1 protein regulates cell polarity, spindle orientation and the localization of Numb, which inhibits Notch signaling. Hence, Eya1 promotes both perpendicular division as well as Numb asymmetric segregation to one daughter in mitotic distal lung epithelium, probably by controlling aPKC zeta phosphorylation. Thus, epithelial cell polarity and mitotic spindle orientation are defective after interfering with Eya1 function in vivo or in vitro. In addition, in Eya1(-/-) lungs, perpendicular division is not maintained and Numb is segregated to both daughter cells in mitotic epithelial cells, leading to inactivation of Notch signaling. As Notch signaling promotes progenitor cell identity at the expense of differentiated cell phenotypes, we test whether genetic activation of Notch could rescue the Eya1(-/-) lung phenotype, which is characterized by loss of epithelial progenitors, increased epithelial differentiation but reduced branching. Indeed, genetic activation of Notch partially rescues Eya1(-/-) lung epithelial defects. These findings uncover novel functions for Eya1 as a crucial regulator of the complex behavior of distal embryonic lung epithelium.
C1 [El-Hashash, Ahmed H. K.; Turcatel, Gianluca; Al Alam, Denise; Buckley, Sue; Bellusci, Saverio; Warburton, David] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dev Biol & Regenerat Med Program,Saban Res Inst, Los Angeles, CA 90027 USA.
   [Tokumitsu, Hiroshi] Kagawa Univ, Fac Med, Takamatsu, Kagawa 760, Japan.
RP El-Hashash, AHK (reprint author), Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dev Biol & Regenerat Med Program,Saban Res Inst, 4661 Sunset Blvd, Los Angeles, CA 90027 USA.
EM aelhashash@chla.usc.edu; dwarburton@chla.usc.edu
RI Turcatel, Gianluca/P-5369-2014
FU NIH-NHLBI [P01 HL 60231, RO1 HL 44060, RO1 HL44977]; CIRM; GM
FX We thank Drs M. Rosenfeld, R. Hegde, P. Nare and K. Kiyosh for Eya1
   constructs/proteins. This study was funded by NIH-NHLBI P01 HL 60231,
   RO1s HL 44060, HL44977 and GM grants, and by a CIRM grant to D. W. and
   A. H. E.-H. Deposited in PMC for release after 12 months.
CR Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9
   Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017
   Bishop AE, 2004, CELL PROLIFERAT, V37, P89, DOI 10.1111/j.1365-2184.2004.00302.x
   Boitano S, 2004, AM J PHYSIOL-LUNG C, V287, pL455, DOI 10.1152/ajplung.00172.2004
   Buckley S, 2005, AM J PHYSIOL-LUNG C, V288, pL569, DOI 10.1152/ajplung.00278.2004
   Buteau J, 2001, DIABETES, V50, P2237, DOI 10.2337/diabetes.50.10.2237
   Cardoso WV, 2000, DEV DYNAM, V219, P121, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1053>3.3.CO;2-8
   Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020
   Casanova JE, 2007, EMBO REP, V8, P233, DOI 10.1038/sj.embor.7400928
   Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446
   Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265
   Cayouette M, 2001, J NEUROSCI, V21, P5643
   Cereijido M, 2000, AM J PHYSIOL-GASTR L, V279, pG477
   Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009
   Chen XYP, 1998, J CELL BIOL, V141, P1169, DOI 10.1083/jcb.141.5.1169
   Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101
   Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849
   Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095
   del Moral PM, 2006, DEV BIOL, V293, P77, DOI 10.1016/j.ydbio.2006.01.020
   Del Moral PM, 2006, DEV BIOL, V290, P177, DOI 10.1016/j.ydbio.2005.11.022
   Dho SE, 2006, MOL BIOL CELL, V17, P4142, DOI 10.1091/mbc.E06-02-0097
   DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141
   Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7
   DUTIL EM, 1994, J BIOL CHEM, V269, P29359
   Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7
   ELHASHASH AH, 2011, DEV BIOL IN PRESS
   Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608
   Fougerousse F, 2002, J MUSCLE RES CELL M, V23, P255, DOI 10.1023/A:1020990825644
   French MB, 2002, J IMMUNOL, V168, P3173, DOI 10.4049/jimmunol.168.7.3173
   Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0
   Guseh JS, 2009, DEVELOPMENT, V136, P1751, DOI 10.1242/dev.029249
   Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100
   Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500
   Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103
   Jenic J, 2007, ANNU REV BIOCHEM, V76, P513, DOI 10.1146/annurev.biochem.76.052705.164916
   KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0
   Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922
   Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083
   Lu Yun, 2008, Proc Am Thorac Soc, V5, P300, DOI 10.1513/pats.200710-162DR
   Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048
   Matsui R, 1999, CELL SIGNAL, V11, P221, DOI 10.1016/S0898-6568(98)00070-9
   Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005
   Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090
   Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4
   Nelson WJ, 2003, NEWS PHYSIOL SCI, V18, P143, DOI 10.1152/nips.01435.2002
   Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602
   Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003
   Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172
   Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114
   Ogawa H, 2009, J CELL SCI, V122, P3242, DOI 10.1242/jcs.050955
   Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7
   Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499
   Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289
   Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124
   Post LC, 2000, MECH DEVELOP, V98, P95, DOI 10.1016/S0925-4773(00)00432-9
   Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317
   Rawlins Emma L, 2008, Proc Am Thorac Soc, V5, P675, DOI 10.1513/pats.200801-006AW
   RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0
   Schlosser G, 2008, DEV BIOL, V320, P199, DOI 10.1016/j.ydbio.2008.05.523
   Shen Q, 2002, DEVELOPMENT, V129, P4843
   Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252
   Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365
   Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.embro.7601495
   Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898
   Tefft D, 2005, DEV BIOL, V282, P422, DOI 10.1016/j.ydbio.2005.03.022
   Tefft D, 2002, AM J PHYSIOL-LUNG C, V283, pL700, DOI 10.1152/ajplung.00372.2001
   Tepass U, 2003, NAT CELL BIOL, V5, P595, DOI 10.1038/ncb0703-595
   Tsao PN, 2008, J BIOL CHEM, V283, P29532, DOI 10.1074/jbc.M801565200
   Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884
   Wang C, 2009, DEVELOPMENT, V136, P2287, DOI 10.1242/dev.035758
   Wang ZZ, 2009, EMBO J, V28, P2360, DOI 10.1038/emboj.2009.190
   Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1
   Warburton D, 2008, NATURE, V453, P733, DOI 10.1038/453733a
   Xiong WJ, 2009, DEV CELL, V16, P271, DOI 10.1016/j.devcel.2008.12.005
   Xu JS, 2006, J BIOL CHEM, V281, P38894, DOI 10.1074/jbc.M609339200
   Xu PX, 1997, P NATL ACAD SCI USA, V94, P11974, DOI 10.1073/pnas.94.22.11974
   Xu PX, 1999, NAT GENET, V23, P113
   Xu PX, 1997, DEVELOPMENT, V124, P219
   Xu PX, 2002, DEVELOPMENT, V129, P3033
   Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014
   Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021
   Zou D, 2004, DEVELOPMENT, V131, P5561, DOI 10.1242/dev.01437
   Zou D, 2008, HUM MOL GENET, V17, P3340, DOI 10.1093/hmg/ddn229
NR 83
TC 38
Z9 41
U1 2
U2 8
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD APR 1
PY 2011
VL 138
IS 7
BP 1395
EP 1407
DI 10.1242/dev.058479
PG 13
WC Developmental Biology
SC Developmental Biology
GA 731NS
UT WOS:000288116500017
PM 21385765
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Kadi, AA
AF Kadi, Adnan A.
TI RETRACTED: Synthesis and antimicrobial activity of some new
   quinazolin-4(3H)-one derivatives (Retracted article. See vol. 15, pg.
   95, 2011)
SO JOURNAL OF SAUDI CHEMICAL SOCIETY
LA English
DT Article; Retracted Publication
DE Antimicrobial activity; Quinazolin-4(3H)-one; Synthesis; Thioureide
ID ACUTE RESPIRATORY SYNDROME; INFECTIONS
AB A new series of 6-iodo-2-phenylquinazolin-4(3H)-one derivatives was prepared and screened for antimicrobial activity. The thioureide derivatives 4-6, the carbohydrazide derivatives 19-21 and 24 displayed excellent broad-spectrum antimicrobial activity. Some compounds showed moderate activity against Candida albicans and Pseudomonas aeruginosa. None of the tested compounds was as active as the reference standard drugs ampicillin and clotrimazole. The detailed synthesis, antimicrobial activity, and the minimum inhibitory concentrations (MIC) are reported. (C) 2010 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
C1 King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh 11451, Saudi Arabia.
RP Kadi, AA (reprint author), King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia.
EM akadi@ksu.edu.sa
CR Alafeefy A, 2008, PHARM BIOL, V46, P751, DOI 10.1080/13880200802315907
   Apfel C, 2001, J MED CHEM, V44, P1847, DOI 10.1021/jm000352g
   Berber I, 2003, MICROBIOLOGY+, V72, P42, DOI 10.1023/A:1022221905449
   Carpenter CF, 2004, CLIN INFECT DIS, V38, P994, DOI 10.1086/383472
   Chang ZJ, 2007, BIODRUGS, V21, P9, DOI 10.2165/00063030-200721010-00002
   Chenard BL, 2001, J MED CHEM, V44, P1710, DOI 10.1021/jm000522p
   Grunder G, 2006, ANTIMICROB AGENTS CH, V50, P68, DOI 10.1128/AAC.50.1.68-72.2006
   GURSOY A, 1995, FARMACO, V50, P559
   JIANG JB, 1990, J MED CHEM, V33, P1721, DOI 10.1021/jm00168a029
   PATRICK PM, 1995, MANUAL CLIN MICROBIO, P273
   Prasad MR, 2000, ARZNEIMITTEL-FORSCH, V50, P904
   Raffa D, 1999, PHARMAZIE, V54, P251
   Tobe M, 2003, BIOORGAN MED CHEM, V11, P609, DOI 10.1016/S0968-0896(02)00338-3
   Tran TP, 2007, BIOORG MED CHEM LETT, V17, P1312, DOI 10.1016/j.bmcl.2006.12.005
   Weigelt J, 2005, ANTIMICROB AGENTS CH, V49, P2260, DOI 10.1128/AAC.49.6.2260-2266.2005
   Wong GWK, 2007, PAEDIATR RESPIR REV, V8, P171, DOI 10.1016/j.prrv.2007.04.003
   Xu GF, 2007, BIOORGAN MED CHEM, V15, P3768, DOI 10.1016/j.bmc.2007.03.037
   Yeung Kap-Sun, 2007, Infectious Disorders - Drug Targets, V7, P29, DOI 10.2174/187152607780090739
NR 18
TC 12
Z9 12
U1 2
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1319-6103
EI 2212-4640
J9 J SAUDI CHEM SOC
JI J. Saudi Chem. Soc.
PD APR
PY 2011
VL 15
IS 2
BP 95
EP 100
DI 10.1016/j.jscs.2010.06.001
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 729ZI
UT WOS:000287992800001
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Greenham, K
   Santner, A
   Castillejo, C
   Mooney, S
   Sairanen, I
   Ljung, K
   Estelle, M
AF Greenham, Katie
   Santner, Aaron
   Castillejo, Cristina
   Mooney, Sutton
   Sairanen, IIkka
   Ljung, Karin
   Estelle, Mark
TI RETRACTED: The AFB4 Auxin Receptor Is a Negative Regulator of Auxin
   Signaling in Seedlings (Retracted article. See vol. 25, pg. 819, 2015)
SO CURRENT BIOLOGY
LA English
DT Article; Retracted Publication
ID ARABIDOPSIS-THALIANA; GROWTH; IDENTIFICATION; ELONGATION; MUTATIONS;
   RESPONSES; FAMILY; PLANTS; LIGHT; ACID
AB The plant hormone auxin is perceived by a family of F box proteins called the TIR1/auxin-signaling F box proteins (AFBs). Phylogenetic studies reveal that these proteins fall into four clades in flowering plants called TIR1, AFB2, AFB4, and AFB6 [1]. Genetic studies indicate that members of the TIR1 and AFB2 groups act as positive regulators of auxin signaling [1, 2]. In this report, we demonstrate a unique role for the AFB4 clade. Both AFB4 and AFB5 function as auxin receptors based on in vitro assays. However, unlike other members of the family, loss of AFB4 results in a range of growth defects that are consistent with auxin hypersensitivity, including increased hypocotyl and petiole elongation and increased numbers of lateral roots. Indeed, qRT-PCR experiments show that afb4-2 is hypersensitive to indole-3-acetic acid (IAA) in the hypocotyl, indicating that AFB4 is a negative regulator of auxin response. Furthermore, we show that AFB4 has a particularly important role in the response of seedlings to elevated temperature. Finally, we provide evidence that the AFB4 clade is the major target of the picloram family of auxinic herbicides. These results reveal a previously unknown aspect of auxin receptor function.
C1 [Greenham, Katie; Castillejo, Cristina; Estelle, Mark] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.
   [Santner, Aaron] Cook Inc, Bloomington, IN 47402 USA.
   [Mooney, Sutton] Washington State Univ, Sch Biol Sci, Pullman, WA USA.
   [Sairanen, IIkka; Ljung, Karin] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, SE-90183 Umea, Sweden.
RP Estelle, M (reprint author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.
EM mestelle@ucsd.edu
OI Ljung, Karin/0000-0003-2901-189X
FU US Department of Energy [De-FG02-02ER15312]; National Institutes of
   Health [GM43644]; Swedish Governmental Agency for Innovation Systems
   (VINNOVA); Swedish Research Council (VR)
FX This work was supported by grants to M.E. from the US Department of
   Energy (De-FG02-02ER15312) and National Institutes of Health (GM43644)
   and to K.L. from the Swedish Governmental Agency for Innovation Systems
   (VINNOVA) and the Swedish Research Council (VR).
CR CHANG IK, 1983, PESTIC BIOCHEM PHYS, V19, P203, DOI 10.1016/0048-3575(83)90141-4
   Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743
   de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520
   Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014
   Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005
   Fujimori T, 2004, PLANT CELL PHYSIOL, V45, P1078, DOI 10.1093/pcp/pch124
   Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678
   Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197
   HAMAKER JW, 1963, SCIENCE, V141, P363, DOI 10.1126/science.141.3578.363
   Leyser O, 2010, PLANT PHYSIOL, V154, P501, DOI 10.1104/pp.110.161323
   Lorrain S, 2009, PLANT J, V60, P449, DOI 10.1111/j.1365-313X.2009.03971.x
   Lucas M, 2011, PLANT PHYSIOL, V155, P384, DOI 10.1104/pp.110.165126
   Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050
   Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946
   Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106
   Savaldi-Goldstein S, 2008, P NATL ACAD SCI USA, V105, P15190, DOI 10.1073/pnas.0806324105
   SCOTT PC, 1970, PLANT PHYSIOL, V46, P680, DOI 10.1104/pp.46.5.680
   Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903
   Walsh TA, 2006, PLANT PHYSIOL, V142, P542, DOI 10.1104/pp.106.085969
   Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306
NR 20
TC 59
Z9 62
U1 2
U2 25
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD MAR 22
PY 2011
VL 21
IS 6
BP 520
EP 525
DI 10.1016/j.cub.2011.02.029
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 740WW
UT WOS:000288826100029
PM 21396817
OA Bronze, Green Accepted
DA 2018-12-27
ER

PT J
AU Singhal, RK
   Sharma, SC
   Kumari, P
   Kumar, S
   Xing, YT
   Deshpande, UP
   Shripathi, T
   Saitovitch, E
AF Singhal, R. K.
   Sharma, S. C.
   Kumari, P.
   Kumar, Sudhish
   Xing, Y. T.
   Deshpande, U. P.
   Shripathi, T.
   Saitovitch, Elisa
TI RETRACTED: Study of electronic structure and magnetization correlations
   in hydrogenated and vacuum annealed Ni doped ZnO (Retracted article. See
   vol. 115, 239902, 2014)
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article; Retracted Publication
ID ROOM-TEMPERATURE FERROMAGNETISM; THIN-FILMS; MN; SEMICONDUCTOR;
   NANOPARTICLES; PHOTOEMISSION; CRYSTALS; ORIGIN
AB The influence of hydrogen and vacuum annealing on the structural, electronic, and magnetic properties of Ni-doped ZnO pellets viz. Zn0.95Ni0.05O has been investigated using x-ray diffraction (XRD), magnetization, resistance measurements, and x-ray photoelectron spectroscopy (XPS). Rietveld refinement of the XRD patterns confirms that all the polycrystalline samples possess wurtzite type hexagonal structure with no evidence of secondary phases. The superconducting quantum interference device magnetometry measurements exhibit a paramagnetic state for the as-synthesized Zn0.95Ni0.05O. However, the post annealing in H-2 as well as in vacuum, drive it to a ferromagnetic state at 300 K. The obtained values of coercivity are 177 and 270 Oe, and the saturation magnetizations are 1.67 and 1.91 emu/g, respectively, for the H-2 and vacuum annealed samples. Temperature dependent magnetization results show that the Curie temperatures are nearly the same (similar to 550 K) for both the annealed samples. Resistance of the annealed samples is three orders of magnitude lower than their as-synthesized counterparts. The XPS results confirm bivalency of Ni ions and creation of O vacancies upon annealing, due to the Ni (3d)-O (2p) hybridization. The ferromagnetism and the consequent electronic property changes are reversible with regard to reheating the samples in air, in agreement with the reported switch "on" and "off" ferromagnetic ordering in the doped ZnO. (C) 2011 American Institute of Physics. [doi:10.1063/1.3556458]
C1 [Singhal, R. K.; Sharma, S. C.; Kumari, P.] Univ Rajasthan, Dept Phys, Jaipur 302055, Rajasthan, India.
   [Singhal, R. K.; Saitovitch, Elisa] CBPF, BR-22290180 Rio De Janeiro, Brazil.
   [Kumar, Sudhish] ML Sukhadia Univ, Dept Phys, Udaipur 313002, India.
   [Xing, Y. T.] Univ Fed Fluminense, Inst Fis, BR-24210346 Rio De Janeiro, Brazil.
   [Deshpande, U. P.; Shripathi, T.] UGC DAE CSR, Indore 452001, Madhya Pradesh, India.
RP Singhal, RK (reprint author), Univ Rajasthan, Dept Phys, Jaipur 302055, Rajasthan, India.
EM singhal46@yahoo.co.in
CR Bodker F, 2000, J MAGN MAGN MATER, V221, P32, DOI 10.1016/S0304-8853(00)00392-9
   Cheng XM, 2003, J APPL PHYS, V93, P7876, DOI 10.1063/1.1556125
   Cong CJ, 2006, SOLID STATE COMMUN, V138, P511, DOI 10.1016/j.ssc.2006.04.020
   Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019
   Dietl T, 2002, SEMICOND SCI TECH, V17, P377, DOI 10.1088/0268-1242/17/4/310
   El-Hilo M, 2009, J MAGN MAGN MATER, V321, P2279, DOI 10.1016/j.jmmm.2009.01.040
   Ghosh S, 2008, APPL PHYS A-MATER, V90, P765, DOI 10.1007/s00339-007-4353-6
   Huang XH, 2009, SCRIPTA MATER, V60, P984, DOI 10.1016/j.scriptamat.2009.02.038
   HUFNER S, 1973, PHYS REV B, V8, P4857, DOI 10.1103/PhysRevB.8.4857
   Ichiyanagi Y, 2003, PHYSICA B, V329, P862, DOI 10.1016/S0921-4526(02)02578-4
   Jeong SH, 2003, APPL PHYS LETT, V82, P2625, DOI 10.1063/1.1568543
   Jin ZW, 2001, APPL PHYS LETT, V78, P3824, DOI 10.1063/1.1377856
   Kim JH, 2004, SOLID STATE COMMUN, V131, P677, DOI 10.1016/j.ssc.2004.06.033
   Kim JH, 2002, J APPL PHYS, V92, P6066, DOI 10.1063/1.1513890
   Kim K.S., 1972, J ELECTRON SPECTROSC, V1, P251, DOI [DOI 10.1016/0368-2048(72)85014-X, DOI 10.1016/S0368-2048(01)00249-3]
   Kittilstved KR, 2006, NAT MATER, V5, P291, DOI 10.1038/nmat1616
   Kundaliya DC, 2004, NAT MATER, V3, P709, DOI 10.1038/nmat1221
   Lee HJ, 2002, APPL PHYS LETT, V81, P4020, DOI 10.1063/1.1517405
   Mao XY, 2008, J MAGN MAGN MATER, V320, P1102, DOI 10.1016/j.jmmm.2007.10.022
   Norton DP, 2003, APPL PHYS LETT, V82, P239, DOI 10.1063/1.1537457
   Pandey B, 2008, J MAGN MAGN MATER, V320, P3347, DOI 10.1016/j.jmmm.2008.07.018
   Park JH, 2004, APPL PHYS LETT, V84, P1338, DOI 10.1063/1.1650915
   RADOVANOVIC PV, 2003, PHYS REV LETT, V91
   Rodriguez-Carvajal J., 2003, FULLPROF VERSION 3 0
   Samariya A, 2010, APPL SURF SCI, V257, P585, DOI 10.1016/j.apsusc.2010.07.037
   Samariya A, 2010, MATER CHEM PHYS, V123, P678, DOI 10.1016/j.matchemphys.2010.05.036
   Sato K, 2001, JPN J APPL PHYS 2, V40, pL334, DOI 10.1143/JJAP.40.L334
   Sato K, 2000, JPN J APPL PHYS 2, V39, pL555, DOI 10.1143/JJAP.39.L555
   Schwartz DA, 2004, APPL PHYS LETT, V85, P1395, DOI 10.1063/1.1785872
   Sharma P, 2003, NAT MATER, V2, P673, DOI 10.1038/nmat984
   Singh S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2208563
   Singhal RK, 2010, PHYS STATUS SOLIDI A, V207, P2373, DOI 10.1002/pssa.200925637
   Singhal RK, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3507290
   Singhal RK, 2010, J APPL PHYS, V107, DOI 10.1063/1.3431396
   Singhal RK, 2010, J ALLOY COMPD, V496, P324, DOI 10.1016/j.jallcom.2010.02.005
   Singhal RK, 2010, SOLID STATE COMMUN, V150, P1154, DOI 10.1016/j.ssc.2010.03.018
   Singhal RK, 2009, J ALLOY COMPD, V477, P379, DOI 10.1016/j.jallcom.2008.10.005
   Wagner C. D., 1979, HDB XRAY PHOTOELECTR, P81
   Wakano T, 2001, PHYSICA E, V10, P260, DOI 10.1016/S1386-9477(01)00095-9
   WEAKLIEM HA, 1962, J CHEM PHYS, V36, P2117, DOI 10.1063/1.1732840
   Wu JJ, 2004, APPL PHYS LETT, V85, P1027, DOI 10.1063/1.1779958
   Yin ZG, 2005, SOLID STATE COMMUN, V135, P430, DOI 10.1016/j.ssc.2005.05.024
   Yu GH, 2001, J APPL PHYS, V90, P4039, DOI 10.1063/1.1401804
   Zhang SB, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.075205
NR 44
TC 11
Z9 11
U1 4
U2 52
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-8979
EI 1089-7550
J9 J APPL PHYS
JI J. Appl. Phys.
PD MAR 15
PY 2011
VL 109
IS 6
AR 063907
DI 10.1063/1.3556458
PG 7
WC Physics, Applied
SC Physics
GA 745EY
UT WOS:000289149900085
DA 2018-12-27
ER

PT J
AU Valastyan, S
   Chang, A
   Benaich, N
   Reinhardt, F
   Weinberg, RA
AF Valastyan, Scott
   Chang, Amelia
   Benaich, Nathan
   Reinhardt, Ferenc
   Weinberg, Robert A.
TI RETRACTED: Activation of miR-31 function in already-established
   metastases elicits metastatic regression (Retracted article. See vol.
   29, pg. 686, 2015)
SO GENES & DEVELOPMENT
LA English
DT Article; Retracted Publication
DE metastasis; miR-31; breast cancer; metastatic colonization; microRNA
ID BREAST-CANCER METASTASIS; TUMOR-METASTASIS; MICRORNA; INHIBITORS; CELLS;
   SURVIVAL; SPREAD; MODEL; LUNG; RNAS
AB Distant metastases, rather than the primary tumors from which these lesions arise, are responsible for > 90% of carcinoma-associated mortality. Many patients already harbor disseminated tumor cells in their bloodstream, bone marrow, and distant organs when they initially present with cancer. Hence, truly effective anti-metastatic therapeutics must impair the proliferation and survival of already-established metastases. Here, we assess the therapeutic potential of acutely expressing the microRNA miR-31 in already-formed breast cancer metastases. Activation of miR-31 in established metastases elicits metastatic regression and prolongs survival. Remarkably, even brief induction of miR-31 in macroscopic pulmonary metastases diminishes metastatic burden. In contrast, acute miR-31 expression fails to affect primary mammary tumor growth. miR-31 triggers metastatic regression in the lungs by eliciting cell cycle arrest and apoptosis; these responses occur specifically in metastases and can be explained by miR-31-mediated suppression of integrin-alpha 5, radixin, and RhoA. Indeed, concomitant re-expression of these three proteins renders already-seeded pulmonary metastases refractory to miR-31-conferred regression. Upon miR-31 activation, Akt-dependent signaling is attenuated and the proapoptotic molecule Bim is induced; these effects occur in a metastasis-specific manner in pulmonary lesions and are abrogated by concurrent re-expression of integrin-alpha 5, radixin, and RhoA. Collectively, these findings raise the possibility that intervention strategies centered on restoring miR-31 function may prove clinically useful for combating metastatic disease.
C1 [Valastyan, Scott; Chang, Amelia; Benaich, Nathan; Reinhardt, Ferenc; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.
   [Valastyan, Scott; Chang, Amelia; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA.
   [Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA.
RP Weinberg, RA (reprint author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.
EM weinberg@wi.mit.edu
FU NIH; MIT Ludwig Center for Molecular Oncology; U.S. Department of
   Defense; Breast Cancer Research Foundation
FX We thank Julie Valastyan for critical review of this manuscript; M.
   Saelzler, W. Guo, Z. Keckesova, and other members of the Weinberg
   laboratory for helpful discussions and materials; D. Bartel, G. Bokoch,
   S. Crouch, K. Hochedlinger, T. Kafri, S. Kuwada, J. Massague, and P.
   Sharp for reagents; and the Koch Institute Histology Facility for tissue
   sectioning. This research was supported by the NIH, MIT Ludwig Center
   for Molecular Oncology, U.S. Department of Defense, and Breast Cancer
   Research Foundation. S.V. and R.A.W. are inventors on a patent
   application based in part on findings detailed in this manuscript. S.V.
   is a U.S. Department of Defense Breast Cancer Research Program
   Predoctoral Fellow. R.A.W. is an American Cancer Society Research
   Professor and a Daniel K. Ludwig Foundation Cancer Research Professor.
CR Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978
   Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100
   Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079
   Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001
   Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997
   Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003
   Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021
   Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799
   Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385
   Oskarsson T, 2010, J AM CHEM SOC, V132, P3224, DOI 10.1021/ja9101503
   Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375
   Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594
   Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469
   Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207
   Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445
   Valastyan S, 2010, CELL CYCLE, V9, P2124, DOI 10.4161/cc.9.11.11843
   Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410
   Valastyan S, 2009, CELL CYCLE, V8, P3506, DOI 10.4161/cc.8.21.9802
   Valastyan S, 2009, GENE DEV, V23, P2592, DOI 10.1101/gad.1832709
   Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047
   van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967
   Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005
   Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655
   Wszolek MF, 2011, UROL ONCOL-SEMIN ORI, V29, P794, DOI 10.1016/j.urolonc.2009.08.024
NR 28
TC 70
Z9 75
U1 1
U2 12
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD MAR 15
PY 2011
VL 25
IS 6
BP 646
EP 659
DI 10.1101/gad.2004211
PG 14
WC Cell Biology; Developmental Biology; Genetics & Heredity
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA 734VA
UT WOS:000288366800010
PM 21406558
OA Green Published
DA 2018-12-27
ER

PT J
AU Liu, JJ
   Yin, ZY
AF Liu, Jingjing
   Yin, Zhaoyang
TI RETRACTED: Blow-up and global existence for a modified two-component
   Camassa-Holm equation (Retracted article. See vol. 380, pg. 403, 2011)
SO JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS
LA English
DT Article; Retracted Publication
DE Modified two-component Camassa-Holm equation; Strong solutions; Blow-up;
   Blow-up rate; Global existence
ID SHALLOW-WATER EQUATION; WELL-POSEDNESS; WAVES; SCATTERING; BREAKING;
   SYSTEM
AB The present work is mainly concerned with blow-up phenomena and global existence for a modified two-component Camassa-Holm equation. Firstly, a new blow-up criterion and the precise blow-up rate are presented. Then, a new global existence result for strong solutions to the equation is given. Crown Copyright (C) 2010 Published by Elsevier Inc. All rights reserved.
C1 [Liu, Jingjing; Yin, Zhaoyang] Sun Yat Sen Univ, Dept Math, Guangzhou 510275, Guangdong, Peoples R China.
RP Liu, JJ (reprint author), Sun Yat Sen Univ, Dept Math, Guangzhou 510275, Guangdong, Peoples R China.
EM jingjing830306@163.com; mcsyzy@mail.sysu.edu.cn
FU NNSFC [10971235]; RFDP [200805580014]; Sun Yat-sen University; 
   [NCET-08-0579]
FX This work was partially supported by NNSFC (No. 10971235), RFDP (No.
   200805580014), NCET-08-0579 and the key project of Sun Yat-sen
   University. The authors are grateful to the reviewers for the valuable
   comments and suggestions.
CR Beals R, 1998, ADV MATH, V140, P190, DOI 10.1006/aima.1998.1768
   CAMASSA R, 1993, PHYS REV LETT, V71, P1661, DOI 10.1103/PhysRevLett.71.1661
   Camassa R., 1994, ADV APPL MECH, V31, P1, DOI [DOI 10.1016/S0065-2156(08)70254-0), 10.1016/S0065-2156(08)70254-0]
   Chen M, 2006, LETT MATH PHYS, V75, P1, DOI 10.1007/s11005-005-0041-7
   Constantin A, 2000, COMMUN PUR APPL MATH, V53, P603
   Constantin A, 1998, COMMUN PUR APPL MATH, V51, P475, DOI 10.1002/(SICI)1097-0312(199805)51:5<475::AID-CPA2>3.0.CO;2-5
   Constantin A, 1998, ACTA MATH-DJURSHOLM, V181, P229, DOI 10.1007/BF02392586
   Constantin A, 2001, P ROY SOC A-MATH PHY, V457, P953, DOI 10.1098/rspa.2000.0701
   Constantin A, 2000, MATH Z, V233, P75, DOI 10.1007/PL00004793
   Constantin A., 1997, EXPO MATH, V15, P53
   Constantin A., 1998, ANN SCUOLA NORM SU S, V26, P303
   Constantin A, 2007, B AM MATH SOC, V44, P423, DOI 10.1090/S0273-0979-07-01159-7
   Constantin A, 2008, PHYS LETT A, V372, P7129, DOI 10.1016/j.physleta.2008.10.050
   Dai HH, 1998, ACTA MECH, V127, P193, DOI 10.1007/BF01170373
   Danchin R, 2001, DIFFERENTIAL INTEGRA, V14, P953
   ESCHER J, 2008, J FUNCT ANAL, V256, P479
   Escher J, 2008, COMMUN PART DIFF EQ, V33, P377, DOI 10.1080/03605300701318872
   Escher J, 2007, DISCRETE CONT DYN-A, V19, P493
   FUCHSSTEINER B, 1981, PHYSICA D, V4, P47, DOI 10.1016/0167-2789(81)90004-X
   GUAN C, 2010, P 2008 2009 SPEC YEA, P199
   Guan CX, 2010, J DIFFER EQUATIONS, V248, P2003, DOI 10.1016/j.jde.2009.08.002
   HOLM D, 2009, PHYS REV E 2, V79, pNI483
   Ivanov RI, 2007, PHILOS T R SOC A, V365, P2267, DOI 10.1098/rsta.2007.2007
   Li YA, 2000, J DIFFER EQUATIONS, V162, P27, DOI 10.1006/jdeq.1999.3683
   LIU J, GLOBAL EXISTENCE BLO
   Rodriguez-Blanco G, 2001, NONLINEAR ANAL-THEOR, V46, P309, DOI 10.1016/S0362-546X(01)00791-X
   YIN Z, 2004, DISCRETE CONTIN DYN, V10, P393
NR 27
TC 0
Z9 0
U1 1
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-247X
EI 1096-0813
J9 J MATH ANAL APPL
JI J. Math. Anal. Appl.
PD MAR 15
PY 2011
VL 375
IS 2
BP 502
EP 509
DI 10.1016/j.jmaa.2010.09.059
PG 8
WC Mathematics, Applied; Mathematics
SC Mathematics
GA 681TS
UT WOS:000284343200013
OA Bronze
DA 2018-12-27
ER

PT J
AU Ma, YG
   Sahebdivan, S
   Ong, CK
   Tyc, T
   Leonhardt, U
AF Ma, Yun Gui
   Sahebdivan, Sahar
   Ong, C. K.
   Tyc, Tomas
   Leonhardt, Ulf
TI RETRACTED: Evidence for subwavelength imaging with positive refraction
   (Retracted article. See vol. 18, 059702, 2016)
SO NEW JOURNAL OF PHYSICS
LA English
DT Article; Retracted Publication
ID DIFFRACTION LIMIT; OPTICAL HYPERLENS; FISH-EYE; METAMATERIALS; FIELDS;
   LIGHT; LENS
AB The resolution of lenses is normally limited by the wave nature of light. Imaging with perfect resolution was believed to rely on negative refraction, but here we present experimental evidence for subwavelength imaging with positive refraction.
C1 [Sahebdivan, Sahar; Tyc, Tomas; Leonhardt, Ulf] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.
   [Ma, Yun Gui] Natl Univ Singapore, Temasek Labs, Singapore 119260, Singapore.
   [Ong, C. K.] Natl Univ Singapore, Dept Phys, Ctr Superconducting & Magnet Mat, Singapore 117542, Singapore.
   [Tyc, Tomas] Masaryk Univ, Fac Informat, CS-61137 Brno, Czech Republic.
   [Tyc, Tomas] Masaryk Univ, Fac Sci, CS-61137 Brno, Czech Republic.
RP Leonhardt, U (reprint author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.
EM ulf@st-andrews.ac.uk
RI Ong, CK/G-1646-2012
CR Abbe E., 1873, ARCH MIKROSK ANAT, V9, P413, DOI DOI 10.1007/BF02956173
   Benitez P, 2010, OPT EXPRESS, V18, P7650, DOI 10.1364/OE.18.007650
   Blaikie RJ, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/058001
   Chen HY, 2010, NAT MATER, V9, P387, DOI [10.1038/nmat2743, 10.1038/NMAT2743]
   Cornbleet S, 1976, MICROWAVE OPTICS OPT
   DEROSNY L, 2002, PHYS REV LETT, V89
   Erdelyi A., 1981, HIGHER TRANSCENDENTA, VI
   Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759
   Feynman R.P., 2006, FEYNMAN LECT PHYS, V2
   GABRIELLI LH, 2010, ARXIV10072564
   Gonzalez JC, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/023038
   Guenneau S, 2010, J MOD OPTIC, V57, P511, DOI 10.1080/09500341003640061
   Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247
   Kinsler P, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/028001
   Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493
   Leonhardt U., 2010, GEOMETRY LIGHT SCI I
   Leonhardt U, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/10/247
   Leonhardt U, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/028002
   Leonhardt U, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/2/024016
   Leonhardt U, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.057802
   Leonhardt U, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/058002
   Leonhardt U, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.011804
   Leonhardt U, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093040
   Leonhardt U, 2009, SCIENCE, V323, P110, DOI 10.1126/science.1166332
   Lerosey G, 2007, SCIENCE, V315, P1120, DOI 10.1126/science.1134824
   Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368
   LUNEBURG RK, 1964, MATHEMATICAL THEORY
   Marques R, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2397022
   Maxwell J. C., 1854, CAMBRIDGE DUBLIN MAT, V8, P188
   Merlin R, 2011, J OPT-UK, V13, DOI 10.1088/2040-8978/13/2/024017
   Merlin R, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.057801
   Minano JC, 2006, OPT EXPRESS, V14, P9627, DOI 10.1364/OE.14.009627
   Minano JC, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/123023
   Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907
   Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966
   Quabis S, 2000, OPT COMMUN, V179, P1, DOI 10.1016/S0030-4018(99)00729-4
   Schultheiss VH, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143901
   Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628
   Shalaev VM, 2008, SCIENCE, V322, P384, DOI 10.1126/science.1166079
   Smith DR, 2006, J OPT SOC AM B, V23, P391, DOI 10.1364/JOSAB.23.000391
   Smolyaninova VN, 2010, OPT LETT, V35, P3396, DOI 10.1364/OL.35.003396
   Stockman MI, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.177404
   Sun F, 2010, PROG ELECTROMAGN RES, V108, P307, DOI 10.2528/PIER1009100
   TYC T, 2010, ARXIV10103178
   Zhao L, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3043414
NR 45
TC 44
Z9 44
U1 2
U2 23
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1367-2630
J9 NEW J PHYS
JI New J. Phys.
PD MAR 9
PY 2011
VL 13
AR 033016
DI 10.1088/1367-2630/13/3/033016
PG 10
WC Physics, Multidisciplinary
SC Physics
GA 744AP
UT WOS:000289064400001
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Ratner, E
   Keane, F
   Yu, H
   Zelterman, D
   Rutherford, T
   Santin, A
   Schwartz, P
   Slack, F
   Levine, D
   Weidhaas, J
AF Ratner, E.
   Keane, F.
   Yu, H.
   Zelterman, D.
   Rutherford, T.
   Santin, A.
   Schwartz, P.
   Slack, F.
   Levine, D.
   Weidhaas, J.
TI RETRACTED: A 3 ' UTR KRAS variant as a biomarker of poor outcome and
   chemotherapy resistance in ovarian cancer (Retracted article. See vol.
   122, pg. 205, 2011)
SO GYNECOLOGIC ONCOLOGY
LA English
DT Meeting Abstract; Retracted Publication
C1 [Ratner, E.; Keane, F.; Yu, H.; Zelterman, D.; Rutherford, T.; Santin, A.; Schwartz, P.; Slack, F.; Levine, D.; Weidhaas, J.] Yale Univ, Sch Med, Fairfield, CT USA.
NR 0
TC 1
Z9 1
U1 3
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0090-8258
EI 1095-6859
J9 GYNECOL ONCOL
JI Gynecol. Oncol.
PD MAR
PY 2011
VL 121
IS 1
SU 1
MA 3
BP S3
EP S3
DI 10.1016/j.ygyno.2010.12.010
PG 1
WC Oncology; Obstetrics & Gynecology
SC Oncology; Obstetrics & Gynecology
GA 760AF
UT WOS:000290292300005
DA 2018-12-27
ER

PT J
AU Liao, GJ
   Luo, H
   Yan, SF
   Dai, XC
   Chen, M
AF Liao Guo-Jin
   Luo Hong
   Yan Shao-Feng
   Dai Xiao-Chun
   Chen Ming
TI RETRACTED: Determination of the optical constants of the magnetron
   sputtered aluminum oxide films from the transmission spectra (Retracted
   Article)
SO ACTA PHYSICA SINICA
LA Chinese
DT Article; Retracted Publication
DE optical constants; Swanepoel's method; Al2O3 films; annealing
ID SPRAY-PYROLYSIS; THIN-FILMS; PHOTOLUMINESCENCE; LUMINESCENT; THICKNESS
AB By combining Swanepoel's theory and the Wemple-DiDomenico dispersion model, a simple method was established to determine the optical contants of the magnetron sputtered aluminum oxide films directly from the corresponding transmission spectra. The results showed that the magnetron sputtered aluminum oxide films exhibit the optical characteristics of high refractive index of 1.566-1.76 (at 550 nm), negligible absorption in spectral region of 400-1100 nm, as well as the direct band gap of about 3.91-4.2 eV. And the specific values of the optical constants strongly depend on the annealing temperature, which is one of the important technological parameters for the magnetron sputtered aluminum oxide films. Moreover, in the weak and medium absorption spectral regions, the calculated values of refractive indices are in satisfactory agreement with the results derived from the high-resolution Tek3000 film - characterization system, indicating the reliability and feasibility of the method in determining the optical constants of Al(2)O(3)films.
C1 [Liao Guo-Jin; Yan Shao-Feng; Dai Xiao-Chun; Chen Ming] Liaoning Univ Technoligy, Fac Mech Engn & Automat, Jinzhou 121001, Peoples R China.
   [Luo Hong] Petro China NE Refining & Chem Engn Co Ltd, Jinzhou Design Inst, Jinzhou 121001, Peoples R China.
RP Liao, GJ (reprint author), Liaoning Univ Technoligy, Fac Mech Engn & Automat, Jinzhou 121001, Peoples R China.
EM liaoguojin@163.com
FU National Natural Science Foundation of China [50376067]; Research
   Foundation of Education Bureau of Liaoning Province, China [20011316]
FX Project supported by the National Natural Science Foundation of China
   (Grant No. 50376067), the Research Foundation of Education Bureau of
   Liaoning Province, China(Grant No. 20011316).
CR BA DC, 2006, CHINESE J VACUUM SCI, V26, P421
   Bhaskar S, 2001, MAT SCI ENG B-SOLID, V87, P178, DOI 10.1016/S0921-5107(01)00739-5
   Caldino U, 2003, J PHYS-CONDENS MAT, V15, P3821
   Esparza-Garcia AE, 2003, J ELECTROCHEM SOC, V150, pH53, DOI 10.1149/1.1535913
   Gonzalez-Leal JM, 2003, J NON-CRYST SOLIDS, V315, P134, DOI 10.1016/S0022-3093(02)01430-8
   Ishizaka T, 2001, OPT MATER, V15, P293, DOI 10.1016/S0925-3467(00)00045-8
   Kondo Y, 2005, OPT MATER, V27, P1438, DOI 10.1016/j.optmat.2004.10.007
   Lazarouk SK, 1998, APPL PHYS LETT, V73, P2272, DOI 10.1063/1.121699
   LIAO GJ, 2008, ACTA PHYS SINICA, V57, P625
   LIAO GJ, 2007, J NE U NATURAL SCI, V28, P689
   MARQUEZ E, 1995, THIN SOLID FILMS, V254, P83, DOI 10.1016/0040-6090(94)06267-O
   Martinez E, 2000, PHYS STATUS SOLIDI B, V220, P677, DOI 10.1002/1521-3951(200007)220:1<677::AID-PSSB677>3.0.CO;2-Y
   Martinez-Martinez R, 2005, J PHYS-CONDENS MAT, V17, P3647, DOI 10.1088/0953-8984/17/23/016
   Nag A, 2005, MATER CHEM PHYS, V91, P524, DOI 10.1016/j.matchemphys.2004.12.020
   PASTORE GF, 1985, THIN SOLID FILMS, V123, P9, DOI 10.1016/0040-6090(85)90036-7
   RAKOV N, 2004, FLAT PANEL DISPLAYS, V400, pP272
   Serna R, 2001, J APPL PHYS, V90, P5120, DOI 10.1063/1.1409575
   SWANEPOEL R, 1983, J PHYS E SCI INSTRUM, V16, P1214, DOI 10.1088/0022-3735/16/12/023
   TANNAS EL, 1985, FLAT PANEL DISPLAYS, P380
   Tigau N, 2005, J CRYST GROWTH, V277, P529, DOI 10.1016/j.jcrysgro.2005.01.056
   Xu WL, 2004, APPL PHYS LETT, V85, P4364, DOI 10.1063/1.1815072
NR 21
TC 1
Z9 1
U1 5
U2 14
PU CHINESE PHYSICAL SOC
PI BEIJING
PA P O BOX 603, BEIJING 100080, PEOPLES R CHINA
SN 1000-3290
J9 ACTA PHYS SIN-CH ED
JI Acta Phys. Sin.
PD MAR
PY 2011
VL 60
IS 3
AR 034201
PG 7
WC Physics, Multidisciplinary
SC Physics
GA 742FC
UT WOS:000288925700037
DA 2018-12-27
ER

PT J
AU Chirica, I
   Beznea, EF
AF Chirica, Ionel
   Beznea, Elena-Felicia
TI RETRACTED: Buckling analysis of the composite plates with delaminations
   (Retracted article. See vol. 109, pg. 402, 2015)
SO COMPUTATIONAL MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper; Retracted Publication
CT 19th International Workshop on Computational Mechanics of Materials
   (IWCMM 19)
CY SEP 01-04, 2009
CL Ovidius Univ Constanta, Constanta, ROMANIA
HO Ovidius Univ Constanta
DE Polymers; Plate buckling; Delamination
ID COMPRESSION
AB In the paper, a study of the influence of elliptical delamination on the changes in the buckling behaviour of ship deck plates made of composite materials is treated. An delamination model has been developed by using the surface-to-surface contact option, in licensed FEM code COSMOS/M. So, the damaged part of the structures and the undamaged part have been represented by well-known finite elements (layered shell elements). The numerical results are compared with the experiments made on the square plates. The influence of the position and the ellipse's diameters ratio of delaminated zone on the critical buckling force was investigated. (c) 2010 Elsevier B.V. All rights reserved.
C1 [Chirica, Ionel; Beznea, Elena-Felicia] Univ Dunarea Jos Galati, Galati 800008, Romania.
RP Chirica, I (reprint author), Univ Dunarea Jos Galati, 47 Domneasca Str, Galati 800008, Romania.
EM ionel.chirica@ugal.ro
CR Adams DF, 2003, EXPT CHARACTERIZATIO
   Altenbach H., 2001, MECH COMPOSITE STRUC
   Aslan Z, 2009, COMPOS STRUCT, V89, P382, DOI 10.1016/j.compstruct.2008.08.011
   BEZNEA EF, 2008, THESIS U DUNAREA DE
   Hwang SF, 2001, COMPOS STRUCT, V53, P235, DOI 10.1016/S0263-8223(01)00007-1
   Jones R. M, 1999, MECH COMPOSITE MAT
   PARTSEVSKII VV, 1990, MECH COMPOS MATER, V26, P758
   Tafreshi A, 2006, COMPOS STRUCT, V72, P401, DOI 10.1016/j.compstruct.2005.01.009
   Thurley G.J., 1995, BUCKLING POSTBUCKLIN
NR 9
TC 14
Z9 14
U1 3
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-0256
EI 1879-0801
J9 COMP MATER SCI
JI Comput. Mater. Sci.
PD MAR
PY 2011
VL 50
IS 5
BP 1587
EP 1591
DI 10.1016/j.commatsci.2010.08.004
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 742EY
UT WOS:000288925300001
DA 2018-12-27
ER

PT J
AU Arnold, M
   Aarts, MJ
   Siesling, S
   van der Aa, M
   Visser, O
   Coebergh, JW
AF Arnold, Melina
   Aarts, Mieke Josepha
   Siesling, Sabine
   van der Aa, Maaike
   Visser, Otto
   Coebergh, Jan Willem
TI RETRACTED: Breast and stomach cancer incidence and survival in migrants
   in the Netherlands, 1996-2006 (Retracted article. See vol. 21, pg. 602,
   2012)
SO EUROPEAN JOURNAL OF CANCER PREVENTION
LA English
DT Article; Retracted Publication
DE cancer; ethnicity; health transition; prevention; survival
ID 1ST GENERATION MIGRANTS; HELICOBACTER-PYLORI; 2ND-GENERATION IMMIGRANTS;
   MORTALITY; 1ST-GENERATION; RISK; WOMEN; DISPARITIES; POPULATION; SWEDEN
AB Migrant populations experience a health transition that influences their cancer risk, determined by environmental changes and acculturation processes. In this retrospective cohort study, we investigated differences in breast and stomach cancer risk and survival in migrants to the Netherlands. Invasive breast and stomach cancer cases diagnosed between 1996 and 2006 were selected from the Netherlands Cancer Registry. Standardized incidence ratios (SIR) were computed as the ratio of observed and expected cancers. Differences in the survival were expressed as hazard ratio (HR) using Cox regression and relative survival rates (RSR). All migrant women exhibited a significantly lower risk for breast cancer compared with Dutch natives. However, 5-year RSR was lower in all migrants (range 68-73%) compared with Dutch natives (85%). Death rates were increased in Moroccan [HR = 1.2 (1.0-1.5)] and reduced in Indonesian [HR = 0.8 (0.8-0.9)] patients with breast cancer. The incidence of noncardia stomach cancer was significantly elevated in all migrants, being highest in Turkish males [SIR = 1.9 (1.6-2.3)]. Cardia stomach cancer was less frequent in all migrants, being lowest in Surinamese males [SIR = 0.3 (0.2-0.6)]. Death rates for stomach cancer were lower in patients from Morocco [HR = 0.6 (0.4-0.9)], whereas 1-year RSR for stomach cancer was better in all migrant groups. Both lower breast cancer rates and higher stomach cancer rates point to a strong link between environmental exposures, behavioural patterns and cancer risk during the life course. Favourable risks in migrants should be sustained as long as possible whereas survival disparities require careful monitoring and counteraction with preventive means as well as improved access to healthcare. European Journal of Cancer Prevention 20:150-156 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
C1 [Arnold, Melina] Univ Bielefeld, Sch Publ Hlth, Dept Epidemiol & Int Publ Hlth, D-33501 Bielefeld, Germany.
   [Arnold, Melina; Coebergh, Jan Willem] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.
   [Aarts, Mieke Josepha] Eindhoven Canc Registry IKZ, Comprehens Canc Ctr S, Eindhoven, Netherlands.
   [Siesling, Sabine; van der Aa, Maaike] Enschede Groningen Canc Registry IKNO, Comprehens Canc Ctr NE, Groningen, Netherlands.
   [Visser, Otto] Amsterdam Canc Registry IKA, Comprehens Canc Ctr Amsterdam, Amsterdam, Netherlands.
RP Arnold, M (reprint author), Univ Bielefeld, Sch Publ Hlth, Dept Epidemiol & Int Publ Hlth, POB 10 01 31, D-33501 Bielefeld, Germany.
EM melina.arnold@uni-bielefeld.de
OI Arnold, Melina/0000-0003-1700-6831
CR Adami HO, 2008, TXB CANC EPIDEMIOLOG
   *ALL KANK, 2006, SOC CULT EP ASP SIGN
   Arnold M, 2010, EUR J CANCER, V46, P2647, DOI 10.1016/j.ejca.2010.07.050
   Bauer Ullrich, 2008, HLTH INEQUALITIES DE
   Bhopal R. S., 2007, ETHNICITY RACE HLTH
   Bos V, 2004, INT J EPIDEMIOL, V33, P1112, DOI 10.1093/ije/dyh189
   Brodersen J, 2010, POL ARCH MED WEWN, V120, P89
   Clayton D, 1993, STAT MODELS EPIDEMIO
   Curtis E, 2008, CANCER, V112, P171, DOI 10.1002/cncr.23131
   De Vries AC, 2008, SCAND J GASTROENTERO, V43, P403, DOI 10.1080/00365520701814077
   Gotzsche PC, 2009, COCHRANE DB SYST REV, V4
   Harper S, 2009, CANCER EPIDEM BIOMAR, V18, P121, DOI 10.1158/1055-9965.EPI-08-0679
   Hartman E, 2009, EUR J CANCER PREV, V18, P349, DOI 10.1097/CEJ.0b013e32832bf40f
   Hemminki K, 2002, INT J CANCER, V99, P218, DOI 10.1002/ijc.10322
   Hemminki K, 2002, INT J CANCER, V99, P229, DOI 10.1002/ijc.10323
   Kagawa-Singer M, 2010, CA-CANCER J CLIN, V60, P12, DOI 10.3322/caac.20051
   Kamangar F, 2006, JNCI-J NATL CANCER I, V98, P1445, DOI 10.1093/jnci/djj393
   Khalifa MM, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-2
   Kim J, 2009, ANN SURG ONCOL, V16, P2433, DOI 10.1245/s10434-009-0584-4
   Marmot Michael, 1993, Public Health Reviews, V21, P185
   Myrup C, 2008, J NATL CANCER I, V100, P41, DOI 10.1093/jnci/djm276
   Norredam M, 2007, EUR J CANCER, V43, P2717, DOI 10.1016/j.ejca.2007.09.017
   Ogedegbe G, 2005, J NATL MED ASSOC, V97, P162
   Parkin DM, 1996, EUR J CANCER, V32A, P761, DOI 10.1016/0959-8049(96)00062-7
   Price CL, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-103
   Razum O, 2002, TROP MED INT HEALTH, V7, P4, DOI 10.1046/j.1365-3156.2002.00833.x
   Rembold CM, 1998, BRIT MED J, V317, P307, DOI 10.1136/bmj.317.7154.307
   Ronellenfitsch U, 2009, EUR J GASTROEN HEPAT, V21, P319, DOI 10.1097/MEG.0b013e3283155220
   Sobin LH, 2010, INT UNION CANC TNM C
   Spallek J, 2009, CANCER EPIDEMIOL, V33, P413, DOI 10.1016/j.canep.2009.10.006
   *STATL, 2010, STAT NETH CBS
   Stirbu I, 2006, INT J CANCER, V119, P2665, DOI 10.1002/ijc.22200
   Stronks K., 2009, ETHN HLTH, V14, P1
   van der Aa MA, 2008, EUR J CANCER PREV, V17, P453, DOI 10.1097/CEJ.0b013e3282f75ed0
   Vermeer B, 2010, EUR J CANCER PREV, V19, P195, DOI 10.1097/CEJ.0b013e328337214c
   Visser O, 2007, EUR J CANCER, V43, P901, DOI 10.1016/j.ejca.2006.12.010
   Visser O, 2004, BRIT J CANCER, V90, P2135, DOI 10.1038/sj.bjc.6601821
   Weber MF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-144
   Wild SH, 2006, BRIT J CANCER, V94, P1079, DOI 10.1038/sj.bjc.6603031
   Zeeb H, 2008, PSYCHOTHER PSYCH MED, V58, P130, DOI 10.1055/s-2008-1067347
   2008, GLOBOCAN DATABASE DA
   2010, KANKER NEDERLAND DAT
NR 42
TC 9
Z9 10
U1 2
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0959-8278
EI 1473-5709
J9 EUR J CANCER PREV
JI Eur. J. Cancer Prev.
PD MAR
PY 2011
VL 20
IS 3
BP 150
EP 156
DI 10.1097/CEJ.0b013e3283431c40
PG 7
WC Oncology
SC Oncology
GA 741VE
UT WOS:000288892700002
PM 21183855
DA 2018-12-27
ER

PT J
AU Sanna, LJ
   Chang, EC
   Miceli, PM
   Lundberg, KB
AF Sanna, Lawrence J.
   Chang, Edward C.
   Miceli, Paul M.
   Lundberg, Kristjen B.
TI RETRACTED: Rising up to higher virtues: Experiencing elevated physical
   height uplifts prosocial actions (Retracted article. See vol. 49, pg.
   316, 2013)
SO JOURNAL OF EXPERIMENTAL SOCIAL PSYCHOLOGY
LA English
DT Article; Retracted Publication
DE Prosocial behavior; Metaphor-enriched cognition; Embodiment; Helping;
   Cooperation
ID BEHAVIOR; REPRESENTATION; JUDGMENTS; COGNITION; MORALITY
AB Many challenges of society involve getting people to act prosocially in ways that are costly for self-interests but beneficial to the greater good. The authors in four studies examined the novel hypothesis that elevating (vertical) height promotes prosocial actions. In Study 1, shoppers riding up (vs. down) escalators contributed more often to charity. In Study 2, participants sitting higher (vs. lower) helped another longer, while in Study 3 participants sitting higher (vs. lower) were more compassionate. In Study 4, watching video primes depicting scenes from a high perspective led to more cooperative resource conservation. These studies contribute uniquely to the prosociality literature by documenting previously unexamined effects of metaphor-enriched social cognition, and to the metaphor-enriched social cognition literature by documenting effects of elevated height on real prosocial actions. (c) 2010 Elsevier Inc. All rights reserved.
C1 [Sanna, Lawrence J.; Miceli, Paul M.; Lundberg, Kristjen B.] Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA.
   [Sanna, Lawrence J.] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA.
   [Chang, Edward C.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.
RP Sanna, LJ (reprint author), Univ N Carolina, Dept Psychol, CB 3270, Chapel Hill, NC 27599 USA.
EM sanna@unc.edu
CR Ayduk O, 2008, J EXP SOC PSYCHOL, V44, P775, DOI 10.1016/j.jesp.2007.07.004
   Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639
   Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004
   Chasteen AL, 2010, NEUROPSYCHOLOGIA, V48, P627, DOI 10.1016/j.neuropsychologia.2009.09.029
   Dovidio J. F, 2006, SOCIAL PSYCHOL PROSO
   Garcia SM, 2002, J PERS SOC PSYCHOL, V83, P843, DOI 10.1037//0022-3514.83.4.843
   Gawron V, 2004, PROGR ASTRONAUT AERO, V203, P145
   Giessner SR, 2007, ORGAN BEHAV HUM DEC, V104, P30, DOI 10.1016/j.obhdp.2006.10.001
   Keltner Dacher, 2010, COMPASSIONATE INSTIN
   Komorita S.S, 1996, SOCIAL DILEMMAS
   Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970
   Lieberman JD, 1999, AGGRESSIVE BEHAV, V25, P331, DOI 10.1002/(SICI)1098-2337(1999)25:5<331::AID-AB2>3.0.CO;2-1
   Liljenquist K, 2010, PSYCHOL SCI, V21, P381, DOI 10.1177/0956797610361426
   McPherson S, 2009, GROUP PROCESS INTERG, V12, P419, DOI 10.1177/1368430209105044
   Meier BP, 2007, J PERS SOC PSYCHOL, V93, P699, DOI 10.1037/0022-3514.93.5.699
   Meier BP, 2007, PERS INDIV DIFFER, V43, P757, DOI 10.1016/j.paid.2007.02.001
   Miles LK, 2010, PSYCHOL SCI, V21, P222, DOI 10.1177/0956797609359333
   Morris MW, 2007, ORGAN BEHAV HUM DEC, V102, P174, DOI 10.1016/j.obhdp.2006.03.001
   Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1
   Oppenheimer Daniel, 2010, SCI GIVING EXPT APPR
   Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141
   Sanna LJ, 2009, PSYCHOL SCI, V20, P1319, DOI 10.1111/j.1467-9280.2009.02458.x
   Schnall S, 2010, PSYCHOL SCI, V21, P315, DOI 10.1177/0956797609359882
   Schnall S, 2008, PSYCHOL SCI, V19, P1219, DOI 10.1111/j.1467-9280.2008.02227.x
   Semin GR, 2008, EMBODIED GROUNDING: SOCIAL, COGNITIVE, AFFECTIVE, AND NEUROSCIENTIFIC APPROACHES, P1
   van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x
   Van Vugt M, 2000, COOPERATION MODERN S
   WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063
   Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548
   Zhong CB, 2008, PSYCHOL SCI, V19, P838, DOI 10.1111/j.1467-9280.2008.02165.x
   Zhong CB, 2006, SCIENCE, V313, P1451, DOI 10.1126/science.1130726
NR 31
TC 9
Z9 10
U1 3
U2 27
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-1031
EI 1096-0465
J9 J EXP SOC PSYCHOL
JI J. Exp. Soc. Psychol.
PD MAR
PY 2011
VL 47
IS 2
BP 472
EP 476
DI 10.1016/j.jesp.2010.12.013
PG 5
WC Psychology, Social
SC Psychology
GA 735LH
UT WOS:000288415500027
DA 2018-12-27
ER

PT J
AU Lindenberg, S
   Joly, JF
   Stapel, DA
AF Lindenberg, Siegwart
   Joly, Janneke F.
   Stapel, Diederik A.
TI RETRACTED: The Norm-Activating Power of Celebrity: The Dynamics of
   Success and Influence (Retracted article. See vol. 75, pg. 289, 2012)
SO SOCIAL PSYCHOLOGY QUARTERLY
LA English
DT Article; Retracted Publication
DE social norms; norm activation; normative message; celebrity endorsement;
   prestige suggestion; significant others; role model; goals
ID NEIGHBORHOOD DISORDER; SIGNIFICANT OTHERS; BEHAVIOR; CONSEQUENCES;
   ENDORSEMENTS; ENVIRONMENT; RESPONSES; INTIMACY; MEDIATOR; PEOPLE
AB On the basis of previous evidence, we reasoned that even if people do not identify with celebrities, these celebrities can influence their behavior by activating bundles of social norms. Activating a norm means making both content and ''oughtness'' of the norm more directly relevant for behavior. We further reasoned that in order to have this norm-activating effect, celebrities have to have prestige. The question is whether they need to be seen as successful in order to have this effect. In four experimental studies, we examined the effects of a normative message presented by a celebrity on the activation of a target norm and of related and unrelated norms. As predicted, the normative message activated both target and related norms and did not activate unrelated norms. Also as expected, this ability to activate norms vanished entirely when the celebrities were tarnished by waning success. This result also shows that ''success'' and ''lack of success'' of a celebrity can be the result of relatively minor differences in media reporting. As expected, the norm-activating effect of celebrities was not mediated by self-reported measures of seeing celebrities as role models or of identifying with them. Implications for the impact of someone's environment on norm conformity beyond positive and negative sanctions are discussed.
C1 [Lindenberg, Siegwart] Univ Groningen, Dept Behav & Social Sci ICS, Interuniv Ctr Social Sci Theory & Methodol ICS, NL-9712 TG Groningen, Netherlands.
   [Stapel, Diederik A.] Tilburg Univ, TIBER, Tilburg, Netherlands.
RP Lindenberg, S (reprint author), Univ Groningen, Dept Behav & Social Sci ICS, Interuniv Ctr Social Sci Theory & Methodol ICS, Grote Rozenstr 31, NL-9712 TG Groningen, Netherlands.
EM s.m.lindenberg@rug.nl
CR ATKIN C, 1983, J ADVERTISING RES, V23, P57
   Austin EW, 2008, MASS COMMUN SOC, V11, P420, DOI 10.1080/15205430701866600
   Bandura A, 1977, SOCIAL LEARNING THEO
   BARGH JA, 1994, NEBR SYM MOTIV, V41, P71
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Barry CM, 2006, DEV PSYCHOL, V42, P153, DOI 10.1037/0012-1649.42.1.153
   Basil MD, 1996, J BROADCAST ELECTRON, V40, P478
   Bowlby J., 1988, SECURE BASE
   BROWN WJ, 1995, HEALTH COMMUN, V7, P345, DOI 10.1207/s15327027hc0704_4
   Bush AJ, 2004, J ADVERTISING RES, V44, P108, DOI 10.1017/S0021849904040206
   Caughey John L., 1984, IMAGINARY SOCIAL WOR
   Choi SM, 2005, J ADVERTISING, V34, P85, DOI 10.1080/00913367.2005.10639190
   Christie-Mizell CA, 2007, SOC PSYCHOL QUART, V70, P340, DOI 10.1177/019027250707000406
   Chwe M. S., 2003, RATIONAL RITUAL CULT
   Cialdini RB, 2003, CURR DIR PSYCHOL SCI, V12, P105, DOI 10.1111/1467-8721.01242
   CIALDINI RB, 1991, ADV EXP SOC PSYCHOL, V24, P201
   COOLEY CH, 1918, SOCIAL PROCESS, P112
   Erdogan B. Z., 1999, J MARKETING MANAGEME, V15, P291, DOI DOI 10.1362/026725799784870379
   Falk A, 2005, ECONOMETRICA, V73, P2017, DOI 10.1111/j.1468-0262.2005.00644.x
   Ferris KO, 2007, SOCIOL COMPASS, V1, P371, DOI 10.1111/j.1751-9020.2007.00019.x
   Fitzsimons GJ, 2004, MARKET SCI, V23, P82, DOI 10.1287/mksc.1030.0033
   Gamson J., 1994, CLAIMS FAME CELEBRIT
   Geis KJ, 1998, SOC PSYCHOL QUART, V61, P232, DOI 10.2307/2787110
   Gergely G., 2005, INTERACTION STUDIES, V6, P463, DOI DOI 10.1075/IS.6.3.10GER
   Giles David, 2000, ILLUSIONS IMMORTALIT
   Goode William J., 1978, CELEBRATION HEROES P
   Halberstam David, 1999, PLAYING KEEPS M JORD
   HECHTER M, 2001, SOCIAL NORMS, P394
   HOFLING CK, 1966, J NERV MENT DIS, V143, P171, DOI 10.1097/00005053-196608000-00008
   Home C., 2001, SOCIAL NORMS, P3
   Horne C, 2003, EUR SOCIOL REV, V19, P335, DOI 10.1093/esr/19.4.335
   HORTON D, 1956, PSYCHIATR, V19, P215, DOI 10.1080/00332747.1956.11023049
   Joly JF, 2008, PERS SOC PSYCHOL B, V34, P1047, DOI 10.1177/0146167208318401
   Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405
   Kellner D., 2003, MEDIA SPECTACLE
   Kelman HC, 2006, ANNU REV PSYCHOL, V57, P1, DOI 10.1146/annurev.psych.57.102904.190156
   KELMAN HC, 1961, PUBLIC OPIN QUART, V25, P57, DOI 10.1086/266996
   Klapp O. E., 1962, HEROES VILLAINS FOOL
   Kruglanski AW, 2002, ADV EXP SOC PSYCHOL, V34, P331, DOI 10.1016/S0065-2601(02)80008-9
   KRUGMAN HE, 1965, PUBLIC OPIN QUART, V29, P349, DOI 10.1086/267335
   Larson RJ, 2005, J NATL CANCER I, V97, P693, DOI 10.1093/jnci/dji117
   Lindenberg S, 2007, J SOC ISSUES, V63, P117, DOI 10.1111/j.1540-4560.2007.00499.x
   Lines G., 2001, Leisure Studies, V20, P285, DOI 10.1080/02614360110094661
   Lockwood P, 2002, J PERS SOC PSYCHOL, V83, P854, DOI 10.1037//0022-3514.83.4.854
   Lombard M., 1997, J COMPUTER MEDIATED, V3
   MCADAMS DP, 1981, J PERS SOC PSYCHOL, V40, P573, DOI 10.1037/0022-3514.40.3.573
   MCCRACKEN G, 1989, J CONSUM RES, V16, P310, DOI 10.1086/209217
   McGuire W., 1985, HDB SOCIAL PSYCHOL, P233
   MEYER DS, 1995, SOCIOL INQ, V65, P181, DOI 10.1111/j.1475-682X.1995.tb00412.x
   Milgram S., 2004, OBEDIENCE AUTHORITY
   Moeran B, 2003, RES ECON AN, V22, P299
   Money RB, 2006, J ADVERTISING RES, V46, P113, DOI 10.2501/S0021849906060120
   Moos M, 1952, PUBLIC OPIN QUART, V16, P77, DOI 10.1086/266369
   Orbell S, 2004, HEALTH PSYCHOL, V23, P388, DOI 10.1037/0278-6133.23.4.388
   PARSONS T, 1951, VALUES MOTIVES SYSTE, P45
   PEASE A, INT J PRESS POLITICS, V13, P386
   Robinson SL, 1998, ACAD MANAGE J, V41, P658, DOI 10.2307/256963
   ROSENBERG M, 1973, AM BEHAV SCI, V16, P829, DOI 10.1177/000276427301600603
   ROSS EA, 1919, SOCIAL PSYCHOL OUTLI, P11
   RUTKOWSKI GK, 1983, J PERS SOC PSYCHOL, V44, P545, DOI 10.1037/0022-3514.44.3.545
   Salamon SD, 2008, J APPL PSYCHOL, V93, P593, DOI 10.1037/0021-9010.93.3.593
   Schickel Richard, 1985, INTIMATE STRANGERS C
   SEKHAR C, 2006, INNATE MIND, V2, P280
   Shah J, 2003, J PERS SOC PSYCHOL, V84, P661, DOI 10.1037/0022-3514.84.4.661
   Sherif M., 1965, PSYCHOL SOCIAL NORMS
   Silvera DH, 2004, EUR J MARKETING, V38, P1509, DOI DOI 10.1108/03090560410560218
   Stapel DA, 2010, BRIT J SOC PSYCHOL, V49, P175, DOI 10.1348/000712609X436453
   Thrall AT, 2008, INT J PRESS/POLIT, V13, P362, DOI 10.1177/1940161208319098
   Till BD, 1998, J ADVERTISING, V27, P67, DOI 10.1080/00913367.1998.10673543
   Van den Bergh B, 2008, J CONSUM RES, V35, P85, DOI 10.1086/525505
   WEBER M, 1978, M WEBER EC SOC, P241
   ZOHNER D, 1970, J GENET PSYCHOL, V116, P203, DOI 10.1080/00221325.1970.10533920
NR 72
TC 13
Z9 13
U1 2
U2 27
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0190-2725
EI 1939-8999
J9 SOC PSYCHOL QUART
JI Soc. Psychol. Q.
PD MAR
PY 2011
VL 74
IS 1
BP 98
EP 120
DI 10.1177/0190272511398208
PG 23
WC Psychology, Social
SC Psychology
GA 745OO
UT WOS:000289175100007
DA 2018-12-27
ER

PT J
AU Meijers, MHC
   Stapel, DA
AF Meijers, Marijn H. C.
   Stapel, Diederik A.
TI RETRACTED: Me tomorrow, the others later: How perspective fit increases
   sustainable behavior (Retracted article. See vol. 33, pg. 96, 2013)
SO JOURNAL OF ENVIRONMENTAL PSYCHOLOGY
LA English
DT Article; Retracted Publication
DE Sustainable behavior; Pro-environmental behavior; Fit; Perspectives;
   Action-effectiveness
ID REGULATORY FIT; PSYCHOLOGICAL DISTANCE; FUTURE CONSEQUENCES; TIME
   PERSPECTIVE; MORAL CONCERNS; PERSUASION; ORIENTATION; PREDICTORS;
   MEDIATION; VALUES
AB In two studies we show that people are more likely to make sustainable choices when there is a level fit between time perspectives (short term versus long term) and person perspectives (me versus other). When people have both a global time focus (long term) and a global person focus (other) or both a specific time focus (short term) and a specific person focus (me), they attach more importance to sustainability. Furthermore, we show that when there is a level fit between time and person perspectives, feelings concerning the effectiveness of sustainable behavior are likely to increase and as a result people are more willing to make sustainable choices. Implications of these results for promoting sustainable behavior are discussed. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Meijers, Marijn H. C.; Stapel, Diederik A.] Tilburg Univ, TIBER, NL-5000 LE Tilburg, Netherlands.
RP Meijers, MHC (reprint author), Tilburg Univ, TIBER, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM m.h.c.meijers@uvt.nl
CR Agerstrom J, 2009, SOC COGNITION, V27, P261, DOI 10.1521/soco.2009.27.2.261
   Agerstrom J, 2009, BASIC APPL SOC PSYCH, V31, P49, DOI 10.1080/01973530802659885
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037//0033-295X.84.2.191
   Bar-Anan Y, 2006, J EXP PSYCHOL GEN, V135, P609, DOI 10.1037/0096-3445.135.4.609
   Cesario J, 2004, J PERS SOC PSYCHOL, V86, P388, DOI 10.1037/0022-3514.86.3.388
   Cesario J, 2008, SOC PERSONAL PSYCHOL, V2, P444, DOI 10.1111/j.1751-9004.2007.00055.x
   Cesario J, 2008, PSYCHOL SCI, V19, P415, DOI 10.1111/j.1467-9280.2008.02102.x
   Collins LM, 1998, MULTIVAR BEHAV RES, V33, P295, DOI 10.1207/s15327906mbr3302_5
   Dunlap RE, 1998, INT SOCIOL, V13, P473, DOI 10.1177/026858098013004004
   Ebreo A, 2001, ENVIRON BEHAV, V33, P424, DOI 10.1177/00139160121973061
   Eyal T, 2009, J EXP SOC PSYCHOL, V45, P35, DOI 10.1016/j.jesp.2008.07.023
   Freitas AL, 2002, PSYCHOL SCI, V13, P1, DOI 10.1111/1467-9280.00401
   Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x
   Hafner M, 2010, J EXP SOC PSYCHOL, V46, P73, DOI 10.1016/j.jesp.2009.10.001
   Higgins ET, 2005, CURR DIR PSYCHOL SCI, V14, P209, DOI 10.1111/j.0963-7214.2005.00366.x
   Higgins ET, 2003, J PERS SOC PSYCHOL, V84, P1140, DOI 10.1037/0022-3514.84.6.1140
   Joireman JA, 2004, ENVIRON BEHAV, V36, P187, DOI 10.1177/0013916503251476
   Joireman JA, 2001, BRIT J SOC PSYCHOL, V40, P133, DOI 10.1348/014466601164731
   Joireman JA, 2001, J APPL SOC PSYCHOL, V31, P504, DOI 10.1111/j.1559-1816.2001.tb02053.x
   JOIREMAN JA, 2006, JUDGMENTS TIME INTER
   Kim HY, 2009, J CONSUM RES, V35, P877, DOI 10.1086/593700
   Kim YJ, 2006, J ADVERTISING, V35, P143, DOI 10.2753/JOA0091-3367350109
   Knussen C, 2008, ENVIRON BEHAV, V40, P683, DOI 10.1177/0013916507307527
   Kortenkamp KV, 2006, PERS SOC PSYCHOL B, V32, P603, DOI 10.1177/0146167205284006
   Lee AY, 2004, J PERS SOC PSYCHOL, V86, P205, DOI 10.1037/0022-3514.86.2.205
   Leiserowitz AA, 2005, RISK ANAL, V25, P1433, DOI 10.1111/j.1540-6261.2005.00690.x
   Lindsay JJ, 1997, J APPL SOC PSYCHOL, V27, P1799, DOI 10.1111/j.1559-1816.1997.tb01626.x
   MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371
   MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037//1082-989X.7.1.83
   MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2
   Milfont TL, 2006, J ENVIRON PSYCHOL, V26, P72, DOI 10.1016/j.jenvp.2006.03.001
   Miller RL, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004085
   Overpeck JT, 2006, ANNU REV ENV RESOUR, V31, P1, DOI 10.1146/annurev.energy.30.050504.144308
   Rabinovich A, 2010, BRIT J SOC PSYCHOL, V49, P69, DOI 10.1348/014466608X401875
   Rabinovich A, 2009, J ENVIRON PSYCHOL, V29, P391, DOI 10.1016/j.jenvp.2009.09.004
   Rosenfeld D, 2008, SCIENCE, V321, P1309, DOI 10.1126/science.1160606
   Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422
   SRULL TK, 1979, J PERS SOC PSYCHOL, V37, P1660, DOI 10.1037//0022-3514.37.10.1660
   Stern P. C., 1997, ENV SIGNIFICANT CONS
   STRATHMAN A, 1994, J PERS SOC PSYCHOL, V66, P742, DOI 10.1037/0022-3514.66.4.742
   TACKEN G, 2007, INVLOED MEERWAARDE B
   Tanner C, 2003, PSYCHOL MARKET, V20, P883, DOI 10.1002/mar.10101
   Torelli CJ, 2009, J PERS SOC PSYCHOL, V96, P231, DOI 10.1037/a0013836
   Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403
   Trope Y, 2007, J CONSUM PSYCHOL, V17, P83, DOI 10.1016/S1057-7408(07)70013-X
   TULVING E, 1982, J EXP PSYCHOL LEARN, V8, P336, DOI 10.1037//0278-7393.8.4.336
   Zhao X., 2010, J CONSUMER RES, V37
NR 48
TC 6
Z9 6
U1 3
U2 22
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0272-4944
J9 J ENVIRON PSYCHOL
JI J. Environ. Psychol.
PD MAR
PY 2011
VL 31
IS 1
BP 14
EP 20
DI 10.1016/j.jenvp.2010.06.002
PG 7
WC Environmental Studies; Psychology, Multidisciplinary
SC Environmental Sciences & Ecology; Psychology
GA 736XG
UT WOS:000288527700002
DA 2018-12-27
ER

PT J
AU Elkhodairy, KA
   Barakat, NS
   Alanazi, FK
AF Elkhodairy, Kadria A.
   Barakat, Nahla S.
   Alanazi, Fars K.
TI RETRACTED: Solubilization and Amorphization of Non Steroidal
   Anti-Inflammatory Drug with Low Molecular Weight Chitosan for a New
   Guar-Based Colon Delivery Formulation (Retracted article. See vol. 90,
   pg. 556, 2012)
SO LETTERS IN DRUG DESIGN & DISCOVERY
LA English
DT Article; Retracted Publication
DE Etodolac; Binary mixtures; Chitosan; Film coating; Guar gum
ID SELECTIVE CYCLOOXYGENASE-2 INHIBITOR; IN-VITRO; COLORECTAL-CANCER;
   DISSOLUTION PROPERTIES; POLYETHYLENE-GLYCOL; VIVO EVALUATION;
   UP-REGULATION; SYSTEMS; ETODOLAC; RELEASE
AB The solubilization and amorphization of the poorly water soluble nonsteroidal anti-inflammatory drug, Etodolac (ETD) with a hydrophilic polymer, low molecular weight chitosan (CHT), have been investigated. Phase solubility studies were carried out to obtain an insight on the nature of a possible interaction between ETD and CHT in solution. Binary systems of varying drug polymer ratios were prepared using different techniques namely physical mixing, co-grinding and kneading. Drug-polymer interactions were investigated in solid state by differential scanning calorimetry, powder X-ray diffractometry and scanning electron microscopy. The results obtained indicated loss of drug crystallinity. Dissolution rate studies revealed that the drug dissolution was improved with increasing the polymer concentration in the mixture in the following order kneading> co-grinding> physical mixing > pure drug. The prepared capsules containing the binary mixture prepared by kneading in the drug-polymer ratio of 1:19 were coated with guar gum (a film coating material) and their dissolution rates were tested in comparison with commercial capsules present in the Egyptian market. A coating of 10 layers of guar gum prevented the release of etodolac in the acidic pH and permitted its release in colonic environment.
C1 [Elkhodairy, Kadria A.; Barakat, Nahla S.; Alanazi, Fars K.] King Saud Univ, Dept Pharmaceut, Coll Pharm, Riyadh 11495, Saudi Arabia.
   [Alanazi, Fars K.] Al Kayyali Chair Pharmaceut Ind, Riyadh 11495, Saudi Arabia.
RP Barakat, NS (reprint author), King Saud Univ, Dept Pharmaceut, Coll Pharm, POB 22452, Riyadh 11495, Saudi Arabia.
EM nsybarakat@yahoo.com
RI Alanazi, Fars/D-1558-2015
OI Alanazi, Fars/0000-0002-0757-3245; Elkhodairy,
   Kadria/0000-0003-2888-4939
CR ACARTURK F, 1993, PHARMAZIE, V48, P605
   ACERTURK F, 1993, STP PHARMA SCI, V3, P369
   Adamson A., 1976, PHYS CHEM SURFACES
   Asghar LFA, 2008, PHARMAZIE, V63, P736, DOI 10.1691/ph.2008.7416
   Bak GW, 2001, IEEE T DIELECT EL IN, V8, P555, DOI 10.1109/94.933383
   Barakat NS, 2010, J PHARM PHARMACOL, V62, P173, DOI [10.1211/jpp/62.02.0004, 10.1211/jpp.62.02.0004]
   Bodek Kazimiera H, 2002, Acta Pol Pharm, V59, P105
   BRUNELLA C, 2009, DRUG DEV IND PHARM, V35, P877
   CARSON DA, 2006, Patent No. 710556
   EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1
   El-Kamel AH, 2008, INT J PHARM, V358, P248, DOI 10.1016/j.ijpharm.2008.04.021
   Fujita T, 1998, CANCER RES, V58, P4823
   Fukuda M, 2006, INT J PHARM, V310, P90, DOI 10.1016/j.ijpharm.2005.11.042
   Gittings MR, 2001, J PHYS CHEM A, V105, P9310, DOI 10.1021/jp0101825
   Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017
   Gurusamy S, 2006, CHEM PHARM BULL, V54, P1102, DOI 10.1248/cpb.54.1102
   Halsas M, 2001, PHARMAZIE, V56, P718
   HASLAS M, 1999, INT J PHARMACEUT, V189, P179
   Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117
   Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606
   Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10
   Krishnaiah YSR, 2002, J DRUG TARGET, V10, P247, DOI 10.1080/10611860290022697
   Krishnaiah YSR, 2002, INT J PHARMACEUT, V236, P43, DOI 10.1016/S0378-5173(02)00006-6
   Krishnaiah YSR, 2002, EUR J PHARM SCI, V16, P185, DOI 10.1016/S0928-0987(02)00081-7
   Krishnaiah YSR, 1998, INT J PHARM, V171, P137, DOI 10.1016/S0378-5173(98)00172-0
   Lobenberg R, 2000, EUR J PHARM BIOPHARM, V50, P3, DOI 10.1016/S0939-6411(00)00091-6
   Mishima K, 2005, ORAL ONCOL, V41, P77, DOI 10.1016/j.oraloncology.2004.06.009
   MISHRA DN, 2003, EUR J PHARM SCI, V19, P67
   MUCKLOW JC, 1999, MARTINDALE COMPLETE
   Mura P, 2003, EUR J PHARM SCI, V19, P67, DOI 10.1016/S0928-0987(03)00068-X
   Mutalik S, 2008, INT J PHARM, V350, P279, DOI 10.1016/j.ijpharm.2007.09.006
   NAJIB NM, 1989, INT J PHARM, V51, P225, DOI 10.1016/0378-5173(89)90195-6
   Okamoto A, 2008, UROLOGY, V71, P156, DOI 10.1016/j.urology.2007.09.061
   Ozkan Y, 2000, FARMACO, V55, P433, DOI 10.1016/S0014-827X(00)00062-8
   Paul W, 2000, STP PHARMA SCI, V10, P5
   Portero A, 1998, INT J PHARM, V175, P75, DOI 10.1016/S0378-5173(98)00245-2
   Prasad YVR, 1998, J CONTROL RELEASE, V51, P281, DOI 10.1016/S0168-3659(97)00181-8
   SAWAYANAGI Y, 1983, CHEM PHARM BULL, V31, P2064
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P4464
   Sinha VR, 2010, J INCL PHENOM MACRO, V66, P381, DOI 10.1007/s10847-009-9655-1
   Smita Rane, 2009, International Journal of ChemTech Research, V1, P180
   Takeda J, 2004, ONCOL REP, V11, P981
   Tobiska S, 2003, PHARM DEV TECHNOL, V8, P39, DOI 10.1081/PDT-120017522
   Yanaoka K, 2010, INT J CANCER, V126, P1467, DOI 10.1002/ijc.24862
   Yang LB, 2002, INT J PHARM, V235, P1, DOI 10.1016/S0378-5173(02)00004-2
NR 45
TC 3
Z9 3
U1 3
U2 19
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-1808
EI 1875-628X
J9 LETT DRUG DES DISCOV
JI Lett. Drug Des. Discov.
PD MAR
PY 2011
VL 8
IS 3
BP 292
EP 301
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 742ZG
UT WOS:000288983500013
DA 2018-12-27
ER

PT J
AU Kupfer, Y
   Seneviratne, C
   Chawla, K
   Ramachandran, K
   Tessler, S
AF Kupfer, Yizhak
   Seneviratne, Chanaka
   Chawla, Kabu
   Ramachandran, Kavan
   Tessler, Sidney
TI RETRACTED: Chest Tube Drainage of Transudative Pleural Effusions Hastens
   Liberation From Mechanical Ventilation (Retracted article. See vol. 141,
   pg. 284, 2012)
SO CHEST
LA English
DT Article; Retracted Publication
ID GAS-EXCHANGE; PULMONARY MECHANICS; MEDICAL ICU; THORACENTESIS
AB Background: Pleural effusions occur frequently in patients requiring mechanical ventilatory support. Treatment of the precipitating cause and resolution of the pleural effusion may take considerable time. We retrospectively studied the effect of chest tube drainage of transudative pleural effusions on the liberation of patients from mechanical ventilatory support.
   Methods: Patients in the medical ICU (MICU) at Maimonides Medical Center between January 1, 2009, and October 31, 2009, requiring mechanical ventilatory support with a transudative pleural effusion, were studied retrospectively. They were divided into two groups: standard care and standard care plus chest tube drainage. Chest tubes were placed under ultrasound guidance by trained intensivists. Duration of mechanical ventilatory support was the primary end point. Secondary end points included measures of oxygenation, amount of fluid drained, and complications associated with the chest tube.
   Results: A total of 168 patients were studied; 88 were treated with standard care and 80 underwent chest tube drainage. Total duration of mechanical ventilatory support was significantly shorter for patients who had chest tube drainage: 3.8 +/- 0.5 days vs 6.5 +/- 1.1 days for the standard group (P = .03). No differences in oxygenation were noted between the two groups. The average amount of fluid drained was 1,220 mL. No significant complications were caused by chest tube drainage.
   Conclusions: Chest tube drainage of transudative pleural effusions resulted in more rapid liberation from mechanical ventilatory support. It is a very safe procedure when performed under ultrasound guidance by experienced personnel. Trial registry: ClinicalTrials.gov; Identifier: NCT0114285; URL: www.clinicaltrials.gov CHEST 2011; 139(3):519-523
C1 [Kupfer, Yizhak; Seneviratne, Chanaka; Chawla, Kabu; Ramachandran, Kavan; Tessler, Sidney] Maimonides Hosp, Brooklyn, NY 11219 USA.
RP Tessler, S (reprint author), Maimonides Hosp, 953 49th St,Ste 511, Brooklyn, NY 11219 USA.
EM stessler@maimonidesmed.org
CR Ahmed SH, 2004, J TRAUMA, V57, P1184, DOI 10.1097/01.TA.0000145074.98431.15
   BRANDSTETTER RD, 1979, JAMA-J AM MED ASSOC, V242, P1060, DOI 10.1001/jama.242.10.1060
   BROWN NE, 1978, CHEST, V74, P540, DOI 10.1378/chest.74.5.540
   Doelken P, 2006, CHEST, V130, P1354, DOI 10.1378/chest.130.5.1354
   ESTENNE M, 1983, AM J MED, V74, P813, DOI 10.1016/0002-9343(83)91072-0
   Fartoukh M, 2002, CHEST, V121, P178, DOI 10.1378/chest.121.1.178
   GODWIN JE, 1990, ANN INTERN MED, V113, P800, DOI 10.7326/0003-4819-113-10-800
   Light RW, 2001, PLEURAL DIS
   Mattison LE, 1997, CHEST, V111, P1018, DOI 10.1378/chest.111.4.1018
   Mayo PH, 2004, CHEST, V125, P1059, DOI 10.1378/chest.125.3.1059
   SOUSA AS, 1995, EUR RESPIR J, V8, P99, DOI 10.1183/09031936.95.08010099
   WANG JS, 1995, CHEST, V107, P1610, DOI 10.1378/chest.107.6.1610
NR 12
TC 12
Z9 13
U1 3
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0012-3692
J9 CHEST
JI Chest
PD MAR
PY 2011
VL 139
IS 3
BP 519
EP 523
DI 10.1378/chest.10-1012
PG 5
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA 731ZS
UT WOS:000288150500010
PM 20688921
DA 2018-12-27
ER

PT J
AU Nugteren, HM
   Schultz, WCMW
   Van Driel, MF
AF Nugteren, Helena M.
   Schultz, Willibrord C. M. Weijmar
   Van Driel, Mels F.
TI RETRACTED: Physical therapy for premature ejaculation, erectile
   dysfunction and chronic pelvic pain syndrome (December, pg 4,
   2009)(Retracted Article.)
SO BJU INTERNATIONAL
LA English
DT Correction; Retracted Publication
CR Nugteren Helena M, 2009, BJU Int, DOI 10.1111/j.1464-410X.2009.09094.x
NR 1
TC 0
Z9 0
U1 2
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-4096
EI 1464-410X
J9 BJU INT
JI BJU Int.
PD MAR
PY 2011
VL 107
IS 5
BP 866
EP 866
DI 10.1111/j.1464-410X.2011.10101.x
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA 727ON
UT WOS:000287810800037
OA Bronze
DA 2018-12-27
ER

PT J
AU Moon, HI
   Zee, O
AF Moon, Hyung-In
   Zee, Okpyo
TI RETRACTED: Anticancer activity of sesquiterpene lactone from plant food
   (Carpesium rosulatum) in human cancer cell lines (Retracted article. See
   vol. 63, pg. 766, 2012)
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article; Retracted Publication
DE Carpesium rosulatum; anticancer activity; human tumor cell lines;
   sulforhodamine B
ID ANTIPLASMODIAL ACTIVITY; DIVARICATUM; INEUPATOROLIDES; ABROTANOIDES;
   DERIVATIVES
AB In the search for anticancer compounds against human cancer cells (A549, SK-OV-3, SK-MEL-2, XF498, HCT15), it was found that the chloroform extracts obtained from the whole plant food of Carpesium rosulatum M1Q exhibited significant anticancer activity. The structures and stereochemistry of these compounds were established on the basis of analysis of spectra including melting point, [alpha]D-25, infrared, ultraviolet, electron ionization mass spectrometry, mass spectromctry, H-1-nuclear magnetic resonance, C-13-nuclear magnetic resonance and some chemical transformations as follows: compound 1, 4 beta,10 alpha-dihydroxy-guaia-8 alpha,12-olide; compound 2, 4 beta,10 alpha-dihydroxy-1(2),11(13)-guaiadien-8 alpha,12-olide; and compound 3, 3 beta,8 beta-dihydroxy-1 alpha,5 alpha-guaian-10(14)-ene-6 alpha,12-olide. Anticancer activity of compounds obtained from C. rosulatum on five tumor cells line was evaluated by sulforhodamine B methods. Compound 2 was significantly effective on the five human tumor cell lines.
C1 [Moon, Hyung-In; Zee, Okpyo] Sungkyunkwan Univ, Coll Pharm, Dept Pharmacognosy, Suwon 440746, South Korea.
RP Moon, HI (reprint author), Sungkyunkwan Univ, Coll Pharm, Dept Pharmacognosy, Suwon 440746, South Korea.
EM himun68@gmail.com
CR Chung IM, 2010, PHYTOTHER RES, V24, P451, DOI 10.1002/ptr.2881
   COX PA, 1994, CIBA F SYMP, V185, P25
   Kim DK, 1997, J NAT PROD, V60, P1199, DOI 10.1021/np970157d
   Kim JJ, 2009, J ENZYM INHIB MED CH, V24, P247, DOI [10.1080/14756360802051610, 10.1080/14756360802051610 ]
   Kim MR, 2002, J NAT PROD, V65, P583, DOI 10.1021/np010388r
   Li Z, 2002, CANCER RES, V62, P5980
   MARUYAMA M, 1995, PLANTA MED, V61, P388, DOI 10.1055/s-2006-958117
   MARUYAMA M, 1975, PHYTOCHEMISTRY, V14, P2247, DOI 10.1016/S0031-9422(00)91108-7
   MARUYAMA M, 1983, PHYTOCHEMISTRY, V22, P2773, DOI 10.1016/S0031-9422(00)97693-3
   MARUYAMA M, 1977, PHYTOCHEMISTRY, V16, P782, DOI 10.1016/S0031-9422(00)89261-4
   Moon HI, 2007, PARASITOL RES, V100, P1147, DOI 10.1007/s00436-006-0369-7
   Newman DJ, 2002, CURR CANCER DRUG TAR, V2, P279, DOI 10.2174/1568009023333791
   SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107
   YOOK CS, 1981, MED PLANTS KOREA, P392
   Zee OP, 1998, ARCH PHARM RES, V21, P618, DOI 10.1007/BF02975385
NR 15
TC 5
Z9 5
U1 2
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD MAR
PY 2011
VL 62
IS 2
BP 102
EP 105
DI 10.3109/09637486.2010.513682
PG 4
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA 733BJ
UT WOS:000288235100002
PM 20795890
DA 2018-12-27
ER

PT J
AU Xu, YA
   Wu, B
AF Xu, Yuan
   Wu, Bin
TI RETRACTED: Prognostic Factors for Renal Dysfunction After Nephrectomy in
   Renal Cell Carcinomas (Retracted article. See vol. 167, pg. 343, 2011)
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article; Retracted Publication
DE renal cell carcinoma; kidney dysfunction; nephrectomy
ID NEPHRON-SPARING SURGERY; CHRONIC KIDNEY-DISEASE; NORMAL CONTRALATERAL
   KIDNEY; RADICAL NEPHRECTOMY; FOLLOW-UP; OUTCOMES; DONORS; INSUFFICIENCY;
   CREATININE; MASSES
AB Objective. To explore the prognostic factors for renal dysfunction after nephrectomy in patients with renal cell carcinomas.
   Methods. Two hundred twenty-five patients from 2003 to 2010 were analyzed, who have undergone partial nephrectomy or radical nephrectomy for renal tumor, of size <= 4 cm, with normal contralateral kidney. The glomerular filtration rate was computed with the four-variable modification of diet in renal dysfunction (MDRD) criterion. Renal dysfunction was defined as GFR of < 60 mL/min per 1.73 m(2). We applied Cox proportional hazards model to analyze demographic and clinicopathologic parameters to determine the variables independently associated with the development of renal dysfunction.
   Results. One hundred twenty-nine out of 225 patients were included in the partial nephrectomy group, while 96 patients were in the radical nephrectomy groups; 97 out of 225 patients developed renal dysfunction: 86 out of 97 in the radical nephrectomy group and 11 out of 97 in the partial nephrectomy group. The 2-y probability of absence of renal dysfunction with partial nephrectomy or radical nephrectomy was 95.7% and 58.3%, respectively (P < 0.001). Among 20 patients with diabetes, 12 (60.0%) developed renal dysfunction: 10 patients underwent an RN and two underwent a PN. The 2-y probability of absence of renal dysfunction with and without diabetes was 46.5% and 76.4%, respectively (P = 0.006). Multivariate analysis showed that age (P = 0.001), type of operation (P < 0.001), preoperative GFR (P = 0.001), and diabetes (P = 0.042) were associated with the development of renal dysfunction.
   Conclusions. The results of this study show that nephron-sparing surgery (NSS) for renal cell carcinomas should be attempted to prevent renal dysfunction in all eligible patients. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Xu, Yuan; Wu, Bin] Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Urol, Jiangyin City 214400, Jiangsu Prov, Peoples R China.
RP Xu, YA (reprint author), Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Urol, 163 Shoushan Rd, Jiangyin City 214400, Jiangsu Prov, Peoples R China.
EM yuanxu_cn@yahoo.com
CR Belldegrun A, 1999, J CLIN ONCOL, V17, P2868, DOI 10.1200/JCO.1999.17.9.2868
   Clark ATD, 2008, EUR UROL, V54, P143, DOI 10.1016/j.eururo.2008.03.037
   Fehrman-Ekholm I, 2001, TRANSPLANTATION, V72, P444, DOI 10.1097/00007890-200108150-00015
   FehrmanEkholm I, 1997, TRANSPLANTATION, V64, P976, DOI 10.1097/00007890-199710150-00007
   Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031
   Goldfarb DA, 2001, J UROLOGY, V166, P2043, DOI 10.1016/S0022-5347(05)65502-4
   Hafez KS, 1999, J UROLOGY, V162, P1930, DOI 10.1016/S0022-5347(05)68071-8
   Herr HW, 1999, J UROLOGY, V161, P33, DOI 10.1016/S0022-5347(01)62052-4
   Hollenbeck BK, 2006, UROLOGY, V67, P254, DOI 10.1016/j.urology.2005.08.050
   Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8
   Huang WC, 2009, J UROLOGY, V181, P55, DOI 10.1016/j.juro.2008.09.017
   KAPLAN C, 1975, AM J PATHOL, V80, P227
   Lau WKO, 2000, MAYO CLIN PROC, V75, P1236
   Lerner SE, 1996, J UROLOGY, V155, P1868, DOI 10.1016/S0022-5347(01)66032-4
   Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Lucas SM, 2008, J UROLOGY, V179, P75, DOI 10.1016/j.juro.2007.08.156
   McKiernan J, 2002, UROLOGY, V59, P816, DOI 10.1016/S0090-4295(02)01501-7
   Miller DC, 2006, J UROLOGY, V175, P853, DOI 10.1016/S0022-5347(05)00422-2
   NAJARIAN JS, 1992, LANCET, V340, P807, DOI 10.1016/0140-6736(92)92683-7
   Nuttall M, 2005, BJU INT, V96, P58, DOI 10.1111/j.1464-410X.2005.05567.x
   Porpiglia F, 2007, EUR UROL, V52, P1170, DOI 10.1016/j.eururo.2007.04.024
   Sorbellini M, 2006, J UROLOGY, V176, P472, DOI 10.1016/j.juro.2006.03.090
NR 23
TC 0
Z9 1
U1 2
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
EI 1095-8673
J9 J SURG RES
JI J. Surg. Res.
PD MAR
PY 2011
VL 166
IS 1
BP E53
EP E57
DI 10.1016/j.jss.2010.10.035
PG 5
WC Surgery
SC Surgery
GA 732EI
UT WOS:000288167300006
PM 21176917
DA 2018-12-27
ER

PT J
AU Xiong, J
   Koyama, T
   Nisiyama, S
   Ohnishi, Y
   Takahashi, K
AF Xiong, Jun
   Koyama, Tomofumi
   Nisiyama, Satoshi
   Ohnishi, Yuzo
   Takahashi, Kenji
TI RETRACTED: Real-time slope water table forecasting by multi-tank model
   combined with dual ensemble Kalman filter (Retracted article. See vol.
   9, pg. 303, 2012)
SO LANDSLIDES
LA English
DT Article; Retracted Publication
DE Multi-tank model; Rainfall; Dual ensemble Kalman filter; Groundwater
   table; Slope stability; Data assimilation; Optimization
ID RAINFALL-RUNOFF MODELS; SHUFFLED COMPLEX EVOLUTION; DATA ASSIMILATION;
   OPTIMIZATION
AB The multi-tank model is a helpful tool for rainfall-groundwater-runoff analysis since it can represent a nonlinear transport behavior and give predictions very quickly. On one hand, because of its simple and quick calculation, the tank model is useful in water table or stream flow prediction; on the other hand, by reason of its simplicity, its model error is relatively big, the model adjustment through the time variation is necessary. A new data assimilation methodology for online tuning of model parameters and states in the multi-tank model by taking into account new observations was developed, and important model parameters and states are retrieved simultaneously based on dual ensemble Kalman filter. A description of applying multi-tank model to simulate rainfall infiltration process in the slope is presented, and also the implementation of the dual ensemble Kalman filter approach for slope water table forecasting is demonstrated. Based on the observation data, the performance of the new method is studied. Finally, the factor of slope stability could be predicted based on filtered water tables. In this way, an early warning system of slope stability during rainfall could be built, which is helpful for disaster prevention.
C1 [Xiong, Jun; Koyama, Tomofumi; Nisiyama, Satoshi; Ohnishi, Yuzo; Takahashi, Kenji] Kyoto Univ, Dept Urban & Environm Engn, Kyoto 6158540, Japan.
   [Takahashi, Kenji] Pacific Consultants Co Ltd, Dept Tunnel Engn, Chiba 2610004, Japan.
RP Xiong, J (reprint author), Kyoto Univ, Dept Urban & Environm Engn, Kyoto 6158540, Japan.
EM xiongjun79@gmail.com
CR Burgers G, 1998, MON WEATHER REV, V126, P1719, DOI 10.1175/1520-0493(1998)126<1719:ASITEK>2.0.CO;2
   Clark MP, 2008, ADV WATER RESOUR, V31, P1309, DOI 10.1016/j.advwatres.2008.06.005
   DUAN QY, 1993, J OPTIMIZ THEORY APP, V76, P501, DOI 10.1007/BF00939380
   DUAN QY, 1992, WATER RESOUR RES, V28, P1015, DOI 10.1029/91WR02985
   EVENSEN G, 1994, J GEOPHYS RES-OCEANS, V99, P10143, DOI 10.1029/94JC00572
   Evensen G., 2003, OCEAN DYNAM, V53, P343, DOI [10.1007/s10236-003-0036-9, DOI 10.1007/S10236-003-0036-9]
   Houtekamer PL, 1998, MON WEATHER REV, V126, P796, DOI 10.1175/1520-0493(1998)126<0796:DAUAEK>2.0.CO;2
   KALMAN RE, 1960, J BASIC ENG, V82, P35, DOI DOI 10.1115/1.3662552
   Michiue M, 1985, J NAT DISASTER SCI, V7, P1
   Nelson A.T., 1999, THESIS OREGON GRADUA
   OHTSU H, 2000, P JPN SOC CIV ENG, V658, P245
   OHTSU H, 2003, P 2 SE AS WORKSH ROC, P67
   Reichle RH, 2002, MON WEATHER REV, V130, P103, DOI 10.1175/1520-0493(2002)130<0103:HDAWTE>2.0.CO;2
   SUGAWARA M, 1978, RES NOTES NATL RES C, V17, P43
   TAKAHASHI K, 2004, THESIS KYOTO U
   TAKAHASHI Kenji, 2008, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V27, P2501
   TANAKAMARU H, 1993, ANN DISASTER PREVENT, P231
   Thyer M, 1999, WATER RESOUR RES, V35, P767, DOI 10.1029/1998WR900058
   Todini E., 1976, IISA WMO WORKSH REC
   Todini E., 1978, P AGU CHAPM C
   WANG QJ, 1991, WATER RESOUR RES, V27, P2467, DOI 10.1029/91WR01305
   Xiong J., 2009, P S ROCK MECH JPN, V38, P19
NR 22
TC 3
Z9 3
U1 5
U2 19
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1612-510X
EI 1612-5118
J9 LANDSLIDES
JI Landslides
PD MAR
PY 2011
VL 8
IS 1
BP 81
EP 89
DI 10.1007/s10346-010-0223-y
PG 9
WC Engineering, Geological; Geosciences, Multidisciplinary
SC Engineering; Geology
GA 732IM
UT WOS:000288178200006
DA 2018-12-27
ER

PT J
AU Hantke, K
   Winkler, K
   Schultz, JE
AF Hantke, Klaus
   Winkler, Karin
   Schultz, Joachim E.
TI RETRACTED: Escherichia coli Exports Cyclic AMP via TolC (Retracted
   article. See vol. 197, pg. 3849, 2015)
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article; Retracted Publication
ID CATABOLITE REPRESSION; ADENYLYL CYCLASES; CPDA GENE; PHOSPHODIESTERASE;
   IDENTIFICATION; MONOPHOSPHATE; EXPRESSION
AB In Escherichia coli more than 180 genes are regulated by the cyclic AMP (cAMP)-cAMP receptor protein (CRP) complex. However, more than 90% of cAMP that is made by intracellular adenylyl cyclases is found in the culture medium. How is cAMP exported from E. coli? In a tolC mutant, 0.03 mM IPTG (isopropyl-beta-D-thiogalactopyranoside) was sufficient to induce beta-galactosidase compared to 0.1 mM IPTG in the parent strain. In a cya mutant unable to produce cAMP about 1 mM extracellular cAMP was required to induce beta-galactosidase, whereas in a cya tolC mutant 0.1 mM cAMP was sufficient. When cAMP in E. coli cya was generated intracellularly by a recombinant, weakly active adenylyl cyclase from Corynebacterium glutamicum, the critical level of cAMP necessary for induction of maltose degradation was only achieved in a tolC mutant and not in the parent strain. Deletion of a putative cAMP phosphodiesterase of E. coli, CpdA, resulted in a slightly similar, yet more diffuse phenotype. The data demonstrate that export of cAMP via TolC is a most efficient way of E. coli to lower high concentrations of cAMP in the cell and maintain its sensitivity in changing metabolic environments.
C1 [Hantke, Klaus; Winkler, Karin; Schultz, Joachim E.] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany.
RP Hantke, K (reprint author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.
EM hantke@uni-tuebingen.de
FU Deutsche Forschungsgemeinschaft [SFB 766-B8]
FX This study was supported by the Deutsche Forschungsgemeinschaft (SFB
   766-B8).
CR BARZU O, 1994, PROG NUCLEIC ACID RE, V49, P241
   Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07
   BOTSFORD JL, 1984, J BACTERIOL, V160, P826
   CATANESE CA, 1989, J BACTERIOL, V171, P4531, DOI 10.1128/jb.171.9.4531-4536.1989
   EPSTEIN W, 1975, P NATL ACAD SCI USA, V72, P2300, DOI 10.1073/pnas.72.6.2300
   Fuchs EL, 2010, J BACTERIOL, V192, P2779, DOI 10.1128/JB.00168-10
   GIACOMINI A, 1992, FEMS MICROBIOL LETT, V100, P87, DOI 10.1111/j.1574-6968.1992.tb05687.x
   GOLDENBAUM PE, 1979, J BACTERIOL, V140, P459
   Imamura R, 1996, J BIOL CHEM, V271, P25423, DOI 10.1074/jbc.271.41.25423
   Kim HS, 2009, J BACTERIOL, V191, P922, DOI 10.1128/JB.01350-08
   Kimura Y, 2006, J BACTERIOL, V188, P823, DOI 10.1128/JB.188.2.823-828.2006
   Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X
   Narang A, 2009, J BIOSCIENCES, V34, P445, DOI 10.1007/s12038-009-0051-1
   Rosner JL, 2009, J BACTERIOL, V191, P5283, DOI 10.1128/JB.00507-09
   Suh SJ, 2002, MICROBIOL-SGM, V148, P1561, DOI 10.1099/00221287-148-5-1561
   Tan K, 2001, GENOME RES, V11, P566, DOI 10.1101/gr.149301
   WHITNEY EN, 1971, GENETICS, V67, P39
   Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908
NR 18
TC 28
Z9 28
U1 2
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD MAR
PY 2011
VL 193
IS 5
BP 1086
EP 1089
DI 10.1128/JB.01399-10
PG 4
WC Microbiology
SC Microbiology
GA 718QD
UT WOS:000287139200008
PM 21183666
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Suurmond, J
   Schuerwegh, AJM
   Toes, REM
AF Suurmond, J.
   Schuerwegh, A. J. M.
   Toes, R. E. M.
TI RETRACTED: Anti-citrullinated protein antibodies in rheumatoid
   arthritis: a functional role for mast cells and basophils? (Retracted
   Article)
SO ANNALS OF THE RHEUMATIC DISEASES
LA English
DT Article; Retracted Publication
ID HLA-DRB1 SHARED EPITOPE; PEPTIDE ANTIBODIES; AUTOANTIBODIES; IMMUNITY;
   RESPONSES; DISEASE
AB Rheumatoid arthritis (RA) is an autoimmune disease characterised by chronic inflammation of the joints. Anti-citrullinated protein antibodies (ACPA) are highly specific for RA and are associated with a more severe disease progression. ACPA have also been shown to have a pathological role in RA. In animal models of RA, ACPA enhances arthritis. Furthermore, in vitro generated immune complexes with ACPA can activate macrophages and the complement system in the human system. Recently, a direct functional and specific response of Fc epsilon RI+ immune cells towards citrullinated proteins was demonstrated. Basophils of ACPA+ RA patients are activated by citrullinated proteins that cross link the Fc epsilon RI receptor via IgE-ACPA, physiologically bound to the receptor. In addition, synovial mast cells from ACPA+ RA patients show a more activated phenotype than mast cells from ACPA-patients. These findings underline the suggestion that ACPA+ and ACPA-RA are two different disease entities and point to a possible functional role of ACPA and Fc epsilon RI+ cells in the pathogenesis of RA.
C1 [Suurmond, J.; Schuerwegh, A. J. M.; Toes, R. E. M.] LUMC, Dept Rheumatol, NL-2300 RC Leiden, Netherlands.
RP Schuerwegh, AJM (reprint author), LUMC, Dept Rheumatol C1 R, POB 9600,Albinusdreef 2, NL-2300 RC Leiden, Netherlands.
EM A.J.M.Schuerwegh@lumc.nl
RI Suurmond, Jolien/E-8776-2011
FU Dutch Arthritis foundation; Dutch Organisation for Scientific Research;
   Research Foundation Sole Mio; Leiden Research Foundation (STROL); Centre
   for Medical Systems Biology within the framework of the Netherlands
   Genomics Initiative
FX JS is supported by the Dutch Arthritis foundation. AJMS and REMT are
   supported by the Dutch Organisation for Scientific Research (clinical
   fellow, VIDI and VICI grants). AJMS is supported by the Research
   Foundation Sole Mio and the Leiden Research Foundation (STROL). This
   work is further supported by a grant from the Centre for Medical Systems
   Biology within the framework of the Netherlands Genomics Initiative,
   FP06 AUTOCURE and FP07 MASTERSWITCH.
CR Baeten D, 2001, ARTHRITIS RHEUM, V44, P2255, DOI 10.1002/1529-0131(200110)44:10<2255::AID-ART388>3.0.CO;2-#
   Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284
   CRISP AJ, 1984, ARTHRITIS RHEUM, V27, P845, DOI 10.1002/art.1780270802
   Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621
   Gabriel SE, 2001, RHEUM DIS CLIN N AM, V27, P269, DOI 10.1016/S0889-857X(05)70201-5
   Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327
   Gaudenzio N, 2009, BLOOD, V114, P4979, DOI 10.1182/blood-2009-02-202648
   Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008
   Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385
   Klareskog L, 2006, ARTHRITIS RHEUM, V54, P38, DOI 10.1002/art.21575
   Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annrev.immunol.26.021607.090244
   Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422
   Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176
   Makrygiannakis D, 2006, ANN RHEUM DIS, V65, P1219, DOI 10.1136/ard.2005.049403
   MALONE DG, 1986, ARTHRITIS RHEUM, V29, P956, DOI 10.1002/art.1780290803
   Merluzzi S, 2010, BLOOD, V115, P2810, DOI 10.1182/blood-2009-10-250126
   Meyer O, 2003, ANN RHEUM DIS, V62, P120, DOI 10.1136/ard.62.2.120
   Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008
   Pedersen M, 2007, ARTHRITIS RHEUM, V56, P1446, DOI 10.1002/art.22597
   Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740
   Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223
   Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571
   Schellekens GA, 2000, ARTHRITIS RHEUM, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3
   Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046
   Schuerwegh AJM, 2010, P NATL ACAD SCI USA, V107, P2586, DOI 10.1073/pnas.0913054107
   Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738
   Trouw LA, 2009, ARTHRITIS RHEUM-US, V60, P1923, DOI 10.1002/art.24622
   Uysal H, 2009, J EXP MED, V206, P449, DOI 10.1084/jem.20081862
   van der Helm-van Mil AHM, 2006, ARTHRITIS RHEUM, V54, P1117, DOI 10.1002/art.21739
   Verpoort KN, 2006, ARTHRITIS RHEUM, V54, P3799, DOI 10.1002/art.22279
   Verpoort KN, 2005, ARTHRITIS RHEUM, V52, P3058, DOI 10.1002/art.21302
   Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737
NR 32
TC 5
Z9 5
U1 2
U2 12
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-4967
EI 1468-2060
J9 ANN RHEUM DIS
JI Ann. Rheum. Dis.
PD MAR
PY 2011
VL 70
SU 1
BP I55
EP I58
DI 10.1136/ard.2010.138032
PG 4
WC Rheumatology
SC Rheumatology
GA 723OO
UT WOS:000287516800006
PM 21339220
DA 2018-12-27
ER

PT J
AU Niture, SK
   Jaiswal, AK
AF Niture, S. K.
   Jaiswal, A. K.
TI RETRACTED: INrf2 (Keap1) targets Bcl-2 degradation and controls cellular
   apoptosis (Retracted article. See vol. 21, pg. 503, 2014)
SO CELL DEATH AND DIFFERENTIATION
LA English
DT Article; Retracted Publication
DE Nrf2; INrf2 (Keap1); Bcl-2; Anti-apoptotic; Apoptosis
ID UBIQUITIN LIGASE COMPLEX; CUL3-BASED E3 LIGASE; PROTHYMOSIN-ALPHA;
   LUNG-CANCER; PROTEIN; NRF2; STRESS; SURVIVAL; ADAPTER; DOMAIN
AB Cytosolic inhibitor of Nrf2 (INrf2) is an adaptor protein that mediates ubiquitination/degradation of NF-E2-related factor 2 (Nrf2), a master regulator of cytoprotective gene expression. In this paper, we demonstrate that INrf2 degrades endogenous antiapoptotic B-cell CLL/lymphoma 2 (Bcl-2) protein and controls cellular apoptosis. The DGR domain of INrf2 interacts with the BH2 domain of Bcl-2 and facilitates INrf2:Cul3-Rbx1-mediated ubiquitination of Bcl-2 by the conjugation of ubiquitin molecules to lysine17 of Bcl-2. Further studies showed that INrf2 enhanced etoposide-mediated accumulation of Bax, increased release of cytochrome c from mitochondria, activated caspase-3/7, and enhanced DNA fragmentation and apoptosis. Antioxidants antagonized Bcl-2: INrf2 interaction, led to the release and stabilization of Bcl-2, increased Bcl-2: Bax heterodimers and reduced apoptosis. Moreover, dysfunctional/mutant INrf2 in human lung cancer cells failed to degrade Bcl-2, resulting in decreased etoposide and UV/gamma radiation-mediated DNA fragmentation. These data provide the first evidence of INrf2 control of Bcl-2 and apoptotic cell death, with implications in antioxidant protection, survival of cancer cells containing dysfunctional INrf2, and drug resistance. Cell Death and Differentiation (2011) 18, 439-451; doi:10.1038/cdd.2010.114; published online 24 September 2010
C1 [Niture, S. K.; Jaiswal, A. K.] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA.
RP Jaiswal, AK (reprint author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St, Baltimore, MD 21201 USA.
EM ajaiswal@som.umaryland.edu
FU NIH [RO1 ES012265]
FX This work was supported by NIH Grant RO1 ES012265. We thank our
   colleagues for helpful discussions.
CR Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883
   Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004
   Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7
   Deng XM, 2006, MOL CELL BIOL, V26, P4421, DOI 10.1128/MCB.01647-05
   Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102
   Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147
   Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671
   Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200
   Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005
   Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004
   Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200
   Kweon MH, 2006, J BIOL CHEM, V281, P33761, DOI 10.1074/jbc.M604748200
   Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025
   Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200
   Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200
   Mai HQ, 2003, J BIOL CHEM, V278, P1886, DOI 10.1074/jbc.M209044200
   Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009
   Niture SK, 2009, J CELL SCI, V122, P4452, DOI 10.1242/jcs.058537
   Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200
   Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013
   Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852
   Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420
   Strachan GD, 2004, BIOCHEMISTRY-US, V43, P12113, DOI 10.1021/bi0494166
   Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101
   Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248
   Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200
   YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0
   Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004
NR 28
TC 56
Z9 59
U1 1
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1350-9047
EI 1476-5403
J9 CELL DEATH DIFFER
JI Cell Death Differ.
PD MAR
PY 2011
VL 18
IS 3
BP 439
EP 451
DI 10.1038/cdd.2010.114
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 720VQ
UT WOS:000287311100007
PM 20865015
OA Green Accepted, Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Ramadan, MF
AF Ramadan, Mohamed Fawzy
TI RETRACTED: Artificial neural networks: a novel tool for detecting GMO
   (Retracted article. See vol. 12, pg. 175, 2017)
SO JOURNAL FUR VERBRAUCHERSCHUTZ UND LEBENSMITTELSICHERHEIT-JOURNAL OF
   CONSUMER PROTECTION AND FOOD SAFETY
LA English
DT Article; Retracted Publication
DE Genetically modified organisms; Bt-176 transgenic maize; Artificial
   neural networks; Lipid distribution PCR
ID POLYMERASE-CHAIN-REACTION; GENETICALLY-MODIFIED MAIZE; TIME-SERIES; PCR;
   PREDICTION; PRODUCTS; QUALITY; FOOD
AB Introduction of artificial neural network (ANN) into the field of GMO detection is the aim of this investigation. The usefulness of ANN to predict transgenic maize (Bt-176) based on chemical composition of the extracted crude oil was evaluated. The training set, comprised of a composition of major and minor lipid components as inputs and outputs. Crude oil extracted from the genetically modified maize (Bt-176) and non-transgenic maize was characterized in terms of its fatty acids, phytosterols and tocopherols distribution as well as of its lipid classes and unsaponifiables amounts. The results obtained from lipid distribution analysis showed that the grains of Bt-176 maize were comparable in their composition to that of the control maize. The analytical data have been elaborated by supervised pattern recognition technique ANN in order to classify genetically modified maize (Bt-176) and conventional maize as well as to authenticate the origin of the samples.
C1 [Ramadan, Mohamed Fawzy] Zagazig Univ, Dept Biochem, Fac Agr, Zagazig 44511, Egypt.
   [Ramadan, Mohamed Fawzy] King Saud Univ, Coll Food & Agr Sci, Riyadh 11451, Saudi Arabia.
RP Ramadan, MF (reprint author), Zagazig Univ, Dept Biochem, Fac Agr, Zagazig 44511, Egypt.
EM hassanienmohamed@yahoo.com
RI Ramadan, Prof. Mohamed Fawzy/A-3294-2008
OI Ramadan, Prof. Mohamed Fawzy/0000-0002-5431-8503
CR ARENS M, 1994, FETT WISS TECHNOL, V96, P67, DOI 10.1002/lipi.19940960209
   ARTEAGA GE, 1993, J FOOD SCI, V58, P1152, DOI 10.1111/j.1365-2621.1993.tb06136.x
   AZOFF EM, 1994, NEURAL NETWORK TIME, P60
   Chiueh LC, 2001, J FOOD DRUG ANAL, V9, P50
   DELURGIO SA, 1998, FORECASTING PRINCIPL, P693
   EHLERS B, 1997, BUNDESGESUNDHEITSBLA, V4, P118
   Frias S, 2002, NAHRUNG, V46, P370, DOI 10.1002/1521-3803(20020901)46:5<370::AID-FOOD370>3.0.CO;2-F
   Garcia-Canas V, 2002, J AGR FOOD CHEM, V50, P4497, DOI 10.1021/jf025585q
   Garcia-Gonzalez DL, 2003, J AGR FOOD CHEM, V51, P3515, DOI [10.1021/jf021217a, 10.1021/fj021217a]
   GOODACRE R, 1993, J SCI FOOD AGR, V63, P297, DOI 10.1002/jsfa.2740630306
   Gutes A, 2005, BIOSENS BIOELECTRON, V20, P1668, DOI 10.1016/j.bios.2004.07.026
   HEKANAHO J, 1998, P 4 INT WORKSH MULT
   HORIMOTO Y, 1995, J FOOD SCI, V60, P429, DOI 10.1111/j.1365-2621.1995.tb09796.x
   Hupfer C, 1998, Z LEBENSM UNTERS F A, V206, P203, DOI 10.1007/s002170050243
   JAMES C, 2001, 24 ISAAA
   JANSSON PA, 1991, ANAL CHEM, V63, pA357, DOI 10.1021/ac00006a739
   Kaastra I, 1996, NEUROCOMPUTING, V10, P215, DOI 10.1016/0925-2312(95)00039-9
   LAWRENCE J, 1994, INTRO NEURAL NETWORK, P348
   Meyer R, 1996, Z LEBENSM UNTERS FOR, V203, P339, DOI 10.1007/BF01231072
   PRINCIPE JC, 2000, NEURAL ADAPTIVE SYST, P272
   PRZYBYLSKI R, 2005, JAOCS, V77, P925
   Qi M, 2001, EUR J OPER RES, V132, P666, DOI 10.1016/S0377-2217(00)00171-5
   Ramadan MF, 2003, J AGR FOOD CHEM, V51, P969, DOI 10.1021/jf020778z
   Ramadan MF, 2002, EUR FOOD RES TECHNOL, V214, P521, DOI 10.1007/s00217-002-0511-4
   Richards T. J., 1998, Agricultural and Resource Economics Review, V27, P186
   RUAN R, 1995, CEREAL CHEM, V72, P308
   SHACHMUROVE Y, 2002, CARESS WORKING PAPER
   Studer E, 1998, Z LEBENSM UNTERS F A, V207, P207, DOI 10.1007/s002170050320
   Taylor SL, 1997, ENVIRON TOXICOL PHAR, V4, P121, DOI 10.1016/S1382-6689(97)10052-7
   Tengel C, 2001, BIOTECHNIQUES, V31, P426, DOI 10.2144/01312pf01
   Torrecilla JS, 2005, J FOOD ENG, V69, P299, DOI 10.1016/j.jfoodeng.2004.08.020
   TYREE EK, 1994, ASSESSING FINANCIAL
   Vaitilingom M, 1999, J AGR FOOD CHEM, V47, P5261, DOI 10.1021/jf981208v
   VALLEJOCORDOBA B, 1995, J FOOD SCI, V60, P885, DOI 10.1111/j.1365-2621.1995.tb06253.x
   Wailzer B, 2001, J MED CHEM, V44, P2805, DOI 10.1021/jm001129m
   Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7
   ZHANG X, 1992, J MOL BIOL, V225, P1049, DOI 10.1016/0022-2836(92)90104-R
NR 37
TC 3
Z9 3
U1 2
U2 17
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1661-5751
EI 1661-5867
J9 J VERBRAUCH LEBENSM
JI J. Verbrauch. Lebensm.
PD MAR
PY 2011
VL 6
IS 1
BP 13
EP 23
DI 10.1007/s00003-010-0579-x
PG 11
WC Food Science & Technology
SC Food Science & Technology
GA 722UB
UT WOS:000287459400004
DA 2018-12-27
ER

PT J
AU Fujii, Y
AF Fujii, Yoshitaka
TI RETRACTED: Management of postoperative nausea and vomiting in patients
   undergoing laparoscopic cholecystectomy (Retracted article. See vol. 27,
   pg. 2550, 2013)
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Review; Retracted Publication
DE Vomiting; Antiemetics; Combination; Acupressure; Laparoscopic
   cholecystectomy
ID PROPHYLACTIC ANTIEMETIC THERAPY; DEXAMETHASONE REDUCES NAUSEA;
   NITROUS-OXIDE; ANESTHETIC IMPLICATIONS; RISK SCORE; ONDANSETRON;
   PREVENTION; METOCLOPRAMIDE; DROPERIDOL; GRANISETRON
AB The common and distressing complications of postoperative nausea and vomiting (PONV) are the main concern of 40-70% of patients undergoing laparoscopic cholecystectomy (LC). The first step in preventing PONV after LC is to reduce the risk factors involving patient characteristics, surgical procedure, anesthetic technique, and postoperative care. Particularly, the use of propofol-based anesthesia can reduce the incidence of PONV after LC. Second, prophylactic antiemetics including antihistamines (dimenhydrinate), phenothiazines (perphenazine), butyrophenones (droperidol), benzamides (metoclopramide), dexamethasone, and serotonin receptor antagonists (ondansetron, granisetron, tropisetron, dolasetron, and ramosetron) are available for preventing PONV after LC. Third, antiemetic therapy combined with a serotonin receptor antagonist (ondansetron, granisetron) and droperidol or dexamethasone is highly effective in the prevention of PONV after LC. Fourth, acupressure at the P6 point is a nonpharmacologic technique that is as effective as ondansetron for preventing PONV after LC. Knowledge regarding the risk factors for PONV and antiemetics is needed for the management of PONV after LC.
C1 Toho Univ, Sch Med, Dept Anesthesiol 1, Ohta Ku, Tokyo 1438541, Japan.
RP Fujii, Y (reprint author), Toho Univ, Sch Med, Dept Anesthesiol 1, Ohta Ku, 6-11-1 Ohmori Nish, Tokyo 1438541, Japan.
EM yfujii@med.toho-u.ac.jp
CR Agarwal A, 2002, CAN J ANAESTH, V49, P554, DOI 10.1007/BF03017380
   Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022
   Apfel CC, 1998, ACTA ANAESTH SCAND, V42, P495, DOI 10.1111/j.1399-6576.1998.tb05157.x
   AWARD IT, 2002, J CLIN ANESTH, V14, P481
   BEATTIE WS, 1991, CAN J ANAESTH, V38, P298, DOI 10.1007/BF03007618
   BONICA JJ, 1958, ANESTHESIOLOGY, V19, P532, DOI 10.1097/00000542-195807000-00010
   BORGEAT A, 1992, ANESTH ANALG, V74, P539
   BORISON HL, 1953, PHARMACOL REV, V5, P193
   BUNCE KT, 1992, BRIT J ANAESTH, V69, pS60, DOI 10.1093/bja/69.supplement_1.60S
   Cabrera J C, 1997, Rev Esp Anestesiol Reanim, V44, P36
   CUNNINGHAM AJ, 1993, ANESTH ANALG, V76, P1120
   CUNNINGHAM AJ, 1994, SURG ENDOSC-ULTRAS, V8, P1272
   Eberhart LHJ, 1999, EUR J ANAESTH, V16, P284, DOI 10.1046/j.1365-2346.1999.00477.x
   Elhakim M, 2002, CAN J ANAESTH, V49, P922, DOI 10.1007/BF03016875
   Feo CV, 2006, BRIT J SURG, V93, P295, DOI 10.1002/bjs.5252
   FREDRIKSON M, 1992, BRIT J CANCER, V65, P779, DOI 10.1038/bjc.1992.165
   Frey UH, 2009, ACTA ANAESTH SCAND, V53, P1341, DOI 10.1111/j.1399-6576.2009.02081.x
   Fujii Y, 1998, CAN J ANAESTH, V45, P541, DOI 10.1007/BF03012704
   Fujii Y, 1998, EUR J ANAESTH, V15, P287, DOI 10.1017/S0265021598000556
   Fujii Y, 2002, EUR J SURG, V168, P583, DOI 10.1080/11024150201680002
   Fujii Y, 2001, ARCH SURG-CHICAGO, V136, P101, DOI 10.1001/archsurg.136.1.101
   Fujii Y, 2000, EUR J ANAESTH, V17, P64, DOI 10.1046/j.1365-2346.2000.00617.x
   Grover VK, 2009, ANAESTHESIA, V64, P595, DOI 10.1111/j.1365-2044.2008.05860.x
   HARRINGTON RA, 1983, DRUGS, V25, P451, DOI 10.2165/00003495-198325050-00002
   Hartung J, 1996, ANESTH ANALG, V83, P114, DOI 10.1097/00000539-199607000-00020
   Helmy SAK, 1999, ANAESTHESIA, V54, P266, DOI 10.1046/j.1365-2044.1999.00335.x
   Henzi I, 2000, ANESTH ANALG, V90, P186, DOI 10.1097/00000539-200001000-00038
   Hough M, 1998, ANAESTHESIA, V53, P932, DOI 10.1046/j.1365-2044.1998.0617p.x
   IITOMI T, 1995, MASUI, V44, P1727
   JENKINS LC, 1971, CAN ANAESTH SOC J, V18, P434, DOI 10.1007/BF03025695
   Jokela R, 1999, ACTA ANAESTH SCAND, V43, P645, DOI 10.1034/j.1399-6576.1999.430609.x
   KlockgetherRadke A, 1996, EUR J ANAESTH, V13, P3, DOI 10.1097/00003643-199601000-00002
   Kothari SN, 2000, SURG ENDOSC-ULTRAS, V14, P926, DOI 10.1007/s004640080055
   Kovac AL, 2000, DRUGS, V59, P213, DOI 10.2165/00003495-200059020-00005
   Kranke P, 2002, ACTA ANAESTH SCAND, V46, P238, DOI 10.1034/j.1399-6576.2002.t01-1-460303.x
   Lee A, 1999, ANESTH ANALG, V88, P1362, DOI 10.1097/00000539-199906000-00031
   Liberman MA, 2000, AM J SURG, V179, P60, DOI 10.1016/S0002-9610(99)00251-2
   LOESER EA, 1979, CAN ANAESTH SOC J, V26, P125, DOI 10.1007/BF03013781
   McCormick C., 2002, ASA NEWSL, V66, P19
   Naguib M, 1996, CAN J ANAESTH, V43, P226, DOI 10.1007/BF03011739
   OSTMAN PL, 1990, ANESTH ANALG, V71, P536
   PERREAULT L, 1982, CAN ANAESTH SOC J, V29, P428, DOI 10.1007/BF03009404
   Piper SN, 2002, CAN J ANAESTH, V49, P1021, DOI 10.1007/BF03017895
   Quaynor H, 2002, ACTA ANAESTH SCAND, V46, P109, DOI 10.1111/j.1399-6576.2002.aas_460120.x
   ROSE DK, 1992, CAN J ANAESTH, V39, P809, DOI 10.1007/BF03008293
   ROWBOTHAM DJ, 1992, BRIT J ANAESTH, V69, pS46, DOI 10.1093/bja/69.supplement_1.46S
   SAGAR SM, 1991, CANCER TREAT REV, V18, P95, DOI 10.1016/0305-7372(91)90009-O
   SCHIMMER BP, 2001, PHARMACOL BASIS THER, P1649
   Sinclair DR, 1999, ANESTHESIOLOGY, V91, P109, DOI 10.1097/00000542-199907000-00018
   SMESSAERT A, 1959, JAMA-J AM MED ASSOC, V170, P2072, DOI 10.1001/jama.1959.03010170034008
   SMITH DB, 1991, LANCET, V338, P487, DOI 10.1016/0140-6736(91)90555-4
   Sneyd JR, 1998, EUR J ANAESTH, V15, P433, DOI 10.1097/00003643-199807000-00009
   Steinbrook RA, 1998, J CLIN ANESTH, V10, P494, DOI 10.1016/S0952-8180(98)00077-4
   STEWART DJ, 1990, CAN J PHYSIOL PHARM, V68, P304, DOI 10.1139/y90-045
   Sweeney BP, 2002, BRIT J ANAESTH, V89, P810, DOI 10.1093/bja/aef269
   TAYLOR E, 1992, ANESTHESIOLOGY, V76, P541, DOI 10.1097/00000542-199204000-00009
   Walker JB, 2001, CLIN THER, V23, P932, DOI 10.1016/S0149-2918(01)80080-1
   Wang JJ, 1999, BRIT J ANAESTH, V83, P772
   Wang JJ, 2002, ANESTH ANALG, V95, P229, DOI 10.1097/00000539-200207000-00042
   WANG SC, 1950, ARCH NEURO PSYCHIATR, V63, P928, DOI 10.1001/archneurpsyc.1950.02310240087005
   WATCHA MF, 1992, ANESTHESIOLOGY, V77, P162, DOI 10.1097/00000542-199207000-00023
   Wilson EB, 2001, AM J SURG, V181, P138, DOI 10.1016/S0002-9610(00)00574-2
   YOUNG SN, 1981, BRIT J PHARMACOL, V74, P695, DOI 10.1111/j.1476-5381.1981.tb10480.x
NR 63
TC 17
Z9 18
U1 3
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0930-2794
EI 1432-2218
J9 SURG ENDOSC
JI Surg. Endosc.
PD MAR
PY 2011
VL 25
IS 3
BP 691
EP 695
DI 10.1007/s00464-010-1193-9
PG 5
WC Surgery
SC Surgery
GA 726TU
UT WOS:000287749900005
PM 20927550
DA 2018-12-27
ER

PT J
AU Morales, DR
AF Morales, Daniel R.
TI RETRACTED: Prescribing of beta-adrenoceptor antagonists in asthma: an
   observational study (Retracted Article)
SO THORAX
LA English
DT Correction; Retracted Publication
C1 Univ St Andrews, Sch Med, St Andrews KY16 8TF, Fife, Scotland.
RP Morales, DR (reprint author), Univ St Andrews, Sch Med, St Andrews KY16 8TF, Fife, Scotland.
EM danielmorales@nhs.net
CR Morales DR, 2011, THORAX, V66, P269, DOI 10.1136/thx.2010.149286
NR 1
TC 1
Z9 1
U1 2
U2 9
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0040-6376
EI 1468-3296
J9 THORAX
JI Thorax
PD MAR
PY 2011
VL 66
IS 3
BP 269
EP 269
DI 10.1136/thx.2010.149286
PG 1
WC Respiratory System
SC Respiratory System
GA 723AQ
UT WOS:000287478700033
PM 21228425
OA Bronze
DA 2018-12-27
ER

PT J
AU Kalishwaralal, K
   Sheikpranbabu, S
   BarathManiKanth, S
   Haribalaganesh, R
   Ramkumarpandian, S
   Gurunathan, S
AF Kalishwaralal, Kalimuthu
   Sheikpranbabu, Sardarpasha
   BarathManiKanth, Selvaraj
   Haribalaganesh, Ravinarayanan
   Ramkumarpandian, Sureshbabu
   Gurunathan, Sangiliyandi
TI RETRACTED: Gold nanoparticles inhibit vascular endothelial growth
   factor-induced angiogenesis and vascular permeability via Src dependent
   pathway in retinal endothelial cells (Retracted article. See vol. 14,
   pg. 409, 2011)
SO ANGIOGENESIS
LA English
DT Article; Retracted Publication
DE Gold nanoparticles; Src pathway; VEGF; Retinal neovascularization
ID MACULAR DEGENERATION; SIGNALING PATHWAYS; TYROSINE KINASES;
   BLOOD-VESSELS; NITRIC-OXIDE; C-SRC; VEGF; NEOVASCULARIZATION; MICE;
   VASCULOGENESIS
AB The purpose of this study was to investigate the effect of gold nanoparticles on the signaling cascade related to angiogenesis and vascular permeability induced by Vascular Endothelial Growth Factor (VEGF) in Bovine retinal endothelial cells (BRECs). The effect of VEGF and gold nanoparticles on cell viability, migration and tubule formation was assessed. PP2 (Src Tyrosine Kinase inhibitor) was used as the positive control and the inhibitor assay was performed to compare the effect of AuNPs on VEGF induced angiogenesis. The transient transfection assay was performed to study the VEGFR2/Src activity during experimental conditions and was confirmed using western blot analysis. Treatment of BRECs with VEGF significantly increased the cell proliferation, migration and tube formation. Furthermore, gold nanoparticles (500 nM) significantly inhibited the proliferation, migration and tube formation, in the presence of VEGF in BRECs. The gold nanoparticles also inhibited VEGF induced Src phosphorylation through which their mode of action in inhibiting angiogenic pathways is revealed. The fate of the gold nanoparticles within the cells is being analyzed using the TEM images obtained. The potential of AuNPs to inhibit the VEGF165-induced VEGFR-2 phosphorylation is also being confirmed through the receptor assay which elucidates one of the possible mechanism by which AuNPs inhibit VEGF induced angiogenesis. These results indicate that gold nanoparticles can block VEGF activation of important signaling pathways, specifically Src in BRECs and hence modulation of these pathways may contribute to gold nanoparticles ability to block VEGF-induced retinal neovascularization.
C1 [Kalishwaralal, Kalimuthu; Sheikpranbabu, Sardarpasha; BarathManiKanth, Selvaraj; Haribalaganesh, Ravinarayanan; Ramkumarpandian, Sureshbabu; Gurunathan, Sangiliyandi] Kalasalingam Univ, Kalasalingam Acad Res & Educ, Div Mol & Cellular Biol, Dept Biotechnol, Krishnankoil 626190, Tamil Nadu, India.
RP Gurunathan, S (reprint author), Kalasalingam Univ, Kalasalingam Acad Res & Educ, Div Mol & Cellular Biol, Dept Biotechnol, Krishnankoil 626190, Tamil Nadu, India.
EM lvsangs@yahoo.com
FU Council of Scientific and Industrial Research (CSIR), New Delhi
   [37/0347, 9/1012(0003)2K10EMR-I]; Department of Science and Technology
   (DST), New Delhi, India [SR/NM/NS-31/2010]
FX The authors gratefully acknowledge Kyung Jin Lee, Department of Life
   Science, Cell Dynamics Research Centre, Gwangju Institute of Science and
   Technology, Gwangju 500-712, Republic of Korea for performing western
   blot analysis. The authors also wish to acknowledge the support of Dr.
   Puspha Viswanathan, Professor, Cancer Institute (WIA), Chennai, who
   helped us with TEM analysis. Prof G. Sangiliyandi was supported by
   grants from Council of Scientific and Industrial Research (CSIR), New
   Delhi (Project No. 37/0347) and Department of Science and Technology
   (DST), New Delhi (Project No. SR/NM/NS-31/2010), India. Mr.
   Kalishwaralal was supported by the grant for Senior Research Fellowship
   from Council of Scientific and Industrial Research (CSIR), New Delhi
   (Grant No. 9/1012(0003)2K10EMR-I), India.
CR Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732
   AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203
   Banumathi E, 2009, MICROVASC RES, V77, P377, DOI 10.1016/j.mvr.2008.12.005
   Bashshur ZF, 2006, AM J OPHTHALMOL, V142, P1, DOI 10.1016/j.ajo.2006.02.037
   Boyer B, 2002, ONCOGENE, V21, P2347, DOI 10.1038/sj/onc/1205298
   Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0
   Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430
   Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X
   Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1
   Economopoulou M, 2005, BLOOD, V106, P3831, DOI 10.1182/blood-2005-03-0889
   Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X
   Favot L, 2003, THROMB HAEMOSTASIS, V90, P334, DOI 10.1160/TH03-02-0084
   Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016
   Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760
   Gurunathan S, 2009, BIOMATERIALS, V30, P6341, DOI 10.1016/j.biomaterials.2009.08.008
   Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007
   HATA Y, 1995, VIRCHOWS ARCH, V426, P479
   He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130
   Irby RB, 1999, NAT GENET, V21, P187
   Kalimuthu K, 2008, COLLOID SURFACE B, V65, P150, DOI 10.1016/j.colsurfb.2008.02.018
   Kalishwaralal K, 2009, COLLOID SURFACE B, V73, P51, DOI 10.1016/j.colsurfb.2009.04.025
   Kalishwaralal K, 2009, BIORESOURCE TECHNOL, V100, P5356, DOI 10.1016/j.biortech.2009.05.051
   Konopatskaya O, 2006, MOL VIS, V12, P626
   Kumar SA, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/49/495101
   Liu F, 2001, AM J RESP CELL MOL, V24, P711, DOI 10.1165/ajrcmb.24.6.4323
   Liu XO, 2007, COLLOID SURFACE B, V58, P3, DOI 10.1016/j.colsurfb.2006.08.005
   MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9
   Mukherjee P, 2005, CLIN CANCER RES, V11, P3530, DOI 10.1158/1078-0432.CCR-04-2482
   Murugesan S, 2007, FEBS LETT, V581, P1157, DOI 10.1016/j.febslet.2007.02.022
   Nakashio A, 2002, INT J CANCER, V98, P36, DOI 10.1002/ijc.10166
   Nam JS, 2002, CLIN CANCER RES, V8, P2430
   Ojima T, 2006, AM J PATHOL, V168, P331, DOI 10.2353/ajpath.2006.050435
   Paciotti GF, 2004, DRUG DELIV, V11, P169, DOI 10.1080/10717540490433895
   Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2
   Patan S, 2004, CANC TREAT, V117, P3
   Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675
   PRIYABRATA M, 2007, J NANOBIOTECHNOL, V5, P4
   Sastry M, 1998, J PHYS CHEM B, V102, P1404, DOI 10.1021/jp9719873
   SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0
   Sheikpranbabu Sardarpasha, 2009, Journal of Nanobiotechnology, V7, P8, DOI 10.1186/1477-3155-7-8
   Shen BQ, 1999, J BIOL CHEM, V274, P33057, DOI 10.1074/jbc.274.46.33057
   Shen JK, 2006, FASEB J, V20, P723, DOI 10.1096/fj.05-5046fje
   Simeonova PP, 2002, J BIOL CHEM, V277, P2945, DOI 10.1074/jbc.M109163200
   Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513
   Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511
   Xia XB, 2008, MOL VIS, V14, P1965
NR 48
TC 32
Z9 32
U1 4
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-6970
EI 1573-7209
J9 ANGIOGENESIS
JI Angiogenesis
PD MAR
PY 2011
VL 14
IS 1
BP 29
EP 45
DI 10.1007/s10456-010-9193-x
PG 17
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 723HV
UT WOS:000287498300003
PM 21061058
DA 2018-12-27
ER

PT J
AU Pereanu, W
   Younossi-Hartenstein, A
   Lovick, J
   Spindler, S
   Hartenstein, V
AF Pereanu, Wayne
   Younossi-Hartenstein, Amelia
   Lovick, Jennifer
   Spindler, Shana
   Hartenstein, Volker
TI RETRACTED: Lineage-Based Analysis of the Development of the Central
   Complex of the Drosophila Brain (Retracted article. See vol. 521, pg.
   266, 2012)
SO JOURNAL OF COMPARATIVE NEUROLOGY
LA English
DT Article; Retracted Publication
DE Drosophila; brain; central complex; lineage; development
ID LOCUST SCHISTOCERCA-GREGARIA; GANGLION MOTHER CELLS; ELLIPSOID
   BODY-OPEN; IN-FLIGHT CONTROL; NEUROBLAST LINEAGES; NEURAL LINEAGES;
   NERVOUS-SYSTEM; APIS-MELLIFERA; NEURONS; MELANOGASTER
AB Most neurons of the central complex belong to 10 secondary (larvally produced) lineages. In the late larva, undifferentiated axon tracts of these lineages form a primordium in which all of the compartments of the central complex can be recognized as discrete entities. Four posterior lineages (DPMm1, DPMpm1, DPMpm2, and CM4) generate the classes of small-field neurons that interconnect the protocerebral bridge, fan-shaped body, noduli, and ellipsoid body. Three lineages located in the anterior brain, DALv2, BAmv1, and DALcl2, form the large-field neurons of the ellipsoid body and fan-shaped body, respectively. These lineages provide an input channel from the optic tubercle and connect the central complex with adjacent anterior brain compartments. Three lineages in the posterior cortex, CM3, CP2, and DPMpl2, connect the posterior brain neuropil with specific layers of the fan-shaped body. Even though all of the compartments of the central complex are prefigured in the late larval brain by the axon tracts of the above-mentioned lineages, the neuropil differentiates during the first 2 days of the pupal period when terminal branches and synapses of secondary neurons are formed. During this phase the initially straight horizontal layers of the central complex bend in the frontal plane, which produces the characteristic shape of the fan-shaped and ellipsoid body. Our analysis provides a comprehensive picture of the lineages that form the central complex, and will facilitate future studies that address the structure or function of the central complex at the single cell level. J. Comp. Neurol. 519:661-689, 2011. (C) 2010 Wiley-Liss, Inc.
C1 [Pereanu, Wayne; Younossi-Hartenstein, Amelia; Lovick, Jennifer; Spindler, Shana; Hartenstein, Volker] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.
   [Pereanu, Wayne; Younossi-Hartenstein, Amelia; Hartenstein, Volker] Howard Hughes Med Inst, Ashburn, VA 20147 USA.
RP Hartenstein, V (reprint author), 621 Charles E Young Dr S,LS 4214, Los Angeles, CA 90095 USA.
EM volkerh@mcdb.ucla.edu
FU Howard Hughes Medical Institute; National Institutes of Health (NIH)
   [R01 NS054814]
FX Grant sponsor: Howard Hughes Medical Institute; Grant sponsor: National
   Institutes of Health (NIH); Grant number: R01 NS054814 (to. V.H.).
CR ASHBURNER M, 1989, DROSOPHILA LAB MANUA, P214
   Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003
   BAUSENWEIN B, 1994, J COMP NEUROL, V340, P255, DOI 10.1002/cne.903400210
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Bowman SK, 2008, DEV CELL, V14, P535, DOI [10.1016/j.devcel.2008.03.004, 10.1016/i.devcel.2008.03.004]
   de Velasco B, 2007, DEV BIOL, V302, P309, DOI 10.1016/j.ydbio.2006.09.035
   HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   Heinze S, 2008, J COMP NEUROL, V511, P454, DOI 10.1002/cne.21842
   Homberg U, 2003, J COMP NEUROL, V462, P415, DOI 10.1002/cne.10771
   HOMBERG U, 1985, J INSECT PHYSIOL, V31, P251, DOI 10.1016/0022-1910(85)90127-1
   HOMBERG U, 1994, J COMP PHYSIOL A, V175, P597
   Homberg U, 2008, ARTHROPOD STRUCT DEV, V37, P347, DOI 10.1016/j.asd.2008.01.008
   HORTSCH M, 1990, DEVELOPMENT, V110, P1327
   HUBER F, 1960, Z VERGL PHYSIOL, V44, P60, DOI 10.1007/BF00297863
   Ilius M, 2007, J NEUROGENET, V21, P321, DOI 10.1080/01677060701693503
   ILIUS M, 1994, J NEUROGENET, V9, P189, DOI 10.3109/01677069409167279
   Ito K, 1997, DEVELOPMENT, V124, P761
   Ito K, 2008, ADV EXP MED BIOL, V628, P137, DOI 10.1007/978-0-387-78261-4_9
   Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9
   Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2
   Karcavich RE, 2005, DEV DYNAM, V232, P609, DOI 10.1002/dvdy.20273
   Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308
   Kumar A, 2009, DEVELOPMENT, V136, P3433, DOI 10.1242/dev.037226
   Kumar A, 2009, J COMP NEUROL, V517, P87, DOI 10.1002/cne.22112
   Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380
   Larsen C, 2009, DEV BIOL, V335, P289, DOI 10.1016/j.ydbio.2009.06.015
   Lee T, 1999, DEVELOPMENT, V126, P4065
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Loesel R, 2002, ARTHROPOD STRUCT DEV, V31, P77, DOI 10.1016/S1467-8039(02)00017-8
   MILDE JJ, 1988, J INSECT PHYSIOL, V34, P427, DOI 10.1016/0022-1910(88)90113-8
   Muller M, 1997, CELL TISSUE RES, V288, P159, DOI 10.1007/s004410050803
   Nassel DR, 2006, CELL TISSUE RES, V326, P1, DOI 10.1007/s00441-006-0210-8
   NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701
   Nassif C, 1998, J COMP NEUROL, V402, P10
   Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482
   Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003
   OTTO D, 1971, Z VERGL PHYSIOL, V74, P227, DOI 10.1007/BF00297729
   PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   Pereanu W, 2010, J COMP NEUROL, V518, P2996, DOI 10.1002/cne.22376
   Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105
   Renn SCP, 1999, J NEUROBIOL, V41, P189
   SNOW PM, 1988, P NATL ACAD SCI USA, V85, P5291, DOI 10.1073/pnas.85.14.5291
   Spindler SR, 2009, DEV BIOL, V334, P355, DOI 10.1016/j.ydbio.2009.07.035
   Strausfeld N.J., 1976, ATLAS INSECT BRAIN
   STRAUSS R, 1993, J NEUROSCI, V13, P1852
   STRAUSS R, 1992, J NEUROGENET, V8, P125, DOI 10.3109/01677069209083444
   Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438
   Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749
   Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   Vitzthum H, 2002, J NEUROSCI, V22, P1114, DOI 10.1523/JNEUROSCI.22-03-01114.2002
   Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008
   WEGERHOFF R, 1992, CELL TISSUE RES, V268, P341, DOI 10.1007/BF00318803
   Williams JLD, 2008, ARTHROPOD STRUCT DEV, V37, P129, DOI 10.1016/j.asd.2007.05.005
   Young JM, 2010, J COMP NEUROL, V518, P1525, DOI 10.1002/cne.22285
   Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284
   Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483
   Younossi-Hartenstein A, 2006, J COMP NEUROL, V497, P981, DOI 10.1002/cne.20884
   YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7
   Yu HH, 2009, NAT NEUROSCI, V12, P947, DOI 10.1038/nn.2345
NR 64
TC 17
Z9 17
U1 3
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9967
EI 1096-9861
J9 J COMP NEUROL
JI J. Comp. Neurol.
PD MAR 1
PY 2011
VL 519
IS 4
BP 661
EP 689
DI 10.1002/cne.22542
PG 29
WC Neurosciences; Zoology
SC Neurosciences & Neurology; Zoology
GA 719AH
UT WOS:000287169600004
PM 21246549
DA 2018-12-27
ER

PT J
AU Kreipke, CW
   Rafols, JA
   Reynolds, CA
   Schafer, S
   Marinica, A
   Bedford, C
   Fronczak, M
   Kuhn, D
   Armstead, WM
AF Kreipke, Christian W.
   Rafols, Jose A.
   Reynolds, Christian A.
   Schafer, Steven
   Marinica, Alex
   Bedford, Christopher
   Fronczak, Michael
   Kuhn, Donald
   Armstead, William M.
TI RETRACTED: Clazosentan, a novel endothelin A antagonist, improves
   cerebral blood flow and behavior after traumatic brain injury (Retracted
   article. See vol. 39, pg. 472, 2017)
SO NEUROLOGICAL RESEARCH
LA English
DT Article; Retracted Publication
DE Drug therapy; Endothelin; Microcirculation
ID SUPEROXIDE GENERATION; RESPONSES; PHARMACOLOGY; MODEL
AB Objectives: The purpose of this study was to test the efficacy of a novel endothelin receptor A antagonist on blood flow and behavioral outcome given 30 minutes following traumatic brain injury.
   Methods: Male Sprague-Dawley rats (400-450 g) were used in this study. All animals were scanned for initial blood flow using arterial spin labeling magnetic resonance imaging (n=72 total). Half were subjected to traumatic brain injury using a weight acceleration impact device (n=36 total). Sham operated animals were used as control (n=36 total). Thirty minutes following traumatic brain injury, animals were given one intravenous injection of vehicle (0.9% saline) or 1.0 mg/kg clazosentan, a novel endothelin receptor A antagonist, for a total of four groups. At 4, 24, and 48 hours post-traumatic brain injury, blood flow determination continued. On the second day post-traumatic brain injury/sham operation, behavioral testing commenced using a radial arm maze to assess cognitive function.
   Results: Our results indicate that 1.0 mg/kg clazosentan was effective in ameliorating hypoperfusion seen after traumatic brain injury. Saline had no effect. Furthermore, clazosentan treatment was effective in significantly improving behavioral outcome following traumatic brain injury.
   Conclusion: Collectively, these results indicate that clazosentan, given at 30 minutes post-traumatic brain injury, is effective in improving outcome following injury.
C1 [Kreipke, Christian W.; Rafols, Jose A.; Reynolds, Christian A.; Schafer, Steven; Marinica, Alex; Bedford, Christopher; Fronczak, Michael] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.
   [Kreipke, Christian W.; Rafols, Jose A.; Kuhn, Donald] John D Dingell Vet Affairs Med Ctr, Detroit, MI USA.
   [Kuhn, Donald] Wayne State Univ, Sch Med, Dept Psychiat, Detroit, MI 48201 USA.
   [Armstead, William M.] Univ Penn, Dept Anesthesiol, Philadelphia, PA 19104 USA.
RP Kreipke, CW (reprint author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Room 9312 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.
EM ckreipke@med.wayne.edu
FU National Institutes of Health [NINDS NS064976]; Department of Veterans
   Affairs [RX000224]
FX This work was supported by grants from National Institutes of Health
   (no. NINDS NS064976) and a Department of Veterans Affairs Rehabilitation
   Research & Development Merit Award (no. RX000224) to Christian Kreipke.
   The authors wish to thank Actelion for generously providing clazosentan.
   We would also like to thank Dr E. Mark Haacke and Dr Yimen Shen for
   their assistance in using arterial spin labeling-magnetic resonance
   imaging to measure blood flow.
CR Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901
   Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884, DOI 10.1152/ajpheart.1999.277.5.H1884
   Armstead WM, 2001, J NEUROTRAUM, V18, P1039, DOI 10.1089/08977150152693737
   Benigni A, 1999, LANCET, V353, P133, DOI 10.1016/S0140-6736(98)09423-9
   BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333
   Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4
   Dawson DA, 1999, NEUROCHEM RES, V24, P1499, DOI 10.1023/A:1021139713026
   Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5
   GORLACH C, 2001, PFLUGERS ARCH, V44, P844
   IKEDA Y, 1990, NEUROSURGERY, V27, P1
   Kasemsri T, 1997, AM J PHYSIOL-HEART C, V273, pH2639
   Kasemsri T, 1997, STROKE, V28, P190, DOI 10.1161/01.STR.28.1.190
   Kreipke CW, 2010, NEUROL RES, V32, P209, DOI 10.1179/174313209X414515
   Krum Henry, 2003, Curr Opin Investig Drugs, V4, P298
   Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005
   Luscher T F, 1995, Agents Actions Suppl, V45, P237
   MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291
   MENDELOW AD, 1983, BRIT J SURG, V70, P641, DOI 10.1002/bjs.1800701102
   Povlishock JT, 2008, J NEUROTRAUM, V25, P717, DOI 10.1089/neu.2008.9964
   Rafols JA, 2007, NEUROL RES, V29, P337, DOI 10.1179/016164107X204639
   REYNOLDS CA, 2010, NEUROL RES IN PRESS
   Roux S, 1997, J PHARMACOL EXP THER, V283, P1110
   Sato M, 1998, BRAIN RES, V809, P39, DOI 10.1016/S0006-8993(98)00817-8
   Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X
   Uhlmann D, 2006, CURR OPIN INVESTIG D, V7, P272
NR 25
TC 5
Z9 5
U1 2
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0161-6412
EI 1743-1328
J9 NEUROL RES
JI Neurol. Res.
PD MAR
PY 2011
VL 33
IS 2
BP 208
EP 213
DI 10.1179/016164111X12881719352570
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 723OM
UT WOS:000287516600014
PM 21801597
DA 2018-12-27
ER

PT J
AU Singh, A
   Dinawaz, F
   Mewar, S
   Sharma, U
   Jagannathan, NR
   Sahoo, SK
AF Singh, Abhalaxmi
   Dinawaz, Fahima
   Mewar, Sujeet
   Sharma, Uma
   Jagannathan, N. R.
   Sahoo, Sanjeeb Kumar
TI RETRACTED: Composite Polymeric Magnetic Nanoparticles for Co-Delivery of
   Hydrophobic and Hydrophilic Anticancer Drugs and MRI Imaging for Cancer
   Therapy (Retracted article. See vol. 6, pg. 4595, 2014)
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article; Retracted Publication
DE polymeric magnetic nanoparticles; sustained release; dual drug delivery;
   apoptosis; targeted cancer therapy; MRI
ID IRON-OXIDE NANOPARTICLES; PACLITAXEL-LOADED NANOPARTICLES; CONTRAST
   AGENT; BREAST-CANCER; MITOCHONDRIAL-MEMBRANE; INDUCED CYTOTOXICITY;
   POLY(D,L-LACTIDE-CO-GLYCOLIDE); CELLS; RELEASE; TISSUE
AB Exercising complementary roles of polymer-coated magnetic nanoparticles for precise drug delivery and image contrast agents has attracted significant attention in biomedical applications. The objective of this study was to prepare and characterize magnetic nanoparticles embedded in polylactide-co-glycolide matrixes (PLGA-MNPs) as a dual drug delivery and imaging system capable of encapsulating both hydrophilic and hydrophobic drugs. PLGA-MNPs were capable of encapsulating both hydrophobic and hydrophilic drugs in a 2:1 ratio. Biocompatibility, cellular uptake, cytotoxicity, membrane potential, and apoptosis were carried out in two different cancer cell lines (MCF-7 and PANC-1). The molecular basis of induction of apoptosis was validated by Western blotting analysis. For targeted delivery of drugs, targeting ligand such as Herceptin was used, and such a conjugated system demonstrated enhanced cellular uptake and an augmented synergistic effect in an in vitro system when compared with native drugs. Magnetic resonance imaging was carried out both in vitro and in vivo to assess the efficacy of PLGA-MNPs as contrast agents. PLGA-MNPs showed a better contrast effect than commercial contrast agents due to higher T-2 relaxivity with a blood circulation half-life similar to 47 min in the rat model. Thus, our results demonstrated the dual usable purpose of formulated PLGA-MNPs toward either, in therapeutics by delivering different hydrophobic or hydrophilic drugs individually or in combination and imaging for cancer therapeutics in the near future.
C1 [Singh, Abhalaxmi; Dinawaz, Fahima; Sahoo, Sanjeeb Kumar] Inst Life Sci, Lab Nanomed, Bhubaneswar 751023, Orissa, India.
   [Dinawaz, Fahima; Mewar, Sujeet; Sharma, Uma; Jagannathan, N. R.] All India Inst Med Sci, Dept NMR, New Delhi 110029, India.
   [Dinawaz, Fahima; Mewar, Sujeet; Sharma, Uma; Jagannathan, N. R.] All India Inst Med Sci, MRI Facil, New Delhi 110029, India.
RP Sahoo, SK (reprint author), Inst Life Sci, Lab Nanomed, Nalco Sq, Bhubaneswar 751023, Orissa, India.
EM sanjeebsahoo2005@gmail.com
CR Acharya S, 2009, BIOMATERIALS, V30, P5737, DOI 10.1016/j.biomaterials.2009.07.008
   Alexiou C, 2002, J MAGN MAGN MATER, V252, P363, DOI 10.1016/S0304-8853(02)00605-4
   Artemov D, 2003, MAGNET RESON MED, V49, P403, DOI 10.1002/mrm.10406
   Aryal S, 2010, SMALL, V6, P1442, DOI 10.1002/smll.201000631
   Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643
   Briley-Saebo K, 2004, CELL TISSUE RES, V316, P315, DOI 10.1007/s00441-004-0884-8
   BULTE JWM, 1992, MAGNET RESON MED, V25, P148, DOI 10.1002/mrm.1910250115
   Butoescu N, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2701
   Chiu SJ, 2009, CHEM-BIOL INTERACT, V182, P173, DOI 10.1016/j.cbi.2009.08.019
   Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013
   COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438
   Das M, 2009, EXPERT OPIN DRUG DEL, V6, P285, DOI 10.1517/17425240902780166
   Dilnawaz F, 2010, BIOMATERIALS, V31, P3694, DOI 10.1016/j.biomaterials.2010.01.057
   Dong JJ, 2005, CANCER RES, V65, P1961, DOI 10.1158/0008-5472.CAN-04-2501
   Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487
   Guinier A., 1963, DIFFRACTION CRYSTALS, P378
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Hafeli UO, 2004, INT J PHARM, V277, P19, DOI 10.1016/j.ijpharm.2003.03.002
   Ito A, 2004, TISSUE ENG, V10, P833, DOI 10.1089/1076327041348301
   Jain TK, 2005, MOL PHARMACEUT, V2, P194, DOI 10.1021/mp0500014
   Jain TK, 2008, BIOMATERIALS, V29, P4012, DOI 10.1016/j.biomaterials.2008.07.004
   Kim J, 2008, ADV MATER, V20, P478, DOI 10.1002/adma.200701726
   KROEMER G, 1995, FASEB J, V9, pA419
   Lee BJ, 1999, INT J PHARM, V188, P71, DOI 10.1016/S0378-5173(99)00204-5
   Lee SJ, 2005, COLLOID SURFACE A, V255, P19, DOI 10.1016/j.colsurfa.2004.12.019
   Liu XQ, 2007, J CONTROL RELEASE, V119, P52, DOI 10.1016/j.jconrel.2006.11.031
   Liu XQ, 2006, J MAGN MAGN MATER, V306, P248, DOI 10.1016/j.jmmm.2006.03.049
   Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   Mahmoudi M., 2009, COLLOID SURFACE B, V75, P300
   Mejias R., 2010, J NANOMEDICINE LONDO, V5, P397
   Meric F, 2002, MOL CANCER THER, V1, P971
   Misra R, 2009, NANOMEDICINE-UK, V4, P519, DOI 10.2217/NNM.09.28
   Mitragotri S, 2000, PHARMACEUT RES, V17, P1354, DOI 10.1023/A:1007522114438
   Mondesire WH, 2004, CLIN CANCER RES, V10, P7031, DOI 10.1158/1078-0432.CCR-04-0361
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Okassa LN, 2007, EUR J PHARM BIOPHARM, V67, P31, DOI 10.1016/j.ejpb.2006.12.020
   Panyam J, 2003, INT J PHARM, V262, P1, DOI 10.1016/S0378-5173(03)00295-3
   Parveen S, 2008, J DRUG TARGET, V16, P108, DOI [10.1080/10611860701794353, 10.1080/10611860701794353 ]
   Polyak B, 2009, EXPERT OPIN DRUG DEL, V6, P53, DOI [10.1517/17425240802662795 , 10.1517/17425240802662795]
   Prabha S, 2002, INT J PHARM, V244, P105, DOI 10.1016/S0378-5173(02)00315-0
   Prashant C, 2010, BIOMATERIALS, V31, P5588, DOI 10.1016/j.biomaterials.2010.03.070
   Qiu LY, 2007, BIOMATERIALS, V28, P4132, DOI 10.1016/j.biomaterials.2007-05.035
   Raffaella A., 2005, BLOOD, V106, P1400
   Sahoo SK, 2005, MOL PHARMACEUT, V2, P373, DOI 10.1021/mp050032z
   Sahoo SK, 2004, INT J CANCER, V112, P335, DOI 10.1002/ijc.20405
   Sahoo SK, 2003, DRUG DISCOV TODAY, V8, P1112, DOI 10.1016/S1359-6446(03)02903-9
   STARK DD, 1988, RADIOLOGY, V168, P297, DOI 10.1148/radiology.168.2.3393649
   TIEFENAUER LX, 1993, BIOCONJUGATE CHEM, V4, P347, DOI 10.1021/bc00023a007
   Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219
   Wei L, 2009, BIOMATERIALS, V30, P2606, DOI 10.1016/j.biomaterials.2009.01.006
   WEISSLEDER R, 1995, ADV DRUG DELIVER REV, V16, P321, DOI 10.1016/0169-409X(95)00033-4
   Yang J, 2006, INT J PHARM, V324, P185, DOI 10.1016/j.ijpharm.2006.06.029
   Yang J, 2006, J MICROENCAPSUL, V23, P203, DOI 10.1080/02652040500435444
   Yang J, 2007, J MATER CHEM, V17, P2695, DOI 10.1039/b702538f
   Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533
   Zhang LF, 2007, CHEMMEDCHEM, V2, P1268, DOI 10.1002/cmdc.200700121
   ZORATTI M, 1994, J BIOENERG BIOMEMBR, V26, P543, DOI 10.1007/BF00762739
NR 58
TC 110
Z9 111
U1 3
U2 88
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR
PY 2011
VL 3
IS 3
BP 842
EP 856
DI 10.1021/am101196v
PG 15
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 739AV
UT WOS:000288685200034
PM 21370886
DA 2018-12-27
ER

PT J
AU Kim, YW
   Kim, YM
   Yang, YM
   Kay, HY
   Kim, WD
   Lee, JW
   Hwang, SJ
   Kim, SG
AF Kim, Young Woo
   Kim, Young Mi
   Yang, Yoon Mee
   Kay, Hee Yeon
   Kim, Won Dong
   Lee, Jee Woo
   Hwang, Se Jin
   Kim, Sang Geon
TI RETRACTED: Inhibition of LXR alpha-Dependent Steatosis and Oxidative
   Injury by Liquiritigenin, a Licorice Flavonoid, as Mediated with Nrf2
   Activation (Retracted article. See vol. 16, pg. 292, 2012)
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Article; Retracted Publication
ID HIGH-FAT DIET; X-RECEPTOR; NONALCOHOLIC STEATOHEPATITIS;
   GLYCYRRHIZAE-RADIX; METABOLIC SYNDROME; LIVER-DISEASE; INDUCTION;
   STRESS; DITHIOLETHIONES; TRANSCRIPTION
AB Liver X receptor-alpha (LXR alpha) functions as a major regulator of lipid homeostasis through activation of sterol regulatory element binding protein-1c (SREBP-1c), which promotes hepatic steatosis and steatohepatitis. NF-E2-related factor 2 (Nrf2) is the crucial transcription factor that is necessary for the induction of antioxidant enzymes. This study investigated the potential of liquiritigenin (LQ), a hepatoprotective flavonoid in licorice, to inhibit LXR alpha-induced hepatic steatosis, and the underlying mechanism of the action. LQ treatment attenuated fat accumulation and lipogenic gene induction in the liver of mice fed a high fat diet. Also, LQ had the ability to inhibit oxidative liver injury, as shown by decreases in thiobarbituric acid reactive substances formation and nitrotyrosinylation. Moreover, LQ treatment antagonized LXRa agonist (T0901317)-mediatedSREBP-1c activation, and transactivation of the lipogenic target genes. LQ was found to activate Nrf2, and the ability of LQ to inhibit LXR alpha-mediated SREBP-1c activation was reversed by Nrf2 deficiency, which supports the inhibitory role of Nrf2 in LXR alpha-dependent lipogenesis. Consistently, treatment with other Nrf2 activators or forced expression of Nrf2 also inhibited LXR alpha-mediated SREBP-1c activation. Our results demonstrate that LQ has an efficacy to activate Nrf2, which contributes to inhibiting the activity of LXRa that leads to SREBP-1c induction and hepatic steatosis. Antioxid. Redox Signal. 14, 733-745.
C1 [Kim, Young Woo; Kim, Young Mi; Yang, Yoon Mee; Kay, Hee Yeon; Kim, Won Dong; Lee, Jee Woo; Kim, Sang Geon] Seoul Natl Univ, Coll Pharm, Innovat Drug Res Ctr Metab & Inflammatory Dis, Seoul 151742, South Korea.
   [Kim, Young Woo; Kim, Young Mi; Yang, Yoon Mee; Kay, Hee Yeon; Kim, Won Dong; Lee, Jee Woo; Kim, Sang Geon] Seoul Natl Univ, Res Inst Pharmaceut Sci, Innovat Drug Res Ctr Metab & Inflammatory Dis, Seoul, South Korea.
   [Hwang, Se Jin] Hanyang Univ, Coll Med, Seoul 133791, South Korea.
RP Kim, SG (reprint author), Seoul Natl Univ, Coll Pharm, Innovat Drug Res Ctr Metab & Inflammatory Dis, Seoul 151742, South Korea.
EM sgk@snu.ac.kr
FU Korea government (MEST), Korea [2009-0063233]
FX This work was supported by the National Research Foundation of Korea
   grant funded by the Korea government (MEST) (No. 2009-0063233), Korea.
CR Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101
   Cho IJ, 2009, XENOBIOTICA, V39, P182, DOI 10.1080/00498250802549808
   Choe SS, 2007, DIABETES, V56, P1534, DOI 10.2337/db06-1059
   Choi SH, 2010, BIOCHEM PHARMACOL, V79, P1352, DOI 10.1016/j.bcp.2009.12.011
   Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007
   Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024
   Dang HX, 2009, J BIOL CHEM, V284, P6218, DOI 10.1074/jbc.M803702200
   Fonseca V, 2003, AM J MED, V115, P42, DOI 10.1016/S0002-9343(03)00563-1
   Galgani JE, 2008, BRIT J NUTR, V100, P471, DOI 10.1017/S0007114508894408
   Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009
   Hwahng SH, 2009, HEPATOLOGY, V49, P1913, DOI 10.1002/hep.22887
   Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   Kang HE, 2009, J PHARM SCI-US, V98, P4327, DOI 10.1002/jps.21702
   Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061
   Kim SC, 2004, TOXICOLOGY, V197, P239, DOI 10.1016/j.tox.2004.01.010
   Kim YW, 2008, BRIT J PHARMACOL, V154, P165, DOI 10.1038/bjp.2008.79
   Kim YW, 2010, FREE RADICAL BIO MED, V48, P567, DOI 10.1016/j.freeradbiomed.2009.12.006
   Kim YW, 2009, AM J PHYSIOL-GASTR L, V296, pG372, DOI 10.1152/ajpgi.90524.2008
   Kim YW, 2006, CHEM-BIOL INTERACT, V161, P125, DOI 10.1016/j.cbi.2006.03.008
   Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7
   Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100
   Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029
   de Oliveira CPMS, 2008, HEPATOL RES, V38, P159, DOI 10.1111/j.1872-034X.2007.00215.x
   Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003
   Mollica MP, 2009, J HEPATOL, V51, P363, DOI 10.1016/j.jhep.2009.03.023
   Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229
   Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022
   Stadler K, 2008, FREE RADICAL BIO MED, V45, P866, DOI 10.1016/j.freeradbiomed.2008.06.023
   Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822
   Tegeder I, 1999, CLIN PHARMACOKINET, V37, P17, DOI 10.2165/00003088-199937010-00002
   Wang ZY, 2001, NUTR CANCER, V39, P1, DOI 10.1207/S15327914nc391_1
NR 34
TC 12
Z9 13
U1 2
U2 28
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
EI 1557-7716
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD MAR
PY 2011
VL 14
IS 5
BP 733
EP 745
DI 10.1089/ars.2010.3260
PG 13
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 713KO
UT WOS:000286737100001
PM 20677908
DA 2018-12-27
ER

PT J
AU Oliveira, AG
   Carvalho, BM
   Tobar, N
   Ropelle, ER
   Pauli, JR
   Bagarolli, RA
   Guadagnini, D
   Carvalheira, JBC
   Saad, MJA
AF Oliveira, Alexandre G.
   Carvalho, Bruno M.
   Tobar, Natalia
   Ropelle, Eduardo R.
   Pauli, Jose R.
   Bagarolli, Renata A.
   Guadagnini, Dioze
   Carvalheira, Jose B. C.
   Saad, Mario J. A.
TI RETRACTED: Physical Exercise Reduces Circulating Lipopolysaccharide and
   TLR4 Activation and Improves Insulin Signaling in Tissues of DIO Rats
   (Retracted article. See vol. 65, pg. 1124, 2016)
SO DIABETES
LA English
DT Article; Retracted Publication
ID DIET-INDUCED OBESITY; HUMAN SKELETAL-MUSCLE; NECROSIS-FACTOR-ALPHA;
   ADIPOSE-TISSUE; BLOOD-FLOW; FAT DIET; INNATE IMMUNITY; RESISTANCE;
   INFLAMMATION; RECEPTOR
AB OBJECTIVE-Insulin resistance in diet-induced obesity (DIO) is associated with a chronic systemic low-grade inflammation, and Toll-like receptor 4 (TLR4) plays an important role in the link among insulin resistance, inflammation, and obesity. The current study aimed to analyze the effect of exercise on TLR4 expression and activation in obese rats and its consequences on insulin sensitivity and signaling.
   RESEARCH DESIGN AND METHODS-The effect of chronic and acute exercise was investigated on insulin sensitivity, insulin signaling, TLR4 activation, c-Jun NH2-terminal kinase (JNK) and I kappa B kinase (IKK beta) activity, and lipopolysaccharide (LPS) serum levels in tissues of DIO rats.
   RESULTS-The results showed that chronic exercise reduced TLR4 mRNA and protein expression in liver, muscle, and adipose tissue. However, both acute and chronic exercise blunted TLR4 signaling in these tissues, including a reduction in JNK and IKK beta phosphorylation and IRS-1 serine 307 phosphorylation, and, in parallel, improved insulin-induced IR, IRS-1 tyrosine phosphorylation, and Akt serine phosphorylation, and reduced LPS serum levels.
   CONCLUSIONS-Our results show that physical exercise in DIO rats, both acute and chronic, induces an important suppression in the TLR4 signaling pathway in the liver, muscle, and adipose tissue, reduces LPS serum levels, and improves insulin signaling and sensitivity. These data provide considerable progress in our understanding of the molecular events that link physical exercise to an improvement in inflammation and insulin resistance. Diabetes 60:784-796, 2011
C1 [Oliveira, Alexandre G.; Carvalho, Bruno M.; Tobar, Natalia; Ropelle, Eduardo R.; Pauli, Jose R.; Bagarolli, Renata A.; Guadagnini, Dioze; Carvalheira, Jose B. C.; Saad, Mario J. A.] Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil.
RP Saad, MJA (reprint author), Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil.
EM msaad@fcm.unicamp.br
RI Carvalheira, Jose/H-8405-2012; Ropelle, Eduardo/C-3977-2012; Diabetes,
   Inct/I-2186-2013; 5, INCT/H-4505-2013; Oliveira, Alexandre/D-1288-2013
OI Ropelle, Eduardo/0000-0003-1655-9557; Oliveira,
   Alexandre/0000-0002-6620-5477
FU Fundacao de Amparo a Pesquisa do Estado de SAO PAULO; Conselho Nacional
   de Pesquisa; INCT-Obesidade e Diabetes
FX This work was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado de SAO PAULO, Conselho Nacional de Pesquisa, and INCT-Obesidade e
   Diabetes.
CR Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511
   Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005
   Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
   Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959
   Chambers MA, 2009, J PHYSIOL-LONDON, V587, P3363, DOI 10.1113/jphysiol.2008.165639
   Fallon KE, 2001, BRIT J SPORT MED, V35, P170, DOI 10.1136/bjsm.35.3.170
   Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018
   Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979
   Gollisch KSC, 2009, AM J PHYSIOL-ENDOC M, V297, pE495, DOI 10.1152/ajpendo.90424.2008
   GRANGER DN, 1980, GASTROENTEROLOGY, V78, P837
   Greiwe JS, 2001, FASEB J, V15, P475, DOI 10.1096/fj.00-0274com
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955
   Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851
   Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013
   Kopp A, 2009, OBESITY, V17, P648, DOI 10.1038/oby.2008.607
   Kwak YS, 2006, J SPORT SCI, V24, P973, DOI 10.1080/02640410500386233
   Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052
   Luciano E, 2002, EUR J ENDOCRINOL, V147, P149, DOI 10.1530/eje.0.1470149
   Matsumura T, 2000, J INTERF CYTOK RES, V20, P915, DOI 10.1089/10799900050163299
   Mattusch F, 2000, INT J SPORTS MED, V21, P21
   Monroy A, 2009, DIABETOLOGIA, V52, P2169, DOI 10.1007/s00125-009-1451-3
   Musch TI, 2004, J APPL PHYSIOL, V96, P81, DOI 10.1152/japplphysiol.00729.2003
   Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200
   Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200
   PAPPO I, 1991, J SURG RES, V51, P106, DOI 10.1016/0022-4804(91)90078-Z
   Prada PD, 2000, HYPERTENSION, V35, P424, DOI 10.1161/01.HYP.35.1.424
   Prada PO, 2005, ENDOCRINOLOGY, V146, P1576, DOI 10.1210/en.2004-0767
   QAMAR MI, 1987, GUT, V28, P583, DOI 10.1136/gut.28.5.583
   Roepstorff C, 2004, J PHYSIOL-LONDON, V560, P551, DOI 10.1113/jphysiol.2004.066480
   Ropelle ER, 2006, J PHYSIOL-LONDON, V577, P997, DOI 10.1113/jphysiol.2006.120006
   Ryder JW, 2000, J BIOL CHEM, V275, P1457, DOI 10.1074/jbc.275.2.1457
   Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JC134260
   Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898
   Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059
   Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170
   Sriwijitkamol A, 2006, DIABETES, V55, P760, DOI 10.2337/diabetes.55.03.06.db05-0677
   Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003
   Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a
   Thirone ACP, 2004, ENDOCRINOLOGY, V145, P281, DOI 10.1210/en.2003-0575
   Toledo FGS, 2008, DIABETES, V57, P987, DOI 10.2337/db07-1429
   Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595
   Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093
   Vieira VJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1164, DOI 10.1152/ajpendo.00054.2009
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Widegren U, 1998, FASEB J, V12, P1379
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200
   Zanchi NE, 2008, EUR J APPL PHYSIOL, V104, P1045, DOI 10.1007/s00421-008-0861-0
NR 50
TC 70
Z9 77
U1 2
U2 27
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD MAR
PY 2011
VL 60
IS 3
BP 784
EP 796
DI 10.2337/db09-1907
PG 13
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 730UM
UT WOS:000288060300013
PM 21282367
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Ko, SS
   Jordan, VC
AF Ko, Seung Sang
   Jordan, V. Craig
TI RETRACTED: Treatment of osteoporosis and reduction in risk of invasive
   breast cancer in postmenopausal women with raloxifene (Retracted
   article. See vol. 13, pg. 1081, 2012)
SO EXPERT OPINION ON PHARMACOTHERAPY
LA English
DT Editorial Material; Retracted Publication
DE bisphosphonate; breast cancer; lasofoxifene; osteoporosis; raloxifene;
   selective estrogen receptor modulator
ID HORMONE-REPLACEMENT THERAPY; RANDOMIZED CLINICAL-TRIAL; STAR P-2 TRIAL;
   ONCOLOGY TECHNOLOGY-ASSESSMENT; CONTINUING OUTCOMES RELEVANT;
   ESTROGEN-RECEPTOR MODULATORS; SURGICAL ADJUVANT BREAST; VERTEBRAL
   FRACTURE RISK; BONE-MINERAL DENSITY; ZOLEDRONIC ACID
AB Introduction: Raloxifene, a non-steroidal selective estrogen receptor modulator (SERM), offers a new dimension for the treatment and prevention of osteoporosis and risk reduction of invasive breast cancer in postmenopausal populations at high risk. Both osteoporosis and breast cancer are important public health issues for postmenopausal women. It is well known that estrogen and estrogen receptors play an important role in the pathogenesis of both diseases. Initially, hormone replacement therapy (HRT) was used for the purpose of preventing and treating postmenopausal osteoporosis. However, HRT significantly contributed to an increase in breast cancer risk. The SERM, raloxifene, is used for the prevention and for the treatment of postmenopausal osteoporosis and reducing the risk of invasive breast cancer in postmenopausal women.
   Areas covered: This article reviews the emerging evidence of the efficacy of raloxifene in postmenopausal women, summarizes the results and places in perspective their therapeutic uses for women having either a high risk of osteoporosis or breast cancer. Emerging clinical evidence suggests bisphosphonates, currently used as drugs for the treatment of osteoporosis, may also reduce breast cancer risk. The status of other SERMs and bisphosphonates are included for completeness. A Medline search of raloxifene, osteoporosis, breast cancer and SERMs was used to derive a database of 355 references.
   Expert opinion: Readers will understand the value of raloxifene to prevent osteoporosis and breast cancer in postmenopausal women. Although most women do not require pharmacotherapy for menopausal symptoms, many are severely affected by osteoporosis or breast cancer at and beyond menopause and, for such women, pharmacologic intervention is important if they are to retain an acceptable quality of life. It is reasonable to use raloxifene or bisphosphonate as an appropriate drug that targets symptom-free postmenopausal women for treatment and prevention of osteoporosis but raloxifene is proven to reduce the incidence of invasive breast cancer.
C1 [Jordan, V. Craig] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA.
   [Ko, Seung Sang] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA.
   [Ko, Seung Sang] Kwandong Univ, Coll Med, Cheil Gen Hosp, Dept Surg, Seoul 100611, South Korea.
RP Jordan, VC (reprint author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, 3970 Reservoir Rd NW,Res Bldg,Suite E501, Washington, DC 20057 USA.
EM vcj2@georgetown.edu
RI Jordan, V. Craig/H-4491-2011
FU NCI NIH HHS [P30 CA051008-18, P30 CA051008]
CR Aft R, 2010, LANCET ONCOL, V11, P421, DOI 10.1016/S1470-2045(10)70054-1
   Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701
   [Anonymous], 2002, AM BON HLTH STAT OST
   Banks E, 2003, LANCET, V362, P419
   Barrett-Connor E, 2004, J BONE MINER RES, V19, P1270, DOI 10.1359/JBMR.040406
   Barrett-Connor E, 1998, MATURITAS, V31, P1
   Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462
   Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312
   Blumenthal RS, 2004, AM HEART J, V147, P783, DOI 10.1016/j.ahj.2003.12.019
   Briot K, 2007, JOINT BONE SPINE, V74, P24, DOI 10.1016/j.jbspin.2006.05.011
   Brown JP, 2006, J OBSTET GYNAECOL CA, V28, pS95, DOI 10.1016/S1701-2163(16)32087-4
   Brufsky AM, 2009, CLIN BREAST CANCER, V9, P77, DOI 10.3816/CBC.2009.n.015
   Bryant H U, 2001, Rev Endocr Metab Disord, V2, P129, DOI 10.1023/A:1010019410881
   Byrjalsen I, 2008, OSTEOPOROSIS INT, V19, P339, DOI 10.1007/s00198-007-0462-5
   Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173
   Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347
   Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500
   Chlebowski RT, 2010, J CLIN ONCOL, V28, P3582, DOI 10.1200/JCO.2010.28.2095
   Chlebowski RT, 2002, J CLIN ONCOL, V20, P3328, DOI 10.1200/JCO.2002.06.029
   Chlebowski RT, 1999, J CLIN ONCOL, V17, P1939, DOI 10.1200/JCO.1999.17.6.1939
   Coleman RE, 2010, BRIT J CANCER, V102, P1099, DOI 10.1038/sj.bjc.6605604
   Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189
   Cummings SR, 2008, NEW ENGL J MED, V359, P697, DOI 10.1056/NEJMoa0800743
   Cummings SR, 2010, NEW ENGL J MED, V362, P686, DOI 10.1056/NEJMoa0808692
   Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2
   Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609
   Diel IJ, 2008, ANN ONCOL, V19, P2007, DOI 10.1093/annonc/mdn429
   Dowsett M, 2001, CANCER EPIDEM BIOMAR, V10, P961
   Dunn BK, 2005, J CLIN ONCOL, V23, P357, DOI 10.1200/JCO.2005.08.028
   Eidtmann H, 2010, ANN ONCOL, V21, P2188, DOI 10.1093/annonc/mdq217
   Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637
   Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372
   Freedman M, 2001, J NATL CANCER I, V93, P51, DOI 10.1093/jnci/93.1.51
   Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829
   Gelber RP, 2006, INT J QUAL HEALTH C, V18, P23, DOI 10.1093/intqhc/mzi070
   Gnant M, 2009, CURR CANCER DRUG TAR, V9, P824, DOI 10.2174/156800909789760267
   Gradishar W, 2000, CANCER, V88, P2047, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2047::AID-CNCR10>3.0.CO;2-E
   Grey A, 2006, ANN INTERN MED, V145, P791, DOI 10.7326/0003-4819-145-10-200611210-00021
   JENSEN EV, 1982, RECENT PROG HORM RES, V38, P1
   Jolly EE, 2003, MENOPAUSE, V10, P337, DOI 10.1097/01.GME.0000058772.59606.2A
   Jordan VC, 2007, J NATL CANCER I, V99, P350, DOI 10.1093/jnci/djk062
   Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048
   Jordan VC, 2009, BREAST, V18, pS10, DOI 10.1016/S0960-9776(09)70266-8
   Jordan VC, 2001, CANCER RES, V61, P5683
   JORDAN VC, 1988, CANCER INVEST, V6, P589, DOI 10.3109/07357908809082124
   Kanis JA, 2003, BONE, V33, P293, DOI 10.1016/S8756-3282(03)00200-X
   Kristensen B, 2008, ACTA ONCOL, V47, P740, DOI 10.1080/02841860801964988
   Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863
   Kung AWC, 2003, J CLIN ENDOCR METAB, V88, P3130, DOI 10.1210/jc.2002-021855
   Land SR, 2006, JAMA-J AM MED ASSOC, V295, P2742, DOI 10.1001/jama.295.23.joc60075
   Lewis JS, 2005, JNCI-J NATL CANCER I, V97, P1746, DOI 10.1093/jnci/dji400
   Lundstrom E, 2002, AM J OBSTET GYNECOL, V186, P717, DOI 10.1067/mob.2002.121896
   Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941
   MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198
   Maricic M, 2002, ARCH INTERN MED, V162, P1140, DOI 10.1001/archinte.162.10.1140
   Martino S, 2005, CURR MED RES OPIN, V21, P1441, DOI 10.1185/030079905X61839
   Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319
   Mavrokokki T, 2007, J ORAL MAXIL SURG, V65, P415, DOI 10.1016/j.joms.2006.10.061
   Messalli EM, 2007, MATURITAS, V56, P38, DOI 10.1016/j.maturitas.2006.05.007
   Michalska D, 2006, J CLIN ENDOCR METAB, V91, P870, DOI 10.1210/jc.2004-2212
   Morii H, 2003, OSTEOPOROSIS INT, V14, P793, DOI 10.1007/s00198-003-1424-1
   Morii Hirotoshi, 2004, Clin Calcium, V14, P100
   Mueck A. O., 2003, Archives of Gynecology and Obstetrics, V267, P139, DOI 10.1007/s00404-002-0291-x
   Nanetti L, 2008, EUR J CLIN INVEST, V38, P117, DOI 10.1111/j.1365-2362.2007.01905.x
   National Osteoporosis Foundation, 2010, CLIN GUID PREV TREAT
   Neele SJM, 2002, BONE, V30, P599, DOI 10.1016/S8756-3282(01)00706-2
   Newcomb PA, 2010, BRIT J CANCER, V102, P799, DOI 10.1038/sj.bjc.6605555
   Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952
   Pasion EG, 2007, J BONE MINER METAB, V25, P105, DOI 10.1007/s00774-006-0735-7
   Pines A, 2007, MATURITAS, V57, P3, DOI 10.1016/j.maturitas.2007.02.001
   Pinkerton JV, 2010, EXPERT OPIN INV DRUG, V19, P1613, DOI 10.1517/13543784.2010.532487
   Powles T, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1384
   Prestwood KM, 2000, J CLIN ENDOCR METAB, V85, P2197, DOI 10.1210/jc.85.6.2197
   Qu YM, 2005, CURR MED RES OPIN, V21, P1955, DOI 10.1185/030079905X75032
   Rack B, 2010, ANTICANCER RES, V30, P1807
   Recker RR, 2007, BONE, V40, P843, DOI 10.1016/j.bone.2006.11.001
   Rennert G, 2010, J CLIN ONCOL, V28, P3577, DOI 10.1200/JCO.2010.28.1113
   Riggs BL, 2002, J BONE MINER RES, V17, P11, DOI 10.1359/jbmr.2002.17.1.11
   Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219
   Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321
   Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8
   Siris E, 2002, OSTEOPOROSIS INT, V13, P907, DOI 10.1007/s001980200125
   Siris ES, 2005, J BONE MINER RES, V20, P1514, DOI 10.1359/JBMR.050509
   Stefanick ML, 2006, NEW ENGL J MED, V355, P190, DOI 10.1056/NEJMe068120
   Stevenson John C, 2009, Menopause Int, V15, P55, DOI 10.1258/mi.2009.009018
   Swaby RF, 2007, REV ENDOCR METAB DIS, V8, P229, DOI 10.1007/s11154-007-9034-4
   Van Poznak C, 2010, J CLIN ONCOL, V28, P967, DOI 10.1200/JCO.2009.24.5902
   Vastag B, 2006, J NATL CANCER I, V98, P733, DOI 10.1093/jnci/djj253
   Visvanathan K, 2009, J CLIN ONCOL, V27, P3235, DOI 10.1200/JCO.2008.20.5179
   Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074
   Vogel VG, 2010, CANCER PREV RES, V3, P696, DOI 10.1158/1940-6207.CAPR-10-0076
   Watts NB, 2006, ANN INTERN MED, V145, P791, DOI 10.7326/0003-4819-145-10-200611210-00022
   Weinstein RS, 2003, OSTEOPOROSIS INT, V14, P814, DOI 10.1007/s00198-003-1434-z
   Wenger NK, 2002, AM J CARDIOL, V90, P1204, DOI 10.1016/S0002-9149(02)02835-7
   *WHO, 2003, WHO TECH REP SER, V921, P1
   Wijayaratne AL, 1999, ENDOCRINOLOGY, V140, P5828, DOI 10.1210/en.140.12.5828
   Winter MC, 2008, CANCER TREAT REV, V34, P453, DOI 10.1016/j.ctrv.2008.02.004
   Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009
   Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776
NR 100
TC 13
Z9 16
U1 4
U2 13
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1465-6566
J9 EXPERT OPIN PHARMACO
JI Expert Opin. Pharmacother.
PD MAR
PY 2011
VL 12
IS 4
BP 657
EP 674
DI 10.1517/14656566.2011.557360
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 719KR
UT WOS:000287204100015
PM 21294695
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Banerjee, S
   Kong, DJ
   Azmi, AS
   Wang, ZW
   Ahmad, A
   Sethi, S
   Sarkar, FH
AF Banerjee, Sanjeev
   Kong, Dejuan
   Azmi, Asfar S.
   Wang, Zhiwei
   Ahmad, Aamir
   Sethi, Seema
   Sarkar, Fazlul H.
TI RETRACTED: Restoring sensitivity to oxaliplatin by a novel approach in
   gemcitabine-resistant pancreatic cancer cells in vitro and in
   vivo(Retracted article. See vol.139,pg.2146,2016)
SO INTERNATIONAL JOURNAL OF CANCER
LA English
DT Article; Retracted Publication
DE gensitein; chemosensitization; oxaliplatin; NF-kappa B; pancreatic
   cancer
ID FACTOR-KAPPA-B; SOY ISOFLAVONE GENISTEIN; CHEMOTHERAPEUTIC-AGENTS;
   MOLECULAR EVIDENCE; ANTITUMOR-ACTIVITY; CARCINOMA CELLS; APOPTOSIS;
   THERAPY; PREVENTION; CISPLATIN
AB Oxaliplatin (OxP) has been used in combination therapy with gemcitabine for the treatment of pancreatic cancer (PC), but the beneficial effect was marginal, which is believed to be due to de novo and acquired drug resistance of PC. Here, we report our in vitro and in vivo preclinical evidence in support of chemosensitization of drug-resistant cells by a nontoxic chemopreventive agent (genistein). Genistein pretreatment together with low concentration of OxP showed significant reduction in cell viability and colony formation concomitant with increased apoptosis (p < 0.01), which was highly synergistic. Drug resistance of PC is allegedly linked with both constitutive and OxP-induced activation of NF-kappa B, and we found that inactivation of (nuclear factor kappa B) NF-kappa B by genistein before treatment of cells with OxP was required for cell killing, which was consistent with the downregulation of NF-kappa B and its downstream antiapoptotic genes (Bcl-2, XIAPs and survivin). Most importantly, our in vivo experiments using orthotopic mouse model showed significant reduction in tumor size (p < 0.01) and reduction of locoregional lymph node metastasis by combination treatment. These results were also consistent with inactivation of NF-kappa B and the downregulation of NF-kappa B downstream genes, decreased proliferation marker (Ki-67) and increased apoptosis (TUNEL) in tumor remnants, all of which was consistent with in vitro findings. From these results, we conclude that genistein sensitizes drug-resistant PC to OxP, which is mechanistically linked with inactivation of NF-kappa B signaling, resulting in greater antitumor effects, and thus our data suggest that this approach could be useful in improving the treatment outcome for patients diagnosed with PC.
C1 [Banerjee, Sanjeev; Kong, Dejuan; Azmi, Asfar S.; Wang, Zhiwei; Ahmad, Aamir; Sethi, Seema; Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Dept Pathol, Detroit, MI 48201 USA.
RP Sarkar, FH (reprint author), Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Dept Pathol, 740 HWCRC Bldg,4100 John R St, Detroit, MI 48201 USA.
EM fsarkar@med.wayne.edu
OI AZMI, ASFAR/0000-0003-1178-9505
FU National Institutes of Health [R01CA101870, R01CA101871, R01 CA101872,
   R01 CA101873]
FX Grant sponsor: National Institutes of Health; Grant numbers:
   R01CA101870, R01CA101871, R01 CA101872, R01 CA101873
CR Ali S, 2009, CANCER LETT, V278, P201, DOI 10.1016/j.canlet.2009.01.009
   Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235
   Androulakis N, 2005, CANCER INVEST, V23, P9, DOI 10.1081/CNV-200046502
   Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390
   Banerjee S, 2005, CANCER RES, V65, P9064, DOI 10.1158/0008-5472.CAN-05-1330
   Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052
   Banerjee S, 2007, INT J CANCER, V120, P906, DOI 10.1002/ijc.22332
   Banerjee S, 2009, CANCER RES, V69, P5575, DOI 10.1158/0008-5472.CAN-08-4235
   Banerjee S, 2009, CANCER RES, V69, P5592, DOI 10.1158/0008-5472.CAN-09-0838
   Custodio A, 2009, CANCER TREAT REV, V35, P676, DOI 10.1016/j.ctrv.2009.08.012
   Dennis T, 2009, NUTR CANCER, V61, P587, DOI 10.1080/01635580902825530
   Ducreux M, 2007, SEMIN ONCOL, V34, pS25, DOI 10.1053/j.seminoncol.2007.01.006
   El-Rayes BF, 2006, CANCER RES, V66, P10553, DOI 10.1158/0008-5472.CAN-06-2333
   Gadgeel SM, 2009, CANCER-AM CANCER SOC, V115, P2165, DOI 10.1002/cncr.24250
   Hwang JT, 2005, BIOCHEM BIOPH RES CO, V332, P433, DOI 10.1016/j.bbrc.2005.04.143
   Imai Y, 2004, CANCER RES, V64, P4346, DOI 10.1158/0008-5472.CAN-04-0078
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006
   Jin CY, 2009, ANTI-CANCER DRUG, V20, P713, DOI 10.1097/CAD.0b013e32832e8998
   Kong R, 2010, CANCER LETT, V291, P90, DOI 10.1016/j.canlet.2009.10.001
   Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432
   Li YW, 2004, PANCREAS, V28, pE90, DOI 10.1097/00006676-200405000-00020
   Liao CH, 2004, BIOCHEM PHARMACOL, V67, P2031, DOI 10.1016/j.bcp.2004.02.010
   Limtrakul P, 2005, J CHEMOTHERAPY, V17, P86, DOI 10.1179/joc.2005.17.1.86
   Liptay S, 2003, INT J CANCER, V105, P735, DOI 10.1002/ijc.11081
   Liu WS, 2009, DIGEST DIS SCI, V54, P89, DOI 10.1007/s10620-008-0329-4
   Melisi D, 2009, CLIN CANCER RES, V15, P6367, DOI 10.1158/1078-0432.CCR-09-0910
   O'Reilly EM, 2007, SEMIN ONCOL, V34, P347, DOI 10.1053/j.seminoncol.2007.05.009
   Pan X, 2008, CLIN CANCER RES, V14, P8143, DOI [10.1168/1078-0432.CCR-08-1539, 10.1158/1078-0432.CCR-08-1539]
   Park SJ, 2010, CANCER LETT, V292, P54, DOI 10.1016/j.canlet.2009.11.004
   Ren MQ, 2001, EUR J NUTR, V40, P135, DOI 10.1007/PL00007388
   Roginsky AB, 2005, IN VIVO, V19, P61
   ROY CS, INVEST NEW DRUGS
   Saif MW, 2007, EXPERT OPIN PHARMACO, V8, P2719, DOI 10.1517/14656566.8.16.2719
   Sarkar FH, 2009, CANCER TREAT REV, V35, P597, DOI 10.1016/j.ctrv.2009.07.001
   Sarkar FH, 2002, CANCER METAST REV, V21, P265, DOI 10.1023/A:1021210910821
   Sarkar FH, 2003, CANCER INVEST, V21, P744, DOI 10.1081/CNV-120023773
   Sato T, 2003, CANCER SCI, V94, P467, DOI 10.1111/j.1349-7006.2003.tb01466.x
   Sebens S., 2008, V177, P151
   Sung MJ, 2008, KIDNEY INT, V74, P1538, DOI 10.1038/ki.2008.409
   Xiong HQ, 2006, DRUGS, V66, P1059, DOI 10.2165/00003495-200666080-00003
NR 40
TC 14
Z9 16
U1 2
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7136
EI 1097-0215
J9 INT J CANCER
JI Int. J. Cancer
PD MAR 1
PY 2011
VL 128
IS 5
BP 1240
EP 1250
DI 10.1002/ijc.25658
PG 11
WC Oncology
SC Oncology
GA 716HS
UT WOS:000286960300024
PM 20824697
OA Bronze, Green Accepted
DA 2018-12-27
ER

PT J
AU Giudice, J
   Leskow, FC
   Arndt-Jovin, DJ
   Jovin, TM
   Jares-Erijman, EA
AF Giudice, Jimena
   Coluccio Leskow, Federico
   Arndt-Jovin, Donna J.
   Jovin, Thomas M.
   Jares-Erijman, Elizabeth A.
TI RETRACTED: Differential endocytosis and signaling dynamics of insulin
   receptor variants IR-A and IR-B (Retracted article. See vol. 125, pg.
   2786, 2012)
SO JOURNAL OF CELL SCIENCE
LA English
DT Article; Retracted Publication
DE Insulin; Insulin receptor isoforms; Programmable array microscope;
   Quantum dots
ID PROGRAMMABLE ARRAY MICROSCOPE; RESONANCE ENERGY-TRANSFER;
   GROWTH-FACTOR-II; HYBRID RECEPTORS; SKELETAL-MUSCLE; KINASE-ACTIVITY;
   LIGAND-BINDING; MESSENGER-RNA; EGF RECEPTOR; INTERNALIZATION
AB Insulin signaling comprises a complex cascade of events, playing a key role in the regulation of glucose metabolism and cellular growth. Impaired response to insulin is the hallmark of diabetes, whereas upregulated insulin activity occurs in many cancers. Two splice variants of the insulin receptor (IR) exist in mammals: IR-A, lacking exon 11, and full-length IR-B. Although considerable biochemical data exist on insulin binding and downstream signaling, little is known about the dynamics of the IR itself. We created functional IR transgenes fused with visible fluorescent proteins for use in combination with biotinamido-caproyl insulin and streptavidin quantum dots. Using confocal and structured illumination microscopy, we visualized the endocytosis of both isoforms in living and fixed cells and demonstrated a higher rate of endocytosis of IR-A than IR-B. These differences correlated with higher and sustained activation of IR-A in response to insulin and with distinctive ERK1/2 activation profiles and gene transcription regulation. In addition, cells expressing IR-B showed higher AKT phosphorylation after insulin stimulation than cells expressing IR-A. Taken together, these results suggest that IR signaling is dependent on localization; internalized IRs regulate mitogenic activity, whereas metabolic balance signaling occurs at the cell membrane.
C1 [Giudice, Jimena; Jares-Erijman, Elizabeth A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, CIHIDECAR,CONICET, RA-1428 Buenos Aires, DF, Argentina.
   [Giudice, Jimena; Coluccio Leskow, Federico] Univ Buenos Aires, Dept Quim Biol, FCEN, Buenos Aires, DF, Argentina.
   [Arndt-Jovin, Donna J.; Jovin, Thomas M.] Max Planck Inst Biophys Chem, Lab Cellular Dynam, D-37077 Gottingen, Germany.
   [Jovin, Thomas M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Dinam Celular, Buenos Aires, DF, Argentina.
RP Jares-Erijman, EA (reprint author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, CIHIDECAR,CONICET, Intendente Guiraldes 2160,Ciudad Univ,C1428EGA, RA-1428 Buenos Aires, DF, Argentina.
EM eli@qo.fcen.uba.ar
FU CONICET; EMBO; Max-Planck Society; University of Buenos Aires; CONICET
   (Argentina); ANPCyT (Argentina)
FX J.G. is a recipient of a CONICET fellowship and was awarded a short-term
   EMBO fellowship. This work was supported by the Max-Planck Society,
   University of Buenos Aires, CONICET (Argentina) and ANPCyT (Argentina).
   We thank Axel Ullrich for kindly providing plasmids pNTK2-hIR and
   pNTK2-IR/B, T. W. Gadella, Jr for pSCFP-3AC and pSYFP-2F vectors and
   Anabella Srebrow for the pCMV-AKT-HA vector. We thank Laboratorios BETA
   for providing rhIns. We thank Omar Coso for discussions about IR
   signaling and for providing the anti-ERK antibody and pCMV-beta-Gal and
   AP-1-luc reporter plasmids and Patricia Cuasnicu for anti-PY20 antibody.
   We thank Wouter Caarls and Maria Julia Roberti for help and suggestions
   on Matlab use and figure preparation, respectively. We would like to
   thank Matias Blaustein for discussions about AKT experiments and
   Alejandro Colman Lerner for providing the anti-AKT antibody (Santa Cruz
   Biotechnology).
CR Andrews NL, 2009, IMMUNITY, V31, P469, DOI 10.1016/j.immuni.2009.06.026
   BACKER JM, 1990, J BIOL CHEM, V265, P16450
   Bailyes EM, 1997, BIOCHEM J, V327, P209, DOI 10.1042/bj3270209
   Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709
   Bergeron JJM, 1995, BIOSCIENCE REP, V15, P411, DOI 10.1007/BF01204345
   Biener Y, 1996, J BIOL CHEM, V271, P29489, DOI 10.1074/jbc.271.46.29489
   Blanquart C, 2008, BIOCHEM PHARMACOL, V76, P873, DOI 10.1016/j.bcp.2008.07.027
   Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19
   Cambi A, 2007, NANO LETT, V7, P970, DOI 10.1021/nl0700503
   Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862
   Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183
   DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x
   EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4
   Echarte MM, 2007, FEBS LETT, V581, P2905, DOI 10.1016/j.febslet.2007.05.041
   Frasca F, 1999, MOL CELL BIOL, V19, P3278
   GOLDSTEIN BJ, 1990, MOL ENDOCRINOL, V4, P235, DOI 10.1210/mend-4-2-235
   Grimes ML, 1996, J NEUROSCI, V16, P7950
   Haft CR, 1998, ENDOCRINOLOGY, V139, P1618, DOI 10.1210/en.139.4.1618
   Hagen GM, 2007, PROC SPIE, V6441, DOI 10.1117/12.710995
   Hagen GM, 2009, MICROSC RES TECHNIQ, V72, P431, DOI 10.1002/jemt.20686
   Hamer I, 2002, DIABETOLOGIA, V45, P657, DOI 10.1007/s00125-002-0798-5
   HARI J, 1987, J BIOL CHEM, V262, P15341
   Heintzmann R, 2001, J MICROSC-OXFORD, V204, P119, DOI 10.1046/j.1365-2818.2001.00945.x
   Jensen M, 2009, VITAM HORM, V80, P51, DOI 10.1016/S0083-6729(08)00603-1
   KELLERER M, 1993, DIABETOLOGIA, V36, P628, DOI 10.1007/BF00404072
   Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273
   Lidke Diane S, 2007, Methods Mol Biol, V374, P69
   Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140
   Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929
   MCCLAIN DA, 1987, J BIOL CHEM, V262, P14663
   MCKEON C, 1990, MOL ENDOCRINOL, V4, P647, DOI 10.1210/mend-4-4-647
   MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x
   MOSTHAF L, 1991, P NATL ACAD SCI USA, V88, P4728, DOI 10.1073/pnas.88.11.4728
   Pandini G, 1999, CLIN CANCER RES, V5, P1935
   Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200
   PAPA V, 1993, CANCER RES, V53, P3736
   Pastore S, 2005, J IMMUNOL, V174, P5047, DOI 10.4049/jimmunol.174.8.5047
   Patti Mary-Elizabeth, 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P89
   Pol A, 1998, FEBS LETT, V441, P34, DOI 10.1016/S0014-5793(98)01517-8
   REYNET C, 1990, MOL ENDOCRINOL, V4, P304, DOI 10.1210/mend-4-2-304
   Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200
   RUSSELL DS, 1987, J BIOL CHEM, V262, P11833
   Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a
   Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704
   Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001
   SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X
   Sen S, 2009, MOL CELL BIOL, V29, P871, DOI 10.1128/MCB.01709-08
   SORKIN A, 1993, J CELL PHYSIOL, V156, P373, DOI 10.1002/jcp.1041560221
   Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5
   THIES RS, 1990, J BIOL CHEM, V265, P10132
   Uhles S, 2003, J CELL BIOL, V163, P1327, DOI 10.1083/jcb.200306093
   ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0
   VOGT B, 1991, BIOCHEM BIOPH RES CO, V177, P1013, DOI 10.1016/0006-291X(91)90639-O
   Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001
   White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619
   WILDEN PA, 1990, P NATL ACAD SCI USA, V87, P3358, DOI 10.1073/pnas.87.9.3358
   YAMAGUCHI Y, 1991, ENDOCRINOLOGY, V129, P2058, DOI 10.1210/endo-129-4-2058
   YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132
   YAMAMOTOHONDA R, 1990, J BIOL CHEM, V265, P14777
NR 59
TC 30
Z9 30
U1 3
U2 16
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD MAR 1
PY 2011
VL 124
IS 5
BP 801
EP 811
DI 10.1242/jcs.076869
PG 11
WC Cell Biology
SC Cell Biology
GA 720UC
UT WOS:000287307000015
PM 21303927
OA Bronze
DA 2018-12-27
ER

PT J
AU Mahajan, N
   Martinez, MA
   Gutierrez, NL
   Diesendruck, G
   Banaji, MR
   Santos, LR
AF Mahajan, Neha
   Martinez, Margaret A.
   Gutierrez, Natashya L.
   Diesendruck, Gil
   Banaji, Mahzarin R.
   Santos, Laurie R.
TI RETRACTED: The Evolution of Intergroup Bias: Perceptions and Attitudes
   in Rhesus Macaques (Retracted article. See vol. 106, pg. 182, 2014)
SO JOURNAL OF PERSONALITY AND SOCIAL PSYCHOLOGY
LA English
DT Article; Retracted Publication
DE intergroup bias; comparative cognition; rhesus monkeys
ID SOCIAL-DOMINANCE ORIENTATION; POLITICAL-ATTITUDES; CHILDRENS IMPLICIT;
   GENDER-DIFFERENCES; RACIAL PREJUDICE; MACACA-MULATTA; RACE; MONKEYS;
   COGNITION; BEHAVIOR
AB Social psychologists have learned a great deal about the nature of intergroup conflict and the attitudinal and cognitive processes that enable it. Less is known about where these processes come from in the first place. In particular, do our strategies for dealing with other groups emerge in the absence of human-specific experiences? One profitable way to answer this question has involved administering tests that are conceptual equivalents of those used with adult humans in other species, thereby exploring the continuity or discontinuity of psychological processes. We examined intergroup preferences in a nonhuman species, the rhesus macaque (Macaca mulatta). We found the first evidence that a nonhuman species automatically distinguishes the faces of members of its own social group from those in other groups and displays greater vigilance toward outgroup members (Experiments 1-3). In addition, we observed that macaques spontaneously associate novel objects with specific social groups and display greater vigilance to objects associated with outgroup members (Experiments 4-5). Finally, we developed a looking time procedure the Looking Time Implicit Association Test, which resembles the Implicit Association Test (Greenwald & Banaji, 1995) and we discovered that macaques, like humans, automatically evaluate ingroup members positively and outgroup members negatively (Experiments 6-7). These field studies represent the first controlled experiments to examine the presence of intergroup attitudes in a nonhuman species. As such, these studies suggest that the architecture of the mind that enables the formation of these biases may be rooted in phylogenetically ancient mechanisms.
C1 [Mahajan, Neha; Martinez, Margaret A.; Gutierrez, Natashya L.; Santos, Laurie R.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA.
   [Diesendruck, Gil] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel.
   [Diesendruck, Gil] Bar Ilan Univ, Gonda Brain Res Ctr, Ramat Gan, Israel.
   [Banaji, Mahzarin R.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA.
RP Mahajan, N (reprint author), Yale Univ, Dept Psychol, 2 Hillhouse Ave, New Haven, CT 06520 USA.
EM neha.mahajan@yale.edu; laurie.santos@yale.edu
FU NCRR NIH HHS [P40 RR003640-20]
CR Aboud F. E, 1988, CHILDREN PREJUDICE
   Abrams D., 2001, BLACKWELL HDB SOCIAL, P425, DOI DOI 10.1002/9780470998458.CH18
   Akrami N, 2000, EUR J SOC PSYCHOL, V30, P521, DOI 10.1002/1099-0992(200007/08)30:4<521::AID-EJSP5>3.0.CO;2-N
   Allport G. W., 1979, NATURE PREJUDICE
   ALTEMEYER B, 1998, ADV EXPT SOCIAL PSYC, V30, P48, DOI DOI 10.1016/S0065-2601(08)60382-2
   ARONSON E, 1963, J ABNORM PSYCHOL, V66, P584, DOI 10.1037/h0039901
   BAILLARGEON R, 1987, COGNITIVE DEV, V2, P179, DOI 10.1016/S0885-2014(87)90043-8
   Banaji M. R., 2010, HDB SOCIAL PSYCHOL, V1, P353
   BANSE R, 2001, J EXP PSYCHOL, V48, P1145
   Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x
   Baron AS, 2006, PSYCHOL SCI, V17, P53, DOI 10.1111/j.1467-9280.2005.01664.x
   Baumeister RF, 1997, PSYCHOL BULL, V122, P38, DOI 10.1037/0033-2909.122.1.38
   Bigler RS, 2006, ADV CHILD DEV BEHAV, V34, P39, DOI 10.1016/S0065-2407(06)80004-2
   Bigler RS, 2001, CHILD DEV, V72, P1151, DOI 10.1111/1467-8624.00339
   Bigler RS, 1997, CHILD DEV, V68, P530, DOI 10.1111/j.1467-8624.1997.tb01956.x
   Birnbaum D, 2010, CHILD DEV, V81, P757, DOI 10.1111/j.1467-8624.2010.01432.x
   Boelkins R.C., 1972, Primates, V13, P125, DOI 10.1007/BF01840875
   Brannon E. M., 2005, MONKEY BRAIN HUMAN B, P97
   Brewer M. B., 2001, REPRESENTATIONS SOCI, P305
   Brewer MB, 2003, HANDBOOK OF SELF AND IDENTITY, P480
   BREWER MB, 1991, PERS SOC PSYCHOL B, V17, P475, DOI 10.1177/0146167291175001
   BREWER MB, 1985, ANNU REV PSYCHOL, V36, P219, DOI 10.1146/annurev.ps.36.020185.001251
   Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126
   Brosnan SF, 2007, CURR BIOL, V17, P1704, DOI 10.1016/j.cub.2007.08.059
   BROSNAN SF, 2006, J SOCIAL JUSTICE, V19, P153
   CARPENTER C R, 1972, P76
   Carpenter CR, 1942, J COMP PSYCHOL, V33, P113, DOI 10.1037/h0058655
   Chao MM, 2007, PSYCHOL SCI, V18, P341, DOI 10.1111/j.1467-9280.2007.01901.x
   Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550
   Cheney D.L., 1987, P267
   Cheries EW, 2006, PERCEPTION, V35, P1057, DOI 10.1068/p5551
   COMER JP, 1989, TEACH COLL REC, V90, P352
   Cosmides L, 2003, TRENDS COGN SCI, V7, P173, DOI 10.1016/S1364-6613(03)00057-3
   Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044
   Diesendruck G, 2006, CHILD DEV, V77, P539, DOI 10.1111/j.1467-8624.2006.00889.x
   Diesendruck G, 2009, COGNITION, V110, P100, DOI 10.1016/j.cognition.2008.11.001
   Dovidio John F, 2002, Cultur Divers Ethnic Minor Psychol, V8, P88, DOI 10.1037//1099-9809.8.2.88
   Dunham Y, 2008, TRENDS COGN SCI, V12, P248, DOI 10.1016/j.tics.2008.04.006
   Dunham Y, 2006, CHILD DEV, V77, P1268, DOI 10.1111/j.1467-8624.2006.00933.x
   Egan LC, 2007, PSYCHOL SCI, V18, P978, DOI 10.1111/j.1467-9280.2007.02012.x
   Egan LC, 2010, J EXP SOC PSYCHOL, V46, P204, DOI 10.1016/j.jesp.2009.08.014
   EKEHAMMAR B, 1982, BRIT J SOC PSYCHOL, V21, P249, DOI 10.1111/j.2044-8309.1982.tb00546.x
   Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225
   Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002
   FISHMAN JA, 1956, J SOC PSYCHOL, V43, P27, DOI 10.1080/00224545.1956.9919199
   Fiske S. T., 1998, HDB SOCIAL PSYCHOL, V4, P357, DOI DOI 10.1002/9780470561119
   Fiske ST, 2000, EUR J SOC PSYCHOL, V30, P299, DOI 10.1002/(SICI)1099-0992(200005/06)30:3<299::AID-EJSP2>3.0.CO;2-F
   FISKE ST, 2005, REFLECTING NATURE PR, P36
   Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076
   Fodor J. A., 1998, CONCEPTS COGNITIVE S
   Gawronski B, 2003, J EXP SOC PSYCHOL, V39, P16, DOI 10.1016/S0022-1031(02)00517-6
   Glimcher PW, 2003, BRADFORD BOOKS, P1
   GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037//0033-295X.102.1.4
   Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464
   Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288
   HAMLIN JK, 2010, 2010 BIENN M INT SOC
   Hauser M. D., 2004, COGNITIVE NEUROSCIEN, V3, P853
   Heider F, 1958, PSYCHOL INTERPERSONA, DOI [10.1037/10628-000, DOI 10.1037/10628-000]
   Hirschfeld LA, 1998, SOC RES, V65, P331
   Hogg M. A., 2000, EUROPEAN REV SOCIAL, V11, P223, DOI [10.1080/14792772043000040, DOI 10.1080/14792772043000040]
   HOXTER AL, 1994, PERCEPT MOTOR SKILL, V79, P1666, DOI 10.2466/pms.1994.79.3f.1666
   Huston A. C., 1983, HDB CHILD PSYCHOL, V4, P387
   JOST JT, 1994, BRIT J SOC PSYCHOL, V33, P1, DOI 10.1111/j.2044-8309.1994.tb01008.x
   Karpinski A, 2001, J PERS SOC PSYCHOL, V81, P774, DOI 10.1037//0022-3514.81.5.774
   KAUFMANN JH, 1967, SOCIAL COMMUNICATION, P73
   Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x
   Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104
   Knutson KM, 2006, SOC NEUROSCI-UK, V1, P25, DOI 10.1080/17470910600670603
   Kurzban R, 2001, P NATL ACAD SCI USA, V98, P15387, DOI 10.1073/pnas.251541498
   Lakshminaryanan V, 2008, PHILOS T R SOC B, V363, P3837, DOI 10.1098/rstb.2008.0149
   LANGLOIS JH, 1987, DEV PSYCHOL, V23, P363, DOI 10.1037/0012-1649.23.3.363
   LOY J, 1970, AM J PHYS ANTHROPOL, V33, P263, DOI 10.1002/ajpa.1330330212
   MILLER DT, 1999, CULTURAL DIVIDES UND, P213
   MOORE JW, 1984, J EXP EDUC, V52, P168, DOI 10.1080/00220973.1984.11011888
   Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053
   Olson KR, 2008, J PERS SOC PSYCHOL, V94, P757, DOI 10.1037/0022-3514.94.5.757
   Olsson A, 2005, SCIENCE, V309, P785, DOI 10.1126/science.1113551
   Payne BK, 2001, J PERS SOC PSYCHOL, V81, P181, DOI 10.1037//0022-3514.81.2.181
   PERDUE CW, 1990, J PERS SOC PSYCHOL, V59, P475, DOI 10.1037/0022-3514.59.3.475
   POWELL AJ, 2000, 5 ANN M SOC AUSTR SO
   PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037//0022-3514.67.4.741
   Pratto F, 1999, SOCIAL DOMINANCE INT
   Prentice DA, 2006, PSYCHOL SCI, V17, P129, DOI 10.1111/j.1467-9280.2006.01675.x
   Pyszczynski T, 1999, PSYCHOL REV, V106, P835, DOI 10.1037//0033-295X.106.4.835
   Pyszczynski T, 1997, PSYCHOL INQ, V8, P1, DOI 10.1207/s15327965pli0801_1
   Rawlins RC, 1987, CAYO SANTIAGO MACAQU
   Rhodes M, 2009, COGNITIVE PSYCHOL, V59, P244, DOI 10.1016/j.cogpsych.2009.05.001
   Rutland A, 2005, CHILD DEV, V76, P451, DOI 10.1111/j.1467-8624.2005.00856.x
   Santos LR, 2006, ANIM BEHAV, V71, P1175, DOI 10.1016/j.anbehav.2005.10.007
   Santos LR, 2009, CURR OPIN NEUROBIOL, V19, P63, DOI 10.1016/j.conb.2009.05.005
   Santos LR, 2004, DEVELOPMENTAL SCI, V7, P167, DOI 10.1111/j.1467-7687.2004.00335.x
   SANTOS LR, 2008, OXFORD STUDIES EPIST, V2, P87
   Santos LR, 2008, INNATE MIND FDN FUTU, P293
   SAUNDERS CD, 1988, NEURAL MECH BIOL SIG, P430
   Schaller M., 2008, FDN EVOLUTIONARY PSY, P401
   Sherif M, 1961, INTERGROUP CONFLICT
   Shutts K, 2009, J COGN DEV, V10, P1, DOI 10.1080/15248370902966636
   Sidanius J., 1993, EXPLORATIONS POLITIC, P183
   Sidanius J., 1993, PREJUDICE POLITICS A, P173
   Sidanius J, 2001, SOCIAL DOMINANCE INT
   Sinclair S, 2005, J EXP SOC PSYCHOL, V41, P283, DOI 10.1016/j.jesp.2004.06.003
   Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271
   Skowronski JJ, 2001, PSYCHOL WOMEN QUART, V25, P155, DOI 10.1111/1471-6402.00017
   Smuts B. B., 1987, PRIMATE SOC
   Sperber D., 1996, EXPLAINING CULTURE N
   Subiaul F, 2004, SCIENCE, V305, P407, DOI 10.1126/science.1099136
   Tate C, 2001, THEOR PSYCHOL, V11, P495, DOI 10.1177/0959354301114005
   TAYLOR DM, 1994, THEORIES INTERGROUP
   Turner J. C, 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5
   VANDENBERGH JG, 1967, BEHAVIOUR, V29, P179, DOI 10.1163/156853967X00109
   Vargas PT, 2004, PERS SOC PSYCHOL B, V30, P197, DOI 10.1177/0146167203259931
   WARNEKEN F, 2009, TRENDS COGN SCI, V59, P244
   Whitley BE, 1999, J PERS SOC PSYCHOL, V77, P126, DOI 10.1037/0022-3514.77.1.126
   Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046
   WRANGHAM RW, 1998, MINDFIELD RACE ISSUE, P36
NR 115
TC 40
Z9 41
U1 1
U2 51
PU AMER PSYCHOLOGICAL ASSOC
PI WASHINGTON
PA 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA
SN 0022-3514
EI 1939-1315
J9 J PERS SOC PSYCHOL
JI J. Pers. Soc. Psychol.
PD MAR
PY 2011
VL 100
IS 3
BP 387
EP 405
DI 10.1037/a0022459
PG 19
WC Psychology, Social
SC Psychology
GA 724EW
UT WOS:000287559900001
PM 21280966
DA 2018-12-27
ER

PT J
AU Patrick, BA
   Gong, X
   Jaiswal, AK
AF Patrick, B. A.
   Gong, X.
   Jaiswal, A. K.
TI RETRACTED: Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice
   leads to 20S proteasomal degradation of p63 resulting in thinning of
   epithelium and chemical-induced skin cancer (Retracted article. See vol.
   36, pg. 2919, 2017)
SO ONCOGENE
LA English
DT Article; Retracted Publication
DE NQO1; p63; 20S proteasome; skin differentiation; carcinogenicity
ID QUINONE OXIDOREDUCTASE-1; INCREASES SUSCEPTIBILITY; EPIDERMAL
   MORPHOGENESIS; SKIN CARCINOGENESIS; MENADIONE TOXICITY; MOUSE SKIN;
   IN-VIVO; ACTIVATION; ROLES; NQO1
AB NAD(P)H:quinone oxidoreductase 1 (NQO1) is a cytosolic enzyme that protects cells against chemical and radiation-induced oxidative stress and skin cancer. Disruption of NQO1 gene in mice showed thinning of skin epithelium and loss of cytokeratin 14, an early marker of skin differentiation. Immunohistochemistry and western analysis demonstrated downregulation of p63 in NQO1-/- mouse skin, as compared with wild-type (WT) mouse. Further analysis including modulation of NQO1 expression revealed a direct correlation between the levels of NQO1 and p63 in skin-derived keratinocytes and dermal fibroblasts. Modulation of proteasomal activity revealed that p63 is degraded by 20S proteasome and that this degradation is significantly rescued by NQO1. Coimmunoprecipitation studies showed that NQO1 interacts directly with p63 but not 20S to protect against this degradation. In addition, benzo[a]pyrene treatment led to induction of NQO1 and stabilization of p63 in WT but not in NQO1-/- mouse skin and keratinocytes. These data suggest that NQO1 controls stabilization of p63 and progression towards keratinocyte differentiation leading to normal skin development and presumably skin carcinogenesis. Oncogene (2011) 30, 1098-1107; doi:10.1038/onc.2010.491; published online 1 November 2010
C1 [Patrick, B. A.; Jaiswal, A. K.] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St,Howard Hall 404, Baltimore, MD 21201 USA.
   [Gong, X.] Baylor Coll Med, Houston, TX 77030 USA.
RP Jaiswal, AK (reprint author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St,Howard Hall 404, Baltimore, MD 21201 USA.
EM ajaiswal@som.umaryland.edu
FU NIH [RO1 ES007943]; NIEHS [ES007263]
FX We thank our colleagues for helpful discussions and suggestions. This
   work was supported by NIH Grant RO1 ES007943. BAP was supported by Grant
   RO1 ES007943 and also in part is supported by NIEHS training Grant
   ES007263.
CR Ahn KS, 2006, J BIOL CHEM, V281, P19798, DOI 10.1074/jbc.M601162200
   Arrowsmith CH, 1999, CELL DEATH DIFFER, V6, P1169, DOI 10.1038/sj.cdd.4400619
   Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905
   Asher G, 2006, BIOCHEMISTRY-US, V45, P6372, DOI 10.1021/bi0600087
   Candi E, 2008, CELL MOL LIFE SCI, V65, P3126, DOI 10.1007/s00018-008-8119-x
   Chen S, 2000, FREE RADICAL BIO MED, V29, P276, DOI 10.1016/S0891-5849(00)00308-7
   Das A, 2006, FREE RADICAL BIO MED, V40, P1843, DOI 10.1016/j.freeradbiomed.2006.01.025
   Fuchs E, 1996, ANNU REV GENET, V30, P197, DOI 10.1146/annurev.genet.30.1.197
   GELBOIN HV, 1980, PHYSIOL REV, V60, P1107
   Gong X, 2007, CANCER RES, V67, P5380, DOI 10.1158/0008-5472.CAN-07-0323
   GUENGERICH FP, 1988, CANCER RES, V48, P2946
   Iskander K, 2004, CANCER RES, V64, P5925, DOI 10.1158/0008-5472.CAN-04-0763
   Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074
   Joseph P, 1998, BRIT J CANCER, V77, P709, DOI 10.1038/bjc.1998.117
   Joseph P, 1998, BRIT J CANCER, V78, P312, DOI 10.1038/bjc.1998.492
   JOSEPH P, 1994, P NATL ACAD SCI USA, V91, P8413, DOI 10.1073/pnas.91.18.8413
   King KE, 2007, MOL CARCINOGEN, V46, P716, DOI 10.1002/mc.20337
   Koster MI, 2007, CELL CYCLE, V6, P269, DOI 10.4161/cc.6.3.3792
   Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104
   Long DJ, 2000, CANCER RES, V60, P5913
   Long DJ, 2002, J BIOL CHEM, V277, P46131, DOI 10.1074/jbc.M208675200
   Long DJ, 2001, JNCI-J NATL CANCER I, V93, P1166, DOI 10.1093/jnci/93.15.1166
   Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60
   Mills AA, 1999, NATURE, V398, P708
   Moll UM, 2004, MOL CANCER RES, V2, P371
   Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315
   Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382
   Radjendirane Venugopal, 1997, P441
   Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623
   Ross D, 2000, CHEM-BIOL INTERACT, V129, P77, DOI 10.1016/S0009-2797(00)00199-X
   Salvat C, 2000, EUR J BIOCHEM, V267, P3712, DOI 10.1046/j.1432-1327.2000.01404.x
   Shen J, 2010, CANCER RES, V70, P1006, DOI 10.1158/0008-5472.CAN-09-2938
   Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2
   Yang A, 1999, NATURE, V398, P714
NR 34
TC 21
Z9 22
U1 3
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
EI 1476-5594
J9 ONCOGENE
JI Oncogene
PD MAR
PY 2011
VL 30
IS 9
BP 1098
EP 1107
DI 10.1038/onc.2010.491
PG 10
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA 729PX
UT WOS:000287964100008
PM 21042282
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Park, HJ
   Oh, Y
   Kang, HJ
   Han, EJ
   Shin, HY
   Ahn, HS
   Ahn, KS
   Yoon, BH
   Han, BD
AF Park, H. J.
   Oh, Y.
   Kang, H. J.
   Han, E. J.
   Shin, H. Y.
   Ahn, H. S.
   Ahn, K. S.
   Yoon, B. H.
   Han, B. D.
TI RETRACTED: A gene-specific primer extension and liquid bead array system
   for killer-cell immunoglobulin-like receptor genotyping (Retracted
   article. See vol. 77, pg. 251, 2011)
SO TISSUE ANTIGENS
LA English
DT Article; Retracted Publication
DE bead array; gene-specific primer extension; genotyping; killer-cell
   immunoglobulin-like receptor; natural killer cells; specific bulging
   specific primers
ID PCR-SSP METHOD; KIR; DISEASE
AB A simple and accurate method for killer-cell immunoglobulin-like receptor (KIR) genotyping is developed using KIR gene-specific primer extension (GSPE) followed by bead array hybridization (GSPE method). After amplification of exons 4, 5, and 9, KIR GSPE and bead array hybridization were performed to verify the presence or absence of 16 KIR subfamilies. GSPE method was validated with natural killer/KIR reference panel I consisting of 48 cell types provided by 13th International Histocompatibility Working Group (IHWG) and genomic DNA from 17 peripheral blood cells, 8 cell lines, and 8 buccal cells. The results of reference panel from GSPE method were 100% concordant with the IHWG reference typing information. All genomic DNAs except reference panel were typed for KIR genes with sequence-specific primer methods and showed 100% identical typing results using this novel system. In addition, GSPE method can obtain results in 8 h from DNA with 10 ng genomic DNA in a 96-well-based assay format.
C1 [Park, H. J.; Oh, Y.; Han, B. D.] YeBT Co Ltd, Seoul, South Korea.
   [Park, H. J.] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul, South Korea.
   [Park, H. J.] Seoul Natl Univ, Dent Res Inst, Seoul, South Korea.
   [Kang, H. J.; Han, E. J.; Shin, H. Y.; Ahn, H. S.] Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Pediat, Seoul, South Korea.
   [Ahn, K. S.] Baekseok Culture Univ, Dept Hlth & Environm, Cheonan, South Korea.
   [Yoon, B. H.] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.
RP Han, BD (reprint author), YeBT Co Ltd, 917-6 Mok Dong, Seoul, South Korea.
EM bdhan@yebt.net
RI Kang, Hyoung Jin/J-2730-2012; Yoon, Bo Hyun/H-6344-2011
FU small- and medium-business administration in South Korea [S1038279,
   0003789 00110]
FX This study was supported by grants #S1038279 and #0003789 00110 from
   small- and medium-business administration in South Korea.
CR Ashouri E, 2009, TISSUE ANTIGENS, V74, P62, DOI 10.1111/j.1399-0039.2009.01259.x
   Aslanian S, 2007, INT J LAB HEMATOL, V29, P284, DOI 10.1111/j.1751-553X.2007.00854.x
   Crum KA, 2000, TISSUE ANTIGENS, V56, P313, DOI 10.1034/j.1399-0039.2000.560403.x
   Houtchens KA, 2007, IMMUNOGENETICS, V59, P525, DOI 10.1007/s00251-007-0222-x
   Hsu KC, 2002, IMMUNOL REV, V190, P40, DOI 10.1034/j.1600-065X.2002.19004.x
   Kang HJ, 2008, MOL CELL PROBE, V22, P193, DOI 10.1016/j.mcp.2008.02.001
   Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x
   Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003
   Meenagh A, 2008, TISSUE ANTIGENS, V72, P383, DOI 10.1111/j.1399-0039.2008.01093.x
   Middleton D, 2009, IMMUNOLOGY, V129, P8
   Nong T, 2007, TISSUE ANTIGENS, V69, P92, DOI 10.1111/j.1399-0039.2006.762_3.x
   Oh Y, 2007, CANCER SCI, V98, P549, DOI 10.1111/j.1349-7006.2007.00427.x
   Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570
   Roberts CH, 2007, TISSUE ANTIGENS, V69, P597, DOI 10.1111/j.1399-0039.2007.00818.x
   Sun JY, 2005, BONE MARROW TRANSPL, V36, P525, DOI 10.1038/j.bmt.1705089
   Sun JY, 2004, TISSUE ANTIGENS, V64, P462, DOI 10.1111/j.1399-0039.2004.00303.x
   Velardi A, 2008, CURR OPIN IMMUNOL, V20, P581, DOI 10.1016/j.coi.2008.07.004
   Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x
   Yun G, 2007, CLIN IMMUNOL, V123, P272, DOI 10.1016/j.clim.2007.01.011
NR 19
TC 2
Z9 2
U1 0
U2 11
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0001-2815
J9 TISSUE ANTIGENS
JI Tissue Antigens
PD MAR
PY 2011
VL 77
IS 3
BP 251
EP 256
DI 10.1111/j.1399-0039.2010.01618.x
PG 6
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA 718AT
UT WOS:000287092600013
PM 21299533
DA 2018-12-27
ER

PT J
AU Prasad, S
   Yadav, VR
   Kannappan, R
   Aggarwal, BB
AF Prasad, Sahdeo
   Yadav, Vivek R.
   Kannappan, Ramaswamy
   Aggarwal, Bharat B.
TI RETRACTED: Ursolic Acid, a Pentacyclin Triterpene, Potentiates
   TRAIL-induced Apoptosis through p53-independent Up-regulation of Death
   Receptors EVIDENCE FOR THE ROLE OF REACTIVE OXYGEN SPECIES AND JNK
   (Retracted article. See vol. 291, pg. 16924, 2016)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID LEUKEMIC HL-60 CELLS; COLON-CANCER CELLS; DOWN-REGULATION; IN-VIVO;
   ANTITUMOR-ACTIVITY; LUNG-CANCER; TRAIL/APO2L-INDUCED APOPTOSIS;
   IONIZING-RADIATION; MEDIATED APOPTOSIS; SIGNALING PATHWAYS
AB Discovery of the molecular targets of traditional medicine and its chemical footprints can validate the use of such medicine. In the present report, we investigated the effect of ursolic acid (UA), a pentacyclic triterpenoid found in rosemary and holy basil, on apoptosis induced by TRAIL. We found that UA potentiated TRAIL-induced apoptosis in cancer cells. In addition, UA also sensitized TRAIL-resistant cancer cells to the cytokine. When we investigated the mechanism, we found that UA down-regulated cell survival proteins and induced the cell surface expression of both TRAIL receptors, death receptors 4 and 5 (DR4 and -5). Induction of receptors by UA occurred independently of cell type. Gene silencing of either receptor by small interfering RNA reduced the apoptosis induced by UA and the effect of TRAIL. In addition, UA also decreased the expression of decoy receptor 2 (DcR2) but not DcR1. Induction of DRs was independent of p53 because UA induced DR4 and DR5 in HCT116 p53(-/-) cells. Induction of DRs, however, was dependent on JNK because UA induced JNK, and its pharmacologic inhibition abolished the induction of the receptors. The down-regulation of survival proteins and up-regulation of the DRs required reactive oxygen species (ROS) because UA induced ROS, and its quenching abolished the effect of the terpene. Also, potentiation of TRAIL-induced apoptosis by UA was significantly reduced by both ROS quenchers and JNK inhibitor. In addition, UA was also found to induce the expression of DRs, down-regulate cell survival proteins, and activate JNK in orthotopically implanted human colorectal cancer in a nude mouse model. Overall, our results showed that UA potentiates TRAIL-induced apoptosis through activation of ROS and JNK-mediated up-regulation of DRs and down-regulation of DcR2 and cell survival proteins.
C1 [Prasad, Sahdeo; Yadav, Vivek R.; Kannappan, Ramaswamy; Aggarwal, Bharat B.] Univ Texas Houston, MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA.
RP Aggarwal, BB (reprint author), 1515 Holcombe Blvd,Unit 143, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Aggarwal, Bharat/G-3388-2013
FU National Institutes of Health [CA-16672, CA-124787-01A2]; Clayton
   Foundation for Research; Center for Targeted Therapy of M. D. Anderson
   Cancer Center
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants CA-16672 and CA-124787-01A2. This work was also supported
   by a grant from the Clayton Foundation for Research (to B. B. A.) and a
   grant from the Center for Targeted Therapy of M. D. Anderson Cancer
   Center.
CR Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184
   Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926
   Baek JH, 1997, INT J CANCER, V73, P725, DOI 10.1002/(SICI)1097-0215(19971127)73:5<725::AID-IJC19>3.0.CO;2-4
   Belyanskaya LL, 2008, LUNG CANCER, V60, P355, DOI 10.1016/j.lungcan.2007.11.005
   BUTLER MS, 2008, PROG DRUG RES, V65, P3
   Cha HJ, 1998, ONCOGENE, V16, P771, DOI 10.1038/sj.onc.1201587
   Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416
   Choi BM, 2000, PHARMACOL TOXICOL, V86, P53, DOI 10.1034/j.1600-0773.2000.d01-10.x
   Choi YH, 2000, INT J ONCOL, V17, P565
   Corazza N, 2006, J CLIN INVEST, V116, P2493, DOI 10.1172/JCI27726
   Essaady D, 1996, CANCER LETT, V106, P193, DOI 10.1016/0304-3835(96)04312-1
   Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj/onc/1205258
   Gayathri R, 2009, ASIAN PAC J CANCER P, V10, P933
   Gliniak B, 1999, CANCER RES, V59, P6153
   Grotzer MA, 2000, ONCOGENE, V19, P4604, DOI 10.1038/sj.onc.1203816
   Harmand PO, 2005, INT J CANCER, V114, P1, DOI 10.1002/ijc.20588
   Hetschko H, 2008, FEBS J, V275, P1925, DOI 10.1111/j.1742-4658.2008.06351.x
   Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936
   Hsu YL, 2004, LIFE SCI, V75, P2303, DOI 10.1016/j.lfs.2004.04.027
   Huang J, 2008, J PHARMACOL SCI, V107, P370, DOI 10.1254/jphs.08044FP
   HUANG MT, 1994, CANCER RES, V54, P701
   Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319
   Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160
   Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657
   Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8
   Jung EM, 2005, CARCINOGENESIS, V26, P1905, DOI 10.1093/carcin/bgi167
   Kassi E, 2009, CANCER INVEST, V27, P723, DOI 10.1080/07357900802672712
   Kim DK, 2000, INT J CANCER, V87, P629, DOI 10.1002/1097-0215(20000901)87:5<629::AID-IJC2>3.0.CO;2-P
   Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568
   Kim JY, 2008, J CELL BIOCHEM, V105, P1386, DOI 10.1002/jcb.21958
   Kowalczyk MC, 2009, CARCINOGENESIS, V30, P1008, DOI 10.1093/carcin/bgp069
   Kunnumakkara AB, 2008, CLIN CANCER RES, V14, P2128, DOI 10.1158/1078-0432.CCR-07-4722
   Li J, 2002, WORLD J GASTROENTERO, V8, P493, DOI 10.3748/wjg.v8.i3.493
   Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2
   Martelli AM, 2003, LEUKEMIA, V17, P1794, DOI 10.1038/sj.leu.2403044
   Meng RD, 2000, MOL THER, V1, P130, DOI 10.1006/mthe.2000.0025
   Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06
   Nagane M, 2007, J NEUROSURG, V106, P407, DOI 10.3171/jns.2007.106.3.407
   Ng CP, 2002, PROSTATE, V53, P286, DOI 10.1002/pros.10155
   Ozoren N, 2000, INT J ONCOL, V16, P917
   Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815
   Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348
   Prasad S, 2010, MOL CANCER THER, V9, P856, DOI 10.1158/1535-7163.MCT-09-1113
   Ravi R, 2002, CANCER RES, V62, P1583
   Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5
   Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996
   Shiiki K, 2000, CELL DEATH DIFFER, V7, P939, DOI 10.1038/sj.cdd.4400727
   Shishodia S, 2003, CANCER RES, V63, P4375
   Singletary K, 1996, CANCER LETT, V104, P43, DOI 10.1016/0304-3835(96)04227-9
   Srivastava Rakesh K., 2000, Molecular Cell Biology Research Communications, V4, P67, DOI 10.1006/mcbr.2001.0265
   Subbaramaiah K, 2000, CANCER RES, V60, P2399
   Suh N, 1998, CANCER RES, V58, P717
   Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489
   Walczak H, 1999, NAT MED, V5, P157
   Wang QD, 2002, J BIOL CHEM, V277, P36602, DOI 10.1074/jbc.M206306200
   Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8
   Wu WG, 2000, ANTICANCER RES, V20, P4525
   Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200
   Yamai H, 2009, INT J CANCER, V125, P952, DOI 10.1002/ijc.24433
   Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161
   Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792
   Zhang YX, 2010, MOL CARCINOGEN, V49, P374, DOI 10.1002/mc.20610
   Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238
NR 63
TC 90
Z9 93
U1 6
U2 25
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 18
PY 2011
VL 286
IS 7
BP 5546
EP 5557
DI 10.1074/jbc.M110.183699
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 719SY
UT WOS:000287230600064
PM 21156789
OA Bronze
DA 2018-12-27
ER

PT J
AU Jazirehi, AR
   Baritaki, S
   Koya, RC
   Bonavida, B
   Economou, JS
AF Jazirehi, Ali R.
   Baritaki, Stavroula
   Koya, Richard C.
   Bonavida, Benjamin
   Economou, James S.
TI RETRACTED: Molecular Mechanism of MART-1(+)/A*0201(+) Human Melanoma
   Resistance to Specific CTL-Killing Despite Functional Tumor-CTL
   Interaction (Retracted article. See vol. 77, pg. 3718, 2017)
SO CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID NF-KAPPA-B; TCR GENE-TRANSFER; PROTEASOME INHIBITOR; METASTATIC
   MELANOMA; CUTANEOUS MELANOMA; T-LYMPHOCYTES; CELL-LINES; IN-VITRO;
   BCL-XL; APOPTOSIS
AB Durable responses in metastatic melanoma patients remain generally difficult to achieve. Adoptive cell therapy (ACT) with ex vivo engineered lymphocytes expressing high affinity T-cell receptors (TCR alpha/beta) for the melanoma antigen MART-1(27-35)/HLA-A*0201 [ recognized by F5 cytotoxic T lymphocytes (F5 CTL)] has been found to benefit certain patients. However, many other patients are inherently unresponsive and/or relapse for unknown reasons. To analyze the basis for the acquired resistance and strategies to reverse it, we established F5 CTL-resistant (R) human melanoma clones from relatively sensitive parental lines under selective F5 CTL pressure. Surface MART-1(27-35)/HLA-A*0201 in these clones was unaltered and F5 CTLs recognized and interacted with them similar to the parental lines. Nevertheless, the R clones were resistant to F5 CTL killing, exhibited hyperactivation of the NF-kappa B survival pathway, and overexpression of the antiapoptotic genes B cell lymphoma protein 2 (Bcl-2), Bcl-2 related gene (long alternatively spliced variant of Bcl-x gene; Bcl-(xL)), and myeloid cell differentiation 1 (Mcl-1). Sensitivity to F5 CTL-killing could be increased by pharmacological inhibition of the NF-kappa B pathway, Bcl-2 family members, or the proteasome, the latter of which reduced NF-kappa B activity and diminished antiapoptotic gene expression. Specific gene-silencing (by siRNA) confirmed the protective role of antiapoptotic factors by reversing R clone resistance. Together, our findings suggest that long-term immunotherapy may impose a selection for the development of resistant cells that are unresponsive to highly avid and specific melanoma-reactive CTLs, despite maintaining expression of functional peptide: MHC complexes, due to activation of antiapoptotic signaling pathways. Though unresponsive to CTL, our results argue that resistant cells can be resensitized to immunotherapy with coadministration of targeted inhibitors to antiapoptotic survival pathways. Cancer Res; 71(4); 1406-17. (C) 2010 AACR.
C1 [Jazirehi, Ali R.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Div Surg Oncol,Dept Surg, Los Angeles, CA 90095 USA.
   [Baritaki, Stavroula; Bonavida, Benjamin; Economou, James S.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Economou, James S.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
RP Jazirehi, AR (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Div Surg Oncol,Dept Surg, 10833 LeConte Ave,CHS 54-140,Mail Code 178218, Los Angeles, CA 90095 USA.
EM ajazirehi@mednet.ucla.edu
FU Samuel Waxman Foundation; Joy and Jerry Monkarsh Fund; W. M. Keck
   Foundation; Melanoma Research Foundation;  [R01 CA 129816]
FX This work was supported in part by Samuel Waxman Foundation, Joy and
   Jerry Monkarsh Fund, W. M. Keck Foundation, R01 CA 129816, Melanoma
   Research Foundation Career Development Award (to A.R. Jazirehi).
CR Abouzahr S, 2006, P NATL ACAD SCI USA, V103, P1428, DOI 10.1073/pnas.05104514103
   ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489
   Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7
   Amschler K, 2010, J INVEST DERMATOL, V130, P1073, DOI 10.1038/jid.2009.365
   Bai XF, 2003, J CLIN INVEST, V111, P1487, DOI 10.1172/JCI200317656
   Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148
   Baritaki S, 2009, ONCOGENE, V28, P3573, DOI 10.1038/onc.2009.214
   Bush JA, 2003, CLIN EXP METASTAS, V20, P531, DOI 10.1023/A:1025874502181
   Butterfield LH, 1997, GENE, V191, P129, DOI 10.1016/S0378-1119(96)00789-5
   Chouaib S, 2009, CLIN IMMUNOL, V130, P34, DOI 10.1016/j.clim.2008.08.020
   DEMBIC Z, 1987, NATURE, V326, P510, DOI 10.1038/326510a0
   Devalaraja MN, 1999, CANCER RES, V59, P1372
   DOUAWHO CK, 2001, CANCER RES, V61, P215
   Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427
   Hersey P, 2001, NAT REV CANCER, V1, P142, DOI 10.1038/35101078
   Hersey P, 2009, CANCER IMMUNOL IMMUN, V58, P1751, DOI 10.1007/s00262-009-0732-5
   Huang S, 2000, CLIN CANCER RES, V6, P2573
   Huber C, 2005, CELL DEATH DIFFER, V12, P317, DOI 10.1038/sj.cdd.4401563
   Jazirehi AR, 2007, CANCER RES, V67, P1270, DOI 10.1158/0008-5472.CAN-06-2184
   Jazirehi AR, 2005, ONCOGENE, V24, P2121, DOI 10.1038/sj.onc.1208349
   JAZIREHI AR, 2009, P AM ASSOCCANCER RES, P2419
   Jiang CC, 2008, CANCER RES, V68, P6708, DOI 10.1158/0008-5472.CAN-08-0349
   Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548
   Keller SA, 2000, BLOOD, V96, P2537
   Kessels HWHG, 2001, NAT IMMUNOL, V2, P957, DOI 10.1038/ni1001-957
   Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999
   Kim JH, 2009, IMMUNOL LETT, V122, P58, DOI 10.1016/j.imlet.2008.12.006
   Leiter U, 2000, ARCH DERMATOL RES, V292, P225, DOI 10.1007/s004030050479
   Lesinski GB, 2008, CANCER RES, V68, P8351, DOI 10.1158/0008-5472.CAN-08-0426
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015
   McNulty SE, 2004, PIGM CELL RES, V17, P173, DOI 10.1111/j.1600-0749.2004.00128.x
   Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287
   Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003
   Mori N, 2002, BLOOD, V100, P1828, DOI 10.1182/blood-2002-01-0151
   Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583
   Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355
   Rubinstein MP, 2003, J IMMUNOL, V170, P1209, DOI 10.4049/jimmunol.170.3.1209
   Schumacher TNM, 2002, NAT REV IMMUNOL, V2, P512, DOI 10.1038/nri841
   Seeger JM, 2010, CANCER RES, V70, P1825, DOI 10.1158/0008-5472.CAN-09-3175
   Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3
   SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X
   ShattuckBrandt RL, 1997, CANCER RES, V57, P3032
   Sorolla A, 2008, BRIT J DERMATOL, V158, P496, DOI 10.1111/j.1365-2133.2007.08390.x
   Speiser DE, 1997, J EXP MED, V186, P645, DOI 10.1084/jem.186.5.645
   Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178
   Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095
   Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641
   Wang CY, 1999, NAT MED, V5, P412
   Wolter KG, 2007, CELL DEATH DIFFER, V14, P1605, DOI 10.1038/sj.cdd.4402163
   Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750
NR 50
TC 28
Z9 28
U1 1
U2 3
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD FEB 15
PY 2011
VL 71
IS 4
BP 1406
EP 1417
DI 10.1158/0008-5472.CAN-10-1296
PG 12
WC Oncology
SC Oncology
GA 721KP
UT WOS:000287352600023
PM 21159666
OA Bronze, Green Accepted
DA 2018-12-27
ER

PT J
AU Golitz, P
   Neal, A
   Abel, L
AF Goelitz, P.
   Neal, A.
   Abel, L.
TI RETRACTED: ChemBioChem Has Come of Age (Retracted Article)
SO CHEMBIOCHEM
LA English
DT Correction; Retracted Publication
OI Heydenrych, Greta/0000-0003-3329-5901
CR GOLITZ P, 2011, J BIOL CHEM, V12, P3
NR 1
TC 0
Z9 0
U1 3
U2 12
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1439-4227
EI 1439-7633
J9 CHEMBIOCHEM
JI ChemBioChem
PD FEB 11
PY 2011
VL 12
IS 3
BP 346
EP 346
DI 10.1002/cbic.201000747
PG 1
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 726JW
UT WOS:000287718700001
PM 21191982
OA Bronze
DA 2018-12-27
ER

PT J
AU Ren, YQ
   Stein, D
AF Ren, Yongqiang
   Stein, Derek
TI RETRACTED: Coulomb Forces on DNA Polymers in Charged Fluidic Nanoslits
   (Retracted article. See vol. 107, artn no. 049901, 2011)
SO PHYSICAL REVIEW LETTERS
LA English
DT Article; Retracted Publication
ID POLYELECTROLYTES; MOLECULES; SURFACES
AB We investigate the repulsive electrostatic interactions between a DNA polyelectrolyte and the charged walls of a fluidic nanoslit. The scaling of the DNA coil size with the physical slit height revealed electrostatic depletion regions that reduced the effective slit height. These regions exceeded the Debye screening length of the buffer, lambda(buffer)(D), and saturated at approximate to 50 nm when lambda(buffer)(D) reached 10 nm. We explain these results by modeling a semiflexible charged rod near a charged wall and the electrostatic screening by the polyelectrolyte. These results demonstrate the surprisingly long range over which a nanofluidic device can exert field-effect control over confined molecules.
C1 [Ren, Yongqiang; Stein, Derek] Brown Univ, Dept Phys, Providence, RI 02912 USA.
RP Ren, YQ (reprint author), Brown Univ, Dept Phys, Providence, RI 02912 USA.
FU NSF [DMR-0805176]
FX We thank S.-C. Ying, W. Reisner, and J. T. Del Bonis-O'Donnell for
   useful discussions. We also acknowledge useful correspondence with D.
   Bonthuis. This work was supported by NSF Grant No. DMR-0805176.
CR Aubouy M, 2003, J PHYS A-MATH GEN, V36, P5835, DOI 10.1088/0305-4470/36/22/302
   Behrens SH, 2001, J CHEM PHYS, V115, P6716, DOI 10.1063/1.1404988
   Bonthuis DJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.108303
   BORUE VY, 1988, MACROMOLECULES, V21, P3240
   DEGENNES PG, 1979, SCALING CONCEPTS POL, pCH3
   Del Bonis-O'Donnell JT, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/075032
   Dobrynin AV, 2005, MACROMOLECULES, V38, P9304, DOI 10.1021/ma051353r
   Doi M, 1986, THEORY POLYM DYNAMIC
   HOAGLAND DA, 1990, MACROMOLECULES, V23, P2781, DOI 10.1021/ma00212a032
   Hsieh C.-C., 2008, NANO LETT, V8, P1683
   Hsieh CC, 2008, KOREA-AUST RHEOL J, V20, P127
   Jiang ZJ, 2010, LANGMUIR, V26, P8161, DOI 10.1021/la9044682
   Jo K, 2007, P NATL ACAD SCI USA, V104, P2673, DOI 10.1073/pnas.0611151104
   Karnik R, 2005, NANO LETT, V5, P943, DOI 10.1021/nl050493b
   Mayer J. E., 1940, STAT MECH
   Murade CU, 2010, NUCLEIC ACIDS RES, V38, P3423, DOI 10.1093/nar/gkq034
   ODIJK T, 1983, MACROMOLECULES, V16, P1340, DOI 10.1021/ma00242a015
   Odijk T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.060901
   ONSAGER L, 1949, ANN NY ACAD SCI, V51, P627, DOI 10.1111/j.1749-6632.1949.tb27296.x
   Persson F, 2010, CHEM SOC REV, V39, P985, DOI 10.1039/b912918a
   Reisner W, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.058302
   Reisner W, 2009, P NATL ACAD SCI USA, V106, P79, DOI 10.1073/pnas.0811468106
   STIGTER D, 1977, BIOPOLYMERS, V16, P1435, DOI 10.1002/bip.1977.360160705
   Zhang C, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2937441
NR 24
TC 5
Z9 5
U1 1
U2 2
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 0031-9007
EI 1079-7114
J9 PHYS REV LETT
JI Phys. Rev. Lett.
PD FEB 9
PY 2011
VL 106
IS 6
AR 068302
DI 10.1103/PhysRevLett.106.068302
PG 4
WC Physics, Multidisciplinary
SC Physics
GA 718OX
UT WOS:000287135400008
PM 21405500
OA Bronze
DA 2018-12-27
ER

PT J
AU Konson, A
   Pradeep, S
   D'Acunto, CW
   Seger, R
AF Konson, Alexander
   Pradeep, Sunila
   D'Acunto, Cosimo Walter
   Seger, Rony
TI RETRACTED: Pigment Epithelium-derived Factor and Its Phosphomimetic
   Mutant Induce JNK-dependent Apoptosis and p38-mediated Migration Arrest
   (Retracted article. See vol. 292, pg. 8849, 2017)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID ANTI-ANGIOGENIC ACTIVITY; HUMAN ENDOTHELIAL-CELLS; FACTOR EXPRESSION;
   TUMOR-GROWTH; FACTOR PEDF; PPAR-GAMMA; ACTIVATION; INHIBITION; RECEPTOR;
   KINASE
AB Pigment epithelium-derived factor (PEDF) is a potent endogenous inhibitor of angiogenesis and a promising anticancer agent. We have previously shown that PEDF can be phosphorylated and that distinct phosphorylations differentially regulate its physiological functions. We also demonstrated that triple phosphomimetic mutant (EEE-PEDF), has significantly increased antiangiogenic activity and is much more efficient than WT-PEDF in inhibiting neovascularization and tumor growth. The enhanced antiangiogenic effect was associated with a direct ability to facilitate apoptosis of tumor-residing endothelial cells (ECs), and subsequently, disruption of intratumoral vascularization. In the present report, we elucidated the molecular mechanism by which EEE-PEDF exerts more profound effects at the cellular level. We found that EEE-PEDF suppresses EC proliferation due to caspase-3-dependent apoptosis and also inhibits migration of the EC much better than WT-PEDF. Although WT-PEDF and EEE-PEDF did not affect proliferation and did not induce apoptosis of cancer cells, these agents efficiently inhibited cancer cell motility, with EEE-PEDF showing a stronger effect. The stronger activity of EEE-PEDF was correlated with a better binding to laminin receptors. Furthermore, the proapoptotic and antimigratory activities of WT-PEDF and EEE-PEDF were found regulated by differential activation of two distinct MAPK pathways, namely JNK and p38, respectively. We show that JNK and p38 phosphorylation is much higher in cells treated with EEE-PEDF. JNK leads to apoptosis of ECs, whereas p38 leads to anti-migratory effect in both EC and cancer cells. These results reveal the molecular signaling mechanism by which the phosphorylated PEDF exerts its stronger antiangiogenic, antitumor activities.
C1 [Konson, Alexander; Pradeep, Sunila; D'Acunto, Cosimo Walter; Seger, Rony] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.
RP Seger, R (reprint author), Weizmann Inst Sci, Dept Regulat Biol, POB 26, IL-76100 Rehovot, Israel.
EM rony.seger@weizmann.ac.il
FU Israeli Ministry of Industry and Trade; Horowitz Foundation; Phyllis and
   Joseph Gurwin Fund for Scientific Advancement; EU [LSHC CT-2006-037731]
FX This work was supported by grants from the Israeli Ministry of Industry
   and Trade (Nofar program), the Horowitz Foundation, the Phyllis and
   Joseph Gurwin Fund for Scientific Advancement and the EU Sixth Framework
   Program (GROWTHSTOP, LSHC CT-2006-037731).
CR Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5
   Abramson LP, 2003, J PEDIATR SURG, V38, P336, DOI 10.1053/jpsu.2003.50104
   Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200
   Biyashev D, 2010, J BIOL CHEM, V285, P13517, DOI 10.1074/jbc.M110.117374
   Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6
   Cai J, 2006, CLIN CANCER RES, V12, P3510, DOI 10.1158/1078-0432.CCR-06-0094
   Chen HB, 2008, BIOCHEM BIOPH RES CO, V369, P718, DOI 10.1016/j.bbrc.2008.02.100
   Chen LL, 2006, BIOCHEM BIOPH RES CO, V348, P1288, DOI 10.1016/j.bbrc.2006.07.188
   Crawford SE, 2001, J CELL SCI, V114, P4421
   Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245
   Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301
   Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870
   Ek ETH, 2007, CLIN EXP METASTAS, V24, P93, DOI 10.1007/s10585-007-9062-1
   Ek ETH, 2006, TRENDS MOL MED, V12, P497, DOI 10.1016/j.molmed.2006.08.009
   Ek ETH, 2006, MOL CANCER THER, V5, P1641, DOI 10.1158/1535-7163.MCT-06-0107
   ENNIS BW, 1991, CANCER INVEST, V9, P553, DOI 10.3109/07357909109018953
   Guan M, 2003, J CLIN PATHOL, V56, P277, DOI 10.1136/jcp.56.4.277
   Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618
   Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032
   Ho TC, 2009, AM J PHYSIOL-CELL PH, V296, pC273, DOI 10.1152/ajpcell.00432.2008
   Hosomichi J, 2005, BIOCHEM BIOPH RES CO, V335, P756, DOI 10.1016/j.bbrc.2005.07.140
   Hu YL, 1999, AM J PHYSIOL-HEART C, V277, pH1593, DOI 10.1152/ajpheart.1999.277.4.H1593
   Hutchings H, 2002, BIOCHEM BIOPH RES CO, V294, P764, DOI 10.1016/S0006-291X(02)00548-X
   Konson A, 2010, CANCER RES, V70, P6247, DOI 10.1158/0008-5472.CAN-10-0434
   Maik-Rachline G, 2006, BLOOD, V107, P2745, DOI 10.1182/blood-2005-06-2547
   Maik-Rachline G, 2005, BLOOD, V105, P670, DOI 10.1182/blood-2004-04-1569
   McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200
   Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200
   Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026
   Petersen SV, 2003, BIOCHEM J, V374, P199, DOI 10.1042/BJ20030313
   Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392
   STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526
   Stellmach V, 2001, P NATL ACAD SCI USA, V98, P2593, DOI 10.1073/pnas.031252398
   Takenaka K, 2005, LIFE SCI, V77, P3231, DOI 10.1016/j.lfs.2005.05.048
   Tombran-Tink J, 2005, FRONT BIOSCI, V10, P2131, DOI 10.2741/1686
   Tombran-Tink J, 2005, J STRUCT BIOL, V151, P130, DOI 10.1016/j.jsb.2005.05.005
   TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D
   Tsao YP, 2006, LIFE SCI, V79, P545, DOI 10.1016/j.lfs.2006.01.041
   Volpert OV, 2002, NAT MED, V8, P349, DOI 10.1038/nm0402-349
   Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694
   Wang JJ, 2005, DIABETES, V54, P243, DOI 10.2337/diabetes.54.1.243
   Wang L, 2003, MOL THER, V8, P72, DOI 10.1016/S01525-0016(03)00128-X
   Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016
   Yafai Y, 2007, GLIA, V55, P642, DOI 10.1002/glia.20495
   Yilmaz M, 2007, TRENDS MOL MED, V13, P535, DOI 10.1016/j.molmed.2007.10.004
   Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218
   Zaichuk TA, 2004, J EXP MED, V199, P1513, DOI 10.1084/jem.20040474
   Zhang LJ, 2006, INT J MOL MED, V17, P937
NR 48
TC 26
Z9 32
U1 1
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 4
PY 2011
VL 286
IS 5
BP 3540
EP 3551
DI 10.1074/jbc.M110.151548
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 712GE
UT WOS:000286653200039
PM 21059648
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Fujii, Y
   Itakura, M
AF Fujii, Yoshitaka
   Itakura, Michiyo
TI RETRACTED: Antiemetic Efficacy of Low-Dose Midazolam in Patients
   Undergoing Thyroidectomy (Retracted article. See vol. 146, pg. 686,
   2012)
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Article; Retracted Publication
DE complications; vomiting; antiemetics; midazolam; thyroidectomy
ID MIDDLE-EAR SURGERY; POSTOPERATIVE NAUSEA; PREVENTION; PROPOFOL;
   DEXAMETHASONE; DROPERIDOL
AB Objective. Postoperative nausea and vomiting are distressing and frequent adverse events of anesthesia and surgery, with a high incidence following thyroidectomy. The aim of this study was to evaluate the efficacy of low-dose midazolam for preventing postoperative nausea and vomiting in patients undergoing thyroidectomy.
   Study Design. Prospective, randomized, double-blind, placebo-controlled study.
   Setting. University-affiliated hospital. Subjects and Methods. Ninety patients, 30 men and 60 nonpregnant women, received intravenously placebo or midazolam at 2 different doses (50 and 75 mu g/kg; n = 30 of each) immediately after induction of anesthesia. A standard general anesthetic technique, including sevoflurane and air in oxygen, was used. Postoperatively, during the first 24 hours after anesthesia, all episodes of nausea and vomiting were recorded and safety assessment were performed.
   Results. The treatment groups were comparable with regard to patient demographics. The incidence of postoperative vomiting was 17% with midazolam 50 mu g/kg (P = .042) and 13% with midazolam 75 mu g/kg (P = .019), compared with placebo (40%). No difference in the incidence of postoperative nausea was found among the 3 groups. No clinically important adverse events, such as extrapyramidal signs, were found in any of the groups. None of the patients experienced drowsiness or excessive sedation.
   Conclusion. Midazolam 50 mu g/kg is as effective as midazolam 75 mu g/kg for preventing postoperative vomiting, but not postoperative nausea, during the first 24 hours after anesthesia in patients undergoing thyroidectomy.
C1 [Fujii, Yoshitaka; Itakura, Michiyo] Ushiku Aiwa Gen Hosp, Dept Anesthesiol, Ibaraki, Japan.
RP Fujii, Y (reprint author), Toho Univ, Sch Med, Dept Anesthesiol, Ohta Ku, 6-11-1 Ohmori Nishi, Tokyo 1438541, Japan.
EM yfujii@med.toho-u.ac.jp
CR DEJONCKHEERE M, 1990, EUR J ANAESTH, V7, P421
   DIFLORIO T, 1992, ANAESTH INTENS CARE, V20, P383
   Eberhart LHJ, 1999, EUR J ANAESTH, V16, P284, DOI 10.1046/j.1365-2346.1999.00477.x
   Ewalenko P, 1996, BRIT J ANAESTH, V77, P463, DOI 10.1093/bja/77.4.463
   Fujii Y, 1999, LARYNGOSCOPE, V109, P664, DOI 10.1097/00005537-199904000-00028
   Jung JS, 2007, OTOLARYNG HEAD NECK, V137, P753, DOI 10.1016/j.otohns.2007.07.024
   Korttila K, 1997, ACTA ANAESTH SCAND, V41, P914, DOI 10.1111/j.1399-6576.1997.tb04809.x
   LERMAN J, 1995, CAN J ANAESTH, V42, P263, DOI 10.1007/BF03010699
   PHILLIS JW, 1980, BRAIN RES, V195, P494, DOI 10.1016/0006-8993(80)90087-6
   RAMSAY TM, 1994, CAN J ANAESTH, V41, P798, DOI 10.1007/BF03011586
   REVES JG, 1985, ANESTHESIOLOGY, V62, P310, DOI 10.1097/00000542-198503000-00017
   SMITH I, 1994, ANESTHESIOLOGY, V81, P1005
   Sneyd JR, 1998, EUR J ANAESTH, V15, P433, DOI 10.1097/00003643-199807000-00009
   Sonner JM, 1997, J CLIN ANESTH, V9, P398, DOI 10.1016/S0952-8180(97)00069-X
   SPLINTER W, 1994, CAN J OPHTHALMOL, V29, P224
   TAKADA K, 1993, BRIT J ANAESTH, V70, P181, DOI 10.1093/bja/70.2.181
   THOMPSON DP, 1978, PLAST RECONSTR SURG, V61, P40, DOI 10.1097/00006534-197801000-00008
   Vari A, 2010, AM SURGEON, V76, P325
   Wang JJ, 1999, ANESTH ANALG, V89, P200, DOI 10.1097/00000539-199907000-00036
   WATCHA MF, 1992, ANESTHESIOLOGY, V77, P162, DOI 10.1097/00000542-199207000-00023
   WHITE PF, 1993, ANESTHESIOLOGY, V78, P2, DOI 10.1097/00000542-199301000-00002
   Yeo J, 2009, OTOLARYNG HEAD NECK, V141, P684, DOI 10.1016/j.otohns.2009.09.014
NR 22
TC 5
Z9 5
U1 2
U2 10
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0194-5998
EI 1097-6817
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD FEB
PY 2011
VL 144
IS 2
BP 206
EP 209
DI 10.1177/0194599810391728
PG 4
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA 808RV
UT WOS:000293997000012
PM 21493417
DA 2018-12-27
ER

PT J
AU Ahmad, Z
   Ashraf, A
   Fryar, A
   Akhter, G
AF Ahmad, Zulfiqar
   Ashraf, Arshad
   Fryar, Alan
   Akhter, Gulraiz
TI RETRACTED: Composite use of numerical groundwater flow modeling and
   geoinformatics techniques for monitoring Indus Basin aquifer, Pakistan
   (Retracted article. See vol. 187, pg. 304, 2015)
SO ENVIRONMENTAL MONITORING AND ASSESSMENT
LA English
DT Article; Retracted Publication
DE Finite element modeling; Groundwater system; Chaj Doab; Remote sensing;
   GIS; Indus Basin
AB The integration of the Geographic Information System (GIS) with groundwater modeling and satellite remote sensing capabilities has provided an efficient way of analyzing and monitoring groundwater behavior and its associated land conditions. A 3-dimensional finite element model (Feflow) has been used for regional groundwater flow modeling of Upper Chaj Doab in Indus Basin, Pakistan. The approach of using GIS techniques that partially fulfill the data requirements and define the parameters of existing hydrologic models was adopted. The numerical groundwater flow model is developed to configure the groundwater equipotential surface, hydraulic head gradient, and estimation of the groundwater budget of the aquifer. GIS is used for spatial database development, integration with a remote sensing, and numerical groundwater flow modeling capabilities. The thematic layers of soils, land use, hydrology, infrastructure, and climate were developed using GIS. The Arcview GIS software is used as additive tool to develop supportive data for numerical groundwater flow modeling and integration and presentation of image processing and modeling results. The groundwater flow model was calibrated to simulate future changes in piezometric heads from the period 2006 to 2020. Different scenarios were developed to study the impact of extreme climatic conditions (drought/flood) and variable groundwater abstraction on the regional groundwater system. The model results indicated a significant response in watertable due to external influential factors. The developed model provides an effective tool for evaluating better management options for monitoring future groundwater development in the study area.
C1 [Ahmad, Zulfiqar; Akhter, Gulraiz] Quaid I Azam Univ, Dept Earth Sci, Islamabad, Pakistan.
   [Ashraf, Arshad] Natl Agr Res Ctr, Water Resources Res Inst, Islamabad, Pakistan.
   [Fryar, Alan] Univ Kentucky, Dept Earth & Environm Sci, Lexington, KY 40506 USA.
RP Ahmad, Z (reprint author), Quaid I Azam Univ, Dept Earth Sci, Islamabad, Pakistan.
EM fz97@hotmail.com; mashr22@yahoo.com; afryar1@email.uky.edu;
   agulraiz@qau.edu.pk
OI Fryar, Alan/0000-0003-2586-6858
CR Ahmad Z, 1999, PAKISTAN J HYDROCARB, V11, P1999
   Ahmad Z, 1997, J DRAINAGE WATER MAN, V1, P8
   Ahmad Z., 2001, P INT MOD C IGWMC MO
   Ahmad Z., 1997, PAKISTAN J HYDROCARB, V9, P91
   Ahmad Z, 2010, ENVIRON MONIT ASSESS, V166, P41, DOI 10.1007/s10661-009-0983-9
   Arora A. N., 2003, GIS IND 2003 NAT C G
   Ashraf A, 2008, GEOPHYS J INT, V173, P17, DOI 10.1111/j.1365-246X.2007.03708.x
   Bhutta M. N., 1996, P NAT C MAN IRR ENV, V1
   Doherty J, 1995, PEST VER 2 04
   ERDAS Inc, 2001, ERDAS IM V8 5
   Ghulam M, 2007, J ENV HYDROLOGY, V15, P1
   Josef F., 2004, INTEGRATION GIS GROU
   Kidwai Z. D., 1962, B WATER SOILS INVEST
   Pillmann W., 1990, P 5 S INF ENV PROT V
   PPSGDP Report, 2000, 39 PPSGDP GOV PUNJ I
   Qureshi M. K. A., 2003, REPORT GEOLOGY ENV C
   Saraf AK., 1997, P INT S EM TRENDS HY
   Sarwar A., 1999, DEV CONJUNCTIVE USE, P135
   Siddiqi J, 1999, EFFECT EL NINO AGR P
   Soil Survey Report, 1967, REC SOIL SURV GUJR D
   WASID, 1964, AN AQ TESTS PUNJ REG
   WASY, 2004, FEFL 5 1 FIN EL SUBS
NR 22
TC 6
Z9 6
U1 3
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0167-6369
EI 1573-2959
J9 ENVIRON MONIT ASSESS
JI Environ. Monit. Assess.
PD FEB
PY 2011
VL 173
IS 1-4
BP 447
EP 457
DI 10.1007/s10661-010-1398-3
PG 11
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 729VY
UT WOS:000287982000034
PM 20213054
DA 2018-12-27
ER

PT J
AU Chirica, I
   Musat, SD
   Chirica, R
   Beznea, EF
AF Chirica, Ionel
   Musat, Sorin Dumitru
   Chirica, Raluca
   Beznea, Elena-Felicia
TI RETRACTED: Torsional behaviour of the ship hull composite model
   (Retracted article. See vol. 109, pg. 403, 2015)
SO COMPUTATIONAL MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper; Retracted Publication
CT 19th International Workshop on Computational Mechanics of Materials
   (IWCMM 19)
CY SEP 01-04, 2009
CL Ovidius Univ Constanta, Constanta, ROMANIA
HO Ovidius Univ Constanta
DE Composites; Torsion; Ship hull model
ID THIN-WALLED-BEAMS; CROSS-SECTION; ELEMENT
AB In the paper, a new numerical and experimental methodology proposed to study the ship hull torsion is treated. The code TORS, made in accordance with the methodology was tested on the ship hull model made of composite materials. The results are compared with the FEM based licensed soft COSMOS/M and measurements on the scale model (1:50) of a container ship, made of composite materials. (C) 2010 Elsevier BM. All rights reserved.
C1 [Chirica, Ionel; Musat, Sorin Dumitru; Chirica, Raluca; Beznea, Elena-Felicia] Univ Dunarea Jos Galati, Galati 800008, Romania.
RP Chirica, I (reprint author), Univ Dunarea Jos Galati, 47 Domneasca Str, Galati 800008, Romania.
EM ionel.chirica@ugal.ro
CR Kaw K., 1997, MECH COMPOSITE MAT
   Lee J, 2005, COMPOS STRUCT, V70, P212, DOI 10.1016/j.compstruct.2004.08.023
   LIBRESCU L, 2006, THIN WALLED COMPOSIT
   Mitra M, 2004, INT J SOLIDS STRUCT, V41, P1491, DOI 10.1016/j.ijsolstr.2003.10.024
   Musat SD, 1999, INT J NUMER METH ENG, V44, P853, DOI 10.1002/(SICI)1097-0207(19990228)44:6<853::AID-NME534>3.0.CO;2-P
   PAPANGELIS JP, 1995, COMPUT STRUCT, V56, P157, DOI 10.1016/0045-7949(94)00545-E
   PEDERSEN PT, 1982, J SHIP RES, P171
   Prokic A, 2003, COMPUT STRUCT, V81, P39, DOI 10.1016/S0045-7949(02)00345-0
   SHAKOURZADEH H, 1995, COMPUT STRUCT, V55, P1045, DOI 10.1016/0045-7949(94)00509-2
   Tanaka Y, 2009, P 19 INT OFFSH POL E, P748
   Vlasov V Z, 1959, THIN WALLED ELASTIC
   Wright PNH, 2000, PLAST RUBBER COMPOS, V29, P549, DOI 10.1179/146580100101540761
   WU XX, 1991, AIAA J, V29, P736, DOI 10.2514/3.10648
NR 13
TC 10
Z9 11
U1 3
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-0256
EI 1879-0801
J9 COMP MATER SCI
JI Comput. Mater. Sci.
PD FEB
PY 2011
VL 50
IS 4
BP 1381
EP 1386
DI 10.1016/j.commatsci.2010.08.012
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 728UT
UT WOS:000287900700027
DA 2018-12-27
ER

PT J
AU Jang, KJ
   Kweon, DC
   Lee, JW
   Choi, J
   Goo, EH
   Dong, KR
   Lee, JS
   Jin, GH
   Seo, S
AF Jang, Keun Jo
   Kweon, Dae Cheol
   Lee, Jong-Woong
   Choi, Jiwon
   Goo, Eun-Hoe
   Dong, Kyung-Rae
   Lee, Jae-Seung
   Jin, Gye Hwan
   Seo, Sungbo
TI RETRACTED: Measurement of Image Quality in CT Images Reconstructed with
   Different Kernels (Retracted article. See vol. 67, pg. 1709, 2015)
SO JOURNAL OF THE KOREAN PHYSICAL SOCIETY
LA English
DT Article; Retracted Publication
DE Kernel; Image noise; SNR; PSNR; Computed tomography
ID MEDICAL IMAGES; ALGORITHM; ACCURACY; JPEG2000
AB This study measured the image quality obtained with different scanning and reconstruction kernels for computed tomography (CT) and sought methods for visualizing the abdominal and the bar phantoms. Our objective was to evaluate the image quality of spatial domain filtering as an alternative to additional image reconstruction using different kernels in CT. CT images were obtained using a 16-multidetector CT (MDCT) scanner and were reconstructed with various reconstruction kernels. Kernels were grouped as abdominal kernels. Image data sets were reconstructed using a very smooth (B10), smooth (B20), medium smooth (B30), medium (B40), medium sharp (B50), sharp (B60), very sharp (B70), and dedicated, ultra-sharp (B80) reconstruction kernel. The B20 and the B30 kernels provided better peak signal-to-noise ratio (PSNR), less root mean square error (RAISE), maximum absolute error (MAE), and reconstructed convolution kernels comparable to other kernels used as reconstruction kernels. The increase in the diagnostic accuracy of CT images obtained using the abdominal B20 and B30 kernels may be controlled by adjusting the various CT algorithms, to take into account the kernels of the CT algorithm undergoing the examination.
C1 [Jang, Keun Jo] Presbyterian Hosp, Dept Radiol, Jeonju 560750, South Korea.
   [Jang, Keun Jo; Choi, Jiwon] Jeonju Univ, Dept Radiol Sci, Jeonju 560759, South Korea.
   [Kweon, Dae Cheol] Shin Heung Coll Univ, Dept Radiol Sci, Uijongbu 480701, South Korea.
   [Lee, Jong-Woong] Kyung Hee Univ Hosp Gang Dong, Dept Radiol, Seoul 134727, South Korea.
   [Choi, Jiwon] Chonbuk Natl Univ, Sch Med, Dept Physiol, Jeonju 561756, South Korea.
   [Goo, Eun-Hoe] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea.
   [Goo, Eun-Hoe; Lee, Jae-Seung] Soonchunhyang Univ, Dept Phys, Asan 336745, South Korea.
   [Dong, Kyung-Rae] Gwangju Hlth Coll Univ, Dept Radiol Technol, Kwangju 501701, South Korea.
   [Dong, Kyung-Rae] Chosun Univ, Dept Nucl Engn, Kwangju 501759, South Korea.
   [Lee, Jae-Seung] Good Samaritan Hosp, Dept Radiat Oncol, Pohang 791704, South Korea.
   [Jin, Gye Hwan] Nambu Univ, Dept Radiol, Kwangju 506706, South Korea.
   [Seo, Sungbo] Elect & Telecommun Res Inst, Dept IT Convergence Serv Future Technol Res, Taejon 305700, South Korea.
RP Jang, KJ (reprint author), Presbyterian Hosp, Dept Radiol, Jeonju 560750, South Korea.
EM dckweon@gmail.com
FU Ministry of Knowledge Economy [10037283]
FX This work was supported by Grant No. 10037283 from the Industrial
   Strategic Technology Development Program funded by the Ministry of
   Knowledge Economy.
CR Al-Otum HM, 2003, J ELECTRON IMAGING, V12, P511, DOI 10.1117/1.1579701
   Armato SG, 2003, MED PHYS, V30, P461, DOI 10.1118/1.1544679
   Birnbaum BA, 2007, RADIOLOGY, V242, P109, DOI 10.1148/radiol.2421052066
   Boedeker KL, 2004, RADIOLOGY, V232, P295, DOI 10.1148/radiol.2321030383
   Budoff MJ, 2010, CARDIAC CT IMAGING: DIAGNOSIS OF CARDIOVASCULAR DISEASE, SECOND EDITION, P1, DOI 10.1007/978-1-84882-650-2
   Burrus C. S., 1998, INTRO WAVELETS WAVEL
   BUSHBERG JT, 2002, ESSENTIAL PHYS MED I, P312
   COSMAN PC, 1994, P IEEE, V82, P919, DOI 10.1109/5.286196
   Hu H, 1999, MED PHYS, V26, P5, DOI 10.1118/1.598470
   JUDY PF, 1985, BRIT J RADIOL, V58, P137, DOI 10.1259/0007-1285-58-686-137
   Kim DH, 2010, J KOREAN PHYS SOC, V56, P856, DOI 10.3938/jkps.56.856
   KULBIR S, 2009, INT J RECENT TRENDS, V2, P43
   Oh TH, 2003, 4TH NATIONAL CONFERENCE ON TELECOMMUNICATION TECHNOLOGY, PROCEEDINGS, P31, DOI 10.1109/NCTT.2003.1188296
   Prevrhal S, 1999, PHYS MED BIOL, V44, P751, DOI 10.1088/0031-9155/44/3/017
   Sakuldee R, 2007, PROC WRLD ACAD SCI E, V26, P434
   Schaller S, 2003, IEEE T MED IMAGING, V22, P846, DOI 10.1109/TMI.2003.815073
   SEERAM E, 1994, COMPUTED TOMOGRAPHY
   Shih TK, 2002, DISTRIBUTED MULTIMED
   SKODRAS AN, 2000, PATTERN RECOGNITION
   Strub WM, 2007, AM J ROENTGENOL, V189, pW115, DOI 10.2214/AJR.07.2244
   YOO BG, 2007, KOREAN J MED PHYS, V18, P55
NR 21
TC 11
Z9 11
U1 5
U2 13
PU KOREAN PHYSICAL SOC
PI SEOUL
PA 635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA
SN 0374-4884
EI 1976-8524
J9 J KOREAN PHYS SOC
JI J. Korean Phys. Soc.
PD FEB
PY 2011
VL 58
IS 2
BP 334
EP 342
DI 10.3938/jkps.58.334
PG 9
WC Physics, Multidisciplinary
SC Physics
GA 722IO
UT WOS:000287426100029
DA 2018-12-27
ER

PT J
AU Jung, JC
   Moon, HI
AF Jung, Jae-Chul
   Moon, Hyung-In
TI RETRACTED: Larvicidal activity of 4-hydroxycoumarin derivatives against
   Aedes aegypti (Retracted article. See vol. 50, pg. 1199, 2012)
SO PHARMACEUTICAL BIOLOGY
LA English
DT Article; Retracted Publication
DE Aedes aegypti; larvicidal effects; brodifacoum; cis-flocoumafen
AB Context: Coumarins are natural substances found in a variety of plants. It is well known that plant-derived natural products are extensively used as biologically active compounds. Among them, coumarins were the first preservatives used by man, originally in their natural state within plant tissues and then as natural materials obtained by water distillation. During our search for new types of coumarin derivatives possessing a larvicidal activity, we investigated the synthesis of 4-hydroxycoumarin derivatives.
   Objective: The coumarin derivatives were synthesized and the structure determination and larvicidal effects were studied.
   Materials and methods: The structure analyses were conducted by nuclear magnetic resonance (NMR), and mass (MS) spectroscopy revealed that the coumarin derivatives were obtained in good yields, and the eight coumarin derivatives were 3-{1,2,3,4-tetrahydro-3-[4-(4-trifluoromethylbenzyloxy)phenyl}-1-naphthalen-1-on (1), 3-{1,2,3,4-tetrahydro-3-[ 4-(4-trifluoromethylbenzyloxy) phenyl}-1-naphthalen-1-ol (2), brodifacoum (3), difethialone (4), bromadiolone (5), 4-hydroxy-3-(1,2,3,4-tetrahydronaphthalen-1-yl)-2H-chromen-2-one (coumatetralyl) (6), cis-flocoumafen (7) and trans-flocoumafen (8).
   Results: The compounds were tested against the F-21 laboratory strain of Aedes aegypti L. Brodifacoum and cis-flocoumafen mediated strong activity with an LC50 values of 8.23 and 9.34 ppm, respectively.
   Discussion and conclusion: The above indicates that brodifacoum may play a more important role in the toxicity of 4-hydroxycoumarin derivatives.
C1 [Moon, Hyung-In] Wonkwang Univ, Coll Med, Inam Neurosci Res Ctr, Sanbon Med Ctr, Kyonggi Do 435040, South Korea.
   [Moon, Hyung-In] Dongguk Univ, Coll Korean Med, Cardiovasc Med Res Ctr, Gyeong Ju, South Korea.
   [Jung, Jae-Chul] RexGene Biotech Co Ltd, Res & Dev Life Sci, Ochang, South Korea.
RP Moon, HI (reprint author), Wonkwang Univ, Coll Med, Inam Neurosci Res Ctr, Sanbon Med Ctr, Kyonggi Do 435040, South Korea.
EM himoon@wonkwang.ac.kr
CR Elhag EA, 2001, INDIAN VET J, V78, P199
   Jung JC, 2004, BIOORG MED CHEM LETT, V14, P5527, DOI 10.1016/j.bmcl.2004.09.009
   Knio KM, 2008, BIORESOURCE TECHNOL, V99, P763, DOI 10.1016/j.biortech.2007.01.026
   LEE SJ, 2010, IMMUNOPHARMACOL IMMU
   LIU XF, 2000, JINGIXI HUAGONG, V17, P39
   PARK YJ, 2010, IMMUNOPHARMACOL IMMU
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   Senthilkumar A, 2008, PARASITOL RES, V103, P959, DOI 10.1007/s00436-008-1085-2
   Stanchev S, 2008, EUR J MED CHEM, V43, P694, DOI 10.1016/j.ejmech.2007.05.005
   VANHEERDEN PS, 1987, J CHEM SOC P1, P1141
   *WHO, 1981, WHO VBC, V81, P807
   World Health Organisation, 1997, DENG HAEM FEV DIAGN
NR 12
TC 4
Z9 4
U1 2
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1388-0209
EI 1744-5116
J9 PHARM BIOL
JI Pharm. Biol.
PD FEB
PY 2011
VL 49
IS 2
BP 190
EP 193
DI 10.3109/13880209.2010.507769
PG 4
WC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
SC Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy
GA 724WM
UT WOS:000287607100011
PM 21043993
DA 2018-12-27
ER

PT J
AU Saba, T
   Sulong, G
   Rehman, A
AF Saba, T.
   Sulong, G.
   Rehman, A.
TI RETRACTED: Document image analysis: issues, comparison of methods and
   remaining problems (Retracted article. See vol. 42, pg. 1067, 2014)
SO ARTIFICIAL INTELLIGENCE REVIEW
LA English
DT Article; Retracted Publication
DE Image analysis; Noise removal; Wavelet transform; Skew estimation; Hough
   transform; Projection profile; Nearest neighbour; Cross correlation
ID HIGHLY CORRUPTED IMAGES; PEPPER NOISE REMOVAL; FAST SKEW DETECTION;
   IMPULSE NOISE; PRESERVING REGULARIZATION; VARIATIONAL APPROACH; PRINTED
   DOCUMENTS; HOUGH TRANSFORM; WAVELET-DOMAIN; MEDIAN FILTERS
AB Image analysis is an interesting research area with a large variety of challenging applications. Researchers have worked from decades on this topic, as witnessed by the scientific literature. However, document image analysis is the special case in image analysis as their spatial properties are different from natural images. Therefore, the main focus of this paper is to describe image denoising issues in general and document image issues in particular. Since the field of document processing is relatively new, it is also dynamic, so current methods have room for improvement and innovations are still being made. Several algorithms proposed in the literature are described. Critical discussions are reported about the current status of the field and open problems are highlighted. It is also demonstrated that, there are rarely definitive techniques for all cases of a certain problem. We surveyed the state of art, analyzed recent trends and tried to identify challenges for future research in this field.
C1 [Saba, T.; Sulong, G.; Rehman, A.] Univ Technol Malaysia, Dept Comp Graph & Multimedia, Fac Comp Sci & Informat Syst, Skudai Johor 81310, Malaysia.
RP Rehman, A (reprint author), Univ Technol Malaysia, Dept Comp Graph & Multimedia, Fac Comp Sci & Informat Syst, Skudai Johor 81310, Malaysia.
EM tanzilasaba@yahoo.com; ghazalis@utm.my; rkamjad@utm.my
OI Saba, Tanzila/0000-0003-3138-3801
CR Abdel-Dayem AR, 2004, LECT NOTES COMPUT SC, V3212, P191
   Abreu E, 1996, IEEE T IMAGE PROCESS, V5, P1012, DOI 10.1109/83.503916
   AKIYAMA T, 1990, PATTERN RECOGN, V23, P1141, DOI 10.1016/0031-3203(90)90112-X
   Ali M.B.H., 1996, P 13 INT C PATT REC, V3, P758, DOI 10.1109/ICPR.1996.547270
   Alkhatib H., 2008, 19 INT C PATT REC IC, P1
   Amin A, 2000, PATTERN ANAL APPL, V3, P243, DOI 10.1007/s100440070009
   Aradhya VNM, 2007, INT J ROBOT AUTOM, V22, P272, DOI 10.2316/Journal.206.2007.4.206-2992
   Arvind KR, 2007, LECT NOTES COMPUT SC, V4815, P495
   Avanindra, 1997, IEEE T IMAGE PROCESS, V6, P344
   AVILA BT, 2005, P 2005 ACM S DOC ENG
   Bagdanov A, 1997, PROCEEDINGS OF THE FOURTH INTERNATIONAL CONFERENCE ON DOCUMENT ANALYSIS AND RECOGNITION, VOLS 1 AND 2, P401, DOI 10.1109/ICDAR.1997.619878
   BAIRD HS, 1992, P IEEE, V80, P1059, DOI 10.1109/5.156469
   BAIRD HS, 1987, P SPSE 40 S HYBR IM, P739
   Bala E., 2002, P IEEE INT C IM PROC, V3, P581
   Barni M, 2000, IEEE T IMAGE PROCESS, V9, P1704, DOI 10.1109/83.869182
   Ben Hamza A, 1999, J MATH IMAGING VIS, V11, P161, DOI 10.1023/A:1008395514426
   Bharath AA, 2005, IEEE T IMAGE PROCESS, V14, P948, DOI 10.1109/TIP.2005.849295
   Billawala N., 1993, Proceedings of the Second International Conference on Document Analysis and Recognition (Cat. No.93TH0578-5), P53, DOI 10.1109/ICDAR.1993.395783
   BLOOMBERG DS, 1995, P SOC PHOTO-OPT INS, V2422, P302
   BOVIK AC, 1987, IEEE T ACOUST SPEECH, V35, P493, DOI 10.1109/TASSP.1987.1165153
   Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024
   Buccigrossi RW, 1999, IEEE T IMAGE PROCESS, V8, P1688, DOI 10.1109/83.806616
   Chan RH, 2005, IEEE T IMAGE PROCESS, V14, P1479, DOI 10.1109/TIP.2005.852196
   Chang SG, 2000, IEEE T IMAGE PROCESS, V9, P1522, DOI 10.1109/83.862630
   Chinnasarn K, 1998, APCCAS '98 - IEEE ASIA-PACIFIC CONFERENCE ON CIRCUITS AND SYSTEMS, P459, DOI 10.1109/APCCAS.1998.743809
   Choi H, 2004, IEEE SIGNAL PROC LET, V11, P717, DOI 10.1109/LSP.2004.833493
   Chou CH, 2007, PATTERN RECOGN, V40, P443, DOI 10.1016/j.patcog.2005.10.030
   Ciardiello G., 1988, P 9 INT C PATT REC, P739
   Dalong L., 2007, IEEE INT C IM PROC, V4, P425
   DARGHERTY E, 2003, HANDS ON MORPHOLOGIC
   DHANDRA BV, 2006, P 18 INT C PATT REC, V2, P954
   DONG YQ, 2006, ACTA SCI NATRULIUM U, V5
   Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.2307/2291512
   Fan LY, 2001, SIXTH INTERNATIONAL CONFERENCE ON DOCUMENT ANALYSIS AND RECOGNITION, PROCEEDINGS, P34, DOI 10.1109/ICDAR.2001.953750
   Gatos B, 1997, PATTERN RECOGN, V30, P1505, DOI 10.1016/S0031-3203(96)00157-4
   Gonzalez R., 2000, DIGITAL IMAGE PROCES
   Gorman L., 1993, IEEE T PATTERN ANAL, V15, P1162
   HASHIZUME A, 1986, PATTERN RECOGN LETT, V4, P125, DOI 10.1016/0167-8655(86)90034-6
   He K, 2008, 2008 INTERNATIONAL CONFERENCE ON EMBEDDED SOFTWARE AND SYSTEMS SYMPOSIA, PROCEEDINGS, P392, DOI 10.1109/ICESS.Symposia.2008.80
   HINDS J, 1990, P 10 INT C PATT REC, P464
   Hull J.J., 1998, DOCUMENT ANAL SYSTEM, V2, P40
   Ishitani Y., 1993, Proceedings of the Second International Conference on Document Analysis and Recognition (Cat. No.93TH0578-5), P49, DOI 10.1109/ICDAR.1993.395784
   Jain A, 1989, FUNDAMENTALS DIGITAL
   Jiang HF, 1997, PATTERN RECOGN LETT, V18, P675, DOI 10.1016/S0167-8655(97)00032-9
   Jiang X., 1999, P 5 INT C DOC AN REC, P629
   Jung A., 2001, P WORKSH GK NONL REG
   Jung K, 2004, PATTERN RECOGN, V37, P977, DOI 10.1016/j.patcog.2003.10.012
   KO SJ, 1991, IEEE T CIRCUITS SYST, V38, P984, DOI 10.1109/31.83870
   KUMAR J, 2007, IEEE TENCON, P1
   Kuo SS, 2002, IEEE T IMAGE PROCESS, V11, P509, DOI 10.1109/TIP.2002.1006398
   LE DS, 1994, PATTERN RECOGN, V27, P1325, DOI 10.1016/0031-3203(94)90068-X
   Li DL, 2009, IMAGE VISION COMPUT, V27, P623, DOI 10.1016/j.imavis.2008.06.006
   Lins RD, 2004, LECT NOTES COMPUT SC, V3212, P234
   LIOLIOS N, 2001, P INT C IM PROC THES, V1, P1098
   Lu Y, 2003, PATTERN RECOGN LETT, V24, P2315, DOI 10.1016/S0167-8655(03)00057-6
   Mahmoudi M, 2005, IEEE SIGNAL PROC LET, V12, P839, DOI 10.1109/LSP.2005.859509
   MAKRIDIS M, 2007, 9 INT C ADV CONC INT, P877
   MANJUNATH VN, 2006, INT J INF TECHNOL, V3, P194
   MOTWANI MC, 2004, P GLOB SIGN PROC EXP
   Nikolova M, 2004, J MATH IMAGING VIS, V20, P99, DOI 10.1023/B:JMIV.0000011920.58935.9c
   Ozawa H., 1993, Proceedings of the Second International Conference on Document Analysis and Recognition (Cat. No.93TH0578-5), P58, DOI 10.1109/ICDAR.1993.395782
   Pal U, 1996, PATTERN RECOGN LETT, V17, P899, DOI 10.1016/0167-8655(96)00042-6
   Pavlidis T., 1991, P 1 INT C DOC AN REC, P945
   PEAKE GS, 1997, IEEE INT C IM PROC, V2, P230
   PING Z, 2000, P 5 INT C SIGN PROC, V1, P472
   Post W., 1986, P 8 INT C PATT REC, P687
   RADU MV, 2007, P IS T SPIE S EL IM, V6502
   Romberg JK, 2001, IEEE T IMAGE PROCESS, V10, P1056, DOI 10.1109/83.931100
   SADRI J, 2009, P 10 INT C DOC AN RE, P1066, DOI DOI 10.1109/ICDAR.2009.268
   Saragiotis P, 2008, INT J PATTERN RECOGN, V22, P691, DOI 10.1142/S0218001408006417
   Sarfraz M, 2008, I C COMP GRAPH IM VI, P259, DOI 10.1109/CGIV.2008.10
   Sauvola J., 1995, P 9 SCAND C IM AN, P1099
   SEO HJ, 2007, 41 AS C SIGN SYST CO, P518
   SHARIF AE, 2008, J APPL SCI, V8, P2265
   SHIVAKUMARA P, 2002, P NAT WORKSH COMP VI, P39
   SHIVAKUMARA P, 2003, P NAT WORKSH IT SERV, P1
   Singh C, 2008, PATTERN RECOGN, V41, P3528, DOI 10.1016/j.patcog.2008.06.002
   Spitz AL, 1997, IEEE T PATTERN ANAL, V19, P235, DOI 10.1109/34.584100
   Srihari S. N., 1989, Machine Vision and Applications, V2, P141, DOI 10.1007/BF01212455
   Sun CM, 1997, PROCEEDINGS OF THE FOURTH INTERNATIONAL CONFERENCE ON DOCUMENT ANALYSIS AND RECOGNITION, VOLS 1 AND 2, P142, DOI 10.1109/ICDAR.1997.619830
   SUN T, 1994, PATTERN RECOGN LETT, V15, P341, DOI 10.1016/0167-8655(94)90082-5
   Teboul S, 1998, IEEE T IMAGE PROCESS, V7, P387, DOI 10.1109/83.661189
   Wang JR, 1997, PATTERN RECOGN, V30, P503, DOI 10.1016/S0031-3203(96)00081-7
   Wang Z, 1999, IEEE T CIRCUITS-II, V46, P78, DOI 10.1109/82.749102
   Xie JC, 2004, IEEE T IMAGE PROCESS, V13, P179, DOI [10.1109/TIP.2004.823828, 10.1109/tip.2004.823828]
   XINGMEI L, 2007, 2 WORKSH DIG MED ITS, P53
   Yin PY, 2001, IMAGE VISION COMPUT, V19, P567, DOI 10.1016/S0262-8856(00)00098-6
   YOON M, 1995, 3 INT C DOC AN REC, V2, P677
   Yu B, 1996, PATTERN RECOGN, V29, P1599, DOI 10.1016/0031-3203(96)00020-9
   Zhang SQ, 2002, IEEE SIGNAL PROC LET, V9, P360, DOI 10.1109/LSP.2002.805310
   ZHENG Q, 2001, INT C IM PROC, V1, P193
   Zhong JM, 2005, IEEE T IMAGE PROCESS, V14, P1435, DOI 10.1109/TIP.2005.849313
   Zhou J, 2002, PATTERN RECOGN, V35, P1179, DOI 10.1016/S0031-3203(01)00109-1
   ZHOU X, 2006, IEEE INT S EL INS, P237
   Zhu XY, 2002, INT C PATT RECOG, P480, DOI 10.1109/ICPR.2002.1044768
NR 95
TC 16
Z9 16
U1 2
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0269-2821
EI 1573-7462
J9 ARTIF INTELL REV
JI Artif. Intell. Rev.
PD FEB
PY 2011
VL 35
IS 2
BP 101
EP 118
DI 10.1007/s10462-010-9186-6
PG 18
WC Computer Science, Artificial Intelligence
SC Computer Science
GA 723JM
UT WOS:000287502700001
DA 2018-12-27
ER

PT J
AU Mengistu, AM
   Mayer, J
   Boldt, J
   Rohm, KD
   Suttner, SW
AF Mengistu, Andinet M.
   Mayer, Jochen
   Boldt, Joachim
   Roehm, Kerstin D.
   Suttner, Stefan W.
TI RETRACTED: Usefulness of Monitoring Platelet Function by Multiple
   Electrode Aggregometry in Primary Coronary Artery Bypass Surgery
   (Retracted article. See vol. 25, pg. 757, 2011)
SO JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
LA English
DT Article; Retracted Publication
DE multiple-electrode aggregometry; acetylsalicylic acid; clopidogrel;
   point of care; cardiac surgery; platelet function
ID OF-THORACIC-SURGEONS; CARDIAC-SURGERY; CARDIOPULMONARY BYPASS;
   WHOLE-BLOOD; PREOPERATIVE ASPIRIN; PRACTICE GUIDELINE; FUNCTION
   ANALYZER; GRAFT-SURGERY; TRANSFUSION; CLOPIDOGREL
AB Objectives: Antiplatelet therapy is commonly used for the prevention of cardiovascular complications but increases the risk of perioperative bleeding. Multiple-electrode aggregometry (MEA) was investigated for monitoring platelet inhibition by acetylsalicylic acid (ASA) and clopidogrel in patients undergoing elective coronary artery bypass graft (CABG) surgery with regard to clinical outcome as measured by postoperative blood loss and transfusion requirements.
   Design: A prospective observational study.
   Setting: A teaching hospital.
   Participants: One hundred fifty patients scheduled for elective CABG surgery were included: without antiplatelet therapy (group A, n = 50), single ASA exposure (group B, n = 50), and combined therapy with ASA and clopidogrel (group C, n = 50).
   Measurements and Main Results: MEA was assessed preoperatively using either collagen (COL-MEA) or ADP (ADP-MEA). Postoperative blood loss and transfusion requirements were recorded for 24 hours after surgery. Postoperative blood loss significantly increased only from combined antiplatelet therapy (group A: 572 +/- 297 mL, group B: 721 +/- 356 mL, group C: 865 +/- 346, p < 0.01) and correlated with ADP (r(p) = -0.35, p < 0.01) and COL-MEA (r(p) = -0.23, p > 0.01). COL-MEA and ADP-MEA discriminated between preoperative ASA and clopidogrel intake (ASA: sensitivity = 86.3%, and specificity = 89.3%; clopidogrel: sensitivity = 87.5%, and specificity = 95.1%). The postoperative transfusion risk was increased in patients diagnosed for clopidogrel treatment by ADP-MEA (odds ratio = 2.92; confidence interval: 1.44-5.92; p = 0.005).
   Conclusions: MEA is a suitable method for the detection of platelet inhibition by ASA and clopidogrel in patients undergoing CABG surgery. In these patients, preoperative ADP MEA seems to indicate patients at risk for postoperative transfusion requirements. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Mengistu, Andinet M.; Mayer, Jochen; Boldt, Joachim; Roehm, Kerstin D.; Suttner, Stefan W.] Klinikum Ludwigshafen, Dept Anesthesiol & Intens Care Med, D-67063 Ludwigshafen, Germany.
RP Mengistu, AM (reprint author), Klinikum Ludwigshafen, Dept Anesthesiol & Intens Care Med, Bremserstr 79, D-67063 Ludwigshafen, Germany.
EM a.mengistu@gmx.de
CR Baigent C, 2002, BRIT MED J, V324, P71
   Banbury MK, 2006, J AM COLL SURGEONS, V202, P131, DOI 10.1016/j.jamcollsurg.2005.08.028
   Cattaneo M, 1999, ARTERIOSCL THROM VAS, V19, P2281, DOI 10.1161/01.ATV.19.10.2281
   Clemetson KJ, 2001, THROMB HAEMOSTASIS, V86, P189
   Dietrich GV, 1998, THROMB RES, V89, P295, DOI 10.1016/S0049-3848(98)00020-6
   Dropinski J, 2007, THROMB HAEMOSTASIS, V98, P201, DOI 10.1160/TH06-12-0722
   Eagle Kim A, 2004, Circulation, V110, pe340
   Engoren MC, 2002, ANN THORAC SURG, V74, P1180, DOI 10.1016/S0003-4975(02)03766-9
   Fattorutto M, 2003, BRIT J ANAESTH, V90, P692, DOI 10.1093/bja/aeg110
   Ferraris VA, 2005, ANN THORAC SURG, V79, P1454, DOI 10.1016/j.athoracsur.2005.01.008
   Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099
   Filsoufi F, 2008, J CARDIOTHOR VASC AN, V22, P60, DOI 10.1053/j.jvca.2007.10.009
   Forestier F, 2002, BRIT J ANAESTH, V89, P715, DOI 10.1093/bja/aef250
   Hall TS, 2002, CARDIOVASC SURG, V10, P146, DOI 10.1016/S0967-2109(01)00129-6
   Kang Wade, 2007, J Surg Educ, V64, P88, DOI 10.1016/j.jsurg.2006.10.003
   McGrath T, 2008, ANN THORAC SURG, V86, P543, DOI 10.1016/j.athoracsur.2008.04.051
   Mengistu AM, 2008, J CARDIOTHOR VASC AN, V22, P40, DOI 10.1053/j.jvca.2007.02.015
   Mueller T, 2009, CLIN APPL THROMB-HEM, V15, P652, DOI 10.1177/1076029608322547
   Nylander S, 2003, BLOOD COAGUL FIBRIN, V14, P159, DOI 10.1097/01.mbc.0000046190.72384.8c
   Paparella D, 2004, INTENS CARE MED, V30, P1873, DOI 10.1007/s00134-004-2388-0
   Rahe-Meyer N, 2009, ACTA ANAESTH SCAND, V53, P168, DOI 10.1111/j.1399-6576.2008.01845.x
   Rahe-Meyer N, 2008, ANESTH ANALG, V107, P1791, DOI 10.1213/ane.0b013e3181865733
   Ray JG, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-3
   RAY MJ, 1994, BLOOD COAGUL FIBRIN, V5, P679, DOI 10.1097/00001721-199410000-00002
   Savi P, 2001, BIOCHEM BIOPH RES CO, V283, P379, DOI 10.1006/bbrc.2001.4816
   Shenkman B, 2008, THROMB RES, V122, P336, DOI 10.1016/j.thromres.2007.10.018
   Spiess BD, 2004, TRANSFUSION, V44, P1143, DOI 10.1111/j.1537-2995.2004.03322.x
   Sun JCJ, 2008, EUR HEART J, V29, P1057, DOI 10.1093/eurheartj/ehn104
   VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0
   Velik-Salchner C, 2009, ANESTH ANALG, V108, P1747, DOI 10.1213/ane.0b013e3181a198ac
NR 30
TC 8
Z9 9
U1 2
U2 12
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1053-0770
EI 1532-8422
J9 J CARDIOTHOR VASC AN
JI J. Cardiothorac. Vasc. Anesth.
PD FEB
PY 2011
VL 25
IS 1
BP 42
EP 47
DI 10.1053/j.jvca.2010.02.008
PG 6
WC Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System;
   Peripheral Vascular Disease
SC Anesthesiology; Cardiovascular System & Cardiology; Respiratory System
GA 717RN
UT WOS:000287065200008
PM 20427204
DA 2018-12-27
ER

PT J
AU Shen, HJ
AF Shen, Haijun
TI RETRACTED: Kinetic resistance of carbon nanotubes in aqueous solution
   (Retracted article. See vol. 13, pg. 732, 2018)
SO MICRO & NANO LETTERS
LA English
DT Article; Retracted Publication
ID NUCLEIC-ACIDS; SIMULATION; WATER; PROTEINS
AB By using the molecular dynamics (MD) method, the deceleration of (5,5), (7,7), (10,10) and (5,5)/(10,10) carbon nanotubes is first simulated in aqueous solution; their curves of resistance-velocity and resistance-Reynolds (Re) number are also obtained; then the MD results are compared with the macroscopic fluid dynamics (FD) ones of circular cylinder in aqueous solution for low Re numbers. It is shown that, in aqueous solution, the kinetic resistance of the carbon tubes only rests with their Re number, that, under the low Re numbers, the resistance of the carbon tubes in aqueous solution is higher than the macroscopic FD results by several ten times, and that the kinetic resistance of carbon tubes can be estimated through the macroscopic FD results multiplied by (17.1720.19 Re).
C1 Tongji Univ, Sch Aeronaut & Mech, Shanghai 200093, Peoples R China.
RP Shen, HJ (reprint author), Tongji Univ, Sch Aeronaut & Mech, Shanghai 200093, Peoples R China.
EM shj@tongji.edu.cn
CR CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002
   Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0
   FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149
   Ha SN, 1988, CARBOHYD RES, V180, P207, DOI 10.1016/0008-6215(88)80078-8
   HENK W, 2001, SCIENCE, V293, P76
   HOON H, 2007, ENVIRON SCI TECHNOL, V41, P179
   *HYP INC, 2001, HYPERCHEM7 0 US HDB
   JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   MACKERELL AD, 1995, J AM CHEM SOC, V117, P11946, DOI 10.1021/ja00153a017
   Nelson TR, 2010, J PHYS CHEM B, V114, P4609, DOI 10.1021/jp912233e
   Qiu KD, 2006, ACTA PHYS-CHIM SIN, V22, P1542, DOI 10.3866/PKU.WHXB20061221
   SCHLENKRICH M, 1996, MEMBRANE STRUCTURE D, P31
   [沈海军 SHEN Haijun], 2006, [石油化工高等学校学报, Journal of Petrochemical Universities], V19, P60
   [沈海军 Shen Haijun], 2004, [计算机与应用化学, Computers and Applied Chemistry], V21, P485
   [沈海军 Shen Haijun], 2005, [材料科学与工程学报, Journal Materials Science and Engineering], V23, P321
   SHEN HJ, 2006, MATER LETT, V62, P527
   THOMASA AJ, 2010, INT J THERM SCI, V49, P281
   Tritton DJ, 1977, PHYS FLUID DYNAMICS
   Walther JH, 2004, CARBON, V42, P1185, DOI 10.1016/j.carbon.2003.12.071
   Walther JH, 2001, J PHYS CHEM B, V105, P9980, DOI 10.1021/jp011344u
   Wang Y, 2007, CHINESE PHYS LETT, V24, P3276
   YAN Z, 2002, THEORY LOW RENAULT N
NR 23
TC 1
Z9 1
U1 4
U2 5
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1750-0443
J9 MICRO NANO LETT
JI Micro Nano Lett.
PD FEB
PY 2011
VL 6
IS 2
BP 66
EP 69
DI 10.1049/mnl.2010.0188
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 712GK
UT WOS:000286654000002
DA 2018-12-27
ER

PT J
AU Ochalski, ME
   Shuttleworth, JJ
   Chu, TJ
   Orwig, KE
AF Ochalski, Melanie E.
   Shuttleworth, Jennifer J.
   Chu, Tianjiao
   Orwig, Kyle E.
TI RETRACTED: Thalidomide treatment attenuates chemotherapy-induced gonadal
   toxicity (Retracted article. See vol. 103, pg. 863, 2015)
SO FERTILITY AND STERILITY
LA English
DT Editorial Material; Retracted Publication
DE Thalidomide; gonadal protection; chemotherapy-induced gonadal failure;
   alkylating chemotherapy; busulfan; fertility; ovarian follicles
ID MOUSE OVARY; CYCLE; MICE
AB The aim of this study was to investigate gonadal-protective properties of thalidomide in a mouse model of chemotherapy-induced ovarian failure. Administration of thalidomide before alkylating chemotherapy preserved ovarian follicles and lead to the resumption of normal estrous cyclicity. (Fertil Steril (R) 2011;95:819-22. (C)2011 by American Society for Reproductive Medicine.)
C1 [Ochalski, Melanie E.; Shuttleworth, Jennifer J.; Chu, Tianjiao; Orwig, Kyle E.] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA.
RP Ochalski, ME (reprint author), Univ Pittsburgh, Magee Womens Hosp, 300 Halket St, Pittsburgh, PA 15213 USA.
EM ochamm@upmc.edu
OI Orwig, Kyle/0000-0002-7952-8419
FU American Medical Association; Magee-Womens Research Institute and
   Foundation (MWRI F); National Institutes of Health [RR018500, AG024992,
   HD055475, HD008610]; University of Virginia Ligand Core Laboratory
   [U54-HD28934]
FX M.E.O. was supported by an American Medical Association seed grant and a
   Irene McLenahan Young Investigator Award from Magee-Womens Research
   Institute and Foundation (MWRI& F). K.E.O. was funded by National
   Institutes of Health grant nos. RR018500, AG024992, HD055475, and
   HD008610 as well as discretionary funds from MWRI& F.; The authors thank
   Tony Battelli and Mike Bodenheimier for rodent colony maintenance and
   Meena Sukhwani for help with busulfan administration. FSH assays were
   performed by the University of Virginia Ligand Core Laboratory (grant
   no. U54-HD28934).
CR Allen E, 1922, AM J ANAT, V30, P297, DOI 10.1002/aja.1000300303
   Badawy A, 2009, FERTIL STERIL, V91, P694, DOI 10.1016/j.fertnstert.2007.12.044
   Bolon B, 1997, FUND APPL TOXICOL, V39, P1, DOI 10.1006/faat.1997.2338
   Charleston JS, 2007, HUM REPROD, V22, P2103, DOI 10.1093/humrep/dem137
   Dharia SP, 2004, FERTIL STERIL, V82, P460, DOI 10.1016/j.fertnstert.2003.12.038
   Fekete E, 1941, BIOL LABORATORY MOUS, P89
   GENEROSO WM, 1971, MUTAT RES, V13, P171, DOI 10.1016/0027-5107(71)90010-8
   Gougeon A, 2010, ENDOCRINOLOGY, V151, P1299, DOI 10.1210/en.2009-0762
   Horner MJ, 2010, SEER CANC STAT REV 1
   MATTISON DR, 1983, ENVIRON HEALTH PERSP, V48, P43, DOI 10.2307/3429451
   Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095
   NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327
   Oktay K, 2007, ONCOLOGIST, V12, P1055, DOI 10.1637/theoncologist.12-9-1055
   PEDERSEN T, 1968, J REPROD FERTIL, V17, P555
   Teo SK, 2005, AAPS J, V7, pE14, DOI 10.1208/aapsj070103
   Teo SK, 2005, DRUG DISCOV TODAY, V10, P107, DOI 10.1016/S1359-6446(04)03307-0
NR 16
TC 4
Z9 5
U1 4
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD FEB
PY 2011
VL 95
IS 2
BP 819
EP 822
DI 10.1016/j.fertnstert.2010.09.020
PG 4
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 709EA
UT WOS:000286419000094
PM 20889152
DA 2018-12-27
ER

PT J
AU Pastva, AM
   Walker, JKL
   Maddox, LA
   Mukherjee, S
   Giamberardino, C
   Hsia, B
   Potts, E
   Zhu, HM
   Degan, S
   Sunday, ME
   Lawson, BL
   Korfhagen, TR
   Schwartz, DA
   Eu, JP
   Foster, WM
   McMahon, TJ
   Que, L
   Wright, JR
AF Pastva, Amy M.
   Walker, Julia K. L.
   Maddox, Lee A.
   Mukherjee, Sambuddho
   Giamberardino, Charles
   Hsia, Bethany
   Potts, Erin
   Zhu, Hongmei
   Degan, Simone
   Sunday, Mary E.
   Lawson, Barbara L.
   Korfhagen, Thomas R.
   Schwartz, David A.
   Eu, Jerry P.
   Foster, William M.
   McMahon, Timothy J.
   Que, Loretta
   Wright, Jo Rae
TI RETRACTED: Nitric Oxide Mediates Relative Airway Hyporesponsiveness to
   Lipopolysaccharide in Surfactant Protein A-Deficient Mice(Retracted
   article. See vol.55, pg.758,2016)
SO AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
LA English
DT Article; Retracted Publication
DE surfactant protein A; lipopolysaccharide; airway responsiveness
ID S-NITROSYLATION; UNITED-STATES; MURINE MODEL; IN-VIVO; SP-B; ASTHMA;
   MICE; INFLAMMATION; HYPERRESPONSIVENESS; POLYMORPHISMS
AB Surfactant protein A (SP-A) mediates innate immune cell responses to LPS, a cell wall component of gram-negative bacteria that is found ubiquitously in the environment and is associated with adverse health effects. Inhaled LPS induces lung inflammation and increases airway responsiveness (AR). However, the role of SP-A in mediating LPS-induced AR is not well-defined. Nitric oxide (NO) is described as a potent bronchodilator, and previous studies showed that SP-A modulates the LPS-induced production of NO. Hence, we tested the hypothesis that increased AR, observed in response to aerosolized LPS exposure, would be significantly reduced in an SP-A-deficient condition. Wild-type (WT) and SP-A null (SP-A(-/-)) mice were challenged with aerosolized LPS. Results indicate that despite similar inflammatory indices, LPS-treated SP-A(-/-) mice had attenuated AR after methacholine challenge, compared with WT mice. The attenuated AR could not be attributed to inherent differences in SP-D concentrations or airway smooth muscle contractile and relaxation properties, because these measures were similar between WT and SP-A(-/-) mice. LPS-treated SP-A(-/-) mice, however, had elevated nitrite concentrations, inducible nitric oxide synthase (iNOS) expression, and NOS activity in their lungs. Moreover, the administration of the iNOS-specific inhibitor 1400W completely abrogated the attenuated AR. Thus, when exposed to aerosolized LPS, SP-A(-/-) mice demonstrate a relative airway hyporesponsiveness that appears to be mediated at least partly via an iNOS-dependent mechanism. These findings may have clinical significance, because recent studies reported associations between surfactant protein polymorphisms and a variety of lung diseases.
C1 [Pastva, Amy M.; Walker, Julia K. L.; Maddox, Lee A.; Mukherjee, Sambuddho; Giamberardino, Charles; Hsia, Bethany; Potts, Erin; Zhu, Hongmei; Degan, Simone; Sunday, Mary E.; Lawson, Barbara L.; Eu, Jerry P.; Foster, William M.; McMahon, Timothy J.; Que, Loretta; Wright, Jo Rae] Duke Univ, Med Ctr, Durham, NC 27710 USA.
   [Korfhagen, Thomas R.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA.
   [Schwartz, David A.] Natl Jewish Med & Res Ctr, Denver, CO USA.
RP Pastva, AM (reprint author), Duke Univ, Med Ctr, Box 3709, Durham, NC 27710 USA.
EM amy.pastva@duke.edu
RI McMahon, Timothy/K-3986-2012; Walker, Julia/R-7585-2017
OI McMahon, Timothy/0000-0002-3404-3223; Sunday, Mary
   E./0000-0002-6788-1469
FU National Institutes of Health [1K08-AI068822, 5P50HL084917,
   5R01HL068072, 5R01HL058795, 1P30ES011961, VAMC 5R01HL084123,
   5R01HL081285, 5R01HL086887-03, HL-079915, AI-051445, 5P30ES011961]; Ono
   Pharmaceutics; Amgen; Novartis; Roche; Auxilium; American Asthma
   Foundation; Veterans Administration
FX This work was supported by National Institutes of Health grants
   1K08-AI068822 (A. M. P.), 5P50HL084917 (J.R.W., W. M. F., A. M. P., E.
   P., B. H., S. M., C. G., S. D., and M. E. S.), 5R01HL068072 (J.R.W. and
   L. A. M.), 5R01HL058795 (T. R. K.), 1P30ES011961 (D. A. S., J.R.W., and
   W. M. F.), 5R01HL084123 (J.K.L.W.), VAMC (J.K.L.W.), 5R01HL081285
   (J.P.E.), 5R01HL086887-03 (L. Q.), and HL-079915 (T.J.M.).; A.M.P. has
   received sponsored grants from the National Institutes of Health (more
   than $ 100,001). J.K.L.W. holds stock ownership/options for Johnson &
   Johnson (less than $ 5,000), General Electric (less than $ 1,000),
   Kimberly Clark (less than $ 5,000), and 3M (less than $ 5,000). L. A. M.
   holds stock ownership/options with Pfizer (less than $ 1,000) and
   General Electric (less than $ 1,000), and is an employee of the National
   Institutes of Health. C. G. received compensation for serving as an
   expert witness with Wallace and Graham ($ 10,001-$ 50,000), Brayton and
   Purcell ($ 5,001-$ 10,000), Weitz and Luxemberg ($ 50,001-$ 100,000),
   and Waters and Kraus ($ 10,001-$ 50,000), has a patent pending with
   Medimmune for TLR4 hyporesponsive polymorphisms used in respiratory
   syncytial virus vaccine research (less than $ 10,000), and is an
   employee at the National Institutes of Health and National Jewish
   Health. B. H. has received sponsored grants from the National Institutes
   of Health (more than $ 100,001). M. E. S. has received lecture fees from
   Ono Pharmaceutics. T. R. K. is an employee at the York Technical
   Institute (YTI). The spouse of D. A. S. has received industry-sponsored
   grants from Amgen (less than $ 1,000), Eli Lily (less than $ 5,000),
   Novartis (less than $ 5,000), Roche (less than $ 1,000), and Auxilium
   (less than $ 1,000), and has a patent pending with Duke University
   (Reference Number 2809 for Use of Imipramine to Treat Asthma). T.J.M.
   recently filed two new patents via Duke University, which involve the
   use of gastrin-releasing peptide blockade to treat asthma or any
   inflammatory condition, and she has not yet communicated with any
   commercial entity regarding these pending patents. She also received
   sponsored grants from the National Institutes of Health (more than $
   100,000) and the American Asthma Foundation (more than $ 100,000). M. E.
   S. also has a patent pending with the Polycystic Kidney Disease
   Foundation (pending application from a previous grant sponsor) and from
   University of California Santa Barbara (pending application from a
   previous research laboratory). L. Q. has received funding from the
   National Institutes of Health (more than $ 100,000). J.R.W. holds the
   license to patent in which he is a co-inventor from N30 Pharma, LLC, and
   has received sponsored grants from the National Institutes of Health
   (more than $ 100,000) and the Veterans Administration (more than $
   100,000). None of the other authors have a financial relationship with a
   commercial entity that has an interest in the subject of this
   manuscript.; The Duke Human Vaccine Institute Flow Cytometry Core
   Facility is supported by National Institutes of Health grant AI-051445.
   The LPS aerosol exposures and airway physiologic measurements were
   performed in the Inhalational Toxicology Core of the Duke Center for
   Comparative Biology of Vulnerable Populations, which is supported by
   National Institutes of Health grant 5P30ES011961.
CR Alcorn JF, 2004, AM J PHYSIOL-LUNG C, V286, pL129, DOI 10.1152/ajplung.00427.2002
   Atochina EN, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-15
   Becker S, 2002, AM J RESP CELL MOL, V27, P611, DOI 10.1165/rcmb.4868
   Blease K, 2000, INFLAMM RES, V49, P297, DOI 10.1007/PL00000210
   Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840
   Cook DN, 2003, CHEST, V123, p369S, DOI 10.1378/chest.123.3_suppl.369S
   De Sanctis GT, 1999, J EXP MED, V189, P1621, DOI 10.1084/jem.189.10.1621
   DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401
   Du WL, 2005, J BIOL CHEM, V280, P26287, DOI 10.1074/jbc.M502925200
   Floros J, 2009, CRIT REV EUKAR GENE, V19, P125, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.30
   Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5
   GARANTZIOTIS S, 2009, AM J RESP C IN PRESS
   Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP
   Guo XX, 2000, CHEST, V117, p249S, DOI 10.1378/chest.117.5_suppl_1.249S-a
   Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569
   HUNT J, 1995, LANCET, V346, P1235, DOI 10.1016/S0140-6736(95)92947-9
   Kacmarek RM, 1996, AM J RESP CRIT CARE, V153, P128, DOI 10.1164/ajrccm.153.1.8542105
   Kharitonov SA, 2001, AM J RESP CRIT CARE, V164, P727, DOI 10.1164/ajrccm.164.5.2106122c
   Kline JN, 1999, AM J RESP CRIT CARE, V160, P297, DOI 10.1164/ajrccm.160.1.9808144
   Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594
   LeVine AM, 1999, AM J RESP CELL MOL, V20, P279, DOI 10.1165/ajrcmb.20.2.3303
   LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254
   LeVine AM, 1999, J CLIN INVEST, V103, P1015, DOI 10.1172/JCI5849
   LIEW FY, 1991, EUR J IMMUNOL, V21, P2489, DOI 10.1002/eji.1830211027
   Lin Z, 2000, CLIN GENET, V58, P181, DOI 10.1034/j.1399-0004.2000.580305.x
   Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X
   Mulrennan Siobhan A, 2004, Treat Respir Med, V3, P79, DOI 10.2165/00151829-200403020-00002
   Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW
   Piantadosi CA, 2004, ANN INTERN MED, V141, P460, DOI 10.7326/0003-4819-141-6-200409210-00012
   Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646
   Prado CM, 2006, AM J RESP CELL MOL, V35, P457, DOI 10.1165/rcmb.2005-0391OC
   Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228
   Sano H, 1999, J IMMUNOL, V163, P387
   SCHMIDT HHHW, 1992, MOL PHARMACOL, V41, P615
   Schwartz DA, 2001, AM J RESP CRIT CARE, V163, P305, DOI 10.1164/ajrccm.163.2.ed2000a
   STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674
   Stamme C, 2002, AM J RESP CELL MOL, V27, P353, DOI 10.1165/rcmb.4812
   STUEHR DJ, 1985, P NATL ACAD SCI USA, V82, P7738, DOI 10.1073/pnas.82.22.7738
   Takeda K, 2003, AM J RESP CRIT CARE, V168, P783, DOI 10.1164/rccm.200304-548OC
   Trifilieff A, 2000, J IMMUNOL, V165, P1526, DOI 10.4049/jimmunol.165.3.1526
   VANIWAARDEN JF, 1994, BIOCHEM J, V303, P407, DOI 10.1042/bj3030407
   Wagers SS, 2007, J APPL PHYSIOL, V102, P221, DOI 10.1152/japplphysiol.01385.2005
   Walker JKL, 2004, AM J PHYSIOL-LUNG C, V286, pL312, DOI 10.1152/ajplung.00255.2003
   Wang GR, 2003, BIOCHEM J, V369, P179, DOI 10.1042/BJ20021376
   Weber B, 2000, TURKISH J PEDIATR, V42, P181
   Wills-Karp M, 2003, CURR OPIN PULM MED, V9, P21, DOI 10.1097/00063198-200301000-00004
   Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528
   Xiong YL, 1999, J IMMUNOL, V162, P445
NR 48
TC 5
Z9 6
U1 2
U2 7
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1044-1549
EI 1535-4989
J9 AM J RESP CELL MOL
JI Am. J. Respir. Cell Mol. Biol.
PD FEB
PY 2011
VL 44
IS 2
BP 175
EP 184
DI 10.1165/rcmb.2009-0284OC
PG 10
WC Biochemistry & Molecular Biology; Cell Biology; Respiratory System
SC Biochemistry & Molecular Biology; Cell Biology; Respiratory System
GA 753KJ
UT WOS:000289771700006
PM 20348208
OA Green Published
DA 2018-12-27
ER

PT J
AU Sensenig, R
   Kalghatgi, S
   Cerchar, E
   Fridman, G
   Shereshevsky, A
   Torabi, B
   Arjunan, KP
   Podolsky, E
   Fridman, A
   Friedman, G
   Azizkhan-Clifford, J
   Brooks, AD
AF Sensenig, Rachel
   Kalghatgi, Sameer
   Cerchar, Ekaterina
   Fridman, Gregory
   Shereshevsky, Alexey
   Torabi, Behzad
   Arjunan, Krishna Priya
   Podolsky, Erica
   Fridman, Alexander
   Friedman, Gary
   Azizkhan-Clifford, Jane
   Brooks, Ari D.
TI RETRACTED: Non-thermal Plasma Induces Apoptosis in Melanoma Cells via
   Production of Intracellular Reactive Oxygen Species (Retracted article.
   See vol. 41, pg. 656, 2013)
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Apoptosis; Non-thermal plasma; Reactive oxygen species; Cancer therapy;
   Plasma medicine
ID DIELECTRIC BARRIER DISCHARGE; OF-THE-ART; ATMOSPHERIC-PRESSURE;
   RADIATION-THERAPY; BLOOD-COAGULATION; NEEDLE; ELECTROCAUTERY; BACTERIA;
   TORCH; DECONTAMINATION
AB Non-thermal atmospheric pressure dielectric barrier discharge (DBD) plasma may provide a novel approach to treat malignancies via induction of apoptosis. The purpose of this study was to evaluate the potential of DBD plasma to induce apoptosis in melanoma cells. Melanoma cells were exposed to plasma at doses that did not induce necrosis, and cell viability and apoptotic activity were evaluated by Trypan blue exclusion test, Annexin-V/PI staining, caspase-3 cleavage, and TUNEL (R) analysis. Trypan blue staining revealed that non-thermal plasma treatment significantly decreased the viability of cells in a dose-dependent manner 3 and 24 h after plasma treatment. Annexin-V/PI staining revealed a significant increase in apoptosis in plasma-treated cells at 24, 48, and 72 h post-treatment (p < 0.001). Caspase-3 cleavage was observed 48 h post-plasma treatment at a dose of 15 J/cm(2). TUNEL (R) analysis of plasma-treated cells demonstrated an increase in apoptosis at 48 and 72 h post-treatment (p < 0.001) at a dose of 15 J/cm(2). Pre-treatment with N-acetyl-L-cysteine (NAC), an intracellular reactive oxygen species (ROS) scavenger, significantly decreased apoptosis in plasma-treated cells at 5 and 15 J/cm(2). Plasma treatment induces apoptosis in melanoma cells through a pathway that appears to be dependent on production of intracellular ROS. DBD plasma production of intracellular ROS leads to dose-dependent DNA damage in melanoma cells, detected by gamma-H2AX, which was completely abrogated by pre-treating cells with ROS scavenger, NAC. Plasma-induced DNA damage in turn may lead to the observed plasma-induced apoptosis. Since plasma is non-thermal, it may be used to selectively treat malignancies.
C1 [Kalghatgi, Sameer] Boston Univ, Dept Biomed Engn, Ctr Adv Biotechnol, Boston, MA 02215 USA.
   [Sensenig, Rachel; Cerchar, Ekaterina; Shereshevsky, Alexey; Podolsky, Erica; Brooks, Ari D.] Drexel Univ, Coll Med, Dept Surg, Philadelphia, PA 19102 USA.
   [Fridman, Gregory; Arjunan, Krishna Priya] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA.
   [Fridman, Alexander] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Kalghatgi, S (reprint author), Boston Univ, Dept Biomed Engn, Ctr Adv Biotechnol, ERB 301,44 Cummington St, Boston, MA 02215 USA.
EM suk22@drexel.edu
OI Fridman, Gregory/0000-0003-4006-4722
FU NIBIB NIH HHS [R01 EB013011-01, R01 EB013011]
CR Berk Lawrence B, 2008, Cancer Control, V15, P233
   Colt HG, 2006, RESPIROLOGY, V11, P643, DOI 10.1111/j.1400-1843.2006.00890.x
   COULOMBE S, 2007, 1 INT C PLASM MED IC
   COULOMBE S, 2006, PURE APPL CHEM, V78, P1137
   ELIASSON B, 1994, PURE APPL CHEM, V66, pU1766
   Eton Omar, 2005, Cancer Chemother Biol Response Modif, V22, P739
   Fiers W, 1999, ONCOGENE, V18, P7719
   Flaherty KT, 2006, CLIN CANCER RES, V12, p2366S, DOI 10.1158/1078-0432.CCR-05-2505
   Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01
   Fridman A, 2008, PLASMA CHEMISTRY, P1, DOI 10.1017/CBO9780511546075
   FRIDMAN A, 2008, PLASMA BIOL PLASMA M
   FRIDMAN A, 2008, PLASMA CHEM, P848
   Fridman AA, 2004, PLASMA PHYS ENG
   Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217
   Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4
   GEBICKI S, 1993, BIOCHEM J, V289, P743, DOI 10.1042/bj2890743
   Ginsberg GG, 2002, GASTROINTEST ENDOSC, V55, P807, DOI 10.1016/S0016-5107(02)70408-2
   Goree J, 2006, IEEE T PLASMA SCI, V34, P1317, DOI 10.1109/TPS.2006.878431
   GOSTEV V, 2006, 3 INT WORKSH MICR IW
   Hu W, 2003, LANCET ONCOL, V4, P721, DOI 10.1016/S1470-2045(03)01277-4
   Jaattela M, 2002, ANN MED, V34, P480, DOI 10.1080/078538902321012423
   Kalghatgi S., 2008, IEEE 35 INT C PLASM
   KALGHATGI S, 2007, NATO ADV STUDY I PLA
   KALGHATGI S, 2009, P IEEE 17 INT PULS P
   KALGHATGI S, 2008, 30 ANN INT C IEEE EN
   Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x
   Kalghatgi SU, 2007, IEEE T PLASMA SCI, V35, P1559, DOI 10.1109/TPS.2007.905953
   Kawiak A, 2007, TOXICOL APPL PHARM, V223, P267, DOI 10.1016/j.taap.2007.05.018
   Kieft IE, 2005, IEEE T PLASMA SCI, V33, P771, DOI 10.1109/TPS.2005.844528
   Kieft IE, 2006, IEEE T PLASMA SCI, V34, P1331, DOI 10.1109/TPS.2006.876511
   KOGELSCHATZ U, 2004, NONEQUILIBRIUM AIR P
   Kuo SP, 2006, IEEE T PLASMA SCI, V34, P1275, DOI 10.1109/TPS.2006.878389
   Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078
   Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016
   Laroussi M, 2000, IEEE T PLASMA SCI, V28, P184, DOI 10.1109/27.842899
   LAROUSSI M, 2003, NEW J PHYS, V5
   Laroussi M, 2006, PLASMA PROCESS POLYM, V3, P470, DOI 10.1002/ppap.200600005
   Lehnert BE, 2002, HUM EXP TOXICOL, V21, P65, DOI 10.1191/0960327102ht212oa
   Leveille V, 2005, PLASMA SOURCES SCI T, V14, P467, DOI 10.1088/0963-0252/14/3/008
   LORD M J, 1991, Arthroscopy, V7, P33, DOI 10.1016/0749-8063(91)90074-8
   MAJNO G, 1995, AM J PATHOL, V146, P3
   Mandara M, 2006, EXPERT REV ANTICANC, V6, P121, DOI 10.1586/14737140.6.1.121
   Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345
   Pak BJ, 2004, ONCOGENE, V23, P30, DOI 10.1038/sj.onc.1207007
   Porter KA, 1998, AM J SURG, V176, P8, DOI 10.1016/S0002-9610(98)00093-2
   Puhlev I, 2001, CRYOBIOLOGY, V42, P207, DOI 10.1006/cryo.2001.2324
   Raiser J, 2006, J PHYS D APPL PHYS, V39, P3520, DOI 10.1088/0022-3727/39/16/S10
   RAPPAPORT WD, 1990, AM J SURG, V160, P618, DOI 10.1016/S0002-9610(05)80757-3
   Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229
   Ratha J, 2007, MOL CELL BIOCHEM, V304, P143, DOI 10.1007/s11010-007-9495-5
   Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Schild SE, 2009, EXPERT REV ANTICANC, V9, P583, DOI 10.1586/ERA.09.21
   SHARMA A, 2006, IEEE T PLASMA SCI, V34
   Shekhter AB, 2005, NITRIC OXIDE-BIOL CH, V12, P210, DOI 10.1016/j.niox.2005.03.004
   SIEMENS CW, 1862, J FRANKLIN I, V74, P166
   SIMMONS PD, 1981, BRIT J VENER DIS, V57, P273
   Sladek REJ, 2005, J PHYS D APPL PHYS, V38, P1716, DOI 10.1088/0022-3727/38/11/012
   Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454
   Stevens G, 2006, SURG ONCOL CLIN N AM, V15, P353, DOI 10.1016/j.soc.2005.12.010
   Stoffels E, 2006, PLASMA SOURCES SCI T, V15, pS169, DOI 10.1088/0963-0252/15/4/S03
   Stoffels E., 2008, ADV PLASMA TECHNOLOG, P301
   Stoffels E, 2006, J PHYS D APPL PHYS, V39, DOI 10.1088/0022-3727/39/16/E01
   Tarasenko O, 2006, IEEE T PLASMA SCI, V34, P1281, DOI 10.1109/TPS.2006.878378
   Vargo JJ, 2004, GASTROINTEST ENDOSC, V59, P81, DOI 10.1016/S0016-5107(03)02296-X
   Williamson JM, 2006, J PHYS D APPL PHYS, V39, P4400, DOI 10.1088/0022-3727/39/20/016
   Yang JM, 2007, FREE RADICAL BIO MED, V42, P1369, DOI 10.1016/j.freeradbiomed.2007.01.036
   Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001
   Zhang RB, 2006, IEEE T PLASMA SCI, V34, P1370, DOI 10.1109/TPS.2006.878383
NR 69
TC 106
Z9 111
U1 3
U2 53
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD FEB
PY 2011
VL 39
IS 2
BP 674
EP 687
DI 10.1007/s10439-010-0197-x
PG 14
WC Engineering, Biomedical
SC Engineering
GA 719OD
UT WOS:000287213300006
PM 21046465
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Ahmad, A
   Wang, ZW
   Kong, DJ
   Ali, R
   Ali, S
   Banerjee, S
   Sarkar, FH
AF Ahmad, Aamir
   Wang, Zhiwei
   Kong, Dejuan
   Ali, Raza
   Ali, Shadan
   Banerjee, Sanjeev
   Sarkar, Fazlul H.
TI RETRACTED: Platelet-derived growth factor-D contributes to
   aggressiveness of breast cancer cells by up-regulating Notch and
   NF-kappa B signaling pathways (Retracted article. See vol. 158, pg. 605,
   2016)
SO BREAST CANCER RESEARCH AND TREATMENT
LA English
DT Article; Retracted Publication
DE PDGF-D; Breast cancer; Invasion; NF-kappa B; Notch-1; Jagged-1; EMT
ID EPITHELIAL-MESENCHYMAL TRANSITION; PDGF-D; DOWN-REGULATION;
   RECEPTOR-BETA; INVASION; EXPRESSION; INACTIVATION; PROLIFERATION;
   ANGIOGENESIS; PROGRESSION
AB Platelet-derived growth factor-D (PDGF-D) has been linked with several human malignancies; however, its role in breast cancer progression is not known. We found that PDGF-D expressing breast cancer cell lines MDA-MB-231 and SUM-149 are more invasive compared to cell lines with little or no expression of PDGF-D such as MDA-MB-468 and MCF-7 cells. Over-expression of PDGF-D in PDGF-D low expressing MDA-MB-468 and MCF-7 cells by cDNA transfection showed increased cell proliferation while silencing the expression of PDGF-D by siRNA in PDGF-D high expressing MDA-MB-231 and SUM-149 cells showed decreased cell proliferation and increased apoptosis. Moreover, PDGF-D over-expression was positively correlated with the expression of Notch-1 and Jagged-1, and the expression of mesenchymal markers (Vimentin and ZEB-2) with concomitant decreased expression of epithelial marker E-cadherin. Since NF-kappa B activation plays a crucial role in Notch signaling as well as in epithelial-mesenchymal transition and tumor aggressiveness, we determined the DNA binding activity of NF-kappa B and our findings are consistent showing that PDGF-D over-expression led to increased DNA binding activity of NF-kappa B while it was found to be decreased by inactivation of PDGF-D. These results were also consistent with the expression and activity of MMP-9 and VEGF, as well as invasive characteristics. Further, forced expression of Notch-1/Jagged-1 by cDNA transfection de-repressed the effects of PDGF-D silencing on NF-kappa B activity and invasion. From these results, we conclude that PDGF-D plays an important role in breast tumor aggressiveness and this process is mechanistically linked with the activation of Notch and NF-kappa B signaling.
C1 [Ahmad, Aamir; Wang, Zhiwei; Kong, Dejuan; Ali, Raza; Banerjee, Sanjeev; Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Ctr, Detroit, MI 48201 USA.
   [Ali, Shadan] Wayne State Univ, Sch Med, Dept Internal Med, Barbara Ann Karmanos Canc Ctr, Detroit, MI 48201 USA.
RP Sarkar, FH (reprint author), Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Ctr, 740 HWCRC Bldg,4100 John R St, Detroit, MI 48201 USA.
EM fsarkar@med.wayne.edu
RI Wang, Zhiwei/A-6809-2011
OI Ahmad, Aamir/0000-0003-1784-5723
CR Ahmad A, 2008, J CELL BIOCHEM, V105, P1461, DOI 10.1002/jcb.21966
   Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1
   Ahmad A, 2010, J CELL BIOCHEM, V109, P1134, DOI 10.1002/jcb.22492
   Ahmad A, 2009, J CELL BIOCHEM, V108, P916, DOI 10.1002/jcb.22323
   Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588
   Bongarzone ER, 2000, J NEUROSCI RES, V62, P319, DOI 10.1002/1097-4547(20001101)62:3<319::AID-JNR1>3.0.CO;2-G
   Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JC124652
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006
   Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076
   Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101
   LaRochelle WJ, 2002, CANCER RES, V62, P2468
   LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593
   Lev DC, 2005, CLIN CANCER RES, V11, P306
   Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223
   Li XR, 2003, CYTOKINE GROWTH F R, V14, P91, DOI 10.1016/S1359-6101(02)00090-4
   Lokker NA, 2002, CANCER RES, V62, P3729
   Meng QH, 2000, J MOL MED, V78, P155, DOI 10.1007/s001090000088
   Naik MU, 2008, CANCER RES, V68, P2194, DOI 10.1158/0008-5472.CAN-07-3057
   Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020
   Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030
   Romashkova JA, 1999, NATURE, V401, P86
   Sarkar FH, 2008, INT REV IMMUNOL, V27, P293, DOI 10.1080/08830180802276179
   Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007
   Ustach CV, 2005, MOL CELL BIOL, V25, P6279, DOI 10.1128/MCB.25.14.6279-6288.2005
   Ustach CV, 2004, CANCER RES, V64, P1722, DOI 10.1158/0008-5472.CAN-03-3047
   Vrekoussis T, 2007, ONCOL REP, V17, P1115
   Wang C, 2007, MOL CANCER RES, V5, P1031, DOI 10.1158/1541-7786.MCR-06-0391
   WANG Z, 2009, CURR DRUG TARGETS, DOI DOI 10.2174/138921020041844501
   Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803
   Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312
   Wang ZW, 2009, CURR DRUG TARGETS, V10, P38, DOI 10.2174/138945009787122914
   Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281
   Xu L, 2005, CANCER RES, V65, P5711, DOI 10.1158/0008-5472.CAN-04-4313
   Zhao L, 2010, CANCER BIOL THER, V9, P42, DOI 10.4161/cbt.9.1.10282
NR 34
TC 50
Z9 54
U1 3
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0167-6806
EI 1573-7217
J9 BREAST CANCER RES TR
JI Breast Cancer Res. Treat.
PD FEB
PY 2011
VL 126
IS 1
BP 15
EP 25
DI 10.1007/s10549-010-0883-2
PG 11
WC Oncology
SC Oncology
GA 709VT
UT WOS:000286470200002
PM 20379844
DA 2018-12-27
ER

PT J
AU Shyu, KG
   Lien, LM
   Wang, BW
   Kuan, PL
   Chang, H
AF Shyu, Kou-Gi
   Lien, Li-Ming
   Wang, Bao-Wei
   Kuan, Peiliang
   Chang, Hang
TI RETRACTED: Resistin contributes to neointimal formation via oxidative
   stress after vascular injury(Retracted article.See vol.130,pg.1842,2016)
SO CLINICAL SCIENCE
LA English
DT Article; Retracted Publication
DE oxidative stress; resistin; RNA interference; smooth muscle cell;
   vascular injury
ID SMOOTH-MUSCLE-CELLS; CYCLIC MECHANICAL STRETCH; MYOCARDIAL-INFARCTION;
   RNAI THERAPEUTICS; RAT; EXPRESSION; DISCOIDIN-DOMAIN-RECEPTOR-2;
   ATHEROSCLEROSIS; ACCUMULATION; MACROPHAGES
AB Resistin may play a major potential role in vascular remodelling and may contribute to atherogenesis. However, the role of VSMC (vascular smooth muscle cell)-derived resistin in neointimal formation is not well understood. We hypothesize that endogenous resistin derived from VSMCs may contribute to neointimal formation after vascular injury. VSMCs from thoracic aorta of adult Wistar rats were cultured. The carotid artery from adult Wistar rats was injured by balloon catheter. Resistin significantly increased migration and proliferation of VSMCs. Resistin siRNA (small interfering RNA) and resistin antibody significantly inhibited migration and proliferation of VSMCs induced by conditioned medium from stretched VSMCs. Resistin protein and mRNA expression significantly increased at 14 days after carotid injury. Resistin siRNA and NAC (N-acetylcysteine) significantly reduced resistin protein and mRNA expression induced by balloon injury. Carotid artery injury increased ROS (reactive oxygen species) production. Treatment with NAC and resistin siRNA decreased ROS production. The neointimal area was significantly increased after carotid injury and was significantly reduced by resistin siRNA and NAC. In conclusion, resistin increases migration and proliferation of VSMCs, and expression of resistin in carotid artery significantly increases after injury. Resistin siRNA attenuates neointimal formation after carotid injury partly through an antioxidative mechanism. Resistin may play a pivotal role in the pathogenesis of neointimal thickening after mechanical injury.
C1 [Chang, Hang] Shin Kong Wu Ho Su Mem Hosp, Dept Emergency Med, Taipei, Taiwan.
   [Lien, Li-Ming] Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, Taipei, Taiwan.
   [Shyu, Kou-Gi] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.
   [Shyu, Kou-Gi; Wang, Bao-Wei; Kuan, Peiliang] Shin Kong Wu Ho Su Mem Hosp, Div Cardiol, Taipei, Taiwan.
RP Chang, H (reprint author), Shin Kong Wu Ho Su Mem Hosp, Dept Emergency Med, Taipei, Taiwan.
EM shyukg@tmu.edu.tw
FU National Science Council, Taiwan [NSC96-2628-B-341-001-MY3]
FX This work was supported, in part, by the National Science Council,
   Taiwan [grant number NSC96-2628-B-341-001-MY3].
CR BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539
   Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839
   Bureau MF, 2000, BBA-GEN SUBJECTS, V1474, P353, DOI 10.1016/S0304-4165(00)00028-3
   CAE D, 2005, NAT MED, V11, P183
   Calabro P, 2004, CIRCULATION, V110, P3335, DOI 10.1161/01.CIR.0000147825.97879.E7
   Chang H, 2003, BIOCHEM BIOPH RES CO, V302, P95, DOI 10.1016/S0006-291X(03)00111-6
   Choi DS, 2008, INT J CARDIOL, V125, P79, DOI 10.1016/j.ijcard.2007.02.028
   Hung HF, 2008, J HYPERTENS, V26, P2349, DOI 10.1097/HJH.0b013e328311fa30
   Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081
   Jung HS, 2006, CARDIOVASC RES, V69, P76, DOI 10.1016/j.cardiores.2005.09.015
   Lee SH, 2009, CORONARY ARTERY DIS, V20, P33, DOI 10.1097/MCA.0b013e328318ecb0
   Lee TS, 2009, LIFE SCI, V84, P97, DOI 10.1016/j.lfs.2008.11.004
   Liu G, 2007, HISTOL HISTOPATHOL, V22, P211, DOI 10.14670/HH-22.211
   Osawa H, 2008, CLIN ENDOCRINOL, V69, P74, DOI 10.1111/j.1365-2265.2007.03154.x
   Papadopoulos DP, 2009, J CLIN HYPERTENS, V11, P61, DOI 10.1111/j.1751-7176.2008.00070.x
   Piestrzeniewicz K, 2008, METABOLISM, V57, P488, DOI 10.1016/j.metabol.2007.11.009
   Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43
   Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906
   Shyu KG, 2005, HYPERTENSION, V46, P614, DOI 10.1161/01.HYP.0000175811.79863.e2
   Shyu KG, 2008, ARTERIOSCL THROM VAS, V28, P1447, DOI 10.1161/ATVBAHA.108.165993
   STAVRI GT, 1995, CIRCULATION, V92, P11, DOI 10.1161/01.CIR.92.1.11
   Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f
   Takata Y, 2008, HYPERTENSION, V51, P534, DOI 10.1161/HYPERTENSIONAHA.107.103077
   Tolentino MJ, 2004, RETINA-J RET VIT DIS, V24, P132, DOI 10.1097/00006982-200402000-00018
   Wang BW, 2010, CLIN SCI, V118, P221, DOI 10.1042/CS20090155
NR 25
TC 15
Z9 16
U1 2
U2 6
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0143-5221
EI 1470-8736
J9 CLIN SCI
JI Clin. Sci.
PD FEB
PY 2011
VL 120
IS 3-4
BP 121
EP 129
DI 10.1042/CS20100226
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 720IO
UT WOS:000287274500003
PM 20795947
DA 2018-12-27
ER

PT J
AU Habibi, B
   Gahramanzadeh, R
AF Habibi, Biuck
   Gahramanzadeh, Rana
TI RETRACTED: Fabrication and characterization of non-platinum
   electrocatalyst for methanol oxidation in alkaline medium: Nickel
   nanoparticles modified carbon-ceramic electrode (Retracted article. See
   vol. 36, pg. 13866, 2011)
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article; Retracted Publication
DE Non-platinum electrocatalyst; Nickel nanoparticles; Carbon-ceramic;
   Methanol; Alkaline medium
ID FUEL-CELLS; ETHANOL ELECTROOXIDATION; NANOCRYSTALLINE NICKEL; PLATINUM
   NANOPARTICLES; SULFATE-SOLUTIONS; ANODIC-OXIDATION; VITREOUS CARBON; NI;
   CATALYSTS; HYDROXIDE
AB The use of carbon-ceramic electrode (CCE) modified with nickel nanoparticles was studied for the electrocatalytic oxidation of methanol in alkaline medium by cyclic voltammetry and chronoamperometry. After preparation of the carbon-ceramic by sol-gel technique as the electrode matrix, its surface was potentiostatically coated with Ni nanoparticles at -600 mV vs. SCE in an aqueous solution of 0.1 M Na(2)SO(4) (pH = 3.8) containing 5 mM NiCl(2). The CCE modified with nickel nanoparticles (CCE/Ni) was characterized by scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), X-ray diffraction (XRD) and cyclic voltammetry and used as electrocatalyst for oxidation of methanol in alkaline solution. It was shown that the CCE/Ni was the most efficient catalyst in the oxidation of methanol making it more attractive for fuel cell applications. The effective parameters on electrocatalytic oxidation of methanol such as the Ni loading procedure, amount of Ni loading and methanol concentration were investigated and the results were discussed. Finally, the long-term stability of the modified electrode has also been investigated. Published by Elsevier Ltd on behalf of Professor T. Nejat Veziroglu.
C1 [Habibi, Biuck; Gahramanzadeh, Rana] Azarbaijan Univ Tarbiat Moallem, Fac Sci, Dept Chem, Electroanalyt Chem Lab, Tabriz, Iran.
RP Habibi, B (reprint author), Azarbaijan Univ Tarbiat Moallem, Fac Sci, Dept Chem, Electroanalyt Chem Lab, Tabriz, Iran.
EM B.Habibi@azaruniv.edu
FU research council of Azarbaijan University of Tarbiat Moallem
FX The authors gratefully acknowledge the research council of Azarbaijan
   University of Tarbiat Moallem for their financial support.
CR AMJAD M, 1977, J ELECTROCHEM SOC, V124, P203, DOI 10.1149/1.2133266
   Baglio V, 2006, INT J ELECTROCHEM SC, V1, P71
   Barragan VM, 2002, J POWER SOURCES, V104, P66, DOI 10.1016/S0378-7753(01)00896-5
   Basri S, 2010, INT J HYDROGEN ENERG, V35, P7957, DOI 10.1016/j.ijhydene.2010.05.111
   BEDEN B, 1982, J ELECTROANAL CHEM, V142, P171, DOI 10.1016/S0022-0728(82)80014-4
   Bentley RW, 2002, ENERG POLICY, V30, P189, DOI 10.1016/S0301-4215(01)00144-6
   Chen J, 1999, J ELECTROCHEM SOC, V146, P3606, DOI 10.1149/1.1392522
   Chen M, 2008, ELECTROCHEM COMMUN, V10, P443, DOI 10.1016/j.elecom.2008.01.012
   Cullity B. D., 1978, ELEMENTS XRAY DIFFRA
   Danaee I, 2008, INT J HYDROGEN ENERG, V33, P4367, DOI 10.1016/j.ijhydene.2008.05.075
   Danaee I, 2009, INT J HYDROGEN ENERG, V34, P859, DOI 10.1016/j.ijhydene.2008.10.067
   Deivaraj TC, 2003, J MATER CHEM, V13, P2555, DOI 10.1039/b307040a
   Dominquez-Crespo MA, 2009, INT J HYDROGEN ENERG, V34, P1664, DOI 10.1016/j.ijhydene.2008.12.012
   Duarte MME, 2006, ELECTROCHEM COMMUN, V8, P159, DOI 10.1016/j.elecom.2005.11.003
   El-Shafei AA, 1999, J ELECTROANAL CHEM, V471, P89, DOI 10.1016/S0022-0728(99)00235-1
   ENEA O, 1990, ELECTROCHIM ACTA, V35, P375, DOI 10.1016/0013-4686(90)87014-S
   Ficicioglu F, 1997, J ELECTROANAL CHEM, V430, P179
   FLEISCHMANN M, 1971, J ELECTROANAL CHEM, V31, P39, DOI 10.1016/S0022-0728(71)80040-2
   Fraga MA, 2002, J CATAL, V209, P355, DOI 10.1006/jcat.2002.3637
   Golabi SM, 2004, ELECTROANAL, V16, P199, DOI 10.1002/elan.200302768
   Golikand AN, 2009, RUSS J ELECTROCHEM+, V45, P192, DOI 10.1134/S1023193509020104
   Golikand AN, 2007, J IRAN CHEM SOC, V4, P304
   Golikand AN, 2006, RUSS J ELECTROCHEM+, V42, P167, DOI 10.1134/S1023193506020108
   Grden M, 2005, J ELECTROANAL CHEM, V581, P122, DOI 10.1016/j.jelechem.2005.04.026
   Grujicic D, 2006, ELECTROCHIM ACTA, V51, P2678, DOI 10.1016/j.electacta.2005.08.017
   Habibi B, 2010, INT J HYDROGEN ENERG, V35, P8831, DOI 10.1016/j.ijhydene.2010.05.129
   Hameed RMA, 2010, INT J HYDROGEN ENERG, V35, P2517, DOI 10.1016/j.ijhydene.2009.12.145
   Han SB, 2008, ELECTROCHEM COMMUN, V10, P1044, DOI 10.1016/j.elecom.2008.04.034
   Jingyu S., 2007, INT J ELECTROCHEM SC, V2, P64
   Jones JM, 2003, CATAL TODAY, V81, P589, DOI 10.1016/S0920-5861(03)00157-3
   Kim JW, 1999, J ELECTROCHEM SOC, V146, P1075, DOI 10.1149/1.1391723
   Kumar KS, 2008, SURF COAT TECH, V202, P1764, DOI 10.1016/j.surfcoat.2007.07.035
   Lamy C, 2002, J POWER SOURCES, V105, P283, DOI 10.1016/S0378-7753(01)00954-5
   Lev O, 1997, CHEM MATER, V9, P2354, DOI 10.1021/cm970367b
   Liu SJ, 2004, ELECTROCHIM ACTA, V49, P3235, DOI 10.1016/j.electacta.2004.02.038
   Martinez-Huerta MV, 2006, APPL CATAL B-ENVIRON, V69, P75, DOI 10.1016/j.apcatb.2006.05.020
   Munoz AG, 2003, THIN SOLID FILMS, V429, P119, DOI 10.1016/S0040-6090(03)00277-3
   Opallo M, 2003, ELECTROCHEM COMMUN, V5, P737, DOI 10.1016/S1388-2481(03)00176-0
   Park KW, 2002, J PHYS CHEM B, V106, P1869, DOI 10.1021/jp013168v
   Petrovic Z, 2006, THIN SOLID FILMS, V513, P193, DOI 10.1016/j.tsf.2006.01.026
   Pournaghi-Azar MH, 2005, J ELECTROANAL CHEM, V580, P23, DOI 10.1016/j.jelechem.2005.02.021
   Rahim MAA, 2007, FUEL CELLS, V7, P298, DOI 10.1002/fuce.200600046
   Rahim MAA, 2006, J POWER SOURCES, V154, P59, DOI 10.1016/j.jpowsour.2005.03.198
   Rahim MAA, 2004, J POWER SOURCES, V134, P160, DOI 10.1016/j.jpowsour.2004.02.034
   Razmi H, 2008, ELECTROCHIM ACTA, V53, P8178, DOI 10.1016/j.electacta.2008.06.033
   Revenga-Parra M, 2008, SENSOR ACTUAT B-CHEM, V130, P730, DOI 10.1016/j.snb.2007.10.038
   Riley DJ, 2002, CURR OPIN COLLOID IN, V7, P186, DOI 10.1016/S1359-0294(02)00047-X
   Singh RN, 2007, INT J ELECTROCHEM SC, V2, P762
   Singh RN, 2009, INT J HYDROGEN ENERG, V34, P2052, DOI 10.1016/j.ijhydene.2008.12.047
   Skowronski JM, 2005, J SOLID STATE ELECTR, V9, P890, DOI 10.1007/s10008-005-0046-2
   SOLAR JM, 1991, J CATAL, V129, P330, DOI 10.1016/0021-9517(91)90039-7
   Spinace E, 2004, J POWER SOURCES, V129, P121, DOI 10.1016/j.jpowsour.2003.11.056
   Stradiotto NR, 2009, ELECTROANAL, V21, P2627, DOI 10.1002/elan.200900325
   Tang HL, 2007, ELECTROCHIM ACTA, V52, P3714, DOI 10.1016/j.electacta.2006.10.053
   TARASZEWSKA J, 1994, J ELECTROANAL CHEM, V364, P209, DOI 10.1016/0022-0728(93)02919-9
   Tehrani RMA, 2009, FUEL CELLS, V9, P579, DOI 10.1002/fuce.200800122
   Tripkovic AV, 1998, J ELECTROANAL CHEM, V448, P173, DOI 10.1016/S0022-0728(97)00141-1
   Van der Ven A, 2006, J ELECTROCHEM SOC, V153, pA210, DOI 10.1149/1.2138572
   Vilchez F, 2008, J ELECTROANAL CHEM, V614, P8, DOI 10.1016/j.jelechem.2007.10.026
   VUKOVIC M, 1994, J APPL ELECTROCHEM, V24, P878, DOI 10.1007/BF00348775
   Wasmus S, 1999, J ELECTROANAL CHEM, V461, P14, DOI 10.1016/S0022-0728(98)00197-1
   Witham CK, 2000, ELECTROCHEM SOLID ST, V3, P497
   Xu CW, 2007, ELECTROCHEM COMMUN, V9, P2009, DOI 10.1016/j.elecom.2007.05.028
   Yi QF, 2008, CATAL COMMUN, V9, P2053, DOI 10.1016/j.catcom.2008.03.051
   Zach MP, 2000, ADV MATER, V12, P878, DOI 10.1002/1521-4095(200006)12:12<878::AID-ADMA878>3.0.CO;2-X
   ZHANG CJ, 1987, J ELECTROCHEM SOC, V134, P2966, DOI 10.1149/1.2100324
   ZHANG CJ, 1989, J ELECTROCHEM SOC, V136, P3333, DOI 10.1149/1.2096447
   Zhao YC, 2010, INT J HYDROGEN ENERG, V35, P3249, DOI 10.1016/j.ijhydene.2010.01.112
NR 68
TC 21
Z9 21
U1 5
U2 35
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD FEB
PY 2011
VL 36
IS 3
BP 1913
EP 1923
DI 10.1016/j.ijhydene.2010.11.024
PG 11
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA 740WT
UT WOS:000288825800002
DA 2018-12-27
ER

PT J
AU Basselin, M
   Ramadan, E
   Igarashi, M
   Chang, LS
   Chen, M
   Kraft, AD
   Harry, GJ
   Rapoport, SI
AF Basselin, Mireille
   Ramadan, Epolia
   Igarashi, Miki
   Chang, Lisa
   Chen, Mei
   Kraft, Andrew D.
   Harry, G. Jean
   Rapoport, Stanley I.
TI RETRACTED: Imaging upregulated brain arachidonic acid metabolism in
   HIV-1 transgenic rats (Retracted article. See vol.35, pg. 1386, 2015)
SO JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
LA English
DT Article; Retracted Publication
DE arachidonic acid; brain imaging; eicosanoids; HIV-1; phospholipase A(2)
ID CENTRAL-NERVOUS-SYSTEM; PHOSPHOLIPASE A(2); ADMINISTRATION INCREASES;
   FRONTAL-CORTEX; NEUROINFLAMMATION; DISEASE; CYCLOOXYGENASE-2;
   ACTIVATION; EXPRESSION; INHIBITOR
AB Human immunodeficiency virus (HIV)-associated infection involves the entry of virus-bearing monocytes into the brain, followed by microglial activation, neuroinflammation, and upregulated arachidonic acid (AA) metabolism. The HIV-1 transgenic (Tg) rat, a noninfectious HIV-1 model, shows neurologic and behavioral abnormalities after 5 months of age. We hypothesized that brain AA metabolism would be elevated in older HIV-1 Tg rats in vivo. Arachidonic acid incorporation from the plasma into the brain of unanesthetized 7-to-9-month-old rats was imaged using quantitative autoradiography, after [1-C-14] AA infusion. Brain phospholipase (PLA(2)) activities and eicosanoid concentrations were measured, and enzymes were localized by immunostaining. AA incorporation coefficients k* and rates J(in), measures of AA metabolism, were significantly higher in 69 of 81 brain regions in HIV-1 Tg than in control rats, as were activities of cytosolic (c) PLA(2)-IV, secretory (s)PLA(2), and calcium independent (i) PLA(2)-VI, as well as prostaglandin E-2 and leukotriene B-4 concentrations. Immunostaining of somatosensory cortex showed elevated cPLA(2)-IV, sPLA(2)-IIA, and cyclooxygenase-2 in neurons. Brain AA incorporation and other markers of AA metabolism are upregulated in HIV-1 Tg rats, in which neurologic changes and neuroinflammation have been reported. Positron emission tomography with [1-C-11] AA could be used to test whether brain AA metabolism is upregulated in HIV-1-infected patients, in relation to cognitive and behavioral disturbances. Journal of Cerebral Blood Flow & Metabolism (2011) 31, 486-493; doi: 10.1038/jcbfm.2010.111; published online 28 July 2010
C1 [Basselin, Mireille; Ramadan, Epolia; Igarashi, Miki; Chang, Lisa; Chen, Mei; Rapoport, Stanley I.] NIA, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA.
   [Kraft, Andrew D.; Harry, G. Jean] Natl Inst Environm Hlth Sci, Lab Toxicol & Pharmacol, NIH, Res Triangle Pk, NC USA.
RP Ramadan, E (reprint author), NIA, Brain Physiol & Metab Sect, NIH, Bldg 9,Room 1S126, Bethesda, MD 20892 USA.
EM ramadanir@mail.nih.gov
FU National Institute on Aging; National Institute of Environmental Health
   Science, NIH
FX The research was supported by the Intramural Research Programs of the
   National Institute on Aging and the National Institute of Environmental
   Health Science, NIH.
CR Anthony IC, 2008, INT REV PSYCHIATR, V20, P15, DOI 10.1080/09540260701862037
   Bagetta G, 1998, BIOCHEM BIOPH RES CO, V244, P819, DOI 10.1006/bbrc.1998.8321
   Basselin M, 2007, NEUROCHEM RES, V32, P1857, DOI 10.1007/s11064-007-9372-3
   Bosetti F, 2007, J NEUROCHEM, V102, P577, DOI 10.1111/j.1471-4159.2007.04558.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brust D, 2006, AIDS, V20, P985, DOI 10.1097/01.aids.0000222070.52996.76
   Chang YC, 2008, NEUROCHEM RES, V33, P2318, DOI 10.1007/s11064-008-9731-8
   D'Aversa TG, 2005, J NEUROSCI RES, V81, P436, DOI 10.1002/jnr.20486
   DEGEORGE JJ, 1989, J NEUROSCI RES, V24, P413, DOI 10.1002/jnr.490240311
   DeMar JC, 2006, BBA-MOL CELL BIOL L, V1761, P1050, DOI 10.1016/j.bbalip.2006.06.006
   Esposito G, 2008, J NUCL MED, V49, P1414, DOI 10.2967/jnumed.107.049619
   Farias SE, 2008, J LIPID RES, V49, P1990, DOI 10.1194/jlr.M800200-JLR200
   Flora G, 2006, NEUROMOL MED, V8, P337, DOI 10.1385/NMM:8:3:337
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GRIFFIN DE, 1994, ANN NEUROL, V35, P592, DOI 10.1002/ana.410350513
   HOECK WG, 1993, P NATL ACAD SCI USA, V90, P4475, DOI 10.1073/pnas.90.10.4475
   Kan H, 2006, J MOL CELL CARDIOL, V40, P131, DOI 10.1016/j.yjmcc.2005.10.006
   Kaufmann WE, 1997, PROSTAG OTH LIPID M, V54, P601, DOI 10.1016/S0090-6980(97)00128-7
   Killebrew DA, 2005, CELL MOL BIOL, V51, pOL745, DOI 10.1170/89
   Lashomb AL, 2009, J NEUROVIROL, V15, P14, DOI 10.1080/13550280802232996
   Lee H, 2004, J NEUROCHEM, V91, P936, DOI 10.1111/j.1471-4159.2004.02786.x
   Lee HJ, 2008, J LIPID RES, V49, P162, DOI 10.1194/jlr.M700406-JLR200
   May S, 2007, J NEUROIMMUNE PHARM, V2, P97, DOI 10.1007/s11481-006-9057-8
   Moolwaney AS, 2005, MOL BRAIN RES, V137, P202, DOI 10.1016/j.molbrainres.2005.03.01
   Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103
   Norman JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003731
   Ong WY, 1999, J BRAIN RES, V39, P391
   PAXINOS G, 1987, RAT BRAIN STEREOTAXI
   Rao JS, 2007, J NEUROCHEM, V102, P1918, DOI 10.1111/j.1471-4159.2007.04648.x
   RAPOPORT SI, 1982, AM J PHYSIOL, V242, pR339
   Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298
   ROBINSON PJ, 1992, BRAIN RES REV, V17, P187, DOI 10.1016/0165-0173(92)90016-F
   Rosa AO, 2009, BBA-MOL CELL BIOL L, V1791, P697, DOI 10.1016/j.bbalip.2009.03.009
   Rosenberger TA, 2004, J NEUROCHEM, V88, P1168, DOI 10.1046/j.1471-4159.2003.02246.x
   Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0
   Striggow F, 1997, BIOCHEM BIOPH RES CO, V237, P413, DOI 10.1006/bbrc.1997.7152
   Strokin M, 2004, INT J DEV NEUROSCI, V22, P551, DOI 10.1016/j.ijdevneu.2004.07.002
   WESSELINGH SL, 1994, ADV NEUROIMMUNOL, V4, P199, DOI 10.1016/S0960-5428(06)80258-5
   Yang HC, 1999, ANAL BIOCHEM, V269, P278, DOI 10.1006/abio.1999.4053
NR 39
TC 27
Z9 28
U1 1
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0271-678X
EI 1559-7016
J9 J CEREBR BLOOD F MET
JI J. Cereb. Blood Flow Metab.
PD FEB
PY 2011
VL 31
IS 2
BP 486
EP 493
DI 10.1038/jcbfm.2010.111
PG 8
WC Endocrinology & Metabolism; Hematology; Neurosciences
SC Endocrinology & Metabolism; Hematology; Neurosciences & Neurology
GA 715XY
UT WOS:000286930100011
PM 20664612
OA Green Published
DA 2018-12-27
ER

PT J
AU Phromnoi, K
   Reuter, S
   Sung, BY
   Prasad, S
   Kannappan, R
   Yadav, VR
   Chanmahasathien, W
   Limtrakul, P
   Aggarwal, BB
AF Phromnoi, Kanokkarn
   Reuter, Simone
   Sung, Bokyung
   Prasad, Sahdeo
   Kannappan, Ramaswamy
   Yadav, Vivek R.
   Chanmahasathien, Wisinee
   Limtrakul, Pornngarm
   Aggarwal, Bharat B.
TI RETRACTED: A Novel Pentamethoxyflavone Down-Regulates Tumor Cell
   Survival and Proliferative and Angiogenic Gene Products through
   Inhibition of I kappa B Kinase Activation and Sensitizes Tumor Cells to
   Apoptosis by Cytokines and Chemotherapeutic Agents (Retracted article.
   See vol. 90, pg. 64, 2014)
SO MOLECULAR PHARMACOLOGY
LA English
DT Article; Retracted Publication
ID NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; CANCER CELLS; TRANSCRIPTION FACTOR;
   POLYMETHOXYLATED FLAVONES; GARDENIA-OBTUSIFOLIA; MULTIDRUG-RESISTANCE;
   CARCINOMA CELLS; MONOCYTIC CELLS; P-GLYCOPROTEIN
AB Most anticancer drugs have their origin in traditional medicinal plants. We describe here a flavone, 5,3'-dihydroxy-3,6,7,8,4'-pentamethoxyflavone (PMF), from the leaves of the Thai plant Gardenia obtusifolia, that has anti-inflammatory and anticancer potential. Because the nuclear factor-kappa B (NF-kappa B) pathway is linked to inflammation and tumorigenesis, we investigated the effect of PMF on this pathway. We found that PMF suppressed NF-kappa B activation induced by inflammatory agents, tumor promoters, and carcinogens. This suppression was not specific to the cell type. Although PMF did not directly modify the ability of NF-kappa B proteins to bind to DNA, it inhibited I kappa B alpha (inhibitory subunit of NF-kappa B) kinase, leading to suppression of phosphorylation and degradation of I kappa B alpha, and suppressed consequent p65 nuclear translocation, thus abrogating NF-kappa B-dependent reporter gene expression. Suppression of the NF-kappa B cell signaling pathway by the flavone led to the inhibition of expression of NF-kappa B-regulated gene products that mediate inflammation (cyclooxygenase-2), survival (XIAP, survivin, Bcl-xL, and cFLIP), proliferation (cyclin D1), invasion (matrix metalloproteinase-9), and angiogenesis (vascular endothelial growth factor). Suppression of antiapoptotic gene products by PMF correlated with the enhancement of apoptosis induced by tumor necrosis factor-alpha and the chemotherapeutic agents cisplatin, paclitaxel, and 5-flurouracil. Overall, our results indicate that PMF suppresses the activation of NF-kappa B and NF-kappa B-regulated gene expression, leading to the enhancement of apoptosis. This is the first report to demonstrate that this novel flavone has anti-inflammatory and anticancer effects by targeting the IKK complex.
C1 [Phromnoi, Kanokkarn; Reuter, Simone; Sung, Bokyung; Prasad, Sahdeo; Kannappan, Ramaswamy; Yadav, Vivek R.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.
   [Phromnoi, Kanokkarn; Chanmahasathien, Wisinee; Limtrakul, Pornngarm] Chiang Mai Univ, Dept Biochem, Fac Med, Chiang Mai 50000, Thailand.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Aggarwal, Bharat/G-3388-2013
OI Limtrakul, Pornngarm/0000-0003-4968-6667
FU National Institutes of Health National Cancer Institute [CA16672,
   CA124787-01A2]; Center for Targeted Therapy of M. D. Anderson Cancer
   Center; Royal Golden Jubilee Scholarship
FX This work was supported by the National Institutes of Health National
   Cancer Institute [Grants CA16672, CA124787-01A2]; the Center for
   Targeted Therapy of M. D. Anderson Cancer Center; and the Royal Golden
   Jubilee Scholarship for the PhD Program [Grant RGJ].
CR Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003
   ATTAURRAHMAN, 1988, PLANTA MED, P173
   Cai H, 2009, CANCER PREV RES, V2, P743, DOI 10.1158/1940-6207.CAPR-09-0081
   Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585
   Chen KH, 2007, BIOCHEM PHARMACOL, V73, P215, DOI 10.1016/j.bcp.2006.09.018
   Choi CH, 2002, BIOCHEM BIOPH RES CO, V295, P832, DOI 10.1016/S0006-291X(02)00755-6
   Dong P, 2010, J CHROMATOGR A, V1217, P642, DOI 10.1016/j.chroma.2009.11.097
   Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026
   Egan LJ, 1999, J BIOL CHEM, V274, P26448, DOI 10.1074/jbc.274.37.26448
   Eguchi A, 2007, BIOFACTORS, V31, P107, DOI 10.1002/biof.5520310201
   Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200
   Fushiya S, 1999, PLANTA MED, V65, P404, DOI 10.1055/s-1999-14084
   Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj/leu/2402482
   Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1
   Giri DK, 1998, J BIOL CHEM, V273, P14008, DOI 10.1074/jbc.273.22.14008
   Guttridge DC, 1999, MOL CELL BIOL, V19, P5785
   Haldar S, 1996, CANCER RES, V56, P1253
   Hirata T, 2009, BIOORGAN MED CHEM, V17, P25, DOI 10.1016/j.bmc.2008.11.039
   Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8
   HUSSAIN M M, 1991, International Journal of Pharmacognosy, V29, P94
   LAURENS A, 1985, PHARMAZIE, V40, P482
   Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5
   Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002
   LICHIUS JJ, 1994, J NAT PROD, V57, P1012, DOI 10.1021/np50109a024
   Lin X, 1999, IMMUNITY, V10, P271, DOI 10.1016/S1074-7613(00)80027-8
   MAHON TM, 1995, J BIOL CHEM, V270, P28557, DOI 10.1074/jbc.270.48.28557
   Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0
   Nasuhara Y, 1999, J BIOL CHEM, V274, P19965, DOI 10.1074/jbc.274.28.19965
   Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090
   Pan MH, 2002, CARCINOGENESIS, V23, P1677, DOI 10.1093/carcin/23.10.1677
   Patanasethanont D, 2007, EUR J PHARMACOL, V566, P67, DOI 10.1016/j.ejphar.2007.04.001
   Phromnoi K, 2010, ANTICANCER RES, V30, P3599
   Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X
   Sale S, 2009, EUR J CANCER, V45, P2731, DOI 10.1016/j.ejca.2009.07.004
   Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200
   Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044
   Sarkar FH, 2008, FRONT BIOSCI-LANDMRK, V13, P2950, DOI 10.2741/2900
   Sergeev IN, 2006, LIFE SCI, V80, P245, DOI 10.1016/j.lfs.2006.09.006
   SERTIE JAA, 1990, PLANTA MED, V56, P36, DOI 10.1055/s-2006-960879
   SHI Q, 1995, J NAT PROD, V58, P475, DOI 10.1021/np50118a001
   Simeonidis S, 1999, P NATL ACAD SCI USA, V96, P49, DOI 10.1073/pnas.96.1.49
   Smith C, 2001, J IMMUNOL, V167, P5895, DOI 10.4049/jimmunol.167.10.5895
   Sun Yinshi, 2009, Se Pu, V27, P244
   Takada Y, 2004, J BIOL CHEM, V279, P4750, DOI 10.1074/jbc.M304546200
   Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3
   Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0
   Takanaga H, 2000, J PHARMACOL EXP THER, V293, P230
   TAKASE H, 1989, JPN J PHARMACOL, V49, P301, DOI 10.1254/jjp.49.301
   Tuchinda P, 2002, TETRAHEDRON, V58, P8073, DOI 10.1016/S0040-4020(02)00999-7
   Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72
   Watanabe J, 2005, BIOSCI BIOTECH BIOCH, V69, P1, DOI 10.1271/bbb.69.1
   Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866
   Xiao H, 2009, MOL NUTR FOOD RES, V53, P398, DOI 10.1002/mnfr.200800057
   Xiong HQ, 2004, INT J CANCER, V108, P181, DOI 10.1002/ijc.11562
   Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315
   Yasuda T, 2003, CHEM PHARM BULL, V51, P1426, DOI 10.1248/cpb.51.1426
   Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453
   Zheng GD, 2009, J AGR FOOD CHEM, V57, P6552, DOI 10.1021/jf901225e
NR 59
TC 8
Z9 8
U1 3
U2 6
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0026-895X
EI 1521-0111
J9 MOL PHARMACOL
JI Mol. Pharmacol.
PD FEB
PY 2011
VL 79
IS 2
BP 279
EP 289
DI 10.1124/mol.110.067512
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 707TT
UT WOS:000286311800008
PM 20930110
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Zhou, S
   Potts, EN
   Cuttitta, F
   Foster, WM
   Sunday, ME
AF Zhou, Shutang
   Potts, Erin N.
   Cuttitta, Frank
   Foster, W. Michael
   Sunday, Mary E.
TI RETRACTED: Gastrin-releasing peptide blockade as a broad-spectrum
   anti-inflammatory therapy for asthma (Retracted article. See vol. 112,
   pg. E1813, 2015)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Retracted Publication
DE gastrin-releasing peptide receptor phosphorylation; mouse models;
   bombesin
ID BOMBESIN-LIKE PEPTIDE; PULMONARY NEUROENDOCRINE SYSTEM; INDUCED
   OXIDATIVE STRESS; CELL LUNG-CANCER; BRONCHOPULMONARY DYSPLASIA;
   PROTEIN-KINASE; GUINEA-PIG; SENSORY NEUROPEPTIDES; RECEPTOR SUBTYPES;
   AIRWAY DISEASE
AB Gastrin-releasing peptide (GRP) is synthesized by pulmonary neuroendocrine cells in inflammatory lung diseases, such as bronchopulmonary dysplasia (BPD). Many BPD infants develop asthma, a serious disorder of intermittent airway obstruction. Despite extensive research, early mechanisms of asthma remain controversial. The incidence of asthma is growing, now affecting >300 million people worldwide. To test the hypothesis that GRP mediates asthma, we used two murine models: ozone exposure for air pollution-induced airway hyperreactivity (AHR), and ovalbumin (OVA)-induced allergic airway disease. BALB/c mice were given small molecule GRP blocking agent 77427, or GRP blocking antibody 2A11, before exposure to ozone or OVA challenge. In both models, GRP blockade abrogated AHR and bronchoalveolar lavage (BAL) macrophages and granulocytes, and decreased BAL cytokines implicated in asthma, including those typically derived from Th1 (e.g., IL-2, TNF alpha), Th2 (e g., IL-5, IL-13), Th17 (IL-17), macrophages (e. g., MCP-1, IL-1), and neutrophils (KC = IL-8). Dexamethasone generally had smaller effects on all parameters. Macrophages, T cells, and neutrophils express GRP receptor (GRPR). GRP blockade diminished serine phosphorylation of GRPR with ozone or OVA. Thus, GRP mediates AHR and airway inflammation in mice, suggesting that GRP blockade is promising as a broad-spectrum therapeutic approach to treat and/or prevent asthma in humans.
C1 [Zhou, Shutang; Sunday, Mary E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.
   [Potts, Erin N.; Foster, W. Michael; Sunday, Mary E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.
   [Cuttitta, Frank] NCI, Angiogenesis Core Facil, Radiat Oncol Branch, NIH, Gaithersburg, MD 20877 USA.
RP Zhou, S (reprint author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.
EM shutang.zhou@duke.edu; mary.sunday@duke.edu
RI Cuttitta, Frank/B-4758-2016
FU American Asthma Foundation; National Institutes of Health [AI081672,
   ES016347]
FX We thank Dr. Robert P. Orange and Prof. Baruj Benacerraf for invaluable
   discussions. This work was supported by an Established Investigator
   Award (to M. E. S.) from the American Asthma Foundation. Mouse model
   development and airway physiology were supported by National Institutes
   of Health Grants AI081672 and ES016347 (to W.M.F.).
CR AGUAYO SM, 1992, NEW ENGL J MED, V327, P1285, DOI 10.1056/NEJM199210293271806
   Ally RA, 2003, MOL PHARMACOL, V64, P890, DOI 10.1124/mol.64.4.890
   Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342
   BAXTER LT, 1994, CANCER RES, V54, P1517
   Beasley R, 2002, J ALLERGY CLIN IMMUN, V109, pS482, DOI 10.1067/mai.2002.122716
   BOUSBAA H, 1991, AM REV RESPIR DIS, V144, P714, DOI 10.1164/ajrccm/144.3_Pt_1.714
   Chanez P, 1998, AM J RESP CRIT CARE, V158, P985, DOI 10.1164/ajrccm.158.3.9608104
   Chang LYL, 2003, AM J RESP CRIT CARE, V167, P57, DOI 10.1164/rccm.200203-232OC
   Chaudhry A, 1999, CLIN CANCER RES, V5, P3385
   CORJAY MH, 1991, J BIOL CHEM, V266, P18771
   Cotran RS, 1999, ROBBINS PATHOLOGIC B
   Csillag A, 2010, J IMMUNOL, V184, P2377, DOI 10.4049/jimmunol.0803938
   Cullen A, 2000, PEPTIDES, V21, P1627, DOI 10.1016/S0196-9781(00)00294-1
   Cullen A, 2002, AM J RESP CRIT CARE, V165, P1093, DOI 10.1164/rccm.2108044
   Dahl R, 2006, RESP MED, V100, P1307, DOI 10.1016/j.rmed.2005.11.020
   DELAFUENTE M, 1991, IMMUNOLOGY, V73, P205
   DELRIO M, 1994, REGUL PEPTIDES, V49, P185, DOI 10.1016/0167-0115(94)90140-6
   DEMICHELE MAA, 1994, AM J RESP CELL MOL, V11, P66, DOI 10.1165/ajrcmb.11.1.8018339
   Deterding RR, 2005, PEDIATR PULM, V40, P157, DOI 10.1002/ppul.20243
   Dozor AJ, 2010, ANN NY ACAD SCI, V1203, P133, DOI 10.1111/j.1749-6632.2010.05562.x
   DUSSER DJ, 1989, J CLIN INVEST, V84, P900, DOI 10.1172/JCI114251
   Evans M, 1998, AM J EPIDEMIOL, V148, P460
   Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185
   Fischer JR, 1997, ANN ONCOL, V8, P457, DOI 10.1023/A:1008242000431
   Gaga M, 2005, CLIN EXP ALLERGY, V35, P954, DOI 10.1111/j.1365-2222.2005.02281.x
   Groneberg DA, 2004, ALLERGY, V59, P1139, DOI 10.1111/j.1398-9995.2004.00665.x
   Hollingsworth JW, 2007, J IMMUNOL, V179, P4367, DOI 10.4049/jimmunol.179.7.4367
   IMPICCIATORE M, 1973, J PHARM PHARMACOL, V25, P872, DOI 10.1111/j.2042-7158.1973.tb09965.x
   JOOS GF, 1994, EUR RESPIR J, V7, P1161
   Kelley MJ, 1997, CHEST, V112, P256, DOI 10.1378/chest.112.1.256
   Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892
   KING KA, 1995, P NATL ACAD SCI USA, V92, P4357, DOI 10.1073/pnas.92.10.4357
   LACH E, 1993, AM J PHYSIOL, V264, pL80
   LEMAIRE I, 1991, NEUROPEPTIDES, V20, P217, DOI 10.1016/0143-4179(91)90011-7
   Levine SJ, 2010, ANN INTERN MED, V152, P232, DOI 10.7326/0003-4819-152-4-201002160-00008
   Lilly CM, 2005, J ALLERGY CLIN IMMUN, V115, pS526, DOI 10.1016/j.jaci.2005.01.028
   Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinves.3700412
   Martinez A, 2005, ONCOGENE, V24, P4106, DOI 10.1038/sj.onc.1208581
   Meloni F, 1996, RESPIRATION, V63, P28
   Nag SS, 2003, J ALLERGY CLIN IMMUN, V111, P558, DOI 10.1067/mai.2003.131
   Ng DKK, 2000, PEDIATR INT, V42, P603, DOI 10.1046/j.1442-200x.2000.01314.x
   POLAK JM, 1993, ANAT REC, V236, P169, DOI 10.1002/ar.1092360120
   Rosen D, 2006, AM J RESP CRIT CARE, V174, P75, DOI 10.1016/rccm.200511-1784OC
   ROZENGURT E, 1990, PHILOS T ROY SOC B, V327, P209, DOI 10.1098/rstb.1990.0055
   Savov JD, 2004, AM J RESP CELL MOL, V31, P69, DOI 10.1165/rcmb.2003-0001OC
   Shore SA, 2003, J CLIN INVEST, V112, P495, DOI 10.1172/JCI200319642
   Shriver SP, 2000, JNCI-J NATL CANCER I, V92, P24, DOI 10.1093/jnci/92.1.24
   Subramaniam M, 2003, AM J RESP CRIT CARE, V168, P601, DOI 10.1164/rccm.200212-1434OC
   Subramaniam M, 2007, AM J RESP CRIT CARE, V176, P902, DOI 10.1164/rccm.200611-1734OC
   Sunday ME, 1998, J CLIN INVEST, V102, P584, DOI 10.1172/JCI2329
   SUNDAY ME, 1990, AM J RESP CELL MOL, V3, P199, DOI 10.1165/ajrcmb/3.3.199
   Van Lommel A, 1999, ARCH HISTOL CYTOL, V62, P1, DOI 10.1679/aohc.62.1
   Voynow JA, 2009, AM J RESP CELL MOL, V41, P107, DOI 10.1165/rcmb.2008-0381OC
   WHARTON J, 1978, NATURE, V273, P769, DOI 10.1038/273769a0
   Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002
   Williams AS, 2008, EUR J PHARMACOL, V600, P117, DOI 10.1016/j.ejphar.2008.09.031
   Williams BY, 1996, MOL PHARMACOL, V50, P716
   Yule KA, 1999, EXP LUNG RES, V25, P261
NR 58
TC 21
Z9 22
U1 2
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 1
PY 2011
VL 108
IS 5
BP 2100
EP 2105
DI 10.1073/pnas.1014792108
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 714JA
UT WOS:000286804700066
PM 21252304
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Mead, DW
   Harris, CK
   Killough, PM
AF Mead, David W.
   Harris, Chris K.
   Killough, Patrick M.
TI RETRACTED: Kuhn-Grun analysis of polarized Rayleigh and Raman scattering
   experiments to deduce segmental orientation in polymeric systems
   (Retracted article. See vol. 50, pg. 715, 2011)
SO RHEOLOGICA ACTA
LA English
DT Article; Retracted Publication
DE Constitutitve equation; Rheo-optics; Statistical theory of
   viscoelasticity
ID ANISOTROPIC FLUIDS; LINEAR-POLYMERS; FLOW; VISCOELASTICITY; DYNAMICS;
   STRETCH
AB The intensity of Rayleigh and Raman scattered light from molecular structural units is proportional to the quadratic polarizability tensor and the derived polarizability tensor, respectively. The orientation of the polymer skeletal backbone is directly related to the orientation of the scattering structural units comprising it. The mathematical structure of the quadratic scattering tensors for a single Kuhn bond are deduced in terms of the unit vector along a Kuhn bond from symmetry considerations alone (Boehler 1987). Subsequent application of the Kuhn-Grun conditional probability analysis (Kuhn and Grun, Kolloid Z 101:248-271, 1942), which uses a freely jointed chain model, yields a general expression for the quadratic Raman and polarizability tensors for a single chain segment with five independent terms. Each term is multiplied by a spectroscopic parameter that is a complex function of the intrinsic spectroscopic tensors and the orientation distribution of monomers within an elementary Kuhn bond. A small stretch analysis of the Kuhn-Grun representation of the quadratic polarizability reveals that independent fourth moments of the segmental orientation distribution function can only be determined experimentally when the deformation or stretch of the flexible polymer is large and finite, thus severely restricting a primary advantage of the Raman and Rayleigh scattering methods. A general segmental additivity theorem is rigorously proven which demonstrates that polarized scattering experiments physically reflect the average orientation and stretch of flexible polymer skeletal backbone segments, or sub-segments, independent of chain architecture or molecular weight. Constitutive equations are fundamentally constructed to determine Kuhn bond orientation and are intrinsically related to the Kuhn-Grun analysis. The decoupling approximation, which is always invoked in Doi-Edwards type models of entangled polymeric liquids, is examined in light of the Kuhn-Grun analysis.
C1 [Mead, David W.; Harris, Chris K.; Killough, Patrick M.] Illinois Inst Technol, Ctr Mol Study Condensed Soft Matter, Chicago, IL 60616 USA.
RP Mead, DW (reprint author), Illinois Inst Technol, Ctr Mol Study Condensed Soft Matter, Chicago, IL 60616 USA.
EM meaddavid@hotmail.com
FU NSF [0625072]
FX Final manuscript preparation was done at the Benjamin Levich Institute
   for Physio-Chemical Hydrodynamics, City College of New York, CUNY, with
   financial support from NSF Grant #0625072.
CR ABE Y, 1970, J CHEM PHYS, V52, P2814, DOI 10.1063/1.1673405
   ADVANI SG, 1990, J RHEOL, V34, P367, DOI 10.1122/1.550133
   ARCHER LA, 1994, J RHEOL, V38, P1101, DOI 10.1122/1.550586
   Boehler JP, 1987, APPL TENSOR FUNCTION, V292
   BOWER DI, 1972, J POLYM SCI POL PHYS, V10, P2135, DOI 10.1002/pol.1972.180101103
   DOI M, 1987, J NON-NEWTON FLUID, V23, P151, DOI 10.1016/0377-0257(87)80016-2
   Doi M, 1986, THEORY POLYM DYNAMIC
   ERICKSEN JL, 1960, ARCH RATION MECH AN, V4, P231
   ERICKSEN JL, 1961, T SOC RHEOL, V5, P23, DOI 10.1122/1.548883
   Flory PJ, 1969, STATISTICAL MECHANIC
   HAND GL, 1962, J FLUID MECH, V13, P33, DOI 10.1017/S0022112062000476
   HOLLIDAY L, 1975, STRUCTURE PROPERTIES
   Ionescu TC, 2008, J RHEOL, V52, P567, DOI 10.1122/1.2838250
   JEN S, 1977, J CHEM PHYS, V66, P4635, DOI 10.1063/1.433720
   Kroger M, 1997, MACROMOLECULES, V30, P526, DOI 10.1021/ma960317c
   Kuhn W, 1942, KOLLOID Z, V101, P248, DOI 10.1007/BF01793684
   Landau L. D., 1986, THEORY ELASTICITY
   Larson R G, 1988, CONSTITUTIVE EQUATIO
   LARSON RG, 1989, J RHEOL, V33, P185, DOI 10.1122/1.550059
   Long DA, 1977, RAMAN SPECTROSCOPY
   Mark JE, 2007, RUBBERLIKE ELASTICITY: A MOLECULAR PRIMER, 2ND EDITION, P1, DOI 10.1017/CBO9780511541322
   Marrucci G, 2003, PHILOS T R SOC A, V361, P677, DOI 10.1098/rsta.2002.1156
   Mead DW, 2007, RHEOL ACTA, V46, P369, DOI 10.1007/s00397-006-0128-9
   MEAD DW, 1995, RHEOL ACTA, V34, P339, DOI 10.1007/BF00367151
   MEAD DW, 2011, RHEOLOGICA IN PRESS
   MEAD DW, 2011, ANAL POLARI IN PRESS
   Treloar L. R. G., 1975, PHYS RUBBER ELASTICI
   Wapperom P, 2004, J NON-NEWTON FLUID, V122, P33, DOI 10.1016/j.jnnfm.2003.10.008
NR 28
TC 2
Z9 2
U1 4
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0035-4511
EI 1435-1528
J9 RHEOL ACTA
JI Rheol. Acta
PD FEB
PY 2011
VL 50
IS 2
BP 179
EP 198
DI 10.1007/s00397-011-0537-2
PG 20
WC Mechanics
SC Mechanics
GA 750DY
UT WOS:000289526200009
DA 2018-12-27
ER

PT J
AU Liu, HL
   Ding, QA
   Yang, KY
   Zhang, T
   Li, GL
   Wu, G
AF Liu, Hongli
   Ding, Qian
   Yang, Kunyu
   Zhang, Tao
   Li, Guiling
   Wu, Gang
TI RETRACTED: Meta-analysis of systemic lupus erythematosus and the risk of
   cervical neoplasia (Retracted article. See vol. 50, pg. 2147, 2011)
SO RHEUMATOLOGY
LA English
DT Article; Retracted Publication
DE Meta-analysis; Systemic lupus erythematosus; Cervical neoplasia
ID SQUAMOUS INTRAEPITHELIAL LESIONS; CARCINOMA IN-SITU; INTRAVENOUS
   CYCLOPHOSPHAMIDE; CERVICOVAGINAL CYTOLOGY; CANCER; WOMEN; DYSPLASIA;
   BIAS
AB Methods. A systematic review of English-language studies was conducted. Data on the risk of cervical neoplasia risk in patients with SLE were pooled using case-control models. Replication studies that tested the association between SLE and cervical neoplasia risk were reviewed for meta-analysis. The meta-analysis procedure was used to pool odds ratios (ORs) with 95% CIs to evaluate the association.
   Results. Seven replication studies fulfilled the selection criteria for inclusion in the meta-analysis. Homogeneity was confirmed across the replication studies. The common OR was 4.17 (95% CI 3.03, 5.74; P < 0.00001) for the study. The association was confirmed when individuals with SLE have an increased susceptibility to cervical neoplasia risk.
   Conclusion. This meta-analysis demonstrates the positive association between SLE and cervical neoplasia risk. Individuals with SLE have a heightened risk of developing cervical cancer.
C1 [Liu, Hongli; Ding, Qian; Yang, Kunyu; Zhang, Tao; Li, Guiling; Wu, Gang] Huazhong Univ Sci & Technol, Ctr Canc, Wuhan Union Hosp, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China.
RP Liu, HL (reprint author), Huazhong Univ Sci & Technol, Ctr Canc, Wuhan Union Hosp, Tongji Med Coll, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.
EM liuhl60@gmail.com
CR Bao YP, 2008, INT J GYNECOL CANCER, V18, P71, DOI 10.1111/j.1525-1438.2007.00959.x
   Bateman H, 2000, LUPUS, V9, P542, DOI 10.1177/096120330000900711
   Bernatsky S, 2004, RHEUMATOLOGY, V43, P1386, DOI 10.1093/rheumatology/keh331
   Bernatsky S, 2009, RHEUMATOLOGY, V48, P149, DOI 10.1093/rheumatology/ken442
   Bernatsky SR, 2006, J RHEUMATOL, V33, P45
   Beskow AH, 2005, INT J CANCER, V117, P690, DOI 10.1002/ijc.21212
   Biljana M, 1999, ST HEAL T, V68, P323
   BLUMENFELD Z, 1994, LUPUS, V3, P59, DOI 10.1177/096120339400300112
   Blumenfeld Z, 2001, J SOC GYNECOL INVEST, V8, pS60, DOI 10.1016/S1071-5576(00)00112-X
   Cantor SB, 2005, ACTA CYTOL, V49, P405, DOI 10.1159/000326174
   Dasanu CA, 2008, SOUTH MED J, V101, P1161, DOI 10.1097/SMJ.0b013e31818956f6
   Dhar JP, 2001, GYNECOL ONCOL, V82, P4, DOI 10.1006/gyno.2001.6207
   Dobkin PL, 2001, J RHEUMATOL, V28, P2442
   Febronio MV, 2007, LUPUS, V16, P430, DOI 10.1177/0961203307079298
   Gayed M, 2009, LUPUS, V18, P479, DOI 10.1177/0961203309102556
   Ishida Wannapa Settheetham, 2004, Asian Pac J Cancer Prev, V5, P383
   KING CS, 1992, CENT AFR J MED, V38, P198
   Klumb EM, 2010, LUPUS, V19, P1485, DOI 10.1177/0961203310372952
   Kurokawa H, 2002, HEAD NECK-J SCI SPEC, V24, P731, DOI 10.1002/hed.10130
   Lean IJ, 2009, J DAIRY SCI, V92, P3545, DOI 10.3168/jds.2009-2140
   LEWIS RB, 1976, ARTHRITIS RHEUM, V19, P1256, DOI 10.1002/art.1780190605
   Liang MH, 2006, ARTHRITIS RHEUM, V54, P421, DOI 10.1002/art.21625
   Mercado Ulises, 2009, Ginecol Obstet Mex, V77, P423
   Nath R, 2007, ARTHRIT RHEUM-ARTHR, V57, P619, DOI 10.1002/art.22667
   NYBERG G, 1981, ARTHRITIS RHEUM, V24, P648, DOI 10.1002/art.1780240503
   Ognenovski VM, 2004, J RHEUMATOL, V31, P1763
   Shi HZ, 2008, RESPIROLOGY, V13, P518, DOI 10.1111/j.1440-1843.2008.01291.x
   Silcocks P, 2009, J EPIDEMIOL COMMUN H, V63, P856, DOI 10.1136/jech.2008.075069
   Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8
   Tam LS, 2004, ARTHRITIS RHEUM, V50, P3619, DOI 10.1002/art.20616
   Thomas DB, 2002, CANCER CAUSE CONTROL, V13, P683, DOI 10.1023/A:1019527113057
   Yacobi S, 2002, TERATOLOGY, V66, P300, DOI 10.1002/tera.10109
   Zarchi MK, 2009, ASIAN PAC J CANCER P, V10, P969
NR 33
TC 15
Z9 16
U1 2
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1462-0324
EI 1462-0332
J9 RHEUMATOLOGY
JI RHEUMATOLOGY
PD FEB
PY 2011
VL 50
IS 2
BP 343
EP 348
DI 10.1093/rheumatology/keq304
PG 6
WC Rheumatology
SC Rheumatology
GA 709TK
UT WOS:000286464100016
PM 20929972
OA Other Gold
DA 2018-12-27
ER

PT J
AU Abhary, M
   Siritunga, D
   Stevens, G
   Taylor, NJ
   Fauquet, CM
AF Abhary, Mohammad
   Siritunga, Dimuth
   Stevens, Gene
   Taylor, Nigel J.
   Fauquet, Claude M.
TI RETRACTED: Transgenic Biofortification of the Starchy Staple Cassava
   (Manihot esculenta) Generates a Novel Sink for Protein (Retracted
   article. See vol. 7, 2012)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID RECOMBINANT STORAGE PROTEIN; ZEOLIN; PLANTS; CRANTZ; IMPROVEMENT;
   EXPRESSION; POTATO; FOOD; GENE; ROOT
AB Although calorie dense, the starchy, tuberous roots of cassava provide the lowest sources of dietary protein within the major staple food crops (Manihot esculenta Crantz). (Montagnac JA, Davis CR, Tanumihardjo SA. (2009) Compr Rev Food Sci Food Saf 8:181-194). Cassava was genetically modified to express zeolin, a nutritionally balanced storage protein under control of the patatin promoter. Transgenic plants accumulated zeolin within de novo protein bodies localized within the root storage tissues, resulting in total protein levels of 12.5% dry weight within this tissue, a fourfold increase compared to non-transgenic controls. No significant differences were seen for morphological or agronomic characteristics of transgenic and wild type plants in the greenhouse and field trials, but relative to controls, levels of cyanogenic compounds were reduced by up to 55% in both leaf and root tissues of transgenic plants. Data described here represent a proof of concept towards the potential transformation of cassava from a starchy staple, devoid of storage protein, to one capable of supplying inexpensive, plant-based proteins for food, feed and industrial applications.
C1 [Abhary, Mohammad; Taylor, Nigel J.; Fauquet, Claude M.] Donald Danforth Plant Sci Ctr, Int Lab Trop Agr Biotechnol, St Louis, MO USA.
   [Siritunga, Dimuth] Univ Puerto Rico Mayaguez, Dept Biol, Mayaguez, PR USA.
   [Stevens, Gene] Univ Missouri, Delta Ctr, Portageville, MO USA.
RP Abhary, M (reprint author), Donald Danforth Plant Sci Ctr, Int Lab Trop Agr Biotechnol, St Louis, MO USA.
EM iltab@danforthcenter.org
FU Bill and Melinda Gates Foundation
FX The Bill and Melinda Gates Foundation funded this work. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Bellucci M, 2007, J BIOTECHNOL, V131, P97, DOI [10.1016/j.jbiotec.2007.06.004, 10.1016/j.jbiotee.2007.06.004]
   Bellucci M, 2007, PLANT CELL TISS ORG, V90, P85, DOI 10.1007/s11240-007-9258-8
   Chakraborty S, 2000, P NATL ACAD SCI USA, V97, P3724, DOI 10.1073/pnas.050012697
   Dellaporta SL, 1983, PLANT MOL BIOL REP, V14, P19, DOI DOI 10.1007/BF02712670
   EGNIN M, 2001, IN VITRO CELL DEV, V37, P36
   El-Sharkawy MA, 2004, PLANT MOL BIOL, V56, P481, DOI 10.1007/s11103-005-2270-7
   Jorgensen K, 2005, PLANT PHYSIOL, V139, P363, DOI 10.1104/pp.105.065904
   KAWANO K, 1990, EUPHYTICA, V46, P195, DOI 10.1007/BF00027218
   KAWANO K, 1987, CROP SCI, V27, P69, DOI 10.2135/cropsci1987.0011183X002700010018x
   Kim J., 1992, Molecular approaches to improving food quality and safety., P1
   KOSTERTOPFER M, 1989, MOL GEN GENET, V219, P390, DOI 10.1007/BF00259611
   Mainieri D, 2004, PLANT PHYSIOL, V136, P3447, DOI 10.1104/pp.104.046409
   Montagnac JA, 2009, COMPR REV FOOD SCI F, V8, P181, DOI 10.1111/j.1541-4337.2009.00077.x
   Nassar NMA, 2007, GENET MOL RES, V6, P292
   OMOLE TA, 1977, CASSAVA ANIMAL FEED, P51
   ROSLING H, 1988, CASSAVA TOXICITY FOO
   Schreuder MM, 2001, EUPHYTICA, V120, P35, DOI 10.1023/A:1017530932536
   Sheffield J, 2006, PROTEOMICS, V6, P1588, DOI 10.1002/pmic.200500503
   Siritunga D, 2004, PLANT MOL BIOL, V56, P661, DOI 10.1007/s11103-004-3415-9
   Sreeja VG, 2002, PLANT FOOD HUM NUTR, V57, P141, DOI 10.1023/A:1015200529646
   STEPHENSON K, NUTR J, V9, P9
   Stupak M, 2006, TRENDS FOOD SCI TECH, V17, P634, DOI 10.1016/j.tifs.2006.06.004
   Vetter J, 2000, TOXICON, V38, P11, DOI 10.1016/S0041-0101(99)00128-2
   Yeoh HH, 1996, J SCI FOOD AGR, V70, P51, DOI 10.1002/(SICI)1097-0010(199601)70:1<51::AID-JSFA463>3.0.CO;2-W
   YOUNG VR, 1994, AM J CLIN NUTR, V59, p1203S, DOI 10.1093/ajcn/59.5.1203S
   Zhang P, 2003, TRANSGENIC RES, V12, P243, DOI 10.1023/A:1022918925882
   2007, WHO TECHNICAL REPORT
NR 27
TC 11
Z9 13
U1 1
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 25
PY 2011
VL 6
IS 1
AR e16256
DI 10.1371/journal.pone.0016256
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 712IZ
UT WOS:000286661400039
PM 21283593
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Jiang, SX
   Alberich-Jorda, M
   Zagozdzon, R
   Parmar, K
   Fu, YG
   Mauch, P
   Banu, N
   Makriyannis, A
   Tenen, DG
   Avraham, S
   Groopman, JE
   Avraham, HK
AF Jiang, Shuxian
   Alberich-Jorda, Meritxell
   Zagozdzon, Radoslaw
   Parmar, Kalindi
   Fu, Yigong
   Mauch, Peter
   Banu, Naheed
   Makriyannis, Alexandros
   Tenen, Daniel G.
   Avraham, Shalom
   Groopman, Jerome E.
   Avraham, Hava Karsenty
TI RETRACTED: Cannabinoid receptor 2 and its agonists mediate hematopoiesis
   and hematopoietic stem and progenitor cell mobilization (Retracted
   article. See vol. 118, pg. 2027, 2011)
SO BLOOD
LA English
DT Article; Retracted Publication
ID COLONY-STIMULATING FACTOR; CB2 RECEPTOR; BONE-MARROW; ENDOCANNABINOID
   SYSTEM; IMMUNE CELLS; BRAIN-INJURY; MIGRATION; DIFFERENTIATION;
   EXPRESSION; LIGAND
AB Endocannabinoids are arachidonic acid derivatives and part of a novel bioactive lipid signaling system, along with their G-coupled cannabinoid receptors (CB1 and CB2) and the enzymes involved in their biosynthesis and degradation. However, their roles in hematopoiesis and hematopoietic stem and progenitor cell (HSPC) functions are not well characterized. Here, we show that bone marrow stromal cells express endocannabinoids (anandamide and 2-arachidonylglycerol), whereas CB2 receptors are expressed in human and murine HSPCs. On ligand stimulation with CB2 agonists, CB2 receptors induced chemotaxis, migration, and enhanced colony formation of bone marrow cells, which were mediated via ERK, PI3-kinase, and G alpha i-Rac1 pathways. In vivo, the CB2 agonist AM1241 induced mobilization of murine HSPCs with shortand long-term repopulating abilities. In addition, granulocyte colony-stimulating factor -induced mobilization of HSPCs was significantly decreased by specific CB2 antagonists and was impaired in Cnr2(-/-)cannabinoid type 2 receptor knockout mice. Taken together, these results demonstrate that the endocannabinoid system is involved in hematopoiesis and that CB2/CB2 agonist axis mediates repopulation of hematopoiesis and mobilization of HSPCs. Thus, CB2 agonists may be therapeutically applied in clinical conditions, such as bone marrow transplantation. (Blood.2011; 117(3):827-838)
C1 [Avraham, Hava Karsenty] Beth Israel Deaconess Med Ctr, Div Expt Med, Harvard Inst Med, Boston, MA 02215 USA.
   [Jiang, Shuxian; Alberich-Jorda, Meritxell; Zagozdzon, Radoslaw; Parmar, Kalindi; Fu, Yigong; Mauch, Peter; Banu, Naheed; Tenen, Daniel G.; Avraham, Shalom; Groopman, Jerome E.; Avraham, Hava Karsenty] Harvard Univ, Sch Med, Boston, MA USA.
   [Alberich-Jorda, Meritxell; Tenen, Daniel G.] Harvard Stem Cell Inst, Boston, MA USA.
   [Parmar, Kalindi; Mauch, Peter] Dana Farber Canc Inst, Boston, MA 02115 USA.
   [Makriyannis, Alexandros] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA.
   [Makriyannis, Alexandros] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA.
   [Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore.
RP Avraham, HK (reprint author), Beth Israel Deaconess Med Ctr, Div Expt Med, Harvard Inst Med, 99 Brookline Ave,3rd Floor, Boston, MA 02215 USA.
EM havraham@bidmc.harvard.edu
OI Avraham, Hava/0000-0002-7545-3640; Tenen, Daniel/0000-0002-6423-3888
FU National Institutes of Health [CA 096805, CA135226]; National Blood
   Foundation; European Hematology Association; DOD [BC086398, CA10941,
   HL56745, CA118316]
FX This work was supported by the National Institutes of Health (grants CA
   096805 and CA135226, H. K. A.), National Blood Foundation (H. K. A.),
   and European Hematology Association (EHA research fellowship, M.A.-J.;
   DOD concept award BC086398, S.J.; CA10941, P. M.; and HL56745 and
   CA118316, D.G.T.).
CR Adams GB, 2009, NATURE, V459, P103, DOI 10.1038/nature07859
   Bab I, 2008, J NEUROENDOCRINOL, V20, P69, DOI 10.1111/j.1365-2826.2008.01675.x
   Bensinger WI, 1996, STEM CELLS, V14, P90, DOI 10.1002/stem.140090
   Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385
   Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9
   Carayon P, 1998, BLOOD, V92, P3605
   De Laurentiis A, 2010, NEUROIMMUNOMODULAT, V17, P153, DOI 10.1159/000258711
   Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055
   Durand EM, 2010, CURR OPIN HEMATOL, V17, P308, DOI 10.1097/MOH.0b013e32833a888c
   Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001
   GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x
   Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015
   Gazitt Y, 2003, STEM CELLS, V22, P65, DOI 10.1634/stemcells.22-1-65
   Ghosh S, 2006, MOL IMMUNOL, V43, P2169, DOI 10.1016/molimm.2006.01.005
   Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797
   He F, 2007, MOL PHARMACOL, V72, P1289, DOI 10.1124/mol.107.036566
   Hess DA, 2007, BIOL BLOOD MARROW TR, V13, P747
   Hess DA, 2007, BIOL BLOOD MARROW TR, V13, P398, DOI 10.1016/j.bbmt.2006.12.445
   Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335
   Humblet Valerie, 2005, Mol Imaging, V4, P448
   Jackson JS, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt17
   Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641
   Jorda MA, 2004, BLOOD, V104, P526, DOI 10.1182/blood-2003-12-4257
   Jorda MA, 2002, BLOOD, V99, P2786
   Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026
   Kishimoto S, 2005, J BIOCHEM, V137, P217, DOI 10.1093/jb/mvi021
   Klein TW, 2004, J NEUROIMMUNOL, V147, P91, DOI 10.1016/j.neuroim.2003.10.019
   Malcher-Lopes R, 2009, VITAM HORM, V81, P263, DOI 10.1016/S0083-6729(09)81011-X
   MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0
   Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6
   Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523
   Misra P, 2008, J NUCL MED, V49, P963, DOI 10.2967/jnumed.107.050054
   Molina-Holgado F, 2007, EUR J NEUROSCI, V25, P629, DOI 10.1111/j.1460-9568.2007.05322.x
   MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0
   Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043
   Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582
   Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200
   Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje
   Papayannopoulou T, 2003, BLOOD, V101, P4739, DOI 10.1182/blood-2002-09-2741
   Parolaro D, 1999, LIFE SCI, V65, P637, DOI 10.1016/S0024-3205(99)00286-6
   Patinkin D, 2008, EUR J PHARMACOL, V595, P1, DOI 10.1016/j.ejphar.2008.05.002
   Pelus LM, 2008, CURR OPIN HEMATOL, V15, P285, DOI 10.1097/MOH.0b013e328302f43a
   Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710
   Petty JM, 2009, J IMMUNOL, V182, P604, DOI 10.4049/jimmunol.182.1.604
   Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003
   Randall MD, 2007, BRIT J PHARMACOL, V152, P671, DOI 10.1038/sj.bjp.0707420
   Schmid PC, 1997, P NATL ACAD SCI USA, V94, P4188, DOI 10.1073/pnas.94.8.4188
   Shoemaker JL, 2005, J PHARMACOL EXP THER, V315, P828, DOI 10.1124/jpet.105.089474
   Song ZH, 2000, J PHARMACOL EXP THER, V294, P204
   Valk P, 1997, BLOOD, V90, P1448
   Williams J, 2007, ANAL CHEM, V79, P5582, DOI 10.1021/ac0624086
   Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780
NR 52
TC 17
Z9 20
U1 2
U2 9
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD JAN 20
PY 2011
VL 117
IS 3
BP 827
EP 838
DI 10.1182/blood-2010-01-265082
PG 12
WC Hematology
SC Hematology
GA 709GM
UT WOS:000286426300014
PM 21063029
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Anderson, DE
   Vogel, EK
   Awh, E
AF Anderson, David E.
   Vogel, Edward K.
   Awh, Edward
TI RETRACTED: Precision in Visual Working Memory Reaches a Stable Plateau
   When Individual Item Limits Are Exceeded (Retracted article. See vol.
   35, pg. 12081, 2015)
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article; Retracted Publication
ID SHORT-TERM-MEMORY; POSTERIOR PARIETAL CORTEX; NEURAL MEASURES; CAPACITY;
   REPRESENTATIONS; INTELLIGENCE; MAINTENANCE; MECHANISMS; ATTENTION;
   STORAGE
AB Multiple studies have demonstrated that resolution in working memory (WM) declines as the number of stored items increases. Discrete-resource models predict that this decline should reach a stable plateau at relatively small set sizes because item limits prevent additional information from being encoded into WM at larger set sizes. By contrast, flexible-resource models predict that the monotonic declines in precision will continue indefinitely as set size increases and resources are distributed without any fixed item limit. In the present work, we found that WM resolution exhibited monotonic declines until set size reached three items, after which resolution achieved a clear asymptote. Moreover, analyses of individual differences showed a strong correlation between each observer's item limit and the set size at which WM resolution achieved asymptote. These behavioral observations were corroborated by measurements of contralateral delay activity (CDA), an event-related potential waveform that tracks the number of items maintained during the delay period. CDA activity rose monotonically and achieved asymptote at a set size that predicted individual WM capacity. Moreover, this neural measure of on-line storage also predicted the set size at which mnemonic resolution reached a stable plateau for each observer. Thus, independent behavioral and neural measures of WM capacity support a clear prediction of discrete-resource models. Precision in visual WM reaches asymptote when individual item limits are exceeded.
C1 [Anderson, David E.; Vogel, Edward K.; Awh, Edward] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.
RP Awh, E (reprint author), 1227 Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.
EM awh@uoregon.edu
FU National Institutes of Health [R01 MH077105-01A2]
FX This work was supported by National Institutes of Health Grant R01
   MH077105-01A2 (E.A., E.K.V.). E.A. and D.E.A. conceived and designed the
   experiment, D.E.A. collected and analyzed data, and D.E.A., E.K.V., and
   E.A. wrote the manuscript.
CR Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X
   Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x
   Barton B, 2009, J EXP PSYCHOL HUMAN, V35, P1359, DOI 10.1037/a0015792
   BAYS P, 2010, ARCH GEN PSYCHIAT ON, V16
   Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023
   Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7
   Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357
   Cusack R, 2009, PSYCHON B REV, V16, P641, DOI 10.3758/PBR.16.4.641
   Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008
   Ester EF, 2009, J NEUROSCI, V29, P15258, DOI 10.1523/JNEUROSCI.4388-09.2009
   Fukuda K, 2010, PSYCHON B REV, V17, P673, DOI 10.3758/17.5.673
   Gold JM, 2010, ARCH GEN PSYCHIAT, V67, P570, DOI 10.1001/archgenpsychiatry.2010.65
   Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832
   Jonides J, 2005, CURR DIR PSYCHOL SCI, V14, P2, DOI 10.1111/j.0963-7214.2005.00323.x
   LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473
   Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660
   Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846
   McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7
   Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366
   Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005
   Raffone A, 2001, J COGNITIVE NEUROSCI, V13, P766, DOI 10.1162/08989290152541430
   Rouder JN, 2008, P NATL ACAD SCI USA, V105, P5975, DOI 10.1073/pnas.0711295105
   Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x
   Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144
   Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466
   Umemoto A, 2010, COGNITION, V117, P69, DOI 10.1016/j.cognition.2010.07.001
   Vogel EK, 2008, CURR DIR PSYCHOL SCI, V17, P171, DOI 10.1111/j.1467-8721.2008.00569.x
   Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171
   Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447
   Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656
   Wilken P, 2004, J VISION, V4, P1120, DOI 10.1167/4.12.11
   Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262
   Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860
NR 33
TC 116
Z9 120
U1 4
U2 27
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JAN 19
PY 2011
VL 31
IS 3
BP 1128
EP 1138
DI 10.1523/JNEUROSCI.4125-10.2011
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 708OS
UT WOS:000286373700037
PM 21248137
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Prasad, S
   Yadav, VR
   Ravindran, J
   Aggarwal, BB
AF Prasad, Sahdeo
   Yadav, Vivek R.
   Ravindran, Jayaraj
   Aggarwal, Bharat B.
TI RETRACTED: ROS and CHOP Are Critical for Dibenzylideneacetone to
   Sensitize Tumor Cells to TRAIL through Induction of Death Receptors and
   Downregulation of Cell Survival Proteins (Retracted article. See vol.
   78, pg. 5185, 2018)
SO CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID APOPTOSIS-INDUCING LIGAND; DR5 UP-REGULATION; COLON-CANCER CELLS;
   IN-VIVO; DECOY RECEPTORS; C-FLIP; RESISTANCE; ACTIVATION; INHIBITION;
   EXPRESSION
AB Because tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) selectively kills tumor cells, it is being tested in cancer patients. Unfortunately, patients develop resistance to the cytokine, therefore, agents that can sensitize cells to TRAIL are urgently needed. In this study, we investigated whether dibenzylideneacetone (DBA) can sensitize cancer cells to TRAIL and potentiates TRAIL-induced apoptosis. As indicated by accumulation of the membrane phospholipid phosphatidylserine, DNA breaks, intracellular esterase activity, and activation of caspase-8, -9, and -3, we concluded that DBA potentiated TRAIL-induced apoptosis in colon cancer cells. DBA also converted TRAIL resistant-cells to TRAIL-sensitive. When examined for the mechanism, we found that DBA decreased the expression of antiapoptotic proteins and decoy recptor-2 and increased proapoptotic proteins. DBA also induced both death receptor (DR)-5 and DR4. Knockdown of DR5 and DR4 by small interfering RNA (SiRNA) reduced the sensitizing effect of DBA on TRAIL-induced apoptosis. In addition, DBA increased the expression of CHOP proteins. Knockdown of CHOP by siRNA decreased the induction of DBA-induced DR5 expression and apoptosis. Induction of receptors by DBA, however, was p53-independent, as deletion of p53 had no effect on receptor induction. We observed that DBA-induced induction of DR5 and DR4 was mediated through generation of reactive oxygen species (ROS), as N-acetylcysteine blocked the induction of death receptors and suppression of cell survival proteins by DBA. Overall, our results show that DBA potentiates TRAIL-induced apoptosis through downregulation of cell survival proteins and upregulation of death receptors via activation of ROS and CHOP mediated pathways. Cancer Res; 71(2); 538-49. (C) 2010 AACR.
C1 [Prasad, Sahdeo; Yadav, Vivek R.; Ravindran, Jayaraj; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Aggarwal, Bharat/G-3388-2013
FU Clayton Foundation for Research; National Institutes of Health
   [CA-16672, NIH CA-124787-01A2]; Center for Targeted Therapy of MD
   Anderson Cancer Center
FX This work was supported by a grant from the Clayton Foundation for
   Research (B.B. Aggarwal), a core grant from the National Institutes of
   Health (CA-16672), a program project grant from National Institutes of
   Health (NIH CA-124787-01A2), and a grant from the Center for Targeted
   Therapy of MD Anderson Cancer Center.
CR Asakuma J, 2003, CANCER RES, V63, P1365
   Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926
   Bhandarkar SS, 2008, CLIN CANCER RES, V14, P5743, DOI 10.1158/1078-0432.CCR-08-0405
   Burns TF, 2001, ONCOGENE, V20, P4601, DOI 10.1038/sj.onc.1204484
   Camidge DR, 2010, CLIN CANCER RES, V16, P1256, DOI 10.1158/1078-0432.CCR-09-1267
   Chen JJ, 2008, J IMMUNOL, V180, P8030, DOI 10.4049/jimmunol.180.12.8030
   Chen SZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-23
   Goncharenko-Khaider N, 2010, ONCOGENE, V29, P5523, DOI 10.1038/onc.2010.288
   Hotte SJ, 2008, CLIN CANCER RES, V14, P3450, DOI 10.1158/1078-0432.CCR-07-1416
   Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006
   Jo M, 2000, NAT MED, V6, P564
   Jung EM, 2006, CARCINOGENESIS, V27, P2008, DOI 10.1093/carcin/bgl026
   Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397
   LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187
   Lee TJ, 2006, BIOCHEM BIOPH RES CO, V351, P1024, DOI 10.1016/j.bbrc.2006.10.163
   Lee TJ, 2009, FREE RADICAL BIO MED, V46, P1639, DOI 10.1016/j.freeradbiomed.2009.03.022
   Leverkus M, 2003, J INVEST DERMATOL, V121, P149, DOI 10.1046/j.1523-1747.2003.12332.x
   Liao XB, 2003, MOL CANCER THER, V2, P1215
   Lim JH, 2009, CARCINOGENESIS, V30, P729, DOI 10.1093/carcin/bgn265
   Ma XM, 2009, WORLD J GASTROENTERO, V15, P3874, DOI 10.3748/wjg.15.3874
   Meng RD, 2000, MOL THER, V1, P130, DOI 10.1006/mthe.2000.0025
   Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06
   Mullally JE, 2002, MOL PHARMACOL, V62, P351, DOI 10.1124/mol.62.2.351
   Nam SY, 2003, CANCER SCI, V94, P1066, DOI 10.1111/j.1349-7006.2003.tb01402.x
   Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812
   Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Pellerito O, MOL PHARM, V77, P854
   Plummer R, 2007, CLIN CANCER RES, V13, P6187, DOI 10.1158/1078-0432.CCR-07-0950
   Prasad S, 2010, MOL CANCER THER, V9, P856, DOI 10.1158/1535-7163.MCT-09-1113
   Ren YG, 2004, MOL BIOL CELL, V15, P5064, DOI 10.1091/mbc.E04-03-0184
   Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102
   Schultze K, 2006, APOPTOSIS, V11, P1503, DOI 10.1007/s10495-006-8896-3
   Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1
   Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996
   Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818
   Su RY, 2008, MOL CANCER THER, V7, P3429, DOI 10.1158/1535-7163.MCT-08-0498
   Sung BK, 2010, J BIOL CHEM, V285, P35418, DOI 10.1074/jbc.M110.172767
   Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489
   Thorburn A, 2008, DRUG RESIST UPDATE, V11, P17, DOI 10.1016/j.drup.2008.02.001
   Walczak H, 1999, NAT MED, V5, P157
   Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386
   Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141
   Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200
   Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161
   Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792
   Zou W, 2007, CANCER BIOL THER, V6, P99, DOI 10.4161/cbt.6.1.3555
NR 48
TC 52
Z9 52
U1 1
U2 9
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD JAN 15
PY 2011
VL 71
IS 2
BP 538
EP 549
DI 10.1158/0008-5472.CAN-10-3121
PG 12
WC Oncology
SC Oncology
GA 706CI
UT WOS:000286193900025
PM 21127198
OA Bronze, Green Accepted
DA 2018-12-27
ER

PT J
AU Gupta, SC
   Reuter, S
   Phromnoi, K
   Park, B
   Hema, PS
   Nair, M
   Aggarwal, BB
AF Gupta, Subash C.
   Reuter, Simone
   Phromnoi, Kanokkarn
   Park, Byoungduck
   Hema, Padmanabhan S.
   Nair, Mangalam
   Aggarwal, Bharat B.
TI RETRACTED: Nimbolide Sensitizes Human Colon Cancer Cells to TRAIL
   through Reactive Oxygen Species- and ERK-dependent Up-regulation of
   Death Receptors, p53, and Bax (Retracted article. See vol. 291, pg.
   16925, 2016)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID NF-KAPPA-B; TREE AZADIRACHTA-INDICA; INDUCED APOPTOSIS;
   HYDROGEN-PEROXIDE; DOWN-REGULATION; MEDIATED APOPTOSIS; ALPHA KINASE;
   TUMOR-CELLS; DNA-DAMAGE; RESISTANCE
AB TNF-related apoptosis-inducing ligand (TRAIL) shows promise as a cancer treatment, but acquired tumor resistance to TRAIL is a roadblock. Here we investigated whether nimbolide, a limonoid, could sensitize human colon cancer cells to TRAIL. As indicated by assays that measure esterase activity, sub-G(1) fractions, mitochondrial activity, and activation of caspases, nimbolide potentiated the effect of TRAIL. This limonoid also enhanced expression of death receptors (DRs) DR5 and DR4 in cancer cells. Gene silencing of the receptors reduced the effect of limonoid on TRAIL-induced apoptosis. Using pharmacological inhibitors, we found that activation of ERK and p38 MAPK was required for DR up-regulation by nimbolide. Gene silencing of ERK abolished the enhancement of TRAIL-induced apoptosis. Moreover, our studies indicate that the limonoid induced reactive oxygen species production, which was required for ERK activation, up-regulation of DRs, and sensitization to TRAIL; these effects were mimicked by H2O2. In addition, nimbolide down-regulated cell survival proteins, including I-FLICE, cIAP-1, cIAP-2, Bcl-2, Bcl-xL, survivin, and X-linked inhibitor of apoptosis protein, and up-regulated the pro-apoptotic proteins p53 and Bax. Interestingly, p53 and Bax up-regulation by nimbolide was required for sensitization to TRAIL but not for DR up-regulation. Overall, our results indicate that nimbolide can sensitize colon cancer cells to TRAIL-induced apoptosis through three distinct mechanisms: reactive oxygen species- and ERK-mediated up-regulation of DR5 and DR4, downregulation of cell survival proteins, and up-regulation of p53 and Bax.
C1 [Gupta, Subash C.; Reuter, Simone; Phromnoi, Kanokkarn; Park, Byoungduck; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA.
   [Hema, Padmanabhan S.; Nair, Mangalam] Natl Inst Interdisciplinary Sci & Technol CSIR, Organ Chem Sect, Trivandrum 695019, Kerala, India.
RP Aggarwal, BB (reprint author), Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA.
EM aggarwal@mdanderson.org
RI Aggarwal, Bharat/G-3388-2013; TVM, NIIST/E-5132-2012
OI TVM, NIIST/0000-0002-5814-466X
FU National Institutes of Health [CA016672, CA-124787-01A2]; Clayton
   Foundation for Research; Center for Targeted Therapy of the M.D.
   Anderson Cancer Center
FX This work was supported, in whole or in part, by National Institutes of
   Health Support Grant CA016672 (to the M. D. Anderson Cancer Center) and
   National Institutes of Health Program Project Grant CA-124787-01A2. This
   work was also supported by a grant from the Clayton Foundation for
   Research (to B. B. A.) and a grant from the Center for Targeted Therapy
   of the M.D. Anderson Cancer Center.
CR Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184
   Anitha G, 2006, J ASIAN NAT PROD RES, V8, P445, DOI 10.1080/10286020500173267
   [Anonymous], 1993, CA CAN J CLIN, V43, P47
   Bellail AC, 2009, REV RECENT CLIN TRIA, V4, P34, DOI 10.2174/157488709787047530
   Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320
   Bratton SB, 2003, CELL DEATH DIFFER, V10, P4, DOI 10.1038/sj.cdd.4401176
   Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416
   Clohessy JG, 2006, J BIOL CHEM, V281, P5750, DOI 10.1074/jbc.M505688200
   Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901
   Gupta SC, 2010, J BIOL CHEM, V285, P35406, DOI 10.1074/jbc.M110.161984
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936
   HOLMAN RA, 1957, NATURE, V179, P1033, DOI 10.1038/1791033a0
   JEFFERSON GT, 1958, NATURE, V182, P892, DOI 10.1038/182892a0
   KHALID SA, 1989, J NAT PROD, V52, P922, DOI 10.1021/np50065a002
   Kumar GH, 2009, INVEST NEW DRUG, V27, P246, DOI 10.1007/s10637-008-9170-z
   Kwon D, 2008, BIOCHEM BIOPH RES CO, V372, P870, DOI 10.1016/j.bbrc.2008.05.148
   LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274
   Lee YJ, 2001, ONCOGENE, V20, P1476, DOI 10.1038/sj.onc.1204225
   Lopez-Lazaro M, 2007, CANCER LETT, V252, P1, DOI 10.1016/j.canlet.2006.10.029
   MacFarlane M, 2002, ONCOGENE, V21, P6809, DOI 10.1038/sj.onc.1205853
   Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4
   Moon DO, 2010, MOL CANCER THER, V9, P1583, DOI 10.1158/1535-7163.MCT-09-0942
   Nair MS, 1997, PHYTOCHEMISTRY, V46, P1177, DOI 10.1016/S0031-9422(97)00448-2
   Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197
   Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l
   Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815
   Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111
   Petronelli A, 2009, CANCER LETT, V282, P214, DOI 10.1016/j.canlet.2009.03.018
   Pezzuto J. M., 1986, NEW TRENDS NATURAL P, V26, P371
   Priyadarsini RV, 2009, FREE RADICAL RES, V43, P492, DOI 10.1080/10715760902870637
   Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096
   ROCHANAKIJ S, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P66
   Roy MK, 2007, PHYTOTHER RES, V21, P245, DOI 10.1002/ptr.2058
   Sastry BS, 2006, BIOORG MED CHEM LETT, V16, P4391, DOI 10.1016/j.bmcl.2006.05.105
   Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807
   Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996
   Siddiqui S, 1942, CURR SCI, V11, P278
   Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209
   Takada Y, 2004, J BIOL CHEM, V279, P26287, DOI 10.1074/jbc.M400963200
   Taniguchi H, 2008, CANCER RES, V68, P8918, DOI 10.1158/0008-5472.CAN-08-1120
   Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128
   Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627
   Wang R, 2007, CANCER RES, V67, P7856, DOI 10.1158/0008-5472.CAN-07-0151
   Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8
   Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141
   Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161
NR 47
TC 69
Z9 74
U1 3
U2 11
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 14
PY 2011
VL 286
IS 2
BP 1134
EP 1146
DI 10.1074/jbc.M110.191379
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 703TU
UT WOS:000286005000024
PM 21078664
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Chattopadhyay, SK
   Chatterjee, A
   Tandon, S
   Maulik, PR
   Kant, R
AF Chattopadhyay, Sunil K.
   Chatterjee, Arnab
   Tandon, Sudeep
   Maulik, Prakas R.
   Kant, Ruchir
TI RETRACTED: Isolation of optically active nevirapine, a
   dipyridodiazepinone metabolite from the seeds of Cleome viscosa
   (Retracted article. See vol. 67, pg. 4291, 2011)
SO TETRAHEDRON
LA English
DT Article; Retracted Publication
DE Cleome viscosa; Nevirapine; Dipyridodiazepinone; Secondary metabolite;
   Optically active
ID HIV-1 REVERSE-TRANSCRIPTASE
AB The optically active nevirapine, a natural analogue of the previously designed and synthesized optically inactive nevirapine, a non-nucleoside inhibitor of HIV-1 reverse transcriptase, has been isolated and fully characterized from the seeds of Cleome viscosa. The structure of natural nevirapine has been confirmed by X-ray crystallography. It is an interesting discovery to find out that optically inactive nevirapine was designed and synthesized before the isolation of optically active nevirapine from the seeds of C. viscosa. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Chattopadhyay, Sunil K.; Chatterjee, Arnab; Tandon, Sudeep] Cent Inst Med & Aromat Plants CSIR, Proc Chem & Chem Engn Dept, Lucknow 226015, Uttar Pradesh, India.
   [Maulik, Prakas R.; Kant, Ruchir] Cent Drug Res Inst CSIR, Mol & Struct Biol Div, Lucknow 226001, Uttar Pradesh, India.
RP Chattopadhyay, SK (reprint author), Cent Inst Med & Aromat Plants CSIR, Proc Chem & Chem Engn Dept, PO CIMAP, Lucknow 226015, Uttar Pradesh, India.
EM chattsk@yahoo.com
FU CSIR [NWP-09]
FX We thank the Director, CIMAP, Lucknow and Mr. Jamil Ahmad, Technical
   Officer for their cooperation. Financial assistance from the CSIR
   networking project NWP-09 is gratefully acknowledged.
CR Caira MR, 2008, CRYST GROWTH DES, V8, P17, DOI 10.1021/cg070522r
   CHATTOPADHYAY SK, 1999, Patent No. 182637
   CHATTOPADHYAY SK, 1999, Patent No. 182638
   CHAUHAN JS, 1979, INDIAN J CHEM B, V17, P300
   *CSIR, 1950, WEALTH IND RAW MAT C, V2, P231
   *CSIR, 2001, WEALTH IND RAW M C S, V2, P66
   Genovese S, 2009, PHYTOCHEMISTRY, V70, P1082, DOI 10.1016/j.phytochem.2009.06.016
   Hannongbua S, 2001, J COMPUT AID MOL DES, V15, P997, DOI 10.1023/A:1014881723431
   HARGRAVE KD, 1991, J MED CHEM, V34, P2231, DOI 10.1021/jm00111a045
   KUMAR S, 1988, PHYTOCHEMISTRY, V27, P636, DOI 10.1016/0031-9422(88)83163-7
   MAHATO SB, 1979, J AM CHEM SOC, V101, P4720, DOI 10.1021/ja00510a048
   ONEIL MJ, 2006, MERCK INDEX, P6491
   Pereira BG, 2007, CRYST GROWTH DES, V7, P2016, DOI 10.1021/cg0704495
   RAY AB, 1985, TETRAHEDRON, V41, P209, DOI 10.1016/S0040-4020(01)83488-8
   Songsak T, 2002, FITOTERAPIA, V73, P209, DOI 10.1016/S0367-326X(02)00061-8
   SRIVASTAVA SK, 1979, INDIAN J CHEM B, V18, P86
   Tandon S, 2010, IND CROP PROD, V31, P335, DOI 10.1016/j.indcrop.2009.11.014
NR 17
TC 6
Z9 6
U1 2
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0040-4020
J9 TETRAHEDRON
JI Tetrahedron
PD JAN 14
PY 2011
VL 67
IS 2
BP 452
EP 454
DI 10.1016/j.tet.2010.11.020
PG 3
WC Chemistry, Organic
SC Chemistry
GA 710GN
UT WOS:000286499000021
DA 2018-12-27
ER

PT J
AU De Domenico, I
   Vaughn, MB
   Paradkar, PN
   Lo, E
   Ward, DM
   Kaplan, J
AF De Domenico, Ivana
   Vaughn, Michael B.
   Paradkar, Prasad N.
   Lo, Eric
   Ward, Diane M.
   Kaplan, Jerry
TI RETRACTED: Decoupling Ferritin Synthesis from Free Cytosolic Iron
   Results in Ferritin Secretion (Retracted article. See vol. 15, pg. 927,
   2012)
SO CELL METABOLISM
LA English
DT Article; Retracted Publication
ID HUMAN-SERUM FERRITIN; REGULATORY PROTEINS; GLYCOSYLATED FERRITIN;
   FERROPORTIN DISEASE; EPITHELIAL-CELLS; RAT-LIVER; H-CHAIN; STORAGE;
   HOMEOSTASIS; OVERLOAD
AB Ferritin is a multisubunit protein that is responsible for storing and detoxifying cytosolic iron. Ferritin can be found in serum but is relatively iron poor. Serum ferritin occurs in iron overload disorders, in inflammation, and in the genetic disorder hyperferritinemia with cataracts. We show that ferritin secretion results when cellular ferritin synthesis occurs in the relative absence of free cytosolic iron. In yeast and mammalian cells, newly synthesized ferritin monomers can be translocated into the endoplasmic reticulum and transits through the secretory apparatus. Ferritin chains can be translocated into the endoplasmic reticulum in an in vitro translation and membrane insertion system. The insertion of ferritin monomers into the ER occurs under low-free-iron conditions, as iron will induce the assembly of ferritin. Secretion of ferritin chains provides a mechanism that limits ferritin nanocage assembly and ferritin-mediated iron sequestration in the absence of the translational inhibition of ferritin synthesis.
C1 [Vaughn, Michael B.; Paradkar, Prasad N.; Lo, Eric; Ward, Diane M.; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.
   [De Domenico, Ivana] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA.
RP Kaplan, J (reprint author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.
EM jerry.kaplan@path.utah.edu
FU NIH [DK030534]
FX The authors thank R. Schekman (University of California, Berkeley) for
   the yeast strains, S. Tort (Wake Forest University) and P. Arosio
   (University of Brescia, Italy) for ferritin antibodies, P. Ponka (McGill
   University) for desferasirox, and J. Barasch (Columbia University) for
   the 5' IRE constructs. The authors also thank members of the Kaplan
   laboratory for editing the manuscript. This work was supported by NIH
   grant DK030534 to J.K.
CR Burd CG, 1997, MOL BIOL CELL, V8, P1089
   Chen OS, 1998, J NUTR, V128, P525
   Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433
   CLEGG GA, 1980, PROG BIOPHYS MOL BIO, V36, P53
   Coffman LG, 2009, P NATL ACAD SCI USA, V106, P570, DOI 10.1073/pnas.0812010106
   Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815
   CRAGG SJ, 1981, BIOCHEM J, V199, P565, DOI 10.1042/bj1990565
   De Domenico I, 2009, BLOOD, V114, P4546, DOI 10.1182/blood-2009-05-224188
   Erhardt JG, 2004, J NUTR, V134, P3127
   FORD GC, 1984, PHILOS T R SOC B, V304, P551, DOI 10.1098/rstb.1984.0046
   Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007
   Geiser DL, 2006, INSECT BIOCHEM MOLEC, V36, P177, DOI 10.1016/j.ibmb.2005.12.001
   Ghosh S, 2004, BLOOD, V103, P2369, DOI 10.1182/blood-2003-09-3050
   Goralska M, 2003, J BIOL CHEM, V278, P42920, DOI 10.1074/jbc.M305827200
   Hetet G, 2003, BLOOD, V102, P1904, DOI 10.1182/blood-2003-02-0439
   Kannengiesser C, 2009, HAEMATOL-HEMATOL J, V94, P335, DOI 10.3324/haematol.2008.000125
   Kim HJ, 2003, APPL ENVIRON MICROB, V69, P1999, DOI 10.1128/AEM.69.4.1999-2005.2003
   KIVIRIKKO KI, 1989, FASEB J, V3, P1609
   Lambotte O, 2003, J RHEUMATOL, V30, P1027
   Lee PL, 2009, ANNU REV PATHOL-MECH, V4, P489, DOI 10.1146/annurev.pathol.4.110807.092205
   LEVI S, 1994, J MOL BIOL, V238, P649, DOI 10.1006/jmbi.1994.1325
   Li JY, 2004, AM J PHYSIOL-CELL PH, V287, pC1547, DOI 10.1152/ajpcell.00260.2004
   LUZZAGO A, 1989, EMBO J, V8, P569, DOI 10.1002/j.1460-2075.1989.tb03411.x
   Millholland JM, 2003, J BIOL CHEM, V278, P23963, DOI 10.1074/jbc.M210050200
   Missirlis F, 2007, GENETICS, V177, P89, DOI 10.1534/genetics.107.075150
   Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742
   Pictrangelo A, 2004, NAT CLIN PRACT GASTR, V1, P39, DOI 10.1038/ncpgasthep0019
   Pietrangelo A, 2004, BLOOD CELL MOL DIS, V32, P131, DOI 10.1016/j.bcmd.2003.08.003
   Rambod M, 2008, CLIN J AM SOC NEPHRO, V3, P1691, DOI 10.2215/CJN.01070308
   Recalcati S, 2008, J AUTOIMMUN, V30, P84, DOI 10.1016/j.jaut.2007.11.003
   Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807
   Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326
   Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643
   STIRLING CJ, 1992, MOL BIOL CELL, V3, P129
   TACCHINI L, 1992, BIOCHIM BIOPHYS ACTA, V1131, P133, DOI 10.1016/0167-4781(92)90067-A
   ten Kate J, 2001, J RHEUMATOL, V28, P2213
   tenKate J, 1997, EUR J CLIN CHEM CLIN, V35, P53
   Theil EC, 2004, ANNU REV NUTR, V24, P327, DOI 10.1146/annurev.nutr.24.012003.132212
   THEIL EC, 1990, ADV ENZYMOL RAMB, V63, P421
   Tran TN, 1997, BLOOD, V90, P4979
   TRIKHA J, 1995, J MOL BIOL, V248, P949, DOI 10.1006/jmbi.1995.0274
   Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333
   Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116
   Wang FD, 2007, NAT GENET, V39, P1025, DOI 10.1038/ng2059
   WORWOOD M, 1979, CLIN SCI MOL MED, V56, P83, DOI 10.1042/cs0560083
   Zohn IE, 2007, BLOOD, V109, P4174, DOI 10.1182/blood-2007-01-066068
NR 46
TC 11
Z9 11
U1 2
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD JAN 5
PY 2011
VL 13
IS 1
BP 57
EP 67
DI 10.1016/j.cmet.2010.12.003
PG 11
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 716KL
UT WOS:000286967400010
PM 21195349
OA Green Accepted, Bronze
DA 2018-12-27
ER

PT J
AU Gualberto, A
   Hixon, ML
   Karp, DD
   Li, D
   Green, S
   Dolled-Filhart, M
   Paz-Ares, LG
   Novello, S
   Blakely, J
   Langer, CJ
   Pollak, MN
AF Gualberto, A.
   Hixon, M. L.
   Karp, D. D.
   Li, D.
   Green, S.
   Dolled-Filhart, M.
   Paz-Ares, L. G.
   Novello, S.
   Blakely, J.
   Langer, C. J.
   Pollak, M. N.
TI RETRACTED: Pre-treatment levels of circulating free IGF-1 identify NSCLC
   patients who derive clinical benefit from figitumumab (Retracted
   article. See vol. 107, pg. 2024, 2012)
SO BRITISH JOURNAL OF CANCER
LA English
DT Article; Retracted Publication
DE IGF-IR; IGF-1; figitumumab; NSCLC
ID GROWTH-FACTOR-I; CELL LUNG-CANCER; FACTOR-BINDING PROTEIN-1; ANTIBODY
   CP-751,871; ELDERLY POPULATION; COLORECTAL-CANCER; BETA-CATENIN;
   INSULIN; BIOACTIVITY; THERAPY
AB BACKGROUND: Phase III trials of the anti-insulin-like growth factor type 1 receptor (IGF-IR) antibody figitumumab (F) in unselected non-small-cell lung cancer (NSCLC) patients were recently discontinued owing to futility. Here, we investigated a role of free IGF-1 (fIGF-1) as a potential predictive biomarker of clinical benefit from F treatment. MATERIALS AND METHODS: Pre-treatment circulating levels of fIGF-1 were tested in 110 advanced NSCLC patients enrolled in a phase II study of paclitaxel and carboplatin given alone (PC) or in combination with F at doses of 10 or 20 mg kg(-1) (PCF10, PCF20). RESULTS: Cox proportional hazards model interactions were between 2.5 and 3.5 for fIGF-1 criteria in the 0.5-0.9 ng ml(-1) range. Patients above each criterion had a substantial improvement in progression-free survival on PCF20 related to PC alone. Free IGF-1 correlated inversely with IGF binding protein 1 (IGFBP-1, rho = -0.295, P = 0.005), and the pre-treatment ratio of insulin to IGFBP-1 was also predictive of F clinical benefit. In addition, fIGF-1 levels correlated with tumour vimentin expression (rho = 0.594, P = 0.021) and inversely with E-cadherin (rho = -0.389, P = 0.152), suggesting a role for fIGF-1 in tumour de-differentiation. CONCLUSION: Free IGF-1 may contribute to the identification of a subset of NSCLC patients who benefit from F therapy. British Journal of Cancer (2011) 104, 68-74. doi:10.1038/sj.bjc.6605972 www.bjcancer.com Published online 23 November 2010 (C) 2011 Cancer Research UK
C1 [Gualberto, A.; Li, D.; Green, S.] Pfizer Oncol, Dept Clin Dev & Med Affairs, New London, CT 06320 USA.
   [Gualberto, A.; Hixon, M. L.] Brown Univ, Warren Alpert Med Sch, Dept Pathol & Lab Med, Providence, RI 02903 USA.
   [Karp, D. D.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Oncol, Houston, TX 77030 USA.
   [Dolled-Filhart, M.] HistoRx Inc, New Haven, CT 06511 USA.
   [Paz-Ares, L. G.] Virgen del Rocio Univ Hosp, Dept Med Oncol, Seville 41013, Spain.
   [Novello, S.] Univ Turin, Dept Med Oncol, I-10043 Turin, Italy.
   [Blakely, J.] West Clin, Dept Med Oncol, Memphis, TN 38120 USA.
   [Langer, C. J.] Univ Penn, Abramson Canc Ctr, Div Hematol Oncol, Philadelphia, PA 19104 USA.
   [Pollak, M. N.] McGill Univ, Dept Med Oncol, Montreal, PQ H3T 1E2, Canada.
RP Gualberto, A (reprint author), Pfizer Oncol, Dept Clin Dev & Med Affairs, New London, CT 06320 USA.
EM antonio.gualberto@mpi.com
RI Pollak, Michael/G-9094-2011; IBIS, NUEVAS TERAPIA/P-3415-2015
OI Pollak, Michael/0000-0003-3047-0604; 
FU NIH PHS [ES015704]; Pfizer Inc.
FX We thank our patients for their participation in this trial. This work
   was supported in part by NIH PHS Grants ES015704 (to MLH), and by Pfizer
   Inc.
CR Attia N, 1999, J CLIN ENDOCR METAB, V84, P2324, DOI 10.1210/jc.84.7.2324
   Bereket A, 1996, CLIN ENDOCRINOL, V45, P321, DOI 10.1046/j.1365-2265.1996.7760786.x
   Borai A, 2007, ANN CLIN BIOCHEM, V44, P324, DOI 10.1258/000456307780945778
   Brugts MP, 2008, J CLIN ENDOCR METAB, V93, P2515, DOI 10.1210/jc.2007-1633
   Brugts MP, 2008, J CLIN ENDOCR METAB, V93, P2539, DOI 10.1210/jc.2007-2454
   Brugts MP, 2010, DIABETES, V59, P505, DOI 10.2337/db09-0583
   Chang YS, 2002, CLIN CANCER RES, V8, P3796
   Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879
   Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070
   Dubaquie Y, 2001, ENDOCRINOLOGY, V142, P165, DOI 10.1210/en.142.1.165
   Dubaquie Y, 1999, BIOCHEMISTRY-US, V38, P6386, DOI 10.1021/bi990089p
   FAVONI RE, 1994, INT J CANCER, V56, P858, DOI 10.1002/ijc.2910560618
   Frystyk J, 2007, PITUITARY, V10, P181, DOI 10.1007/s11102-007-0025-y
   Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172
   GUALBERTO A, 2009, J CLIN ONCOL S, V27
   Gualberto A, 2010, EXPERT OPIN BIOL TH, V10, P575, DOI 10.1517/14712591003689980
   Han JY, 2006, LUNG CANCER, V54, P227, DOI 10.1016/j.lungcan.2006.07.014
   Janssen JAMJL, 1998, ARTERIOSCL THROM VAS, V18, P277, DOI 10.1161/01.ATV.18.2.277
   Jassem J, 2010, J CLIN ONCOL, V28, p15s
   Julien-Grille S, 2005, RISE FALL EPITHELIAL
   Juul A, 1997, J CLIN ENDOCR METAB, V82, P2497, DOI 10.1210/jc.82.8.2497
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Karp DD, 2009, J CLIN ONCOL, V27, P2516, DOI 10.1200/JCO.2008.19.9331
   Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2
   Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168
   LEE PDK, 1993, P SOC EXP BIOL MED, V204, P4
   Morali OG, 2001, ONCOGENE, V20, P4942, DOI 10.1038/sj.onc.1204660
   Playford MP, 2000, P NATL ACAD SCI USA, V97, P12103, DOI 10.1073/pnas.210394297
   Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536
   Sakai K, 2001, DIABETES, V50, P32, DOI 10.2337/diabetes.50.1.32
   Sauter G, 2009, J CLIN ONCOL, V27, P1323, DOI 10.1200/JCO.2007.14.8197
   Shepherd FA, 2010, J CLIN ONCOL, V28, P903, DOI 10.1200/JCO.2009.26.3996
   Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280
   Spitz MR, 2002, CANCER EPIDEM BIOMAR, V11, P1413
   Wolpin BM, 2009, J CLIN ONCOL, V27, P176, DOI 10.1200/JCO.2008.17.9945
   ZWEIG MH, 1993, CLIN CHEM, V39, P561
NR 36
TC 69
Z9 70
U1 2
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0007-0920
J9 BRIT J CANCER
JI Br. J. Cancer
PD JAN 4
PY 2011
VL 104
IS 1
BP 68
EP 74
DI 10.1038/sj.bjc.6605972
PG 7
WC Oncology
SC Oncology
GA 702SN
UT WOS:000285915900012
PM 21102589
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Arsenault, BJ
   Barter, P
   DeMicco, DA
   Bao, WH
   Preston, GM
   LaRosa, JC
   Grundy, SM
   Deedwania, P
   Greten, H
   Wenger, NK
   Shepherd, J
   Waters, DD
   Kastelein, JJP
AF Arsenault, Benoit J.
   Barter, Philip
   DeMicco, David A.
   Bao, Weihang
   Preston, Gregory M.
   LaRosa, John C.
   Grundy, Scott M.
   Deedwania, Prakash
   Greten, Heiner
   Wenger, Nanette K.
   Shepherd, James
   Waters, David D.
   Kastelein, John J. P.
CA TNT Study Investigators
TI RETRACTED: Prediction of Cardiovascular Events in Statin-Treated Stable
   Coronary Patients by Lipid and Nonlipid Biomarkers (Retracted article.
   See vol. 61, pg. 1750, 2013)
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article; Retracted Publication
DE biomarkers; coronary heart disease; inflammation; lipids; oxidative
   stress; statins
ID C-REACTIVE PROTEIN; HEART-DISEASE; RISK PREDICTION; INFLAMMATION;
   ATHEROSCLEROSIS; ATORVASTATIN; TRIAL; MEN; PROGRESSION; THERAPY
AB Objectives The aim of this study was to investigate the relationship between lipid and nonlipid biomarker levels achieved during statin therapy and the incidence of major cardiovascular events (MCVEs) in patients with stable coronary heart disease (CHD).
   Background Several plasma nonlipid biomarkers have been shown to predict MCVEs in population studies.
   Methods This is a nested case-control study in the TNT (Treating to New Targets) study population, a randomized trial that compared the efficacy of high-(80 mg) versus low-dose (10 mg) atorvastatin for the secondary prevention of CHD. Fasting plasma levels of standard lipids and of 18 nonlipid biomarkers were obtained after an 8-week run-in period on atorvastatin 10 mg and again 1 year after being randomized to 10 or 80 mg atorvastatin in 507 patients who experienced MCVEs during the 4.9 years of study follow-up and in 1,020 control subjects. An MCVE was defined as CHD death; nonfatal, non-procedure-related myocardial infarction; resuscitated cardiac arrest; or fatal or nonfatal stroke.
   Results Low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides were all predictive of recurrent MCVEs (p <= 0.009). Concentrations of many of the 18 nonlipid biomarkers were lowered by atorvastatin therapy (independent of dose). However, almost none of the nonlipid biomarker levels, whether measured after the 8-week run-in period or after 1 year of treatment with 10 or 80 mg atorvastatin, were predictive of recurrent MCVEs.
   Conclusions In patients with stable CHD, atorvastatin improved plasma levels of an expanded panel of nonlipid biomarkers. However, independently of atorvastatin dose, the achieved levels of the vast majority of nonlipid biomarkers did not predict MCVEs. (A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels [TNT]; NCT00327691) (J Am Coll Cardiol 2011;57:63-9) (C) 2011 by the American College of Cardiology Foundation
C1 [Arsenault, Benoit J.; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands.
   [Barter, Philip] Heart Res Inst, Sydney, NSW, Australia.
   [DeMicco, David A.; Bao, Weihang; Preston, Gregory M.] Pfizer Inc, New York, NY USA.
   [LaRosa, John C.] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA.
   [Grundy, Scott M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.
   [Deedwania, Prakash] Univ Calif San Francisco, Sch Med, San Francisco, CA USA.
   [Deedwania, Prakash] Vet Affairs Cent Calif Healthcare Syst, San Francisco, CA USA.
   [Greten, Heiner] Univ Klinikum, Eppendorf, Germany.
   [Wenger, Nanette K.] Emory Univ, Sch Med, Atlanta, GA USA.
   [Shepherd, James] Univ Glasgow, Glasgow, Lanark, Scotland.
   [Waters, David D.] San Francisco Gen Hosp, San Francisco, CA 94110 USA.
RP Kastelein, JJP (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9,Room F4-159-2, NL-1105 AZ Amsterdam, Netherlands.
EM j.j.kastelein@amc.uva.nl
FU Pfizer
FX This study was funded by Pfizer. For full author disclosures, please see
   the end of this paper.
CR Arsenault BJ, 2009, AM J CARDIOL, V104, P240, DOI 10.1016/j.amjcard.2009.03.027
   Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34
   Boekholdt SM, 2006, ATHEROSCLEROSIS, V187, P415, DOI 10.1016/j.atherosclerosis.2005.09.023
   Bonnet J, 2008, CLIN THER, V30, P2298, DOI 10.1016/j.clinthera.2008.12.023
   Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804
   Essebag V, 2003, AM HEART J, V146, P581, DOI 10.1016/S0002-8703(03)00512-X
   Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656
   Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010
   Koenig W, 2009, EUR HEART J, V30, P2742, DOI 10.1093/eurheartj/ehp302
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323
   Meuwese MC, 2008, ATHEROSCLEROSIS, V197, P916, DOI 10.1016/j.atherosclerosis.2007.08.01
   Morrow DA, 2006, CIRCULATION, V114, P281, DOI 10.1161/CIRCULATIONAHA.106.628909
   Mueller T, 2003, CLIN CHEM, V49, P976, DOI 10.1373/49.6.976
   Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071
   Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360
   Rader DJ, 2007, AM J MED, V120, pS12, DOI 10.1016/j.amjmed.2007.01.003
   Rana JS, 2009, HEART, V95, P1682, DOI 10.1136/hrt.2009.170134
   Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646
   Ridker PM, 2009, J THROMB HAEMOST, V7, P332, DOI 10.1111/j.1538-7836.2009.03404.x
   Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251
   Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378
   Sarwar N, 2007, EUR HEART J, V28, P2491, DOI 10.1093/eurheartj/ehm115
   Singh U, 2008, AM J CARDIOL, V102, P321, DOI 10.1016/j.amjcard.2008.03.057
   Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064
NR 25
TC 0
Z9 0
U1 2
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD JAN 4
PY 2011
VL 57
IS 1
BP 63
EP 69
DI 10.1016/j.jacc.2010.06.052
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 698FF
UT WOS:000285577900010
OA Bronze
DA 2018-12-27
ER

PT J
AU Omar, S
   Ouni, R
   Mazhouda, K
AF Omar, Sami
   Ouni, Raouf
   Mazhouda, Kamel
TI RETRACTED: On the zeros of Dirichlet L-functions (Retracted article. See
   vol. 20, 2017)
SO LMS JOURNAL OF COMPUTATION AND MATHEMATICS
LA English
DT Article; Retracted Publication
ID RIEMANN-HYPOTHESIS; CRITERION
AB In this paper, we compute and verify the positivity of the Li coefficients for the Dirichlet L-functions using an arithmetic formula established in Omar and Mazhouda, J. Number Theory 125 (2007) no. 1, 50-58; J. Number Theory 130 (2010) no. 4, 1109-1114. Furthermore, we formulate a criterion for the partial Riemann hypothesis and we provide some numerical evidence for it using new formulas for the Li coefficients.
C1 [Omar, Sami] King Khalid Univ, Dept Math, Abha 9004, Saudi Arabia.
   [Omar, Sami; Ouni, Raouf] Fac Sci Tunis, Dept Math, Tunis 2092, Tunisia.
   [Mazhouda, Kamel] Fac Sci Monastir, Dept Math, Monastir 5000, Tunisia.
RP Omar, S (reprint author), King Khalid Univ, Dept Math, Abha 9004, Saudi Arabia.
EM sami.omar@fst.rnu.tn; raouf.ouni@fst.rnu.tn; kamel.mazhouda@fsm.rnu.tn
CR Brown FCS, 2005, J NUMBER THEORY, V111, P1, DOI 10.1016/j.jnt.2004.07.016
   Coffey MW, 2005, MATH PHYS ANAL GEOM, V8, P211, DOI 10.1007/s11040-005-7584-9
   Davenport H, 1980, MULTIPLICATIVE NUMBE
   GOURDON X., 10 13 1 ZEROS RIEMAN
   KOEPF W., 1994, COMPL VAR, V25, P237
   Li XJ, 2004, ILLINOIS J MATH, V48, P491
   Li XJ, 1997, J NUMBER THEORY, V65, P325, DOI 10.1006/jnth.1997.2137
   MASLANKA K., 2004, OPUSCULA MATH, V24, P103
   OMAR S., 2011, ZEROS HECKE L FUNCTI
   Omar S, 2007, J NUMBER THEORY, V125, P50, DOI 10.1016/j.jnt.2006.09.013
   Omar S, 2010, FINITE FIELDS TH APP, V16, P477, DOI 10.1016/j.ffa.2010.09.004
   Omar S, 2010, J NUMBER THEORY, V130, P1098, DOI 10.1016/j.jnt.2009.08.012
   Omar S, 2010, J NUMBER THEORY, V130, P1109, DOI 10.1016/j.jnt.2009.10.010
NR 13
TC 8
Z9 8
U1 3
U2 3
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1461-1570
J9 LMS J COMPUT MATH
JI LMS J. Comput. Math.
PY 2011
VL 14
BP 140
EP 154
DI 10.1112/S1461157010000215
PG 15
WC Mathematics, Applied; Mathematics
SC Mathematics
GA 947CV
UT WOS:000304405300001
OA Bronze
DA 2018-12-27
ER

PT J
AU Suurmond, J
   Dorjee, AL
   Boon, MR
   Knol, EF
   Huizinga, TWJ
   Toes, REM
   Schuerwegh, AJM
AF Suurmond, Jolien
   Dorjee, Annemarie L.
   Boon, Mariette R.
   Knol, Edward F.
   Huizinga, Tom W. J.
   Toes, Rene E. M.
   Schuerwegh, Annemie J. M.
TI RETRACTED: Mast cells are the main interleukin 17-positive cells in
   anticitrullinated protein antibody-positive and -negative rheumatoid
   arthritis and osteoarthritis synovium (Retracted article. See vol. 17,
   pg. 354, 2015)
SO ARTHRITIS RESEARCH & THERAPY
LA English
DT Article; Retracted Publication
ID T-CELLS; CLASSIFICATION; CRITERIA; JOINTS; NUMBERS
AB Introduction: Mast cells have been implicated to play a functional role in arthritis, especially in autoantibody-positive disease. Among the cytokines involved in rheumatoid arthritis (RA), IL-17 is an important inflammatory mediator. Recent data suggest that the synovial mast cell is a main producer of IL-17, although T cells have also been implicated as prominent IL-17 producers as well. We aimed to identify IL-17 expression by mast cells and T cells in synovium of arthritis patients.
   Methods: Synovial samples of anticitrullinated protein antibody-positive (ACPA+) and ACPA-negative (ACPA-) RA and osteoarthritis (OA) patients were stained for IL-17 in combination with CD117 (mast cells), CD3 (T cells) and CD68 (macrophages). Concentrations of IL-17 in synovial fluid were determined by ELISA.
   Results: The number of IL-17+ cells in synovium was comparable in all groups. Although the vast majority of IL-17+ cells are mast cells, no difference in the percentage of IL-17+ mast cells was observed. Nonetheless, levels of IL-17 in synovial fluid were increased in ACPA+ RA patients compared to ACPA-RA and OA patients.
   Conclusions: The synovial mast cell is the main IL-17+ cell in all three arthritis groups analyzed. These data are relevant for studies aimed at blocking IL-17 in the treatment of arthritis.
C1 [Suurmond, Jolien; Dorjee, Annemarie L.; Boon, Mariette R.; Huizinga, Tom W. J.; Toes, Rene E. M.; Schuerwegh, Annemie J. M.] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands.
   [Knol, Edward F.] Univ Med Ctr Utrecht, Dept Dermatol Allergol, NL-3584 CX Utrecht, Netherlands.
RP Suurmond, J (reprint author), Leiden Univ, Med Ctr, Dept Rheumatol, POB 9600,Albinusdreef 2,C1-R, NL-2300 RC Leiden, Netherlands.
EM j.suurmond@lumc.nl
OI Knol, Edward/0000-0001-7368-9820; Suurmond, Jolien/0000-0002-4092-8925
FU Dutch Arthritis Foundation; Netherlands Organization for Scientific
   Research; Research Foundation Sole Mio and the Leiden Research
   Foundation (STROL); Centre for Medical Systems Biology (CMSB) within the
   Netherlands Genomics Initiative (NGI)
FX JS's work is supported by the Dutch Arthritis Foundation. AJMS's and
   REMT's work is supported by the Netherlands Organization for Scientific
   Research (clinical fellow and Vici grants). AJMS's work is also
   supported by the Research Foundation Sole Mio and the Leiden Research
   Foundation (STROL). This work was further supported by a grant from the
   Centre for Medical Systems Biology (CMSB) within the framework of the
   Netherlands Genomics Initiative (NGI), FP06 AutoCure and FP07
   MASTERSWITCH.
CR ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502
   ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816
   Appel H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3370
   ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302
   Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E
   Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334
   Gullick NJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012516
   Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566
   Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385
   Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176
   Lubberts E, 2008, CYTOKINE, V41, P84, DOI 10.1016/j.cyto.2007.09.014
   MALONE DG, 1986, ARTHRITIS RHEUM, V29, P956, DOI 10.1002/art.1780290803
   McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005
   Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449
   Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291
   Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423
   Schellekens GA, 2000, ARTHRITIS RHEUM, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3
   Schuerwegh AJM, 2010, P NATL ACAD SCI USA, V107, P2586, DOI 10.1073/pnas.0913054107
   Stamp LK, 2009, J RHEUMATOL, V36, P2403, DOI 10.3899/jrheum.081304
   Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341
   Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832
NR 21
TC 66
Z9 72
U1 2
U2 18
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1478-6354
EI 1478-6362
J9 ARTHRITIS RES THER
JI Arthritis Res. Ther.
PY 2011
VL 13
IS 5
AR R150
DI 10.1186/ar3466
PG 7
WC Rheumatology
SC Rheumatology
GA 904DR
UT WOS:000301174600010
PM 21933391
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Li, YW
   Li, YX
   Zhong, SK
   Li, FP
   Yang, JW
AF Li, Yanwei
   Li, Yuexiao
   Zhong, Shengkui
   Li, Fengpeng
   Yang, Jianwen
TI RETRACTED: Synthesis and Electrochemical Properties of Y-Doped
   LiNi1/3Mn1/3Co1/3O2 Cathode Materials for Li-Ion Battery (Retracted
   article. See vol. 141, pg. 195, 2013)
SO INTEGRATED FERROELECTRICS
LA English
DT Article; Proceedings Paper; Retracted Publication
CT 9th Chinese International Nanoscience and Technology Symposium
CY NOV 15-19, 2010
CL Xian, PEOPLES R CHINA
DE Lithium ion batteries; LiNi1/3Mn1/3Co1/3O2; Y-doping; Cyclic
   Voltammogram (CV)
ID LINI1/3CO1/3MN1/3O2; COPRECIPITATION; LICOO2
AB The layered Li(Ni1/3Co1/3Mn1/3)(1-x)YxO2 cathode materials (x = 0, 0.03, 0.06, 0.09) were prepared by a co-precipitation method. The properties of the Y-doped LiNi1/3Mn1/3Co1/3O2 were investigated by X-ray diffraction (XRD), scanning electron microscopic (SEM), and electrochemical measurements. XRD studies show that the Y-doped LiNi1/3Mn1/3Co1/3O2 has the same layered structure as the undoped LiNi1/3Mn1/3Co1/3O2. SEM images exhibit that the particle size of Y-doped LiNi1/3Mn1/3Co1/3O2 is smaller than that of the undoped LiNi1/3Mn1/3Co1/3O2 and the smallest particle size is only about 2 mu m. The Y-doped LiNi1/3Mn1/3Co1/3O2 samples were investigated on the Li extraction/insertion performances through charge/discharge, cyclic voltammogram (CV), and electrochemical impedance spectra (EIS). The optimal doping content of Y is that x = 0.06 in the Li(Ni1/3Co1/3Mn1/3)(1-x)YxO2 samples to achieve high discharge capacity and good cyclic stability. The electrode reaction reversibility was enhanced, and the charge transfer resistance was decreased through Y-doping. The improved electrochemical performances of the Y-doped LiNi1/3Mn1/3Co1/3O2 cathode materials are attributed to the addition of Y3+ ion by stabilizing the layer structure.
C1 [Li, Yanwei; Li, Yuexiao; Zhong, Shengkui; Li, Fengpeng; Yang, Jianwen] Guilin Univ Technol, Coll Chem & Bioengn, Guilin 541004, Peoples R China.
   [Zhong, Shengkui] Guilin Univ Technol, Key Lab New Proc Technol Nonferrous Met & Mat, Minist Educ, Guilin 541004, Peoples R China.
RP Zhong, SK (reprint author), Guilin Univ Technol, Coll Chem & Bioengn, Guilin 541004, Peoples R China.
EM zhongshk@glite.edu.cn
FU Guangxi Natural Science Foundation of China [0991247, 0991025, 0832259]
FX The authors thank the financial supports from Guangxi Natural Science
   Foundation of China (No. 0991247, No. 0991025, and No. 0832259)
CR Ambrose R., 1942, J AM CHEM SOC, V64, P1866
   Arai H, 1997, SOLID STATE IONICS, V95, P275, DOI 10.1016/S0167-2738(96)00598-X
   Cao H, 2005, SOLID STATE IONICS, V176, P1207, DOI 10.1016/j.ssi.2005.02.023
   Ceder G, 1999, ELECTROCHEM SOLID ST, V2, P550, DOI 10.1149/1.1390900
   Choi J, 2004, ELECTROCHEM SOLID ST, V7, pA365, DOI 10.1149/1.1792271
   Koksbang R, 1996, SOLID STATE IONICS, V84, P1, DOI 10.1016/S0167-2738(96)83001-3
   Koyama Y, 2003, J POWER SOURCES, V119, P644, DOI 10.1016/S0378-7753(03)00194-0
   Lee MH, 2004, ELECTROCHIM ACTA, V50, P939, DOI 10.1016/j.electacta.2004.07.038
   Liu JJ, 2007, J UNIV SCI TECHNOL B, V14, P173, DOI 10.1016/S1005-8850(07)60034-6
   Naoaki Y., 2003, J POWER SOURCES, V119-121, P171
   Randolph A. L., 2001, J POWER SOURCES, V97-98, P681
   Tsai YW, 2005, CHEM MATER, V17, P3191, DOI 10.1021/cm048027v
   Yoon WS, 1999, J POWER SOURCES, V81, P517, DOI 10.1016/S0378-7753(98)00226-2
   Zhang Y, 2006, SOLID STATE IONICS, V177, P3303, DOI 10.1016/j.ssi.2006.09.008
   Zhong SW, 2006, T NONFERR METAL SOC, V16, P137, DOI 10.1016/S1003-6326(06)60024-1
NR 15
TC 5
Z9 5
U1 3
U2 48
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1058-4587
EI 1607-8489
J9 INTEGR FERROELECTR
JI Integr. Ferroelectr.
PY 2011
VL 127
BP 150
EP 156
DI 10.1080/10584587.2011.575736
PG 7
WC Engineering, Electrical & Electronic; Physics, Applied; Physics,
   Condensed Matter
SC Engineering; Physics
GA 847YB
UT WOS:000297010500023
DA 2018-12-27
ER

PT J
AU Weber, S
   Hill, BJ
   Ren, DX
   Beatty, RL
AF Weber, Scott
   Hill, Betty J.
   Ren, Dianxu
   Beatty, Rodger L.
TI RETRACTED: Measurement of Parenting Intention, Decision-Making, and
   Expectations (Retracted article. See vol. 47, pg. 163, 2011)
SO PERSPECTIVES IN PSYCHIATRIC CARE
LA English
DT Article; Retracted Publication
DE Parenting; reliability; sexual minorities; Theory of Planned Behavior;
   validity
ID VALIDITY
AB PURPOSE.
   This article described the field-testing of the 28-item Parenting Paradigms Scale, a measure of adults' intentions and behavioral assumptions related to parenting and parenthood.
   DESIGN AND METHODS.
   Three parent groups developed prospective items describing parenting attitudes and expectations that reflected the four constructs of Aizen's Theory of Planned Behavior, a theoretical framework for predicting behavior.
   FINDINGS.
   The resulting Parenting Paradigms Scale was reviewed for content validity, was pilot tested, and was administered to 340 lesbian and gay adults 18-72 years of age who were parents to at least one child younger than 18 years old at the time of assessment.
   PRACTICE IMPLICATIONS.
   The Parenting Paradigms Scale measure demonstrated reliability and validity as a measure of social norms, assumptions, and expectations regarding parenting or planned parenting.
C1 [Weber, Scott; Ren, Dianxu] Univ Pittsburgh, Sch Nursing, Ctr Res & Evaluat, Pittsburgh, PA 15261 USA.
   [Hill, Betty J.] Persad Ctr Inc, Pittsburgh, PA USA.
   [Beatty, Rodger L.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA.
RP Weber, S (reprint author), Univ Pittsburgh, Sch Nursing, Ctr Res & Evaluat, Pittsburgh, PA 15261 USA.
EM webersjm@pitt.edu
CR AIZEN I, 1980, UNDERSTANDING ATTITU
   Aizen I., 2005, ATTITUDES PERSONALIT
   American Academy of Child and Adolescent Psychiatry, 2006, CHILDR LESB GAY BIS
   American Academy of Pediatrics, 2009, PAT ED ONL HLTH CAR
   American Psychiatric Association, 1981, DIAGN STAT MAN MENT
   Anderson R. E., 1995, MULTIVARIATE DATA AN
   Blanton H, 1999, J PERS SOC PSYCHOL, V76, P420, DOI 10.1037//0022-3514.76.3.420
   Borenstein M., 1997, POWER PRECISION RELE
   Buunk A. P., 2006, SOCIAL COMP SOCIAL P, P15
   Byrne B. M., 2001, STRUCTURAL EQUATION
   Chicago-Kent College of Law, 2009, TABL 4 STAT LAWS SUR
   Child Welfare League of America, 2009, POS STAT PAR CHILDR
   Dang A., 2004, BLACK SAME SEX HOUSE
   DeVellis R. F., 2003, SCALE DEV
   EAGLE RS, 1994, AM J ORTHOPSYCHIAT, V64, P421, DOI 10.1037/h0079546
   FERKETICH S, 1990, NURS RES, V39, P59, DOI 10.1097/00006199-199001000-00012
   FERKETICH S, 1991, RES NURS HEALTH, V14, P165, DOI 10.1002/nur.4770140211
   Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202
   Fishbein M., 1975, BELIEF ATTITUDE INTE
   HELGESON VS, 1995, PERS SOC PSYCHOL B, V21, P1200, DOI 10.1177/01461672952111008
   IMLE MA, 1988, ADV NURS SCI, V11, P61, DOI 10.1097/00012272-198810000-00007
   Kernsmith PD, 2008, J TECHNOL HUMAN SERV, V26, P223, DOI 10.1080/15228830802096598
   Kline P., 1994, EASY GUIDE FACTOR AN
   Knapp T R, 1989, West J Nurs Res, V11, P634, DOI 10.1177/019394598901100517
   LYNN MR, 1986, NURS RES, V35, P382
   National Center for Lesbian Rights, 2004, AD LESB GAY BIS PAR
   Nunnally JC, 1994, PSYCHOMETRIC THEORY
   Patterson C. J., 1996, LESBIAN GAY BISEXUAL, P26
   Patterson C. J., 2005, LESBIAN GAY PARENTIN
   Pedhazur E. J., 1991, MEASUREMENT DESIGN A
   Pett MA, 2003, MAKING SENSE FACTOR
   Pruitt D., 2000, YOUR ADOLESCENT EMOT
   Pruitt D., 2000, YOUR CHILD EMOTIONAL
   Streiner D, 2003, HLTH MEASUREMENT SCA
   Tabachnick B. G., 2001, USING MULTIVARIATE S
   Thompson B., 2004, EXPLORATORY CONFIRMA
   Tigges LM, 1998, J RURAL STUD, V14, P203, DOI 10.1016/S0743-0167(97)00037-5
   Tigges LM, 1998, SOCIOL QUART, V39, P53, DOI 10.1111/j.1533-8525.1998.tb02349.x
   Weber S., 2007, PARENTS BEHAV UNPUB
   Weber S., 2007, PARENTS ATTITU UNPUB
   Weber S., 2007, PARENTS INTENT UNPUB
   Weber S., 2007, PARENTS SUBJEC UNPUB
   White T., 1999, 16 H BENJ INT GEND D
   WOOD JV, 1989, PSYCHOL BULL, V106, P231, DOI 10.1037//0033-2909.106.2.231
   Wood JV, 1996, PERS SOC PSYCHOL B, V22, P520, DOI 10.1177/0146167296225009
NR 45
TC 2
Z9 2
U1 3
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0031-5990
EI 1744-6163
J9 PERSPECT PSYCHIATR C
JI Perspect. Psychiatr. Care
PD JAN
PY 2011
VL 47
IS 1
BP 35
EP 47
DI 10.1111/j.1744-6163.2010.00262.x
PG 13
WC Nursing; Psychiatry
SC Nursing; Psychiatry
GA 700RO
UT WOS:000285762200007
DA 2018-12-27
ER

PT J
AU Lu, N
   Meng, L
   Chen, DZ
   Zhang, GQ
AF Lu, Nan
   Meng, Lin
   Chen, Dezhan
   Zhang, Guiqiu
TI RETRACTED: Enantioselectivity of aza-MBH-type reaction of nitroalkene to
   N-tosylimine catalyzed by thiourea-tertiary amine: a theoretical study
   (Retracted article. See vol. 2, pg. 13042, 2012)
SO RSC ADVANCES
LA English
DT Article; Retracted Publication
ID BAYLIS-HILLMAN REACTION; CONJUGATED NITROALKENES;
   MOLECULAR-INTERACTIONS; DENSITY; ALDEHYDES; ENERGIES; ADDUCTS; SOLVENT;
   QUANTUM; ENTRY
AB Thiourea-tertiary amine-catalyzed enantioselective aza-Morita-Baylis-Hillman reaction of nitroalkene and N-tosylimine has been investigated using density functional theory. Enantioselectivity is dominated by the cooperative effect of non-covalent and weak covalent interactions imposed by different units of catalyst. As a Lewis base, the tertiary amine unit activates the nitroalkene via a weak covalent bond. The weak covalent interaction orients the reaction in a major path with smaller variations of this bond. The aromatic ring unit activates N-tosylimine via pi-pi stacking. The non-covalent interaction selects the major path with smaller changes of the efficient packing areas. The thiourea unit donates a more compact H-bonded network in the species of the major path. Our conclusion is supported by the ee value which is much higher in the solution phase of xylene (97.6%) than DMF (27.2%).
C1 [Lu, Nan; Meng, Lin; Chen, Dezhan; Zhang, Guiqiu] Shandong Normal Univ, Coll Chem Chem Engn & Mat Sci, Jinan 250014, Peoples R China.
RP Lu, N (reprint author), Shandong Normal Univ, Coll Chem Chem Engn & Mat Sci, Jinan 250014, Peoples R China.
EM dchen@sdnu.edu.cn
FU National Basic Research Program of China (973 Program) [2007CB936000];
   National Natural Science Foundations of China [20975064]; Natural
   Science Foundation of Shandong Province [ZR2009BZ003]
FX This work was supported by National Basic Research Program of China (973
   Program, 2007CB936000), National Natural Science Foundations of China
   (No. 20975064) and Natural Science Foundation of Shandong Province (No.
   ZR2009BZ003).
CR Becke AD, 1996, J CHEM PHYS, V104, P1040, DOI 10.1063/1.470829
   BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304
   BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561
   Chen DZ, 2009, TETRAHEDRON-ASYMMETR, V20, P1367, DOI 10.1016/j.tetasy.2009.05.027
   Dadwal M, 2006, ORG BIOMOL CHEM, V4, P2525, DOI 10.1039/b604899d
   Deb I, 2006, ORG LETT, V8, P1201, DOI 10.1021/o10600411
   Friestad GK, 2007, TETRAHEDRON, V63, P2541, DOI 10.1016/j.tet.2006.11.076
   Frisch M. J., 2003, GAUSSIAN 03 REVISION
   FUKUI K, 1970, J PHYS CHEM-US, V74, P4161, DOI 10.1021/j100717a029
   Hunter KC, 2005, J PHYS CHEM A, V109, P9554, DOI 10.1021/jp0527709
   Kataoka T, 2005, EUR J ORG CHEM, P45, DOI 10.1002/ejoc.200400610
   Krafft ME, 2006, CHEM COMMUN, P2977, DOI 10.1039/b603510h
   Krafft ME, 2006, J AM CHEM SOC, V128, P4174, DOI 10.1021/ja057595o
   Langer P, 2000, ANGEW CHEM INT EDIT, V39, P3049, DOI 10.1002/1521-3773(20000901)39:17<3049::AID-ANIE3049>3.0.CO;2-5
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Li CJ, 2009, ACCOUNTS CHEM RES, V42, P335, DOI 10.1021/ar800164n
   Lii JH, 1999, J COMPUT CHEM, V20, P1593, DOI 10.1002/(SICI)1096-987X(19991130)20:15<1593::AID-JCC1>3.0.CO;2-A
   Lloyd DR, 2000, CHEM PHYS LETT, V323, P198, DOI 10.1016/S0009-2614(00)00482-6
   Lozynski M, 1998, J PHYS CHEM A, V102, P2899, DOI 10.1021/jp973142x
   Lu N, 2011, J MOL CATAL A-CHEM, V339, P99, DOI 10.1016/j.molcata.2011.03.003
   Maity P, 2009, J AM CHEM SOC, V131, P4196, DOI 10.1021/ja810136m
   Masson G, 2007, ANGEW CHEM INT EDIT, V46, P4614, DOI 10.1002/anie.200604366
   PELLISSIER H, 2006, TETRAHEDRON, V62, P2143, DOI DOI 10.1016/J.TET.2005.10.041
   Pohmakotr M, 2007, J ORG CHEM, V72, P5418, DOI 10.1021/jo0705566
   REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486
   REED AE, 1988, CHEM REV, V88, P899, DOI 10.1021/cr00088a005
   Reynolds TE, 2008, ORG LETT, V10, P5227, DOI 10.1021/ol802227t
   Shi Y.-L., 2007, J ORG CHEM, V18, P2905
   Simkin BY, 1995, QUANTUM CHEM STAT TH
   Singh V, 2008, TETRAHEDRON, V64, P4511, DOI 10.1016/j.tet.2008.02.087
   TAPIA O, 1992, J MATH CHEM, V10, P139, DOI 10.1007/BF01169173
   TOMASI J, 1994, CHEM REV, V94, P2027, DOI 10.1021/cr00031a013
   Truhlar DG, 1996, J PHYS CHEM-US, V100, P12771, DOI 10.1021/jp953748q
   VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159
   Wadhwa K, 2009, J ORG CHEM, V74, P6681, DOI 10.1021/jo9012332
   Wang X, 2009, ORG LETT, V11, P3310, DOI 10.1021/ol9011458
   WIBERG KB, 1968, TETRAHEDRON, V24, P1083, DOI 10.1016/0040-4020(68)88057-3
   Zhao GL, 2005, ORG BIOMOL CHEM, V3, P3686, DOI 10.1039/b510572b
   Zhao Y, 2004, J PHYS CHEM A, V108, P2715, DOI 10.1021/jp049908s
   Zhu RX, 2006, TETRAHEDRON-ASYMMETR, V17, P1611, DOI 10.1016/j.tetasy.2006.05.033
NR 40
TC 7
Z9 7
U1 5
U2 36
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2011
VL 1
IS 6
BP 1113
EP 1118
DI 10.1039/c1ra00015b
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 833YH
UT WOS:000295920900028
DA 2018-12-27
ER

PT J
AU Mitike, G
   Mariam, DH
   Tsui, A
AF Mitike, Getnet
   Mariam, Damen Haile
   Tsui, Amy
TI RETRACTED: Patterns of knowledge and condom use among population groups:
   Results from the 2005 Ethiopian Behavioral Surveillance Surveys on HIV
   (Retracted article. See vol. 25, pg. 236, 2011)
SO ETHIOPIAN JOURNAL OF HEALTH DEVELOPMENT
LA English
DT Article; Retracted Publication
ID AIDS KNOWLEDGE; HIGH-RISK
AB Background: Behavioral surveys help interpret the magnitude of HIV/AIDS. We analyzed indicators of knowledge on HIV/AIDS and condom use among different groups of populations selected for behavioral surveillance in Ethiopia.
   Methods: We used HIV/AIDS Behavioural Surveillance Surveys (BSS) data collected from ten target groups in Ethiopia. These were female sex workers, military personnel, police force, pastoralists, long distance truck drivers, intercity bus drivers, road construction workers, teachers, factory workers and ANC catchment populations.
   Results: Data from 14,524 individuals were analyzed. The majority were male (63.6%). Knowledge of the three preventive methods (abstinence, faithfulness and consistent condom use), misconceptions and comprehensive knowledge was 57%, 75% and 18.5%, respectively. Female sex workers and the defence force showed positive results in using condom during last sexual encounter and did so consistently with non regular sexual partners and paying partners. Women, pastoralists and the illiterate were negatively impacted.
   Conclusion: Inadequate and incorrect knowledge on HIV/AIDS was observed with special deficiency among the underserved groups such as pastoralists. Women and the older age group were found to be at a disadvantage. The findings indicate the need to expand prevention activities to hard-to-reach groups and such a certain specific population segments. Population groups such as female sex workers and the defense force that were known to be severely affected by the epidemic and are focus of HIV/AIDS interventions showed positive behaviors. Although this is encouraging, considerable proportion of the study groups did not use condom during sex with non regular partners. This underscores the importance of intensifying interventions across all groups and extended to their localities. [Ethiop J Health Dev. 2011;25(1):35-45]
C1 [Mitike, Getnet; Mariam, Damen Haile] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia.
   [Tsui, Amy] Johns Hopkins Univ, Sch Publ Hlth, Dept Populat & Family Hlth Sci, Baltimore, MD 21218 USA.
RP Mitike, G (reprint author), Univ Addis Ababa, Sch Publ Hlth, POB 9713, Addis Ababa, Ethiopia.
EM getnetmk@gmail.com
FU Global Fund
FX We acknowledge the institutions that implemented the behavioral
   surveillance survey: Federal Ministry of Health, Federal HAPCO, the
   Department of Community Health, Addis Ababa University, the Central
   Statistics Authority and the Ethiopian Public Health Association and the
   Global Fund for financing the survey.
CR ABERA Z, 2003, ETHIOP J HEALTH DEV, V17, P53
   ALEMU S, 2004, ETHIOP J HEALTH DEV, V18, P82
   Alene G. D., 2002, Ethiopian Journal of Health Development, V16, P277
   Anita S, 2007, Med J Malaysia, V62, P227
   Ayranci U, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-95
   BELACHEW T, 2004, ETHIOP J HLTH SCI, V14, P27
   Dandona R, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-87
   de Visser R, 2001, AIDS EDUC PREV, V13, P413, DOI 10.1521/aeap.13.5.413.24146
   Egger M, 2000, LANCET, V355, P2101, DOI 10.1016/S0140-6736(00)02376-X
   ESHETU M, 2004, ETHIOP J HEALTH DEV, V18, P75
   Family Health International (FHI), 2000, BEH SURV SURV GUID R
   *FMOH, 2006, 6 FMOH
   Gibney L, 2003, SOC SCI MED, V56, P1411, DOI 10.1016/S0277-9536(02)00138-7
   Gordon G, 2006, REPROD HEALTH MATTER, V14, P68, DOI 10.1016/S0968-8080(06)28266-1
   HAILE M, 2005, THESIS ADDIS ABABA U
   Hartell CG, 2005, ADOLESCENCE, V40, P171
   *HIV AIDS PREV CON, 2003, MAINSTR GUID HIV AID
   HLDADIK W, 2006, SEX TRANSM INFECT S1, V82, P32
   KEFENIE H, 1990, ETHIOP J HEALTH DEV, V4, P197
   KHODAKEVICH L, 1990, ETHIOP J HEALTH DEV, V4, P191
   Laukamm-Josten U, 2000, AIDS CARE, V12, P27, DOI 10.1080/09540120047440
   LESTER FT, 1988, ETHIOPIAN MED J, V26, P139
   Lindberg C E, 2000, J Assoc Nurses AIDS Care, V11, P80, DOI 10.1016/S1055-3290(06)60387-7
   MEHRET M, 1990, ETHIOP J HEALTH DEV, V4, P183
   MEHRET M, 1990, ETHIOP J HEALTH DEV, V4, P171
   MEKONNEN TM, 2005, HIV AIDS BEHAV SURVE
   Mitike G, 2002, HIV AIDS BEHAV SURVE
   *MOH, 1999, STRAT FRAM NAT RESP
   Negash Y, 2003, ETHIOP J HEALTH DEV, V17, P205
   Negassa H., 1990, ETHIOP J HEALTH DEV, V4, P107
   Nwokocha Ada R C, 2002, J Pediatr Adolesc Gynecol, V15, P93, DOI 10.1016/S1083-3188(01)00150-4
   *ORC MACR CSA, 2006, ETH DEM HLTH SURV 20
   Sikand A, 1996, J ADOLESCENT HEALTH, V18, P325, DOI 10.1016/1054-139X(95)00228-K
   Tapia-Aguirre V, 2004, ARCH MED RES, V35, P334, DOI 10.1016/j.arcmed.2004.05.002
   Tavoosi A, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-17
   TSEGA E, 1988, ETHIOPIAN MED J, V26, P179
   *UNAIDS, 2007, AIDS EP UPD
   Zulkifli S N, 2002, Med J Malaysia, V57, P3
NR 38
TC 3
Z9 3
U1 1
U2 12
PU ADDIS ABABA UNIV, DEPT COMMUNITY HEALTH
PI ADDIS ABABA
PA TIKUR ANBESSA HOSP, PO BOX 32812, ADDIS ABABA, 00000, ETHIOPIA
SN 1021-6790
J9 ETHIOP J HEALTH DEV
JI Ethiop. J. Health Dev.
PY 2011
VL 25
IS 1
BP 35
EP 45
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 817PZ
UT WOS:000294687600007
DA 2018-12-27
ER

PT J
AU Gould, K
AF Gould, Katharine
TI RETRACTED: Parenting the Asperger's Child: Extraordinary Demands and
   Pitfalls (Retracted Article)
SO PSYCHOANALYTIC INQUIRY
LA English
DT Article; Retracted Publication
AB The Editors and Publishers of Psychoanalytic Inquiry, after listening to certain representatives, have retracted the article.
C1 [Gould, Katharine] Rush Presbyterian St Lukes Med Ctr, Dept Psychiat, Rush Therapeut Day Sch, Chicago, IL 60612 USA.
RP Gould, K (reprint author), 2222 N Racine Ave, Chicago, IL 60614 USA.
EM katgould@rcn.com
CR Spitz RA, 1950, INT J PSYCHOANAL, V31, P138
   Winnicott D. W, 1994, PLAYING REALITY
   WINNICOTT DW, 1972, HOLDING INTERPRETATI
NR 3
TC 0
Z9 0
U1 2
U2 6
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0735-1690
EI 1940-9133
J9 PSYCHOANAL INQ
JI Psychoanal. Inq.
PY 2011
VL 31
IS 3
SI SI
BP 320
EP 333
AR PII 937271880
DI 10.1080/07351690.2010.513624
PG 14
WC Psychology, Psychoanalysis
SC Psychology
GA 772WE
UT WOS:000291267800009
DA 2018-12-27
ER

PT J
AU Dekhil, AB
   Hannachi, Y
   Ghorbel, A
   Boubaker, T
AF Dekhil, Abdelbasset B.
   Hannachi, Yasser
   Ghorbel, Ali
   Boubaker, Taoufik
TI RETRACTED: Removal of lead and cadmium ions from aqueous solutions using
   the macroalga Caulerpa racemosa (Retracted article. See vol. 32, pg.
   801, 2016)
SO CHEMISTRY AND ECOLOGY
LA English
DT Article; Retracted Publication
DE Caulerpa racemosa; Langmuir and Freundlich models; biosorption; FTIR
   analysis; kinetic; heavy metal biosorption; Dubinin-Radushkevich
   isotherm
ID METAL-IONS; BIOMASS; BIOSORPTION; PB(II); EQUILIBRIUM; SORPTION; CD(II);
   ADSORPTION; ALGAE
AB In this study, Caulerpa racemosa was characterised and used for the removal of Cd(II) and Pb(II) from aqueous solutions. The effect of pH, adsorbent dosage, contact time and temperature on the adsorption process was studied in batch experiments. Langmuir and Freundlich models were applied to describe the biosorption isotherm of the metal ions by C. racemosa biomass. The adsorption data can be well described by the Langmuir isotherm. The monolayer biosorption capacity of C. racemosa biomass for Pb(II) and Cd(II) ions was found to be 34.5 and 29mg center dot g-1, respectively. The mean free energy calculated from the Dubinin-Radushkevich isotherm indicated that the biosorption of Pb(II) and Cd(II) onto C. racemosa macroalga took place by chemisorption. Kinetics data of both metal ions were best described by a pseudo-second-order model. Thermodynamic studies showed that the adsorption was spontaneous and exothermic in nature. Analysis with FTIR indicated that possible functional groups involved in metal sorption by this alga were O-H bending, N-H stretching, C-N stretching, C-O and S=O stretching.
C1 [Dekhil, Abdelbasset B.; Hannachi, Yasser; Ghorbel, Ali; Boubaker, Taoufik] Univ Monastir, Unite Rech Chim Theor & React, Monastir, Tunisia.
   [Hannachi, Yasser] Belgorod State Technol Univ, Dept Colloid Chem, Belgorod, Russia.
RP Hannachi, Y (reprint author), Univ Monastir, Unite Rech Chim Theor & React, Monastir, Tunisia.
EM yasser102@yahoo.fr
CR Anayurt RA, 2009, CHEM ENG J, V151, P255, DOI 10.1016/j.cej.2009.03.002
   Bursali EA, 2009, CHEM ENG J, V150, P385, DOI 10.1016/j.cej.2009.01.016
   Cengiz S, 2008, BIORESOURCE TECHNOL, V99, P2357, DOI 10.1016/j.biortech.2007.05.011
   Cheremisinoff P.N, 1995, HDB WATER WASTEWATER
   Doyurum S, 2006, J HAZARD MATER, V138, P22, DOI 10.1016/j.jhazmat.2006.03.071
   DRASH GA, 1993, SCI TOTAL ENVIRON, V67, P75, DOI DOI 10.1016/0048-9697(83)90105-5
   DUBININ MM, 1947, ZH FIZ KHIM+, V21, P1351
   Farajzadeh MA, 2004, SEP PURIF TECHNOL, V38, P197, DOI 10.1016/j.seppur.2003.11.005
   Freundlich H., 1906, PHYS CHEM SOC, V40, P1361
   Helfferich F.G., 1962, ION EXCHANGE
   Ho YS, 2000, ADSORPT SCI TECHNOL, V18, P639, DOI 10.1260/0263617001493693
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Lacher C, 2002, MINER ENG, V15, P187, DOI 10.1016/S0892-6875(01)00212-6
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Malik UR, 2005, TALANTA, V66, P166, DOI 10.1016/j.talanta.2004.11.013
   MATHEICKAL TJ, 1998, THESIS GRIFFITH U
   Mehta SK, 2005, CRIT REV BIOTECHNOL, V25, P113, DOI 10.1080/07388550500248571
   Moore JW, 1984, HEAVY METALS NATURAL
   Sari A, 2008, J HAZARD MATER, V157, P448, DOI 10.1016/j.jhazmat.2008.01.008
   Sari A, 2007, BIOCHEM ENG J, V37, P151, DOI 10.1016/j.bej.2007.04.007
   Sari A, 2009, J HAZARD MATER, V164, P1004, DOI 10.1016/j.jhazmat.2008.09.002
   Smith J. M., 1981, CHEM ENG KINETICS
   Tchobanoglous G., 2003, WASTEWATER ENG TREAT, P580
   Volesky B, 1990, BIOSORPTION HEAVY ME
   YAVUZ O, 2007, POLISH J ENV STUD, V3, P467
   Yu QM, 1999, WATER RES, V33, P1534, DOI 10.1016/S0043-1354(98)00363-7
NR 27
TC 12
Z9 12
U1 3
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0275-7540
EI 1029-0370
J9 CHEM ECOL
JI Chem. Ecol.
PY 2011
VL 27
IS 3
BP 221
EP 234
AR PII 936609253
DI 10.1080/02757540.2010.529077
PG 14
WC Biochemistry & Molecular Biology; Ecology; Environmental Sciences
SC Biochemistry & Molecular Biology; Environmental Sciences & Ecology
GA 768UG
UT WOS:000290963300003
DA 2018-12-27
ER

PT J
AU Zonouz, AM
   Moghani, D
AF Zonouz, Adeleh Moshtaghi
   Moghani, Davoud
TI RETRACTED: Synthesis of 1,4-Dihydropyridine Derivatives Under
   Solvent-Free and Grinding Conditions (Retracted article. See vol. 43,
   pg. 156, 2012)
SO SYNTHETIC COMMUNICATIONS
LA English
DT Article; Retracted Publication
DE 1; 4-Dihydropyridines; grinding; Hantzsch reaction; multicomponent
   reaction; solvent-free
ID ONE-POT SYNTHESIS; CALCIUM-CHANNEL; POLYHYDROQUINOLINE DERIVATIVES;
   HANTZSCH 1,4-DIHYDROPYRIDINES; ANTAGONIST; MOIETY
AB [image omitted] An efficient and environmentally friendly synthesis of 6-amino-5-cyano-1,4-dihydropyridine derivatives was developed by the one-pot reaction of ethyl acetoacetate, [(2-aryl)methylene]malononitriles, and ammonium acetate at room temperature with grinding. The key advantages are the short reaction times, good yields, simple workup, and easy purification. The present method does not involve any hazardous solvent.
C1 [Zonouz, Adeleh Moshtaghi; Moghani, Davoud] Azarbaijan Univ Tarbiat Moallem, Dept Chem, Fac Sci, Tabriz, Iran.
RP Zonouz, AM (reprint author), Azarbaijan Univ Tarbiat Moallem, Dept Chem, Fac Sci, Tabriz, Iran.
EM adelehmz@yahoo.com
FU Research Office of Azarbaijan University of Tarbiat Moallem
FX We thank the Research Office of Azarbaijan University of Tarbiat Moallem
   for financial support.
CR BOSSERT F, 1981, ANGEW CHEM INT EDIT, V20, P762, DOI 10.1002/anie.198107621
   Budriesi R, 2005, BIOORGAN MED CHEM, V13, P3423, DOI 10.1016/j.bmc.2005.03.007
   Chari MA, 2005, CATAL COMMUN, V6, P624, DOI 10.1016/j.catcom.2005.03.010
   Donelson JL, 2006, J MOL CATAL A-CHEM, V256, P309, DOI 10.1016/j.molcata.2006.03.079
   FERRY DR, 1982, N-S ARCH PHARMACOL, V321, P80, DOI 10.1007/BF00586355
   GODFRAIND T, 1986, PHARMACOL REV, V38, P321
   GOLDMANN S, 1991, ANGEW CHEM INT EDIT, V30, P1559, DOI 10.1002/anie.199115591
   GUZMAN A, 1990, J ORG CHEM, V55, P5793, DOI 10.1021/jo00309a026
   Hosseini-Sarvari M, 2007, CHINESE J CHEM, V25, P1563, DOI 10.1002/cjoc.200790288
   ITIL TM, 1984, CURR THER RES CLIN E, V35, P405
   Kikuchi S, 2008, TETRAHEDRON LETT, V49, P114, DOI 10.1016/j.tetlet.2007.11.003
   Klusa V., 1995, Drugs of the Future, V20, P135
   Ko S, 2005, TETRAHEDRON LETT, V46, P5771, DOI 10.1016/j.tetlet.2005.05.148
   LANIS RA, 1983, J MED CHEM, V25, P775
   Lee JH, 2005, TETRAHEDRON LETT, V46, P7329, DOI 10.1016/j.tetlet.2005.08.137
   Leon R, 2008, EUR J MED CHEM, V43, P668, DOI 10.1016/j.ejmech.2007.06.001
   Mager P P, 1992, Drug Des Discov, V8, P273
   MANNHOLD R, 1992, EUR J MED CHEM, V27, P229, DOI 10.1016/0223-5234(92)90006-M
   Marco-Contelles J, 2006, J MED CHEM, V49, P7607, DOI 10.1021/jm061047j
   Moshtaghi ZA, 2006, ARKIVOC, P15
   MOSHTAGHI ZA, 2005, SYNTHETIC COMMUN, V35, P2895
   Nguyen JT, 2005, BIOORGAN MED CHEM, V13, P1725, DOI 10.1016/j.bmc.2004.12.002
   Reddy GM, 2007, CURR ORG CHEM, V11, P847
   SAUSINS A, 1988, HETEROCYCLES, V27, P269
   SCHRAMM M, 1983, NATURE, V303, P535, DOI 10.1038/303535a0
   TROSCHUTZ R, 1989, ARCH PHARM, V322, P285, DOI 10.1002/ardp.19893220509
   Vohra RK, 2006, ADV SYNTH CATAL, V348, P2571, DOI 10.1002/adsc.200600343
   Wang LM, 2005, TETRAHEDRON, V61, P1539, DOI 10.1016/j.tet.2004.11.079
NR 28
TC 12
Z9 12
U1 3
U2 20
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0039-7911
EI 1532-2432
J9 SYNTHETIC COMMUN
JI Synth. Commun.
PY 2011
VL 41
IS 14
BP 2152
EP 2160
AR PII 937839506
DI 10.1080/00397911.2010.499488
PG 9
WC Chemistry, Organic
SC Chemistry
GA 769BM
UT WOS:000290984000015
DA 2018-12-27
ER

PT J
AU Abdel-Rehim, ZS
AF Abdel-Rehim, Z. S.
TI RETRACTED: Heat Transfer Analysis of a Packed Bed-PCM Capsules Latent
   Heat Thermal Energy Storage System (Retracted article. See vol. 35, pg.
   2086, 2013)
SO ENERGY SOURCES PART A-RECOVERY UTILIZATION AND ENVIRONMENTAL EFFECTS
LA English
DT Article; Retracted Publication
DE latent heat; numerical model; packed bed; PCM capsules; performance
   analysis and heat transfer working fluid; thermal energy storage
AB Heat transfer analysis of a packed bed-PCM latent heat thermal energy storage system is presented in this study. The packed bed cylindrical column is filled with spherical capsules of PCM (paraffin wax) that is used for a solar water heating application. In this study, the physical model is developed to use for analyzing the thermal performance of packed bed-PCM latent heat thermal energy storage. The model depends on energy a balance equation that can be applicable only to the sensible heat storage materials and can be converted to an enthalpy equation that can be applicable to the PCM storage bed. The governing equations are numerically solved using simple an explicit and first order finite difference technique. The results obtained are used for the thermal behavior of both charging and discharging modes. The effects of mass flow rate and inlet heat transfer fluid temperature (Stefan number) on the thermal performance of the PCM capsules of different radii are investigated. The melt/solid fraction distribution of the bed as function of time and axial position during charging and discharging modes is investigated. The results show that higher inlet heat transfer fluid temperature and higher mass flow rate of heat transfer fluid indicates a shorter time for complete charging processes. The complete solidification time is also longer compared to the melting time. This is due to the very low heat transfer coefficient during solidification. The charging and discharging rate are significantly higher for the PCM capsule of the smaller radius compared to those of a larger radius. The phase transition temperature range reduces the complete melting time; a difference of 31.7% is observed for the case when the PCM has melting in the temperature range as compared to that for a PCM with at fixed temperature.
C1 Natl Res Ctr, Giza 12622, Egypt.
RP Abdel-Rehim, ZS (reprint author), Natl Res Ctr, Giza 12622, Egypt.
EM abdelrehimz@yahoo.com
OI Abdel Rehim, Zeinab/0000-0002-5472-5969
CR CHANDRA P, 1981, SOL ENERGY, V27, P547, DOI 10.1016/0038-092X(81)90050-5
   Cho K, 2000, INT J HEAT MASS TRAN, V43, P3183, DOI 10.1016/S0017-9310(99)00329-4
   Ismail KAR, 2002, APPL THERM ENG, V22, P1705, DOI 10.1016/S1359-4311(02)00080-7
   Kousksou T, 2005, APPL THERM ENG, V25, P1534, DOI 10.1016/j.applthermaleng.2004.09.010
   Ozisik M. N., 1994, FINITE DIFFERENCE ME
   Regin AF, 2008, RENEW SUST ENERG REV, V12, P2438, DOI 10.1016/j.rser.2007.06.009
   REGIN AF, 2006, P ASME ISHMT HEAT MA
   Vyshak NR, 2007, ENERG CONVERS MANAGE, V48, P2161, DOI [10.1016/j.enconman.2006.12.013, 10.1016/j.enconrnan.2006.12.013]
   WAKAO N, 1979, CHEM ENG SCI, V34, P325, DOI 10.1016/0009-2509(79)85064-2
   Zalba B, 2003, APPL THERM ENG, V23, P251, DOI 10.1016/S1359-4311(02)00192-8
NR 10
TC 6
Z9 6
U1 2
U2 28
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1556-7036
EI 1556-7230
J9 ENERG SOURCE PART A
JI Energy Sources Part A-Recovery Util. Environ. Eff.
PY 2011
VL 33
IS 14
BP 1326
EP 1343
AR PII 936999378
DI 10.1080/15567030903330868
PG 18
WC Energy & Fuels; Engineering, Chemical; Environmental Sciences
SC Energy & Fuels; Engineering; Environmental Sciences & Ecology
GA 756TT
UT WOS:000290038300003
DA 2018-12-27
ER

PT J
AU Shin, DH
   Shin, YJ
AF Shin, Dong-Hee
   Shin, Youn-Joo
TI RETRACTED: Consumers' Trust in Virtual Mall Shopping: The Role of Social
   Presence and Perceived Security (Retracted article. See vol. 29, pg.
   438, 2013)
SO INTERNATIONAL JOURNAL OF HUMAN-COMPUTER INTERACTION
LA English
DT Article; Retracted Publication
ID UNDERSTANDING PURCHASING BEHAVIORS; TECHNOLOGY ACCEPTANCE MODEL;
   E-COMMERCE; USER ACCEPTANCE; FLOW THEORY; E-SERVICES; ONLINE;
   ENVIRONMENTS; PERFORMANCE; EXPERIENCE
AB This study analyzes the impact of social presence on perceived security and intention in virtual shopping malls. Following the conceptual model of social presence proposed by Hassanein and Head (2007), this study discusses social presence in a virtual environment as a complex multidimensional construct characterized by directed relationships among a set of uni-dimensional constructs. Given the rising importance of security, this study investigates the influence of social presence on perceived security in virtual activities. A prototype of the virtual shopping mall is designed as an experimental medium for which the user interface consists of both 3D graphics and an avatar. Valid questionnaires were gathered from student samples, and hypotheses were then tested to measure this set of constructs and fit a series of structural equation models that test Hassanein and Head's (2007) theory. The proposed model is strongly supported, and it provides additional insight into the effect and consequences of social presence. The results of the model show that social presence is a key behavioral antecedent to using virtual malls and user perception of security is a focal feature of user attitude. The results further suggest that perceived social presence can be a key factor of the virtual shopping activities by enhancing user perception of security and behavioral attitude in virtual malls. This study provides a more intensive view of virtual reality users and is an important step toward a better understanding of user behaviors in virtual environments.
C1 [Shin, Youn-Joo] Sungkyunkwan Univ, Dept Interact Sci, Seoul 110745, South Korea.
RP Shin, YJ (reprint author), Sungkyunkwan Univ, Dept Interact Sci, 53 Myungryun Dong, Seoul 110745, South Korea.
EM cecilshin@hanmail.net
FU Ministry of Education, Science and Technology [R31-2008-000-10062-0,
   NRF-2010-B00171]
FX This research was supported by WCU (World Class University) program
   through the National Research Foundation of Korea funded by the Ministry
   of Education, Science and Technology (Grant No. R31-2008-000-10062-0;
   NRF-2010-B00171).
CR Bagozzi R. P., 1988, J ACAD MARKET SCI, V16, P74, DOI DOI 10.1007/BF02723327
   Barfield W., 1995, VIRTUAL REALITY RES, V1, P3
   Benbasat I., 2002, E SERVICE J, V1, P5, DOI DOI 10.2979/ESJ.2002.1.3.5
   Bente G, 2008, HUM COMMUN RES, V34, P287, DOI 10.1111/j.1468-2958.2008.00322.x
   BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.107.2.238
   Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002001
   Chellappa R. K., 2002, Logistics Information Management, V15, P358, DOI 10.1108/09576050210447046
   Cheng FF, 2009, BEHAV INFORM TECHNOL, V28, P323, DOI 10.1080/01449290701770574
   Cheung CMK, 2006, J AM SOC INF SCI TEC, V57, P479, DOI 10.1002/asi.20312
   CHIN WW, 1998, QUANT METH SER, P295, DOI DOI 10.1016/J.AAP.2008.12.010
   Cho V, 2006, INFORM MANAGE-AMSTER, V43, P502, DOI 10.1016/j.im.2005.12.002
   CHRISTY C, 2006, J AM SOC INFORM SCI, V57, P479
   Chung DH, 2005, CYBERPSYCHOL BEHAV, V8, P538, DOI 10.1089/cpb.2005.8.538
   Cohen J., 1988, STAT POWER ANAL BEHA, Vxxi
   CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297, DOI DOI 10.1007/BF02310555
   Cyr D, 2007, INTERACT COMPUT, V19, P43, DOI 10.1016/j.intcom.2006.07.010
   DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008
   EtezadiAmoli J, 1996, INFORM MANAGE, V30, P65, DOI 10.1016/0378-7206(95)00052-6
   Featherman MS, 2003, INT J HUM-COMPUT ST, V59, P451, DOI 10.1016/S1071-5819(03)00111-3
   FETSCHERIN M, 2007, USER ACCEPTANCE VIRT
   Flavian C, 2006, IND MANAGE DATA SYST, V106, P601, DOI 10.1108/02635570610666403
   Fontaine G., 1992, PRESENCE-TELEOP VIRT, V1, P482, DOI DOI 10.1162/PRES.1992.1.4.482
   FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312
   Fortin DR, 2005, J BUS RES, V58, P387, DOI 10.1016/S0148-2963(03)00106-1
   *GARTN RES, 2007, RIS VIRT MALL SHOPP
   Gefen D, 1997, MIS QUART, V21, P389, DOI 10.2307/249720
   Gefen D, 2004, OMEGA-INT J MANAGE S, V32, P407, DOI 10.1016/j.omega.2004.01.006
   Gefen D, 2003, IEEE T ENG MANAGE, V50, P307, DOI 10.1109/TEM.2003.817277
   Hassanein K, 2005, INT J ELECTRON COMM, V10, P31, DOI 10.2753/JEC1086-4415100202
   HASSANEIN K, 2007, INT J HUMAN COMPUTER, V64, P1230
   Hayashi A., 2004, J INFORM SYSTEMS ED, V15, P139
   Heeter C., 1992, PRESENCE-TELEOP VIRT, V1, P262, DOI DOI 10.1162/PRES.1992.1.2.262
   Hoffman DL, 1996, J MARKETING, V60, P50, DOI 10.2307/1251841
   Joreskog K. G., 1996, LISREL 8 USERS REFER
   KLUG C, 2006, PLAYING VIDEO GAMES, P91
   Koufaris M, 2002, INFORM SYST RES, V13, P205, DOI 10.1287/isre.13.2.205.83
   Kreijns K, 2004, CYBERPSYCHOL BEHAV, V7, P155, DOI 10.1089/109493104323024429
   Laforet S, 2005, INT J BANK MARK, V23, P362, DOI 10.1108/02652320510629250
   LAROCHE M, 2004, J SERV RES-US, V6, P373, DOI DOI 10.1177/1094670503262955
   Lee KC, 2005, EXPERT SYST APPL, V28, P333, DOI 10.1016/j.eswa.2004.10.013
   Lee KC, 2007, IEEE T ENG MANAGE, V54, P729, DOI 10.1109/TEM.2007.906851
   Lee KC, 2008, COMPUT HUM BEHAV, V24, P88, DOI 10.1016/j.chb.2007.01.018
   Lee KM, 2006, INT J HUM-COMPUT ST, V64, P962, DOI 10.1016/j.ijhcs.2006.05.002
   LEFEBVRE LA, 1998, P 31 HAW INT C SYST, V6, P33
   Liu C, 2005, INFORM MANAGE-AMSTER, V42, P289, DOI 10.1016/j.im.2004.01.003
   LOMBARD M, 2000, 3 INT WORKSH PRES DE
   LOWRY P, 2007, P 40 HAW INT C SYST, P12
   McKnight DH, 2002, INFORM SYST RES, V13, P334, DOI 10.1287/isre.13.3.334.81
   Miyazaki AD, 2001, J CONSUM AFF, V35, P27, DOI 10.1111/j.1745-6606.2001.tb00101.x
   Nakashima Ellen, 2007, WASHINGTON POST 0924, pA1
   Nash EB, 2000, INT J HUM-COMPUT INT, V12, P1, DOI 10.1207/S15327590IJHC1201_1
   NIJITE D, 2005, J SERVICES RES, V5, P43
   Nunnally JC, 1978, PSYCHOMETRIC THEORY
   Papadopoulou Panagiota, 2007, Virtual Reality, V11, P107, DOI 10.1007/s10055-006-0059-x
   Pavlou PA, 2004, INFORM SYST RES, V15, P37, DOI 10.1287/isre.1040.0015
   Salisbury WD, 2001, IND MANAGE DATA SYST, V101, P165, DOI 10.1108/02635570110390071
   Sallnas EL, 2005, PRESENCE-TELEOP VIRT, V14, P434, DOI 10.1162/105474605774785253
   SCHIFRIN M, 2007, ROCKING VIRTUAL WORL
   Schroeder R., 2002, SOCIAL LIFE AVATARS, P19
   Shankar V, 2002, J STRATEGIC INF SYST, V11, P325, DOI 10.1016/S0963-8687(02)00022-7
   Shen KN, 2008, INT J HUM-COMPUT INT, V24, P722, DOI 10.1080/10447310802335789
   Sheridan T. B., 1992, PRESENCE-TELEOP VIRT, V1, P120, DOI DOI 10.1162/PRES.1992.1.1.120
   Shin D., 2005, INT J TECHNOLOGY POL, V5, P283
   Shin D., 2005, KNOWLEDGE TECHNOLOGY, V18, P101
   Shin DH, 2008, INTERACT COMPUT, V20, P433, DOI 10.1016/j.intcom.2008.04.001
   Shin DH, 2006, INTERNET RES, V16, P553, DOI 10.1108/10662240610711012
   Shin DH, 2008, CYBERPSYCHOL BEHAV, V11, P378, DOI 10.1089/cpb.2007.0117
   Shin DH, 2007, GOV INFORM Q, V24, P624, DOI 10.1016/j.giq.2006.06.011
   Shin DH, 2010, INT J HUM-COMPUT INT, V26, P317, DOI 10.1080/10447310903575473
   Shin DH, 2009, COMPUT HUM BEHAV, V25, P1343, DOI 10.1016/j.chb.2009.06.001
   Short J., 1976, SOCIAL PSYCHOL TELEC
   Stashevsky S., 2002, QUALITATIVE MARKET R, V5, P291, DOI DOI 10.1108/13522750210443245
   SWANMINATHAN V, 1999, J COMPUTER MEDIATED, V5
   Tamborini R, 2006, LEA COMMUN SER, P225
   VRIES P, 2006, LECT NOTES COMPUTER, V3962, P1
   Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686
   XU S, 2003, P 10 INT C HUM COMP, V2, P333
   YE L, 2005, LECT NOTES COMPUTER, V3168, P309
   Yenisey MM, 2005, BEHAV INFORM TECHNOL, V24, P259, DOI 10.1080/0144929042000320992
   Yoon SY, 2008, INT J HUM-COMPUT INT, V24, P288, DOI 10.1080/10447310801920516
NR 80
TC 21
Z9 21
U1 3
U2 37
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1044-7318
EI 1532-7590
J9 INT J HUM-COMPUT INT
JI Int. J. Hum.-Comput. Interact.
PY 2011
VL 27
IS 5
BP 450
EP 475
AR PII 933189456
DI 10.1080/10447318.2011.552060
PG 26
WC Computer Science, Cybernetics; Ergonomics
SC Computer Science; Engineering
GA 746MA
UT WOS:000289249800003
DA 2018-12-27
ER

PT J
AU Schwinghammer, SA
   Stapel, DA
AF Schwinghammer, Saskia A.
   Stapel, Diederik A.
TI RETRACTED: Measure by Measure: When Implicit and Explicit Social
   Comparison Effects Differ (Retracted article. See vol. 12, pg. 467,
   2013)
SO SELF AND IDENTITY
LA English
DT Article; Retracted Publication
DE Social comparison; Self-activation; Self-regulation; Self-processes;
   Self-evaluation maintenance; Implicit-explicit measures
ID SELF-ESTEEM; INFORMATION; ACTIVATION; CONTRAST; OTHERS; SELVES; ME
AB This study demonstrates that the structure of social comparison effects depends on the type of activated self-cognitions and the type of measure that is used. When neutral or negative self-cognitions are activated, social comparison information is processed defensively (both upward and downward comparison standards lead to positive explicit self-ratings). On an implicit level, however, upward comparison standards increase negativity. When positive self-cognitions are activated, explicit self-ratings show non-defensive contrast effects (upward standards lead to negative self-ratings and downward standards lead to positive self-ratings). On an implicit level no negative consequences surface. These results suggest that social comparison effects can manifest themselves in different forms, and that these will paint different pictures of the social comparison outcomes. Therefore, it is argued that future social comparison research should incorporate both explicit and implicit measures.
C1 [Schwinghammer, Saskia A.] Wageningen Univ, Dept Commun Sci, NL-6700 EW Wageningen, Netherlands.
   [Stapel, Diederik A.] Tilburg Univ, TIBER, NL-5000 LE Tilburg, Netherlands.
RP Schwinghammer, SA (reprint author), Wageningen Univ, Dept Commun Sci, POB 8130, NL-6700 EW Wageningen, Netherlands.
EM Saskia.Schwinghammer@wur.nl
CR Alicke MD, 1997, J PERS SOC PSYCHOL, V73, P781, DOI 10.1037/0022-3514.73.4.781
   BANAJI MR, 1999, SOC PERS SOC PSYCH P
   BASSILI JN, 1986, J PERS SOC PSYCHOL, V50, P239, DOI 10.1037/0022-3514.50.2.239
   Beauregard KS, 1998, J PERS SOC PSYCHOL, V74, P606, DOI 10.1037/0022-3514.74.3.606
   Blanton H, 2008, J PERS SOC PSYCHOL, V94, P1018, DOI 10.1037/0022-3514.94.6.1018
   Bosson JK, 2000, J PERS SOC PSYCHOL, V79, P631, DOI 10.1037//0022-3514.79.4.631
   BROWN JD, 1992, J PERS SOC PSYCHOL, V62, P717, DOI 10.1037//0022-3514.62.5.717
   Campbell WK, 2007, PSYCHOL SCI, V18, P227, DOI 10.1111/j.1467-9280.2007.01880.x
   Clark M. S., 1982, COGNITIVE SOCIAL PSY, P73, DOI DOI 10.2307/3033676
   Duval S., 1972, THEORY OBJECTIVE SEL
   Fein S, 1997, J PERS SOC PSYCHOL, V73, P31, DOI 10.1037/0022-3514.73.1.31
   GILBERT DT, 1991, J PERS SOC PSYCHOL, V60, P509, DOI 10.1037/0022-3514.60.4.509
   GILBERT DT, 1995, J PERS SOC PSYCHOL, V69, P227, DOI 10.1037/0022-3514.69.2.227
   Hetts JJ, 1999, J EXP SOC PSYCHOL, V35, P512, DOI 10.1006/jesp.1999.1391
   Klein WMP, 2001, MOTIV EMOTION, V25, P23, DOI 10.1023/A:1010607821908
   Mussweiler T, 2001, SOC COGNITION, V19, P145, DOI 10.1521/soco.19.2.145.20705
   Pelham BW, 2005, J EXP SOC PSYCHOL, V41, P84, DOI 10.1016/j.jesp.2003.10.008
   PYSZCZYNSKI T, 1985, J EXP SOC PSYCHOL, V21, P195, DOI 10.1016/0022-1031(85)90015-0
   Schwinghammer SA, 2006, PERS SOC PSYCHOL B, V32, P27, DOI 10.1177/0146167205277096
   Sherman DK, 2002, CURR DIR PSYCHOL SCI, V11, P119, DOI 10.1111/1467-8721.00182
   Spencer SJ, 2001, MOTIV EMOTION, V25, P41, DOI 10.1023/A:1010659805978
   Stapel DA, 2004, J PERS SOC PSYCHOL, V87, P468, DOI 10.1037/0022-3514.87.4.468
   Stapel DA, 2004, SOC COGNITION, V22, P147, DOI 10.1521/soco.22.1.147.30989
   Stapel DA, 2001, J PERS SOC PSYCHOL, V80, P766, DOI 10.1037//0022-3514.80.5.766
   Steele Claude, 1988, ADV EXPT SOCIAL PSYC, P261, DOI DOI 10.1016/S0065-2601(08)60229-4
   SVENSON O, 1981, ACTA PSYCHOL, V47, P143, DOI 10.1016/0001-6918(81)90005-6
   TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037//0033-2909.103.2.193
   TESSER A, 1988, J PERS SOC PSYCHOL, V54, P49, DOI 10.1037/0022-3514.54.1.49
   Tesser A., 1988, ADV EXPT SOCIAL PSYC, P181, DOI DOI 10.1016/S0065-2601(08)60227-0
   Tiggemann M, 2004, J PSYCHOSOM RES, V57, P73, DOI 10.1016/S0022-3999(03)00565-8
   WOOD JV, 1989, PSYCHOL BULL, V106, P231, DOI 10.1037//0033-2909.106.2.231
   Zeigler-Hill V, 2006, J PERS, V74, P119, DOI 10.1111/j.1467-6494.2005.00371.x
NR 32
TC 2
Z9 2
U1 1
U2 13
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1529-8868
EI 1529-8876
J9 SELF IDENTITY
JI Self Identity
PY 2011
VL 10
IS 2
BP 166
EP 184
AR PII 920985087
DI 10.1080/15298861003680117
PG 19
WC Psychology, Social
SC Psychology
GA 733PC
UT WOS:000288273800003
DA 2018-12-27
ER

PT J
AU Nelissen, RMA
   van de Ven, N
   Stapel, D
AF Nelissen, Rob M. A.
   van de Ven, Niels
   Stapel, Diederik
TI RETRACTED: Status concerns and financial debts in adolescents (Retracted
   article. See vol. 8, pg. 216, 2013)
SO SOCIAL INFLUENCE
LA English
DT Article; Retracted Publication
DE Social comparison; Status; Conspicuous consumption; Debts; Adolescents
ID CONSPICUOUS CONSUMPTION; MONEY MANAGEMENT; CONSUMER DEBT; PSYCHOLOGY;
   STRAIN; SELF; DETERMINANTS; SYMPTOMS; BEHAVIOR; LIFE
AB Are status concerns associated with debts? Social comparison theory suggests that three status-based motives may underlie consumption: status enhancement, maintenance, and restoration. We tested whether each motive contributed to adolescents' consumer debt. Status restoration appeared the best predictor of adolescents' debt. Furthermore, the association between status restoration and debt was only significant for people with no other means to regain status. This suggests that accumulation of consumption debt is in fact the result of a strategy that is aimed at status restoration. This confirms ideas about the social nature of consumption and extends insights into the psychological nature of debt behavior.
C1 [Nelissen, Rob M. A.] Tilburg Univ, Dept Social Psychol, NL-5000 LE Tilburg, Netherlands.
   [Nelissen, Rob M. A.] Tilburg Univ, TIBER, NL-5000 LE Tilburg, Netherlands.
RP Nelissen, RMA (reprint author), Tilburg Univ, Dept Social Psychol, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM r.m.a.nelissen@uvt.nl
RI Van de Ven, Niels/B-4222-2008
OI van de Ven, Niels/0000-0002-6730-9200
CR Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037//0278-6133.19.6.586
   Ball S. B., 1998, J SOCIO-ECON, V27, P495
   BELK RW, 1988, J CONSUM RES, V15, P139, DOI 10.1086/209154
   BERGER J, 1980, ANNU REV SOCIOL, V6, P479, DOI 10.1146/annurev.so.06.080180.002403
   Bourdieu P, 1984, DISTINCTION SOCIAL C
   BRAUN OL, 1989, J ECON PSYCHOL, V10, P161, DOI 10.1016/0167-4870(89)90018-4
   Carducci BJ, 1998, J BUS PSYCHOL, V12, P355, DOI 10.1023/A:1025031614989
   CBS (Statistics Netherlands), 2009, STATLINE
   CUMMINS DD, 2005, EVOLUTIONARY PSYCHOL, P676
   de Botton A, 2004, STATUS ANXIETY
   Duesenberry J. S., 1949, INCOME SAVING THEORY
   FENIGSTEIN A, 1975, J CONSULT CLIN PSYCH, V43, P522, DOI 10.1037/h0076760
   Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202
   Frank R, 1999, LUXURY FEVER
   FURNHAM A, 1984, PERS INDIV DIFFER, V5, P501, DOI 10.1016/0191-8869(84)90025-4
   Gibbons FX, 1999, J PERS SOC PSYCHOL, V76, P129, DOI 10.1037/0022-3514.76.1.129
   Griskevicius V, 2007, J PERS SOC PSYCHOL, V93, P85, DOI 10.1037/0022-3514.93.1.85
   Hirsch Fred, 1976, SOCIAL LIMITS GROWTH
   Jenkins R, 2008, PSYCHOL MED, V38, P1485, DOI 10.1017/S0033291707002516
   Kahneman D, 2003, AM ECON REV, V93, P162, DOI 10.1257/000282803321946985
   Kidwell B, 2004, J ECON PSYCHOL, V25, P601, DOI 10.1016/S0167-4870(03)00073-4
   Kidwell B, 2003, J APPL SOC PSYCHOL, V33, P1244, DOI 10.1111/j.1559-1816.2003.tb01948.x
   KRAUSE N, 1987, PSYCHOL AGING, V2, P185, DOI 10.1037//0882-7974.2.2.185
   KRAUSE N, 1992, PSYCHOL AGING, V7, P4, DOI 10.1037/0882-7974.7.1.4
   Krugman Paul, 2009, RETURN DEPRESSION EC
   LEA SEG, 1995, J ECON PSYCHOL, V16, P681, DOI 10.1016/0167-4870(95)00013-4
   LEA SEG, 1993, J ECON PSYCHOL, V14, P85, DOI 10.1016/0167-4870(93)90041-I
   Leary MR, 2009, PERS SOC PSYCHOL REV, V13, P151, DOI 10.1177/1088868309342595
   Leibenstein H, 1950, Q J ECON, V64, P183, DOI 10.2307/1882692
   LIVINGSTONE SM, 1992, J ECON PSYCHOL, V13, P111, DOI 10.1016/0167-4870(92)90055-C
   Long Scott, 1997, REGRESSION MODELS CA
   *MONEYZINE, 2008, CONS DEBT STAT
   NELISSEN RMA, 2009, CONSEQUENCES CONSPIC
   *NIBUD, 2008, FINANCIEEL GEDRAG JO
   Price Richard H, 2002, J Occup Health Psychol, V7, P302, DOI 10.1037/1076-8998.7.4.302
   Roberts R, 2000, BRIT J HEALTH PSYCH, V5, P289, DOI 10.1348/135910700168928
   Rosenberg M., 1965, SOC ADOLESCENT SELF
   Rucker DD, 2008, J CONSUM RES, V35, P257, DOI 10.1086/588569
   Rucker DD, 2009, J EXP SOC PSYCHOL, V45, P549, DOI 10.1016/j.jesp.2009.01.005
   SCHOR JB, 1998, OVERSPENT AM
   Schwinghammer SA, 2006, PERS SOC PSYCHOL B, V32, P27, DOI 10.1177/0146167205277096
   STAPEL DA, 2006, SOCIAL COMPARISON TH
   Stone B, 2006, J ECON PSYCHOL, V27, P543, DOI 10.1016/j.joep.2005.11.002
   Sullivan T., 1989, WE FORGIVE OUR DEBTO
   Tennyson S, 2001, J CONSUM AFF, V35, P241, DOI 10.1111/j.1745-6606.2001.tb00112.x
   Veblen T., 1899, THEORY LEISURE CLASS
   Vinokur AD, 1996, J PERS SOC PSYCHOL, V71, P166, DOI 10.1037/0022-3514.71.1.166
   Webley P, 2001, BRIT J PSYCHOL, V92, P423, DOI 10.1348/000712601162275
   West S. G, 1991, MULTIPLE REGRESSION
   WONG AS, 1998, J BUSINESS PSYCHOL, V5, P525
NR 50
TC 5
Z9 5
U1 2
U2 17
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1553-4510
EI 1553-4529
J9 SOC INFLUENCE
JI Soc. Influ.
PY 2011
VL 6
IS 1
BP 39
EP 56
AR PII 930079122
DI 10.1080/15534510.2010.525855
PG 18
WC Psychology, Social
SC Psychology
GA 715RG
UT WOS:000286901000004
DA 2018-12-27
ER

PT J
AU Noordewier, MK
   Stapel, DA
AF Noordewier, Marret K.
   Stapel, Diederik A.
TI RETRACTED: Stereotype Disconfirmation Affect: When Sweet Hooligans Make
   You Happy and Honest Salesmen Make You Sad (Retracted article. See vol.
   34, pg. 192, 2012)
SO BASIC AND APPLIED SOCIAL PSYCHOLOGY
LA English
DT Article; Retracted Publication
ID GROUP MEMBERS; ACTIVATION; OTHERS
AB People do not like inconsistencies, and therefore disconfirmation of stereotypes often feels unpleasant. However, people do like other people to be nice, thus negative stereotypes that are positively disconfirmed should be pleasant. The question then is, when does the (in)congruency and when does the likeability or positivity of the target determine people's affective responses? In two experiments we show that when people are under cognitive load, affective responses are determined by the (in)congruency, regardless of whether the target is positive or negative (positive affect after confirmation, negative affect after disconfirmation). However, when people have sufficient cognitive resources, their affective responses are determined by the positivity of the target, regardless of the (in)congruency (positive affect after a positive target, negative affect after a negative target).
C1 [Noordewier, Marret K.] Tilburg Univ, Dept Commun & Informat Sci, Tilburg Ctr Cognit & Commun TiCC, TIBER, NL-5000 LE Tilburg, Netherlands.
RP Noordewier, MK (reprint author), Tilburg Univ, Dept Commun & Informat Sci, Tilburg Ctr Cognit & Commun TiCC, TIBER, POB 90153, NL-5000 LE Tilburg, Netherlands.
EM m.k.noordewier@uvt.nl
CR Abelson R. P., 1968, THEORIES COGNITIVE C
   Allport G. W., 1954, NATURE PREJUDICE
   ELLIOT AJ, 1994, J PERS SOC PSYCHOL, V67, P382, DOI 10.1037/0022-3514.67.3.382
   Festinger L., 1957, THEORY COGNITIVE DIS
   FISKE ST, 1987, J EXP SOC PSYCHOL, V23, P399, DOI 10.1016/0022-1031(87)90038-2
   GILBERT DT, 1989, THINKING LIGHTLY OTH
   Harmon-Jones Eddie, 1999, COGNITIVE DISSONANCE
   Heredia RR, 2002, EXP PSYCHOL, V49, P208, DOI 10.1027//1618-3169.49.3.208
   JOHNSTON L, 1992, J EXP SOC PSYCHOL, V28, P360, DOI 10.1016/0022-1031(92)90051-K
   Kunda Z, 1997, J PERS SOC PSYCHOL, V72, P720, DOI 10.1037//0022-3514.72.4.720
   KUNDA Z, 1995, J PERS SOC PSYCHOL, V68, P565, DOI 10.1037/0022-3514.68.4.565
   Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93
   MACRAE CN, 1994, J PERS SOC PSYCHOL, V66, P37, DOI 10.1037/0022-3514.66.1.37
   NEUBERG SL, 1993, J PERS SOC PSYCHOL, V65, P113, DOI 10.1037/0022-3514.65.1.113
   Noordewier MK, 2010, PERS SOC PSYCHOL B, V36, P642, DOI 10.1177/0146167209357746
   Ruys KI, 2008, EXP PSYCHOL, V55, P182, DOI 10.1027/1618-3169.55.3.182
   Schneider D. J., 2004, PSYCHOL STEREOTYPING
   SETA JJ, 1993, PERS SOC PSYCHOL B, V19, P722, DOI 10.1177/0146167293196007
   Sherman JW, 1998, J PERS SOC PSYCHOL, V75, P589, DOI 10.1037/0022-3514.75.3.589
   Sinclair L, 1999, J PERS SOC PSYCHOL, V77, P885, DOI 10.1037//0022-3514.77.5.885
   Srull T.K, 1989, MEMORY COGNITION ITS
   WEBER R, 1983, J PERS SOC PSYCHOL, V45, P961, DOI 10.1037/0022-3514.45.5.961
   Wyer Jr R. S., 1980, PERSON MEMORY COGNIT, P155
   Yzerbyt VY, 1999, J PERS SOC PSYCHOL, V77, P449, DOI 10.1037/0022-3514.77.3.449
NR 24
TC 1
Z9 1
U1 1
U2 14
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0197-3533
EI 1532-4834
J9 BASIC APPL SOC PSYCH
JI Basic Appl Soc. Psychol.
PY 2011
VL 33
IS 1
BP 1
EP 6
AR PII 934031345
DI 10.1080/01973533.2010.540135
PG 6
WC Psychology, Social
SC Psychology
GA 726SW
UT WOS:000287747500001
DA 2018-12-27
ER

PT J
AU Tornabene, F
AF Tornabene, Francesco
TI RETRACTED: Free vibrations of laminated composite doubly-curved shells
   and panels of revolution via the GDQ method (Retracted article. See vol.
   247, pg. 226, 2012)
SO COMPUTER METHODS IN APPLIED MECHANICS AND ENGINEERING
LA English
DT Article; Retracted Publication
DE Free vibrations; Doubly-curved shells of revolution; Laminated composite
   shells; First-order shear deformation theory; Generalized differential
   quadrature method
ID DIFFERENTIAL QUADRATURE METHOD; SHEAR-DEFORMABLE SHELLS; STATIC
   ANALYSIS; CONICAL SHELLS; ELEMENT METHOD; SECTOR PLATES;
   FREQUENCY-CHARACTERISTICS; REISSNER/MINDLIN PLATES; STRUCTURAL ELEMENTS;
   BOUNDARY-CONDITIONS
AB In this paper, the Generalized Differential Quadrature (GDQ) method is applied to study the dynamic behaviour of laminated composite doubly-curved shells of revolution. The First-order Shear Deformation Theory (FSDT) is used to analyze the above mentioned moderately thick structural elements. The governing equations of motion, written in terms of stress resultants, are expressed as functions of five kinematic parameters, by using the constitutive and kinematic relationships. The solution is given in terms of generalized displacement components of points lying on the middle surface of the shell. The discretization of the system by means of the Differential Quadrature (DQ) technique leads to a standard linear eigenvalue problem, where two independent variables are involved. Results are obtained taking the meridional and circumferential co-ordinates into account, without using the Fourier modal expansion methodology. Examples of hyperbolic, catenary, cycloid, parabolic, elliptic and circular shell and panel structures are presented to illustrate the validity and the accuracy of the GDQ method. Furthermore, GDQ results are compared with those presented in literature and the ones obtained by using commercial programs such as Abaqus, Ansys, Nastran, Straus and Pro/Mechanica. Very good agreement is observed. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Tornabene, Francesco] Univ Bologna, DISTART Dept, Fac Engn, I-40126 Bologna, Italy.
RP Tornabene, F (reprint author), Univ Bologna, DISTART Dept, Fac Engn, I-40126 Bologna, Italy.
EM francesco.tornabene@mail.ing.unibo.it
RI Tornabene, Francesco/E-4789-2012
OI Tornabene, Francesco/0000-0002-5968-3382
FU Italian Ministry for University and Scientific, Technological Research
   MIUR
FX This research was supported by the Italian Ministry for University and
   Scientific, Technological Research MIUR (40% and 60%). The research
   topic is one of the subjects of the Centre of Study and Research for the
   Identification of Materials and Structures (CIMEST)-"M. Capurso" of the
   University of Bologna (Italy).
CR Alfano G, 2001, INT J NUMER METH ENG, V50, P707, DOI 10.1002/1097-0207(20010130)50:3<707::AID-NME55>3.0.CO;2-1
   Alibeigloo A, 2009, COMPOS STRUCT, V88, P342, DOI 10.1016/j.compstruct.2008.04.018
   Ambartusumyan S.A., 1964, NASATTF118
   Artioli E, 2006, J PRESS VESS-T ASME, V128, P370, DOI 10.1115/1.2217970
   Artioli E, 2005, ENG STRUCT, V27, P1879, DOI 10.1016/j.engstruct.2005.06.005
   Artioli E, 2005, STRUCT ENG MECH, V19, P459, DOI 10.12989/sem.2005.19.4.459
   Auricchio F, 2003, J APPL MECH-T ASME, V70, P381, DOI 10.1115/1.15720901
   Auricchio F, 1999, INT J NUMER METH ENG, V44, P1481, DOI 10.1002/(SICI)1097-0207(19990410)44:10<1481::AID-NME554>3.0.CO;2-Q
   Bert C. W., 1996, APPL MECH REV, V49, P1, DOI DOI 10.1115/1.3101882
   Ding H, 2006, COMPUT METHOD APPL M, V195, P516, DOI 10.1016/j.cma.2005.02.006
   Flugge W., 1960, STRESSES SHELLS
   Fung TC, 2002, COMPUT METHOD APPL M, V191, P1311, DOI 10.1016/S0045-7825(01)00324-3
   Goldenveizer A. L., 1961, THEORY ELASTIC THIN
   GOULD PL, 1999, ANAL PLATES SHELLS
   GOULD PL, 1984, FINITE ELEMENT ANAL
   Han JB, 1997, COMPUT METHOD APPL M, V141, P265, DOI 10.1016/S0045-7825(96)01115-2
   Han JB, 1999, COMPUT METHOD APPL M, V177, P51, DOI 10.1016/S0045-7825(99)00371-0
   Hosseini-Hashemi S, 2010, INT J MECH SCI, V52, P1025, DOI 10.1016/j.ijmecsci.2010.04.009
   Hsu MH, 2005, COMPUT METHOD APPL M, V194, P1, DOI 10.1016/j.cma.2003.08.011
   Hua L, 2000, INT J NUMER METH ENG, V48, P1703, DOI 10.1002/1097-0207(20000830)48:12<1703::AID-NME961>3.0.CO;2-X
   Hua L, 1998, INT J MECH SCI, V40, P443, DOI 10.1016/S0020-7403(97)00057-X
   Hua L, 2001, INT J SOLIDS STRUCT, V38, P3995, DOI 10.1016/S0020-7683(00)00272-9
   Huang YQ, 2004, COMPUT METHOD APPL M, V193, P3471, DOI 10.1016/j.cma.2003.12.039
   Karami G, 2002, COMPUT METHOD APPL M, V191, P3509, DOI 10.1016/S0045-7825(02)00289-X
   Kraus H., 1967, THIN ELASTIC SHELLS
   Lam KY, 2002, J SOUND VIB, V251, P329, DOI 10.1006/jsvi.2001.3993
   Leissa A. W., 1969, NASA
   Leissa A W, 1973, NASA
   Liew KM, 1998, COMPUT METHOD APPL M, V159, P369, DOI 10.1016/S0045-7825(97)00279-X
   Liew KM, 1996, INT J SOLIDS STRUCT, V33, P2647, DOI 10.1016/0020-7683(95)00174-3
   Liew KM, 1997, COMMUN NUMER METH EN, V13, P73, DOI 10.1002/(SICI)1099-0887(199702)13:2<73::AID-CNM32>3.3.CO;2-N
   Liew KM, 2002, INT J MECH SCI, V44, P2103, DOI 10.1016/S0020-7403(02)00167-4
   Liew KM, 2000, J SOUND VIB, V230, P335, DOI 10.1006/jsvi.1999.2623
   Liew KM, 2002, COMPUT METHOD APPL M, V191, P3811, DOI 10.1016/S0045-7825(02)00309-2
   Liu FL, 1999, COMPUT METHOD APPL M, V179, P407, DOI 10.1016/S0045-7825(99)00049-3
   Liu FL, 1999, COMPUT METHOD APPL M, V177, P77, DOI 10.1016/S0045-7825(98)00376-4
   Malekzadeh P, 2004, COMPUT METHOD APPL M, V193, P4781, DOI 10.1016/j.cma.2004.05.005
   Markus S, 1988, MECH VIBRATIONS CYLI
   Marzani A, 2008, J SOUND VIB, V315, P176, DOI 10.1016/j.jsv.2008.01.056
   Messina A, 2003, INT J SOLIDS STRUCT, V40, P3069, DOI 10.1016/S0020-7683(03)00115-X
   Ng TY, 1999, INT J NUMER METH ENG, V44, P819, DOI 10.1002/(SICI)1097-0207(19990228)44:6<819::AID-NME528>3.3.CO;2-S
   Ng TY, 2003, INT J MECH SCI, V45, P567, DOI 10.1016/S0020-7403(03)00042-0
   Novozhilov VV, 1964, THIN SHELL THEORY
   Reddy JN, 2003, MECH LAMINATED COMPO
   Redekop D, 2005, INT J PRES VES PIP, V82, P618, DOI 10.1016/j.ijpvp.2005.02.003
   REISSNER E, 1945, J APPL MECH-T ASME, V12, pA69
   Shu C, 1996, J SOUND VIB, V194, P587, DOI 10.1006/jsvi.1996.0379
   Shu C., 2000, DIFFERENTIAL QUADRAT
   Soedel W, 2004, VIBRATIONS SHELLS PL
   Timoshenko S, 1959, THEORY PLATES SHELLS
   Toorani MH, 2000, J SOUND VIB, V237, P561, DOI 10.1006/jsvi.2000.3073
   Tornabene F, 2007, THESIS U BOLOGNA
   Tornabene F, 2010, ADV THEOR APPL MECH, V3, P121
   Tornabene F, 2008, EUR J MECH A-SOLID, V27, P1001, DOI 10.1016/j.euromechsol.2007.12.007
   Tornabene F, 2007, COMPUT MATH APPL, V53, P1538, DOI 10.1016/j.camwa.2006.03.039
   Tornabene F, 2009, J SOUND VIB, V328, P259, DOI 10.1016/j.jsv.2009.07.031
   Tornabene F, 2009, COMPUT METHOD APPL M, V198, P2911, DOI 10.1016/j.cma.2009.04.011
   Tornabene F, 2009, EUR J MECH A-SOLID, V28, P991, DOI 10.1016/j.euromechsol.2009.04.005
   Tornabene F, 2009, MECCANICA, V44, P255, DOI 10.1007/s11012-008-9167-x
   Ventsel E, 2001, THIN PLATES SHELLS
   Viola E, 2004, STRUCT ENG MECH, V17, P789, DOI 10.12989/sem.2004.17.6.789
   Viola E, 2006, FAR E J APPL MATH, V25, P23
   VIOLA E, 2005, STRUCT INTEGR DURAB, V1, P155
   Viola E, 2007, J SOUND VIB, V299, P143, DOI 10.1016/j.jsv.2006.07.001
   Viola E, 2009, MECH RES COMMUN, V36, P587, DOI 10.1016/j.mechrescom.2009.02.001
   Vlasov V. Z., 1964, GEN THEORY SHELLS IT
   Wang XH, 2006, J SOUND VIB, V292, P424, DOI 10.1016/j.jsv.2005.07.049
   Wang XW, 2007, COMPUT METHOD APPL M, V196, P2242, DOI 10.1016/j.cma.2006.11.009
   Wang XW, 2004, COMPUT METHOD APPL M, V193, P3957, DOI 10.1016/j.cma.2004.02.010
   Wu CP, 1998, INT J SOLIDS STRUCT, V35, P1953, DOI 10.1016/S0020-7683(97)00153-4
   Wu CP, 2001, INT J MECH SCI, V43, P1853, DOI 10.1016/S0020-7403(01)00010-8
   Wu TY, 2003, COMPUT METHOD APPL M, V192, P1629, DOI 10.1016/S0045-7825(02)00650-3
   Wu TY, 2002, COMPUT METHOD APPL M, V191, P5365, DOI 10.1016/S0045-7825(02)00463-2
NR 73
TC 45
Z9 45
U1 3
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0045-7825
EI 1879-2138
J9 COMPUT METHOD APPL M
JI Comput. Meth. Appl. Mech. Eng.
PY 2011
VL 200
IS 9-12
BP 931
EP 952
DI 10.1016/j.cma.2010.11.017
PG 22
WC Engineering, Multidisciplinary; Mathematics, Interdisciplinary
   Applications; Mechanics
SC Engineering; Mathematics; Mechanics
GA 727YT
UT WOS:000287840000005
DA 2018-12-27
ER

PT J
AU Liu, TM
   Zheng, YS
   Hu, J
AF Liu, Tie-Min
   Zheng, Yuan-Suo
   Hu, Jie
TI RETRACTED: Surface modification of aramid fibers with novel chemical
   approach (Retracted article. See vol. 69, pg. 509, 2012)
SO POLYMER BULLETIN
LA English
DT Article; Retracted Publication
DE Aramid fibers; Interfacial properties; Surface treatment; Friedel-Crafts
   Reaction
ID AROMATIC POLYAMIDE FIBERS; KEVLAR FIBER; MECHANICAL-PROPERTIES;
   BISMALEIMIDE RESIN; MATRIX COMPOSITES; EPOXY ADHESION; MORPHOLOGY;
   PERFORMANCE
AB Friedel-Crafts Reaction as a simple and convenient approach to the surface modification of aramid fiber was introduced in this paper. Epoxy chloropropane was chosen as the treatment reagent to modify aramid fibers surface via Graft reaction. After the modification, the interfacial properties of aramid/epoxy composites were investigated by the single fiber pull-out test (SFP), and the mechanical properties of aramid fibers were investigated by the tensile strength test. The results showed that the interfacial shear strength (IFSS) value of aramid/epoxy composites was enhanced by about 50%, and the tensile strength of aramid fibers had no obvious damage. The crystalline state of aramid fibers was determined by X-ray diffraction instrument (XRD), and the results showed that there were not any distinct crystal type varieties. The surface elements of aramid fibers were determined by X-ray photoelectron spectroscopy (XPS), the analysis of which showed that the oxygen/carbon ratio of aramid fiber surface increased obviously. The possible changes of the chemical structure of aramid fibers were investigated via Fourier transform infrared spectrum (FTIR), and the analysis of which showed that the epoxy functional groups were grafted into the molecule structure of aramid fibers. The surface morphology of aramid fibers was analyzed by Scanning electron microscope (SEM), and the SEM results showed that the physical structure of aramid fibers was not etched or damaged obviously. The surface energy of aramid fibers was investigated via the dynamic capillary method, and the results showed that the surface energy was enhanced by 31.5%, and then the wettability degree of aramid fiber surface was enhanced obviously too. All of the results indicated that this novel chemical modification approach not only can improve the interfacial bonding strength of aramid/epoxy composites remarkably, but also have no negative influence on the intrinsic tensile strength of aramid fibers.
C1 [Liu, Tie-Min] Xi An Jiao Tong Univ, Sch Mat Sci & Engn, Xian 710049, Shaanxi, Peoples R China.
   [Zheng, Yuan-Suo; Hu, Jie] Xi An Jiao Tong Univ, Sch Sci, Xian 710049, Shaanxi, Peoples R China.
RP Liu, TM (reprint author), Xi An Jiao Tong Univ, Sch Mat Sci & Engn, Xian 710049, Shaanxi, Peoples R China.
EM liliang5054@163.com
FU Postdoctoral Science Foundation of China [20090451371]
FX This research is financially supported by the Postdoctoral Science
   Foundation of China, under project number: No. 20090451371.
CR DOBB MG, 1977, J POLYM SCI POL PHYS, V15, P2201, DOI 10.1002/pol.1977.180151212
   FRIEDRICH K, 1985, COMPOS SCI TECHNOL, V22, P43, DOI 10.1016/0266-3538(85)90090-9
   HAGEGE R, 1979, J MICROSC-OXFORD, V115, P65, DOI 10.1111/j.1365-2818.1979.tb00152.x
   HE H, 1990, ACTA MATERIAE COMPOS, V7, P17
   HSIEH YL, 1991, J COLLOID INTERF SCI, V144, P127, DOI 10.1016/0021-9797(91)90243-2
   Iijima T, 1997, J APPL POLYM SCI, V65, P1451
   Imielinska K, 2004, COMPOS SCI TECHNOL, V64, P2271, DOI 10.1016/j.compscitech.2004.03.002
   Lacks DJ, 2000, PHYS REV LETT, V84, P4629, DOI 10.1103/PhysRevLett.84.4629
   LI LS, 1983, J MACROMOL SCI PHYS, VB22, P269, DOI 10.1080/00222348308215504
   LI Y, 2002, STRUCT STRENGTH RES, V15, P9
   Lin JS, 2002, EUR POLYM J, V38, P79, DOI 10.1016/S0014-3057(01)00176-8
   Lin TK, 2000, COMPOS SCI TECHNOL, V60, P1873, DOI 10.1016/S0266-3538(00)00074-9
   Lin TK, 1999, J ADHES SCI TECHNOL, V13, P545, DOI 10.1163/156856199X00109
   Mamedov MK, 2006, RUSS J APPL CHEM+, V79, P408, DOI 10.1134/S1070427206030141
   MORGAN RJ, 1993, POLYMER, V34, P835, DOI 10.1016/0032-3861(93)90371-G
   NARDIN M, 1993, COMPOS INTERFACE, V1, P54
   PANAR M, 1983, J POLYM SCI POL PHYS, V21, P1955, DOI 10.1002/pol.1983.180211006
   Park R, 1998, COMPOS SCI TECHNOL, V58, P1621, DOI 10.1016/S0266-3538(97)00228-5
   Park SJ, 1999, J MATER SCI LETT, V18, P373, DOI 10.1023/A:1006624532228
   Park SJ, 2002, J COLLOID INTERF SCI, V252, P249, DOI 10.1006/jcis.2002.8479
   PEIJS AAJM, 1990, COMPOSITES, V21, P513, DOI 10.1016/0010-4361(90)90424-U
   SIMMENS SC, 1980, J POLYM SCI POL PHYS, V18, P871, DOI 10.1002/pol.1980.180180418
   So YH, 2000, PROG POLYM SCI, V25, P137, DOI 10.1016/S0079-6700(99)00038-6
   SUEMATSU K, 1985, MACROMOLECULES, V18, P2083, DOI 10.1021/ma00152a049
   TAKAYANAGI M, 1987, POLYM J, V19, P21, DOI 10.1295/polymj.19.21
   TAKEDA S, 1988, J APPL POLYM SCI, V35, P1351, DOI 10.1002/app.1988.070350520
   WANG CM, 2002, FIBRE COMPOS, V19, P18
   WANG LC, 2004, ORGANIC CHEM
   WANG YZ, 1997, HDB CHEM
   Wu SR, 1996, J APPL POLYM SCI, V62, P1347, DOI 10.1002/(SICI)1097-4628(19961128)62:9<1347::AID-APP5>3.0.CO;2-H
   Yue CY, 1999, COMPOS PART B-ENG, V30, P205, DOI 10.1016/S1359-8368(98)00053-5
   Yue CY, 2000, COMPOS SCI TECHNOL, V60, P421, DOI 10.1016/S0266-3538(99)00137-2
   Zhang YH, 2007, J APPL POLYM SCI, V106, P2251, DOI 10.1002/app.26887
NR 33
TC 19
Z9 25
U1 8
U2 98
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0170-0839
EI 1436-2449
J9 POLYM BULL
JI Polym. Bull.
PD JAN
PY 2011
VL 66
IS 2
BP 259
EP 275
DI 10.1007/s00289-010-0313-y
PG 17
WC Polymer Science
SC Polymer Science
GA 708FM
UT WOS:000286347700008
DA 2018-12-27
ER

PT S
AU Li, BQ
   Ding, YS
   Liang, X
   Hao, KR
   Wang, HP
AF Li, Bao-Qing
   Ding, Yong-Sheng
   Liang, Xiao
   Hao, Kuang-Rong
   Wang, Hua-Ping
BE Zhou, X
TI RETRACTED: An Intelligent Optimizing Approach for Spinning Process Based
   on Immune Neural Network Expert System (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE immune neural network; expert system; differentiation; spinning
   production
ID CARBON-FIBERS
AB This paper presents an immune optimization method based neural network expert system for spinning production. A radial basis function neural network (RBFNN) is applied to build the double-RBFNN model and the immune operators are then introduced to enhance the adaptability and learning ability of the neural network model. The immune optimized neural network model is embedded in the expert system to adjust and deploy the main factors affecting the spinning performance, such as optimizing the spinning crafts. It is also used to predict the performance of the spinning process and help to obtain good predictions, compared with the actual value. Simulation results demonstrate that it can get the desired results for the process optimization. The method proposes a new idea in connection with the differential fiber spinning crafts optimization. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Li, Bao-Qing; Ding, Yong-Sheng; Liang, Xiao; Hao, Kuang-Rong] Donghua Univ, Coll Informat Sci & Technol, Minist Educ, Engn Res Ctr Digitized Text & Fash Technol, Shanghai 201620, Peoples R China.
RP Li, BQ (reprint author), Donghua Univ, Minist Educ, Engn Res Ctr Digitized Text & Fash Technol, Coll Informat Sci & Technol, Shanghai 201620, Peoples R China.
EM baoqing_111@126.com
CR Castro LN, 2002, ARTIFICIAL IMMUNE SY
   Chabini I, 1998, P ANN M TRANSP RES B
   Dorigo M., 1997, IEEE Transactions on Evolutionary Computation, V1, P53, DOI 10.1109/4235.585892
   EDIE DD, 1993, CARBON, V31, P941, DOI 10.1016/0008-6223(93)90196-H
   Edie DD, 1998, CARBON, V36, P345, DOI 10.1016/S0008-6223(97)00185-1
   Fu Gang, 2005, PRESENT SITUATION PR
   Hatta K., 2001, Systems and Computers in Japan, V32, P29, DOI 10.1002/1520-684X(200101)32:1<29::AID-SCJ4>3.0.CO;2-G
   HE S f, 2008, P 11 ANN EL MACH SYS, P556
   Jiao LC, 2000, IEEE T SYST MAN CY A, V30, P552, DOI 10.1109/3468.867862
   Leandro NC, 2002, P IEEE C EV COMP, V1, P669
   Lee H, 2001, INT J ADV MANUF TECH, V18, P586, DOI 10.1007/s001700170035
   Liao GC, 2005, ELECTR ENG, V87, P267, DOI 10.1007/s00202-004-0245-3
   Lixia Zheng, 2004, ARTIFICIAL INTELLIGE
   Lobo F.G, 2000, THESIS U NOVA LISBOA
   Ma S, 2001, IEEE ACM T NETWORK, V9, P634, DOI 10.1109/90.958331
   Miller T. M., 1990, NEURAL NETWORKS CONT
   Mochida I, 1996, CARBON, V34, P941, DOI 10.1016/0008-6223(95)00172-7
   Poulos M, 2001, MED INFORM INTERNET, V26, P35, DOI 10.1080/14639230010015843
   Sandgren E., 1988, P ASME DES TECHN C K, P95
NR 19
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 972
EP 979
DI 10.1016/j.egypro.2011.10.344
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401001
DA 2018-12-27
ER

PT S
AU Zhou, HQ
   Long, X
   Gao, XP
   Liu, ZF
AF Zhou Hanqing
   Long Xiang
   Gao Xiaopeng
   Liu Zhifang
BE Zhou, X
TI RETRACTED: Automatic Black Box Test System for Digital TV Software
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE DTV software test; automated verification; functional failure detection;
   automatic software test
ID QUALITY
AB To meet the growing demand for entertainment, the software running on Digital TV(DTV) becomes more and more powerful and complex. How to efficiently and accurately verify the applications puts a great challenge upon manufactures and application vendors. In this paper, we propose a fully automated system supporting black box test for software on DTV. The objectives and design of the testing system are thoroughly discussed. Finally, the usability and effectiveness of the proposed methodology has been experimentally evaluated. Detailed analysis of the experiment results has been reported, which shows that our system can improve the testing efficiency and have a high performance with verification accuracy. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhou Hanqing; Long Xiang; Gao Xiaopeng] Beihang Univ, Sch Comp Sci & Engn, Beijing, Peoples R China.
RP Zhou, HQ (reprint author), Beihang Univ, Sch Comp Sci & Engn, Beijing, Peoples R China.
EM qdzhouhanqing@gmail.com
CR [Anonymous], 2001, OBJ PERC VID QUAL ME
   Bo Jiang, 2007, 2 INT WORKSH AUT SOF, P8
   Gwak T, 2004, COMP STAND INTER, V26, P205, DOI 10.1016/j.csi.2003.10.002
   Liang PAN, 2008, VIDEO ENG, V32
   Liu ZF, 2009, ICICTA: 2009 SECOND INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTATION TECHNOLOGY AND AUTOMATION, VOL IV, PROCEEDINGS, P641, DOI 10.1109/ICICTA.2009.869
   Liu Zhong-Hua, 2011, International Journal of Neuropsychopharmacology, V14, P618, DOI 10.1017/S1461145710000520
   Marijan D., 2009, IEEE CIRC SYST INT C, P1
   Marijan D., 2009, 16 IEEE INT C DIG SI, P1
   Marijan D, 2010, IEEE T CONSUM ELECTR, V56, P125, DOI 10.1109/TCE.2010.5439135
   Peng Chengyuan, 2002, THESIS HELSINKI U TE
   Rama, 2007, 8 INT WORKSH IM AN M, P19
   Rau, 2000, IEEE INT C CONS EL A, P228
   Santiago Valdivino, 2008, 2008 Second IEEE International Conference on Secure System Integration and Reliability Improvement (SSIRI), P81, DOI 10.1109/SSIRI.2008.49
   Sheikh HR, 2006, IEEE T IMAGE PROCESS, V15, P430, DOI 10.1109/TIP.2005.859378
   Sivaraman Ganesh, 2001, P 2001 IEEE INT C MU, P784
   Wang G. D., 2007, 8 ACIS INT C SOFTW E, V3, P1107
   Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861
   Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823
   Xuesong Chen, 2010, ELECT TECHNOLOGY, V32, P64
NR 19
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 980
EP 988
DI 10.1016/j.egypro.2011.10.345
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401002
DA 2018-12-27
ER

PT S
AU Liu, P
   Zhang, LX
   Yang, XF
AF Liu Ping
   Zhang Lingxiao
   Yang Xinfeng
BE Zhou, X
TI RETRACTED: Data Fusion of Distributed D-S Evidence Theory Based on
   Predicted Reliability (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Incomplete information systems; null value estimates; feature reduction;
   DS evidence theory
AB The available evidence on the basis of source credibility factor algorithm to predict the reliability coefficient proposed the concept and give a specific formula; and introduced the training method of the credibility factor balancing factor. Second, the reliability coefficient of the forecast given in the formula with the original DS theory of evidence combination rule to combine, to ensure all the properties of the original synthesis of the rules by adding the prediction based on the reliability coefficient to solve the conflict of evidence. Finally, Simulation proves effectiveness of the algorithm. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Liu Ping; Zhang Lingxiao; Yang Xinfeng] Nanyang Inst Technol, Comp Sci & Technol Dept, Nanyang 473000, Peoples R China.
RP Yang, XF (reprint author), Nanyang Inst Technol, Comp Sci & Technol Dept, Nanyang 473000, Peoples R China.
EM ywind2005@163.com
CR Durrant-Whyte HF, 2001, INT J ROBOT RES, V7
   Francois Delmotte, 2004, IEEE T SMC A, V34
   Fu Yao-wen, 2004, Acta Electronica Sinica, V32, P1433
   Lefevre E., 2002, Information Fusion, V3, P149, DOI 10.1016/S1566-2535(02)00053-2
   Mahler R, 2004, P SOC PHOTO-OPT INS, V5429, P1, DOI 10.1117/12.544505
   Ossalah Mourad, 2004, INT J INTELL SYST, V19
   Richard T., 2003, MILITARY TECHNOLOGY, V27, P29
   Smets P, 2005, INT J APPROX REASON, V38, P133, DOI 10.1016/j.ijar.2004.05.003
   W Ziarko, 2002, ROUGH SET APPROACHES
   Yesha Y, 2004, INFORM FUSION, V5, P299
NR 10
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 989
EP 994
DI 10.1016/j.egypro.2011.10.346
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401003
DA 2018-12-27
ER

PT S
AU Zhang, J
   Huang, XT
   Yang, XF
AF Zhang Jing
   Huang Xiantong
   Yang Xinfeng
BE Zhou, X
TI RETRACTED: Research of Data Mining of Association Pattern Pairs in
   Multidimensional Structured Database (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Pattern Pairs; Multidimensional Structured Database; Data Mining
AB User preference model first proposed using an intelligent method to set the minimum support. Secondly, we propose a new data mining problem, the structure of the database to find frequent patterns associated pair. To effectively address these problems, we developed a series of cutting ability with a strong algorithm. The new algorithm is also discussed in the one-dimensional and multi-dimensional structure of the database found on the applicability of the model and to assess the efficiency of the new algorithm. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang Jing; Huang Xiantong; Yang Xinfeng] Nanyang Inst Technol, Comp Sci & Technol Dept, Nanyang 473000, Peoples R China.
RP Yang, XF (reprint author), Nanyang Inst Technol, Comp Sci & Technol Dept, Nanyang 473000, Peoples R China.
EM ywind2005@163.com
CR Borgelt C, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P51, DOI 10.1109/ICDM.2002.1183885
   Cheng J., GRAPH SYNTHETIC GENE
   Cong Gao, 2004, P 2004 ACM SIGMOD IN, P129
   Fayyad U.M., 1996, ADV KNOWLEDGE DISCOV, P471
   Garriga G. C., 2007, P ICDM 07, P481
   Hsu WM, 2002, J INTELL INF SYST, V19, P7, DOI 10.1023/A:1015508302797
   Ke Y., 2006, P 12 ACM SIGKDD INT, P227
   Kitamoto, 2001, 2 INT WORKSH MULT DA, P68
   Liu B, 1999, IEEE T KNOWL DATA EN, V11, P817, DOI 10.1109/69.824588
   Ordonez C., 1999, IEEE ADV DIG LIB C, P113
   SONGRAM P, 2006, P 3 INT C INF TECHN, P512
   SRINIVASAN A, 1994, P 4 INT WORKSH IND L, P217
   Xiong H, 2006, DATA MIN KNOWL DISC, V13, P219, DOI 10.1007/s10618-006-0043-9
   Zaiane O. R, 1998, CASCON M MINDS, P76
NR 14
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 995
EP 1000
DI 10.1016/j.egypro.2011.10.347
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401004
DA 2018-12-27
ER

PT S
AU Cao, CJ
   Zhan, ZQ
AF Cao, Chaojie
   Zhan, Zhiqiang
BE Zhou, X
TI RETRACTED: Strategies for Incident Assignment and Escalation Based on
   BDIM (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE BDIM; incident management; strategy design; incident assignment;
   incident escalation
AB For IT support organizations, incident management plays an important role in the whole IT management. The improvement of the incident management can improve customer satisfaction and increase business profits. Traditional incident management applies inefficient strategies on the process of incident assignment and escalation. In this work, new strategies for incident assignment and escalation are developed using Business Driven IT Management concepts. Experimental result shows these strategies improve the business performance in incident management. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Cao, Chaojie; Zhan, Zhiqiang] Beijing Univ Posts & Telecommun, State Key Lab Networking & Switching Technol, Beijing 100876, Peoples R China.
RP Cao, CJ (reprint author), Beijing Univ Posts & Telecommun, State Key Lab Networking & Switching Technol, Beijing 100876, Peoples R China.
EM caochaojie@bupt.edu.cn
CR Barash G., 2007, P 2 IEEE WORKSH BUS
   IT Infrastructure Library, ITIL SERV DEL ITIL S
   Lu Chuanlai, 2007, QUEUE THEORY, P94
   Marcu P., 2009, P IFIP IEEE S INT MA, P569
   Moura Antao, 2008, IEEE COMMUNICATI OCT, P148
NR 5
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1001
EP 1005
DI 10.1016/j.egypro.2011.10.348
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401005
DA 2018-12-27
ER

PT S
AU Zhai, XN
   Zhao, Y
   Wang, JY
   Li, YP
   Wang, QQ
   Xie, HL
AF Zhai, Xiuna
   Zhao, Yan
   Wang, Jingyan
   Li, Yongping
   Wang, Quanquan
   Xie, Honglan
BE Zhou, X
TI RETRACTED: Adaptive SVM Fusion for Robust Multi-Biometrics Verification
   with Missing Data (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Multi-biometrics; Missing Data Robustness; Performance Metrics; Adaptive
   SVM
ID FACE
AB Conventional multimodal biometrics systems usually do not account for missing data (missing modalities or incomplete score lists) that is commonly encountered in real applications. The presence of missing data in multimodal biometric systems can be inconvenient to the client, as the system will reject the submitted biometric data and request for another trial. In such cases, robust multimodal biometric verification is needed. In this paper, we present the criteria, fusion method and performance metrics of a robust multimodal biometrics verification system that verifies the client's identity at any condition of data missing. A novel adaptive SVM classification method is proposed for missing dimensional values, which can handle the missing data in multimodal biometrics. We show that robust multibiometrics imposes additional requirements on multimodal fusion when compared to conventional multibiometrics. We also argue that the usual performance metrics of false accept and false reject rates are insufficient yardsticks for robust verification and propose new metrics against which we benchmark our system. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhai, Xiuna; Zhao, Yan] N China Inst Aerosp Engn, Dept Foundamental Sci, Langfang, Hebei, Peoples R China.
RP Zhai, XN (reprint author), N China Inst Aerosp Engn, Dept Foundamental Sci, Langfang, Hebei, Peoples R China.
EM zhaixiuna2006@yahoo.com.cn
RI Wang, Jim/A-9270-2012
CR Dinerstein S., 2007, IEEE INT C SYST MAN, P1530
   Fatukasi Omolara, 2008, 2 IEEE INT C BIOM TH, P1
   Fox NA, 2007, IEEE T MULTIMEDIA, V9, P701, DOI 10.1109/TMM.2007.893339
   Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881
   Kittler J., 2007, QUALITY DEPENDENT FU, V6539, P653903
   Krzysztof Kryszczuk, KRZYSZTOF KRYSZCZUK
   Li Yongping, 2007, 2007 IEEE S COMP INT, P1
   Mohammadi HRS, 2007, ICSPC: 2007 IEEE INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING AND COMMUNICATIONS, VOLS 1-3, PROCEEDINGS, P504
   Nandakumar Karthik, 2009, LNCS, P743
   NIST, NIST BIOM IM SOFTW N
   Ross A, 2003, PATTERN RECOGN LETT, V24, P2115, DOI 10.1016/S0167-8655(03)00079-5
   Sim T, 2007, IEEE T PATTERN ANAL, V29, P687, DOI 10.1109/TPAMI.2007.1010
   Wang JY, 2009, IEEE SYS MAN CYBERN, P917, DOI 10.1109/ICSMC.2009.5346745
   Wang YH, 2003, LECT NOTES COMPUT SC, V2688, P805
NR 14
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1006
EP 1012
DI 10.1016/j.egypro.2011.10.349
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401006
DA 2018-12-27
ER

PT S
AU Li, L
AF Li, Lv
BE Zhou, X
TI RETRACTED: Multi-stages & Multi-models Particle Swarm Optimization Based
   Wireless Sensor Networks Coverage (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Wireless Sensor Networks; Particle Swarm Optimization; Multi-stages;
   Multi-models
AB Modified particle swarm optimization based on multi-stage & multi-models is an improved particle swarm optimization algorithm, with strong global search ability. The problem of solving wireless sensor networks coverage problems is transferred to the problem of function optimization, and the MM-PSO is applied to solving the problem, achieving sensor node based adaptive deployment. Simulation results show that the method has better coverage results and coverage than particle swarm optimization. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Nanchang Inst Technol, Sch Informat Engn, Nanchang 330099, Peoples R China.
RP Li, L (reprint author), Nanchang Inst Technol, Sch Informat Engn, Nanchang 330099, Peoples R China.
EM lvli623@163.com
CR Feng Zhi-bo, 2011, Application Research of Computers, V28, P1272, DOI 10.3969/j.issn.1001-3695.2011.04.020
   Kennedy J., 1995, P IEEE INT C NEUR NE, P1942, DOI [DOI 10.1109/ICNN.1995.488968, 10.1109/ICNN.1995.488968]
   Kennedy J, 1999, P IEEE C EVOLUTIONAR, V7, P1931
   Liu Wei-ting, 2011, Journal of Computer Applications, V31, P338, DOI 10.3724/SP.J.1087.2011.00338
   Shen Lin-cheng, 2008, Systems Engineering and Electronics, V30, P1986
   Shi Y, 1998, P IEEE INT C EV COMP, P69, DOI DOI 10.1109/ICEC.1998.699146
   Wu Liwei, 2008, J NANCHANG INSTILUTE, V27, P1
   Zhao Jia, 2010, Computer Engineering and Applications, V46, P32, DOI 10.3778/j.issn.1002-8331.2010.33.009
NR 8
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1013
EP 1017
DI 10.1016/j.egypro.2011.10.350
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401007
DA 2018-12-27
ER

PT S
AU Shao, F
   Meng, B
AF Shao, Fei
   Meng, Bo
BE Zhou, X
TI RETRACTED: A Non-interactive Deniable Authentication Protocol based on
   Elliptic Curve Discrete Logarithm Problem (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE impersonation attack; known session-key attack; security protocol
ID ELGAMAL SIGNATURE SCHEME
AB Deniable authentication protocol is the security protocol which is mainly used in special applications, for example, electronic voting. Owning to the inefficiency of the interactive deniable authentication protocol, the non-interactive deniable authentication protocol has got the serious interest in security protocol field. In this study a non-interactive deniable authentication based on elliptic curve discrete logarithm problem is presented. The proposed non-interactive deniable authentication protocol is secure and efficient. Its deniability is proved in formal method by automatic tool. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Shao, Fei; Meng, Bo] Wuhan Univ, State Key Lab Software Engn, Wuhan 430072, Peoples R China.
RP Meng, B (reprint author), Wuhan Univ, State Key Lab Software Engn, Wuhan 430072, Peoples R China.
EM shaofei@whu.edu.cn
CR Blanchet B, 2008, IEEE T DEPEND SECURE, V5, P193, DOI 10.1109/TDSC.2007.1005
   Bos J. W., SECURITY 1024 BIT RS
   Brown D.R.L., DENIABLE AUTHENTICAT
   KOBLITZ N, 1987, MATH COMPUT, V48, P203, DOI 10.2307/2007884
   Law L, 2003, DESIGN CODE CRYPTOGR, V28, P119, DOI 10.1023/A:1022595222606
   Lee WB, 2007, INFORM SCIENCES, V177, P1376, DOI 10.1016/j.ins.2006.09.020
   Lu RX, 2005, COMPUT STAND INTER, V27, P401, DOI 10.1016/j.csi.2004.09.007
   Meng B., 2009, INFORM TECHNOLOGY J, V8, P302
   Shao ZH, 2004, COMPUT STAND INTER, V26, P449, DOI 10.1016/j.csi.2003.11.001
NR 9
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1018
EP 1025
DI 10.1016/j.egypro.2011.10.351
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401008
DA 2018-12-27
ER

PT S
AU Zhou, HJ
   Fu, S
AF Zhou, Hangjun
   Fu, Sha
BE Zhou, X
TI RETRACTED: Causal Order Mechanisms Based on the Virtual Receiving Time
   in A Distributed Multimedia System (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Distributed Multimedia System; Causal Order; Real-time mechanism;
   Consistency
AB For a distributed multimedia system into which humans or devices are embedded, data is required to be transmitted and delivered in real time. Moreover, the delivery has to be ensured with causal order, otherwise, the confusing anomalies to the participants might happen. However, while a distributed multimedia system is running on WAN, especially with a large number of participating sites, the traditional mechanisms are not suitable to maintain the causality in real time due to the large message transmission latency in the network. In this paper, we propose the novel causal order mechanisms for ensuring the real-time causal consistency. The mechanisms use the virtual receiving time to reduce the amount of causal control information in each message and diminish the transmission overhea(a)d. Experimental results show that the mechanisms could damp the network latency effects and preserve the causal order consistency with the real-time requirement. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhou, Hangjun; Fu, Sha] Hunan Univ Finance & Econ, Dept Informat Management, Changsha, Hunan, Peoples R China.
RP Zhou, HJ (reprint author), Hunan Univ Finance & Econ, Dept Informat Management, Changsha, Hunan, Peoples R China.
EM zhjnudt@gmail.com
CR Baldoni R, 1998, COMPUT SYST SCI ENG, V13, P263
   Hernandez S. P., 2004, ANN REV SCAL COMT SC, V3, P61, DOI 10.1142/9789812794727_0003
   LAMPORT L, 1978, COMMUN ACM, V21, P558, DOI 10.1145/359545.359563
   RAYNAL M, 1991, INFORM PROCESS LETT, V39, P343, DOI 10.1016/0020-0190(91)90008-6
   Schiper A, 1989, P 3 INT WORKSH DISTR, P219
   SCHWARZ R, 1994, DISTRIB COMPUT, V7, P149, DOI 10.1007/BF02277859
   Strassburger S., 2008, P 2008 WINT SIM C, P777
   Wang B, 2008, ACM T MULTIM COMPUT, V4, DOI 10.1145/1352012.1352020
NR 8
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1026
EP 1031
DI 10.1016/j.egypro.2011.10.352
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401009
DA 2018-12-27
ER

PT S
AU Zeng, H
   Dong, X
   Wang, XQ
AF Zeng, Hui
   Dong, Xin
   Wang, Xiuqing
BE Zhou, X
TI RETRACTED: Improved Center-symmetric Local Binary Pattern Descriptor For
   Local Feature Region Description (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Local feature region; LBP operator; CS-LBP descriptor; ICS-LBP
   descriptor
ID SCALE; RECOGNITION; DETECTORS
AB This paper proposes a novel method for local image feature region description, called ICS-LBP descriptor (Improved Center Symmetric Local Binary Pattern). It uses a SIFT-like grid that makes the descriptor containing more structural information. The use of CS-LBP operator can reduce the dimension of the descriptor significantly and it makes the descriptor containing the gradient orientation information. The weighted texture spectrum histogram is proposed to make the descriptor containing the image gradient magnitude information. Extensive experiments validated this improved descriptor. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zeng, Hui; Dong, Xin] Univ Sci & Technol Beijng Beijing, Sch Automat & Elect Engn, Beijing, Peoples R China.
RP Zeng, H (reprint author), Univ Sci & Technol Beijng Beijing, Sch Automat & Elect Engn, Beijing, Peoples R China.
EM hzeng@163.com
CR Ahonen T, 2006, IEEE T PATTERN ANAL, V28, P2037, DOI 10.1109/TPAMI.2006.244
   Bay H., 2006, P EUR C COMP VIS, V1, P404, DOI DOI 10.1007/11744023
   Fergus R, 2003, PROC CVPR IEEE, P264
   Heikkila M, 2009, PATTERN RECOGN, V42, P425, DOI 10.1016/j.patcog.2008.08.014
   Ke Y, 2004, PROC CVPR IEEE, P506
   Lazebnik S, 2005, IEEE T PATTERN ANAL, V27, P1265, DOI 10.1109/TPAMI.2005.151
   Li J, 2008, NEUROCOMPUTING, V71, P1771, DOI 10.1016/j.neucom.2007.11.032
   Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94
   Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x
   Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188
   Mikolajczyk K, 2004, INT J COMPUT VISION, V60, P63, DOI 10.1023/B:VISI.0000027790.02288.f2
   Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623
   Takala V, 2005, LECT NOTES COMPUT SC, V3540, P882
   Tan X, 2010, IEEE T IMAGE PROCESS, V19, P2010
   Tan XY, 2010, IEEE T IMAGE PROCESS, V19, P1635, DOI 10.1109/TIP.2010.2042645
   Tuytelaars T, 2004, INT J COMPUT VISION, V59, P61, DOI 10.1023/B:VISI.0000020671.28016.e8
NR 16
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1032
EP 1038
DI 10.1016/j.egypro.2011.10.353
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401010
DA 2018-12-27
ER

PT S
AU Chen, ZZ
   Liu, ZF
AF Chen, Zhaozhu
   Liu, Zhaofeng
BE Zhou, X
TI RETRACTED: A study of Knowledge Management in Construction Project
   Management (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Analytical tool; Knowledge management; Construction project management
AB The paper defined an analytical tool for knowledge management. Construction project management is faced with a rising number of pressures, such as cost, quality, human resource. Both project manager and design engineer need help analyzing large numbers of data when making decisions. This paper provides a way for knowledge management in construction project management. This article focuses on one analysis, using an analytical processing tool in conjunction with knowledge management techniques. The objective of the analysis was to discover how to use knowledge management techniques to make decisions that can be easy, how to apply these techniques to find a method for project management. The process used to identify knowledge management effect is described. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Chen, Zhaozhu] Shandong Jianzhu Univ, Sch Management Engn, Jinan 250100, Peoples R China.
RP Chen, ZZ (reprint author), Shandong Jianzhu Univ, Sch Management Engn, Jinan 250100, Peoples R China.
EM chenzhaozhu678@163.com
CR Massey AP, 2002, MIS QUART, V26, P269, DOI 10.2307/4132333
   Maynard M., 2001, FORTUNE          JAN
   Melymuka K., 2002, COMPUTERWORLD   0708
   Mooney S. F., 2000, NATL UNDERWRITE 1225, V104
   Pan SL, 2003, J STRATEGIC INF SYST, V12, P71, DOI 10.1016/S0963-8687(02)00023-9
   Parkinson J., 1996, 60 MINUTE SOFTWARE S
   Schultze U, 2002, MIS QUART, V26, P213, DOI 10.2307/4132331
   van der Spek, 2003, HDB KNOWLEDGE MANA K, V1k, P443
NR 8
TC 0
Z9 0
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1039
EP 1044
DI 10.1016/j.egypro.2011.10.354
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401011
DA 2018-12-27
ER

PT S
AU Bao, KJ
   Li, YH
AF Bao, Kongjun
   Li, Yinhua
BE Zhou, X
TI RETRACTED: The Development of Diamond Strength Testing System based on
   Microprocessor (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Diamond Strength testing; Strength Testing System; Microprocessor;
   Mathematical Statistics
AB In order to improve the quality of diamond and other super-hard materials, fast and accurate detection of its strength is significant. The System use air pressure, broken automatic detection, automatic samples, testing is completed automatically returned. By resistance strain gauges to the pressure value is converted to voltage signal, after a high-precision A/D converter chip into a numerical quantity, given to high-performance MCU processing. Sample test system can be set according to sample size, data communications, data statistics and report printing, with a large-screen LCD display, dynamic display of strength parameters of the distribution curve. System is reliable test data stability, good repeatability and high reliability. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Bao, Kongjun] Zhengzhou Univ Light Ind, Coll Comp & Commun Engn, Zhengzhou 450002, Peoples R China.
RP Bao, KJ (reprint author), Zhengzhou Univ Light Ind, Coll Comp & Commun Engn, Zhengzhou 450002, Peoples R China.
EM baokongjun@zzuli.edu.cn
CR CAI Zeng shen, 2001, J EXPT MECH      FEB, P14
   Fares C, 2009, DAMAGE AND FRACTURE MECHANICS, P1, DOI 10.1007/978-90-481-2669-9_1
   Johnson Wesley M., J MAT SCI MAT MED, V18, P591
   Khilo N. A., J APPL SPECTROSCOPY, V76, P434
   Li Yinhua, 2007, DIAMOND ABRASIVES EN, V157, P53
   Road Hui, 2009, DIAMOND ABRASIVES EN, V169, P69
NR 6
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1045
EP 1049
DI 10.1016/j.egypro.2011.10.355
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401012
DA 2018-12-27
ER

PT S
AU Fu, S
   Xiao, YZ
AF Fu, Sha
   Xiao, Yezhi
BE Zhou, X
TI RETRACTED: An Effective Process of Information Security Risk Assessment
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE information security; risk assessment; asset; threat; vulnerability;
   s(a)afety control measures
AB Information security risk assessment is an important assessment method and decision-making mechanism during the course to establish the information security system, and it is also an important part of information security research. This paper reviews the development of information security risk assessment and points out the importance of it in each application field. Furthermore, the problem of information security risk assessment is proposed, and the major methods in the field of information security risk assessment are elaborated, analyzed and studied. Finally, the work processes at present and the development prospects in the future are discussed. To sum up, the work in this paper has the valuable significance both in theory and practice on all aspects of the construction of information and the development of information security. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Fu, Sha] Hunan Univ Finance & Econ, Dept Informat Management, Changsha 410205, Hunan, Peoples R China.
RP Fu, S (reprint author), Hunan Univ Finance & Econ, Dept Informat Management, Changsha 410205, Hunan, Peoples R China.
EM fusha15@163.com
CR [Anonymous], 2007, GB T 20984 2007 INF
   Chang PT, 2005, COMPUT MATH APPL, V49, P1797, DOI 10.1016/j.camwa.2004.10.042
   Chen Xin, 2009, Computer Engineering and Design, V30, P38
   Fan Hong, 2006, METHODS APPL INFORM
   [冯登国 Feng Dengguo], 2004, [通信学报, Journal of China Institute of Communications], V25, P10
   Fu Sha, 2007, SCI TECHNOLOGY ENG, V7, P2350
   Fu Yu, 2010, Acta Electronica Sinica, V38, P1489
   Gao Yang, 2009, Journal of Southeast University (Natural Science Edition), V39, P225
   Liu Fang, 2004, FUZZY SYSTEMS MATH, V18, P51
   [刘勇 Liu Yong], 2010, [计算机科学, Computer Science], V37, P45
   [汪楚娇 WANG Chujiao], 2006, [武汉大学学报. 理学版, Journal of Wuhan University. Natural Science Edition], V52, P622
   Xiao Min, 2009, Journal of Wuhan University of Technology, V31, P43, DOI 10.3963/j.issn.1671-4431.2009.18.012
   Yang Yang, 2009, Computer Engineering and Applications, V45, P94, DOI 10.3778/j.issn.1002-8331.2009.03.027
NR 13
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1050
EP 1057
DI 10.1016/j.egypro.2011.10.356
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401013
DA 2018-12-27
ER

PT S
AU Xu, CD
   Yi, JB
   Wang, JY
AF Xu, Chundong
   Yi, Jianbing
   Wang, Jiyuan
BE Zhou, X
TI RETRACTED: Application of genetic algorithm on digital watermark against
   geometric attacks (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE DCT; invisibility; genetic algorithm; embedding strength; geometric
   attacks
ID IMAGE WATERMARKING
AB Against geometric attacks and Contradiction of robustness and invisibility were the chronic problem in watermark algorithm. This paper solves problem of against geometric attacks by blocked carrier image and embedded watermark following the specific sequence, and adopts the genetic algorithm to optimize embedding strength to reach comprehensive optimizing of robustness and invisibility. The result illustrated that the watermark algorithm has sound ability of against geometric attacks, higher security and has good robustness and invisibility as well. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xu, Chundong; Yi, Jianbing; Wang, Jiyuan] Jiangxi Univ Sci & Technol, Sch Informat Engn, Ganzhou 341000, Peoples R China.
RP Xu, CD (reprint author), Jiangxi Univ Sci & Technol, Sch Informat Engn, Ganzhou 341000, Peoples R China.
EM xcd201@tom.com
CR Barni M, 2001, IEEE T IMAGE PROCESS, V10, P783, DOI 10.1109/83.918570
   Chu WC, 2003, IEEE T MULTIMEDIA, V5, P34, DOI 10.1109/TMM.2003.808816
   Cox IJ, 1997, IEEE T IMAGE PROCESS, V6, P1673, DOI 10.1109/83.650120
   Holland J. H., 1975, ADAPTATION NATURAL A
   Kumsawat P, 2005, IEEE T SIGNAL PROCES, V53, P4707, DOI 10.1109/TSP.2005.859323
   Shieh CS, 2004, PATTERN RECOGN, V37, P555, DOI 10.1016/j.patcog.2003.07.003
   Shih FY, 2005, INFORM SCIENCES, V175, P200, DOI 10.1016/j.ins.2005.01.013
   ShihY Wuyita, 2005, J VIS COMMUN IMAGE R, V16
   Wu YT, 2004, PATTERN RECOGN, V37, P2349, DOI 10.1016/j.patcog.2004.05.003
NR 9
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1058
EP 1063
DI 10.1016/j.egypro.2011.10.357
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401014
DA 2018-12-27
ER

PT S
AU Cao, ZL
   Dong, EQ
AF Cao, Zhulou
   Dong, Enqing
BE Zhou, X
TI RETRACTED: CoSaMP with Shannon Sampling (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE compressive sensing; CoSaMP; Shannon sampling; theoretical guarantee;
   sparse
AB Recent research shows that CoSaMP with partially known support has better performance than traditional CoSaMP. However, there is lack of theoretical analysis for this algorithm. In this paper, we propose a new algorithm which combines CoSaMP with Shannon sampling and obtain the theoretical guarantee. The proposed method measures partially known support part of a sparse signal with Shannon sampling and measures the rest part with compressive sensing. Comparisons with previous related works are shown. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Cao, Zhulou] Shandong Univ Weihai, Sch Math & Stat, Weihai 264209, Peoples R China.
RP Cao, ZL (reprint author), Shandong Univ Weihai, Sch Math & Stat, Weihai 264209, Peoples R China.
EM zlouc@sdu.edu.cn
CR [Anonymous], RICE COMPRESSIVE SEN
   Baraniuk RG, 2010, IEEE T INFORM THEORY, V56, P1982, DOI 10.1109/TIT.2010.2040894
   Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083
   Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731
   Carrillo RE, 2010, INT CONF ACOUST SPEE, P3654, DOI 10.1109/ICASSP.2010.5495901
   Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582
   Jacques L, 2010, SIGNAL PROCESS, V90, P3308, DOI 10.1016/j.sigpro.2010.05.025
   Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391
   Needell D, 2009, APPL COMPUT HARMON A, V26, P301, DOI 10.1016/j.acha.2008.07.002
   Patel VM, 2010, IEEE J-STSP, V4, P244, DOI 10.1109/JSTSP.2009.2039181
   Vaswani N., IEEE T SIGNAL PROCES, V58, P595
   Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79
NR 12
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1064
EP 1069
DI 10.1016/j.egypro.2011.10.358
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401015
DA 2018-12-27
ER

PT S
AU Zhao, H
   Wang, SG
AF Zhao, Hu
   Wang, Sangen
BE Zhou, X
TI RETRACTED: Home Robot Localization Based on RSSI Technology (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE RSSI; CC2431; Home Robot; Location estimation
AB The technology of home robot localization includes ultrasonic localization, RFID and RSSI(Received Signal Strength Indicator) technology. By comparison, the RSSI technology is more suited for the complex indoor environment with smaller size and higher efficiency. This paper introduces the location engine integrated in CC2431 and the application of CC2431 Texas Instruments Chip in home robots localization. The experimental results show that the system has high accuracy and stable performance. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhao, Hu] SW Univ, Coll Engn & Technol, Chongqing 400716, Peoples R China.
RP Zhao, H (reprint author), SW Univ, Coll Engn & Technol, Chongqing 400716, Peoples R China.
EM tiger100118@163.com
CR Bahl P., 2000, IEEE INFOCOM, V2, P775, DOI DOI 10.1109/INFC0M.2000.832252
   Brown PJ, 1997, IEEE PERS COMMUN, V4, P58, DOI 10.1109/98.626984
   Castro P., 2001, UBIQUITOUS COMPU SEP, P26
   Guccione S, 2000, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON CLIMBING AND WALKING ROBOTS, P777
NR 4
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1070
EP 1073
DI 10.1016/j.egypro.2011.10.359
PG 4
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401016
DA 2018-12-27
ER

PT S
AU Yang, H
AF Yang, Hong
BE Zhou, X
TI RETRACTED: Particle swarm optimization with modified velocity strategy
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Particle swarm optimization; evolutionary computation; global
   optimization
AB Particle swarm optimization (PSO) is an intelligent optimization technique, which has shown a good performance in many real world and benchmark problems. In this paper, we propose an improved PSO variant, called PSO with modified velocity strategy (MVPSO), in which each particle is attracted by the global best particle and a random particle chosen from a set of good particles. In order to verify the performance of MVPSO, ten well-known benchmark problems are used in the experimentas. Simulation results show that MVPSO obtains better performance than standard PSO and two other improved PSO variants. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Hunan Normal Univ, Dept Comp Teaching, Changsha 410081, Hunan, Peoples R China.
RP Yang, H (reprint author), Hunan Normal Univ, Dept Comp Teaching, Changsha 410081, Hunan, Peoples R China.
EM yanghong_hn@yahoo.com.cn
CR EBERHART R, 1998, 7 ANN C EV PROGR SAN
   Higashi N, 2003, IEEE SWARM INT S IND, P72, DOI DOI 10.1109/SIS.2003.1202250
   Hsieh ST, 2009, IEEE T SYST MAN CY B, V39, P444, DOI 10.1109/TSMCB.2008.2006628
   Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/ICNN.1995.488968
   Liang JJ, 2006, IEEE T EVOLUT COMPUT, V10, P281, DOI 10.1109/TEVC.2005.857610
   Riget J., 2002, DIVERSITY GUIDED PAR
   Shi Y, 1998, P IEEE INT C EV COMP, P69, DOI DOI 10.1109/ICEC.1998.699146
   Stacey A, 2003, IEEE C EVOL COMPUTAT, P1425
   Suganthan P.N., 1999, IEEE C EV COMP, P1958
   Yao X, 1999, IEEE T EVOLUT COMPUT, V3, P82, DOI 10.1109/4235.771163
NR 10
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1074
EP 1079
DI 10.1016/j.egypro.2011.10.360
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401017
DA 2018-12-27
ER

PT S
AU Liu, YF
   Ren, SQ
AF Liu, Yuefeng
   Ren, Shaoqing
BE Zhou, X
TI RETRACTED: Embedded System Application in the Automatic Measuring Device
   of Artillery Chamber Geometrical Parameters (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Embedded System; Artillery Chamber; Geometrical Parameter; Automatic
   Measuring; Grating-scales
AB This paper designed automatic artillery chamber geometrical measurement device based on ARM920T microprocessor core and the WinCE system, which demanded in exact detecting manufacturing precision of artillery chamber in the process of machining artillery tube. Discussed the system component and entire structure, also, introduced the method in m(a)easuring geometrical parameters and Embedded System control strategies. Over half a year applications show that its performances completely match the design requirements. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Liu, Yuefeng] Inner Mongolia Univ Sci & Technol, Inst Informat Engn, Baotou 014010, Peoples R China.
RP Liu, YF (reprint author), Inner Mongolia Univ Sci & Technol, Inst Informat Engn, Baotou 014010, Peoples R China.
EM liuyuefeng01035@163.com
CR [江晓军 JIANG Xiaojun], 2008, [计量学报, Acta Metrologica Sinica], V29, P309
   Ruan Taiyua, 2010, COMPUTER MEASUREMENT, V18
   WANG Jia, 2006, J TEST MEASUREMENT T, V20, P37
NR 3
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1080
EP 1085
DI 10.1016/j.egypro.2011.10.361
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401018
DA 2018-12-27
ER

PT S
AU Deng, SB
   Li, M
AF Deng, Shaobo
   Li, Min
BE Zhou, X
TI RETRACTED: The Factorization of Model based on Rough Logic (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE rough logic; model; factorization
AB This paper firstly introduces rough logic, and proposes factorization of model based on rough logic, and proposes the optimal factorization of model, so one complex model could be factorized into several simple models, which are easy to be handled. this paper gives them som(a)e properties. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Deng, Shaobo; Li, Min] NanChang Inst Technol, Sch Informat Engn, Nanchang 330099, Peoples R China.
RP Deng, SB (reprint author), NanChang Inst Technol, Sch Informat Engn, Nanchang 330099, Peoples R China.
EM houjiyuan2002@163.com
CR Lin TY, 1998, ROUGH SETS KNOWLEDGE, V1, P107
   Liu Qing, 2004, Chinese Journal of Computers, V27, P865
   LIU Qing, 2001, J SOFTWARE, V12, P416
   Pawlak Z., 1998, P 1998 IEEE INT C FU, P106
   Qing Liu., 2001, ROUGH SET ROUGH INFE
   Rasiawa H, 1985, P 31 MATH METH SPEC, P123
   Skowron A., 1995, LECT NOTES COMPUTER, V195, p[208, 288]
   Wang G Y, 2001, ROUGH SET THEORY ITS
   Wu Xingdong, 2006, P INT FOR THEOR GRC, V25, P28
   [闫林 YAN Lin], 2006, [模式识别与人工智能, Pattern recognition and artificial intelligence], V19, P433
   Yao YY, 1999, P 1999 IEEE CAN C EL, P1553
   YoungLin Tsau, 2006, P INT FORUM THEORY G, V25, P1
   Zhang Wenxiu, 2001, ROUGH SET THEORY MET
NR 13
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1086
EP 1090
DI 10.1016/j.egypro.2011.10.362
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401019
DA 2018-12-27
ER

PT S
AU Guan, SJ
AF Guan, Sujie
BE Zhou, X
TI RETRACTED: The Optimal Factorization of Model (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE rough set; model; optimal factorization
AB this paper gives them some properties. This paper firstly introduces rough logic, and proposes factorization of model based on rough logic, and proposes the optimal factorization of model, so one complex model could be factorized into several simple models, which are easy to be handled. this paper not only gives them some properties, but also analyze the time complexity of it. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 NanChang Inst Technol, Sch Informat Engn, Nanchang 330099, Peoples R China.
RP Guan, SJ (reprint author), NanChang Inst Technol, Sch Informat Engn, Nanchang 330099, Peoples R China.
EM houjiyuan2002@163.com
CR Hu Feng, 2007, Chinese Journal of Computers, V30, P963
   Lin TY, 1998, ROUGH SETS KNOWLEDGE, V1, P107
   Liu Qing, 2004, Chinese Journal of Computers, V27, P865
   LIU Qing, 2001, J SOFTWARE, V12, P416
   Pawlak Z., 1998, P 1998 IEEE INT C FU, P106
   Qing Liu., 2001, ROUGH SET ROUGH INFE
   Rasiawa H, 1985, P 31 MATH METH SPEC, P123
   Skowron A., 1995, LECT NOTES COMPUTER, V195, p[208, 288]
   Wang G Y, 2001, ROUGH SET THEORY ITS
   Wu Xingdong, 2006, P INT FOR THEOR GRC, V25, P28
   [闫林 YAN Lin], 2006, [模式识别与人工智能, Pattern recognition and artificial intelligence], V19, P433
   Yao YY, 1999, P 1999 IEEE CAN C EL, P1553
   YoungLin Tsau, 2006, P INT FORUM THEORY G, V25, P1
   Zhang Wenxiu, 2001, ROUGH SET THEORY MET
NR 14
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1091
EP 1097
DI 10.1016/j.egypro.2011.10.363
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401020
DA 2018-12-27
ER

PT S
AU Ren, XJ
   Fang, DY
   Chen, XJ
AF Ren Xuejun
   Fang Dingyi
   Chen Xiaojiang
BE Zhou, X
TI RETRACTED: A Sensor Node Lossless Compression Algorithm Tailored from
   H.264 integer DCT Transform (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Wireless Sensor Networks; Data Compression; Integer DCT Transform; H.264
AB Efficient utilization of energy is a core area of research in wireless sensor networks. Data compression methods to reduce the number of bits to be transmitted by the communication module will significantly reduce the energy requirement and increase the lifetime of t(a)he sensor node. The discrete cosine transform can significantly reduce the spatio-temporal correlations among input data and then achieve effective compression ratio. However, the original DCT transform algorithm is too complicated to be applied in the sensor nodes. This paper proposes a lossless algorithm, which tailored from H. 264 integer DCT transform, particularly suited for memory and computational resource constrained wireless sensor node. The algorithm transforms sensor data to result data which are input to an entropy encoder. The entropy encoder performs compression by encoding result data more compactly based on their statistical characteristics. Compared with the typical lossless algorithm, the purposed algorithm indicated better compression for non-slowly-varying data. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Ren Xuejun; Fang Dingyi; Chen Xiaojiang] NW Univ Xian, Sch Informat Sci & Technol, Xian 710127, Peoples R China.
RP Ren, XJ (reprint author), NW Univ Xian, Sch Informat Sci & Technol, Xian 710127, Peoples R China.
EM renxj163@163.com
CR [Anonymous], 2002, JVTF100 ITUT
   [Anonymous], SENS DAT DOWNL URL I
   Barr KC, 2006, ACM T COMPUT SYST, V24, P250, DOI 10.1145/1151690.1151692
   Daubechies I, 1998, J FOURIER ANAL APPL, V4, P247, DOI 10.1007/BF02476026
   Marcelloni F, 2008, IEEE COMMUN LETT, V12, P411, DOI 10.1109/LCOMM.2008.080300
   Ren X., 2010, WICOM2010, P1
   Su W., 2002, COMPUTER NETWORKS
   Tharini C, 2009, Journal of Computer Sciences, V5, P466, DOI 10.3844/jcssp.2009.466.470
NR 8
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1098
EP 1102
DI 10.1016/j.egypro.2011.10.364
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401021
DA 2018-12-27
ER

PT S
AU Dong, X
   Guo, Y
AF Dong, Xin
   Guo, Yin
BE Zhou, X
TI RETRACTED: 3D Ear Recognition Using SIFT Keypoint Matching (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE SIFT; keypoint detection; 2.5D image
ID SHAPE
AB In this paper, we present a novel algorithm for 3D ear recognition. The basic idea is to rotate each 3D point cloud representing an individual's ear around the x, y or z axes, respectively generating multiple 2.5D images at each step of the rotation. Then we use SIFT descriptors to extract and describe the features of human ears. The test ear images are recognized by the application of a new weighted keypoint matching algorithm. Experimental results show that this method is both accurate and efficient. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Dong, Xin; Guo, Yin] Univ Sci & Technol Beijing, Beijing 100083, Peoples R China.
RP Dong, X (reprint author), Univ Sci & Technol Beijing, Beijing 100083, Peoples R China.
EM jamesdongxin@gmail.com
CR [Anonymous], 2006, COMPUTER VISION RES
   Bay H., 2008, COMPUTER VISION IMAG, V110, P346
   Bhanu B., 2003, P WORKSH MULT US AUT, P91
   Chandrasekhar V., 2009, IEEE C COMP VIS PATT
   Chen H, 2004, INT C PATT RECOG, P574, DOI 10.1109/ICPR.2004.1334594
   Chen H., 2005, P 7 IEEE WORKSH APPL, P123
   Chen H, 2007, IEEE T PATTERN ANAL, V29, P718, DOI 10.1109/TPAMI.2007.1005
   Choras M, 2006, P 4 INT C ART MOT DE, P58
   Choras M, 2005, ELECT LETT COMPUTER, V5, P84
   Hurley D., 2002, IMAGE VISION COMPUT, V20, P429
   Hurley DJ, 2005, COMPUT VIS IMAGE UND, V98, P491, DOI 10.1016/j.cviu.2004.11.001
   Iannarelli A, 1989, EAR IDENTIFICATION
   KOENDERINK JJ, 1992, IMAGE VISION COMPUT, V10, P557, DOI 10.1016/0262-8856(92)90076-F
   Mayo M, 2009, ADV VID SIGN BAS SUR
   MESSER K, 1999, AUDIO VIDEO BASED BI, P72
   Moreno B., 1999, Proceedings IEEE 33rd Annual 1999 International Carnahan Conference on Security Technology (Cat. No.99CH36303), P469, DOI 10.1109/CCST.1999.797956
   Yan P, 2007, IEEE T PATTERN ANAL, V29, P1297, DOI 10.1109/TPAMI.2007.1067
NR 17
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1103
EP 1109
DI 10.1016/j.egypro.2011.10.365
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401022
DA 2018-12-27
ER

PT S
AU Su, LL
   Su, J
   Shan, HM
   Xu, G
   Pengtao
AF Su Lili
   Su Jian
   Shan Hongmei
   Xu Guan
   Pengtao
BE Zhou, X
TI RETRACTED: Research of Error Compensation Methods and Equipment for
   Bogie Wheel Alignment Parameters in Horizontal Plane (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE railway vehicle; bogie wheelset; error compensation; wheel profile;
   alignment parameter
AB To obtain more accurate detection results of railway vehicle wheelset rim inside distance, wheelbase difference and diagonal difference, measurement error owning to wheelset profile is analyzed and described. Measurement model of bogie wheel alignment parameters in horizontal plane, which has the function of wheel profile error compensation, is set up. As the main measurement instrument, high-precision grating displacement sensors detect the profile of wheels, and send signals to computer for real-time recording the rim fluctuation, actual wheel center is calculated according to this curve. Detection result is compensated by software after wheel rim inside distance, wheelbase difference, as well as diagonal difference measurement. Measurement result shows this method can meet with the detecting requirement. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Su Lili] Jilin Univ, State Key Lab Automot Dynam Simulat, Changchun 130025, Peoples R China.
RP Su, J (reprint author), Jilin Univ, State Key Lab Automot Dynam Simulat, Changchun 130025, Peoples R China.
EM sujianjd@163.com
CR [Anonymous], UIC518
   [Anonymous], 1999, 12299 BS ENV
   EICKHOFF BM, 1995, VEHICLE SYST DYN, V24, P469, DOI 10.1080/00423119508969105
   Zeng J, 1999, VEHICLE SYST DYN, V33, P552
   Zeng Jing, 2001, Chinese Journal of Mechanical Engineering, V14, P97
NR 5
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1110
EP 1115
DI 10.1016/j.egypro.2011.10.366
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401023
DA 2018-12-27
ER

PT S
AU Fei, L
   Gang, L
AF Fei, Lu
   Gang, Lu
BE Zhou, X
TI RETRACTED: An Improved Distance Threshold PEGASIS Protocol for Wireless
   Sensor Network (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Wireless sensor network; PEGASIS; Distance Threshold Algorithm; Network
   lifetime
AB In wireless sensor network, every node's energy is limited, so how to reduce energy consumption is an important issue to be considered in wireless sensor network routing. This paper proposes a routing protocol for the applications of Wireless Sensor Network. It is a protocol based on the PEGASIS protocol but uses an improved distance threshold algorithm while constructing the chain with the greedy algorithm. PEGASIS is a typical low energy consumption routing protocol for wireless sensor network, but the chain building mechanism based on the greedy algorithm may also cause some defects. This paper suggests an improved algorithm to solve these problems. During the chain building process, we use a distance threshold to prevent the algorithm from choosing too long distance values between the neighbor nodes. Compared with the original PEGASIS, the improved protocol can build a better chain. Simulation results have shown that the proposed protocol significantly prolongs the network lifetime. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Fei, Lu; Gang, Lu] E China Normal Univ, Dept Comp Sci & Technol, Shanghai 200241, Peoples R China.
RP Fei, L (reprint author), E China Normal Univ, Dept Comp Sci & Technol, Shanghai 200241, Peoples R China.
EM lufei880907@163.com
CR Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4
   BOKAREVA T, 2004, P GLOB 2004, P85
   Dasgupta K., 2003, P IEEE WIR COMM NETW
   Guo Wenjing, 2010, 2010 2 INT WORKSH ED
   LINDSEY S, 2002, IEEE AER C P, P1125
   strin D., 2002, MOB SEP 23 28 WEST P
   Ye F., 2001, P INT C COMP COMM NE
NR 7
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1116
EP 1121
DI 10.1016/j.egypro.2011.10.367
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401024
DA 2018-12-27
ER

PT S
AU Xiao, JZ
   Xiao, L
   Huang, TY
AF Xiao Jing-zhong
   Xiao Li
   Huang Tian-yun
BE Zhou, X
TI RETRACTED: The Design and Implementation of Event Management System of
   Message Middleware (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Global State; Event Management; Distributed System
AB Middleware is an essential component for developing any large scale distributed applications. With the continuing developing of the Internet and the growing demand for more and larger scaled distributed applications, middleware will sure to be the most competitive approach to implement those applications. According the aims and implementing mechanisms, middlewares could be categorized approximately into three classes: RPC-Based Middleware, Messaging-Oriented Middleware and Object Request Broker Middleware. One important component of Messaging-Oriented Middleware is the Event Management Subsystem (EMS). The thesis ends with the discussion on the designing and implementing of the Event Management Subsystem of Messaging-Oriented Middleware. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xiao Jing-zhong] SW Univ Nationalities, Sch Comp Sci & Technol, Chengdu 610041, Peoples R China.
RP Xiao, JZ (reprint author), SW Univ Nationalities, Sch Comp Sci & Technol, Chengdu 610041, Peoples R China.
EM x267@163.com
CR Blair GS., 2009, REFLECTIVE MIDDLEWAR
   F Eliassen, 1999, P 7 IEEE WORKSH FUT
   G Coulson, 1998, P 1998 MIDDL C
   Mainwaring A, 2002, WSNA 02 ATL GEORG US
   Mikko Kohvakka, 2006, P 2 INT WORKSH MULT, P95
   Milner, 1999, COMMUNICATION MOBILE
   Parlavantzas N, 2009, REFLECTIVE COMPONENT
NR 7
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1122
EP 1127
DI 10.1016/j.egypro.2011.10.368
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401025
DA 2018-12-27
ER

PT S
AU Yu, Y
   Li, SZ
   Liua, XJ
AF Yu Yun
   Li Suzhen
   Liua, X. J.
BE Zhou, X
TI RETRACTED: Multi-model Predictive Control for Pressurized Water Reactor
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Multi-model; bayesian probability weighting; point reactor model;
   Predictive Control
ID NUCLEAR-REACTORS; DESIGN
AB In A-Mode operating pressurized water reactor (PWR), the temperature control system of reactor coolant in primary loop undertakes many tasks, such as load tracking, over-temperature restraint in the core, over-power and other important functions. In a sense, the coolant temperature control is the most important part in reactor control. Currently, most nuclear power plants are running with a basic load in China, with a loose requirement to the sensitivity and response speed of temperature control system. However, with the increase of nuclear power plants, the capacity of changing load in a wide range and swift speed is more and more important. Hence, the model uncertainty should be considered in the control system design to increase the robustness of control system. For such high-order object, traditional PID control method can rarely meet the stability and robustness of control system. Based on point-kinetic model and heat transfer model in reactor, this article designs a suitable temperature model for control purpose, by using multi-model predictive control strategy. The simulation results indicate that the system can reach stable condition under large load change condition. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yu Yun; Li Suzhen; Liua, X. J.] N China Elect Power Univ, Dept Control & Comp Engineer, Beijing, Peoples R China.
RP Liua, XJ (reprint author), N China Elect Power Univ, Dept Control & Comp Engineer, Beijing, Peoples R China.
EM crazybluefish@163.com; lisuzhen9759@126.com
CR ATHANS M, 1971, IEEE T AUTOMAT CONTR, VAC16, P529, DOI 10.1109/TAC.1971.1099818
   Aufderheide B, 2001, IEEE DECIS CONTR P, P4863, DOI 10.1109/CDC.2001.980977
   BENABDENNOUR A, 1992, IEEE T NUCL SCI, V39, P2286, DOI 10.1109/23.211438
   Liao Zhongyue, 1995, NUCL POWER ENG
   MIDDLETON RH, 1988, IEEE T AUTOMAT CONTR, V33, P50, DOI 10.1109/9.360
   Muhando Endusa Billy, 2008, RENEW ENERG, P1942
   RAMASWAMY P, 1993, IEEE T NUCL SCI, V40, P1253, DOI 10.1109/TNS.1993.8526778
   Ren LX, 2005, IEEE T ENERGY CONVER, V20, P237, DOI 10.1109/TEC.2004827708
   Schultz M. A., 1961, CONTROL NUCL REACTOR
   Shulin Ding, 2006, ATOMIC ENERGY SCI TE
   SINGH RP, 1988, IEEE T AUTOMAT CONTR, V33, P122, DOI 10.1109/9.376
   Xie Zhongsheng, 2000, NUCL REACTOR PHYS TH
   [于雷 Yu Lei], 2004, [海军工程大学学报, Journal of naval university of engineering], V16, P54
NR 13
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1128
EP 1137
DI 10.1016/j.egypro.2011.10.369
PG 10
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401026
DA 2018-12-27
ER

PT S
AU Du, XP
   Wu, SQ
   Shao, B
   Yang, JK
AF Du, Xiaoping
   Wu, Shuqiong
   Shao, Bing
   Yang, Jiankai
BE Zhou, X
TI RETRACTED: A Fast Algorithm for Recognizing Real-Time Road Signs
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Intelligent Traffic; Road Signs Recognition; Algorithm; HSI; SIFT
AB By researching current road signs recognition methods, we found that SIFT is rarely used for real time system because its computation cost is high; while PCA-SIFT often fails when objective images have obvious changes in scaling and rotation. To solve the problems of SIFT and PCA-SIFT, we propose a more effective real time road signs recognition algorithm named HSI-SIFT, it combines HSI image segmentation with SIFT recognition. We illustrate that HSI-SIFT can be used for real time road signs recognition efficiently; and it is more accurate and robust than PCA-SIFT to changes in scaling, rotation and illumination; moreover, HSI-SIFT is about 10 times faster than PCA-SIFT on average. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Du, Xiaoping; Wu, Shuqiong; Shao, Bing; Yang, Jiankai] Beihang Univ, Sch Software, Beijing 100191, Peoples R China.
RP Du, XP (reprint author), Beihang Univ, Sch Software, Beijing 100191, Peoples R China.
EM wsq2008buaa@gmail.com
CR Arlicot A, 2009, J INT ARCH PHOTOGRAM, V38, P205
   Broggi Alberto, 2007, Proceedings of the 2007 IEEE Intelligent Vehicles Symposium, P981
   Dawei L, 2006, J T CHINESE SOC AGR, V4, P51
   Farag A. A., 2004, P ACIVS SEPT, P125
   Ke Y, 2004, PROC CVPR IEEE, P506
   Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94
   Rahman O M, 2009, J EUROPEAN J SCI RES, V25, P478
   Yamauchi H, 2007, P INT C MECH ICM2007, P1
NR 8
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1138
EP 1145
DI 10.1016/j.egypro.2011.10.370
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401027
DA 2018-12-27
ER

PT S
AU Xi, Y
AF Xi, Ye
BE Zhou, X
TI RETRACTED: An Improved OTP Authentication System and its Application in
   Mobile Commerce (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE E-commerce; OTP; Authentication; S/KEY; Integer attack; Mobile
ID SMART CARDS; SCHEME; EFFICIENT
AB E-commerce based on Internet is gradually becoming a new mode for commercial activities and the greatest misgiving of enterprises to conduct e-commerce is "safety". One-time password (OTP) scheme can help to solve password problems such as password conjecture and wiretapping, which occurs by repeatedly using the same password. The S/KEY one-time password system is one of most popular authentication schemes, however it can not withstand small integer attack. This work illustrates as well as discusses of the S/KEY based authentication schemes with their pros and cons. This paper suggests an improved one-time password system based on bidirectional virtual authorization in mobile application systems. Our proposed Scheme can defend copy attacks, replay attacks, integer attack and Brute-Force Attack. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Wenzhou Med Coll, Wenzhou 325035, Peoples R China.
RP Xi, Y (reprint author), Wenzhou Med Coll, Wenzhou 325035, Peoples R China.
EM yexi2010@gmail.com
CR Chien HY, 2002, COMPUT SECUR, V21, P372, DOI 10.1016/S0167-4048(02)00415-7
   Goyal V, 2005, INT C INF TECHN COD
   Haller N. M., 1994, Proceedings Internet Society Symposium on Network and Distributed System Security 1994, P151
   Hu Tianlin, 2005, INFORM TECHNOLOGY, V9, P140
   Hwang MS, 2002, MATH COMPUT MODEL, V36, P103, DOI 10.1016/S0895-7177(02)00106-1
   Kim Hyun-Chul, 2008, P 4 INT C NETW COMP, V1, P18
   Ku WC, 2005, IEICE T COMMUN, VE88B, P2165, DOI 10.1093/ietcom/e88-b.5.2165
   LAMPORT L, 1981, COMMUN ACM, V24, P770, DOI 10.1145/358790.358797
   Li Fengyin, 2003, COMPUTER SYSTEMS APP, V4, P34
   Li Xiaojin, 2007, MICROCOMPUTER APPL, V23, P52
   Li Yan, 2008, 2008 INT C WIR COMM
   Qi Ming, 2000, E BUSINESS PRACTICAL
   Saxena Ashutosh, 2008, 3 INT C COMM SYST SO
   Sun H.M., 2001, INF SEC C 2001 MAY, P221
   Sun HM, 2000, IEEE T CONSUM ELECTR, V46, P958, DOI 10.1109/30.920446
   Wu Thomas, 1998, INT SOC NETW DISTR S
NR 16
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1146
EP 1154
DI 10.1016/j.egypro.2011.10.371
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401028
DA 2018-12-27
ER

PT S
AU Lin, ZG
   Zhang, YN
   Guo, Z
   Liang, J
AF Lin, ZengGang
   Zhang, YanNing
   Guo, Zhe
   Liang, Jun
BE Zhou, X
TI RETRACTED: An Effective Algorithm for Detecting Edges on Triangular Mesh
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE 3D Mesh; edge detection; deformation function; double threshold value;
   non-maximum suppression
AB In order to detect the feature edges on 3D mesh precisely, the paper proposes an effective algorithm by using the related endpoint's information to detect the 3D edge. The algorithm first selected the candidate feature vertexes by multi-stage adjacent information, calculated the deformation value on each candidate point; Then calculated the edge's feature value by endpoint's deformation value and other related information, calculated the statistical data on feature value to determine two threshold value; Finally, filtered out the seminal feature edges by higher threshold value, extended the feature edges by lower value to get complete edge, filtered the false feature edges by total length and linearity. Experiment results in real 3D models show the algorithm's validity and superiority (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Lin, ZengGang; Zhang, YanNing; Guo, Zhe; Liang, Jun] Northwestern Polytech Univ, Coll Comp Sci, Xian 710072, Peoples R China.
RP Zhang, YN (reprint author), Northwestern Polytech Univ, Coll Comp Sci, Xian 710072, Peoples R China.
EM talcool@163.com
CR Alliez P, 2003, ACM T GRAPHIC, V22, P485, DOI 10.1145/882262.882296
   GUO YW, 2005, J ZHEJIANG UNIV-SC A, V6, P460, DOI DOI 10.1631/JZUS.2005.A0460
   Hubeli A., 2001, P C VIS 01 2001, P287
   Kudelski Dimitri, 2010, 2010 SHAP MOD INT C, P246
   Lee S., 2009, COMPUT GRAPH FORUM, V28, P1995
   Lin Jinjie, 2010, 2010 2 INT C COMP MO, P575
   MEYER M, 2003, VISUALIZATION MATH, V3, P35, DOI DOI 10.1007/978-3-662-05105-4
   Novatnack John, 2006, P 3 INT S 3D DAT PRO, P946
   Osada R, 2001, INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS, PROCEEDING, P154, DOI 10.1109/SMA.2001.923386
   Stylianou G, 2003, MATH VISUAL, P269
   Sun Y., 2002, TRIANGLE MESH BASED, V3, P825
   Wang Lirong, 2009, WORLD C COMP SCI INF, V1, P698
NR 12
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1155
EP 1162
DI 10.1016/j.egypro.2011.10.372
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401029
DA 2018-12-27
ER

PT S
AU Wang, J
   Xu, LY
   Zhong, F
   Xu, YJ
   Liu, N
AF Wang, Jian
   Xu, Lingyu
   Zhong, Fei
   Xu, Yijun
   Liu, Na
BE Zhou, X
TI RETRACTED: The clustering analysis of multi-satellite monitoring SST
   data on the basis of variable precision (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE SST; clustering; probability; variable-precision; precision interval;
   equal-precision; confidence level
AB In consideration of satellite remote sensing quality and precision imbalance at present, and the boundedness brought by using the method of average deviation, standard deviation and etc., this paper puts forward a kind of flexible assessment method which is based on clustering idea that it works into the precision of each point and confidence level changes with the variation of the quality and quantity of information source, which can provides the accurate assessment of variable precision or confidence area of each point, then improves on the quality and precision of the assessment and fusion of SST data. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Jian; Xu, Lingyu; Zhong, Fei; Xu, Yijun; Liu, Na] Shanghai Univ, Dept Comp Engn & Sci, Shanghai 200072, Peoples R China.
RP Wang, J (reprint author), Shanghai Univ, Dept Comp Engn & Sci, Shanghai 200072, Peoples R China.
EM nightstar@shu.edu.cn
CR Chan PK, 2005, IEEE GEOSCI REMOTE S, V2, P270, DOI 10.1109/LGRS.2005.846838
   Gomez J, 2003, SIAM PROC S, P83
   Hu CM, 2009, IEEE T GEOSCI REMOTE, V47, P2071, DOI 10.1109/TGRS.2009.2024992
   Huang ZX, 1999, IEEE T FUZZY SYST, V7, P446, DOI 10.1109/91.784206
   Kerdprasop K, 2005, LECT NOTES COMPUT SC, V3589, P488
   Kim Jin-Soo, 1998, GEOSC REM SENS S P 6, p921~923
   Meissner Thomas, 2007, GEOSC REM SENS S 23, p862~864
   Sun Ji-Gui, 2008, Journal of Software, V19, P48, DOI 10.3724/SP.J.1001.2008.00048
   Xu Lingyu, 2009 INT C WEB INF S, p807~810
NR 9
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1163
EP 1171
DI 10.1016/j.egypro.2011.10.373
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401030
DA 2018-12-27
ER

PT S
AU Tian, LJ
   Liu, CQ
   Xie, JQ
AF Tian, Lijun
   Liu, Chaoqun
   Xie, Jianquan
BE Zhou, X
TI RETRACTED: A Dynamic Mapping Algorithm for Graph Isomorphism (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE graph isomorphism; algorithm; DMAGI; dynamic mapping; pattern
   recognition
AB The graph isomorphism problem is still an open question if it is NP-Complete or not. This paper proposed a dynamic mapping algorithm for graph isomorphism (DMAGI). DMAGI used Length-L path numbers as partition metrics which could divide not similar vertices into trivial cells easily. For those similar vertices, DMAGI took a dynamic mapping procedure. DMAGI was tested on graphs such as: random connected graphs, pseudo random k-regular graphs, regular rings, and regular 2D meshes. The results indicate that the time requirement of DMAGI don't increase exponentially with the graph size of all these types. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Tian, Lijun; Liu, Chaoqun; Xie, Jianquan] Hunan Univ Finance & Econ, Dept Informat Technol, 139 Fenglin 2nd Rd, Changsha 410205, Hunan, Peoples R China.
RP Tian, LJ (reprint author), Hunan Univ Finance & Econ, Dept Informat Technol, 139 Fenglin 2nd Rd, Changsha 410205, Hunan, Peoples R China.
EM 79704736@qq.com
CR Bagrow JP, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/68004
   Bondy J. A., 2008, GRAPH THEORY, V244, DOI [10.1007/978-1-84628-970-5, DOI 10.1007/978-1-84628-970-5]
   Cordelia L. P., 2001, P 3 IAPR TC15 WORKSH, P149
   Foggia P., 2001, P 3 IAPR TC 15 WORKS, P188
   Garey M. R., 1990, COMPUTERS INTRACTABI
   Kandel A., 2007, APPL GRAPH THEORY CO
   MCKAY BD, 1981, C NUMERANTIUM, V30, P45
   ULLMANN JR, 1976, J ACM, V23, P31, DOI 10.1145/321921.321925
NR 8
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1172
EP 1178
DI 10.1016/j.egypro.2011.10.374
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401031
DA 2018-12-27
ER

PT S
AU Liu, GQ
   Yang, SX
   Tang, Y
AF Liu, Guoquan
   Yang, Simon X.
   Tang, Yi
BE Zhou, X
TI RETRACTED: Stability results for neural networks of neutral-type with
   discrete interval and unbounded distributed delays (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Stability; neural networks; neutral-type; lyapunov-krasovskii
   functional; unbounded distributed delays
ID GLOBAL ROBUST STABILITY; STATE ESTIMATION; EXPONENTIAL STABILITY; LMI
   APPROACH; TIME DELAYS
AB This paper investigates the stability criterion of neural networks of neutral-type with discrete interval and unbounded distributed delays. A new delay-dependent condition is obtained by using more general Lyapunov-Krasovskii functionals. Meanwhile, this condition is expressed in terms of a linear matrix inequality (LMI), which can be checked easily using the MATLAB LMI toolbox. A numerical example is given to illustrate the availability of the proposed results. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Liu, Guoquan; Yang, Simon X.; Tang, Yi] Chongqing Univ, Coll Automat, Chongqing 400044, Peoples R China.
RP Liu, GQ (reprint author), Chongqing Univ, Coll Automat, Chongqing 400044, Peoples R China.
EM guoquanliu1982@hotmail.com
CR Arik S, 2003, IEEE T CIRCUITS-I, V50, P156, DOI 10.1109/TCSI.2002.807515
   Feng JE, 2009, NEUROCOMPUTING, V72, P2576, DOI 10.1016/j.neucom.2008.10.018
   He Yuyao, 2000, Control Theory & Applications, V17, P847
   Huang CX, 2009, NEUROCOMPUTING, V72, P3352, DOI 10.1016/j.neucom.2008.12.030
   Huang H, 2008, NEUROCOMPUTING, V71, P2857, DOI 10.1016/j.neucom.2007.08.008
   Itoh M, 2004, INT J BIFURCAT CHAOS, V14, P1725, DOI 10.1142/S0218127404010308
   Kirschner H, 2000, INFORM SCIENCES, V129, P31, DOI 10.1016/S0020-0255(00)00067-0
   Labonte G, 2000, KLUWER INT SER ENG C, V541, P575
   Liao XF, 2005, PHYSICA D, V200, P139, DOI 10.1016/j.physd.2004.10.009
   Miljkovic V, 2001, PHYSICA A, V295, P526, DOI 10.1016/S0378-4371(01)00169-8
   Park JH, 2008, APPL MATH COMPUT, V203, P217, DOI 10.1016/j.amc.2008.04.025
   Park JH, 2009, CHAOS SOLITON FRACT, V41, P1174, DOI 10.1016/j.chaos.2008.04.049
   Park JH, 2009, APPL MATH COMPUT, V208, P69, DOI 10.1016/j.amc.2008.11.017
   Qi HD, 2007, IEEE T CIRCUITS-I, V54, P1131, DOI 10.1109/TCSI.2007.895524
   Rakkiyappan R, 2008, NEUROCOMPUTING, V71, P1039, DOI 10.1016/j.neucom.2007.11.002
   Singh V, 2007, CHAOS SOLITON FRACT, V31, P224, DOI 10.1016/j.chaos.2005.09.050
   Van Hulle MM, 2005, NEUROCOMPUTING, V69, P1, DOI 10.1016/j.neucom.2005.07.001
   Xiang HJ, 2009, NONLINEAR ANAL-REAL, V10, P2407, DOI 10.1016/j.nonrwa.2008.04.021
   Xu SY, 2005, J COMPUT APPL MATH, V183, P16, DOI 10.1016/j.cam.2004.12.025
   Zhang YJ, 2010, APPL MATH COMPUT, V216, P768, DOI 10.1016/j.amc.2010.01.075
NR 20
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1179
EP 1185
DI 10.1016/j.egypro.2011.10.375
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401032
DA 2018-12-27
ER

PT S
AU Shi, DQ
   Gao, GL
   Gao, ZW
   Xiao, P
AF Shi Dequan
   Gao Guili
   Gao Zhiwei
   Xiao Peng
BE Zhou, X
TI RETRACTED: Temperature Control System of Resistance-heated Furnace Based
   on Variable Fuzzy-PI Control (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Fuzzy-PI control; resistance-heated furnace; temperature control
ID DESIGN
AB In order to solve the problem that resistance-heated furnace has the disadvantage of non-linearity, slow time-variant and large delay and so on, a temperature control system of the resistance-heated furnace has been designed according to the fuzzy-PI algorithm. Because this method has the merits of both PI and fuzzy control, the temperature control effect is improved to large extent. When the temperature error between given value and measured value is too large, the fuzzy control is adopted. When the error is too small, the PI control is used. The simulation test is performed by MATLAB, and the results indicate that this system has the advantages of small overshoot, short adjusting time and good robustness. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Shi Dequan; Gao Guili; Gao Zhiwei; Xiao Peng] Harbin Univ Sci & Technol, Dept Mat Sci & Engn, Harbin 150040, Peoples R China.
RP Shi, DQ (reprint author), Harbin Univ Sci & Technol, Dept Mat Sci & Engn, Harbin 150040, Peoples R China.
EM shidequan2008@yahoo.com.cn
CR Ang KH, 2005, IEEE T CONTR SYST T, V13, P559, DOI 10.1109/TCST.2005.847331
   Bezuidenhout JJ, 2009, MINER ENG, V22, P995, DOI 10.1016/j.mineng.2009.03.009
   COHEN J, 1960, REV SCI INSTRUM, V31, P267, DOI 10.1063/1.1716954
   DF Campbell, 2009, J STRUCT ENG, V54, P1048
   Feng QG, 2009, APPL MECH MATER, V16-19, P140, DOI 10.4028/www.scientific.net/AMM.16-19.140
   Li Y, 2006, IEEE CONTR SYST MAG, V26, P32
   Moon UC, 2003, IEEE T CONTR SYST T, V11, P548, DOI 10.1109/TCST.2003.813385
NR 7
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1186
EP 1191
DI 10.1016/j.egypro.2011.10.376
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401033
DA 2018-12-27
ER

PT S
AU Xiao, JZ
   Xiao, L
   Huang, TY
AF Xiao Jing-zhong
   Xiao Li
   Huang Tian-yun
BE Zhou, X
TI RETRACTED: Reserch of mechanism for message transmission of
   Message-oriented middleware (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE distribute system; message tranmisssion; message Queue
AB The most prominent features of messaging middleware is to provide data transmission reliability and efficiency, mainly to solve the distributed system data transmission requirements. TONGLINK / Q messaging middleware has undergone years of development and application of reliable transmission of information exchange has an irreplaceable role in the field, its advanced low-level flow control algorithm to ensure efficient data transmission. In this article TongLink / Q provide message transport mechanism was studied to improve the reliability of its messaging transmission. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Xiao Jing-zhong; Xiao Li; Huang Tian-yun] SW Univ Nationalities, Sch Comp Sci & Technol, Chengdu 610041, Peoples R China.
RP Xiao, JZ (reprint author), SW Univ Nationalities, Sch Comp Sci & Technol, Chengdu 610041, Peoples R China.
EM x267@163.com
CR [Anonymous], 1999, COMMUNICATION MOBILE
   F Eliassen, 1999, P 7 IEEE WORKSH FUT
   G Coulson, 1998, P 1998 MIDDL C
   J Polastre, 2002, WSNA 02 ATL GEORG
   Rgs, 2009, RGS REFLECTIVE MIDDL
   Tero Arpinen, 2006, P 2 INT WORKSH MULT, P95
   vantzas N, 2009, REFLECTIVE COMPONENT
NR 7
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1192
EP 1198
DI 10.1016/j.egypro.2011.10.377
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401034
DA 2018-12-27
ER

PT S
AU Liang, J
   Xie, XF
   Cao, J
   Zhang, LJ
AF Liang Jie
   Xie Xiao-fang
   Cao Jian
   Zhang Long-jie
BE Zhou, X
TI RETRACTED: Sensor placement strategy in bearing-only passive location
   system (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE passive location; cross location; location error
ID TARGET LOCALIZATION
AB The paper studies the relationship of the location error and distribution of two sensors. Through mathematical calculation, an expression of the optimal distribution of two sensors and a figure depicted the optimal maneuver direction under different distance are given. The simulation results show that the approach obviously improves the precision and stabilization of the system of two sensors passive bearing-only cross location. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Liang Jie; Xie Xiao-fang; Cao Jian; Zhang Long-jie] Naval Aeronaut & Astronaut Univ, Yantai 264001, Peoples R China.
RP Zhang, LJ (reprint author), Naval Aeronaut & Astronaut Univ, Yantai 264001, Peoples R China.
EM xiaobing99991@sina.com
CR Dogancay K, 2005, SIGNAL PROCESS, V85, P481, DOI 10.1016/j.sigpro.2004.10.014
   Dogancay K, 2004, SIGNAL PROCESS, V84, P475, DOI 10.1016/j.sigpro.2003.12.002
   Liang-Jie, IEEE 2010 3 INT C CO, V3, P591
   Lin X., 2002, P SPIE C SIGN DAT PR
   Oshman Y, 1999, IEEE T AERO ELEC SYS, V35, P892, DOI 10.1109/7.784059
   TORRIERI DJ, 1984, IEEE T AERO ELEC SYS, V20, P183, DOI 10.1109/TAES.1984.310439
   Xiu J.-J., 2005, IEE P RADAR SONAR NA, V152
NR 7
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1199
EP 1205
DI 10.1016/j.egypro.2011.10.378
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401035
DA 2018-12-27
ER

PT S
AU Shi, DQ
   Gao, GL
   Gao, ZW
   Xiao, P
   Tang, HY
AF Shi Dequan
   Gao Guili
   Gao Zhiwei
   Xiao Peng
   Tang Huiying
BE Zhou, X
TI RETRACTED: Design on Fuzzy Neural Network Temperature Controller of
   Heating Furnace (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Fuzzy control; heating furnace; neural network; temperature control
AB In order to solve these disadvantages of non-linearity, time variant and large delay of heating furnace, a fuzzy neural network temperature controller is designed according to the fuzzy control and neural network theory. In this controller, not only can the reasoning process of neural network be described by the fuzzy rules, but also the fuzzy rules can be dynamically adjusted by the neural network. Moreover, the learning algorithm of the fuzzy neural network temperature controller is given. Simulation results show that the fuzzy neural network temperature controller has good regulating performance, and it can meet the requirement of heating furnace during industrial production. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Shi Dequan; Gao Guili; Gao Zhiwei; Xiao Peng; Tang Huiying] Harbin Univ Sci & Technol, Dept Mat Sci & Engn, Harbin 150040, Peoples R China.
RP Shi, DQ (reprint author), Harbin Univ Sci & Technol, Dept Mat Sci & Engn, Harbin 150040, Peoples R China.
EM shidequan2008@yahoo.com.cn
CR Astrom KJ, 2001, CONTROL ENG PRACT, V9, P1163, DOI 10.1016/S0967-0661(01)00062-4
   BDO Anderson, 2007, IEEE T SYS MAN CYBER, V2, P559
   Bezuidenhout JJ, 2009, MINER ENG, V22, P995, DOI 10.1016/j.mineng.2009.03.009
   Feng QG, 2009, APPL MECH MATER, V16-19, P140, DOI 10.4028/www.scientific.net/AMM.16-19.140
   Gottwald S, 2005, FUZZY SET SYST, V156, P357, DOI 10.1016/j.fss.2005.05.031
   Izadinia H, 2009, NEURAL NETWORKS, V22, P633, DOI 10.1016/j.neunet.2009.06.041
   LIM CM, 1991, IEEE T ROBOTIC AUTOM, V7, P688, DOI 10.1109/70.97890
   MURATA N, 1994, IEEE T NEURAL NETWOR, V5, P865, DOI 10.1109/72.329683
   Nagasawa S, 1997, COMPUT IND ENG, V33, P565, DOI 10.1016/S0360-8352(97)00194-0
   TL Teng, 2000, COMPUTER METHODS APP, V189, P1673
NR 10
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1206
EP 1211
DI 10.1016/j.egypro.2011.10.379
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401036
DA 2018-12-27
ER

PT S
AU Song, XJ
   Liu, W
   Tan, BX
AF Song, Xiaojie
   Liu, Wei
   Tan, Boxue
BE Zhou, X
TI RETRACTED: Diesel Engine Air Tightness Feature Recognitionbased on
   Multi-scale Analysis (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Cylinder air tightness; starting voltage; mallat algorithm; feature
   recognition
AB Cylinder air tightness is an important indicator to the comprehensive performance of internal combustion engine. It can be got the low-frequency and high-frequency signals of the starting voltage waveform using multi-scale analysis method and by binary discrete wavelet transform with the Mallat algorithm. The experiment results show that the working conditions of diesel engine starting process can be shown from the low-frequency signals, and the main frequency distribution can be recognised from the high frequency partial. This algorithm can effectively identify signal characteristics, and provide a reliable basis for signal feature recognition. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Song, Xiaojie; Liu, Wei; Tan, Boxue] Shandong Univ Tecnol, Sch Elect & Elect Engn, Zi Bo, Peoples R China.
RP Liu, W (reprint author), Shandong Univ Tecnol, Sch Elect & Elect Engn, Zi Bo, Peoples R China.
EM weikey@sdut.edu.cn
CR Hengrui MA, 2003, T CSICE, V21, p91~95
   Tao LIU, 2006, PRACTICAL INTRO WAVE, p101~110
   [王洋 Wang Yang], 2003, [内燃机学报, Transactions of Csice], V21, P276
   Xinqing Wang, 2001, MECH ENG, V14, p262~265
   Yu ZHANG, 1999, CHINESE INTERNAL COM, p55~59
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1212
EP 1216
DI 10.1016/j.egypro.2011.10.380
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401037
DA 2018-12-27
ER

PT S
AU Zhong, B
   Zhan, RJ
   Wang, SH
AF Zhong, Bin
   Zhan, Renjun
   Wang, Shaohua
BE Zhou, X
TI RETRACTED: Load's 2-Degree of Freedom Swing Angle Model and Dynamic
   Simulation for Overhead Crane or Gantry Crane (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE gantry crane; overhead crane; crane-trolley-load; load's swing angle;
   dynamic simulation
AB Exactly positioning of the trolley and promptly eliminating of the load swing for bridge crane are efficient approaches in order to improve the operational efficiency of over-head cranes and gantry cranes. So, it is necessary that model construction for dynamic equations of the trolley-load system and finding out load swing rules and decision factors of load's swing angel while studying anti-swing control scheme. Construct 2-degree of freedom angel's math model of the load-swing through constructing the trolley-load system's dynamic 3-dimention (3-D) equations, and properly simplify those equations. The rope's length of load and trolley-acceleration can obviously affect the swing angel's value of load. Dynamic simulation results show that the rope-length's force is more prominent than the trolley-acceleration's for the swing angel of load and the trolley's running acceleration (deceleration) can obviously affect the value of load's swing angle when the rope length is determined, the value will increase with increasing acceleration (deceleration), and the trolley's running acceleration (deceleration) can not obviously affect the load's swing frequency. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhong, Bin; Zhan, Renjun; Wang, Shaohua] Engn Univ Chinese Armed Police Force, Equipment Transportat Dept, Xian, Peoples R China.
RP Zhong, B (reprint author), Engn Univ Chinese Armed Police Force, Equipment Transportat Dept, Xian, Peoples R China.
EM zhongbinchina@163.com
CR Altshuller DA, 2008, IEEE T AUTOMAT CONTR, V53, P2158, DOI 10.1109/TAC.2008.930193
   Hesketh Z., 2010, CONTROL THEORY APPL, V4, P2071, DOI [10.049/iet-cta.2009.0558, DOI 10.1049/IET-CTA.2009.0558]
   Lew J. Y., 2003, AM CONTR C P 2003, V2, P1434, DOI [10.1109/ACC.2003.123979, DOI 10.1109/ACC.2003.1239792]
   Li F., 2006, INT CONTR AUT 2006 W, V2, P8024, DOI [10.1109/WCICA.2006.1713535, DOI 10.1109/WCICA.2006.1713535]
   Park MS, 2008, IEEE T IND ELECTRON, V55, P3972, DOI 10.1109/TIE.2008.2004385
   Richiedei D, 2008, AMC '08: 10TH INTERNATIONAL WORKSHOP ON ADVANCED MOTION CONTROL, VOLS 1 AND 2, PROCEEDINGS, P92
   Shyu K. K., 2005, IND EL SOC IECON 200, V6, DOI [10.1109/IECON.2005.1568895, DOI 10.1109/IEC0N.2005.1568895]
   Trabia M. B., 2006, FUZZ SYST 2006 IEEE, P627, DOI [10.1109/FUZZY.2006.1681777, DOI 10.1109/FUZZY.2006.1681777]
   Wang J. M., 2003, INT ROB SYST IROS 20, V2, P1192, DOI [10.109/IROS.2003.248807, DOI 10.1109/IROS.2003.1248807]
   Xiao J. M., 2007, CONTR C CCC 2007 CHI, P388, DOI [10.109/CHICC.2006.4347285, DOI 10.1109/CHICC.2006.4347285]
   Zhai J. Y., 2008, CONTR DEC C CCDC 200, P3812, DOI [10.1109/CCDC.2008.4598045, DOI 10.1109/CCDC.2008.4598045]
NR 11
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1217
EP 1223
DI 10.1016/j.egypro.2011.10.381
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401038
DA 2018-12-27
ER

PT S
AU Zhang, YS
   Wang, YY
AF Zhang, Yanshun
   Wang, Yuanyuan
BE Zhou, X
TI RETRACTED: Research of backlash nonlinearity on three-axis inertial
   stabilized platform (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Three-axis Inertial Stabilized Platform; Backlash; Vibration; Accuracy;
   modeling
AB Backlash nonlinearity exists widely in Three-axis Inertial Stabilized Platform with large torque, which has great influence on the dynamic and static properties of the platform. So a Three-axis Inertial Stabilized Platform control system with backlash was discussed. The structure and parameters of regulator of system were designed. Then the mathematic model of Three-axis Inertial Stabilized Platform control system was established by Simulink. The dynamic characters of the system were analyzed. The backlash nonlinear of drive system was lead in. The stability of system influenced by gear backlash was analyzed. It will positively guide the design of the mechanical drive and control systems. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Yanshun; Wang, Yuanyuan] Beihang Univ, Sch Instrument Sci & Optoelect Engn, Beijing 100191, Peoples R China.
RP Zhang, YS (reprint author), Beihang Univ, Sch Instrument Sci & Optoelect Engn, Beijing 100191, Peoples R China.
EM zhangyanshun@buaa.edu.cn
CR Ali S., 2008, 2008 IEEE INT C ROB, P393
   Masten Michael K., 2008, IEEE CONTROL SYSTEMS
   Mohammadiasl Ebrahim, 2009, 2009 IEEE RSJ INT C
   Ruyi Zhu, 2009, 30 AS C REM SENS 200, P1
   Sander-Tavallaey Shiva, 2009, 18 IEEE INT C CONTR
NR 5
TC 0
Z9 0
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1224
EP 1230
DI 10.1016/j.egypro.2011.10.382
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401039
DA 2018-12-27
ER

PT S
AU Wang, YY
   Zhang, YS
AF Wang, Yuanyuan
   Zhang, Yanshun
BE Zhou, X
TI RETRACTED: Research of noise suppression for MEMS gyro ADXRS150
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE drift error; the time series theory; Kalman filter; noise suppression
AB The random drift of MEMS gyro is too large due to these effects of external environmental factors and manufacturing imperfect. In order to compensate the random drift error of an ADXRS150 MEMS gyro, in this paper, the output of ADXRS150 in static are sampled. Then based on the time series theory, ARIMA model of ADXRS150 output data is established. Taken this model as the state equation and the sampled data as the measurement equation, the Kalman filter is designed to process the data. These conclusions in the final part of this paper indicate that the model and the filtering method can can restrain the gyro noise of the MEMS gyro ADXRS150 and improve its precision effectively and greatly. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Yuanyuan; Zhang, Yanshun] Beihang Univ, Sch Instrument Sci & Optoelect Engn, Beijing 100191, Peoples R China.
RP Wang, YY (reprint author), Beihang Univ, Sch Instrument Sci & Optoelect Engn, Beijing 100191, Peoples R China.
EM zhangyanshun@buaa.edu.cn
RI du, shaohe/O-7462-2014
OI du, shaohe/0000-0001-9876-5180
CR Broersen PMT, 2005, IEEE T INSTRUM MEAS, V54, P1862, DOI 10.1109/TIM.2005.853232
   Feng Ya-lin, 2006, Microelectronics, V36, P66
   [傅建国 Fu Jianguo], 2005, [传感器技术, Journal of Transducer Technology], V24, P75
   Mevlut T, 2006, EXPERT SYSTEMS APPL, V31, P41
   Shuzi Yan, 1992, ANAL APPL TIME SERIE
   Zhang S., 1999, J CHINESE INERTIAL T, V7, P70
   Zhou M, 2006, IEE P-GENER TRANSM D, V153, P187, DOI 10.1049/ip-gtd:20045131
NR 7
TC 0
Z9 0
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1231
EP 1236
DI 10.1016/j.egypro.2011.10.383
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401040
DA 2018-12-27
ER

PT S
AU Yang, Y
   Zhang, WT
   Yang, Y
   Cui, X
AF Yang, Yan
   Zhang, Wentao
   Yang, Yang
   Cui, Xiao
BE Zhou, X
TI RETRACTED: A Multi-Channel Assignment and Switching Based Routing
   Protocol for Mobile Internet (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Mobile Internet; Multi-Channel Routing; Channel Assignment
ID MAC PROTOCOL; NETWORKS
AB In this paper, we explore the problem of multi-channel assignment and switching based routing for Mobile Internet. A new routing schema to solve this problem is presented, which is called Multi-channel Assignment and Switching based Routing, namely MASR. In this method, node-based channel assignment is considered, and we introduce the concept of dependent router, with which a hierarchical and fragmented routing protocol is proposed. Extensive simulations are conducted and the results have shown that compared with MCRP and MCP-LB, our schema has better performance. It can improve the total throughput of the network greatly. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yang, Yan] Huazhong Normal Univ, Dept Comp Sci, Wuhan 430079, Peoples R China.
RP Yang, Y (reprint author), Huazhong Normal Univ, Dept Comp Sci, Wuhan 430079, Peoples R China.
EM ms_yangyan@163.com
CR Adya Atul, 2004, IEEE BROADNETS, P344, DOI DOI 10.1109/BR0ADNETS.2004.8
   Bahl P., 2004, P 10 ANN INT C MOB C, P216, DOI DOI 10.1145/1023720.1023742
   Chandra R., 2004, P IEEE INFOCOM 04 MA, V2, P882
   Draves Richard, 2004, P 10 ANN INT C MOB C, P114, DOI DOI 10.1145/1023720.1023732
   Jain N, 2001, IEEE IC COMP COM NET, P432, DOI 10.1109/ICCCN.2001.956301
   Meng X., 2006, ICC, V8, P3596
   NASIPURI A, 2000, IEEE VEH TECHN C VTC, V1, P211
   Raniwala A., 2004, MOBILE COMPUTING COM, P50
   So J., 2004, P 5 ACM INT S MOB AD, P222, DOI DOI 10.1145/989459.989487
   So Jungmin, 2005, P 2 INT C QUAL SERV
   Wu SL, 2002, COMPUT J, V45, P101, DOI 10.1093/comjnl/45.1.101
   Wu SL, 2000, I-SPAN 2000: INTERNATIONAL SYMPOSIUM ON PARALLEL ARCHITECTURES ALGORITHMS AND NETWORKS, PROCEEDINGS, P232, DOI 10.1109/ISPAN.2000.900290
   Xu Leiming, 2006, P 25 IEEE PERF COMP, P223
NR 13
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1237
EP 1244
DI 10.1016/j.egypro.2011.10.384
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401041
DA 2018-12-27
ER

PT S
AU Li, JT
AF Li, Jingtian
BE Zhou, X
TI RETRACTED: The law protects for computer software (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE law protects; computer software; software business; patent right
ID PATENTS
AB As each country in the world including our nation hasn't special computer software protection right, the law protects method for computer software is presented in the paper. Protects problems of software copyright, software patent right and trademarks are presented firstly. Then, the software that can be applied for patent is introduced and four characteristics of trade secrets are introduced. Finally, the evidence category of handing in the litigation is introduced. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Zhongnan Univ Econ & Law, Sch Law, Wuhan 430074, Peoples R China.
RP Li, JT (reprint author), Zhongnan Univ Econ & Law, Sch Law, Wuhan 430074, Peoples R China.
EM jingtianlii@163.com
CR Abraham Sherly Elizabeth, 2009, Computer Law and Security Report, V25, P554, DOI 10.1016/j.clsr.2009.09.007
   Beresford K., 2001, World Patent Information, V23, P253, DOI 10.1016/S0172-2190(00)00070-3
   Chabchoub N, 2005, TECHNOVATION, V25, P971, DOI 10.1016/j.technovation.2004.02.015
   Hall BH, 2010, RES POLICY, V39, P994, DOI 10.1016/j.respol.2010.04.007
   Mann RJ, 2007, RES POLICY, V36, P193, DOI 10.1016/j.respol.2006.10.002
   McQueen DH, 2003, TECHNOVATION, V23, P533, DOI 10.1016/S0166-4972(02)00011-1
NR 6
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1245
EP 1249
DI 10.1016/j.egypro.2011.10.385
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401042
DA 2018-12-27
ER

PT S
AU Zhu, XW
   Li, FR
AF Zhu Xianwen
   Li Furong
BE Zhou, X
TI RETRACTED: Traffic flow prediction based on artificial life and RBF
   nerual network (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE traffic flow; artificial life; RBF nerual network; prediction method
ID NEURAL-NETWORKS
AB The prediction of traffic flow is very key importance for the traffic plan, traffic management, traffic control and safety. RBF neural network is a kind of feed-forward neural network, which is composed of the different layers with the input layer, hidden layer and output layer. The hybrid method of artificial life and RBF nerual network is presented to predict the traffic flow. The experimental data are used to testify the traffic flow prediction ability of the hybrid method of artificial life and RBF nerual network. It can be seen that the traffic flow prediction results of the hybrid method of artificial life and RBF nerual network are better than those of RBF nerual network and BP nerual network. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhu Xianwen; Li Furong] Sch Int Studies, Zhumadian 46300, Peoples R China.
RP Zhu, XW (reprint author), Sch Int Studies, Zhumadian 46300, Peoples R China.
EM zhuxianwenn@163.com
CR Afantitis A, 2005, J MOL STRUC-THEOCHEM, V716, P193, DOI 10.1016/j.theochem.2004.11.021
   Dommarco RC, 2006, WEAR, V260, P1317, DOI 10.1016/j.wear.2005.09.009
   Montazer GA, 2009, NEUROCOMPUTING, V72, P1797, DOI 10.1016/j.neucom.2008.05.011
   Olsen MM, 2008, ARTIF INTELL, V172, P884, DOI 10.1016/j.artint.2007.10.015
   Tsai CH, 2004, J FRANKLIN I, V341, P361, DOI [10.1016/j.jfranklin.2004.01.001, 10.1016/j.franklin.2004.01.001]
NR 5
TC 1
Z9 1
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1250
EP 1254
DI 10.1016/j.egypro.2011.10.386
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401043
DA 2018-12-27
ER

PT S
AU Zhu, XW
   Li, JF
AF Zhu Xianwen
   Li Jingfu
BE Zhou, X
TI RETRACTED: Image recognition method based on artificial life and support
   vector machine (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE image process; artificial life; support vector machine; separating
   hyperplane; classifier
ID CLASSIFICATION
AB Image recognition is very key importance for image process. Thus, the novel image recognition method based on the hybrid model of support vector machine and artificial life is presented in the paper. The artificial life is the important research method for the traditional biology and the ecology, and the research of artificial life contributes to indicate the most essential feature that life needs and basic regulation of life evolution. FERET face database is applied to research the face recognition performance of the hybrid model of support vector machine and artificial life. It can be seen that the face recognition results of the hybrid model of support vector machine and artificial life are better than those of BP nerual network and normal support vector machine. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhu Xianwen; Li Jingfu] Sch Int Studies, Zhumadian 46300, Peoples R China.
RP Zhu, XW (reprint author), Sch Int Studies, Zhumadian 46300, Peoples R China.
EM zhuxianwenn@163.com
CR Cardenas ML, 2010, J THEOR BIOL, V263, P79, DOI 10.1016/j.jtbi.2009.11.010
   Cervantes J, 2008, NEUROCOMPUTING, V71, P611, DOI 10.1016/j.neucom.2007.07.028
   Gold C, 2003, NEUROCOMPUTING, V55, P221, DOI 10.1016/S0925-2312(03)00375-8
   Kikuchi T, 2005, PATTERN RECOGN LETT, V26, P1937, DOI 10.1016/j.patrec.2005.03.014
   Lupisella ML, 2004, ADV SPACE RES-SERIES, V33, P1318, DOI 10.1016/j.asr.2003.03.030
   Sanchez-Hernandez C, 2007, ECOL INFORM, V2, P83, DOI 10.1016/j.ecoinf.2007.04.003
   Terzic J, 2010, SENSOR ACTUAT A-PHYS, V161, P278, DOI 10.1016/j.sna.2010.05.005
   Tran QA, 2005, PATTERN RECOGN LETT, V26, P1174, DOI 10.1016/j.patrec.2004.11.001
NR 8
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1255
EP 1259
DI 10.1016/j.egypro.2011.10.387
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401044
DA 2018-12-27
ER

PT S
AU Cheng, ZL
AF Cheng Zhi-li
BE Zhou, X
TI RETRACTED: Product dynamic design based on virtual reality (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE product dynamic design; virtual reality; innovative techniques; virtual
   environment
ID THERAPY
AB With the help of rapid advances in the computer environment, the computer-aided design is the remarkable progresses in the method of engineering design in the last few years. In this paper, a novel dynamic design by using the virtual reality (VR) technology is presented. The theory of virtual reality is introduced. Then, the structure of product dynamic design based on virtual reality is given. The system of product dynamic design based on virtual reality mainly include user interface of virtual environment, database, input and output interface, information control transfer and computation optimization. The experimental results show that product dynamic design based on virtual reality is feasible. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Wuhan Inst Technol, Coll Art Design, Wuhan 430073, Peoples R China.
RP Cheng, ZL (reprint author), Wuhan Inst Technol, Coll Art Design, Wuhan 430073, Peoples R China.
EM Chengzhili@126.com
CR dos Santos IJAL, 2009, INT J IND ERGONOM, V39, P159, DOI 10.1016/j.ergon.2008.08.005
   Barrack RL, 2001, ORTHOP CLIN N AM, V32, P569, DOI 10.1016/S0030-5898(05)70227-3
   Botella C, 2000, BEHAV THER, V31, P583, DOI 10.1016/S0005-7894(00)80032-5
   Brinkman WP, 2010, INTERACT COMPUT, V22, P299, DOI 10.1016/j.intcom.2010.03.005
   Kan HY, 2001, COMPUT IND, V45, P197, DOI 10.1016/S0166-3615(01)00093-8
   Knudsen BE, 2005, UROLOGY, V66, P732, DOI 10.1016/j.urology.2005.04.060
   Lee SH, 2009, PHARMACOL BIOCHEM BE, V91, P393, DOI 10.1016/j.pbb.2008.08.014
   Mahdjoub M, 2010, COMPUT AIDED DESIGN, V42, P402, DOI 10.1016/j.cad.2009.02.009
   Sung RCW, 2009, COMPUT AIDED DESIGN, V41, P1082, DOI 10.1016/j.cad.2009.09.006
   Talaba D, 2010, COMPUT AIDED DESIGN, V42, P361, DOI 10.1016/j.cad.2010.01.001
   Vankipuram M, 2010, J BIOMED INFORM, V43, P661, DOI 10.1016/j.jbi.2010.05.016
   Wald J, 2004, BEHAV THER, V35, P621, DOI 10.1016/S0005-7894(04)80035-2
   Whyte J, 2000, AUTOMAT CONSTR, V10, P43, DOI 10.1016/S0926-5805(99)00012-6
   Woksepp S, 2008, ADV ENG INFORM, V22, P520, DOI 10.1016/j.aei.2008.06.007
   Zwolinski P, 2007, CIRP ANN-MANUF TECHN, V56, P135, DOI 10.1016/j.cirp.2007.05.045
NR 15
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1260
EP 1264
DI 10.1016/j.egypro.2011.10.388
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401045
DA 2018-12-27
ER

PT S
AU Cheng, ZL
   Cheng, W
AF Cheng Zhi-lia
   Cheng Wei
BE Zhou, X
TI RETRACTED: Interface design method of diagnosis system for complex
   product (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE interface design; diagnosis system; complex product; performance
ID ISSUES
AB The study indicate that the diagnosis system for complex product is very important to find out the faults of complex product. In the paper, interface design method of diagnosis system for complex product is presented. Firstly, the structure of diagnosis system for complex product is given; and the use of diagnosis system for complex product is intoduced. The user interface of the diagnosis system for complex product is given in the paper. The experimental results show that the user interface of the diagnosis system for complex product is feasible. Therefore, the interface design of the diagnosis system for complex product has good application. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Cheng Zhi-lia] Wuhan Inst Technol, Coll Art Design, Wuhan 430073, Peoples R China.
RP Cheng, ZL (reprint author), Wuhan Inst Technol, Coll Art Design, Wuhan 430073, Peoples R China.
EM Chengzhili@126.com
CR Ahmed S, 2007, J SYST SOFTWARE, V80, P1408, DOI 10.1016/j.jss.2006.10.037
   Colman AW, 2000, INT J HUM-COMPUT ST, V52, P1007, DOI 10.1006/ijhc.2000.0369
   Griffiths T, 2001, INTERACT COMPUT, V14, P31, DOI 10.1016/S0953-5438(01)00042-X
   Leuthold S, 2008, INT J HUM-COMPUT ST, V66, P257, DOI 10.1016/j.ijhcs.2007.10.006
   Muller W, 2001, COMPUT GRAPH-UK, V25, P593, DOI 10.1016/S0097-8493(01)00087-5
   Onibere EA, 2001, INTERACT COMPUT, V13, P497, DOI 10.1016/S0953-5438(00)00052-7
   Rosinski Paula, 2009, Computers and Composition, V26, P149, DOI 10.1016/j.compcom.2009.05.004
   Shin JH, 2004, COMP STAND INTER, V26, P357, DOI 10.1016/j.csi.2003.11.005
   Zaatri A., 2003, Information Fusion, V4, P135, DOI 10.1016/S1566-2535(03)00018-6
NR 9
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1265
EP 1269
DI 10.1016/j.egypro.2011.10.389
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401046
DA 2018-12-27
ER

PT S
AU Dai, YW
   Li, XQ
AF Dai, Yawen
   Li, Xiaoqiang
BE Zhou, X
TI RETRACTED: Method of Dual-process Synchronization control and Time
   Information Processing in Wireless Structure Health Monitoring
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Time synchronization; synchronization control; time information
AB Synchronization control is indispensable for the application of wireless sensor networks (WSN) in structure health monitoring (SHM), and it is fundamental for the field diagnosis in this kind of application; how to acquire accurate time information is critical for the synchronization control. This paper presents a method of synchronization control and time information processing as follows: network time is initialized by time stripping; and then sensor nodes get sampling time information by dual-process synchronization control; gateway optimize the time information by smoothing compensation algorith. This method can prevent the impact for time information caused by time synchronization and loss of packet during the high-frequency acquisition, and increase reliability for the field diagnosis in SHM. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Dai, Yawen; Li, Xiaoqiang] Wuhan Univ Technol, Sch Sci, Wuhan 430070, Peoples R China.
RP Dai, YW (reprint author), Wuhan Univ Technol, Sch Sci, Wuhan 430070, Peoples R China.
EM daiyaweny@163.com; oioulx@163.com
CR Chung DDL, 1998, MAT SCI ENG R, V22, P57, DOI 10.1016/S0927-796X(97)00021-1
   Ian F, 2002, IEEE COMMUN MAG, V40, P102
   Jeremy Elson K R o, 2003, 1 WORKSH HOT TOP NER
   Lin X, 2001, SMART MATER STRUCT, V10, P907, DOI 10.1088/0964-1726/10/5/307
   Wang Heng, 2008, China: CN 101335587A, Patent No. 101335587
   Zhuoqiu Li, 2007, CARBON FIBER INTELLI
NR 6
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1270
EP 1277
DI 10.1016/j.egypro.2011.10.390
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401047
DA 2018-12-27
ER

PT S
AU Wang, XL
   Wang, HC
AF Wang Xiuling
   Wang Haocheng
BE Zhou, X
TI RETRACTED: Study on race and hazard of combinational logic circuit
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE combinational logic circuit; race hazard; detect; elimination
ID SWITCHING CIRCUITS
AB The reasons and types, detection methods, elimination and simulation of the race and hazard phenomenon in combination logic circuit are introduced and analyzed. The removing methods of race and hazard are pointed out with examples. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang Xiuling] Inner Mongolia Univ Technol, Coll Informat Engn, Inner Mongolia 010051, Peoples R China.
RP Wang, XL (reprint author), Inner Mongolia Univ Technol, Coll Informat Engn, Inner Mongolia 010051, Peoples R China.
EM wxltt3756@yahoo.com.cn
CR BREDESON JG, 1972, INFORM CONTROL, V20, P114, DOI 10.1016/S0019-9958(72)90299-9
   BUTLER SW, 1992, INT SYM MVL, P372, DOI 10.1109/ISMVL.1992.186819
   EICHELBE.EB, 1965, IBM J RES DEV, V9, P90, DOI 10.1147/rd.92.0090
   Garrod Susan A.R., 1991, DIGITAL LOGIC ANAL A
   HUFFMAN DA, 1957, J ACM, V4, P47, DOI 10.1145/320856.320866
   HURST SL, 1984, IEEE T COMPUT, V33, P1160
   Hurtado M., 1975, P 13 ANN ALL C CIRC
   Seitz C., SYSTEM TIMING, V7
   Tietze U., 1991, ELECT CIRCUIT DESIGN
NR 9
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1278
EP 1283
DI 10.1016/j.egypro.2011.10.391
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401048
DA 2018-12-27
ER

PT S
AU Zhao, XA
   You, YY
   Zhang, Y
AF Zhao, Xiaoan
   You, Yanyan
   Zhang, Ying
BE Zhou, X
TI RETRACTED: Simulation of the sub-group behavior in sports stadium based
   on agent (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Pedestrian evacuation; Simulation; Agent; Cellular automata; sub-group;
   microscopic Model
AB In this paper, we propose a Micro-modeling approach for pedestrian dynamics, which based on the agent technology. For this model, a computer program is developed to simulate and analyze evacuation phenomenon in sports stadium. Firstly, researches have analyzed the modeling method of agent and environment; the evacuation used the method of gird generation in venues and building individual decision-making model by agent. Secondly, we mainly study the behavior of sub-group, in order to reproduce the behavior, three cases have been studied to analyze the impact of evacuation. Simulation processes and results display that the model is very close to real movements of people. Therefore, this model can be used for the design of sports stadium and as the basis of command plans. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhao, Xiaoan; You, Yanyan; Zhang, Ying] Hebei Univ Technol, Sch Comp Sci & Engn, Tianjin 100400, Peoples R China.
RP Zhao, XA (reprint author), Hebei Univ Technol, Sch Comp Sci & Engn, Tianjin 100400, Peoples R China.
EM zhxa2006@yahoo.com.cn
CR Burstedde C, 2001, PHYSICA A, V295, P507, DOI 10.1016/S0378-4371(01)00141-8
   Shi JY, 2009, AUTOMAT CONSTR, V18, P338, DOI 10.1016/j.autcon.2008.09.009
   Tcknomo K., 2002, MICROSCOPIC PEDESTRI
   Yang LZ, 2005, BUILD ENVIRON, V40, P411, DOI 10.1016/j.buildenv.2004.08.005
NR 4
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1284
EP 1291
DI 10.1016/j.egypro.2011.10.392
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401049
DA 2018-12-27
ER

PT S
AU Li, DD
   Shi, XZ
AF Li Dandan
   Shi Xiuzhang
BE Zhou, X
TI RETRACTED: Research of the Rationality on Teaching Evaluation Indicator
   System Based on Factor Analysis (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE factor analysis; cluster analysis; combined weighting
AB This paper has been analysis the rationality of the teaching evaluation index system, the indexes in a homogeneous basis, with the factor analysis, principal component analysis and reliability analysis to determine whether the need for indicators of change, in order to simplify the index system; using cluster analysis of the structure of index system, the more similar the indicators grouped; Finally, assignment reasonable weight for the new index system according to the combination of the weighting method. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Li Dandan; Shi Xiuzhang] Beijing City Univ, Dept Software & Informat Management, Beijing, Peoples R China.
RP Li, DD (reprint author), Beijing City Univ, Dept Software & Informat Management, Beijing, Peoples R China.
EM ldd2003@bcu.edu.cn
CR Baohua Liang, 2007, THESIS GUANGXI NORMA
   Da-Hai Liu, 2008, SPSS 15 0 STAT ANAL
   wen Chen, 2007, THESIS HARBIN I TECH
   Zuying Hu, 1996, HIGHER TEACHER ED, V3, P38
   杨有红, 2006, [会计研究, Accounting Research], P17
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1292
EP 1298
DI 10.1016/j.egypro.2011.10.393
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401050
DA 2018-12-27
ER

PT S
AU Zhang, BJ
   Liu, CH
AF Zhang, Bojun
   Liu, Chunhui
BE Zhou, X
TI RETRACTED: Modeling and Simulating Research of Integrated Fuzzy Control
   for Automobile Steering Stability (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE four-wheel steering; direct yaw-moment control; handling stability;
   fuzzy control
ID YAW-MOMENT CONTROL; ACTIVE SAFETY
AB In this paper, four-wheel steering and direct yaw-moment integrated fuzzy controller is designed. To verify the effectiveness of the integrated fuzzy controller, a nonlinear three-degree-of-freedom model is employed for computer simulation. Considering the nonlinear effects of tyre, Pacejka tyre model was adopted to set up the nonlinear vehicle dynamic model. Simulation on the nonlinear vehicle with integrated controller in Matlab/Simulink software environment was described for a step input. The simulations suggest, compared with FWS and 4WS, the integrated controller can make the handling and stability performance on big lateral acceleration and slip angle improved, and make the driver drive the vehicle normally. The conclusion can be useful for the system design of vehicle stability control system. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Bojun] Tianjin Univ Technol & Educ, Sch Automobile & Transportat, Tianjin, Peoples R China.
RP Zhang, BJ (reprint author), Tianjin Univ Technol & Educ, Sch Automobile & Transportat, Tianjin, Peoples R China.
EM zhangbojun808@126.com
CR A BAKKER, 1987, B70421 SAE
   Furukawa Y, 1997, VEHICLE SYST DYN, V28, P59, DOI 10.1080/00423119708969350
   Nagai M, 1997, VEHICLE SYST DYN, V27, P357, DOI 10.1080/00423119708969336
   Nagai M, 2007, VEHICLE SYST DYN, V45, P413, DOI 10.1080/00423110701275162
   Park JH, 2001, JSME INT J C-MECH SY, V44, P404, DOI 10.1299/jsmec.44.404
   Yang Xiujian, 2008012598 SAE
NR 6
TC 0
Z9 2
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1299
EP 1304
DI 10.1016/j.egypro.2011.10.394
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401051
DA 2018-12-27
ER

PT S
AU Liu, P
   Li, SG
   Wen, WS
   Li, C
AF Liu, Peng
   Li, Shigang
   Wen, Wusong
   Li, Cui
BE Zhou, X
TI RETRACTED: Design and implementation of motion controller based on ARM
   and FPGA (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE MOTION CONTROLLER; SINGLE NEURON; ARM; FPGA; ADAPTIVE PID CONTROL
AB This paper takes ARM9 processor-AT91RM9200 and CYCLONE series FPGA-EP1C6Q240C8 as core to design motion control system of Industrial Computed Tomography. This paper introduces Key techniques of motion control system in detail from two aspects of hardware and software, using Adaptive PID Control Based on Single neuron as motion control algorithm in the system, then give the simulation result of Adaptive PID Control Based on Single neuron, at last list the system operation results. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Liu, Peng; Li, Shigang; Wen, Wusong; Li, Cui] Chongqing Commun Coll, Chongqing 400035, Peoples R China.
RP Liu, P (reprint author), Chongqing Commun Coll, Chongqing 400035, Peoples R China.
EM cqu_ict_liupeng@sina.com
CR Bowes SR, 1997, IEEE T IND ELECTRON, V44, P670, DOI 10.1109/41.633469
   CHEN X S, 2004, NUCL ELECT DETECTION, V24, P56
   Guo Z P, 1996, NONDESTRUCTIVE TESTI, V18, P27
   KAO YAO-TZE, 1992, P IEEE INT S, P639
   Lei Y, 2008, 2008 INTERNATIONAL CONFERENCE ON SMART MANUFACTURING APPLICATION, P470, DOI 10.1109/ICSMA.2008.4505567
   Wang J P, 1995, MANUFACTURING AUTOMA, V17, P44
   ZHANG P, 2006, J CHONGQING U NATURA, V29, P91
   Zonglian Guo, 2008, DIANLI ZIDONGHUA SHE, V28, P93
NR 8
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1305
EP 1312
DI 10.1016/j.egypro.2011.10.395
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401052
DA 2018-12-27
ER

PT S
AU Tian, HL
AF Tian, Hongliang
BE Zhou, X
TI RETRACTED: A dynamic modeling methodology to fixed plane joint interface
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Fixed plane joint interface; Virtual material; Hertz contact theory;
   Fractal geometry theory; Experimental modal analysis
AB The concept of virtual material was advised when the flexible joint interface may be considered as a virtual material with the same cross area. The virtual material is rigidly connected with two components situated in both sides of flexible joint interface. Adding an element, a complex assembled part including a joint interface could be equaled as a simple component without any joint interface in order to simplify the complicated problem about flexible joint interface. The interaction between normal and tangential characteristics of fixed interface taken into account, a variety of exact analytic solutions of elastic modulus, shear modulus, Poisson ratio and density were deduced from virtual material through Hertz contact theory and fractal geometry theory. Using experimental results about a series of test specimens, exact analytic expressions for virtual material's parameters were verified in terms of qualitative comparison principle of resembling vibration shapes and quantitative comparison principle of natural frequencies. Virtual material model vibration shapes show excellent agreement with experimental results. The relative deviations between the virtual material model natural frequencies and experimental ones are between -3% and 10%. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 China Three Gorges Univ, Coll Mech & Mat Engn, Yichang 443002, Peoples R China.
RP Tian, HL (reprint author), China Three Gorges Univ, Coll Mech & Mat Engn, Yichang 443002, Peoples R China.
EM thl19732003@yahoo.com.cn
CR Karpel M, 2007, J VIB ACOUST, V129, P73, DOI 10.1115/1.2202156
   Mao KM, 2010, INT J MACH TOOL MANU, V50, P156, DOI 10.1016/j.ijmachtools.2009.10.017
   Mindlin Raymond David, 1949, ASME J APPL MECH, V16, P259
   Shi X, 2005, J VIB ACOUST, V127, P52, DOI 10.1115/1.1857920
   Yoshimura M., 1979, ANN CIRP, V28, P241
   YUAN JX, 1985, J ENG IND-T ASME, V107, P64, DOI 10.1115/1.3185967
NR 6
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1313
EP 1319
DI 10.1016/j.egypro.2011.10.396
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401053
DA 2018-12-27
ER

PT S
AU Gong, XY
   Lia, BH
   Chai, XD
AF Gong, Xia-yi
   Lia, Bo-hu
   Chai, Xu-dong
BE Zhou, X
TI RETRACTED: The application and discussion of internet of things on
   wireless remote transmission of water consumption data (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Internet of things; Wireless remote transmission; Energy-saving; Water
   consumption
AB Through analysis and evaluation of water consumption on-site survey of near 200 large public buildings, the necessity of the application and discussion of internet of things on wireless remote transmission of water consumption data and subentry measure are discussed. This paper advances the program of wireless remote monitoring system based on internet of things, which not only provides the ways to obtain data foundation for government policy decision by internet of things on wireless remote transmission, but finds the method and potential for energy-saving. At the same time, it can implement the development of internet of things and come up to the aim of energy-saving based on internet of things. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Gong, Xia-yi; Lia, Bo-hu] Beijing Univ Aeronaut & Astronaut, Beijing 100191, Peoples R China.
RP Gong, XY (reprint author), Beijing Univ Aeronaut & Astronaut, Beijing 100191, Peoples R China.
EM gongwhite56166@sina.com
CR [Anonymous], 2007, EN AUD REG STAT ORG, V1, P1
   Jie Yuan, 2004, WIRELESS NETWORK APP
   Jun Li, 2008, BUILDING TECHNOLOGY, V7, P28
   Kai Wang, AUTOMATION INSTRUMEN
   Qian Ye, 2008, ENERGY SAVING TECHNO, V4, P51
   Ruihong Lian, 2007, FU JIAN ELECT POWER, V27, P25
   Weiding Long, 2007, J HV AC, V34, P19
   Zigbee Alliance: Network specification, 2006, 05347413 ZIGB ALL
NR 8
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1320
EP 1326
DI 10.1016/j.egypro.2011.10.397
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401054
DA 2018-12-27
ER

PT S
AU Zhang, LW
   Zhang, WW
AF Zhang, Li-wei
   Zhang, Wei-wei
BE Zhou, X
TI RETRACTED: Optimal Layout of Pressure Monitoring Points in Water
   Distribution Systems Based on Improved Genetic Algorithm (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE water distribution system; pressure monitoring point; optimal layout;
   sensitivity value; the improved genetic algorithm
AB The traditional pressure monitoring points layout of water distribution system is unreasonable, which cannot effectively and accurately reflect the running state of the pipe network when some pipe has busted, a model of optimal layout of pressure monitoring points in water distribution system is put forward to solve this problem. It takes accumulative sensitivity value and maximum variance of sensitivity value of pressure monitoring points as the objective function, the improved genetic algorithm is introduced to solve the problem, which better solves the defect of duplication of coding when the collocation of pressure monitoring points is optimized with the standard genetic operation. The results of the model can be selected to ensure that the selected measuring points not only can control bursting accidents but also lock the regional to the greatest extent. The application value of the method is verified by a simulation. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Li-wei; Zhang, Wei-wei] Tongji Univ, Coll Environm Sci & Engn, Shanghai 200092, Peoples R China.
RP Zhang, LW (reprint author), Tongji Univ, Coll Environm Sci & Engn, Shanghai 200092, Peoples R China.
EM zhangliwei001612@163.com
CR bin ZHAO Hong, 2003, THEORY ANAL WATER SU
   Jiaqiu YE, 2010, DIANGONG DIANQI, V3, P29
   LEE BH, 1992, J ENVIRON ENG-ASCE, V118, P4, DOI 10.1061/(ASCE)0733-9372(1992)118:1(4)
   mei TIAN Yi, 2003, SHUILI XUEBAO, V4, P123
   Meixia Liu, 2009, STUDY OPTIMAL LOCATI
   Mou LV, 2001, SYSTEMS ENG THEORY P, V21, P139
   Ting-lin HUANG, 2001, CHINA WATER WASTEWAT, V17, P50
   Xiaoping WANG, 2002, CAO LIMING GENETIC A
NR 8
TC 0
Z9 0
U1 2
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1327
EP 1333
DI 10.1016/j.egypro.2011.10.398
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401055
DA 2018-12-27
ER

PT S
AU Yang, ZG
AF Yang, Zhigang
BE Zhou, X
TI RETRACTED: Research on the New Channel Estimation Algorithm for
   MIMO-OFDM System Based on Training Sequence (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE channel estimation; MIMO-OFDM; training sequence; new algorithm
AB Supporting high mobility will be an important character of the future wireless communication systems. It challenges the channel estimation technique a lot and there are two tough problems in front of us, they are multi-path fading channel and bandwidth efficiency. Orthogonal Frequency Division Multiplexing (OFDM) technique changed the frequency selective multi-path fading channel into flat fading channel in frequency domain which effectively mitigates the effects of multi-path propagation and, hence, increase data rate. In this paper, we discuss the principle of MIMO-OFDM systems based on the introduction of fading channels. Furthermore, the channel estimation technique in MIMO-OFDM system is investigated, with the emphasis on training-assisted channel estimation method. Firstly, we summarize and analyses the exiting channel estimation methods in MIMO-OFDM system. Secondly, we proposed a new channel estimation method for MIMO-OFDM system based on training sequence. A novel pilot pattern with higher frequency efficiency is established and we use a reasonable manner to insert pilot so that the system greatly reduced the training cycle, increased data rates. Finally, in order to track the time-varying channel, an improved direct decision method is further adopted. Theoretical analysis and numerical results show that the new channel estimation scheme can offer a good performance and a high ability to track the time-varying channel. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Chongqing Univ Arts & Sci, Sch Comp, Chongqing 402160, Peoples R China.
RP Yang, ZG (reprint author), Chongqing Univ Arts & Sci, Sch Comp, Chongqing 402160, Peoples R China.
EM ayzg163@163.com
CR [Anonymous], 2003, IEEE GLOB C, V1, P317
   Baek MS, 2004, IEEE T BROADCAST, V50, P414, DOI 10.1109/TBC.2004.837885
   Foschini G.J., 1998, WIRELESS PERSONAL CO, P6
   Gong Y, 2003, IEEE T WIREL COMMUN, V2, P876, DOI 10.1109/TWC.2003.816797
   Li Y, 2002, IEEE T COMMUN, V50, P1471, DOI 10.1109/TCOMM.2002.802566
   Li Y, 2000, IEEE T VEH TECHNOL, V49, P1207, DOI 10.1109/25.875230
   Li Y, 1999, IEEE J SEL AREA COMM, V17, P461, DOI 10.1109/49.753731
   Moon JK, 2000, IEEE T CONSUM ELECTR, V46, P161, DOI 10.1109/30.826394
   Piechocki Robert J., 2003, PERS MOB COMM C ISS, P101
   Yue Jiang, 2004, IEEE 6 CAS S EM TECH, P709
NR 10
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1334
EP 1341
DI 10.1016/j.egypro.2011.10.399
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401056
DA 2018-12-27
ER

PT S
AU Zhang, QH
   Yin, DF
AF Zhang Qing-hui
   Yin Da-feng
BE Zhou, X
TI RETRACTED: Research on Interference Suppression of Pseudo-random Code
   Phase Modulation Fuse Based on EDTWD Analysis method (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE EDTWD; pseudo-random code phase modulation fuse; interference
   suppression; adaptive interference cancellation
AB The anti-jamming ability of pseudo-random code phase modulation fuse is very strong. But the effectiveness of suppressing narrow-band interference is limited by the signal bandwidth. Thus, an effective method is developed to identify the narrow-band interference in the wide-band spread spectrum signal. Extended discrete-time Wigner-Ville distribution (EDTWD) analysis method is adopted to extract and reconstruct the narrow-band interference in the received signal of pseudo-random code phase modulation fuse. Then the interference is cancelled by the adaptive interference cancellation. The method doesn't require any prior knowledge of interference signal, makes the received signal distorted little and can also be used in the circumstance of some interference sources. The simulation result showed that the interference signal after being separated and then synthesized had the similar frequency characteristics as before. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang Qing-hui; Yin Da-feng] Henan Univ Technol, Sch Informat Sci & Technol, Zhengzhou 45001, Peoples R China.
RP Zhang, QH (reprint author), Henan Univ Technol, Sch Informat Sci & Technol, Zhengzhou 45001, Peoples R China.
EM zqh131@163.com
CR Guangshu Hu, 1997, DIGIT SIGNAL PROCESS, P386
   Hongbin Ren, 1997, MODERN DEFENCE TECHN, P18
   Jinlei Jian, 1998, TELECOMMUNICATION EN, V12, P73
   Krattenthaler Werner, 1993, IEEE T SIGNAL PR JAN
   Yaohuan Gong, 2003, ADAPTIVE FILTER ADAP, P416
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1342
EP 1347
DI 10.1016/j.egypro.2011.10.400
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401057
DA 2018-12-27
ER

PT S
AU Song, WD
   Zhao, CW
   Huo, JX
AF Song Weidong
   Zhao Chengwang
   Huo Junxiu
BE Zhou, X
TI RETRACTED: Improved differential evolution algorithm for solving WTA
   problem (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE WTA; differential evolution; across; aberrance
AB Weapon-Target Assignment problem (WTA) is a Nonlinear Programming problem and complicated. Using improved Differential Evolution (DE) algorithm to solve WTA problems is proposed. To avoid drawbacks of basic DE for solving optimal problem, such as being subject to falling into local optimization and unfitting to solve questions that is un-continuous, a new coding way of original swarm is established, which reduced the solution space. Furthermore, some improvement in the aberrance and intercross of standard DE was made to make it applicable to WTA. Simulation results demonstrate that the algorithm can converge to the ideal steady state with high speed and provide practical solutions, especially when the scale of WTA problem is big. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Song Weidong; Zhao Chengwang] Shijiazhuang Mech Engn Coll, 97 W Heping Rd, Shijiazhuang 050003, Peoples R China.
   [Huo Junxiu] Artillery Command Acad, Dept 3, Langfang, Peoples R China.
RP Zhao, CW (reprint author), Shijiazhuang Mech Engn Coll, 97 W Heping Rd, Shijiazhuang 050003, Peoples R China.
EM zhaochengwang1977@yahoo.com.cn
CR Cao Qiying, 2001, Control Theory & Applications, V18, P76
   E Watcholder, 1989, ORSA J COMPUTING, P232
   Fang Qiang, 2004, DIFFERENTIAL EVOLUTI, P25
   Gao Shang, 2005, Systems Engineering and Electronics, V27, P1250
   Gao Shang, 2005, SYSTEMS ENG ELECT, V27, P1259
   Gao Ying, J ELECT INFORM, V28, P50
   Kong Xiao-hong, 2006, CONTROL AUTOM, V22, P184
   P Llyod S, 1991, DEFENSE TECHNIQUE, P45
   Shang Gao, 2003, COMPUTER ENG APPL, V29, P78
   Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328
   Wangyongshou, 1993, MODERN DEFENCE TECHN, V21, P13
   Zhu Qi-dan, 1997, J HERBIN ENG U, P36
NR 12
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1348
EP 1353
DI 10.1016/j.egypro.2011.10.401
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401058
DA 2018-12-27
ER

PT S
AU Pu, F
AF Pu, Fei
BE Zhou, X
TI RETRACTED: Fault Localization through Reasoning and SAT Solving
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE fault diagnosing; assumption-based reasoning; satisfiability;
   constraint; counterexample
ID EXPLAINING COUNTEREXAMPLES; DIAGNOSIS
AB Model checking is an efficient technique for detecting errors of a system. However diagnosing program faults are most time consuming hard work. One of the major advantages of model checking is the production of a counterexample when a property violation is detected. The error trace produced by a model checker may exhibit the symptom related to the cause of errors. Thus, counterexamples can be enough and are indicative for the cause of violation of the property. We present an assumption-based approach to localize the cause of a property violation using reasoning with constraints. The assumption among the statements in counterexample is made to point out which statement(s) is (are) faulty. Some constraints will be introduced from the specifications of the program. Moreover, we transform the counterexample into a propositional logic formula which is then fed to a SAT solver or a theorem prover together with constraints. A calculus of reasoning with these constraints proceeds under a certain assumption. If the result is satisfied, the assumption is correct (we localize errors in those statements which the assumption suppose them to be faulty), otherwise, the assumption is wrong and another assumption should be made. Some examples support the applicability and effectiveness of our approach. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Pu, Fei] Zhejiang Gongshang Univ, Coll Comp & Informat Engn, Hangzhou 310018, Zhejiang, Peoples R China.
RP Pu, F (reprint author), Zhejiang Gongshang Univ, Coll Comp & Informat Engn, Hangzhou 310018, Zhejiang, Peoples R China.
EM pufei@mail.zjgsu.edu.cn
CR BALL T, 2003, P 30 ACM SIGPLAN SIG, P97
   Beer I, 2009, LECT NOTES COMPUT SC, V5643, P94, DOI 10.1007/978-3-642-02658-4_11
   Clark E. M., 1999, MODEL CHECKING
   Cleve H, 2005, PROC INT CONF SOFTW, P342
   GREINER R, 1989, ARTIF INTELL, V41, P79, DOI 10.1016/0004-3702(89)90079-9
   Groce A, 2003, LECT NOTES COMPUT SC, V2648, P121
   Groce A., 2006, International Journal on Software Tools for Technology Transfer, V8, P229, DOI 10.1007/s10009-005-0202-0
   Jobstmann B, 2005, LECT NOTES COMPUT SC, V3576, P226
   Kob G., 2006, LNCS, V3922, P278
   Liu C, 2006, IEEE T SOFTWARE ENG, V32, P831, DOI 10.1109/TSE.2006.105
   REITER R, 1987, ARTIF INTELL, V32, P57, DOI 10.1016/0004-3702(87)90062-2
   Rothermel G, 1998, IEEE T SOFTWARE ENG, V24, P401, DOI 10.1109/32.689399
   Visser W, 2000, FIFTEENTH IEEE INTERNATIONAL CONFERENCE ON AUTOMATED SOFTWARE ENGINEERING, PROCEEDINGS, P3, DOI 10.1109/ASE.2000.873645
   Wang C, 2006, LECT NOTES COMPUT SC, V4218, P82
   Zhang X., 2006, P 28 INT C SOFTW ENG, P272
NR 15
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1354
EP 1363
DI 10.1016/j.egypro.2011.10.402
PG 10
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401059
DA 2018-12-27
ER

PT S
AU Ye, LW
   Shao, XF
   Wang, Y
AF Ye, Ling-wei
   Shao, Xiao-fang
   Wang, Yong
BE Zhou, X
TI RETRACTED: A Computation Model for Parallelism (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Gestalt theory; aw of parallelism; Symmetry axis
AB This paper puts forward a mathematical method for computing the parallel extent of two image elements-a specific instance of the Gestalt law of parallelism. The experimental results show that the method is consistent with the human perception results. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Ye, Ling-wei; Shao, Xiao-fang; Wang, Yong] Naval Aeronaut Engn Inst, QingDao Branch, Qingdao, Peoples R China.
RP Ye, LW (reprint author), Naval Aeronaut Engn Inst, QingDao Branch, Qingdao, Peoples R China.
EM xiaoxiao_0731@163.com
CR Desolneux A, 2003, J PHYSIOL-PARIS, V97, P311, DOI 10.1016/j.jphysparis.2003.09.006
   Shao Xiaofang, 2010, 6 INT C NAT COMP ICN, V4, P1940
   Sternberg R. J., 2003, COGNITIVE PSYCHOL
   Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1364
EP 1367
DI 10.1016/j.egypro.2011.10.403
PG 4
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401060
DA 2018-12-27
ER

PT S
AU Wang, X
   Wang, JL
   Wang, LD
AF Wang, Xin
   Wang, Jialin
   Wang, Lidong
BE Zhou, X
TI RETRACTED: Designing of classifiers based on simulated annealing
   algorithm and fuzzy rules (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Data mining; Classification; Fuzzy system; Simulated annealing algorithm
AB Fuzzy association rules are easily understood by users. Simulated annealing algorithm is an effective approximation algorithm which is suitable for solving large-scale combinatorial optimization problem. In this paper we proposed a classifier design method based on simulated annealing algorithm and fuzzy association rules. It can achieve satisfied accuracy and a small number of classification rules. Experiments demonstrated the effectiveness and advantages of the proposed algorithm. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Xin; Wang, Lidong] Dalian Maritime Univ, Dept Math, Linghai Rd 1, Dalian 116026, Peoples R China.
RP Wang, X (reprint author), Dalian Maritime Univ, Dept Math, Linghai Rd 1, Dalian 116026, Peoples R China.
EM xenawang@163.com
CR Agrawal R, 1993, MINING ASS RULES SET, P207
   Blake C., 1998, UCI REPOSITORY MACHI
   Ho SY, 2004, IEEE T SYST MAN CY B, V34, P1031, DOI 10.1109/TSMCB.2003.819160
   Hu YC, 2005, INFORM SCIENCES, V175, P1, DOI 10.1016/j.ins.2004.10.002
   Ishibuchi H, 1997, FUZZY SET SYST, V89, P135, DOI 10.1016/S0165-0114(96)00098-X
   Lei Z, 2008, INFORM SCIENCES, V178, P1836, DOI 10.1016/j.ins.2007.11.019
   Lenstra J. K., 1977, ANN DISCRETE MATH, V1, P343, DOI DOI 10.1016/S0167-5060(08)70743-X
   Lewis D. D., 1988, 10 EUR C MACH LEARN, P4
   Nicholas M., 1953, J CHEM PHYS, V21, P1087, DOI DOI 10.1063/1.1699114
   Quinlan J. R., 1993, C4 5 PROGRAMS MACHIN
   Srikant R, 1996, P ACM SIGMOD INT C M
   Tzung-Pei H., 3 INT C KNOWL BAS II
NR 12
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1368
EP 1376
DI 10.1016/j.egypro.2011.10.404
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401061
DA 2018-12-27
ER

PT S
AU Zhi, Y
   Yu, JY
   Zhao, GR
AF Zhi, Yue
   Yu, Jinyong
   Zhao, Guorong
BE Zhou, X
TI RETRACTED: Robust Control for Nonlinear Uncertain Systems Using
   Parameter Dependent Lyapunov Functions (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE polynomial nonlinear system; prameter-dependent Lyapunov method; sum of
   squares; nonlinear matix inequality
ID STABILITY CONDITIONS; OPTIMIZATION; SUM
AB This note provides sufficient robust stability conditions for continuous time polytopic nonlinear systems. Parameter-dependent Lyapunov functional is introduced in order to make possible the state feedback robust control synthesis, and less conservative sufficient conditions are formulated in terms of nonlinear state dependent matrix inequalities. These conditions can be verified by the technique of sum of squares (SOS) approach.. Numerical example is included for illustration. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhi, Yue; Yu, Jinyong; Zhao, Guorong] Naval Aeronaut & Astronaut Univ, Dept Control Engn, Yantai 264001, Shandong, Peoples R China.
RP Zhi, Y (reprint author), Naval Aeronaut & Astronaut Univ, Dept Control Engn, Yantai 264001, Shandong, Peoples R China.
EM zyue060610@126.com
CR de Oliveira MC, 1999, SYST CONTROL LETT, V37, P261, DOI 10.1016/S0167-6911(99)00035-3
   de Oliveira MC, 2005, SYST CONTROL LETT, V54, P1131, DOI 10.1016/j.sysconle.2005.02.015
   Dettori M, 2000, IEEE DECIS CONTR P, P4187, DOI 10.1109/CDC.2001.914554
   Gao HJ, 2007, J COMPUT APPL MATH, V206, P366, DOI 10.1016/j.cam.2006.07.027
   Geromel JC, 1998, LINEAR ALGEBRA APPL, V285, P69, DOI 10.1016/S0024-3795(98)10123-4
   Ichihara H, 2005, P AMER CONTR CONF, P3433, DOI 10.1109/ACC.2005.1470502
   Ma HJ, 2009, INT J ROBUST NONLIN, V19, P591, DOI 10.1002/rnc.1346
   Parrilo P. A., 2000, THESIS
   Zhao D, 2007, P 2007 AM CONTR C NE, P6015
NR 9
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1377
EP 1382
DI 10.1016/j.egypro.2011.10.405
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401062
DA 2018-12-27
ER

PT S
AU Li, YN
   Wang, YP
   Ma, K
   Zhang, ZS
AF Li, Yanni
   Wang, Yuping
   Ma, Kun
   Zhang, Zhensong
BE Zhou, X
TI RETRACTED: A Novel Efficient Query Strategy for the Deep Web Data
   Integration System (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Deep Web; Data Integration System; Inquiry; Hit Rate
ID OPTIMIZATION
AB There is tremendous rich information "hidden" in the Deep Web. With the Deep Web data integration system, we can get abundant helpful information we need. To build a practical and useful Deep Web data integration system, one of the key problems is to raise the query efficiency; in this paper, adopting the idea of high-speed cache, we get the most frequent and commonest keywords sequences by mining the user query logs. And we store in advance the query results of the most frequent and commonest keywords sequences in the local index database of the Deep Web data integration system so as to lead to a decrease in query time and an increase in query quality. In order to elevate the hit rate of query and reduce the query time, a well-designed logical pattern and corresponding strategy for updating the content of the local index database are proposed. Finally, a theoretical analysis is made of the query strategies put forward. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Li, Yanni] Xidian Univ, Software Engn Inst, Xian 710071, Peoples R China.
RP Li, YN (reprint author), Xidian Univ, Software Engn Inst, Xian 710071, Peoples R China.
EM yannili@mail.xidian.edu.cn
CR Abramowicz W, 2007, INFORM SYSTEMS ARCHI
   [Anonymous], 2008, DIG EXP UN GROWTH FO
   Bai YF, 2008, INT C COMP SCI SOFTW, P611
   Bayir MA, 2007, IEEE T SYST MAN CY C, V37, P147, DOI 10.1109/TSMCC.2006.876060
   Beran PP, 2010, 10 IEEE ACM INT C CL, P542
   Bruno N, 2010, ICDE C, P589
   Cali A, 2010, 12 INT AS PAC WEB C, P191
   Cali A, 2010, ACM INT C P SERIES, V426, P724
   Cecchini RL, 2009, COMPUTER SCI, P145
   Chaudhuri S, 1998, 1998 P 17 ACM SIGACT
   Fan H, 2007, 3 INT C SEM KNOWL GR, P254
   Feng Ming-yuan, 2009, Application Research of Computers, V26, P3375, DOI 10.3969/j.issn.1001-3695.2009.09.049
   Hameurlain A, 2000, DAT EXP SYST APPL 20, P629
   Han K, 2009, INT COMP INT SYST 20, V3, P515
   Hsu CN, 2000, IEEE T KNOWL DATA EN, V12, P959, DOI 10.1109/69.895804
   HSU WJ, 1984, BIT, V24, P45, DOI 10.1007/BF01934514
   Huang KS, 2004, INT COMP S, P15
   Ibrahim SNA, 2009, 3 AS INT C MOD SIM, P91
   Inmon WH, 2003, BUILDING DATA WAREHO, P25
   Korkin D, 2008, 37 INT C PAR PROC, P354
   Liu HF, 2009, J HEBEI ACAD SCI, V26, P11
   Liu W, 2006, P 1 INT MULT COMP CO, V1, P27
   Liu Wei, 2007, Chinese Journal of Computers, V30, P1475
   Lu JG, 2008, IEEE WIC ACM INT C W, P718
   Mendkovich N, 2009, P ITI 2009 31 INT C, P22
   Peng DL, 2009, 2009 INT C WEB INF S, P347
   Seshadri S, 2009, IEEE T PARALL DISTR, V20, P1439, DOI 10.1109/TPDS.2008.232
   Singh MR, 2002, IEEE INTERNET COMPUT, V6, P4, DOI 10.1109/MIC.2002.1036032
   Xu JL, 2009, INT JOINT C ART INT, P510
   Zhong H, 2008, COMPUTER APPL SOFTWA, V25, P60
NR 30
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1383
EP 1391
DI 10.1016/j.egypro.2011.10.406
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401063
DA 2018-12-27
ER

PT S
AU Li, YN
   Wang, YP
   Yang, XF
   Zhang, ZS
   Zheng, Y
   Zheng, L
AF Li, Yanni
   Wang, Yuping
   Yang, Xiaofei
   Zhang, Zhensong
   Zheng, Ying
   Zheng, Li
BE Zhou, X
TI RETRACTED: NMLCS: A Novel Parallel Algorithm for Searching for the
   Multiple Longest Common Subsequences (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE MLCS; match; parallel processing
ID LCS
AB Searching for the multiple longest common subsequences (MLCS) has found significant applications in the areas of bioinformatics, information processing, data mining, etc. There is a variety of MLCS algorithms, but none of the existing algorithms give effective solutions under the condition of a large alphabet, a considerable number of sequences and a long average length of sequences. Aiming at the defects of the MLCS algorithms available, this paper proposes a novel parallel algorithm for the MLCS-NMLCS based on the ideas of parallel processing and match pair by pre-processing. Experimental results show that our NMLCS resolves the problems mentioned above with great efficiency and significantly reduces time-space complexity as compared with other MLCS algorithms. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Li, Yanni] Xidian Univ, Software Engn Inst, Xian 710071, Peoples R China.
RP Li, YN (reprint author), Xidian Univ, Software Engn Inst, Xian 710071, Peoples R China.
EM yannili@mail.xidian.edu.cn
CR Alves CER, 2006, ALGORITHMICA, V45, P301, DOI 10.1007/s00453-006-1216-z
   Bakhouya M, 2008, P 14 INT EUR C PAR P, P654
   Bansal N, 2010, ALGORITHMICA, V56, P270, DOI 10.1007/s00453-008-9175-1
   BAXEVANIS AD, 2001, BIOINFORMATICS PRACT
   Blum C, 2007, LECT NOTES COMPUT SC, V4638, P150
   Breimer EA, 2003, J EXPT ALGORITHMS, V8, P1
   Chan HL, 2008, MATH COMPUT SCI, V1, P543, DOI 10.1007/s11786-007-0030-6
   Chan WT, 2007, J COMB OPTIM, V13, P277, DOI 10.1007/s10878-006-9031-7
   Chen YC, 2009, J COMB OPTIM, P1
   Cooharojananone N, 2009, LECT NOTES COMPUT SC, V5879, P777, DOI 10.1007/978-3-642-10467-1_68
   EDMISTON EW, 1988, INT J PARALLEL PROG, V17, P259, DOI 10.1007/BF02427852
   Galper AR, 1990, PARALLEL SIMILARITY
   Gondree M, 2009, P 8 ACM WORKSH PRIV, P81
   HSU WJ, 1984, BIT, V24, P45, DOI 10.1007/BF01934514
   IRVING RW, 1992, LECT NOTES COMPUT SC, V644, P214
   Jansen T, 2010, ALGORITHMICA, V57, P170, DOI 10.1007/s00453-008-9243-6
   Korkin D, 2008, 37 INT C PAR PROC, P354
   Lander E., 1988, Proceedings of the 1988 International Conference on Parallel Processing, P257
   LIU W., 2006, COMP COMP SCI IMSCCS, V1, P27
   LU M, 1994, IEEE T PARALL DISTR, V5, P835, DOI 10.1109/71.298210
   MAIER D, 1978, J ACM, V25, P322, DOI 10.1145/322063.322075
   Mozes S, 2008, LECT NOTES COMPUT SC, V5029, P230, DOI 10.1007/978-3-540-69068-9_22
   Parvinnia E, 2008, INT C BIOMEDICAL ENG, V1, P57
   Rahman MS, 2007, COMBINATOTIAL PATTER, V4580, P265
   Sankoff D, 1972, SCIENCES, V69, P4
   Brodal GS, 2006, LECT NOTES COMPUT SC, V4009, P330
NR 26
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1392
EP 1404
DI 10.1016/j.egypro.2011.10.407
PG 13
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401064
DA 2018-12-27
ER

PT S
AU Zheng, GM
   Lin, WG
AF Zheng, GuangMing
   Lin, Weigan
BE Zhou, X
TI RETRACTED: A Study of Meandered Microstrip Coupler With Dielectric Cover
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Coupler; dielectric cover; Directivity; Coupling
ID DIRECTIONAL-COUPLERS; DESIGN; CIRCUITS
AB A novel design technique to improve the directivity of a microstrip direction coupler by a meandered structure with dielectric cover is proposed in this paper. Increasing of even-mode phase velocity by the proposed meandering method structure with dielectric cover is reported for the first time. An analytical method to obtain closed-form equations of even-mode, phase velocity is developed. The proposed structure is verified by experiments. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zheng, GuangMing] Xian Inst Posts & Telecommuicat, Sch Elect Engn, Xian 710061, Peoples R China.
RP Zheng, GM (reprint author), Xian Inst Posts & Telecommuicat, Sch Elect Engn, Xian 710061, Peoples R China.
EM gmzheng1224@163.com
CR Dydyk M, 1999, IEEE T MICROW THEORY, V47, P956, DOI 10.1109/22.769332
   Kajfez D., 1978, MICROWAVES, V27, P64
   KLEIN JL, 1990, ELECTRON LETT, V26, P274, DOI 10.1049/el:19900182
   March S. L., 1982, IEEE MTT S INT MICR, P410
   MONACO VA, 1974, IEEE T MICROW THEORY, VTT22, P249, DOI 10.1109/TMTT.1974.1128208
   PAOLINO DD, 1978, IEEE T MICROW THEORY, V26, P646, DOI 10.1109/TMTT.1978.1129456
   Podell A., 1970, IEEE MTT S INT MICR, P33
   Schaller G., 1977, OPTIMUM, V31, P301
   Schiffman B.M., 1958, Institute of Radio Engineers Transactions on Microwave Theory and Techniques, VMTT-6, P232, DOI 10.1109/TMTT.1958.1124543
   SU L, 1983, IEEE T MICROW THEORY, V31, P1017
   Uysal S., 1989, SYNTHESIS-STUTTGART, V37, P969
NR 11
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1405
EP 1408
DI 10.1016/j.egypro.2011.10.408
PG 4
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401065
DA 2018-12-27
ER

PT S
AU Zheng, GM
   Lin, WG
AF Zheng, GuangMing
   Lin, Weigan
BE Zhou, X
TI RETRACTED: Design of an Economical Compact Coaxial cavity Combline
   Filter for 3G TD Base station (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE coupling coefficient; combline filter; CST; Coupling Matrix Synthesis
ID COUPLING MATRIX; MICROWAVE FILTERS; RESONATOR FILTERS
AB The cross coupled microwave filter is widely used in the communication sub system. The synthesis of the cross coupled filter is from prescribed transmission zeros and return loss till the attainment of the coupling matrix of each cavity. A compact narrowband combline high rejection filter with cross coupled is presented. A configuration using identical resonator post with capacitance-loading is introduced. Tested results show that with order-8 filter center frequency at 2017.5MHz, return loss lower than -25dB can be achieved over a relative bandwidth of 1.29%. Sample filter has been fabricated and tested result confirmed the theory results. In this paper, tested results will be given to illustrate the concept. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zheng, GuangMing] Xian Inst Posts & Telecommuicat, Sch Elect Engn, Xian 710061, Peoples R China.
RP Zheng, GM (reprint author), Xian Inst Posts & Telecommuicat, Sch Elect Engn, Xian 710061, Peoples R China.
EM gmzheng1224@163.com
CR Amari S, 2002, IEEE T MICROW THEORY, V50, P1969, DOI 10.1109/TMTT.2002.801348
   Amari S, 2004, IEEE T MICROW THEORY, V52, P607, DOI 10.1109/TMTT.2003.821939
   ATIA AE, 1974, IEEE T CIRCUITS SYST, VCA21, P649, DOI 10.1109/TCS.1974.1083913
   BELL HC, 1982, IEEE T MICROW THEORY, V30, P1335, DOI 10.1109/TMTT.1982.1131257
   Cameron R J, 1981, IEEE T MICROW THEORY, V29, P649
   Cameron RJ, 2003, IEEE T MICROW THEORY, V51, P1, DOI 10.1109/TMTT.2002.806937
   Cameron RJ, 1999, IEEE T MICROW THEORY, V47, P433, DOI 10.1109/22.754877
   Hoft M., 2006, EUR MICR C SEPT, P1323
   Lee JS, 2003, MICROW OPT TECHN LET, V38, P64, DOI 10.1002/mop.10972
   Tamiazzo S, 2005, IEEE T MICROW THEORY, V53, P1693, DOI 10.1109/TMTT.2005.847065
   Van Valkenburg M. E., 1960, INTRO MODERN NETWORK
NR 11
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1409
EP 1415
DI 10.1016/j.egypro.2011.10.409
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401066
DA 2018-12-27
ER

PT S
AU Shi, YJ
   Li, R
AF Shi, Ying Jing
   Li, Rui
BE Zhou, X
TI RETRACTED: The rolling angle feedback based coordinated stable control
   law design of UAV (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE aircraft control; unmanned aerial vehicle (UAV); coordinated stability;
   integrated guidance and control (IGC)
ID EVOLUTIONARY ALGORITHM
AB The coordinated stable control of an UAV with the reconnaissance and attack task is considered in this paper. Arc circle is introduced before turning to reduce recognition difficult of electro-optical pod. The integrated guidance and control system design method is used for UAV due to the good characters of the pitching mode, rolling mode and Dutch Roll mode of the linearized ontology mode. The altitude hold strategy and rolling angle feedback based coordinated turning strategy are applied respectively to accomplish the reconnaissance and attack task. The six freedom degree simulations are given to illustrate the efficiency of the proposed method. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Shi, Ying Jing] Univ Elect Sci & Technol China, Inst Astronaut & Aeronaut, Chengdu 611731, Peoples R China.
RP Shi, YJ (reprint author), Univ Elect Sci & Technol China, Inst Astronaut & Aeronaut, Chengdu 611731, Peoples R China.
EM Yingjing.Shi@gmail.com
CR Bortoff SA, 2000, P AMER CONTR CONF, P364, DOI 10.1109/ACC.2000.878915
   Brock O., 1999, P IEEE INT C ROB AUT, V1, P341
   Dong A, 2004, 5 WORLD C 2004, V5, P4681
   Egerstedt M., 1997, P 5 S INT ROB SYST, P237
   Hocaoglu C, 2001, IEEE T EVOLUT COMPUT, V5, P169, DOI 10.1109/4235.930309
   Smierzchalski R, 2000, IEEE T EVOLUT COMPUT, V4, P227, DOI 10.1109/4235.873234
   Wzorek M., 2006, P 16 INT C AUT PLANN, P438
   Zheng CW, 2003, INT J PATTERN RECOGN, V17, P63, DOI 10.1142/S021800140300223X
NR 8
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1416
EP 1423
DI 10.1016/j.egypro.2011.10.410
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401067
DA 2018-12-27
ER

PT S
AU Zhang, Y
   Wang, ZG
   Xu, J
AF Zhang, Ying
   Wang, Zhigong
   Xu, Jian
BE Zhou, X
TI RETRACTED: Design of Low Noise Distributed Amplifier with Adjustable
   gain control in 0.15um GaAs PHEMT (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE distributed amplifiers; adjustable gain control; cascode structure; low
   noise
AB In this paper, a distributed amplifier with adjustable gain control is designed based on 0.15um GaAs PHEMT which consists of nine gain cells, and the novel cascode structure is adopted to extend the output voltage and bandwidth. The amplifier provides 16dB high gain with only 2.5dB noise figure in a wide band from 2 to 24GHz and the gain flatness is excellent +/- 0.2dB from 3.5-23.5GHz. An optional gate bias is specially designed to allow greater than 10dB gain control range. The circuit requires only 60mA from a +5V supply and the area is 2.36*1.01mm2. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Ying; Wang, Zhigong; Xu, Jian] Southeast Univ, Inst RF&OE ICs, Nanjing, Peoples R China.
RP Zhang, Y (reprint author), Southeast Univ, Inst RF&OE ICs, Nanjing, Peoples R China.
EM zhangyingnjupt@126.com
CR Cai Shuicheng, 2007, INT C MICR MILL WAV, P1
   HORTON WH, 1950, P IRE, V38, P748, DOI 10.1109/JRPROC.1950.233433
   Kim W.S., 1999, 42 MIDW S CIRC SYST, P1040
   LARUE RA, 1986, IEEE T MICROW THEORY, V34, P1542, DOI 10.1109/TMTT.1986.1133576
   Michael M., 2005, IEEE MICROW MAG, V6, P54
   Percival W S, 1937, THERMONIC VALVE CIRC
   Sewiolo B, 2009, IEEE 10 ANN WIR MICR, P1
   Sewiolo B, 2009, IEEE T MICROW THEORY, V57, P2329, DOI 10.1109/TMTT.2009.2029029
   YUEN C, 1990, IEEE T MICROW THEORY, V38, P2016, DOI 10.1109/22.64588
NR 9
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1424
EP 1429
DI 10.1016/j.egypro.2011.10.411
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401068
DA 2018-12-27
ER

PT S
AU Ye, P
   Ni, YC
   Zhang, LL
   Hu, M
AF Ye, Peng
   Ni, Youcong
   Zhang, Linlin
   Hu, Ming
BE Zhou, X
TI RETRACTED: Formal Specification for a Reflection-based Coordination
   Model Using PiOZ (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE software architecuture; reuse; reflection; coordination model; PiOZ
AB This paper proposes the way of specification by which the CM4AR can be formally described in the PiOZ. CM4AR (coordination model for architecture reuse), which is constructed and designed on the basis of architectural reflection theory, can provides the support for reusing software architecture and its constituents at design time. CM4AR is logically divided into meta-level and base-level. When CM4AR is used to support architecture reuse, the interaction between meta-level and base-level will occur and the two levels in the CM4AR must be consistent all the time. The consistency between the two levels is ensured by the correctness of causal connection between the two levels. In this paper we propose the formal specification for the CM4AR in order to characterize the causal connection between meta-level and base-level precisely. So there are three parts of the formal specification, including the formal specification of base-level, meta-level and interaction between two levels. The result of this paper is the foundation for proving the correctness of causal connection between two levels in the future. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Ye, Peng; Hu, Ming] Wuhan Text Univ, Coll Math & Comp, Wuhan 430073, Peoples R China.
RP Ye, P (reprint author), Wuhan Text Univ, Coll Math & Comp, Wuhan 430073, Peoples R China.
EM whuyp@126.com
CR Cazzola W., 1999, RIDSI23499 U STUD MI
   Costa F.M., 2001, THESIS LANCASTER U L
   Maes P, 1987, P ACM C OBJ OR PROGR, P147
   Medvidovic N, 2000, IEEE T SOFTWARE ENG, V26, P70, DOI 10.1109/32.825767
   MILNER R, 1992, INFORM COMPUT, V100, P1, DOI 10.1016/0890-5401(92)90008-4
   Smith G., 2000, OBJECT Z SPECIFICATI
   Stepney S, 1992, OBJECT ORIENTATION Z
   Taguchi K, 2004, IEEE INT C ENG COMP, P97, DOI 10.1109/ICECCS.2004.1310908
   Ye Peng, 2009, P 2009 INT C TEST ME, P67
NR 9
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1430
EP 1436
DI 10.1016/j.egypro.2011.10.412
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401069
DA 2018-12-27
ER

PT S
AU Zhang, CF
   Li, RT
   Zheng, XZ
AF Zhang, Chunfang
   Li, Ruitai
   Zheng, Xizhen
BE Zhou, X
TI RETRACTED: Classification and Recognition of Vehicle and Pedestrian in
   Surveillance (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Target classification; Interest points; Bag of words; Probabilistic
   Latent Semantic Analysis(PLSA)
AB In this paper, we present a novel classifying method for vehicle and pedestrian categories in intelligent traffic surveillance. A dual-layer Bag-of-Words model solve the problem of detecting and recognizing the moving vehicles and pedestrian. In the learning and recognizing stage a two-layer Probabilistic Latent Semantic Analysis is proposed. The experimental results show that the classification and recognition method achieved higher accuracy and speed at the outside compared to existing methods. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Chunfang; Li, Ruitai] Hebei Normal Univ Shijiazhuang, Dept Math & Informat, Shijiazhuang, Peoples R China.
RP Zhang, CF (reprint author), Hebei Normal Univ Shijiazhuang, Dept Math & Informat, Shijiazhuang, Peoples R China.
EM zhangchunfang20032003@yahoo.com.cn
CR Bissacco A., P ADV NEUR INF PROC, P169
   Blank M., P 10 IEEE INT C COMP, P1395
   Blei D. M., J MACHINE LEARNING R, V3, P993
   Blei D. M., P ADV NEUR INF PROC, P9
   Dollar P., P 2 JOINT IEEE INT W, P65
   Fei-Fei L., P IEEE COMP SOC C CO, P524
   Hofmann T., P 22 ANN INT C RES D, P50
   Ke Y., IEEE INT C COMP VIS, P166
   Laptev I., IEEE INT C PATT REC, P1
   Laptev I., IEEE COMP SOC C COMP, P1
   Laptev Ivan, P 9 INT C NIC FRANC, P432
   Liu Jingen, IEEE COMP SOC C COMP, P1
   Niebles J. C., INT J COMPUTER VISIO, V79, P299
   Niebles J. C., IEEE COMP SOC C COMP, P1
   Nowozin S., IEEE INT C COMP VIS, P1
   Russell B. C., P IEEE COMP SOC C CO, P1605
   Schuldt C., IEEE INT C PATT REC, P32
   Sivic J., P IEEE INT C COMP VI, P370
   Wong S.-F., P IEEE COMP SOC C CO, P1
NR 19
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1437
EP 1444
DI 10.1016/j.egypro.2011.10.413
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401070
DA 2018-12-27
ER

PT S
AU Zhou, TX
   Ji, GK
   Du, ZQ
AF Zhou, Tianxian
   Ji, Guangkai
   Du, Zhaoqun
BE Zhou, X
TI RETRACTED: Jacobian Algorithm on Features Selection and Evaluation of
   CHES-FY System (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Fabric; characterization; fuzzy; feature; physical properties
ID HANDLE EVALUATION SYSTEM; FABRICS
AB The main content dealt with in the paper was to adopt fuzzy algorithm to select features for characterizing multiple physical properties, which were acquired from the pulling-out force and distance curve by a new apparatus. It was a comprehensive handle evaluation system for fabrics and yarns (CHES-FY), which can reflect weight, bending, friction and tension properties as well as stiffness tactile. The paper presented the structure and principle of the CHES-FY system, and the Jacobian algorithm and Karhunen-Loeve (K-L) transformation were used to obtain several features selected from the pulling-out force and distance curve for the experimental fabrics. These features were proved to be effective in characterizing weight, bending, friction and tensile properties of fabric by comparisons with measured results by standard testers. There existed good correlations in utilizing these features selected by fuzzy algorithm to evaluate physical behaviour of fabrics. It indicated that it was greatly helpful for fuzzy method in the application of textile fabrics fields. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhou, Tianxian; Du, Zhaoqun] Donghua Univ, Teaching Affair Off, Shanghai 201620, Peoples R China.
RP Du, ZQ (reprint author), Donghua Univ, Teaching Affair Off, Shanghai 201620, Peoples R China.
EM duzq@dhu.edu.cn
CR Chattopadhyay R., 2004, TEXTILE PROGR, V35, P1, DOI [10.1080/00405160408688961, DOI 10.1080/00405160408688961]
   Du ZQ, 2007, MEAS SCI TECHNOL, V18, P3555, DOI 10.1088/0957-0233/18/11/040
   Du ZQ, 2007, MEAS SCI TECHNOL, V18, P3547, DOI 10.1088/0957-0233/18/11/039
   Fan JT, 2001, TEXT RES J, V71, P605, DOI 10.1177/004051750107100706
   Kawabata S, 1980, STANDARDIZATION ANAL
   Kuo CFJ, 2004, TEXT RES J, V74, P231, DOI 10.1177/004051750407400308
   LY NG, 1991, TEXT RES J, V61, P402, DOI 10.1177/004051759106100707
   PAN N, 1992, TEXT RES J, V62, P279, DOI 10.1177/004051759206200505
   Pan RR, 2010, FIBER POLYM, V11, P303, DOI 10.1007/s12221-010-0303-6
NR 9
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1445
EP 1450
DI 10.1016/j.egypro.2011.10.414
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401071
DA 2018-12-27
ER

PT S
AU Guo, LP
AF Guo, Li-Ping
BE Zhou, X
TI RETRACTED: Locating of the earth fault of the single-phase at the tree
   distribution network (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE fault location; selection of line mode; tree distribution network;
   ranging the traveling wave
AB This paper proposes method through the combination of ranging the C-type traveling wave and the analysis and selection of line to the component of the line mode to locate the fault point. Inject into high amplitude and narrow signals in the beginning of a line and detect circuit returning from the arrival time of the waveform. Comparing of the normal waveform and failure waveform in both cases, receive the reflected wave fault at the arrival time. And then determine the fault distance. Using the effect from the fault which generating the shocks of the traveling wave and comparing the shock time of each branch line, the line which acquires the longest duration of vibration is the fault line. Through the theoretical analysis, Matlab simulation and effective analysis of the selected data, this paper proves the correctness of the method and demonstrates that the method of fault location in distribution networks is practical. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Inner Mongolia Technol Univ, Inst Elect Power, Hohhot 010051, Peoples R China.
RP Guo, LP (reprint author), Inner Mongolia Technol Univ, Inst Elect Power, Hohhot 010051, Peoples R China.
EM nmg0806@sina.com
CR Ceng Ping, 2004, RELAY, V32, P13, DOI CNKI: SUN: JDQW.0.2004-02-004
   Whittard Johns A T, 1999, P IEEE GEN TRANSM DI, V142, P73
   Yan Feng, 2004, CSEE, V24, P37, DOI CNKI:SUN:ZGDC.0.2004-09-007
   Yu Sheng-Nan, 2007, Relay, V35, P1
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1451
EP 1455
DI 10.1016/j.egypro.2011.10.415
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401072
DA 2018-12-27
ER

PT S
AU Yi, L
AF Yi, Li
BE Zhou, X
TI RETRACTED: Approach to Analyze Time Series Similarity Pattern Mining
   Based on Haar (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Time Series; Haar Wavelets; Similarity Pattern Mining
AB Time series data mining is a rather complex branch, which is a technique that extracts the most valuable information from large amount of his(a)tory time series data. Haar wavelet technology will be used in time series similarity-pattern mining. This dissertation discusses the problem on time series similarity-pattern mining from similarity measurement, storage structure, searching integrality. Finally simulation results show that the Haar wavelet technology used in time-series similar pattern mining in a good performance. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Qingdao Univ, Int Inst, Qingdao 266071, Peoples R China.
RP Yi, L (reprint author), Qingdao Univ, Int Inst, Qingdao 266071, Peoples R China.
EM lyqgx@126.com
CR Cai Zhi, J COMPUTER RES DEV
   Chan K., 1999, EFFICIENT TIME SERIE
   Das G., 1998, Proceedings Fourth International Conference on Knowledge Discovery and Data Mining, P16
   Han Jiawei, EFFICIENT MINING PAR
   Jin Liang, EFFICIENT SIMILARITY
   Jin Xiaoming, 2002, SIMILARITY MEASURE B
   Kahveci Tamer, 2001, VARIABLE LENGTH QUER
   Kahveci Tamer, 2003, OPTIMIZING SIMILARIT
   Keogh Eamonn, PROBABILISTIC APPROA
   Lee Sangjun, 2002, EFFICIENT SIMILARITY, P5
   LiLee Mong, 2003, P 29 VLDB C
   MIGUEL A, BRANI VIDAKOVIC WAVE
   Moon Yang-Sae, 2000, EFFICIENT TIME SERIE
   Tang Liang, 2004, THESIS SHANGHAI NORM
   Tang Liang, 2004, THESIS SHANGHAI TEAC
   Tao Yufei, 2004, P 30 VLDB C
   Tsai Chih, 2000, COMPUTER RES DEV, V37, P1107
   Wu Y-L., 2000, P 9 INT C INF KNOWL, P488
   Yang Min, 2001, SHANDONG NORMAL U, V16, P348
   Yang Min, 2002, THESIS HOHAI U
   Yang Min, J SHANDONG TEACHERS
   Zhang Jun, 2003, LOCATION BASED SPATI
   Zhang Xiru, NONLINEAR TIME SERIE
   Zheng Cheng, 2003, J MINIMICROSYSTEMS
NR 24
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1456
EP 1464
DI 10.1016/j.egypro.2011.10.416
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401073
DA 2018-12-27
ER

PT S
AU Shao, ZZ
   Wang, HG
   Liu, H
AF Shao Zeng-zhen
   Wang Hong-guo
   Liu Hong
BE Zhou, X
TI RETRACTED: Sequential Evolutionary Game Simulation Characterized by
   Learning and Emotion (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE emotion; Sequential evolutionary game; Learning mechanism; simulation
AB A novel model which introduces emotion character is proposed to simulate group game process more truly. According to different kinds of agents, this model builds individual learning mechanism and Strategy mutation mechanism based on emotion character. The Simulations show that the learning ability promotes individual's even cooperation rate of game and improves group total payoff. And, simulations also show that emotion factor would lead to dramatically fluctuation, whereas has little influences on group even total payoff. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Shao Zeng-zhen; Wang Hong-guo; Liu Hong] Shandong Normal Univ, Inst Informat Sci & Engn, Jinan 250014, Peoples R China.
RP Shao, ZZ (reprint author), Shandong Normal Univ, Inst Informat Sci & Engn, Jinan 250014, Peoples R China.
EM shaozengzhen@163.com
CR [Anonymous], J ARTIFICIAL SOC SOC, V12, P7
   Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829
   FU Yu-Ying, 2009, J ZHEJIANG U ENG SCI, P1644
   Hastie R, 2001, ANNU REV PSYCHOL, V52, P653, DOI 10.1146/annurev.psych.52.1.653
   Li Jing, 2008, CHINESE J ELECTRON, V36, P413
   Mellers B, 1999, J EXP PSYCHOL GEN, V128, P332, DOI 10.1037/0096-3445.128.3.332
   Meng QM, 2008, J CENT SOUTH UNIV T, V15, P694, DOI 10.1007/s11771-008-0129-1
   NIE Yong-you, 2010, J SHANGHAI U ENGLISH, V14, P116
   Ohdaira, 12 INT S ART LIF ROB
   Tankersley D, 2007, NAT NEUROSCI, P150
   Wenming C, 2008, CHINESE J ELECTRON, V17, P261
   WU H, 2004, SYSTEMS ENG THEORY P, P90
   ZHOU Chang-le, 2003, EXAMPLES HEART BRAIN
NR 13
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1465
EP 1473
DI 10.1016/j.egypro.2011.10.417
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401074
DA 2018-12-27
ER

PT S
AU Jing, W
   Tan, GJ
   Li, J
AF Jing, Wei
   Tan, Guojun
   Li, Jun
BE Zhou, X
TI RETRACTED: Loss analysis of three-level active neutral-point-clamped
   converter under fault tolerance operation (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE loss; three-level A(a)NPC; fault tolerant operation; modulation strategy
ID INVERTERS
AB Compared with traditional three-level neutral-point-clamped (NPC) converter, the recently proposed three-level active NPC (ANPC) converter has the ability to overcome the unbalanced loss distribution, and therefore result in increased output power or switching frequency. In industrial applications, fault tolerance ability of power converters is very important considering system availability, safety and reliability. This paper introduced the control schemes to get stable and continuous output under single device fault for both open-circuit and short-circuit fault cases. By analyzing the phase relationship of reference voltage and load current, the loss calculation method under fault tolerant operation was proposed. Calculation results show that the devices junction temperatures under fault tolerant operation are within the safe operation area (SOA) even they are a little bit higher compared to normal operation, which also confirm the effectiveness of the fault tolerant control schemes. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Jing, Wei; Tan, Guojun] China Univ Min & Technol, Sch Informat & Elect Engn, Xuzhou 221008, Peoples R China.
   [Li, Jun] North Carolina State Univ, FREEDEM Syst Ctr, Raleigh, NC 27606 USA.
RP Jing, W (reprint author), China Univ Min & Technol, Sch Informat & Elect Engn, Xuzhou 221008, Peoples R China.
EM jing@yahoo.cn
CR Abu-Rub H, 2010, IEEE T IND ELECTRON, V57, P2581, DOI 10.1109/TIE.2010.2043039
   Bruckner T, 2001, IEEE POWER ELECTRON, P1135, DOI 10.1109/PESC.2001.954272
   Ceballos S., 2007, IEEE INT S IND EL, P3180
   Ceballos S, 2008, IEEE T IND ELECTRON, V55, P982, DOI 10.1109/TIE.2008.917072
   Li J, 2009, APEC: 2009 IEEE APPLIED POWER ELECTRONICS CONFERENCE AND EXPOSITION, VOLS 1- 4, P840, DOI 10.1109/APEC.2009.4802759
   Li SM, 2006, IEEE T POWER ELECTR, V21, P933, DOI 10.1109/TPEL.2006.876867
NR 6
TC 0
Z9 0
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1474
EP 1482
DI 10.1016/j.egypro.2011.10.418
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401075
DA 2018-12-27
ER

PT S
AU Lin, YG
AF Lin, Yuanguai
BE Zhou, X
TI RETRACTED: Design of ZigBee Wireless Sensor Networks nodes for
   Agricultural Environmental Monitoring (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE wireless sensor networks; ZigBee; monitoring nodes; JN5139; agricultural
   environmental monitoring
AB The intelligent agricultural environment monitoring system is one of the applications of wireless sensor networks, which has an extensive application and bright foreground. Monitoring nodes, as the basic unit of an intelligent monitoring system for agricultural environment, are the basic unit to realize the monitoring function. A solution of such monitoring nodes based on JN5139 is proposed. The paper briefly presents the architecture of the nodes and introduces the design of each part. The monitoring nodes can obtain the temperature, humidity and illumination information in real time, and then transferred to the remote monitoring center. The actual test result demonstrates that the nodes works stead. The performance of lower power consumption is prominent. And has easy to use and other advantages. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Qiongzhou Univ, Coll Elect Informat & Engn, Sanya 572022, Hainan, Peoples R China.
RP Lin, YG (reprint author), Qiongzhou Univ, Coll Elect Informat & Engn, Sanya 572022, Hainan, Peoples R China.
EM lyg_top@163.com
CR Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4
   [Anonymous], 2010, 8012154 IEEE
   [Anonymous], 2010, JENNIC JN5139 WIRELE
   Liang Nia-Chiang, 2006, IEEE INT C SYST MAN
   Lin Yuanguai, 2009, J QIONGZHOU, P37
   Lin Yuanguai, 2009, J QIONGZHOU, P32
   Liu Hang, 2008, AGR NETWORK INFORM, P16
   Sensirion, 2010, HUM SENS
   Sensirion, 2010, HUM SENS SHT10
NR 9
TC 4
Z9 4
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1483
EP 1490
DI 10.1016/j.egypro.2011.10.419
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401076
DA 2018-12-27
ER

PT S
AU Wang, XF
   Qiu, SB
   Wang, Q
AF Wang Xiaofang
   Qiu Shubo
   Wang Qiang
BE Zhou, X
TI RETRACTED: A New Method of Paper Defect Recognition Based on Wavelet
   Packet Decomposition and BP Neural Network (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE paper defect recognition; feature vector; wavelet packet decomposition;
   BP neural network
AB A new approach of paper defect recognition is proposed. To implement this method, computer is used to acquire paper image and the subtraction algorithm is used to determine if the image contains defect at first. For the image with paper defect, wavelet packet decomposition is applied to extracting the feature vector of the defect. A BP neural network is designed for recognizing the defect type according to the feature vector. This approach provides a unified detection algorithm for different types of paper defects. The experiment data prove this method is valid and can be applied in modern paper defect inspection system. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang Xiaofang; Qiu Shubo] Shandong Polytech Univ, Sch Elect Engn & Automat, Jinan, Shandong, Peoples R China.
RP Qiu, SB (reprint author), Shandong Polytech Univ, Sch Elect Engn & Automat, Jinan, Shandong, Peoples R China.
EM qiushubo@126.com
CR Brechet L, 2007, IEEE T BIO-MED ENG, V54, P2186, DOI 10.1109/TBME.2007.896596
   Cen Lu, 2003, J SHANGXI U SCI TECH, V21, P85
   Ghazvini M., 2009, P WORLD AC SCI ENG T, V49, P901
   Haykin Simon, 2008, NEURAL NETWORKS LEAR, P91
   Kabir S, 2008, CAN J CIVIL ENG, V35, P258, DOI 10.1139/L07-105
   Mursalin Tamnum E, 2005, J THEORETICAL APPL I, P561
   Nosrati S. M., 2007, P 4 C IR MACH VIS IM
   Rimac-Drlje A., 2005, P IEEE INT S IND EL, V3, P1255
   SUN Yu, 2004, CHINA PULP PAPER IND, V25, P23
   WANG Yong-jun, 2010, J CHINA PULP PAPER, V20, P59
NR 10
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1491
EP 1497
DI 10.1016/j.egypro.2011.10.420
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401077
DA 2018-12-27
ER

PT S
AU Chen, CL
   Cao, YH
   Ye, HB
   Song, YJ
AF Chen, Chunliang
   Cao, Yanhua
   Ye, Hongbing
   Song, Yongjun
BE Zhou, X
TI RETRACTED: Runtime Prediction of Armored Vehicle Engine Based on Neural
   Network (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE BP neural network; prediciton; armred vehicle engine
AB To a great extent, engine's runtime of armored vehicle reflects its technical state. By estimating engine's runtime, the remaining service life can be forecasted. In this paper, the virtues of neural network prediction are introduced. Aiming at a certain armored vehicle engine, the BP neural network regression prediction model is constructed based on four typical state parameters including cylinder compression pressures, acceleration time, deceleration time and supply fuel advance angle. The model is trained and validated by samples data. The prediction results indicate that the model is effective and feasible. At last, two prediction problems that need to be studied hard are proposed. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Chen, Chunliang; Cao, Yanhua; Ye, Hongbing] Acad Armored Forces Engn, Dept Tech Support Engn, Beijing 100072, Peoples R China.
   [Song, Yongjun] Naval Aeronaut & Astronaut Univ, Grad Adm Unit, Yantai 264001, Peoples R China.
RP Cao, YH (reprint author), Acad Armored Forces Engn, Dept Tech Support Engn, Beijing 100072, Peoples R China.
EM mark_cao1983@163.com
CR Brothernton Tom, 2001, 2001 IEEE AER C, V6, P163
   [梁旭 LIANG Xu], 2007, [测控技术, Measurement & Control Technology], V26, P5
   Liu Jianmin, 2006, THESIS ACAD ARMORED
   Roemer M. J., 2001, 2001 IEEE AER C P 10, V6, P3139
   Wang SL, 2008, 2008 CHINESE CONTROL AND DECISION CONFERENCE, VOLS 1-11, P2516, DOI 10.1109/CCDC.2008.4597778
   Zheng Xiaoping, 2009, THEORY METHOD ACCIDE, P211
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1498
EP 1504
DI 10.1016/j.egypro.2011.10.421
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401078
DA 2018-12-27
ER

PT S
AU Yao, SF
   Sun, YS
   Yao, G
AF Yao Sufen
   Sun Yunshan
   Yao Ge
BE Zhou, X
TI RETRACTED: Fuzzy-PI Parameters Optimization of Photoelectric Automatic
   Follow System Based on Ant Colony Algorithm (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE tracking; fuzzy control; ant colony algorithm
AB A chip microcomputer controlled electro-optical tracking control system was introduced. Ant colony algorithm and fuzzy PID control algorithm were combined. Ant colony algorithm with global optimization ability was utilized to optimize the three parameters of PID controller. It effectively and quickly overcomes the contradiction between the convergence speed and the steady-state characteristics. Practice shows that this system possesses good dynamic performance and steady-state control accuracy, and high robust. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yao Sufen; Sun Yunshan] Tianjin Univ Commerce, Inst Informat Engn, Tianjin 300134, Peoples R China.
RP Yao, SF (reprint author), Tianjin Univ Commerce, Inst Informat Engn, Tianjin 300134, Peoples R China.
EM zhjq@tjcu.edu.cn
CR [Anonymous], 1997, APPL FUZZY MATH AUTO, V7, P169
   Dorigo M, 2000, FUTURE GENER COMP SY, V6, P851
   Huang Yifu, 1996, MICROCOMPUTER CONTRO
   YE Xiao-yong, 2007, J SYSTEM SIMULATION, V24, P643
NR 4
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1505
EP 1509
DI 10.1016/j.egypro.2011.10.422
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401079
DA 2018-12-27
ER

PT S
AU Song, YJ
   Li, BS
   Ye, HB
   Cao, YH
AF Song, Yongjun
   Li, Bingshang
   Ye, Hongbing
   Cao, Yanhua
BE Zhou, X
TI RETRACTED: Application of Prognostics and Health Management in Armored
   Equipment Maintenance Based on aFMEA (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE armored equipment; maintenance; PHM; aFMEA; module
AB In view of some shortcomings of armored equipment maintenance, Prognostics and Health Management (PHM) technology was introduced. Aiming at an armored vehicle engine, augmented-Failure Mode and Effect Analysis(aFMEA) was proceeded. Analysis on failure symptoms and sensor installation was introduced into the traditional FMEA method, aFMEA is no longer limited to static analysis on failure mode and effect. Based on the description of function requirement definition and development process, the structure of armored equipment PHM system was established, its function module was designed as well. The investigation and discussion on establishment methods of armored equipment PHM system was proceeded. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Song, Yongjun] Naval Aeronaut & Astronaut Univ, Grad Adm Unit, Yantai 264001, Peoples R China.
RP Song, YJ (reprint author), Naval Aeronaut & Astronaut Univ, Grad Adm Unit, Yantai 264001, Peoples R China.
EM syj1359@sohu.com
CR Patnaik Alok R., 2006, IEEE CCECE CCGEI OTT, P2476
   Pecht Michael G., 2009, ACTA AERONAUTICA AST, V26, P626
   SHI Wang, 2008, LOGISTICS SCI TECH, V5, P93
   [孙博 SUN Bo], 2007, [测控技术, Measurement & Control Technology], V26, P12
   swiler Laura P., 2003, 20033820 SAND, P2003
   TIAN Jin, 2006, AVIATION MAINTENANCE, P34
   Wang Hanzhong, 2008, Journal of the Academy of Equipment Command & Technology, V19, P83
   ZHANG Jingjing, 2009, ELECT PRODUCT RELIAB, V27, P17
   Zhang Q., 2007, REAILWAY LOCOMOTIVE, V27, P35
NR 9
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1510
EP 1516
DI 10.1016/j.egypro.2011.10.423
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401080
DA 2018-12-27
ER

PT S
AU Yang, SK
   Fu, JP
AF Yang Shunkun
   Fu Jianping
BE Zhou, X
TI RETRACTED: A model driven testing environment for embedded software
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Hardware-in-the-loop (HIL); real-time simulation (RTS); automated
   software testing; test environment; software system testing; test model
AB This paper presents a hardware-in-loop (HIL) real-time simulation environment for embedded software testing, namely the Embedded Software Simulation Test Environment (ESSTE). We give a detailed description of methods, architecture and critical components of ESSTE. For validation purposes, the proposed real-time HIL testing approach and ESSTE is applied in experiments and some application examples. Experiment results show that the test environment employed in this paper can be applied to systems in practice. And different domain of applications approved that the proposed ESSTE can go far forward to improve the reliability and quality of the embedded software. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yang Shunkun; Fu Jianping] Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China.
RP Yang, SK (reprint author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China.
EM ysk@buaa.edu.cn
CR Droste David B., 2005, AUTOTESTCON 2005, P560
   Forsyth P., 2004, P IEEE 35 ANN POW EL, V1, P329
   Gonzalez Alberto, 2008, AUT SOFTW ENG WORKSH, P41
   Hashempour H, 2007, IEEE T INSTRUM MEAS, V56, P1734, DOI 10.1109/TIM.2007.895611
   Kuhn T, 2008, LECT NOTES COMPUT SC, V5095, P278, DOI 10.1007/978-3-540-69100-6_19
   Kum D. H., 2006, SICE ICASE INT JOINT, P4414
   Lu B, 2007, IEEE T IND ELECTRON, V54, P919, DOI 10.1009/TIE.2007.892253
   Shende Prabodh, 2008, IEEE AUTOTESTCON, P118
   Simmons S, 2006, J SOFTW MAINT EVOL-R, V18, P457, DOI 10.1002/smr.338
   Song Dong LiLin, 2008, 2 INT S SYST CONTR A, P1
   Syed T, 2008, IEEE IMTC P, P1833, DOI 10.1109/IMTC.2008.4547343
   Xiao Litian, 2008, P 7 WORLD C INT CONT, P4178
NR 12
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1517
EP 1525
DI 10.1016/j.egypro.2011.10.424
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401081
DA 2018-12-27
ER

PT S
AU Mei, BS
   Zhang, XP
   Zhang, L
AF Mei Bai-shan
   Zhang Xi-ping
   Zhang Lei
BE Zhou, X
TI RETRACTED: Influence and countermeasures for protection of distribution
   network when wind farms connected (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Windfarm operation; Distribution network; Protection; Impact; Adaptive
   protection
AB In order to research the influence of Grid-connected with wind farm to protection in distribution system, in this article a simulation model of Grid-connected with a 3 MW wind farm is constructed. Three-phase short circuit faults at the point in the transmission line and at the access point of the wind farm are simulated. In both short-circuit case weather the wind farm exist or not the differences is analyzed. Simulation results show that in order to ensure the stable operation of the system, the wind farms' impact to the system can not be ignored. Finally, an new method of protection is proposed, the grid which connect with wind farms is divided into several areas, the protection device cut the fault zone in time, while other regions will not be affected (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Mei Bai-shan; Zhang Xi-ping; Zhang Lei] Shanghai Univ Elect Power, Fac Elect & Automat Engn, Shanghai, Peoples R China.
RP Mei, BS (reprint author), Shanghai Univ Elect Power, Fac Elect & Automat Engn, Shanghai, Peoples R China.
EM zhangxiping1xt@163.com
CR [Anonymous], REP LIN PROT SUBC PO
   [Anonymous], 1547 IEEE
   Chinchilla M, 2006, IEEE T ENERGY CONVER, V21, P130, DOI 10.1109/TEC.2005.853735
   Muller S, 2002, IEEE IND APPL MAG, V8, P26, DOI 10.1109/2943.999610
   Relay Protection, 2004, IEEE T ENERGY CONVER, V20, P388
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1526
EP 1531
DI 10.1016/j.egypro.2011.10.425
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401082
DA 2018-12-27
ER

PT S
AU Qinru, F
   Ren, WH
AF Qinru Fan
   Ren Wen-hua
BE Zhou, X
TI RETRACTED: The short-time spectrum analysis of real-time sampling speech
   with DSP TMS320VC5416 chip (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Short-time spectrum analysis; FFT algorithm; The proceeding of real-time
   sampling speech; DSP TMS320VC5416
ID RECOGNITION
AB For automatic speech recognition (ASR), the research centers mainly on algorithm of improving robust, researchers put less emphasis on realization and application of better speech algorithm. Real-time proceeding of speech recognition directly influence on its application, so real-time proceeding of speech recognition is as important as study of algorithm. Speech transform domain method is a necessary technique of speech recognition, so real-time analysis of transform domain method is necessary. In transform domain methods, the short-time spectrum analysis is simple and easy to realize, especially the short-time FFT algorithm is applied to the short-time spectrum analysis. FFT algorithm reduces multiplications greatly. For the purpose, this paper presents short-time spectrum analysis of real-time sampling speech based on FFT algorithm. We use DSP TMS320VC5416 chip and speech codec ASIC TLV320AIC23 as hardware, the real-time speech signal is acquired by ASIC TLV320AIC23. When working frequency of TMS320VC5416 is set 160 MHz and sampling frequency is 44.1 kHz, the short-time FFT is radix-2 DIF-FFT algorithm and the length of short-time window is 128, the simulation waves and data show that the short-time FFT algorithm analysis based on TMS320VC5416 chip can meet real-time of system. For estimation of proceeding error, we make a calculation of radix-2 DIT-IFFT. Comparing the result of DIT-IFFT and sampling speech data, error is less than 10(-3). (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Qinru Fan] Zhejiang Univ, Dept Ningbo Inst Technol, 1 Qian Hu S Rd, Ningbo 315100, Zhejiang, Peoples R China.
RP Qinru, F (reprint author), Zhejiang Univ, Dept Ningbo Inst Technol, 1 Qian Hu S Rd, Ningbo 315100, Zhejiang, Peoples R China.
EM fanqinru@nit.net.cn
CR Benzeghiba M, 2007, SPEECH COMMUN, V49, P763, DOI 10.1016/j.specom.2007.02.006
   Coy A, 2007, SPEECH COMMUN, V49, P384, DOI 10.1016/j.specom.2006.11.002
   Haque S, 2009, SPEECH COMMUN, V51, P58, DOI 10.1016/j.specom.2008.06.002
   Li P, 2010, COMPUT SPEECH LANG, V24, P30, DOI 10.1016/j.csl.2008.05.005
   Nicole R., 2009, DIGITAL SIGNAL PROCE
   Texas Instruments, 2005, DAT MAN TMS320VC5416
   Texas Instruments, 2002, TLV320AIC23 DAT MAN
   Zhang Xiongwei, 2003, PRINCIPLE APPL DSP C
NR 8
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1532
EP 1539
DI 10.1016/j.egypro.2011.10.426
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401083
DA 2018-12-27
ER

PT S
AU Wu, Q
   Wei, RX
AF Wu Qin
   Wei Ruxiang
BE Zhou, X
TI RETRACTED: Study of Software Requirement Risk Based on Fuzzy Influence
   Diagram (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Software requirement risk; influence diagram; fuzzy influence diagram;
   relation; node; arc; fuzzy matrix
AB Fuzzy influence diagram is combination of fuzzy maths and influence diagram, which is applied to account probability of software requirement risk in this thesis. It's introduced for the basic knowledge of fuzzy influence diagram and factors are selected from software requirement engineering which may result in software requirement risk. Relation level of those risk factors is shown by influence diagram, while function level and value level are analyzed by fuzzy maths. An example is given to demonstrate the feasibility and applicability of fuzzy influence diagram to account probability of software requirement risk. At last, algorithm steps are summarized for applying influence diagram and the main two difficulty of the application is indicated. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wu Qin] Naval Univ Engn, Dept Equipment Econ & Management, Wuhan 430033, Peoples R China.
RP Wu, Q (reprint author), Naval Univ Engn, Dept Equipment Econ & Management, Wuhan 430033, Peoples R China.
EM XiaoPangziJune@163.com
CR Chee C.L., 1082340995 IEEE, P128
   Cheng Tiexin, 2004, J SYSTEM ENG, P178
   Huang Guoxing, 2008, SOFTWARE REQUIREMENT, p[3, 219]
   Yang Lunbiao, 2005, FUZZY MATHS, P57
   Zhan Ruiyuan, 1995, METHODS APPL INFLUEN, p[22, 20, 67]
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1540
EP 1550
DI 10.1016/j.egypro.2011.10.427
PG 11
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401084
DA 2018-12-27
ER

PT S
AU Bo, YL
   Jiang, JQ
   Zhu, WL
   Song, CY
AF Bo, Yuling
   Jiang, Jingqing
   Zhu, Weiling
   Song, Chuyi
BE Zhou, X
TI RETRACTED: A Hybrid Algorithm Based on Improved Crossover PSO and Powell
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Particle Swarm Optimization; Powell Algorithm; Function Optimization
AB This paper presents an improved crossover PSO by introducing the linear inertia weight and linear adaptive learning rates to crossover PSO to overcome the shortcoming of premature convergence and trapping in local optimum solution. Further more, a hybrid algorithm based on improved crossover PSO and Powell is proposed to enhance both global and local searching ability. The simulation results show the improved performance. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Bo, Yuling; Jiang, Jingqing; Zhu, Weiling; Song, Chuyi] Inner Mongolia Univ Nationalities, Coll Math, Tongliao 028000, Peoples R China.
RP Jiang, JQ (reprint author), Inner Mongolia Univ Nationalities, Coll Comp Sci & Technol, Tongliao 028000, Peoples R China.
EM jiangjingqing@yahoo.com.cn
CR Huang Huajuan, 2008, COMPUTER APPL, V28, P3062
   Kennedy J., 1995, P IEEE INT C NEUR NE, P1942, DOI [DOI 10.1109/ICNN.1995.488968, 10.1109/ICNN.1995.488968]
   Li Jianyong, 2004, THESIS ZHEJIANG U
   Li Rong-jun, 2009, Application Research of Computers, V26, P1700
   Sargent R. W. H., 1973, OPTIMIZATION DESIGN
   Suganthan P. N., 1999, Proceedings of the 1999 Congress on Evolutionary Computation-CEC99 (Cat. No. 99TH8406), P1958, DOI 10.1109/CEC.1999.785514
   Wang Li, 2007, COMPUTER ENG APPL, V43, P47
   Zhang Jian, 2010, Journal of Hebei University of Technology, V39, P51
   Zhang L P., 2006, LECT NOTES COMPUTER, V27, P2412
   Zhang Minhui, 2005, THESIS ZHEJIANG U
NR 10
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1551
EP 1557
DI 10.1016/j.egypro.2011.10.428
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401085
DA 2018-12-27
ER

PT S
AU Yuan, P
   Li, FF
   He, YQ
AF Yuan Peng
   Li Fengfeng
   He Yinqiang
BE Zhou, X
TI RETRACTED: Object Location based on Radon transform Phase correlation
   and Up-sampling (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Radon transforms; phase correlation; up-sampling; object location
AB In order to resolve the problem of high accurate location for accurate electronic assembly equipments, a novel method based on Radon transform, phase correlation and up-sampling is presented in this paper for object location. Firstly, the Radon transform is applied to convert the region of objects from Cartesian coordinates to Polar coordinates, and the translation and rotation in Cartesian coordinates will be converted to translation in Polar coordinates. Then, the phase correlation and up-sampling technique will be combined to obtain high accurate sub-pixel translation estimation. Finally, the rotation and translation of objects in Cartesian coordinates will be estimated accurately. Experimental results verified the proposed method which is also applied in the real time mounting components for accurate electronic assembly. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yuan Peng] S China Univ Technol, Minist Educ, Engn Res Ctr Precis Elect Mfg Equipments, Guangzhou 510640, Guangdong, Peoples R China.
RP Yuan, P (reprint author), S China Univ Technol, Minist Educ, Engn Res Ctr Precis Elect Mfg Equipments, Guangzhou 510640, Guangdong, Peoples R China.
EM pangyuan@scut.edu.cn
CR Chen Zhi, 2009, Optics and Precision Engineering, V17, P1884
   Feldmann K, 2003, INT J COMP INTEG M, V16, P479, DOI 10.1080/0951192031000115796
   Fisher E., 2000, Surface Mount Technology, V14, P152
   Gao Hongxia, 2007, IEEE MULT SYST CONTR, P375
   Heitz G, 2009, INT J COMPUT VISION, V84, P40, DOI 10.1007/s11263-009-0228-y
   Hu Zhen-Hui, 2008, WORLD ACAD SCI ENG T, V41, P120
   Jun W., 2006, INT C MECH AUT, P228
   Lai SH, 2000, COMPUT VIS IMAGE UND, V78, P84, DOI 10.1006/cviu.1999.0829
   Shih CL, 2005, INT J ADV MANUF TECH, V26, P491, DOI 10.1007/s00170-003-1617-y
   [夏奇 Xia Qi], 2004, [光学技术, Optical Technology], V30, P146
   Xia Qi, 2004, Journal of Huazhong University of Science and Technology, V32, P8
NR 11
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1558
EP 1566
DI 10.1016/j.egypro.2011.10.429
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401086
DA 2018-12-27
ER

PT S
AU Yuan, P
   Liu, Y
   Xu, KC
AF Yuan Peng
   Liu Yang
   Xu Kaichun
BE Zhou, X
TI RETRACTED: Rotational Angle Detection Based on Projection and Upsampling
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Projections; Upsampling; Rotational angle; Mounting components
ID ROBUST
AB Since the diversity of shapes among surface mounting components in precision electronic assembly, it has become more difficult for locating inspection of surface mounting components. In this paper, we have proposed a novel method for angle detection based on projections. Firstly, a strong connection between the rotation angle and the support length will be constructed. Then, the proposed method for angle detection based on projections will be given in detail. Next, the accuracy of the proposed method will be analyzed. To improve the accuracy of the angle detection, the zero-padding interpolation method is successfully applied. Experiments results show that the present method is effective, accurate and efficient for angle detection. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yuan Peng; Liu Yang; Xu Kaichun] S China Univ Technol, Minist Educ, Engn Res Ctr Precis Elect Mfg Equipments, Guangzhou, Guangdong, Peoples R China.
RP Yuan, P (reprint author), S China Univ Technol, Minist Educ, Engn Res Ctr Precis Elect Mfg Equipments, Guangzhou, Guangdong, Peoples R China.
EM pangyuan@scut.edu.cn
CR Gao Hongxia, 2007, P IEEE MULT SYST CON, P375
   Gao Hongxia, 2007, IEEE MULT SYST CONTR, P375
   Heitz G, 2009, INT J COMPUT VISION, V84, P40, DOI 10.1007/s11263-009-0228-y
   Hu Zhen-Hui, 2008, WORLD ACAD SCI ENG T, V41, P120
   Jun W., 2006, INT C MECH AUT, P228
   Lai SH, 2000, COMPUT VIS IMAGE UND, V78, P84, DOI 10.1006/cviu.1999.0829
   Lai SH, 2001, J ELECTRON IMAGING, V10, P359, DOI 10.1117/1.1313240
   Mettam G. R., 1999, INTRO ELECT AGE, P281
   Qi Qifeng, 2001, Proceedings of IFAC Conference on New Technologies for Computer Control. NTCC 2001, P193
   Shih CL, 2005, INT J ADV MANUF TECH, V26, P491, DOI 10.1007/s00170-003-1617-y
   SMITH J. O., 2002, MATH DISCRETE FOURIE
   van der Geer J., 2000, J SCI COMMUN, V163, P51
   Walsh D., 2001, ELECT PACKAGE PRODUC, V8, P1
   Wei SD, 2006, IEEE T IMAGE PROCESS, V15, P2936, DOI 10.1109/TIP.2006.877500
   [夏奇 Xia Qi], 2004, [光学技术, Optical Technology], V30, P146
   Xia Qi, 2004, Journal of Huazhong University of Science and Technology, V32, P8
NR 17
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1567
EP 1574
DI 10.1016/j.egypro.2011.10.430
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401087
DA 2018-12-27
ER

PT S
AU Zhang, ZY
   Liu, SZ
AF Zhang Zongyun
   Liu Shizhong
BE Zhou, X
TI RETRACTED: Select Algorithm for Local Certificate Repository of
   Self-organized Key Management Scheme in Ad hoc Networks (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Ad hoc net work; self-organized key management; certificate chain;
   select algorithm
AB Click here and insert your abstract text. Based on the Maximum Degree Construction algorithm, a new select algorithm is proposed in this paper. In the algorithm, each node and its neighbors issue the certificates each other to generate the local In-degree and Out-degree certificate repository. Similar to the ant colony algorithm, it finds the certificate chain between the source node and destination node by selecting the node of the maximum certificated times from the beginning. The algorithm reduces the complexity of the selection, provides a guarantee to find the certificate chain, and saves the spending of space as well. Next, this paper gives the simulation of the algorithm and the simulated results show that this is an optimized select algorithm for local certificate repository. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang Zongyun] Weifang Univ, Weifang 261061, Peoples R China.
RP Zhang, ZY (reprint author), Weifang Univ, Weifang 261061, Peoples R China.
EM zongyunzhang@163.com
CR Capkun S, 2003, IEEE T MOBILE COMPUT, V2, P52, DOI 10.1109/TMC.2003.1195151
   Capkun S., 2002, P ACM NEW SEC PAR WO
   Dorigo M., 1997, IEEE Transactions on Evolutionary Computation, V1, P53, DOI 10.1109/4235.585892
   HUBAUX JP, 2001, P 2 ACM INT S MOB AD, P146, DOI DOI 10.1145/501436.501437
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1575
EP 1579
DI 10.1016/j.egypro.2011.10.431
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401088
DA 2018-12-27
ER

PT S
AU Wang, CH
   Sun, ZH
AF Wang Caihong
   Sun Zhihai
BE Zhou, X
TI RETRACTED: Distributed Decision Support System for the Safety of
   Coalmine (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Safety of coalmine; Meta-service system; Intelligent; Decision support
   system
AB As decision in coal industry was difficulty, considering the distributed intelligent resources environment, a novel distributed decision supported based on meta-service system. And that this paper defines meta-service system on the basis of intelligent engineering. Then a distributed concurrent and collaborative design platform is presented. The mode of expression, reasoning mechanism and architecture of the decision support system for the safety of coal mine were put forward. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang Caihong; Sun Zhihai] N China Inst Sci & Technol, Sanhe 101601, Peoples R China.
RP Wang, CH (reprint author), N China Inst Sci & Technol, Sanhe 101601, Peoples R China.
EM chwang@ncist.edu.cn
CR [Anonymous], 2008, SAFETY CRITICAL DEFE, V4, P186
   Callahan S, 2006, J COMPUT INF SCI ENG, V6, P263, DOI 10.1115/1.2218361
   HUANG Mu-tao, 2007, SYSTEM ENG THEORY PR, V4, P115
   Jia Qi, 2009, Computer Engineering and Design, V30, P116
   Yu Xiubao, 2007, COAL SCI TECHNOLOGY, V35, P104
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1580
EP 1584
DI 10.1016/j.egypro.2011.10.432
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401089
DA 2018-12-27
ER

PT S
AU Zhang, QF
   He, HF
   Peng, QY
   Zhu, Z
AF Zhang, Qingfeng
   He, Haifeng
   Peng, Qingyu
   Zhu, Zi
BE Zhou, X
TI RETRACTED: Relationship between the quantity of sampled stars and the
   ePSF mode's accuracy in Astrometry (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Effective Point-spread Function; PSF Mode; Undersampled Image;
   Positional Measurement; Astrometry
AB Effective point-spread function (ePSF) method is an excellent method for the positional measurements of stars in undersampled stellar images, whose critical step is deriving an accurate ePSF mode. In the presentation, we investigate the effects of the grid density and the sample density on the mode's accuracy through some experiments on positional measurement in synthetic undersampled stellar images. We find that constructing a stable ePSF mode requires two samples in every cell (basic unit of pixel segmentation) for a certain grid. That is, ideally, 2n(2) sampled stars in a stellar image are enough for constructing a stable ePSF mode. Whether the derived stable ePSF mode is accurate is related to the grid density, the denser the mode's grid is, the more accurate it is. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Qingfeng; He, Haifeng; Peng, Qingyu] Jinan Univ, Sino French Joint Lab Astrometry Dynam & Space Sc, Guangzhou 510632, Guangdong, Peoples R China.
RP Zhang, QF (reprint author), Jinan Univ, Sino French Joint Lab Astrometry Dynam & Space Sc, Guangzhou 510632, Guangdong, Peoples R China.
EM zhang.qingfeng135@gmail.com
CR Anderson J, 2000, PUBL ASTRON SOC PAC, V112, P1360, DOI 10.1086/316632
   Anderson J, 2006, ASTRON ASTROPHYS, V454, P1029, DOI 10.1051/0004-6361:20065004
   Anderson J, 2010, PUBL ASTRON SOC PAC, V122, P1035, DOI 10.1086/656399
   Da Rocha C., 2010, ASTRON ASTROPHYS, V525, pA86
   KING IR, 1971, PUBL ASTRON SOC PAC, V83, P199, DOI 10.1086/129100
   [张志渊 Zhang Zhiyuan], 2010, [天文研究与技术, Astronomical Research & Technology], V7, P132
NR 6
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1585
EP 1590
DI 10.1016/j.egypro.2011.10.433
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401090
DA 2018-12-27
ER

PT S
AU Jiang, LF
AF Jiang Lifei
BE Zhou, X
TI RETRACTED: Research and Development of the Enviroment
   Measurement-Control System in Greenhouse (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE greenhouse; the measurement-control system; sensor; information fusion
AB This paper introduces a control system on the environment in greenhouse. By detecting the environmental factors in the greenhouse such as air temperature, air humidity, soil moisture, light intensity and the density of co2, etc, the environment measurement-control system can fit the environment in greenhouse for the crop growth well by controlling the heater, pumps and other facilities, which is important to improve the agro-ecological and production conditions effectively, promote the scientific development of agricultural resources and the rational use of land utilization and the labor productivity. Based on the environment measurement-control system, the automatic scientific production and management in greenhouse is realized. This paper has a research on the development of the hardware and the software of the system, and escribes the development of the control system from a single intelligent node to the complex network system, and introduces the error processing technology, the multi-sensor information fusion technology and the fuzzy expert system applied in the software design. Besides these, this paper analysizes the problems in the system and predicts its further development. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Tangshan Normal Univ, Tangshan City, Hebei Province, Peoples R China.
RP Jiang, LF (reprint author), Tangshan Normal Univ, Tangshan City, Hebei Province, Peoples R China.
EM jianglifei1977@163.com
CR ai Gao Li-, 2008, J AGR MECHANIZATION, V7, P119
   Juan Tang, 2007, MICROCOMPUTER INFORM, V23, P192
   Wanyong Liang, 2009, J ANHUI AGR SCI, V37, P87
   Xiangqian Zhu, 2008, J AGR MECHANIZATION, V4, P180
   Yanfang Wang, 2009, J AGR MECHANIZATION, V10, P110
NR 5
TC 0
Z9 0
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1591
EP 1595
DI 10.1016/j.egypro.2011.10.434
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401091
DA 2018-12-27
ER

PT S
AU Liu, HT
   Su, TX
   Tong, ZH
   Chang, JZ
   Li, GL
AF Liu, H. T.
   Su, T. X.
   Tong, Z. H.
   Chang, J. Z.
   Li, G. L.
BE Zhou, X
TI RETRACTED: Low-grade Waste Heat Utilization In Activated Carbon
   Production (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE waste heat recovery; design; deep processing and using of coal; steam
   output
ID RECOVERY
AB Large amounts of waste heat is produced during the deep processing and using of coal. To fully utilize the waste heat of low temperature vapour coming from the Serp Furnace, the recovery system and technical process were designed. The main facilities parameters were figured out, such as the flash vaporization rate, sizes of flash drum, steam output. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Liu, H. T.; Su, T. X.; Tong, Z. H.; Chang, J. Z.] N Univ China, Sch Mechatronice Engn, Taiyuan 030051, Peoples R China.
RP Liu, HT (reprint author), N Univ China, Sch Mechatronice Engn, Taiyuan 030051, Peoples R China.
EM lht@nuc.edu.cn
CR ALRABGHI OM, 1993, HEAT RECOV SYST CHP, V13, P463, DOI 10.1016/0890-4332(93)90047-Y
   Butcher CJ, 2007, INT J HEAT MASS TRAN, V50, P2355, DOI 10.1016/j.ijheatmasstransfer.2006.10.047
   Goldstein RJ, 2010, INT J HEAT MASS TRAN, V53, P4397, DOI 10.1016/j.ijheatmasstransfer.2010.05.005
   Grossman G., 1982, INT J REFRIG, V5, P361
   Jeong S, 1998, APPL THERM ENG, V18, P1, DOI 10.1016/S1359-4311(97)00040-9
   Li GL, 2010, SHANXI ENERGY CONVER, V1, P60
   Liu HB, 2010, RESOUR CONSERV RECY, V54, P1331, DOI 10.1016/j.resconrec.2010.05.005
   Miller BG, 2011, CLEAN COAL ENGINEERING TECHNOLOGY, P133, DOI 10.1016/B978-1-85617-710-8.00005-4
   MIYATAKE O, 1981, DESALINATION, V36, P113, DOI 10.1016/S0011-9164(00)88635-X
   Shih H, 2007, DESALINATION, V204, P464, DOI 10.1016/j.desal.2006.02.044
NR 10
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1596
EP 1601
DI 10.1016/j.egypro.2011.10.435
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401092
DA 2018-12-27
ER

PT S
AU Zhao, K
AF Zhao Kai
BE Zhou, X
TI RETRACTED: Research on Network Data Fusion Based on Wireless Sensor
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Wireless sensor; data fusion
AB Wireless sensor network is a field of information technology in recent years. In order to obtain accurate and timely information and to ensure the robustness of sensor network, sensor nodes must monitor to some extent. There is overlap, so the sensor node and the data collected is some redundancy [6]. To avoid this problem, wireless sensor network in the process of data collection need to adopt data fusion (data aggregation or data fusion) technology. This paper introduces wireless sensor network data fusion concepts and roles, and it analyzes the data fusion in wireless sensor networks the major technical challenges. It describes the data fusion that is currently the main model, and finally, we give the wireless sensor networks main fusion. We hope that the contents of this article in the wireless sensor network for the majority of researchers in data integration to provide a reference. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Northwestern Polytech Univ, Xian 710072, Peoples R China.
RP Zhao, K (reprint author), Northwestern Polytech Univ, Xian 710072, Peoples R China.
EM zhaokai_zh@yeah.net
CR Bennett J.C.R., 2003, AGGREGAION MECH TRAD
   Bennett J.C.R., 2006, MULTIAGENT BASED DAT
   Bergmann, 2000, RES OVERVIEW DATA FU
   Bergmann E.V., 2007, DATA FUSION ALGORITH
   Choi JS, 2002, DECISION FUSION TRAN
   Demers A., 2004, REV DATA AGGREGATION
   Golestani S.J., 2004, RES APPL MULTISENSOR
   Li Li, 2005, NEW ALGORITHM OUTLIE
   Markley F.L., 2006, IN NETWORK DATA AGGR
   Prem M, 2002, STUDY DATA FUSION MO
   Rubinstein D, 2007, DATA AGGREGATION WIR
   Zhang L., 2000, DESIGN MODEL DATA LI
NR 12
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1602
EP 1609
DI 10.1016/j.egypro.2011.10.436
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401093
DA 2018-12-27
ER

PT S
AU Li, YX
AF Li, Yuxia
BE Zhou, X
TI RETRACTED: The Application of Apriori Algorithm in the Area of
   Association Rules (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Data mining; association rules; Apriori algorithm
AB Data mining is a multidisciplinary research field, which combines database technology, artificial intelligence, machine learning, statistics, knowledge engineering and object-oriented approach and the letter retrieval and highperformance computing and data visualization research results of the latest technology and so on. Association rules in data mining is an important research. This paper gives the basic concepts of association rules based on the Apriori algorithm and its detailed description of the optimization method. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 Harbin Normal Univ, Dept Comp Sci, Harbin, Peoples R China.
RP Li, YX (reprint author), Harbin Normal Univ, Dept Comp Sci, Harbin, Peoples R China.
EM rdd2002103@yahoo.com.cn
CR Clark M.V., 2002, PIMRC 92 C P IEEE CO, P174
   Clark M.V., 2002, IMPROVED ALGORITHM M, P356
   CLARK MV, 1992, IEEE T COMMUN, V40, P1128, DOI 10.1109/26.142803
   CLARK MV, 1994, IEEE T VEH TECHNOL, V43, P47, DOI 10.1109/25.282265
   Diepstraten W., 2005, ASS RULE MINING ALGO
   Jakes W.C., 2004, RES IMPROVED ALGORIT
   Kruys J., 2002, STUDIES COMPLEXITY A, P133
   Noneaker D.L., 2003, ASS RULES MINING ALG
   Salz J., 2008, KIND CONNECTION RULE
   Tuch B.J., 2001, RES ANAL FAST APRIOR, P103
   Winters J.H., 2006, STUDY ASS RULES EXCA
   Winters J.H., 2005, IEEE J SEL AREA COMM, P871
NR 12
TC 0
Z9 0
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1610
EP 1615
DI 10.1016/j.egypro.2011.10.437
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401094
DA 2018-12-27
ER

PT S
AU Li, PP
   Zhao, XY
   Yang, B
AF Li Pingping
   Zhao Xiuyang
   Yang Bo
BE Zhou, X
TI RETRACTED: Automatic knot adjustment for B-spline surface approximation
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE B-spline surface; Estimation of distribution algorithm; Gaussian mixture
   moldel; Knot adjustment; Expectations maximization algorithm
AB Fairing B-spline surface is regarded as one major precondition for surface reconstruction. To obtain a good surface approximation, a novel method is proposed in this paper. The knots of the B-spline surface are treated as variables, and are optimized by the estimation of distribution algorithm. The initial knots are decided by the parameterization of the measured data points. The experiment results show that this method can obtain more precise surface approximate. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Li Pingping; Zhao Xiuyang; Yang Bo] Univ Jinan, Sch Informat Sci & Engn, Jinan 250022, Peoples R China.
RP Zhao, XY (reprint author), Univ Jinan, Sch Informat Sci & Engn, Jinan 250022, Peoples R China.
EM zhaoxy@ujn.edu.cn
CR Chen Chuanbo, 2002, FUNDAMENTALS COMPUTE
   Liu Li, 2007, RES SURFACE RECONSTR
   Lozano J. A., 2001, ESTIMATION DISTRIBUT
   Lu Q, 2005, IEEE T SYST MAN CY C, V35, P195, DOI 10.1109/TSMCC.2004.841914
   Shi Fazhong, 2001, COMPUT AIDED GEOM D
   Varady T, 1997, COMPUT AIDED DESIGN, V29, P255, DOI 10.1016/S0010-4485(96)00054-1
   Ventresca, 2008, J INF SCI, V178, P4038
   Zhang Xiuping, 2010, MECH ENG AUTOMATION, P194
   Zhao Xiuyang, 2006, 3D RECONSTRUCTION FI
NR 9
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1616
EP 1620
DI 10.1016/j.egypro.2011.10.438
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401095
DA 2018-12-27
ER

PT S
AU Lu, ZL
   Huang, X
AF Lu, Zuliang
   Huang, Xiao
BE Zhou, X
TI RETRACTED: A priori error estimates of mixed methods for optimal control
   problems governed by parabolic equations (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE a priori error estimates; mixed finite element method; general parabolic
   optimal control problems
ID FINITE-ELEMENT METHODS
AB In this paper, we investigate a priori error estimates of mixed finite element methods for general optimal control problem governed by parabolic equations. The state and co-state are approximated by the Raviart-Thomas mixed finite element spaces and the control is approximated by piecewise constant functions. We derive a priori error estimates for the state and the control approximation of parabolic optimal control problem. Finally, we present a numerical example which confirms the theoretical results. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Lu, Zuliang] Xiangtan Univ, Coll Civil Engn & Mech, Xiangtan, Peoples R China.
RP Lu, ZL (reprint author), Xiangtan Univ, Coll Civil Engn & Mech, Xiangtan, Peoples R China.
EM zulianglux@126.com
CR Chen YP, 2008, J COMPUT APPL MATH, V211, P76, DOI 10.1016/j.cam.2006.11.015
   Chen YP, 2006, INT J NUMER ANAL MOD, V3, P311
   Chen YP, 2010, FINITE ELEM ANAL DES, V46, P957, DOI 10.1016/j.finel.2010.06.011
   Chen YP, 2010, COMPUT METHOD APPL M, V199, P1415, DOI 10.1016/j.cma.2009.11.009
   Liu W, 2008, ADAPTIVE FINITE ELEM
   Lu ZL, 2009, NUMER ANAL APPL, V2, P74, DOI 10.1134/S1995423909010078
   Lu ZL, 2009, ADV APPL MATH MECH, V1, P242
NR 7
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1621
EP 1625
DI 10.1016/j.egypro.2011.10.439
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401096
DA 2018-12-27
ER

PT S
AU Wang, KN
   Zhang, XX
   Wang, W
AF Wang, Ke-ning
   Zhang, Xiong-xing
   Wang, Wei
BE Zhou, X
TI RETRACTED: Design of A Four-annulus Integrated Disk Electrode for
   Bioelectrical Impedance Spectroscopy Measurement (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE bioelectrical impedance spectroscopy; pork quality; four-annulus
   integrated disk electrode; Cole-Cole model
ID ELECTRICAL-IMPEDANCE; PROBE
AB In order to study the relationships between pork quality and the BIS of porcine tissues, a novel four-annulus integrated disk (FAID) electrode was designed and manufactured. The contrastive measurement experiments on two fresh isolated animal tissues, namely porcine underback and porcine liver using the FAID electrode were performed. The results show that the impedance amplitude-frequency characteristics and phase-frequency characteristics of the two kinds of tissues have significant differences. The Cole-Cole parameters fitting are then performed using the measured BIS data. The fitting results show that the arrangement of the BIS data on the complex plane is in good concordance with the Cole-Cole plot respectively, and the extracted results, R0, R infinity, alpha and fC, also indicate the difference between the two tissues. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang, Ke-ning; Zhang, Xiong-xing; Wang, Wei] Xian Technol Univ, Sch Optoelect Engn, 4 Jin Hua Bei Rd, Xian 710032, Shaanxi Provinc, Peoples R China.
RP Wang, KN (reprint author), Xian Technol Univ, Sch Optoelect Engn, 4 Jin Hua Bei Rd, Xian 710032, Shaanxi Provinc, Peoples R China.
EM wangkening2000@sohu.com
CR Aaron R, 1997, PHYS MED BIOL, V42, P1245, DOI 10.1088/0031-9155/42/7/002
   Altmann M, 2004, J ANIM SCI, V82, P816
   Faes TJC, 1999, PHYSIOL MEAS, V20, pR1, DOI 10.1088/0967-3334/20/4/201
   Gonzalez-Correa CA, 2003, PHYSIOL MEAS, V24, P291, DOI 10.1088/0967-3334/24/2/305
   Jones DM, 2003, PHYSIOL MEAS, V24, P605, DOI 10.1088/0967-3334/24/2/369
   Kun S, 1999, MED BIOL ENG COMPUT, V37, P428, DOI 10.1007/BF02513325
   Nebuya S, 2005, PHYSIOL MEAS, V26, pS111, DOI 10.1088/0967-3334/26/2/011
   Osterman KS, 2004, PHYS MED BIOL, V49, P665, DOI 10.1088/0031-9155/49/5/002
   Palko T., 1995, 1995 14 C BIOM ENG S, p1/45
   Passauer J., 2009, NEPHROL DIAL TR 1016
   Paulson KS, 2004, IEEE T BIO-MED ENG, V51, P1838, DOI 10.1109/TBME.2004.831518
   Seoane F, 2005, PHYSIOL MEAS, V26, P849, DOI 10.1088/0967-3334/26/5/021
   Songer J., 2001, THESIS WORCESTER POL
   Tonkovic S., 2000, P 22 ANN INT C IEEE, V1, P757
   Whitman A, 1996, J ANIM SCI, V74, P80
NR 15
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1626
EP 1633
DI 10.1016/j.egypro.2011.10.440
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401097
DA 2018-12-27
ER

PT S
AU Yang, DH
   Li, Q
AF Yang Daheng
   Li Qi
BE Zhou, X
TI RETRACTED: The Variance of Measurement of Sound Absorption of Material
   in the Underwater Reverberation Chamber (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE sound absorption coefficient; reverberation chamber; reverberation time;
   ensemble variance
AB Random-incidence sound absorption coefficient of underwater acoustics materials can be measured by the method of reverberation chamber. Method of reverberation chamber used in underwater acoustics area is analog to national standard (GBJ 47 similar to 83) about "Measurement of sound absorption in a reverberation room" in air acoustics area. The ensemble variance has a great impact to the accuracy of sound absorption coefficient of underwater acoustics material. The accuracy of sound absorption coefficient can be guaranteed by reducing the ensemble variance in the measurement of reverberation time. Ensemble variance is influenced by the uniformity of the sound field, the excitation mode of source and the variation of volume. temperature and air bubble of water. The maximum value of ensemble variance approaches 10%. The value of ensemble variance can reduce to 3% by some effective methods. Results of this research are helpful to reduce the errors in the measurement of sound absorption coefficient of under water acoustic material. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yang Daheng; Li Qi] Harbin Engn Univ, Coll Underwater Acoust Engn, Harbin 150001, Peoples R China.
RP Yang, DH (reprint author), Harbin Engn Univ, Coll Underwater Acoust Engn, Harbin 150001, Peoples R China.
EM taozi121@126.com
CR [Anonymous], 2003, GBT202472006ISO35420
   Bartel Thomas W., 1978, JASA, V63-6, P1841
   Li Qi, 1990, THESIS HARBIN ENG U
   Li Shui, 2007, Acta Acustica, V32, P349
   [刘永伟 LIU Yong-wei], 2010, [兵工学报, Acta Armamentarii], V31, P309
   Song Yang, 2009, NOISE VIBRATION CONT, V2, P11
   Wen Hongtao, 2010, Acta Acustica, V35, P45
   Wu Qixue, 2006, AUDIO ENG, V10, P19
NR 8
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1634
EP 1639
DI 10.1016/j.egypro.2011.10.441
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401098
DA 2018-12-27
ER

PT S
AU Yang, B
   Wang, J
AF Yang, Bin
   Wang, Jian
BE Zhou, X
TI RETRACTED: A Hybrid Approach Based on Genetic Algorithms and Iterative
   Fourier Techniques for the Synthesis of Large Planar Thinned Arrays
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE genetic algorithm (GA); iterative Fourier technique (IFT); sidelobe
   control; thinned arrays
ID FFT TECHNIQUES
AB A hybrid approach for the synthesis of large planar thinned antenna arrays is presented. The proposed solution exploits and combines the most attractive features of a binary genetic algorithm (GA) and those of a newly developed iterative Fourier technique (IFT). Numerical experiments show improvements of the proposed solution with respect to previous results. It can significantly reduce computational complexity comparing with conventional GAs, also avoids the defect of IFTs that it is easy to be trapped into local minima. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Yang, Bin; Wang, Jian] Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China.
RP Wang, J (reprint author), Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China.
EM wangj01@mails.tsinghua.edu.cn
CR Balanis CA, 2005, ANTENNA THEORY ANAL
   Donelli M, 2009, IEEE T ANTENN PROPAG, V57, P2491, DOI 10.1109/TAP.2009.2024570
   Haupt RL, 2007, IEEE T ANTENN PROPAG, V55, P577, DOI 10.1109/TAP.2007.891510
   Jin NB, 2007, IEEE T ANTENN PROPAG, V55, P556, DOI 10.1109/TAP.2007.891552
   Keizer WPMN, 2008, IEEE T ANTENN PROPAG, V56, P2757, DOI 10.1109/TAP.2008.927580
   Keizer WPMN, 2009, IEEE T ANTENN PROPAG, V57, P3359, DOI 10.1109/TAP.2009.2029382
   Mailloux R. J., 2005, PHASED ARRAY ANTENNA
   Murino V, 1996, IEEE T SIGNAL PROCES, V44, P119, DOI 10.1109/78.482017
   Quevedo-Teruel O., 2006, SYNTHESIS-STUTTGART, V5, P349
   Steinberg B., 1976, PRINCIPLES APERTURE
NR 10
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1640
EP 1647
DI 10.1016/j.egypro.2011.10.442
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401099
DA 2018-12-27
ER

PT S
AU Zhang, W
   Li, L
   Gu, YQ
   Shen, H
   Tian, HX
   Li, P
AF Zhang, Wei
   Li, Li
   Gu, Yongqing
   Shen, Hong
   Tian, Hongxia
   Li, Ping
BE Zhou, X
TI RETRACTED: On the Improvement of Detecting Gas Meter for Intelligent
   Accounting (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE gas meter; contactless; advanced charging; MCU
AB The widely used mechanical gas meter are plagued by great defects which have brought much great inconvenience to administrative departments and the users. Therefore, based on the intrinsic gas meter, a testing system for intelligent billing, which centered on 89S52 MCU, has been designed. It supposes such advanced functions as automatic metrology, billing, balance displaying, alarm and security detection, and it is suitable for widely spread and used for its high stability and practicality. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhang, Wei; Li, Li; Gu, Yongqing; Shen, Hong; Tian, Hongxia] Henan Inst Sci & Technol, Xinxiang 453003, Peoples R China.
RP Zhang, W (reprint author), Henan Inst Sci & Technol, Xinxiang 453003, Peoples R China.
EM zhangwei_131@163.com
CR Fang Honglin, 2010, METROLOGY MEASUREMEN, V37, P45
   Jiang Yang, 2010, SHANGHAI MEASUREMENT, V215, P15
   LIU Zhen, 2006, SHANDONG METALLURGY, V28, P27
   LIU Zhi-hai, 2010, TECHNIQUES AUTOMATIO, V29, P47
   TONG Hai-jun, 2006, IND MEASUREMENT, V16, P20
   ZHANG Qing-chun, 2010, INSTRUMENTATION TECH, V5, P34
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1648
EP 1653
DI 10.1016/j.egypro.2011.10.443
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401100
DA 2018-12-27
ER

PT S
AU Peng, CM
   Qi, ZD
   Zhang, X
AF Peng Chunming
   Qi Zhidong
   Zhang Xu
BE Zhou, X
TI RETRACTED: A Research On the Parameters Of Fractional-order (PID
   mu)-D-lambda Controller (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Fractional-order control system; (PID mu)-D-lambda controller;
   Parameters; Simulation
AB The research of fractional-order control system was more and more extensive in the field of control theory, while the simulation is an important means of the control study. In this paper, fractional-order systems and fractional-order (PID mu)-D-lambda controller were introduced. Then certain simulations were used to analyze the influence of variations of (PID mu)-D-lambda controllers' parameters and the order of integrator and differentiator to the performances of fractional-order control systems. At last, some useful conclusions were given about the merit of the fractional-order (PID mu)-D-lambda controllers. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Peng Chunming; Qi Zhidong; Zhang Xu] Nan Jing Univ Sci & Technol, Automat Dept, Nanjing 210094, Jiangsu, Peoples R China.
RP Qi, ZD (reprint author), Nan Jing Univ Sci & Technol, Automat Dept, Nanjing 210094, Jiangsu, Peoples R China.
EM qi_zhidong@126.com
CR CAO Liu-lin, 2006, CONTROL ENG CHINA, V13
   Podlubny I, 1999, IEEE T AUTOMAT CONTR, V44, P208, DOI 10.1109/9.739144
   Podlubny I., 1999, FRACTIONAL DIFFERENT
   XUE D, 2002, P 4 WORLD C INT CONT, V4, P3228
   Xue DY, 2007, MATLAB SOLUTIONS MAT
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1654
EP 1661
DI 10.1016/j.egypro.2011.10.444
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401101
DA 2018-12-27
ER

PT S
AU Hua, Z
   Piao, S
AF Hua, Zhao
   Piao, Sheng
BE Zhou, X
TI RETRACTED: Application of 3D Solid Modeling in Measurement and Error
   Evaluation of Spiral Bevel Gear (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE 3-d solid modeling; spiral bevel gear; error; measurement; evaluation
AB It is very important to get real factor and ideal factor for the spiral bevel gear's error measurement and evaluation. According to its complexity tooth surface shape, the real factor was gotten by CMM which could measure the coordinates of the intersection points in the real gear tooth surface. For the ideal factor, this paper proposed that it was gotten by building the 3d solid modeling in UG based on the gear's basic parameters and cutter head parameters. The application of 3d solid modeling in spiral bevel gear's error measurement and evaluation was explained by measuring and evaluating the automobile rear axle's driven gear. The result shows that this way is very effective and feasible. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Hua, Zhao; Piao, Sheng] Nan Yang Inst Technol, Nan Yang 473004, Henan, Peoples R China.
RP Piao, S (reprint author), Nan Yang Inst Technol, Nan Yang 473004, Henan, Peoples R China.
EM nylm1996@126.com
CR [方宗德 FANG Zongde], 2007, [航空学报, Acta Aeronautica et Astronautica Sinica], V28, P456
   GONG Qing, 2006, J TOOL ENG, V40, P120
   LIU Zhen-yu, 2004, THESIS SE U, P3
   LU Han-cong, 2007, THESIS XIAN U TECHNO, P3
   [王军 Wang Jun], 2003, [机械传动, Journal of Mechanical Transmission], V27, P23
   [Wang Jun 王军], 2003, Chinese Journal of Aeronautics, V16, P182
   XU Zhong-zi, THESIS BEIJING U TEC
NR 7
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1662
EP 1669
DI 10.1016/j.egypro.2011.10.445
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401102
DA 2018-12-27
ER

PT S
AU Pu, YY
   Li, WW
   Liu, X
   Min, ZH
   Xie, S
AF Pu, Yuanyuan
   Li, Weiwei
   Liu, Xin
   Min, Zhihong
   Xie, Shi
BE Zhou, X
TI RETRACTED: Local Color Transfer Algorithm Based on CTWC and the
   Application in Styled Rendering of Yunnan Heavy Color Painting
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Local color transfer; CTWC; Yunnan Heavy Color Painting;
   non-photorealistic rendering
AB In this paper, a local color transfer algorithm based on CTWC (Color Transfer Weight Coefficients) is proposed. Firstly, interactively select one or more corresponding areas in the original image and the target image, those colors need to transfer. Secondly, use the low pass Butterworth filter function to calculate the CTWC of each selected areas in the original image. The CTWC represents the influence degree of color transformation of the pixels in the selected areas of the original image, and the value of CTWC is inversely proportional to the color statistical distance of the selected corresponding areas between the original and target image. Finally, the Reinhard Algorithm is improved by the calculation method of CTWC and gets the local color transfer algorithm based on CTWC. For multi-regional local color transfer, an iterative image merge method is proposed to fuse the multi-regional local color transformation's result images. In the end, the color transfer is used for Yunnan heavy color painting digital simulation and stylized rendering and the results of experiment shows it can obviously improve the rendering effect. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Pu, Yuanyuan; Li, Weiwei; Liu, Xin; Min, Zhihong; Xie, Shi] Yunnan Univ, Sch Informat Sci & Engn, Kunming 650091, Yunnan, Peoples R China.
RP Pu, YY (reprint author), Yunnan Univ, Sch Informat Sci & Engn, Kunming 650091, Yunnan, Peoples R China.
EM km_pyy@126.com
CR Hertzmann A., 1998, Computer Graphics. Proceedings. SIGGRAPH 98 Conference Proceedings, P453
   [李龙生 LI Longsheng], 2007, [中国图象图形学报, Journal of Image and Graphics], V12, P1423
   Li Y, 2007, COMPUT ANIMAT VIRT W, V18, P395, DOI 10.1002/cav.188
   Luft T., NPAR2006, P11
   Maslennikova A., 2007, P GRAPHICON 2007, P75
   Reinhard E, 2001, IEEE COMPUT GRAPH, V21, P34, DOI 10.1109/38.946629
   Salisbury M. P., 1997, Computer Graphics Proceedings, SIGGRAPH 97, P401
   Sun Mei-jun, 2004, Journal of System Simulation, V16, P2317
   Xiaoyan Qian, 2006, COMPUT AIDED DESIGN, V18, P1332
   Xu SH, 2005, IEEE INTELL SYST, V20, P32, DOI 10.1109/MIS.2005.41
   Yang CK, 2008, VISUAL COMPUT, V24, P303, DOI 10.1007/s00371-007-0183-y
   Yanwen Guo, 2006, J ZHENGJIAN U SCI A, P1152
   Zhang Xianquan, 2005, Journal of Computer Aided Design & Computer Graphics, V17, P1378
NR 13
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1670
EP 1678
DI 10.1016/j.egypro.2011.10.446
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401103
DA 2018-12-27
ER

PT S
AU Zhu, YS
   Qiao, GF
   Zhang, J
   Sun, HT
   Meng, TH
AF Zhu, Yunshuai
   Qiao, Guifang
   Zhang, Jun
   Sun, Hongtao
   Meng, Tianhua
BE Zhou, X
TI RETRACTED: Design of a foldable jumping robot for rough terrain
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE foldable jumping robot; jumping & rolling mechanism; take-off angle;
   dynamic simulation
ID ARCHITECTURE; NETWORKS
AB In obstacle-dense environments and uneven terrain, jumping can be a very efficient mode of locomotion for small robots. In this paper, a novel foldable jumping mechanism is proposed and the design of a miniature robot with a hybrid motion pattern of jumping and rolling is presented. The proposed robot is adjustable in take-off angle and jumping height according to the environment. The jump performance is verified by dynamic simulation. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhu, Yunshuai; Qiao, Guifang; Zhang, Jun; Sun, Hongtao; Meng, Tianhua] Southeast Univ, 2 Sipailou, Nanjing 210096, Jiangsu, Peoples R China.
RP Zhu, YS (reprint author), Southeast Univ, 2 Sipailou, Nanjing 210096, Jiangsu, Peoples R China.
EM zhuys_seu@qq.com
CR Armour R, 2007, BIOINSPIR BIOMIM, V2, pS65, DOI 10.1088/1748-3182/2/3/S01
   Buksh SR, 2009, IEEE INT CONF CON AU, P1862, DOI 10.1109/ICCA.2009.5410146
   Kovac M, 2008, IEEE INT CONF ROBOT, P373, DOI 10.1109/ROBOT.2008.4543236
   Kovac Mirko, 2009, IEEE RSJ INT C INT R, P583, DOI DOI 10.1109/IROS.2009.5354005
   Li Fei, 2009, IEEE INT C ROB BIOM, P933
   Scarfogliero U, 2007, IEEE INT CONF ROBOT, P467, DOI 10.1109/ROBOT.2007.363830
   Song GM, 2008, IEEE T CONSUM ELECTR, V54, P1110, DOI 10.1109/TCE.2008.4637595
   Song GM, 2008, SENSOR ACTUAT A-PHYS, V147, P216, DOI 10.1016/j.sna.2008.05.005
   Wang M, 2008, J BIONIC ENG, V5, P181, DOI 10.1016/S1672-6529(08)60023-2
NR 9
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1679
EP 1683
DI 10.1016/j.egypro.2011.10.447
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401104
DA 2018-12-27
ER

PT S
AU Su, XH
   Xu, SP
AF Su Xiao-hui
   Xu Shu-Ping
BE Zhou, X
TI RETRACTED: The research of security and real-time based on the control
   information network (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Remote control; Virtual server; Network time-delay; Model predictive
   control
ID CONTROL-SYSTEMS; STABILITY
AB Aiming at the security issues, the construction of the remote motor control server based on the Web is studied, the scheme of two server programs based on the virtual server technology is proposed. The safety and application occasion of the scheme are described respectively, and the encryption algorithm which Improve certification accuracy is proposed. Aiming at the real-time problem, a new control method is proposed, which is based on neural network predictive control to solve the existing closed-loop network control system random delay. The experiment verification and system simulated are completed. These methods provide a new way to integrate the control network and information network, and to lay a solid foundation for the development of the control network. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Su Xiao-hui; Xu Shu-Ping] Xian Technol Univ, Sch Comp Sci & Engn, Xian 710032, Peoples R China.
RP Xu, SP (reprint author), Xian Technol Univ, Sch Comp Sci & Engn, Xian 710032, Peoples R China.
EM xusp686@163.com
CR Chang Lee Kyung, 2001, REMOTE CONTROLLER DE, P1845
   Goldberg Ken, 2006, IEEE ROBOTICS AUTOMA, V3, P35
   [刘其成 Liu Qicheng], 2004, [计算机工程, Computer Engineering], V30, P41
   Walsh GC, 2002, IEEE T CONTR SYST T, V10, P438, DOI 10.1109/87.998034
   Xiao-hong Wu, 2004, ZHEJIANG U TECHNOLOG, V132, P700
   Zhang W, 2001, IEEE CONTR SYST MAG, V21, P84, DOI 10.1109/37.898794
NR 6
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1684
EP 1690
DI 10.1016/j.egypro.2011.10.448
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401105
DA 2018-12-27
ER

PT S
AU He, J
   He, XR
   Liu, SX
   Yang, SR
AF He Juan
   He Xiaorong
   Liu Shuxi
   Yang Shaorong
BE Zhou, X
TI RETRACTED: Robust Networks for Initial Alignment of Strap-down Inertial
   Navigation Systems (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE SINS; initial alignment; Kalman filter; neural networks; H infinity
   filter
AB This paper presents a method for the initial alignment of strap-down inertial navigation system on stationary base. In the coarse alignment, Magnetism compass and accelerometer are used to get the initial pose angles. In the precise alignment, radial basis function network (RBF network), in which radial function chosen by averaging method and weights adjusted by an improved H infinity robust filter, is applied to correct the pose angles to ensure the robustness and real-time computing. Simulation results show that comparing with ordinary H infinity filter learning algorithm and extended Kalman filter, this method is efficient and rapid for initial alignment. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [He Juan; He Xiaorong; Liu Shuxi] Chongqing Univ Technol, Sch Elect Informat & Automat, Chongqing 400054, Peoples R China.
RP He, J (reprint author), Chongqing Univ Technol, Sch Elect Informat & Automat, Chongqing 400054, Peoples R China.
EM applehej@163.com
CR Nishiyama K, 2001, IEEE T NEURAL NETWOR, V12, P1265, DOI 10.1109/72.963763
   SG Mohinder, 1991, IEEE T AUTOMAT CONTR, V36, P4
   Singhal S., 1989, ICASSP-89: 1989 International Conference on Acoustics, Speech and Signal Processing (IEEE Cat. No.89CH2673-2), P1187, DOI 10.1109/ICASSP.1989.266646
   XingZhi, 2000, NEUROFUZZY FLEXIBLE, P167
   Yang Li, 1996, Journal of Nanjing University of Aeronautics & Astronautics, V28, P487
   王丹力, 1999, [航天控制, Aerospace Control], P44
NR 6
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1691
EP 1700
DI 10.1016/j.egypro.2011.10.449
PG 10
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401106
DA 2018-12-27
ER

PT S
AU Wang, XM
   Zhao, XM
   Zhang, LC
   Zhang, YL
AF Wang Xuanmin
   Zhao Xiangmo
   Zhang Lichuan
   Zhang Yinglong
BE Zhou, X
TI RETRACTED: Design of Bit Error Rate Tester Based on a High Speed Bit and
   Sequence Synchronization (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE BER tester; M sequence genetator; PLL; Inserting error-bit; bit
   synchronization; sequence synchronization
AB In traditional BER (Bit Error Rate) tester, bit synchronization applied digital PLL and sequence synchronization utilized sequence's correlation. It resulted in a low speed on bit and sequence synchronization. This paper came up new method to realize bit and sequence synchronization. which were Bit-edge-tracking method and Immitting-sequence method. The BER tester based on FPGA was designed. The functions of inserting error-bit and removing the false sequence synchronization were added. The results of Debugging and simulating display that the time to realize bit synchronization is less than a bit width, the lagged time of the tracking bit pulse is 1/8 of the code cycle, and there is only a M sequence's cycle to realize sequence synchronization. This new BER tester has many advantages, such as a short time to realize bit and sequence synchronization, no false sequence synchronization, testing the ability of the receiving port's error -correcting and a simple hardware. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wang Xuanmin; Zhao Xiangmo; Zhang Lichuan; Zhang Yinglong] Changan Univ, Sch Informat Engn, Xian 71064, Peoples R China.
RP Wang, XM (reprint author), Changan Univ, Sch Informat Engn, Xian 71064, Peoples R China.
EM xmwang@chd.edu.cn
CR Jiming Hu, 2006, ELECT MEASUREMENT TE, V29, P112
   Liyong Zhang, 2008, HARBIN U SCI J   JUL, P94
   Song Pan, 2010, EDA TECHNOLOGY UTILI, P326
   Tong Pan, 2009, INSTRUMENT TECHN MAR, P27
   Weiqi Wu, 2008, OPTICAL COMMUNIC FEB, P52
   Xingliang Wang, 2009, DIGITAL COMMUNICATIO, P246
   Yinfang Chen, 2010, OPTICAL COMMUNICATIO, P45
   Yunyu Zhang, 2005, AUTOMATIC INSTRU JUL, P23
   Zengyou Sun, 2006, NE ELECT POWER U JAN, P71
NR 9
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1701
EP 1706
DI 10.1016/j.egypro.2011.10.450
PG 6
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401107
DA 2018-12-27
ER

PT S
AU Wei, XP
   Yao, SL
   Zhang, Q
AF Wei, Xiaopeng
   Yao, Shulei
   Zhang, Qiang
BE Zhou, X
TI RETRACTED: An Efficient Sequence Retrieval Method Based on Motion
   Capture Data (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Human motion retrieval; ICA; ISODATA
AB In this paper, a novel approach is presented for the motion retrieval based on the similarity of the motion data. For each sequence in the database, the Independent Component Analysis (ICA) algorithm is used to extract features, the reference vector's distribution is estimated instead of the original data. The reference vector is clustered using Iterative Self-organizing Data Analysis Techniques Algorithm (ISODATA). Finally the similarity between the query example and motion sequence in the database is measured using the Mahalanobis distance. Experimental results on the CMU datab(a)ase demonstrate that the proposed approach achieves good performance. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Wei, Xiaopeng; Yao, Shulei; Zhang, Qiang] Dalian Univ Technol, Minist Educ, Key Lab Adv Design & Intelligent Comp, Dalian, Peoples R China.
RP Zhang, Q (reprint author), Dalian Univ Technol, Minist Educ, Key Lab Adv Design & Intelligent Comp, Dalian, Peoples R China.
EM zhangq@dlu.edu.cn
CR Amari SI, 2002, NEUROCOMPUTING, V49, P1, DOI 10.1016/S0925-2312(02)00509-X
   CMU, 2003, CAM MELL MOCAP DAT
   Forbes K., 2005, P 2005 ACM SIGGRAPH, P67, DOI DOI 10.1145/1073368.1073377
   Jain A. K., 2000, IEEE T PATTERN ANAL
   KEOPH E, 2004, P 30 VLDB C, P780
   Kovar L, 2004, ACM T GRAPHIC, V23, P559, DOI 10.1145/1015706.1015760
   Liu F, 2003, COMPUT VIS IMAGE UND, V92, P265, DOI 10.1016/j.cviu.2003.06.001
   Muller M, 2005, ACM T GRAPHIC, V24, P677, DOI 10.1145/1073204.1073247
   Quaternion M., 2005, ACM T GRAPHIC, V24, P670
   Smith L. I, 2002, TUTORIAL PRINCIPAL C
   VENKATESWARAN J, 2006, P 32 VLDB C, P139
   Webb A. R, 2002, STAT PATTERN RECOGNI
   Xiang J., 2007, HHMSP, V1, P604
   Yang XiaoMing, 2006, IMPLEMENTATION ANAL, V2, P66
NR 14
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1707
EP 1714
DI 10.1016/j.egypro.2011.10.451
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401108
DA 2018-12-27
ER

PT S
AU Zhao, M
   Li, HF
AF Zhao Min
   Li Hongfei
BE Zhou, X
TI RETRACTED: The Computer Aided Design of Stone Slab Paving (Retracted
   Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Stone slab paving; Stone slab numbering; Object ARX; CAD Secondary
   development
AB The aims of this paper is to study a computer aided design method of stone slab paving which is based on the AutoCAD's secondary development tools of ObjectARX in the development environment of VC++2005. NET. The ObjectARX development technology and the realization principle of the stone slab paving system are introduced in the paper. Paving dialog is designed with VC++ to realize stone parametric paving, and the engineering slabs can be numbered automatically with the use of extended data. Moreover the design and connection of various menus are completed in the paper. The function of stone slab paving system is shown by giving an example, and the paving result is analyzed and summed up in the end. The paving of complex zones can be finished automatically by computer software instead of manual work. It has improved the design process of stone decoration. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Zhao Min; Li Hongfei] Shenyang Jianzhu Univ, Sch Traff & Mech Engn, Shenyang 110168, Peoples R China.
RP Li, HF (reprint author), Shenyang Jianzhu Univ, Sch Traff & Mech Engn, Shenyang 110168, Peoples R China.
EM lhf26732341@126.com
CR [Anonymous], OBJECTARX DEV UNPUB
   McAuley Charles, 2000, PROFRAMMING AUTOCAD
   Min Zhao, 2005, BUILDING DECORATED S
   Tao Wen, 2003, J ZHEJIANG I SCI TEC, V20, P37
   Yude Dong, 2009, CAD SECONDARY DEV TH
   Zhangfan, TUTORIAL OBJEC UNPUB
NR 6
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1715
EP 1719
DI 10.1016/j.egypro.2011.10.452
PG 5
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401109
DA 2018-12-27
ER

PT S
AU Feng, XZ
   He, XH
   Feng, BL
AF Feng Xiuzhen
   He Xiaohong
   Feng Bianling
BE Zhou, X
TI RETRACTED: A Study on Application of Multidimensional Association Rule
   Mining in Adverse Drug Reactions (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE data cube; multidimensional association rule; Adverse Drug Reactions
   (ADRs)
AB With the serious problem of adverse drug reactions (ADRs), we conduct multi-dimensional association rule mining method based on data cube with online analytical processing technology (OLAP) by establishing multi-dimensional database of ADRs. The slicing technique of OLAP operation is introduced into the mining process to mine multidimensional association relationship of ADRs and finally explore the useful and deep knowledge hidden in ADRs. The example presents some good prospects in the field of adverse drug reactions, which also paves a solid foundation for further evaluation and early warning on adverse drug reactions. This is significantly meaningful to provide supports for prescription on the illnesses treatments. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Feng Xiuzhen; He Xiaohong] Beijing Univ Technol, Beijing 100124, Peoples R China.
RP He, XH (reprint author), Beijing Univ Technol, Beijing 100124, Peoples R China.
EM hexhong86@163.com
CR Bate A, 2002, DRUG SAFETY, V25, P393, DOI 10.2165/00002018-200225060-00002
   BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29
   Changan Yuan, 2009, PRINCIPLES DATA MINI, P650
   Chen Wen-ge, 2009, Application Research of Computers, V26, P1394
   Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677
   [高学东 Gao Xuedong], 2003, [计算机工程, Computer Engineering], V29, P74
   [高鹰 Gao Ying], 2004, [计算机科学, Computer Science], V31, P13
   Guoqiang Shen, 2006, J CHINESE COMPUTER S, V27, P291
   Qian Zeng-jin, 2007, Application Research of Computers, V24, P61
   Ruijuan Hu, 2009, J CHANGCHUN U SCI TE, V32, P282
   [伊卫国 Yin Weiguo], 2006, [东北师大学报. 自然科学版, Journal of Northeast Normal University. Natural Science], V38, P15
   武煜, 2010, [江苏医药, Jiangsu Medical Journal], V36, P579
NR 12
TC 0
Z9 0
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1720
EP 1726
DI 10.1016/j.egypro.2011.10.453
PG 7
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401110
DA 2018-12-27
ER

PT S
AU Siddiqui, SM
   Fang, JC
AF Siddiqui, Saman Mukhtar
   Fang Jiancheng
BE Zhou, X
TI RETRACTED: Navigation solution with Wavelet and Allan variance
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE Allan Variance; Wavelet Denoising; MEMS; Navigation
AB Recent advent of micromachining revolutionized the conventional inertial navigation applications. From robotics, biomedical equipment and mining to high precision aerospace applications, low cost, easily manufactured Micro Electro Mechanical Systems (MEMS) inertial sensors had made their way with partial success. Although their synergism with GPS proved beneficial in most cases, GPS overall un reliability and frequent outages forced research scholars to design intelligent stochastic error modeling techniques to account for time dependent, huge, non Gaussian, uncorrelated and environment dependent errors. The noise behavior of MEMS can be divided broadly in high frequency and low frequency types. This paper explores Allan variance technique in characterizing low frequency stochastic errors in addition with Wavelet Denoising technique to filter high frequency noise or white noise. After using these techniques with Extended Kalman Filter, integration of GPS with IMU gave significant improvement in presence of GPS outages. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 [Siddiqui, Saman Mukhtar; Fang Jiancheng] Beihang Univ, 37 Xueyuan, Beijing 100191, Peoples R China.
RP Siddiqui, SM (reprint author), Beihang Univ, 37 Xueyuan, Beijing 100191, Peoples R China.
EM siddiqui_saman@hotmail.com
CR Ding W., 2007, P IGNSS S SYDN AUSTR
   El-Diasty M, 2007, MEAS SCI TECHNOL, V18, P3321, DOI 10.1088/0957-0233/18/11/009
   El-Sheimy N, 2004, IEEE AERO EL SYS MAG, V19, P32, DOI 10.1109/MAES.2004.1365016
   Ford J. J., 1999, DSTORR0141 WEAP SYST
   Hou H., 2004, THESIS CALGARY U CAN
   Nassar S., 2004, THESIS CALGARY U CAN
   Solimeno A., 2007, THESIS LISBON U PRAG
   Titterton D. H., 2004, STRAPDOWN INERTIAL N, P253
NR 8
TC 1
Z9 1
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1727
EP 1735
DI 10.1016/j.egypro.2011.10.454
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401111
DA 2018-12-27
ER

PT S
AU Ye, C
AF Ye, Chen
BE Zhou, X
TI RETRACTED: Design and implementation of automatic control system of
   oxygen-enriched air & top-blown copper smelting furnace based on DCS
   (Retracted Article)
SO 2011 INTERNATIONAL CONFERENCE ON ENERGY AND ENVIRONMENTAL SCIENCE-ICEES
   2011
SE Energy Procedia
LA English
DT Proceedings Paper; Retracted Publication
CT International Conference on Energy and Environmental Science (ICEES)
CY OCT, 2011
CL Singapore, SINGAPORE
SP Singapore Inst Elect (SIE)
DE copper smelting; batch control strategies; secondary batch algorithm;
   air-oxygen-oil control strategies; process control; DCS
AB Top-blown furnace is known to be effectively adopted in copper smelting. This paper elaborates automatic control strategies of oxygen-enriched air & top-blown smelting system based on the real project named KUNPENG COPPER SMELTER in China. We design and implement a control system by using several novel schemes, such as batch algorithm, secondary batch algorithm, feed rate algorithm, and propose a method of automatic process control of air, oxygen and oil in smelting mode, including requirement calculation, ratio control, selective control and multi-mode output control. Meanwhile, the configuration of the smelting control system based on Emerson DeltaV is introduced. The result reported is remarkable that the reaction is complete and the high temperature is stable and maintainable. (C) 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of the Organizers of 2011 International Conference on Energy and Environmental Science.
C1 China Nonferrous Engn & Res Inst, Dept Automat, Beijing, Peoples R China.
RP Ye, C (reprint author), China Nonferrous Engn & Res Inst, Dept Automat, Beijing, Peoples R China.
EM yec.automation@gmail.com
CR Cheng Li-ping, 2001, J KUNMING U SCI TECH, V26, P16
   Fu Jiang, 2007, IND HEATING, V36, P35
   Jiang Ji-mu, 2001, NONFERROUS SMELTING, V30, P1
   Kong Fan-yi, 2003, NONFERROUS SMELTING, V32, P1
   Li Yun, 2000, J KUNMING U SCI TECH, V25, P80
   Liu Wen-can, 2003, NONFERROUS SMELTING, V32, P66
   Shi Xuan-qian, 2001, NONFERROUS SMELTING, V30, P1
   Shi Yi-feng, 2006, CHINA NONFERROUS MET, V2, P12
   Shi You-gao, 2004, CHINA NONFERROUS MET, V33, P11
NR 9
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 11
BP 1736
EP 1743
DI 10.1016/j.egypro.2011.10.455
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYK25
UT WOS:000299096401112
DA 2018-12-27
ER

EF